PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhao, JB; Tian, Z; Kadomatsu, T; Xie, PY; Miyata, K; Sugizaki, T; Endo, M; Zhu, SS; Fan, HQ; Horiguchi, H; Morinaga, J; Terada, K; Yoshizawa, T; Yamagata, K; Oike, Y				Zhao, Jiabin; Tian, Zhe; Kadomatsu, Tsuyoshi; Xie, Peiyu; Miyata, Keishi; Sugizaki, Taichi; Endo, Motoyoshi; Zhu, Shunshun; Fan, Haoqiu; Horiguchi, Haruki; Morinaga, Jun; Terada, Kazutoyo; Yoshizawa, Tatsuya; Yamagata, Kazuya; Oike, Yuichi			Age-dependent increase in angiopoietin-like protein 2 accelerates skeletal muscle loss in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; catalase; exercise; inflammation; muscle atrophy; reactive oxygen species (ROS); senescence; ANGPTL2; sarcopenia; satellite cell	OXIDATIVE STRESS; SATELLITE CELLS; ANTIOXIDANT ENZYMES; ENDOTHELIAL-CELLS; STEM-CELLS; INFLAMMATION; SARCOPENIA; EXERCISE; ANGPTL2; ALPHA	Skeletal muscle atrophy, or sarcopenia, is commonly observed in older individuals and in those with chronic disease and is associated with decreased quality of life. There is recent medical and broad concern that sarcopenia is rapidly increasing worldwide as populations age. At present, strength training is the only effective intervention for preventing sarcopenia development, but it is not known how this exercise regimen counteracts this condition. Here, we report that expression of the inflammatory mediator angiopoietin-like protein 2 (ANGPTL2) increases in skeletal muscle of aging mice. Moreover, in addition to exhibiting increased inflammation and accumulation of reactive oxygen species (ROS), denervated atrophic skeletal muscles in a mouse model of denervation-induced muscle atrophy had increased ANGPTL2 expression. Interestingly, mice with a skeletal myocyte-specific Angptl2 knockout had attenuated inflammation and ROS accumulation in denervated skeletal muscle, accompanied by increased satellite cell activity and inhibition of muscular atrophy compared with mice harboring wildtype Angptl2. Moreover, consistent with these phenotypes, wildtype mice undergoing exercise training displayed decreased ANGPTL2 expression in skeletal muscle. In conclusion, ANGPTL2 up-regulation in skeletal myocytes accelerates muscle atrophy, and exercise-induced attenuation of ANGPTL2 expression in those tissues may partially explain how exercise training prevents sarcopenia.	[Zhao, Jiabin; Tian, Zhe; Kadomatsu, Tsuyoshi; Xie, Peiyu; Miyata, Keishi; Sugizaki, Taichi; Endo, Motoyoshi; Zhu, Shunshun; Fan, Haoqiu; Horiguchi, Haruki; Morinaga, Jun; Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Miyata, Keishi] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol Allergy & Vasc Biol, Kumamoto 8608556, Japan; [Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Grad Sch Med Sci, Dept Med Biochem, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Tian, Z; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	zhetian0118@gmail.com; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022; Endo, Motoyoshi/T-5840-2019	Miyata, Keishi/0000-0003-0336-1859; Yoshizawa, Tatsuya/0000-0002-5728-1996	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [17H05652]; Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST) [13417915]; CREST Programme of the Japan Agency for Medical Research and Development (AMED) [17gm0610007h0005]; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED; Grants-in-Aid for Scientific Research [16H05328] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST); CREST Programme of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan Grant 17H05652 (to Y. O.), Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST) Grant 13417915 (to Y. O.), the CREST Programme of the Japan Agency for Medical Research and Development (AMED) Grant 17gm0610007h0005 (to Y. O.), and by the Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED. The authors declare that they have no conflicts of interest with the contents of this article.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Hawke TJ, 2005, EXERC SPORT SCI REV, V33, P63, DOI 10.1097/00003677-200504000-00002; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Jackson MJ, 2016, MOL ASPECTS MED, V50, P33, DOI 10.1016/j.mam.2016.05.002; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Jansen S, 2009, REPRODUCTION, V138, P493, DOI 10.1530/REP-09-0038; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jo E, 2012, AGING CLIN EXP RES, V24, P412, DOI 10.3275/8464; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Nakamura YK, 2009, NUTRITION, V25, P800, DOI 10.1016/j.nut.2009.01.003; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Poli G, 2000, IUBMB LIFE, V50, P315, DOI 10.1080/15216540051081092; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; Seene T, 2012, ARCH GERONTOL GERIAT, V54, P374, DOI 10.1016/j.archger.2011.05.002; Shimamoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112900; Snijders T, 2017, CURR OPIN CLIN NUTR, V20, P186, DOI 10.1097/MCO.0000000000000360; Sullivan-Gunn MJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-104; Sung JY, 2000, IMMUNOPHARMACOLOGY, V47, P35, DOI 10.1016/S0162-3109(99)00185-X; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tian Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13016; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Wang P, 2002, WORLD J GASTROENTERO, V8, P531, DOI 10.3748/wjg.v8.i3.531; Woods JA, 2012, AGING DIS, V3, P130; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058	44	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1596	1609		10.1074/jbc.M117.814996	http://dx.doi.org/10.1074/jbc.M117.814996			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29191837	hybrid, Green Published			2022-12-26	WOS:000424201700013
J	Monti, JLE; Montes, MR; Rossi, RC				Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.			Steady-state analysis of enzymes with non-Michaelis-Menten kinetics: The transport mechanism of Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme kinetics; enzyme mechanism; membrane transport; Na; K plus -ATPase; ATPase activity; Rb plus occlusion; kinetic mechanisms; non-Michaelis-Menten kinetics; steady-state kinetics	SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; NA+,K+-ATPASE REACTIONS; HYDROLYSIS KINETICS; CATALYZED REACTIONS; K+-ATPASE; RED-CELLS; BINDING; NA; EXCHANGE	Procedures to define kinetic mechanisms from catalytic activity measurements that obey the Michaelis-Menten equation are well established. In contrast, analytical tools for enzymes displaying non-Michaelis-Menten kinetics are underdeveloped, and transient-state measurements, when feasible, are therefore preferred in kinetic studies. Of note, transient-state determinations evaluate only partial reactions, and these might not participate in the reaction cycle. Here, we provide a general procedure to characterize kinetic mechanisms from steady-state determinations. We described non-Michaelis-Menten kinetics with equations containing parameters equivalent to k(cat) and K-m and modeled the underlying mechanism by an approach similar to that used under Michaelis-Menten kinetics. The procedure enabled us to evaluate whether Na+/K+-ATPase uses the same sites to alternatively transport Na+ and K+. This ping-pong mechanism is supported by transient-state studies but contradicted to date by steady-state analyses claiming that the release of one cationic species as product requires the binding of the other (ternary-complex mechanism). To derive robust conclusions about the Na+/K+-ATPase transport mechanism, we did not rely on ATPase activity measurements alone. During the catalytic cycle, the transported cations become transitorily occluded (i.e. trapped within the enzyme). We employed radioactive isotopes to quantify occluded cations under steady-state conditions. We replaced K+ with Rb+ because K-42(+) has a short half-life, and previous studies showed that K+- and Rb+-occluded reaction intermediates are similar. We derived conclusions regarding the rate of Rb+ deocclusion that were verified by direct measurements. Our results validated the ping-pong mechanism and proved that Rb+ deocclusion is accelerated when Na+ binds to an allosteric, nonspecific site, leading to a 2-fold increase in ATPase activity.	[Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1053 Buenos Aires, DF, Argentina; [Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.] Univ Buenos Aires, CONICET, Inst Quim & Fis Quim Biol IQUIFI, RA-1053 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Monti, JLE (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1053 Buenos Aires, DF, Argentina.; Monti, JLE (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Fis Quim Biol IQUIFI, RA-1053 Buenos Aires, DF, Argentina.	litomonti@gmail.com		Monti, Jose Luis Eugenio/0000-0002-9508-7414	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-2014 1053]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220150100250CO]; Universidad de Buenos Aires Ciencia y Tecnica, Argentina [2014-2017 20020130100302BA]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica, Argentina	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2012-2014 1053, Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 11220150100250CO, and Universidad de Buenos Aires Ciencia y Tecnica Grant 2014-2017 20020130100302BA, Argentina. The authors declare that they have no conflicts of interest with the contents of this article.	ANTIA IJ, 1992, BRIT J CLIN PHARMACO, V34, P535, DOI 10.1111/j.1365-2125.1992.tb05659.x; Banerjee U, 2012, PROG NEURO-PSYCHOPH, V37, P56, DOI 10.1016/j.pnpbp.2011.12.006; BLOSTEIN R, 1985, J BIOL CHEM, V260, P829; BLOSTEIN R, 1983, J BIOL CHEM, V258, P7948; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHA S, 1968, J BIOL CHEM, V243, P820; CHIPPERFIELD AR, 1976, J PHYSIOL-LONDON, V260, P371, DOI 10.1113/jphysiol.1976.sp011520; Clarke RJ, 2003, ANN NY ACAD SCI, V986, P159, DOI 10.1111/j.1749-6632.2003.tb07154.x; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; Cornish-Bowden A., 2014, PERSPECT SCI, V1, P74, DOI DOI 10.1016/J.PISC.2014.02.006; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; FORBUSH B, 1984, P NATL ACAD SCI-BIOL, V81, P5310, DOI 10.1073/pnas.81.17.5310; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Garcia A, 2013, BIOPHYS J, V105, P2695, DOI 10.1016/j.bpj.2013.11.004; Garrahan P. J., 1976, CURRENT TOPICS MEMBR, VVol. 8, P29; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P159, DOI 10.1113/jphysiol.1967.sp008294; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P175, DOI 10.1113/jphysiol.1967.sp008295; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Glynn IM, 2002, ANNU REV PHYSIOL, V64, P1, DOI 10.1146/annurev.physiol.64.081501.130716; GLYNN IM, 1976, J PHYSIOL-LONDON, V256, P465, DOI 10.1113/jphysiol.1976.sp011333; HARA Y, 1986, J BIOCHEM, V99, P531, DOI 10.1093/oxfordjournals.jbchem.a135509; HARA Y, 1986, J BIOL CHEM, V261, P2655; HILL CM, 1977, MOL CELL BIOCHEM, V15, P173, DOI 10.1007/BF01734107; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KARLISH SJD, 1974, ANN NY ACAD SCI, V242, P461, DOI 10.1111/j.1749-6632.1974.tb19110.x; Kaufman SB, 2006, J BIOL CHEM, V281, P15721, DOI 10.1074/jbc.M600953200; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; LEE KH, 1980, NATURE, V285, P338, DOI 10.1038/285338a0; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; Monti JLE, 2013, BBA-BIOMEMBRANES, V1828, P1374, DOI 10.1016/j.bbamem.2013.01.010; Nomenclature Committee of the International Union of Biochemistry (NC-IUB), 1983, ARCH BIOCHEM BIOPHYS, V224, P732, DOI [10.1016/0003-9861(83)90262-X, DOI 10.1016/0003-9861(83)90262-X6870287]; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; PLESNER IW, 1985, BIOCHIM BIOPHYS ACTA, V818, P235, DOI 10.1016/0005-2736(85)90564-4; PLESNER L, 1988, BIOCHIM BIOPHYS ACTA, V937, P51, DOI 10.1016/0005-2736(88)90226-X; PLESNER L, 1985, BIOCHIM BIOPHYS ACTA, V818, P222, DOI 10.1016/0005-2736(85)90563-2; PLESNER L, 1988, BIOCHIM BIOPHYS ACTA, V937, P63, DOI 10.1016/0005-2736(88)90227-1; Plesner L, 1988, Prog Clin Biol Res, V268A, P335; POLVANI C, 1988, J BIOL CHEM, V263, P16757; ROBINSON JD, 1974, FEBS LETT, V38, P325, DOI 10.1016/0014-5793(74)80083-9; ROBINSON JD, 1973, ARCH BIOCHEM BIOPHYS, V156, P232, DOI 10.1016/0003-9861(73)90361-5; ROBINSON JD, 1974, ANN NY ACAD SCI, V242, P185, DOI 10.1111/j.1749-6632.1974.tb19090.x; ROSSI RC, 1989, BIOCHIM BIOPHYS ACTA, V981, P85, DOI 10.1016/0005-2736(89)90085-0; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SACHS JR, 1977, J PHYSIOL-LONDON, V273, P489, DOI 10.1113/jphysiol.1977.sp012106; SACHS JR, 1980, J PHYSIOL-LONDON, V302, P219; SACHS JR, 1986, J PHYSIOL-LONDON, V381, P149, DOI 10.1113/jphysiol.1986.sp016319; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SCHULZ AR, 1994, ENZYME KINETICS DIAS; Segel IH., 1993, ENZYME KINETICS BEHA; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; WONG JTF, 1962, CAN J BIOCHEM PHYS, V40, P763	57	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1373	1385		10.1074/jbc.M117.799536	http://dx.doi.org/10.1074/jbc.M117.799536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191836	Green Published, hybrid			2022-12-26	WOS:000423515000023
J	Morales, TGP; Ratia, K; Wang, DS; Gogos, A; Driver, TG; Federle, MJ				Morales, Tiara G. Perez; Ratia, Kiira; Wang, Duo-Sheng; Gogos, Artemis; Driver, Tom G.; Federle, Michael J.			A novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; O PEPO; PEPTIDE; EXPRESSION; VIRULENCE; RGG; PROTEIN; GROWTH; GENE; ROPB	Bacteria produce chemical signals (pheromones) to coordinate behaviors across a population in a process termed quorum sensing (QS). QS systems comprising peptide pheromones and their corresponding Rgg receptors are widespread among Firmicutes and may be useful targets for manipulating microbial behaviors, like suppressing virulence. The Rgg2/3 QS circuit of the human pathogen Streptococcus pyogenes controls genes affecting resistance to host lysozyme in response to short hydrophobic pheromones (SHPs). Considering that artificial activation of a QS pathway may be as useful in the objective of manipulating bacteria as inhibiting it, we sought to identify small-molecule inducers of the Rgg2/3 QS system. We report the identification of a small molecule, P516-0475, that specifically induced expression of Rgg2/3-regulated genes in the presence of SHP pheromones at concentrations lower than typically required for QS induction. In searching for the mode of action of P516-0475, we discovered that an S. pyogenes mutant deficient in pepO, a neprilysin-like metalloendopeptidase that degrades SHP pheromones, was unresponsive to the compound. P516-0475 directly inhibited recombinant PepO in vitro as an uncompetitive inhibitor. We conclude that this compound induces QS by stabilizing SHP pheromones in culture. Our study indicates the usefulness of cell-based screens that modulate pathway activities to identify unanticipated therapeutic targets contributing to QS signaling.	[Morales, Tiara G. Perez; Federle, Michael J.] Univ Illinois, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA; [Ratia, Kiira] Univ Illinois, UIC High Throughput Screening Core Facil, Chicago, IL 60607 USA; [Wang, Duo-Sheng; Driver, Tom G.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gogos, Artemis; Federle, Michael J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA; [Driver, Tom G.] Huaqiao Univ, Inst Next Generat Matter Transformat, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Huaqiao University	Federle, MJ (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, 900 S Ashland Ave M-C870 3152 MBRB, Chicago, IL 60607 USA.	mfederle@uic.edu	Wang, Duo-Sheng/O-9846-2018	Wang, Duo-Sheng/0000-0002-3519-2386; Gogos, Artemis/0000-0002-0555-3814	National Institutes of Health [AI091779, AI125452]; Burroughs Wellcome Fund PATH award; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125452, R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund PATH award(Burroughs Wellcome Fund); Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI091779 and AI125452, the Burroughs Wellcome Fund PATH award, and the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Aggarwal C, 2015, MBIO, V6, DOI 10.1128/mBio.00393-15; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Bayes-Genis A, 2016, J AM COLL CARDIOL, V68, P639, DOI 10.1016/j.jacc.2016.04.060; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chang JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168461; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chen YQ, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.492; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Do H, 2017, P NATL ACAD SCI USA, V114, pE8498, DOI 10.1073/pnas.1705972114; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Makthal N, 2016, MOL MICROBIOL, V99, P1119, DOI 10.1111/mmi.13294; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Parashar V, 2015, P NATL ACAD SCI USA, V112, P5177, DOI 10.1073/pnas.1500357112; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; SULAVIK MC, 1992, J BACTERIOL, V174, P3577, DOI 10.1128/JB.174.11.3577-3586.1992; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Velarde JJ, 2014, J BIOL CHEM, V289, P36315, DOI 10.1074/jbc.M114.605394; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438	37	5	5	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					931	940		10.1074/jbc.M117.810994	http://dx.doi.org/10.1074/jbc.M117.810994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203527	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000422864500014
J	Tang, XJ; Zhao, S; Chiu, APY; Wang, X; Yang, L; He, DH				Tang, Xiujuan; Zhao, Shi; Chiu, Alice P. Y.; Wang, Xin; Yang, Lin; He, Daihai			Analysing increasing trends of Guillain-Barre A Syndrome (GBS) and dengue cases in Hong Kong using meteorological data	PLOS ONE			English	Article							BURDEN; FEVER	Background Guillain-Barre A Syndrome (GBS) is a severe paralytic neuropathy associated with virus infections such as Zika virus and Chikungunya virus. There were also case reports of dengue fever preceding GBS. With the aim to understand the mechanisms of GBS and dengue outbreaks, this ecological study investigates the relationships between GBS, dengue, meteorological factors in Hong Kong and global climatic factors from January 2000 to June 2016. Methods The correlations between GBS, dengue, Multivariate El Nino Southern Oscillation Index (MEI) and local meteorological data were explored by Spearman's Rank correlations and cross-correlations. Three Poisson regression models were fitted to identify non-linear associations among GBS, dengue and MEI. Cross wavelet analyses were applied to infer potential non-stationary oscillating associations among GBS, dengue and MEI. Findings and conclusion We report a substantial increasing of local GBS and dengue cases (mainly imported) in recent year in Hong Kong. The seasonalities of GBS and dengue are different, in particular, GBS is low while dengue is high in the summer. We found weak but significant correlations between GBS and local meteorological factors. MEI could explain over 17% of dengue's variations based on Poisson regression analyses. We report a possible non-stationary oscillating association between dengue fever and GBS cases in Hong Kong. This study has led to an improved understanding about the timing and ecological relationships between MEI, GBS and dengue.	[Tang, Xiujuan; Wang, Xin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Zhao, Shi; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University; Hong Kong Polytechnic University	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	He, Daihai/AAT-8735-2021; YANG, Lin/F-9601-2014; Zhao, Shi/AAW-6992-2021	YANG, Lin/0000-0002-5964-3233; Zhao, Shi/0000-0001-8722-6149; He, Daihai/0000-0003-3253-654X	Shenzhen Science and Technology Innovation Project Grant [JCYJ20150402102135501]; Start-up Fund for New Recruits from the Hong Kong Polytechnic University	Shenzhen Science and Technology Innovation Project Grant; Start-up Fund for New Recruits from the Hong Kong Polytechnic University	This study was supported by Shenzhen Science and Technology Innovation Project Grant (JCYJ20150402102135501) and Start-up Fund for New Recruits from the Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Shenzhen Science and Technology Innovation Project Grant (JCYJ20150402102135501) and Start-up Fund for New Recruits from the Hong Kong Polytechnic University.	Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Centre for Health Protection, COMM DIS WATCH 2013; Centre for Health Protection, COMM DIS WATCH 2014; Centre for Health Protection, COMM DIS WATCH 2012; Centre for Health Protection, COMM DIS WATCH 2015; Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612; Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Hui ACF, 2005, J CLIN NEUROSCI, V12, P134, DOI 10.1016/j.jocn.2003.10.018; Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kumar Sudhir, 2005, Neurol India, V53, P250; Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482; Ma YM, 2010, PEDIATR INT, V52, P13, DOI 10.1111/j.1442-200X.2009.02951.x; Mazzarella A, 2013, THEOR APPL CLIMATOL, V111, P601, DOI 10.1007/s00704-012-0696-9; Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]; Qureshi N. K., 2012, Journal of Medicine, V13, P246; Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0; Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016; Sulekha C, 2004, INDIAN PEDIAT; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422; Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576; van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112; Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; World Health Organization, 2009, DENGUE GUIDELINES DI; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114	42	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0187830	10.1371/journal.pone.0187830	http://dx.doi.org/10.1371/journal.pone.0187830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200423	Green Published, gold, Green Submitted			2022-12-26	WOS:000417033200002
J	Lin, YY; Chen, CY; Ding, ST				Lin, Yuan-Yu; Chen, Ching-Yi; Ding, Shih-Torng			Adiponectin receptor 1 resists the decline of serum osteocalcin and GPRC6A expression in ovariectomized mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; ENERGY-METABOLISM; BETA-CELL; DIET; DISEASES; OBESITY	Hormonal changes that cause metabolic complications are a common problem in postmenopausal women. Adiponectin and osteocalcin are cytokines associated with glucose regulatory and insulin sensitized function in postmenopausal stages. The current study investigated the role of adiponectin signaling and osteocalcin mediated function in glucose metabolism in ovariectomized mice. In a mouse menopausal-related metabolic disorder model, overexpression of adiponectin receptor 1 improved glucose tolerance and caused resistance to body weight increase and decline of serum osteocalcin. Furthermore, adiponectin receptor 1 transgenic ovariectomized mice had higher GPRC6A (the putative osteocalcin receptor) expression in muscle tissue. Immunofluorescence indicated that GPRC6A and adiponectin receptor 1 were co-localized in mouse muscle tissues. The present finding suggested adiponectin receptor 1 can mediate the improvement of glucose metabolism by osteocalcin in ovariectomized mice. Our findings imply the possibility to ameliorate menopause-induced metabolic disorder by GPRC6A and adiponectin signaling.	[Lin, Yuan-Yu] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung, Taiwan; [Chen, Ching-Yi; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan	Tunghai University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan.	sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Lin, Yuan-Yu/0000-0002-3397-3218; Ding, Shih-Torng/0000-0002-9866-1776; Chen, Ching-Yi/0000-0002-5776-084X	Ministry of Science and Technology in Taiwan [102-2313-B-002-026-MY3, MOST 106-2313-B-002-044]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by the Grants 102-2313-B-002-026-MY3 and MOST 106-2313-B-002-044 grants from Ministry of Science and Technology in Taiwan.	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chedraui P, 2014, MATURITAS, V79, P86, DOI 10.1016/j.maturitas.2014.06.008; Choudhury AB, 2014, ARCH PHYSIOL BIOCHEM, V120, P73, DOI 10.3109/13813455.2013.877488; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Edwards BJ, 2013, PERIODONTOL 2000, V61, P177, DOI 10.1111/j.1600-0757.2011.00407.x; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Kaaja Risto J, 2008, Menopause Int, V14, P21, DOI 10.1258/mi.2007.007032; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin YY, 2014, BONE, V64, P147, DOI 10.1016/j.bone.2014.03.051; Liu BH, 2013, EXP ANIM TOKYO, V62, P347, DOI 10.1538/expanim.62.347; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Ludgero-Correia A, 2012, NUTRITION, V28, P316, DOI 10.1016/j.nut.2011.07.014; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001	23	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0189063	10.1371/journal.pone.0189063	http://dx.doi.org/10.1371/journal.pone.0189063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194451	Green Published, gold			2022-12-26	WOS:000416867800018
J	Liu, HW; Wang, XJ; Qi, HT; Wang, Q; Chen, YC; Li, Q; Zhang, YY; Qiu, L; Fontana, JE; Zhang, BH; Wang, WL; Xie, YG				Liu, Huawei; Wang, Xiaojing; Qi, Huaiting; Wang, Qian; Chen, Yongchao; Li, Qiang; Zhang, Yuying; Qiu, Li; Fontana, Julia Elise; Zhang, Baohong; Wang, Weiling; Xie, Yingge			The infection and impact of Azorhizobium caulinodans ORS571 on wheat (Triticum aestivum L.)	PLOS ONE			English	Article							LEGUMINOSARUM BV TRIFOLII; RHIZOBIAL INOCULATION; GROWTH; ASSOCIATION; ROOTS; YIELD	Based on our previous study, cereal crop wheat (Triticum aestivum L.) could be infected by rhizobia Azorhizobium caulinodans ORS571, and form para-nodules with the induction of 2.4-dichlorophenoxyacetic acid, a common plant growth regulator. To enhance this infection and the potential agricultural application, we compared six different infection methods (Direct seed dip; Seed germination dip; Pruned-root dip; Foliar spray; Circum-soil dip; Seed dip and circum-soil dip) for achieving the high efficient infection of A. caulinodans into wheat plants by employing a green fluorescent protein (gfp)-labeled Azorhizobium caulinodans strain ORS571. With proper methods, copious rhizobia could enter the interior and promote the growth of wheat to the hilt. Circum-soil dip was proved to be the most efficient method, seed germination dip and pruned-root dip is the last recommended to infect wheat, seed germination dip and seed dip and circum-soil dip showed better effects on plant growth, pruned-root dip did not show too much effect on plant growth. This study laid the foundation for understanding the interaction between rhizobia and cereal crops and the growth-promoting function of rhizobia.	[Liu, Huawei; Chen, Yongchao; Li, Qiang; Zhang, Yuying; Wang, Weiling] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wang, Xiaojing; Qi, Huaiting; Wang, Qian; Xie, Yingge] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China; [Qiu, Li] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Fontana, Julia Elise; Zhang, Baohong] East Carolina Univ, Dept Biol, Greenville, NC USA	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; University of North Carolina; East Carolina University	Wang, WL (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Xie, YG (corresponding author), Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China.	ylwwl@nwsuaf.edu.cn; xieyingge1976@nwsuaf.edu.cn			International Cooperation and Exchanges Project of Shaanxi Province [2015KW-028]; Fundamental Research Funds of Northwest AF University [2452015033]	International Cooperation and Exchanges Project of Shaanxi Province; Fundamental Research Funds of Northwest AF University	This work was partially supported by International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), Fundamental Research Funds of Northwest A&F University (2452015033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), Fundamental Research Funds of Northwest A&F University (2452015033).	Biswas JC, 2000, AGRON J, V92, P880, DOI 10.2134/agronj2000.925880x; Biswas JC, 2000, SOIL SCI SOC AM J, V64, P1644, DOI 10.2136/sssaj2000.6451644x; Bressan W, 2004, BIOCONTROL, V49, P315, DOI 10.1023/B:BICO.0000025372.51658.93; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; El-Shahed A. M., 2006, Pakistan Journal of Biological Sciences, V9, P1693, DOI 10.3923/pjbs.2006.1693.1699; Goswami Dweipayan, 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2015.1127500; Govind Gupta, 2015, Journal of Microbial and Biochemical Technology, V7, P96; Grobelak A, 2015, ECOL ENG, V84, P22, DOI 10.1016/j.ecoleng.2015.07.019; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Ji KX, 2010, J MICROBIOL BIOTECHN, V20, P238, DOI 10.4014/jmb.0906.06042; Kennedy IR, 1997, PLANT SOIL, V194, P65, DOI 10.1023/A:1004260222528; Mahaffee WF, 1997, MICROB ECOL, V34, P210, DOI 10.1007/s002489900050; NDOYE I, 1994, J BACTERIOL, V176, P1060, DOI 10.1128/JB.176.4.1060-1068.1994; Nie YF., 1983, NATURE, V6, P326; Peng SB, 2002, AGRON J, V94, P925, DOI 10.2134/agronj2002.9250; Phillips DA, 1999, P NATL ACAD SCI USA, V96, P12275, DOI 10.1073/pnas.96.22.12275; Phillips DA, 2000, RELEASE NITROGEN KEY, P205; Rasmussen M., 2003, ASM NEWS, P737; Sabry SRS, 1997, P ROY SOC B-BIOL SCI, V264, P341, DOI 10.1098/rspb.1997.0049; Stone PJ, 2001, MOL PLANT MICROBE IN, V14, P93, DOI 10.1094/MPMI.2001.14.1.93; Yang J, 2017, SCI TOTAL ENVIRON, V592, P758, DOI 10.1016/j.scitotenv.2016.10.182; Yanni YG, 1997, PLANT SOIL, V194, P99, DOI 10.1023/A:1004269902246; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069	23	9	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187947	10.1371/journal.pone.0187947	http://dx.doi.org/10.1371/journal.pone.0187947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190702	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900024
J	Marinho, ED; Custodio, IDD; Ferreira, IB; Crispim, CA; Paiva, CE; Maia, YCD				Marinho, Eduarda da Costa; Dias Custodio, Isis Danyelle; Ferreira, Isabela Borges; Crispim, Cibele Aparecida; Paiva, Carlos Eduardo; de Paiva Maia, Yara Cristina			Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study	PLOS ONE			English	Article							RECEIVING CHEMOTHERAPY; WEIGHT-GAIN; TASTE; CHOICE; APPETITE; SMELL; CYCLOPHOSPHAMIDE; DETERMINANTS; MANAGEMENT; HEDONICS	Breast cancer (BC) treatment includes mostly chemotherapy (CT), which can cause side effects like nausea, taste changes, early satiety, slow gastric emptying and xerostomia. In this way, the individual's relationship with food may change during the treatment. The aim of this study was to evaluate the impact of chemotherapy on perceptions related to food intake of women with BC. Fifty-five women with BC were followed, and data were collected at three periods during first-line CT: beginning (T0), intermediate (T1) and end (T2). A visual analogue scale (VAS) (0 to 10 cm) for hunger, appetite for various food categories and meal enjoyment was investigated. The frequency and intensity of side effects were evaluated using a 4 cm scale. The results showed a higher prevalence of taste changes in T1 (p = 0.044) and more nausea in T1 and T2 (p = 0.018). Furthermore, the intensity of nausea was higher in T2 (p = 0.01) than in the other periods. We observed moderate hunger in T0, T1 and T2 (p = 0.113), but the overall appetite increased between T0 and T2 (p = 0.003). Meal enjoyment was reduced from T0 to T1 and returned back to the initial value in T2 (p = 0.021). The appetite for salty (p = 0.004) and spicy (p = 0.03) foods was increased in T1. There was an increase of body weight (p = 0.008), body mass index (BMI) (p = 0.009) and waist circumference (WC) (p = 0.03) during CT. CT changes food hedonism, increasing the overall appetite and the appetite for salty and spicy foods. Moreover, we observed the negative impact of CT on meal enjoyment and an increase in side effects and anthropometric parameters.	[Marinho, Eduarda da Costa; Dias Custodio, Isis Danyelle; Crispim, Cibele Aparecida; de Paiva Maia, Yara Cristina] Univ Fed Uberlandia, Grad Program Hlth Sci, Uberlandia, MG, Brazil; [Ferreira, Isabela Borges; Crispim, Cibele Aparecida; de Paiva Maia, Yara Cristina] Univ Fed Uberlandia, Med Fac, Nutr Course, Uberlandia, MG, Brazil; [Paiva, Carlos Eduardo] Pio XII Fdn, Barretos Canc Hosp, Dept Clin Oncol, Grad Program Oncol,Palliat Care & Qual Life Res G, Barretos, SP, Brazil; [Marinho, Eduarda da Costa; Dias Custodio, Isis Danyelle; Ferreira, Isabela Borges; Crispim, Cibele Aparecida; de Paiva Maia, Yara Cristina] Ave Campus Umuarama, Uberlandia, MG, Brazil; [Paiva, Carlos Eduardo] Rua Antenor Duarte Vilela, Barretos, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Hospital de Cancer de Barretos	Maia, YCD (corresponding author), Univ Fed Uberlandia, Grad Program Hlth Sci, Uberlandia, MG, Brazil.; Maia, YCD (corresponding author), Univ Fed Uberlandia, Med Fac, Nutr Course, Uberlandia, MG, Brazil.; Maia, YCD (corresponding author), Ave Campus Umuarama, Uberlandia, MG, Brazil.	yara.maia@ufu.br	Crispim, Cibele CAC/R-1269-2016; Paiva, Carlos E/F-4810-2012; Maia, Yara/AAT-8314-2020	Crispim, Cibele CAC/0000-0002-6638-8197; Paiva Maia, Yara Cristina de/0000-0001-9169-5028; Custodio, Isis Danyelle Dias/0000-0003-2741-5110; Ferreira, Isabela Borges/0000-0002-3138-6992; Paiva, Carlos Eduardo/0000-0002-7934-1451	Graduate Program in Health Sciences (Federal University of Uberlandia, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Graduate Program in Health Sciences (Federal University of Uberlandia, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study received financial support from Graduate Program in Health Sciences (Federal University of Uberlandia, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil and to Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STAT UINT ANT; Arpino G, 2015, BREAST CANCER RES TR, V154, P127, DOI 10.1007/s10549-015-3586-x; Atalay C, 2015, TURK J SURG, V31, P124, DOI 10.5152/UCD.2015.3123; Bao J, 2015, CANCER MED-US, V4, P500, DOI 10.1002/cam4.388; Beaver K, 2016, EUR J ONCOL NURS, V20, P77, DOI 10.1016/j.ejon.2015.06.001; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Boltong A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103512; Boltong A, 2012, SUPPORT CARE CANCER, V20, P2765, DOI 10.1007/s00520-012-1398-7; Boltong A, 2012, CANCER TREAT REV, V38, P152, DOI 10.1016/j.ctrv.2011.04.008; Brenne E, 2013, PALLIAT SUPPORT CARE, V11, P491, DOI 10.1017/S1478951512000909; Byrnes NK, 2013, FOOD QUAL PREFER, V28, P213, DOI 10.1016/j.foodqual.2012.09.008; Calixto-Lima L, 2012, NUTR HOSP, V27, P65, DOI [10.1590/S0212-16112012000100008, 10.3305/nh.2012.27.1.5417]; Castro MC, 2014, ACTA PAUL ENFERM, V27, P412, DOI 10.1590/1982-0194201400069; Celio L, 2016, SUPPORT CARE CANCER, V24, P1025, DOI 10.1007/s00520-015-2871-x; Cohen J, 2014, APPETITE, V75, P135, DOI 10.1016/j.appet.2014.01.001; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; Custodio IDD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157113; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; Drachman JG, 2013, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2013.1.306; Drapeau V, 2005, BRIT J NUTR, V93, P273, DOI 10.1079/BJN20041312; Dy GK, 2013, CA-CANCER J CLIN, V63, P249, DOI 10.3322/caac.21184; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feeney E, 2011, P NUTR SOC, V70, P135, DOI 10.1017/S0029665110003976; Felipe RS, 2013, NUTR HOSP, V28, P1829; FERNSTROM MH, 1987, BIOL PSYCHIAT, V22, P529, DOI 10.1016/0006-3223(87)90180-6; Gozzo Thais de Oliveira, 2013, Rev. Gaúcha Enferm., V34, P110; Hong Jae Hee, 2009, J Support Oncol, V7, P58; Jeon YW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0849-z; Jordan K, 2014, BREAST CARE, V9, P246, DOI 10.1159/000366300; Kosaka Y, 2016, SUPPORT CARE CANCER, V24, P1405, DOI 10.1007/s00520-015-2905-4; Kuklau N, 2016, ERNAHRUNGS UMSCHAU, V63, pM14, DOI 10.4455/eu.2016.002; Kwok A, 2015, SUPPORT CARE CANCER, V23, P1561, DOI 10.1007/s00520-014-2496-5; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Liedtke S, 2012, OBESITY, V20, P1088, DOI 10.1038/oby.2011.383; Linden HM, 2007, J CLIN ONCOL, V25, P656, DOI 10.1200/JCO.2006.07.0847; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Lyon D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1151-z; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; Lima MTM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3559-z; Verde SMML, 2009, REV NUTR, V22, P795, DOI 10.1590/S1415-52732009000600002; Nissen MJ, 2011, CLIN BREAST CANCER, V11, P52, DOI 10.3816/CBC.2011.n.009; Ogundiran TO, 2012, CANCER CAUSE CONTROL, V23, P565, DOI 10.1007/s10552-012-9916-y; Piccart MJ, 2001, J CLIN ONCOL, V19, P3103, DOI 10.1200/JCO.2001.19.12.3103; Poortvliet PC, 2007, BRIT J NUTR, V97, P584, DOI 10.1017/S000711450738135X; Reddy SM, 2013, BRIT J CANCER, V109, P872, DOI 10.1038/bjc.2013.441; Rockenbach G, 2011, NUTR HOSP, V26, P737, DOI [10.1590/S0212-16112011000400011, 10.3305/nh.2011.26.4.5067]; Rogers PJ, 2015, APPETITE, V90, P1, DOI 10.1016/j.appet.2015.02.032; Silva AASC, 2017, APPETITE, V108, P255, DOI 10.1016/j.appet.2016.10.005; Sobal J, 2014, MIND BRAIN EDUC, V8, P6, DOI 10.1111/mbe.12044; Soyer MT, 2008, ASIA PAC J CLIN NUTR, V17, P208; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Waterhouse J, 2003, CHRONOBIOL INT, V20, P1075, DOI 10.1081/CBI-120025536; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	55	22	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187573	10.1371/journal.pone.0187573	http://dx.doi.org/10.1371/journal.pone.0187573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190717	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900016
J	Srimani, S; Saha, I; Chaudhuri, D				Srimani, Soumi; Saha, Indranil; Chaudhuri, Debnath			Prevalence and association of metabolic syndrome and vitamin D deficiency among postmenopausal women in a rural block of West Bengal, India	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; INSULIN-RESISTANCE; D INADEQUACY; LIFE-STYLE; RISK; CALCIUM; OBESITY; ADULTS	Background Prevalence of metabolic syndrome (MS) and vitamin D deficiency was reported among postmenopausal women (PMW) in India. However, no report is available regarding the association of MS and 25-hydroxyvitamin D [25(OH) D] among PMW in India. This study aimed to find out the prevalence of MS and 25(OH) D status as well as their association among rural PMW of West Bengal, India. Materials and methods This cross-sectional study was conducted among 222 randomly selected rural PMW in Singur Block, West Bengal, India. Serum 25(OH) D, Blood pressure (BP), waist circumference (WC), fasting blood glucose (FBG), triglycerides (TG) and high density lipoprotein cholesterol (HDL-C) were measured using standard procedures. MS was defined as per International Diabetes Federation, 2005 (for Asian-Indians) criteria. Statistical tests were done using SPSS software. Results Prevalence of metabolic syndrome was 46%. 51% and 19% PMW were vitamin D insufficient and deficient, respectively. 22% and 53% women having MS were vitamin D insufficient and deficient, respectively. Among the PMW, 21% and 47% with WC >= 80cm; 22% and 62% with FBG >= 110mg/dl; 21% and 54% with TG >= 150mg/dl; 23% and 51% with HDLC< 50mg/dl, 15% and 55% with BP >= 130/85mm of Hg were vitamin D insufficient and deficient, respectively. Significant statistical association between FBG and 25(OH)D status existed (p = 0.01). Significant positive correlation between WC and 25(OH)D level (p = 0.004) and significant negative correlation between FBG and 25(OH)D level observed (p = 0.02). WC was the only statistically significant predictor of the dependent variable. Odds of non-sufficient 25(OH) D level increased with decrease in WC. Conclusion High prevalence of MS as well as vitamin D insufficiency and deficiency existed among PMW of Singur block, West Bengal, India. 25(OH) D had significant inverse and direct relationship with FBG and WC. Low 25(OH) D may be one of the potential risk factors for developing MS in PMW or vice-versa.	[Srimani, Soumi; Chaudhuri, Debnath] All India Inst Hyg & Publ Hlth, Dept Biochem & Nutr, Kolkata, W Bengal, India; [Saha, Indranil] IQ City Med Coll, Dept Community Med, Durgapur, W Bengal, India; [Saha, Indranil] Narayana Hrudayalaya Hosp, Durgapur, W Bengal, India		Chaudhuri, D (corresponding author), All India Inst Hyg & Publ Hlth, Dept Biochem & Nutr, Kolkata, W Bengal, India.	dchaudhuri_bn@rediffmail.com	Saha, Indranil/C-5556-2017	Saha, Indranil/0000-0001-6622-7695; Srimani, Soumi/0000-0002-6741-1205	Indian Council of Medical Research [3/1/3/JRF-2012/HRD/40967]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research 3/1/3/JRF-2012/HRD/40967 (Receiver: Soumi Srimani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arya V, 2004, OSTEOPOROSIS INT, V15, P56, DOI 10.1007/s00198-003-1491-3; Bachhel Rachna, 2015, Int J Appl Basic Med Res, V5, P7, DOI 10.4103/2229-516X.149220; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Chowdhury TA, 2009, PRIM CARE DIABETES, V3, P115, DOI 10.1016/j.pcd.2009.03.004; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084; Deedwania PC, 2014, DIABETES METAB SYND, V8, P156, DOI 10.1016/j.dsx.2014.04.033; Feneis JF, 2010, AM J THER, V17, pE221, DOI 10.1097/MJT.0b013e3181d16999; Figueiredo-Neto AA, 2010, ARQ BRAS CARDIOL, V91, P1; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Ghosh J, 2016, IJAR, V2, P151; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Heidari R, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-59; Herrmann W, 1983, Z Gesamte Inn Med, V38, P17; HODGKIN P, 1973, LANCET, V2, P167; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; HYLDSTRUP L, 1993, ACTA ENDOCRINOL-COP, V129, P393, DOI 10.1530/acta.0.1290393; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Indhavivadhana S, 2011, CLIMACTERIC, V14, P58, DOI 10.3109/13697137.2010.481735; Jabbar Z, 2009, NEPHROLOGY, V14, P345, DOI 10.1111/j.1440-1797.2008.01082.x; JAKOBSEN LK, 1960, SCAND J CLIN LAB INV, V12, P76, DOI 10.3109/00365516009046170; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Kota S, 2011, J ASS PHYS INDIA, V59, P695; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lim SK, 2008, CURR MED RES OPIN, V24, P99, DOI 10.1185/030079908X253429; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mayne PD, 1994, CLIN CHEM DIAGNOSIS, V11, P224; Michos ED, 2009, FUTUR CARDIOL, V5, P15, DOI 10.2217/14796678.5.1.15; Misra Anoop, 2014, Nestle Nutr Inst Workshop Ser, V78, P133, DOI 10.1159/000354952; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; O'Keefe EL, 2016, PROG CARDIOVASC DIS, V58, P505, DOI 10.1016/j.pcad.2015.08.010; Pandey Shefali, 2010, J Midlife Health, V1, P63, DOI 10.4103/0976-7800.76214; Penckofer S, 2008, DIABETES EDUCATOR, V34, P939, DOI 10.1177/0145721708326764; Pinelli NR, 2010, DIABETES CARE, V33, P1373, DOI 10.2337/dc09-2199; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Richart T, 2011, AM J HYPERTENS, V24, P102, DOI 10.1038/ajh.2010.124; Romaguera J, 2010, MENOPAUSE, V17, P388, DOI 10.1097/gme.0b013e3181bd5393; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Singh J., 2016, J BIOELECTRON NANOTE, V1, DOI DOI 10.13188/2475-224X.1000003; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tandon Vishal R, 2014, J Midlife Health, V5, P121, DOI 10.4103/0976-7800.141188; Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924	56	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188331	10.1371/journal.pone.0188331	http://dx.doi.org/10.1371/journal.pone.0188331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190744	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900048
J	Qian, ZY; Zhang, QW; Liu, Y; Chen, PJ				Qian, Zhenyu; Zhang, Qingwen; Liu, Yu; Chen, Peijie			Assemblies of amyloid-beta(30-36) hexamer and its G33V/L34T mutants by replica-exchange molecular dynamics simulation	PLOS ONE			English	Article							BETA-AMYLOID PEPTIDE; ALZHEIMERS-DISEASE; PROTEIN AGGREGATION; A-BETA(16-22) PEPTIDES; MONTE-CARLO; BARREL; OLIGOMERS; MECHANISM; STABILITY; WATER	The aggregation of amyloid-beta peptides is associated with the pathogenesis of Alzheimer's disease, in which the 30-36 fragments play an important part as a fiber-forming hydrophobic region. The fibrillar structure of A beta(30-36) has been detected by means of X-ray diffraction, but its oligomeric structural determination, biophysical characterization, and pathological mechanism remain elusive. In this study, we have investigated the structures of A beta(30-36) hexamer as well as its G33V and L34T mutants in explicit water environment using replica-exchange molecular dynamics (REMD) simulations. Our results show that the wild-type (WT) A beta(30-36) hexamer has a preference to form beta-barrel and bilayer beta-sheet conformations, while the G33V or L34T mutation disrupts the beta-barrel structures: the G33V mutant is homogenized to adopt beta-sheet-rich bilayers, and the structures of L34T mutant on the contrary get more diverse. The hydrophobic interaction plays a critical role in the formation and stability of oligomeric assemblies among all the three systems. In addition, the substitution of G33 by V reduces the beta-sheet content in the most populated conformations of A beta(30-36) oligomers through a steric effect. The L34T mutation disturbs the interpeptide hydrogen bonding network, and results in the increased coil content and morphological diversity. Our REMD runs provide structural details of WT and G33V/L34T mutant A beta(30-36) oligomers, and molecular insight into the aggregation mechanism, which will be helpful for designing novel inhibitors or amyloid-based materials.	[Qian, Zhenyu; Liu, Yu; Chen, Peijie] Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China; [Qian, Zhenyu; Liu, Yu; Chen, Peijie] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Zhang, Qingwen] Shanghai Univ Sport, Coll Phys Educ & Training, Shanghai, Peoples R China	Shanghai University of Sport; Shanghai University of Sport; Shanghai University of Sport	Qian, ZY; Chen, PJ (corresponding author), Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China.; Qian, ZY; Chen, PJ (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	qianzhenyu@sus.edu.cn; chenpeijie@sus.edu.cn		Zhang, Qingwen/0000-0002-8885-1066; Qian, Zhenyu/0000-0002-3921-3818	China Postdoctoral Science Foundation [2016M601634]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the China Postdoctoral Science Foundation (grant no.: 2016M601634) (http://jj.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdC Alonso, 2001, P NATL ACAD SCI US, V98; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berhanu WM, 2014, ADV PROTEIN CHEM STR, P113; Berhanu WM, 2013, PROTEINS, V81, P1542, DOI 10.1002/prot.24302; Berhanu WM, 2012, PROTEIN SCI, V21, P1837, DOI 10.1002/pro.2164; Bonhommeau S., 2017, ANGEW CHEM, V129, P1797, DOI DOI 10.1002/ANGE.201610399; Brunelle P, 2002, J ALZHEIMERS DIS, V4, P283, DOI 10.3233/JAD-2002-4403; Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Cheng PN, 2012, NAT CHEM, V4, P927, DOI [10.1038/NCHEM.1433, 10.1038/nchem.1433]; Chouchane K, 2015, J PHYS CHEM B, V119, P10543, DOI 10.1021/acs.jpcb.5b07365; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Do TD, 2016, J AM CHEM SOC, V138, P549, DOI 10.1021/jacs.5b09536; Du WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07992; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Gremer L, 2017, SCIENCE; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Henry S, 2015, BIOMACROMOLECULES, V16, P944, DOI 10.1021/bm501837w; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Irback A, 2008, PROTEINS, V71, P207, DOI 10.1002/prot.21682; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larini L, 2012, BIOPHYS J, V103, P576, DOI 10.1016/j.bpj.2012.06.027; Latshaw David C, 2015, BIOPHYS J, V109, P124; Lei JT, 2016, PHYS CHEM CHEM PHYS, V18, P8098, DOI 10.1039/c5cp06538k; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu RT, 2004, J NEUROSCI RES, V75, P162, DOI 10.1002/jnr.10859; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642; Lu Y, 2011, J PHYS CHEM B, V115, P1282, DOI 10.1021/jp110269a; Lu Y, 2009, PROTEINS, V75, P954, DOI 10.1002/prot.22305; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nadler W, 2008, J PHYS CHEM B, V112, P10386, DOI 10.1021/jp805085y; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okamoto Y, 2004, J MOL GRAPH MODEL, V22, P425, DOI 10.1016/j.jmgm.2003.12.009; Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Panda PK, 2016, GENOM DATA, V7, P189, DOI 10.1016/j.gdata.2016.01.003; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Spencer RK, 2014, J AM CHEM SOC, V136, P5595, DOI 10.1021/ja5017409; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Truex NL, 2016, J AM CHEM SOC, V138, P13882, DOI 10.1021/jacs.6b06000; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vignaud H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080262; Wang JQ, 2016, COLLOID SURFACE B, V147, P116, DOI 10.1016/j.colsurfb.2016.07.052; Xi WH, 2016, J PHYS CHEM B, V120, P4548, DOI 10.1021/acs.jpcb.6b01724; Xie LG, 2014, BIOPHYS J, V107, P1930, DOI 10.1016/j.bpj.2014.08.034; Xie LG, 2014, NANOSCALE, V6, P9752, DOI 10.1039/c4nr01005a; Xie LG, 2013, J PHYS CHEM B, V117, P10149, DOI 10.1021/jp405869a; Zhang HL, 2017, J CHEM THEORY COMPUT, V13, P3936, DOI 10.1021/acs.jctc.7b00383; Zhou XY, 2014, J PHYS CHEM B, V118, P6733, DOI 10.1021/jp503458w	75	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188794	10.1371/journal.pone.0188794	http://dx.doi.org/10.1371/journal.pone.0188794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186195	gold, Green Submitted, Green Published			2022-12-26	WOS:000416484900060
J	Vettraino, AM; Li, HM; Eschen, R; Morales-Rodriguez, C; Vannini, A				Vettraino, Anna Maria; Li, Hong-Mei; Eschen, Rene; Morales-Rodriguez, Carmen; Vannini, Andrea			The sentinel tree nursery as an early warning system for pathway risk assessment: Fungal pathogens associated with Chinese woody plants commonly shipped to Europe	PLOS ONE			English	Article							SP-NOV; 1ST REPORT; BOTRYOSPHAERIACEAE; VITICOLA; COLLETOTRICHUM; IDENTIFICATION; PATTERNS; DIEBACK; ORIGIN	Introduction of and invasion by alien plant pathogens represents the main cause of emerging infectious diseases affecting domesticated and wild plant species worldwide. The trade in living plants is the most common pathway of introduction. Many of the alien tree pathogens recently introduced into Europe were not previously included on any quarantine lists. To help determine the potential risk of pest introduction through trading of ornamental plants, a sentinel nursery was established in Beijing, China in 2008. The sentinel nursery planting included four of the most common ornamental woody species shipped to Europe including Ilex comuta var. fortunae, Zelkova schneideriana, Fraxinus chinensis and Buxus microphylla. Symptoms developing on these species within the sentinel nursery were detected in 2013 and consisted of necrotic spots on leaves, canker and stem necrosis, shoot blight and shoot necrosis. Fungi associated with the trees and their symptoms included Alternaria alternata detected from all hosts; Diaporthe liquidambaris and Diaporthe capsici from bark and leaf necrosis of Zelkova schneideriana; Botryosphaeria dothidea and Nothophoma quercina from stem cankers on Fraxinus chinensis and leaf necrosis on Ilex cornuta; and Pseudonectria foliicola from leaf necrosis on Buxus microphylla. Next generation sequencing analysis from asymptomatic tissues detected eighteen OTU's at species level among which some taxa had not been previously recorded in Europe. These results clearly demonstrate that looking at trees of internationally traded species in the region of origin can reveal the presence of potentially harmful organisms of major forestry, landscape or crop trees. Results of this study also provide an indication as to how some disease agents can be introduced using pathways other than the co-generic hosts. Hence, sentinel nurseries represent one potential mechanism to address the current lack of knowledge about pests in the countries from where live plants are shipped and the threats they represent to native flora and crops in importing countries.	[Vettraino, Anna Maria; Morales-Rodriguez, Carmen; Vannini, Andrea] Univ Tuscia, DIBAF, Viterbo, Italy; [Li, Hong-Mei] Chinese Acad Agr Sci, CABI, Beijing, Peoples R China; [Eschen, Rene] CABI, Delemont, Switzerland	Tuscia University; Chinese Academy of Agricultural Sciences	Vannini, A (corresponding author), Univ Tuscia, DIBAF, Viterbo, Italy.	vannini@unitus.it	Morales-Rodriguez, Carmen/L-5090-2017; Vannini, Andrea/L-5071-2017	Morales-Rodriguez, Carmen/0000-0002-2971-2840; Vannini, Andrea/0000-0003-4318-9088; Diamandis, Stephanos/0000-0001-5650-0547	Seventh Framework Programme EC FP7-KBBE	Seventh Framework Programme EC FP7-KBBE	This research was supported by the Seventh Framework Programme EC FP7-KBBE-2009-2013 to Andrea Vannini. ISEFOR-Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change. The funders had no role in study design, data collection and	Adesemoye AO, 2014, PLANT DIS, V98, P55, DOI 10.1094/PDIS-05-13-0492-RE; Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Bai FY, 2002, J GEN APPL MICROBIOL, V48, P17, DOI 10.2323/jgam.48.17; Bai JY, 2016, CAN J PLANT PATHOL, V38, P527, DOI 10.1080/07060661.2016.1266389; Berbee ML, 1999, MYCOLOGIA, V91, P964, DOI 10.2307/3761627; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; [Chang Changqing 常长青], 2005, [菌物学报, Mygosystema], V24, P6; Chen SF, 2013, J PLANT PATHOL, V95, P451; Comont G, 2016, PLANT DIS, V100, P2328, DOI 10.1094/PDIS-04-16-0576-PDN; Damm U, 2008, PERSOONIA, V20, P87, DOI 10.3767/003158508X324227; Damm U, 2007, MYCOLOGIA, V99, P664, DOI 10.3852/mycologia.99.5.664; Danggomen A., 2013, Thai Journal of Agricultural Science, V46, P157; Eschen R, 2015, DIVERS DISTRIB, V21, P36, DOI 10.1111/ddi.12267; Farr DF., FUNGAL DATABASES; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gonthier P, 2012, ECOL APPL, V22, P2135, DOI 10.1890/12-0420.1; Gonzaga LL, 2015, J APPL MICROBIOL, V118, P485, DOI 10.1111/jam.12696; Gonzalez-Dominguez E, 2017, PLANT PATHOL, V66, P77, DOI 10.1111/ppa.12556; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Holland S.M., 2003, ANAL RAREFACTION; Jami F, 2014, FUNGAL BIOL-UK, V118, P168, DOI 10.1016/j.funbio.2013.11.007; Kirschner R, 2014, MYCOSCIENCE, V55, P190, DOI 10.1016/j.myc.2013.08.004; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Liu X, 2007, MYCOTAXON, V100, P137; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Luque J, 2005, MYCOLOGIA, V97, P1111, DOI 10.3852/mycologia.97.5.1111; Moral J, 2017, PLANT DIS, V101, P306, DOI 10.1094/PDIS-06-16-0806-RE; Mougou A, 2008, FOREST PATHOL, V38, P275, DOI 10.1111/j.1439-0329.2008.00544.x; Orgiazzi A., 2013, Diversity, V5, P73; Page RDM, 2001, TREEVIEW VERSION 166; Reblova M, 2011, FUNGAL DIVERS, V46, P67, DOI 10.1007/s13225-010-0077-6; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120864; Roy HE, 2017, CONSERV LETT, V10, P477, DOI 10.1111/conl.12297; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbez-Torres JR, 2011, PHYTOPATHOL MEDITERR, V50, pS5; Vettraino A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120571; Vishniac HS, 2002, CAN J MICROBIOL, V48, P463, DOI 10.1139/W02-041; Wang QM, 2015, STUD MYCOL, P27, DOI 10.1016/j.simyco.2015.08.002; Wang XH, 2012, FUNGAL DIVERS, V52, P209, DOI 10.1007/s13225-011-0140-y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yun YH, 2016, PLANT DIS, V100, P2533, DOI 10.1094/PDIS-06-16-0870-PDN; Zhang R, 2009, MYCOTAXON, V109, P129, DOI 10.5248/109.129; Zhao YJ, 2012, MYCOTAXON, V122, P25, DOI 10.5248/122.25	50	20	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188800	10.1371/journal.pone.0188800	http://dx.doi.org/10.1371/journal.pone.0188800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186190	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900061
J	Choi, BH; Wijayananda, HI; Lee, SH; Lee, DH; Kim, JS; Oh, SI; Park, EW; Lee, CK; Lee, SH				Choi, Bong Hwan; Wijayananda, Hasini I.; Lee, Soo Hyun; Lee, Doo Ho; Kim, Jong Seok; Oh, Seok Il; Park, Eung Woo; Lee, Cheul Koo; Lee, Seung Hwan			Genome-wide analysis of the diversity and ancestry of Korean dogs	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SOUTHERN EAST-ASIA; GENETIC-STRUCTURE; NATIVE DOG; ORIGIN; HISTORY; SNP; DOMESTICATION	There are various hypotheses on dog domestication based on archeological and genetic studies. Although many studies have been conducted on the origin of dogs, the existing literature about the ancestry, diversity, and population structure of Korean dogs is sparse. Therefore, this study is focused on the origin, diversity and population structure of Korean dogs. The study sample comprised four major categories, including non-dogs (coyotes and wolves), ancient, modern and Korean dogs. Selected samples were genotyped using an Illumina CanineHD array containing 173,662 single nucleotide polymorphisms. The genome-wide data were filtered using quality control parameters in PLINK 1.9. Only autosomal chromosomes were used for further analysis. The negative off-diagonal variance of the genetic relationship matrix analysis depicted, the variability of samples in each population. FIS (inbreeding rate within a population) values indicated, a low level of inbreeding within populations, and the patterns were in concordance with the results of Nei's genetic distance analysis. The lowest FST (inbreeding rate between populations) values among Korean and Chinese breeds, using a phylogenetic tree, multi-dimensional scaling, and a TreeMix likelihood tree showed Korean breeds are highly related to Chinese breeds. The Korean breeds possessed a unique and large diversity of admixtures compared with other breeds. The highest and lowest effective population sizes were observed in Korean Jindo Black (485) and Korean Donggyeong White (109), respectively. The historical effective population size of all Korean dogs showed declining trend from the past to present. It is important to take immediate action to protect the Korean dog population while conserving their diversity. Furthermore, this study suggests that Korean dogs have unique diversity and are one of the basal lineages of East Asian dogs, originating from China.	[Choi, Bong Hwan; Park, Eung Woo] RDA, Natl Inst Anim Sci, Anim Genome & Bioinformat, Wonju, South Korea; [Wijayananda, Hasini I.; Lee, Soo Hyun; Lee, Doo Ho; Lee, Seung Hwan] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Kim, Jong Seok; Oh, Seok Il] Korean Jindo & Domest Anim Ctr, Jindo, South Korea; [Lee, Cheul Koo] Korea Univ, Dept Biotechnol, Seoul, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Chungnam National University; Korea University	Lee, SH (corresponding author), Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea.	slee46@cnu.ac.kr		Lee, Seung Hwan/0000-0003-1508-4887; Lee, Darrall/0000-0002-6990-4441; I Wijayananda, Hasini/0000-0003-1330-8541	AGENDA project of the National Institute of Animal Science, Rural Development Administration, Republic of Korea [PJ0119502017]	AGENDA project of the National Institute of Animal Science, Rural Development Administration, Republic of Korea	This study was supported by awards from the AGENDA project (grant no. PJ0119502017) of the National Institute of Animal Science, Rural Development Administration, Republic of Korea.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alam M, 2012, ASIAN AUSTRAL J ANIM, V25, P1063, DOI 10.5713/ajas.2012.12048; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], DOMESTIC DOG ITS EVO; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cho GJ, 2005, ASIAN AUSTRAL J ANIM, V18, P1071, DOI 10.5713/ajas.2005.1071; Choi S. G., 2008, KOREAN J COMPANION A, V5, P7; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fan ZX, 2016, GENOME RES, V26, P163, DOI 10.1101/gr.197517.115; FAO, 1996, SEC GUID DEV NAT FAR; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Ha J. H., 1998, Korean Journal of Animal Science, V40, P711; Ha J. H., 1998, Korean Journal of Animal Science, V40, P701; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Kim KS, 2001, J HERED, V92, P398, DOI 10.1093/jhered/92.5.398; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lee CG, 2000, ASIAN AUSTRAL J ANIM, V13, P381, DOI 10.5713/ajas.2000.381; Lee EW, 2014, J VET MED SCI, V76, P1359, DOI 10.1292/jvms.14-0189; Lee Seung-Hwan, 2014, J Anim Sci Technol, V56, P2, DOI 10.1186/2055-0391-56-2; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Maniatis T., 1982, MOL CLONING; Meuwissen T, 2009, ACTA AGR SCAND A-AN, V59, P71, DOI 10.1080/09064700903118148; NEI M, 1978, GENETICS, V89, P583; Nomura T, 2001, J ANIM SCI, V79, P366; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; RCore Team, 2020, R LANG ENV STAT COMP; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schwartz MK, 1998, ANIM CONSERV, V1, P293, DOI 10.1111/j.1469-1795.1998.tb00040.x; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; SVED J A, 1971, Theoretical Population Biology, V2, P125; TANABE Y, 1991, ZOOL SCI, V8, P639; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; Wang L, 2016, ZOOL RES, V37, P315, DOI 10.13918/j.issn.2095-8137.2016.6.315; WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang HC, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3525-9; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	57	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188676	10.1371/journal.pone.0188676	http://dx.doi.org/10.1371/journal.pone.0188676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182674	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000049
J	Val, S; Krueger, A; Poley, M; Cohen, A; Brown, K; Panigrahi, A; Preciado, D				Val, Stephanie; Krueger, Anna; Poley, Marian; Cohen, Ariella; Brown, Kristy; Panigrahi, Aswini; Preciado, Diego			Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells	FASEB JOURNAL			English	Article						otitis media; quantitative proteomic; infection; innate immunity; vesicle	ACUTE OTITIS-MEDIA; PHOSPHATASE-1-DEPENDENT INHIBITION; EXTRACELLULAR VESICLES; P38 MAPK; EXPRESSION; RNA; MICRORNAS; MUC5AC; IDENTIFICATION; BIOMARKERS	Nontypeable Haemophilus influenzae (NTHi), one of the most common acute otitis media (OM) pathogens, is postulated to promote middle-ear epithelial remodeling in the progression of OM from acute to chronic. The goal of this study was to examine early quantitative proteomic secretome effects of NTHi lysate exposure in a human middle-ear epithelial cell (HMEEC) line. NTHi lysates were used to stimulate HMEEC, and conditional quantitative stable isotope labeling with amino acids in cell culture of cell secretions was performed. Mass spectrometry analysis identified 766 proteins across samples. Of interest, several heterogeneous nuclear ribonucleoproteins (hnRNPs) were regulated by NTHi lysate treatment, especially hnRNP A2B1 and hnRNP Q, known to be implicated in microRNA (miRNA) packaging in exosomes. After purification, the presence of exosomes in HMEEC secretions was characterized by dynamic light scattering (<100 nm), transmission electron microscopy, and CD63/heat shock protein 70 positivity. hnRNP A2B1 and hnRNP Q were confirmed to be found in exosomes by Western blot and proteomic analysis. Finally, exosomal miRNA content comprised 110 unique miRNAs, with 5 found to be statistically induced by NTHi lysate (miR-378a-3p + miR-378i, miR-200a-3p, miR-378g, miR30d-5p, and miR-222-3p), all known to target innate immunity genes. This study demonstrates that NTHi lysates promote release of miRNA-laden exosomes from middle-ear epithelium in vitro.	[Val, Stephanie; Krueger, Anna; Poley, Marian; Cohen, Ariella; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA; [Brown, Kristy; Panigrahi, Aswini] Childrens Natl Hlth Syst, Ctr Genet Med Res, Washington, DC 20010 USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC 20010 USA	Children's National Health System; Children's National Health System; Children's National Health System	Val, S (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.	sval@cnmc.org			U.S. National Institutes of Health (NIH) [2R24HD050846-06]; National Institute of Child Health and Human Development [5P30HD040677, UL1TR000075]; NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program [1U54HD090257-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677, U54HD090257] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Drs. Mary C. Rose and Colberg-Poley (Center for Genetic Medicine) for their kind advice. This work was partially supported by U.S. National Institutes of Health (NIH) Core Grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), National Institute of Child Health and Human Development 5P30HD040677 (Intellectual and Developmental Disabilities Research Center), and UL1TR000075 (NIH National Center for Advancing Translational Sciences), and for the proteomics analysis supported by Award Number 1U54HD090257-01 from NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program. The EM analysis was carried out at the George Washington University Nanofabrication and Imaging Center (GWNIC) with the help of Christine Brantner and Anastas Popratiloff. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Cherry Donald K, 2002, Adv Data, P1; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Grubb MS, 2010, CLIN PEDIATR, V49, P970, DOI 10.1177/0009922810370363; Hathout Y, 2005, J PROTEOME RES, V4, P620, DOI 10.1021/pr049749p; Inamura K, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030036; Janas T, 2015, FEBS LETT, V589, P1391, DOI 10.1016/j.febslet.2015.04.036; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jorgensen M, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20920; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kesimer M, 2015, METHODS, V87, P59, DOI 10.1016/j.ymeth.2015.03.013; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Klein JO, 2002, AM J MANAG CARE, V8, pS345; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Krishn Shiv Ram, 2015, Curr Pharmacol Rep, V1, P355; Lasser C, 2012, EXPERT OPIN BIOL TH, V12, pS189, DOI 10.1517/14712598.2012.680018; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Li HG, 2014, EUR REV MED PHARMACO, V18, P2048; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin J, 2016, TUMOR BIOL, V37, P15835, DOI 10.1007/s13277-016-5410-6; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Liu J, 2009, INT REV IMMUNOL, V28, P139, DOI 10.1080/08830180902943058; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mobergslien A, 2014, J INNATE IMMUN, V6, P105, DOI 10.1159/000351460; Moon SK, 2006, ACTA OTO-LARYNGOL, V126, P564, DOI 10.1080/00016480500452525; Pellatt DF, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.11; Preciado D, 2016, INT J PEDIATR OTORHI, V80, P8, DOI 10.1016/j.ijporl.2015.11.016; Preciado D, 2013, LARYNGOSCOPE, V123, pE66, DOI 10.1002/lary.24097; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, P201, DOI 10.1177/0194599815624407; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Samuels TL, 2016, INT J PEDIATR OTORHI, V88, P104, DOI 10.1016/j.ijporl.2016.06.056; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Sato-Kuwabara Y, 2015, INT J ONCOL, V46, P17, DOI 10.3892/ijo.2014.2712; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Song JJ, 2011, INT J PEDIATR OTORHI, V75, P648, DOI 10.1016/j.ijporl.2011.02.001; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Val S, 2017, PEDIATR RES, V81, P911, DOI 10.1038/pr.2017.25; Val S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152865; Val S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148612; Val S, 2015, JAMA OTOLARYNGOL, V141, P997, DOI 10.1001/jamaoto.2015.2338; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Whitby PW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-925; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Yang J, 2013, ACTA BIOCH BIOPH SIN, V45, P938, DOI 10.1093/abbs/gmt100	54	7	7	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1855	1867		10.1096/fj.201700248RR	http://dx.doi.org/10.1096/fj.201700248RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29191962	Green Published			2022-12-26	WOS:000429051400010
J	Forghany, Z; Robertson, F; Lundby, A; Olsen, JV; Baker, DA				Forghany, Zary; Robertson, Francesca; Lundby, Alicia; Olsen, Jesper V.; Baker, David A.			Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; AP1 transcription factor (AP-1); gene regulation; Notch pathway; signaling	ETS TRANSCRIPTION FACTORS; DELTA-LIKE 4; SIGNALING PATHWAY; GAMMA-SECRETASE; TEL ETV6; ANGIOGENESIS; DEGRADATION; MECHANISMS; BINDING; REGION	Notch signaling is a ubiquitous signal transduction pathway found in most if not all metazoan cell types characterized to date. It is indispensable for cell differentiation as well as tissue growth, tissue remodeling, and apoptosis. Although the canonical Notch signaling pathway is well characterized, accumulating evidence points to the existence of multiple, less well-defined layers of regulation. In this study, we investigated the function of the intracellular domain (ICD) of the Notch ligand Delta-like 4 (DLL4). We provide evidence that the DLL4 ICD is required for normal DLL4 subcellular localization. We further show that it is cleaved and interacts with the JUN proto-oncogene, which forms part of the activator protein 1 (AP-1) transcription factor complex. Mechanistically, the DLL4 ICD inhibited JUN binding to DNA and thereby controlled the expression of JUN target genes, including DLL4. Our work further demonstrated that JUN strongly stimulates endothelial cell tube formation and that DLL4 constrains this process. These results raise the possibility that Notch/DLL4 signaling is bidirectional and suggest that the DLL4 ICD could represent a point of cross-talk between Notch and receptor tyrosine kinase (RTK) signaling.	[Forghany, Zary; Robertson, Francesca; Baker, David A.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Lundby, Alicia; Olsen, Jesper V.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark; [Lundby, Alicia] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Robertson, Francesca] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; University of Copenhagen; University of Oxford	Baker, DA (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands.	d.baker@lumc.nl	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938	Dutch Cancer Society [30861]; Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); Novo Nordisk Foundation Center for Protein Research	This work was supported by Dutch Cancer Society Grant 30861 (to D. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Ayllon V, 2015, LEUKEMIA, V29, P1741, DOI 10.1038/leu.2015.74; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Braune EB, 2016, DISCOV MED, V21, P189; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2708, DOI 10.1021/bi9923555; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Craig MP, 2016, ANGIOGENESIS, V19, P275, DOI 10.1007/s10456-016-9511-z; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Duryagina R, 2013, STEM CELLS DEV, V22, P2736, DOI 10.1089/scd.2012.0638; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Josten F, 2004, DEV BIOL, V267, P181, DOI 10.1016/j.ydbio.2003.11.016; Jung J, 2011, MOL CELLS, V32, P161, DOI 10.1007/s10059-011-1046-y; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kitagawa M, 2016, J BIOCHEM, V159, P287, DOI 10.1093/jb/mvv123; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Licht AH, 2006, J CELL BIOL, V175, P981, DOI 10.1083/jcb.200605149; Liebler SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053074; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Lundby A, 2014, NAT METHODS, V11, P868, DOI [10.1038/nmeth.2997, 10.1038/NMETH.2997]; Lundby A, 2011, METHODS MOL BIOL, V753, P143, DOI 10.1007/978-1-61779-148-2_10; Meester JAN, 2015, AM J HUM GENET, V97, P475, DOI 10.1016/j.ajhg.2015.07.015; Metrich M, 2015, CARDIOVASC RES, V108, P74, DOI 10.1093/cvr/cvv209; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Palmer WH, 2015, TRENDS CELL BIOL, V25, P697, DOI 10.1016/j.tcb.2015.07.010; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Randi AM, 2009, BIOCHEM SOC T, V37, P1248, DOI 10.1042/BST0371248; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Shah AV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16002; Sharghi-Namini S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04031; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheldon H, 2010, BLOOD, V116, P2385, DOI 10.1182/blood-2009-08-239228; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sun X, 1996, DEVELOPMENT, V122, P2465; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059	72	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1229	1242		10.1074/jbc.M117.819045	http://dx.doi.org/10.1074/jbc.M117.819045			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29196606	Green Published, hybrid			2022-12-26	WOS:000423515000011
J	Du, HQ; Shi, YH; Li, DF; Fan, WN; Wang, GQ; Wang, CZ				Du, Hongqi; Shi, Yinghua; Li, Defeng; Fan, Wenna; Wang, Guoqiang; Wang, Chengzhang			Screening and identification of key genes regulating fall dormancy in alfalfa leaves	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; UBIQUITIN LIGASE FAMILY; ABSCISIC-ACID; PLANT-GROWTH; CELL-CYCLE; TRANSCRIPTION FACTORS; PHOTOSYSTEM-II; SEED DORMANCY; TIP GROWTH; ARABIDOPSIS	Fall dormancy (FD) determines the adaptation of an alfalfa variety and affects alfalfa production and quality. However, the molecular mechanism underlying FD remains poorly understood. Here, 44 genes regulating FD were identified by comparison of the transcriptomes from leaves of Maverick (fall-dormant alfalfa) and CUF101(non-fall-dormant), during FD and non-FD and were classified them depending on their function. The transcription of IAA-amino acid hydrolase ILR1-like 1, abscisic acid receptor PYL8, and monogalactosyldiacylglycerol synthase-3 in Maverick leaves was regulated by daylength and temperature, and the transcription of the abscisic acid receptor PYL8 was mainly affected by daylength. The changes in the expression of these genes and the abundance of their messenger RNA (mRNA) in Maverick leaves differed from those in CUF101 leaves, as evidenced by the correlation analysis of their mRNA abundance profiles obtained from April to October. The present findings suggested that these genes are involved in regulating FD in alfalfa.	[Du, Hongqi; Shi, Yinghua; Li, Defeng; Wang, Guoqiang; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Henan, Peoples R China; [Fan, Wenna] Henan Univ Sci & Technol, Sch Anim Sci & Technol, Luoyang, Henan, Peoples R China	Henan Agricultural University; Henan University of Science & Technology	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Henan, Peoples R China.	wangcz@henau.edu.cn		Wang, Chengzhang/0000-0002-2967-5066	Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region [201403048-6]; China Forage and Grass Research System [CARS-34]; National Natural Science Foundation of China [31172261]	Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region; China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Thanks for support of Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region (No.201403048-6), China Forage and Grass Research System(No.CARS-34)and The National Natural Science Foundation of China (No.31172261). Hongqi Du designed the experiment, performed most of the research, analyzed the data and drafted the manuscript. Yinghua Shi plays role in drafting and revising the manuscript. Chengzhang Wang designed the experiment, supervised the study, and revised the manuscript.Defeng Li, Wenna Fan,Yanhua Wang and Guoqiang Wang give some helps in the process of study.; Thanks for support of Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region (No.201403048-6), China Forage and Grass Research System(No.CARS-34) and The National Natural Science Foundation of China (No.31172261). We express our gratitude to Doc. Yanlei Cui and Doc. Xuyan Peng for their help in the revision of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alves MS, 2011, PLANT SIGNAL BEHAV, V6, P1993, DOI 10.4161/psb.6.12.18268; [Anonymous], 2008, PHYSIOL PLANTARUM, V132, P79; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Barnes DK, 1979, FALL DORMANCY ALFALF; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cao Y, 1990, MODIFIED TECHNIQUE M; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; COX M.M., 2000, LEHNINGER PRINCIPLES, V3th, P306; de Pellegrini LG, 2010, REV BRAS ZOOTECN, V39, P1894, DOI 10.1590/S1516-35982010000900006; Rodriguez-Gacio MD, 2009, PLANT SIGNAL BEHAV, V4, P1035, DOI 10.4161/psb.4.11.9902; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Du HongQi, 2014, Acta Agrestia Sinica, V22, P572; Edwards A, 2007, MOL PLANT MICROBE IN, V20, P1183, DOI 10.1094/MPMI-20-10-1183; Fan WN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105304, 10.1371/journal.pone.0114612]; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; [樊文娜 Fan Wenna], 2011, [草地学报, Acta Agrestia Sinica], V19, P975; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Harvey SH, 2002, GENOME BIOL, V3; Hemsley P.A. TL, 2007, P 18 INT C AR RES BE; Hoenicka H, HETEROLOGOUS OVEREXP, P1001; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; JIANG CZ, 1994, PLANT J, V5, P787, DOI 10.1046/j.1365-313X.1994.5060787.x; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kallenbach RL, 2001, CROP SCI, V41, P774, DOI 10.2135/cropsci2001.413774x; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Koh S, 2002, PLANT PHYSIOL, V128, P21, DOI 10.1104/pp.010332; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kumar A, 2009, PHOTOSYNTH RES, V100, P143, DOI 10.1007/s11120-009-9438-y; Kurasawa Y, SSENTIAL ROLES KIF4, P3237; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lally D, ANTISENSE EXPRESSION, P1317; Larry R., CHARACTERIZATION CER; Lensch M, 2001, J BIOL CHEM, V276, P33645, DOI 10.1074/jbc.M100506200; Li ZG, 2009, J EXP BOT, V60, P3521, DOI 10.1093/jxb/erp195; Liscum E, GENETICS AUX IAA ARF, P387; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MAGNUS V, 1992, J PLANT GROWTH REGUL, V11, P67, DOI 10.1007/BF00198017; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; MATE CJ, 1993, PLANT PHYSIOL, V102, P1119, DOI 10.1104/pp.102.4.1119; Mate CJ, 1996, PLANTA, V198, P604, DOI 10.1007/BF00262648; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Merida A, 1999, PLANT PHYSIOL, V120, P401, DOI 10.1104/pp.120.2.401; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Muschietti J, ABSCISIC ACID ABA RE; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Null R., 2011, COMPUTING, V1, P12; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Portis R, 1990, ACTIVATION OFRIBULOS, V94, P245; Quail P, 1999, GENE DEV, V13, P2017; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; RINNE P, 1994, PHYSIOL PLANTARUM, V90, P451, DOI 10.1111/j.1399-3054.1994.tb08801.x; Riou-Khamlichi C, 2000, MOL CELL BIOL, V20, P4513, DOI 10.1128/MCB.20.13.4513-4521.2000; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; SCHIEFELBEIN J, 1993, PLANT PHYSIOL, V103, P979, DOI 10.1104/pp.103.3.979; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Sedbrook JC, 2002, ARABIDOPSIS SKU5 GEN, P1635; SHIH SC, 1967, CROP SCI, V7, P385, DOI 10.2135/cropsci1967.0011183X000700040033x; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Staswick P, 2009, PLANT SIGNAL BEHAV, V4, P757, DOI 10.1104/pp.109.138529; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Sultan SE, 2010, CURR OPIN PLANT BIOL, V13, P96, DOI 10.1016/j.pbi.2009.09.021; Tang WJ, 2012, PLANT CELL, V24, P1984, DOI 10.1105/tpc.112.097022; Teuber LR, 1998, 3 N AM ALF IMPR C AG, pA; Tysdal HM, 1933, J AGRIC RES, V46, P0483; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Van Aken O, MITOCHONDRIAL TYPE 1, P850; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wetzel CM, 2009, J EXP BOT, V60, P1715, DOI 10.1093/jxb/erp051; Williams ME, 2010, PLANT CELL, V22, P1; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Wu W, 2013, BBA-BIOENERGETICS, V1827, P709, DOI 10.1016/j.bbabio.2013.02.013; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, GLYCOPROTEIN SPECIFI, P239; Zhang M, 2010, PLANT J, V63, P312, DOI 10.1111/j.1365-313X.2010.04238.x; Zhang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122170; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	101	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188964	10.1371/journal.pone.0188964	http://dx.doi.org/10.1371/journal.pone.0188964			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211806	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200053
J	Hietanen, MA; Price, NSC; Cloherty, SL; Hadjidimitrakis, K; Ibbotson, MR				Hietanen, Markus A.; Price, Nicholas S. C.; Cloherty, Shaun L.; Hadjidimitrakis, Kostas; Ibbotson, Michael R.			Long-term sensorimotor adaptation in the ocular following system of primates	PLOS ONE			English	Article							EYE-MOVEMENTS; NEURAL BASIS; VESTIBULOOCULAR REFLEX; RESPONSES; MONKEY; INACTIVATION; DEPENDENCE; TRACKING; VERMIS	The sudden movement of a wide-field image leads to a reflexive eye tracking response referred to as short-latency ocular following. If the image motion occurs soon after a saccade the initial speed of the ocular following is enhanced, a phenomenon known as post-saccadic enhancement. We show in macaque monkeys that repeated exposure to the same stimulus regime over a period of months leads to progressive increases in the initial speeds of ocular following. The improvement in tracking speed occurs for ocular following with and without a prior saccade. As a result of the improvement in ocular following speeds, the influence of post-saccadic enhancement wanes with increasing levels of training. The improvement in ocular following speed following repeated exposure to the same oculomotor task represents a novel form of sensori-motor learning in the context of a reflexive movement.	[Hietanen, Markus A.; Cloherty, Shaun L.; Ibbotson, Michael R.] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia; [Hietanen, Markus A.; Cloherty, Shaun L.; Ibbotson, Michael R.] Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic, Australia; [Hietanen, Markus A.; Price, Nicholas S. C.; Cloherty, Shaun L.; Ibbotson, Michael R.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia; [Price, Nicholas S. C.; Cloherty, Shaun L.; Hadjidimitrakis, Kostas; Ibbotson, Michael R.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Hietanen, Markus A.] Swinburne Univ Technol, Dept Fdn & Pathways, Hawthorn, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; Swinburne University of Technology	Ibbotson, MR (corresponding author), Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia.; Ibbotson, MR (corresponding author), Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic, Australia.; Ibbotson, MR (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	mibbotson@nvri.org.au	Cloherty, Shaun L./AAH-5029-2019; Hietanen, Markus A/C-5111-2008; ibbotson, michael/F-9030-2011	Cloherty, Shaun L./0000-0002-7679-1764; ibbotson, michael/0000-0002-3803-6653; Price, Nicholas/0000-0001-9404-7704	Australian Research Council through the Centre of Excellence for Integrative Brain Function [CE140100007]; National Health and Medical Research Council of Australia [GNT1028710]; Lions Clubs of Victoria	Australian Research Council through the Centre of Excellence for Integrative Brain Function(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lions Clubs of Victoria	This work was supported by the Australian Research Council [http://arc.gov.au] through the Centre of Excellence for Integrative Brain Function (CE140100007 to MRI), by the National Health and Medical Research Council of Australia [http://nhmrc.gov.au] (GNT1028710 to MRI) and the Lions Clubs of Victoria [http://lionsclubs.org.au/] to SLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazquez PM, 2007, J NEUROPHYSIOL, V97, P1114, DOI 10.1152/jn.00983.2006; Blum J, 2014, J VISION, V14, DOI 10.1167/14.3.23; Bourrelly C, 2016, J NEUROPHYSIOL, V116, P2739, DOI 10.1152/jn.00519.2016; Cloherty SL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00122; Cloherty SL, 2010, VISION RES, V50, P2683, DOI 10.1016/j.visres.2010.08.020; Fukushima K, 1996, NEUROSCI RES, V25, P391; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107, DOI 10.1017/S0952523800000158; GRUSSER OJ, 1994, BEHAV BRAIN SCI, V17, P262, DOI 10.1017/S0140525X00034415; Havermann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039708; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kahlon M, 1996, J NEUROSCI, V16, P7270; Katoh A, 2005, EUR J NEUROSCI, V21, P1315, DOI 10.1111/j.1460-9568.2005.03946.x; KAWANO K, 1986, J NEUROPHYSIOL, V56, P1355, DOI 10.1152/jn.1986.56.5.1355; Kawano K, 1999, CURR OPIN NEUROBIOL, V9, P467, DOI 10.1016/S0959-4388(99)80070-1; Kojima Y, 2011, BRAIN RES, V1401, P30, DOI 10.1016/j.brainres.2011.05.027; Kuki Y, 2004, NEUROREPORT, V15, P1007, DOI 10.1097/00001756-200404290-00015; LISBERGER SG, 1988, TRENDS NEUROSCI, V11, P147, DOI 10.1016/0166-2236(88)90140-3; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILES FA, 1986, J NEUROPHYSIOL, V56, P1381, DOI 10.1152/jn.1986.56.5.1381; MILES FA, 1986, J NEUROPHYSIOL, V56, P1321, DOI 10.1152/jn.1986.56.5.1321; Ono S, 2007, J NEUROPHYSIOL, V98, P2918, DOI 10.1152/jn.00115.2007; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P632, DOI 10.1152/jn.1995.73.2.632; Price NSC, 2010, J NEUROSCI, V30, P14036, DOI 10.1523/JNEUROSCI.2336-10.2010; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Shutoh F, 2002, NEUROSCI RES, V42, P141, DOI 10.1016/S0168-0102(01)00308-X; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wakita R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04273-9; Wurtz RH, 2013, SCHOLARPEDIA, V8, P12335, DOI DOI 10.4249/SCHOLARPEDIA.12335; Yamamoto K, 2002, ANN NY ACAD SCI, V978, P439, DOI 10.1111/j.1749-6632.2002.tb07586.x; Yamamoto K, 2002, J NEUROPHYSIOL, V87, P1554, DOI 10.1152/jn.00166.2001	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189030	10.1371/journal.pone.0189030	http://dx.doi.org/10.1371/journal.pone.0189030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200430	Green Published, gold			2022-12-26	WOS:000417033200025
J	Fujita, Y; Seekaki, P; Ogata, N; Chiba, K				Fujita, Yuko; Seekaki, Panpaki; Ogata, Norichika; Chiba, Kazuhiro			Physiological effects of a novel artificially synthesized antimalarial cyclic peptide: Mahafacyclin B	PLOS ONE			English	Article							CELL-SHAPE; CYCLIZATION; PROTEINS; BINDING; TOOLS; BOX	Mahafacyclin B is a cyclic peptide isolated from the latex of Jatropha mahafalensis and is an antimalarial agent. However, the physiological effects of mahafacyclin B in mammalian cells are not known. Here, we assessed the growth, morphology, and alterations in the transcriptome of CHO-K1 cells exposed to mahafacyclin B (0-22 mu M). Mahafacyclin B at 2.2 mu M did not affect the proliferation or death of CHO-K1 cells. Mahafacyclin B was not toxic to mammalian cells at 2.2 mu M, which represents a normal physiological concentration at which mahafacyclin B retains its antimalarial properties. Interestingly, mahafacyclin B altered the size and morphology of CHO-K1 cells. Comparative transcriptomics revealed that mahafacyclin B modulated the expression of a specific subset of genes.	[Fujita, Yuko; Chiba, Kazuhiro] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Seekaki, Panpaki] Nihon BioData Corp, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Ogata, Norichika] Chitose Bio Evolut Pte Ltd, Cent Singapore, Singapore, Singapore	Tokyo University of Agriculture & Technology	Chiba, K (corresponding author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.; Ogata, N (corresponding author), Chitose Bio Evolut Pte Ltd, Cent Singapore, Singapore, Singapore.	norichik@nbiodata.com; chiba@cc.tuat.ac.jp	Chiba, Kazuhiro/C-3796-2013	Chiba, Kazuhiro/0000-0002-9580-5236; Ogata, Norichika/0000-0002-6856-6655	Promotion of Science (JSPS) [20146938]; Nihon BioData Corporation; JSPS KAKENHI [20146938]; Grants-in-Aid for Scientific Research [14J06938] Funding Source: KAKEN	Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nihon BioData Corporation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Japan Society for the Promotion of Science (JSPS), 20146938 to Yuko Fujita (https://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ogata is a member of a commercial company: Nihon BioData Corporation (NBD). NBD is Ogata's company, and Ogata bought some materials using the company's money. The funder, Nihon BioData Corporation, provided support in the form of materials for author NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by JSPS KAKENHI, Grant Number 20146938.	Akanuma T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11963; Baraguey C, 2001, J CHEM SOC PERK T 1, P2098, DOI 10.1039/b008538n; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; de Kreuk BJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11394; Fujita Y, 2013, ORG LETT, V15, P1155, DOI 10.1021/ol4003477; Gilliland SM, 2012, BIOLOGICALS, V40, P270, DOI 10.1016/j.biologicals.2012.02.002; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Illesinghe J, 2009, CHEM COMMUN, P295, DOI 10.1039/b814092h; Joo SH, 2012, BIOMOL THER, V20, P19, DOI 10.4062/biomolther.2012.20.1.019; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Khan AS, 2009, BIOLOGICALS, V37, P196, DOI 10.1016/j.biologicals.2009.02.016; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20823; Ma Hailun, 2011, PDA J Pharm Sci Technol, V65, P685, DOI 10.5731/pdajpst.2011.00843; Ma HL, 2011, J VIROL, V85, P6579, DOI 10.1128/JVI.00147-11; Martin MA, 2000, GEODERMA, V98, P1, DOI 10.1016/S0016-7061(00)00049-5; McNairn AJ, 2005, EXP CELL RES, V308, P345, DOI 10.1016/j.yexcr.2005.05.009; Meneses C, 2010, J ORG CHEM, V75, P564, DOI 10.1021/jo902116p; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Moorkens E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00193; Ogata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144822; Ong YS, 2017, CURR TOP MED CHEM, V17, P2302, DOI 10.2174/1568026617666170224121658; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Rangamani P, 2013, CELL, V154, P1356, DOI 10.1016/j.cell.2013.08.026; Sayyadi N, 2005, ORG LETT, V7, P5497, DOI 10.1021/ol0522891; Seekaki P, 2017, PREPRINT; Seekaki P, 2017, LECT NOTES COMPUT SC, V10362, P529, DOI 10.1007/978-3-319-63312-1_46; Shameer K, 2014, CIRC-CARDIOVASC GENE, V7, P607, DOI 10.1161/CIRCGENETICS.113.000233; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Unigen Inc, 2017, NOT SAL SHAR OUR CO; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Wu DJ, 2016, J AUTOIMMUN, V73, P73, DOI 10.1016/j.jaut.2016.06.004; Zhao JF, 2013, ORG LETT, V15, P5182, DOI 10.1021/ol402279h	35	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188415	10.1371/journal.pone.0188415	http://dx.doi.org/10.1371/journal.pone.0188415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190661	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900055
J	Hart, H; Lim, L; Mehta, MA; Chatzieffraimidou, A; Curtis, C; Xu, XH; Breen, G; Simmons, A; Mirza, K; Rubia, K				Hart, Heledd; Lim, Lena; Mehta, Mitul A.; Chatzieffraimidou, Antonia; Curtis, Charles; Xu, Xiaohui; Breen, Gerome; Simmons, Andrew; Mirza, Kah; Rubia, Katya			Reduced functional connectivity of fronto-parietal sustained attention networks in severe childhood abuse	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SEROTONIN TRANSPORTER POLYMORPHISM; LONG-TERM CONSEQUENCES; SOCIOECONOMIC-STATUS; 5-HTTLPR GENOTYPES; MONOAMINE-OXIDASE; EARLY DEPRIVATION; HEALTH BEHAVIOR; STRESS-DISORDER; MENTAL-HEALTH	Childhood maltreatment is associated with attention deficits. We examined the effect of childhood abuse and abuse-by-gene (5-HTTLPR, MAOA, FKBP5) interaction on functional brain connectivity during sustained attention in medication/drug-free adolescents. Functional connectivity was compared, using generalised psychophysiological interaction (gPPI) analysis of functional magnetic resonance imaging (fMRI) data, between 21 age-and gender-matched adolescents exposed to severe childhood abuse and 27 healthy controls, while they performed a parametrically modulated vigilance task requiring target detection with a progressively increasing load of sustained attention. Behaviourally, participants exposed to childhood abuse had increased omission errors compared to healthy controls. During the most challenging attention condition abused participants relative to controls exhibited reduced connectivity, with a left-hemispheric bias, in typical fronto-parietal attention networks, including dorsolateral, rostromedial and inferior prefrontal and inferior parietal regions. Abuse-related connectivity abnormalities were exacerbated in individuals homozygous for the risky C-allele of the single nucleotide polymorphism rs3800373 of the FK506 Binding Protein 5 (FKBP5) gene. Findings suggest that childhood abuse is associated with decreased functional connectivity in fronto-parietal attention networks and that the FKBP5 genotype moderates neurobiological vulnerability to abuse. These findings represent a first step towards the delineation of abuse-related neurofunctional connectivity abnormalities, which hopefully will facilitate the development of specific treatment strategies for victims of childhood maltreatment.	[Hart, Heledd; Lim, Lena; Chatzieffraimidou, Antonia; Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England; [Mehta, Mitul A.; Simmons, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England; [Curtis, Charles; Xu, Xiaohui; Breen, Gerome] Inst Psychiat Psychol & Neurosci, MRC SGDP Ctr, NIHR BRC Mental Hlth, London, England; [Curtis, Charles; Xu, Xiaohui; Breen, Gerome] SLaM NHS Trust, Kings Coll London, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Hart, H (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England.	heledd.hart@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Hart, Heledd/0000-0003-3826-9999; Lim, Lena/0000-0002-3301-923X; Rubia, Katya/0000-0002-1410-7701; Curtis, Charles/0000-0002-2992-1941	Kids Company; Reta Lila Weston Trust for Medical Research; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; National Medical Research Council (Singapore); NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust	Kids Company; Reta Lila Weston Trust for Medical Research; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; National Medical Research Council (Singapore)(National Medical Research Council, Singapore); NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust	The research was supported by Kids Company and the Reta Lila Weston Trust for Medical Research to KR. HH was supported by Kids Company, the Reta Lila Weston Trust for Medical Research and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. LL was supported by the National Medical Research Council (Singapore), Kids Company and the Reta Lila Weston Trust for Medical Research. AS and KR have received support from the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PT, 1998, CHILD ABUSE NEGLECT, V22, P759, DOI 10.1016/S0145-2134(98)00062-3; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Benoit RG, 2011, CEREB CORTEX; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bevilacqua L, 2012, ARCH GEN PSYCHIAT, V69, P62, DOI 10.1001/archgenpsychiatry.2011.152; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bucker J, 2012, COMPR PSYCHIAT, V53, P758, DOI 10.1016/j.comppsych.2011.12.006; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Chipman P, 2007, AM J MED GENET B, V144B, P561, DOI 10.1002/ajmg.b.30480; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Cooke BM, 2014, HORM BEHAV, V65, P416, DOI 10.1016/j.yhbeh.2014.03.004; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; Dackis MN, 2012, DEV PSYCHOPATHOL, V24, P1237, DOI 10.1017/S0954579412000673; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DePrince AP, 2009, CHILD ABUSE NEGLECT, V33, P353, DOI 10.1016/j.chiabu.2008.08.002; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Elton A, 2014, HUM BRAIN MAPP, V35, P1654, DOI 10.1002/hbm.22280; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hart H, 2017, PSYCHOL MED IN PRESS; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Huang H, 2012, NEUROPSYCHOPHARMACOL, V37, P2693, DOI 10.1038/npp.2012.133; Jedd K, 2015, DEV PSYCHOPATHOL, V27, P1577, DOI 10.1017/S0954579415000954; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Langner R., 2013, SUSTAINING ATTENTION; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lim L, 2015, AM J PSYCHIAT, DOI appiajp201514081042; Lim L., 2014, AM J PSYCHIAT; Lim L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165547; Loman MM, 2013, J CHILD PSYCHOL PSYC, V54, P37, DOI 10.1111/j.1469-7610.2012.02602.x; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Markett S, 2014, HUM BRAIN MAPP, V35, P1700, DOI 10.1002/hbm.22285; Marshall TR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002272; McDermott JM, 2013, PSYCHOSOCIAL DEPRIVA; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Murphy CM, 2014, AM J PSYCHIAT, V171, P1107, DOI 10.1176/appi.ajp.2014.12030352; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Olsson CA, 2005, MOL PSYCHIATR, V10, P868, DOI 10.1038/sj.mp.4001677; Paul Robert, 2008, Neuropsychiatr Dis Treat, V4, P193; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004; Raine A, 2001, AGGRESSIVE BEHAV, V27, P111, DOI 10.1002/ab.4; Roberts S, 2015, DEPRESS ANXIETY, V32, P861, DOI 10.1002/da.22430; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Rubia K, 1998, NEUROPSYCHOLOGIA, V36, P1283, DOI 10.1016/S0028-3932(98)00038-4; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith AB, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00136; Smith AB, 2011, NEUROIMAGE, V56, P1693, DOI 10.1016/j.neuroimage.2011.01.072; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Taylor A, 2007, DEV PSYCHOPATHOL, V19, P1029, DOI 10.1017/S095457940700051X; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Trickett PK, 2011, CHILD ABUSE NEGLECT, V35, P876, DOI 10.1016/j.chiabu.2011.08.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Werff SJA, 2013, PSYCHOL MED, V43, P1825, DOI 10.1017/S0033291712002942; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weder N, 2009, BIOL PSYCHIAT, V65, P417, DOI 10.1016/j.biopsych.2008.09.013; Zoroglu SS, 2002, NEUROPSYCHOBIOLOGY, V45, P176, DOI 10.1159/000063667	96	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188744	10.1371/journal.pone.0188744	http://dx.doi.org/10.1371/journal.pone.0188744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190830	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900116
J	Li, XF; Roevros, N; Dehairs, F; Chou, L				Li, Xuefeng; Roevros, Nathalie; Dehairs, Frank; Chou, Lei			Biological responses of the marine diatom Chaetoceros socialis to changing environmental conditions: A laboratory experiment	PLOS ONE			English	Article							OCEAN ACIDIFICATION; DUST DEPOSITION; SOUTHERN-OCEAN; CLIMATE-CHANGE; MINERAL DUST; WORLD OCEAN; NUTRIENT-LIMITATION; COMMUNITY STRUCTURE; ATMOSPHERIC INPUT; NITROGEN-FIXATION	Diatoms constitute a major group of phytoplankton, accounting for similar to 20% of the world's primary production. It has been shown that iron (Fe) can be the limiting factor for phytoplankton growth, in particular, in the HNLC (High Nutrient Low Chlorophyll) regions. Iron plays thus an essential role in governing the marine primary productivity and the efficiency of biological carbon pump. Oceanic systems are undergoing continuous modifications at varying rates and magnitudes as a result of changing climate. The objective of our research is to evaluate how changing environmental conditions (dust deposition, ocean warming and acidification) can affect marine Fe biogeochemistry and diatom growth. Laboratory culture experiments using a marine diatom Chaetoceros socialis were conducted at two temperatures (13 degrees C and 18 degrees C) and under two pCO(2) (carbon dioxide partial pressure) (400 mu atm and 800 mu atm) conditions. The present study clearly highlights the effect of ocean acidification on enhancing the release of Fe upon dust deposition. Our results also confirm that being a potential source of Fe, dust provides in addition a readily utilizable source of macronutrients such as dissolved phosphate (PO4) and silicate (DSi). However, elevated atmospheric CO2 concentrations may also have an adverse impact on diatom growth, causing a decrease in cell size and possible further changes in phytoplankton composition. Meanwhile, ocean warming may lead to the reduction of diatom production and cell size, inducing poleward shifts in the biogeographic distribution of diatoms. The changing climate has thus a significant implication for ocean phytoplankton growth, cell size and primary productivity, phytoplankton distribution and community composition, and carbon (C), nitrogen (N), phosphorus (P), silicon (Si) and Fe biogeochemical cycles in various ways.	[Li, Xuefeng; Roevros, Nathalie; Chou, Lei] Univ Libre Bruxelles, Serv Biogeochim & Modelisat, Syst Terre Oceanog Chim & Geochim Eaux, Brussels, Belgium; [Li, Xuefeng; Dehairs, Frank] Vrije Univ Brussel, Earth Syst Sci & Analyt, Environm & Geochem, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Li, XF (corresponding author), Univ Libre Bruxelles, Serv Biogeochim & Modelisat, Syst Terre Oceanog Chim & Geochim Eaux, Brussels, Belgium.; Li, XF (corresponding author), Vrije Univ Brussel, Earth Syst Sci & Analyt, Environm & Geochem, Brussels, Belgium.	xuefli@ulb.ac.be			F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation [FC99216]; Universite A Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB); F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation	F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation(Fonds de la Recherche Scientifique - FNRS); Universite A Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB); F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation(Fonds de la Recherche Scientifique - FNRS)	This work was financed by F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation to XL (mandate no. FC99216, www.fnrs.be). Additional funding was provided by the Universite Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financed by F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation and X. Li was a FNRS Aspirant fellow (mandate no. FC99216). Additional funding was provided by the Universite A Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB). We would like to thank Master students Raphael Mathieu and Harold Ingber from the ULB for their great help with the culture work. Claire Mourgues, David Verstraten and Debany Fonseca-Batista from the VUB assisted in the EA-IRMS analyses. Prof. Alain Bernard (ULB) performed the XRD analyses of the dust samples. Adriana Anzil and Gaelle Speeckaert of Laboratoire d'Ecolgoie des Systemes Aquatiques (ULB) provided the Chaetoceros socialis strain. We are grateful to all the colleagues who were involved in our research from ULB and VUB.	[Anonymous], 2007, CONTRIBUTION WORKING; [Anonymous], 2006, SCOPE; Astrahan P, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00222; Baker AR, 2010, MAR CHEM, V120, P4, DOI 10.1016/j.marchem.2008.09.003; Baker AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024764; Baker AR, 2006, MAR CHEM, V98, P43, DOI 10.1016/j.marchem.2005.06.004; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Booth BC, 2002, DEEP-SEA RES PT II, V49, P5003, DOI 10.1016/S0967-0645(02)00175-3; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2003, GLOB CHANGE IGBP SER, P157; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carbonnel V, 2009, BIOGEOCHEMISTRY, V96, P49, DOI 10.1007/s10533-009-9344-6; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chen KY, 2010, ATMOS OCEAN SCI LETT, V3, P155, DOI 10.1080/16742834.2010.11446858; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Degerlund M, 2010, ESTUAR COAST, V33, P242, DOI 10.1007/s12237-009-9167-7; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Du HQ, 2014, SCI TOTAL ENVIRON, V479, P77, DOI 10.1016/j.scitotenv.2014.01.095; Duarte CM, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000140; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Fu FX, 2008, HARMFUL ALGAE, V7, P76, DOI 10.1016/j.hal.2007.05.006; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P697, DOI 10.1029/2000GB900001; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gonzalez-Davila M, 2010, BIOGEOSCIENCES, V7, P3067, DOI 10.5194/bg-7-3067-2010; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Herut B, 1999, LIMNOL OCEANOGR, V44, P1683, DOI 10.4319/lo.1999.44.7.1683; Hoffmann LJ, 2008, POLAR BIOL, V31, P1067, DOI 10.1007/s00300-008-0448-6; Hoffmann LJ, 2012, MAR ECOL PROG SER, V470, P191, DOI 10.3354/meps10082; Hopkinson BM, PNAS, V108, P3830; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; King AL, 2015, MAR ECOL PROG SER, V537, P59, DOI 10.3354/meps11458; Krishnamurthy A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001115; Krishnamurthy A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003440; Lauder H.S., 1864, T MICROSCOPICAL SOC, V12, P75, DOI [10.1111/j.1365-2818.1864.tb01628.x, DOI 10.1111/J.1365-2818.1864.TB01628.X]; Lekunberri I, 2010, J PLANKTON RES, V32, P381, DOI 10.1093/plankt/fbp137; Lewis E., 1998, ORNLCDIAC105; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Luo C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002964; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Mahowald NM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017880; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; Markaki Z, 2003, LIMNOL OCEANOGR, V48, P1557, DOI 10.4319/lo.2003.48.4.1557; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Okin GS, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003858; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; REDFIELD AC, 1958, AM SCI, V46, P205; Ridame C, 2002, LIMNOL OCEANOGR, V47, P856, DOI 10.4319/lo.2002.47.3.0856; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Schlosser C, 2012, LIMNOL OCEANOGR, V57, P684, DOI 10.4319/lo.2012.57.3.0684; Sedwick PN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001586; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sullivan RC, 2007, ATMOS CHEM PHYS, V7, P1213, DOI 10.5194/acp-7-1213-2007; Tan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057656; Tew KS, 2014, HYDROBIOLOGIA, V741, P79, DOI 10.1007/s10750-014-1856-y; Tortell PD, 2002, LIMNOL OCEANOGR, V47, P1012, DOI 10.4319/lo.2002.47.4.1012; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Usher CR, 2003, CHEM REV, V103, P4883, DOI 10.1021/cr020657y; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Weber T, 2014, P NATL ACAD SCI USA, V111, P8741, DOI 10.1073/pnas.1317193111; Woodward S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023482; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Yu HB, 2015, GEOPHYS RES LETT, V42, P1984, DOI 10.1002/2015GL063040; Zhuang GS, 1992, GLOBAL BIOGEOCHEM CY, V6, P161, DOI 10.1029/92GB00756	100	6	6	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188615	10.1371/journal.pone.0188615	http://dx.doi.org/10.1371/journal.pone.0188615			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190826	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900084
J	Taylor, RM; Sunde, RA				Taylor, Rachel M.; Sunde, Roger A.			Selenium requirements based on muscle and kidney selenoprotein enzyme activity and transcript expression in the turkey poult (Meleagris gallopavo)	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; NUTRIENT-REQUIREMENTS; EXUDATIVE DIATHESIS; SODIUM SELENITE; DEFICIENCY; SELENOMETHIONINE; LIVER; RATS; AVAILABILITY	The current NRC selenium (Se) requirement for turkeys is 0.2 mu g Se/g diet. We previously fed turkey poults a Se-deficient diet (0.005 mu g Se/g) supplemented with 10 graded levels of Se (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1.0 mu g Se/g as Na2SeO3, 5/treatment) for 4 wk, and found that the minimum dietary Se requirement was 0.3 mu g Se/g based on selenoprotein enzyme activity in blood, liver, gizzard and pancreas. Because the turkey is primarily a production animal, we expanded this analysis to kidney, heart, breast and thigh. Se concentrations in Se-deficient poults were 5.0, 9.8, 33, and 15% of levels in poults fed 0.4 mu g Se/g in liver, kidney, thigh and breast, respectively. Increasing Se supplementation resulted in hyperbolic response curves for all tissues; breakpoint analysis indicated minimum Se requirements of 0.34-0.36 mu g Se/g based on tissue Se levels in liver, kidney and thigh. Similarly, GPX1 activity in muscle tissues and kidney responded hyperbolically to increasing dietary Se, reaching well-defined plateaus with breakpoints at 0.30-0.36 mu g Se/g. Minimum Se requirements based on GPX4 activity were 0.30-0.32 mu g Se/g for breast and thigh. Selenoprotein transcript expression decreased significantly in Se deficiency for only 2, 3, 5, and 6 mRNA in breast, thigh, heart, and kidney, respectively, out of 24 known avian selenoproteins. Se response curves for regulated selenoprotein transcripts were hyperbolic, and reached well-defined plateaus with breakpoints in a narrow range of 0.08-0.19 mu g Se/g. No selenoprotein transcript was altered by supernutritional Se. In summary, these results clearly indicate that the NRC dietary Se requirement should be raised to 0.4 mu g Se/g, at least for poults, to meet the nutritional needs of the young turkey. The Se response curve plateaus further show that limits for turkey supplementation with selenite could safely be raised to 0.5 mu g Se/g diet.	[Taylor, Rachel M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			National Institute of Food and Agriculture, United States Department of Agriculture [233618, 1004389]; Wisconsin Alumni Foundation [12046295]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); Wisconsin Alumni Foundation	This research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 233618 and 1004389, and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295).	Applegate TJ, 2014, J APPL POULTRY RES, V23, P567, DOI 10.3382/japr.2014-00980; Aquilina G, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3219; Aquilina G, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4398; Aquilina G, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3046; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Boehler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101408; Boehler CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071525; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; CANTOR AH, 1975, J NUTR, V105, P96, DOI 10.1093/jn/105.1.96; CANTOR AH, 1982, POULTRY SCI, V61, P478, DOI 10.3382/ps.0610478; Fischer J, 2008, BRIT POULTRY SCI, V49, P583, DOI 10.1080/00071660802337258; Fradejas-Villar N, 2017, NUCLEIC ACIDS RES, V45, P4094, DOI 10.1093/nar/gkw1255; GABRIELSEN BO, 1980, J NUTR, V110, P1096, DOI 10.1093/jn/110.6.1096; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Hocking PM, 2014, BRIT POULTRY SCI, V55, P1, DOI 10.1080/00071668.2014.877692; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; LEI XG, 1995, J NUTR, V125, P1438; Li JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152392; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKOWN DM, 1978, J RADIOANAL CHEM, V43, P411, DOI 10.1007/BF02519502; National Research Council, 1994, NUTR REQ POULTR; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; OSMAN M, 1976, POULTRY SCI, V55, P987, DOI 10.3382/ps.0550987; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; SCOTT ML, 1967, J NUTR, V91, P573, DOI 10.1093/jn/91.4.573; Seyedali A, 2014, RNA, V20, P1248, DOI 10.1261/rna.043463.113; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Sunde RA, 2016, ADV NUTR, V7, P1129, DOI 10.3945/an.116.012872; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2010, EXP BIOL MED, V235, P1046, DOI 10.1258/ebm.2010.010111; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Sunde Roger A., 2016, SELENIUM ITS MOL BIO, P175, DOI 10.1007/978-3-319- 41283-2_14; Taylor RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151665; USDA, 2017, POULTR PROD VAL 2017; Wang YX, 2011, BIOL TRACE ELEM RES, V143, P261, DOI 10.1007/s12011-010-8839-2; Yao HD, 2013, J NUTR, V143, P613, DOI 10.3945/jn.112.172395; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2; Zhao L, 2017, J NUTR, V147, P789, DOI 10.3945/jn.116.247338; Zhao X, 2014, BIOL TRACE ELEM RES, V161, P341, DOI 10.1007/s12011-014-0139-9	46	12	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189001	10.1371/journal.pone.0189001	http://dx.doi.org/10.1371/journal.pone.0189001			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190764	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900188
J	Dey, A; Barik, D				Dey, Anupam; Barik, Debashis			Parallel arrangements of positive feedback loops limit cell-to-cell variability in differentiation	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; NOISE; MEMORY; FLUCTUATIONS; BISTABILITY; PROPAGATION; HYSTERESIS; ACTIVATION; ORIGINS; MOTIFS	Cellular differentiations are often regulated by bistable switches resulting from specific arrangements of multiple positive feedback loops (PFL) fused to one another. Although bist-ability generates digital responses at the cellular level, stochasticity in chemical reactions causes population heterogeneity in terms of its differentiated states. We hypothesized that the specific arrangements of PFLs may have evolved to minimize the cellular heterogeneity in differentiation. In order to test this we investigated variability in cellular differentiation controlled either by parallel or serial arrangements of multiple PFLs having similar average properties under extrinsic and intrinsic noises. We find that motifs with PFLs fused in parallel to one another around a central regulator are less susceptible to noise as compared to the motifs with PFLs arranged serially. Our calculations suggest that the increased resistance to noise in parallel motifs originate from the less sensitivity of bifurcation points to the extrinsic noise. Whereas estimation of mean residence times indicate that stable branches of bifurcations are robust to intrinsic noise in parallel motifs as compared to serial motifs. Model conclusions are consistent both in AND- and OR-gate input signal configurations and also with two different modeling strategies. Our investigations provide some insight into recent findings that differentiation of preadipocyte to mature adipocyte is controlled by network of parallel PFLs.	[Dey, Anupam; Barik, Debashis] Univ Hyderabad, Sch Chem, Cent Univ PO, Hyderabad, Telangana, India	University of Hyderabad	Barik, D (corresponding author), Univ Hyderabad, Sch Chem, Cent Univ PO, Hyderabad, Telangana, India.	dbariksc@uohyd.ac.in	Barik, Debashis/D-3632-2018	Barik, Debashis/0000-0003-1681-1273; DEY, ANUPAM/0000-0002-9071-8774	Science and Engineering Research Board, Department of Science and Technology (India) [EMR/2015/001899]; INSPIRE program of Department of Science and Technology, India	Science and Engineering Research Board, Department of Science and Technology (India)(Department of Science & Technology (India)); INSPIRE program of Department of Science and Technology, India	The work was supported by funding from the Science and Engineering Research Board, Department of Science and Technology (India), grant no. EMR/2015/001899, to DB. AD acknowledges fellowship from INSPIRE program of Department of Science and Technology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ahrends R, 2014, SCIENCE, V344, P1384, DOI 10.1126/science.1252079; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Avendan MS, 2013, NATURE COMMINICATION; Barik D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005230; Beach RR, 2017, CELL, V169, P229, DOI 10.1016/j.cell.2017.03.021; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cardelli L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20214; Chang DE, 2010, P NATL ACAD SCI USA, V107, P175, DOI 10.1073/pnas.0908314107; Das D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005491; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghusinga KR, 2017, P NATL ACAD SCI USA, V114, P693, DOI 10.1073/pnas.1609012114; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Horsthemke W., 1984, NOISE INDUCED TRANSI; Huang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep28096; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Maithreye R, 2007, PHYS BIOL, V4, P48, DOI 10.1088/1478-3975/4/1/006; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sherman MS, 2015, CELL SYST, V1, P315, DOI 10.1016/j.cels.2015.10.011; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sveiczer Akos, 2004, Briefings in Functional Genomics & Proteomics, V2, P298, DOI 10.1093/bfgp/2.4.298; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tomioka R, 2004, J THEOR BIOL, V229, P501, DOI 10.1016/j.jtbi.2004.04.034; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Waddington C., 1957, STRATEGY GENES; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wang LM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000764; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yang XJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001673; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Zhang J, 2014, SCI SIGNAL, V7	65	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188623	10.1371/journal.pone.0188623	http://dx.doi.org/10.1371/journal.pone.0188623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186174	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900046
J	Sevin-Pujol, A; Sicard, M; Rosenberg, C; Auriac, MC; Lepage, A; Niebel, A; Gough, C; Bensmihen, S				Sevin-Pujol, Amelie; Sicard, Melanie; Rosenberg, Charles; Auriac, Marie-Christine; Lepage, Agnes; Niebel, Andreas; Gough, Clare; Bensmihen, Sandra			Development of a GAL4-VP1 6/UAS trans activation system for tissue specific expression in Medicago truncatula	PLOS ONE			English	Article							GENE-EXPRESSION; AGROBACTERIUM-RHIZOGENES; ARABIDOPSIS-THALIANA; ROOT-NODULES; CELLS; INITIATION; PROTEIN; NODULATION; PROMOTERS; TOMATO	Promoters with tissue-specific activity are very useful to address cell-autonomous and non cell autonomous functions of candidate genes. Although this strategy is widely used in Arabidopsis thaliana, its use to study tissue-specific regulation of root symbiotic interactions in legumes has only started recently. Moreover, using tissue specific promoter activity to drive a GAL4-VP16 chimeric transcription factor that can bind short upstream activation sequences (UAS) is an efficient way to target and enhance the expression of any gene of interest. Here, we developed a collection of promoters with different root cell layers specific activities in Medicago truncatula and tested their abilities to drive the expression of a chimeric GAL4-VP16 transcription factor in a trans-activation UAS: P-Glucuronidase (GUS) reporter gene system. By developing a binary vector devoted to modular Golden Gate cloning together with a collection of adapted tissue specific promoters and coding sequences we could test the activity of four of these promoters in trans-activation GAL4/UAS systems and compare them to "classical" promoter GUS fusions. Roots showing high levels of tissue specific expression of the GUS activity could be obtained with this trans-activation system. We therefore provide the legume community with new tools for efficient modular Golden Gate cloning, tissue specific expression and a trans-activation system. This study provides the ground work for future development of stable transgenic lines in Medicago truncatula.	[Sevin-Pujol, Amelie; Sicard, Melanie; Rosenberg, Charles; Auriac, Marie-Christine; Lepage, Agnes; Niebel, Andreas; Gough, Clare; Bensmihen, Sandra] Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bensmihen, S (corresponding author), Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France.	sandra.bensmihen@inra.fr	NIEBEL, Andreas/AAL-7687-2020	LEPAGE, Agnes/0000-0002-2883-4547; Niebel, Andreas/0000-0002-3402-8381; bensmihen, sandra/0000-0003-1351-7220; Auriac, Marie-Christine/0000-0002-1202-032X	"Laboratoire d'Excellence (LABEX)" TULIP [ANR-10-LABX-41]	"Laboratoire d'Excellence (LABEX)" TULIP	This work was supported by the "Laboratoire d'Excellence (LABEX)" TULIP (ANR-10-LABX-41). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bucher M, 2002, PLANT PHYSIOL, V128, P911, DOI 10.1104/pp.010998; Chabaud M, MEDICAGO TRUNCATULA; Complainville A, 2003, PLANT CELL, V15, P2778, DOI 10.1105/tpc.017020; Couzigou JM, 2012, PLANT CELL, V24, P4498, DOI 10.1105/tpc.112.103747; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; Engineer CB, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-9; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fliegmann J, 2016, FEBS LETT, V590, P1477, DOI 10.1002/1873-3468.12191; Galweiler L, 2000, PLANT J, V23, P143, DOI 10.1046/j.1365-313x.2000.00805.x; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Gavrilovic S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0105-y; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Herrbach V, 2014, J PLANT PHYSIOL, V171, P301, DOI 10.1016/j.jplph.2013.09.006; Jardinaud MF, 2016, PLANT PHYSIOL, V171, P2256, DOI 10.1104/pp.16.00711; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Mirabella R, 2004, PLANT PHYSIOL, V135, P1879, DOI 10.1104/pp.103.038539; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Orman-Ligeza B, 2016, DEVELOPMENT, V143, P3328, DOI 10.1242/dev.136465; Radoeva T, 2016, PLANT PHYSIOL, V171, P1169, DOI 10.1104/pp.16.00213; Rival P, 2012, DEVELOPMENT, V139, P3383, DOI 10.1242/dev.081620; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sbabou L, 2010, J EXP BOT, V61, P1351, DOI 10.1093/jxb/erp400; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Vailleau F, 2007, MOL PLANT MICROBE IN, V20, P159, DOI 10.1094/MPMI-20-2-0159; Vermeer JEM, 2014, SCIENCE, V343, P178, DOI 10.1126/science.1245871; Wang H, 2017, NAT METHODS, V14, P145, DOI [10.1038/NMETH.4109, 10.1038/nmeth.4109]; Xiao TT, 2014, DEVELOPMENT, V141, P3517, DOI 10.1242/dev.110775	34	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188923	10.1371/journal.pone.0188923	http://dx.doi.org/10.1371/journal.pone.0188923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186192	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900070
J	Rolland, M; Villemot, J; Marais, A; Theil, S; Faure, C; Cadot, V; Valade, R; Vitry, C; Rabenstein, F; Candresse, T				Rolland, Mathieu; Villemot, Julie; Marais, Armelle; Theil, Sebastien; Faure, Chantal; Cadot, Valerie; Valade, Romain; Vitry, Cindy; Rabenstein, Frank; Candresse, Thierry			Classical and next generation sequencing approaches unravel Bymovirus diversity in barley crops in France	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; LINKED PROTEIN VPG; POLYMYXA-GRAMINIS; RYM4-MEDIATED RESISTANCE; INFECTING BARLEY; RYM5 RESISTANCE; BAYMV; GENE; ISOLATE; GENOME	Despite the generalized use of cultivars carrying the rym4 resistance gene, the impact of viral mosaic diseases on winter barleys increased in recent years in France. This change could reflect i) an increased prevalence of the rym4 resistance-breaking pathotype of Barley yellow mosaic virus Y (BaYMV-2), ii) the emergence of rym4 resistance-breaking patho-types of Barley mild mosaic virus (BaMMV) or iii) the emergence of other viruses. A study was undertaken to determine the distribution and diversity of viruses causing yellow mosaic disease. A collection of 241 symptomatic leaf samples from susceptible, rym4 and rym5 varieties was gathered from 117 sites. The viruses present in all samples were identified by specific RT-PCR assays and, for selected samples, by double-stranded RNA next-generation sequencing (NGS). The results show that BaYMV-2 is responsible for the symptoms observed in varieties carrying the resistance gene rym4. In susceptible varieties, both BaYMV-1 and BaYMV-2 were detected, together with BaMMV. Phylogenetic analyses indicate that the rym4 resistance-breaking ability independently evolved in multiple genetic backgrounds. Parallel analyses revealed a similar scenario of multiple independent emergence events in BaMMV for rym5 resistance-breaking, likely involving multiple amino acid positions in the viral-linked genome protein. NGS analyses and classical techniques provided highly convergent results, highlighting and validating the power of NGS approaches for diagnostics and viral population characterization.	[Rolland, Mathieu; Villemot, Julie; Cadot, Valerie] Grp Etud & Controle Varietes & Semences, Beaucouze, France; [Marais, Armelle; Theil, Sebastien; Faure, Chantal; Candresse, Thierry] Univ Bordeaux, INRA, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France; [Valade, Romain; Vitry, Cindy] ARVALIS Inst Vegetal, Thiverval Grignon, France; [Rabenstein, Frank] Julius Kuhn Inst, Quedlinburg, Germany; [Rolland, Mathieu] Agence Natl Securite Sanit Alimentat Environm & T, Lab Sante Vegetaux, Angers, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Julius Kuhn-Institut; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Rolland, M (corresponding author), Grp Etud & Controle Varietes & Semences, Beaucouze, France.; Rolland, M (corresponding author), Agence Natl Securite Sanit Alimentat Environm & T, Lab Sante Vegetaux, Angers, France.	mathieu.rolland@anses.fr		Candresse, Thierry/0000-0001-9757-1835	CASDAR "MOSA-Hordeum" project [C-2013-08]; French Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret (MAAF)	CASDAR "MOSA-Hordeum" project; French Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret (MAAF)	This work was supported by the CASDAR "MOSA-Hordeum" project (No C-2013-08) coordinated by GEVES and financed by the French Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret (MAAF).	Achon MA, 2003, PLANT DIS, V87, P1004, DOI 10.1094/PDIS.2003.87.8.1004C; Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; ADAMS MJ, 1987, PLANT PATHOL, V36, P610, DOI 10.1111/j.1365-3059.1987.tb02284.x; ADAMS MJ, 1993, ANN APPL BIOL, V123, P37, DOI 10.1111/j.1744-7348.1993.tb04070.x; ADAMS MJ, 1991, PLANT PATHOL, V40, P53, DOI 10.1111/j.1365-3059.1991.tb02292.x; ADAMS MJ, 1988, ANN APPL BIOL, V112, P133, DOI 10.1111/j.1744-7348.1988.tb02048.x; Ayme V, 2006, MOL PLANT MICROBE IN, V19, P557, DOI 10.1094/MPMI-19-0557; Bakardjieva N., 2004, Bulgarian Journal of Agricultural Science, V10, P161; BATISTA MF, 1989, PLANT PATHOL, V38, P226, DOI 10.1111/j.1365-3059.1989.tb02137.x; Candresse T, 2016, ARCH VIROL, V161, P741, DOI 10.1007/s00705-015-2709-3; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Chen JP, 1996, PLANT PATHOL, V45, P1117, DOI 10.1046/j.1365-3059.1996.d01-198.x; Deb M, 2008, J VIROL METHODS, V148, P17, DOI 10.1016/j.jviromet.2007.10.015; Faccini N., 2001, Informatore Agrario, V57, P56; FATAKHUN AT, 1987, MIKROBIOL Z, V49, P76; Friedt W, 2000, P 8 INT BARL GEN S; Friedt W., 1987, BARLEY GENET, P659; Fukuhara T, 2006, ARCH VIROL, V151, P995, DOI 10.1007/s00705-005-0688-5; GRANER A, 1993, THEOR APPL GENET, V86, P689, DOI 10.1007/BF00222657; Habekuss A, 2008, J PHYTOPATHOL, V156, P36, DOI 10.1111/j.1439-0434.2007.01324.x; Hariri D., 1990, Proceedings of the First Symposium of the International Working Group on Plant Viruses with Fungal Vectors, Braunschweig, Germany, 21-24 August 1990, P109; Hariri D, 2003, EUR J PLANT PATHOL, V109, P921, DOI 10.1023/B:EJPP.0000003663.32298.f4; Hariri D, 2007, EUR J PLANT PATHOL, V118, P1, DOI 10.1007/s10658-006-9095-3; HILL SA, 1980, PLANT PATHOL, V29, P197, DOI 10.1111/j.1365-3059.1980.tb01212.x; HILL SA, 1989, EPPO B, V19, P555, DOI DOI 10.1111/j.1365-2338.1989.tb00432.x; Huth W., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P152; Huth W., 1978, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V30, P184; HUTH W, 1990, INTERVIROLOGY, V31, P38, DOI 10.1159/000150132; Huth W., 1989, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V41, P6; Huth W., 1984, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V36, P49; Ikata S., 1940, NOJI KAIRYO SHIRYO, V154, P1; Jezewska M, 2009, PLANT PATHOL, V58, P784, DOI 10.1111/j.1365-3059.2009.02129.x; Kanyuka K, 2005, MOL PLANT PATHOL, V6, P449, DOI [10.1111/j.1364-3703.2005.00294.x, 10.1111/J.1364-3703.2005.00294.X]; Kanyuka K, 2004, ARCH VIROL, V149, P1469, DOI 10.1007/s00705-004-0318-7; Kanyuka K, 2003, MOL PLANT PATHOL, V4, P393, DOI [10.1046/j.1364-3703.2003.00177.x, 10.1046/J.1364-3703.2003.00177.X]; Kashiwazaki S, 1996, J GEN VIROL, V77, P581, DOI 10.1099/0022-1317-77-4-581; KASHIWAZAKI S, 1989, J GEN VIROL, V70, P3015, DOI 10.1099/0022-1317-70-11-3015; Kashiwazaki S., 1990, Proceedings of the First Symposium of the International Working Group on Plant Viruses with Fungal Vectors, Braunschweig, Germany, 21-24 August 1990, P105; Katis N, 1997, EUR J PLANT PATHOL, V103, P281, DOI 10.1023/A:1008689308869; Kuhne T, 2003, J GEN VIROL, V84, P2853, DOI 10.1099/vir.0.19347-0; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LANGENBERG WG, 1986, NETH J PLANT PATHOL, V92, P133, DOI 10.1007/BF02000336; Lapierre H., 1980, NOUVELLES MALADIES V; Lee Kui-Jae, 1996, Annals of the Phytopathological Society of Japan, V62, P397, DOI 10.3186/jjphytopath.62.397; Li H, 2016, FRONTIERS PLANT SCI, V7; Maroquin C, 1982, B RECHERCHES AGRONOM; Moury B, 2014, INFECT GENET EVOL, V27, P472, DOI 10.1016/j.meegid.2013.11.024; Mumford R, 2004, J VIROL METHODS, V117, P153, DOI 10.1016/j.jviromet.2004.01.006; Nomura K, 1996, J PHYTOPATHOL, V144, P103, DOI 10.1111/j.1439-0434.1996.tb01496.x; Rabenstein F, 2011, P 8 S INT WORK GROUP; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Sorel M, 2014, MOL PLANT MICROBE IN, V27, P1014, DOI 10.1094/MPMI-04-14-0111-R; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Steyer S, 1995, AGRONOMIE, V15, P433, DOI 10.1051/agro:19950708; Szunics L., 2000, Acta Agronomica Hungarica, V48, P237, DOI 10.1556/AAgr.48.2000.3.3; Tao Y, 2012, ARCH VIROL, V157, P1261, DOI 10.1007/s00705-012-1294-y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOYAMA, 1970, Annals of the Phytopathological Society of Japan, V36, P223; USUGI T, 1989, Annals of the Phytopathological Society of Japan, V55, P26, DOI 10.3186/jjphytopath.55.26; Vaianopoulos C, 2007, Commun Agric Appl Biol Sci, V72, P333; Villemot J, 2016, J VIROL METHODS, V234, P101, DOI 10.1016/j.jviromet.2016.03.019; Wellie-Stephan O, 2010, INNOVATION, V4, P18	62	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188495	10.1371/journal.pone.0188495	http://dx.doi.org/10.1371/journal.pone.0188495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182661	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000032
J	Liao, L; Yu, Y; Shao, BY; Su, XX; Wang, H; Kuang, HJ; Jing, H; Shuai, Y; Yang, DQ; Jin, Y				Liao, Li; Yu, Yang; Shao, Bingyi; Su, Xiaoxia; Wang, Han; Kuang, Huijuan; Jing, Huan; Shuai, Yi; Yang, Deqin; Jin, Yan			Redundant let-7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis	FASEB JOURNAL			English	Article						immunosuppression; miRNA; T cells	MESENCHYMAL STEM-CELLS; TNF-ALPHA; BONE LOSS; ESTROGEN DEFICIENCY; T-CELLS; MICRORNA; OSTEOBLASTOGENESIS; IMMUNOSUPPRESSION; TRANSPLANTATION; STIMULATION	Bone marrow-derived mesenchymal stem cell (BMSC) cytotherapy has emerged as a promising treatment strategy for refractory immune diseases; however, the influence of the pathologic conditions of donors on the immunomodulatory properties of BMSCs is still poorly understand. Here, we found that BMSCs that were derived from donors with osteoporosis were ineffective as cytotherapy for patients with experimental colitis and graft-vs.-host disease (GVHD). In vivo and in vitro assays revealed that the capacity of osteoporotic BMSCs to induce T-cell apoptosis declined as a result of decreased Fas and FasL protein. Additional analysis revealed that let-7a, a microRNA induced by TNF-alpha in osteoporosis, inhibited the expression of the Fas/FasL system via post-transcriptional regulation. By knocking down let-7a expression, we successfully recovered the immunosuppressive capacity of osteoporotic BMSCs and improved their therapy for experimental colitis and GVHD. Taken together, our study demonstrates that the immunomodulatory properties of BMSCs are suppressed in osteoporosis and illustrates the molecular mechanism that underlies this suppression. These findings might have important implications for the development of targeted strategies to improve BMSC cytotherapy.	[Liao, Li; Kuang, Huijuan; Jing, Huan; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Shaanxi Int Joint Res Ctr Oral Dis, Natl Clin Res Ctr Oral Dis, State Key Lab Mil Stomatol,Ctr Tissue Engn,Sch St, Xian, Shaanxi, Peoples R China; [Liao, Li; Kuang, Huijuan; Jing, Huan; Jin, Yan] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Med Univ, Stomatol Hosp, Dept Endodont, Chongqing, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Wang, Han] Guangzhou Med Univ, Affiliated Hosp 1, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Shuai, Yi] Peoples Liberat Army, Nanjing Gen Hosp Nanjing Mil Command, Dept Stomatol, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Chongqing Medical University; Xi'an Jiaotong University; Guangzhou Medical University; Nanjing General Hospital	Yang, DQ (corresponding author), Chongqing Med Univ, Stomatol Hosp, 426 Songshibei Rd, Chongqing 401147, Peoples R China.; Jin, Y (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Ctr Tissue Engn, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yangde-qin@gmail.com; yanjin@fmmu.edu.cn	Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009; Yang, Deqin/0000-0002-2579-8384	Nature Science Foundation of China [31601113, 31030033, 81600912, 81470710]; National Key Research and Development Program of China [2017YFA0104900]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (Grant 2017YFA0104900) and the Nature Science Foundation of China (Grants 31601113, 81600912, 31030033, and 81470710). The authors declare no conflicts of interest.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2011, ENDOCR DEV, V21, P91, DOI 10.1159/000328138; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Choi SW, 2014, NAT REV CLIN ONCOL, V11, P536, DOI 10.1038/nrclinonc.2014.102; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Geng LY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/169082; Gu F, 2012, CLIN IMMUNOL, V145, P142, DOI 10.1016/j.clim.2012.08.012; Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85; He XW, 2012, DIGEST DIS SCI, V57, P3136, DOI 10.1007/s10620-012-2290-5; Kimble RB, 1997, J BONE MINER RES, V12, P935, DOI 10.1359/jbmr.1997.12.6.935; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lepperdinger G, 2011, CURR OPIN IMMUNOL, V23, P518, DOI 10.1016/j.coi.2011.05.007; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Lim JY, 2014, CELL TRANSPLANT, V23, P703, DOI 10.3727/096368913X664577; Lysaght T, 2013, CELL STEM CELL, V13, P647, DOI 10.1016/j.stem.2013.11.013; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemoto Y, 2013, GUT, V62, P1142, DOI 10.1136/gutjnl-2012-302029; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Parekkadan B, 2011, GASTROENTEROLOGY, V140, P966, DOI 10.1053/j.gastro.2010.10.013; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Shao BY, 2015, FASEB J, V29, P3935, DOI 10.1096/fj.15-272823; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sui BD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30186; Sun Y, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/284215; Teitelbaum SL, 2004, P NATL ACAD SCI USA, V101, P16711, DOI 10.1073/pnas.0407335101; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Wahl EC, 2010, J BONE MINER RES, V25, P114, DOI 10.1359/jbmr.090708; Wang L, 2013, STEM CELLS, V31, P1383, DOI 10.1002/stem.1388; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Xu LL, 2014, CELL BIOCHEM BIOPHYS, V70, P771, DOI 10.1007/s12013-014-9980-x; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yao J, 2012, REJUV RES, V15, P495, DOI 10.1089/rej.2012.1325; Yu B, 2016, TRENDS MOL MED, V22, P641, DOI 10.1016/j.molmed.2016.06.002; Yu Y, 2017, MOL THER, V25, P480, DOI 10.1016/j.ymthe.2016.11.015	49	7	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1982	1992		10.1096/fj.201700885R	http://dx.doi.org/10.1096/fj.201700885R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203591				2022-12-26	WOS:000429051400020
J	Banda, HT; Thomson, R; Mortimer, K; Bello, GAF; Mbera, GB; Malmborg, R; Faragher, B; Squire, SB				Banda, Hastings T.; Thomson, Rachael; Mortimer, Kevin; Bello, George A. F.; Mbera, Grace B.; Malmborg, Rasmus; Faragher, Brian; Squire, S. Bertel			Community prevalence of chronic respiratory symptoms in rural Malawi: Implications for policy	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SUB-SAHARAN AFRICA; ASTHMA; TUBERCULOSIS; BURDEN; COPD	Background No community prevalence studies have been done on chronic respiratory symptoms of cough, wheezing and shortness of breath in adult rural populations in Malawi. Case detection rates of tuberculosis (TB) and chronic airways disease are low in resource-poor primary health care facilities. Objective To understand the prevalence of chronic respiratory symptoms and recorded diagnoses of TB in rural Malawian adults in order to improve case detection and management of these diseases. Methods A population proportional, cross-sectional study was conducted to determine the proportion of the population with chronic respiratory symptoms that had a diagnosis of tuberculosis or chronic airways disease in two rural communities in Malawi. Households were randomly selected using Google Earth Pro software. Smart phones loaded with Open Data Kit Essential software were used for data collection. Interviews were conducted with 15795 people aged 15 years and above to enquire about symptoms of chronic cough, wheeze and shortness of breath. Results Overall 3554 (22.5%) participants reported at least one of these respiratory symptoms. Cough was reported by 2933, of whom 1623 (55.3%) reported cough only and 1310 (44.7%) combined with wheeze and/or shortness of breath. Only 4.6% (164/3554) of participants with chronic respiratory symptoms had one or more of the following diagnoses in their health passports (patient held medical records): TB, asthma, bronchitis and chronic obstructive pulmonary disease). Conclusions The high prevalence of chronic respiratory symptoms coupled with limited recorded diagnoses in patient-held medical records in these rural communities suggests a high chronic respiratory disease burden and unmet health need.	[Banda, Hastings T.; Bello, George A. F.; Mbera, Grace B.] Res Equ & Community Hlth Trust, Lilongwe, Malawi; [Thomson, Rachael; Mortimer, Kevin; Faragher, Brian; Squire, S. Bertel] Univ Liverpool Liverpool Sch Trop Med, Collaborat Appl Hlth Res & Delivery, Liverpool, Merseyside, England; [Malmborg, Rasmus] LHL Int, Oslo, Norway	Liverpool School of Tropical Medicine	Squire, SB (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Collaborat Appl Hlth Res & Delivery, Liverpool, Merseyside, England.	bertie.squire@lstmed.ac.uk		Squire, Stephen/0000-0001-7173-9038; Mortimer, Kevin/0000-0002-8118-8871; Thomson, Rachael/0000-0001-5010-3428	Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation); ATLAS Alliance; NORAD; National Institute of Health Research	Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation); ATLAS Alliance; NORAD(CGIAR); National Institute of Health Research(National Institute for Health Research (NIHR))	This study was funded by the Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation), The ATLAS Alliance and NORAD. The funder provided support in the form of salaries for author RM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. We thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - "IMPALA" for helping to make this work possible. In relation to IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National Institute of Health Research using Official Development Assistance (ODA) funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Ahmed R, 2017, MALAWI MED J, V29, P203, DOI 10.4314/mmj.v29i2.24; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; [Anonymous], 2010, MAL DEM HLTH SURV 20; Banda HT, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1068-4; Bello G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183312; Bousquet J, 2007, ALLERGY, V62, P216, DOI 10.1111/j.1398-9995.2007.01307.x; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Chaulet P., 2004, WHOHTMTB2004; Chisunkha B, 2016, EUR RESPIR J, V47, P1876, DOI 10.1183/13993003.00045-2016; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; Hasselgren M, 2001, SCAND J PRIM HEALTH, V19, P54, DOI 10.1080/028134301300034701; I-Shirawi NA-JH, 2006, PATHOGENESIS ETIOLOG, V1, P41; Kanyerere H., 2005, Malawi Medical Journal, V17, P36; Lainez YB, 2009, TROP MED INT HEALTH, V14, P564, DOI 10.1111/j.1365-3156.2009.02257.x; Makaula P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-328; Martins P, 2009, ALLERGY, V64, P1061, DOI 10.1111/j.1398-9995.2009.01956.x; Mather, 2006, GLOBAL BURDEN DIS RI; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Pauwels R, 2000, CHEST, V117, p332S, DOI 10.1378/chest.117.5_suppl_2.332S; Piddock Katy C, 2014, Ann Am Thorac Soc, V11, P915, DOI 10.1513/AnnalsATS.201311-413OC; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Voll-Aanerud M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-107; World Health Organization, 2020, GLOBAL TUBERCULOSIS	25	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188437	10.1371/journal.pone.0188437	http://dx.doi.org/10.1371/journal.pone.0188437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216193	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000417337800022
J	Cassidy, S; Trenell, MI; Anderson, KN				Cassidy, Sophie; Trenell, Michael I.; Anderson, Kirstie N.			The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; UNITED-STATES; SLEEP DURATION; METAANALYSIS; OBESITY; RISK; PAIN; QUESTIONNAIRE; VALIDITY; ADULTS	Objective There has been a significant increase in the prescribing of medication for chronic non-cancer pain. In a UK population sample, we aimed to assess cardio-metabolic (CM) health in those taking these chronic pain medications. Methods 133,401 participants from the UK Biobank cohort were studied. BMI, waist cm and hypertension were compared between those on drugs prescribed for chronic pain and CM drugs to those on CM drugs only. Multiple confounders were controlled for. Results Those taking opiates and CM drugs had the worst CM health profile with a 95%, 82% and 63% increased odds of reporting obesity, 'ery high risk' waist circumference and hypertension, respectively (OR [95% CI] 1.95 [1.75-2.17], 1.82 [1.63-2.03], 1.63 [1.45-1.84]), compared to those on CM drugs alone. Those taking neuropathic pain medications and CM drugs also demonstrate worse CM profile than those taking CM drugs only. Conclusions The impact of medications for chronic pain and sleep upon CM health and obesity is of concern for these classes of drugs which have been recently labelled as dependency forming medications. The results from this cross sectional study warrants further investigation and adds further support to calls for these medications to be prescribed for shorter periods.	[Cassidy, Sophie; Trenell, Michael I.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Anderson, Kirstie N.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Cassidy, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	sophie.cassidy@ncl.ac.uk		cassidy, sophie/0000-0002-0228-7274; Trenell, Michael/0000-0001-8253-5620; Anderson, Kirstie N/0000-0001-5767-918X	Medical Research Council [MR/L016354/1, MC_QA137853, G0700718] Funding Source: Medline; Alzheimer&apos;s Society [189] Funding Source: Medline; Department of Health [SRF-2011-04-017] Funding Source: Medline; ESRC [ES/K007688/1] Funding Source: UKRI; MRC [MR/L016354/1, G0700718] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer&apos;s Society; Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], PRESCRIBING PATTERNS; BERKEN GH, 1984, J AFFECT DISORDERS, V7, P133, DOI 10.1016/0165-0327(84)90031-4; Bohra MH, 2014, BRIT J PAIN, V8, P107, DOI 10.1177/2049463714525355; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Broussard JL, 2016, CURR OPIN ENDOCRINOL, V23, P353, DOI 10.1097/MED.0000000000000276; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cassidy S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010038; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Colameco S, 2009, POSTGRAD MED, V121, P61, DOI 10.3810/pgm.2009.07.2032; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Freeman R, 2008, DIABETES CARE, V31, P1448, DOI 10.2337/dc07-2105; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hardy T, 2007, DIABETES CARE, V30, P21, DOI 10.2337/dc06-0947; IPAQ, 2005, GUIDELINES DATA PROC; Li Q, 2015, PHARMACOECONOMICS, V33, P735, DOI 10.1007/s40273-014-0248-5; Markota M, 2016, MAYO CLIN PROC, V91, P1632, DOI 10.1016/j.mayocp.2016.07.024; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008242.pub3; Mysels David J, 2010, J Opioid Manag, V6, P445; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Pak TY, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0081-5; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Quilici S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-6; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Toth C, 2014, THER ADV DRUG SAF, V5, P38, DOI 10.1177/2042098613505614; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187982	10.1371/journal.pone.0187982	http://dx.doi.org/10.1371/journal.pone.0187982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211804	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200023
J	Hoyle, D; Aslam, TM				Hoyle, David; Aslam, Tariq Mehmood			Generative mathematical modelling to demonstrate virtual simulations of neovascular age related macular degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RANIBIZUMAB; VEGF; CHORIOCAPILLARIS; BEVACIZUMAB; AFLIBERCEPT; BINDING; CELLS	Purpose To develop a generative mathematical model of wet age-related macular degeneration (AMD) and model the impact of injections of anti-vascular endothelial growth factor to virtual patients with the condition. Methods We isolated key pathophysiological components of macular degeneration in terms of macular edema development and response to anti-vascular endothelial growth factor (VEGF) agents. We developed mathematical models for each of these components using constants determined from published biological experimentation. Consequently, we combined the mathematical models of the separate components to arrive at an end-to-end model of the evolution of macular edema size and its response to treatment. Results We present a series of simulations based upon our idealised model. Initially, we demonstrate the theoretical change in macular edema height in wet macular degeneration over time without and with anti-VEGF interventions. In our final simulation, we demonstrate the powerful possibilities of virtual clinical trials by simulating a virtual model of a landmark study using our existing mathematical AMD model. Conclusions Using our mathematical modelling based upon known pathological and pharmacological processes we have been able to model the effect of intravitreal injection of an anti-VEGF agent on macular edema from age related macular degeneration. We were subsequently able to mathematically simulate a major clinical trial with results that mirror many key features of the clinical established study. We anticipate that the generative model presented here can evolve to be a useful supportive tool in the challenge to deliver optimal therapy for patients with wet macular degeneration.	[Aslam, Tariq Mehmood] Univ Manchester, Sch Pharm & Optometry, Fac Biol Med & Hlth, Manchester, Lancs, England; [Aslam, Tariq Mehmood] NHS Cent Manchester Univ Hosp, Royal Eye Hosp, Manchester, Lancs, England; [Aslam, Tariq Mehmood] Heriot Watt Univ, Edinburgh, Midlothian, Scotland	University of Manchester; Manchester Royal Eye Hospital; Heriot Watt University	Aslam, TM (corresponding author), Univ Manchester, Sch Pharm & Optometry, Fac Biol Med & Hlth, Manchester, Lancs, England.; Aslam, TM (corresponding author), NHS Cent Manchester Univ Hosp, Royal Eye Hosp, Manchester, Lancs, England.; Aslam, TM (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	Tariq.aslam@manchester.ac.uk	; Aslam, Tariq/A-8532-2016	Hoyle, David/0000-0003-3483-5885; Aslam, Tariq/0000-0002-9739-7280				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chong V, 2016, EYE, V30, P1526, DOI 10.1038/eye.2016.202; Della NG, 1996, INVEST OPHTH VIS SCI, V37, P1921; Ferreira A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133968; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Imoukhuede PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044791; Klettner A, 2014, BRIT J OPHTHALMOL, V98, P1448, DOI 10.1136/bjophthalmol-2014-305105; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Moshfeghi DM, 2007, RETINA-J RET VIT DIS, V27, P269, DOI 10.1097/IAE.0b013e31802e3e9b; Ohno-Matsui Kyoko, 2004, Curr Opin Ophthalmol, V15, P197, DOI 10.1097/01.icu.0000120709.35941.e9; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; RCoreTeam, 2015, LANGUAGE ENV STAT CO; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Yang JH, 2014, MOL PHARMACEUT, V11, P3421, DOI 10.1021/mp500160v	21	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189053	10.1371/journal.pone.0189053	http://dx.doi.org/10.1371/journal.pone.0189053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211782	Green Published, gold			2022-12-26	WOS:000417212200061
J	Schober, DA; Croy, CH; Ruble, CL; Tao, R; Felder, CC				Schober, Douglas A.; Croy, Carrie H.; Ruble, Cara L.; Tao, Ran; Felder, Christian C.			Identification, expression and functional characterization of M4L, a muscarinic acetylcholine M-4 receptor splice variant	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; SURFACE EXPRESSION; SYSTEM; SCHIZOPHRENIA; SEQUENCE; DNA	Rodent genomic alignment sequences support a 2-exon model for muscarinic M-4 receptor. Using this model a novel N-terminal extension was discovered in the human muscarinic acetylcholine M-4 receptor. An open reading frame was discovered in the human, mouse and rat with a common ATG (methionine start codon) that extended the N-terminus of the muscarinic acetylcholine M-4 receptor subtype by 155 amino acids resulting in a longer variant. Transcriptional evidence for this splice variant was confirmed by RNA-Seq and RT-PCR experiments performed from human donor brain prefrontal cortices. We detected a human upstream exon indicating the translation of the mature longer M-4 receptor transcript. The predicted size for the longer two-exon M-4 receptor splice variant with the additional 155 amino acid N-terminal extension, designated M4L is 69.7 kDa compared to the 53 kDa canonical single exon M-4 receptor (M4S). Western blot analysis from a mammalian overexpression system, and saturation radioligand binding with [H-3]-NMS (N-methyl-scopolamine) demonstrated the expression of this new splice variant. Comparative pharmacological characterization between the M4L and M4S receptors revealed that both the orthosteric and allosteric binding sites for both receptors were very similar despite the addition of an N-terminal extension.	[Schober, Douglas A.; Croy, Carrie H.; Ruble, Cara L.; Felder, Christian C.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci, Indianapolis, IN 46285 USA; [Tao, Ran] Lieber Inst Brain Dev, Baltimore, MD USA	Eli Lilly	Felder, CC (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci, Indianapolis, IN 46285 USA.	felder_christian@lilly.com		Felder, Christian/0000-0003-1134-8881	Eli Lilly and Company; Lieber Institute for Brain Development; Johns Hopkins University School of Medicine; LIBD	Eli Lilly and Company(Eli Lilly); Lieber Institute for Brain Development; Johns Hopkins University School of Medicine(Johns Hopkins University); LIBD	Funding for this study was supported by Eli Lilly and Company, a commercial organization and the Lieber Institute for Brain Development, a non-profit Maryland Medical Research Institution affiliated with The Johns Hopkins University School of Medicine. The Eli Lilly and Company and LIBD provided support in the form of salaries for authors DAS, CCF, CHC, CLR and RT, respectively. They did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Buchli R, 1999, J CELL BIOCHEM, V74, P264, DOI 10.1002/(SICI)1097-4644(19990801)74:2<264::AID-JCB11>3.0.CO;2-Z; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Croy CH, 2014, MOL PHARMACOL, V86, P106, DOI 10.1124/mol.114.091751; Dautzenberg FM, 1999, J NEUROENDOCRINOL, V11, P941; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gonzalez A, 2011, BIOCHEMISTRY-US, V50, P4981, DOI 10.1021/bi2001278; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Minneman K P, 2001, Mol Interv, V1, P108; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruble CL, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0325-6; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Sarmiento JM, 2004, J BIOL CHEM, V279, P47017, DOI 10.1074/jbc.M410011200; Schober DA, 2014, MOL PHARMACOL, V86, P116, DOI 10.1124/mol.114.091785; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; Thal D, 2016, NATURE IN PRESS; Thompson MD, 2005, CRIT REV CL LAB SCI, V42, P311, DOI 10.1080/10408360591001895; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188330	10.1371/journal.pone.0188330	http://dx.doi.org/10.1371/journal.pone.0188330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211764	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200026
J	Singh, M; Friess, DA; Vilela, B; De Alban, JDT; Monzon, AKV; Veridiano, RKA; Tumaneng, RD				Singh, Minerva; Friess, Daniel A.; Vilela, Bruno; De Alban, Jose Don T.; Monzon, Angelica Kristina V.; Veridiano, Rizza Karen A.; Tumaneng, Roven D.			Spatial relationships between above-ground biomass and bird species biodiversity in Palawan, Philippines	PLOS ONE			English	Article							TROPICAL FOREST; ALOS-PALSAR; REDD PLUS; CARBON; RICHNESS; HABITAT; DEFORESTATION; TEXTURE; DEGRADATION; DIVERSITY	This study maps distribution and spatial congruence between Above-Ground Biomass (AGB) and species richness of IUCN listed conservation-dependent and endemic avian fauna in Palawan, Philippines. Grey Level Co-Occurrence Texture Matrices (GLCMs) extracted from Landsat and ALOS-PALSAR were used in conjunction with local field data to model and map local-scale field AGB using the Random Forest algorithm (r = 0.92 and RMSE = 31.33 Mg.ha(-1)). A support vector regression (SVR) model was used to identify the factors influencing variation in avian species richness at a 1km scale. AGB is one of the most important determinants of avian species richness for the study area. Topographic factors and anthropogenic factors such as distance from the roads were also found to strongly influence avian species richness. Hotspots of high AGB and high species richness concentration were mapped using hotspot analysis and the overlaps between areas of high AGB and avian species richness was calculated. Results show that the overlaps between areas of high AGB with high IUCN red listed avian species richness and endemic avian species richness were fairly limited at 13% and 8% at the 1-km scale. The overlap between 1) low AGB and low IUCN richness, and 2) low AGB and low endemic avian species richness was higher at 36% and 12% respectively. The enhanced capacity to spatially map the correlation between AGB and avian species richness distribution will further assist the conservation and protection of forest areas and threatened avian species.	[Singh, Minerva] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Friess, Daniel A.] Natl Univ Singapore, Dept Geog, 1Arts Link, Singapore, Singapore; [Vilela, Bruno] Washington Univ St Louis, Dept Biol, St Louis, MO USA; [De Alban, Jose Don T.; Monzon, Angelica Kristina V.; Veridiano, Rizza Karen A.; Tumaneng, Roven D.] Fauna & Flora Int, Philippines Programme, Tagaytay City, Cavite, Philippines; [De Alban, Jose Don T.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Monzon, Angelica Kristina V.] Univ Cambridge, Dept Geog, Cambridge, England; [Veridiano, Rizza Karen A.] Johann Heinrich von Thunen Inst Int Forestry & Fo, Hamburg, Germany; [Tumaneng, Roven D.] Philippine Council Ind Energy & Emerging Technol, Emerging Technol Dev Div, Dept Sci & Technol, Taguig City, Philippines	University of Cambridge; National University of Singapore; Washington University (WUSTL); National University of Singapore; University of Cambridge; Johann Heinrich von Thunen Institute; Department of Science & Technology (DOST), Philippines	Singh, M (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	minerva_singh@yahoo.co.in	Vilela, Bruno/L-1594-2015; De Alban, Jose Don/C-7742-2019; Friess, Dan/G-2056-2011	Vilela, Bruno/0000-0003-4072-0558; De Alban, Jose Don/0000-0002-1671-5786; Veridiano, Rizza Karen/0000-0002-2323-8383; Friess, Daniel/0000-0002-3087-5233; Singh, Minerva/0000-0002-7148-0078; Jaojoco, Angelica Kristina/0000-0002-1583-584X	EU; IUCN-EA	EU(European Commission); IUCN-EA	This work was supported by EU-funded Improving Forest Governance and Sustainable Upland Development through Climate Change Mitigation Financing Strategies in Southern Palawan (ADVANCE REDD+), and the IUCN-EA-funded Forest Conservation through Non-Timber Forest Products Sustainable Management and REDD+. Funding was received by JA. The funders played no role in the study design, data collection, analysis, decision to publish or preparation of manuscript.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Advanced Land Observing Satellite, 2012, NEW GLOB 25M RES PAL; Ahmed SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1742; Castillo-Santiago MA, 2010, INT J REMOTE SENS, V31, P2767, DOI 10.1080/01431160903095460; [Anonymous], 2016, SUMM HOTSP AN PAR RE; [Anonymous], 2011, CBD TECHNICAL SERIES, V59; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Barooah, 2013, INT J ADV RES ELECT, V2, P4206; Basnet TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150498; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Beaudrot L, 2016, ECOL APPL, V26, P1098, DOI 10.1890/15-0935; Birdlife International, 2016, IMP BIRD BIOD AR FAC; BirdLife International and Nature Serve, 2015, BIRD SPEC DISTR MAPS; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown S, 1997, ESTIMATING BIOMASS B, P134; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Carandang AP, 2012, ANAL KEY DRIVERS DEF; Carreiras JMB, 2013, REMOTE SENS-BASEL, V5, P1524, DOI 10.3390/rs5041524; Couteron P, 2005, J APPL ECOL, V42, P1121, DOI 10.1111/j.1365-2664.2005.01097.x; Crain BJ, 2014, DIVERS DISTRIB, V20, P652, DOI 10.1111/ddi.12179; Cutler MEJ, 2012, ISPRS J PHOTOGRAMM, V70, P66, DOI 10.1016/j.isprsjprs.2012.03.011; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; De Alban JT, 2013, FOREST CHANGE DETECT; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Dube T, 2014, SENSORS-BASEL, V14, P15348, DOI 10.3390/s140815348; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Dutra LV, 2009, AN 14 S BRAS SENS RE; Eckert S, 2012, REMOTE SENS-BASEL, V4, P810, DOI 10.3390/rs4040810; Englhart S., 2013, THESIS; ESA, 2016, ESA DAT US EL; Foody GM, 2001, GLOBAL ECOL BIOGEOGR, V10, P379, DOI 10.1046/j.1466-822X.2001.00248.x; Gaese K., 1997, J BIOGEOGR, V24, P49; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gil-Tena A, 2010, FOREST SYST, V19, P113; Gleason CJ, 2012, REMOTE SENS ENVIRON, V125, P80, DOI 10.1016/j.rse.2012.07.006; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Guneralp I, 2014, INT J APPL EARTH OBS, V33, P119, DOI 10.1016/j.jag.2014.05.004; Haines-Young R, 2009, LAND USE POLICY, V26, pS178, DOI 10.1016/j.landusepol.2009.08.009; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herzog S.K., 2011, CLIMATE CHANGE BIODI; Jachowski NRA, 2013, APPL GEOGR, V45, P311, DOI 10.1016/j.apgeog.2013.09.024; Jaeger J. A. G., 2011, Landscape fragmentation in Europe; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jones Z., 2015, P 73 ANN MPSA C; Kapos V, 2008, CARBON BIODIVERSITY, V101, P163; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Kuhn M, 2015, CARET CLASSIFICATION; Kumar R, 2014, ECOL INDIC, V45, P444, DOI 10.1016/j.ecolind.2014.05.003; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Langner A, 2015, LAND-BASEL, V4, P656, DOI 10.3390/land4030656; Lasco RD, 2013, MITIG ADAPT STRAT GL, V18, P1109, DOI 10.1007/s11027-012-9411-5; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lees AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122432; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Mallari NAD, 2011, ORYX, V45, P234, DOI 10.1017/S0030605310001031; Mallari NAD, 2001, KEY CONSERVATION SIT, P485; Mallari NAD, 2013, ENVIRON MANAGE, V51, P1236, DOI 10.1007/s00267-013-0053-5; Martin T, 2010, CONSERV SOC, V8, P127, DOI DOI 10.4103/0972-4923.68914; McCain CM, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0022548, DOI 10.1002/9780470015902.A0022548]; Mermoz S, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030217; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mitchard ETA, 2012, BIOGEOSCIENCES, V9, P179, DOI 10.5194/bg-9-179-2012; Mitchard ETA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/049001; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Moura MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152468; Murray JP, 2015, CONSERV BIOL, V29, P1434, DOI 10.1111/cobi.12500; Nadal-Romero E, 2014, EARTH SURF PROC LAND, V39, P1705, DOI 10.1002/esp.3549; NASA JPL, 2009, ASTER GLOB DIG EL MO; Newman ME, 2014, FOREST ECOL MANAG, V315, P138, DOI 10.1016/j.foreco.2013.12.033; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Osti M, 2014, USING SPATIAL ANAL E; Ouma YO, 2006, J ENVIRON INFORM, V8, P70, DOI 10.3808/jei.200600078; Panela S., 2015, PALAWAN PALM OIL PRE; Pereira RA, 2006, BANWA, P130; Pfeifer M, 2016, REMOTE SENS ENVIRON, V176, P84, DOI 10.1016/j.rse.2016.01.014; Phelps J, 2012, BIOL CONSERV, V154, P53, DOI 10.1016/j.biocon.2011.12.031; Phelps J, 2010, GLOBAL ENVIRON CHANG, V20, P322, DOI 10.1016/j.gloenvcha.2010.01.002; QUINNELL R, 1988, Oryx, V22, P30; Rejou-Mechain M, 2015, REMOTE SENS ENVIRON, V169, P93, DOI 10.1016/j.rse.2015.08.001; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Rocha R, 2015, TROPICAL CONSERVATIO, V8; Rompre G, 2007, J BIOGEOGR, V34, P802, DOI 10.1111/j.1365-2699.2006.01657.x; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Shataee S., 2012, International Journal of Remote Sensing, V33, P6254, DOI 10.1080/01431161.2012.682661; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Singh M, 2015, J TROP FOR SCI, V27, P227; Singh M, 2015, REMOTE SENS-BASEL, V7, P5057, DOI 10.3390/rs70505057; Singh M, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083695; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; Suresh M, 2014, INT ARCH PHOTOGRAMM, V40-8, P651, DOI 10.5194/isprsarchives-XL-8-651-2014; Tavora JF, 2012, CLIMATE RELEVANT MOD; Thapa RB, 2015, REMOTE SENS ENVIRON, V160, P122, DOI 10.1016/j.rse.2015.01.007; Thapa RB, EXAMINING HIGH RESOL; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Vilela B, 2015, PROJECT LETSR TITLE; WorldClim, 2016, WORDCL TIL; Zhang ZY, 2016, FORESTS, V7, DOI 10.3390/f7060122	105	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0186742	10.1371/journal.pone.0186742	http://dx.doi.org/10.1371/journal.pone.0186742			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206228	gold, Green Published, Green Submitted			2022-12-26	WOS:000417033200001
J	Bindusree, G; Natarajan, P; Kalva, S; Madasamy, P				Bindusree, Ganigara; Natarajan, Purushothaman; Kalva, Sukesh; Madasamy, Parani			Whole genome sequencing of Oryza sativa L. cv. Seeragasamba identifies a new fragrance allele in rice	PLOS ONE			English	Article							SNP-SEEK DATABASE; FUNCTIONAL MARKERS; QUANTITATIVE TRAIT; MOLECULAR MARKERS; AROMATIC RICE; GENE; DISCOVERY; 2-ACETYL-1-PYRROLINE; POLYMORPHISMS; COMPOUND	Fragrance of rice is an important trait that confers a large economic benefit to the farmers who cultivate aromatic rice varieties. Several aromatic rice varieties have limited geographic distribution, and are endowed with variety-specific unique fragrances. BADH2 was identified as a fragrance gene in 2005, and it is essential to identify the fragrance alleles from diverse geographical locations and genetic backgrounds. Seeragasamba is a short-grain aromatic rice variety of the indica type, which is cultivated in a limited area in India. Whole genome sequencing of this variety identified a new badh2 allele (badh2-p) with an 8 bp insertion in the promoter region of the BADH2 gene. When the whole genome sequences of 76 aromatic varieties in the 3000 rice genome project were analyzed, the badh2-p allele was present in 13 varieties (approximately 17%) of both indica and japonica types. In addition, the badh2-p allele was present in 17 varieties that already had the loss-of-function allele, badh2-E7. Taken together, the frequency of badh2-p allele (approximately 40%) was found to be greater than that of the badh2-E7 allele (approximately 34%) among the aromatic rice varieties. Therefore, it is suggested to include badh2-p as a predominant allele when screening for fragrance alleles in aromatic rice varieties.	[Bindusree, Ganigara; Natarajan, Purushothaman; Kalva, Sukesh; Madasamy, Parani] SRM Univ, Dept Genet Engn, Genom Lab, Kattankulathur, India	SRM Institute of Science & Technology Chennai	Madasamy, P (corresponding author), SRM Univ, Dept Genet Engn, Genom Lab, Kattankulathur, India.	parani.m@ktr.srmuniv.ac.in	Natarajan, Purushothaman/A-1093-2013; Madasamy, Parani/H-4911-2012	Natarajan, Purushothaman/0000-0001-5505-7109; Parani, Madasamy/0000-0002-2265-1715	SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies, SRM University, Chennai, Tamil Nadu, India [BT/PR12987/INF/22/205/2015]	SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies, SRM University, Chennai, Tamil Nadu, India	This study was financially supported by SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies (Order No. BT/PR12987/INF/22/205/2015), SRM University, Chennai, Tamil Nadu, India.; This study was financially supported by SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies (Order No. BT/PR12987/INF/22/205/2015), SRM University, Chennai, Tamil Nadu, India. The HPCC facility (Genome Server) at SRM University was used for the genome analysis.	AHN SN, 1992, THEOR APPL GENET, V84, P825, DOI 10.1007/BF00227391; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Amarawathi Y, 2008, MOL BREEDING, V21, P49, DOI 10.1007/s11032-007-9108-8; Andrews S., 2010, REFERENCE SOURCE; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; Buttery R, IDENTIFICATION RICE; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P1; He Q, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0412-4; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorieux M, 1996, THEOR APPL GENET, V93, P1145, DOI 10.1007/BF00230138; Mansueto L, 2017, NUCLEIC ACIDS RES, V45, pD1075, DOI 10.1093/nar/gkw1135; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mohan M. M., 2013, Electronic Journal of Plant Breeding, V4, P1148; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myint KM, 2012, RICE, V5, P1, DOI 10.1186/1939-8433-5-20; Ootsuka K, 2014, BREEDING SCI, V64, P115, DOI 10.1270/jsbbs.64.115; Rai VP, 2015, TURK J BOT, V39, P209, DOI 10.3906/bot-1405-117; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Sakthivel K, 2009, MOL BREEDING, V24, P185, DOI 10.1007/s11032-009-9283-x; Shao GN, 2011, PLANT BREEDING, V130, P172, DOI 10.1111/j.1439-0523.2009.01764.x; Shao GN, 2013, GENOMICS, V101, P157, DOI 10.1016/j.ygeno.2012.11.010; Shi WW, 2008, MOL BREEDING, V22, P185, DOI 10.1007/s11032-008-9165-7; Shi YQ, 2014, MOL BREEDING, V33, P701, DOI 10.1007/s11032-013-9986-x; Tyagi AK, 2004, J GENET, V83, P79, DOI 10.1007/BF02715832; Wakte K, 2017, J SCI FOOD AGR, V97, P384, DOI 10.1002/jsfa.7875; Wettewa W, 2014, J AGR SCI, V9; Yoshihashi T, 2002, J AGR FOOD CHEM, V50, P2001, DOI 10.1021/jf011268s; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022	34	12	14	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188920	10.1371/journal.pone.0188920	http://dx.doi.org/10.1371/journal.pone.0188920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190814	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900169
J	Guo, LT; Gao, ZH; Ge, HQ				Guo, Liting; Gao, Zhihong; Ge, Huanqi			Effects of serum 25-hydroxyvitaminD level on decreased bone mineral density at femoral neck and total hip in Chinese type 2 diabetes	PLOS ONE			English	Article							VITAMIN-D; OSTEOPOROTIC FRACTURES; POSITIVE ASSOCIATION; GLYCEMIC CONTROL; ELDERLY-WOMEN; RISK; MEN; CALCIUM; OLDER; MELLITUS	Objective The aims of this study is to observe the levels of serum 25-hydroxyvitaminD (25OHD), parathyroid hormone and bone mineral density (BMD) in type 2 diabetes as well as to analyze the correlationship between 25OHD level and BMD. Methods The subjects included 368 type 2 diabetic patients, ages ranged 40-79 years and 300 nondiabetic control subjects matched for age, gender and body mass index. The serum 25OHD concentration, parathyroid hormone level and BMD VALUE at lumbar spine (L1-L4), femoral neck, total hip and total body were measured. The BMDs (g/cm(2)) was measured by LUNAR's DEXA dual-energy X-ray absorptiometry. Results. Compared with control subjects, the serum 25OHD level, BMDs at the femoral neck and total hip declined in type 2 diabetes[(45 +/- 17 vs. 36 +/- 12 nmol/L), (0.93 +/- 0.17 vs. 0.85 +/- 0.14 g/cm(2)), (0.93 +/- 0.14 vs. 0.87 +/- 0.15g/cm(2)) (all P< 0.05)]; The parathyroid hormone level in type 2 diabetes was higher in type 2 diabetes than that in control subjects (8.5 +/- 4.2 vs. 5.6 +/- 3.9 pmol/L) (P<0.05). Compared with diabetes duration <= 10 years group, BMDs at the femoral neck and total hip decreased in diabetes duration > 10years group [(0.88 +/- 0.11 vs. 0.81 +/- 0.15 g/cm(2)), (0.91 +/- 0.14 vs. 0.84 +/- 0.16g/cm(2))(All P< 0.05)]; The parathyroid hormone level increased in diabetes duration > 10years group than diabetes duration <= 10 years group (10.6 +/- 9.1 vs. 7.1 +/- 3.7 pmol/L) (P<0.05). Compared with hemoglobin A1c (HbA1c) +/- 8% group, 25OHD and BMDs at the femoral neck and total hip in HbA1c <= 8% group decreased [(40 +/- 15 vs. 32 +/- 13 nmol/l), (0.89 +/- 0.13 vs. 0.83 +/- 0.13 g/cm(2)), (0.95 +/- 0.13 vs. 0.83 +/- 0.16 g/cm(2)) (All P< 0.05)] and the parathyroid hormone level increased (7.2 +/- 4.0 vs. 10.0 +/- 8.8 pmol/L) (P< 0.05). The morbidity of diabetic osteoporosis and osteopenia (41.0%, 47.8%) were higher than those in control subjects (27.0%, 33.3%) (X-2 = 4.37 and 4.70, P = 0.04 and 0.03); Diabetes duration, HbA1c and parathyroid hormone levels were longer or higher in Diabetic osteoporosis group than those in normal BMD group and osteopenia group(All p<0.05). Simple factor correlation analysis showed that the BMD at the femoral neck was negatively correlated with the age, diabetes duration, HbA1c, parathyroid hormone (rs = -0.18,-.23,- 0.18,-0.25), and positively correlated with 25OHD (rs = 0.23). Conclusions Decreased BMDs and increased incidence of osteoporosis were observed in type 2 diabetic patients, which are closely related to the serum 25OHD level. These findings were more prominent at the femoral neck and total hip for patients with a longer diabetic history and	[Guo, Liting; Ge, Huanqi] Teda Int Cardiovasc Hosp, Dept Endocrinol, Tianjin, Peoples R China; [Gao, Zhihong] Tianjin Med Univ, Gen Hosp, Dept Endocrinol, Tianjin, Peoples R China	Tianjin Medical University	Ge, HQ (corresponding author), Teda Int Cardiovasc Hosp, Dept Endocrinol, Tianjin, Peoples R China.; Gao, ZH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Endocrinol, Tianjin, Peoples R China.	zhg2831@163.com; Gehuanqi@163.com			Health and Family Planning Committee of Tianjin Binhai New Area [2016BWKY025]; LTG	Health and Family Planning Committee of Tianjin Binhai New Area; LTG	The funder is Health and Family Planning Committee of Tianjin Binhai New Area; Grant number: 2016BWKY025; http://www.bh.gov.cn/html/WSJ/portal/index/index.htm; Grant recipient: LTG.	Abdulameer SA, 2012, PATIENT PREFER ADHER, V6, P435, DOI 10.2147/PPA.S32745; Akhter N, 2009, OSTEOPOROSIS INT, V20, P745, DOI 10.1007/s00198-008-0746-4; Anagnostis P, 2009, OSTEOPOROSIS INT, V20, P197, DOI 10.1007/s00198-008-0648-5; Bartl R, 2004, OSTEOPOROSIS DIAGNOS, P58; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2005, ARTHRIT RHEUM-ARTHR, V53, P821, DOI 10.1002/art.21601; Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Bridges MJ, 2005, ACTA DIABETOL, V42, P82, DOI 10.1007/s00592-005-0183-1; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chen H, 2013, CHINESE J OSTEOPOROS, V6, P20; CHRISTIANSEN C, 1982, SCAND J CLIN LAB INV, V42, P487; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; [董砚虎 Dong Yanhu], 2002, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V18, P111; Hamilton EJ, 2012, ACTA DIABETOL, V49, P153, DOI 10.1007/s00592-011-0324-7; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Koh WP, 2010, DIABETES CARE, V33, P1766, DOI 10.2337/dc10-0067; Kwon D J, 1996, J Obstet Gynaecol Res, V22, P157; Lipscombe LL, 2007, DIABETES CARE, V30, P835, DOI 10.2337/dc06-1851; Loureiro MB, 2014, DIABETES RES CLIN PR, V103, P452, DOI 10.1016/j.diabres.2013.12.018; Majima T, 2005, OSTEOPOROSIS INT, V16, P907, DOI 10.1007/s00198-004-1786-z; Merlotti D, 2010, NUTR METAB CARDIOVAS, V20, P683, DOI 10.1016/j.numecd.2010.07.008; NAGASAKA S, 1995, ENDOCR J, V42, P377, DOI 10.1507/endocrj.42.377; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Nguyen TV, 1996, AM J EPIDEMIOL, V144, P255, DOI 10.1093/oxfordjournals.aje.a008920; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yacov F, 2016, PLOS ONE, V11; Yaturu S, 2009, MED SCI MONITOR, V15, pCR5; Zhang LL, 2013, CHIN J DIABETES, V11, P1008; [张智海 Zhang Zhihai], 2015, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V21, P1	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188894	10.1371/journal.pone.0188894	http://dx.doi.org/10.1371/journal.pone.0188894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190676	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900161
J	Hakimzadeh, N; Pinas, VA; Molenaar, G; de Waard, V; Lutgens, E; van Eck-Smit, BLF; de Bruin, K; Piek, JJ; Eersels, JLH; Booij, J; Verberne, HJ; Windhorst, AD				Hakimzadeh, Nazanin; Pinas, Victorine A.; Molenaar, Ger; de Waard, Vivian; Lutgens, Esther; van Eck-Smit, Berthe L. F.; de Bruin, Kora; Piek, Jan J.; Eersels, Jos L. H.; Booij, Jan; Verberne, Hein J.; Windhorst, Albert D.			Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques	PLOS ONE			English	Article							IN-VITRO; INHIBITORS; POTENT; LYMPHOCYTES; DEFICIENT; RUPTURE; DISEASE	Molecular imaging of matrix metalloproteinases (MMPs) may allow detection of atherosclerotic lesions vulnerable to rupture. In this study, we develop a novel radiolabelled compound that can target gelatinase MMP subtypes (MMP2/9) with high selectivity and inhibitory potency. Inhibitory potencies of several halogenated analogues of MMP subtype-selective inhibitors (N-benzenesulfonyliminodiacetyl monohydroxamates and N-halophenoxy-benzenesulfonyl iminodiacetyl monohydroxamates) were in the nanomolar range for MMP2/9. The analogue with highest inhibitory potency and selectivity was radiolabelled with [I-123], resulting in moderate radiochemical yield, and high radiochemical purity. Biodistribution studies in mice, revealed stabilization in blood 1 hour after intravenous bolus injection. Intravenous infusion of the radioligand and subsequent autoradiography of excised aortas showed tracer uptake in atheroprone mice. Distribution of the radioligand showed co-localization with MMP2/9 immunohistochemical staining. In conclusion, we have developed a novel selective radiolabeled MMP2/9 inhibitor, suitable for single photon emission computed tomography (SPECT) imaging that effectively targets atherosclerotic lesions in mice.	[Hakimzadeh, Nazanin] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Hakimzadeh, Nazanin] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Pinas, Victorine A.; van Eck-Smit, Berthe L. F.; de Bruin, Kora; Booij, Jan; Verberne, Hein J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Pinas, Victorine A.; Eersels, Jos L. H.; Windhorst, Albert D.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Molenaar, Ger] BV Cyclotron VU, Amsterdam, Netherlands; [de Waard, Vivian; Lutgens, Esther] Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Lutgens, Esther] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich	Windhorst, AD (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	ad.windhorst@vumc.nl	Booij, Jan/AAD-7159-2019	Eersels, Jos Leon/0000-0001-7521-583X; Windhorst, Albert/0000-0002-1250-7656; Piek, Jan/0000-0001-8666-7129	project EMINENCE [01C-204]; EU project INMIND [HEALTH-F2-2011-278850]; Dutch Heart foundation	project EMINENCE; EU project INMIND; Dutch Heart foundation(Netherlands Heart Foundation)	This work was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project EMINENCE (grant 01C-204) and the EU FP7 project INMIND, grant nr HEALTH-F2-2011-278850 (Molenaar, Windhorst). The financial contribution of the Dutch Heart foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Golestani R, 2016, J CLIN MED, V5, DOI 10.3390/jcm5060057; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Hansson GK, 2015, J INTERN MED; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hugenberg V, 2012, J MED CHEM, V55, P4714, DOI 10.1021/jm300199g; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Jeng AY, 1998, BIOORG MED CHEM LETT, V8, P897, DOI 10.1016/S0960-894X(98)00142-5; Knol RJJ, 2008, J NEUROSCI METH, V168, P341, DOI 10.1016/j.jneumeth.2007.10.028; Lebel Rejean, 2014, Contrast Media Mol Imaging, V9, P187, DOI 10.1002/cmmi.1555; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Matusiak N, 2013, CURR PHARM DESIGN, V19, P4647, DOI 10.2174/1381612811319250011; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newby AC, 2015, MATRIX BIOL, V44-46, P157, DOI 10.1016/j.matbio.2015.01.015; Ohshima S, 2009, J NUCL MED, V50, P612, DOI 10.2967/jnumed.108.055889; Oviedo-Orta E, 2008, IMMUNOLOGY, V124, P42, DOI 10.1111/j.1365-2567.2007.02728.x; Santos MA, 2006, BIOORGAN MED CHEM, V14, P7539, DOI 10.1016/j.bmc.2006.07.011; Scozzafava A, 2000, J MED CHEM, V43, P3677, DOI 10.1021/jm000027t; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18	24	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187767	10.1371/journal.pone.0187767	http://dx.doi.org/10.1371/journal.pone.0187767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190653	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900020
J	Hohman, TJ; Dumitrescu, L; Oksol, A; Wagener, M; Gifford, KA; Jefferson, AL				Hohman, Timothy J.; Dumitrescu, Logan; Oksol, Amy; Wagener, Madison; Gifford, Katherine A.; Jefferson, Angela L.		Alzheimer's Dis Neuroimaging Initi	APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; PATHOLOGY; ASSOCIATION; EPSILON-2; GENOTYPE; PART; AD; POPULATION; BIOMARKERS; SCLEROSIS	Biomarker definitions for preclinical Alzheimer's disease (AD) have identified individuals with neurodegeneration (ND+) without beta-amyloidosis (A beta-) and labeled them with suspected non-AD pathophysiology (SNAP). We evaluated Apolipoprotein E (APOE) epsilon 2 and epsilon 4 allele frequencies across biomarker definitions D A beta-/ND-(n = 268), A beta+/ND-(n = 236), A beta-/ND+ or SNAP (n = 78), A beta+/ND+ (n = 204) D hypothesizing that SNAP would have an APOE profile comparable to A beta-/ND-. Using AD Neuroimaging Initiative data (n = 786, 72 +/- 7 years, 48% female), amyloid status (A beta+ or A beta-) was defined by cerebrospinal fluid (CSF) A beta-42 levels, and neurodegeneration status (ND+ or ND-) was defined by hippocampal volume from MRI. Binary logistic regression related biomarker status to APOE epsilon 2 and epsilon 4 allele carrier status, adjusting for age, sex, education, and cognitive diagnosis. Compared to the biomarker negative (A beta-/ND-) participants, higher proportions of epsilon 4 and lower proportions of epsilon 2 carriers were observed among A beta+/ND-(epsilon 4: OR = 6.23, p< 0.001; epsilon 2: OR = 0.53, p = 0.03) and A beta+/ND+ participants (epsilon 4: OR = 12.07, p< 0.001; epsilon 2: OR = 0.29, p = 0.004). SNAP participants were statistically comparable to biomarker negative participants (p-values> 0.30). In supplemental analyses, comparable results were observed when coding SNAP using amyloid imaging and when using CSF tau levels. In contrast to APOE, a polygenic risk score for AD that excluded APOE did not show an association with amyloidosis or neurodegeneration (p-values> 0.15), but did show an association with SNAP defined using CSF tau (beta = 0.004, p = 0.02). Thus, in a population with low levels of cerebrovascular disease and a lower prevalence of SNAP than the general population, APOE and known genetic drivers of AD do not appear to contribute to the neurodegeneration observed in SNAP. Additional work in population based samples is needed to better elucidate the genetic contributors to various etiological drivers of SNAP.	[Hohman, Timothy J.; Dumitrescu, Logan; Oksol, Amy; Wagener, Madison; Gifford, Katherine A.; Jefferson, Angela L.; Alzheimer's Dis Neuroimaging Initi] Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37235 USA	Vanderbilt University	Hohman, TJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37235 USA.	Timothy.J.Hohman@Vanderbilt.edu	Hohman, Timothy/AFN-9053-2022	Hohman, Timothy/0000-0002-3377-7014; Jefferson, Angela/0000-0002-8245-0587	Alzheimer's Association [IIRG 08 88733, R01-AG034962, R01-HL111516, K24-AG046373]; Paul B. Beeson Career Development Award (National Center for Research Resources and National Institutes of Health) [K23-AG045966, UL1-TR000445]; Vanderbilt Memory & Alzheimer's Center; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG 024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research;  [K01-AG049164];  [K12-HD043483]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG045966, K24AG046373, K01AG049164] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Paul B. Beeson Career Development Award (National Center for Research Resources and National Institutes of Health); Vanderbilt Memory & Alzheimer's Center; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by K01-AG049164 (TJH), K12-HD043483 (TJH, KAG), Alzheimer's Association IIRG 08 88733 (AU), R01-AG034962 (AU), R01-HL111516 (AU), K24-AG046373 (AU), Paul B. Beeson Career Development Award in Aging K23-AG045966 (KAG), UL1-TR000445 (Vanderbilt Clinical Translational Science Award from the National Center for Research Resources and National Institutes of Health), and the Vanderbilt Memory & Alzheimer's Center. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG 024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors report no conflicts of interest. This research was supported in part by K01-AG049164 (TJH), K12-HD043483 (TJH, KAG), Alzheimer's Association IIRG-08-88733 (AU), R01-AG034962 (AU), R01-HL111516 (AU), K24-AG046373 (AU), Paul B. Beeson Career Development Award in Aging K23-AG045966 (KAG), UL1-TR000445 (Vanderbilt Clinical Translational Science Award from the National Center for Research Resources and National Institutes of Health), and the Vanderbilt Memory & Alzheimer's Center.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.finih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Caroli A, 2015, NEUROLOGY, V84, P508, DOI 10.1212/WNL.0000000000001209; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Ghebremedhin E, 1998, ACTA NEUROPATHOL, V96, P222, DOI 10.1007/s004010050886; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2016, NATURE REV NEUROLOGY; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jellinger KA, 1998, BRAIN PATHOL, V8, P367; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; McCarron MO, 2000, ANN NY ACAD SCI, V903, P176, DOI 10.1111/j.1749-6632.2000.tb06366.x; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Mormino EC, 2016, NEUROLOGY, V87, P481, DOI 10.1212/WNL.0000000000002922; Mormino EC, 2014, JAMA NEUROL, V71, P1379, DOI 10.1001/jamaneurol.2014.2031; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Nelson PT, 2016, J NEUROPATH EXP NEUR, V75, P482, DOI 10.1093/jnen/nlw033; Nelson PT, 2011, BRAIN, V134, P1506, DOI 10.1093/brain/awr053; Nicoll JAR, 2011, NEUROPATH APPL NEURO, V37, P285, DOI 10.1111/j.1365-2990.2010.01130.x; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Scott JA, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00221; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Toledo JB, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-26; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X; Wisse LEM, 2015, NEUROBIOL AGING, V36, P3152, DOI 10.1016/j.neurobiolaging.2015.08.029; Yip AG, 2005, NEUROLOGY, V65, P259, DOI 10.1212/01.wnl.0000168863.49053.4d	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188501	10.1371/journal.pone.0188501	http://dx.doi.org/10.1371/journal.pone.0188501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190651	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900063
J	Redding, DW; Lucas, TCD; Blackburn, TM; Jones, KE				Redding, David W.; Lucas, Tim C. D.; Blackburn, Tim M.; Jones, Kate E.			Evaluating Bayesian spatial methods for modelling species distributions with clumped and restricted occurrence data	PLOS ONE			English	Article							AUTOCORRELATION; BIAS; INFERENCE; MAXENT; NICHE; INLA	Statistical approaches for inferring the spatial distribution of taxa (Species Distribution Models, SDMs) commonly rely on available occurrence data, which is often clumped and geographically restricted. Although available SDM methods address some of these factors, they could be more directly and accurately modelled using a spatially-explicit approach. Software to fit models with spatial autocorrelation parameters in SDMs are now widely available, but whether such approaches for inferring SDMs aid predictions compared to other methodologies is unknown. Here, within a simulated environment using 1000 generated species' ranges, we compared the performance of two commonly used non-spatial SDM methods (Maximum Entropy Modelling, MAXENT and boosted regression trees, BRT), to a spatial Bayesian SDM method (fitted using R-INLA), when the underlying data exhibit varying combinations of clumping and geographic restriction. Finally, we tested how any recommended methodological settings designed to account for spatially non-random patterns in the data impact inference. Spatial Bayesian SDM method was the most consistently accurate method, being in the top 2 most accurate methods in 7 out of 8 data sampling scenarios. Within high-coverage sample datasets, all methods performed fairly similarly. When sampling points were randomly spread, BRT had a 1-3% greater accuracy over the other methods and when samples were clumped, the spatial Bayesian SDM method had a 4%-8% better AUC score. Alternatively, when sampling points were restricted to a small section of the true range all methods were on average 10-12% less accurate, with greater variation among the methods. Model inference under the recommended settings to account for autocorrelation was not impacted by clumping or restriction of data, except for the complexity of the spatial regression term in the spatial Bayesian model. Methods, such as those made available by R-INLA, can be successfully used to account for spatial autocorrelation in an SDM context and, by taking account of random effects, produce outputs that can better elucidate the role of covariates in predicting species occurrence. Given that it is often unclear what the drivers are behind data clumping in an empirical occurrence dataset, or indeed how geographically restricted these data are, spatially-explicit Bayesian SDMs may be the better choice when modelling the spatial distribution of target species.	[Redding, David W.; Lucas, Tim C. D.; Blackburn, Tim M.; Jones, Kate E.] UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, London, England; [Lucas, Tim C. D.] Univ Oxford, Big Data Inst, Oxford, England; [Blackburn, Tim M.; Jones, Kate E.] Zool Soc London, Inst Zool, London, England	University of London; University College London; University of Oxford; Zoological Society of London	Redding, DW (corresponding author), UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, London, England.	dwredding@gmail.com	Jones, Kate/Y-3317-2019; Blackburn, Tim M/A-7685-2011; Blackburn, Tim/AAC-3144-2019; Redding, David/M-1766-2019; Jones, Kate E/G-4768-2010	Jones, Kate/0000-0001-5231-3293; Blackburn, Tim/0000-0003-0152-2663; Redding, David/0000-0001-8615-1798; Jones, Kate E/0000-0001-5231-3293; Lucas, Tim/0000-0003-4694-8107	Ecosystem Services for Poverty Alleviation Programme (ESPA), Dynamic Drivers of Disease in Africa Consortium, NERC [NE-J001570-1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); Natural Environment Research Council [NE/J001422/1, NE/J001570/1, NE/J000507/2] Funding Source: researchfish; MRC [MR/R02491X/1] Funding Source: UKRI; NERC [NE/J001570/1, NE/J001422/1, NE/J000507/2] Funding Source: UKRI	Ecosystem Services for Poverty Alleviation Programme (ESPA), Dynamic Drivers of Disease in Africa Consortium, NERC; Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded with support from the Ecosystem Services for Poverty Alleviation Programme (ESPA), Dynamic Drivers of Disease in Africa Consortium, NERC project no. NE-J001570-1, to David W. Redding and Kate E. Jones. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baddeley A, 2015, SPATIAL POINT PATTER; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Beguin J, 2012, METHODS ECOL EVOL, V3, P921, DOI 10.1111/j.2041-210X.2012.00211.x; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Crase B, 2014, GLOBAL CHANGE BIOL, V20, P2566, DOI 10.1111/gcb.12598; Diggle PJ, 2010, J R STAT SOC C-APPL, V59, P191, DOI 10.1111/j.1467-9876.2009.00701.x; Drake JM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0086; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Golding N, 2016, METHODS ECOL EVOL, V7, P598, DOI 10.1111/2041-210X.12523; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hefley TJ, 2017, ECOLOGY, V98, P632, DOI 10.1002/ecy.1674; Hijmans RP, 2013, DISMO SPECIES DISTRI, P811; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Lindgren F, 2015, J STAT SOFTW, V63, P1, DOI 10.18637/jss.v063.i19; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; Miller JA, 2012, PROG PHYS GEOG, V36, P681, DOI 10.1177/0309133312442522; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Redding DW, 2016, METHODS ECOL EVOL, V7, P646, DOI 10.1111/2041-210X.12549; Redding DW, 2016, PHILOS T ROYAL SOC B; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Rue H, 2017, ANNU REV STAT APPL, V4, P395, DOI 10.1146/annurev-statistics-060116-054045; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Simpson D, 2015, BIOMETRIKA; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thuiller W, 2015, ECOL LETT, V18, P1321, DOI 10.1111/ele.12526; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	44	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187602	10.1371/journal.pone.0187602	http://dx.doi.org/10.1371/journal.pone.0187602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190296	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900017
J	Schausberger, P; Walzer, A; Murata, Y; Osakabe, M				Schausberger, Peter; Walzer, Andreas; Murata, Yasumasa; Osakabe, Masahiro			Low level of polyandry constrains phenotypic plasticity of male body size in mites	PLOS ONE			English	Article							SEXUAL SELECTION; REPRODUCTIVE SUCCESS; PHYTOSEIULUS-PERSIMILIS; SPERM COMPETITION; MATING-BEHAVIOR; MATE CHOICE; EVOLUTION; COSTS; CONSEQUENCES; LIMITS	Polyandry, i.e. females mating with multiple males, is more common than previously anticipated and potentially provides both direct and indirect fitness benefits to females. The level of polyandry (defined by the lifetime number of male mates of a female) is an important determinant of the occurrence and intensity of sexual selection acting on male phenotypes. While the forces of sexual selection acting on phenotypic male traits such as body size are relatively well understood, sexual selection acting on phenotypic plasticity of these traits is unexplored. We tackled this issue by scrutinizing the link between polyandry and phenotypic plasticity of male body size in two sympatric plant-inhabiting predatory mite species, Phytoseiulus persimilis and Neoseiulus californicus. These two species are similar in life history, ecological niche requirements, mating behavior, polygyny and female body size plasticity but strikingly differ in the level of both polyandry and phenotypic plasticity of male body size (both lower in P. persimilis). We hypothesized that deviations from standard body size, i.e. the size achieved under favorable conditions, incur higher costs for males in the less polyandrous P. persimilis. To test our hypotheses, we conducted two experiments on (i) the effects of male body size on spermatophore transfer in singly mating females and (ii) the effects of mate sequence (switching the order of standard-sized and small males) on mating behavior and paternity success in doubly mating females. In P. persimilis but not N. californicus, small males transferred fewer but larger spermatophores to the females; in both species, females re-mated more likely with standard-sized following small than small following standard-sized males; in P. persimilis, first standardsized males sired a higher proportion of offspring produced after re-mating by the female than first small males, whereas in N. californicus the paternity success of small and standard- sized males was independent of the mating sequence. Based on our results and pertinent previous studies, which showed that females of P. persimilis, but not N. californicus, prefer mating with standard-sized over small males and allow them fertilizing more eggs, the lack of interspecific difference in female body size plasticity, and the absence of any clue pointing at a role of natural selection, we suggest that the interspecific difference in male body size plasticity is sexually selected. Our study provides an indication of sexual selection constraining plasticity of male phenotypes, suggesting that the level of polyandry may be an important co-determinant of the level of phenotypic plasticity of male body size.	[Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Schausberger, Peter; Walzer, Andreas] Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Murata, Yasumasa; Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Sakyo Ku, Kyoto, Japan	University of Vienna; Kyoto University	Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.; Schausberger, P (corresponding author), Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.	peter.schausberger@univie.ac.at	Osakabe, Masahiro/H-8587-2019	Osakabe, Masahiro/0000-0002-2246-3431; Schausberger, Peter/0000-0002-1529-3198	Austria Science Fund (FWF) [P 23504-617]; Austrian Science Fund (FWF) [P 23504, P 25876] Funding Source: researchfish	Austria Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by a grant from the Austria Science Fund (FWF; P 23504-617) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO H, 1979, ACAROLOGIA, V20, P196; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson Malte, 1994; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 1999, BEHAV ECOL, V10, P358, DOI 10.1093/beheco/10.4.358; Auld HL, 2016, ETHOLOGY, V122, P597, DOI 10.1111/eth.12506; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Collet J, 2012, P NATL ACAD SCI USA, V109, P8641, DOI 10.1073/pnas.1200219109; Croft BA, 1999, EXP APPL ACAROL, V23, P599, DOI 10.1023/A:1006236310613; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Gotoh T, 2008, EXP APPL ACAROL, V44, P185, DOI 10.1007/s10493-008-9143-0; Harano T, 2012, J ETHOL, V30, P337, DOI 10.1007/s10164-012-0331-3; Helle W., 1985, SPIDER MITES THEIR A, V1; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Klemme I, 2007, BEHAV ECOL SOCIOBIOL, V61, P1911, DOI 10.1007/s00265-007-0431-1; Knuttel H, 2001, J EXP BIOL, V204, P2447; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Krantz GW, MANUAL ACAROLOGY; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kvarnemo C, 2004, BIOL J LINN SOC, V83, P369, DOI 10.1111/j.1095-8312.2004.00395.x; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Murren CJ, 2015, HEREDITY, V115, P293, DOI 10.1038/hdy.2015.8; Nonaka E, 2014, EVOL ECOL, V28, P1057, DOI 10.1007/s10682-014-9728-5; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Sabelis Maurice W., 1994, P70; SABELIS MW, 1988, EXP APPL ACAROL, V4, P301, DOI 10.1007/BF01196192; Saleh NW, 2014, J INSECT BEHAV, V27, P346, DOI 10.1007/s10905-013-9425-1; Savalli UM, 1998, ANIM BEHAV, V55, P473, DOI 10.1006/anbe.1997.0622; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154355; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Stennett MD, 1997, J CHEM ECOL, V23, P2803, DOI 10.1023/A:1022519228346; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Walzer A, 2015, ANIM BEHAV, V100, P96, DOI 10.1016/j.anbehav.2014.11.017; Walzer A, 2014, BIOL J LINN SOC, V111, P889, DOI 10.1111/bij.12235; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188924	10.1371/journal.pone.0188924	http://dx.doi.org/10.1371/journal.pone.0188924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190832	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900170
J	VanSteelandt, A; Aho, J; Franklin, K; Likofata, J; Kamgang, JB; Keita, S; Koivogui, L; Magassouba, N; Martel, LD; Dahourou, AG				VanSteelandt, Amanda; Aho, Josephine; Franklin, Kristyn; Likofata, Jacques; Kamgang, Jean Baptiste; Keita, Sakoba; Koivogui, Lamine; Magassouba, N'Faly; Martel, Lise D.; Dahourou, Anicet George			Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories	PLOS ONE			English	Article								Background Rapid Diagnostic Tests (RDTs) for Ebola Virus Disease (EVD) at the point of care have the potential to increase access and acceptability of EVD testing and the speed of patient isolation and secure burials for suspect cases. A pilot program for EVD RDTs in high risk areas of Guinea was introduced in October 2015. This paper presents concordance data between EVD RDTs and PCR testing in the field as well as an assessment of the acceptability, feasibility, and quality assurance of the RDT program. Methods and findings Concordance data were compiled from laboratory surveillance databases. The operational measures of the laboratory-based EVD RDT program were evaluated at all 34 sentinel sites in Guinea through: (1) a technical questionnaire filled by the lab technicians who performed the RDTs, (2) a checklist filled by the evaluator during the site visits, and (3) direct observation of the lab technicians performing the quality control test. Acceptability of the EVD RDT was good for technicians, patients, and families although many technicians (69.8%) expressed concern for their safety while performing the test. The feasibility of the program was good based on average technician knowledge scores (6.6 out of 8) but basic infrastructure, equipment, and supplies were lacking. There was much room for improvement in quality assurance of the program. Conclusions The implementation of new diagnostics in weak laboratory systems requires general training in quality assurance, biosafety and communication with patients in addition to specific training for the new test. Corresponding capacity building in terms of basic equipment and a long-term commitment to transfer supervision and quality improvement to national public health staff are necessary for successful implementation.	[VanSteelandt, Amanda; Kamgang, Jean Baptiste; Dahourou, Anicet George] Ctr Dis Control & Prevent, Dept Global Hlth Protect, Epidemiol Informat Surveillance & Lab Branch, Atlanta, GA 30333 USA; [Aho, Josephine] Publ Hlth Agcy Canada, Canadian Field Epidemiol Program, Ottawa, ON, Canada; [Franklin, Kristyn] Publ Hlth Agcy Canada, Ctr Food Bome Environm & Zoonot Infect Dis, Outbreak Management Div, Guelph, ON, Canada; [Likofata, Jacques] Lab Prov Sante Publ Prov Equateur, Mbandaka, DEM REP CONGO; [Keita, Sakoba] Agence Natl Secur Sanit, Conakry, Guinea; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Magassouba, N'Faly] Univ Gamal Abdel Nasser, Lab Fievres Hemorrag & Guinee, Conakry, Guinea; [Martel, Lise D.] Ctr Dis Control & Prevent, CDC Guinea Off, Conakry, Guinea	Centers for Disease Control & Prevention - USA; Public Health Agency of Canada; Public Health Agency of Canada	VanSteelandt, A (corresponding author), Ctr Dis Control & Prevent, Dept Global Hlth Protect, Epidemiol Informat Surveillance & Lab Branch, Atlanta, GA 30333 USA.	Amanda.VanSteelandt@gmail.com						[Anonymous], 2016, WORLD HLTH ORG SITUA; Huang JY, 2016, MMWR-MORBID MORTAL W, V65, P328, DOI 10.15585/mmwr.mm6512a4; Lindblade KA, 2016, EMERG INFECT DIS; Louis FJ, 2017, AFR J LAB MED, V6, DOI 10.4102/ajlm.v6i1.484; OraSure Technologies Inc, 2016, OR EB RAP ANT TEST I; R Core Team, 2013, R LANG ENV STAT COMP	6	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188047	10.1371/journal.pone.0188047	http://dx.doi.org/10.1371/journal.pone.0188047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190713	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900030
J	Wang, MJ; Yang, S; Sun, Y; Gao, J				Wang, Minjie; Yang, Su; Sun, Yi; Gao, Jun			Human mobility prediction from region functions with taxi trajectories	PLOS ONE			English	Article								People in cities nowadays suffer from increasingly severe traffic jams due to less awareness of how collective human mobility is affected by urban planning. Besides, understanding how region functions shape human mobility is critical for business planning but remains unsolved so far. This study aims to discover the association between region functions and resulting human mobility. We establish a linear regression model to predict the traffic flows of Beijing based on the input referred to as bag of POIs. By solving the predictor in the sense of sparse representation, we find that the average prediction precision is over 74% and each type of POI contributes differently in the predictor, which accounts for what factors and how such region functions attract people visiting. Based on these findings, predictive human mobility could be taken into account when planning new regions and region functions.	[Wang, Minjie; Yang, Su; Sun, Yi; Gao, Jun] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Coll Comp Sci, Shanghai, Peoples R China	Fudan University	Yang, S (corresponding author), Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Coll Comp Sci, Shanghai, Peoples R China.	suyang@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [61472087]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (NSFC, Grant NO. 61472087). The funding is received by SY. The URL of NSFC is: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai H, 2016, PHYSICA A, V457, P590, DOI 10.1016/j.physa.2016.03.047; Chen J., 2015, P 2015 ACM INT S WEA, P97; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jing Y, 2012, SIGKDD C KNOWL DISC; Li Y, 2017, TRANSPORT RES C-EMER, V77, P306, DOI 10.1016/j.trc.2017.02.005; Pan G, 2013, IEEE T INTELL TRANSP, V14, P113, DOI 10.1109/TITS.2012.2209201; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Petri G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01798; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; Toole Jameson L., 2012, P ACM SIGKDD INT WOR, P1, DOI [10.1145/2346496.2346498, DOI 10.1145/2346496.2346498]; Do TMT, 2014, IEEE T MOBILE COMPUT, V13, P638, DOI 10.1109/TMC.2013.19; Wang M, 2016 IEEE INT C IEEE, V7, P540; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Yan ZX, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2483669.2483682; YU HY, 2017, SENSORS BASEL, V17, DOI DOI 10.3390/S17071501; Zhang WS, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P943	20	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188735	10.1371/journal.pone.0188735	http://dx.doi.org/10.1371/journal.pone.0188735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190708	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900112
J	Efimova, SS; Tevyashova, AN; Olsufyeva, EN; Bykov, EE; Ostroumova, OS				Efimova, Svetlana S.; Tevyashova, Anna N.; Olsufyeva, Evgenia N.; Bykov, Evgeny E.; Ostroumova, Olga S.			Pore-forming activity of new conjugate antibiotics based on amphotericin B	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; LIPID-BILAYER MEMBRANES; POLYENE MACROLIDE ANTIBIOTICS; ACHOLEPLASMA-LAIDLAWII CELLS; PHOSPHOLIPID-MEMBRANES; CHEMICAL-MODIFICATION; STEROL INTERACTIONS; LECITHIN LIPOSOMES; MOLECULAR-DYNAMICS; DIPOLE MODIFIERS	A series of amides of the antifungal antibiotic amphotericin B (AmB) and its conjugates with benzoxaboroles was tested to determine whether they form pores in lipid bilayers and to compare their channel characteristics. The tested derivatives produced pores of larger amplitude and shorter lifetime than those of the parent antibiotic. The pore conductance was related to changes in the partial charge of the hydrogens of the hydroxyl groups in the lac tone ring that determined the anion coordination in the channel. Neutralization of one of the polar group charges in the AmB head during chemical modification produced a pronounced effect by diminishing the dwell time of the polyene channel compared to modification of both groups. In this study, compounds that had a modification of one carboxyl or amino group were less effective in initializing phase separation in POPC-membranes compared to derivatives that had modifications of both polar groups as well as the parent antibiotic. The effects were attributed to the restriction of the aggregation process by electrical repulsion between charged derivatives in contrast to neutral compounds. The significant correlation between the ability of derivatives to increase the permeability of model membranes causing the appearance of single channels in lipid bilayers or inducing calcein leakage from unilamellar vesicles and the minimal inhibitory concentration indicated that the antifungal effect of the conjugates was due to pore formation in the membranes of target cells.	[Efimova, Svetlana S.; Ostroumova, Olga S.] Russian Acad Sci, Inst Cytol, Grp Ion Channel Modeling, St Petersburg, Russia; [Tevyashova, Anna N.; Olsufyeva, Evgenia N.; Bykov, Evgeny E.] Russian Acad Med Sci, Lab Chem Transformat Antibiot, Gause Inst New Antibiot, Moscow, Russia; [Tevyashova, Anna N.] DI Mendeleev Univ Chem Technol Russia, Moscow, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Russian Academy of Medical Sciences; Russian Academy of Sciences; Gause Institute of New Antibiotics; Mendeleev University of Chemical Technology of Russia	Efimova, SS (corresponding author), Russian Acad Sci, Inst Cytol, Grp Ion Channel Modeling, St Petersburg, Russia.	ssefimova@mail.ru	Efimova, Svetlana S./I-8716-2014; Ostroumova, Olga S./N-8636-2013; Tevyashova, Anna/A-8293-2014	Efimova, Svetlana S./0000-0002-2429-2007; Ostroumova, Olga/0000-0002-7312-4579	Russian Foundation of Science [14-14-00565-P, SP-69.2015.4]; Russian Science Foundation [17-14-00055] Funding Source: Russian Science Foundation	Russian Foundation of Science; Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported by the Russian Foundation of Science (# 14-14-00565-P) (OSO) and SP-69.2015.4 (SSE).	Adediran SA, 2009, MOL PHARMACEUT, V6, P1582, DOI 10.1021/mp9001602; ANDREOLI TE, 1974, ANN NY ACAD SCI, V235, P448, DOI 10.1111/j.1749-6632.1974.tb43283.x; Antillon A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162171; Baginski M, 2002, BBA-BIOMEMBRANES, V1567, P63, DOI 10.1016/S0005-2736(02)00581-3; BALAKRISHNAN AR, 1993, BIOCHEMISTRY-US, V32, P4139, DOI 10.1021/bi00066a040; BONILLAMARIN M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P65, DOI 10.1016/0005-2736(91)90269-E; BORISOVA MP, 1986, J MEMBRANE BIOL, V90, P13, DOI 10.1007/BF01869681; Brutyan RA, 1996, J GEN PHYSIOL, V107, P69, DOI 10.1085/jgp.107.1.69; Chulkov EG, 2014, CHEM PHYS LIPIDS, V183, P204, DOI 10.1016/j.chemphyslip.2014.07.008; Cohen BE, 2016, ANTIMICROB AGENTS CH, V60, P5122, DOI 10.1128/AAC.00878-16; Cohen BE, 2010, J MEMBRANE BIOL, V238, P1, DOI 10.1007/s00232-010-9313-y; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DUFOURC EJ, 1984, BIOCHIM BIOPHYS ACTA, V778, P435, DOI 10.1016/0005-2736(84)90391-2; Efimova SS, 2014, ACTA NATURAE, V6, P67, DOI 10.32607/20758251-2014-6-4-67-79; Grigoriev VB, 2002, J MOL NEUROSCI, V18, P271, DOI 10.1385/JMN:18:3:271; Hac-Wydro K, 2005, BIOPHYS CHEM, V116, P77, DOI 10.1016/j.bpc.2005.03.001; Halperin A, 2016, J MED CHEM, V59, P1197, DOI 10.1021/acs.jmedchem.5b01862; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; KASUMOV KM, 1979, BIOCHIM BIOPHYS ACTA, V551, P229, DOI 10.1016/0005-2736(89)90001-1; Khutorsky V, 1996, BIOPHYS J, V71, P2984, DOI 10.1016/S0006-3495(96)79491-2; KHUTORSKY VE, 1992, BIOCHIM BIOPHYS ACTA, V1108, P123, DOI 10.1016/0005-2736(92)90015-E; Kleinberg M, 2006, INT J ANTIMICROB AG, V27, pS12, DOI 10.1016/j.ijantimicag.2006.03.013; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Milhaud J, 2002, BBA-BIOMEMBRANES, V1558, P95, DOI 10.1016/S0005-2736(01)00416-3; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; MORENOBELLO M, 1988, BIOCHIM BIOPHYS ACTA, V944, P97, DOI 10.1016/0005-2736(88)90321-5; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Ostroumova OS, 2014, EUR BIOPHYS J BIOPHY, V43, P207, DOI 10.1007/s00249-014-0946-0; Ostroumova OS, 2014, CHEM PHYS LIPIDS, V178, P77, DOI 10.1016/j.chemphyslip.2013.12.005; Ostroumova OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045135; Ostroumova OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030261; Paquet MJ, 2002, CHEM PHYS LIPIDS, V119, P1, DOI 10.1016/S0009-3084(02)00071-3; Preobrazhenskaya MN, 2009, J MED CHEM, V52, P189, DOI 10.1021/jm800695k; Schaechter, 2009, ENCY MICROBIOLOGY, P205, DOI [10.1016/B978-012373944-5.00331-X, DOI 10.1016/B978-012373944-5.00331-X]; Shatursky OY, 2014, J MEMBRANE BIOL, V247, P211, DOI 10.1007/s00232-013-9626-8; Silvius J.R., 1982, LIPID PROTEIN INTERA; Solovieva SE, 2011, RUSS CHEM REV+, V80, P103, DOI 10.1070/RC2011v080n02ABEH004145; Sternal K, 2004, J MOL MODEL, V10, P223, DOI 10.1007/s00894-004-0190-0; Tan TRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152112; Tevyashova AN, 2016, J ANTIBIOT, V69, P549, DOI 10.1038/ja.2016.34; Tevyashova AN, 2013, ANTIMICROB AGENTS CH, V57, P3815, DOI 10.1128/AAC.00270-13; Zhang J, 2013, SCI CHINA CHEM, V56, P1372, DOI 10.1007/s11426-013-4981-y	44	15	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188573	10.1371/journal.pone.0188573	http://dx.doi.org/10.1371/journal.pone.0188573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186162	Green Submitted, Green Published, gold			2022-12-26	WOS:000416484900044
J	Kubo, T; Yamada, E; Kubo, MO				Kubo, Tai; Yamada, Eisuke; Kubo, Mugino O.			Masticatory jaw movement of Exaeretodon argentinus (Therapsida: Cynodontia) inferred from its dental microwear	PLOS ONE			English	Article							ENAMEL	Dental microwear of four postcanine teeth of Exaeretodon argentinus was analyzed using both two dimensional (2D) and three dimensional (3D) methods to infer their masticatory jaw movements. Results of both methods were congruent, showing that linear microwear features (scratches) were well aligned and mostly directed to the antero-posterior direction in all four teeth examined. These findings support the palinal masticatory jaw movement, which was inferred in previous studies based on the observation of gross morphology of wear facets. In contrast, the lack of detection of lateral scratches confirmed the absence of the lateral jaw movement that was also proposed by a previous study. Considering previous microwear studies on cynodonts, palinal jaw movements observed in Exaeretodon evolved within cynognathian cynodonts from the fully orthal jaw movement of its basal member. Although there are currently only three studies of dental microwear of non-mammalian cynodonts including the present study, microwear analysis is a useful tool for the reconstruction of masticatory jaw movement and its future application to various cynodonts will shed light on the evolutionary process of jaw movement towards the mammalian condition in more detail.	[Kubo, Tai; Yamada, Eisuke] Univ Tokyo, Univ Museum, Bunkyo Ku, Hongo 7-3-1, Tokyo, Japan; [Yamada, Eisuke] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Sch Adv Sci, SOKENDAI, Hayama, Kanagawa, Japan; [Kubo, Mugino O.] Univ Tokyo, Dept Nat Environm Studies, Grad Sch Frontier Sci, Kashiwanoha 5-1-5, Chiba, Japan	University of Tokyo; Graduate University for Advanced Studies - Japan; University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Hongo 7-3-1, Tokyo, Japan.	taikubo@um.u-tokyo.ac.jp		Kubo, Mugino/0000-0002-7748-7377; Kubo, Tai/0000-0003-3207-0399	JSPS KAKENHI [17K14411]; Fujiwara Natural History Foundation; Grants-in-Aid for Scientific Research [17K14411, 16K16340] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujiwara Natural History Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TK was funded by JSPS KAKENHI Grant Number 17K14411 (URL:http://www.jsps.go.jp.) and Fujiwara Natural History Foundation (URL:http://fujiwara-nh.or.jp/), when this study was conducted.	Abdala F, 2002, J VERTEBR PALEONTOL, V22, P313, DOI 10.1671/0272-4634(2002)022[0313:ANSOTT]2.0.CO;2; Abdala Fernando, 2007, REVISTA BRASILEIRA DE PALEONTOLOGIA, V10, P71; Arman SD, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/2/024007; CHATTERJEE S, 1982, J PALEONTOL, V56, P203; Crompton A. W., 1972, B BRIT MUS NAT HIST, V71, P21; CROMPTON AW, 1968, BIOL REV, V43, P427, DOI 10.1111/j.1469-185X.1968.tb00966.x; CROMPTON AW, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P55; GONI R, 1990, Ameghiniana, V27, P327; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; GRINE F E, 1977, Palaeontologia Africana, V20, P123; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Kubo T, 2014, ACTA PALAEONTOL POL, V59, P305, DOI 10.4202/app.2013.0027; Liu Jun, 2007, Revista Brasileira de Paleontologia, V10, P133; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranivoharimanana L, 2011, J VERTEBR PALEONTOL, V31, P1292, DOI 10.1080/02724634.2011.618154; Rasband W. S, 2015, IMAGEJ; Rybczynski N, 2001, LIFE O PAST, P299; Schmidt Christopher W., 2008, Proceedings of the Indiana Academy of Science, V117, P95; Simpson GG, 1926, AM J SCI, V11, P228; SOLOUNIAS N, 1993, J ZOOL, V229, P421, DOI 10.1111/j.1469-7998.1993.tb02646.x; Tausch J, 2015, SCANNING, V37, P446, DOI 10.1002/sca.21234; Teaford Mark F., 1994, Evolutionary Anthropology, V3, P17, DOI 10.1002/evan.1360030107; TEAFORD MF, 1989, ARCH ORAL BIOL, V34, P929, DOI 10.1016/0003-9969(89)90048-4; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; Thompson TA, 2004, ROSE; Ungar P.S., 2015, BIOSURFACE BIOTRIBOL, V1, P25, DOI [10.1016/j.bsbt.2014.12.001, DOI 10.1016/J.BSBT.2014.12.001]; Varriale FJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2132; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188023	10.1371/journal.pone.0188023	http://dx.doi.org/10.1371/journal.pone.0188023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186178	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900020
J	Cayatte, C; Bennett, AS; Rajani, GM; Hostetler, L; Maynard, SK; Lazzaro, M; McTamney, P; Ren, KS; O'Day, T; McCarthy, MP; Schneider-Ohrum, K				Cayatte, Corinne; Bennett, Angie Snell; Rajani, Gaurav Manohar; Hostetler, Leigh; Maynard, Sean K.; Lazzaro, Michelle; McTamney, Patrick; Ren, Kuishu; O'Day, Terrence; McCarthy, Michael P.; Schneider-Ohrum, Kirsten			Inferior immunogenicity and efficacy of respiratory syncytial virus fusion proteinbased subunit vaccine candidates in aged versus young mice	PLOS ONE			English	Article							IMMUNE-RESPONSES; INFLUENZA-VIRUS; OLDER-ADULTS; T-CELLS; INFECTION; HOSPITALIZATIONS; GLYCOPROTEIN; ANTIBODIES; ADJUVANT; DISEASE	Respiratory syncytial virus (RSV) is recognized as an important cause of lower and upper respiratory tract infections in older adults, and a successful vaccine would substantially lower morbidity and mortality in this age group. Recently, two vaccine candidates based on soluble purified glycoprotein F (RSV F), either alone or adjuvanted with glucopyranosyl lipid A formulated in a stable emulsion (GLA-SE), failed to reach their primary endpoints in clinical efficacy studies, despite demonstrating the desired immunogenicity profile and efficacy in young rodent models. Here, one of the RSV F vaccine candidates (post-fusion conformation, RSV post-F), and a stabilized pre-fusion form of RSV F (RSV pre-F, DS-Cav1) were evaluated in aged BALB/c mice. Humoral and cellular immunogenicity elicited after immunization of naive, aged mice was generally lower compared to young animals. In aged mice, RSV post-F vaccination without adjuvant poorly protected the respiratory tract from virus replication, and addition of GLA-SE only improved protection in the lungs, but not in nasal turbinates. RSV pre-F induced higher neutralizing antibody titers compared to RSV post-F (as previously reported) but interestingly, RSV F-specific CD8T cell responses were lower compared to RSV post-F responses regardless of age. The vaccines were also tested in RSV seropositive aged mice, in which both antigen forms similarly boosted neutralizing antibody titers, although GLA-SE addition boosted neutralizing activity only in RSV pre-F immunized animals. Cell-mediated immune responses in the aged mice were only slightly boosted and well below levels induced in seronegative young mice. Taken together, the findings suggest that the vaccine candidates were not able to induce a strong anti-RSV immune response in recipient mice with an aged immune system, in agreement with recent human clinical trial results. Therefore, the aged mouse model could be a useful tool to evaluate improved vaccine candidates, targeted to prevent RSV disease in older adults.	[Cayatte, Corinne; Bennett, Angie Snell; Rajani, Gaurav Manohar; Maynard, Sean K.; Lazzaro, Michelle; McTamney, Patrick; Ren, Kuishu; McCarthy, Michael P.; Schneider-Ohrum, Kirsten] MedImmune, Dept Infect Dis Vaccines, Gaithersburg, MD 20878 USA; [Hostetler, Leigh] MedImmune, Lab Anim Resources, Gaithersburg, MD USA; [O'Day, Terrence] MedImmune, Dept Stat Sci, Gaithersburg, MD USA; [Schneider-Ohrum, Kirsten] GlaxoSmithKline Vaccines, Discovery Performance Unit, Rockville, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; GlaxoSmithKline	Cayatte, C (corresponding author), MedImmune, Dept Infect Dis Vaccines, Gaithersburg, MD 20878 USA.	cayattec@medimmune.com	Rajani, Gaurav Manohar/AAX-9919-2021	Maynard, Sean/0000-0002-0953-4362; Cayatte, Corinne/0000-0002-0022-4384	MedImmune	MedImmune(AstraZenecaMedimmune)	All authors were MedImmune employees when the work was performed and the study was entirely funded by MedImmune.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Boyington JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159709; CANNON MJ, 1987, IMMUNOLOGY, V62, P133; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; Cayatte C, 2013, J VIROL, V87, P11107, DOI 10.1128/JVI.01554-13; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Crowe JE, 2001, J IMMUNOL, V167, P3910, DOI 10.4049/jimmunol.167.7.3910; Ebbert JO, 2005, RESPIRATION, V72, P263, DOI 10.1159/000085367; Falloon J, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00157-17, 10.1128/cvi.00157-17]; Falloon J, 2016, VACCINE, V34, P2847, DOI 10.1016/j.vaccine.2016.04.002; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fulton RB, 2013, J VIROL, V87, P12694, DOI 10.1128/JVI.02282-12; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Kurzweil V, 2013, EXPERT REV VACCINES, V12, P1047, DOI 10.1586/14760584.2013.824706; Lambert SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119509; Lee SS, 2013, J TRANSP GEOGR, V29, P11, DOI 10.1016/j.jtrangeo.2012.12.002; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Patton K, 2015, VACCINE, V33, P4472, DOI 10.1016/j.vaccine.2015.07.025; Schneider-Ohrum K, 2017, J VIROL, V91, DOI 10.1128/JVI.02180-16; Schneider-Ohrum K, 2011, VACCINE, V29, P9081, DOI 10.1016/j.vaccine.2011.09.051; Walsh EE, 2013, J INFECT DIS, V207, P1424, DOI 10.1093/infdis/jit038; Walsh EE, 2004, J MED VIROL, V73, P295, DOI 10.1002/jmv.20090; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Zhang YX, 2002, EXP BIOL MED, V227, P133, DOI 10.1177/153537020222700208; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	32	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188708	10.1371/journal.pone.0188708	http://dx.doi.org/10.1371/journal.pone.0188708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182682	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000053
J	McKnight, CG; Morris, SC; Perkins, C; Zhu, ZQ; Hildeman, DA; Bendelac, A; Finkelman, FD				McKnight, Christopher G.; Morris, Suzanne C.; Perkins, Charles; Zhu, Zhenqi; Hildeman, David A.; Bendelac, Albert; Finkelman, Fred D.			NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma	PLOS ONE			English	Article							KILLER T-CELLS; ALLERGIC AIRWAY INFLAMMATION; THYMIC STROMAL LYMPHOPOIETIN; MOUSE MODEL; ATOPIC ASTHMA; ALPHA-GALACTOSYLCERAMIDE; INKT-CELLS; EOSINOPHILIC INFLAMMATION; IMMUNE-RESPONSES; BRONCHIAL-ASTHMA	CD1d-deficiency results in a selective deletion of NKT cells in mice that is reported to prevent murine allergic airway disease (AAD). Because we find 2-3 fold lower basal IL-4 production in CD1d-mice than in wild-type (WT) mice, we hypothesized that the contribution made by NKT cells to AAD would depend on the strength of the stimulus used to induce the disease. Consequently, we compared CD1d-deficient mice to WT mice in the development of AAD, using several models of disease induction that differed in the type and dose of allergen, the site of sensitization and the duration of immunization. Surprisingly we found equivalent allergic inflammation and airway disease in WT and CD1d-mice in all models investigated. Consistent with this, NKT cells constituted only similar to 2% of CD4(+) T cells in the lungs of mice with AAD, and IL-4-transcribing NKT cells did not expand with disease induction. Concerned that the congenital absence of NKT cells might have caused a compensatory shift within the immune response, we administered an anti-CD1d monoclonal Ab (mAb) to block NKT function before airway treatments, before or after systemic sensitization to antigen. Such Ab treatment did not affect disease severity. We suggest that the differences reported in the literature regarding the significance of NKT cells in the induction of allergic airway disease may have less to do with the methods used to study the disease and more to do with the animals themselves and/or the facilities used to house them.	[McKnight, Christopher G.; Morris, Suzanne C.; Zhu, Zhenqi; Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45221 USA; [McKnight, Christopher G.; Morris, Suzanne C.; Perkins, Charles] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45220 USA; [Perkins, Charles; Hildeman, David A.; Finkelman, Fred D.] Cincinnati Childrens Hosp & Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bendelac, Albert] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Chicago; University of Chicago	McKnight, CG (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45221 USA.; McKnight, CG (corresponding author), Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45220 USA.	mcknigcr@ucmail.uc.edu	Hildeman, David/AAA-1757-2020	Hildeman, David/0000-0002-0421-8483	NIH ARRA [R01 HL097360]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060515] Funding Source: NIH RePORTER	NIH ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH ARRA R01 HL097360, University of Cincinnati Fellow to Faculty Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Araujo LM, 2004, EUR J IMMUNOL, V34, P327, DOI 10.1002/eji.200324151; Atochina EN, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-15; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BENSASSON SZ, 1990, J IMMUNOL, V145, P1127; Bilenki L, 2004, EUR J IMMUNOL, V34, P345, DOI 10.1002/eji.200324303; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Brooks CR, 2010, J ALLERGY CLIN IMMUN, V126, P882, DOI 10.1016/j.jaci.2010.06.041; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Chaouche-Drider N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005396; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Chuang YH, 2011, J IMMUNOL, V186, P4687, DOI 10.4049/jimmunol.1003659; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Damayanti T, 2010, AM J RESP CRIT CARE, V181, P688, DOI 10.1164/rccm.200910-1598OC; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Dinarello CA, 2005, IMMUNITY, V23, P461, DOI 10.1016/j.immuni.2005.10.004; Elkhal A, 2006, J ALLERGY CLIN IMMUN, V118, P1363, DOI 10.1016/j.jaci.2006.08.010; Finkelman Fred, 2003, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0628s54; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Galbiati F, 2000, EUR J IMMUNOL, V30, P29, DOI 10.1002/1521-4141(200001)30:1&lt;29::AID-IMMU29&gt;3.0.CO;2-7; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; Grela F, 2011, J IMMUNOL, V186, P284, DOI 10.4049/jimmunol.1001348; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin N, 2007, J IMMUNOL, V179, P2961, DOI 10.4049/jimmunol.179.5.2961; Karisola P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129446; Kim DH, 2008, J IMMUNOL, V180, P2062, DOI 10.4049/jimmunol.180.4.2062; Kim HY, 2009, J IMMUNOL, V182, P3252, DOI 10.4049/jimmunol.0803339; Kim JO, 2004, J ALLERGY CLIN IMMUN, V114, P1332, DOI 10.1016/j.jaci.2004.09.004; Koh YI, 2010, CLIN EXP IMMUNOL, V161, P159, DOI 10.1111/j.1365-2249.2010.04151.x; Koh YI, 2012, INT ARCH ALLERGY IMM, V158, P131, DOI 10.1159/000330908; Koh YI, 2010, INT ARCH ALLERGY IMM, V153, P239, DOI 10.1159/000314364; Koh YI, 2008, J IMMUNOL, V181, P4560, DOI 10.4049/jimmunol.181.7.4560; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Kotsimbos TC, 1996, P ASSOC AM PHYSICIAN, V108, P368; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Li YF, 2008, RESP MED, V102, P984, DOI 10.1016/j.rmed.2008.02.008; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Lu YM, 2015, MOL CELL BIOCHEM, V403, P25, DOI 10.1007/s11010-015-2333-2; Lundblad LKA, 2017, PULM PHARMACOL THER, V45, P80, DOI 10.1016/j.pupt.2017.05.003; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Matsuda H, 2010, J IMMUNOL, V185, P253, DOI 10.4049/jimmunol.0902301; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Meyer EH, 2007, J IMMUNOL, V179, P4661, DOI 10.4049/jimmunol.179.7.4661; Morishima Y, 2005, EUR J IMMUNOL, V35, P2803, DOI 10.1002/eji.200525994; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mutalithas K, 2007, J ALLERGY CLIN IMMUN, V119, P1274, DOI 10.1016/j.jaci.2007.02.021; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; Nambiar J, 2015, MABS-AUSTIN, V7, P638, DOI 10.1080/19420862.2015.1016693; Nie HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119901; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Nishimura T, 1997, J IMMUNOL, V158, P5698; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Okano M, 1999, ALLERGY, V54, P593, DOI 10.1034/j.1398-9995.1999.00063.x; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rayapudi M, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2013.13; Reynolds C, 2009, J ALLERGY CLIN IMMUN, V124, P860, DOI 10.1016/j.jaci.2009.07.022; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rock M, 2009, ANN ALLERG ASTHMA IM, V102, P432, DOI 10.1016/S1081-1206(10)60517-0; Sanford AN, 2002, COMPARATIVE MED, V52, P429; Scanlon ST, 2011, J EXP MED, V208, P2113, DOI 10.1084/jem.20110522; Scheuplein F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140729; Selvanantham T, 2016, J IMMUNOL, V197, P4464, DOI 10.4049/jimmunol.1601410; Shi HZ, 1998, AM J RESP CRIT CARE, V157, P1818, DOI 10.1164/ajrccm.157.6.9710023; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Yamamoto H, 2007, ALLERGY, V62, P1451, DOI 10.1111/j.1398-9995.2007.01464.x; Yanagibashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P372, DOI 10.1271/bbb.80612; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	108	14	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188221	10.1371/journal.pone.0188221	http://dx.doi.org/10.1371/journal.pone.0188221			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182669	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000014
J	Kong, SY; Kim, W; Lee, HR; Kim, HJ				Kong, Sun-Young; Kim, Woosuk; Lee, Ha-Rim; Kim, Hyun-Jung			The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells	FASEB JOURNAL			English	Article						epigenetics; H3K4 demethylase; NSC differentiation; eIF-4E; MAPK-interacting kinase	INITIATION-FACTOR 4E; MESSENGER-RNA; STEM-CELLS; BINDING; CANCER; EXPRESSION; DIFFERENTIATION; ACTIVATION; INHIBITION; EIF4E	Histone demethylases are known to play important roles in the determination of the fate of stem cells and in cancer progression. In this study, we show that the lysine 4 of histone H3 (H3K4), lysine-specific demethylase 5A (KDM5A) is essential for the repression of astrocyte differentiation in neural progenitor cells (NPCs), and its expression is regulated by translational machinery. Knockdown of KDM5A in NPCs increased astrocytogenesis, and conversely, KDM5A overexpression reduced the transcriptional activity of the Gfap promoter. Induction of astrocytogenesis by ciliary neurotrophic factor (CNTF) or small interfering RNA-induced knockdown of KDM5A decreased KDM5A recruitment to the Gfap promoter and increased H3K4 methylation. The transcript level of Kdm5a was high, whereas KDM5A protein level was low in CNTF induced astrocytes. During astroglial differentiation, translational activity indicated by the phosphorylation of eukaryotic translation initiation factor (eIF)4E was decreased. Treatment of NPCs with the cercosporamide, a MAPK-interacting kinases inhibitor, reduced eIF4E phosphorylation and KDM5A protein expression, increased GFAP levels, and enhanced astrocytogenesis. These data suggest that KDM5A is a key regulator that maintains NPCs in an undifferentiated state by repressing astrocytogenesis and that its expression is translationally controlled during astrocyte differentiation. Thus, KDM5A is a promising target for the modulation of NPC fate.	[Kong, Sun-Young; Kim, Woosuk; Lee, Ha-Rim; Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, 221 Heukseok Dong, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, 221 Heukseok Dong, Seoul 156756, South Korea.	hyunjungkim@cau.ac.kr			Chung-Ang University Excellent Student Scholarship; National Research Foundation of Korea - South Korean government [NRF2017R1A1A1A05000876]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS39055, NS057098]	Chung-Ang University Excellent Student Scholarship; National Research Foundation of Korea - South Korean government; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Chung-Ang University Excellent Student Scholarship and the National Research Foundation of Korea Grant NRF2017R1A1A1A05000876 (to H.J.K.), funded by the South Korean government. The Alabama Neuroscience Blueprint Core was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS39055 and NS057098. The authors declare no conflicts of interest.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Genheden M, 2015, J NEUROSCI, V35, P972, DOI 10.1523/JNEUROSCI.2641-14.2015; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 1997, BIOCHEM BIOPH RES CO, V240, P15, DOI 10.1006/bbrc.1997.7592; Hirano K, 2016, STEM CELLS, V34, P1872, DOI 10.1002/stem.2362; Horton JR, 2016, CELL CHEM BIOL, V23, P769, DOI 10.1016/j.chembiol.2016.06.006; Hsieh J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018911; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; KIM YW, 1994, MOL CELL BIOL, V14, P7256, DOI 10.1128/MCB.14.11.7256; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Kong SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118188; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lambrot R, 2015, FASEB J, V29, P4402, DOI 10.1096/fj.14-267328; Lee HS, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040312; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; Marcotrigiano J, 1997, Nucleic Acids Symp Ser, P8; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Scott PAE, 1998, BRIT J CANCER, V77, P2120, DOI 10.1038/bjc.1998.356; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; SHANTZ LM, 1994, CANCER RES, V54, P2313; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Vinogradova M, 2016, NAT CHEM BIOL, V12, P531, DOI 10.1038/nchembio.2085; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang CD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.238; Yoffe Y, 2016, GENE DEV, V30, P1991, DOI 10.1101/gad.285239.116; Yoon HJ, 2014, BIOORGAN MED CHEM, V22, P927, DOI 10.1016/j.bmc.2013.12.018; Yoon HJ, 2013, BIOORGAN MED CHEM, V21, P7165, DOI 10.1016/j.bmc.2013.08.066; Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.3969/J.ISSN.1000-2324.2014.02.01; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035; Zhou Q, 2016, MOL BIOL CELL, V27, P627, DOI 10.1091/mbc.E15-07-0513	56	24	24	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1108	1119		10.1096/fj.201700780R	http://dx.doi.org/10.1096/fj.201700780R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29212818	Green Published			2022-12-26	WOS:000425146900048
J	Guerster, M; Walter, U				Guerster, Markus; Walter, Ulrich			Aerodynamics of a highly irregular body at transonic speeds-Analysis of STRATOS flight data	PLOS ONE			English	Article							ALTITUDE FREE-FALL	In this paper, we analyze the trajectory and body attitude data of Felix Baumgartner's supersonic free fall through the atmosphere on October 14, 2012. As one of us UW) was scientific advisor to the Red Bull Stratos team, the analysis is based on true body data body mass, wetted pressure suit surface area) and actual atmospheric data from weather balloon measurements. We also present a fully developed theoretical analysis and solution of atmospheric free fall. By matching the flight data against this solution, we are able to derive and track the drag coefficient CD from the subsonic to the transonic and supersonic regime, and back again. Although the subsonic drag coefficient is the expected CD = 0.60 +/- 0.05, surprisingly the transonic compressibility drag coefficient is only 19% of the expected value. We provide a plausible explanation for this unexpected result.	[Guerster, Markus; Walter, Ulrich] Tech Univ Munich, Inst Astronaut, Garching, Germany	Technical University of Munich	Guerster, M (corresponding author), Tech Univ Munich, Inst Astronaut, Garching, Germany.	markus.guerster@tum.de						Anderson J.D., 2011, FUNDAMENTALS AERODYN, P357; [Anonymous], 1960, SKY DIVE EDGE SPACE; Benacka J, 2010, AM J PHYS, V78, P616, DOI 10.1119/1.3298375; Colino JM, 2013, EUR J PHYS, V34, P841, DOI 10.1088/0143-0807/34/4/841; Hoerner S. F, 1965, HOERNER FLUID DYNAMI, V2nd; Markoff J., 2014, NY TIMES; Mohazzabi P, 1996, AM J PHYS, V64, P1242, DOI 10.1119/1.18386; Rygalov VY, 2014, 44 INT C ENV SYST 13; Stratos RB, 2013, SUMMARY REPORT FINDI; Vadim R, 2011, 41 INT C ENV SYST	10	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187798	10.1371/journal.pone.0187798	http://dx.doi.org/10.1371/journal.pone.0187798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216204	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800012
J	Yeh, CC; Fan, YY; Xu, YC; Yang, YL; Simpson, PC; Mann, MJ				Yeh, Che-Chung; Fan, Yanying; Xu, Yanchun; Yang, Yi-Lin; Simpson, Paul C.; Mann, Michael J.			Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA(1B)-ADRENERGIC RECEPTORS; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; CARDIAC MYOCYTES; BLOOD-PRESSURE; STIMULATION; APOPTOSIS; KNOCKOUT; SURVIVAL	Rationale We have hypothesized that post-infarction cardiac remodeling can be influenced by shifts in the balance between intracellular mediators of "pathologic" and "physiologic" hypertrophy. Although alpha1 adrenergic receptors (alpha1-ARs) mediate pro-adaptive hypertrophy during pressure overload, little is known about their role or downstream mediators after myocardial infarction. Methods We performed loss-of-function experiments via coronary ligation in alpha1A-AR knockout (AKO) mice. Post-myocardial infarction (MI) remodeling was evaluated via echocardiography, quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis of cardiac fetal gene expression, histologic analysis of myocyte size, post-MI fibrosis and apoptosis, and Western blot analysis of apoptotic regulators. Results Alpha1A-AR knockout paradoxically increased post-MI hypertrophy compared to wild type controls (WT), but also increased ventricular dilatation, fibrosis, apoptosis, and 4-week post-MI mortality (64% in AKO vs. 25% in WT, P = 0.02), suggesting a shift toward greater pathologic hypertrophy in the absence of pro-adaptive alpha1A effects. alpha1A-AR knockout increased phospho-p38 levels in the pre-MI myocardium compared to WT (0.55 +/- 0.16 vs. 0.03 +/- 0.01, P<0.05) but decreased phospho-ERK1/2 post-MI (0.49 +/- 0.35 arbitrary units vs. 1.55 +/- 0.43 in WT, P<0.05). Furthermore, expression of pro-apoptotic factor Bax was increased (1.19 +/- 0.15 vs. 0.78 +/- 0.08, P<0.05) and expression of anti-apoptotic factors Bcl2 was decreased (0.26 +/- 0.01 vs. 0.55 +/- 0.06, P<0.01) compared to WT. Conclusions Alpha1A-AR provides an important counterbalance to pathologic pathways during post-MI remodeling that may be mediated through ERK1/2 signaling; these observations provide support for further development of an alpha1A-AR/ERK-based molecular intervention for this chronic, often fatal disease.	[Yeh, Che-Chung; Fan, Yanying; Xu, Yanchun; Yang, Yi-Lin; Mann, Michael J.] Univ Calif San Francisco, Cardiothorac Translat Res Lab, San Francisco, CA 94143 USA; [Simpson, Paul C.] Vet Affairs Med Ctr, Div Cardiol, San Francisco, CA 94121 USA; [Simpson, Paul C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Mann, MJ (corresponding author), Univ Calif San Francisco, Cardiothorac Translat Res Lab, San Francisco, CA 94143 USA.	Michael.Mann@ucsf.edu			National Institutes of Health [K08HL079239, R01HL083118, R01HL31113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants K08HL079239, R01HL083118, and R01HL31113 to MJM and PCS (https://www.nih.gov/).	Badenhorst D, 2003, HYPERTENSION, V41, P499, DOI 10.1161/01.HYP.0000056601.29613.DD; COHN JN, 1993, CIRCULATION, V87, P1; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Du XJ, 2004, J MOL CELL CARDIOL, V37, P979, DOI 10.1016/j.yjmcc.2004.07.010; Frantz S, 2007, BRIT J PHARMACOL, V150, P130, DOI 10.1038/sj.bjp.0706963; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Hosoda C, 2005, MOL PHARMACOL, V67, P912, DOI 10.1124/mol.104.007500; Hosoda C, 2007, AM J PHYSIOL-HEART C, V293, pH514, DOI 10.1152/ajpheart.00626.2006; Hu ZW, 1999, J PHARMACOL EXP THER, V290, P28; Huang Y, 2008, AM J PHYSIOL-HEART C, V295, pH699, DOI 10.1152/ajpheart.01204.2007; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Kajstura J, 1996, LAB INVEST, V74, P86; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Mani K, 2002, J MOL CELL CARDIOL, V34, P709, DOI 10.1006/jmcc.2002.2042; McCloskey DT, 2003, J MOL CELL CARDIOL, V35, P1207, DOI 10.1016/S0022-2828(03)00227-X; McCloskey DT, 2002, J MOL CELL CARDIOL, V34, P1007, DOI 10.1006/jmcc.2002.2049; Montgomery MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168409; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Qin FZ, 2005, BBA-MOL BASIS DIS, V1740, P499, DOI 10.1016/j.bbadis.2004.11.007; Ren J, 2005, J MOL CELL CARDIOL, V38, P617, DOI 10.1016/j.yjmcc.2005.01.012; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rorabaugh BR, 2005, CARDIOVASC RES, V65, P436, DOI 10.1016/j.cardiores.2004.10.009; Woo SH, 1999, PFLUG ARCH EUR J PHY, V437, P335, DOI 10.1007/s004240050787; Yeh CC, 2013, J CELL BIOCHEM, V114, P47, DOI 10.1002/jcb.24299; Yeh CC, 2010, J CELL BIOCHEM, V109, P1185, DOI 10.1002/jcb.22498	26	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188471	10.1371/journal.pone.0188471	http://dx.doi.org/10.1371/journal.pone.0188471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216197	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800025
J	Zomorodian, M; Lai, SH; Homayounfar, M; Ibrahim, S; Pender, G				Zomorodian, Mehdi; Lai, Sai Hin; Homayounfar, Mehran; Ibrahim, Shaliza; Pender, Gareth			Development and application of coupled system dynamics and game theory: A dynamic water conflict resolution method	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEM; RESOURCES MANAGEMENT; RESERVOIR OPERATION; PROGRAMMING MODEL; COOPERATIVE GAMES; RIVER-BASIN; ALLOCATION; DSS; INFORMATION; RELIABILITY	Conflicts over water resources can be highly dynamic and complex due to the various factors which can affect such systems, including economic, engineering, social, hydrologic, environmental and even political, as well as the inherent uncertainty involved in many of these factors. Furthermore, the conflicting behavior, preferences and goals of stakeholders can often make such conflicts even more challenging. While many game models, both cooperative and non-cooperative, have been suggested to deal with problems over utilizing and sharing water resources, most of these are based on a static viewpoint of demand points during optimization procedures. Moreover, such models are usually developed for a single reservoir system, and so are not really suitable for application to an integrated decision support system involving more than one reservoir. This paper outlines a coupled simulation-optimization modeling method based on a combination of system dynamics (SD) and game theory (GT). The method harnesses SD to capture the dynamic behavior of the water system, utilizing feedback loops between the system components in the course of the simulation. In addition, it uses GT concepts, including pure-strategy and mixed-strategy games as well as the Nash Bargaining Solution (NBS) method, to find the optimum allocation decisions over available water in the system. To test the capability of the proposed method to resolve multi-reservoir and multi-objective conflicts, two different deterministic simulation-optimization models with increasing levels of complexity were developed for the Langat River basin in Malaysia. The later is a strategic water catchment that has a range of different stakeholders and managerial bodies, which are however willing to cooperate in order to avoid unmet demand. In our first model, all water users play a dynamic pure-strategy game. The second model then adds in dynamic behaviors to reservoirs to factor in inflow uncertainty and adjust the strategies for the reservoirs using the mixed-strategy game and Markov chain methods. The two models were then evaluated against three performance indices: Reliability, Resilience and Vulnerability (R-R-V). The results showed that, while both models were well capable of dealing with conflict resolution over water resources in the Langat River basin, the second model achieved a substantially improved performance through its ability to deal with dynamicity, complexity and uncertainty in the river system.	[Zomorodian, Mehdi; Lai, Sai Hin; Ibrahim, Shaliza] Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia; [Homayounfar, Mehran] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA; [Pender, Gareth] Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Edinburgh, Midlothian, Scotland	Universiti Malaya; State University System of Florida; University of Florida; Heriot Watt University	Lai, SH (corresponding author), Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia.	laish@um.edu.my	Ibrahim, Shaliza/A-5854-2010; Lai, Sai Hin/H-3164-2018; Homayounfar, Mehran/AAH-2141-2020; Pender, Gareth/C-2340-2014	Ibrahim, Shaliza/0000-0001-9413-957X; Lai, Sai Hin/0000-0002-7143-4805; Pender, Gareth/0000-0003-2265-8228; Zomorodian, Mehdi/0000-0002-6855-534X	Government of Malaysia; British Council fund [IF004-2015]; University of Malaya fund the project through the BKS Grant [BKS008-2016]	Government of Malaysia; British Council fund; University of Malaya fund the project through the BKS Grant	The Government of Malaysia and British Council fund this project through the Newton-Ungku Omar Fund with Grant No. IF004-2015. University of Malaya fund the project through the BKS Grant No. BKS008-2016.	ANANDALINGAM G, 1991, EUR J OPER RES, V51, P233, DOI 10.1016/0377-2217(91)90253-R; [Anonymous], MANAGING WATER RESOU; Anzaldi G, 2014, PROCEDIA ENGINEER, V89, P1097, DOI 10.1016/j.proeng.2014.11.230; Castelletti A, 2008, APPL MATH COMPUT, V206, P21, DOI 10.1016/j.amc.2007.09.069; Chae S, 2004, MATH SOC SCI, V48, P37, DOI 10.1016/j.mathsocsci.2003.11.002; Chang FJ, 2013, J HYDROL, V507, P124, DOI 10.1016/j.jhydrol.2013.10.027; DINAR A, 1992, THEOR DECIS, V32, P1, DOI 10.1007/BF00133625; Droubi A, 2008, ENVIRON SCI ENG, P199, DOI 10.1007/978-3-540-85047-2_16; DUNN JC, 1989, J OPTIMIZ THEORY APP, V63, P23, DOI 10.1007/BF00940728; DYER JS, 1973, MANAGE SCI B-APPL, V20, P507, DOI 10.1287/mnsc.20.4.507; Fayaed SS, 2013, WATER RESOUR MANAG, V27, P3679, DOI 10.1007/s11269-013-0373-5; Ganji A, 2008, WATER RESOUR MANAG, V22, P51, DOI 10.1007/s11269-006-9143-y; Ganji A, 2007, ADV WATER RESOUR, V30, P528, DOI 10.1016/j.advwatres.2006.04.004; Ganji A, 2007, ADV WATER RESOUR, V30, P157, DOI 10.1016/j.advwatres.2006.03.008; Ghahraman B, 2002, IRRIGATION SCI, V21, P127, DOI 10.1007/s002710100040; Gohari A, 2013, J HYDROL, V491, P23, DOI 10.1016/j.jhydrol.2013.03.021; Han Z, 2005, IEEE T COMMUN, V53, P1366, DOI 10.1109/TCOMM.2005.852826; HARSANYI JC, 1972, MANAGE SCI B-APPL, V18, pP80; HARSANYI JC, 1963, INT ECON REV, V4, P194, DOI 10.2307/2525487; HASHIMOTO T, 1982, WATER RESOUR RES, V18, P14, DOI 10.1029/WR018i001p00014; Homayoun-Far M, 2010, ADV WATER RESOUR, V33, P752, DOI 10.1016/j.advwatres.2010.04.001; Homayounfar M, 2015, WATER RESOUR MANAG, V29, P2599, DOI 10.1007/s11269-015-0959-1; Homayounfar M, 2014, WATER RESOUR MANAG, V28, P3207, DOI 10.1007/s11269-014-0669-0; Homayounfar M, 2011, WATER RESOUR MANAG, V25, P3427, DOI 10.1007/s11269-011-9863-5; Kahil MT, 2016, WATER RESOUR ECON, V13, P60, DOI 10.1016/j.wre.2015.10.001; Karamouz M., 2003, WATER RESOURCES SYST; Kjeldsen TR, 2004, HYDROLOGICAL SCI J, V49; Li YP, 2009, STOCH ENV RES RISK A, V23, P781, DOI 10.1007/s00477-008-0258-y; Li YP, 2006, ADV WATER RESOUR, V29, P776, DOI 10.1016/j.advwatres.2005.07.008; Madani K, 2014, ENVIRON MODELL SOFTW, V51, P240, DOI 10.1016/j.envsoft.2013.09.029; Madani K, 2010, J HYDROL, V381, P225, DOI 10.1016/j.jhydrol.2009.11.045; Maia R, 2009, DESALINATION, V237, P81, DOI 10.1016/j.desal.2007.12.024; Mirchi A, 2012, WATER RESOUR MANAG, V26, P2421, DOI 10.1007/s11269-012-0024-2; Mousavi H, 2000, ADV WATER RESOUR, V23, P613, DOI 10.1016/S0309-1708(99)00053-6; Mousavi SJ, 2004, ADV WATER RESOUR, V27, P1105, DOI 10.1016/j.advwatres.2004.07.007; Nandalal KDW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002172; Nash J, 1953, ECONOMETRICA, V21, P128, DOI 10.2307/1906951; ORON G, 1991, J WATER RES PL-ASCE, V117, P287, DOI 10.1061/(ASCE)0733-9496(1991)117:3(287); Park Y, 2008, STOCH ENV RES RISK A, V22, P169, DOI 10.1007/s00477-007-0105-6; Pedro-Monzonis M, 2016, J HYDROL, V533, P1, DOI 10.1016/j.jhydrol.2015.11.034; Philpot S, 2016, J ENVIRON MANAGE, V180, P247, DOI 10.1016/j.jenvman.2016.05.027; Qin HP, 2011, ENVIRON MODELL SOFTW, V26, P1502, DOI 10.1016/j.envsoft.2011.07.003; Reny PJ, 1999, ECONOMETRICA, V67, P1029, DOI 10.1111/1468-0262.00069; Salewicz KA, 2004, GLOBAL ENVIRON CHANG, V14, P25, DOI 10.1016/j.gloenvcha.2003.11.007; Sechi GM, 2013, WATER RESOUR MANAG, V27, P1781, DOI 10.1007/s11269-012-0171-5; Simonovic SP, 2009, WATER RESOUR MANAG, V23, P2163; Singh A, 2014, AGR WATER MANAGE, V141, P23, DOI 10.1016/j.agwat.2014.04.003; Soncini-Sessa R, 2003, ENVIRON MODELL SOFTW, V18, P395, DOI 10.1016/S1364-8152(03)00035-5; TEJADAGUIBERT JA, 1993, WATER RESOUR RES, V29, P3969, DOI 10.1029/93WR02277; TEJADAGUIBERT JA, 1995, WATER RESOUR RES, V31, P2571, DOI 10.1029/95WR02172; United Nations Educational Scientific and Cultural Organization (UNESCO), 2014, WAT POST 2015 DEV AG; Videira N, 2017, ENVIRONMENTAL MODELING WITH STAKEHOLDERS: THEORY, METHODS, AND APPLICATIONS, P241, DOI 10.1007/978-3-319-25053-3_12; Weng SQ, 2010, EXPERT SYST APPL, V37, P8242, DOI 10.1016/j.eswa.2010.05.061; YEH WWG, 1985, WATER RESOUR RES, V21, P1797, DOI 10.1029/WR021i012p01797; Zarghami M, 2015, WATER RESOUR MANAG, V29, P4285, DOI 10.1007/s11269-015-1060-5; Zarghami M, 2012, RESOUR CONSERV RECY, V60, P99, DOI 10.1016/j.resconrec.2011.11.008; Zarghami M, 2011, MULTICRITERIA ANALYSIS: APPLICATIONS TO WATER AND ENVIRONMENT MANAGEMENT, P1, DOI 10.1007/978-3-642-17937-2; Zeng Y, 2012, EXPERT SYST APPL, V39, P10091, DOI 10.1016/j.eswa.2012.02.065	58	13	14	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188489	10.1371/journal.pone.0188489	http://dx.doi.org/10.1371/journal.pone.0188489			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216200	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800026
J	Patrnogic, J; Leclerc, V				Patrnogic, Jelena; Leclerc, Vincent			The serine protease homolog spheroide is involved in sensing of pathogenic Gram-positive bacteria	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; DROSOPHILA TOLL PATHWAY; DORSOVENTRAL POLARITY; PROTEINASE HOMOLOG; HOST-DEFENSE; ACTIVATION; VIRULENCE; IMMUNITY; GENES; MELANOGASTER	In Drosophila, recognition of pathogens such as Gram-positive bacteria and fungi triggers the activation of proteolytic cascades and the subsequent activation of the Toll pathway. This response can be achieved by either detection of pathogen associated molecular patterns or by sensing microbial proteolytic activities ("danger signals"). Previous data suggested that certain serine protease homologs (serine protease folds that lack an active catalytic triad) could be involved in the pathway. We generated a null mutant of the serine protease homolog spheroide (sphe). These mutant flies are susceptible to Enterococcus faecalis infection and unable to fully activate the Toll pathway. Sphe is required to activate the Toll pathway after challenge with pathogenic Gram-Positive bacteria. Sphe functions in the danger signal pathway, downstream or at the level of Persephone.	[Patrnogic, Jelena; Leclerc, Vincent] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR9022, Strasbourg, France; [Patrnogic, Jelena] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; George Washington University	Leclerc, V (corresponding author), Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR9022, Strasbourg, France.	v.leclerc@unistra.fr	Patrnogić, Jelena/AAV-3993-2021		European Research Council [ERC-2009-AdG_20090506]; Fondation pour la Recherche Medicale [FDT20130928085]	European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by the European Research Council grant ERC-2009-AdG_20090506 and Fondation pour la Recherche Medicale grant FDT20130928085 (J.P).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cho YS, 2012, CURR BIOL, V22, P1013, DOI 10.1016/j.cub.2012.03.065; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; HOGG PJ, 1991, J BIOL CHEM, V266, P10953; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kawabata S, 1996, FEBS LETT, V398, P146, DOI 10.1016/S0014-5793(96)01224-0; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MURUGASUOEI B, 1995, GENE DEV, V9, P139, DOI 10.1101/gad.9.2.139; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Qureshi SH, 2014, BBA-PROTEINS PROTEOM, V1844, P1631, DOI 10.1016/j.bbapap.2014.06.011; Reichhart J-M, 2011, DROSOPHILA SERPINS M; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188339	10.1371/journal.pone.0188339	http://dx.doi.org/10.1371/journal.pone.0188339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211760	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200027
J	Campbell, RD; Rosell, F; Newman, C; Macdonald, DW				Campbell, Ruairidh D.; Rosell, Frank; Newman, Chris; Macdonald, David W.			Age-related changes in somatic condition and reproduction in the Eurasian beaver: Resource history influences onset of reproductive senescence	PLOS ONE			English	Article							CASTOR-FIBER; BODY-MASS; OLDER MOTHERS; EVOLUTION; SUCCESS; COSTS; POPULATIONS; PERFORMANCE; ALLOCATION; RESTRAINT	Using 15 years of data from a stable population of wild Eurasian beavers (Castor fiber), we examine how annual and lifetime access to food resources affect individual age-related changes in reproduction and somatic condition. We found an age-related decline in annual maternal reproductive output, after a peak at age 5-6. Rainfall, an established negative proxy of annual resource availability for beavers, was consistently associated with lower reproductive output for females of all ages. In contrast, breeding territory quality, as a measure of local resource history over reproductive lifetimes, caused differences in individual patterns of reproductive senescence; animals from lower quality territories senesced when younger. Litter size was unrelated to maternal age, although adult body weight increased with age. In terms of resource effects, in poorer years but not in better years, older mothers produced larger offspring than did younger mothers, giving support to the constraint theory. Overall, our findings exemplify state-dependent life-history strategies, supporting an effect of resources on reproductive senescence, where cumulative differences in resource access, and not just reproductive strategy, mediate long-term reproductive trade-offs, consistent with the disposable soma and reproductive restraint theories. We propose that flexible life-history schedules could play a role in the dynamics of populations exhibiting reproductive skew, with earlier breeding opportunities leading to an earlier senescence schedule through resource dependent mechanisms.	[Campbell, Ruairidh D.; Rosell, Frank] Univ Coll Southeast Norway, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway; [Campbell, Ruairidh D.; Newman, Chris; Macdonald, David W.] Univ Oxford, Zool Dept, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England; [Campbell, Ruairidh D.] Scottish Nat Heritage, Great Glen House, Inverness, Scotland	University College of Southeast Norway; University of Oxford	Rosell, F (corresponding author), Univ Coll Southeast Norway, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway.	frank.rosell@usn.no			University College of Southeast Norway; Peoples Trust for Endangered Species	University College of Southeast Norway; Peoples Trust for Endangered Species	This study was financially supported by a University College of Southeast Norway grant to RDC and FR and through a grant from the Peoples Trust for Endangered Species to DWM, also supporting CN.	ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Barton K., 2012, MUMIN MULTI MODEL IN; Bates D, LME4 LINEAR MIXED EF; Beirne C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1086; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bowen WD, 2006, J ANIM ECOL, V75, P1340, DOI 10.1111/j.1365-2656.2006.01157.x; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell R.D., 2010, THESIS; Campbell RD, 2005, BEHAV ECOL SOCIOBIOL, V58, P597, DOI 10.1007/s00265-005-0942-6; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Charmantier A, 2014, QUANTITATIVE GENETICS IN THE WILD, P68; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; de Magalhaes JP, 2002, EXP GERONTOL, V37, P769, DOI 10.1016/S0531-5565(02)00008-6; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Green WCH, 1990, BEHAV ECOL, V1, P148, DOI 10.1093/beheco/1.2.148; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hartman G, 1997, CAN J ZOOL, V75, P959, DOI 10.1139/z97-116; Hayflick L, 1994, HOW AND WHY WE AGE; Hayward AD, 2015, EXP GERONTOL, V71, P56, DOI 10.1016/j.exger.2015.08.003; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lemaitre JF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0209; Marshall DJ, 2010, ECOLOGY, V91, P2862, DOI 10.1890/09-0156.1; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Medawar P., 1952, UNSOLVED PROBLEM BIO; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; NOLET BA, 1994, CAN J ZOOL, V72, P1227, DOI 10.1139/z94-164; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Parker H, 2001, WILDLIFE BIOL, V7, P237, DOI 10.2981/wlb.2001.015; Penteriani V, 2009, OIKOS, V118, P321, DOI 10.1111/j.1600-0706.2008.17190.x; Pinheiro J., 2011, R PACKAGE VERSION, V3, P1; R Core Team, 2016, R FDN STAT COMP; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rosell F., 1999, BEVER; Schwarze D, BEAVER NATURAL HIST; Speakman JR, 2010, INTEGR COMP BIOL, V50, P793, DOI 10.1093/icb/icq049; SVENDSEN GE, 1989, CAN J ZOOL, V67, P336, DOI 10.1139/z89-049; Tafani M, 2013, OECOLOGIA, V172, P427, DOI 10.1007/s00442-012-2499-1; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WILBUR HM, 1974, AM NAT, V108, P805, DOI 10.1086/282956; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilsson L, 1971, VILTREVY, V8, P115	67	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187484	10.1371/journal.pone.0187484	http://dx.doi.org/10.1371/journal.pone.0187484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206840	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700004
J	Chancharoenthana, W; Leelahavanichkul, A; Taratummarat, S; Wongphom, J; Tiranathanagul, K; Eiam-Ong, S				Chancharoenthana, Wiwat; Leelahavanichkul, Asada; Taratummarat, Sujittra; Wongphom, Jutamas; Tiranathanagul, Khajohn; Eiam-Ong, Somchai			Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-GROWTH-FACTOR; CORONARY STENT IMPLANTATION; NEOINTIMAL LESION FORMATION; ARTERY-DISEASE; DEPENDENT MECHANISM; MICRORNA CONTROL; BALLOON INJURY; POTENTIAL ROLE; CELLS	Intimal hyperplasia (IH) is a common cause of vasculopathy due to direct endothelial damage (such as post-coronary revascularization) or indirect injury (such as chronic kidney disease, or CKD). Although the attenuation of coronary revascularization-induced IH (direct-vascular-injury-induced IH) by cilostazol, a phosphodiesterase III inhibitor, has been demonstrated, our understanding of the effect on CKD-induced IH (indirect-vascular-injuryinduced IH) is limited. Herein, we tested if cilostazol attenuated CKD-induced IH in a mouse model of ischemic-reperfusion injury with unilateral nephrectomy (ChrI/R), a normotensive non-proteinuria CKD model. Cilostazol (50 mg/kg/day) or placebo was orally administered once daily from 1-week post-nephrectomy. At 20 weeks, cilostazol significantly attenuated aortic IH as demonstrated by a 34% reduction in the total intima area with 50% and 47% decreases in the ratios of tunica intima area/tunica media area and tunica intima area/(tunicaintima + tunica media area), respectively. The diameters of aorta and renal function were unchanged by cilostazol. Interestingly, cilostazol decreased miR-221, but enhanced miR143 and miR-145 in either in vitro or aortic tissue, as well as attenuated several pro-inflammatory mediators, including asymmetrical dimethylarginine, high-sensitivity C-reactive protein, vascular endothelial growth factor in aorta and serum pro-inflammatory cytokines (IL-6 and TNF-alpha). We demonstrated a proof of concept of the effectiveness of cilostazol in attenuating IH in a Chr I/R mouse model, a CKD model with predominantly indirect-vascular- injury-induced IH. These considerations warrant further investigation to develop a new primary prevention strategy for CKD-related IH.	[Chancharoenthana, Wiwat; Tiranathanagul, Khajohn; Eiam-Ong, Somchai] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand; [Chancharoenthana, Wiwat; Tiranathanagul, Khajohn; Eiam-Ong, Somchai] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Chancharoenthana, Wiwat] CRA, HRH Princess Chulabhorn Coll Med Sci, Chulabhorn Hosp, Dept Med,Div Nephrol & Hypertens,Sect Intervent N, Bangkok, Thailand; [Leelahavanichkul, Asada; Taratummarat, Sujittra] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Wongphom, Jutamas] Chulalongkorn Univ, Dept Pathol, Fac Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulabhorn Research Institute; Chulabhorn Royal Academy; Chulabhorn Hospital; HRH Princess Chulabhorn College of Medical Science; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	a_leelahavanit@yahoo.com	Chancharoenthana, Wiwat/ABA-8259-2021	Chancharoenthana, Wiwat/0000-0002-2965-146X	Ratchadapiseksomphot Research Grant, Faculty of Medicine, Chulalongkorn University [RA57/055]	Ratchadapiseksomphot Research Grant, Faculty of Medicine, Chulalongkorn University	This work was supported by the Ratchadapiseksomphot Research Grant (RA57/055), Faculty of Medicine, Chulalongkorn University.	Aoki M, 2001, DIABETOLOGIA, V44, P1034, DOI 10.1007/s001250100593; Aoki M, 1999, HYPERTENSION, V34, P192, DOI 10.1161/01.HYP.34.2.192; Baldus S, 2006, CIRCULATION, V113, P1871, DOI 10.1161/CIRCULATIONAHA.105.590083; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Biscetti F, 2013, INT J CARDIOL, V167, P910, DOI 10.1016/j.ijcard.2012.03.103; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chancharoenthana W, 2013, THER APHER DIAL, V17, P557, DOI 10.1111/1744-9987.12016; Chen CY, 1997, J SURG RES, V67, P106, DOI 10.1006/jsre.1996.4922; Chen LJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-79; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chitalia N, 2015, SEMIN DIALYSIS, V28, pE35, DOI 10.1111/sdi.12335; Dang LTH, 2013, ARTERIOSCL THROM VAS, V33, P193, DOI 10.1161/ATVBAHA.112.300142; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fischer JW, 2004, J VASC SURG, V40, P115, DOI 10.1016/j.jvs.2004.03.037; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Grenda R, 2007, NEPHROL DIAL TRANSPL, V22, P3487, DOI 10.1093/ndt/gfm300; Heinen Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001472; Hori A, 2012, EUR J VASC ENDOVASC, V43, P62, DOI 10.1016/j.ejvs.2011.07.015; Iida O, 2013, CIRCULATION, V127, P2307, DOI 10.1161/CIRCULATIONAHA.112.000711; Inoue T, 2004, J AM COLL CARDIOL, V44, P1408, DOI 10.1016/j.jacc.2004.06.066; Ishii H, 2008, CLIN J AM SOC NEPHRO, V3, P1034, DOI 10.2215/CJN.05761207; Jeong SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12742; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kamishirado H, 2002, AM HEART J, V144, P303, DOI 10.1067/mhj.2002.122874; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Leelahavanichkul A, 2015, HEPATOL RES, V45, P1341, DOI 10.1111/hepr.12501; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; Marschner JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149489; Masuda H, 1999, BRIT J PHARMACOL, V126, P211, DOI 10.1038/sj.bjp.0702298; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; MOLLER JC, 1985, VIRCHOWS ARCH A, V406, P389, DOI 10.1007/BF00710231; Nakamura T, 2001, LIFE SCI, V69, P1709, DOI 10.1016/S0024-3205(01)01258-9; Qiu JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0852; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Rogers M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000481; Seujange Y, 2013, RENAL FAILURE, V35, P118, DOI 10.3109/0886022X.2012.741468; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; TANAKA T, 1988, PHARMACOLOGY, V36, P313, DOI 10.1159/000138400; Tseng CN, 2015, THROMB HAEMOSTASIS, V113, P813, DOI 10.1160/TH14-07-0608; Tsuchikane E, 1999, CIRCULATION, V100, P21, DOI 10.1161/01.CIR.100.1.21; Tsuchikane E, 1998, AM HEART J, V135, P495, DOI 10.1016/S0002-8703(98)70327-8; van der Zwan LP, 2011, CLIN SCI, V121, P71, DOI 10.1042/CS20100595; Wasse H, 2012, J VASC ACCESS, V13, P168, DOI 10.5301/jva.5000024; Yamamoto Kiyohito, 2007, Ann Thorac Cardiovasc Surg, V13, P322; Yang J, 2006, AM J PHYSIOL-HEART C, V291, pH3087, DOI 10.1152/ajpheart.00412.2006	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187872	10.1371/journal.pone.0187872	http://dx.doi.org/10.1371/journal.pone.0187872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206849	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700006
J	Contreras, GA; Strieder-Barboza, C; de Souza, J; Gandy, J; Mavangira, V; Lock, AL; Sordillo, LM				Contreras, G. Andres; Strieder-Barboza, Clarissa; de Souza, Jonas; Gandy, Jeff; Mavangira, Vengai; Lock, Adam L.; Sordillo, Lorraine M.			Periparturient lipolysis and oxylipid biosynthesis in bovine adipose tissues	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HORMONE-SENSITIVE LIPASE; TRANSITION DAIRY-COWS; ADIPOCYTE LIPOLYSIS; LIPID MOBILIZATION; METABOLIC STRESS; LINOLEIC-ACID; PLASMA; INFLAMMATION; MACROPHAGES	The periparturient period of dairy cows is characterized by intense lipolysis in adipose tissues (AT), which induces the release of free fatty acids (FFA) into circulation. Among FFA, polyunsaturated fatty acids are susceptible to oxidation and can modulate inflammatory responses during lipolysis within AT. Linoleic and arachidonic acid oxidized products (oxylipids) such as hydroxy-octadecadienoic acids (HODE) and hydroxy-eicosatetraenoic acids (HETE), were recently identified as products of lipolysis that could modulate AT inflammation during lipolysis. However, the effect of lipolysis intensity during the transition from gestation to lactation on fatty acid substrate availability and subsequent AT oxylipid biosynthesis is currently unknown. We hypothesized that in periparturient dairy cows, alterations in AT and plasma fatty acids and oxylipid profiles coincide with changes in lipolysis intensity and stage of lactation. Blood and subcutaneous AT samples were collected from periparturient cows at -27 +/- 7 (G1) and -10 +/- 5 (G2) d prepartum and at 8 +/- 3 d postpartum (PP). Targeted lipidomic analysis was performed on plasma and AT using HPLC-MS/MS. We report that FFA concentrations increased as parturition approached and were highest at PP. Cows exhibiting high lipolysis rate at PP (FFA> 1.0 mEq/L) had higher body condition scores at G1 compared to cows with low lipolysis rate (FFA<1.0 mEq/L). Concentrations of plasma linoleic and arachidonic acids were increased at PP. In AT, 13-HODE, and 5-, 11- and 15-HETE were increased at PP compared to G1 and G2. Concentrations of beta hydroxybutyrate were positively correlated with those of 13-HODE and 15-HETE in AT. Plasma concentrations of 5- and 20-HETE were increased at PP. These data demonstrate that prepartum adiposity predisposes cows to intense lipolysis post-partum and may exacerbate AT inflammation because of increased production of pro-inflammatory oxylipids including 5-and 15-HETE and 13-HODE. These results support a role for certain linoleic and arachidonic acid-derived oxylipids as positive and negative modulators of AT inflammation during periparturient lipolysis.	[Contreras, G. Andres; Strieder-Barboza, Clarissa; Gandy, Jeff; Mavangira, Vengai; Sordillo, Lorraine M.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [de Souza, Jonas; Lock, Adam L.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Contreras, GA (corresponding author), Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.	contre28@msu.edu	Strieder-Barboza, Clarissa/N-7006-2013; Strieder-Barboza, Clarissa/AAD-8089-2021; Contreras, Andres/I-8282-2019; mavangira, vengai/AAN-4454-2020; Lock, Adam/HCH-4180-2022	Strieder-Barboza, Clarissa/0000-0001-8824-4023; Contreras, Andres/0000-0003-4969-2178; mavangira, vengai/0000-0002-6491-8676; Sordillo, Lorraine/0000-0001-8873-3134	USDA-National Institute of Food and Agriculture (Washington, DC) [2014-68004-21972, 2015-67015-23207]; Department of Large Animal Clinical Sciences (East Lansing, MI) research funds; Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds; Michigan Alliance for Animal Agriculture (East Lansing, MI) [AA16-023]	USDA-National Institute of Food and Agriculture (Washington, DC); Department of Large Animal Clinical Sciences (East Lansing, MI) research funds; Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds; Michigan Alliance for Animal Agriculture (East Lansing, MI)	This project was supported in part by USDA-National Institute of Food and Agriculture (Washington, DC) grants 2014-68004-21972 to LMS and 2015-67015-23207 to GAC, Department of Large Animal Clinical Sciences (East Lansing, MI) research funds to GAC, Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds to GAC and LMS, and the Michigan Alliance for Animal Agriculture grant. AA16-023 (East Lansing, MI) to GAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported in part by USDA-National Institute of Food and Agriculture (Washington, DC) grants 2014-68004-21972 and 2015-67015-23207, Department of Large Animal Clinical Sciences (East Lansing, MI), Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI), and the Michigan Alliance for Animal Agriculture (East Lansing, MI).	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aitken SL, 2009, J DAIRY SCI, V92, P589, DOI 10.3168/jds.2008-1551; Balvers MGJ, 2012, INT IMMUNOPHARMACOL, V13, P204, DOI 10.1016/j.intimp.2012.03.022; Barquissau V, 2017, BIOCHIMIE, V136, P3, DOI 10.1016/j.biochi.2016.12.012; Bionaz M, 2013, PPAR RES, V2013, DOI 10.1155/2013/684159; Bradford BJ, 2015, J DAIRY SCI, V98, P6631, DOI 10.3168/jds.2015-9683; Casado-Diaz A, 2013, GENES NUTR, V9, P375; Chatterjee M, 2013, MOL CARCINOGEN, V52, P359, DOI 10.1002/mc.21858; Contreras GA, 2010, J DAIRY SCI, V93, P2508, DOI 10.3168/jds.2009-2876; Contreras GA, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0174-4; Contreras GA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12993; Contreras GA, 2016, J DAIRY SCI, V99, P10009, DOI 10.3168/jds.2016-11552; Contreras GA, 2015, J DAIRY SCI, V98, P6176, DOI 10.3168/jds.2015-9370; De Koster J, 2016, J DAIRY SCI, V99, P2319, DOI 10.3168/jds.2015-10440; Douglas GN, 2007, J DAIRY SCI, V90, P2941, DOI 10.3168/jds.2006-225; ENGELS F, 1986, FEBS LETT, V209, P249, DOI 10.1016/0014-5793(86)81121-8; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Gandra JR, 2016, J DAIRY SCI, V99, P4590, DOI 10.3168/jds.2015-9974; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gartung A, 2016, J BIOL CHEM, V291, P16001, DOI 10.1074/jbc.M116.725937; Giordano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044610; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x; Kabara E, 2014, COMP IMMUNOL MICROB, V37, P49, DOI 10.1016/j.cimid.2013.10.007; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kuhn MJ, 2017, J AGR FOOD CHEM, V65, P4980, DOI 10.1021/acs.jafc.7b01602; Kwon HJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.190; Lee YH, 2016, AM J PHYSIOL-REG I, V310, pR55, DOI 10.1152/ajpregu.00355.2015; Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Locher LF, 2011, J DAIRY SCI, V94, P4514, DOI 10.3168/jds.2011-4145; Long EK, 2013, BBA-MOL CELL BIOL L, V1831, P1199, DOI 10.1016/j.bbalip.2013.04.004; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Lynes MD, 2017, NAT MED; Mavangira V, 2015, J DAIRY SCI, V98, P6202, DOI 10.3168/jds.2015-9570; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McNamara JP, 2005, J DAIRY SCI, V88, P2498, DOI 10.3168/jds.S0022-0302(05)72927-1; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Pearson T, 2009, AM J PHYSIOL-ENDOC M, V297, pE647, DOI 10.1152/ajpendo.00227.2009; RACLOT T, 1993, J LIPID RES, V34, P1515; Raclot T, 2001, J LIPID RES, V42, P2049; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Raphael W, 2014, J DAIRY SCI, V97, P3615, DOI 10.3168/jds.2013-7656; Ryman VE, 2015, PROSTAG OTH LIPID M, V121, P207, DOI 10.1016/j.prostaglandins.2015.09.006; Sodhi K, 2012, PROSTAG OTH LIPID M, V98, P133, DOI 10.1016/j.prostaglandins.2011.12.004; Song YS, 2016, PROSTAG OTH LIPID M, V123, P1, DOI 10.1016/j.prostaglandins.2016.02.001; Sordillo LM, 2013, VET CLIN N AM-FOOD A, V29, P267, DOI 10.1016/j.cvfa.2013.03.002; Strieder-Barboza C, 2015, LIVEST SCI, V177, P159, DOI 10.1016/j.livsci.2015.04.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080316; Zachut M, 2010, J DAIRY SCI, V93, P5877, DOI 10.3168/jds.2010-3427; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199	61	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188621	10.1371/journal.pone.0188621	http://dx.doi.org/10.1371/journal.pone.0188621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206843	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700015
J	Delabouglise, A; James, A; Valarcher, JF; Hagglund, S; Raboisson, D; Rushton, J				Delabouglise, Alexis; James, Andrew; Valarcher, Jean-Francois; Hagglund, Sara; Raboisson, Didier; Rushton, Jonathan			Linking disease epidemiology and livestock productivity: The case of bovine respiratory disease in France	PLOS ONE			English	Article							CALFHOOD HEALTH-STATUS; WEIGHT-GAIN; FEEDLOT PERFORMANCE; TREATMENT RECORDS; ECONOMIC-IMPACT; MILK-PRODUCTION; CARCASS TRAITS; ANIMAL HEALTH; DAIRY CALVES; VEAL CALVES	Concerns are growing over the impact of livestock farming on environment and public health. The livestock industry is faced with the double constraint of limiting its use of natural resources and antimicrobials while ensuring its economic sustainability. In this context, reliable methods are needed to evaluate the effect of the prevention of endemic animal diseases on the productivity of livestock production systems. In this study, an epidemiological and productivity model was used to link changes in Bovine Respiratory Disease (BRD) incidence with the productivity of the beef and dairy cattle sectors in France. Cattle production parameters significantly affected by BRD were selected through literature review. Previous field study results and national cattle performance estimates were used to infer growth performances, mortality rates and carcass quality in the cattle affected and not affected by BRD. A steady-state deterministic herd production model was used to predict the productivity of the dairy and beef sector and their defined compartments (breeding-fattening, feedlot young bulls, and feedlot veal) in case of BRD incidence reduction by 20%, 50% or 100%. Results suggested that BRD should be controlled at a priority in beef breeding farms as eradication of BRD in beef calves would increase the whole beef sector's productivity by 4.7-5.5% while eradication in other production stages would result in lower productivity gain in their respective sectors. However, the analysis performed at compartment level showed that, in both the beef and dairy sector, young bull and veal feedlot enterprises derive more economic benefits from BRD eradication for their own compartment (increase in productivity of 8.7-12.8% for beef young bulls) than the breeding farms (increase in productivity of 5.1-6% for beef calves), which may limit the investments in BRD control.	[Delabouglise, Alexis; Rushton, Jonathan] Univ London, Royal Vet Coll, Dept Prod & Populat Hlth, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, Hatfield, Herts, England; [James, Andrew] Univ Reading, Vet Epidemiol & Econ Res Unit, Reading, Berks, England; [Valarcher, Jean-Francois; Hagglund, Sara] Swedish Univ Agr Sci, Ruminant Med & Vet Epidemiol, Uppsala, Sweden; [Raboisson, Didier] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Rushton, Jonathan] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	University of London; University of London Royal Veterinary College; University of Reading; Swedish University of Agricultural Sciences; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of Liverpool	Delabouglise, A (corresponding author), Univ London, Royal Vet Coll, Dept Prod & Populat Hlth, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, Hatfield, Herts, England.	alexis.delabouglise@gmail.com	VALARCHER, JEAN FRANCOIS/AAE-4857-2020; Raboisson, Didier/AAL-4025-2020; Hägglund, Sara/AAE-4867-2020	VALARCHER, JEAN FRANCOIS/0000-0002-8564-5603; Raboisson, Didier/0000-0003-1630-6218; Hägglund, Sara/0000-0002-6983-5722; Delabouglise, Alexis/0000-0001-5837-7052	SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon Programme of the European Union [633184]	SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon Programme of the European Union	The study was funded by the research project SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon 2020 Programme of the European Union (project ID 633184). SAPHIR aims to develop innovative, safe, affordable and effective vaccine strategies effective against endemic pathogens responsible for high economic losses in livestock. By generating vaccine strategies for these pathogens in pigs, poultry and ruminants, SAPHIR will aid in strengthening the profitability of food animal systems, improve animal welfare and reduce xenobiotic usage in farming with a One Health perspective (http://www.h2020-saphir.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreste Conjoncture, 2013, AGRESTE CONJONCTURE; Andrews AH, 2000, CATTLE PRACT, V8; [Anonymous], 2014, R LANG ENV STAT COMP; Arcangioli MA, 2008, VET J, V177, P89, DOI 10.1016/j.tvjl.2007.03.008; Assie S., 2003, 10emes Rencontres autour des Recherches sur les Ruminants, Paris, France, 3-4 decembre 2003, P293; Assie S, 2004, PREV VET MED, V63, P271, DOI 10.1016/j.prevetmed.2004.01.014; Assie S, 2001, EIGHTH CONFERENCE ON RUMINANT RESEARCH, P145; Assie S, 2009, VET REC, V165, P195, DOI 10.1136/vr.165.7.195; Assie S, 2004, INCIDENCE IMPACT ECO; Assie S, 2009, PREV VET MED, V91, P218, DOI 10.1016/j.prevetmed.2009.06.003; Babcock AH, 2009, J ANIM SCI, V87, P314, DOI 10.2527/jas.2008-1201; Bareille N, 2008, RENC RECH RUMINANTS, V15; BATEMAN KG, 1990, CAN VET J, V31, P689; BRITNEY JB, 1984, PREV VET MED, V3, P45, DOI 10.1016/0167-5877(84)90023-0; Brooks K. R., 2011, Professional Animal Scientist, V27, P195; Carnell R., LHS LATIN HYPERCUBE; CORREA MT, 1988, PREV VET MED, V6, P253, DOI 10.1016/0167-5877(88)90037-2; CURTIS CR, 1989, PREV VET MED, V7, P173, DOI 10.1016/0167-5877(89)90020-2; Delobel L, 2003, MALADIES RESPIRATOIR; Donovan GA, 1998, PREV VET MED, V33, P1, DOI 10.1016/S0167-5877(97)00059-7; Esslemont R. J., 1999, Bovine Practitioner, V33, P174; Eurostat, MEAT PROD STAT 2014; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Fulton RW, 2002, CAN J VET RES, V66, P173; Garcia MD, 2010, J ANIM SCI, V88, P491, DOI 10.2527/jas.2009-1874; Gardner BA, 1999, J ANIM SCI, V77, P3168; Gautier-Bouchardon AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087672; Gay E, 2009, PREV VET MED, V89, P265, DOI 10.1016/j.prevetmed.2009.02.013; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Griffin D, 2014, ANIM HEALTH RES REV, V15, P138, DOI 10.1017/S1466252314000255; Groupe Economie du Betail Institut de l'Elevage, 2011, PROD VIAND BOV FRANC; HEALY AM, 1993, BRIT VET J, V149, P549, DOI 10.1016/S0007-1935(05)80039-9; Holland BP, 2010, J ANIM SCI, V88, P2486, DOI 10.2527/jas.2009-2428; Irsik Max, 2006, Bovine Practitioner, V40, P65; JIM GK, 1993, CAN VET J, V34, P668; Joly M, 2007, INCIDENCE EFFET PERF; Lago A, 2006, J DAIRY SCI, V89, P4014, DOI 10.3168/jds.S0022-0302(06)72445-6; Le Grand D, 2008, B ACAD VET FRANCE, V161, P159; Loneragan GH, 2001, J AM VET MED ASSOC, V219, P1122, DOI 10.2460/javma.2001.219.1122; Martin SW, 1999, CAN VET J, V40, P560; Martineau C, 2007, INDICATEURS ZOOTECHN; Montgomery SP, 2009, J ANIM SCI, V87, P328, DOI 10.2527/jas.2008-0969; National Research Council, 1980, NUTR REQ RUM LIV; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Onono JO, 2013, TROP ANIM HEALTH PRO, V45, P423, DOI 10.1007/s11250-012-0233-y; PAN Livestock Services Limited, 1991, LIV PROD EFF CALC US; Pardon B, 2011, VET REC, V169, P278, DOI 10.1136/vr.d4406; Pardon B, 2015, PREV VET MED, V120, P169, DOI 10.1016/j.prevetmed.2015.04.009; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Pesneau E, 2008, INCIDENCE IMPACT PER; Reinhardt CD, 2009, J ANIM SCI, V87, P3030, DOI 10.2527/jas.2008-1293; Rio O., 1999, FREQUENCE RISQUES MO; Roeber D. L., 2001, Professional Animal Scientist, V17, P39; Rossini K.L, 2004, EFFECTS CALFHOOD RES; Rushton J, 2015, ZOONOSES PUBLIC HLTH, V62, P10, DOI 10.1111/zph.12193; Schaffer AP, 2016, JAVMA-J AM VET MED A, V248, P1157, DOI 10.2460/javma.248.10.1157; Schneider MJ, 2009, J ANIM SCI, V87, P1821, DOI 10.2527/jas.2008-1283; SISCHO WM, 1990, PREV VET MED, V8, P141, DOI 10.1016/0167-5877(90)90007-5; Sivula NJ, 1996, PREV VET MED, V27, P155, DOI 10.1016/0167-5877(95)01000-9; Stanton AL, 2012, J DAIRY SCI, V95, P4950, DOI 10.3168/jds.2011-5067; Svensson C, 2003, PREV VET MED, V58, P179, DOI 10.1016/S0167-5877(03)00046-1; Taylor JD, 2010, CAN VET J, V51, P1095; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; VANDERMEI J, 1987, VET QUART, V9, P203, DOI 10.1080/01652176.1987.9694101; Virtala AMK, 1996, J DAIRY SCI, V79, P1040, DOI 10.3168/jds.S0022-0302(96)76457-3; Waggoner J. W., 2007, Professional Animal Scientist, V23, P174; WALTNERTOEWS D, 1986, CAN J VET RES, V50, P314; Warnick LD, 1997, PREV VET MED, V31, P263, DOI 10.1016/S0167-5877(96)01105-1; Warnick LD, 1995, J DAIRY SCI, V78, P2819, DOI 10.3168/jds.S0022-0302(95)76912-0; WARNICK LD, 1994, KENYA VET, V18, P177; Williams P, 2007, CATTLE PRACT, V15, P244; WITTUM TE, 1994, PREV VET MED, V19, P15, DOI 10.1016/0167-5877(94)90011-6; Wittum TE, 1996, J AM VET MED ASSOC, V209, P814	73	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189090	10.1371/journal.pone.0189090	http://dx.doi.org/10.1371/journal.pone.0189090			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206855	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000417110700047
J	Ozdemir, AC; Wynn, GM; Vester, A; Weitzmann, MN; Neigh, GN; Srinivasan, S; Rudd, MK				Ozdemir, Alev Cagla; Wynn, Grace M.; Vester, Aimee; Weitzmann, M. Neale; Neigh, Gretchen N.; Srinivasan, Shanthi; Rudd, M. Katharine			GNB3 overexpression causes obesity and metabolic syndrome	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BROWN ADIPOCYTES; OPEN-FIELD; SOCIAL-INTERACTION; MOLECULAR-BASIS; GAMMA-SUBUNITS; BODY-WEIGHT; G-PROTEINS; MICE; FAT	The G-protein beta subunit 3 (GNB3) gene has been implicated in obesity risk; however, the molecular mechanism of GNB3-related disease is unknown. GNB3 duplication is responsible for a syndromic form of childhood obesity, and an activating DNA sequence variant (C825T) in GNB3 is also associated with obesity. To test the hypothesis that GNB3 overexpression causes obesity, we created bacterial artificial chromosome (BAC) transgenic mice that carry an extra copy of the human GNB3 risk allele. Here we show that GNB3-T/+ mice have increased adiposity, but not greater food intake or a defect in satiety. GNB3-T/+ mice have elevated fasting plasma glucose, insulin, and C-peptide, as well as glucose intolerance, indicating type 2 diabetes. Fasting plasma leptin, triglycerides, cholesterol and phospholipids are elevated, suggesting metabolic syndrome. Based on a battery of behavioral tests, GNB3-T/+ mice did not exhibit anxiety-or depressive-like phenotypes. GNB3-T/+ and wild-type animals have similar activity levels and heat production; however, GNB3-T/+ mice exhibit dysregulation of acute thermogenesis. Finally, Ucp1 expression is significantly lower in white adipose tissue (WAT) in GNB3-T/+ mice, suggestive of WAT remodeling that could lead to impaired cellular thermogenesis. Taken together, our study provides the first functional link between GNB3 and obesity, and presents insight into novel pathways that could be applied to combat obesity and type 2 diabetes.	[Ozdemir, Alev Cagla; Wynn, Grace M.; Rudd, M. Katharine] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Vester, Aimee] Emory Univ, Dept Environm Hlth Sci, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Weitzmann, M. Neale] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Weitzmann, M. Neale; Srinivasan, Shanthi] Atlanta VA Med Ctr, Decatur, GA USA; [Neigh, Gretchen N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Neigh, Gretchen N.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Srinivasan, Shanthi] Emory Univ, Sch Med, Div Digest Dis, Atlanta, GA USA; [Rudd, M. Katharine] Lab Corp Amer Holdings, Ctr Mol Biol & Pathol, Res Triangle Pk, NC 27709 USA	Emory University; Emory University; Rollins School Public Health; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Virginia Commonwealth University; Emory University	Rudd, MK (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Rudd, MK (corresponding author), Lab Corp Amer Holdings, Ctr Mol Biol & Pathol, Res Triangle Pk, NC 27709 USA.	ruddm2@labcorp.com	Srinivasan, Shanthi/A-6133-2013; Neigh, Gretchen/AAW-5691-2020	Neigh, Gretchen/0000-0003-0955-9161	Emory Discovery Fund; Emory University School of Medicine; Department of Human Genetics at Emory University; Emory Integrated Core Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Emory Discovery Fund; Emory University School of Medicine; Department of Human Genetics at Emory University; Emory Integrated Core Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from the Emory Discovery Fund, an internal grant from the Department of Human Genetics at Emory University.; Some experiments were conducted with the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.	Blakemore AIF, 2010, ANN NY ACAD SCI, V1214, P180, DOI 10.1111/j.1749-6632.2010.05880.x; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Burgado J, 2014, BEHAV BRAIN RES, V275, P120, DOI 10.1016/j.bbr.2014.08.060; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; COUSIN B, 1992, J CELL SCI, V103, P931; Crowley VEF, 2008, ANN CLIN BIOCHEM, V45, P245, DOI 10.1258/acb.2007.007193; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fukumoto K, 2014, PSYCHOPHARMACOLOGY, V231, P2291, DOI 10.1007/s00213-013-3378-0; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Goldlust IS, 2013, P NATL ACAD SCI USA, V110, P14990, DOI 10.1073/pnas.1305999110; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Klenke S, 2011, PHARMACOGENET GENOM, V21, P594, DOI 10.1097/FPC.0b013e3283491153; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Obregon MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00479; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Poon LSW, 2009, CELL SIGNAL, V21, P737, DOI 10.1016/j.cellsig.2009.01.018; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Sabin MA, 2011, BEST PRACT RES CL EN, V25, P207, DOI 10.1016/j.beem.2010.09.010; Sargolini F, 2003, BEHAV BRAIN RES, V138, P153, DOI 10.1016/S0166-4328(02)00238-3; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teerds KJ, 2011, HUM REPROD UPDATE, V17, P667, DOI 10.1093/humupd/dmr017; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; World Health Organization, 2016, OB OV FACT SHEET; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Ye YC, 2014, CELL SIGNAL, V26, P2514, DOI 10.1016/j.cellsig.2014.07.030; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188763	10.1371/journal.pone.0188763	http://dx.doi.org/10.1371/journal.pone.0188763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206867	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700022
J	Kimura, S; Nakao, S; Kitaura, A; Iwamoto, T; Houri, K; Matsushima, M; Hamasaki, S				Kimura, Seishi; Nakao, Shinichi; Kitaura, Atsuhiro; Iwamoto, Tatushige; Houri, Kei; Matsushima, Mayuka; Hamasaki, Shinichi			Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients	PLOS ONE			English	Article							TORSADE-DE-POINTES; TRANSMURAL DISPERSION; TEND INTERVAL; HEART-RATE; REPOLARIZATION; ANESTHESIA; PROPOFOL	QTc interval prolongation is a serious diabetic complication and increases mortality rate. Hyperglycemia inhibits the rapid component of delayed rectifier potassium channel currents (Ikr) and prolongs the QTc interval on electrocardiograms. Sevoflurane also inhibits the Ikr and causes QTc interval prolongation. In fact, torsade de pointes occurred in a patient with poorly controlled diabetes mellitus during sevoflurane anesthesia. We enrolled 74 patients, including 37 normoglycemic patients (glycated hemoglobin [HbA1c]: <6.5%) (NG group) and 37 chronically hyperglycemic patients (HbA1c: >= 6.5%) (HG group). Anesthesia was induced with 2 mg/kg propofol and 0.3 mu g/kg/min remifentanil, and maintained with 2% sevoflurane in 40% O-2 and 0.2-0.3 mu g/kg/min remifentanil. The QT interval and Tp-e interval (from the peak to the end of the T wave) were measured before and at 5, 10, 30, 60, 90, and 120 min after the administration of sevoflurane and adjusted for the patient's heart rate (QTc and Tp-ec, respectively). P-values of <0.05 were considered statistically significant. The QTc and the Tp-ec intervals of the two groups did not differ significantly before the administration of sevoflurane. The QTc interval gradually increased with time in both groups and was significantly longer than the baseline value at 10 min after the administration of sevoflurane in both groups. The QTc interval of the HG group was significantly longer than that of the NG group at 90 min and 120 min after the administration of sevoflurane. The Tp-ec interval was not affected by sevoflurane in either group. We have demonstrated that sevoflurane significantly prolongs the QTc interval, and that the extent of the prolongation is significantly greater in chronically hyperglycemic patients than in normoglycemic patients. Although Tp-ec is not affected by sevoflurane, it should be noted that the simultaneous blockade of potassium channels would increase the risk of arrhythmias.	[Kimura, Seishi; Nakao, Shinichi; Kitaura, Atsuhiro; Iwamoto, Tatushige; Houri, Kei; Matsushima, Mayuka; Hamasaki, Shinichi] Kindai Univ, Fac Med, Dept Anesthesiol, Osakasayama, Osaka, Japan		Nakao, S (corresponding author), Kindai Univ, Fac Med, Dept Anesthesiol, Osakasayama, Osaka, Japan.	nakaos@med.kindai.ac.jp						Antzelevitch C, 2001, EUR J CLIN INVEST, V31, P555, DOI 10.1046/j.1365-2362.2001.00849.x; Belardinelli L, 2003, TRENDS PHARMACOL SCI, V24, P619, DOI 10.1016/j.tips.2003.10.002; Chua KCM, 2016, HEART RHYTHM, V13, P2181, DOI 10.1016/j.hrthm.2016.08.022; Cohen J.E., 1988, STAT POWER ANAL BEHA; Hreiche R, 2009, J MOL CELL CARDIOL, V47, P210, DOI 10.1016/j.yjmcc.2009.02.004; Kang JS, 2006, ANESTHESIOLOGY, V104, P1015, DOI 10.1097/00000542-200605000-00018; Nakao S, 2010, ANESTH ANALG, V110, P775, DOI 10.1213/ANE.0b013e3181cde713; Saussine M, 2006, PEDIATR ANESTH, V16, P63, DOI 10.1111/j.1460-9592.2005.01593.x; Stern K, 2016, DIABETIC MED, V33, P1415, DOI 10.1111/dme.13085; Tacken MCT, 2011, ACTA ANAESTH BELG, V62, P105; Thiruvenkatarajan V, 2010, ANAESTH INTENS CARE, V38, P555, DOI 10.1177/0310057X1003800323; Veglio M, 2000, DIABETES CARE, V23, P1381, DOI 10.2337/diacare.23.9.1381; Whitsel EA, 2000, DIABETES CARE, V23, P241, DOI 10.2337/diacare.23.2.241; Whyte SD, 2005, ANESTH ANALG, V100, P71, DOI 10.1213/01.ANE.0000140781.18391.41; Yamada M, 2006, ANESTH ANALG, V102, P98, DOI 10.1213/01.ANE.0000184257.54917.99; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	16	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188555	10.1371/journal.pone.0188555	http://dx.doi.org/10.1371/journal.pone.0188555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194447	gold, Green Submitted, Green Published			2022-12-26	WOS:000416867800014
J	Arena, R; Zacchini, F; Toschi, P; Palazzese, L; Czernik, M; Ptak, GE				Arena, Roberta; Zacchini, Federica; Toschi, Paola; Palazzese, Luca; Czernik, Marta; Ptak, Grazyna Ewa			Developmental peculiarities in placentae of ovine uniparental conceptuses	PLOS ONE			English	Article							IMPRINTED GENES; GIANT-CELLS; SHEEP; MOUSE; EXPRESSION; VASCULOGENESIS; ANGIOGENESIS; DISRUPTION; PREGNANCY; EMBRYOS	Genomic imprinting is an epigenetic phenomenon regulating mono-allelic expression of genes depending on their parental origin. Defective genomic imprinting is involved in several placental disorders, such as intrauterine growth restriction and pre-eclampsia. Uniparental embryos, having maternal-only or paternal-only genomes (parthenogenotes [ PAR] and androgenotes [ AND], respectively), are useful models to study placentation. The aim of this work was to reveal the effect of parental genome (maternal and paternal) on placentation. To do this, uniparental (AND and PAR) and biparental (CTR) in vitro produced sheep embryos transferred to recipient females were collected at day 20 of pregnancy and their placentae were analyzed. qPCR analysis showed that imprinted genes (H19, IGF2R and DLK1) were expressed accordingly to their parental origin while the expression f DNA methyltransferases () was disregulated, especially in PAR (P < 0.05). AND placentae were significantly hypomethylated compared to both PAR and CTR (P = 0.023). Chorion-allantoid of AND showed impaired development of vessels and reduced mRNA expression of vasculogenetic factors (ANG2 P = 0.05; VEGFR2 P< 0.001; TIE2 P < 0.001). Morphologically, PAR placentae were characterized by abnormal structure of the trophoectodermal epithelium and reduced total number (P< 0.03) of Trophoblastic Binucleate Cells. A reduced implantation rate of both classes of uniparental embryos (P< 0.03) was also noted. Our results provide new insights into the characterization of uniparental embryos and demonstrate the complementary role of parental genomes for the correct establishment of pregnancy. Thus, our findings may suggest new targets to improve our understanding of the origin of imprinting-related placental dysfunction.	[Arena, Roberta; Zacchini, Federica; Ptak, Grazyna Ewa] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland; [Toschi, Paola; Palazzese, Luca; Czernik, Marta; Ptak, Grazyna Ewa] Univ Teramo, Fac Vet Med, Teramo, Italy; [Ptak, Grazyna Ewa] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Teramo; Jagiellonian University	Ptak, GE (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland.; Ptak, GE (corresponding author), Univ Teramo, Fac Vet Med, Teramo, Italy.; Ptak, GE (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.	g.ptak@uj.edu.pl	Arena, Ross/A-3141-2008; Zacchini, Federica/GQY-5276-2022; Palazzese, Luca/AAI-6008-2020	Arena, Ross/0000-0002-6675-1996; Zacchini, Federica/0000-0001-7942-2625; Palazzese, Luca/0000-0002-3842-8438; CZERNIK, Marta Teresa/0000-0002-4535-4932; TOSCHI, PAOLA/0000-0003-0963-7254	European Union's Horizon Research and Innovation Programme [692185]; European Union Seventh Framework Programme for research, technological development and demonstration [312097]; European Research Council Programme IDEAS [210103]; Polish National Science Center [2015/19/D/NZ4/03696]	European Union's Horizon Research and Innovation Programme; European Union Seventh Framework Programme for research, technological development and demonstration; European Research Council Programme IDEAS; Polish National Science Center	The research leading to these results received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 692185 (Acronym ERAofART) and European Union Seventh Framework Programme for research, technological development and demonstration GA 312097 (Acronym FECUND) and the European Research Council Programme IDEAS GA 210103 (Acronym ANGIOPLACE) to GEP. This study was also partially financed by the Polish National Science Center GA 2015/19/D/NZ4/03696 to FZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolini E, 2011, FASEB J, V25, P1737, DOI 10.1096/fj.10-175273; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Barry JS, 2008, SEMIN PERINATOL, V32, P225, DOI 10.1053/j.semperi.2007.11.004; Bressan FF, 2009, PLACENTA, V30, P823, DOI 10.1016/j.placenta.2009.07.007; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Grazul-Bilska AT, 2013, THERIOGENOLOGY, V79, P94, DOI 10.1016/j.theriogenology.2012.09.013; Gutierrez-Marcos JF, 2012, PLACENTA, V33, pE3, DOI 10.1016/j.placenta.2012.08.006; HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607; Lagutina I, 2004, BIOL REPROD, V70, P400, DOI 10.1095/biolreprod.103.021972; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mochizuki M, 1992, Nihon Sanka Fujinka Gakkai Zasshi, V44, P918; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Nelissen ECM, 2014, HUM REPROD, V29, P2821, DOI 10.1093/humrep/deu241; NewmanSmith E, 1997, DEV GENET, V20, P1, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;1::AID-DVG1&gt;3.0.CO;2-B; Ogawa H, 2009, PLACENTA, V30, P448, DOI 10.1016/j.placenta.2009.02.006; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; Ptak GE, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140027; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Srivastava M, 2003, J BIOL CHEM, V278, P5977, DOI 10.1074/jbc.M208437200; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; WIMSATT WA, 1951, AM J ANAT, V89, P233, DOI 10.1002/aja.1000890204; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011; Zacchini F, 2011, CELL REPROGRAM, V13, P495, DOI 10.1089/cell.2011.0021	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188278	10.1371/journal.pone.0188278	http://dx.doi.org/10.1371/journal.pone.0188278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190766	Green Published, gold			2022-12-26	WOS:000416841900043
J	Atnaf, M; Yao, N; Martina, K; Dagne, K; Wegary, D; Tesfaye, K				Atnaf, Mulugeta; Yao, Nasser; Martina, Kyalo; Dagne, Kifle; Wegary, Dagne; Tesfaye, Kassahun			Molecular genetic diversity and population structure of Ethiopian white lupin landraces: Implications for breeding and conservation	PLOS ONE			English	Article							CORE COLLECTION; ALBUS L.; ANTHRACNOSE RESISTANCE; GERMPLASM; ISSR; IDENTIFICATION; CULTIVARS; INFERENCE; SOFTWARE; STRATEGY	White lupin is one of the four economically important species of the Lupinus genus and is an important grain legume in the Ethiopian farming system. However, there has been limited research effort to characterize the Ethiopian white lupin landraces. Fifteen polymorphic simple sequence repeat (SSR) markers were used to assess the genetic diversity and population structure of 212 Ethiopian white lupin (Lupinus albus) landraces and two genotypes from different species (Lupinus angustifolius and Lupinus mutabilis) were used as outgroup. The SSR markers revealed 108 different alleles, 98 of them from 212 landraces and 10 from out-group genotypes, with an average of 6.5 alleles per locus. The average gene diversity was 0.31. Twenty eight landraces harbored one or more private alleles from the total of 28 private alleles identified in the 212 white lupin accessions. Seventy-seven rare alleles with a frequency of less than 5% were identified and accounted for 78.6% of the total alleles detected. Analysis of molecular variance (AMOVA) showed that 92% of allelic diversity was attributed to individual accessions within populations while only 8% was distributed among populations. At 70% similarity level, the UPGMA dendrogram resulted in the formation of 13 clusters comprised of 2 to 136 landraces, with the out-group genotypes and five landraces remaining distinct and ungrouped. Population differentiation and genetic distance were relatively high between Gondar and Ethiopian white lupin populations collected by Australians. A model-based population structure analysis divided the white lupin landraces into two populations. All Ethiopian white lupin landrace populations, except most of the landraces collected by Australians (77%) and about 44% from Awi, were grouped together with significant admixtures. The study also suggested that 34 accessions, as core collections, were sufficient to retain 100% of SSR diversity. These accessions (core G-34) represent 16% of the whole 212 Ethiopian white lupin accessions and populations from West Gojam, Awi and Australian collections contributed more accessions to the core collection.	[Atnaf, Mulugeta] Ethiopian Inst Agr Res, Pawe Res Ctr, Pawe, Ethiopia; [Atnaf, Mulugeta; Yao, Nasser; Martina, Kyalo] Biosci Eastern & Cent Africa Int Livestock R, Hub, Nairobi Kenya, Kenya; [Atnaf, Mulugeta; Dagne, Kifle; Tesfaye, Kassahun] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Wegary, Dagne] CIMMYT Ethiopia, ILRI Campus,CMC Rd, Addis Ababa, Ethiopia	Ethiopian Institute of Agricultural Research (EIAR); Addis Ababa University; CGIAR; International Livestock Research Institute (ILRI)	Atnaf, M (corresponding author), Ethiopian Inst Agr Res, Pawe Res Ctr, Pawe, Ethiopia.; Atnaf, M (corresponding author), Biosci Eastern & Cent Africa Int Livestock R, Hub, Nairobi Kenya, Kenya.; Atnaf, M (corresponding author), Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	atnafmulugeta@gmail.com			BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	The study was part of PhD research work of the first author (MA) and he is grateful to the Ethiopian Institute of Agricultural Research (EIAR) for giving him study leave. The study was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida). The landrace accessions were kindly provided by the Ethiopian Biodiversity Institute (EBI).MA would also like to thank Elena Hidalgo (Professor in molecular biology, University of Valladolid, Spain) and Belayneh Admasu (Former director of Holeta National biotechnology laboratory of the Ethiopian Institute of Agricultural Research) for their assistance during the initial stage of this work. Authors would like to thank Helen Altshul for her assistance in language proof reading. This work was approved by EIAR as part of its research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was part of PhD research work of the first author (MA) and he is grateful to the Ethiopian Institute of Agricultural Research (EIAR) for giving him study leave. The study was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida). The landrace accessions were kindly provided by the Ethiopian Biodiversity Institute (EBI).MA would also like to thank Elena Hidalgo (Professor in molecular biology, University of Valladolid, Spain) and Belayneh Admasu (Former director of Holeta National biotechnology laboratory of the Ethiopian Institute of Agricultural Research) for their assistance during the initial stage of this work. Authors would like to thank Helen Altshul for her assistance in language proofreading. This work was approved by EIAR as part of its research activities.	Abdie Oumer, 2015, African Journal of Biotechnology, V14, P1552; Adhikari KN, 2009, CROP PASTURE SCI, V60, P472, DOI 10.1071/CP08092; Arnoldi A., 2005, OPTIMIZED PROCESSES; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; Baraket G, 2011, PLANT MOL BIOL REP, V29, P171, DOI 10.1007/s11105-010-0217-x; Bascur B. G., 2005, Agricultura Tecnica, V65, P135; Beebe S, 2001, CROP SCI, V41, P854, DOI 10.2135/cropsci2001.413854x; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Christiansen JL, 2000, GENET RESOUR CROP EV, V47, P425, DOI 10.1023/A:1008728530116; Coimbra RR, 2009, GENET MOL BIOL, V32, P538, DOI 10.1590/S1415-47572009005000059; Dunn DB, 1966, LUPINES CANADA ALASK; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Forsberg NEG, 2015, HEREDITY, V114, P195, DOI 10.1038/hdy.2014.83; Gepts P, 2000, STADLER GEN, P163; Gilbert JE, 1999, THEOR APPL GENET, V98, P1125, DOI 10.1007/s001220051176; Gong YM, 2011, AGR SCI CHINA, V10, P838, DOI 10.1016/S1671-2927(11)60069-2; Gonzalez-Andres F, 2007, GENET RESOUR CROP EV, V54, P27, DOI 10.1007/s10722-005-1407-5; Gwag JG, 2010, GENES GENOM, V32, P299, DOI 10.1007/s13258-010-0014-9; Hall RS, 2005, ASIA PAC J CLIN NUTR, V14, P91; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; He QA, 2011, PLANT MOL BIOL REP, V29, P197, DOI 10.1007/s11105-010-0218-9; HONDELMANN W, 1984, THEOR APPL GENET, V68, P1, DOI 10.1007/BF00252301; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; Johnson SK, 2006, BRIT J NUTR, V95, P372, DOI 10.1079/BJN20051648; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Keneni G, 2005, GENET RESOUR CROP EV, V52, P539, DOI 10.1007/s10722-003-6016-6; Kong QS, 2011, PLANT MOL BIOL REP, V29, P217, DOI 10.1007/s11105-010-0228-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kurlovich B.S, 2002, LUPINS GEOGRAPHY CLA; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Leggett RM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S10; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Y., 2010, LEGUME GENOMICS GENE, V1, P1, DOI DOI 10.5376/LGG.2010.01.0001; Lqari H, 2005, GRASAS ACEITES, V56, P135; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; Massonneau A, 2001, PLANTA, V213, P534, DOI 10.1007/s004250100529; Mulugeta Atnaf, 2015, African Crop Science Journal, V23, P327, DOI 10.4314/acsj.v23i4.3; Mulugeta Atnaf, 2015, American Journal of Experimental Agriculture, V7, P347, DOI 10.9734/AJEA/2015/11253; Mulugeta Atnaf, 2017, Australian Journal of Crop Science, V11, P55, DOI 10.21475/ajcs.2017.11.01.pne226; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Paredes M, 2010, CHIL J AGR RES, V70, P3, DOI 10.4067/S0718-58392010000100001; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2010, DARWIN SOFTWARE; Peters KJ., 2010, LIVESTOCK RES RURAL, V22; Phan HTT, 2007, DNA RES, V14, P59, DOI 10.1093/dnares/dsm009; Pritchard JK, 2000, GENETICS, V155, P945; Raman R., 2014, OPEN J GENETICS, V4, P87, DOI [10.4236/ojgen.2014.42012, DOI 10.4236/OJGEN.2014.42012]; Rodino AP, 2003, EUPHYTICA, V131, P165, DOI 10.1023/A:1023973309788; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Rubio J, 2004, EUPHYTICA, V135, P217, DOI 10.1023/B:EUPH.0000014911.70355.c9; Saeed A, 2011, PLANT MOL BIOL REP, V29, P848, DOI 10.1007/s11105-011-0294-5; Sangiri C, 2007, AUST J BOT, V55, P837, DOI 10.1071/BT07105; Sbabou L, 2010, INT J AGRIC BIOL, V12, P26; Sefera T, 2011, CROP PASTURE SCI, V62, P177, DOI 10.1071/CP10165; Sharma SS, 2011, PLANT MOL BIOL REP, V29, P12, DOI 10.1007/s11105-010-0204-2; Talhinhas P, 2003, PLANT BREEDING, V122, P507, DOI 10.1111/j.1439-0523.2003.00892.x; Upadhyaya HD, 2009, CROP SCI, V49, P573, DOI 10.2135/cropsci2008.06.0378; Vaz AC, 2004, FIELD CROP RES, V87, P23, DOI 10.1016/j.fcr.2003.09.006; Wang J, 2014, SCI WORLD J; Wolko B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P153, DOI 10.1007/978-3-642-14387-8_9; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xiao LQ, 2004, ANN BOT-LONDON, V94, P133, DOI 10.1093/aob/mch119; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yifru T, 2006, PLANT BREEDING, V125, P125, DOI 10.1111/j.1439-0523.2006.01147.x; Yonezawa K., 1995, P35; Zhang J, 2010, AFR J BIOTECHNOL, V9, P123; Zong XuXiao, 2008, Acta Agronomica Sinica, V34, P1518, DOI 10.1016/S1875-2780(09)60003-1	74	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188696	10.1371/journal.pone.0188696	http://dx.doi.org/10.1371/journal.pone.0188696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190792	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900102
J	Bronowski, C; Mustafa, K; Goodhead, I; James, CE; Nelson, C; Lucaci, A; Wigley, P; Humphrey, TJ; Williams, NJ; Winstanley, C				Bronowski, Christina; Mustafa, Kasem; Goodhead, Ian; James, Chloe E.; Nelson, Charlotte; Lucaci, Anita; Wigley, Paul; Humphrey, Tom J.; Williams, Nicola J.; Winstanley, Craig		ENIGMA Consortium	Campylobacter jejuni transcriptome changes during loss of culturability in water	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; HTRA PROTEASE; PHYSIOLOGICAL CHARACTERIZATION; MECHANOSENSITIVE CHANNELS; ELECTRON-TRANSPORT; GENETIC DIVERSITY; STRESS RESPONSES; OXIDATIVE STRESS	Background Water serves as a potential reservoir for Campylobacter, the leading cause of bacterial gastroenteritis in humans. However, little is understood about the mechanisms underlying variations in survival characteristics between different strains of C. jejuni in natural environments, including water. Results We identified three Campylobacter jejuni strains that exhibited variability in their ability to retain culturability after suspension in tap water at two different temperatures (4 degrees C and 25 degrees C). Of the three, strains C. jejuni M1 exhibited the most rapid loss of culturability whilst retaining viability. Using RNAseq transcriptomics, we characterised C. jejuni M1 gene expression in response to suspension in water by analyzing bacterial suspensions recovered immediately after introduction into water (Time 0), and from two sampling time/temperature combinations where considerable loss of culturability was evident, namely (i) after 24 h at 25 degrees C, and (ii) after 72 h at 4 degrees C. Transcript data were compared with a culture-grown control. Some gene expression characteristics were shared amongst the three populations recovered from water, with more genes being up-regulated than down. Many of the up-regulated genes were identified in the Time 0 sample, whereas the majority of down-regulated genes occurred in the 25 degrees C (24 h) sample. Conclusions Variations in expression were found amongst genes associated with oxygen tolerance, starvation and osmotic stress. However, we also found upregulation of flagellar assembly genes, accompanied by down-regulation of genes involved in chemotaxis. Our data also suggested a switch from secretion via the sec system to via the tat system, and that the quorum sensing gene luxS may be implicated in the survival of strain M1 in water. Variations in gene expression also occurred in accessory genome regions. Our data suggest that despite the loss of culturability, C. jejuni M1 remains viable and adapts via specific changes in gene expression.	[Bronowski, Christina; Mustafa, Kasem; Wigley, Paul; Williams, Nicola J.; Winstanley, Craig] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Goodhead, Ian; James, Chloe E.] Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England; [Nelson, Charlotte; Lucaci, Anita] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Humphrey, Tom J.] Swansea Univ, Sch Med, Med Microbiol & Infect Dis, Swansea, W Glam, Wales	University of Liverpool; University of Salford; University of Liverpool; Swansea University	Winstanley, C (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.	C.Winstanley@liverpool.ac.uk	Goodhead, Ian/ABC-9200-2020	Bronowski, Christina/0000-0001-8089-4021; Williams, Nicola/0000-0003-4709-4190; Wigley, Paul/0000-0001-6563-0773; James, Chloe/0000-0002-0131-7988; Goodhead, Ian/0000-0002-3110-9442	Medical Research Council; Natural Environment Research Council; Economic and Social Research Council; Biotechnology and Biosciences Research Council; Food Standards Agency through the Environmental & Social Ecology of Human Infectious Diseases Initiative (Enigma) [G1100799/1]; Biotechnology and Biological Sciences Research Council [BB/K000055/1] Funding Source: researchfish; Medical Research Council [G0900753, MR/K002279/1] Funding Source: researchfish; BBSRC [BB/I024674/1, BB/K000055/1] Funding Source: UKRI; MRC [MR/K002279/1, G0900753] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Food Standards Agency through the Environmental & Social Ecology of Human Infectious Diseases Initiative (Enigma); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council, Natural Environment Research Council, Economic and Social Research Council, Biotechnology and Biosciences Research Council and Food Standards Agency for the funding received for this project through the Environmental & Social Ecology of Human Infectious Diseases Initiative (Enigma; Grant Reference: G1100799/1).	Ahmed IH, 2002, MICROBIOL-SGM, V148, P1203, DOI 10.1099/00221287-148-4-1203; Alter T, 2006, J VET MED B, V53, P351, DOI 10.1111/j.1439-0450.2006.00983.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baek KT, 2011, APPL ENVIRON MICROB, V77, P57, DOI 10.1128/AEM.01603-10; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Birk T, 2004, LETT APPL MICROBIOL, V38, P66, DOI 10.1046/j.1472-765X.2003.01446.x; BLASER MJ, 1980, J CLIN MICROBIOL, V11, P309, DOI 10.1128/JCM.11.4.309-313.1980; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Brondsted L, 2005, APPL ENVIRON MICROB, V71, P3205, DOI 10.1128/AEM.71.6.3205-3212.2005; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Bui XT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-232; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaisowwong W, 2012, J VET MED SCI, V74, P43, DOI 10.1292/jvms.11-0305; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Cools I, 2003, J APPL MICROBIOL, V94, P886, DOI 10.1046/j.1365-2672.2003.01916.x; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; de Vries SPW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01133-4; Drozd M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026336; Flint A, 2012, J BACTERIOL, V194, P334, DOI 10.1128/JB.05740-11; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; French N, 2005, ENVIRON MICROBIOL, V7, P1116, DOI 10.1111/j.1462-2920.2005.00782.x; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gangaiah D, 2009, APPL ENVIRON MICROB, V75, P7838, DOI 10.1128/AEM.01603-09; Garenaux A, 2008, CURR MICROBIOL, V56, P293, DOI 10.1007/s00284-007-9082-8; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Guillou S, 2008, WATER RES, V42, P2213, DOI 10.1016/j.watres.2007.11.035; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0; Hall SJ, 2008, J BACTERIOL, V190, P8075, DOI 10.1128/JB.00821-08; Hanninen ML, 2004, WA SCI TECHNOL, V4, P39, DOI 10.2166/ws.2004.0026; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hofreuter D, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00137; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Jones IG, 1996, PUBLIC HEALTH, V110, P277, DOI 10.1016/S0033-3506(96)80089-8; Jones K, 2001, J APPL MICROBIOL, V90, p68S, DOI 10.1046/j.1365-2672.2001.01355.x; Kakuda T, 2012, VET MICROBIOL, V160, P53, DOI 10.1016/j.vetmic.2012.04.044; Kassem II, 2011, FUTURE MICROBIOL, V6, P1117, DOI [10.2217/FMB.11.94, 10.2217/fmb.11.94]; Kloda A, 2001, EMBO J, V20, P1888, DOI 10.1093/emboj/20.8.1888; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Kornberg A, 1999, Prog Mol Subcell Biol, V23, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Lazaro B, 1999, APPL ENVIRON MICROB, V65, P4677; Li SR, 1996, INFECT IMMUN, V64, P2088, DOI 10.1128/IAI.64.6.2088-2094.1996; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin Stephen, 2006, Journal of Water and Health, V4, P417; Miettinen IT, 2001, WATER SCI TECHNOL, V43, P67, DOI 10.2166/wst.2001.0713; Murphy C, 2005, J MICROBIOL METH, V62, P161, DOI 10.1016/j.mimet.2005.02.005; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Patrone V, 2013, ANTON LEEUW INT J G, V103, P979, DOI 10.1007/s10482-013-9877-5; PEARSON AD, 1993, APPL ENVIRON MICROB, V59, P987, DOI 10.1128/AEM.59.4.987-996.1993; PESCI EC, 1994, INFECT IMMUN, V62, P2687, DOI 10.1128/IAI.62.7.2687-2694.1994; Pittman MS, 2007, MOL MICROBIOL, V63, P575, DOI 10.1111/j.1365-2958.2006.05532.x; Purdy D, 1999, APPL ENVIRON MICROB, V65, P2540; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Said B, 2003, EPIDEMIOL INFECT, V130, P469, DOI 10.1017/S0950268803008495; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Stahl M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00005; SUERBAUM S, 1995, TRENDS MICROBIOL, V3, P168, DOI 10.1016/S0966-842X(00)88913-1; Svensson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106063; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; Tholozan JL, 1999, APPL ENVIRON MICROB, V65, P1110; Thomas C, 2002, J APPL MICROBIOL, V92, P433, DOI 10.1046/j.1365-2672.2002.01550.x; Van Dyke MI, 2010, J APPL MICROBIOL, V109, P1053, DOI 10.1111/j.1365-2672.2010.04730.x; VandeGiessen AW, 1996, EPIDEMIOL INFECT, V117, P245, DOI 10.1017/S0950268800001412; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Williams NJ, 2010, APPL ENVIRON MICROB, V76, P7318, DOI 10.1128/AEM.00511-10; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	94	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188936	10.1371/journal.pone.0188936	http://dx.doi.org/10.1371/journal.pone.0188936			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190673	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900174
J	Muslim, MT; Selamat, H; Alimin, AJ; Haniff, MF				Muslim, Mohd Taufiq; Selamat, Hazlina; Alimin, Ahmad Jais; Haniff, Mohamad Fadzli			Manifold absolute pressure estimation using neural network with hybrid training algorithm	PLOS ONE			English	Article							MODEL	In a modern small gasoline engine fuel injection system, the load of the engine is estimated based on the measurement of the manifold absolute pressure (MAP) sensor, which took place in the intake manifold. This paper present a more economical approach on estimating the MAP by using only the measurements of the throttle position and engine speed, resulting in lower implementation cost. The estimation was done via two-stage multilayer feed-forward neural network by combining Levenberg-Marquardt (LM) algorithm, Bayesian Regularization (BR) algorithm and Particle Swarm Optimization (PSO) algorithm. Based on the results found in 20 runs, the second variant of the hybrid algorithm yields a better network performance than the first variant of hybrid algorithm, LM, LM with BR and PSO by estimating the MAP closely to the simulated MAP values. By using a valid experimental training data, the estimator network that trained with the second variant of the hybrid algorithm showed the best performance among other algorithms when used in an actual retrofit fuel injection system (RFIS). The performance of the estimator was also validated in steadystate and transient condition by showing a closer MAP estimation to the actual value.	[Muslim, Mohd Taufiq] Taman Univ, Apt Touch Sdn Bhd, Skudai, Johor, Malaysia; [Selamat, Hazlina; Haniff, Mohamad Fadzli] Univ Teknol Malaysia, Ctr Artificial Intelligence & Robot CAIRO, Kuala Lumpur, Malaysia; [Alimin, Ahmad Jais] Univ Tun Hussein Onn Malaysia, Mech & Mfg Engn Fac, Batu Pahat, Johor, Malaysia	Universiti Teknologi Malaysia; University of Tun Hussein Onn Malaysia	Muslim, MT (corresponding author), Taman Univ, Apt Touch Sdn Bhd, Skudai, Johor, Malaysia.	mtaufiq23@gmail.com	Selamat, Hazlina/K-6740-2012	Haniff, Mohamad Fadzli/0000-0002-1680-3348; ALIMIN, AHMAD/0000-0002-1141-0094	 [Q.K130000.2509.13H78]		Funded by Q.K130000.2509.13H78, http://rmc.utm.my/, Research University Grant to Hazlina Selamat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A. I., 2016, J COMPUTATIONAL THEO, V13, P450, DOI DOI 10.1166/jctn.2016.4826; Ahmadizar F, 2015, ENG APPL ARTIF INTEL, V39, P1, DOI 10.1016/j.engappai.2014.11.003; Aliouane L, 2014, LECT N EARTH SYST SC, P653, DOI 10.1007/978-3-642-32408-6_142; Bennett C, 2017, MECH SYST SIGNAL PR, V85, P126, DOI 10.1016/j.ymssp.2016.07.015; Chen BC, 2013, ESTIMATION INTAKE MA; DICKINSON P, 2014, IFAC PAPERSONLINE, V47, P2987; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; Hagan M. T, 2014, NEURAL NETWORK DESIG, V2nd; Hushim M. F., 2013, INT J ENV SCI DEV, V4, P375; Kayri Murat, 2016, Mathematical & Computational Applications, V21, DOI 10.3390/mca21020020; Khalid M, 2014, COMPUT-AIDED CIV INF, V29, P221, DOI 10.1111/mice.12005; Kolewe B, 2014, 2014 IEEE 23 INT S I; Kolewe B, 2015, IET CONTROL THEORY A, V9, P1083, DOI 10.1049/iet-cta.2014.0213; MATLAB, MOD FAULT TOL FUEL C; Muslim MT, 2014, RENEW SUST ENERG REV, V35, P279, DOI 10.1016/j.rser.2014.04.037; Muslim MT, 2012, APPL MECH MAT, V229-231, P968; Nakisa Bahareh, 2014, Journal of Computer Science, V10, P1758, DOI 10.3844/jcssp.2014.1758.1765; Nguyen-Truong HT, 2015, CHEM PHYS LETT, V629, P40, DOI 10.1016/j.cplett.2015.04.019; Poland J., 2001, TRAINING, V10, P2; Poloni T, 2014, CONTROL ENG PRACT, V23, P22, DOI 10.1016/j.conengprac.2013.10.011; Slawomir W, 2014, ACTA POLYTECH, V54, P240, DOI 10.14311/AP.2014.54.0240; Suganthan P. N., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1958, DOI 10.1109/CEC.1999.785514	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188553	10.1371/journal.pone.0188553	http://dx.doi.org/10.1371/journal.pone.0188553			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190779	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900073
J	Obata, T; Nakamura, M; Mizumoto, Y; Iizuka, T; Ono, M; Terakawa, J; Daikoku, T; Fujiwara, H				Obata, Takeshi; Nakamura, Mitsuhiro; Mizumoto, Yasunari; Iizuka, Takashi; Ono, Masanori; Terakawa, Jumpei; Daikoku, Takiko; Fujiwara, Hiroshi			Dual expression of immunoreactive estrogen receptor beta and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; UTERINE ENDOMETRIUM; CLINICAL STAGE; FROZEN-SECTION; CANCER-CELLS; ALPHA; ADENOCARCINOMA; RISK; MANAGEMENT; MUTATIONS	Although histological grade and muscular invasion are related to the malignant behaviors of endometrial endometrioid carcinoma, lymphatic and/or distant metastases are unexpectedly encountered, even in patients in the low-risk group. To re-evaluate additional reliable parameters to predict the risk of progression, we examined the immunohistochemical expression profiles of p53 and estrogen receptor (ER)beta proteins. Patients with endometrial endometrioid carcinoma who underwent surgical treatment at our hospital (n = 154) were recruited to this study, and the significance of the relationships between the incidence of regional lymph node metastasis and/or postoperative recurrence and clinical or experimental parameters was evaluated. By multivariate analysis, we found that histological grades, detection of immunoreactive p53 (positive rates more than 10%, p53-stained), and high expression of ER beta (high-ER beta) were independently associated with metastasis and/or recurrence. Among these parameters, the sensitivity and negative predictive values of high-ER beta were very high (up to 100%). In the population with high-ER beta, the positive rates of metastasis and/or recurrence were 61.1% in the p53-stained group and 21.9% in the p53-nonstained (negative) group. Furthermore, the positive rate in the group showing myometrial invasion of more than 1/2 and showing both p53-stained and high-ER beta was 80%. The disease- free survival of patients who were double-positive for p53-stained and high-ER beta was significantly shorter than that in other patients. In summary, our findings showed that increases in ER beta and p53 immunoreactivity were significantly correlated with the incidence of metastasis and/or recurrence in endometrial endometrioid carcinoma, suggesting that double-positivity for p53-stained and high-ER beta may provide a promising clinical indicator to predict the risk of progression.	[Obata, Takeshi; Nakamura, Mitsuhiro; Mizumoto, Yasunari; Iizuka, Takashi; Ono, Masanori; Fujiwara, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa, Japan; [Terakawa, Jumpei; Daikoku, Takiko] Kanazawa Univ, Adv Sci Res Ctr, Inst Expt Anim, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Fujiwara, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa, Japan.	fuji@kuhp.kyoto-u.ac.jp	Ono, Masanori/F-7443-2019; Terakawa, Jumpei/AAF-1435-2020; FUJIWARA, Hiroshi/J-8401-2015	Terakawa, Jumpei/0000-0002-7643-7976; FUJIWARA, Hiroshi/0000-0003-3098-9406	 [26293358]; Grants-in-Aid for Scientific Research [16K11107] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Ms. Nakajima and Ms. Kawakita for their technical assistance and preparation of the manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research (no. 26293358).; This work was supported in part by a Grant-in-Aid for Scientific Research (no. 26293358). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELER VM, 1992, INT J GYNECOL CANCER, V2, P9, DOI 10.1046/j.1525-1438.1992.02010009.x; Bottner M, 2014, J STEROID BIOCHEM, V139, P245, DOI 10.1016/j.jsbmb.2013.03.003; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; ENOMOTO T, 1993, CANCER RES, V53, P1883; Fujimoto J, 2000, ONCOLOGY-BASEL, V58, P334, DOI 10.1159/000012121; Fujimoto J, 2002, ONCOLOGY-BASEL, V62, P269, DOI 10.1159/000059575; Gadducci A, 2011, ANTICANCER RES, V31, P3483; Haring J, 2012, INT J MOL MED, V29, P1127, DOI 10.3892/ijmm.2012.929; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Han SJ, 2012, NAT MED, V18, P1102, DOI 10.1038/nm.2826; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Hernandez E, 2006, OBSTET GYNECOL, V107, P952, DOI 10.1097/01.AOG.0000209463.53764.e7; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; INOUE M, 1994, AM J CLIN PATHOL, V102, P665, DOI 10.1093/ajcp/102.5.665; Kim T, 2010, ABSTR APPL ANAL, DOI 10.1155/2010/150975; Knapp P, 2013, ADV MED SCI-POLAND, V58, P96, DOI 10.2478/v10039-012-0055-1; Kohler MF, 1996, AM J OBSTET GYNECOL, V175, P1246, DOI 10.1016/S0002-9378(96)70036-4; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Lewandowski SA, 2005, ONCOGENE, V24, P4789, DOI 10.1038/sj.onc.1208595; Lim P, 1999, GYNECOL ONCOL, V73, P191, DOI 10.1006/gyno.1999.5365; Lurain JR, 2012, BEREK NOVAKS GYNECOL; Manfredi R, 2004, RADIOLOGY, V231, P372, DOI 10.1148/radiol.2312021184; Mariani A, 2004, GYNECOL ONCOL, V95, P120, DOI 10.1016/j.ygyno.2004.06.042; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Matias-Guiu X, 2013, HISTOPATHOLOGY, V62, P111, DOI 10.1111/his.12053; Miller DS, 2012, CLIN GYNECOLOGIC ONC; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Park JY, 2008, GYNECOL ONCOL, V108, P486, DOI 10.1016/j.ygyno.2007.11.044; Paul M, 2004, CANCER INVEST, V22, P211, DOI 10.1081/CNV-120030209; Quinlivan JA, 2001, BRIT J OBSTET GYNAEC, V108, P798, DOI 10.1111/j.1471-0528.2001.00196.x; Robert JK., 2011, BLAUSTEINS PATHOLOGY, V6; Sakuragi N, 2005, INT J CANCER, V116, P514, DOI 10.1002/ijc.21097; SHIM JU, 1992, AM J OBSTET GYNECOL, V166, P1335, DOI 10.1016/0002-9378(92)91600-F; Takama F, 2001, BRIT J CANCER, V84, P545, DOI 10.1054/bjoc.2000.1589; Tashiro H, 1997, CANCER RES, V57, P3935; Thomas CG, 2011, BREAST CANCER RES TR, V127, P417, DOI 10.1007/s10549-010-1011-z; Thompson DJ, 2016, ENDOCR-RELAT CANCER, V23, P77, DOI 10.1530/ERC-15-0386; Touqan N, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-32; Wang HH, 2015, CANCER LETT, V360, P269, DOI 10.1016/j.canlet.2015.02.028; Zaino RJ, 1996, CANCER-AM CANCER SOC, V77, P1115, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1115::AID-CNCR17>3.0.CO;2-4; Zannoni GF, 2013, HUM PATHOL, V44, P1047, DOI 10.1016/j.humpath.2012.09.007	44	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188641	10.1371/journal.pone.0188641	http://dx.doi.org/10.1371/journal.pone.0188641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190668	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900090
J	Ortiz, AP; Ortiz-Ortiz, KJ; Rios, M; Laborde, J; Kulkarni, A; Pillsbury, M; Lauschke, A; Monsanto, HA; Marques-Goyco, C				Ortiz, Ana Patricia; Ortiz-Ortiz, Karen J.; Rios, Moraima; Laborde, Jose; Kulkarni, Amit; Pillsbury, Matthew; Lauschke, Andreas; Monsanto, Homero A.; Marques-Goyco, Cecile			Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico	PLOS ONE			English	Article							COST-EFFECTIVENESS; ECONOMIC-IMPACT; INFECTION; BURDEN; PREVENTION; MANAGEMENT; VACCINES; CANCER; BOYS; MEN	Background No study has estimated the potential impact of Human Papillomavirus (HPV) vaccination in Puerto Rico, a population with considerable burden of HPV-related morbidities. We evaluated the health and economic impacts of implementing a vaccination strategy for females and males in Puerto Rico, with the quadrivalent HPV (HPV4) vaccine, under different vaccination scenarios. Methods We adapted a mathematical model which estimates the direct and indirect health benefits and costs of HPV4 vaccination in a dynamic population. The model compared three vaccination scenarios against screening only (no-vaccination) for three doses of HPV4 vaccine among individuals aged 11-15 years in Puerto Rico: 1) 34% for females and 13% for males (34%F/13%M), 2) 50% for females and 40% for males (50%F/40%M), and 3) 80% for female and 64% for male (80%F/64%M). Data specific to Puerto Rico was used. When not available, values from the United States were used. Input data consisted of demographic, behavioral, epidemiological, screening, and economic parameters. Results The model predicted decreases in: 1) HPV infection prevalence for females and males, 2) cervical intraepithelial neoplasia and cervical cancer incidence for females, 3) genital warts incidence for females and males, and 4) cervical cancer deaths among females, when various vaccination program scenarios were considered. In addition, when the vaccination percentage was increased in every scenario, the reduction was greater and began earlier. The analysis also evidenced an incremental cost effectiveness ratio (ICER) of $1,964 per quality -adjusted life year gained for the 80%F/64%M uptake scenario. Conclusions HPV vaccine can prove its cost effectiveness and substantially reduce the burden and costs associated to various HPV-related conditions when targeted to the adequate population together with an organized HPV vaccination program.	[Ortiz, Ana Patricia; Ortiz-Ortiz, Karen J.] Univ Puerto Rico, Comprehens Canc Ctr, Canc Control & Populat Sci Program, San Juan, PR 00936 USA; [Ortiz, Ana Patricia; Rios, Moraima] Univ Puerto Rico, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA; [Laborde, Jose] Univ Puerto Rico, Dept Econ, Rio Piedras Campus, San Juan, PR 00936 USA; [Kulkarni, Amit; Pillsbury, Matthew] Merck & Co Inc, Kenilworth, NJ USA; [Lauschke, Andreas] Lauschke Consulting, New York, NY USA; [Monsanto, Homero A.; Marques-Goyco, Cecile] Merck & Co Inc, Latin Amer Med Affairs, San Juan, PR USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras; Merck & Company; Merck & Company	Ortiz, AP (corresponding author), Univ Puerto Rico, Comprehens Canc Ctr, Canc Control & Populat Sci Program, San Juan, PR 00936 USA.; Ortiz, AP (corresponding author), Univ Puerto Rico, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.	ana.ortiz7@upr.edu		Ortiz-Ortiz, Karen/0000-0002-0134-9947	Merck Co	Merck Co(Merck & Company)	Financial support was provided by Merck & Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GARDASIL 9 PACKAGE I; [Anonymous], 2009, CERVARIX PACKAGE INS; [Anonymous], 2006, GARDASIL PACKAGE INS; Aponte-Gonzalez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080639; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bezares M, 2013, INFORM ANUAL ESTADIS; Brisson M, 2016, LANCET PUBLIC HEALTH, V1, pE8, DOI 10.1016/S2468-2667(16)30001-9; Bruni L, 20150408 HPV INF CTR; Centers for Disease Control and Prevention, NIS TEEN VACC COV TA; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS STDS; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Colon-Lopez V, 2010, P R HEALTH SCI J, V29, P232; Commonwealth of Puerto Rico Office of the Governor Planning Board, 2014, INC PROD 2013; Dasbach EJ, 2008, BJOG-INT J OBSTET GY, V115, P947, DOI 10.1111/j.1471-0528.2008.01743.x; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Elbasha EH, 2008, B MATH BIOL, V70, P2126, DOI 10.1007/s11538-008-9338-x; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Gold MR, 1996, COST EFFECTIVENESS H; Gravitt PE, 2005, INFECT DIS CLIN N AM, V19, P439, DOI 10.1016/j.idc.2005.03.008; GREER CE, 1995, J CLIN MICROBIOL, V33, P2058, DOI 10.1128/JCM.33.8.2058-2063.1995; Hariri S, 2013, J ADOLESCENT HEALTH, V53, P679, DOI 10.1016/j.jadohealth.2013.09.018; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Mariani L, 2015, ADV THER, V32, P10, DOI 10.1007/s12325-015-0178-4; Moscoso M, 2008, USO SUSTANCIAS ENTRE; Ortiz-Ortiz KJ, 2010, P R HEALTH SCI J, V29, P241; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Puerto Rico Central Cancer Registry, INC CAS FIL JUN; Puerto Rico Central Cancer Registry, MORT CAS FIL 2008; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Seto K, 2012, DRUGS, V72, P715, DOI 10.2165/11599470-000000000-00000; Stanley M, 2014, HUM VACC IMMUNOTHER, V10, P2109, DOI 10.4161/hv.29137; Suarez E, SEROPREVALENCE HEPAT; Tortolero-Luna G, PUERTO RICO CENTRAL; US Department of Health and Human Welfare Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020 OBJ; World Health Organization (WHO), 2005, COST EFF STRAT PLANN; Yabroff KR, 2011, CANCER EPIDEM BIOMAR, V20, P2006, DOI 10.1158/1055-9965.EPI-11-0650	43	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0184540	10.1371/journal.pone.0184540	http://dx.doi.org/10.1371/journal.pone.0184540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190725	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900002
J	Shi, AN; Qin, J; Mou, BQ; Correll, J; Weng, YJ; Brenner, D; Feng, CD; Motes, D; Yang, W; Dong, LD; Bhattarai, G; Ravelombola, W				Shi, Ainong; Qin, Jun; Mou, Beiquan; Correll, James; Weng, Yuejin; Brenner, David; Feng, Chunda; Motes, Dennis; Yang, Wei; Dong, Lingdi; Bhattarai, Gehendra; Ravelombola, Waltram			Genetic diversity and population structure analysis of spinach by single-nucleotide polymorphisms identified through genotyping-by-sequencing	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; ASSOCIATION ANALYSIS; RESISTANCE; LANDRACES	Spinach (Spinacia oleracea L., 2n = 2x = 12) is an economically important vegetable crop worldwide and one of the healthiest vegetables due to its high concentrations of nutrients and minerals. The objective of this research was to conduct genetic diversity and population structure analysis of a collection of world-wide spinach genotypes using single nucleotide polymorphisms (SNPs) markers. Genotyping by sequencing (GBS) was used to discover SNPs in spinach genotypes. Three sets of spinach genotypes were used: 1) 268 USDA GRIN spinach germplasm accessions originally collected from 30 countries; 2) 45 commercial spinach F1 hybrids from three countries; and 3) 30 US Arkansas spinach cultivars/breeding lines. The results from this study indicated that there was genetic diversity among the 343 spinach genotypes tested. Furthermore, the genetic background in improved commercial F1 hybrids and in Arkansas cultivars/lines had a different structured populations from the USDA germplasm. In addition, the genetic diversity and population structures were associated with geographic origin and germplasm from the US Arkansas breeding program had a unique genetic background. These data could provide genetic diversity information and the molecular markers for selecting parents in spinach breeding programs.	[Shi, Ainong; Qin, Jun; Weng, Yuejin; Yang, Wei; Dong, Lingdi; Bhattarai, Gehendra; Ravelombola, Waltram] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA; [Mou, Beiquan] USDA ARS, Crop Improvement & Protect Res Unit, Salinas, CA USA; [Correll, James; Feng, Chunda] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Brenner, David] Iowa State Univ, Dep Agron, Plant Intro Stn, G212,Agron Hall, Ames, IA USA; [Motes, Dennis] Univ Arkansas, Vegetable Res Ctr, Alma, AR USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; Iowa State University; University of Arkansas System; University of Arkansas Fayetteville	Shi, AN (corresponding author), Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA.	ashi@uark.edu; Beiquan.Mou@ARS.USDA.GOV; jcorrell@uark.edu	Shi, Ainong/L-6384-2017; Bhattarai, Gehendra/ABE-4356-2020; Bhattarai, Gehendra/N-2851-2019	Shi, Ainong/0000-0002-1066-7920; Bhattarai, Gehendra/0000-0002-2381-1629; Bhattarai, Gehendra/0000-0002-2381-1629	USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC) [58-5030-6-076]; USDA Specialty Crop Multistate Program (SCMP); USDA National Institute of Food and Agriculture Hatch [1002423]	USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC); USDA Specialty Crop Multistate Program (SCMP); USDA National Institute of Food and Agriculture Hatch	This work was supported by (1) USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC) with Project Number: 58-5030-6-076; (2) USDA Specialty Crop Multistate Program (SCMP); and (3) the USDA National Institute of Food and Agriculture Hatch project accession number 1002423.	[Anonymous], 2005, HORTSCIENCE, V40, P1019; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Correll JC, 2011, EUR J PLANT PATHOL, V129, P193, DOI 10.1007/s10658-010-9713-y; Dicoteau DR, 2000, VEGETABLE CROPS; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebadi-Segheloo Asghar, 2014, Plant Breeding and Seed Science, V69, P69, DOI 10.1515/plass-2015-0007; Eftekhari S. A., 2010, Iranian Journal of Horticultural Science, V41, P83; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GOODE MJ, 1988, HORTSCIENCE, V23, P931; Hu JG, 2007, GENET RESOUR CROP EV, V54, P1667, DOI 10.1007/s10722-006-9175-4; HULBERT SH, 1991, MOL GEN GENET, V226, P377, DOI 10.1007/BF00260649; Iquira E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0408-y; Khattak JZK, 2007, PLANT BREEDING, V126, P454, DOI 10.1111/j.1439-0523.2007.01392.x; Kuwahara K, 2014, PLANT GENET RESOUR-C, V12, P185, DOI 10.1017/S1479262113000464; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Ma JB, 2016, PLANT BREEDING, V135, P399, DOI 10.1111/pbr.12369; Minoche AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0729-7; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Morelock Teddy E., 2008, V1, P189; NASS (National Agricultural Statistics Service), 2015, VEGETABLES; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; Pritchard JK, 2000, GENETICS, V155, P945; Sabaghnia N., 2014, Acta Agriculturae Slovenica, V103, P101, DOI 10.14720/aas.2014.103.1.11; Shi AN, 2016, EUPHYTICA, V212, P17, DOI 10.1007/s10681-016-1740-0; Shi AiNong, 2016, American Journal of Plant Sciences, V7, P1600; Shi AN, 2016, GENOME, V59, P581, DOI 10.1139/gen-2016-0075; Shi AN, 2016, EUPHYTICA, V208, P143, DOI 10.1007/s10681-015-1610-1; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Deynze A, 2014, PLANT AN GEN 22 C JA; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; [吴娅妮 Wu Yani], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P913; Xu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14598; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077	41	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188745	10.1371/journal.pone.0188745	http://dx.doi.org/10.1371/journal.pone.0188745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190770	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900117
J	Wen, L; Shin, MH; Kang, JH; Yim, YR; Kim, JE; Lee, JW; Lee, KE; Park, DJ; Kim, TJ; Kweon, SS; Lee, YH; Yun, YW; Lee, SS				Wen, Lihui; Shin, Min-Ho; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Kweon, Sun-Seog; Lee, Young-Hoon; Yun, Yong-Woon; Lee, Shin-Seok			Association between grip strength and hand and knee radiographic osteoarthritis in Korean adults: Data from the Dong-gu study	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; DISABILITY; PAIN; PREVALENCE; IMPACT; PINCH; FEATURES; COHORT; RISK	Objectives We assessed whether grip strength was related to various types of radiographic damage in Korean adults with osteoarthritis (OA). Methods Data from 2,251 subjects enrolled in the Dong-gu study, who had no hand joint pain, were analyzed to investigate the relationship between grip strength and OA. Hand grip strength was measured using a hand-held dynamometer, and radiographs of the hand and knee were scored according to a semi-quantitative grading system. Multiple linear regressions were used to explore associations between grip strength and radiographic features of OA. Results Grip strength in men and women was negatively related to hand (both p < 0.001) and knee (men, p < 0.001; women, p = 0.010) OA after adjusting for confounders. Hand (men, p < 0.001; women, p = 0.001) and knee (both p < 0.001) joint space narrowing (JSN) showed the strongest associations with low grip strength, regardless of gender. Moreover, the severity of hand osteophytes in women (p = 0.001), and subchondral cysts (men, p < 0.001) was correlated with low grip strength in both genders. Conclusions Among subjects without hand joint pain, low grip strength was associated significantly with hand and knee radiographic OA, regardless of gender. Among all types of OA radiographic damage, low grip strength showed the strongest association with JSN.	[Wen, Lihui; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea; [Wen, Lihui; Lee, Shin-Seok] Chonnam Natl Univ, Dept Biomed Sci, Med Sch, Gwangju, South Korea; [Shin, Min-Ho; Kweon, Sun-Seog] Chonnam Natl Univ, Dept Prevent Med, Med Sch, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Jeonnam Reg Canc Ctr, Hwasun Hosp, Hwasun, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Dept Prevent Med, Iksan, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Inst Wonkwang Med Sci, Iksan, South Korea; [Yun, Yong-Woon] Bitgoeul Chonnam Natl Univ Hosp, Dept Prevent Med, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Wonkwang University; Wonkwang University	Lee, SS (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea.; Lee, SS (corresponding author), Chonnam Natl Univ, Dept Biomed Sci, Med Sch, Gwangju, South Korea.	shinseok@chonnam.ac.kr	Lee, Shin-Seok/AAC-6779-2021; Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550; Wen, Lihui/0000-0002-6385-0825	Chonnam National University Hospital Biomedical Research Institute [CRI13904-24.4]; Chonnam National University Research Institute of Medical Sciences and Health Promotion Fund, Ministry of Health &Welfare, Republic of Korea	Chonnam National University Hospital Biomedical Research Institute; Chonnam National University Research Institute of Medical Sciences and Health Promotion Fund, Ministry of Health &Welfare, Republic of Korea	This study was supported by the Chonnam National University Hospital Biomedical Research Institute (CRI13904-24.4). We also thank the funders Chonnam National University Research Institute of Medical Sciences and Health Promotion Fund, Ministry of Health &Welfare, Republic of Korea for the Dong-gu study.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Bagis S, 2003, CLIN RHEUMATOL, V22, P420, DOI 10.1007/s10067-003-0792-4; Berry PA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2573; Bohannon RW, 2012, MUSCLE NERVE, V46, P555, DOI 10.1002/mus.23350; Cairns DM, 2010, J ORTHOP RES, V28, P529, DOI 10.1002/jor.21014; Chaisson CE, 1999, ARTHRITIS RHEUM-US, V42, P33, DOI 10.1002/1529-0131(199901)42:1<33::AID-ANR4>3.0.CO;2-I; Dahaghin S, 2005, ANN RHEUM DIS, V64, P682, DOI 10.1136/ard.2004.023564; Ding H, 2010, SCAND J RHEUMATOL, V39, P84, DOI 10.3109/03009740903201834; Dominick KL, 2005, ARTHRITIS RHEUM-US, V52, P1424, DOI 10.1002/art.21035; El-Sherif HE, 2008, OSTEOARTHR CARTILAGE, V16, P12, DOI 10.1016/j.joca.2007.05.011; Frazer LL, 2017, MED ENG PHYS, V48, P158, DOI 10.1016/j.medengphy.2017.06.019; Gherghe AM, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000219; Haugen IK, 2013, OSTEOARTHR CARTILAGE, V21, P1191, DOI 10.1016/j.joca.2013.04.004; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Jones G, 2001, OSTEOARTHR CARTILAGE, V9, P606, DOI 10.1053/joca.2001.0460; Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040; Knoop J, 2014, ARTHRIT CARE RES, V66, P63, DOI 10.1002/acr.22128; Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244; Lee HJ, 2012, CLIN ORTHOP RELAT R, V470, P2202, DOI 10.1007/s11999-012-2253-3; McErlain DD, 2011, BONE, V48, P639, DOI 10.1016/j.bone.2010.11.010; Navarro-Compan V, 2015, RHEUMATOLOGY, V54, P83, DOI 10.1093/rheumatology/keu284; Nordin M., 2001, BASIC BIOMECHANICS M; Oiestad BE, 2015, OSTEOARTHR CARTILAGE, V23, P171, DOI 10.1016/j.joca.2014.10.008; Ozkan B, 2007, CLIN RHEUMATOL, V26, P1621, DOI 10.1007/s10067-007-0555-8; Van den Berg WB, 1999, OSTEOARTHR CARTILAGE, V7, P333, DOI 10.1053/joca.1998.0186; Yoo JI, 2017, J KOREAN MED SCI, V32, P868, DOI 10.3346/jkms.2017.32.5.868; Zhang YQ, 2002, AM J EPIDEMIOL, V156, P1021, DOI 10.1093/aje/kwf141	27	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0185343	10.1371/journal.pone.0185343	http://dx.doi.org/10.1371/journal.pone.0185343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190722	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900005
J	Ben Shimon, M; Zeimer, T; Stein, ES; Artan-Furman, A; Harnof, S; Chapman, J; Eisenkraft, A; Pick, CG; Maggio, N				Ben Shimon, Marina; Zeimer, Talya; Stein, Efrat Shavit; Artan-Furman, Avital; Harnof, Sagi; Chapman, Joab; Eisenkraft, Arik; Pick, Chaim G.; Maggio, Nicola			Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ACTIVATED RECEPTOR 1; BLOOD-BRAIN-BARRIER; SYNAPTIC PLASTICITY; ISCHEMIC-STROKE; NMDA RECEPTORS; INJURY; MICE; DISEASE; HEALTH	Transient amnesia is a common consequence of minimal traumatic brain injury (mTBI). However, while recent findings have addressed the mechanisms involved in its onset, the processes contributing to its recovery have not yet been addressed. Recently, we have found that thrombin is detected at high concentrations in the brain of mice after exposure to mTBI and that in such settings amnesia is rescued by either inhibiting thrombin activity or by blockade of PAR1. Here, we report that mice spontaneously recover from amnesia after two weeks from mTBI exposure. At this time point, long term potentiation was equally evoked in injured vs. control animals with thrombin concentration in the brain being normalized at this stage. These findings, which refer to the specific aspect of memory retrieval upon mTBI, together with our previous work, hint to a strong correlation between cognitive defects in the context of mTBI and thrombin concentrations in the brain. This may suggest that a possible scavenging of thrombin in the brain at early phases following mTBI may improve memory function.	[Ben Shimon, Marina; Zeimer, Talya; Stein, Efrat Shavit; Artan-Furman, Avital; Chapman, Joab; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel; [Ben Shimon, Marina; Harnof, Sagi; Chapman, Joab; Maggio, Nicola] Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel; [Harnof, Sagi] Rabin Med Ctr, Dept Neurosurg, Petah Tiqwa, Israel; [Chapman, Joab; Pick, Chaim G.; Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Eisenkraft, Arik] Hebrew Univ Jerusalem, Inst Res Mil Med, Fac Med, Jerusalem, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat, Sackler Fac Med, Tel Aviv, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Maggio, N (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Maggio, N (corresponding author), Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel.	Nicola.maggio@sheba.health.gov.il	Chapman, Joab/E-4598-2010	Chapman, Joab/0000-0002-2161-9764	Institute of Military Medicine at the Hebrew University of Jerusalem [4440691738]; Kamin research program grant from the Israeli Ministry of Economy and Industry [56338]; Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center	Institute of Military Medicine at the Hebrew University of Jerusalem; Kamin research program grant from the Israeli Ministry of Economy and Industry; Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center	This work was supported by a grant from the Institute of Military Medicine at the Hebrew University of Jerusalem (#4440691738) to NM and CGP and a Kamin research program grant (#56338) from the Israeli Ministry of Economy and Industry to NM. NM is the recipient of a Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Institute of Military Medicine at the Hebrew University of Jerusalem (#4440691738) to NM and CGP and a Kamin research program grant (#56338) from the Israeli Ministry of Economy and Industry to NM. NM is the recipient of a Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center. This work was performed in partial fulfillment of the requirements for a Ph.D degree of Marina Ben Shimon.	Becker D, 2014, NEUROPHARMACOLOGY, V86, P212, DOI 10.1016/j.neuropharm.2014.07.013; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Cole W.R., 2016, NEUROCOGNITIVE PSYCH; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Flynn Frederick G, 2010, Continuum (Minneap Minn), V16, P79, DOI 10.1212/01.CON.0000391454.15052.e4; Friedman A, 2015, SEMIN CELL DEV BIOL, V38, P1, DOI 10.1016/j.semcdb.2015.03.006; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Funahashi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050049; Garcia PS, 2015, NEUROCHEM RES, V40, P2220, DOI 10.1007/s11064-015-1711-1; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SY, 2007, J PHYSIOL-LONDON, V581, P887, DOI 10.1113/jphysiol.2007.134676; Lunko O O, 2015, Fiziol Zh, V61, P5; Maggio N, 2014, NEUROSCIENCE, V281, P135, DOI 10.1016/j.neuroscience.2014.09.041; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Maggio N, 2012, HIPPOCAMPUS, V22, P267, DOI 10.1002/hipo.20893; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Oh SJ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-38; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Veksler R, 2014, ARCH MED RES, V45, P646, DOI 10.1016/j.arcmed.2014.11.016; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188524	10.1371/journal.pone.0188524	http://dx.doi.org/10.1371/journal.pone.0188524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN9ZL	29182653	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000033
J	Wilke, P; Masuch, A; Fahron, O; Zylla, S; Leipold, T; Petersmann, A				Wilke, Petra; Masuch, Annette; Fahron, Oliver; Zylla, Stephanie; Leipold, Tobias; Petersmann, Astrid			Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department	PLOS ONE			English	Article							OPTIMAL CUTOFF LEVELS; MYOCARDIAL-INFARCTION	Early diagnosis of myocardial infarction (MI) with cardiac troponin (cTn) assays at the pointof- care (POC) is suggested to shorten turn-around-time in the emergency department (ED). The present study aimed at comparing the diagnostic performance of two POC cTn assays with that of a central laboratory high-sensitivity (hs) method, under routine ED conditions. In 2,163 non-selected ED patients suspected for MI, the diagnostic performance of the POC troponin I (TnI), troponin T (TnT), and hs-TnT assay for the prediction of MI was evaluated based on receiver operating characteristic (ROC) analyses and compared with the performance based on the manufacturers' cut-offs. Due to an observed association between renal function as determined by estimated glomerular filtration rate (eGFR) and cTn concentrations, all analyses were stratified by renal function. In patients with normal renal function (eGFR > 60 mL/min/1.73m 2), POC and hs assays showed a comparable diagnostic performance as quantified by the area under the ROC curve (AUC) of about 0.88. The ROCderived optimal cut-off (OCO) levels for the different cTn assays clearly changed with decreasing kidney function. Impaired kidney function required OCO to be three to five times higher to achieve a comparable performance. Particularly cTnT concentrations were strongly associated with renal function. The three cTn assays demonstrated equivalent diagnostic performance in ED-patients admitted with suspected ACS in relation to the release diagnosis, supporting the use of POC testing in this setting. The present results implicate that application of eGFR-specific OCOs may decrease false-positives among patients with impaired renal function. Providing individual cut-offs depending on patients' eGFR might be an appropriate add-on tool to improve specificity in the diagnosis of MI.	[Wilke, Petra; Fahron, Oliver] Rhon AG, Klinikum Frankfurt Oder GmbH, Cent Emergency Dept, Frankfurt, Oder, Germany; [Masuch, Annette; Zylla, Stephanie; Petersmann, Astrid] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Leipold, Tobias] ClinPath GmbH, Berlin, Germany; [Fahron, Oliver] Publ Hlth Dept, Frankfurt, Oder, Germany	Greifswald Medical School	Petersmann, A (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	astrid.petersmann@uni-greifswald.de		Masuch, Annette/0000-0002-8168-5042	Radiometer Germany [AQT90FLEX]; ClinPath GmbH	Radiometer Germany; ClinPath GmbH	The study was supported by Radiometer Germany who kindly provided the AQT90FLEX TnT test materials and ClinPath GmbH. The funders also provided support in the form of salaries [TL] and honoraria for talks [PW, AP] for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Saleh Ayman, 2014, CMAJ Open, V2, pE199, DOI 10.9778/cmajo.20130074; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Amsterdam EA, 2010, CIRCULATION, V122, P1756, DOI 10.1161/CIR.0b013e3181ec61df; Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Bundesorztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Chenevier-Gobeaux C, 2013, AM J CARDIOL, V111, P1701, DOI 10.1016/j.amjcard.2013.02.024; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; Dorr M, 2010, HEART, V96, P1434, DOI 10.1136/hrt.2010.201384; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hjortshoj S, 2011, CLIN CHIM ACTA, V412, P370, DOI 10.1016/j.cca.2010.11.015; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Jones Graham, 2008, Clin Biochem Rev, V29 Suppl 1, pS93; Krintus M, 2015, INT J CARDIOL, V187, P256, DOI 10.1016/j.ijcard.2015.03.282; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lippi G, 2016, CIRCULATION, V133, pE374, DOI 10.1161/CIRCULATIONAHA.115.018157; Lippi G, 2012, J EMERG MED, V43, pE487, DOI 10.1016/j.jemermed.2012.05.016; Montera MW, 2015, ARQ BRAS CARDIOL, V104, P337, DOI 10.5935/abc.20150061; Parikh RH, 2015, CLIN BIOCHEM, V48, P247, DOI 10.1016/j.clinbiochem.2015.01.004; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; RiliBak, 2015, J LAB MED, V39, P26, DOI DOI 10.1515/LABMED-2014-0046; Roffi M, 2015, REV ESP CARDIOL, V68, P1125, DOI 10.1016/j.rec.2015.10.009; ter Avest E, 2016, EUR J EMERG MED, V23, P95, DOI 10.1097/MEJ.0000000000000225; Thokala P, 2012, HEART, V98, P1498, DOI 10.1136/heartjnl-2012-302188; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Twerenbold R, 2015, CIRCULATION, V131, P2041, DOI 10.1161/CIRCULATIONAHA.114.014245; Vafaie M, 2015, INT J CARDIOL, V198, P26, DOI 10.1016/j.ijcard.2015.06.122; Ziebig R, 2003, CLIN CHEM, V49, P1191, DOI 10.1373/49.7.1191	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188706	10.1371/journal.pone.0188706	http://dx.doi.org/10.1371/journal.pone.0188706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182678	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000052
J	Gao, JJ; Yao, LC; Xia, TT; Liao, XB; Zhu, DY; Xiang, Y				Gao, Jingjing; Yao, Licheng; Xia, Tingting; Liao, Xuebin; Zhu, Deyu; Xiang, Ye			Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048	FASEB JOURNAL			English	Article						neurodegeneration diseases; neurologic disorders; therapeutic target	3-HYDROXYLASE INHIBITION; BRAIN; MODEL; PATHWAY; SYSTEM; LEVODOPA	The human kynurenine 3-monooxygenase (hKMO) is a potential therapeutic target for neurodegenerative and neurologic disorders. Inhibition of KMO by Ro 61-8048, a potent, selective, and the most widely used inhibitor of KMO, was shown effective in various models of neurodegenerative or neurologic disorders. However, the molecular basis of hKMO inhibition by Ro 61-8048 is not clearly understood. Here, we report biochemistry studies on hKMO and crystal structures of an hKMO homolog, pfKMO from Pseudomonas fluorescens, in complex with the substrate L-kynurenine and Ro 61-8048. We found that the C-terminal similar to 110 aa are essential for the enzymatic activity of hKMO and the homologous C-terminal region of pfKMO folds into a distinct, all-alpha-helical domain, which associates with the N-terminal catalytic domain to form a unique tunnel in proximity to the substrate-binding pocket. The tunnel binds the Ro 61-8048 molecule, which fills most of the tunnel, and Ro 61-8048 is hydrogen bonded with several completely conserved residues, including an essential catalytic residue. Modification of Ro 61-8048 and biochemical studies of the modified Ro 61-8048 derivatives suggested that Ro 61-8048 inhibits the enzyme in an allosteric manner by affecting the conformation of the essential catalytic residue and by blocking entry of the substrate or product release. The unique binding sites distinguish Ro 61-8048 as a noncompetitive and highly selective inhibitor from other competitive inhibitors, which should facilitate further optimization of Ro 61-8048 and the development of new inhibitory drugs to hKMO.	[Gao, Jingjing; Xiang, Ye] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Ctr Infect Dis Res, Sch Med,Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China; [Yao, Licheng; Xia, Tingting; Liao, Xuebin] Tsinghua Univ, Sch Pharmaceut Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Zhu, Deyu] Shandong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Shandong University	Zhu, DY (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.; Xiang, Y (corresponding author), Tsinghua Univ, B308,Med Sci Bldg, Beijing 100084, Peoples R China.	zhudeyu@sdu.edu.cn; yxiang@mail.tsinghua.edu.cn		Xiang, Ye/0000-0003-0230-9522	973 Program [2015CB910102]; Beijing Municipal Science and Technology Commission [Z161100000116032]; National Natural Science Foundation of China [31470721]; Junior Thousand Talents Program of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; Beijing Advanced Innovation Center for Structural Biology; Shandong Province Natural Science Foundation [ZR2015CM001]	973 Program(National Basic Research Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Junior Thousand Talents Program of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; Beijing Advanced Innovation Center for Structural Biology; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	The authors thank Haitao Li, Shilong Fan, Haiteng Deng, and Jin Li (Tsinghua University) and Jing Zhu (Shandong University) for their support. The authors thank the Tsinghua University Branch of the China National Center for Protein Sciences, and the Center of Biomedical Analysis of Tsinghua University for providing facility support. The authors thank the staff at the Shanghai Synchrotron Research Facility beam line BL17U for assistance with data collection. This work was supported by funds from the 973 Program (Grant 2015CB910102), the Beijing Municipal Science and Technology Commission (Grant Z161100000116032), the National Natural Science Foundation of China (Grant 31470721), the Junior Thousand Talents Program of China, the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, and the Beijing Advanced Innovation Center for Structural Biology (to Y.X.), and the Shandong Province Natural Science Foundation (Grant ZR2015CM001; to D.Z.). The coordinates and structure factor files have been deposited into the Protein Data Bank (http://www.pdb.org) under accession numbers 5Y7A, 5Y77, and 5Y66. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Beaumont V, 2016, EXP NEUROL, V282, P99, DOI 10.1016/j.expneurol.2016.05.005; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Hutchinson JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15827; Justinova Z, 2013, NAT NEUROSCI, V16, P1652, DOI 10.1038/nn.3540; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; Maddison DC, 2015, SEMIN CELL DEV BIOL, V40, P134, DOI 10.1016/j.semcdb.2015.03.002; Mole DJ, 2016, NAT MED, V22, P202, DOI 10.1038/nm.4020; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Rojewska E, 2016, NEUROPHARMACOLOGY, V102, P80, DOI 10.1016/j.neuropharm.2015.10.040; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Samadi P, 2005, MOVEMENT DISORD, V20, P792, DOI 10.1002/mds.20596; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vamos E, 2009, J NEUROL SCI, V283, P21, DOI 10.1016/j.jns.2009.02.326; Walker AL, 2017, J MED CHEM, V60, P3383, DOI 10.1021/acs.jmedchem.7b00055; Wilson K, 2014, PROTEIN EXPRES PURIF, V95, P96, DOI 10.1016/j.pep.2013.11.015; Zadori D, 2009, J NEURAL TRANSM, V116, P1403, DOI 10.1007/s00702-009-0263-4; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	31	14	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2036	2045		10.1096/fj.201700397RR	http://dx.doi.org/10.1096/fj.201700397RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208702				2022-12-26	WOS:000429051400025
J	Kim, J; Fukuto, HS; Brown, DA; Bliska, JB; London, E				Kim, JiHyun; Fukuto, Hana S.; Brown, Deborah A.; Bliska, James B.; London, Erwin			Effects of host cell sterol composition upon internalization of Yersinia pseudotuberculosis and clustered beta 1 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial adhesion; cholesterol; endocytosis; integrin; sterol; YadA; adhesins; bacterial internalization; invasin; sterol substitution	LIPID RAFTS; EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; CAMPYLOBACTER-JEJUNI; INVASIN EXPRESSION; PERFRINGOLYSIN-O; MAMMALIAN-CELLS; DOMAINS RAFTS; III SECRETION; CHOLESTEROL	Yersinia pseudotuberculosis is a foodborne pathogenic bacterium that causes acute gastrointestinal illness, but its mechanisms of infection are incompletely described. We examined how host cell sterol composition affected Y. pseudotuberculosis uptake. To do this, we depleted or substituted cholesterol in human MDA-MB-231 epithelial cells with various alternative sterols. Decreasing host cell cholesterol significantly reduced pathogen internalization. When host cell cholesterol was substituted with various sterols, only desmosterol and 7-dehydrocholesterol supported internalization. This specificity was not due to sterol dependence of bacterial attachment to host cells, which was similar with all sterols studied. Because a key step in Y. pseudotuberculosis internalization is interaction of the bacterial adhesins invasin and YadA with host cell 1 integrin, we compared the sterol dependence of wildtype Y. pseudotuberculosis internalization with that of inv, yadA, and invyadA mutant strains. YadA deletion decreased bacterial adherence to host cells, whereas invasin deletion had no effect. Nevertheless, host cell sterol substitution had a similar effect on internalization of these bacterial deletion strains as on the wildtype bacteria. The invyadA double mutant adhered least to cells and so was not significantly internalized. The sterol structure dependence of Y. pseudotuberculosis internalization differed from that of endocytosis, as monitored using antibody-clustered 1 integrin and previous studies on other proteins, which had a more permissive sterol dependence. This study suggests that agents could be designed to interfere with internalization of Yersinia without disturbing endocytosis.	[Kim, JiHyun; Brown, Deborah A.; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Fukuto, Hana S.; Bliska, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Fukuto, Hana S.; Bliska, James B.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	erwin.london@stonybrook.edu		Bliska, James/0000-0002-6047-8837	National Institutes of Health [GM 122493, AI099222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM 122493 (to E. L.) and AI099222 (to J. B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amphlett A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv202; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Clemente R, 2009, J VIROL, V83, P2655, DOI 10.1128/JVI.02206-08; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Davis W, 2011, BBA-MOL CELL BIOL L, V1811, P1152, DOI 10.1016/j.bbalip.2011.07.010; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Durand EA, 2010, CELL MICROBIOL, V12, P1064, DOI 10.1111/j.1462-5822.2010.01451.x; Eberhart GP, 1998, J CLIN ENDOCR METAB, V83, P836, DOI 10.1210/jc.83.3.836; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hudson KJ, 2005, CELL MICROBIOL, V7, P1474, DOI 10.1111/j.1462-5822.2005.00571.x; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; Jafurulla M, 2014, BBA-BIOMEMBRANES, V1838, P158, DOI 10.1016/j.bbamem.2013.08.015; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987; Kim J, 2017, J CELL SCI, V130, P2682, DOI 10.1242/jcs.201731; KONKEL ME, 1992, MICROB PATHOGENESIS, V13, P357, DOI 10.1016/0882-4010(92)90079-4; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lin QQ, 2013, BIOPHYS J, V105, P2733, DOI 10.1016/j.bpj.2013.11.002; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Mikula KM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00169; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Pankov R, 2005, ARCH BIOCHEM BIOPHYS, V442, P160, DOI 10.1016/j.abb.2005.08.003; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Romanenko VG, 2009, AM J PHYSIOL-CELL PH, V296, pC878, DOI 10.1152/ajpcell.00438.2008; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sato Y, 2006, J MICROBIOL, V44, P98; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zerenturk EJ, 2013, PROG LIPID RES, V52, P666, DOI 10.1016/j.plipres.2013.09.002; Zhang Y, 2011, INFECT IMMUN, V79, P4322, DOI 10.1128/IAI.05396-11; Zwerger M, 2010, MOL BIOL CELL, V21, P354, DOI 10.1091/mbc.E09-08-0739	69	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1466	1479		10.1074/jbc.M117.811224	http://dx.doi.org/10.1074/jbc.M117.811224			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29197826	Green Published, hybrid			2022-12-26	WOS:000423515000030
J	Huang, T; Mathieu, M; Lee, S; Wang, XH; Kee, YS; Bevers, JJ; Ciferri, C; Estavez, A; Wong, MD; Chiang, NY; Nakamura, G; Brezski, RJ				Huang, Tao; Mathieu, Mary; Lee, Sophia; Wang, Xinhua; Kee, Yee Seir; Bevers, Jack J., III; Ciferri, Claudio; Estavez, Alberto; Wong, Manda; Chiang, Nancy Y.; Nakamura, Gerald; Brezski, Randall J.			Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTICALLY-INACTIVATED IGGS; TUMOR-NECROSIS-FACTOR; IN-VITRO; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; EFFECTOR FUNCTION; GLOBULIN FACTORS; HOST IMMUNITY; RECEPTOR 1	Anti-hinge antibodies (AHAs) are an autoantibody subclass that, following proteolytic cleavage, recognize cryptic epitopes exposed in the hinge regions of immunoglobulins (Igs) and do not bind to the intact Ig counterpart. AHAs have been postulated to exacerbate chronic inflammatory disorders such as inflammatory bowel disease and rheumatoid arthritis. On the other hand, AHAs may protect against invasive microbial pathogens and cancer. However, despite more than 50 years of study, the origin and specific B cell compartments that express AHAs remain elusive. Recent research on serum AHAs suggests that they arise during an active immune response, in contrast to previous proposals that they derive from the preexisting immune repertoire in the absence of antigenic stimuli. We report here the isolation and characterization of AHAs from memory B cells, although anti-hinge-reactive B cells were also detected in the naive B cell compartment. IgG AHAs cloned from a single human donor exhibited restricted specificity for proteasecleaved F(ab')2 fragments and did not bind the intact IgG counterpart. The cloned IgG-specific AHA-variable regions were mutated from germ line-derived sequences and displayed a high sequence variability, confirming that these AHAs underwent class-switch recombination and somatic hypermutation. Consistent with previous studies of serum AHAs, several of these clones recognized a linear, peptide-like epitope, but one clone was unique in recognizing a conformational epitope. All cloned AHAs could restore immune effector functions to proteolytically generated F(ab') 2 fragments. Our results confirm that a diverse set of epitope-specific AHAs can be isolated from a single human donor.	[Huang, Tao; Mathieu, Mary; Lee, Sophia; Wang, Xinhua; Kee, Yee Seir; Bevers, Jack J., III; Chiang, Nancy Y.; Nakamura, Gerald; Brezski, Randall J.] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Ciferri, Claudio; Estavez, Alberto; Wong, Manda] Genentech Inc, Struct Biol Dept, CryoEM Unit, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Brezski, RJ (corresponding author), Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA.	brezski.randall@gene.com	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Wong, Manda/0000-0001-5830-1517	Genentech	Genentech(Roche HoldingGenentech)	This work was supported by Genentech. All authors are present or former paid employees of Genentech.	Biancheri P, 2015, GASTROENTEROLOGY, V149, P1564, DOI 10.1053/j.gastro.2015.07.002; Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2; Brezski RJ, 2008, J IMMUNOL, V181, P3183, DOI 10.4049/jimmunol.181.5.3183; Brezski RJ, 2014, MABS-AUSTIN, V6, P1265, DOI 10.4161/mabs.29825; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Brezski RJ, 2011, THESCIENTIFICWORLDJO, V11, P1153, DOI 10.1100/tsw.2011.107; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Cordy JC, 2015, CLIN EXP IMMUNOL, V182, P139, DOI 10.1111/cei.12680; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Falkenburg WJJ, 2017, J IMMUNOL, V198, P82, DOI 10.4049/jimmunol.1601096; Fan XJ, 2015, MOL CANCER THER, V14, P681, DOI 10.1158/1535-7163.MCT-14-0715; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; Gearing AJH, 2002, IMMUNOL LETT, V81, P41, DOI 10.1016/S0165-2478(01)00333-9; Holland MC, 2013, J CLIN IMMUNOL, V33, P1192, DOI 10.1007/s10875-013-9915-0; Jordan RE, 2016, IMMUNOL LETT, V172, P29, DOI 10.1016/j.imlet.2016.02.009; Kim HS, 2016, MABS-AUSTIN, V8, P1536, DOI 10.1080/19420862.2016.1219006; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Lin ZH, 2014, NAT PROTOC, V9, P1563, DOI 10.1038/nprot.2014.104; Malia TJ, 2014, PROTEINS, V82, P1656, DOI 10.1002/prot.24545; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; OSTERLAND CK, 1963, VOX SANG, V8, P133; Rispens T, 2012, J IMMUNOL METHODS, V375, P93, DOI 10.1016/j.jim.2011.09.011; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TERNESS P, 1995, J IMMUNOL, V154, P6446; Trouw LA, 2017, NAT REV RHEUMATOL, V13, P331, DOI 10.1038/nrrheum.2017.15; van de Stadt LA, 2014, ARTHRITIS RHEUMATOL, V66, P1133, DOI 10.1002/art.38335; van Schie KA, 2015, MABS-AUSTIN, V7, P662, DOI 10.1080/19420862.2015.1048411; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; WALLER M, 1966, J IMMUNOL, V97, P438; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; YANO S, 1995, EUR J IMMUNOL, V25, P3128, DOI 10.1002/eji.1830251121; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]	35	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					906	919		10.1074/jbc.RA117.000165	http://dx.doi.org/10.1074/jbc.RA117.000165			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191832	Green Published, hybrid			2022-12-26	WOS:000422864500012
J	Wang, H; Chen, XJ; Wang, DH; Yao, C; Wang, Q; Xie, JY; Shi, XL; Xiang, Y; Liu, WL; Zhang, LQ				Wang, Hua; Chen, Xiangjun; Wang, Dianhong; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Xiang, Ye; Liu, Wanli; Zhang, Linqi			Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto-and heterologous viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPREHENSIVE ANALYSIS; CRYSTAL-STRUCTURE; VACCINE; TARGET; RECOGNITION; TRIMERS; DESIGN; AIDS; GLYCOSYLATION; IMMUNIZATION	Recent discoveries of broadly neutralizing antibodies (bnAbs) in HIV-1-infected individuals have led to the identification of several major "vulnerable sites" on the HIV-1 envelope (Env) glycoprotein. These sites have provided precise targets for HIV-1 vaccine development, but identifying and utilizing many of these targets remain technically challenging. Using a yeast surface display-based approach, we sought to identify epitope-focused antigenic domains (EADs) containing one of the "vulnerable sites," the CD4-binding site (CD4bs), through screening and selection of a combinatorial antigen library of the HIV-1 envelope glycoprotein with the CD4bs bnAb VRC01. We isolated multiple EADs and found that their trimeric forms have biochemical and structural features that preferentially bind and activate B cells that express VRC01 in vitro. More importantly, these EADs could induce detectable levels of neutralizing antibodies against genetically related autologous and heterologous subtype B viruses in guinea pigs. Our results demonstrate that an epitope-focused approach involving a screen of a combinatorial antigen library is feasible. The EADs identified here represent a promising collection of possible targets in the rational design of HIV-1 vaccines and lay the foundation for harnessing the specific antigenicity of CD4bs for protective immunogenicity in vivo.	[Wang, Hua; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Wang, Hua; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Xiangjun; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, MOE Key Lab Prot Sci,Inst Immunol, Beijing 100084, Peoples R China; [Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 100084, Peoples R China; [Yao, Chen] NIAMS, Lymphocyte Cell Biol Sect, NIH, Bethesda, MD 20892 USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med A209, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; liu, wanli/H-5690-2011	liu, wanli/0000-0003-2624-6802; Yao, Chen/0000-0001-6852-5661; Xiang, Ye/0000-0003-0230-9522; Liu, Wanli/0000-0003-0395-2800	National Institutes of Health from NIAID [HHSN27201100016C]	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. K. Dane Wittrup and Annie Gai at Massachusetts Institute of Technology for providing the yeast surface display vector pCTCON2; Drs. John Mascola at Vaccine Research Center, National Institutes of Health, and Michel Nussenzweig at Rockefeller University for providing HIV-1 bnAbs; Drs. Peter Kwong and Tongqing Zhou at National Institutes of Health for providing RSC3 and RSC3 Delta 371I proteins; Drs. David Montefiori and Hongmei Gao at Duke University Medical Center for tier phenotying of the CNE pseudovirues; Dr. Xinquan Wang and student Dr. Xi Liu at Tsinghua University for providing the Sf9 cell line, pFastBac (TM) dual vector, and technical suggestions; Dr. Susan K. Pierce at National Institutes of Health for providing the Human Ramos B cell line; Dr. Chenqi Xu at Chinese Academy of Science for providing the Gcamp5 gene; Dr. Yi Shi at Chinese Academy of Science for providing the NL4-3 SOSIP. 664 gp140 trimer protein, and Kelly Arledge previously of our laboratory for providing valuable suggestions and input. National Institutes of Health Contract HHSN27201100016C from NIAID was awarded to Duke University Medical Center.	Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9552; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2015, JAMA-J AM MED ASSOC, V313, P2419, DOI 10.1001/jama.2015.2427; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jiang XQ, 2016, J VIROL, V90, P11007, DOI 10.1128/JVI.01409-16; Jin S, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0243-3; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yang Z, 2015, INTERNATIONAL CONFERENCE ON AUTOMATION, MECHANICAL AND ELECTRICAL ENGINEERING (AMEE 2015), P1; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep25856; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855; Zuo T, 2011, J BIOL CHEM, V286, P33511, DOI 10.1074/jbc.M111.270553	57	10	11	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					830	846		10.1074/jbc.M117.816447	http://dx.doi.org/10.1074/jbc.M117.816447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187598	Green Published, hybrid			2022-12-26	WOS:000422864500007
J	Zhang, WC; Du, LJ; Zheng, XJ; Chen, XQ; Shi, CJ; Chen, BY; Sun, XN; Li, C; Zhang, YY; Liu, Y; Xiao, H; Leng, QB; Jiang, XQ; Zhang, ZY; Sun, SY; Duan, SZ				Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Chen, Xiao-Qing; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Xiao, Hui; Leng, Qibin; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong			Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC T(H)17 CELLS; REGULATORY T-CELLS; VACCINE ADJUVANT; VIRUS-INFECTION; ACTIVATION; INDUCTION; PATHWAY; HOMEOSTASIS; DISEASE; KINASE	Type I IFN production and signaling in macrophages play critical roles in innate immune responses. High salt (i.e. high concentrations of NaCl) has been proposed to be an important environmental factor that influences immune responses in multiple ways. However, it remains unknown whether high salt regulates type I IFN production and signaling in macrophages. Here, we demonstrated that high salt promoted IFN beta production and its signaling in both human and mouse macrophages, and consequentially primed macrophages for strengthened immune sensing and signaling when challenged with viruses or viral nucleic acid analogues. Using both pharmacological inhibitors and RNA interference we showed that these effects of high salt on IFN beta signaling were mediated by the p38 MAPK/ATF2/AP1 signaling pathway. Consistently, high salt increased resistance to vesicle stomatitis virus (VSV) infection in vitro. In vivo data indicated that a high-salt diet protected mice from lethal VSV infection. Taken together, these results identify high salt as a crucial regulator of type I IFN production and signaling, shedding important new light on the regulation of innate immune responses.	[Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Sch Stomatol, Ninth Peoples Hosp, Sch Med, Shanghai 200011, Peoples R China; [Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Sch Med, Natl Clin Res Ctr Stomatol, Shanghai Res Inst Stomatol, Shanghai 200011, Peoples R China; [Du, Lin-Juan; Zheng, Xiao-Jun; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Chen, Xiao-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xiao, Hui; Leng, Qibin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Sun, SY (corresponding author), Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Sch Med, Dept Oral & Maxillofacial Head Neck Oncol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Duan, SZ (corresponding author), Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Sch Med, Lab Oral Microbiota & System Dis, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	shuyangs@shsmu.edu.cn; duansz@shsmu.edu.cn	Du, Linjuan/GZL-3707-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022	Zhang, Wu-Chang/0000-0002-8494-306X; Zheng, Xiaojun/0000-0002-2105-170X	National Natural Science Foundation of China [81725003, 31671181, 31371153, 91339110]; Shanghai Summit & Plateau Discipline Developing Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit & Plateau Discipline Developing Projects	This work was supported by the National Natural Science Foundation of China Grants 81725003, 31671181, 31371153, and 91339110 and the Shanghai Summit & Plateau Discipline Developing Projects. The authors declare that they have no conflicts of interest with the contents of this article.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2014, IMMUNITY, V41, P868, DOI 10.1016/j.immuni.2014.10.005; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lehmann MH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0252-1; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Luo M., 2017, CELL RES; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Safa K, 2015, J AM SOC NEPHROL, V26, P2341, DOI 10.1681/ASN.2014090914; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28065; Yang JH, 2015, J VIROL, V89, P10860, DOI 10.1128/JVI.01627-15; Zhang WC, 2015, CELL RES, V25, P893, DOI 10.1038/cr.2015.87; Zhao Y, 2016, CELL METAB, V23, P699, DOI 10.1016/j.cmet.2016.02.019; Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13	33	22	22	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1030	1039		10.1074/jbc.M117.805093	http://dx.doi.org/10.1074/jbc.M117.805093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203528	Green Published, hybrid			2022-12-26	WOS:000422864500023
J	Bernabo, N; Ciccarelli, R; Greco, L; Ordinelli, A; Mattioli, M; Barboni, B				Bernabo, Nicola; Ciccarelli, Rosa; Greco, Luana; Ordinelli, Alessandra; Mattioli, Mauro; Barboni, Barbara			Scientometric study of the effects of exposure to non-ionizing electromagnetic fields on fertility: A contribution to understanding the reasons of partial failure	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ALCOHOL-CONSUMPTION; REPRODUCTION; VARICOCELE; MARIJUANA; SMOKING	The exposure to Non-Ionizing-Electromagnetic Fields (NI-EMFs) is often indicated as a cofactor responsible for the fertility reduction, which has been described in recent years. Despite the great interest in this topic and the research effort in exploring it, to date, there are no reliable data. Therefore, we carried out a scientometric analysis of the scientific literature published in peer reviewed Journals concerning this topic to better understand the reasons of this partial failure. To this aim, we identified and analysed 104 papers, published in last 26 years in peer-reviewed Journals, present in ISI Web of Knowledge Core Collection. Then, we analysed the impact of the Journals in which the papers were published as well as that of the single papers, the paper citation dynamics, the keywords citation busts, the geographical localization of citations and the co-authorship dynamics of the Authors. As a result, we found that different animal models (rodent, rabbit, guinea pig, and swine) and different experimental approaches (epidemiological vs. experimental studies) have the same impact, highlighting the lack of universally adopted standard in research activity. The analysis of the temporal trend in keywords and the high differences in citations between the different countries (also in those belonging to the same geographical and socio-economical area) pointed out the difficulties in approaching this branch of study. Lastly, it was evident that the Authors did not behave as a connected community, but as unconnected clusters of very small size. In conclusion, based on the results of our analysis, we think that important efforts must be undertaken to adopt more standardized models and to improve the research quality and the information exchange within the scientific community, with the aim of improving the reliability and usefulness of the results of research regarding the effect of NI-EMFs on fertility.	[Bernabo, Nicola; Ciccarelli, Rosa; Greco, Luana; Ordinelli, Alessandra; Mattioli, Mauro; Barboni, Barbara] Univ Teramo, Fac Biosci & Agrofood & Environm Technol, Teramo, Italy	University of Teramo	Bernabo, N (corresponding author), Univ Teramo, Fac Biosci & Agrofood & Environm Technol, Teramo, Italy.	nbernabo@unite.it	Ordinelli, Alessandra/G-5543-2019	Ordinelli, Alessandra/0000-0003-1001-1590; Bernabo, Nicola/0000-0001-5140-9656				Agarwal A, 2014, ASIAN J ANDROL, V17, P433; Alshahrani S, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-103; Alvarez S, 2015, FERTIL STERIL, V103, P22, DOI 10.1016/j.fertnstert.2014.11.008; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Bernabo N, 2016, CURR CHEM BIOL, V10, P18; Bernabo N, 2016, SCIENTOMETRICS, V109, P103, DOI 10.1007/s11192-016-1969-3; Bomer K, 2011, SBE 2020 WHITE PAP, V69, P1; Brents Lisa K., 2016, Yale Journal of Biology and Medicine, V89, P175; Brezina Paul R, 2012, J Reprod Infertil, V13, P3; Chaouat G, 2008, NAT MED, V14, P1218, DOI 10.1038/nm1108-1218; Cho CL, 2016, ASIAN J ANDROL, V18, P186, DOI 10.4103/1008-682X.170441; Dai JB, 2015, ASIAN J ANDROL, V17, P954, DOI 10.4103/1008-682X.150847; Department of Energy South Africa, 2013, WHAT IS SOL PARK INF, P1; Dondorp W, 2010, HUM REPROD, V25, P578, DOI 10.1093/humrep/dep458; du Plessis SS, 2015, J ASSIST REPROD GEN, V32, P1575, DOI 10.1007/s10815-015-0553-8; European Commisson, 2006, HEAL ELECTROMAGN FIE, V1994, P1; GARFIELD E, 1980, CURR CONTENTS, P5; Gonzalez-Alcaide G, 2008, FERTIL STERIL, V90, P941, DOI 10.1016/j.fertnstert.2007.07.1378; Harlev A, 2015, WORLD J MENS HEALTH, V33, P143, DOI 10.5534/wjmh.2015.33.3.143; IARC, 2016, IARC MONOGR, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Klonoff-Cohen H, 2003, FERTIL STERIL, V79, P330, DOI 10.1016/S0015-0282(02)04582-X; Kumar Shiv Basant, 2015, Asian Pac J Cancer Prev, V16, P6967; Park B, 2004, PROSTAG LEUKOTR ESS, V70, P189, DOI 10.1016/j.plefa.2003.04.007; Practice T., 2012, FERTIL STERIL, V98, P1400; Reuters T., 2014, WEB SCI COR COLL, P1; Romeo C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/912878; Science E, 2016, GUIDE ICT RELATED AC; Sedha S, 2015, ROLE OXIDATIVE STRES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sikka SC, 2008, ASIAN J ANDROL, V10, P134, DOI 10.1111/j.1745-7262.2008.00370.x; Snijder CA, 2012, HUM REPROD UPDATE, V18, P284, DOI 10.1093/humupd/dms005; Sun J, 2016, BIOL TRACE ELEM RES, V22; Union E, 2015, DEMOGRAPHY REPORT SH; Wdowiak A, 2014, ANN AGR ENV MED, V21, P450, DOI 10.5604/1232-1966.1108623; Wesselink AK, 2016, REPROD TOXICOL, V62, P39, DOI 10.1016/j.reprotox.2016.04.022; Xu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15512; Xu C, 2016, TOXICOLOGICAL ASSESS, V7; Zalata A, 2015, INT J FERTIL STERIL, V9, P129	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187890	10.1371/journal.pone.0187890	http://dx.doi.org/10.1371/journal.pone.0187890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211813	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200022
J	Dong, XX; Shulzhenko, N; Lemaitre, J; Greer, RL; Peremyslova, K; Quamruzzaman, Q; Rahman, M; Ibn Hasan, OS; Joya, SA; Golam, M; Christiani, DC; Morgun, A; Kile, ML				Dong, Xiaoxi; Shulzhenko, Natalia; Lemaitre, Julien; Greer, Renee L.; Peremyslova, Kate; Quamruzzaman, Quazi; Rahman, Mahmudar; Ibn Hasan, Omar Sharif; Joya, Sakila Afroz; Golam, Mostofa; Christiani, David C.; Morgun, Andriy; Kile, Molly L.			Arsenic exposure and intestinal microbiota in children from Sirajdikhan, Bangladesh	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; CARDIOVASCULAR-DISEASE; METAL RESISTANCE; SEQUENCING DATA; DRINKING-WATER; MECHANISMS; PREGNANCY; DATABASE; GENOMES; SEARCH	Background Arsenic has antimicrobial properties at high doses yet few studies have examined its effect on gut microbiota. This warrants investigation since arsenic exposure increases the risk of many diseases in which gut microbiota have been shown to play a role. We examined the association between arsenic exposure from drinking water and the composition of intestinal microbiota in children exposed to low and high arsenic levels during prenatal development and early life. Results 16S rRNA gene sequencing revealed that children with high arsenic exposure had a higher abundance of Proteobacteria in their stool compared to matched controls with low arsenic exposure. Furthermore, whole metagenome shotgun sequencing identified 332 bacterial SEED functions that were enriched in the high exposure group. A separate model showed that these genes, which included genes involved in virulence and multidrug resistance, were positively correlated with arsenic concentration within the group of children in the high arsenic group. We performed reference free genome assembly, and identified strains of E. coli as contributors to the arsenic enriched SEED functions. Further genome annotation of the E. coli genome revealed two strains containing two different arsenic resistance operons that are not present in the gut microbiome of a recently described European human cohort (Metagenomics of the Human Intestinal Tract, MetaHIT). We then performed quantification by qPCR of two arsenic resistant genes (ArsB, ArsC). We observed that the expression of these two operons was higher among the children with high arsenic exposure compared to matched controls. Conclusions This preliminary study indicates that arsenic exposure early in life was associated with altered gut microbiota in Bangladeshi children. The enrichment of E. coli arsenic resistance genes in the high exposure group provides an insight into the possible mechanisms of how this toxic compound could affect gut microbiota.	[Dong, Xiaoxi; Peremyslova, Kate; Morgun, Andriy] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Shulzhenko, Natalia; Lemaitre, Julien; Greer, Renee L.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Quamruzzaman, Quazi; Rahman, Mahmudar; Ibn Hasan, Omar Sharif; Joya, Sakila Afroz; Golam, Mostofa] Dhaka Community Hosp, Wireless Railgate, Dhaka, Bangladesh; [Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Heath, Boston, MA USA; [Kile, Molly L.] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Harvard University; Harvard T.H. Chan School of Public Health; Oregon State University	Morgun, A (corresponding author), Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA.; Kile, ML (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.	anemorgun@hotmail.com; molly.kile@oregonstate.edu		dong, xiaoxi/0000-0003-3852-331X; Lemaitre, Julien/0000-0001-6239-0110	Division of Health Sciences at Oregon State University; National Institute of Environmental Health Sciences [R01ES023441, R01ES015533, K01ES017800, P30E5000210]	Division of Health Sciences at Oregon State University; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to acknowledge funding from the Division of Health Sciences at Oregon State University and National Institute of Environmental Health Sciences R01ES023441, R01ES015533, K01ES017800, and P30E5000210. Funding bodies did not have influence on design of the study, collection, analysis, interpretation of data or writing the manuscript.	Alava P, 2013, J HAZARD MATER, V262, P1237, DOI 10.1016/j.jhazmat.2012.05.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSesso JM, 1998, REPROD TOXICOL, V12, P385, DOI 10.1016/S0890-6238(98)00021-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fangstrom B, 2009, TOXICOL APPL PHARM, V239, P208, DOI 10.1016/j.taap.2008.12.019; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Fenosa A, 2009, J ANTIMICROB CHEMOTH, V63, P668, DOI 10.1093/jac/dkp027; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; HUYSMANS KD, 1990, WATER AIR SOIL POLL, V53, P159, DOI 10.1007/BF00155000; Kile ML, 2005, CANCER EPIDEM BIOMAR, V14, P2419, DOI 10.1158/1055-9965.EPI-05-0306; Kile ML, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-29; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Miller WH, 2002, CANCER RES, V62, P3893; Milton AH, 2005, EPIDEMIOLOGY, V16, P82, DOI 10.1097/01.ede.0000147105.94041.e6; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Morgun A, 2015, GUT; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pop M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r76; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rodrigues EG, 2015, J EXPO SCI ENV EPID, V25, P639, DOI 10.1038/jes.2015.45; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Simon R, 2007, CANCER INFORM, V3, P11; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang W, 2013, J EPIDEMIOLOGY COMMU; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; White AG, 2014, INT J ENV RES PUB HE, V11, P2299, DOI 10.3390/ijerph110202299; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	62	24	27	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188487	10.1371/journal.pone.0188487	http://dx.doi.org/10.1371/journal.pone.0188487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211769	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200036
J	Fu, KQ; Miyamoto, Y; Sumi, K; Saika, E; Muramatsu, S; Uno, K; Nitta, A				Fu, Kequan; Miyamoto, Yoshiaki; Sumi, Kazuyuki; Saika, Eriko; Muramatsu, Shin-ichi; Uno, Kyosuke; Nitta, Atsumi			Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit	PLOS ONE			English	Article							ACOUSTIC STARTLE REFLEX; DEPRESSION-LIKE BEHAVIOR; CENTRAL-NERVOUS-SYSTEM; PREPULSE INHIBITION; MOOD DISORDERS; METHAMPHETAMINE; MICE; SCHIZOPHRENIA; SHATI/NAT8L; IMPAIRMENT	Transmembrane protein 168 (TMEM168) comprises 697 amino acid residues, including some putative transmembrane domains. It is reported that TMEM168 controls methamphetamine (METH) dependence in the nucleus accumbens (NAc) of mice. Moreover, a strong link between METH dependence-induced adaptive changes in the brain and mood disorders has been evaluated. In the present study, we investigated the effects of accumbal TMEM168 in a battery of behavioral paradigms. The adeno-associated virus (AAV) Tmem168 vector was injected into the NAc of C57BL/6J mice (NAc-TMEM mice). Subsequently, the accumbal TMEM168 mRNA was increased approximately by seven-fold when compared with the NAc-Mock mice (controls). The NAc-TMEM mice reported no change in the locomotor activity, cognitive ability, social interaction, and depression-like behaviors; however, TMEM168 overexpression enhanced anxiety in the elevated-plus maze and light/dark box test. The increased anxiety was reversed by pretreatment with the antianxiety drug diazepam (0.3 mg/kg i.p.). Moreover, the NAc-TMEM mice exhibited decreased prepulse inhibition (PPI) in the startle response test, and the induced schizophrenia-like behavior was reversed by pretreatment with the antipsychotic drug risperidone (0.01 mg/kg i.p.). Furthermore, accumbal TMEM168 overexpression decreased the basal levels of extracellular GABA in the NAc and the high K+ (100 mM)-stimulated GABA elevation; however, the total contents of GABA in the NAc remained unaffected. These results suggest that the TMEM168-regulated GABAergic neuronal system in the NAc might become a novel target while studying the etiology of anxiety and sensorimotor gating deficits.	[Fu, Kequan; Miyamoto, Yoshiaki; Sumi, Kazuyuki; Saika, Eriko; Uno, Kyosuke; Nitta, Atsumi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Toyama, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Div Neurol, Dept Med, Shimotsuke, Tochigi, Japan; [Muramatsu, Shin-ichi] Univ Tokyo, Inst Med Sci, Ctr Gene & Cell Therapy, Tokyo, Japan	University of Toyama; Jichi Medical University; University of Tokyo	Nitta, A (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Toyama, Japan.	nitta@pha.u-toyama.ac.jp	Nitta, Atsumi/AAF-4211-2019; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shinichi/0000-0002-3185-7790; Nitta, Atsumi/0000-0001-6916-9160	Program for Next Generation World-Leading Researchers [NEXT] [LS047]; Japan Society for the Promotion of Science [26293213, JP15H04662, JP15K15050, JP17K19801]; Japan Agency for Medical Research and Development (AMED) [16mk0101076h0001]; Smoking Research Foundation Grant for Biomedical Research and Foundation; Kobayashi International Foundation	Program for Next Generation World-Leading Researchers [NEXT]; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation Grant for Biomedical Research and Foundation; Kobayashi International Foundation	This work was supported by Program for Next Generation World-Leading Researchers [NEXT Program LS047]; the grant-in-aid for Scientific Research (KAKENHI) (B) [JSPS KAKENHI Grant Number, 26293213, JP15H04662], Challenging Exploratory Research [JSPS KAKENHI Grant Number, JP15K15050 and JP17K19801] from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/index.html (SM, AN); Japan Agency for Medical Research and Development (AMED) [16mk0101076h0001], http://www.amed.go.jp/en/ (AN); Smoking Research Foundation Grant for Biomedical Research and Foundation, http://www.srf.or.jp/ (AN); and Kobayashi International Foundation, http://www.kisf.or.jp/english/index.html (KF, AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; Arai S, 2008, NEUROPSYCHOPHARMACOL, V33, P3164, DOI 10.1038/npp.2008.41; Azogu I, 2017, NEUROPHARMACOLOGY; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dai HM, 2004, ANN NY ACAD SCI, V1025, P257, DOI 10.1196/annals.1316.032; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; de la Tremblaye PB, 2016, EXP NEUROL, V284, P84, DOI 10.1016/j.expneurol.2016.07.019; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fletcher PJ, 2001, NEUROPSYCHOPHARMACOL, V24, P399, DOI 10.1016/S0893-133X(00)00215-3; Fu KQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13289-0; Fu KQ, 2016, PSYCHOPHARMACOLOGY, V233, P831, DOI 10.1007/s00213-015-4159-8; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Grant KM, 2012, J NEUROIMMUNE PHARM, V7, P113, DOI 10.1007/s11481-011-9288-1; Grossmann A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145968; Hellem TL, 2016, J SUBST ABUSE TREAT, V71, P16, DOI 10.1016/j.jsat.2016.08.011; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Lang DJ, 2001, AM J PSYCHIAT, V158, P625, DOI 10.1176/appi.ajp.158.4.625; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; Lubbers BR, 2014, PROG BRAIN RES, V214, P263, DOI 10.1016/B978-0-444-63486-3.00012-8; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Mierzejewski P, 2016, EUR J PHARMACOL, V773, P51, DOI 10.1016/j.ejphar.2016.01.009; Miyamoto Y, 2001, J NEUROSCI, V21, P750, DOI 10.1523/JNEUROSCI.21-02-00750.2001; Miyamoto Y, 2014, INT J NEUROPSYCHOPH, V17, P1283, DOI 10.1017/S146114571400011X; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Park YK, 2016, NAT REV NEUROSCI, V17, P745, DOI 10.1038/nrn.2016.138; Paxions G, 2008, MOUSE BRAININ STEREO; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schutova B, 2010, PHYSIOL BEHAV, V99, P381, DOI 10.1016/j.physbeh.2009.12.004; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Talalaenko A N, 2006, Neurosci Behav Physiol, V36, P749, DOI 10.1007/s11055-006-0083-z; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506; Toriumi K, 2015, EUR NEUROPSYCHOPHARM, V25, P2108, DOI 10.1016/j.euroneuro.2015.08.003; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109	50	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189006	10.1371/journal.pone.0189006	http://dx.doi.org/10.1371/journal.pone.0189006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211814	Green Submitted, Green Published, gold			2022-12-26	WOS:000417212200054
J	Sanz-Veiga, PA; Jorge, LR; Benitez-Vieyra, S; Amorim, FW				Sanz-Veiga, Priscila Andre; Jorge, Leonardo Re; Benitez-Vieyra, Santiago; Amorim, Felipe W.			Pericarpial nectary-visiting ants do not provide fruit protection against pre-dispersal seed predators regardless of ant species composition and resource availability	PLOS ONE			English	Article							BEARING EXTRAFLORAL NECTARIES; EXTRA-FLORAL NECTARIES; PLANT-PROTECTION; HERBIVORE INTERACTIONS; REPRODUCTIVE FITNESS; DEFENSE; FORMICIDAE; SECRETION; RUBIACEAE; COMMUNITY	Extrafloral nectaries can occur in both vegetative and reproductive plant structures. In many Rubiaceae species in the Brazilian Cerrado, after corolla abscission, the floral nectary continues to secret nectar throughout fruit development originating post-floral pericarpial nectaries which commonly attract many ant species. The occurrence of such nectar secreting structures might be strategic for fruit protection against seed predators, as plants are expected to invest higher on more valuable and vulnerable parts. Here, we performed ant exclusion experiments to investigate whether the interaction with ants mediated by the pericarpial nectaries of Tocoyena formosa affects plant reproductive success by reducing the number of pre-dispersal seed predators. We also assessed whether ant protection was dependent on ant species composition and resource availability. Although most of the plants were visited by large and aggressive ant species, such as Ectatomma tuberculatum and species of the genus Camponotus, ants did not protect fruits against seed predators. Furthermore, the result of the interaction was neither related to ant species composition nor to the availability of resources. We suggest that these results may be related to the nature and behavior of the most important seed predators, like Hemicolpus abdominalis weevil which the exoskeleton toughness prevent it from being predated by most ant species. On the other hand, not explored factors, such as reward quality, local ant abundance, ant colony characteristics and/or the presence of alternative energetic sources could also account for variations in ant frequency, composition, and finally ant protective effects, highlighting the conditionality of facultative plant-ant mutualisms.	[Sanz-Veiga, Priscila Andre; Amorim, Felipe W.] Univ Estadual Paulista, LEPI, Programa Posgrad Ciencias Biol Bot, Inst Biociencias, Sao Paulo, Brazil; [Jorge, Leonardo Re] Univ Estadual Campinas, Dept Biol Anim, Sao Paulo, Brazil; [Benitez-Vieyra, Santiago] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Amorim, Felipe W.] Univ Estadual Paulista, LEPI, Dept Bot, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual de Campinas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidade de Sao Paulo; Universidade Estadual Paulista	Sanz-Veiga, PA; Amorim, FW (corresponding author), Univ Estadual Paulista, LEPI, Programa Posgrad Ciencias Biol Bot, Inst Biociencias, Sao Paulo, Brazil.; Amorim, FW (corresponding author), Univ Estadual Paulista, LEPI, Dept Bot, Inst Biociencias, Sao Paulo, Brazil.	psanzveiga@gmail.com; amorimfelipe@yahoo.com.br	Jorge, Leonardo Ré/A-1528-2009; Benitez-Vieyra, Santiago/AAT-3076-2020; Veiga, Priscila Andre Sanz/AAH-9229-2021; Amorim, Felipe W./AAE-6641-2020; Sanz-Veiga, Priscila/D-4550-2019	Jorge, Leonardo Ré/0000-0003-4518-4328; Benitez-Vieyra, Santiago/0000-0003-4116-7969; Veiga, Priscila Andre Sanz/0000-0002-7096-2411; Amorim, Felipe W./0000-0002-6026-0395; Sanz-Veiga, Priscila/0000-0002-7096-2411	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484469/2013-2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/16082-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Proc. 484469/2013-2014: http://cnpq.br/) to FWA. PASV was supported by a Masters scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes: http://www.capes.gov.br/). LRJ was supported by a postdoc scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Proc. 14/16082-9: http//www.fapesp.br/). SBV is staff researcher of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET: http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva E, 2016, AUSTRAL ECOL, V41, P263, DOI 10.1111/aec.12307; Alves-Silva E, 2015, J NAT HIST, V49, P841, DOI 10.1080/00222933.2014.954020; Amorim Felipe Wanderley, 2006, Braz. J. Bot., V29, P353, DOI 10.1590/S0100-84042006000300003; Anzaldo SS, 2017, ZOOKEYS, P51, DOI 10.3897/zookeys.683.12080; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Belchior C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158283; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; BENTLEY BL, 1976, ECOLOGY, V57, P815, DOI 10.2307/1936195; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; CEPAGRI-CENTRO DE PESQUISAS METEOROLOGICAS E CLIMATICAS APLICADAS A AGRICULTURA, 2015, CLIM MUN PAUL; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; DAVIDSON DW, 1991, ANT - PLANT INTERACTIONS, P289; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; de la Fuente MAS, 1999, OECOLOGIA, V118, P192, DOI 10.1007/s004420050718; DEJEAN A, 1992, INSECT SOC, V39, P129, DOI 10.1007/BF01249289; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Del-Claro K, 2013, SOCIOBIOLOGY, V60, P217; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Di Giusto B, 2001, OECOLOGIA, V129, P367, DOI 10.1007/s004420100734; Eberhard WG, 1999, BIOTROPICA, V31, P535, DOI 10.1111/j.1744-7429.1999.tb00399.x; ELIAS TS, 1978, BRITTONIA, V30, P175, DOI 10.2307/2806648; Falcao JCF, 2014, J PLANT INTERACT, V9, P137, DOI 10.1080/17429145.2013.782513; Freitas L, 2000, FLORA, V195, P398; Grasso DA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv002; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; HEADS PA, 1985, ECOL ENTOMOL, V10, P29, DOI 10.1111/j.1365-2311.1985.tb00532.x; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Hsieh TC, 2016, INT SYMP WIREL; INOUYE DW, 1979, ECOLOGY, V60, P1, DOI 10.2307/1936460; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jones IM, 2017, FLA ENTOMOL, V100, P539, DOI 10.1653/024.100.0308; Jones IM, 2017, BIOTROPICA, V49, P83, DOI 10.1111/btp.12363; KEELER KH, 1981, AM J BOT, V68, P295, DOI 10.2307/2442861; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; KOPTUR S, 1988, ECOLOGY, V69, P278, DOI 10.2307/1943183; Koptur S, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P75, DOI 10.1017/CBO9780511542220.004; KOPTUR S, 1984, ECOLOGY, V65, P1787, DOI 10.2307/1937775; Koptur S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138157; Koricheva J, 2012, BIOL LETTERS, V8, P628, DOI 10.1098/rsbl.2012.0271; Lanan MC, 2013, OECOLOGIA, V172, P779, DOI 10.1007/s00442-012-2528-0; Lange D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169492; Lange D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105574; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Lenoir L, 2006, ECOL ENTOMOL, V31, P601, DOI 10.1111/j.1365-2311.2006.00818.x; Miller TEX, 2013, J ECOL, V102, P496; Miller TEX, 2007, OIKOS, V116, P500, DOI 10.1111/j.2007.0030-1299.15317.x; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Nogueira A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123806; Nogueira A, 2012, PLANT ECOL, V213, P289, DOI 10.1007/s11258-011-9974-3; ODOWD DJ, 1983, OECOLOGIA, V59, P191, DOI 10.1007/BF00378837; Oksanen J., 2017, Ordination methods, diversity analysis and other functions for community and vegetation ecologists version 2.4-3; Oliveira PS, 1997, FUNCT ECOL, V11, P323, DOI 10.1046/j.1365-2435.1997.00087.x; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, OECOLOGIA, V81, P487, DOI 10.1007/BF00378956; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; Ruhren S, 2003, PLANT ECOL, V166, P189, DOI 10.1023/A:1023248431116; Santos Jean Carlos, 2001, Revista Brasileira de Zoociencias, V3, P77; SCHEMSKE DW, 1980, J ECOL, V68, P959, DOI 10.2307/2259468; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; SILBERBA.I, 1972, OSTERR BOT Z, V120, P1, DOI 10.1007/BF01373254; SILBERBAUERGOTTSBERGER I, 1975, PLANT SYST EVOL, V123, P157, DOI 10.1007/BF00989402; Sobrinho TG, 2002, SOCIOBIOLOGY, V39, P353; Paiva EAS, 2009, ANN BOT-LONDON, V104, P937, DOI 10.1093/aob/mcp175; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Wackers FL, 2004, ECOLOGY, V85, P1512, DOI 10.1890/03-0422; Whitehead SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102604	86	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188445	10.1371/journal.pone.0188445	http://dx.doi.org/10.1371/journal.pone.0188445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211790	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200033
J	Niemela, O; Niemela, M; Bloigu, R; Aalto, M; Laatikainen, T				Niemela, Onni; Niemela, Markus; Bloigu, Risto; Aalto, Mauri; Laatikainen, Tiina			Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; SERUM ALANINE AMINOTRANSFERASE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; GLOBAL BURDEN; REDUCED MORTALITY; HEART-DISEASE; RISK-FACTOR; ALL-CAUSE	Objectives To estimate the prevalence and risk factors for abnormal liver enzymes in a large age- and gender stratified population- based sample of apparently healthy individuals with or without alcohol consumption and other health-related risk factors (adiposity, physical inactivity, smoking). Methods Data on alcohol use, smoking, diet and physical activity were recorded using structured questionnaires from 13,976 subjects (6513 men, 7463 women, aged 25-74 years) in the national FINRISK studies. Alcohol data was used to categorize the participants into abstainers, light drinkers, moderate drinkers and heavy drinkers. Serum gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT) activities were measured using standard kinetic methods. Results Male light drinkers, moderate drinkers and heavy drinkers showed significantly higher relative risks of abnormal GGT than abstainers: 1.37 (95% confidence interval 1.11 to 1.71, p < 0.01), 2.72 (2.08 to 3.56, p < 0.0005), and 6.10 (4.55 to 7.17, p < 0.0005), respectively. Corresponding values for women were 1.22 (0.99 to 1.51, p = 0.065), 1.90 (1.44 to 2.51, p < 0.0005), and 5.91 (3.80 to 9.17, p < 0.0005). Estimated threshold doses for a significant GGT elevation was 14 standard weekly alcohol doses for men and 7 for women. Excess body weight and age over 40 years modulated the thresholds towards smaller quantities of alcohol. The risk of abnormal GGT was also significantly influenced by physical inactivity and smoking. The relative risks of abnormal ALT activities were increased in male heavy drinkers, especially in those presenting with adiposity and sedentary lifestyle. Conclusions Alcohol use markedly increases the risk for abnormal liver enzyme activities in those presenting with age over 40 years, obesity, smoking or sedentary lifestyle. The data should be considered in public health recommendations and in the definitions of safe limits of alcohol use.	[Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland; [Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Seinajoki, Finland; [Niemela, Onni] Univ Tampere, Seinajoki, Finland; [Niemela, Markus] Univ Oulu, Dept Med, Oulu, Finland; [Bloigu, Risto] Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland; [Aalto, Mauri] Seinajoki Cent Hosp, Dept Psychiat, Tampere, Finland; [Aalto, Mauri] Univ Tampere, Tampere, Finland; [Laatikainen, Tiina] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	Seinajoki Central Hospital; Seinajoki Central Hospital; University of Oulu; University of Oulu; Seinajoki Central Hospital; Finland National Institute for Health & Welfare; University of Eastern Finland	Niemela, O (corresponding author), Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland.	onni.niemela@epshp.fi	Laatikainen, Tiina/ABD-6622-2021	Laatikainen, Tiina/0000-0002-6614-4782; Aalto, Mauri/0000-0003-3424-3767				Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Carmiel-Haggai M, 2003, GASTROENTEROLOGY, V125, P1818, DOI 10.1053/j.gastro.2003.09.019; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Catena C, 2016, HYPERTENSION, V68, P1208, DOI 10.1161/HYPERTENSIONAHA.116.08145; Choi Y., 2017, CANC RES TREAT; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Danielsson J, 2013, ALCOHOL ALCOHOLISM, V48, P303, DOI 10.1093/alcalc/agt017; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Duffy JC, 1992, J OFF STAT, V8, P327; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Gluud C, 2005, BRIT MED J, V330, P724, DOI 10.1136/bmj.330.7493.724; Goh GBB, 2014, HEPATOLOGY, V60, P661, DOI 10.1002/hep.27054; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Klatsky AL, 2015, J INTERN MED, V278, P238, DOI 10.1111/joim.12390; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Kuulasmaa K, 2017, EUROPEAN HLTH RISK M; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; LANCA AJ, 1991, HEPATOLOGY, V14, P857, DOI 10.1002/hep.1840140518; Lau K, 2015, ALIMENT PHARM THER, V41, P467, DOI 10.1111/apt.13067; Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; LEMMENS P, 1992, J STUD ALCOHOL, V53, P476, DOI 10.15288/jsa.1992.53.476; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Mannisto S, 2014, BR J NUTR, V111, P887; McManus DD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004060; Mu RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072916; Niemela O, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020166; Park EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063439; Peltonen M, 2008, KANSALLINEN FINRISKI; Perreault K, 2017, BRIT J SPORT MED, V51, P651, DOI 10.1136/bjsports-2016-096194; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sipila P, 2016, ADDICTION, V111, P245, DOI 10.1111/add.13152; SPEISKY H, 1990, HEPATOLOGY, V11, P843, DOI 10.1002/hep.1840110520; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Sundberg CJ, 2016, BRIT J SPORT MED, V50, P319, DOI 10.1136/bjsports-2016-096026; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Tsai J, 2012, J BEHAV MED, V35, P200, DOI 10.1007/s10865-011-9353-5; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wittchen HU, 2012, SCIENCE, V338, P15, DOI 10.1126/science.1230817; Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR	70	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188574	10.1371/journal.pone.0188574	http://dx.doi.org/10.1371/journal.pone.0188574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206836	Green Published, gold			2022-12-26	WOS:000417110700014
J	Parker, RL; O'Neill, HC; Henley, BM; Wageman, CR; Drenan, RM; Marks, MJ; Miwa, JM; Grady, SR; Lester, HA				Parker, Rell L.; O'Neill, Heidi C.; Henley, Beverley M.; Wageman, Charles R.; Drenan, Ryan M.; Marks, Michael J.; Miwa, Julie M.; Grady, Sharon R.; Lester, Henry A.			Deletion of lynx1 reduces the function of alpha 6*nicotinic receptors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; SUBUNIT STOICHIOMETRY; RNA-SEQ; EXPRESSION; MODULATION; ACTIVATION; MECHANISMS; SUBTYPES	The alpha 6 nicotinic acetylcholine receptor (nAChR) subunit is an attractive drug target for treating nicotine addiction because it is present at limited sites in the brain including the reward pathway. Lynx1 modulates several nAChR subtypes; lynx1-nAChR interaction sites could possibly provide drug targets. We found that dopaminergic cells from the substantia nigra pars compacta (SNc) express lynx1 mRNA transcripts and, as assessed by co-immunoprecipitation, alpha 6 receptors form stable complexes with lynx1 protein, although co-transfection with lynx1 did not affect nicotine-induced currents from cell lines transfected with alpha 6 and beta 2. To test whether lynx1 is important for the function of alpha 6 nAChRs in vivo, we bred transgenic mice carrying a hypersensitive mutation in the alpha 6 nAChR subunit (alpha 6L90S) with lynx1 knockout mice, providing a selective probe of the effects of lynx1 on alpha 6* nAChRs. Lynx1 removal reduced the alpha 6 component of nicotine-mediated rubidium efflux and dopamine (DA) release from synaptosomal preparations with no effect on numbers of alpha 6 beta 2 binding sites, indicating that lynx1 is functionally important for alpha 6* nAChR activity. No effects of lynx1 removal were detected on nicotine-induced currents in slices from SNc, suggesting that lynx1 affects presynaptic alpha 6* nAChR function more than somatic function. In the absence of agonist, lynx1 removal did not alter DA release in dorsal striatum as measured by fast scan cyclic voltammetry. Lynx1 removal affected some behaviors, including a novel-environment assay and nicotine-stimulated locomotion. Trends in 24-hour home-cage behavior were also suggestive of an effect of lynx1 removal. Conditioned place preference for nicotine was not affected by lynx1 removal. The results show that some functional and behavioral aspects of alpha 6nAChRs are modulated by lynx1.	[Parker, Rell L.; Henley, Beverley M.; Lester, Henry A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [O'Neill, Heidi C.; Wageman, Charles R.; Marks, Michael J.; Grady, Sharon R.] Univ Colorado Boulder, Inst Behav Genet, Boulder, CO USA; [Drenan, Ryan M.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Marks, Michael J.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	California Institute of Technology; University of Colorado System; University of Colorado Boulder; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Boulder; Lehigh University	Parker, RL (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.		O'Neill, Heidi/AAP-8909-2021	Henley, Beverley M./0000-0002-6211-2433; Parker, Rell/0000-0002-4538-1818; Miwa, Julie/0000-0002-4418-3756	California Tobacco-Related Diseases Research Program [22DT-0008, 19KT-0032]; NIH / NIDA [DA003194, DA012242, P30-DA015663, DA017279, DA019375, DA030396, DA035942, DA033831, DA032464]	California Tobacco-Related Diseases Research Program; NIH / NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This research was supported by funds provided by California Tobacco-Related Diseases Research Program (tittp//www.trdrp.org), Grant 22DT-0008 to RLP, and 19KT-0032 to JMM. Additional support was provided by NIH / NIDA(https://www.drugabuse.gov/) grants, DA003194, DA012242, and P30-DA015663 to MJM, DA017279 to HAL, and DA019375 to HAL and MJM, DA030396 and DA035942 to RMD, and DA033831, DA032464 to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Bordia T, 2015, NEUROSCIENCE, V295, P187, DOI 10.1016/j.neuroscience.2015.03.040; Brunzell DH, 2012, NICOTINE TOB RES, V14, P1258, DOI 10.1093/ntr/nts089; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Chen C, 2013, J NEUROCHEM, V126, P318, DOI 10.1111/jnc.12199; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; George AA, 2017, FASEB J, V31, P1398, DOI 10.1096/fj.201600733R; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; Henley BM, 2013, BIOCHEM PHARMACOL, V86, P1074, DOI 10.1016/j.bcp.2013.07.031; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V288, P15888; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Marks MJ, 2011, J PHARMACOL EXP THER, V337, P187, DOI 10.1124/jpet.110.178236; Matta JA, 2017, CELL REP, V19, P688, DOI 10.1016/j.celrep.2017.04.008; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Perez XA, 2013, J NEUROCHEM, V127, P762, DOI 10.1111/jnc.12442; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Powers MS, 2013, GENES BRAIN BEHAV; Quik M, 2011, BIOCH PHARM; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sajo M, 2016, J NEUROSCI, V36, P9472, DOI 10.1523/JNEUROSCI.0580-16.2016; Sanjakdar SS, 2015, NEUROPSYCHOPHARMACOL, V40, P350, DOI 10.1038/npp.2014.177; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thomsen MS, 2016, NEUROBIOL AGING, V46, P13, DOI 10.1016/j.neurobiolaging.2016.06.009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wall T, 2015, TI299423 CAL I TECHN; Watkins Simon, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1216s48; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005	51	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188715	10.1371/journal.pone.0188715	http://dx.doi.org/10.1371/journal.pone.0188715			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206881	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700017
J	Williams, E; Villar-Prados, A; Bowser, J; Broaddus, R; Gladden, AB				Williams, Erin; Villar-Prados, Alejandro; Bowser, Jessica; Broaddus, Russell; Gladden, Andrew B.			Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITIONS; ADHERENS JUNCTIONS; ACTIVATION; ADENOCARCINOMA; ORIENTATION; EXPRESSION; CARCINOMA; SURFACE; MERLIN	Cell adhesion and apicobasal polarity together maintain epithelial tissue organization and homeostasis. Loss of adhesion has been described as a prerequisite for the epithelial to mesenchymal transition. However, what role misregulation of apicobasal polarity promotes tumor initiation and/or early progression remains unclear. We find that human low-grade endometrial cancers are associated with disrupted localization of the apical polarity protein Par3 and Ezrin while, the adhesion molecule E-cadherin remains unchanged, accompanied by decreased Notch signaling, and altered Notch receptor localization. Depletion of Par3 or Ezrin, in a cell-based model, results in loss of epithelial architecture, differentiation, increased proliferation, migration and decreased Notch signaling. Re-expression of Par3 in endometrial cancer cell lines with disrupted Par3 protein levels blocks proliferation and reduces migration in a Notch dependent manner. These data uncover a function for apicobasal polarity independent of cell adhesion in regulating Notch-mediated differentiation signals in endometrial epithelial cells.	[Williams, Erin; Villar-Prados, Alejandro; Gladden, Andrew B.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Williams, Erin; Villar-Prados, Alejandro; Broaddus, Russell; Gladden, Andrew B.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Bowser, Jessica] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gladden, AB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Gladden, AB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	agladden@mdanderson.org		Villar-Prados, Alejandro/0000-0001-6900-3267; Bowser, Jessica L./0000-0003-0655-7769; Gladden, Andrew/0000-0003-4519-5510	National Center for Research Resources [TL1RR024147]; Department of Defense-Congressionally Directed Medical Research Program [W81XWH-14-1-0053]; National Cancer Institute, Uterine Cancer SPORE [P50CA098258]; NIH/NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense-Congressionally Directed Medical Research Program(United States Department of Defense); National Cancer Institute, Uterine Cancer SPORE; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Center for Research Resources TL1RR024147 Jessica Bowser; Department of Defense-Congressionally Directed Medical Research Program, http://cdmrp.army.mil/default (W81XWH-14-1-0053), A.B.G.; National Cancer Institute, Uterine Cancer SPORE, https://www.cancer.gov (P50CA098258), R.B. Supported by the NIH/NCI under award number P30CA016672 and use of the Tissue Biospecimen and Pathology Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Anant S, 1998, DEVELOPMENT, V125, P1361; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; CHEON HK, 1969, OBSTET GYNECOL, V34, P680; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x; Danjo Y, 1998, J CELL SCI, V111, P3323; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Duong LM, 2011, J WOMENS HEALTH, V20, P1157, DOI 10.1089/jwh.2010.2529; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Elia N, CURR PROTOC CELL BIO, p209AD; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Hao Y, 2010, CURR BIOL, V18, P1492; Hassounah NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068521; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; HENDRICKSON MR, 1983, AM J SURG PATHOL, V7, P819, DOI 10.1097/00000478-198307080-00011; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jalali A, 2011, J NEUROSCI RES, V89, P299, DOI 10.1002/jnr.22562; Jonusiene V, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0438-y; Jundt F, 2015, JAGGED1 INDUCED NOTC, V103, P3511; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kaitu'u-Lino TJ, 2009, ENDOCRINOLOGY, V150, P1904, DOI 10.1210/en.2008-0738; Karst W M H., 1988, DIFFERENTIATION BEHA, V22, P211; Kopan R., 2012, COLD SPRING HARB PER, V4, P1; Kurman RJ, 1994, BLAUSTEINS PATHOLOGY; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MASTERTON R, 1975, J REPROD FERTIL, V42, P537; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Novak E, 1924, J AMER MED ASSOC, V83, P900, DOI 10.1001/jama.1924.02660120016004; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qiu MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-78; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silverberg SG, 2000, MODERN PATHOL, V13, P309, DOI 10.1038/modpathol.3880053; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Tan O, 2012, FERTIL STERIL, V97, P192, DOI 10.1016/j.fertnstert.2011.10.039; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tian JQ, 1999, AM J PHYSIOL, V21, P1245; Wang Z, 2010, J CELL BIOCH, V736; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whelan JT, 2009, J CELL BIOCHEM, V107, P992, DOI 10.1002/jcb.22199; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	63	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189081	10.1371/journal.pone.0189081	http://dx.doi.org/10.1371/journal.pone.0189081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206870	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700045
J	Jones, AR; Coleman, EL; Husni, NR; Deeney, JT; Raval, F; Steenkamp, D; Dooms, H; Nikolajczyk, BS; Corkey, BE				Jones, Albert R.; Coleman, Emily L.; Husni, Nicholas R.; Deeney, Jude T.; Raval, Forum; Steenkamp, Devin; Dooms, Hans; Nikolajczyk, Barbara S.; Corkey, Barbara E.			Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY-ACID OXIDATION; OXYGEN; CYTOKINES; TNF; SUSCEPTIBILITY; INTERLEUKIN-1; INFLAMMATION; SUPEROXIDE; INHIBITION	Triggers of the autoimmune response that leads to type 1 diabetes (T1D) remain poorly understood. A possibility is that parallel changes in both T cells and target cells provoke autoimmune attack. We previously documented greater Ca2+ transients in fibroblasts from T1D subjects than non-T1D after exposure to fatty acids (FA) and tumor necrosis factor alpha (TNF alpha). These data indicate that metabolic and signal transduction defects present in T1D can be elicited ex vivo in isolated cells. Changes that precede T1D, including inflammation, may activate atypical responses in people that are genetically predisposed to T1D. To identify such cellular differences in T1D, we quantified a panel of metabolic responses in fibroblasts and peripheral blood cells (PBMCs) from age-matched T1D and non-T1D subjects, as models for non-immune and immune cells, respectively. Fibroblasts from T1D subjects accumulated more lipid, had higher LC-CoA levels and converted more FA to CO2, with less mitochondrial proton leak in response to oleate alone or with TNF alpha, using the latter as a model of inflammation. T1D-PBMCs contained and also accumulated more lipid following FA exposure. In addition, they formed more peroxidized lipid than controls following FA exposure. We conclude that both immune and non-immune cells in T1D subjects differ from controls in terms of responses to FA and TNF alpha. Our results suggest a differential sensitivity to inflammatory insults and FA that may precede and contribute to T1D by priming both immune cells and their targets for autoimmune reactions.	[Jones, Albert R.; Husni, Nicholas R.; Deeney, Jude T.; Corkey, Barbara E.] Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Coleman, Emily L.] Yale Univ, Sch Med, New Haven, CT USA; [Raval, Forum] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Steenkamp, Devin] Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Dooms, Hans] Boston Univ, Sch Med, Evans Dept Med, Rheumatol Sect, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Univ Kentucky, Sch Med, Dept Translat Res Diabet, Lexington, KY 40536 USA; [Nikolajczyk, Barbara S.] Univ Kentucky, Sch Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA	Boston University; Yale University; Boston University; Boston University; Boston University; University of Kentucky; University of Kentucky	Corkey, BE (corresponding author), Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	bcorkey@bu.edu	Corkey, Barbara/E-7712-2015	Corkey, Barbara/0000-0002-5467-1630; Dooms, Hans/0000-0001-7964-0876	Zoltan Kohn Endowment; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI [1UL1TR001430]; National Institute of Health [DK46200-24, DK099618-01, DK074778-09, DK056690-12, DK035914-27, R01DK108056, R01 DE025383, NIDDK P30DK057521]	Zoltan Kohn Endowment; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Zoltan Kohn Endowment, the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430 and the following grants from the National Institute of Health: DK46200-24, DK099618-01, DK074778-09, DK056690-12, DK035914-27 to BEC; R01DK108056 and R01 DE025383 to BSN; and NIDDK P30DK057521 (BADERC) to HD.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Beyan H, 2010, DIABETES, V59, P1751, DOI 10.2337/db09-1433; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; CAMPBELL IL, 1989, J CELL BIOCHEM, V40, P57, DOI 10.1002/jcb.240400107; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; Chee J, 2011, J IMMUNOL, V187, P1702, DOI 10.4049/jimmunol.1100511; CHOSICH N, 1994, AUTOIMMUNITY, V18, P163, DOI 10.3109/08916939409007992; Coppieters K. T., 2012, COLD SPRING HARB PER, V2, P1, DOI [10.1101/cshperspect.a007682, DOI 10.1101/cshperspect.a007682]; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Eerligh P, 2004, GENES IMMUN, V5, P36, DOI 10.1038/sj.gene.6364036; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; Glisic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036040; GRUNFELD C, 1988, J LIPID RES, V29, P1327; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Ha J, 1997, J PHARMACOL EXP THER, V281, P1457; Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315; HOEK JB, 1988, BIOCHEM J, V254, P1; Husni NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087068; Hussain MJ, 1996, DIABETOLOGIA, V39, P60; Hyoty HL, 2002, ANN MED, V34, P138, DOI 10.1080/713782135; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mosaad YM, 2012, WORLD J DIABETES, V3, P149, DOI 10.4239/wjd.v3.i8.149; NACHIAPPAN V, 1994, SHOCK, V1, P123, DOI 10.1097/00024382-199402000-00007; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Peltz M, 2004, SURGERY, V136, P150, DOI 10.1016/j.surg.2004.04.007; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Schneider DA, 2014, DIABETOLOGIA, V57, P2009, DOI 10.1007/s00125-014-3340-7; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Xie XY, 2012, PHYTOMEDICINE, V20, P3, DOI 10.1016/j.phymed.2012.09.003	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188474	10.1371/journal.pone.0188474	http://dx.doi.org/10.1371/journal.pone.0188474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206239	Green Published, gold, Green Submitted			2022-12-26	WOS:000417033200007
J	Laviola, G; Zoratto, F; Ingiosi, D; Carito, V; Huzard, D; Fiore, M; Macri, S				Laviola, Giovanni; Zoratto, Francesca; Ingiosi, Danilo; Carito, Valentina; Huzard, Damien; Fiore, Marco; Macri, Simone			Low empathy-like behaviour in male mice associates with impaired sociability, emotional memory, physiological stress reactivity and variations in neurobiological regulations	PLOS ONE			English	Article							CALLOUS-UNEMOTIONAL TRAITS; NEUROTROPHIC FACTOR; CONDUCT DISORDER; MORPHINE ANALGESIA; SOCIAL MODULATION; INBRED STRAINS; DEFICIENT MICE; FORMALIN TEST; MOUSE MODEL; OXYTOCIN	Deficits in empathy have been proposed to constitute a hallmark of several psychiatric disturbances like conduct disorder, antisocial and narcissistic personality disorders. Limited sensitivity to punishment, shallow or deficient affect and reduced physiological reactivity to environmental stressors have been often reported to co-occur with limited empathy and contribute to the onset of antisocial phenotypes. Empathy in its simplest form (i.e. emotional contagion) is addressed in preclinical models through the evaluation of the social transmission of emotional states: mice exposed to a painful stimulus display a higher response if in the presence of a familiar individual experiencing a higher degree of discomfort, than in isolation. In the present study, we investigated whether a reduction of emotional contagion can be considered a predictor of reduced sociality, sensitivity to punishment and physiological stress reactivity. To this aim, we first evaluated emotional contagion in a group of Balb/cJ mice and then discretised their values in four quartiles. The upper (i.e. Emotional Contagion Prone, ECP) and the lower (i.e. Emotional Contagion Resistant, ECR) quartiles constituted the experimental groups. Our results indicate that mice in the lower quartile are characterized by reduced sociability, impaired memory of negative events and dampened hypothalamic- pituitary-adrenocortical reactivity to external stressors. Furthermore, in the absence of changes in oxytocin receptor density, we show that these mice exhibit elevated concentrations of oxytocin and vasopressin and reduced density of BDNF receptors in behaviourall-relevant brain areas. Thus, not only do present results translate to the preclinical investigation of psychiatric disturbances, but also they can contribute to the study of emotional contagion in terms of its adaptive significance.	[Laviola, Giovanni; Zoratto, Francesca; Ingiosi, Danilo; Macri, Simone] ISS, Reference Ctr Behav Sci & Mental Hlth, Rome, Italy; [Carito, Valentina; Fiore, Marco] Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Huzard, Damien] Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, Lausanne, Switzerland	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Laviola, G (corresponding author), ISS, Reference Ctr Behav Sci & Mental Hlth, Rome, Italy.	giovanni.laviola@iss.it	Zoratto, Francesca/K-6031-2016; Laviola, Giovanni/K-4392-2016; Laviola, Giovanni/AAA-2391-2022; Pippi, Pippo/B-6112-2015; Fiore, Marco/GLT-0780-2022	Zoratto, Francesca/0000-0002-3626-8928; Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; fiore, marco/0000-0001-6806-9715; Macri, Simone/0000-0003-2946-4784	European Community's Seventh Framework Programme [603016, 278367]	European Community's Seventh Framework Programme	The authors of this manuscript received funding from the European Community's Seventh Framework Programme (FP7) under grant agreement no 603016 (Project MATRICS) and no 278367 (Project EMTICS). This paper reflects only the authors' views and the European Unionis not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2014, PSYCHOL MED, V44, P3523, DOI 10.1017/S003329171400097X; Abu-Akel A, 2015, SOC NEUROSCI-UK, V10, P7, DOI 10.1080/17470919.2014.948637; ALLEVA E, 1986, PHYSIOL BEHAV, V36, P779, DOI 10.1016/0031-9384(86)90368-9; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bales KL, 2004, HORM BEHAV, V45, P354, DOI 10.1016/j.yhbeh.2004.01.004; Barry CT, 2000, J ABNORM PSYCHOL, V109, P335, DOI [10.1037/0021-843X.109.2.335, 10.1037//0021-843X.109.2.335]; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Bos PA, 2015, NEUROIMAGE, V113, P217, DOI 10.1016/j.neuroimage.2015.03.049; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; Branchi I, 2009, PHYSIOL BEHAV, V96, P532, DOI 10.1016/j.physbeh.2008.12.003; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Cirulli F, 1996, PHARMACOL BIOCHEM BE, V54, P99, DOI 10.1016/0091-3057(95)02169-8; Crawley J. N., 2007, WHATS WRONG MY MOUSE; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Decety J, 2010, DEVELOPMENTAL SCI, V13, P886, DOI 10.1111/j.1467-7687.2009.00940.x; Diamantopoulou A, 2012, BRAIN RES, V1466, P112, DOI 10.1016/j.brainres.2012.05.016; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Eisenbarth H, 2016, J YOUTH ADOLESCENCE, V45, P1889, DOI 10.1007/s10964-016-0520-4; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Fairchild G, 2008, BIOL PSYCHIAT, V64, P599, DOI 10.1016/j.biopsych.2008.05.022; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Ferreira R, 2016, HORM BEHAV, V84, P84, DOI 10.1016/j.yhbeh.2016.05.017; FESTING MFW, 1976, NATURE, V263, P230, DOI 10.1038/263230a0; Festing MFW, 2016, METHODS MOL BIOL, V1438, P1, DOI 10.1007/978-1-4939-3661-8_1; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Frick P J, 1999, Clin Child Fam Psychol Rev, V2, P149; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; Gioiosa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004143; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Hagewoud R, 2011, J SLEEP RES, V20, P259, DOI 10.1111/j.1365-2869.2010.00895.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Keum S, 2016, GENES BRAIN BEHAV, V15, P231, DOI 10.1111/gbb.12278; Kirsch P, 2015, DIALOGUES CLIN NEURO, V17, P463; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lipps T, 1903, ARCH GESAMTE PSYCHOL, V1, P185; Loney BR, 2003, J CLIN CHILD ADOLESC, V32, P66, DOI 10.1207/15374420360533077; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Lutz PE, 2013, CURR OPIN NEUROBIOL, V23, P473, DOI 10.1016/j.conb.2013.02.005; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Macri S, 2017, NEUROSCIENCE BIOBEHA; Macri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13257; Malki K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1431-6; Marco EM, 2012, J PSYCHOPHARMACOL, V26, P150, DOI 10.1177/0269881111408459; Maroun M, 2016, BIOL PSYCHIAT, V79, P203, DOI 10.1016/j.biopsych.2015.07.016; Martin LJ, 2015, CURR BIOL, V25, P326, DOI 10.1016/j.cub.2014.11.028; McDonald N.M., 2011, FREE WILL EMOTIONS M; Meyza KZ, 2017, NEUROSCI BIOBEHAV R, V76, P216, DOI 10.1016/j.neubiorev.2016.10.028; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Moffitt T E, 1994, Prog Exp Pers Psychopathol Res, P233; Mogil JS, 2015, PAIN, V156, pS35, DOI 10.1097/01.j.pain.0000460341.62094.77; Mogil JS, 2012, TRENDS COGN SCI, V16, P143, DOI 10.1016/j.tics.2011.12.012; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Morley-Fletcher S, 2003, PSYCHONEUROENDOCRINO, V28, P386, DOI 10.1016/S0306-4530(02)00030-6; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z; OFFORD DR, 1994, J AM ACAD CHILD PSY, V33, P1069, DOI 10.1097/00004583-199410000-00001; Oosterlaan J, 2005, PSYCHIAT RES, V134, P1, DOI 10.1016/j.psychres.2004.12.005; Palanza P, 2001, PHYSIOL BEHAV, V72, P255, DOI 10.1016/S0031-9384(00)00406-6; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Panksepp J, 2009, BIOL PSYCHIAT, V65, P725, DOI 10.1016/j.biopsych.2009.02.004; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; PIAZZA PV, 1993, P NATL ACAD SCI USA, V90, P11738, DOI 10.1073/pnas.90.24.11738; PIERETTI S, 1991, GEN PHARMACOL, V22, P929, DOI 10.1016/0306-3623(91)90232-U; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Resendez SL, 2013, REV NEUROSCIENCE, V24, P51, DOI 10.1515/revneuro-2012-0068; Rosas-Vidal LE, 2014, NEUROPSYCHOPHARMACOL, V39, P2161, DOI 10.1038/npp.2014.64; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; Scattoni ML, 2013, BEHAV BRAIN RES, V251, P35, DOI 10.1016/j.bbr.2012.12.028; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sivaselvachandran S, 2018, NEUROSCI BIOBEHAV R, V91, P130, DOI 10.1016/j.neubiorev.2016.06.007; Smith A, 2006, PSYCHOL REC, V56, P3, DOI 10.1007/BF03395534; Smith ML, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600855; Sprenger T, 2006, PAIN, V122, P63, DOI 10.1016/j.pain.2006.01.003; Stadler C, 2011, PSYCHIAT RES, V187, P204, DOI 10.1016/j.psychres.2010.05.004; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Terranova ML, 2001, PHYSIOL BEHAV, V73, P393, DOI 10.1016/S0031-9384(01)00447-4; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Valverde O, 2012, NEUROSCIENCE, V204, P193, DOI 10.1016/j.neuroscience.2011.09.031; van Goozen SHM, 2000, J AM ACAD CHILD PSY, V39, P1438, DOI 10.1097/00004583-200011000-00019; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; VANYUKOV MM, 1993, PSYCHIAT RES, V46, P9, DOI 10.1016/0165-1781(93)90003-Y; Velez L, 2010, BEHAV GENET, V40, P201, DOI 10.1007/s10519-009-9325-5; von Polier GG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/349530; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Watanabe S., 2011, PLOS ONE, V6, DOI 10.1371/journal,pone.0023357; Watt D., 2000, CONSCIOUSNESS EMOTIO, V1, P91, DOI DOI 10.1075/CE.1.1.06WAT; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; Zoratto F, 2011, PROG NEURO-PSYCHOPH, V35, P1479, DOI 10.1016/j.pnpbp.2011.02.016	115	29	29	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188907	10.1371/journal.pone.0188907	http://dx.doi.org/10.1371/journal.pone.0188907			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200428	Green Published, Green Submitted, gold			2022-12-26	WOS:000417033200022
J	Lozano-Velasco, E; Wangensteen, R; Quesada, A; Garcia-Padilla, C; Osorio, JA; Ruiz-Torres, MD; Aranega, A; Franco, D				Lozano-Velasco, Estefania; Wangensteen, Rosemary; Quesada, Andres; Garcia-Padilla, Carlos; Osorio, Julia A.; Dolores Ruiz-Torres, Maria; Aranega, Amelia; Franco, Diego			Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling	PLOS ONE			English	Article							FAMILIAL ATRIAL-FIBRILLATION; OF-FUNCTION MUTATION; THYROID-HORMONE; REDOX REGULATION; ARTERIAL-HYPERTENSION; ACUTE EXPOSURE; RISK; MECHANISMS; HEART; GENE	PITX2 is a homeobox transcription factor involved in embryonic left/right signaling and more recently has been associated to cardiac arrhythmias. Genome wide association studies have pinpointed PITX2 as a major player underlying atrial fibrillation (AF). We have previously described that PITX2 expression is impaired in AF patients. Furthermore, distinct studies demonstrate that Pitx2 insufficiency leads to complex gene regulatory network remodeling, i.e. Wnt>microRNAs, leading to ion channel impairment and thus to arrhythmogenic events in mice. Whereas large body of evidences has been provided in recent years on PITX2 downstream signaling pathways, scarce information is available on upstream pathways influencing PITX2 in the context of AF. Multiple risk factors are associated to the onset of AF, such as e.g. hypertension (HTN), hyperthyroidism (HTD) and redox homeostasis impairment. In this study we have analyzed whether HTN, HTD and/or redox homeostasis impact on PITX2 and its downstream signaling pathways. Using rat models for spontaneous HTN (SHR) and experimentally-induced HTD we have observed that both cardiovascular risk factors lead to severe Pitx2 downregulation. Interesting HTD, but not SHR, leads to upregulation of Wnt signaling as well as deregulation of multiple microRNAs and ion channels as previously described in Pitx2 insufficiency models. In addition, redox signaling is impaired in HTD but not SHR, in line with similar findings in atrial-specific Pitx2 deficient mice. In vitro cell culture analyses using gain- and loss-of-function strategies demonstrate that Pitx2, Zfhx3 and Wnt signaling influence redox homeostasis in cardiomyocytes. Thus, redox homeostasis seems to play a pivotal role in this setting, providing a regulatory feedback loop. Overall these data demonstrate that HTD, but not HTN, can impair Pitx2>>Wnt pathway providing thus a molecular link to AF.	[Lozano-Velasco, Estefania; Garcia-Padilla, Carlos; Osorio, Julia A.; Dolores Ruiz-Torres, Maria; Aranega, Amelia; Franco, Diego] Univ Jaen, Dept Expt Biol, Cardiac & Skeletal Muscle Dev Grp, Jaen, Spain; [Wangensteen, Rosemary; Quesada, Andres] Univ Jaen, Dept Hlth Sci, Jaen, Spain	Universidad de Jaen; Universidad de Jaen	Franco, D (corresponding author), Univ Jaen, Dept Expt Biol, Cardiac & Skeletal Muscle Dev Grp, Jaen, Spain.	dfranco@ujaen.es	Velasco, Estefanía Lozano/B-2209-2017; Aranega, Amelia/AAA-8908-2019	Velasco, Estefanía Lozano/0000-0002-5615-2754; Aranega, Amelia/0000-0002-0046-9410; Garcia-Padilla, Carlos/0000-0003-2061-3157; Franco, Diego/0000-0002-5669-7164	Ministerio de Economia y Competitividad, Gobierno de Espana [BFU2012-38111, BFU2015-67131]; Junta de Andalucia Regional Council [CTS -1614]; Carlos III Health Institute of Spain "Feder una manera de hacer Europa" [P13/02384]	Ministerio de Economia y Competitividad, Gobierno de Espana; Junta de Andalucia Regional Council(Junta de Andalucia); Carlos III Health Institute of Spain "Feder una manera de hacer Europa"	This study was partially supported by grants BFU2012-38111, BFU2015-67131 (Ministerio de Economia y Competitividad, Gobierno de Espana), and CTS -1614 (Junta de Andalucia Regional Council) to DF and AA. This study was supported by the grant P13/02384 from Carlos III Health Institute of Spain "Feder una manera de hacer Europa" to RW. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234; Aguirre LA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0138-0; Anderson EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000713; Anumonwo JMB, 2014, CARDIOL CLIN, V32, P485, DOI 10.1016/j.ccl.2014.07.007; ARAI M, 1991, CIRC RES, V69, P266, DOI 10.1161/01.RES.69.2.266; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen WJ, 2011, BASIC RES CARDIOL, V106, P163, DOI 10.1007/s00395-010-0149-5; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Daimi H, 2015, HEART RHYTHM, V12, P1333, DOI 10.1016/j.hrthm.2015.02.018; de Lange FJ, 2003, GENESIS, V37, P1, DOI 10.1002/gene.10220; DUDLEY SC, 1993, CIRC RES, V73, P301, DOI 10.1161/01.RES.73.2.301; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Emdin CA, 2015, EUROPACE, V17, P701, DOI 10.1093/europace/euv021; Franco D, 2011, CARDIOVASC RES, V91, P223, DOI 10.1093/cvr/cvr078; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Goudis CA, 2015, J CARDIOL; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hakim FA, 2014, FUTUR CARDIOL, V10, P745, DOI [10.2217/FCA.14.32, 10.2217/fca.14.32]; Jalife J, 2015, TRENDS CARDIOVAS MED, V25, P475, DOI 10.1016/j.tcm.2014.12.015; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jiang M, 2000, AM J PHYSIOL-HEART C, V278, pH1429, DOI 10.1152/ajpheart.2000.278.5.H1429; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kohler AC, 2014, J MOL CELL CARDIOL, V73, P92, DOI 10.1016/j.yjmcc.2014.03.001; Kreuzberg U, 2000, AM J PHYSIOL-HEART C, V278, pH723, DOI 10.1152/ajpheart.2000.278.3.H723; Kumar Kartik R, 2015, Card Electrophysiol Clin, V7, P173, DOI 10.1016/j.ccep.2015.03.002; L'honore A, 2014, DEV CELL, V29, P392, DOI 10.1016/j.devcel.2014.04.006; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Li YD, 2015, MOL MED REP, V12, P3243, DOI 10.3892/mmr.2015.3831; Liao CX, 2016, MOL BIOSYST, V12, P328, DOI 10.1039/c5mb00806a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Velasco E, 2016, CARDIOVASC RES, V109, P55, DOI 10.1093/cvr/cvv207; Lozano-Velasco E, 2011, CELLS TISSUES ORGANS, V194, P349, DOI 10.1159/000323533; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; MAGER S, 1992, PFLUG ARCH EUR J PHY, V421, P425, DOI 10.1007/BF00370252; Martinez-Gonzalez MA, 2014, CIRCULATION, V130, P18, DOI 10.1161/CIRCULATIONAHA.113.006921; Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061; Okamoto K., 1963, JAP CIRC J, V27, P282; Philippen LE, 2015, J MOL CELL CARDIOL, V89, P51, DOI 10.1016/j.yjmcc.2015.03.014; Reilly SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac4296; Rodriguez-Gomez I, 2013, J ENDOCRINOL, V216, P43, DOI 10.1530/JOE-12-0208; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Scridon A, 2015, EUROPACE, V17, P160, DOI 10.1093/europace/euu139; Shan HL, 2013, INT J CARDIOL, V167, P2798, DOI 10.1016/j.ijcard.2012.07.009; Shimoni Y, 1997, J PHYSIOL-LONDON, V500, P65, DOI 10.1113/jphysiol.1997.sp021999; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tao Y, 2014, CIRC-CARDIOVASC GENE, V7, P23, DOI 10.1161/CIRCGENETICS.113.000259; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Violi F, 2014, EUROPACE, V16, P1107, DOI 10.1093/europace/euu040; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang J, 2014, P NATL ACAD SCI USA, V111, P9181, DOI 10.1073/pnas.1405411111; Wang YG, 2003, J PHYSIOL-LONDON, V546, P491, DOI 10.1113/jphysiol.2002.032847; Wolke C, 2015, BBA-GEN SUBJECTS, V1850, P1555, DOI 10.1016/j.bbagen.2014.12.012; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Yadava M, 2014, CARDIOL CLIN, V32, P627, DOI 10.1016/j.ccl.2014.07.002; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zhang QT, 2014, CARDIOVASC THER, V32, P233, DOI 10.1111/1755-5922.12089; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	66	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188473	10.1371/journal.pone.0188473	http://dx.doi.org/10.1371/journal.pone.0188473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194452	gold, Green Submitted, Green Published			2022-12-26	WOS:000416867800011
J	Carnesecchi, J; Cerutti, C; Vanacker, JM; Forcet, C				Carnesecchi, Julie; Cerutti, Catherine; Vanacker, Jean-Marc; Forcet, Christelle			ERR alpha protein is stabilized by LSD1 in a demethylation-independent manner	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; CANCER-CELL-MIGRATION; BREAST-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; IN-VIVO; TARGET; PROLIFERATION; METHYLATION; BIOMARKERS	The LSD1 histone demethylase is highly expressed in breast tumors where it constitutes a factor of poor prognosis and promotes traits of cancer aggressiveness such as cell invasiveness. Recent work has shown that the Estrogen-Related Receptor a (ERR alpha) induces LSD1 to demethylate the Lys 9 of histone H3. This results in the transcriptional activation of a number of common target genes, several of which being involved in cellular invasion. High expression of ERR alpha protein is also a factor of poor prognosis in breast tumors. Here we show that, independently of its demethylase activities, LSD1 protects ERR alpha from ubiquitination, resulting in overexpression of the latter protein. Our data also suggests that the elevation of LSD1 mRNA and protein in breast cancer (as compared to normal tissue) may be a key event to increase ERRa protein, independently of its corresponding mRNA.	[Carnesecchi, Julie; Cerutti, Catherine; Vanacker, Jean-Marc; Forcet, Christelle] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS UMR5242, Ecole Normale Super Lyon, Lyon, France; [Carnesecchi, Julie] Heidelberg Univ, COS Heidelberg, Dept Dev Biol, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Ruprecht Karls University Heidelberg	Forcet, C (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS UMR5242, Ecole Normale Super Lyon, Lyon, France.	christelle.forcet@ens-lyon.fr		Cerutti, Catherine/0000-0002-7396-9387; Carnesecchi, Julie/0000-0002-3872-2215	Ligue contre le Cancer (comite Rhone)	Ligue contre le Cancer (comite Rhone)	This work was funded by Ligue contre le Cancer (comite Rhone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Cai Q, 2013, ONCOGENE, V32, P2079, DOI 10.1038/onc.2012.221; Carnesecchi J, 2017, P NATL ACAD SCI US; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Deblois G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12156; Derr RS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-604; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Fujimoto J, 2009, J STEROID BIOCHEM, V116, P71, DOI 10.1016/j.jsbmb.2009.04.012; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Han L, 2016, TUMOR BIOL, V37, P13205, DOI 10.1007/s13277-016-5200-1; Hino S, 2016, CANCER SCI, V107, P1187, DOI 10.1111/cas.13004; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kallen J, 2007, J BIOL CHEM, V282, P23231, DOI 10.1074/jbc.M703337200; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kroiss A, 2015, ONCOGENE, V34, P2846, DOI 10.1038/onc.2014.222; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Maiques-Diaz A, 2016, EPIGENOMICS-UK, V8, P1103, DOI 10.2217/epi-2016-0009; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagasawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118002; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Sailland J, 2014, P NATL ACAD SCI USA, V111, P15108, DOI 10.1073/pnas.1402094111; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tam IS, 2016, J STEROID BIOCHEM, V157, P13, DOI 10.1016/j.jsbmb.2015.06.009; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tiwari A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17621; Tribollet V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156445; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	44	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188871	10.1371/journal.pone.0188871	http://dx.doi.org/10.1371/journal.pone.0188871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190800	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900151
J	Chatterjee, PK; Yeboah, MM; Solanki, MH; Kumar, G; Xue, XY; Pavlov, VA; Al-Abed, Y; Metz, CN				Chatterjee, Prodyot K.; Yeboah, Michael M.; Solanki, Malvika H.; Kumar, Gopal; Xue, Xiangying; Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.			Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; VAGUS NERVE-STIMULATION; INHIBITS CYTOKINE PRODUCTION; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; IN-VITRO; ACETYLCHOLINE; RECEPTORS; APOPTOSIS; NEPHROTOXICITY	Acute kidney injury (AKI) is the most common side effect of cisplatin, a widely used chemotherapy drug. Although AKI occurs in up to one third of cancer patients receiving cisplatin, effective renal protective strategies are lacking. Cisplatin targets renal proximal tubular epithelial cells leading to inflammation, reactive oxygen species, tubular cell injury, and eventually cell death. The cholinergic anti-inflammatory pathway is a vagus nerve-mediated reflex that suppresses inflammation via alpha 7 nicotinic acetylcholine receptors (alpha 7nAChRs). Our previous studies demonstrated the renoprotective and anti-inflammatory effects of cholinergic agonists, including GTS-21. Therefore, we examined the effect of GTS-21 on cisplatin-induced AKI. Male C57BL/6 mice received either saline or GTS-21 (4mg/kg, i.p.) twice daily for 4 days before cisplatin and treatment continued through euthanasia; 3 days post-cisplatin mice were euthanized and analyzed for markers of renal injury. GTS-21 significantly reduced cisplatin-induced renal dysfunction and injury (p< 0.05). GTS-21 significantly attenuated renal Ptgs2/COX-2 mRNA and IL-6, IL-1 beta, and CXCL1 protein expression, as well as neutrophil infiltration after cisplatin. GTS-21 blunted cisplatin-induced renal ERK1/2 activation, as well as renal ATP depletion and apoptosis (p< 0.05). GTS-21 suppressed the expression of CTR1, a cisplatin influx transporter and enhanced the expression of cisplatin efflux transporters MRP2, MRP4, and MRP6 (p< 0.05). Using breast, colon, and lung cancer cell lines we showed that GTS-21 did not inhibit cisplatin's tumor cell killing activity. GTS-21 protects against cisplatin-AKI by attenuating renal inflammation, ATP depletion and apoptosis, as well as by decreasing renal cisplatin influx and increasing efflux, without impairing cisplatin-mediated tumor cell killing. Our results support further exploring the cholinergic anti-inflammatory pathway for preventing cisplatin-induced AKI.	[Chatterjee, Prodyot K.; Xue, Xiangying; Pavlov, Valentin A.; Metz, Christine N.] Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA; [Yeboah, Michael M.] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA; [Solanki, Malvika H.; Kumar, Gopal; Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.] Northwell Hlth, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Solanki, Malvika H.] Med Coll Wisconsin, Dept Pathol & Lab Med, Milwaukee, WI 53226 USA; [Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA; [Al-Abed, Yousef] Northwell Hlth, Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY USA	Northwell Health; Medical College of Wisconsin; Northwell Health; Medical College of Wisconsin; Northwell Health	Metz, CN (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA.; Metz, CN (corresponding author), Northwell Hlth, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA.; Metz, CN (corresponding author), Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA.	cmetz@northwell.edu		Pavlov, Valentin/0000-0002-1994-2853; Christine, Metz/0000-0002-1013-1691	Feinstein Institute for Medical Research; Elmezzi Graduate School of Molecular Medicine at Northwell Health	Feinstein Institute for Medical Research; Elmezzi Graduate School of Molecular Medicine at Northwell Health	This work was supported, in part, by the Feinstein Institute for Medical Research to CNM and the Elmezzi Graduate School of Molecular Medicine at Northwell Health. In addition, Mr. Chander Iyer sponsored the Advancing Women in Science and Medicine (AWSM) Scientific Achievement Award (to CNM). Role of sponsors/funders had no role in study design, data colection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Al-Sharea A, 2017, ATHEROSCLEROSIS, V265, P47, DOI 10.1016/j.atherosclerosis.2017.08.010; Aleksunes LM, 2008, TOXICOLOGY, V250, P82, DOI 10.1016/j.tox.2008.06.009; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Chatterjee PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035361; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Chavan SS, 2017, J IMMUNOL, V198, P3389, DOI 10.4049/jimmunol.1601613; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Criado M, 2016, FUTURE MED CHEM, V8, P731, DOI 10.4155/fmc-2015-0001; Cui N, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/912726; Dowling O, 2007, MOL MED, V13, P576, DOI 10.2119/2007-00067.Dowling; Eguchi Y, 1997, CANCER RES, V57, P1835; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Fernandez-Rojas B, 2015, MOL CELL BIOCHEM, V406, P183, DOI 10.1007/s11010-015-2436-9; Gergalova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031361; Gigliotti JC, 2013, J AM SOC NEPHROL, V24, P1451, DOI 10.1681/ASN.2013010084; Guzman-Mejia F, 2017, J NEUROIMMUNE PHARM; Han KQ, 2015, INT J ONCOL, V47, P2131, DOI 10.3892/ijo.2015.3203; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Hanada K, 2000, J PHARM PHARMACOL, V52, P1345, DOI 10.1211/0022357001777496; Hanna NH, 2014, NEW ENGL J MED, V371, P2005, DOI 10.1056/NEJMra1407550; Honma S, 2013, EUR J PHARMACOL, V715, P181, DOI 10.1016/j.ejphar.2013.05.023; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102342; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; JOHNSSON A, 1995, CANCER CHEMOTH PHARM, V37, P23; JUNG KY, 1989, TOXICOL APPL PHARM, V100, P369, DOI 10.1016/0041-008X(89)90285-8; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Lai NY, 2017, J INTERN MED; Li DJ, 2014, CELL PHYSIOL BIOCHEM, V33, P468, DOI 10.1159/000358627; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu Y, 2015, CELL PHYSIOL BIOCHEM, V35, P627, DOI 10.1159/000369724; Loram LC, 2012, J PAIN, V13, P1162, DOI 10.1016/j.jpain.2012.08.009; Lu B, 2014, MOL MED, V20, P350, DOI 10.2119/molmed.2013.00117; Lykhmus O, 2014, INT J BIOCHEM CELL B, V53, P246, DOI 10.1016/j.biocel.2014.05.030; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; MILLARD RE, 1979, J CLIN PATHOL, V32, P1045, DOI 10.1136/jcp.32.10.1045; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2009, AM J PHYSIOL-RENAL, V296, pF505, DOI 10.1152/ajprenal.90545.2008; Parada E, 2010, FREE RADICAL BIO MED, V49, P1815, DOI 10.1016/j.freeradbiomed.2010.09.017; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Shord SS, 2006, ANTI-CANCER DRUG, V17, P207, DOI 10.1097/00001813-200602000-00013; Sodani K, 2012, CHIN J CANCER, V31, P58, DOI 10.5732/cjc.011.10329; Solanki MH, 2014, AM J PHYSIOL-RENAL, V307, pF369, DOI 10.1152/ajprenal.00127.2014; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; Touchette DR, 2006, J AGING PHARMACOTHER, V13, P109, DOI DOI 10.3109/J397V13N02_; Tracey KJ, 2016, CELL, V164, P343, DOI 10.1016/j.cell.2016.01.018; TRESKES M, 1993, CANCER CHEMOTH PHARM, V33, P93, DOI 10.1007/BF00685326; TRESKES M, 1992, ANTICANCER RES, V12, P2261; Truong LD, 2015, FASEB J, V29, P3558, DOI 10.1096/fj.14-262493; Vukelic M, 2013, J IMMUNOL, V191, P1800, DOI 10.4049/jimmunol.1203467; Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10; Yamamato E, 2012, EXP TOXICOL PATHOL, V64, P625, DOI 10.1016/j.etp.2010.12.005; Yang M, 2015, EXP BIOL MED, V240, P1717, DOI 10.1177/1535370215589906; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yeboah MM, 2008, AM J PHYSIOL-RENAL, V295, pF654, DOI 10.1152/ajprenal.90255.2008; Yu XW, 2017, AM J TRANSL RES, V9, P1222; Zhou Z, 2015, MOL MED REP, V12, P6925, DOI 10.3892/mmr.2015.4318	75	16	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188797	10.1371/journal.pone.0188797	http://dx.doi.org/10.1371/journal.pone.0188797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190774	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900126
J	Perez-Gonzalez, A; Ceccarelli, FS; Monte, BGO; Proud, DN; DaSilva, MB; Bichuette, ME				Perez-Gonzalez, Abel; Sara Ceccarelli, F.; Monte, Bruno G. O.; Proud, Daniel N.; DaSilva, Marcio Bernardino; Bichuette, Maria E.			Light from dark: A relictual troglobite reveals a broader ancestral distribution for kimulid harvestmen (Opiliones: Laniatores: Kimulidae) in South America	PLOS ONE			English	Article							ATLANTIC FOREST; ARACHNIDA; DIVERSITY; EVOLUTIONARY; BIOGEOGRAPHY; PHYLOGENY; BRAZIL; PERSPECTIVE; MORPHOLOGY; SELECTION	A new troglobitic harvestman, Relictopiolus galadriel gen. nov et sp. nov., is described from Olhos d'Agua cave, Itacarambi, Minas Gerais State, Brazil. Morphological characters, including male genitalia and exomorphology, suggest that this species belongs to the family Kimulidae, and it appears to share the greatest similarities with Tegipiolus pachypus. Bayesian inference analyses of a molecular dataset strongly support the inclusion of this species in Kimulidae and confirm the hypothesized sister-group relationship between R. galadriel and T. pachypus. A time calibrated phylogeny indicates that these sister-taxa diverged from a common ancestor approximately 40 Mya, during the Paleogene. The current range of Kimulidae illustrates a remarkable disjunct distribution, and leads us to hypothesize that the ancestral distribution of Kimulidae was once much more widespread across eastern Brazil. This may be attributed to the Eocene radiation associated with the warming (and humidifying) events in the Cenozoic when the best conditions for evergreen tropical vegetation in South America were established and followed by the extinction of kimulid epigean populations together with the retraction of rain forests during the Oligocene to Miocene cooling. The discovery of this relictual troglobite indicates that the Olhos d'Agua cave was a stable refugium for this ancient lineage of kimulids and acted as a "museum" of biodiversity. Our findings, considered collectively with the diverse troglofauna of the Olhos d'Agua cave, highlight it as one of the most important hotspots of troglobite diversity and endemism in the Neotropics. Given the ecological stresses on this habitat, the cavernicolous fauna are at risk of extinction and we emphasize the urgent need for appropriate conservation actions. Finally, we propose the transfer of Acanthominua, Euminua, Euminuoides and Pseudominua from Kimulidae to Zalmoxidae, resulting in two new synonymies and 13 new combinations.	[Perez-Gonzalez, Abel; Sara Ceccarelli, F.; Proud, Daniel N.] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Buenos Aires, DF, Argentina; [Monte, Bruno G. O.] Univ Fed Sao Carlos, Programa Posgrad Ecol & Recursos Nat, Rodovia Washington Luis, Sao Carlos, SP, Brazil; [Monte, Bruno G. O.; Bichuette, Maria E.] Univ Fed Sao Carlos, Dept Ecol & Biol Evolut, Rodovia Washington Luis, Sao Carlos, SP, Brazil; [DaSilva, Marcio Bernardino] Univ Fed Paraiba, Dept Sistemat & Ecol, Joao Pessoa, Paraiba, Brazil; [Sara Ceccarelli, F.] CONACYT Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Carretera Ensenada Tijuana, Ensenada Bc, Mexico; [Proud, Daniel N.] Moravian Coll, Environm Studies & Sci Program, Bethlehem, PA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal da Paraiba	Perez-Gonzalez, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Buenos Aires, DF, Argentina.	abelaracno@gmail.com	Pérez-González, Abel/R-4999-2019; Ceccarelli, F. Sara/L-3208-2019; Bichuette, Maria Elina/C-5262-2013; DaSilva, Marcio B/I-4038-2012	Pérez-González, Abel/0000-0002-4245-3302; Bichuette, Maria Elina/0000-0002-9515-4832; DaSilva, Marcio B/0000-0002-2824-1071; Proud, Daniel/0000-0003-1842-6395	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of Argentina [PICT 2011-1007-PI Martin Ramirez, PICT 2015-0283-PI Martin Ramirez, PICT 2015-2202-PI Abel Perez Gonzalez]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina [PIP 11220150100672CO-PI Andres Ojanguren-Affilastro, PUE 2017-2021-PI Martin Ramirez, 4817/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [PQ 303715/2011-1]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the grants PICT 2011-1007-PI Martin Ramirez (APG); PICT 2015-0283-PI Martin Ramirez (APG) and PICT 2015-2202-PI Abel Perez Gonzalez (APG) from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of Argentina and the grants PIP 11220150100672CO-PI Andres Ojanguren-Affilastro (APG) and PUE 2017-2021-PI Martin Ramirez (APG) from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. This work was also partially supported by postdoctoral scholarship grants (resolution 4817/2013) from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina (FSC and DNP) and the scholarship PQ 303715/2011-1 from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (M.E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbSaber AN, DOMINIOS MORFOCLIMAT; ACOSTA L., 2007, HARVESTMEN BIOL OPIL, P494; Amorim DS, 1996, NEOTROPICAL BIOGEOGR, P183; Boyer SL, 2016, J BIOGEOGR, V43, P1400, DOI 10.1111/jbi.12717; Caporiacco L. di, 1951, ACTA BIOL VENEZ, V1, P1; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Castro-Fernandes MC, 2013, GEOL USP SER CIENT, V13, P3; Cokendolpher J.C., 1992, Bulletin of the British Arachnological Society, V9, P53; Cokendolpher JC, 1998, J ARACHNOL, V26, P9; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cruz-Lopez JA, 2016, ZOOL J LINN SOC-LOND, V177, P602, DOI 10.1111/zoj.12382; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; CULVER D. C., 2016, Z GEOMORPHOL, V60, P103, DOI [10.1127/zfg_suppl/2016/00306, DOI 10.1127/ZFG_SUPPL/2016/00306]; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; DaSilva MB, 2017, CURR ZOOL, V63, P525, DOI 10.1093/cz/zow092; DaSilva MB, 2015, CLADISTICS, V31, P692, DOI 10.1111/cla.12121; DaSilva MB, ZOOTAXA, V2508, P45; Saraiva NED, 2016, ZOOTAXA, V4205, P532, DOI 10.11646/zootaxa.4205.6.2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fernandez R, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2340; Garcia M.J., 2007, PALEONTOLOGIA CENARI, P689; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Giribet G, 2010, CLADISTICS, V26, P408, DOI 10.1111/j.1096-0031.2009.00296.x; Gnaspini P, 2011, J ZOOL SYST EVOL RES, V49, P273, DOI 10.1111/j.1439-0469.2011.00626.x; Gonzalez-Sponga M.A., 1987, ARACNIDOS VENEZUELA; Hara MR, 2008, ZOOTAXA, P50, DOI 10.11646/zootaxa.1744.1.5; Hyland EG, 2017, GEOL SOC AM BULL, V129, P244, DOI 10.1130/B31493.1; *IBGE, 2004, MAP VEG; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jaramillo C, 2013, ANNU REV EARTH PL SC, V41, P741, DOI 10.1146/annurev-earth-042711-105403; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kury AB, 2007, BOL MUS NAC, P243; Kury Adriano B., 2007, Revista Iberica de Aracnologia, V13, P147; Kury Adriano B., 2003, Revista Iberica de Aracnologia Volumen Especial Monografico, V1, P1; Kury AB, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6482; Kury AB, 2011, ZOOTAXA, P47; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Machado G, 1933, B MUS NAC, V9, P99; Mello-Leitao C. de., 1935, Archivos do Museu Nacional Rio de Janeiro, V36, P87; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; Murienne J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0932; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perez-Gonzalez A., 2007, HARVESTMEN BIOL OPIL, P207; PILO L.B., 1991, CONGRESSO ASSOCIACAO, P57; Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00; POULSON TL, 1969, SCIENCE, V165, P971; Rambla Maria, 1994, P215; Ramos AM, 2009, NORMAIS CLIMATO LOGI; Roewer C.F., 1963, SENCKENBERG BIOL, V44, P5; ROEWER C. FR, 1952, SENCKENBERGIANA, V33, P37; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Selden PA, 2016, CRETACEOUS RES, V65, P206, DOI 10.1016/j.cretres.2016.05.004; Sharma PP, 2017, MOL PHYLOGENET EVOL, V106, P164, DOI 10.1016/j.ympev.2016.09.019; Sharma PP, 2012, ZOOTAXA, P1; Sharma PP, 2012, P ROY SOC B-BIOL SCI, V279, P3501, DOI 10.1098/rspb.2012.0675; Sharma PP, 2011, INVERTEBR SYST, V25, P106, DOI 10.1071/IS11002; SILHAVY V, 1978, ACTA ENTOMOL BOHEMOS, V75, P58; Silva Marconi Souza, 2016, Subterranean Biology, V19, P1, DOI 10.3897/subtbiol.19.8207; Soares H. E. M., 1966, Papeis do Departamento de Zoologia Sao Paulo, V18, P103; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Trajano Eleonora, 2017, Subterranean Biology, V22, P1, DOI 10.3897/subtbiol.22.9759; Trajano E, 2016, BIODIVERS CONSERV, V25, P1805, DOI 10.1007/s10531-016-1151-5; Trajano Eleonora, 2009, Speleobiology Notes, V1, P24; Trajano Eleonora, 2009, Subterranean Biology, V7, P1; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Willemart RH, 2013, REV BIOL, V10, P46, DOI [DOI 10.7594/REVBI0.10.02.08, 10.7594/revbio.10.02.08]; Wolff JO, 2016, ZOOL J LINN SOC-LOND, V177, P558, DOI 10.1111/zoj.12375; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zachos JC, 2002, NATURE, V419, P897, DOI 10.1038/419897b	81	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187919	10.1371/journal.pone.0187919	http://dx.doi.org/10.1371/journal.pone.0187919			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190302	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900023
J	Sahu, PK; Mondal, S; Sharma, D; Vishwakarma, G; Kumar, V; Das, BK				Sahu, Parmeshwar Kumar; Mondal, Suvendu; Sharma, Deepak; Vishwakarma, Gautam; Kumar, Vikash; Das, Bikram Kishore			InDel marker based genetic differentiation and genetic diversity in traditional rice (Oryza sativa L.) landraces of Chhattisgarh, India	PLOS ONE			English	Article							MAP-BASED CLONING; MULTILOCUS GENOTYPE DATA; MICROSATELLITE MARKERS; RESISTANCE GENES; GENOME; CULTIVARS; ARABIDOPSIS; INFERENCE; POTATO; SYSTEM	Rice has been cultivating and utilizing by humans for thousands of years under diverse environmental conditions. Therefore, tremendous genetic differentiation and diversity has occurred at various agro-ecosystems. The significant indica japonica differentiation in rice provides great opportunities for its genetic improvement. In the present investigation, a total of 42 polymorphic InDel markers were used for differentiating 188 rice landraces and two local varieties of Chhattisgarh, India into indica and japonica related genotypes based on `InDel molecular index'. Frequency of japonica alleles varied from 0.11 to 0.89 among landraces. Results revealed that 104 rice landraces have indica type genetic architecture along with three tested indica cultivars Swarna, Mahamaya and Rajeshwari. Another 60 landraces were placed under 'close to indica' type. It was found that three rice landraces i.e. Kalajeera, Kapri, Tulsimala were 'close to japonica' type and 21 landraces were 'intermediate' type. The result from the calculation of `InDel molecular index' was further verified with STRUCTURE, AMOVA, PCA and cluster analysis. Population structure analysis revealed two genetically distinct populations within the 190 rice landraces/genotypes. Based on AMOVA, 'intermediate' type, 'close to japonica' type and Dongjinbyeo (a japonica cultivar from Republic of Korea) displayed significant genetic differentiation phi(PT) = 0.642, P = 0.000) from 'indica' and ` close to indica' groups. The PCA scatter plot and dendrogram demonstrated a clear pattern of two major group differentiations. 'Close to japonica' type and ` intermediate' type landraces/genotypes were grouped with Dongjinbyeo and formed a separate cluster at 30% Jaccard's similarity level from rest of the landraces/genotypes which were ` close to indica' or ` indica' type. Such a significant genetic differentiation among the locally adapted landraces could be exploited for the development of rice varieties introgressing higher yield potential and better plant types of japonica type as per the need of consumers and rice traders.	[Sahu, Parmeshwar Kumar; Sharma, Deepak] Indira Gandhi Krishi Vishwavidyalaya, Dept Genet & Plant Breeding, Raipur, Chhattisgarh, India; [Mondal, Suvendu; Vishwakarma, Gautam; Kumar, Vikash; Das, Bikram Kishore] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India	Indira Gandhi Krishi Vishwavidyalaya (IGKV); Bhabha Atomic Research Center (BARC)	Sharma, D (corresponding author), Indira Gandhi Krishi Vishwavidyalaya, Dept Genet & Plant Breeding, Raipur, Chhattisgarh, India.; Mondal, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.	suvenduhere@yahoo.co.in; deepakigkv@gmail.com	Sahu, Parmeshwar K/GYU-5561-2022; Mondal, Suvendu/E-6354-2011; Sahu, Dr. Parmeshwar K./M-7265-2018	Mondal, Suvendu/0000-0001-7638-140X; Sharma, Deepak/0000-0002-9456-4805; Sahu, Dr. Parmeshwar K./0000-0003-2199-1790	Department of Science and Technology, government of India	Department of Science and Technology, government of India(Department of Science & Technology (India))	PKS got the INSPIRE fellowship for his PhD study from the Department of Science and Technology, government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAR DS, 2003, MONOGRAPH GENUS ORYZ, P283; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Cao X.X., 2007, FRONTIERS BIOL CHINA, V2, P291, DOI [10.1007/s11515-007-0042-2, DOI 10.1007/S11515-007-0042-2]; Cheng K., 1984, ACTA AGRON SIN, V10, P271; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Das S, 2015, DNA RES, V22, P377, DOI 10.1093/dnares/dsv020; Deepak Sharma, 2013, African Journal of Agricultural Research, V8, P5004; Edwards JD, 2004, MOL GENET GENOMICS, V271, P298, DOI 10.1007/s00438-004-0979-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; FAO Rice Market Monitor and Agricultural Organization of the United Nations, 2017, RIC MARK MON, VXX, P1, DOI DOI 10.1016/J.KNEE.2017.11.005; Frankel OH, 1981, CONSERVATION EVOLUTI; Fukuoka S, 2006, GENET RESOUR CROP EV, V53, P753, DOI 10.1007/s10722-004-4635-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Kottapalli KR, 2010, BIOTECHNOL LETT, V32, P989, DOI 10.1007/s10529-010-0249-1; Liu P, 2012, J SYST EVOL, V50, P1, DOI 10.1111/j.1759-6831.2011.00173.x; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Milbourne D, 1997, MOL BREEDING, V3, P127, DOI 10.1023/A:1009633005390; Morishima H, 1984, BIOL RICE, P3; Niihama M, 2015, BREEDING SCI, V65, P357, DOI 10.1270/jsbbs.65.357; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Panigrahi P., 2016, THESIS, P177; Peng S., 2004, P 4 INT CROP SCI C; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2006, MOL BREEDING, V18, P171, DOI 10.1007/s11032-006-9025-2; RICHHARIA R H, 1979, Oryza, V16, P1; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Steele KA, 2008, FIELD CROP RES, V105, P81, DOI 10.1016/j.fcr.2007.08.001; Sun J, 2013, NEW PHYTOL, V197, P290, DOI 10.1111/nph.12012; [王俊 Wang Jun], 2003, [世界科技研究与发展, World Sci-Tech R and D], V25, P35; Wu DH, 2013, EUPHYTICA, V192, P131, DOI 10.1007/s10681-013-0925-z; Xiong ZY, 2010, GENET RESOUR CROP EV, V57, P891, DOI 10.1007/s10722-009-9528-x; Yamaki S, 2013, BREEDING SCI, V63, P246, DOI 10.1270/jsbbs.63.246; Yonemaru JI, 2015, BREEDING SCI, V65, P249, DOI 10.1270/jsbbs.65.249; Zeng YX, 2013, GENET MOL RES, V12, P5226, DOI 10.4238/2013.October.30.7	45	9	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188864	10.1371/journal.pone.0188864	http://dx.doi.org/10.1371/journal.pone.0188864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190790	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900149
J	Serrano-Villar, S; Hernandez-Novoa, B; de Benito, A; del Romero, J; Ocampo, A; Blanco, JR; Masia, M; Sendagorta, E; Sanz, G; Moreno, S; Perez-Molina, JA				Serrano-Villar, Sergio; Hernandez-Novoa, Beatriz; de Benito, Amparo; del Romero, Jorge; Ocampo, Antonio; Ramon Blanco, Jose; Masia, Mar; Sendagorta, Elena; Sanz, Gonzalo; Moreno, Santiago; Perez-Molina, Jose A.			Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM	PLOS ONE			English	Article							CANCER PRECURSORS; MESSENGER-RNA; CYTOLOGY; PERFORMANCE; WOMEN; BIOMARKERS; EXPRESSION; DYSPLASIA	Background Screening of anal cancer in HIV-infected MSM with anal cytology results in high rates of false positive results and elevated burden of high-resolution anoscopies. High-risk HPV upregulates p16 and Ki67 expression in epithelial cells. We assessed the usefulness of P16/Ki-67 immunostaining cytology for the diagnosis of precancerous anal lesions. Methodology Cross-sectional multicenter study. Concomitant anal liquid cytology with p16/Ki-67 immunostaining and HRA with biopsy of acetowhite lugol-negative lesions was performed in HIV-infected MSM. We compared the diagnostic performance of an abnormal anal cytology and p16/Ki-67 immunostaining relative to HRA-guided biopsy by logistic regression and comparison of ROC areas. Results We included 328 HIV-infected MSM. HSIL was histologically diagnosed in 72 subjects (25.1%), and 2 (0.6%) were diagnosed with anal cancer. An abnormal cytology showed a sensitivity of 95.6% and a specificity of 58.8% for the diagnosis of biopsy-proven HSIL. P16/Ki67 positivity was associated with the presence of biopsy-proven HSIL (P trend = 0.004) but with low sensitivity (41.2%) and specificity (71%). The combination of standard cytology with P16/Ki67 immunostaining did not increment the predictive value of standard cytology alone (AUC 0.685 vs. 0.673, respectively, P = 0.688). Conclusion In HIV-infected MSM P16/Ki67 immunostaining does not improve the diagnostic accuracy of anal cytology, which shows a high sensitivity yet poor specificity. Other approaches aimed at improving the diagnostic accuracy of current techniques for the diagnostic of precancerous HSIL are warranted.	[Serrano-Villar, Sergio; Hernandez-Novoa, Beatriz; Moreno, Santiago; Perez-Molina, Jose A.] Univ Alcala, Hosp Unversitario Ramon y Cajal, Fac Med, Dept Infect Dis,IRYCIS, Madrid, Spain; [de Benito, Amparo] Hosp Univ Ramon y Cajal, Dept Histopathol, Madrid, Spain; [del Romero, Jorge] Ctr Sandoval, Madrid, Spain; [Ocampo, Antonio] Hosp Univ Vigo, HIV Unit, Vigo, Spain; [Ramon Blanco, Jose] Hosp San Pedro, Ctr Invest Biomed, Logrono, Spain; [Masia, Mar] Hosp Univ Elche, Infect Dis Unit, Elche, Spain; [Sendagorta, Elena] Hosp Univ La Paz, Dept Dermatol, Madrid, Spain; [Sanz, Gonzalo] Hosp Univ Clin San Carlos, Dept Gen Surg, Madrid, Spain; [Hernandez-Novoa, Beatriz] Viiv Healthcare Med Dept, Madrid, Spain	Universidad de Alcala; Hospital Universitario Ramon y Cajal; Complexo Hospitalario Universitario de Vigo; Hospital Universitario La Paz	Serrano-Villar, S (corresponding author), Univ Alcala, Hosp Unversitario Ramon y Cajal, Fac Med, Dept Infect Dis,IRYCIS, Madrid, Spain.	sergio.serrano@salud.madrid.org	Blanco, Jose-Ramon/L-6768-2018; Serrano-Villar, Sergio/AEU-8833-2022; Masia, Mar/U-7510-2017	Blanco, Jose-Ramon/0000-0002-4268-0150; Serrano-Villar, Sergio/0000-0002-5447-3554; Masia, Mar/0000-0001-9878-2458; Perez-Molina, Jose Antonio/0000-0001-8735-4124; , IIS Galicia Sur/0000-0003-3812-7413	Redes Tematicas de Investigacion en SIDA (ISCIII RETIC) [RD12/0017/0029, RD12/0017/0037]; Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas [EC11-143]; Instituto de Salud Carlos III [PI15/00345]; European Development Regional Fund "A way to achieve Europe" (ERDF); Spanish Ministry of Science and Innovation	Redes Tematicas de Investigacion en SIDA (ISCIII RETIC)(Instituto de Salud Carlos III); Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund "A way to achieve Europe" (ERDF)(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0029 and RD12/0017/0037), EC11-143 "Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas", and by the Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016, project PI15/00345) and co-financed by the European Development Regional Fund "A way to achieve Europe" (ERDF). S.S.V. is supported by the Spanish Ministry of Science and Innovation (Contratos Juan Rodes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CORRELATION HISTOLOG, DOI DOI 10.1016/J.YGYN0.2012.05.004; [Anonymous], 2017, EACS GUIDELINES; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darragh TM, 2001, BETHESDA SYSTEM REPO; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Dupin C, 2015, DIGEST LIVER DIS, V47, P423, DOI 10.1016/j.dld.2015.01.150; Jin F, 2017, AIDS, V31, P1303, DOI [10.1097/qad.0000000000001462, 10.1097/QAD.0000000000001462]; Jin FY, 2016, CANCER CYTOPATHOL, V124, P415, DOI 10.1002/cncy.21702; Ordi J, 2014, CANCER CYTOPATHOL, V122, P227, DOI 10.1002/cncy.21366; Palefsky JM, 1997, J ACQ IMMUN DEF SYND, V14, P415, DOI 10.1097/00042560-199704150-00004; Reuschenbach M, 2010, GYNECOL ONCOL, V119, P98, DOI 10.1016/j.ygyno.2010.06.011; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Tornesello ML, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519619; Uijterwaal MH, 2015, INT J CANCER, V136, P2361, DOI 10.1002/ijc.29290; Wentzensen N, 2012, AIDS, V26, P2185, DOI 10.1097/QAD.0b013e328359f255; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Zucchetto A, 2016, JAIDS-J ACQ IMM DEF, V73, P190, DOI 10.1097/QAI.0000000000001033	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188851	10.1371/journal.pone.0188851	http://dx.doi.org/10.1371/journal.pone.0188851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190817	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900143
J	Lee, J; Rodero, MP; Patel, J; Moi, D; Mazzieri, R; Khosrotehrani, K				Lee, James; Rodero, Mathieu Paul; Patel, Jatin; Moi, Davide; Mazzieri, Roberta; Khosrotehrani, Kiarash			Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization	FASEB JOURNAL			English	Article						chronic wound healing; antibody therapy; inflammation	NECROSIS-FACTOR-ALPHA; OB/OB MICE; SKIN; INFLAMMATION; REPAIR; IL-17	Inflammation is a critical phase in the healing of skin wounds. Excessive inflammation and inflammatory macrophages are known to cause impaired wound closure and outcome. This prompted us to test the role of IL-23 in IL-17 expression and in modulating wound inflammation and macrophage polarization. Full-thickness wounds (4 x 6 mm) were created on the dorsal surface of multiple genetically modified mouse models. Obese diabetic mouse wounds were treated with anti-IL-17A, anti-IL-23, or isotype-matched antibodies. We found IL-23- but not IL-12-deficient mice displayed significantly reduced IL-17 expression in wounds. This was rescued by delivery of recombinant IL-23. IL-23- and IL-17-deficient mice showed a significant increase in noninflammatory macrophages. Obese diabetic mice treated with anti-IL-17A and anti-IL-23p19 blocking antibodies had significantly improved wound reepithelialization. Similarly, IL-17(-/-) obese mice had accelerated wound closure, resulting in reduced iNOS expression and inflammatory macrophages while maintaining prohealing CD206 and lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE1)-expressing macrophages. This study highlights the importance of the IL-17 pathway in wound closure offering new possibilities of therapeutic intervention in chronic wounds.	[Lee, James; Rodero, Mathieu Paul; Patel, Jatin; Khosrotehrani, Kiarash] Univ Queensland, Ctr Clin Res, Woolloongabba, Qld, Australia; [Moi, Davide; Mazzieri, Roberta; Khosrotehrani, Kiarash] Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland	Khosrotehrani, K (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Woolloongabba, Qld, Australia.	k.khosrotehrani@uq.edu.au	Khosrotehrani, Kiarash/M-8025-2015; rodero, mathieu/C-8083-2011; Patel, Jatin/P-2668-2016; Mazzieri, Roberta/C-9773-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; rodero, mathieu/0000-0002-1300-0187; Patel, Jatin/0000-0002-3511-0029; Patel, Jatin/0000-0002-6731-0009; Mazzieri, Roberta/0000-0002-5172-0927; Moi, Davide/0000-0002-1198-5146	National Health and Medical Research Council; Australian Research Council [1048385]; Diabetes Australia [Y14G-KHOK]; National Health and Medical Research Council fellowship; Australian postgraduate award scholarship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Diabetes Australia; National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award scholarship	The authors thank the Herston Medical Research Centre (The University of Queensland) for the animal facilities and carers. This work was funded by the National Health and Medical Research Council and the Australian Research Council Project Grant 1048385 and Diabetes Australia Grant Y14G-KHOK. K.K. was supported by a National Health and Medical Research Council fellowship. J.L. was supported by an Australian postgraduate award scholarship. The authors declare no conflict of interest.	Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Keijsers RRMC, 2014, J INVEST DERMATOL, V134, P1276, DOI 10.1038/jid.2013.526; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Rodero MP, 2013, J INVEST DERMATOL, V133, P783, DOI 10.1038/jid.2012.368; Rodero MP, 2013, EXP DERMATOL, V22, P143, DOI 10.1111/exd.12068; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Takagi N, 2017, EXP DERMATOL, V26, P137, DOI 10.1111/exd.13115; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048	23	29	34	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2086	2094		10.1096/fj.201700773R	http://dx.doi.org/10.1096/fj.201700773R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208701	Green Submitted			2022-12-26	WOS:000429051400029
J	Paasch, F; den Brave, F; Psakhye, I; Pfander, B; Jentsch, S				Paasch, Florian; den Brave, Fabian; Psakhye, Ivan; Pfander, Boris; Jentsch, Stefan			Failed mitochondrial import and impaired proteostasis trigger SUMOylation of mitochondrial proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (HSP70); mitochondria; proteasome; proteostasis; small ubiquitin-like modifier (SUMO); mitochondrial proteins; protein quality control; SUMOylation	UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; QUALITY-CONTROL; SUMO MODIFICATION; STRESS-RESPONSE; ALCOHOL-DEHYDROGENASE; MISFOLDED PROTEINS; PRECURSOR PROTEIN	Modification by the ubiquitin-like protein SUMO affects hundreds of cellular substrate proteins and regulates a wide variety of physiological processes. While the SUMO system appears to predominantly target nuclear proteins and, to a lesser extent, cytosolic proteins, hardly anything is known about the SUMOylation of proteins targeted to membrane-enclosed organelles. Here, we identify a large set of structurally and functionally unrelated mitochondrial proteins as substrates of the SUMO pathway in yeast. We show that SUMO modification of mitochondrial proteins does not rely on mitochondrial targeting and, in fact, is strongly enhanced upon import failure, consistent with the modification occurring in the cytosol. Moreover, SUMOylated forms of mitochondrial proteins particularly accumulate in HSP70- and proteasome-deficient cells, suggesting that SUMOylation participates in cellular protein quality control. We therefore propose that SUMO serves as a mark for nonfunctional mitochondrial proteins, which only sporadically arise in unstressed cells but strongly accumulate upon defective mitochondrial import and impaired proteostasis. Overall, our findings provide support for a role of SUMO in the cytosolic response to aberrant proteins.	[Paasch, Florian; den Brave, Fabian; Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany; [Pfander, Boris] Max Planck Inst Biochem, Res Grp DNA Replicat & Genome Integr, Klopferspitz 18, D-82152 Martinsried, Germany; [Psakhye, Ivan] FIRC Inst Mol Oncol, IFOM, Via Adamello 16, I-20139 Milan, Italy	Max Planck Society; Max Planck Society; IFOM - FIRC Institute of Molecular Oncology	den Brave, F (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.; Pfander, B (corresponding author), Max Planck Inst Biochem, Res Grp DNA Replicat & Genome Integr, Klopferspitz 18, D-82152 Martinsried, Germany.	denbrave@biochem.mpg.de; bpfander@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X; den Brave, Fabian/0000-0001-6955-4616; Pfander, Boris/0000-0003-2180-5054	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; Louis-Jeantet Foundation; European Research Council (ERC); EU Marie Curie Training Network	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Louis-Jeantet Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); EU Marie Curie Training Network(European Commission)	Research in the S.J. lab is supported by Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, Louis-Jeantet Foundation, and a European Research Council (ERC) Advanced Grant. Research in the B.P. lab is supported by Max Planck Society and Deutsche Forschungsgemeinschaft. This work was also supported by a stipend from EU Marie Curie Training Network (to I. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeywardana T, 2015, BIOCHEMISTRY-US, V54, P959, DOI 10.1021/bi501512m; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Castoralova M, 2012, BBA-MOL CELL RES, V1823, P911, DOI 10.1016/j.bbamcr.2012.01.010; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cullin C, 1996, YEAST, V12, P1511, DOI 10.1002/(SICI)1097-0061(199612)12:15<1511::AID-YEA41>3.0.CO;2-B; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Liebelt F, 2016, AM J PHYSIOL-CELL PH, V311, pC284, DOI 10.1152/ajpcell.00091.2016; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2; Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103; Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pearce DA, 1997, J BIOL CHEM, V272, P31829, DOI 10.1074/jbc.272.50.31829; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Psakhye I, 2016, METHODS MOL BIOL, V1475, P219, DOI 10.1007/978-1-4939-6358-4_16; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; SUGAR J, 1970, ARCH INT PHYS BIOCH, V78, P1009; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; TERADA K, 1995, MOL CELL BIOL, V15, P3708; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	81	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					599	609		10.1074/jbc.M117.817833	http://dx.doi.org/10.1074/jbc.M117.817833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183993	hybrid, Green Published			2022-12-26	WOS:000419915400016
J	Schmidt, FA; Ruprecht, K; Connolly, F; Maas, MB; Paul, F; Hoffmann, J; Harms, L; Schreiber, SJ				Schmidt, Felix A.; Ruprecht, Klemens; Connolly, Florian; Maas, Matthew B.; Paul, Friedemann; Hoffmann, Jan; Harms, Lutz; Schreiber, Stephan J.			B-mode ultrasound assessment of pupillary function: Feasibility, reliability and normal values	PLOS ONE			English	Article							LIGHT REFLEX; PUPILLOMETRY	Purpose To evaluate B-mode ultrasound as a novel method for the examination of pupillary function and to provide normal values for the pupillary reflex as assessed by B-mode ultrasound. Methods 100 subjects (49 female, 51 male, mean [range] age 51 [18-80 years]) with no history of ophthalmologic disease, no clinically detectable pupillary defects, and corrected visual acuity >= 0.8 were included in this prospective observational study. B-mode ultrasound was performed with the subjects eyes closed using an Esaote-Mylab25 system according to current guidelines for orbital insonation. A standardized light stimulus was applied. Results The mean +/- standard deviation left and right pupillary diameters (PD) at rest were 4.7 +/- 0.8 and 4.5 +/- 0.8 mm. Following an ipsilateral light stimulus (L-stim), left and right constricted PD were 2.8 +/- 0.6 and 2.7 +/- 0.6 mm. Following a contralateral L-stim, left and right constricted PD were 2.7 +/- 0.6 and 2.6 +/- 0.5 mm. Left and right pupillary constriction time (PCT) following ipsilateral L-stim were 970 +/- 261.6 and 967 +/- 220 ms. Left and right PCT following a contralateral L-stim were 993.8 +/- 192.6 and 963 +/- 189.4 ms. Patient age was inversely correlated with PD at rest and with PD after ipsilateral and contralateral L-stim (all p<0.001), but not with PCT. Conclusions B-mode ultrasound is a simple, rapid and objective method for the quantitative assessment of pupillary function, which may prove useful in a variety of settings where eyelid retraction is impeded or an infrared pupillometry device is unavailable.	[Schmidt, Felix A.; Ruprecht, Klemens; Connolly, Florian; Paul, Friedemann; Harms, Lutz] Charite, Dept Neurol, Berlin, Germany; [Schmidt, Felix A.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Maas, Matthew B.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann] Charite, Berlin, Germany; [Hoffmann, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Schreiber, Stephan J.] Asklepios Fachklinikum Brandenburg, Dept Neurol, Brandenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Northwestern University; Feinberg School of Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schmidt, FA (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Schmidt, FA (corresponding author), Charite, NeuroCure Clin Res Ctr, Berlin, Germany.	felix.schmidt@charite.de	Paul, Friedemann/ABF-9415-2020; Hoffmann, Jan/AAP-8376-2020	paul, friedemann/0000-0002-6378-0070				Adhikari P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161175; Bergamin O, 2003, OPHTHALMOLOGY, V110, P106, DOI 10.1016/S0161-6420(02)01445-8; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; Chang DS, 2013, OPHTHALMOLOGY, V120, P2217, DOI 10.1016/j.ophtha.2013.04.012; Fotiou D F, 2007, Electromyogr Clin Neurophysiol, V47, P11; Harries A, 2010, AM J EMERG MED, V28, P956, DOI 10.1016/j.ajem.2009.06.026; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; LOEWENFELD IE, 1974, AM J OPHTHALMOL, V78, P304, DOI 10.1016/0002-9394(74)90093-2; LONGTIN A, 1989, B MATH BIOL, V51, P605; MCGRAW P, 1995, BRIT MED J, V310, P1481, DOI 10.1136/bmj.310.6993.1481; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Payen J-F, 2012, Ann Fr Anesth Reanim, V31, pe155, DOI 10.1016/j.annfar.2012.04.020; Trier H G, 1982, Ultraschall Med, V3, P164, DOI 10.1055/s-2007-1010120; Wachler BSB, 1999, OPHTHALMOLOGY, V106, P319; Wilhelm H, 2003, J NEURO-OPHTHALMOL, V23, P42, DOI 10.1097/00041327-200303000-00010; Wilhelm H, 1998, J NEUROL, V245, P573, DOI 10.1007/s004150050248	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189016	10.1371/journal.pone.0189016	http://dx.doi.org/10.1371/journal.pone.0189016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211788	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000417212200056
J	Baker, KK; Padhi, B; Torondel, B; Das, P; Dutta, A; Sahoo, KC; Das, B; Dreibelbis, R; Caruso, B; Freeman, MC; Sager, L; Panigrahi, P				Baker, Kelly K.; Padhi, Bijaya; Torondel, Belen; Das, Padmalaya; Dutta, Ambarish; Sahoo, Krushna Chandra; Das, Bhabani; Dreibelbis, Robert; Caruso, Bethany; Freeman, Matthew C.; Sager, Lauren; Panigrahi, Pinaki			From menarche to menopause: A population-based assessment of water, sanitation, and hygiene risk factors for reproductive tract infection symptoms over life stages in rural girls and women in India	PLOS ONE			English	Article							ABNORMAL VAGINAL DISCHARGE; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; PREGNANT-WOMEN; EMOTIONAL DISTRESS; PRETERM DELIVERY; HEALTH; ASSOCIATION; INSECURITY; STRESS	Women face greater challenges than men in accessing water, sanitation, and hygiene (WASH) resources to address their daily needs, and may respond to these challenges by adopting unsafe practices that increase the risk of reproductive tract infections (RTIs). WASH practices may change as women transition through socially-defined life stage experiences, like marriage and pregnancy. Thus, the relationship between WASH practices and RTIs might vary across female reproductive life stages. This cross-sectional study assessed the relationship between WASH exposures and self-reported RTI symptoms in 3,952 girls and women from two rural districts in India, and tested whether social exposures represented by reproductive life stage was an effect modifier of associations. In fully adjusted models, RTI symptoms were less common in women using a latrine without water for defecation versus open defecation (Odds Ratio (OR) = 0.69; Confidence Interval (CI) = 0.48, 0.98) and those walking shorter distances to a bathing location (OR = 0.79, CI = 0.63, 0.99), but there was no association between using a latrine with a water source and RTIs versus open defecation (OR = 1.09; CI = 0.69, 1.72). Unexpectedly, RTI symptoms were more common for women bathing daily with soap (OR = 6.55, CI = 3.60, 11.94) and for women washing their hands after defecation with soap (OR = 10.27; CI = 5.53, 19.08) or ash/soil/ mud (OR = 6.02; CI = 3.07, 11.77) versus water only or no hand washing. WASH practices of girls and women varied across reproductive life stages, but the associations between WASH practices and RTI symptoms were not moderated by or confounded by life stage status. This study provides new evidence that WASH access and practices are associated with self-reported reproductive tract infection symptoms in rural Indian girls and women from different reproductive life stages. However, the counterintuitive directions of effect for soap use highlights that causality and mechanisms of effect cannot be inferred from this study design. Future research is needed to understand whether improvements in water and sanitation access could improve the practice of safe hygiene behaviors and reduce the global burden of RTIs in women.	[Baker, Kelly K.; Sager, Lauren] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Padhi, Bijaya; Das, Padmalaya; Dutta, Ambarish; Sahoo, Krushna Chandra; Das, Bhabani] Asian Inst Publ Hlth, Bhubaneswar, India; [Torondel, Belen] London Sch Hyg & Trop Med, London, England; [Dreibelbis, Robert] Univ Oklahoma, Norman, OK 73019 USA; [Caruso, Bethany; Freeman, Matthew C.] Emory Univ, Atlanta, GA 30322 USA; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Omaha, NE USA	University of Iowa; University of London; London School of Hygiene & Tropical Medicine; University of Oklahoma System; University of Oklahoma - Norman; Emory University; University of Nebraska System; University of Nebraska Medical Center	Baker, KK (corresponding author), Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA.	kelly-k-baker@uiowa.edu	Padhi, Bijaya K/E-7102-2010; Sahoo, Krushna Chandra/AAF-2813-2020; Padhi, Bijaya Kumar/AAW-2384-2021	Padhi, Bijaya K/0000-0002-2828-2375; Padhi, Bijaya Kumar/0000-0002-2828-2375; Dreibelbis, Robert/0000-0002-9716-0419; Baker, Kelly/0000-0002-3774-2628; Das, Bhabani Sankar/0000-0001-8492-9033; Caruso, Bethany/0000-0001-9738-9857; Dutta, Ambarish/0000-0002-4019-7472	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development [PO 6981]	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development	This research received financial support from the Sanitation and Hygiene Applied Research for Equity (SHARE) consortium (https//www..shareresearchorg/), which was funded by the UK Department for International Development (grant no. PO 6981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Arun Kumar, 2004, Journal of Communicable Diseases, V36, P1; Ahuja Maninder, 2016, J Midlife Health, V7, P126; Al Riyami A, 2005, MED PRIN PRACT, V14, P92, DOI 10.1159/000083918; Alexander M, 2007, INT FAM PLAN PERSPEC, V33, P150, DOI 10.1363/ifpp.33.150.07; Alijahan Rahele, 2014, Iran J Reprod Med, V12, P47; Anand E, 2015, SEX REPROD HEALTHC, V6, P249, DOI 10.1016/j.srhc.2015.06.001; Ashorn P, 2015, NESTLE NUTR WORKS SE, V81, P37, DOI 10.1159/000365802; Bahram Amini, 2009, Oman Med J, V24, P288, DOI 10.5001/omj.2009.58; Balsara ZP, 2010, J HEALTH POPUL NUTR, V28, P501; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Betha K, 2016, INFECT DIS OBSTET GY, V2016; Bhilwar Meenakshi, 2015, J Nat Sci Biol Med, V6, pS29, DOI 10.4103/0976-9668.166059; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Cammack AL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.054; Caruso BA, 2015, LANCET, V386, P650, DOI 10.1016/S0140-6736(15)61497-0; Chen QX, 2013, AM J PUBLIC HEALTH, V103, pE67, DOI 10.2105/AJPH.2012.300995; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Cohen BE, 2012, WOMEN HEALTH ISS, V22, pE461, DOI 10.1016/j.whi.2012.06.005; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Crucitti T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016310; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; Dambhare Dharampal G, 2012, Glob J Health Sci, V4, P105, DOI 10.5539/gjhs.v4n1p105; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Fisher J, 2008, P I CIVIL ENG-MUNIC, V161, P223, DOI 10.1680/muen.2008.161.4.223; Goto A, 2005, J EPIDEMIOL, V15, P163, DOI 10.2188/jea.15.163; Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; Jaya, 2009, INT PERSPECT SEX R H, V35, P97, DOI 10.1363/ipsrh.35.097.09; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Kenyon CR, 2014, CURR OPIN OBSTET GYN, V26, P448, DOI 10.1097/GCO.0000000000000112; Kerubo E, 2016, SEX TRANSM INFECT, V92, P251, DOI 10.1136/sextrans-2015-052371; Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905; Khawaja M, 2009, J WOMENS HEALTH, V18, P1701, DOI 10.1089/jwh.2008.0962; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Kojima N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2282-3; Krupp K, 2007, Glob Public Health, V2, P395, DOI 10.1080/17441690701238031; Lata Indu, 2010, Indian J Community Med, V35, P285, DOI 10.4103/0970-0218.66855; Li XD, 2014, EUR J CLIN MICROBIOL, V33, P1525, DOI 10.1007/s10096-014-2103-1; Lien PT, 2002, STUD FAMILY PLANN, V33, P217, DOI 10.1111/j.1728-4465.2002.00217.x; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Mbizvo M E, 2004, Cent Afr J Med, V50, P41; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Murphy K, 2016, J INFECT DIS, V214, pS29, DOI 10.1093/infdis/jiw140; Nagarkar Aarti, 2015, Indian J Sex Transm Dis AIDS, V36, P18, DOI 10.4103/0253-7184.156690; Narayankhedkar A., 2015, J SEX TRANSM DIS, V2015; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Paige DM, 1998, J NURSE-MIDWIFERY, V43, P83, DOI 10.1016/S0091-2182(97)00161-4; Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451; Patel V, 2006, ARCH GEN PSYCHIAT, V63, P404, DOI 10.1001/archpsyc.63.4.404; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Patel V, 2008, J PSYCHOSOM RES, V64, P255, DOI 10.1016/j.jpsychores.2007.10.015; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Romoren M, 2007, B WORLD HEALTH ORGAN, V85, P297, DOI 10.2471/BLT.06.031922; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Sharma A. K., 2004, Journal of Communicable Diseases, V36, P93; Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Sznajder KK, 2014, INT J OCCUP ENV HEAL, V20, P33, DOI 10.1179/2049396713Y.0000000053; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165; Tumwine JK, 2002, UGANDA COUNTRY STUDY, Vxix; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; Winter SC, 2016, INT J ENVIRON HEAL R, V26, P291, DOI 10.1080/09603123.2015.1111309; Wojcik A, 2013, INT J OCCUP MED ENV, V26, P477, DOI 10.2478/s13382-013-0118-y; Wutich A, 2009, MED ANTHROPOL Q, V23, P436, DOI 10.1111/j.1548-1387.2009.01072.x; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042; ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047	79	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188234	10.1371/journal.pone.0188234	http://dx.doi.org/10.1371/journal.pone.0188234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206842	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000417110700010
J	Sedlak, SM; Bauer, MS; Kluger, C; Schendel, LC; Milles, LF; Pippig, DA; Gaub, HE				Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.			Monodisperse measurement of the biotin-streptavidin interaction strength in a well-defined pulling geometry	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; PROTEIN-LIGAND INTERACTION; MONOVALENT STREPTAVIDIN; ENERGY LANDSCAPE; SPECTROSCOPY; BINDING; AVIDIN; ADHESION; SITE; DNA	The widely used interaction of the homotetramer streptavidin with the small molecule biotin has been intensively studied by force spectroscopy and has become a model system for receptor ligand interaction. However, streptavidin's tetravalency results in diverse force propagation pathways through the different binding interfaces. This multiplicity gives rise to polydisperse force spectroscopy data. Here, we present an engineered monovalent streptavidin tetramer with a single cysteine in its functional subunit that allows for site-specific immobilization of the molecule, orthogonal to biotin binding. Functionality of streptavidin and its binding properties for biotin remain unaffected. We thus created a stable and reliable molecular anchor with a unique high-affinity binding site for biotinylated molecules or nanoparticles, which we expect to be useful for many single-molecule applications. To characterize the mechanical properties of the bond between biotin and our monovalent streptavidin, we performed force spectroscopy experiments using an atomic force microscope. We were able to conduct measurements at the single-molecule level with 1: 1-stoichiometry and a well-defined geometry, in which force exclusively propagates through a single subunit of the streptavidin tetramer. For different force loading rates, we obtained narrow force distributions of the bond rupture forces ranging from 200 pN at 1,500 pN/s to 230 pN at 110,000 pN/s. The data are in very good agreement with the standard Bell-Evans model with a single potential barrier at Delta x(0) = 0.38 nm and a zero-force off-rate k(off,0) in the 10(-6) s(-1) range.	[Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.] Ludwig Maximilians Univ Munchen, Lehrstuhl Angew Physik, Munich, Germany; [Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.] Ludwig Maximilians Univ Munchen, Ctr NanoSci CeNS, Munich, Germany	University of Munich; University of Munich	Gaub, HE (corresponding author), Ludwig Maximilians Univ Munchen, Lehrstuhl Angew Physik, Munich, Germany.	gaub@lmu.de		Bauer, Magnus/0000-0003-1357-2852; Sedlak, Steffen/0000-0002-7037-1793	European Research Council Advanced Grant [ERC-2011-ADG_20110310]; Deutsche Forschungsgemeinschaft [SFB1032]; Nanosystems Initiative Munich	European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich	Funding was provided by the European Research Council Advanced Grant (HEG) ERC-2011-ADG_20110310 to Hermann E. Gaub and the SFB1032 (HEG) of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SMS and MSB thank the Nanosystems Initiative Munich for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 1996, FEBS LETT, V390, P161, DOI 10.1016/0014-5793(96)00651-5; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aschenbrenner D, 2015, CHEMPHYSCHEM, V16, P2085, DOI 10.1002/cphc.201500193; Baumann F, 2016, NAT NANOTECHNOL, V11, P89, DOI [10.1038/NNANO.2015.231, 10.1038/nnano.2015.231]; BAYER EA, 1985, ANAL BIOCHEM, V149, P529, DOI 10.1016/0003-2697(85)90609-8; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fairhead M, 2014, J MOL BIOL, V426, P199, DOI 10.1016/j.jmb.2013.09.016; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Friedsam C, 2003, J PHYS-CONDENS MAT, V15, pS1709, DOI 10.1088/0953-8984/15/18/305; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Gumpp H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3148224; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hu QZ, 2016, CHEM COMMUN, V52, P3705, DOI 10.1039/c5cc10535h; Hyre DE, 2006, PROTEIN SCI, V15, P459, DOI 10.1110/ps.051970306; Kim M, 2011, ADV MATER, V23, P5684, DOI 10.1002/adma.201103316; Knezevic J, 2012, J AM CHEM SOC, V134, P15225, DOI 10.1021/ja3061276; Kriegel F, 2017, NUCLEIC ACIDS RES, V45, P5920, DOI 10.1093/nar/gkx280; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lo YS, 1999, LANGMUIR, V15, P1373, DOI 10.1021/la981003g; Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g; Milles LF, 2016, J PHYS CHEM B; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Ott W, 2017, ACS NANO, V11, P6346, DOI 10.1021/acsnano.7b02694; Ott W, 2017, J STRUCT BIOL, V197, P3, DOI 10.1016/j.jsb.2016.02.011; Piramowicz MD, 2006, ACTA BIOCHIM POL, V53, P93; Puchner EM, 2008, BIOPHYS J, V95, P426, DOI 10.1529/biophysj.108.129999; Qureshi MH, 2002, PROTEIN EXPRES PURIF, V25, P409, DOI 10.1016/S1046-5928(02)00021-9; Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Schwaiger I, 2004, NAT STRUCT MOL BIOL, V11, P81, DOI 10.1038/nsmb705; Spate AK, 2016, CHEMBIOCHEM, V17, P1374, DOI 10.1002/cbic.201600197; Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024; Ta H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8977; Taninaka A, 2010, INT J MOL SCI, V11, P2134, DOI 10.3390/ijms11052134; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o; Zhang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35915	55	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188722	10.1371/journal.pone.0188722	http://dx.doi.org/10.1371/journal.pone.0188722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206886	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700018
J	Celma, L; Corbinais, C; Vercruyssen, J; Veaute, X; Li de la Sierra-Gallay, IL; Guerois, R; Busso, D; Mathieu, A; Marsin, S; Quevillon-Cheruel, S; Radicella, JP				Celma, Louisa; Corbinais, Christopher; Vercruyssen, Julien; Veaute, Xavier; Li de la Sierra-Gallay, Ines; Guerois, Raphael; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Quevillon-Cheruel, Sophie; Radicella, J. Pablo			Structural basis for the substrate selectivity of Helicobacter pylori NucT nuclease activity	PLOS ONE			English	Article							REPRESSOR-OPERATOR INTERACTION; PHOSPHOLIPASE-D SUPERFAMILY; CRYSTAL-STRUCTURE; PIRNA BIOGENESIS; PLASMID PKM101; D FAMILY; RECOMBINATION; SEQUENCE; SERVER; MEMBER	The Phospholipase D (PLD) superfamily of proteins includes a group of enzymes with nuclease activity on various nucleic acid substrates. Here, with the aim of better understanding the substrate specificity determinants in this subfamily, we have characterised the enzymatic activity and the crystal structure of NucT, a nuclease implicated in Helicobacter pylori purine salvage and natural transformation and compared them to those of its bacterial and mammalian homologues. NucT exhibits an endonuclease activity with a strong preference for single stranded nucleic acids substrates. We identified histidine124 as essential for the catalytic activity of the protein. Comparison of the NucT crystal structure at 1.58 angstrom resolution reported here with those of other members of the sub-family suggests that the specificity of NucT for single-stranded nucleic acids is provided by the width of a positively charged groove giving access to the catalytic site.	[Celma, Louisa; Vercruyssen, Julien; Li de la Sierra-Gallay, Ines; Guerois, Raphael; Marsin, Stephanie; Quevillon-Cheruel, Sophie] Univ Paris Sud, CNRS, CEA, I2BC, Gif Sur Yvette, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] CEA, Inst Mol & Cellular Radiobiol, Fontenay Aux Roses, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] Univ Paris Diderot, CEA, INSERM, UMR967, Fontenay Aux Roses, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] Univ Paris Sud, Fontenay Aux Roses, France; [Mathieu, Aurelie] INRA, UMR1319, Micalis Inst, Jouy En Josas, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Quevillon-Cheruel, S (corresponding author), Univ Paris Sud, CNRS, CEA, I2BC, Gif Sur Yvette, France.; Radicella, JP (corresponding author), CEA, Inst Mol & Cellular Radiobiol, Fontenay Aux Roses, France.; Radicella, JP (corresponding author), Univ Paris Diderot, CEA, INSERM, UMR967, Fontenay Aux Roses, France.; Radicella, JP (corresponding author), Univ Paris Sud, Fontenay Aux Roses, France.	sophie.quevillon-cheruel@i2bc.paris-saclay.fr; pablo.radicella@cea.fr	Radicella, J. Pablo/AAU-3178-2020; , raph/AAF-4380-2019	Radicella, J. Pablo/0000-0002-8807-7226; GUEROIS, Raphael/0000-0001-5294-2858; CELMA, Louisa/0000-0002-6473-8915; MARSIN, Stephanie/0000-0002-7074-7818	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Institut National pour la Sante et la recherche Medicale [UMR967]; University Paris-Sud 11 [UMR8619]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Indo-French Centre for Promotion of Advanced research (CEFIPRA) [5203-5]; French Ministry of Education; DIM-Malinf	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la recherche Medicale; University Paris-Sud 11; French Infrastructure for Integrated Structural Biology (FRISBI); Indo-French Centre for Promotion of Advanced research (CEFIPRA); French Ministry of Education; DIM-Malinf	This work was supported by funds from the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique and Institut National pour la Sante et la recherche Medicale (UMR967), by the University Paris-Sud 11 (UMR8619), by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 and by a grant from the Indo-French Centre for Promotion of Advanced research (CEFIPRA) (grant number 5203-5 to JPR). LC and CC were supported by Ph.D fellowships from the French Ministry of Education and the DIM-Malinf, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeYonker NJ, 2013, J AM CHEM SOC, V135, P13764, DOI 10.1021/ja4042753; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humbert O, 2011, MOL MICROBIOL, V79, P387, DOI 10.1111/j.1365-2958.2010.07456.x; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Liechti GW, 2013, J BACTERIOL, V195, P4387, DOI 10.1128/JB.00388-13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Nureki Osamu, 2014, Biomed J, V37, P369, DOI 10.4103/2319-4170.132909; O'Rourke EJ, 2004, J BACTERIOL, V186, P2586, DOI 10.1128/JB.186.9.2586-2593.2004; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Voigt F, 2012, RNA, V18, P2128, DOI 10.1261/rna.034967.112; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao Y, 1997, PROTEIN SCI, V6, P2655	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189049	10.1371/journal.pone.0189049	http://dx.doi.org/10.1371/journal.pone.0189049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206236	Green Submitted, Green Published, gold			2022-12-26	WOS:000417033200026
J	Neadle, D; Allritz, M; Tennie, C				Neadle, Damien; Allritz, Matthias; Tennie, Claudio			Food cleaning in gorillas: Social learning is a possibility but not a necessity	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; MOUNTAIN GORILLAS; PAN-TROGLODYTES; EVOLUTION; VARIABILITY; CHIMPANZEES; CULTURES; PRIMATE; DIET	Food cleaning is widespread in the animal kingdom, and a recent report confirmed that (amongst other behaviours) wild western lowland gorillas also show food cleaning. The authors of this report conclude that this behaviour, based on its distribution patterns, constitutes a potential candidate for culture. While different conceptualisations of culture exist, some more and some less reliant on behavioural form copying, all of them assign a special role to social learning processes in explaining potentially cultural behaviours. Here we report the results of an experiment that tested to what extent food cleaning behaviour in a group of captive Western lowland gorillas (Gorilla gorilla gorilla) relies on social learning processes. Subjects were provided with clean and dirty apples. When they were provided with dirty apples, all subjects showed evidence of food cleaning in at least 75% of trials. Preferred cleaning techniques differed between individuals, four out of five of subjects expressed a behaviour analogous to that reported in wild conspecifics. Given this occurrence of food cleaning in a culturally unconnected population of gorillas, we conclude that social learning is unlikely to play a central role in the emergence of the food cleaning behavioural form in Western lowland gorillas; instead, placing a greater emphasis on individual learning of food cleaning's behavioural form.	[Neadle, Damien] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Allritz, Matthias] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Tennie, Claudio] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany	University of Birmingham; University of St Andrews; Eberhard Karls University of Tubingen	Neadle, D (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	DLN521@bham.ac.uk		Neadle, Damien/0000-0001-8559-436X; Tennie, Claudio/0000-0002-5302-4925	Economic and Social Research Council [ES/J50001X/1]; European Research Council under the European Union's Seventh Framework Programme/ERC [609819]; European Research Council under the European Union's Horizon Programme (H2020-EU.1.1.)/ERC [714658]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); European Research Council under the European Union's Horizon Programme (H2020-EU.1.1.)/ERC	Damien Neadle has received funding from the Economic and Social Research Council, under a full PhD Studentship ES/J50001X/1. Matthias Allritz has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 609819 (SOMICS). Claudio Tennie has received funding from the European Research Council under the European Union's Horizon 2020 Programme (H2020-EU.1.1.)/ERC grant agreement no 714658. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Alem S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002564; Allritz M, 2013, PRIMATES, V54, P361, DOI 10.1007/s10329-013-0355-5; Bandini E, 2017, PEERJ, V5, DOI 10.7717/peerj.3814; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Galef B.G., 1976, ADV STUDY BEHAV VOL, V6, P77, DOI DOI 10.1016/S0065-3454(08)60082-0; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Hirata S, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P487; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kis A, 2015, ANIM COGN, V18, P325, DOI 10.1007/s10071-014-0803-7; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Laland K. N., 2009, QUESTION ANIMAL CULT; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Nakamichi M, 1998, FOLIA PRIMATOL, V69, P35, DOI 10.1159/000021561; Nkurunungi JB, 2004, AFR J ECOL, V42, P289, DOI 10.1111/j.1365-2028.2004.00523.x; Pradhan GR, 2012, J HUM EVOL, V63, P180, DOI 10.1016/j.jhevol.2012.04.008; Reindl E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01715-2; Reindl E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2402; Robbins MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160483; Robbins MM, 2003, INT J PRIMATOL, V24, P467, DOI 10.1023/A:1023741328338; RUVOLO M, 1994, P NATL ACAD SCI USA, V91, P8900, DOI 10.1073/pnas.91.19.8900; Sarabian C, 2015, BIOL LETTERS, V11, P1; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Sommer V, 2016, ANIM COGN, V19, P245, DOI 10.1007/s10071-015-0903-z; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Terkel Joseph, 1996, P17, DOI 10.1016/B978-012273965-1/50003-0; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1998, DEVELOPMENTAL SCI, V1, P1, DOI 10.1111/1467-7687.00002; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van de Waal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035694; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; VISALBERGHI E, 1995, J COMP PSYCHOL, V109, P52, DOI 10.1037/0735-7036.109.1.52; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2000, COGNITIVE SCI, V24, P477; Wilson A.C., 1985, Scientific American, V253, P148	49	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188866	10.1371/journal.pone.0188866	http://dx.doi.org/10.1371/journal.pone.0188866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200437	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000417033200017
J	Zhang, L; Du, HR; Zhao, YN; Wu, RW; Zhang, XL				Zhang, Lu; Du, Hongru; Zhao, Yannan; Wu, Rongwei; Zhang, Xiaolei			Urban networks among Chinese cities along "the Belt and Road": A case of web search activity in cyberspace	PLOS ONE			English	Article							WORLD CITY NETWORK; INTERCITY LINKAGES; INTERNET; GEOGRAPHY; TELECOMMUNICATIONS; BACKBONE	"The Belt and Road" initiative has been expected to facilitate interactions among numerous city centers. This initiative would generate a number of centers, both economic and political, which would facilitate greater interaction. To explore how information flows are merged and the specific opportunities that may be offered, Chinese cities along "the Belt and Road" are selected for a case study. Furthermore, urban networks in cyberspace have been characterized by their infrastructure orientation, which implies that there is a relative dearth of studies focusing on the investigation of urban hierarchies by capturing information flows between Chinese cities along "the Belt and Road". This paper employs Baidu, the main web search engine in China, to examine urban hierarchies. The results show that urban networks become more balanced, shifting from a polycentric to a homogenized pattern. Furthermore, cities in networks tend to have both a hierarchical system and a spatial concentration primarily in regions such as Beijing-Tianjin-Hebei, Yangtze River Delta and the Pearl River Delta region. Urban hierarchy based on web search activity does not follow the existing hierarchical system based on geospatial and economic development in all cases. Moreover, urban networks, under the framework of "the Belt and Road", show several significant corridors and more opportunities for more cities, particularly western cities. Furthermore, factors that may influence web search activity are explored. The results show that web search activity is significantly influenced by the economic gap, geographical proximity and administrative rank of the city.	[Zhang, Lu; Du, Hongru; Wu, Rongwei; Zhang, Xiaolei] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Zhang, Lu] Univ Ghent, Dept Geog, Ghent, Belgium; [Zhang, Lu; Zhao, Yannan; Wu, Rongwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Lu] Sinobelgian Joint Lab Geoinformat, Urumqi, Peoples R China; [Zhang, Lu] Sinobelgian Joint Lab Geoinformat, Ghent, Belgium; [Zhao, Yannan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Ghent University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Du, HR; Zhang, XL (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	duhongru@sina.com; zhangxl@ms.xjb.ac.cn	; Zhang, Lu/C-4821-2019	zhao, Yan-nan/0000-0002-4717-5022; Zhang, Lu/0000-0001-9002-621X	Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences [TSS-2015-014-FW-3-3]	Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences	This research has received financial support by the Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences (TSS-2015-014-FW-3-3)	Adams PC, 1997, GEOGR REV, V87, P155, DOI 10.2307/216003; Allen J., 1999, CITIES POWER INFLUEN; Allen J, 2010, URBAN STUD, V47, P2895, DOI 10.1177/0042098010377364; [Anonymous], 2012, RISE NETWORK SOC, DOI DOI 10.1002/9781444319514; [Anonymous], 2014, TRADE TRANSPORT CORR; Batty M, 1997, FUTURES, V29, P337, DOI 10.1016/S0016-3287(97)00018-9; Batty M., 1990, EDITORIAL; Beaverstock J.V., 2002, GLOBAL NETW, V2, P111, DOI [10.1111/1471-0374.00031, DOI 10.1111/1471-0374.00031]; Boulton A., 2011, ICTS MOBILE UBIQUITO, P67, DOI 10.4018/978-1-60960-051-8.ch005; Burch H, 1999, COMPUTER, V32, P97, DOI 10.1109/2.755008; Castells M., 2001, RISE INFORM SOC; Choi JH, 2006, GLOBAL NETW, V6, P81, DOI 10.1111/j.1471-0374.2006.00134.x; CNNIC, STAT REP CHIN INT DE; Derudder B, 2005, URBAN STUD, V42, P2371, DOI 10.1080/00420980500379503; Derudder B, 2013, CHINESE GEOGR SCI, V23, P261, DOI 10.1007/s11769-013-0604-y; Devriendt L, 2008, J URBAN TECHNOL, V15, P5, DOI 10.1080/10630730802401926; Devriendt L, 2010, TELECOMMUN POLICY, V34, P417, DOI 10.1016/j.telpol.2010.05.009; Dicken P., 2001, GLOBAL NETW, V1, P89, DOI DOI 10.1111/1471-0374.00007; Grace J., 2004, INFORM COMMUNICATION; Graham S, 1999, URBAN STUD, V36, P929, DOI 10.1080/0042098993286; Greenstein S., 2007, MOTION IMAGING J SMP, V117, P32; Grubesic TH, 2005, TELECOMMUN POLICY, V29, P69, DOI 10.1016/j.telpol.2004.08.001; Grubesic TH, 2011, J TRANSP GEOGR, V19, P93, DOI 10.1016/j.jtrangeo.2009.12.006; Hillis K, 1998, PROG HUM GEOG, V22, P543, DOI 10.1191/030913298669028680; Jarv O, 2015, URBAN STUD, V52, P2680, DOI 10.1177/0042098014550459; Junde L., 2006, EC GEOGRAPHY, V6; Kellerman A, 1997, TELECOMMUN POLICY, V21, P553, DOI 10.1016/S0308-5961(97)00025-6; Liebelson D., 2014, MAP HERE ARE COUNTRI; Liu XJ, 2016, REG STUD, V50, P1302, DOI 10.1080/00343404.2015.1004535; Long M., 2011, AREAL RES DEV, V30, P93, DOI [10.3969/j.issn.1003-2363.2011.03.019, DOI 10.3969/J.ISSN.1003-2363.2011.03.019]; Lu LC, 2012, CHINESE GEOGR SCI, V22, P602, DOI 10.1007/s11769-012-0555-8; Malecki EJ, 2002, ECON GEOGR, V78, P399, DOI 10.2307/4140796; Moss ML, 1997, J URBAN TECHNOL, V4, P261; Nannan Z, 2002, HUMAN GEOGRAPHY, V17, P20; OTA M, 1993, REG SCI URBAN ECON, V23, P695, DOI 10.1016/0166-0462(93)90018-A; [潘峰华 Pan Fenghua], 2013, [地理学报, Acta Geographica Sinica], V68, P449; Pred A., 1977, CITY SYSTEMS ADV EC; Rutherford J, 2004, J URBAN TECHNOL, V11, P1, DOI 10.1080/10630730500064166; Short JR, 1996, INT J URBAN REGIONAL, V20, P697, DOI 10.1111/j.1468-2427.1996.tb00343.x; Summers T, 2016, THIRD WORLD Q, V37, P1628, DOI 10.1080/01436597.2016.1153415; Tao M., 2016, FEATURE CHINA BUILT; TAYLOR P.J., 2008, GAWC RES B, P1; Taylor PJ, 2009, ENVIRON PLANN A, V41, P2550, DOI 10.1068/a42235; Taylor PJ, 2002, URBAN STUD, V39, P2367, DOI 10.1080/00420980220080011; Terlouw K, 2011, GEOFORUM, V42, P578, DOI 10.1016/j.geoforum.2011.05.003; Tian S., 2016, SPOTLIGHT PUTIN EYES; Timberlake M, 2008, J AM PLANN ASSOC, V74, P384, DOI 10.1080/01944360802146410; Townsend AM, 2001, AM BEHAV SCI, V44, P1697, DOI 10.1177/00027640121957998; Vijver EVD, 2016, PROMET D TRAFFIC D T, V28; Wall R, 2009, NETSCAPE CITIES GLOB; Wheeler DC, 1999, PROF GEOGR, V51, P327, DOI 10.1111/0033-0124.00169; Williams J.F., 2004, ASIAN GEOGR, V23, P121, DOI [10.1080/10225706.2004.9684116, DOI 10.1080/10225706.2004.9684116]; [赵映慧 Zhao Yinghui], 2017, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V31, P51; [钟业喜 ZHONG Yexi], 2011, [地理研究, Geographical Research], V30, P785; Zook M, 2006, ANNU REV INFORM SCI, V40, P53, DOI 10.1002/aris.1440400109; Zook MA, 2001, AM BEHAV SCI, V44, P1679, DOI 10.1177/00027640121958113	56	12	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188868	10.1371/journal.pone.0188868	http://dx.doi.org/10.1371/journal.pone.0188868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200421	Green Submitted, gold, Green Published			2022-12-26	WOS:000417033200018
J	Kancherla, V; Hasan, MOSI; Hamid, R; Paul, L; Selhub, J; Oakley, G; Quamruzzaman, Q; Mazumdar, M				Kancherla, Vijaya; Hasan, Md Omar Sharif Ibne; Hamid, Rezina; Paul, Ligi; Selhub, Jacob; Oakley, Godfrey; Quamruzzaman, Quazi; Mazumdar, Maitreyi			Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; SPINA-BIFIDA; REPRODUCTIVE AGE; PREVENTION; FOLATE; WOMEN; MORTALITY	Neural tube defects contribute to severe morbidity and mortality in children and adults; however, they are largely preventable through maternal intake of folic acid before and during early pregnancy. We examined the association between maternal prenatal folic acid supplement intake and risk of myelomeningocele (a severe and common type of neural tube defect) in the offspring. We performed secondary analysis using data from a case-control study conducted at Dhaka Community Hospital, Bangladesh between April and November of 2013. Cases and controls included children with and without myelomeningocele, respectively, and their mothers. Cases were identified from local hospitals and rural health clinics served by Dhaka Community Hospital. Controls were selected from pregnancy registries located in the same region as the cases, and matched (1:1) to cases by age and sex. Myelomeningocele in the offspring was confirmed by a pediatrician with expertise in classifying neural tube defects. Maternal prenatal folic acid supplement intake was the main exposure of interest. We estimated crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) using conditional logistic regression analysis. There were 53 pairs of matched cases and controls in our study. Overall, 51% of case mothers reported using folic acid supplements during pregnancy compared to 72% of control mothers (p = 0.03). Median plasma folate concentrations at the time of study visit were 2.79 ng/mL and 2.86 ng/mL among case and control mothers, respectively (p = 0.85). Maternal prenatal folic acid use significantly decreased the odds of myelomeningocele in the offspring (unadjusted OR = 0.42, 95% CI = 0.18-0.96). The association was slightly attenuated after adjusting for maternal age at the time of pregnancy (adjusted OR = 0.43, 95% CI = 0.18-1.02). Our study confirms the protective association between maternal prenatal folic acid supplement use and myelomeningocele among children born in Bangladesh. Our findings point to an overall low folic acid supplement use and low plasma folate concentrations among women of reproductive age in Bangladesh. Mandatory fortification of staple foods with folic acid can address low folate status among women of child-bearing age, and prevent child morbidity and mortality associated with myelomeningocele in Bangladesh.	[Kancherla, Vijaya; Oakley, Godfrey] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hasan, Md Omar Sharif Ibne; Quamruzzaman, Quazi] Dhaka Community Hosp, Dhaka, Bangladesh; [Hamid, Rezina] Bangladesh Med Coll, Dhaka, Bangladesh; [Paul, Ligi; Selhub, Jacob] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Mazumdar, Maitreyi] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Mazumdar, Maitreyi] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Emory University; Rollins School Public Health; Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kancherla, V (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	vkanche@emory.edu			National Institutes of Environmental Health Sciences (NIEHS), National Institutes of Health [R01 ES 016317]; Child Neurology Foundation; Harvard T.H. Chan School of Public Health NIEHS Center [P30 ES 000002]; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD 18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES017437, R01ES026317, P30ES000002] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences (NIEHS), National Institutes of Health; Child Neurology Foundation; Harvard T.H. Chan School of Public Health NIEHS Center; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this study was provided by the National Institutes of Environmental Health Sciences (NIEHS), National Institutes of Health (R01 ES 016317) (Grantee: MM). Additional support was provided by the Child Neurology Foundation, the Harvard T.H. Chan School of Public Health NIEHS Center (P30 ES 000002) and the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD 18655). The authors declare that there are no financial or personal relationships or affiliations that could influence or bias the manuscript, and that there are no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, EPIDEMIOLOGY, V22, P731, DOI 10.1097/EDE.0b013e3182227887; Akhtar S, 2016, CRIT REV FOOD SCI, V56, P2320, DOI 10.1080/10408398.2013.832143; Alam N, 2010, J HEALTH POPUL NUTR, V28, P86; [Anonymous], 2012, GUID DAIL IR FOL AC; Atta CAM, 2016, AM J PUBLIC HEALTH, V106, pE24, DOI 10.2105/AJPH.2015.302902; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Christianson A., 2006, GLOBAL REPORT BIRTH; Cordero AM, 2015, MMWR-MORBID MORTAL W, V64, P421; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Elwood J H, 1973, Ulster Med J, V42, P213; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; Grosse SD, 2016, AM J PREV MED, V50, pS74, DOI 10.1016/j.amepre.2015.10.012; HORNE DW, 1988, CLIN CHEM, V34, P2357; Kancherla V, 2014, BIRTH DEFECTS RES A, V100, P563, DOI 10.1002/bdra.23259; Khambalia A, 2009, J NUTR, V139, P1179, DOI 10.3945/jn.108.101022; Kondo A, 2015, BRIT J NUTR, V114, P84, DOI 10.1017/S0007114515001439; Leyvraz M, 2015, NUTRIENTS, V7, P9960, DOI [10.3390/nu7125511, 10.3390/nu8090541]; Lindstrom E, 2011, ACTA OBSTET GYN SCAN, V90, P47, DOI 10.1111/j.1600-0412.2010.01014.x; Mazumdar M, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0020-0; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Mosley BS, 2009, AM J EPIDEMIOL, V169, P9, DOI 10.1093/aje/kwn331; MULINARE J, 1988, JAMA-J AM MED ASSOC, V260, P3141, DOI 10.1001/jama.260.21.3141; Oakeshott P, 2010, DEV MED CHILD NEUROL, V52, P749, DOI 10.1111/j.1469-8749.2009.03543.x; Shaheen R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-5; Sutton M, 2008, BIRTH DEFECTS RES A, V82, P701, DOI 10.1002/bdra.20498; WALD N, 1991, LANCET, V338, P131	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188726	10.1371/journal.pone.0188726	http://dx.doi.org/10.1371/journal.pone.0188726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190654	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900110
J	Ortega-Moreno, L; Giraldez, BG; Soto-Insuga, V; Losada-Del Pozo, R; Rodrigo-Moreno, M; Alarcon-Morcillo, C; Sanchez-Martin, G; Diaz-Gomez, E; Guerrero-Lopez, R; Serratosa, JAM				Ortega-Moreno, Laura; Giraldez, Beatriz G.; Soto-Insuga, Victor; Losada-Del Pozo, Rebeca; Rodrigo-Moreno, Maria; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.		Grp Espanol Genetica Epilepsias	Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; DNA-SEQUENCING DATA; INFANTILE SPASMS; MENTAL-RETARDATION; CLINICAL-PRACTICE; ENCEPHALOPATHY; GENETICS; DISORDERS; PHENOTYPE; SEIZURES	Pediatric epilepsies are a group of disorders with a broad phenotypic spectrum that are associated with great genetic heterogeneity, thus making sequential single-gene testing an impractical basis for diagnostic strategy. The advent of next-generation sequencing has increased the success rate of epilepsy diagnosis, and targeted resequencing using genetic panels is the a most cost-effective choice. We report the results found in a group of 87 patients with epilepsy and developmental delay using targeted next generation sequencing (custom-designed Haloplex panel). Using this gene panel, we were able to identify disease-causing variants in 17 out of 87 (19.5%) analyzed patients, all found in known epilepsyassociated genes (KCNQ2, CDKL5, STXBP1, SCN1A, PCDH19, POLG, SLC2A1, ARX, ALG13, CHD2, SYNGAP1, and GRIN1). Twelve of 18 variants arose de novo and 6 were novel. The highest yield was found in patients with onset in the first years of life, especially in patients classified as having early-onset epileptic encephalopathy. Knowledge of the underlying genetic cause provides essential information on prognosis and could be used to avoid unnecessary studies, which may result in a greater diagnostic cost-effectiveness.	[Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Epilepsy Unit, Madrid, Spain; [Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Neurol Lab, Madrid, Spain; [Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] CIBERER, Madrid, Spain; [Soto-Insuga, Victor; Losada-Del Pozo, Rebeca; Rodrigo-Moreno, Maria] UAM, Hosp Univ Fdn Jimenez Diaz, Dept Pediat, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid	Guerrero-Lopez, R; Serratosa, JAM (corresponding author), UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Epilepsy Unit, Madrid, Spain.; Guerrero-Lopez, R; Serratosa, JAM (corresponding author), UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Neurol Lab, Madrid, Spain.; Guerrero-Lopez, R; Serratosa, JAM (corresponding author), CIBERER, Madrid, Spain.	rguerrero@fjd.es; jmserratosa@me.com		Gil-Nagel MD PhD, Antonio/0000-0003-4515-0793; Serratosa, Jose/0000-0003-2239-8948	Ministerio de Economia y Competitividad [SAF2010-18586, SAF2013-48960-P]; Fundacion Conchita Rabago de Jimenez Diaz; Centro de Investigacion Biomedica en Red de Enfermedades Raras	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Conchita Rabago de Jimenez Diaz; Centro de Investigacion Biomedica en Red de Enfermedades Raras	This work was supported by the Ministerio de Economia y Competitividad (SAF2010-18586 and SAF2013-48960-P) to GSM, LOM (www.mineco.gob.es); Fundacion Conchita Rabago de Jimenez Diaz (www.fundamonconchitarabago.net) to LOM and Centro de Investigacion Biomedica en Red de Enfermedades Raras (www.ciberer.es) to RGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; Bahi-Buisson N, 2012, AM J MED GENET A, V158A, P1612, DOI 10.1002/ajmg.a.35401; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Capelli LP, 2012, EUR J MED GENET, V55, P132, DOI 10.1016/j.ejmg.2011.10.004; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Coll M, 2016, INT J LEGAL MED, V130, P331, DOI 10.1007/s00414-015-1269-0; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; Della Mina E, 2015, EUR J HUM GENET, V23, P354, DOI 10.1038/ejhg.2014.92; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dimassi S, 2016, CLIN GENET, V89, P198, DOI 10.1111/cge.12636; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Dolk H, 2016, NEUROLOGY, V86, P1716, DOI 10.1212/WNL.0000000000002540; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gursoy S, 2016, J CHILD NEUROL, V31, P523, DOI 10.1177/0883073815599262; Hata Y, 2016, BRAIN PATHOL; Helbig KL, 2016, GENETICS MED OFFICIA; Hildebrand MS, 2016, NEUROLOGY, V86, P1605, DOI 10.1212/WNL.0000000000002608; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Hirose S, 2013, EPILEPSIA, V54, P946, DOI 10.1111/epi.12168; Holland KD, 2010, NEUROLOGY, V75, P1132, DOI 10.1212/WNL.0b013e3181f6bc97; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kobayashi Y, 2016, BRAIN DEV-JPN, V38, P285, DOI 10.1016/j.braindev.2015.09.011; Kodera H, 2013, EPILEPSIA, V54, P1262, DOI 10.1111/epi.12203; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwong AKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126446; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lemke JR, 2016, NEUROLOGY; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marini C, 2012, EPILEPSIA, V53, P2111, DOI 10.1111/j.1528-1167.2012.03649.x; Marth G, 2012, ARXIV12073907V2; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mercimek-Mahmutoglu S, 2015, EPILEPSIA, V56, P707, DOI 10.1111/epi.12954; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Moller RS, 2016, MOL SYNDROMOL, V7, P210, DOI 10.1159/000448369; Orsini A, 2017, NEUROSCIENCE LETT; Ottman R, 2010, EPILEPSIA, V51, P655, DOI 10.1111/j.1528-1167.2009.02429.x; Parrini E, 2016, HUMAN MUTATION; Poduri A, 2014, NAT REV NEUROL, V10, P293, DOI 10.1038/nrneurol.2014.60; Pong AW, 2011, PEDIATR NEUROL, V44, P317, DOI 10.1016/j.pediatrneurol.2011.01.017; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Romaniello R, 2015, NEUROREPORT, V26, P254, DOI 10.1097/WNR.0000000000000337; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Scheffer IE, 2014, NEUROPEDIATRICS, V45, P70, DOI 10.1055/s-0034-1371508; Scheffer IE, 2011, EPILEPSY CURR, V11, P107, DOI 10.5698/1535-7511-11.4.107; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Striano P, 2016, PHARMACOL RES, V107, P426, DOI 10.1016/j.phrs.2016.04.006; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Joseph DSAB, 2017, CURR OPIN NEUROL, V30, P193, DOI 10.1097/WCO.0000000000000433; Thomas RH, 2014, NAT REV NEUROL, V10, P283, DOI 10.1038/nrneurol.2014.62; Trump N, 2016, J MED GENETICS; Tuchman R, 2009, BRAIN DEV-JPN, V31, P95, DOI 10.1016/j.braindev.2008.09.009; Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65; van Harssel JJT, 2013, NEUROGENETICS, V14, P23, DOI 10.1007/s10048-013-0353-1; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Weber YG, 2017, EXPERT REV MOL DIAGN, V17, P739, DOI 10.1080/14737159.2017.1335598; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Zollino M, 2011, EUR J HUM GENET, V19, P239, DOI 10.1038/ejhg.2010.172	74	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188978	10.1371/journal.pone.0188978	http://dx.doi.org/10.1371/journal.pone.0188978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190809	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900182
J	Rechner, O; Neugart, S; Schreiner, M; Wu, S; Poehling, HM				Rechner, Ole; Neugart, Susanne; Schreiner, Monika; Wu, Sasa; Poehling, Hans-Michael			Can narrow-bandwidth light from UV-A to green alter secondary plant metabolism and increase Brassica plant defenses against aphids?	PLOS ONE			English	Article							HYDROXYCINNAMIC ACID-DERIVATIVES; DIFFERENT FLAVONOL GLYCOSIDES; HEMIPTERA APHIDIDAE; PERFORMANCE; QUALITY; GROWTH; ACCUMULATION; RADIATION; BLUE; IDENTIFICATION	Light of different wavelengths is essential for plant growth and development. Short-wavelength radiation such as UV can shift the composition of flavonoids, glucosinolates, and other plant metabolites responsible for enhanced defense against certain herbivorous insects. The intensity of light-induced, metabolite-based resistance is plant-and insect species- specific and depends on herbivore feeding guild and specialization. The increasing use of light-emitting diodes (LEDs) in horticultural plant production systems in protected environments enables the creation of tailor-made light scenarios for improved plant cultivation and induced defense against herbivorous insects. In this study, broccoli (Brassica oleracea var. italica) plants were grown in a climate chamber under broad spectra photosynthetic active radiation (PAR) and were additionally treated with the following narrow-bandwidth light generated with LEDs: UV-A (365 nm), violet (420 nm), blue (470 nm), or green (515 nm). We determined the influence of narrow-bandwidth light on broccoli plant growth, secondary plant metabolism (flavonol glycosides and glucosinolates), and plant-mediated light effects on the performance and behavior of the specialized cabbage aphid Brevicoryne brassicae. Green light increased plant height more than UV-A, violet, or blue LED treatments. Among flavonol glycosides, specific quercetin and kaempferol glycosides were increased under violet light. The concentration of 3-indolylmethyl glucosinolate in plants was increased by UV-A treatment. B. brassicae performance was not influenced by the different light qualities, but in host-choice tests, B. brassicae preferred previously blue-illuminated plants (but not UV-A-, violet-, or green-illuminated plants) over control plants.	[Rechner, Ole; Poehling, Hans-Michael] Inst Hort Prod Syst, Sect Phytomed, Hannover, Germany; [Neugart, Susanne; Schreiner, Monika; Wu, Sasa] Leibniz Inst Vegetable & Ornamental Crops, Dept Plant Qual, Grossbeeren, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Rechner, O (corresponding author), Inst Hort Prod Syst, Sect Phytomed, Hannover, Germany.	rechner@ipp.uni-hannover.de	Neugart, Susanne/B-3760-2014	Neugart, Susanne/0000-0002-4574-6733; Rechner, Ole/0000-0003-2127-1750; Schreiner, Monika/0000-0002-5629-4429	German Research Foundation DFG [Po 207/39-1]	German Research Foundation DFG(German Research Foundation (DFG))	The research project was funded by the German Research Foundation DFG, grant Po 207/39-1 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2015, SCI HORTIC-AMSTERDAM, V189, P12, DOI 10.1016/j.scienta.2015.03.028; Acharya J, 2016, J PLANT DIS PROTECT, V123, P321, DOI 10.1007/s41348-016-0029-9; Ahmad N, 2016, J PHOTOCH PHOTOBIO B, V154, P51, DOI 10.1016/j.jphotobiol.2015.11.015; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; Bantis F, 2016, SCI HORTIC-AMSTERDAM, V198, P277, DOI 10.1016/j.scienta.2015.11.014; BLACKMAN RL, 1994, APHIDS WORLD TREES I; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burdick SC, 2015, POPUL ECOL, V57, P457, DOI 10.1007/s10144-015-0501-6; Cao HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21954; Dader B, 2014, J PHOTOCH PHOTOBIO B, V138, P307, DOI 10.1016/j.jphotobiol.2014.06.009; Dhakal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117712; Doring TF, 2014, ANN APPL BIOL, V165, P3, DOI 10.1111/aab.12142; Fan XX, 2013, ACTA PHYSIOL PLANT, V35, P2721, DOI 10.1007/s11738-013-1304-z; Fazal H, 2016, J PHOTOCH PHOTOBIO B, V159, P1, DOI 10.1016/j.jphotobiol.2016.03.008; Gotz M, 2010, PROTOPLASMA, V243, P95, DOI 10.1007/s00709-009-0064-5; Gulidov S, 2013, J PLANT DIS PROTECT, V120, P122, DOI 10.1007/BF03356463; Hernandez R, 2016, ENVIRON EXP BOT, V121, P66, DOI 10.1016/j.envexpbot.2015.04.001; Hoffmann AM, 2015, ENVIRON EXP BOT, V109, P254, DOI 10.1016/j.envexpbot.2014.06.017; Hu ZQ, 2013, ARCH BIOL SCI, V65, P247, DOI 10.2298/ABS1301247H; Huche-Thelier L, 2016, ENVIRON EXP BOT, V121, P22, DOI 10.1016/j.envexpbot.2015.06.009; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Kim YJ, 2015, J AGR FOOD CHEM, V63, P6772, DOI 10.1021/acs.jafc.5b02086; Krumbein A., 2005, Journal of Applied Botany and Food Quality, V79, P168; Kuhlmann F, 2010, PLANT BIOLOGY, V12, P676, DOI 10.1111/j.1438-8677.2009.00257.x; Kuhlmann F, 2009, J EXP BOT, V60, P3467, DOI 10.1093/jxb/erp182; Mewis I, 2012, PLANT CELL PHYSIOL, V53, P1546, DOI 10.1093/pcp/pcs096; Neugart S, 2014, J AGR FOOD CHEM, V62, P4054, DOI 10.1021/jf4054066; Neugart S, 2012, PHYSIOL PLANTARUM, V145, P582, DOI 10.1111/j.1399-3054.2012.01567.x; PINHEIRO J, 2012, R DEV CORE TEAM NLME; Qian HM, 2016, FOOD CHEM, V196, P1232, DOI 10.1016/j.foodchem.2015.10.055; R Core Team, 2018, R LANG ENV STAT COMP; Rechner O, 2016, J CHEM ECOL, V42, P989, DOI 10.1007/s10886-016-0755-2; Rechner O, 2014, J PLANT DIS PROTECT, V121, P125, DOI 10.1007/BF03356500; Schmidt S, 2010, RAPID COMMUN MASS SP, V24, P2009, DOI 10.1002/rcm.4605; Schreiner M, 2012, CRIT REV PLANT SCI, V31, P229, DOI 10.1080/07352689.2012.664979; Singh D, 2015, RENEW SUST ENERG REV, V49, P139, DOI 10.1016/j.rser.2015.04.117; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Vanninen I, 2010, ANN APPL BIOL, V157, P393, DOI 10.1111/j.1744-7348.2010.00438.x; Wang YH, 2013, AM J BOT, V100, P70, DOI 10.3732/ajb.1200354; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiesner M, 2013, J AGR FOOD CHEM, V61, P1943, DOI 10.1021/jf303970k; Yang YX, 2015, PLANT GROWTH REGUL, V76, P167, DOI 10.1007/s10725-014-9986-9; Zimmermann NS, 2007, MOL NUTR FOOD RES, V51, P1537, DOI 10.1002/mnfr.200700103	43	16	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188522	10.1371/journal.pone.0188522	http://dx.doi.org/10.1371/journal.pone.0188522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190278	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900067
J	Anderson, DG; Bissett, TG; Yerka, SJ; Wells, JJ; Kansa, EC; Kansa, SW; Myers, KN; DeMuth, RC; White, DA				Anderson, David G.; Bissett, Thaddeus G.; Yerka, Stephen J.; Wells, Joshua J.; Kansa, Eric C.; Kansa, Sarah W.; Myers, Kelsey Noack; DeMuth, R. Carl; White, Devin A.			Sea-level rise and archaeological site destruction: An example from the southeastern United States using DINAA (Digital Index of North American Archaeology)	PLOS ONE			English	Article							CLIMATE-CHANGE; CULTURAL-HERITAGE; GRAND CHALLENGES; 20-1ST CENTURY; IMPACT; VULNERABILITY; COAST; RESOURCES	The impact of changing climate on terrestrial and underwater archaeological sites, historic buildings, and cultural landscapes can be examined through quantitatively-based analyses encompassing large data samples and broad geographic and temporal scales. The Digital Index of North American Archaeology (DINAA) is a multi-institutional collaboration that allows researchers online access to linked heritage data from multiple sources and data sets. The effects of sea-level rise and concomitant human population relocation is examined using a sample from nine states encompassing much of the Gulf and Atlantic coasts of the southeastern United States. A 1 m rise in sea-level will result in the loss of over >13,000 recorded historic and prehistoric archaeological sites, as well as over 1000 locations currently eligible for inclusion on the National Register of Historic Places (NRHP), encompassing archaeological sites, standing structures, and other cultural properties. These numbers increase substantially with each additional 1 m rise in sea level, with >32,000 archaeological sites and >2400 NRHP properties lost should a 5 m rise occur. Many more unrecorded archaeological and historic sites will also be lost as large areas of the landscape are flooded. The displacement of millions of people due to rising seas will cause additional impacts where these populations resettle. Sea level rise will thus result in the loss of much of the record of human habitation of the coastal margin in the Southeast within the next one to two centuries, and the numbers indicate the magnitude of the impact on the archaeological record globally. Construction of large linked data sets is essential to developing procedures for sampling, triage, and mitigation of these impacts.	[Anderson, David G.; Yerka, Stephen J.] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; [Bissett, Thaddeus G.] Northern Kentucky Univ, Dept Anthropol, Highland Hts, KY 41076 USA; [Wells, Joshua J.] Indiana Univ South Bend, Dept Anthropol, South Bend, IN USA; [Kansa, Eric C.; Kansa, Sarah W.] Alexandria Arch Inst Open Context, San Francisco, CA USA; [Myers, Kelsey Noack; DeMuth, R. Carl] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [White, Devin A.] Oak Ridge Natl Lab, Geog Informat Sci & Technol Grp, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; Northern Kentucky University; Indiana University System; Indiana University South Bend; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Oak Ridge National Laboratory	Anderson, DG (corresponding author), Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA.	dander19@utk.edu		Yerka, Stephen/0000-0003-2131-4992; Kansa, Sarah Whitcher/0000-0001-7920-5321; Kansa, Eric/0000-0001-5620-4764	National Science Foundation [NSF 1217240, 1623621, 1216810, 1623644]; Institute of Museum and Library Services [LG-70-16-0056-16]; Division Of Behavioral and Cognitive Sci [1623644] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute of Museum and Library Services; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The development of DINAA is funded by the National Science Foundation (Awards Numbers NSF 1217240, 1623621, 1216810, 1623644), and the Institute of Museum and Library Services (Award #LG-70-16-0056-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessa L, 2015, BEST PRACTICES INTEG; Alexander C, 2008, FINAL REPORT THREATE; Allison I, 2009, COPENHAGEN DIAGNOSIS; Altschul JH, 2017, P NATL ACAD SCI USA, V114, P10999, DOI 10.1073/pnas.1715950114; Anderson D.G., 2013, PALEOAMERICAN ODYSSE, P183; Anderson D.G., 2007, CLIMATE CHANGE CULTU, P1; Anderson D.G., 2010, ARCHAEOLOGY E N AM, V38, P63; Anderson DavidG., 2007, CLIMATE CHANGE CULTU, P457; Anderson DG, 2015, MOBILITY ANCIENT SOC, P59; [Anonymous], 2017, DIN COAST DYN INT AS; Archaeology Southwest, 2012, ARCH CAF EXPL PROT P; Azmi NF, 2015, J DESIGN BUILT ENV, V15; Balsillie JH, 2009, GULF MEXICO ITS ORIG, V1, P53; Balsillie JH, 2004, FLORIDA GEOLOGICAL S, V103; Beavers RL, 2015, COASTAL ADAPTATION S, P19; Berenfield M.L, 2015, G WRIGHT FORUM, V32, P5; BIRD M K, 1992, Archaeology in Oceania, V27, P75; Bright E.A., 2012, LANDSCAN 2011; Caffrey M., 2008, NATL PARKS CLIMATE C, V25, P86; Caffrey M., 2013, PARK SCI, V30, P6; CARD (Canadian Archaeological Radiocarbon Database), 2017, WELCOME TO CARD 2 0; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Center for International Earth Science Information Network D CIESIN D Columbia University, 2013, LOW EL COAST ZON LEC; Clement JoelP., 2014, STRATEGY IMPROVING M; CRA (Chaco Research Archive), 2017, ENH ACC OV CENT ARCH; Dasgupta S, 2007, 4136 DC WORLD BANK P; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; DINAA (Digital Index of North American Archaeology), 2017, PROJ DIG IND N AM AR; Donoghue JF, 2011, CLIMATIC CHANGE, V107, P17, DOI 10.1007/s10584-011-0077-x; Edenhofer O., 2014, CONTRIBUTION WORKING; Erlandson J. M., 2008, J ISL COAST ARCHAEOL, V3, P167, DOI DOI 10.1080/15564890802436766; Erlandson JM, 2012, J COAST CONSERV, V16, P137, DOI 10.1007/s11852-010-0104-5; Evans A, 2012, ARCHAEOLOGICAL ANAL; Faught M.K., 2011, SUBMERGED PREHISTORY, P145; Faught MK, 2004, AM ANTIQUITY, V69, P275, DOI 10.2307/4128420; Faught MK, 2004, J FIELD ARCHAEOLOGY; Fiske S, 2014, ANTHR CLIMATE CHANGE; Fitzpatrick SM, 2006, J FIELD ARCHAEOL, V31, P251, DOI 10.1179/009346906791071954; Georgia SHPO, COASTAL STATE SITE D; Goetz P., 2010, THESIS; GonzuYlez J.L., 2006, EOS T, V87, P493, DOI [DOI 10.1029/2006EO450001, 10.1029/2006EO450001]; Gregory D., 2015, INT ARCH PHOTOGRAMME, V1, P367; Guedes JAD, 2016, P NATL ACAD SCI USA, V113, P14483, DOI 10.1073/pnas.1616188113; Gupta N, 2017, J ARCHAEOL METHOD TH, V24, P852, DOI 10.1007/s10816-016-9298-7; Haggarty JC, 1991, 1990 EXXON CULTURAL; Hally DJ, 1994, OCMULGEE ARCHAEOLOGY; Hambrecht G, 2017, AM ANTIQUITY, V82, P627, DOI 10.1017/aaq.2017.30; HAMDANLAB, 2016, GULF MEX SCHEM SHIPW; Hanson T., 2016, BILOXI CHITIMACHA CH; Hassan FA, 2007, AFR ARCHAEOL REV, V24, P73, DOI 10.1007/s10437-007-9018-5; Heitman C, 2017, ACM J COMPUT CULT HE, V10, DOI 10.1145/3012288; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; HOFFMAN Susanna M, 1999, ANGRY EARTH DISASTER, P302; Holtz D., 2014, NATL LANDMARKS RISK; Hutchings RM, 2017, MARITIME HERITAGE CR; Introduction Rockman M., 2011, ARCHAEOLOGY SOC ITS, P1; Iowa archaeology, 2015, FLOR GEORG SIT FIL L; Kansa EC, 2017, ANTIQUITY FORTHCOMIN; King TF, 2012, SAVING PLACES MATTER; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Kowlok J., 2015, COASTAL ADAPTATION S, P19; Lane PJ, 2015, J FIELD ARCHAEOL, V40, P485, DOI 10.1179/2042458215Y.0000000022; Lewis RB, 2000, AM ANTIQUITY, V65, P525, DOI 10.2307/2694534; Lightfoot KG, 2015, HOLOCENE, V25, P1581, DOI 10.1177/0959683615588376; Marwick B, 2017, SAA ARCHAEOLOGICAL R, V17, P8, DOI DOI 10.17605/0SF.I0/3D6XX; Marzeion B, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034001; Mccoy MD, 2017, J ARCHAEOL SCI, V84, P74, DOI 10.1016/j.jas.2017.06.003; McFadden PS, 2016, GEOARCHAEOLOGY, V31, P355, DOI 10.1002/gea.21549; McGranahan G., 2006, TIEMPO, V59, P23; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McKibben B, 2014, NEW YORK REV BOOKS, V61, P46; Mitchell P, 2008, ANTIQUITY, V82, P1093, DOI 10.1017/S0003598X00097805; Moore LJ, 2014, MAR GEOL, V355, P244, DOI 10.1016/j.margeo.2014.05.022; Murphy P., 2009, CONSERVATION MANAGEM, V11, P9, DOI DOI 10.1179/135050309X12508566208281; Neal WH, 2013, COASTAL CARE; Neumann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118571; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; NPS (National Park Service), 2014, CLIM CHANG STEW CULT, P14; NPS (National Park Service), 2012, POL MEM; NPS NRHP (National Park Service National Register of Historic Places Program: Research), 2017, NAT REG HIST PLAC PR; Nutley DM, 2006, LAST GLOBAL WARMING; O'Donoughue JM, 2008, THESIS; Oliver-Smith A, 2012, CATASTROPHE CULTURE; ORNL (Oak Ridge National Laboratory Geographic Information Science Technology Computational Science and Engineering Division), 2017, LANDSC 2011; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Peek K, 2015, ADAPTING CLIMATE CHA; Perez-Alvaro E., 2016, J CULTURAL HERITAGE; PeriodO, 2017, PER GAZ PER DEF LINK; PIDBA (Paleoindian Database of the Americas), 2017, PIDBA PALEOINDIAN DA; Pritchard EE, 2009, TVA ARCHAEOLOGY 70 5; Raviele M., 2014, ARCHAEOLOGY INTERDIS; Reeder LA, 2012, J COAST CONSERV, V16, P187, DOI 10.1007/s11852-010-0131-2; Reeder-Myers L, 2015, QUATERNARY RES, V83, P263, DOI 10.1016/j.yqres.2015.01.002; Reeder-Myers LA, 2015, J ISL COAST ARCHAEOL, V10, P436, DOI 10.1080/15564894.2015.1008074; Reger D, 1992, EXXON VALDEZ OIL SPI; Robinson MH, 2010, GEOARCHAEOLOGY, V25, P312, DOI 10.1002/gea.20309; Rockman M, 2016, CULTURAL RESOURCES P; Rockman M., 2012, ARCHAEOLOGY SOC ITS, P193, DOI DOI 10.1007/978-1-4419-9881-1_14; Rockman M., 2015, GEORG WRIGHT FORUM, V32, P37; Rogers LJ, 2015, J GEOPHYS RES EARTH; Rowland M.J., 1992, AUST ARCHAEOL, V34, P29, DOI [DOI 10.1080/03122417.1992.11681449, 10.1080/03122417.1992.11681449]; Russo M., 2006, NATL HIST LANDMARK T; Russo M., 1996, ARCHAEOLOGY MIDHOLOC, P177; Sabloff Jeremy A., 2008, ARCHAEOLOGY MATTERS, DOI DOI 10.4324/9781315434056; Sandweiss DH, 2012, ANNU REV ANTHROPOL, V41, P371, DOI 10.1146/annurev-anthro-092611-145941; Sanger Matthew, 2010, ANTHR PAPERS, V93, P201; Sassaman KE, 2014, NEW HIST PRECOLUMBIA, P143; Sassaman KE, 2016, J ISL COAST ARCHAEOL, P1; Sassaman KE., 2016, KNOWLEDGE MOTION CON, P271; Sassaman KE, 2012, ARCHAEOLOGIES, V8, P250, DOI 10.1007/s11759-012-9205-0; Sassaman Kenneth E., 2013, BIG HIST HUMAN LIVES, P171; Save-Soderbergh T., 1987, TEMPLES TOMBS ANCIEN; Schupp CA, 2015, COASTAL ADAPTATION S; Schwadron M., 2015, COASTAL ADAPTATION S, P7; Sheehan B., 2015, BEHAV SOCIAL SCI LIB, V34, P173, DOI DOI 10.1080/01639269.2015.1096155; Shi BH, 2012, J ISL COAST ARCHAEOL, V7, P183, DOI 10.1080/15564894.2012.686083; Smith J., 2015, ARCHAEOLOGY EVERYONE; Smith M., 2015, 1 AM C REV INT 2015; Sobotkova A, 2016, MOBILIZING DIGITAL F, P337; Sorset SR, 2015, ANN C HIST UND ARCH; Spennemann D. H. R., 1999, INT J PUBLIC ADMIN, V22, P745, DOI DOI 10.1080/01900699908525403; Spennemann DH, 1987, B INDOPACIFIC PREHIS, V7, P75; Spennemann DH, 2004, DISASTER MANAGEMENT, P113; Spigelman M., 2016, MOBILIZING DIGITAL F, P399; Strauss BH, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014033; tDAR (The Digital Archaeological Record), 2017, TDAR DIG ARCH REC SE; Thomas DH, 2008, ANTHROPOL PAP AM MUS, P42; Thompson VD, 2010, J FIELD ARCHAEOL, V35, P283, DOI 10.1179/009346910X12707321358991; Thompson VD, 2009, AM ANTIQUITY, V74, P255, DOI 10.1017/S0002731600048599; Titus JG, 2008, BACKGROUND DOCUMENTS, P2; Torresan S, 2008, SUSTAIN SCI, V3, P45, DOI 10.1007/s11625-008-0045-1; Ullah IIT, 2015, ADV ARCHAEOL PRACT, V3, P331, DOI 10.7183/2326-3768.3.4.331; UN Framework Convention on Climate Change, 2020, JOIN RACE; UN-United Nations, 2015, SEND FRAM DIS RISK R; United Nations, 2013, FRAM CONV CLIM CHAN; United Nations, 2016, HUM SETTL COAST ATL; USGS (United States Geological Survey), 2017, US GEOL SURV S NAT E; Vafeidis AT, 2008, J COASTAL RES, V24, P917, DOI 10.2112/06-0725.1; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [10.7930/J0KW5CXT, DOI 10.7930/J0KW5CXT]; Weiss JL, 2011, CLIMATIC CHANGE, V105, P635, DOI 10.1007/s10584-011-0024-x; Wells JJ, 2014, LIT LINGUIST COMPUT, V29, P349, DOI 10.1093/llc/fqu028; Westley K, 2011, J ISL COAST ARCHAEOL, V6, P351, DOI 10.1080/15564894.2010.520076; White A., 2017, E WOODLANDS HOUSEHOL; Wolinsky MA, 2009, J GEOPHYS RES; Yang ZQ, 2015, ESTUAR COAST SHELF S, V156, P19, DOI 10.1016/j.ecss.2014.08.015; ZELINSKY W, 1994, PROF GEOGR, V46, P29, DOI 10.1111/j.0033-0124.1994.00029.x; Zhong LJ, 2008, CONT SHELF RES, V28, P2565, DOI 10.1016/j.csr.2008.07.007	148	68	68	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188142	10.1371/journal.pone.0188142	http://dx.doi.org/10.1371/journal.pone.0188142			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186200	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900023
J	Li, JJ; Zhang, RB; Yang, Y				Li, Jianjun; Zhang, Rubo; Yang, Yu			Multi-AUV autonomous task planning based on the scroll time domain quantum bee colony optimization algorithm in uncertain environment	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; ASSIGNMENT; NAVIGATION	Research on distributed task planning model for multi-autonomous underwater vehicle (MAUV). A scroll time domain quantum artificial bee colony (STDQABC) optimization algorithm is proposed to solve the multi-AUV optimal task planning scheme. In the uncertain marine environment, the rolling time domain control technique is used to realize a numerical optimization in a narrowed time range. Rolling time domain control is one of the better task planning techniques, which can greatly reduce the computational workload and realize the tradeoff between AUV dynamics, environment and cost. Finally, a simulation experiment was performed to evaluate the distributed task planning performance of the scroll time domain quantum bee colony optimization algorithm. The simulation results demonstrate that the STDQABC algorithm converges faster than the QABC and ABC algorithms in terms of both iterations and running time. The STDQABC algorithm can effectively improve MAUV distributed tasking planning performance, complete the task goal and get the approximate optimal solution.	[Li, Jianjun; Zhang, Rubo] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Li, Jianjun; Yang, Yu] Harbin Univ Commerce, Sch Comp & Informat Engn, Harbin, Heilongjiang, Peoples R China; [Zhang, Rubo] Dalian Nationalities Univ, Coll Electromech & Informat Engn, Dalian, Liaoning, Peoples R China	Harbin Engineering University; Harbin University of Commerce; Dalian Minzu University	Li, JJ (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.; Li, JJ (corresponding author), Harbin Univ Commerce, Sch Comp & Informat Engn, Harbin, Heilongjiang, Peoples R China.	hrbec2008@126.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022					Awad AI, 2015, PROCEDIA COMPUT SCI, V65, P920, DOI 10.1016/j.procs.2015.09.064; Beheshti Z, 2015, APPL SOFT COMPUT, V28, P345, DOI 10.1016/j.asoc.2014.12.015; Bibuli M, 2015, ANNU REV CONTROL, V40, P127, DOI 10.1016/j.arcontrol.2015.09.007; Civicioglu P, 2013, ARTIF INTELL REV, V39, P315, DOI 10.1007/s10462-011-9276-0; Ferrante E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004273; Grozinger CM, 2014, APIDOLOGIE, V45, P327, DOI 10.1007/s13592-013-0253-2; He B, 2015, MEASUREMENT, V71, P89, DOI 10.1016/j.measurement.2015.02.026; Houts S. E., 2014, P OC STJOHNS CAN SEP, P1; Kang QM, 2011, MICROPROCESS MICROSY, V35, P10, DOI 10.1016/j.micpro.2010.11.001; Karaboga D, 2014, ARTIF INTELL REV, V42, P21, DOI 10.1007/s10462-012-9328-0; Loubiere P, 2016, APPL SOFT COMPUT, V41, P515, DOI 10.1016/j.asoc.2015.12.044; Malisoff M, 2015, SIAM J CONTROL OPTIM, V53, P2203, DOI 10.1137/120904354; Ozkale C, 2013, APPL MATH MODEL, V37, P7822, DOI 10.1016/j.apm.2013.01.045; Pamosoaji A. K., 2011, 8th Asian Control Conference (ASCC 2011), P85; Paull L, 2014, IEEE INT CONF ROBOT, P6592, DOI 10.1109/ICRA.2014.6907832; Pendharkar PC, 2015, J COMPUT SCI-NETH, V7, P37, DOI 10.1016/j.jocs.2015.01.001; Peng ZH, 2015, INFORM SCIENCES, V316, P163, DOI 10.1016/j.ins.2015.04.025; Sun J, 2012, EVOL COMPUT, V20, P349, DOI 10.1162/EVCO_a_00049; Yan Z, 2014, MATH PROBL ENG, V178, P368; Yuan DF, 2013, COMPUTER MODERN, V3, P9; Zhang S, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/302702	21	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188291	10.1371/journal.pone.0188291	http://dx.doi.org/10.1371/journal.pone.0188291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186166	Green Submitted, Green Published, gold			2022-12-26	WOS:000416484900026
J	Li, X; Wang, MH; Qin, C; Fan, WH; Tian, DS; Liu, JL				Li, Xiao; Wang, Ming-Huan; Qin, Chuan; Fan, Wen-Hui; Tian, Dai-Shi; Liu, Jun-Li			Fingolimod suppresses neuronal autophagy through the mTOR/p70S6K pathway and alleviates ischemic brain damage in mice	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; CEREBRAL-ISCHEMIA; MULTIPLE-SCLEROSIS; CELL-DEATH; RAT MODEL; FTY720; ACTIVATION; STROKE; INJURY; SPHINGOSINE-1-PHOSPHATE	The bioactive, signaling lipid, sphingosine-1-phosphate (S1P), and its analog, fingolimod (FTY720), have previously shown neuroprotective effects against ischemic brain injury. However, the underlying mechanisms have not yet been fully clarified. The roles of autophagy in ischemic stroke are being increasingly recognized. In the present study, we sought to determine whether the S1P pathway is involved in neuronal autophagy and investigate its possible mechanisms following stroke. Interestingly, we found that FTY720 significantly attenuates infarct volumes and reduces neuronal apoptosis on days 1 and 3 post stroke, accompanied by amelioration of functional deficits. Additionally, FTY720 was found to decrease the induction of autophagosome proteins, microtubule-associated protein 1 light chain 3(LC3-II) and Beclin1, following ischemic stroke in a dose-dependent manner. Meanwhile, protein levels of the mammalian target of rapamycin (mTOR) and the 70-kDa ribosomal protein, S6 kinase1 (p70S6K), were also up-regulated in FTY720-treated animals, and the nonspecific SphK inhibitor, N,N-dimethylsphingosine (DMS), was found to cause a reverse effect. Our results indicate that modulation of the S1P signaling pathway by FTY720 could effectively decrease neuronal autophagy through the mTOR/p70S6K pathway and attenuate ischemic brain injury in mice.	[Li, Xiao; Wang, Ming-Huan; Qin, Chuan; Fan, Wen-Hui; Tian, Dai-Shi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China; [Li, Xiao] Wuhan Gen Hosp PLA, Dept Geriatr, Wuhan, Hubei, Peoples R China; [Liu, Jun-Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, JL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan, Hubei, Peoples R China.	junli78@foxmail.com		Tian, Dai-shi/0000-0002-7627-0811	National Natural Science Foundation of China [81571132, 81171157, 81301000]; Fundamental Research Funds for the Central Universities [2017KFYXJJ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (81571132, 81171157 and 81301000) and the Fundamental Research Funds for the Central Universities (2017KFYXJJ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Alinari L, 2012, AUTOPHAGY, V8, P416, DOI 10.4161/auto.19050; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brunkhorst R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070124; Calise S, 2012, BBA-MOL CELL RES, V1823, P439, DOI 10.1016/j.bbamcr.2011.11.016; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fu Y, 2014, P NATL ACAD SCI USA, V111, P18315, DOI 10.1073/pnas.1416166111; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Haussinger D, 1999, GASTROENTEROLOGY, V116, P921, DOI 10.1016/S0016-5085(99)70076-4; Huang JS, 1999, ARCH BIOCHEM BIOPHYS, V366, P131, DOI 10.1006/abbi.1999.1203; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kalhori V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066189; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Q, 2014, BIOCHEM BIOPH RES CO, V444, P182, DOI 10.1016/j.bbrc.2014.01.032; Liao AJ, 2012, EUR J PHARM SCI, V45, P600, DOI 10.1016/j.ejps.2011.12.014; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Manchon JFM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15213; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mitroi DN, 2017, AUTOPHAGY, V13, P885, DOI 10.1080/15548627.2017.1291471; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Qu WS, 2010, NEUROCHEM RES, V35, P1716, DOI 10.1007/s11064-010-0234-z; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xu J, 2017, NEUROCHEM RES, V42, P2968, DOI 10.1007/s11064-017-2328-3; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79	46	37	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188748	10.1371/journal.pone.0188748	http://dx.doi.org/10.1371/journal.pone.0188748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186197	gold, Green Submitted, Green Published			2022-12-26	WOS:000416484900057
J	Obata, Y; Ruzankin, P; Berkowitz, DE; Steppan, J; Barodka, V				Obata, Yurie; Ruzankin, Pavel; Berkowitz, Dan E.; Steppan, Jochen; Barodka, Viachaslau			Difference between ejection times measured at two different peripheral locations as a novel marker of vascular stiffness	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS	Pulse wave velocity (PWV) has been recommended as an arterial damage assessment tool and a surrogate of arterial stiffness. However, the current technology does not allow to measure PWV both continuously and in real-time. We reported previously that peripherally measured ejection time (ET) overestimates ET measured centrally. This difference in ET is associated with the inherent vascular properties of the vessel. In the current study we examined ETs derived from plethysmography simultaneously at different peripheral locations and examined the influence of the underlying arterial properties on ET prolongation by changing the subject's position. We calculated the ET difference between two peripheral locations (Delta EI) and its corresponding PWV for the same heartbeat. The Delta ET increased with a corresponding decrease in PWV. The difference between Delta ET in the supine and standing (which we call ET index) was higher in young subjects with low mean arterial pressure and low PWV. These results suggest that the difference in ET between two peripheral locations in the supine vs standing positions represents the underlying vascular properties. We propose Delta ET in the supine position as a potential novel real-time continuous and non-invasive parameter of vascular properties, and the ET index as a potential non-invasive parameter of vascular reactivity.	[Obata, Yurie; Berkowitz, Dan E.; Steppan, Jochen; Barodka, Viachaslau] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Cardiac Anesthesia, Baltimore, MD 21205 USA; [Ruzankin, Pavel] Sobolev Inst Math, Novosibirsk, Russia; [Ruzankin, Pavel] Novosibirsk State Univ, Novosibirsk, Russia	Johns Hopkins University; Russian Academy of Sciences; Sobolev Institute of Mathematics; Novosibirsk State University	Barodka, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Cardiac Anesthesia, Baltimore, MD 21205 USA.	vbarodk1@jhmi.edu	Ruzankin, Pavel S./I-8485-2014	Ruzankin, Pavel S./0000-0002-5262-3037; Barodka, Viachaslau/0000-0002-0953-0994				Alivon M, 2015, ARCH CARDIOVASC DIS, V108, P227, DOI 10.1016/j.acvd.2014.12.003; Avolio A, 2002, J HYPERTENS, V20, P2341, DOI 10.1097/00004872-200212000-00007; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lim J, 2015, AM J PHYSIOL-REG I, V309, pR1540, DOI 10.1152/ajpregu.00368.2015; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Ng K, 2011, AM J PHYSIOL-RENAL, V300, pF1431, DOI 10.1152/ajprenal.00079.2011; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nurnberger J, 2003, J HYPERTENS, V21, P2125, DOI 10.1097/01.hjh.0000098125.00558.40; Obata Y, 2017, HYPERTENS RES, V40, P811, DOI 10.1038/hr.2017.43; Obata Y, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00047; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Phillips JP, 2014, IEEE ENG MED BIO, P3809, DOI 10.1109/EMBC.2014.6944453; Salvi P, 2013, J APPL PHYSIOL, V115, P1610, DOI 10.1152/japplphysiol.00475.2013; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Steppan J, 2016, HYPERTENS RES, V39, P27, DOI 10.1038/hr.2015.109; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; Steppan J, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/263585; Teng XF, 2004, PHYSIOL MEAS, V25, P1323, DOI 10.1088/0967-3334/25/5/020; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Tsai WC, 2005, AM J HYPERTENS, V18, P1118, DOI 10.1016/j.amjhyper.2005.03.739; Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04; Wentland AL, 2013, J MAGN RESON IMAGING, V37, P853, DOI 10.1002/jmri.23877	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187781	10.1371/journal.pone.0187781	http://dx.doi.org/10.1371/journal.pone.0187781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186151	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900011
J	Deniz, S; Kurt, B; Oguzoncul, AF; Nazlican, E; Akbaba, M; Nayir, T				Deniz, Serdar; Kurt, Burak; Oguzoncul, Ayse Ferdane; Nazlican, Ersin; Akbaba, Muhsin; Nayir, Tufan			Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MAMMOGRAPHY	The aim of this study is to gather information about the knowledge, attitudes and behaviours of women regarding breast and cervical cancer, to increase the knowledge level of the relevant age group and to begin including the relevant age group in screening programs. This cross-sectional study is composed of 6910 women aged 30-69 years in Malatya, Turkey. The study aimed to reach 1782 women with a survey, and all of them were reached. The questionnaire form was completed with face-to-face interview. For statistical analysis, data were evaluated as number and percentage distributions. The average age of the women was 45.6 +/- 11.4. Nearly half of the women (46.4%) did not know that scans for early detection of breast and cervical cancers were free. Only 22.2% of women knew that breast cancer could be diagnosed early by mammography. 72.7% had never received a mammogram. One third (31.6%) of women did not know it was possible to recognize cervical cancer early, and two thirds (64.5%) of women had not received a Pap smear test. It has been determined that Turkish women do not have adequate knowledge about cancer diagnosis, early cancer diagnosis, and screening.	[Deniz, Serdar] Malatya Hlth Directorate, Malatya, Turkey; [Kurt, Burak; Nazlican, Ersin; Akbaba, Muhsin] Cukurova Univ, Dept Publ Hlth, Fac Med, Adana, Turkey; [Oguzoncul, Ayse Ferdane] Firat Univ, Dept Publ Hlth, Fac Med, Elazig, Turkey; [Nayir, Tufan] Minist Hlth Turkey Republ, Ankara, Turkey	Cukurova University; Firat University; Ministry of Health - Turkey	Kurt, B (corresponding author), Cukurova Univ, Dept Publ Hlth, Fac Med, Adana, Turkey.	kurtburak@msn.com	Deniz, Serdar/AAA-6094-2019; Nayir, Tufan/HHS-7629-2022; Nazlıcan, Ersin/J-8179-2018	Deniz, Serdar/0000-0002-6941-4813; Nayir, Tufan/0000-0003-4810-5410; Nazlıcan, Ersin/0000-0002-1460-1996				Acikgoz A., 2010, MEME SERVIKS KANSERI; Akyuz A, 2006, GULHANE MED J, V48, P25; Altunkan H, 2008, J BREAST HEALTH, V4, P84; Avci IA, 2007, J BREAST HEALTH, V3, P4; Behbakht K, 2004, OBSTET GYNECOL, V104, P1355, DOI 10.1097/01.AOG.0000143881.53058.81; Bora Ba ara B, 2013, HLTH MINISTERY TURKE, P34; Discigil G, 2007, MARMARA MED J, V20, P29; Duman N. B, 2013, UHOD-ULUSLAR HEMATOL, V23, P19; Dundar PE, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-43; Ekici E, 2007, J BREAST HEALTH, V3, P136; Ervik M, 2012, CANC INCIDENCE MORTA; Guvenc G, 2008, KADINLANN HUMAN PAPI; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Juon HS, 2003, PREV MED, V37, P585, DOI 10.1016/j.ypmed.2003.09.006; Karahan A, 2001, HEMSIRELERIN KENDI K, P57; Karayurt O, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-359; Kimmick GG, 2000, HEMATOL ONCOL CLIN N, V14, P213, DOI 10.1016/S0889-8588(05)70285-9; Kling M, 2010, INT J DERMATOL, V49, P377, DOI 10.1111/j.1365-4632.2010.04316.x; Ozan H, 2011, ULUDAG U TIP FAKULTE, V37, P145; Ozmen V, 2011, J BREAST HEALTH, V7, P1; Pinar G, 2008, INT J HEMATOL ONCOL, V18; Ramasamy, 2013, AM J PUBLIC HLTH RES, V1, P135, DOI [10.12691/ajphr-1-6-2, DOI 10.12691/AJPHR-1-6-2]; Secginli S, 2006, INT J NURS STUD, V43, P161, DOI 10.1016/j.ijnurstu.2005.02.004; Shrestha LB, 2000, HEALTH AFFAIR, V19, P204, DOI 10.1377/hlthaff.19.3.204; Takin L., 2007, DOGUM KADIN SAGLIGI; Tezcan S., 1992, EPIDEMIYOLOJI TIBBI; Warner E, 2014, JAMA-J AM MED ASSOC, V292, P1317	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188571	10.1371/journal.pone.0188571	http://dx.doi.org/10.1371/journal.pone.0188571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182654	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000038
J	Garciarena, CD; Malik, A; Swietach, P; Moreno, AP; Vaughan-Jones, RD				Garciarena, Carolina D.; Malik, Akif; Swietach, Pawel; Moreno, Alonso P.; Vaughan-Jones, Richard D.			Distinct moieties underlie biphasic H+ gating of connexin43 channels, producing a pH optimum for intercellular communication	FASEB JOURNAL			English	Article						gap junctions; acid-base; heart; brain; electrical synapse	GAP-JUNCTION PROTEIN; INTRACELLULAR PH; DEPENDENT MODULATION; GUINEA-PIG; VENTRICULAR MYOCYTES; CELLS; CALCIUM; PHOSPHORYLATION; PROTON; RAT	Most mammalian cells can intercommunicate via connexin-assembled, gap-junctional channels. To regulate signal transmission, connexin (Cx) channel permeability must respond dynamically to physiological and pathophysiological stimuli. One key stimulus is intracellular pH (pH(i)), which is modulated by a tissue's metabolic and perfusion status. Our understanding of the molecular mechanism of H+ gating of Cx43 channels-the major isoform in the heart and brain-is incomplete. To interrogate the effects of acidic and alkaline pH(i) on Cx43 channels, we combined voltage-clamp electrophysiology with pH(i) imaging and photolytic H+ uncaging, performed over a range of pH(i) values. We demonstrate that Cx43 channels expressed in HeLa or N2a cell pairs are gated biphasically by pHi via a process that consists of activation by H+ ions at alkaline pH(i) and inhibition at more acidic pH(i). For Cx43 channel-mediated solute/ion transmission, the ensemble of these effects produces a pH(i) optimum, near resting pH(i). By using Cx43 mutants, we demonstrate that alkaline gating involves cysteine residues of the C terminus and is independent of motifs previously implicated in acidic gating. Thus, we present a molecular mechanism by which cytoplasmic acid-base chemistry fine tunes intercellular communication and establishes conditions for the optimal transmission of solutes and signals in tissues, such as the heart and brain.	[Garciarena, Carolina D.; Malik, Akif; Swietach, Pawel; Vaughan-Jones, Richard D.] Univ Oxford, Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford, England; [Garciarena, Carolina D.] Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Dublin, Ireland; [Moreno, Alonso P.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA	University of Oxford; Royal College of Surgeons - Ireland; Utah System of Higher Education; University of Utah	Moreno, AP (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA.	alonso.moreno@utah.edu	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	British Heart Foundation [RG/08/016, RG/15/9/31534]; E.P. Abraham Cephalosporin Fund; Nora Eccles Harrison Treadwell Foundation; U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL63969]; Royal Society Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063969] Funding Source: NIH RePORTER; British Heart Foundation [RG/15/9/31534, RG/08/016/26423] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); E.P. Abraham Cephalosporin Fund; Nora Eccles Harrison Treadwell Foundation; U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute; Royal Society Fellowship(Royal Society of London); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	The authors thank Dr. Ningning Zhuang [Cardiovascular Research and Training Institute (CVRTI)] for contributions to the electrophysiologic data set. The authors appreciate the encouragement and reviews from Dr. Kenneth Spitzer (CVRTI). This work was supported by British Heart Foundation Programme Grants RG/08/016 (to R.D.V.-J.), and RG/15/9/31534 (to R.D.V.-J. and P.S.), the E.P. Abraham Cephalosporin Fund (to R.D.V.-J and C.D.G), the Nora Eccles Harrison Treadwell Foundation, and U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute Grant R01 HL63969 (to A.P.M.), and the Royal Society Fellowship (to P.S.). The authors declare no conflicts of interest.	Boassa D, 2010, TRAFFIC, V11, P1471, DOI 10.1111/j.1600-0854.2010.01109.x; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; DAHL G, 1991, EUR J BIOCHEM, V197, P141, DOI 10.1111/j.1432-1033.1991.tb15892.x; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Dovmark TH, 2017, ONCOGENE, V36, P4538, DOI 10.1038/onc.2017.71; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; EK JF, 1994, CIRC RES, V74, P1058, DOI 10.1161/01.RES.74.6.1058; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; GIMLICH RL, 1988, J CELL BIOL, V107, P1065, DOI 10.1083/jcb.107.3.1065; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; LAZRAK A, 1993, BIOPHYS J, V65, P2002, DOI 10.1016/S0006-3495(93)81242-6; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LIU SG, 1993, BIOPHYS J, V64, P1422, DOI 10.1016/S0006-3495(93)81508-X; Lurtz MM, 2007, AM J PHYSIOL-CELL PH, V293, pC1806, DOI 10.1152/ajpcell.00630.2006; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; Palacios-Prado N, 2010, P NATL ACAD SCI USA, V107, P9897, DOI 10.1073/pnas.1004552107; Palacios-Prado N, 2009, J PHYSIOL-LONDON, V587, P3251, DOI 10.1113/jphysiol.2009.171496; Peters NS, 1997, CIRCULATION, V95, P988; Pogoda K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0099-3; Skeberdis VA, 2011, J PHYSIOL-LONDON, V589, P3495, DOI 10.1113/jphysiol.2011.209072; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2002, J BIOMOL NMR, V23, P245, DOI 10.1023/A:1019892719979; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Swietach P, 2005, J PHYSIOL-LONDON, V566, P793, DOI 10.1113/jphysiol.2005.086165; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Swietach P, 2007, BIOPHYS J, V92, P641, DOI 10.1529/biophysj.106.096560; Swietach P, 2013, P NATL ACAD SCI USA, V110, pE2064, DOI 10.1073/pnas.1222433110; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; TURIN L, 1977, NATURE, V270, P56, DOI 10.1038/270056a0; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Willoughby D, 2001, J PHYSIOL-LONDON, V530, P405, DOI 10.1111/j.1469-7793.2001.0405k.x; Xie H, 2017, BIOMED RES INT, V2017; Zaniboni M, 2003, CIRC RES, V93, P726, DOI 10.1161/01.RES.0000093986.47383.CE	46	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1969	1981		10.1096/fj.201700876R	http://dx.doi.org/10.1096/fj.201700876R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29183963	Green Published			2022-12-26	WOS:000429051400019
J	Tuerde, D; Kimura, T; Miyasaka, T; Furusawa, K; Shimozawa, A; Hasegawa, M; Ando, K; Hisanaga, S				Tuerde, Dilina; Kimura, Taeko; Miyasaka, Tomohiro; Furusawa, Kotaro; Shimozawa, Aki; Hasegawa, Masato; Ando, Kanae; Hisanaga, Shin-ichi			Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; Alzheimer disease; brain; development; phosphorylation; Tau protein (Tau); AT8; Phos-tag; hypothyroidism; isoform	ALZHEIMERS-DISEASE; THYROID-HORMONE; FETAL-TAU; EXON 10; EXPRESSION; CEREBELLUM; NEURODEGENERATION; PLASTICITY; DISORDERS; SEQUENCES	Tau is a microtubule (MT)-associated protein that regulates MT dynamics in the axons of neurons. Tau binds to MTs via its C-terminal MT-binding repeats. There are two types of tau, those with three (3R) or four (4R) MT-binding repeats; 4R tau has a stronger MT-stabilizing activity than 3R tau. The MT-stabilizing activity of tau is regulated by phosphorylation. Interestingly, both the isoform and phosphorylation change at the time of neuronal circuit formation during postnatal development; highly phosphorylated 3R tau is replaced with 4R tau, which is less phosphorylated. However, it is not known how the transition of the isoforms and phosphorylation are regulated. Here, we addressed this question using developing mouse brains. Detailed analysis of developing brains revealed that the switch from 3R to 4R tau occurred during postnatal day 9 (P9) to P18 under the same time course as the conversion of phosphorylation from high to low. However, hypothyroidism, which is known to delay brain development, delayed the timing of tau dephosphorylation but not the exchange of isoforms, indicating that isoform switching and phosphorylation are not necessarily linked. Furthermore, we confirmed this finding by using mouse brains that expressed a single isoform of human tau. Human tau, either 3R or 4R, reduced phosphorylation levels during development even though the isoform did not change. We also found that 3R tau and 4R tau were phosphorylated differently in vivo even at the same developmental days. These results show for the first time that the phosphorylation and isoform alteration of tau are regulated differently during mouse development.	[Tuerde, Dilina; Kimura, Taeko; Furusawa, Kotaro; Ando, Kanae; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Miyasaka, Tomohiro] Doshisha Univ, Fac Life & Med Sci, Neuropathol, Kyotanabe, Kyoto 6100394, Japan; [Shimozawa, Aki; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan University; Doshisha University; Tokyo Metropolitan Institute of Medical Science	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		Miyasaka, Tomohiro/0000-0003-4867-7910; Hisanaga, Shin-ichi/0000-0002-7572-472X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-aid Project Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control) of Japan (to T. M., M. H., K. A., and S. H.) and by a MEXT grant-in-aid (to S. H. and T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson GW, 2008, CEREBELLUM, V7, P60, DOI 10.1007/s12311-008-0021-4; ANIELLO F, 1991, P NATL ACAD SCI USA, V88, P4035, DOI 10.1073/pnas.88.9.4035; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2010, J COMP NEUROL, V518, P2538, DOI 10.1002/cne.22351; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jovanov-Milosevic N, 2012, INT J BIOCHEM CELL B, V44, P1290, DOI 10.1016/j.biocel.2012.05.001; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Kimura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33479; Kimura T, 2016, AM J PATHOL, V186, P398, DOI 10.1016/j.ajpath.2015.10.009; Kimura T, 2013, J BIOL CHEM, V288, P7968, DOI 10.1074/jbc.M112.433326; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Koibuchi N, 2003, CEREBELLUM, V2, P279, DOI 10.1080/14734220310011920; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Oyanagi K, 2015, J NEUROSCI RES, V93, P592, DOI 10.1002/jnr.23519; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Sawano E, 2013, J NEUROSCI RES, V91, P382, DOI 10.1002/jnr.23161; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Singh TJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P43, DOI 10.1006/abbi.1996.0140; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Sugiyama S, 2009, DEV GROWTH DIFFER, V51, P369, DOI 10.1111/j.1440-169X.2009.01093.x; Takahashi M, 2008, J NEUROCHEM, V104, P640, DOI 10.1111/j.1471-4159.2007.05049.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yoshioka N, 2011, J NEUROSCI RES, V89, P381, DOI 10.1002/jnr.22552; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	53	29	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1781	1793		10.1074/jbc.M117.798918	http://dx.doi.org/10.1074/jbc.M117.798918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29196605	Green Published, hybrid			2022-12-26	WOS:000424201700028
J	Dieze, A; Stephan, T; Hilzendegen, C; Stroebele-Benschop, N				Dieze, Anastasia; Stephan, Theodora; Hilzendegen, Carolin; Stroebele-Benschop, Nanette			The impact of viewing a video with and without head phones on snack intake: A pilot study	PLOS ONE			English	Article							DUTCH EATING BEHAVIOR; INCREASED MEAL INTAKE; FOOD-INTAKE; ENVIRONMENTAL-FACTORS; QUESTIONNAIRE DEBQ; TELEVISION; OBESITY; INCREASES; ASSOCIATION; ADOLESCENTS	Research shows that many small changes to the environment impact one's eating behavior. The aim of this study was to examine whether the type of audio transmission would affect snack intake depending on the degree of immersion. A sample of 174 university students were randomized to either viewing a movie wearing headphones or listening over loud speakers while consuming a snack of their choice. Significant differences were found with more snacks consumed in the group without headphones compared to the group wearing headphones. Particularly women tend to eat less (about 10% of the offered snack less) when wearing headphones while viewing a movie. The results seem to indicate that audio transmission mode might impact eating behavior.	[Dieze, Anastasia; Stephan, Theodora; Hilzendegen, Carolin; Stroebele-Benschop, Nanette] Univ Hohenheim, Inst Nutr Med, Dept Nutr Psychol, Stuttgart, Germany	University Hohenheim	Stroebele-Benschop, N (corresponding author), Univ Hohenheim, Inst Nutr Med, Dept Nutr Psychol, Stuttgart, Germany.	n.stroebele@uni-hohenheim.de						Arno A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3272-x; Barrada JR, 2016, EUR EAT DISORD REV, V24, P503, DOI 10.1002/erv.2448; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bellisle F, 2001, AM J CLIN NUTR, V74, P197; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Braude L, 2014, APPETITE, V76, P9, DOI 10.1016/j.appet.2014.01.005; Chaput JP, 2011, AM J CLIN NUTR, V93, P1196, DOI 10.3945/ajcn.110.008680; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hill JO, 2008, OBES REV, V9, P41, DOI 10.1111/j.1467-789X.2007.00437.x; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jastreboff AM, 2014, EAT BEHAV, V15, P286, DOI 10.1016/j.eatbeh.2014.03.008; Kaiser D, 2016, PSYCHOL MUSIC, V44, P1419, DOI 10.1177/0305735616636207; Kallinen K, 2007, COMPUT HUM BEHAV, V23, P303, DOI 10.1016/j.chb.2004.10.014; Lombard M, 1997, J CMC, V3; Lyons EJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-60; Marsh S, 2013, APPETITE, V71, P259, DOI 10.1016/j.appet.2013.08.017; Mekhmoukh A, 2012, APPETITE, V59, P90, DOI 10.1016/j.appet.2012.03.021; Nagl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162510; Oh J, 2014, J MEDIA PSYCHOL-GER, V26, P81, DOI 10.1027/1864-1105/a000114; Peneau S, 2009, BRIT J NUTR, V102, P1854, DOI 10.1017/S0007114509991280; Rosiek A, 2015, INT J ENV RES PUB HE, V12, P9408, DOI 10.3390/ijerph120809408; Spence C., 2014, FLAVOUR, DOI [10.1186/2044-7248-3-9, DOI 10.1186/2044-7248-3-9]; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; Stroebele N, 2006, APPETITE, V47, P285, DOI 10.1016/j.appet.2006.04.001; Swinburn B, 2008, INT J OBESITY, V32, pS132, DOI 10.1038/ijo.2008.249; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Velema E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3927-7; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077055; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686	34	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188457	10.1371/journal.pone.0188457	http://dx.doi.org/10.1371/journal.pone.0188457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216205	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800023
J	Feldmann-Wustefeld, T; Miyakoshi, M; Petilli, MA; Schubo, A; Makeig, S				Feldmann-Wustefeld, Tobias; Miyakoshi, Makoto; Petilli, Marco Alessandro; Schubo, Anna; Makeig, Scott			Reduced visual attention in heterogeneous textures is reflected in occipital alpha and theta band activity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SEARCH; OSCILLATIONS; DISSOCIATION; PERFORMANCE; MECHANISM; SALIENCE; MODELS; N2PC; POP	Increasing context heterogeneity has been found to reduce attention deployment towards an embedded target item. Heterogeneity in visual search tasks is typically induced by segmenting the background into several perceptual groups. In the present study, however, context heterogeneity was induced by varying whole-field heterogeneity, i.e., the degree of distractor variability within the entire context. This allowed us to (i) more gradually vary context heterogeneity, and (ii) investigate attention deployment on a whole-field scale. Results showed that both search performance and amplitude of the N2pc (lateralized ERP; posterior contralateral negativity in the N2 range) monotonically decreased with increasing context heterogeneity, which confirmed that there was less efficient attention deployment for more heterogeneous contexts. The amplitude of the bilateral N2 exhibited a U-shaped function, suggesting global perception for the lowest and highest levels of heterogeneity, but local processing for intermediate heterogeneity levels. Independent component analyses revealed an occipital ERP-contributing effective source cluster that may reflect stimulus representations on a saliency map. With increasing heterogeneity, these sources exhibited more theta band activity for distractors and less theta band activity for targets. Alpha band activity of a second component cluster varied with heterogeneity level, and low-theta/delta activity of a third source cluster distinguished target presence versus absence. In sum, our results suggest that independent brain sources contributed to the differential processing of heterogeneous versus homogeneous contexts.	[Feldmann-Wustefeld, Tobias] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Miyakoshi, Makoto; Petilli, Marco Alessandro; Makeig, Scott] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA; [Petilli, Marco Alessandro] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Schubo, Anna] Philipps Univ Marburg, Fac Psychol Expt & Biol Psychol, Marburg, Germany	University of Chicago; University of California System; University of California San Diego; University of Milano-Bicocca; Philipps University Marburg	Feldmann-Wustefeld, T (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	tobiasfw@uchicago.edu	Petilli, Marco A/AAQ-3337-2020	Petilli, Marco A/0000-0002-9948-0029; Miyakoshi, Makoto/0000-0002-4062-6679	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB/TRR135]; Deutsche Studienstiftung	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Deutsche Studienstiftung	This research was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; SFB/TRR135, TP B3) to AS, by a Ph.D. grant to TFW by the Deutsche Studienstiftung, and by a gift to SM from The Swartz Foundation (Old Field NY).; This research was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; SFB/TRR135, TP B3) to AS, by a Ph.D. grant to TFW by the Deutsche Studienstiftung, and by a gift to S.M. from The Swartz Foundation (Old Field NY). The authors wish to thank Nicole Hakim for her valuable comments.	Avraham T, 2008, J VISION, V8, DOI 10.1167/8.4.9; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donk M, 2010, J EXP PSYCHOL HUMAN, V36, P286, DOI 10.1037/a0017605; Dowdall JR, 2012, NEUROPSYCHOLOGIA, V50, P2442, DOI 10.1016/j.neuropsychologia.2012.06.015; Dugue L, THETA OSCILLATIONS M, P945; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Feldmann-Wustefeld T, 2014, VISION RES, V97, P108, DOI 10.1016/j.visres.2014.02.008; Feldmann-Wustefeld T, 2013, ATTEN PERCEPT PSYCHO, V75, P1644, DOI 10.3758/s13414-013-0508-z; Feldmann-Wustefeld T, 2013, PSYCHOPHYSIOLOGY, V50, P722, DOI 10.1111/psyp.12061; Feldmann-Wustefeld T, 2013, J VISION, V13, DOI 10.1167/13.3.11; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Friston KJ, 1998, TRENDS COGN SCI, V2, P373, DOI 10.1016/S1364-6613(98)01227-3; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; HEINZE HJ, 1993, NEUROPSYCHOLOGIA, V31, P841, DOI 10.1016/0028-3932(93)90132-J; HUMPHREYS GW, 1989, J EXP PSYCHOL GEN, V118, P258, DOI 10.1037/0096-3445.118.3.258; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knierim JJ, 1992, NEURONAL RESPONSES S, V67; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1994, LUCK 1994 JEPHPP N2P; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1999, J NEUROSCI, V19, P2665; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mazza V, 2009, PSYCHOPHYSIOLOGY, V46, P771, DOI 10.1111/j.1469-8986.2009.00814.x; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; Meinecke C, 2002, PERCEPTION, V31, P591, DOI 10.1068/p3201; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; NOTHDURFT HC, 1992, PERCEPT PSYCHOPHYS, V52, P355, DOI 10.3758/BF03206697; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palmer J a, 2008, COMPLEX CROSS SPECTR, V12, P660; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rosenholtz R, 2001, J EXP PSYCHOL HUMAN, V27, P985, DOI 10.1037//0096-1523.27.4.985; Schubo A, 2004, COGNITIVE BRAIN RES, V21, P317, DOI 10.1016/j.cogbrainres.2004.06.007; Schubo A, 2007, BRAIN RES; Schubo A, 2007, BRAIN RES, V1138, P136, DOI 10.1016/j.brainres.2006.12.059; Schubo A, 2011, NEUROSCI LETT, V502, P46, DOI 10.1016/j.neulet.2011.07.022; Talsma D, 2009, BRAIN STRUCTURES INV, P761; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Wei P, 2009, NEUROIMAGE, V45, P993, DOI 10.1016/j.neuroimage.2008.12.053; Wykowska A, 2011, ATTEN PERCEPT PSYCHO, V73, P1034, DOI 10.3758/s13414-011-0122-x	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187763	10.1371/journal.pone.0187763	http://dx.doi.org/10.1371/journal.pone.0187763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216195	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000417337800011
J	de Francisco, P; Martin-Gonzalez, A; Turkewitz, AP; Gutierrez, JC				de Francisco, Patricia; Martin-Gonzalez, Ana; Turkewitz, Aaron P.; Gutierrez, Juan Carlos			Extreme metal adapted, knockout and knockdown strains reveal a coordinated gene expression among different Tetrahymena thermophila metallothionein isoforms	PLOS ONE			English	Article							STRESS-INDUCIBLE METALLOTHIONEIN; TRANSCRIPTION FACTOR-IIIA; ZINC; CLONING; COPPER; INDUCTION; TOLERANCE; EVOLUTION; NEMATODE; SINGLE	Metallothioneins (MT) constitute a superfamily of small cytosolic proteins that are able to bind metal cations through numerous cysteine (Cys) residues. Like other organisms the ciliate Tetrahymena thermophila presents several MT isoforms, which have been classified into two subfamilies (Cd-and Cu-metallothioneins). The main aim of this study was to examine the specific functions and transcriptional regulation of the five MT isoforms present in T. thermophila, by using several strains of this ciliate. After a laboratory evolution experiment over more than two years, three different T. thermophila strains adapted to extreme metal stress (Cd2+, Cu2+ or Pb2+) were obtained. In addition, three knockout and/or knockdown strains for different metallothionein (MT) genes were generated. These strains were then analyzed for expression of the individual MT isoforms. Our results provide a strong basis for assigning differential roles to the set of MT isoforms. MTT1 appears to have a key role in adaptation to Cd. In contrast, MTT2/4 are crucial for Cu-adaptation and MTT5 appears to be important for Pb-adaptation and might be considered as an "alarm" MT gene for responding to metal stress. Moreover, results indicate that likely a coordinated transcriptional regulation exists between the MT genes, particularly among MTT1, MTT5 and MTT2/4. MTT5 appears to be an essential gene, a first such report in any organism of an essential MT gene.	[de Francisco, Patricia; Martin-Gonzalez, Ana; Gutierrez, Juan Carlos] UCM, Fac Biol, Dept Microbiol 3, Madrid, Spain; [Turkewitz, Aaron P.] Univ Chicago, Dept Mol Genet & Cell Biol, Cummings Life Sci Ctr, 920 E 58Th St, Chicago, IL 60637 USA	Complutense University of Madrid; University of Chicago	Gutierrez, JC (corresponding author), UCM, Fac Biol, Dept Microbiol 3, Madrid, Spain.	juancar@bio.ucm.es	De Francisco, Patricia/AAC-4045-2021; MARTIN, ANA/ABG-7710-2020; De Francisco, Patricia/W-1289-2017	De Francisco, Patricia/0000-0003-0806-5514; Gutierrez, Juan Carlos/0000-0003-0909-3349	MINECO [CGL2016-75494-R]; NIH [GM-105783]; Spanish Ministry of Education [FPU12/02789]	MINECO(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education(Spanish Government)	This work was supported by MINECO CGL2016-75494-R; NIH GM-105783; A PhD scholarship was awarded to PdF by the Spanish Ministry of Education (FPU12/02789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD scholarship was awarded to PdF by the Spanish Ministry of Education (FPU12/02789).	Adamo GM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-1; Amaro F, 2008, GENE, V423, P85, DOI 10.1016/j.gene.2008.07.002; Amaro F, 2014, BIOMETALS, V27, P195, DOI 10.1007/s10534-014-9704-0; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Atrian Silvia, 2013, Biomol Concepts, V4, P143, DOI 10.1515/bmc-2012-0049; Blindauer CA, 2008, J INORG BIOCHEM, V102, P507, DOI 10.1016/j.jinorgbio.2007.10.032; Boldrin F, 2006, EUKARYOT CELL, V5, P422, DOI 10.1128/EC.5.2.422-425.2006; Boldrin F, 2002, PROTIST, V153, P283, DOI 10.1078/1434-4610-00105; Butler PR, 1996, BIOTECHNOL BIOENG, V49, P185, DOI 10.1002/(SICI)1097-0290(19960120)49:2<185::AID-BIT7>3.0.CO;2-M; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CassidyHanley D, 1997, GENETICS, V146, P135; Cheung, 2005, BBA-GENE STRUCT EXPR, V1731, P191, DOI [10.1016/j.bbaexp.2005.09.006, 10.1016/j.bbaexp.2005.9.006]; Costa D, 2012, ECOTOXICOLOGY, V21, P2078, DOI 10.1007/s10646-012-0961-9; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Daniels MJ, 2006, GENES CELLS, V11, P647; de Francisco P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2658-6; Diaz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000291; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Espart Anna, 2015, Int J Biol Sci, V11, P456, DOI 10.7150/ijbs.11060; Fu CJ, 2006, PROTIST, V157, P193, DOI 10.1016/j.protis.2006.02.006; Gadd GM, 2000, ENCY MICROBIOLOGY, P607; Guimaraes PMR, 2008, APPL ENVIRON MICROB, V74, P1748, DOI 10.1128/AEM.00186-08; Guo LN, 2008, GENE, V423, P29, DOI 10.1016/j.gene.2008.04.023; Gutierrez JC, 2011, J BIOL INORG CHEM, V16, P1025, DOI 10.1007/s00775-011-0820-9; Gutierrez JC, 2009, BIOESSAYS, V31, P805, DOI 10.1002/bies.200900011; Hockner M, 2011, J BIOL INORG CHEM, V16, P1057, DOI 10.1007/s00775-011-0826-3; Huang M, 2004, J INORG BIOCHEM, V98, P639, DOI 10.1016/j.jinorgbio.2004.02.004; Huang Y, 2016, PLOS GENET, V12, P1; Huggins CJ, 2016, MOL CELL BIOL, V36, P693, DOI 10.1128/MCB.00911-15; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; Kataoka K, 2010, J MICROBIOL METH, V82, P342, DOI 10.1016/j.mimet.2010.07.009; Klaassen CD, 1998, ENVIRON HEALTH PERSP, V106, P297, DOI 10.2307/3433930; Knipp M, 2005, BIOCHEMISTRY-US, V44, P3159, DOI 10.1021/bi047636d; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liu J, 1996, FUND APPL TOXICOL, V29, P294, DOI 10.1006/faat.1996.0034; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Niederwanger M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081747; Orihuela R, 2011, CHEM COMMUN, V47, P12155, DOI 10.1039/c1cc14819b; Ostrakhovitch EA, 2006, FEBS LETT, V580, P1235, DOI 10.1016/j.febslet.2006.01.036; Pedrini-Martha V, 2017, COMP BIOCHEM PHYS C, V199, P38, DOI 10.1016/j.cbpc.2017.02.009; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Quiming NS, 2005, J HEALTH SCI, V51, P8, DOI 10.1248/jhs.51.8; Sakulsak N, 2012, INT J MORPHOL, V30, P1007, DOI 10.4067/S0717-95022012000300039; Timmermans MJTN, 2005, ECOTOXICOLOGY, V14, P727, DOI 10.1007/s10646-005-0020-x; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Straalen NM, 2011, ECOTOXICOLOGY, V20, P574, DOI 10.1007/s10646-011-0631-3; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Vidal F, 1993, ZYGOTE, V1, P225, DOI 10.1017/S0967199400001507; Winkler AA, 2007, ADV BIOCHEM ENG BIOT, V10, P57, DOI DOI 10.1007/10_; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189076	10.1371/journal.pone.0189076	http://dx.doi.org/10.1371/journal.pone.0189076			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206858	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000417110700044
J	El-Bassossy, HM; Al-Thubiani, WS; Elberry, AA; Mujallid, MI; Ghareib, SA; Azhar, AS; Banjar, ZM; Watson, ML				El-Bassossy, Hany M.; Al-Thubiani, Wafaa S.; Elberry, Ahmed A.; Mujallid, Mohammad I.; Ghareib, Salah A.; Azhar, Ahmad S.; Banjar, Zainy M.; Watson, Malcolm L.			Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation	PLOS ONE			English	Article							MYOCARDIAL INFARCTED RATS; ARRHYTHMOGENIC CARDIOMYOPATHY; INSULIN-RESISTANCE; HEART-FAILURE; NITRIC-OXIDE; INHIBITION; MECHANISMS; DIAGNOSIS; MODEL; AORTA	Background The study aims to analyse the action of zingerone in diabetes-related cardiac arrhythmias. Methods Diabetes was induced by streptozocin while treatment groups received 20 mg/kg zingerone daily. Following extra seven weeks, electrocardiography, extraction of blood, urine and heart for biochemical analysis, histopathology and immunofluorescence were undertaken. Results The suppression of QT and QTc prolongation in diabetic rats was indicative of prolonged cardiac repolarisation that was greatly reduced by zingerone treatment. In addition, the reduction in PR interval attested that zingerone improved AV delay in diabetic rats. The fibrogenic transforming growth factor beta 1 upregulation in diabetic hearts was suppressed by zingerone. The marked glycogen deposition and muscle degeneration seen in diabetic heart sections were also alleviated by zingerone. Furthermore, zingerone prevented the decrease in of the serum anti-inflammatory cytokine adiponectin in diabetics. The heightened levels of oxidative stress markers 8-isoprostane and uric acid in diabetic rats were suppressed. In the diabetic heart, the reduced catalase activity was improved and the excessive expression of angiotensin receptor 1 was inhibited by zingerone. Conclusion Cardiac delayed repolarisation and AV conduction in rats with diabetes were halted by zingerone. It appears that inhibition of cardiac fibrosis and associated inflammation-oxidative stress signalling underpins the zingerone effect.	[El-Bassossy, Hany M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia; [El-Bassossy, Hany M.] Zagazig Univ, Fac Pharm, Zagazig, Egypt; [Al-Thubiani, Wafaa S.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Al-Thubiani, Wafaa S.] Umm AL Qura Univ, Fac Sci Appl, Mecca, Saudi Arabia; [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Dept Pharmacol, Bani Suwayf, Egypt; [Mujallid, Mohammad I.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Ghareib, Salah A.] Zagazig Univ, Dept Pharmacol, Fac Pharm, Zagazig, Egypt; [Azhar, Ahmad S.] King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah, Saudi Arabia; [Banjar, Zainy M.] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia; [Watson, Malcolm L.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University; Umm Al Qura University; Egyptian Knowledge Bank (EKB); Beni Suef University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University; King Abdulaziz University; University of Bath	El-Bassossy, HM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia.; El-Bassossy, HM (corresponding author), Zagazig Univ, Fac Pharm, Zagazig, Egypt.	helbassossy@kau.edu.sa	El-Bassossy, Hany M/I-1576-2012; Watson, Malcolm/AAA-6435-2020; El-Bassossy, Hany/O-2242-2019; Elberry, Ahmed A/I-1539-2012; Mujallid, Mohammad/AAL-4064-2020	El-Bassossy, Hany M/0000-0002-6838-6945; El-Bassossy, Hany/0000-0002-6838-6945; Elberry, Ahmed A/0000-0002-0073-3066; AL-Thubiani, wafa/0000-0003-3075-0681; Watson, Malcolm/0000-0001-9902-9521	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia [12-MED-3063-03]; National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia [12-MED-3063-03]	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia; National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia, https://www.kacst.edu.sa/eng/Pages/default.aspx - award number (12-MED-3063-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia, https://www. kacst.edu.sa/eng/Pages/default.aspx -award number (12-MED-3063-03). The authors also acknowledge with thanks the Science and Technology Unit, King Abdulaziz University, for technical support.	Ahmad B., 2015, SCI WORLD J, V2015; Ahmad Bilal, 2015, ScientificWorldJournal, V2015, P816364, DOI 10.1155/2015/816364; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Asimaki A, 2015, CAN J CARDIOL, V31, P1313, DOI 10.1016/j.cjca.2015.04.012; Azhar A, 2015, J ENDOCRINOL INVEST, V38, P437, DOI 10.1007/s40618-014-0209-z; Azhar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098281; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Cheong KO, 2016, ARCH PHARM RES, V39, P279, DOI 10.1007/s12272-015-0696-2; Choi MH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6842568; El-Bassossy HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0445-9; El-Bassossy HM, 2013, BRIT J PHARMACOL, V169, P693, DOI 10.1111/bph.12144; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103; Freckmann Guido, 2012, J Diabetes Sci Technol, V6, P1060; Ghareib SA, 2016, EUR J PHARMACOL, V780, P174, DOI 10.1016/j.ejphar.2016.03.046; Ghareib SA, 2015, DRUG DES DEV THER, V9, P6019, DOI 10.2147/DDDT.S94346; Gliemann L, 2014, FREE RADICAL RES, V48, P71, DOI 10.3109/10715762.2013.835045; GRIMM W, 1990, PACE, V13, P2086, DOI 10.1111/j.1540-8159.1990.tb06947.x; Hayat SA, 2004, CLIN SCI, V107, P539, DOI 10.1042/CS20040057; Hemalatha KL, 2016, EUR J PHARMACOL, V791, P595, DOI 10.1016/j.ejphar.2016.08.023; Hemalatha KL, 2015, J BIOCHEM MOL TOXIC, V29, P182, DOI 10.1002/jbt.21683; Hemalatha KL, 2015, J BIOCHEM MOL TOXIC, V29, P63, DOI 10.1002/jbt.21668; Hemalatha KL, 2016, RSC ADV, V6, P112332, DOI 10.1039/c6ra23330a; Kmecova J, 2010, EUR J PHARMACOL, V641, P187, DOI 10.1016/j.ejphar.2010.05.038; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Miguel-Carrasco JL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/726940; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Major P, 2016, BRIT J PHARMACOL, V173, P2046, DOI 10.1111/bph.13500; Mani V, 2016, MICROCHIM ACTA, P1; Miki T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0125-8; Movahed MR, 2007, DIABETES OBES METAB, V9, P276, DOI 10.1111/j.1463-1326.2006.00609.x; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; PODLAHA R, 1992, HORM METAB RES, V26, P84; Riegersperger M, 2011, INT UROL NEPHROL, V43, P441, DOI 10.1007/s11255-011-9929-6; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Sharma V, 2006, CAN J CARDIOL, V22, P305, DOI 10.1016/S0828-282X(06)70914-X; Tanaka K, 2014, CIRC-HEART FAIL, V7, P976, DOI 10.1161/CIRCHEARTFAILURE.114.001279; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; Vinothkumar R, 2014, EUR J CANCER PREV, V23, P361, DOI 10.1097/CEJ.0b013e32836473ac; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Yiu WH, 2010, LAB INVEST, V90, P620, DOI 10.1038/labinvest.2010.38	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189074	10.1371/journal.pone.0189074	http://dx.doi.org/10.1371/journal.pone.0189074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206854	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700043
J	Gaye, A; Gibbons, GH; Barry, C; Quarells, R; Davis, SK				Gaye, Amadou; Gibbons, Gary H.; Barry, Charles; Quarells, Rakale; Davis, Sharon K.			Influence of socioeconomic status on the whole blood transcriptome in African Americans	PLOS ONE			English	Article							GENE-EXPRESSION; CORTISOL-LEVELS; SOCIAL STRESS; HEALTH; INFLAMMATION; DISEASE; SUSCEPTIBILITY; DISPARITIES; ARTHRITIS; POVERTY	Background The correlation between low socioeconomic status (SES) and poor health outcome or higher risk of disease has been consistently reported by many epidemiological studies across various race/ancestry groups. However, the biological mechanisms linking low SES to disease and/or disease risk factors are not well understood and remain relatively understudied. The analysis of the blood transcriptome is a promising window for elucidating how social and environmental factors influence the molecular networks governing health and disease. To further define the mechanistic pathways between social determinants and health, this study examined the impact of SES on the blood transcriptome in a sample of African-Americans. Methods An integrative approach leveraging three complementary methods (Weighted Gene Co-expression Network Analysis, Random Forest and Differential Expression) was adopted to identify the most predictive and robust transcriptome pathways associated with SES. We analyzed the expression of 15079 genes (RNA-seq) from whole blood across 36 samples. Results The results revealed a cluster of 141 co-expressed genes over-expressed in the low SES group. Three pro-inflammatory pathways (IL-8 Signaling, NF-kappa B Signaling and Dendritic Cell Maturation) are activated in this module and over-expressed in low SES. Random Forest analysis revealed 55 of the 141 genes that, collectively, predict SES with an area under the curve of 0.85. One third of the 141 genes are significantly over-expressed in the low SES group. Conclusion Lower SES has consistently been linked to many social and environmental conditions acting as stressors and known to be correlated with vulnerability to chronic illnesses (e.g. asthma, diabetes) associated with a chronic inflammatory state. Our unbiased analysis of the blood transcriptome in African-Americans revealed evidence of a robust molecular signature of increased inflammation associated with low SES. The results provide a plausible link between the social factors and chronic inflammation.	[Gaye, Amadou; Gibbons, Gary H.; Davis, Sharon K.] NHGRI, NIH, Bethesda, MD 20892 USA; [Gibbons, Gary H.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Barry, Charles] Brown Univ, Providence, RI 02912 USA; [Quarells, Rakale] Morehouse Sch Med, Cardiovasc Res Inst, Community Hlth & Prevent Med, Atlanta, GA 30310 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Brown University; Morehouse School of Medicine	Gaye, A (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	amadou.gaye@nih.gov		Gaye, Amadou/0000-0002-1180-2792	National Institutes of Health [1RC4M D005964-0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID) was supported by the National Institutes of Health grant #1RC4M D005964-0 to GHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce MA, 2015, ADV CHRONIC KIDNEY D, V22, P46, DOI 10.1053/j.ackd.2014.06.008; Bruce MA, 2009, J INVEST MED, V57, P583, DOI 10.2310/JIM.0b013e31819dbb91; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chow JCC, 2003, AM J PUBLIC HEALTH, V93, P792, DOI 10.2105/AJPH.93.5.792; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Costello EJ, 2001, AM J PUBLIC HEALTH, V91, P1494, DOI 10.2105/AJPH.91.9.1494; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GLASER R, 1994, PSYCHONEUROENDOCRINO, V19, P765, DOI 10.1016/0306-4530(94)90023-X; Gosling JA, 2014, SLEEP MED, V15, P979, DOI 10.1016/j.sleep.2014.04.007; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Langfelder P, 2014, DATA ANAL QUESTIONS; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Miller GE, 2015, P NATL ACAD SCI USA, V112, P10325, DOI 10.1073/pnas.1505063112; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Piper C, 2014, ARTHRITIS RHEUMATOL, V66, P1955, DOI 10.1002/art.38647; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; REYNES JF, 1993, AM J PREV MED, V9, P365, DOI 10.1016/S0749-3797(18)30689-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Slavich GM, 2013, CLIN PSYCHOL SCI, V1, P331, DOI 10.1177/2167702613478594; Stringhini S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24780; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Wang XD, 2015, INT J CLIN EXP PATHO, V8, P7929; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Wu H, 2015, BIOINFORMATICS, V31, P233, DOI 10.1093/bioinformatics/btu640; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187290	10.1371/journal.pone.0187290	http://dx.doi.org/10.1371/journal.pone.0187290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206834	gold, Green Published, Green Submitted			2022-12-26	WOS:000417110700003
J	Leuning, DG; Engelse, MA; Lievers, E; Bijkerk, R; Reinders, MEJ; de Boer, HC; van Kooten, C; Rabelink, TJ				Leuning, Danielle G.; Engelse, Marten A.; Lievers, Ellen; Bijkerk, Roel; Reinders, Marlies E. J.; de Boer, Hetty C.; van Kooten, Cees; Rabelink, Ton J.			The human kidney capsule contains a functionally distinct mesenchymal stromal cell population	PLOS ONE			English	Article							RENAL CAPSULE; STEM-CELLS; PRECURSORS	We recently demonstrated that the adult human kidney cortex contains a perivascular stromal cell (kPSC) that shows organotypic properties and is important for repair and stabilisation of kidney function. Not only the kidney cortex but also the kidney capsule contains stromal cells that are important for the three dimensional organisation of the kidney during nephrogenesis. They provide the barrier function of the capsule which is critical for homeostatic processes such as pressure natriuresis. We postulated that stromal cells derived from the kidney capsule may therefore also have specific properties and functions. To this end, we isolated these capsule mesenchymal stromal cells (cMSC) from human cadaveric kidneys that were not suitable for transplantation. There were several similarities between cMSCs and kPSCs including support of vascular plexus formation, phenotypic marker expression and resistance against myofibroblast transformation. However, compared to kPSCs, cMSCs showed distinct mRNA and miRNA expression profiles, showed increased immunosuppressive capacity, and displayed strongly reduced HGF production, contributing to the inability to enhance kidney epithelial repair. Therefore cMSCs are a distinct, novel human kidney-derived MSC-population and these data underpin the large functional diversity of phenotypic similar stromal cells in relation to their anatomic site, even within one organ.	[Leuning, Danielle G.; Engelse, Marten A.; Lievers, Ellen; Bijkerk, Roel; Reinders, Marlies E. J.; de Boer, Hetty C.; van Kooten, Cees; Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Vasc & Regenerat Med, Dept Internal Med,Div Nephrol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rabelink, TJ (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Vasc & Regenerat Med, Dept Internal Med,Div Nephrol, Leiden, Netherlands.	a.j.rabelink@lumc.nl	Bijkerk, Roel/AAC-6977-2020; van Kooten, Cees/E-5694-2018; Rabelink, Ton J./A-5316-2008; Reinders, Marlies/AAF-2710-2019	Bijkerk, Roel/0000-0002-6438-4133; van Kooten, Cees/0000-0002-6257-0899; Rabelink, Ton J./0000-0001-6780-5186; Reinders, Marlies/0000-0001-9543-567X	European Community's Seventh Framework Program [305436]	European Community's Seventh Framework Program	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 305436 (STELLAR), http://cordis.europa.eu/project/rcn/105515_en.html.; The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 305436 (STELLAR).	Boivin FJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00081; Boivin FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120347; Bruno Stefania, 2012, Methods Mol Biol, V879, P367, DOI 10.1007/978-1-61779-815-3_22; Chen WCW, 2015, STEM CELLS, V33, P557, DOI 10.1002/stem.1868; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; GARCIAESTAN J, 1989, AM J PHYSIOL, V256, pF63, DOI 10.1152/ajprenal.1989.256.1.F63; Leuning DG, 2014, SEMIN NEPHROL, V34, P351, DOI 10.1016/j.semnephrol.2014.06.002; Leuning DG, 2016, STEM CELLS TRANSL ME; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Li W, 2014, DEV DYNAM, V243, P853, DOI [10.1002/dvdy.24134, 10.1002/DVDY.24134]; Little MH, 2016, NAT REV NEPHROL, V12, P624, DOI 10.1038/nrneph.2016.126; Naftali-Shani N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000253; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF1254, DOI 10.1152/ajprenal.00406.2009; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Wystrychowski W, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0343-y; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187118	10.1371/journal.pone.0187118	http://dx.doi.org/10.1371/journal.pone.0187118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206835	Green Submitted, gold, Green Published			2022-12-26	WOS:000417110700002
J	Bulut, T; Hung, YH; Tzeng, O; Wu, DH				Bulut, Talat; Hung, Yi-Hui; Tzeng, Ovid; Wu, Denise H.			Neural correlates of processing sentences and compound words in Chinese	PLOS ONE			English	Article							BROCAS AREA; CORTICAL REPRESENTATION; SYNTACTIC STRUCTURE; FUNCTIONAL-ANATOMY; TEMPORAL CORTEX; LANGUAGE; COMPREHENSION; BRAIN; FMRI; ACTIVATION	Sentence reading involves multiple linguistic operations including processing of lexical and compositional semantics, and determining structural and grammatical relationships among words. Previous studies on Indo-European languages have associated left anterior temporal lobe (aTL) and left interior frontal gyrus (IFG) with reading sentences compared to reading unstructured word lists. To examine whether these brain regions are also involved in reading a typologically distinct language with limited morphosyntax and lack of agreement between sentential arguments, an FMRI study was conducted to compare passive reading of Chinese sentences, unstructured word lists and disconnected character lists that are created by only changing the order of an identical set of characters. Similar to previous findings from other languages, stronger activation was found in mainly left-lateralized anterior temporal regions (including aTL) for reading sentences compared to unstructured word and character lists. On the other hand, stronger activation was identified in left posterior temporal sulcus for reading unstructured words compared to unstructured characters. Furthermore, reading unstructured word lists compared to sentences evoked stronger activation in left IFG and left inferior parietal lobule. Consistent with the literature on Indo-European languages, the present results suggest that left anterior temporal regions subserve sentence-level integration, while left IFG supports restoration of sentence structure. In addition, left posterior temporal sulcus is associated with morphological compounding. Taken together, reading Chinese sentences engages a common network as reading other languages, with particular reliance on integration of semantic constituents.	[Bulut, Talat; Wu, Denise H.] Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan; [Bulut, Talat] Istanbul Medipol Univ, Dept Speech & Language Therapy, Istanbul, Turkey; [Hung, Yi-Hui] Yale Univ, Haskins Labs, New Haven, CT USA; [Hung, Yi-Hui] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan; [Tzeng, Ovid] Acad Sinica, Inst Linguist, Taipei, Taiwan	National Central University; Istanbul Medipol University; Yale University; Haskins Laboratories; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Wu, DH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan.	denisewu@cc.ncu.edu.tw		Hung, Yi-Hui/0000-0003-2777-8341; Tzeng, Ovid J. L./0000-0002-0844-7865	National Science Council of Taiwan (NSC) [1022628-H-008-002-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council of Taiwan (NSC 1022628-H-008-002-MY3). [vim most goy tv]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Science Council Taiwan (NSC 102-2628-H008-002-MY3).	[Anonymous], 1993, LECT GOVT BINDING PI; [Anonymous], 2013, SPM8 MANUAL; Ben-Shachar M, 2004, NEUROIMAGE, V21, P1320, DOI 10.1016/j.neuroimage.2003.11.027; Ben-Shachar M, 2003, PSYCHOL SCI, V14, P433, DOI 10.1111/1467-9280.01459; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Bozic M, 2010, LANG LINGUIST COMPAS, V4, P1063, DOI 10.1111/j.1749-818x.2010.00254.x; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Caplan D, 2008, CORTEX, V44, P257, DOI 10.1016/j.cortex.2006.06.005; Chomsky N., 2014, ASPECTS THEORY SYNTA; Chomsky N., 2002, SYNTACTIC STRUCTURES, V2nd; Culicover PW, 2006, TRENDS COGN SCI, V10, P413, DOI 10.1016/j.tics.2006.07.007; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Feng SW, 2015, J NEUROLINGUIST, V33, P104, DOI 10.1016/j.jneuroling.2014.09.002; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00416; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Huang K, 2012, NEUROPSYCHOLOGIA, V50, P2598, DOI 10.1016/j.neuropsychologia.2012.07.011; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Hung YH, 2015, NEUROIMAGE, V122, P33, DOI 10.1016/j.neuroimage.2015.07.045; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Jobard G, 2007, NEUROIMAGE, V34, P784, DOI 10.1016/j.neuroimage.2006.06.067; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Laine M, 1999, NEUROSCI LETT, V271, P85, DOI 10.1016/S0304-3940(99)00527-3; Lehtonen M, 2006, BRAIN LANG, V98, P182, DOI 10.1016/j.bandl.2006.04.011; Luke KK, 2002, HUM BRAIN MAPP, V16, P133, DOI 10.1002/hbm.10029; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Makuuchi M, 2012, PHILOS T R SOC B, V367, P2033, DOI 10.1098/rstb.2012.0095; Marangolo P, 2006, CORTEX, V42, P1093, DOI 10.1016/S0010-9452(08)70221-1; Maruyama M, 2012, NEUROIMAGE, V61, P1444, DOI 10.1016/j.neuroimage.2012.04.020; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; Meinzer M, 2009, NEUROPSYCHOLOGIA, V47, P1964, DOI 10.1016/j.neuropsychologia.2009.03.008; Meyer L, 2012, NEUROIMAGE, V62, P1987, DOI 10.1016/j.neuroimage.2012.05.052; Myers J., 2006, REPRESENTATION PROCE, P169, DOI 10.1093/acprof:oso/9780199228911.003.0008; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Sakai KL, 2002, NEURON, V35, P1177, DOI 10.1016/S0896-6273(02)00873-5; Schneider W., 2002, PSYCHOL SOFTWARE TOO, V3, P1, DOI [10.1186/1756-0381-3-1, DOI 10.1186/1756-0381-3-1]; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Stowe LA, 2005, LINGUA, V115, P997, DOI 10.1016/j.lingua.2004.01.013; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P1963, DOI 10.1016/j.neuropsychologia.2005.03.008; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; Wang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124388; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	57	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188526	10.1371/journal.pone.0188526	http://dx.doi.org/10.1371/journal.pone.0188526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194453	Green Published, gold, Green Submitted			2022-12-26	WOS:000416867800013
J	Kondori, NR; Paul, P; Robbins, JP; Liu, K; Hildyard, JCW; Wells, DJ; de Belleroche, JS				Kondori, Nazanin Rahmani; Paul, Praveen; Robbins, Jacqueline P.; Liu, Ke; Hildyard, John C. W.; Wells, Dominic J.; de Belleroche, Jacqueline S.			Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; D-SERINE; PROLONGS SURVIVAL; ANIMAL-MODEL; DEGENERATION; RECEPTOR; TDP-43; GENES; MICE	Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neuromuscular disorder characterised by selective loss of motor neurons leading to fatal paralysis. Current therapeutic approaches are limited in their effectiveness. Substantial advances in understanding ALS disease mechanisms has come from the identification of pathogenic mutations in dominantly inherited familial ALS (FALS). We previously reported a coding mutation in D-amino acid oxidase (DAO(R199W)) associated with FALS. DAO metabolises D-serine, an essential co-agonist at the N-Methyl-D-aspartic acid glutamate receptor subtype (NMDAR). Using primary motor neuron cultures or motor neuron cell lines we demonstrated that expression of DAO(R199W), promoted the formation of ubiquitinated protein aggregates, activated autophagy and increased apoptosis. The aim of this study was to characterise the effects of DAO(R199W) in vivo, using transgenic mice overexpressing DAO(R199W). Marked abnormal motor features, e.g. kyphosis, were evident in mice expressing DAO(R199W), which were associated with a significant loss (19%) of lumbar spinal cord motor neurons, analysed at 14 months. When separated by gender, this effect was greater in females (26%; p<0.0132). In addition, we crossed the DAO(R199W) transgenic mouse line with the SOD1(G93A) mouse model of ALS to determine whether the effects of SOD1(G93A) were potentiated in the double transgenic line (DAO(R199W)/SOD1(G93A)). Although overall survival was not affected, onset of neurological signs was significantly earlier in female double transgenic animals than their female SOD1(G93A) littermates (125 days vs 131 days, P = 0.0239). In summary, some significant in vivo effects of DAO(R199W) on motor neuron function (i.e. kyphosis and loss of motor neurons) were detected which were most marked in females and could contribute to the earlier onset of neurological signs in double transgenic females compared to SOD1(G93A) littermates, highlighting the importance of recognizing gender effects present in animal models of ALS.	[Kondori, Nazanin Rahmani; Paul, Praveen; Robbins, Jacqueline P.; de Belleroche, Jacqueline S.] Imperial Coll London, Neurogenet Grp, Div Brain Sci, Hammersmith Hosp Campus, London, England; [Kondori, Nazanin Rahmani; Liu, Ke; Hildyard, John C. W.; Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, Neuromuscular Dis Grp, London, England; [Robbins, Jacqueline P.] Univ Oxford, Dept Psychiat, Oxford, England; [Liu, Ke] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England	Imperial College London; University of London; University of London Royal Veterinary College; University of Oxford; University of Liverpool	de Belleroche, JS (corresponding author), Imperial Coll London, Neurogenet Grp, Div Brain Sci, Hammersmith Hosp Campus, London, England.	j.belleroche@imperial.ac.uk	Hildyard, John/AAB-2260-2021	Hildyard, John/0000-0003-2283-2118; Robbins, Jacqueline P/0000-0002-6556-5999; de Belleroche, Jacqueline/0000-0002-0689-9577; Wells, Dominic/0000-0002-1425-6344	Motor Neurone Disease Association (UK)	Motor Neurone Disease Association (UK)	This project was funded by the Motor Neurone Disease Association (UK) following rigorous review of study design, methods for data collection and analysis provided in the grant application. They were not involved in the subsequent study or manuscript preparation.; We are grateful to the Motor Neurone Disease Association (UK) for funding this project.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Chen H. J, 2012, ENDOPLASMIC RETICULU, P323; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hampton TG, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/235354; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Jotova I, 1999, AMINO ACIDS, V17, P267, DOI 10.1007/BF01366925; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kaneb HMJ, 2012, PRECLINICAL TESTING; KONNO R, 1984, J NUTR, V114, P1617, DOI 10.1093/jn/114.9.1617; KONNO R, 1983, GENETICS, V103, P277; Li Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2779; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Martinez FJ, 2016, NEURON, V92, P780, DOI 10.1016/j.neuron.2016.09.050; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NEWMAN DS, 1995, J NEUROL SCI, V129, P38, DOI 10.1016/0022-510X(95)00058-A; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paul P, 2014, NEUROBIOL AGING, V35, P876, DOI 10.1016/j.neurobiolaging.2013.09.005; Paul P, 2012, AMINO ACIDS, V43, P1823, DOI 10.1007/s00726-012-1385-9; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; SASAKI M, 1992, BIOCHIM BIOPHYS ACTA, V1139, P315, DOI 10.1016/0925-4439(92)90107-X; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tedeschi G, 2012, METHODS MOL BIOL, V794, P381, DOI 10.1007/978-1-61779-331-8_26; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Vincelette J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2331; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watson C., 2008, SPINAL CORD; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188912	10.1371/journal.pone.0188912	http://dx.doi.org/10.1371/journal.pone.0188912			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194436	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000416867800016
J	Jung, H; Jung, SM; Rim, YA; Park, N; Nam, Y; Lee, J; Park, SH; Ju, JH				Jung, Hyerin; Jung, Seung Min; Rim, Yeri Alice; Park, Narae; Nam, Yoojun; Lee, Jennifer; Park, Sung-Hwan; Ju, Ji Hyeon			Arthritic role of Porphyromonas gingivalis in collagen-induced arthritis mice	PLOS ONE			English	Article							IMPROVING BIOSCIENCE RESEARCH; RHEUMATOID-ARTHRITIS; PEPTIDYLARGININE DEIMINASE; CITRULLINATED PROTEINS; ARRIVE GUIDELINES; BACTERIAL ADHESION; TUMOR-MARKERS; FIBRONECTIN; ASSOCIATION; ANTIBODIES	Epidemiological studies show an association between rheumatoid arthritis (RA) and periodontal disease. Porphyromonas gingivalis (P. gingivalis) is a well-known pathogen in periodontitis. This study investigated the pathogenic effects of P. gingivalis on autoimmune arthritis in vivo. Collagen-induced arthritis (CIA) mice were intraperitoneally injected with W83 and 2561 strains of P. gingivalis. Infection with P. gingivalis exacerbated arthritis score in CIA mice. Synovial inflammation and bone destruction in CIA mice infected with P. gingivalis were more severe than in uninfected CIA mice. Both W83 and 2561 strains were more pro-arthritic after arthritis symptom was fully activated. Interestingly, only W83 strain was arthritogenic before autoimmune reaction initiated. Citrullination was detected in synovial tissue of CIA mice and CIA mice inoculated with P. gingivalis, but not in normal control mice. The citrullinated area was greater in P. gingivalis-infected CIA mice than in non-infected CIA mice. This study showed that P. gingivalis exacerbated disease in a mouse model of autoimmune arthritis and increased the expression of citrullinated antigens in the synovium. The arthritogenic effects of P. gingivalis were at least in part, dependent upon the bacterial strain with or without fimbriae expression, route and time of infection. P. gingivalis-mediated citrullination may explain the possible link between periodontal disease and RA.	[Jung, Hyerin; Rim, Yeri Alice; Park, Narae; Nam, Yoojun; Lee, Jennifer; Ju, Ji Hyeon] Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea; [Jung, Hyerin; Rim, Yeri Alice; Park, Narae; Nam, Yoojun; Lee, Jennifer; Park, Sung-Hwan; Ju, Ji Hyeon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Jung, Seung Min] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System	Ju, JH (corresponding author), Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea.; Ju, JH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea.	juji@catholic.ac.kr		Ju, Ji Hyeon/0000-0002-1381-5466	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI14C3417]; Advanced Production Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries [312037-05]	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Advanced Production Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries	This work was supported by a grant from the Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI14C3417), and by a grant from the Advanced Production Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries (312037-05).	Abdullah SN, 2013, ANAEROBE, V23, P102, DOI 10.1016/j.anaerobe.2013.07.001; Arajo VMA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/259074; Berne C, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0018-2015; Bingham CO, 2013, CURR OPIN RHEUMATOL, V25, P345, DOI 10.1097/BOR.0b013e32835fb8ec; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Chang X, 2005, RHEUMATOLOGY, V44, P1374, DOI 10.1093/rheumatology/kei023; Chang XT, 2009, RHEUMATOL INT, V29, P1411, DOI 10.1007/s00296-009-0870-2; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; de Aquino SG, 2014, J IMMUNOL, V192, P4103, DOI 10.4049/jimmunol.1301970; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Ebina K, 2009, BIOCHEM BIOPH RES CO, V378, P186, DOI 10.1016/j.bbrc.2008.11.005; Eriksson B, 2000, DIGESTION, V62, P33, DOI 10.1159/000051853; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Fox DA, 2015, J IMMUNOL, V195, P5, DOI 10.4049/jimmunol.1501021; Geng J, 2011, ADV EXP MED BIOL, V715, P315, DOI 10.1007/978-94-007-0940-9_20; Ghosh A, 2008, INFECT IMMUN, V76, P5514, DOI 10.1128/IAI.00625-08; Harre U, J CLIN INVESTIGATION, V122, P1791; Huckel M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1869; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; Jansen LMA, 2003, J RHEUMATOL, V30, P1691; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.24; Kinloch A, 2008, ARTHRITIS RHEUM, V58; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; LEDERMANN JA, 1994, EUR J CANCER, V30A, P574, DOI 10.1016/0959-8049(94)90519-3; Li L, 2008, J AM CHEM SOC, V130, P1918, DOI 10.1021/ja0760877; Ling S, 2013, ARTHRITIS RHEUM-US, V65, P618, DOI 10.1002/art.37814; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Mangat P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3000; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Moscarello MA, 2007, NEUROCHEM RES, V32, P251, DOI 10.1007/s11064-006-9144-5; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; NIEDERMAN R, 1990, ARCH ORAL BIOL, V35, pS205, DOI 10.1016/0003-9969(90)90159-8; NIKLINSKI J, 1995, EUR J CANCER PREV, V4, P129, DOI 10.1097/00008469-199504000-00002; Okada M, 2013, J PERIODONTOL, V84, pE74, DOI 10.1902/jop.2013.130079; Park N, 2017, SCI REP-UK, V7, DOI 10.1038/srep39593; Persson G Rutger, 2012, J ORAL MICROBIOLOGY, V4; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Rim YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep06935; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Sanchez-Pernaute O, 2013, ANN RHEUM DIS, V72, P1400, DOI 10.1136/annrheumdis-2012-201906; Sandal I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1143-6; Sato K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07196-7; Sharma A, 1996, APPL ENVIRON MICROB, V62, P3933, DOI 10.1128/AEM.62.11.3933-3938.1996; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006; Totaro MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4243; van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Voskuyl AE, 1998, CLIN EXP RHEUMATOL, V16, P429; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yamada R, 2005, FRONT BIOSCI, V10, P54, DOI 10.2741/1506; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07	68	18	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188698	10.1371/journal.pone.0188698	http://dx.doi.org/10.1371/journal.pone.0188698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190705	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900103
J	Nabi, G; Hao, YJ; Zeng, XY; Zheng, JS; McLaughlin, RW; Wang, D				Nabi, Ghulam; Hao, Yujiang; Zeng, Xianyuan; Zheng Jinsong; McLaughlin, Richard W.; Wang, Ding			Hematologic and biochemical differences between two free ranging Yangtze finless porpoise populations: The implications of habitat	PLOS ONE			English	Article							PLASMA CHEMICAL-CONSTITUENTS; SERUM CHEMISTRY; BLOOD-CHEMISTRY; NEOPHOCAENA-ASIAEORIENTALIS; TOTAL CHOLESTEROL; BELUGA WHALES; DOLPHIN; CONSERVATION; HEALTHY; PARAMETERS	The goals of this study were to compare the serum chemistry and hematology values of wild and semi-natural free-ranging Yangtze Finless Porpoises (Neophocaena asiaeorientalis ssp. asiaeorientalis) populations and to ascertain how these values change with the different environmental condition. For this study, samples were collected from 81 YFPs, 35 living in the wild and 46 living in a semi-natural reserve. Each population was divided into 8 life history categories; Male Calf, Female Calf, Juvenile Male, Juvenile Female, Adult Male, Pregnant, Lactating and Pregnant plus Lactating. Statistically significant differences in the various parameters were observed in the same life history categories for both populations. Generally, Lipid Profile, Hepatic Enzymes, Creatine Kinase, Red Blood Cells, Hemoglobin, Hematocrit and Neutrophils were significantly higher in the Tian-E-Zhou Oxbow population while, Creatinine, Phosphate, Lactate Dehydrogenase, Bilirubin and Lymphocytes were significantly higher in the Poyang Lake YFPs. Across the groups in the Tian-E-Zhou Oxbow population, a significant decrease in serum Albumin, Alkaline Phosphatase and Calcium, while a significant increase in the Neutrophils and Platelets was observed. Similarly, in the Poyang Lake, Alkaline Phosphatase levels in the Female Calves group, High Density Lipoprotein Cholesterol in Lactating group, basophil counts in Pregnant plus Lactating group, lymphocytes counts in Juvenile Females group and Globulin and Total Protein levels in Pregnant group were significantly higher. This study in health assessments can help us to understand the effect of sex, age, reproductive status and environmental conditions on the well-being of Yangtze Finless Porpoises.	[Nabi, Ghulam; Hao, Yujiang; Zeng, Xianyuan; Zheng Jinsong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Nabi, Ghulam; Zeng, Xianyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [McLaughlin, Richard W.] Gateway Tech Coll, Gen Studies, Kenosha, WI USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, YJ; Wang, D (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China.	hao.yj@ihb.ac.cn; wangd@ihb.ac.cn			National Natural Science Foundation of China [31430080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 31430080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, ICES J MAR SCI, V59, P438, DOI 10.1006/jmsc.2001.1159; ANDERSEN S, 1968, NORD VET MED, V20, P267; ANDERSEN SOREN, 1966, NORD VETERINAER MED, V18, P51; [Anonymous], THESIS; [Anonymous], 1957, CHRONIC ILLNESS US, VI, P45; [Anonymous], FRESENIUS ENV B; [Anonymous], 2000, BIOL CONSERVATION FR; [Anonymous], 2013, NEOPHOCAENA ASIAEORI; [Anonymous], 2015, PROGR ACHIEVED NATUR; Antje K, 2012, ISRN ZOOLOGY; Asper ED, 1990, BOTTLENOSE DOLPHIN; Bayard M, 2006, AM FAM PHYSICIAN, V73, P1961; Berkow R., 1982, THE MERCK MANUAL, P820; Beuers U, 2005, SEMIN LIVER DIS, V25, P311, DOI 10.1055/s-2005-916322; Bondesson Jeffrey D., 1996, Emergency Medicine Clinics of North America, V14, P695, DOI 10.1016/S0733-8627(05)70275-3; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; BOSSART GD, 1984, J AM VET MED ASSOC, V185, P1413; BOSSART GD, 1990, J AM VET MED ASSOC, V196, P127; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Carey C, 2005, INTEGR COMP BIOL, V45, P4, DOI 10.1093/icb/45.1.4; CASTELLINI MA, 1992, EXPERIENTIA, V48, P575, DOI 10.1007/BF01920242; CASTELLINI MA, 1986, AM J PHYSIOL, V251, pR429, DOI 10.1152/ajpregu.1986.251.2.R429; CHEREL Y, 1992, J COMP PHYSIOL B, V162, P305, DOI 10.1007/BF00260757; Chown SL, 2008, P ROY SOC B-BIOL SCI, V275, P1469, DOI 10.1098/rspb.2008.0137; Colares EP, 2000, BRAZ ARCH BIOL TECHN, V43, P165, DOI 10.1590/S1516-89132000000200005; COOK RA, 1990, J ZOO WILDLIFE MED, V21, P65; DAILEY M, 1978, J WILDLIFE DIS, V14, P503, DOI 10.7589/0090-3558-14.4.503; de Leeuw J, 2010, REG ENVIRON CHANGE, V10, P95, DOI 10.1007/s10113-009-0096-6; Gao Anli, 1993, Aquatic Mammals, V19, P3; Gasper Mason C, 2005, Med Health R I, V88, P400; Greig DJ, 2010, J WILDLIFE DIS, V46, P1172, DOI 10.7589/0090-3558-46.4.1172; Hao YJ, 2009, MAR FRESHW BEHAV PHY, V42, P315, DOI 10.1080/10236240903302161; Harder John D., 1994, P275; HELLGREN EC, 1993, J MAMMAL, V74, P304, DOI 10.2307/1382385; Hoffmayer ER, 2006, J FISH BIOL, V68, P645, DOI 10.1111/j.0022-1112.2006.00942.x; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; Hua Y., 1987, Acta Hydrobiologica Sinica, V11, P99; Huey R.B., 1991, American Naturalist, V137, P91; Iwama GK, 1999, AM ZOOL, V39, P901; Jaber JR, 2003, J COMP PATHOL, V129, P226, DOI 10.1016/S0021-9975(03)00008-2; Jain NC, 1986, SCHALMS VET HEMATOLO, P601; Kakuschke A, 2011, MAR POLLUT BULL, V62, P1891, DOI 10.1016/j.marpolbul.2011.05.034; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Koopman HN, 1999, MAR MAMMAL SCI, V15, P52, DOI 10.1111/j.1748-7692.1999.tb00781.x; Kopec DA, 1995, MOSS LANDING MARINE, V1995, P96; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210/jc.86.6.2344; Lawler DF, 2014, PMMC CASE REP MAR MA, V1, P1; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Mayer S.A., 1998, REV SCI JUSTIFICATIO; Medway W, 1986, ZOO WILD ANIMAL MED, P38; Mei ZG, 2014, BIOL CONSERV, V172, P117, DOI 10.1016/j.biocon.2014.02.033; Mei ZG, 2012, BIOL CONSERV, V153, P192, DOI 10.1016/j.biocon.2012.04.029; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Mitchell SC, 2005, OIKOS, V110, P634, DOI 10.1111/j.0030-1299.2005.13810.x; Mueller B, 2011, MAR MAMMAL SCI, V27, P350, DOI 10.1111/j.1748-7692.2010.00404.x; Ongley ED, 1996, CROP EVAPOTRANSPIRAT, V55, P37; Patel MD, 2016, VET WORLD, V9, P38, DOI 10.14202/vetworld.2016.38-42; Pethybridge H, 2011, MAR BIOL, V158, P2741, DOI 10.1007/s00227-011-1773-9; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097877; PONGANIS PJ, 1992, AM J PHYSIOL, V262, pR322, DOI 10.1152/ajpregu.1992.262.2.R322; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Resendes AR, 2002, J PARASITOL, V88, P206, DOI 10.1645/0022-3395(2002)088[0206:HSIASD]2.0.CO;2; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; ROLETTO J, 1993, J ZOO WILDLIFE MED, V24, P145; Rosen DAS, 2008, J COMP PHYSIOL B, V178, P573, DOI 10.1007/s00360-007-0247-3; Savendahl L, 1999, J NUTR, V129, P2005, DOI 10.1093/jn/129.11.2005; Schelle P, 2010, RIVER DOLPHINS PEOPL; SCHWEIGERT FJ, 1993, COMP BIOCHEM PHYS A, V105, P353, DOI 10.1016/0300-9629(93)90220-X; Serdar B, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-114; Shiozaki A, 2017, J VET MED SCI, V79, P534, DOI 10.1292/jvms.16-0421; Sokolovic M, 2010, J HEPATOL, V52, P737, DOI 10.1016/j.jhep.2009.11.028; St Aubin DJ, 2013, MAR MAMMAL SCI, V29, P14, DOI 10.1111/j.1748-7692.2011.00536.x; STAUBIN DJ, 1989, CAN J FISH AQUAT SCI, V46, P796, DOI 10.1139/f89-099; Strassburg C P, 2006, Praxis (Bern 1994), V95, P1363; Sun SL, 2012, HYDROL EARTH SYST SC, V16, P2005, DOI 10.5194/hess-16-2005-2012; Tift MS, 2011, COMP BIOCHEM PHYS B, V159, P214, DOI 10.1016/j.cbpb.2011.04.005; Vaughn G., 1999, UNDERSTANDING EVALUA; Venn-Watson S, 2008, J WILDLIFE DIS, V44, P318, DOI 10.7589/0090-3558-44.2.318; Venn-Watson S, 2007, JAVMA-J AM VET MED A, V231, P596, DOI 10.2460/javma.231.4.596; Wang D, 2010, ESTABLISHING PROTECT; Wang D., 2013, B CHIN ACAD SCI, V27, P46; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang Z, 2013, INT CONF ASIC; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WILLIAMS TD, 1983, J WILDLIFE DIS, V19, P44, DOI 10.7589/0090-3558-19.1.44; WILSON E O, 1992; Wolf P L, 1999, Indian J Clin Biochem, V14, P59, DOI 10.1007/BF02869152; WOLKERS H, 1994, CAN J ZOOL, V72, P1291, DOI 10.1139/z94-172; Worthy GAJ, 1982, HARP SEAL PERSPECTIV, P186; Wu Chi-hong, 2006, Zhonghua Yi Xue Za Zhi, V86, P390	96	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188570	10.1371/journal.pone.0188570	http://dx.doi.org/10.1371/journal.pone.0188570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190288	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900077
J	Rodriguez, IB; Ho, TY				Rodriguez, Irene B.; Ho, Tung-Yuan			Interactive effects of spectral quality and trace metal availability on the growth of Trichodesmium and Symbiodinium	PLOS ONE			English	Article							DIAZOTROPHIC CYANOBACTERIA TRICHODESMIUM; NITROGEN-FIXATION; MARINE CYANOBACTERIUM; BIOOPTICAL PROPERTIES; N-2 FIXATION; LIGHT; PHYTOPLANKTON; LIMITATION; PHOTOSYNTHESIS; ZOOXANTHELLAE	Light and trace metals are critical growth factors for algae but how the interdependence of light quality and metal availability affects algal growth remains largely unknown. Our previous studies have demonstrated the importance of Ni and Fe on the growth of Trichodesmium and Symbiodinium, respectively, two important marine primary producers inhabiting environments with high light intensities. Here, we investigated the effects of light quality and intensity with availability of either Ni or Fe on their growth. For Trichodesmium, we found that specific growth rates for high Ni treatments were all significantly higher than in corresponding low Ni treatments with varying light quality and intensity. The inhibitory effect of low intensity red light was also countered by sufficient Ni supply. For Symbiodinium, we found that growth rates and biomass were reduced by 75% under low intensity red light and the stress can only be partially relieved by sufficient Fe supply. The results show that trace metal availability plays an important role in relieving the stress induced by low red light condition for both Trichodesmium and Symbiodinium although the cyanobacterium performs better in this growth condition. The difference may be attributed to the presence of phycocyanin, a unique pigment attuned to absorption of red light, in Trichodesmium. Our study shows that the concerted effects of light intensity and quality compounded with trace metal availability may influence the growth of photosynthetic organisms in the ocean.	[Rodriguez, Irene B.; Ho, Tung-Yuan] Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan; [Ho, Tung-Yuan] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Ho, TY (corresponding author), Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan.; Ho, TY (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	tyho@gate.sinica.edu.tw	Ho, Tung-Yuan/F-2323-2017	Rodriguez, Irene/0000-0001-9848-9526	Taiwan Ministry of Science and Technology [106-2611-M-001 -003 -, 105-2119-M-001 -039 -MY3]; Academia Sinica	Taiwan Ministry of Science and Technology; Academia Sinica(Academia Sinica - Taiwan)	This research was financially supported by Taiwan Ministry of Science and Technology grants numbers 106-2611-M-001 -003 -, 105-2119-M-001 -039 -MY3 and Career Development Award from Academia Sinica.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barros MP, 2013, AQUAT TOXICOL, V142, P195, DOI 10.1016/j.aquatox.2013.08.012; Bell PRF, 2005, HYDROBIOLOGIA, V543, P25, DOI 10.1007/s10750-004-5713-2; Breitbarth E, 2004, LIMNOL OCEANOGR-METH, V2, P282, DOI 10.4319/lom.2004.2.282; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2001, METHOD MICROBIOL, V30, P501, DOI 10.1016/S0580-9517(01)30060-0; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Dupont CL, 2008, APPL ENVIRON MICROB, V74, P23, DOI 10.1128/AEM.01007-07; DYKENS JA, 1982, NATURE, V297, P579, DOI 10.1038/297579a0; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fu FX, 2003, FEMS MICROBIOL ECOL, V45, P203, DOI 10.1016/S0168-6496(03)00157-0; GALLON JR, 1981, TRENDS BIOCHEM SCI, V6, P19, DOI 10.1016/0968-0004(81)90008-6; Ho TY, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00139; Ho TY, 2013, LIMNOL OCEANOGR, V58, P112, DOI 10.4319/lo.2013.58.1.0112; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hsieh P, 2014, PHOTOCHEM PHOTOBIOL, V90, P533, DOI 10.1111/php.12208; Hsieh P, 2013, INT BIODETER BIODEGR, V84, P258, DOI 10.1016/j.ibiod.2012.11.007; King AL, 2011, ISME J, V5, P1388, DOI 10.1038/ismej.2010.211; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Maruyama S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119406; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Rodriguez IB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00082; Rodriguez IB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04445; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; SIDDIQUI PJA, 1992, J PHYCOL, V28, P320, DOI 10.1111/j.0022-3646.1992.00320.x; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P618, DOI 10.4319/lo.1999.44.3.0618; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda WG, 1998, SCI TOTAL ENVIRON, V219, P165, DOI 10.1016/S0048-9697(98)00226-5; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; WALSBY AE, 1978, BRIT PHYCOL J, V13, P103, DOI 10.1080/00071617800650121; Walters K.J., 2013, COMMUN INTEGR BIOL, V6, DOI DOI 10.4161/cib.25005; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Westall J. C., 1976, 18 MASS I TECHN; Wijgerde T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092781; Williams R.J.P., 1991, BIOL CHEM ELEMENTS	45	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188777	10.1371/journal.pone.0188777	http://dx.doi.org/10.1371/journal.pone.0188777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190820	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900121
J	Tchelidze, P; Benassarou, A; Kaplan, H; O'Donohue, MF; Lucas, L; Terryn, C; Rusishvili, L; Mosidze, G; Lalun, N; Ploton, D				Tchelidze, Pavel; Benassarou, Aassif; Kaplan, Herve; O'Donohue, Marie-Francoise; Lucas, Laurent; Terryn, Christine; Rusishvili, Levan; Mosidze, Giorgi; Lalun, Nathalie; Ploton, Dominique			Nucleolar sub-compartments in motion during rRNA synthesis inhibition: Contraction of nucleolar condensed chromatin and gathering of fibrillar centers are concomitant	PLOS ONE			English	Article							TRANSCRIPTION MACHINERY; GENOMIC ARCHITECTURE; ORGANIZATION; GENES; PROTEIN; CONSTRUCTION; EPIGENETICS; BIOGENESIS; DYNAMICS; CAPS	The nucleolus produces the large polycistronic transcript (47S precursor) containing the 18S, 5.8S and 28S rRNA sequences and hosts most of the nuclear steps of pre-rRNA processing. Among numerous components it contains condensed chromatin and active rRNA genes which adopt a more accessible conformation. For this reason, it is a paradigm of chromosome territory organization. Active rRNA genes are clustered within several fibrillar centers (FCs), in which they are maintained in an open configuration by Upstream Binding Factor (UBF) molecules. Here, we used the reproducible reorganization of nucleolar components induced by the inhibition of rRNA synthesis by Actinomycin D (AMD) to address the steps of the spatiotemporal reorganization of FCs and nucleolar condensed chromatin. To reach that goal, we used two complementary approaches: i) time-lapse confocal imaging of cells expressing one or several GFP-tagged proteins (fibrillarin, UBF, histone H2B) and ii) ultrastructural identification of nucleolar components involved in the reorganization. Data obtained by time lapse confocal microscopy were analyzed through detailed 3D imaging. This allowed us to demonstrate that AMD treatment induces no fusion and no change in the relative position of the different nucleoli contained in one nucleus. In contrast, for each nucleolus, we observed step by step gathering and fusion of both FCs and nucleolar condensed chromatin. To analyze the reorganization of FCs and condensed chromatin at a higher resolution, we performed correlative light and electron microscopy electron microscopy (CLEM) imaging of the same cells. We demonstrated that threads of intranucleolar condensed chromatin are localized in a complex 3D network of vacuoles. Upon AMD treatment, these structures coalesce before migrating toward the perinucleolar condensed chromatin, to which they finally fuse. During their migration, FCs, which are all linked to ICC, are pulled by the latter to gather as caps disposed at the periphery of nucleoli.	[Tchelidze, Pavel; Rusishvili, Levan; Mosidze, Giorgi] Tbilisi State Univ, Fac Exact & Life Sci, Dept Morphol, Tbilisi, Georgia; [Benassarou, Aassif; Lucas, Laurent] Univ Reims, EA CRESTIC 3804, Reims, France; [Kaplan, Herve] Univ Reims, Reims, France; [O'Donohue, Marie-Francoise] Univ Toulouse, UPS, CNRS, CBI,Lab Biol Mol Eukaryote, Toulouse, France; [Terryn, Christine] Univ Reims, Platform Cellular & Tissular Imaging PICT, Reims, France; [Lalun, Nathalie; Ploton, Dominique] Univ Reims, CNRS, UMR 7369, Reims, France	Ivane Javakhishvili Tbilisi State University; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Reims Champagne-Ardenne	Ploton, D (corresponding author), Univ Reims, CNRS, UMR 7369, Reims, France.	dominique.ploton@univ-reims.fr	Ploton, Dominique DP/W-7169-2018	Ploton, Dominique DP/0000-0002-4541-3146; O'Donohue, Marie-Francoise/0000-0002-1204-8285				Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Benassarou A, 2002, VISION MODELING, AND VISUALIZATION 2002, PROCEEDINGS, P147; Bittar E, 2003, P 3 IASTED INT C VIS, P187; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Busch H, 1970, NUCLEOLUS, P1; Caudron-Herger M, 2015, EMBO J, V34, P2758, DOI 10.15252/embj.201591458; Cheutin T, 2002, J CELL SCI, V115, P3297; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2010, COLD SPRING HARB PER, V2, P38; DERENZINI M, 1990, J HISTOCHEM CYTOCHEM, V38, P1237, DOI 10.1177/38.9.2201735; Derenzini M, 1998, AM J PATHOL, V152, P1291; Derenzini M, 2006, J HISTOCHEM CYTOCHEM, V54, P131, DOI 10.1369/jhc.5R6780.2005; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Dundr M., 2010, COLD SPRING HARBOR P, V2, P1; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Floutsakou I, 2013, GENOME RES, V23, P2003, DOI 10.1101/gr.157941.113; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Grob A, 2014, CELL CYCLE, V13, P2501, DOI 10.4161/15384101.2014.949124; Grob A, 2014, GENE DEV, V28, P220, DOI 10.1101/gad.234591.113; Hadjiolov A.A., 1985, Cell Biology Monographs, V12, P1; Heliot L, 1997, MOL BIOL CELL, V8, P2199, DOI 10.1091/mbc.8.11.2199; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Jacob MD, 2013, MOL BIOL CELL, V24, P2943, DOI 10.1091/mbc.E13-04-0223; Jacob MD, 2016, NUCLEUS, V3, P314; Keene DR, 2008, MICROSC MICROANAL, V14, P342, DOI 10.1017/S1431927608080306; Leslie M, 2014, SCIENCE, V345, P506, DOI 10.1126/science.345.6196.506; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Mosgoeller W, 2004, MOL BIOL INTELL UNIT, P10; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Nolin F, 2013, CELL MOL LIFE SCI, V70, P2383, DOI 10.1007/s00018-013-1267-7; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; Olson M.O.J., 2004, SCI STKE, V2004, ppe10; Olson MOJ, 2011, NUCL PROTEIN REV, V15, P5; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pederson T, 2010, COLD SPRING HARB PER, V10, P1; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Polishchuk RS, 2001, CURRENT PROTOCOLS CE, P1; Pollock C, 2011, MOL BIOL CELL, V22, P858, DOI 10.1091/mbc.E10-09-0768; Pollock C, 2009, J CELL BIOCHEM, V107, P189, DOI 10.1002/jcb.22107; PUVIONDUTILLEUL F, 1992, EUR J CELL BIOL, V58, P149; Rashka I, 2006, INT REV CYTOL, V255, P177; REYNOLDS RC, 1964, CANCER RES, V24, P1269; ROUSSEL P, 1993, J CELL SCI, V104, P327; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; SIMARD R, 1974, CELL NUCLEUS, V3, P447; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Spector DL, 2001, J CELL SCI, V114, P2891; Stimpson K, 2014, PLOS ONE, V9, P2; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tchelidze Pavel, 2008, V463, P137, DOI 10.1007/978-1-59745-406-3_10; THIRY M, 1993, CELL TISSUE RES, V271, P33, DOI 10.1007/BF00297539; THIRY M, 1991, J CELL SCI, V99, P759; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Thiry M., 1996, MOL BIOL INTELLIGENC, P1; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhu L, 2015, CURR OPIN CELL BIOL, V34, P23, DOI 10.1016/j.ceb.2015.04.003; [No title captured]	82	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187977	10.1371/journal.pone.0187977	http://dx.doi.org/10.1371/journal.pone.0187977			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190286	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900026
J	Luu, TP; Brantley, JA; Nakagome, S; Zhu, FS; Contreras-Vidal, JL				Trieu Phat Luu; Brantley, Justin A.; Nakagome, Sho; Zhu, Fangshi; Contreras-Vidal, Jose L.			Electrocortical correlates of human level-ground, slope, and stair walking	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; TREADMILL WALKING; ACTIVATION PATTERNS; POSTERIOR PARIETAL; BRAIN ACTIVATION; SPEED CONTROL; GAIT; EEG; LOCOMOTION; SYNCHRONIZATION	This study investigated electrocortical dynamics of human walking across different unconstrained walking conditions (i. e., level ground (LW), ramp ascent (RA), and stair ascent (SA)). Non-invasive active-electrode scalp electroencephalography (EEG) signals were recorded and a systematic EEG processing method was implemented to reduce artifacts. Source localization combined with independent component analysis and k-means clustering revealed the involvement of four clusters in the brain during the walking tasks: Left and Right Occipital Lobe (LOL, ROL), Posterior Parietal Cortex (PPC), and Central Sensorimotor Cortex (SMC). Results showed that the changes of spectral power in the PPC and SMC clusters were associated with the level of motor task demands. Specifically, we observed a and beta suppression at the beginning of the gait cycle in both SA and RA walking (relative to LW) in the SMC. Additionally, we observed significant beta rebound (synchronization) at the initial swing phase of the gait cycle, which may be indicative of active cortical signaling involved in maintaining the current locomotor state. An increase of low gamma band power in this cluster was also found in SA walking. In the PPC, the low. band power increased with the level of task demands (from LW to RA and SA). Additionally, our results provide evidence that electrocortical amplitude modulations (relative to average gait cycle) are correlated with the level of difficulty in locomotion tasks. Specifically, the modulations in the PPC shifted to higher frequency bands when the subjects walked in RA and SA conditions. Moreover, low. modulations in the central sensorimotor area were observed in the LW walking and shifted to lower frequency bands in RA and SA walking. These findings extend our understanding of cortical dynamics of human walking at different level of locomotion task demands and reinforces the growing body of literature supporting a shared-control paradigm between spinal and cortical networks during locomotion.	[Trieu Phat Luu; Brantley, Justin A.; Nakagome, Sho; Zhu, Fangshi; Contreras-Vidal, Jose L.] Univ Houston, Dept Elect & Comp Engn, Noninvas Brain Machine Interface Syst Lab, Houston, TX 77004 USA	University of Houston System; University of Houston	Luu, TP (corresponding author), Univ Houston, Dept Elect & Comp Engn, Noninvas Brain Machine Interface Syst Lab, Houston, TX 77004 USA.	ptluu2@central.uh.edu	Zhu, Fangshi/AAS-9876-2021; Contreras-Vidal, Jose L/AAW-9299-2020	Zhu, Fangshi/0000-0002-3587-5531; Contreras-Vidal, Jose L/0000-0002-6499-1208	NSF [IIS-1302339]; Direct For Computer & Info Scie & Enginr [1302339] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research is supported by NSF award IIS-1302339 to Jose L Contreras-Vidal. There was no additional external funding received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by NSF award IIS-1302339. There was no additional external funding received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation. The authors would like to acknowledge Dr. Beom-Chan Lee for generously sharing the Xsens MVN system. We also would like to acknowledge the Center for Neuromotor and Biomechanics Research (CNBR) for permitting use of other equipment and space. We also would like to thank Dr. Recep A Ozdemir for his assistance in data collection.	Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Andujar JE, 2010, J NEUROPHYSIOL, V103, P986, DOI 10.1152/jn.00912.2009; BEISTEINER R, 1995, EVOKED POTENTIAL, V96, P183, DOI 10.1016/0168-5597(94)00226-5; Bradford JC, 2016, J NEUROPHYSIOL, V115, P958, DOI 10.1152/jn.00089.2015; Brantley J. A., 2016, INT C IEEE ENG MED B; Bulea TC, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00247; Bulea TC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00376; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cevallos C, 2015, NEUROPSYCHOLOGIA; Cheron G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/375148; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Doi T, 2013, AGING CLIN EXP RES, V25, P539, DOI 10.1007/s40520-013-0119-5; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gramann K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00202; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hamacher D, 2015, NEUROSCIENCE BIOBEHA; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; He Y, 2014, 2014 36 ANN INT C IE; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; Kilicarslan A, 2013, ENG MED BIOL SOC EMB; Kilicarslan A, 2013, IEEE ENG MED BIO, P5606, DOI 10.1109/EMBC.2013.6610821; Lajoie K, 2012, J NEUROPHYSIOL, V107, P2283, DOI 10.1152/jn.00756.2011; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lau TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-14; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Luu T.P., 2016, 2016 38 ANN INT C IE; Luu TP, 2015, VIRT REH PROC ICVR 2; McFadyen BJ, 1997, EXP BRAIN RES, V114, P500, DOI 10.1007/PL00005659; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Neuper C, 1996, NEUROSCI LETT, V216, P17; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Peterson DS, 2014, CLIN NEUROPHYSIOL, V125, P995, DOI 10.1016/j.clinph.2013.10.008; Peterson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090634; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Presacco A, 2012, IEEE T NEUR SYS REH, V20, P212, DOI 10.1109/TNSRE.2012.2188304; Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Seeber M, 2015, NEUROIMAGE, V112, P318, DOI 10.1016/j.neuroimage.2015.03.045; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Severens M, 2012, ENG MED BIOL SOC EMB, P1; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Trenado C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00380; Luu TP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036006; Van de Crommert HWAA, 1998, GAIT POSTURE, V7, P251, DOI 10.1016/S0966-6362(98)00010-1; Wagner J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00093; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Yu CS, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00265	62	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188500	10.1371/journal.pone.0188500	http://dx.doi.org/10.1371/journal.pone.0188500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190704	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900062
J	Visram, S; Crossley, SJ; Cheetham, M; Lake, A				Visram, Shelina; Crossley, Stephen J.; Cheetham, Mandy; Lake, Amelia			Children and young people's perceptions of energy drinks: A qualitative study	PLOS ONE			English	Article							CONSUMPTION PATTERNS; COLLEGE-STUDENTS; ALCOHOL; ADOLESCENTS; MOTIVATIONS; HEALTH; BEHAVIORS; ADULTS; RISK	Background Consumption of soft drinks is declining in many countries, yet energy drink sales continue to increase, particularly amongst young consumers. Little is currently known about the drivers behind these trends. Energy drinks are high in sugar and caffeine, and evidence indicates that regular or heavy use by under 18s is likely to be detrimental to health. This study aimed to explore children and young people's attitudes and perceptions in relation to energy drinks in a UK context. Methods Eight focus groups were conducted with pupils aged 10-11 years (n = 20) and 13-14 years (n = 17) from four schools in northern England. A sub-sample also took part in a mapping exercise to generate further insights. Data were analysed using the constant comparative approach. Results Energy drinks were reportedly consumed in a variety of public and private places, generally linked to social activities, sports and computer gaming (particularly amongst boys). Participants demonstrated strong brand awareness and preferences that were linked to taste and perceived value for money. The relatively low price of energy drinks and their widespread availability were identified as key factors, along with gendered branding and marketing. Some participants demonstrated a critical approach to manufacturers' claims and many were keen to become better informed, often through school-or peer-based interventions. Other potential interventions included age restrictions, voluntary schemes involving retailers and improved labelling. Conclusions The lack of a single dominant factor in participants' consumption choices suggests that there is unlikely to be a 'silver bullet' in attempting to address this issue. However, the findings provide support for policy-level interventions that seek to change the behaviours of manufacturers and retailers as well as consumers, and actively involve children and young people where possible.	[Visram, Shelina; Crossley, Stephen J.; Lake, Amelia] Univ Durham, Sch Med Pharm & Hlth, Queens Campus, Stockton On Tees, England; [Visram, Shelina; Cheetham, Mandy; Lake, Amelia] Newcastle Univ, Fuse UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Cheetham, Mandy] Univ Teesside, Sch Hlth & Social Care, Middlesbrough, Cleveland, England	Durham University; Newcastle University - UK; University of Teesside	Visram, S (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Queens Campus, Stockton On Tees, England.; Visram, S (corresponding author), Newcastle Univ, Fuse UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England.	shelina.visram@newcastle.ac.uk		Cheetham, Mandy/0000-0002-2616-9205; Visram, Shelina/0000-0001-9576-2689; Lake, Amelia/0000-0002-4657-8938	Childrens Foundation Child Health Research Programme [1000013]; MRC [MR/K02325X/1]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research under UK Clinical Research Collaboration; Wolfson Research Institute for Health and Wellbeing at Durham University; Medical Research Council [MR/K02325X/1B, MR/K02325X/1] Funding Source: researchfish	Childrens Foundation Child Health Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); Wolfson Research Institute for Health and Wellbeing at Durham University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Childrens Foundation Child Health Research Programme (registered charity no. 1000013). SV, MC and AAL are members of Fuse (UKCRC Centre for Translational Research in Public Health) (MRC grant ref. no. MR/K02325X/1). Funding for Fuse comes from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, and is gratefully acknowledged. The views expressed in this paper do not necessarily represent those of the funders or the UKCRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all of the children and young people who participated in the study. Many thanks also to the four head teachers who allowed us access to their schools and to the teachers who helped us to recruit their students. Support, guidance and expertise offered by the project advisory group-particularly Joanne Boyd from County Durham Drug and Alcohol Advice Services-was invaluable in undertaking the study. Colleagues from the Wolfson Research Institute for Health and Wellbeing at Durham University provided input into the initial funding application. Deborah Riby was a key member of the wider study team, but was not involved in qualitative fieldwork or data interpretation.	[Anonymous], 2017, AUSTR REIZE ENERGY D; Arria AM, 2014, NUTR REV, V72, P87, DOI 10.1111/nure.12129; Barbour R., 2008, DOING FOCUS GROUPS Q; BSDA, 2016, LEAD WAY ANN REP 201; Buchanan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171226; Bunting H, 2013, APPETITE, V65, P132, DOI 10.1016/j.appet.2013.02.011; Champlin S, 2013, 141 APHA ANN M EXP; Cheetham M, 2014, SEX EDUC-SEX SOC LEA, V14, P115, DOI 10.1080/14681811.2013.836963; Constantinides E., 2010, J MARKETING MANAGEME, V22, P407; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Costa BM, 2014, APPETITE, V80, P183, DOI 10.1016/j.appet.2014.05.013; Dorfman L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001241; Droste N, 2014, ALCOHOL CLIN EXP RES, V38, P2087, DOI 10.1111/acer.12438; Eckschmidt F, 2013, TRAFFIC INJ PREV, V14, P671, DOI 10.1080/15389588.2012.755261; Fields SK, 2015, BEVERAGES, V1, P218, DOI 10.3390/beverages1030218; Gordon R, 2012, AUSTRALAS MARK J, V20, P122, DOI 10.1016/j.ausmj.2011.10.005; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Heary CM, 2002, J PEDIATR PSYCHOL, V27, P47, DOI 10.1093/jpepsy/27.1.47; Huhtinen H., 2013, EUR J PUBLIC HEALTH, V23, DOI [10.1093/eurpub/ckt123.050, DOI 10.1093/EURPUB/CKT123.050]; Ibrahim NK, 2014, PAK J MED SCI, V30, P1415, DOI 10.12669/pjms.306.5396; ICCR, 2016, INT CHAIR CARD RISK; Johnson S, 2015, PREVENTIVE MED REPOR, V4, P496; Jones SC, 2011, AUSTRALAS MARK J, V19, P189, DOI 10.1016/j.ausmj.2011.05.005; Kitzinger J., 1995, BMJ, V311; Kristjansson AL, 2014, PREV MED, V58, P40, DOI 10.1016/j.ypmed.2013.10.011; Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008; Levant RF, 2015, HEALTH PSYCHOL, V34, P1100, DOI 10.1037/hea0000214; Marczinski CA, 2011, INT J ENV RES PUB HE, V8, P3232, DOI 10.3390/ijerph8083232; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Miyake ER, 2015, ADDICT BEHAV, V43, P60, DOI 10.1016/j.addbeh.2014.12.009; Mordor Intelligence LLP, 2016, GLOB EN DRINKS MARK; Musaiger O, 2014, GLOB J HLTH SCI, V6, P42; National Institutes of Health, 2014, COMM BAS PART RES NI; Nelson BD, 2008, CLIN J SPORT MED, V18, P200; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Nomisma-Arete Consortium, 2013, EXT SCI REP; O'Dea JA, 2003, HEALTH EDUC RES, V18, P98, DOI 10.1093/her/18.1.98; Oddy W., 2009, BMJ-BRIT MED J, V339, P64; Peacock A, 2015, ALCOHOL CLIN EXP RES, V39, P1083, DOI 10.1111/acer.12729; Peacock A, 2014, APPETITE, V76, P60, DOI 10.1016/j.appet.2014.01.003; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Santangelo B, 2013, DIGEST LIVER DIS, V45, pe275; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Shaw C., 2011, GUIDELINES RES CHILD; Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Tyrrell RL, 2017, J PUBLIC HEALTH-UK, V39, P95, DOI 10.1093/pubmed/fdw019; Verster JC, 2016, HUM PSYCHOPHARM CLIN, V31, P2, DOI 10.1002/hup.2513; Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380	50	26	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188668	10.1371/journal.pone.0188668	http://dx.doi.org/10.1371/journal.pone.0188668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190753	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900098
J	Mitchell, S; Williams, JP; Bhatti, H; Kachaamy, T; Weber, J; Weiss, GJ				Mitchell, Scott; Williams, John P.; Bhatti, Harsimrandeep; Kachaamy, Toufic; Weber, Jeffrey; Weiss, Glen J.			A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy	PLOS ONE			English	Article							QUALITY-OF-LIFE; NECK-CANCER; HEAD; MALNUTRITION; IMPACT	Background Many patients with cancer or other systemic illnesses can experience malnutrition. One way to mitigate malnutrition is by insertion of a percutaneous endoscopic gastrostomy feeding tube (PEG tube). The goal of this retrospective matched cohort study is to evaluate if PEG tube placement improved nutritional status and overall survival (OS) in advanced gastro-esophageal (GE) cancer patients who are undergoing anti-neoplastic therapy. Methods GE cancer patients who were treated and evaluated by a nutritionist and had at least 2 nutritionist follow-up visits were identified. Patients with PEG tube were matched to patients that did not undergo PEG placement (non-PEG). Clinical characteristics, GE symptoms reported at nutrition follow-up visits, and OS were recorded. Results 20 PEG and 18 non-PEG cases met criteria for further analyses. After correction for multiple testing, there were no OS differences between PEG and non-PEG, treatment naive and previously treated. However, PEG esophageal carcinoma has statistically significant inferior OS compared with non-PEG esophageal carcinoma. PEG placement did not significantly reduce the proportion of patients with weight loss between the initial nutrition assessment and 12-week follow-up. Conclusions In this small study, PEG placement had inferior OS outcome for GE esophageal carcinoma, no improvement in OS for other evaluated groups, and did not reduce weight loss between baseline and 12-week follow-up. Unless there is prospective randomized trial that can show superiority of PEG placement in this population, PEG placement in this group cannot be endorsed.	[Mitchell, Scott; Williams, John P.; Bhatti, Harsimrandeep] Arizona State Univ, Tempe, AZ USA; [Kachaamy, Toufic; Weber, Jeffrey; Weiss, Glen J.] Canc Treatment Ctr Amer, Western Reg Med Ctr, Goodyear, AZ 85338 USA; [Weiss, Glen J.] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Tempe; University of Arizona	Weiss, GJ (corresponding author), Canc Treatment Ctr Amer, Western Reg Med Ctr, Goodyear, AZ 85338 USA.; Weiss, GJ (corresponding author), Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA.	drglenweiss@outlook.com		weiss, glen/0000-0002-6067-597X	Western Regional Medical Center	Western Regional Medical Center	This work was funded by Western Regional Medical Center.	Capuano G, 2010, SUPPORT CARE CANCER, V18, P433, DOI 10.1007/s00520-009-0681-8; Corry J, 2009, HEAD NECK-J SCI SPEC, V31, P867, DOI 10.1002/hed.21044; Davies Michelle, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS64, DOI 10.1016/j.ejon.2005.09.005; Dwolatzky T, 2001, CLIN NUTR, V20, P535, DOI 10.1054/clnu.2001.0489; Gay F, ACTA GASTROENTEROL B, V55, P285; Isenring EA, 2004, BRIT J CANCER, V91, P447, DOI 10.1038/sj.bjc.6601962; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Loser C, 1998, DIGEST DIS SCI, V43, P2549, DOI 10.1023/A:1026615106348; Silander E, 2012, HEAD NECK-J SCI SPEC, V34, P1, DOI 10.1002/hed.21700; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007	10	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188628	10.1371/journal.pone.0188628	http://dx.doi.org/10.1371/journal.pone.0188628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186164	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900047
J	Tschinkel, WR; Hanley, N				Tschinkel, Walter R.; Hanley, Nicholas			Vertical organization of the division of labor within nests of the Florida harvester ant, Pogonomyrmex badius	PLOS ONE			English	Article							TEMPORAL POLYETHISM; AGE POLYETHISM; HYMENOPTERA-FORMICIDAE; CARBON-DIOXIDE; LIFE-HISTORY; FIRE ANT; TRANSPORT; WORKERS; SOCIOGENESIS; ALLOCATION	In the Florida harvester ant, Pogonomyrmex badius, foragers occur only in the top 15 cm of the nest, whereas brood and brood-care workers reside mostly in the deepest regions, yet the food and seeds foragers collect must be transported downward 30 to 80 cm to seed chambers and up to 2 m to brood chambers. Using mark-recapture techniques with fluorescent printer's ink, we identified a class of workers that ranges widely within the vertical structure of the nest, rapidly moving materials dropped by foragers in the upper regions downward, and excavated soil from deeper upward. Within the nest, only 5% of foragers were recovered below 20 cm depth, but about 30% of transfer workers and 82% of unmarked workers were found there. Below 70 cm depth, 90% of workers were unmarked, and were probably involved mostly in brood care. During the summer, the transfer workers comprise about a quarter of the nest population, while foragers make up about 40%. Workers marked as transfer workers later appear as foragers, while those marked as foragers die and disappear from the foraging population, suggesting that transfer workers are younger, and age into foraging. The importance of these findings for laboratory studies of division of labor are discussed. The efficient allocation of labor is a key component of superorganismal fitness.	[Tschinkel, Walter R.; Hanley, Nicholas] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation (United States) [IOS-1021632]	National Science Foundation (United States)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (United States) IOS-1021632. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBOGBA C, 1994, BEHAV PROCESS, V32, P47, DOI 10.1016/0376-6357(94)90026-4; Bernadou A, 2015, BEHAV ECOL SOCIOBIOL, V69, P1365, DOI 10.1007/s00265-015-1950-9; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Brown MJF, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_18.1; Camargo RS, 2007, J APPL ENTOMOL, V131, P139, DOI 10.1111/j.1439-0418.2006.01129.x; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Fresneau D, 1984, ACTES COLL INSECT SO, V1, P87; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; Hart AG, 2001, ANIM BEHAV, V62, P227, DOI 10.1006/anbe.2001.1743; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; KONDOH M, 1968, Japanese Journal of Ecology, V18, P124; Kwapich CL, 2016, BEHAV ECOL SOCIOBIOL, V70, P221, DOI 10.1007/s00265-015-2039-1; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; LENOIR A, 1983, Z TIERPSYCHOL, V63, P213; Lenoir A., 1980, Biologie et Ecologie Mediterraneenne, V7, P197; MACKAY WP, 1983, J KANSAS ENTOMOL SOC, V56, P538; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Murdock TC, 2015, INSECT SOC, V62, P265, DOI 10.1007/s00040-015-0403-9; Nickele MA, 2015, MYRMECOL NEWS, V21, P73; Oster G.F., 1978, Monographs in Population Biology, pi; Pamminger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079616; Penick CA, 2008, INSECT SOC, V55, P176, DOI 10.1007/s00040-008-0987-4; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; PORTER SD, 1980, ECOL ENTOMOL, V5, P263, DOI 10.1111/j.1365-2311.1980.tb01149.x; Porter SD, 1980, SOCIAL STRUCTURE HAR; Powell S, 1999, ANIM BEHAV, V58, P965, DOI 10.1006/anbe.1999.1238; Ratnieks FLW, 1999, INSECT SOC, V46, P95, DOI 10.1007/s000400050119; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Rosengren R., 1977, ACTA ZOOL FENN, V149, P1; Seid MA, 2005, J COMP NEUROL, V488, P269, DOI 10.1002/cne.20545; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; TRANIELLO JFA, 1978, SCIENCE, V202, P770, DOI 10.1126/science.202.4369.770; Tripet F, 2004, ETHOLOGY, V110, P863, DOI 10.1111/j.1439-0310.2004.01023.x; Tschinkel W.R., 2006, FIRE ANTS, P747; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139922; Tschinkel WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059911; Tschinkel WR, 2013, MYRMECOL NEWS, V18, P99; Tschinkel WR, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0126; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; TSCHINKEL WR, 1987, INSECT SOC, V34, P143, DOI 10.1007/BF02224081; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; Vieira AS, 2010, ACTA ETHOL, V13, P23, DOI 10.1007/s10211-010-0069-2	52	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188630	10.1371/journal.pone.0188630	http://dx.doi.org/10.1371/journal.pone.0188630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182686	gold, Green Published, Green Submitted			2022-12-26	WOS:000416402000045
J	Bain, AR; Ainslie, PN; Hoiland, RL; Barak, OF; Drvis, I; Stembridge, M; MacLeod, DM; McEneny, J; Stacey, BS; Tuaillon, E; Marchi, N; De Maudave, AF; Dujic, Z; MacLeod, DB; Bailey, DM				Bain, Anthony R.; Ainslie, Philip N.; Hoiland, Ryan L.; Barak, Otto F.; Drvis, Ivan; Stembridge, Mike; MacLeod, Douglas M.; McEneny, Jane; Stacey, Benjamin S.; Tuaillon, Eduoard; Marchi, Nicola; De Maudave, Alexis Fayd'Herbe; Dujic, Zeljko; MacLeod, David B.; Bailey, Damian M.			Competitive apnea and its effect on the human brain: focus on the redox regulation of blood-brain barrier permeability and neuronal-parenchymal integrity	FASEB JOURNAL			English	Article						hypoxia; hypercapnea; hypertension; cerebral perfusion; free radicals	BREATH-HOLD DIVERS; CEREBRAL OXIDATIVE-METABOLISM; INDUCED ATP RELEASE; NITRIC-OXIDE; S-NITROSOHEMOGLOBIN; EXTREME APNEA; FREE-RADICALS; VITAMIN-C; ALPHA-TOCOPHEROL; HYPOXIA	Static apnea provides a unique model that combines transient hypertension, hypercapnia, and severe hypoxemia. With apnea durations exceeding 5 min, the purpose of the present study was to determine how that affects cerebral free-radical formation and the corresponding implications for brain structure and function. Measurements were obtained before and following a maximal apnea in 14 divers with transcerebral exchange kinetics, measured as the product of global cerebral blood flow (duplex ultrasound) and radial arterial to internal jugular venous concentration differences (a-v(D)). Apnea increased the systemic (arterial) and, to a greater extent, the regional (jugular venous) concentration of the ascorbate free radical, resulting in a shift from net cerebral uptake to output (P < 0.05). Peroxidation (lipid hydroperoxides, LDL oxidation), NO bioactivity, and S100 beta were correspondingly enhanced (P < 0.05), the latter interpreted as minor and not a pathologic disruption of the blood-brain barrier. However, those changes were insufficient to cause neuronal-parenchymal damage confirmed by the lack of change in the a-v(D) of neuron-specific enolase and human myelin basic protein (P > 0.05). Collectively, these observations suggest that increased cerebral oxidative stress following prolonged apnea in trained divers may reflect a functional physiologic response, rather than a purely maladaptive phenomenon.	[Bain, Anthony R.; Ainslie, Philip N.; Hoiland, Ryan L.] Univ British Columbia, Sch Hlth & Exercise Sci, Ctr Heart Lung & Vasc Hlth, Kelowna, BC, Canada; [Bain, Anthony R.] Univ Colorado, Integrat Physiol, Boulder, CO 80309 USA; [Barak, Otto F.; Dujic, Zeljko] Univ Split, Sch Med, Split, Croatia; [Barak, Otto F.] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Drvis, Ivan] Univ Zagreb, Sch Kinesiol, Zagreb, Croatia; [Stembridge, Mike] Cardiff Metropolitan Univ, Cardiff Ctr Exercise & Hlth, Cardiff, S Glam, Wales; [MacLeod, Douglas M.] Emory Univ, Goizueta Business Sch, Atlanta, GA 30322 USA; [McEneny, Jane] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Stacey, Benjamin S.; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Glyntaff Campus,Cemetery Rd, Pontypridd CF37 4AT, Glam, Wales; [Tuaillon, Eduoard] Univ Montpellier I, UMR, INSERM, EFS, Montpellier, France; [Marchi, Nicola; De Maudave, Alexis Fayd'Herbe] CNRS, INSERM, Lab Cerebrovasc Mech Brain Disorders, UMR,Dept Neurosci,Inst Funct Genom, Montpellier, France; [MacLeod, David B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	University of British Columbia; University of Colorado System; University of Colorado Boulder; University of Split; University of Novi Sad; University of Zagreb; University of Zagreb, Faculty of Kinesiology; Cardiff Metropolitan University; Emory University; Queens University Belfast; University of South Wales; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Duke University	Bailey, DM (corresponding author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Glyntaff Campus,Cemetery Rd, Pontypridd CF37 4AT, Glam, Wales.	damian.bailey@southwales.ac.uk	Barak, Otto F/E-3771-2016; Bailey, Damian Miles/AAQ-1840-2020; Marchi, Nicola/J-8607-2016	Barak, Otto F/0000-0001-6727-8304; Marchi, Nicola/0000-0001-9124-0226; Fayd'herbe de Maudave, Alexis/0000-0002-0903-1108; Stembridge, Mike/0000-0003-0818-6420; Tuaillon, Edouard/0000-0001-5866-9530; Dujic, Zeljko/0000-0002-6450-0130	Royal Society Wolfson Research Fellow [WM170007]; Higher Education Funding Council of Wales; Physiological Society; Canada Research Chair (CRC); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant; NSERC postdoctoral fellowship; Autonomic Province of Vojvodina, Serbia [142-451- 2541]; Croatian Science Foundation Grant [IP-2014-09-1937]	Royal Society Wolfson Research Fellow; Higher Education Funding Council of Wales(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Physiological Society; Canada Research Chair (CRC)(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC postdoctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Autonomic Province of Vojvodina, Serbia; Croatian Science Foundation Grant	The authors acknowledge the valued technical input/scientific discussions with P. E. James and N. Jones (Cardiff Metropolitan University) and the cheerful cooperation of all participants. D.M.B. is a Royal Society Wolfson Research Fellow (WM170007). This study was funded in part by the Higher Education Funding Council of Wales and The Physiological Society (to D.M.B.). P.N.A. was funded by a Canada Research Chair (CRC) and Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant. A.R.B. was funded through a NSERC postdoctoral fellowship. O.F.B. was also funded by the Autonomic Province of Vojvodina, Serbia (142-451- 2541). D.J., I.D., O.F.B., and P.N.A. were also funded by a Croatian Science Foundation Grant (IP-2014-09-1937). The authors declare no conflicts of interest.	Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Andersson JPA, 2009, J APPL PHYSIOL, V107, P809, DOI 10.1152/japplphysiol.91434.2008; Bailey DM, 2014, ACTA PHYSIOL, V212, P175, DOI 10.1111/apha.12313; Bailey DM, 2007, FREE RADICAL RES, V41, P182, DOI 10.1080/10715760601028867; Bailey DM, 2017, HIGH ALT MED BIOL, V18, P73, DOI 10.1089/ham.2016.0081; Bailey DM, 2017, CIRCULATION, V135, P166, DOI 10.1161/CIRCULATIONAHA.116.024226; Bailey DM, 2011, J CEREBR BLOOD F MET, V31, P1020, DOI 10.1038/jcbfm.2011.2; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; Bailey DM, 2006, FREE RADICAL BIO MED, V40, P591, DOI 10.1016/j.freeradbiomed.2005.09.024; Bain AR, 2017, J CEREBR BLOOD F MET, V37, P3231, DOI 10.1177/0271678X16686093; Bain AR, 2016, J PHYSIOL-LONDON, V594, P5317, DOI 10.1113/JP272404; BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Carassiti D, 2017, NEUROPATHOL APPL NEU; CATIGNANI GL, 1983, CLIN CHEM, V29, P708; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dugan L. L, 1999, BASIC NEUROCHEMISTRY; Dunn JF, 1997, ADV EXP MED BIOL, V428, P645; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Ewing JF, 1998, FREE RADICAL BIO MED, V25, P621, DOI 10.1016/S0891-5849(98)00083-5; Ezraty B, 2011, EMBO REP, V12, P321, DOI 10.1038/embor.2011.7; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, CIRC RES, V94, P851, DOI 10.1161/01.RES.0000126697.64381.37; Gren M, 2016, BRAIN INJURY, V30, P1226, DOI 10.1080/02699052.2016.1179792; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; Ivancev V, 2007, J PHYSIOL-LONDON, V582, P723, DOI 10.1113/jphysiol.2007.128991; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Joulia F, 2003, RESP PHYSIOL NEUROBI, V137, P19, DOI 10.1016/S1569-9048(03)00110-1; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kjeld T, 2015, SCAND J MED SCI SPOR, V25, pe253, DOI 10.1111/sms.12309; Kohshi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105006; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; MADSEN PL, 1993, J CEREBR BLOOD F MET, V13, P646, DOI 10.1038/jcbfm.1993.83; Matsuo R, 2014, CASE REP NEUROL, V6, P23, DOI 10.1159/000357169; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCDOWELL IFW, 1995, ANN CLIN BIOCHEM, V32, P167, DOI 10.1177/000456329503200206; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; NEMOTO EM, 1979, STROKE, V10, P44, DOI 10.1161/01.STR.10.1.44; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Pardridge William M, 2005, NeuroRx, V2, P3; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Poss WB, 1996, AM J PHYSIOL-LUNG C, V270, pL941, DOI 10.1152/ajplung.1996.270.6.L941; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Steinback CD, 2010, AUTON NEUROSCI-BASIC, V156, P138, DOI 10.1016/j.autneu.2010.05.002; Stembridge M, 2017, EXP PHYSIOL, V102, P1288, DOI 10.1113/EP086429; Sureda A, 2004, FREE RADICAL BIO MED, V37, P1744, DOI 10.1016/j.freeradbiomed.2004.07.033; Theunissen S, 2013, DIVING HYPERB MED, V43, P63; Thiel VE, 2001, ANTIOXID REDOX SIGN, V3, P273, DOI 10.1089/152308601300185223; THURNHAM DI, 1988, CLIN CHEM, V34, P377; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Willie CK, 2015, J CEREBR BLOOD F MET, V35, P66, DOI 10.1038/jcbfm.2014.170; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135429; Wolff S. P., 1994, METHOD ENZYMOL, V233, P183; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929	64	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2305	2314		10.1096/fj.201701031R	http://dx.doi.org/10.1096/fj.201701031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29191963				2022-12-26	WOS:000429051400047
J	Hwang, YS; Seo, M; Bang, S; Kim, H; Han, JY				Hwang, Young Sun; Seo, Minseok; Bang, Sohyun; Kim, Heebal; Han, Jae Yong			Transcriptional and translational dynamics during maternal-to-zygotic transition in early chicken development	FASEB JOURNAL			English	Article						aves; early embryo; RNA-seq; intrauterine development	PRIMORDIAL GERM-CELLS; PRIMITIVE STREAK FORMATION; COMPLEMENTARY NORMAL TABLE; GENE-EXPRESSION DATA; PREIMPLANTATION EMBRYOS; GENOME ACTIVATION; XENOPUS-EMBRYOS; MOUSE EMBRYO; 1ST STAGES; CLEAVAGE	Maternal-to-zygotic transition (MZT) is the critical process for the establishment of embryonic identity across vertebrates. During this period, the massive transcriptional activation, called zygotic genome activation (ZGA), is mediated by maternally stored factors, and maternal mRNA clearance by conserved zygotic microRNAs (miRNAs) occurs; however, the important transition in avian species was identified by morphologic perspectives only. In this study, we performed transcriptome analysis to examine the molecular transitions of intrauterine development in chickens. On the basis of coexpression analyses on RNA sequencing data, 2 waves of ZGA-mediated MZT were observed across the early embryonic stages and were associated with transcriptional and translational dynamics. Furthermore, definite transitions were observed according to the distinct developmental characteristics between cleavage and the area pellucida formation period in the functional analysis. Finally, epigenetic modification and the evolutionarily conserved miRNA expression suggest that certain MZT proceeds from Eyal-Giladi and Kochav stage VIII in early chicken development. We expect our study to provide an evolutionary link among vertebrates from the perspective of MZT regulation.	[Hwang, Young Sun; Kim, Heebal; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Seo, Minseok; Bang, Sohyun; Kim, Heebal] Seoul Natl Univ, C&K Genom, SNU Res Pk, Seoul, South Korea; [Seo, Minseok] Harvard Med Sch, Channing Div Network Med, Boston, MA USA; [Seo, Minseok] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kim, Heebal; Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Japan	Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Shinshu University	Han, JY (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Hwang, Young Sun/0000-0002-6443-9579	National Research Foundation of Korea - South Korean government [NRF-2015R1A3A2033826]	National Research Foundation of Korea - South Korean government	This work was supported by a National Research Foundation of Korea grant funded by the South Korean government (Grant NRF-2015R1A3A2033826). The authors declare no conflicts of interest.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Aoshima K, 2015, EMBO REP, V16, P803, DOI 10.15252/embr.201439700; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Gilbert I, 2009, MOL REPROD DEV, V76, P762, DOI 10.1002/mrd.21030; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ihara M, 2011, BIOL REPROD, V84, P944, DOI 10.1095/biolreprod.110.089680; Kendall M.G., 1968, ADV THEORY STAT, V3; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KOCHAV S, 1980, DEV BIOL, V79, P296, DOI 10.1016/0012-1606(80)90117-7; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Mak SS, 2015, ELIFE, V4, DOI 10.7554/eLife.07178; Nagai H, 2015, DEVELOPMENT, V142, P1279, DOI 10.1242/dev.118604; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Svoboda P, 2010, EMBO REP, V11, P590, DOI 10.1038/embor.2010.102; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020	37	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2004	2011		10.1096/fj.201700955R	http://dx.doi.org/10.1096/fj.201700955R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29212819				2022-12-26	WOS:000429051400022
J	Chakraborty, A; Dorsett, KA; Trummell, HQ; Yang, ES; Oliver, PG; Bonner, JA; Buchsbaum, DJ; Bellis, SL				Chakraborty, Asmi; Dorsett, Kaitlyn A.; Trummell, Hoa Q.; Yang, Eddy S.; Oliver, Patsy G.; Bonner, James A.; Buchsbaum, Donald J.; Bellis, Susan L.			ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; COLON-CANCER CELLS; DEATH RECEPTOR; LINE SUIT-2; IN-VITRO; KAPPA-B; SIALYLATION; EXPRESSION; METABOLISM; APOPTOSIS	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis. Gemcitabine, as a single agent or in combination therapy, remains the frontline chemotherapy despite its limited efficacy due to de novo or acquired chemoresistance. There is an acute need to decipher mechanisms underlying chemoresistance and identify new targets to improve patient outcomes. Here, we report a novel role for the ST6Gal-I sialyltransferase in gemcitabine resistance. Utilizing MiaPaCa-2 and BxPC-3 PDAC cells, we found that knockdown (KD) of ST6Gal-I expression, as well as removal of surface alpha 2-6 sialic acids by neuraminidase, enhances gemcitabine-mediated cell death assessed via clonogenic assays and cleaved caspase 3 expression. Additionally, KD of ST6Gal-I potentiates gemcitabine-induced DNA damage as measured by comet assays and quantification of gamma H2AX foci. ST6Gal-I KD also alters mRNA expression of key gemcitabine metabolic genes, RRM1, RRM2, hENT1, and DCK, leading to an increased gemcitabine sensitivity ratio, an indicator of gemcitabine toxicity. Gemcitabine-resistant MiaPaCa-2 cells display higher ST6Gal-I levels than treatment-naive cells along with a reduced gemcitabine sensitivity ratio, suggesting that chronic chemotherapy selects for clonal variants with more abundant ST6Gal-I. Finally, we examined Suit2 PDAC cells and Suit2 derivatives with enhanced metastatic potential. Intriguingly, three metastatic and chemoresistant subclones, S2-CP9, S2-LM7AA, and S2-013, exhibit up-regulated ST6Gal-I relative to parental Suit2 cells. ST6Gal-I KD in S2-013 cells increases gemcitabine-mediated DNA damage, indicating that suppressing ST6Gal-I activity sensitizes inherently resistant cells to gemcitabine. Together, these findings place ST6Gal-I as a critical player in imparting gemcitabine resistance and as a potential target to restore PDAC chemoresponse.	[Chakraborty, Asmi; Dorsett, Kaitlyn A.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA; [Trummell, Hoa Q.; Yang, Eddy S.; Oliver, Patsy G.; Bonner, James A.; Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu	chakraborty, asmi/AAX-5384-2021	chakraborty, asmi/0000-0002-6528-8602; Buchsbaum, Donald/0000-0003-2797-5847	National Institutes of Health [P30AR048311, P30AI027767]; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge assistance from the University of Alabama at Birmingham Flow Cytometry Core Facility (National Institutes of Health Grants P30AR048311 and P30AI027767).	Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Holdbrooks A. T., 2017, J BIOL CHEM; Hong XH, 2016, NUCLEIC ACIDS RES, V44, P8855, DOI 10.1093/nar/gkw748; Horiuchi T, 2016, J SURG RES, V206, P1, DOI 10.1016/j.jss.2016.06.047; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Hung SW, 2015, CANCER LETT, V359, P233, DOI 10.1016/j.canlet.2015.01.017; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Joseph R, 2014, J ONCOL PHARM PRACT, V20, P393, DOI 10.1177/1078155213506477; Kirby MK, 2016, MOL ONCOL, V10, P1169, DOI 10.1016/j.molonc.2016.05.004; Kitamura N, 2001, CLIN EXP METASTAS, V18, P561, DOI 10.1023/A:1011900818419; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Le N, 2016, DIGEST LIVER DIS, V48, P223, DOI 10.1016/j.dld.2015.11.001; Lee M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-47; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Pappas S, 2015, SURGERY, V158, P888; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Rauchwerger DR, 2000, CANCER RES, V60, P6075; Recchi MA, 1998, CANCER RES, V58, P4066; Saif M, 2012, THER ADV MED ONCOL, V4, P341, DOI 10.1177/1758834012453755; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simon PO, 2009, INT J CANCER, V125, P942, DOI 10.1002/ijc.24424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573, DOI 10.1093/oxfordjournals.jbchem.a132675; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Waters JA, 2015, SURGERY, V158, P881, DOI 10.1016/j.surg.2015.04.043; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zinzi L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00163	53	45	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					984	994		10.1074/jbc.M117.808584	http://dx.doi.org/10.1074/jbc.M117.808584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191829	hybrid, Green Published			2022-12-26	WOS:000422864500019
J	Cangelosi, Q; Means, SA; Ho, H				Cangelosi, Quentin; Means, Shawn A.; Ho, Harvey			A multi-scale spatial model of hepatitis-B viral dynamics	PLOS ONE			English	Article							VIRUS-REPLICATION; HEPATOCYTE TURNOVER; LIVER; INFECTION; CELLS; DNA; TRANSIENT; INTERFERON; METABOLISM; AGONISTS	Chronic hepatitis B viral infection (HBV) afflicts around 250 million individuals globally and few options for treatment exist. Once infected, the virus entrenches itself in the liver with a notoriously resilient colonisation of viral DNA (covalently-closed circular DNA, cccDNA). The majority of infections are cleared, yet we do not understand why 5% of adult immune responses fail leading to the chronic state with its collateral morbid effects such as cirrhosis and eventual hepatic carcinoma. The liver environment exhibits particularly complex spatial structures for metabolic processing and corresponding distributions of nutrients and transporters that may influence successful HBV entrenchment. We assembled a multi-scaled mathematical model of the fundamental hepatic processing unit, the sinusoid, into a whole-liver representation to investigate the impact of this intrinsic spatial heterogeneity on the HBV dynamic. Our results suggest HBV may be exploiting spatial aspects of the liver environment. We distributed increased HBV replication rates coincident with elevated levels of nutrients in the sinusoid entry point (the periportal region) in tandem with similar distributions of hepatocyte transporters key to HBV invasion (e.g., the sodium-taurocholate cotransporting polypeptide or NTCP), or immune system activity. According to our results, such co-alignment of spatial distributions may contribute to persistence of HBV infections, depending on spatial distributions and intensity of immune response as well. Moreover, inspired by previous HBV models and experimentalist suggestions of extra-hepatic HBV replication, we tested in our model influence of HBV blood replication and observe an overall nominal effect on persistent liver infection. Regardless, we confirm prior results showing a solo cccDNA is sufficient to re-infect an entire liver, with corresponding concerns for transplantation and treatment.	[Cangelosi, Quentin] Inst Natl Sci Appl, Computat & Math Engn, Toulouse, France; [Means, Shawn A.; Ho, Harvey] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand	Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; University of Auckland	Means, SA (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.	s.means@auckland.ac.nz			Faculty Research Development Fund of The University of Auckland, New Zealand [3707110, 3712133]; Medical Technologies Centre of Research Excellence (MedTech CoRE) - Tertiary Education Commission of New Zealand	Faculty Research Development Fund of The University of Auckland, New Zealand; Medical Technologies Centre of Research Excellence (MedTech CoRE) - Tertiary Education Commission of New Zealand	This study was financially supported by the Faculty Research Development Fund (No. 3707110 & 3712133) of The University of Auckland, New Zealand and the Medical Technologies Centre of Research Excellence (MedTech CoRE) funded by the Tertiary Education Commission of New Zealand to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the financial support from the Faculty Research Development Fund (No. 3707110 & 3712133) of The University of Auckland, New Zealand. HH also acknowledges the financial support from the Medical Technologies Centre of Research Excellence (MedTech CoRE) funded by the Tertiary Education Commission of New Zealand.	Allweiss L, 2017, GUT; Amaya MJ, 2013, COMPR PHYSIOL, V3, P515, DOI 10.1002/cphy.c120013; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Chalhoub E, 2007, ANN BIOMED ENG, V35, P474, DOI 10.1007/s10439-006-9217-2; Chang JH, 2015, ANTIVIR RES, V121, P152, DOI 10.1016/j.antiviral.2015.07.006; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Ciupe SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039591; de Sousa BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012512; DEJEAN A, 1984, J GEN VIROL, V65, P651, DOI 10.1099/0022-1317-65-3-651; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Goyal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161978; Grellier L, 1996, LANCET, V348, P1212, DOI 10.1016/S0140-6736(96)04444-3; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Guo JT, 2000, J VIROL, V74, P1495, DOI 10.1128/JVI.74.3.1495-1505.2000; Guo JT, 2015, ANTIVIR RES, V122, P91, DOI 10.1016/j.antiviral.2015.08.005; Ho H, 2013, MED ENG PHYS, V35, P1053, DOI 10.1016/j.medengphy.2012.10.008; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Huang YX, 2016, MED SCI MONITOR, V22, P1673, DOI 10.12659/MSM.898680; Ikeda K, 2009, J VIRAL HEPATITIS, V16, P437, DOI 10.1111/j.1365-2893.2009.01085.x; Jhuang HJ, 2015, ONCOTARGET, V6, P7788, DOI 10.18632/oncotarget.3050; Li AP, 2007, CHEM-BIOL INTERACT, V168, P16, DOI 10.1016/j.cbi.2007.01.001; Mason A, 2005, AM J GASTROENTEROL, V100, P972, DOI 10.1111/j.1572-0241.2005.41308.x; MASON A, 1993, HEPATOLOGY, V18, P781, DOI 10.1002/hep.1840180406; Mason WS, 2007, J VIRAL HEPATITIS, V14, P22, DOI 10.1111/j.1365-2893.2007.00911.x; Mason WS, 2009, J VIROL, V83, P1778, DOI 10.1128/JVI.01587-08; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Murray JM, 2015, J THEOR BIOL, V366, P91, DOI 10.1016/j.jtbi.2014.11.020; NATHANSON MH, 1992, HEPATOLOGY, V15, P107, DOI 10.1002/hep.1840150119; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Qesmi R, 2011, SIAM J APPL MATH, V71, P1509, DOI 10.1137/10079690X; Reaiche-Miller GY, 2013, VIROLOGY, V446, P357, DOI 10.1016/j.virol.2013.08.014; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Schweitzer A, 2015, LANCET; Schwen LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133653; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188209	10.1371/journal.pone.0188209	http://dx.doi.org/10.1371/journal.pone.0188209			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216213	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800019
J	Ooishi, Y; Mukai, H; Watanabe, K; Kawato, S; Kashino, M				Ooishi, Yuuki; Mukai, Hideo; Watanabe, Ken; Kawato, Suguru; Kashino, Makio			Increase in salivary oxytocin and decrease in salivary cortisol after listening to relaxing slow-tempo and exciting fast-tempo music	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; HEART-RATE; SUBJECTIVE RESPONSES; HEALTHY-MEN; TESTOSTERONE; THERAPY; ANXIETY; REACTIVITY; NEURONS; SYSTEM	Relaxation and excitation are components of the effects of music listening. The tempo of music is often considered a critical factor when determining these effects: listening to slow-tempo and fast-tempo music elicits relaxation and excitation, respectively. However, the chemical bases that underlie these relaxation and excitation effects remain unclear. Since parasympathetic and sympathetic nerve activities are facilitated by oxytocin and glucocorticoid, respectively, we hypothesized that listening to relaxing slow-tempo and exciting fast-tempo music is accompanied by increases in the oxytocin and cortisol levels, respectively. We evaluated the change in the salivary oxytocin and cortisol levels of participants listening to slow-tempo and fast-tempo music sequences. We measured the heart rate (HR) and calculated the heart rate variability (HRV) to evaluate the strength of autonomic nerve activity. After listening to a music sequence, the participants rated their arousal and valence levels. We found that both the salivary oxytocin concentration and the high frequency component of the HRV (HF) increased and the HR decreased when a slow-tempo music sequence was presented. The salivary cortisol level decreased and the low frequency of the HRV (LF) to HF ratio (LF/HF) increased when a fast-tempo music sequence was presented. The ratio of the change in the oxytocin level was correlated with the change in HF, LF/HF and HR, whereas that in the cortisol level did not show any correlation with indices of autonomic nerve activity. There was no correlation between the change in oxytocin level and self-reported emotions, while the change in cortisol level correlated with the arousal level. These findings suggest that listening to slow-tempo and fast-tempo music is accompanied by an increase in the oxytocin level and a decrease in the cortisol level, respectively, and imply that such music listening-related changes in oxytocin and cortisol are involved in physiological relaxation and emotional excitation, respectively.	[Ooishi, Yuuki; Watanabe, Ken; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Morinosato Wakamiya Atsu, Kanagawa, Japan; [Mukai, Hideo] Meiji Univ, Sch Sci & Technol, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa, Japan; [Mukai, Hideo; Kawato, Suguru] Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Meguro Ku, Tokyo, Japan; [Watanabe, Ken; Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Midori Ku, Yokohama, Kanagawa, Japan; [Kashino, Makio] Japan Sci & Technol Agcy, CREST, JST, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Meiji University; University of Tokyo; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Ooishi, Y (corresponding author), NTT Corp, NTT Commun Sci Labs, Morinosato Wakamiya Atsu, Kanagawa, Japan.	ooishi.yuuki@lab.ntt.co.jp	nyakky, k/GXF-5548-2022; Campailla, Jasmin/AAK-2420-2021	Ooishi, Yuuki/0000-0003-1231-7366; Watanabe, Ken/0000-0002-3035-1333	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; NTT Corporation	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NTT Corporation	This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency to M.K. NTT Corporation provided support in the form of salaries for authors Yuuki Ooishi, Ken Watanabe and Makio Kashino. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the'author contributions' section.	Arch JJ, 2014, PSYCHONEUROENDOCRINO, V42, P49, DOI 10.1016/j.psyneuen.2013.12.018; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Boccia ML, 2013, NEUROSCIENCE, V253, P155, DOI 10.1016/j.neuroscience.2013.08.048; Camm AJ, 1996, EUR HEART J, V17, P354; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Elliott D, 2011, J MUSIC THER, V48, P264, DOI 10.1093/jmt/48.3.264; Gerra G, 1998, INT J PSYCHOPHYSIOL, V28, P99, DOI 10.1016/S0167-8760(97)00071-8; GOLCZYNSKA A, 1995, CLIN PHARMACOL THER, V58, P90, DOI 10.1016/0009-9236(95)90076-4; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Goncharov N, 2006, AGING MALE, V9, P111, DOI 10.1080/13685530600713060; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewen KM, 2011, BIOL PSYCHOL, V87, P340, DOI 10.1016/j.biopsycho.2011.04.003; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; HAAS F, 1986, J APPL PHYSIOL, V61, P1185, DOI 10.1152/jappl.1986.61.3.1185; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Iwanaga M, 1999, J MUSIC THER, V36, P26, DOI 10.1093/jmt/36.1.26; Kern P, 2013, J MUSIC THER, V50, P274, DOI 10.1093/jmt/50.4.274; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; Leow LA, 2015, ANN NY ACAD SCI, V1337, P53, DOI 10.1111/nyas.12658; Matsui F, 2009, ENDOCR J, V56, P1083, DOI 10.1507/endocrj.K09E-186; Nilsson U, 2009, J CLIN NURS, V18, P2153, DOI 10.1111/j.1365-2702.2008.02718.x; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rimmele U, 2003, NEUROREPORT, V14, P2485, DOI 10.1097/00001756-200312190-00038; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Rong WF, 1999, BRAIN RES, V815, P51, DOI 10.1016/S0006-8993(98)01090-7; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; SAPOLSKY RM, 1994, SEMIN NEUROSCI, V6, P261, DOI 10.1006/smns.1994.1033; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; STANDLEY JM, 1986, J MUSIC THER, V23, P56, DOI 10.1093/jmt/23.2.56; Suda M, 2008, NEUROREPORT, V19, P75, DOI 10.1097/WNR.0b013e3282f3476f; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; Whitehead-Pleaux AM, 2006, J MUSIC THER, V43, P136, DOI 10.1093/jmt/43.2.136; Yamashita K, 2009, STEROIDS, V74, P920, DOI 10.1016/j.steroids.2009.06.007; Zhou P, 2010, INT CONF BIOMED, P965, DOI 10.1109/BMEI.2010.5639814	47	30	32	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189075	10.1371/journal.pone.0189075	http://dx.doi.org/10.1371/journal.pone.0189075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211795	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200063
J	Courjon, J; Lemaignen, A; Ghout, I; Therby, A; Belmatoug, N; Dinh, A; Gras, G; Bernard, L				Courjon, Johan; Lemaignen, Adrien; Ghout, Idir; Therby, Audrey; Belmatoug, Nadia; Dinh, Aurelien; Gras, Guillaume; Bernard, Louis		DTS Study Grp	Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; EPIDEMIOLOGY; FEATURES	Background The incidence of pyogenic vertebral osteomyelitis (PVO) has increased over the past two decades. One possible cause of this increase is the aging of the population, which results in more comorbidities in high income countries. Objective To better characterize the clinical presentation and outcome of PVO in the elderly. Design We conducted a post-hoc analysis of a previously published trial that studied treatment duration in PVO and compared the presentation and outcomes according to age. Participants Our analysis included 351 patients among whom 85 (24%) were 75-years-old or more. Results There were no significant differences in the socio-demographics of the patients. Neoplasia and chronic inflammatory diseases were more common in the older group: 34% vs. 19% (p = 0.021) and 9% versus 1% (p = 0.004), respectively. There were no significant differences in clinical and radiological presentations between the groups in terms of back pain (337/351, 97%), fever (182/351, 52%), PVO localization, neurological signs and epidural abscess. Associated infective endocarditis (IE) was more frequent in the older group (37% vs. 14%, p<0.001). Streptococci were more frequently involved in infections of older patients 29% vs. 14%, p = 0.003) in contrast to Staphylococcus aureus (31% vs. 45%, p = 0.03). Older patients displayed higher mortality rates at 1 year (21% vs. 3%, p< 0.001) and more adverse events related to cardiorespiratory failure (10.6% vs. 3.8%, p = 0.025), but had similar quality of life among the survivors. Conclusion During PVO, the clinical and radiological findings are similar in older patients. Global mortality rates are higher in older patients compared to younger patients, which could be explained by the increased frequency of neoplasia at diagnosis and higher prevalence of associated IE in the elderly.	[Courjon, Johan] Univ Hosp Nice, Hop Archet 1, Dept Infect Dis, Nice, France; [Courjon, Johan] Univ Cote Azur, Nice, France; [Lemaignen, Adrien; Gras, Guillaume; Bernard, Louis] Univ Hosp Tours, Hop Bretonneau, Dept Internal Med & Infect Dis, Tours, France; [Lemaignen, Adrien; Bernard, Louis] Francois Rabelais Univ, Tours, France; [Ghout, Idir] Hop Ambroise Pare, AP HP, Clin Res Unit, Boulogne, France; [Therby, Audrey] Hop Mignot, Ctr Hosp Versailles, Dept Internal Med & Infect Dis, Le Chesnay, France; [Belmatoug, Nadia] Hop Beaujon, AP HP, Dept Internal Med, Clichy, France; [Dinh, Aurelien] Hop Raymond Poincare, AP HP, Dept Infect Dis, Garches, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Courjon, J (corresponding author), Univ Hosp Nice, Hop Archet 1, Dept Infect Dis, Nice, France.; Courjon, J (corresponding author), Univ Cote Azur, Nice, France.	courjon.j@chu-nice.fr	Dinh, Aurélien/AAI-5355-2021; Courjon, Joha/G-2768-2018; Lemaignen, Adrien/L-5921-2018	Lemaignen, Adrien/0000-0001-5974-5689; Courjon, Johan/0000-0002-0445-5104	French Ministry of Health through national Hospital Program for Clinical Research	French Ministry of Health through national Hospital Program for Clinical Research	The DTS trial was funded by French Ministry of Health through a national Hospital Program for Clinical Research to Louis Bernard. The funder of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report.	Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; [Anonymous], R FDN STAT COMP; Belzunegui J, 2000, CLIN RHEUMATOL, V19, P344, DOI 10.1007/PL00011175; Bernard L, 2015, LANCET, V385, P875, DOI 10.1016/S0140-6736(14)61233-2; CAHILL DW, 1991, J NEUROSURG, V74, P878, DOI 10.3171/jns.1991.74.6.0878; Carragee EJ, 1997, J BONE JOINT SURG AM, V79A, P874, DOI 10.2106/00004623-199706000-00011; Chelsom J, 1998, SCAND J INFECT DIS, V30, P147, DOI 10.1080/003655498750003537; Doutchi Mahamadou, 2015, New Microbes and New Infections, V7, P1, DOI 10.1016/j.nmni.2015.04.008; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S0950268807008850; Grammatico-Guillon L, 2012, J HOSP INFECT, V82, P40, DOI 10.1016/j.jhin.2012.04.025; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Koslow M, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.02.023; Le Moal G, 2002, EUR J CLIN MICROBIOL, V21, P671, DOI 10.1007/s10096-002-0798-x; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; Mulleman D, 2006, J RHEUMATOL, V33, P91; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murillo O, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.007; Murillo O, 2014, CLIN MICROBIOL INFEC, V20, pO33, DOI 10.1111/1469-0691.12302; THOMPSON D, 1988, BRIT MED J, V296, P1309, DOI 10.1136/bmj.296.6632.1309; Zimmerli W, 2010, NEW ENGL J MED, V362, P1022, DOI 10.1056/NEJMcp0910753	21	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188470	10.1371/journal.pone.0188470	http://dx.doi.org/10.1371/journal.pone.0188470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206837	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700012
J	Flotre, CH; Varsi, K; Helm, T; Bolann, B; Bjorke-Monsen, AL				Flotre, Christina Herland; Varsi, Kristin; Helm, Thea; Bolann, Bjorn; Bjorke-Monsen, Anne-Lise			Predictors of mercury, lead, cadmium and antimony status in Norwegian never-pregnant women of fertile age	PLOS ONE			English	Article							TRACE-ELEMENTS; BLOOD CADMIUM; FISH CONSUMPTION; REFERENCE VALUES; HEAVY-METALS; CORD BLOOD; POPULATION; EXPOSURE; HEALTH; HAIR	Background The toxic trace elements mercury (Hg), lead (Pb), cadmium (Cd) and antimony (Sb) are transferred over the placenta to the fetus and secreted into the breastmilk. All four elements bioaccumulate in the body and as maternal age at delivery is increasing in industrialized countries, the burden of toxic trace elements in never-pregnant women of fertile age is of concern. Methods Healthy, never-pregnant women aged 18 to 40 years (n = 158) were recruited between June 2012 and March 2015 in Bergen, Norway. Clinical data were collected and non-fasting venous blood samples were analyzed for whole blood Hg, Pb and Cd and serum Sb by ICPMS and related to diet and life style factors. Results In a multiple linear regression model, increasing age was associated with higher levels of Hg and Sb, but diet and life style factors were more important predictors. Median whole blood Hg was increased by a factor of 70 in women who had fish for dinner >= 1/week, compared to women who rarely or never ate fish (p< 0.001). Alcohol intake was the strongest predictor for whole blood Pb, while use of tobacco was the strongest predictor for whole blood Cd. Being a vegetarian was associated with lower levels of both Hg and Sb. Conclusions As toxic trace elements tend to bioaccumulate in the body, increasing maternal age at delivery may represent a threat to the next generation. In a group of healthy Norwegian neverpregnant women, age contributed to Hg and Sb levels, but diet and life style factors were stronger determinants of whole blood Hg, Pb, Cd and serum Sb levels. Continuous public actions are needed to reduce modifiable and preventable sources of potentially deleterious toxins to minimize the exposure in children and fertile women.	[Flotre, Christina Herland; Helm, Thea] Univ Bergen, Fac Med, Bergen, Norway; [Varsi, Kristin; Bolann, Bjorn; Bjorke-Monsen, Anne-Lise] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Bolann, Bjorn] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Bjorke-Monsen, AL (corresponding author), Haukeland Hosp, Lab Clin Biochem, Bergen, Norway.	almo@helse-bergen.no						Abadin H, 2007, TOXICOLOGICAL PROFIL; Abass K, 2017, ENVIRON SCI POLLUT R, V24, P1347, DOI 10.1007/s11356-016-7824-5; Aoki Y, 2017, ENVIRON RES, V155, P193, DOI 10.1016/j.envres.2017.02.016; Arbuckle TE, 2016, CHEMOSPHERE, V163, P270, DOI 10.1016/j.chemosphere.2016.08.023; Barbieri FL, 2016, INT J ENVIRON HEAL R, V26, P158, DOI 10.1080/09603123.2015.1061114; Birgisdottir BE, 2013, SCI TOTAL ENVIRON, V463, P836, DOI 10.1016/j.scitotenv.2013.06.078; Bolann BJ, 2015, J TRACE ELEM MED BIO, V31, P225, DOI 10.1016/j.jtemb.2014.07.021; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Cerna M, 2012, INT J HYG ENVIR HEAL, V215, P109, DOI 10.1016/j.ijheh.2011.09.007; Christophersen A G, 2014, ALCOHOL OTHER PSYCHO; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Cobbina SJ, 2015, CHEMOSPHERE, V132, P79, DOI 10.1016/j.chemosphere.2015.03.013; Cooper Ross G, 2009, Indian J Occup Environ Med, V13, P3, DOI 10.4103/0019-5278.50716; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Ek WE, 2017, HUM MOL GEN; Fontaine J, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-25; Fu ZY, 2016, SCI TOTAL ENVIRON, V539, P97, DOI 10.1016/j.scitotenv.2015.08.146; GRITZ ER, 1981, CLIN PHARMACOL THER, V30, P201, DOI 10.1038/clpt.1981.149; Hornell A, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20823; Hosomi Ryota, 2012, Glob J Health Sci, V4, P72, DOI 10.5539/gjhs.v4n3p72; Huang Y, 2015, ENVIRON SCI POLLUT R, V22, P4173, DOI 10.1007/s11356-014-3653-6; Hviid MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174770; IYENGAR GV, 1982, SCI TOTAL ENVIRON, V24, P267, DOI 10.1016/0048-9697(82)90005-5; Jackson LW, 2011, HUM REPROD, V26, P2887, DOI 10.1093/humrep/der250; Jain RB, 2013, J TOXICOL ENV HEAL A, V76, P58, DOI 10.1080/15287394.2012.722524; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jenssen MTS, 2012, SCI TOTAL ENVIRON, V439, P220, DOI 10.1016/j.scitotenv.2012.09.024; Kim KH, 2016, J HAZARD MATER, V306, P376, DOI 10.1016/j.jhazmat.2015.11.031; Kim SC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111063; Krajcovicova-Kudlackova Marica, 2006, Central European Journal of Public Health, V14, P126; Kuno R, 2013, INT J HYG ENVIR HEAL, V216, P243, DOI 10.1016/j.ijheh.2012.05.010; Kvaavik E, 2016, NICOTINE TOB RES, V18, P431, DOI 10.1093/ntr/ntv126; Lee BK, 2015, TRENDS MOL MED, V21, P118, DOI 10.1016/j.molmed.2014.11.005; Lee JW, 2012, INT J HYG ENVIR HEAL, V215, P449, DOI 10.1016/j.ijheh.2012.01.002; Leonard A, 1996, MUTAT RES-REV GENET, V366, P1, DOI 10.1016/S0165-1110(96)90003-2; Li JQ, 2014, CELL BIOCHEM BIOPHYS, V70, P1663, DOI 10.1007/s12013-014-0110-6; Midttun O, 2013, ANAL BIOANAL CHEM, V405, P2009, DOI 10.1007/s00216-012-6602-6; Mielke HW, 1998, ENVIRON HEALTH PERSP, V106, P217, DOI 10.2307/3433922; Naughton DP, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-22; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nisse C, 2017, INT J HYG ENVIR HEAL, V220, P341, DOI 10.1016/j.ijheh.2016.09.020; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Rebelo FM, 2016, ENVIRON RES, V151, P671, DOI 10.1016/j.envres.2016.08.027; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; Rosofsky A, 2017, ENVIRON RES, V154, P73, DOI 10.1016/j.envres.2016.12.011; Rossi V, 2016, TOXICOL LETT, V258, pS109, DOI 10.1016/j.toxlet.2016.06.1453; Saghazadeh A, 2017, PROG NEURO-PSYCHOPH, V79, P340, DOI 10.1016/j.pnpbp.2017.07.011; Sanders Alison P, 2015, Curr Environ Health Rep, V2, P284, DOI 10.1007/s40572-015-0058-8; Saravanabhavan G, 2017, INT J HYG ENVIR HEAL, V220, P189, DOI 10.1016/j.ijheh.2016.10.006; Satarug S, 2017, FOOD CHEM TOXICOL, V106, P430, DOI 10.1016/j.fct.2017.06.013; Schwalfenberg G, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/370460; Scinicariello F, 2015, PSYCHOL MED, V45, P807, DOI 10.1017/S0033291714001883; Song MA, 2016, TOXICOL LETT, V245, P68, DOI 10.1016/j.toxlet.2016.01.012; SRIKUMAR TS, 1992, AM J CLIN NUTR, V55, P885, DOI 10.1093/ajcn/55.4.885; Tang ML, 2016, CHEMOSPHERE, V148, P270, DOI 10.1016/j.chemosphere.2016.01.058; Taylor CM, 2014, J DEV ORIG HLTH DIS, V5, P16, DOI 10.1017/S2040174413000500; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Yaginuma-Sakurai K, 2012, J TOXICOL SCI, V37, P123, DOI 10.2131/jts.37.123; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007; Zheng GC, 2014, BIOL TRACE ELEM RES, V160, P437, DOI 10.1007/s12011-014-0057-x	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189169	10.1371/journal.pone.0189169	http://dx.doi.org/10.1371/journal.pone.0189169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206878	Green Submitted, gold, Green Published			2022-12-26	WOS:000417110700052
J	Koparde, V; Razzaq, BA; Suntum, T; Sabo, R; Scalora, A; Serrano, M; Jameson-Lee, M; Hall, C; Kobulnicky, D; Sheth, N; Feltz, J; Contaifer, D; Wijesinghe, D; Reed, J; Roberts, C; Qayyum, R; Buck, G; Neale, M; Toor, A				Koparde, Vishal; Razzaq, Badar Abdul; Suntum, Tara; Sabo, Roy; Scalora, Allison; Serrano, Myrna; Jameson-Lee, Max; Hall, Charles; Kobulnicky, David; Sheth, Nihar; Feltz, Juliana; Contaifer, Daniel, Jr.; Wijesinghe, Dayanjan; Reed, Jason; Roberts, Catherine; Qayyum, Rehan; Buck, Gregory; Neale, Michael; Toor, Amir			Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; ACUTE-LEUKEMIA; MALIGNANCIES; PROPHYLAXIS; EXPRESSION; REGIMEN; GRAFTS; TRIAL	Quantitative relationship between the magnitude of variation in minor histocompatibility antigens (mHA) and graft versus host disease (GVHD) pathophysiology in stem cell transplant (SCT) donor-recipient pairs (DRP) is not established. In order to elucidate this relationship, whole exome sequencing (WES) was performed on 27 HLA matched related (MRD), & 50 unrelated donors (URD), to identify nonsynonymous single nucleotide polymorphisms (SNPs). An average 2,463 SNPs were identified in MRD, and 4,287 in URD DRP (p<0.01); resulting peptide antigens that may be presented on HLA class I molecules in each DRP were derived in silico (NetMHCpan ver2.0) and the tissue expression of proteins these were derived from determined (GTex). MRD DRP had an average 3,670 HLA-binding-alloreactive peptides, putative mHA (pmHA) with an IC50 of <500 nM, and URD, had 5,386 (p<0.01). To simulate an alloreactive donor cytotoxic T cell response, the array of pmHA in each patient was considered as an operator matrix modifying a hypothetical cytotoxic T cell clonal vector matrix; each responding T cell clone's proliferation was determined by the logistic equation of growth, accounting for HLA binding affinity and tissue expression of each alloreactive peptide. The resulting simulated organ-specific alloreactive T cell clonal growth revealed marked variability, with the T cell count differences spanning orders of magnitude between different DRP. Despite an estimated, uniform set of constants used in the model for all DRP, and a heterogeneously treated group of patients, higher total and organ-specific T cell counts were associated with cumulative incidence of moderate to severe GVHD in recipients. In conclusion, exome wide sequence differences and the variable alloreactive peptide binding to HLA in each DRP yields a large range of possible alloreactive donor T cell responses. Our findings also help understand the apparent randomness observed in the development of alloimmune responses.	[Koparde, Vishal; Serrano, Myrna; Sheth, Nihar; Feltz, Juliana; Buck, Gregory] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Razzaq, Badar Abdul; Suntum, Tara; Scalora, Allison; Jameson-Lee, Max; Hall, Charles; Kobulnicky, David; Roberts, Catherine; Toor, Amir] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Internal Med, Bone Marrow Transplant Program, Richmond, VA 23284 USA; [Sabo, Roy] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Contaifer, Daniel, Jr.; Wijesinghe, Dayanjan] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA; [Reed, Jason] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Qayyum, Rehan] Virginia Commonwealth Univ, Dept Internal Med, Sect Hosp Med, Richmond, VA USA; [Buck, Gregory] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Neale, Michael] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Neale, Michael] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Toor, A (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Dept Internal Med, Bone Marrow Transplant Program, Richmond, VA 23284 USA.	amir.toor@vcuhealth.org	Toor, Amir Ahmed/GNM-9504-2022; Neale, Michael/AAD-5056-2020	Toor, Amir Ahmed/0000-0001-5317-8433; Koparde, Vishal/0000-0001-8978-8495; Contaifer Junior, Daniel/0000-0002-3165-4192; Qayyum, Rehan/0000-0003-3086-8014	NIH-NCI Cancer Center Support Grant [P30-CA016059]; Virginia's Commonwealth Health Research Board Grant [236-11-13]	NIH-NCI Cancer Center Support Grant; Virginia's Commonwealth Health Research Board Grant	This study conducted at Virginia Commonwealth University's Massey Cancer Center was supported, in part, by research funding from the NIH-NCI Cancer Center Support Grant (P30-CA016059; PI: Gordon Ginder, MD) and by research funding from Virginia's Commonwealth Health Research Board Grant #236-11-13 (PI: Michael Neale, PhD).	Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Armand P, 2016, BRIT J HAEMATOL, V173, P96, DOI 10.1111/bjh.13931; Bayraktar UD, 2016, BIOL BLOOD MARROW TR, V22, P505, DOI 10.1016/j.bbmt.2015.10.020; Benjamin A., 2015, MAGIC COUNTING MAGIC, pp71; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bolkhovskaya OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108658; Brunstein CG, 2011, BLOOD, V118, P282, DOI 10.1182/blood-2011-03-344853; Ciurea SO, 2015, BLOOD, V126, P1033, DOI 10.1182/blood-2015-04-639831; Czerw T, 2016, ONCOTARGET, V7, P27255, DOI 10.18632/oncotarget.8463; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Eapen M, 2015, J CLIN ONCOL, V33, P364, DOI 10.1200/JCO.2014.57.2446; El-Cheikh J, 2015, CANCER-AM CANCER SOC, V121, P1809, DOI 10.1002/cncr.29271; Freund JE, 1973, PROBABILITY INTRO PR, pp33; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Holtick U, 2015, CRIT REV ONCOL HEMAT, V94, P179, DOI 10.1016/j.critrevonc.2014.12.007; Inamoto Y, 2011, BIOL BLOOD MARROW TR, V17, P1088, DOI 10.1016/j.bbmt.2011.01.017; Jameson-Lee M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00529; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kanda Y, 2016, BONE MARROW TRANSPL, V51, P103, DOI 10.1038/bmt.2015.222; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Koreth J, 2015, BIOL BLOOD MARROW TR, V21, P1907, DOI 10.1016/j.bbmt.2015.05.027; Kroger N, 2016, NEW ENGL J MED, V374, P43, DOI 10.1056/NEJMoa1506002; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Meier J, 2013, BIOL BLOOD MARROW TR, V19, P366, DOI 10.1016/j.bbmt.2012.12.004; Morishima Y, 2015, BLOOD, V125, P1189, DOI 10.1182/blood-2014-10-604785; Morrison F., 1991, ART MODELING DYNAMIC, pp165; Murray JD, 2002, MATH BIOL, P94; Pandiyan P, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00060; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Petersen SL, 2007, DAN MED BULL, V54, P112; Pidala J, 2013, BLOOD, V122, P3651, DOI 10.1182/blood-2013-05-501510; Razzaq BA, 2016, BIOL BLOOD MARROW TR, V22, P850, DOI 10.1016/j.bbmt.2015.11.1103; Ringden O, 2016, LEUKEMIA, V30, P447, DOI 10.1038/leu.2015.232; Ringden O, 2014, TRANSPLANTATION, V98, P569, DOI 10.1097/TP.0000000000000102; Russ Brendan E., 2013, Frontiers in Genetics, V4, P218, DOI 10.3389/fgene.2013.00218; Sampson JK, 2014, BRIT J HAEMATOL, V166, P566, DOI 10.1111/bjh.12898; Storb R, 2013, BIOL BLOOD MARROW TR, V19, P792, DOI 10.1016/j.bbmt.2013.02.006; Susskind L, 2014, MATH INTERLUDE VECTO, P24; Susskind L, 2014, QUANTUM MECH THEORET, P52; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Toor AA, 2015, BIOL BLOOD MARROW TR, V21, P1237, DOI 10.1016/j.bbmt.2015.03.011; Toor AA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00613; Valcarcel D, 2011, BIOL BLOOD MARROW TR, V17, P640, DOI 10.1016/j.bbmt.2010.07.022; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187771	10.1371/journal.pone.0187771	http://dx.doi.org/10.1371/journal.pone.0187771			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194460	Green Published, Green Submitted, gold			2022-12-26	WOS:000416867800008
J	Dzoic, T; Paklar, GB; Grbec, B; Ivatek-Sahdan, S; Zorica, B; Segvic-Bubic, T; Kec, VC; Pleic, IL; Mladineo, I; Grubisic, L; Verley, P				Dzoic, Tomislav; Paklar, Gordana Beg; Grbec, Branka; Ivatek-Sahdan, Stjepan; Zorica, Barbara; Segvic-Bubic, Tanja; Kec, Vanja Cikes; Pleic, Ivana Lepen; Mladineo, Ivona; Grubisic, Leon; Verley, Philippe			Spillover of the Atlantic bluefin tuna offspring from cages in the Adriatic Sea: A multidisciplinary approach and assessment	PLOS ONE			English	Article							THUNNUS-THYNNUS L.; SIZE; AGE	During routine monitoring of commercial purse seine catches in 2011, 87 fingerling specimens of scombrids were collected in the southern Adriatic Sea. Sequencing of the mitochondrial DNA control region locus inferred that specimens belonged to the Atlantic bluefin tuna, Thunnus thynnus (Linnaeus, 1758) (N = 29), bullet tuna, Auxis rochei (Risso, 1810) (N = 30) and little tunny, Euthynnus alletteratus, Rafinesque, 1810 (N = 28). According to previously published growth parameters, the age of the collected specimens was estimated at approximately 30-40 days, suggesting they might have been spawned in the Adriatic Sea, contrary to the current knowledge. A coupled modelling system with hydrodynamic (ROMS) and individual based model (IBM-Ichthyop) was set up to determine the location of the spawning event. Numerical simulations with the IBM model, both backward and forward in time, indicate commercial tuna cages in the middle Adriatic coastal area as possible spawning location. The two other non-commercial species likely opportunistically use the positive environmental (abiotic and biotic) conditions to spawn in the same area.	[Dzoic, Tomislav; Paklar, Gordana Beg; Grbec, Branka] Inst Oceanog & Fisheries, Phys Oceanog Lab, Split, Croatia; [Ivatek-Sahdan, Stjepan] Meteorol & Hydrol Serv, Res & Dev Div, Zagreb, Croatia; [Zorica, Barbara; Kec, Vanja Cikes] Inst Oceanog & Fisheries, Lab Fisheries Sci & Management Pelag & Demersal R, Split, Croatia; [Segvic-Bubic, Tanja; Pleic, Ivana Lepen; Mladineo, Ivona; Grubisic, Leon] Inst Oceanog & Fisheries, Lab Aquaculture, Split, Croatia; [Verley, Philippe] Inst Rech Dev, UMR Bot & Modelling Plant Architecture & Vegetat, Montpellier, France	Croatian Institute of Oceanography & Fisheries (IZOR); Croatian Institute of Oceanography & Fisheries (IZOR); Croatian Institute of Oceanography & Fisheries (IZOR); Institut de Recherche pour le Developpement (IRD)	Dzoic, T (corresponding author), Inst Oceanog & Fisheries, Phys Oceanog Lab, Split, Croatia.	dzoic@izor.hr	Pleić, Ivana Lepen/AAX-7178-2020; Mladineo, Ivona/AAC-5813-2021; Džoić, Tomislav/AAM-8951-2020; Segvic-Bubic, Tanja/O-6841-2016	Pleić, Ivana Lepen/0000-0002-0548-4062; Segvic-Bubic, Tanja/0000-0003-4405-1611; Dzoic, Tomislav/0000-0001-9585-8779; Zorica, Barbara/0000-0002-9131-4675	Croatian Science Foundation [IP-2014-09-9050, IP-2014-09-3606, 001-0013077-0532]; project PERIMON	Croatian Science Foundation; project PERIMON	This work was supported by the Croatian Science Foundation: IP-2014-09-9050 (www.izor.hr/aquapop). The authors who received the funding - TSB, LG. It was also supported by the Croatian Science Foundation: IP-2014-09-3606 (http://jadran.izorhr/-kovac/mariplan/). The authors who received the funding - GBP, TDZ, BG. Croatian Science Foundation: 001-0013077-0532 (http://www.izor.hr) also supported this work. The authors who received the funding - BZ, VCK. Also project PERIMON is added to the list of projects that financially supported our study. The author who received the funding - VCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Alemany F., 1997, THESIS; [Anonymous], 2016, ADV TUNA AQUACULTURE; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bray L, 2017, MAR ENVIRON RES, V125, P73, DOI 10.1016/j.marenvres.2017.01.006; Brickman D, 2002, J ATMOS OCEAN TECH, V19, P83, DOI 10.1175/1520-0426(2002)019<0083:LSMICO>2.0.CO;2; Cermeno P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116638; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Collette BB, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P149; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cushman-Roisin B, PHYS OCEANOGRAPHY AD; De la Gandara F, 2011, P AQ EUR 2011 EUR AQ, P249; De la Gandara F, 2016, ADV TUNA AQUACULTURE, P115; Deflorio M., 2005, COLLECT VOL SCI PAP, V56, P630; DHMZ (Meteorological and Hydrological Service), 2013, REV NO23 CLIM MON AS; Druon JN, 2016, PROG OCEANOGR, V142, P30, DOI 10.1016/j.pocean.2016.01.002; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Grbec B, I OCEANOGRAPHY FISHE; Grubisic L, 2013, FISHERIES, V38, P410, DOI 10.1080/03632415.2013.826201; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kahraman AE, 2008, J APPL ICHTHYOL, V24, P551, DOI 10.1111/j.1439-0426.2008.01068.x; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; La Mesa M, 2005, SCI MAR, V69, P241, DOI 10.3989/scimar.2005.69n2241; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Mather FJ, 1995, HIST DOCUMENT LIFE H, P1; Melia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23705; Mylonas CC, 2007, REV FISH SCI, V15, P183, DOI 10.1080/10641260701484572; Naro-Maciel E, 2017, ECOGRAPHY, V40, P586, DOI 10.1111/ecog.02056; North EW, 2009, ICES INT COUNC EXPLO; Pasaric M., 2006, ACTA ADRIAT, V47, P219; Putman NF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1689; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Reglero P, 39 ANN LARV FISH C 2; Santamaria N., 2000, BIOL MARINA MEDITERR, V8, P765; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; Ticina V, 2007, AQUACULTURE, V269, P538, DOI 10.1016/j.aquaculture.2007.05.029; Uchida RN, 1981, FAO FISH SYNOPS, V124; ZOREARMANDA M, 1968, STUD REV GEN FISH CO, V34, P1	42	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188956	10.1371/journal.pone.0188956	http://dx.doi.org/10.1371/journal.pone.0188956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190825	gold, Green Published			2022-12-26	WOS:000416841900178
J	Fabre, AL; Luis, A; Colotte, M; Tuffet, S; Bonnet, J				Fabre, Anne-Lise; Luis, Aurelie; Colotte, Marthe; Tuffet, Sophie; Bonnet, Jacques			High DNA stability in white blood cells and buffy coat lysates stored at ambient temperature under anoxic and anhydrous atmosphere	PLOS ONE			English	Article							LYOPHILIZED LIPID/DNA COMPLEXES; PERIPHERAL-BLOOD; QUALITY-CONTROL; NUCLEIC-ACIDS; GENOMIC DNA; STORAGE; DEGRADATION; BIOSPECIMENS; AMPLIFICATION; PRESERVATION	Conventional storage of blood-derived fractions relies on cold. However, lately, ambient temperature preservation has been evaluated by several independent institutions that see economic and logistic advantages in getting rid of the cold chain. Here we validated a novel procedure for ambient temperature preservation of DNA in white blood cell and buffy coat lysates based on the confinement of the desiccated biospecimens under anoxic and anhydrous atmosphere in original hermetic minicapsules. For this validation we stored encapsulated samples either at ambient temperature or at several elevated temperatures to accelerate aging. We found that DNA extracted from stored samples was of good quality with a yield of extraction as expected. Degradation rates were estimated from the average fragment size of denatured DNA run on agarose gels and from qPCR reactions. At ambient temperature, these rates were too low to be measured but the degradation rate dependence on temperature followed Arrhenius' law, making it possible to extrapolate degradation rates at 25 degrees C. According to these values, the DNA stored in the encapsulated blood products would remain larger than 20 kb after one century at ambient temperature. At last, qPCR experiments demonstrated the compatibility of extracted DNA with routine DNA downstream analyses. Altogether, these results showed that this novel storage method provides an adequate environment for ambient temperature long term storage of high molecular weight DNA in dehydrated lysates of white blood cells and buffy coats.	[Fabre, Anne-Lise; Luis, Aurelie; Tuffet, Sophie; Bonnet, Jacques] Univ Bordeaux, R&D Dept, Imagene, ENSTBB, 146 Rue Leo Saignat, Bordeaux, France; [Fabre, Anne-Lise; Colotte, Marthe] Prod Platform, Imagene, Rue Henri Desbrueres,Genopole Campus 1,Bat 6, Evry, France; [Bonnet, Jacques] Univ Bordeaux, INSERM, U1218, Inst Bergonie, 229 Cours Argonne, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Genopole; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie	Fabre, AL (corresponding author), Univ Bordeaux, R&D Dept, Imagene, ENSTBB, 146 Rue Leo Saignat, Bordeaux, France.; Fabre, AL (corresponding author), Prod Platform, Imagene, Rue Henri Desbrueres,Genopole Campus 1,Bat 6, Evry, France.	fabre@imagene.eu		Fabre, Anne-Lise/0000-0003-4871-0637	Imagene	Imagene	The work described here was funded by Imagene to A-LF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2000, J PHARM SCI, V89, P682, DOI 10.1002/(SICI)1520-6017(200005)89:5<682::AID-JPS14>3.0.CO;2-#; Bialkowski K, 1996, Z NATURFORSCH C, V51, P119; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Bulla A, 2016, BIOPRESERV BIOBANK, P1429; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Caboux E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039821; Cataldo F, 2006, INT J BIOL MACROMOL, V38, P248, DOI 10.1016/j.ijbiomac.2006.02.029; Cayuela JM, 2015, CLIN BIOCHEM, V48, P982, DOI 10.1016/j.clinbiochem.2015.04.004; Clermont D, 2014, BIOPRESERV BIOBANK, V12, P176, DOI 10.1089/bio.2013.0082; Colotte M, 2009, ANAL BIOCH; Colotte M, 2011, BIOPRESERV BIOBANK, V9, P47, DOI 10.1089/bio.2010.0028; Estillore AD, 2016, CHEM SCI, V7, P6604, DOI 10.1039/c6sc02353c; Evans RK, 2000, J PHARM SCI, V89, P76, DOI 10.1002/(SICI)1520-6017(200001)89:1<76::AID-JPS8>3.0.CO;2-U; Fabre AL, 2014, EUR J HUM GENET, V22, P379, DOI 10.1038/ejhg.2013.145; Fleming AM, 2015, CHEM RES TOXICOL, V28, P1292, DOI 10.1021/acs.chemrestox.5b00096; Grass RN, 2015, ANGEW CHEM INT EDIT, V54, P2552, DOI 10.1002/anie.201411378; GUTHRIE R, 1961, JAMA-J AM MED ASSOC, V178, P863, DOI 10.1001/jama.1961.03040470079019; Holden MJ, 2009, J AGR FOOD CHEM, V57, P7221, DOI 10.1021/jf901165h; Huang LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184692; Hubel A, 2014, BIOPRESERV BIOBANK, V12, P165, DOI 10.1089/bio.2013.0084; Johnson BM, 2017, J ARCHAEOL SCI-REP, V11, P683, DOI 10.1016/j.jasrep.2017.01.006; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Liu XP, 2015, BIOPRESERV BIOBANK, V13, P49, DOI 10.1089/bio.2014.0060; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; Malentacchi F, 2016, CLIN CHIM ACTA, V454, P10, DOI 10.1016/j.cca.2015.12.032; MATSUO S, 1995, BIOCHEM BIOPH RES CO, V208, P1021, DOI 10.1006/bbrc.1995.1436; Molina MDC, 2008, BBA-BIOMEMBRANES, V1778, P2119, DOI 10.1016/j.bbamem.2008.04.003; Molina MD, 2004, J PHARM SCI-US, V93, P2259, DOI 10.1002/jps.20138; Muller R, 2016, BIOPRESERV BIOBANK, V14, P89, DOI 10.1089/bio.2015.0022; Mychaleckyj JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-91; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Pogocki D, 2000, J PHARM SCI-US, V89, P443, DOI 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.3.CO;2-N; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Rahikainen AL, 2016, FORENSIC SCI INT; Rathbun MM, 2017, FORENSIC SCI INT-GEN, V26, P1, DOI 10.1016/j.fsigen.2016.09.008; ROSS KS, 1990, J MED GENET, V27, P569, DOI 10.1136/jmg.27.9.569; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Shao W, 2012, BIOPRESERV BIOBANK, V10, P4, DOI 10.1089/bio.2011.0016; Sharma VK, 2007, PHARM RES-DORDR, V24, P168, DOI 10.1007/s11095-006-9138-7; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; SORIANO P, 1981, EUR J BIOCHEM, V115, P235, DOI 10.1111/j.1432-1033.1981.tb05228.x; SVAREN J, 1987, NUCLEIC ACIDS RES, V15, P8739, DOI 10.1093/nar/15.21.8739; Tuffet S, 2009, International patent, Patent No. [WO 2009115761A2, 2009115761]; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06542-z; Zhou GD, 2016, BIOPRESERV BIOBANK, V14, P165, DOI 10.1089/bio.2015.0075; Zhou JY, 2015, BIOPRESERV BIOBANK, V13, P13, DOI 10.1089/bio.2014.0094	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188547	10.1371/journal.pone.0188547	http://dx.doi.org/10.1371/journal.pone.0188547			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190767	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900072
J	Jiang, CM; Shen, QXJ; Wang, B; He, B; Xiao, SQ; Chen, L; Yu, TQ; Ke, X; Zhong, QF; Fu, J; Chen, Y; Wang, LX; Yin, FY; Zhang, DY; Ghidan, W; Huang, XQ; Cheng, ZQ				Jiang, Chunmiao; Shen, Qingxi J.; Wang, Bo; He, Bin; Xiao, Suqin; Chen, Ling; Yu, Tengqiong; Ke, Xue; Zhong, Qiaofang; Fu, Jian; Chen, Yue; Wang, Lingxian; Yin, Fuyou; Zhang, Dunyu; Ghidan, Walid; Huang, Xingqi; Cheng, Zaiquan			Transcriptome analysis of WRKY gene family in Oryza officinalis Wall ex Watt and WRKY genes involved in responses to Xanthomonas oryzae pv. oryzae stress	PLOS ONE			English	Article							DEFENSE-RELATED GENES; ABSCISIC-ACID; DNA-BINDING; NEGATIVE REGULATORS; EXPRESSION ANALYSIS; SIGNALING PATHWAY; RICE; SUPERFAMILY; ARABIDOPSIS; RESISTANCE	Oryza officinalis Wall ex Watt, a very important and special wild rice species, shows abundant genetic diversity and disease resistance features, especially high resistance to bacterial blight. The molecular mechanisms of bacterial blight resistance in O. officinalis have not yet been elucidated. The WRKY transcription factor family is one of the largest gene families involved in plant growth, development and stress response. However, little is known about the numbers, structure, molecular phylogenetics, and expression of the WRKY genes under Xanthomonas oryzae pv. oryzae (Xoo) stress in O. officinalis due to lacking of O. officinalis genome. Therefore, based on the RNA-sequencing data of O. officinalis, we performed a comprehensive study of WRKY genes in O. officinalis and identified 89 OoWRKY genes. Then 89 OoWRKY genes were classified into three groups based on the WRKY domains and zinc finger motifs. Phylogenetic analysis strongly supported that the evolution of OoWRKY genes were consistent with previous studies of WRKYs, and subgroup IIc OoWRKY genes were the original ancestors of some group II and group III OoWRKYs. Among the 89 OoWRKY genes, eight OoWRKYs displayed significantly different expression (>2-fold, p<0.01) in the O. officinalis transcriptome under Xoo strains PXO99 and C5 stress 48 h, suggesting these genes might play important role in PXO99 and C5 stress responses in O. officinalis. QRT-PCR analysis and confirmation of eight OoWRKYs expression patterns revealed that they responded strongly to PXO99 and C5 stress 24 h, 48 h, and 72 h, and the trends of these genes displaying marked changes were consistent with the 48 h RNA-sequencing data, demonstrated these genes played important roles in response to biotic stress and might even involved in the bacterial blight resistance. Tissue expression profiles of eight OoWRKY genes revealed that they were highly expressed in root, stem, leaf, and flower, especially in leaf (except OoWRKY71), suggesting these genes might be also important for plant growth and organ development. In this study, we analyzed the WRKY family of transcription factors in O. officinalis. Insight was gained into the classification, evolution, and function of the OoWRKY genes, revealing the putative roles of eight significantly different expression OoWRKYs in Xoo strains PXO99 and C5 stress responses in O. officinalis. This study provided a better understanding of the evolution and functions of O. officinalis WRKY genes, and suggested that manipulating eight significantly different expression OoWRKYs would enhance resistance to bacterial blight.	[Jiang, Chunmiao; Wang, Bo; Xiao, Suqin; Chen, Ling; Yu, Tengqiong; Ke, Xue; Zhong, Qiaofang; Fu, Jian; Chen, Yue; Wang, Lingxian; Yin, Fuyou; Zhang, Dunyu; Huang, Xingqi; Cheng, Zaiquan] Yunnan Acad Agr Sci, Biotechnol & Genet Germplasm Inst, Kunming, Yunnan, Peoples R China; [Jiang, Chunmiao; Huang, Xingqi] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Shen, Qingxi J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [He, Bin] Jiangxi Sci & Technol Normal Univ, Nanchang, Jiangxi, Peoples R China; [Ghidan, Walid] Agr Res Ctr, Field Crops Res Inst, Rice Res & Training Ctr, Sakha, Kafr Elsheikh, Egypt	Yunnan Academy of Agricultural Sciences; Yunnan University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Jiangxi Science & Technology Normal University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Huang, XQ (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Genet Germplasm Inst, Kunming, Yunnan, Peoples R China.; Huang, XQ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	hxq311@126.com; czquan-99@163.com	Ghidan, Walid/AAW-5861-2020		NSFC-Yunnan Project [U1302265]; NSFC [31460054, 31460478, 31401707]; Yunnan Key Project [2012CI]	NSFC-Yunnan Project; NSFC(National Natural Science Foundation of China (NSFC)); Yunnan Key Project	This study was supported by the NSFC-Yunnan Project (U1302265) and NSFC Project (31460054 to XK, 31460478 to WL, 31401707 to SX) and granted from Yunnan Key Project (2012CI) to XQH.	Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Cheng Zai-Quan, 2004, Acta Botanica Yunnanica, V26, P267; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Chujo T, 2006, PLANT CELL PHYSL; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Diao WP, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01727, 10.3389/fpls.2016.00211]; Dorn R, 2003, GENETICA, V117, P165, DOI 10.1023/A:1022983810016; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fu XL, 2011, AGR SCI CHINA, V10, P1489, DOI 10.1016/S1671-2927(11)60143-0; Han M, 2013, J PLANT BIOL, V56, P258, DOI 10.1007/s12374-013-0160-0; Harborne JB, 1999, BIOCHEM SYST ECOL, V27, P335, DOI 10.1016/S0305-1978(98)00095-7; Hasegawa M, 2014, MOLECULES, V19, P11404, DOI 10.3390/molecules190811404; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jang JY, 2010, PLANT PATHOLOGY J, V26, P110, DOI 10.5423/PPJ.2010.26.2.110; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Monticone M, 2010, J CELL PHYSIOL, V225, P767, DOI 10.1002/jcp.22279; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peng XX, 2012, PLANTA, V236, P1485, DOI 10.1007/s00425-012-1698-7; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Song H, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/420128; Song Y, 2010, RICE SCI, V17, P60, DOI 10.1016/S1672-6308(08)60105-5; Tan Guang-Xuan, 2004, Acta Genetica Sinica, V31, P724; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu HJ, 2016, DNA RES, V23, P311, DOI 10.1093/dnares/dsw025; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang LY, 2015, PLANT SCI, V236, P214, DOI 10.1016/j.plantsci.2015.04.014; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	54	7	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188742	10.1371/journal.pone.0188742	http://dx.doi.org/10.1371/journal.pone.0188742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190793	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900114
J	Kolodziejczyk, R; Mikula, KM; Kotila, T; Postis, VLG; Jokiranta, TS; Goldman, A; Meri, T				Kolodziejczyk, Robert; Mikula, Kornelia M.; Kotila, Tommi; Postis, Vincent L. G.; Jokiranta, T. Sakari; Goldman, Adrian; Meri, Taru			Crystal structure of a tripartite complex between C3dg, C-terminal domains of factor H and OspE of Borrelia burgdorferi	PLOS ONE			English	Article							REGULATORY DOMAINS; FAMILY PROTEINS; IMMUNE EVASION; RECEPTOR 2; BINDING; LIGAND; RECOGNITION; MODULATION; MUTATIONS; FRAGMENT	Complement is an important part of innate immunity. The alternative pathway of complement is activated when the main opsonin, C3b coats non-protected surfaces leading to opsonisation, phagocytosis and cell lysis. The alternative pathway is tightly controlled to prevent autoactivation towards host cells. The main regulator of the alternative pathway is factor H (FH), a soluble glycoprotein that terminates complement activation in multiple ways. FH recognizes host cell surfaces via domains 19-20 (FH19-20). All microbes including Borrelia burgdorferi, the causative agent of Lyme borreliosis, must evade complement activation to allow the infectious agent to survive in its host. One major mechanism that Borrelia uses is to recruit FH from host. Several outer surface proteins (Osp) have been described to bind FH via the C-terminus, and OspE is one of them. Here we report the structure of the tripartite complex formed by OspE, FH19-20 and C3dg at 3.18 angstrom, showing that OspE and C3dg can bind simultaneously to FH19-20. This verifies that FH19-20 interacts via the "common microbial binding site" on domain 20 with OspE and simultaneously and independently via domain 19 with C3dg. The spatial organization of the tripartite complex explains how OspE on the bacterial surface binds FH19-20, leaving FH fully available to protect the bacteria against complement. Additionally, formation of tripartite complex between FH, microbial protein and C3dg might enable enhanced protection, particularly on those regions on the bacteria where previous complement activation led to deposition of C3d. This might be especially important for slow-growing bacteria that cause chronic disease like Borrelia burgdorferi.	[Kolodziejczyk, Robert; Mikula, Kornelia M.; Goldman, Adrian] Univ Helsinki, Div Biochem, Dept Biosci, Helsinki, Finland; [Kotila, Tommi] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Postis, Vincent L. G.] Leeds Beckett Univ, Fac Hlth & Social Sci, Biomed Res Grp, Leeds, W Yorkshire, England; [Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Goldman, Adrian] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Meri, Taru] Univ Helsinki, Div Gen Microbiol, Dept Biosci, Helsinki, Finland; [Kolodziejczyk, Robert] Pure Biol Ltd, Ul Dunska, Wroclaw, Poland	University of Helsinki; University of Helsinki; Leeds Beckett University; University of Helsinki; University of Leeds; University of Helsinki	Meri, T (corresponding author), Univ Helsinki, Div Gen Microbiol, Dept Biosci, Helsinki, Finland.	taru.meri@helsinki.fi	Postis, Vincent/D-7736-2013	Postis, Vincent/0000-0001-9251-4567; Goldman, Adrian/0000-0001-8032-9700; Kotila, Tommi/0000-0002-9046-5834	Sigrid Juselius Foundation; BBSRC [104399]; Wellcome Trust [478571]; Academy of Finland [255922, 259793]; Biomedicum Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Biomedicum Foundation	This work was supported by grants to AG from the Sigrid Juselius Foundation, the BBSRC (grant number 104399), the Wellcome Trust (grant number 478571), to SJ from the Academy of Finland (grants 255922 and 259793) and to TM from the Biomedicum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS EM, 1991, J IMMUNOL, V147, P3005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Brangulis K, 2015, BBA-PROTEINS PROTEOM, V1854, P349, DOI 10.1016/j.bbapap.2014.12.025; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Caesar Joseph J E, 2014, Elife, V3, DOI 10.7554/eLife.04008; Caesar JJE, 2013, ACTA CRYSTALLOGR F, V69, P624, DOI 10.1107/S1744309113013249; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; GORDON DL, 1995, J IMMUNOL, V155, P348; Hammerschmidt C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/349657; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Hyvarinen S, 2016, BLOOD, V127, P2701, DOI 10.1182/blood-2015-11-680009; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00571; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUHN S, 1995, J IMMUNOL, V155, P5663; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Siegel C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013519; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Williams JH, 2003, CLIN SCI, V104, P615, DOI 10.1042/CS20020176; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	51	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188127	10.1371/journal.pone.0188127	http://dx.doi.org/10.1371/journal.pone.0188127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190743	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000416841900036
J	Kouloussis, NA; Gerofotis, CD; Ioannou, CS; Iliadis, IV; Papadopoulos, NT; Koveos, DS				Kouloussis, Nikos A.; Gerofotis, Christos D.; Ioannou, Charalampos S.; Iliadis, Ioannis V.; Papadopoulos, Nikos T.; Koveos, Dimitris S.			Towards improving sterile insect technique: Exposure to orange oil compounds increases sexual signalling and longevity in Ceratitis capitata males of the Vienna 8 GSS	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; ENHANCES MATING SUCCESS; FLIES DIPTERA; JUVENILE-HORMONE; AGE; TEPHRITIDAE; COMPETITIVENESS; DIET; IRRADIATION; PERFORMANCE	The Mediterranean fruit fly (medfly), Ceratitis capitata, is a notorious insect pest causing huge economic losses worldwide. The sterile insect technique (SIT) is widely used for its control. Using sexually mature sterilized males of the Vienna 8 (tsl) strain in the laboratory, we explored whether exposure of males to citrus compounds (separately or in a mixture) affects their sexual behaviour and if nutritional conditions and age modulate those effects. Exposed males exhibited increased sexual signalling compared to unexposed ones, particularly when fed a rich adult diet. Interestingly, and for the first time reported in medfly, exposure of Vienna 8 males to a mixture of citrus compounds increases longevity under poor adult diet conditions. We discuss the possible associated mechanisms and provide some practical implications of our results towards improving the effectiveness of SIT.	[Kouloussis, Nikos A.; Gerofotis, Christos D.; Iliadis, Ioannis V.; Koveos, Dimitris S.] Aristotle Univ Thessaloniki, Sch Agr, Lab Appl Zool & Parasitol, Thessaloniki, Greece; [Ioannou, Charalampos S.; Papadopoulos, Nikos T.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Ionia, Volos, Greece	Aristotle University of Thessaloniki; University of Thessaly	Kouloussis, NA (corresponding author), Aristotle Univ Thessaloniki, Sch Agr, Lab Appl Zool & Parasitol, Thessaloniki, Greece.	nikoul@agro.auth.gr	Kouloussis, Nikos/B-4544-2011; Koveos, Dimitris/AAU-6857-2020; Papadopoulos, Nikos/AAJ-1721-2020	Kouloussis, Nikos/0000-0003-1802-4193; Papadopoulos, Nikos/0000-0003-2480-8189; D. Gerofotis, Chris/0000-0002-2455-0088	International Atomic Energy Agency [12857/RO]	International Atomic Energy Agency(International Atomic Energy Agency)	This study was funded by International Atomic Energy Agency (Grant No: 12857/RO), https://www.iaea.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos-Duarte CS, 2011, J INSECT BEHAV, V24, P11, DOI 10.1007/s10905-010-9232-x; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Barry JD, 2003, J ECON ENTOMOL, V96, P615, DOI 10.1603/0022-0493-96.3.615; Blay S, 1997, ANIM BEHAV, V54, P59, DOI 10.1006/anbe.1996.0445; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Drew R, 2000, FRUIT FLIES TEPHRITI; Dyck V.A., 2006, STERILE INSECT TECHN; Enkerlin W., 2007, GUIDANCE PACKING SHI; FLATH RA, 1993, J AGR FOOD CHEM, V41, P830, DOI 10.1021/jf00029a029; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Franz G., 1995, MEDITERRANEAN FRUIT, P187; Gerofotis CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28540; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Juan-Blasco M, 2013, J APPL ENTOMOL, V137, P244, DOI 10.1111/j.1439-0418.2011.01688.x; Kaspi R, 2000, ANN ENTOMOL SOC AM, V93, P949, DOI 10.1603/0013-8746(2000)093[0949:PTPFIS]2.0.CO;2; Katsoyannos BI, 1997, ENTOMOL EXP APPL, V82, P181, DOI 10.1023/A:1002940012328; Kouloussis NA, 2013, J APPL ENTOMOL, V137, P30, DOI 10.1111/j.1439-0418.2010.01535.x; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Liedo P, 2002, FLA ENTOMOL, V85, P94, DOI 10.1653/0015-4040(2002)085[0094:EOAOTM]2.0.CO;2; Liquido N. J., 1991, MISCELLANEOUS PUBLIC, V77, P1863; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; Maor M, 2004, ENTOMOL EXP APPL, V110, P225, DOI 10.1111/j.0013-8703.2004.00139.x; Muller HG, 1997, P NATL ACAD SCI USA, V94, P2762, DOI 10.1073/pnas.94.6.2762; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Papadopoulos NT, 2006, J INSECT BEHAV, V19, P403, DOI 10.1007/s10905-006-9031-6; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Papadopoulos NT, 2004, OECOLOGIA, V138, P127, DOI 10.1007/s00442-003-1392-3; Papadopoulos NT, 2001, ENTOMOL EXP APPL, V99, P253, DOI 10.1023/A:1019288301757; Papadopoulos NT, 2008, FRUIT FLIES EC IMPOR; Papanastasiou SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177837; Papanastasiou SA, 2011, J INSECT PHYSIOL, V57, P1368, DOI 10.1016/j.jinsphys.2011.07.004; Papanicolaou A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1049-2; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Roriz AKP, 2013, ZOOLOGIA-CURITIBA, V30, P506, DOI 10.1590/S1984-46702013000500006; Pereira R, 2013, J APPL ENTOMOL, V137, P178, DOI 10.1111/j.1439-0418.2011.01664.x; Reynolds OL, 2014, B ENTOMOL RES, V104, P251, DOI 10.1017/S0007485313000758; Shelly T, 2004, J INSECT BEHAV, V17, P303, DOI 10.1023/B:JOIR.0000031532.29287.95; Shelly TE, 2002, FLA ENTOMOL, V85, P572, DOI 10.1653/0015-4040(2002)085[0572:IOMDOM]2.0.CO;2; Shelly TE, 2001, J ECON ENTOMOL, V94, P1413, DOI 10.1603/0022-0493-94.6.1413; Shelly TE, 2002, FLA ENTOMOL, V85, P150, DOI 10.1653/0015-4040(2002)085[0150:EOADOS]2.0.CO;2; Shelly TE, 2001, ANN ENTOMOL SOC AM, V94, P497, DOI 10.1603/0013-8746(2001)094[0497:ETCACC]2.0.CO;2; Shelly TE, 2007, J ECON ENTOMOL, V100, P1180, DOI 10.1603/0022-0493(2007)100[1180:AVIMSO]2.0.CO;2; Shelly Todd E., 2009, Proceedings of the Hawaiian Entomological Society, V41, P31; Silva N, 2013, J APPL ENTOMOL, V137, P230, DOI 10.1111/j.1439-0418.2011.01681.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Teal PEA, 2000, P NATL ACAD SCI USA, V97, P3708, DOI 10.1073/pnas.060034397; Warburg MS, 1996, PHYSIOL ENTOMOL, V21, P151, DOI 10.1111/j.1365-3032.1996.tb00848.x; WHITTIER TS, 1994, J INSECT BEHAV, V7, P159, DOI 10.1007/BF01990078; Yuval B, 2007, FLA ENTOMOL, V90, P115, DOI 10.1653/0015-4040(2007)90[115:BOCOKO]2.0.CO;2	54	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188092	10.1371/journal.pone.0188092	http://dx.doi.org/10.1371/journal.pone.0188092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190755	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900034
J	Tan, ZM; Jia, XF; Ma, F; Feng, YL; Lu, HZ; Jin, JO; Wu, DG; Yin, L; Liu, L; Zhang, LJ				Tan, Zhimi; Jia, Xiaofang; Ma, Fang; Feng, Yanling; Lu, Hongzhou; Jin, Jun-O; Wu, Dage; Yin, Lin; Liu, Li; Zhang, Lijun			Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz	PLOS ONE			English	Article							LIVER PLASMA-MEMBRANE; ANTIRETROVIRAL THERAPY; PROTEOMIC ANALYSIS; ADVERSE EVENTS; CELL-DEATH; NEVIRAPINE; STRESS; DRUGS; IDENTIFICATION; INHIBITION	Background Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), has been widely used in the therapy of human immunodeficiency virus (HIV) infection. Some of its toxic effects on hepatic cells have been reported to display features of mitochondrial dysfunction through bioenergetic stress and autophagy, etc. However, alteration of protein levels, especially mitochondrial protein levels, in hepatic cells during treatment of EFV has not been fully investigated. Methods We built a cell model of EFV-induced liver toxicity through treating Huh-7 cells with different concentrations of EFV for different time followed by the analysis of cell viability using cell counting kit-8 (CCK8) and reactive oxygen species (ROS) using 2', 7'-dichlorodihydrofluorescein diacetate (DCFH-DA) and MitoSox dye. Proteomic profiles in the mitochondria of Huh-7 cells stimulated by EFV were analyzed. Four differentially expressed proteins were quantified by real time RT-PCR. We also detected the expression of mitochondrial precursor Cob(I) yrinic acid a, c-diamide adenosyltransferase (MMAB) by immunohistochemistry analysis in clinical samples. The expression levels of MMAB and ROS were detected in EFV-treated Huh-7 cells with and without shRNA used to knock down MMAB, and in primary hepatocytes (PHC). The effects of other anti-HIV drugs (nevirapine (NVP) and tenofovirdisoproxil (TDF)), and hydrogen peroxide (H2O2) were also tested. Amino acid analysis and fatty aldehyde dehydrogenase (ALDH3A2) expression after MMAB expression knock-down with shRNA was used to investigate the metabolic effect of MMAB in Huh-7 cells. Results EFV treatment inhibited cell viability and increased ROS production with time- and concentration-dependence. Proteomic study was performed at 2 hours after EFV treatment. After treated Huh-7 cells with EFV (2.5mg/L or 10 mg/L) for 2 h, fifteen differentially expressed protein spots from purified mitochondrion that included four mitochondria proteins were detected in EFV-treated Huh-7 cells compared to controls. Consistent with protein expression levels, mRNA expression levels of mitochondrial protein MMAB were also increased by EFV treatment. In addition, the liver of EFV-treated HIV infected patients showed substantially higher levels of MMAB expression compared to the livers of untreated or protease inhibitor (PI)-treated HIV-infected patients. Furthermore, ROS were found to be decreased in Huh-7 cells treated with shMMAB compared with empty plasmid treated with EFV at the concentration of 2.5 or 10 mg/L. MMAB was increased in EFV-treated Huh-7 cells and primary hepatocytes. However, no change in MMAB expression was detected after treatment of Huh-7 cells and primary hepatocytes with anti-HIV drugs nevirapine (NVP) and tenofovirdisoproxil (TDF), or hydrogen peroxide (H2O2), although ROS was increased in these cells. Finally, knockdown of MMAB by shRNA induced increases in the beta-Alanine (beta-Ala) production levels and decrease in ALDH3A2 expression. Conclusions A mitochondrial proteomic study was performed to study the proteins related to EFV-inducted liver toxicity. MMAB might be a target and potential biomarker of hepatotoxicity in EFV-induced liver toxicity.	[Tan, Zhimi; Jia, Xiaofang; Ma, Fang; Feng, Yanling; Lu, Hongzhou; Jin, Jun-O; Wu, Dage; Yin, Lin; Liu, Li; Zhang, Lijun] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China	Fudan University	Zhang, LJ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.	zhanglijun1221@163.com	Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111; Zhang, Lijun/0000-0002-9266-268X	National Natural Science Funds [81271834]; Key Issues of Shanghai Municipal Commission of Health and Family Planning and Family [201640005]; 13th Five-Year New Drug Platform [5Q2017ZX090970]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Key Issues of Shanghai Municipal Commission of Health and Family Planning and Family; 13th Five-Year New Drug Platform	This study was supported by the National Natural Science Funds (grant no. 81271834), the Key Issues of Shanghai Municipal Commission of Health and Family Planning and Family (grant no. 201640005), and the 13th Five-Year New Drug Platform (grant no. 5Q2017ZX090970) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Apostolova N, 2013, J HEPATOL, V59, P780, DOI 10.1016/j.jhep.2013.06.005; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Bruck S, 2008, EUR J MED RES, V13, P343; Cao R, 2006, J PROTEOME RES, V5, P634, DOI 10.1021/pr050387a; Chen J, 2010, THER DRUG MONIT, V32, P573, DOI 10.1097/FTD.0b013e3181ea953c; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Orozco-Barrios CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008268; Esplugues JV, 2006, CIRC RES, V99, P1067, DOI 10.1161/01.RES.0000250430.62775.99; Fang YJ, 2010, TOXICOL LETT, V199, P69, DOI 10.1016/j.toxlet.2010.08.008; He W, 2010, ANN PLAS SURG, V64, P466, DOI 10.1097/SAP.0b013e3181b4bc8d; Imaizumi N, 2015, REDOX BIOL, V4, P279, DOI 10.1016/j.redox.2015.01.005; Jia XF, 2014, ACTA BIOCH BIOPH SIN, V46, P1001, DOI 10.1093/abbs/gmu075; Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1510, DOI 10.1016/j.drudis.2014.05.012; Kurtyka Don, 2010, Adv Nurse Pract, V18, P33; Lee KK, 2014, REDOX BIOL, V2, P599, DOI 10.1016/j.redox.2014.03.003; Li A P, 1997, Adv Pharmacol, V43, P103, DOI 10.1016/S1054-3589(08)60203-3; Maggiolo F, 2009, J ANTIMICROB CHEMOTH, V64, P910, DOI 10.1093/jac/dkp334; Martinez MA, 2005, MOL GENET METAB, V84, P317, DOI 10.1016/j.ymgme.2004.11.011; McBurney RN, 2009, TOXICOL PATHOL, V37, P52, DOI 10.1177/0192623308329287; Mera PE, 2010, APPL MICROBIOL BIOT, V88, P41, DOI 10.1007/s00253-010-2773-2; Moss Joseph Anthony, 2013, Radiol Technol, V84, P247; Ray S, 2014, PROTEOM CLIN APPL, V8, P53, DOI 10.1002/prca.201300074; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067942; Wei YH, 2008, J PROTEOME RES, V7, P1729, DOI 10.1021/pr7008059; Xu BY, 2007, WORLD J GASTROENTERO, V13, P2100, DOI 10.3748/wjg.v13.i14.2100; Zhang LJ, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-12; Zhang LJ, 2006, PROTEOMICS, V6, P487, DOI 10.1002/pmic.200402007; Zhang LJ, 2005, PROTEOMICS, V5, P4510, DOI 10.1002/pmic.200401318; Zhang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-206	37	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188366	10.1371/journal.pone.0188366	http://dx.doi.org/10.1371/journal.pone.0188366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190729	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900051
J	Zhang, X; Yong, XY; Menon, C				Zhang, Xin; Yong, Xinyi; Menon, Carlo			Evaluating the versatility of EEG models generated from motor imagery tasks: An exploratory investigation on upper-limb elbow-centered motor imagery tasks	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; CHRONIC STROKE; BCI; REHABILITATION; CLASSIFICATION; EXOSKELETON; SYSTEM; DEVICE; ARM	Electroencephalography (EEG) has recently been considered for use in rehabilitation of people with motor deficits. EEG data from the motor imagery of different body movements have been used, for instance, as an EEG-based control method to send commands to rehabilitation devices that assist people to perform a variety of different motor tasks. However, it is both time and effort consuming to go through data collection and model training for every rehabilitation task. In this paper, we investigate the possibility of using an EEG model from one type of motor imagery (e.g.: elbow extension and flexion) to classify EEG from other types of motor imagery activities (e.g.: open a drawer). In order to study the problem, we focused on the elbow joint. Specifically, nine kinesthetic motor imagery tasks involving the elbow were investigated in twelve healthy individuals who participated in the study. While results reported that models from goal-oriented motor imagery tasks had higher accuracy than models from the simple joint tasks in intra-task testing (e.g., model from elbow extension and flexion task was tested on EEG data collected from elbow extension and flexion task), models from simple joint tasks had higher accuracies than the others in inter-task testing (e.g., model from elbow extension and flexion task tested on EEG data collected from drawer opening task). Simple single joint motor imagery tasks could, therefore, be considered for training models to potentially reduce the number of repetitive data acquisitions and model training in rehabilitation applications.	[Menon, Carlo] Simon Fraser Univ, Menrva Res Grp, Sch Mechatron Syst Engn, Metro Vancouver, BC, Canada; Simon Fraser Univ, Menrva Res Grp, Sch Engn Sci, Metro Vancouver, BC, Canada	Simon Fraser University; Simon Fraser University	Menon, C (corresponding author), Simon Fraser Univ, Menrva Res Grp, Sch Mechatron Syst Engn, Metro Vancouver, BC, Canada.	cmenon@sfu.ca	Menon, Carlo/GZG-8210-2022; Coish, Elizabeth/AAU-1245-2020	Menon, Carlo/0000-0002-2309-9977; Zhang, Xin/0000-0001-7623-5787	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (CRC) program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC) program(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funded by Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Research Chair (CRC) program.	Ang KK, 2015, CLIN EEG NEUROSCI, V46, P310, DOI 10.1177/1550059414522229; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Ang KK, 2008, IEEE IJCNN, P2390, DOI 10.1109/IJCNN.2008.4634130; ANG KK, 2012, FRONT NEUROSCI SWITZ, V6; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Boyd LA, 2010, NEUROSCI LETT, V482, P21, DOI 10.1016/j.neulet.2010.06.082; Broetz D, 2010, NEUROREHAB NEURAL RE, V24, P674, DOI 10.1177/1545968310368683; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Choi I, 2017, PLOS ONE; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; Dornhege G, OPTIMIZING SPATIO TE; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Elnady AM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00168; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; GOLDMANRAKIC PS, 1982, SCIENCE, V216, P755, DOI 10.1126/science.6177037; Gomez-Rodriguez M., 2010, 2010 IEEE International Conference on Systems, Man and Cybernetics (SMC 2010), P121, DOI 10.1109/ICSMC.2010.5642217; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; HOCHBERG Y, 1987, WILEY SER PROBAB STA, V312, P2014; Hongtao Wang, 2010, 2010 IEEE International Conference on Information Theory and Information Security, P837, DOI 10.1109/ICITIS.2010.5689710; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Iba Anez J, 2015, BRAIN COMPUTER INTER, P67; Ince NF, 2006, J NEURAL ENG, V3, P235, DOI 10.1088/1741-2560/3/3/006; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kandel ER, 2014, NEUROLOGY; Kothe CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056014; Krebs HI, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-6; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; LI AS, 2015, PLOS ONE, V10; Meng F, 2008, IEEE IJCNN, P4103, DOI 10.1109/IJCNN.2008.4634388; Meng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38565; Min BK, 2017, TRENDS BIOTECHNOL, V35, P585, DOI 10.1016/j.tibtech.2017.03.008; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Ortner R, 2012, STUD HEALTH TECHNOL, V181, P319, DOI 10.3233/978-1-61499-121-2-319; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pinto RD, 2015, P 3 2015 WORKSH ICT, P126; Prasad G, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-60; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Remsik A, 2016, EXPERT REV MED DEVIC, V4440; Royer AS, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016005; Schafer J., 2005, STAT APPL GENET MOL, V4; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Silvoni S, 2011, CLIN EEG NEUROSCI, V42, P245, DOI 10.1177/155005941104200410; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; Tan HG, 2010, IEEE ENG MED BIO, P4234, DOI 10.1109/IEMBS.2010.5627381; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; Muller SMT, 2013, J CONTROL AUTOM ELEC, V24, P97, DOI 10.1007/s40313-013-0002-9; Vuckovic A, 2012, MED ENG PHYS, V34, P964, DOI 10.1016/j.medengphy.2011.11.001; Wang YJ, 2005, P ANN INT IEEE EMBS, P5392; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Young BM, 2014, EXPERT REV MED DEVIC, V11, P537, DOI 10.1586/17434440.2014.941811	66	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188293	10.1371/journal.pone.0188293	http://dx.doi.org/10.1371/journal.pone.0188293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186170	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900027
J	Veach, V; Moilanen, A; Di Minin, E				Veach, Victoria; Moilanen, Atte; Di Minin, Enrico			Threats from urban expansion, agricultural transformation and forest loss on global conservation priority areas	PLOS ONE			English	Article							BIODIVERSITY; MARINE; IMPACTS; LAND; MAP	Including threats in spatial conservation prioritization helps identify areas for conservation actions where biodiversity is at imminent risk of extinction. At the global level, an important limitation when identifying spatial priorities for conservation actions is the lack of information on the spatial distribution of threats. Here, we identify spatial conservation priorities under three prominent threats to biodiversity (residential and commercial development, agricultural expansion, and forest loss), which are primary drivers of habitat loss and threaten the persistence of the highest number of species in the International Union for the Conservation of Nature (IUCN) Red List, and for which spatial data is available. We first explore how global priority areas for the conservation of vertebrate (mammals, birds, and amphibians) species coded in the Red List as vulnerable to each threat differ spatially. We then identify spatial conservation priorities for all species vulnerable to all threats. Finally, we identify the potentially most threatened areas by overlapping the identified priority areas for conservation with maps for each threat. We repeat the same with four other well-known global conservation priority area schemes, namely Key Biodiversity Areas, Biodiversity Hotspots, the global Protected Area Network, and Wilderness Areas. We find that residential and commercial development directly threatens only about 4% of the global top 17% priority areas for species vulnerable under this threat. However, 50% of the high priority areas for species vulnerable to forest loss overlap with areas that have already experienced some forest loss. Agricultural expansion overlapped with similar to 20% of high priority areas. Biodiversity Hotspots had the greatest proportion of their total area under direct threat from all threats, while expansion of low intensity agriculture was found to pose an imminent threat to Wilderness Areas under future agricultural expansion. Our results identify areas where limited resources should be allocated to mitigate risks to vertebrate species from habitat loss.	[Veach, Victoria; Moilanen, Atte] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Di Minin, Enrico] Univ Helsinki, Dept Geosci, Helsinki, Finland; [Di Minin, Enrico] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Helsinki; University of Helsinki; University of Kwazulu Natal	Di Minin, E (corresponding author), Univ Helsinki, Dept Geosci, Helsinki, Finland.; Di Minin, E (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.	enrico.di.minin@helsinki.fi	Moilanen, Atte/A-5005-2011; Di Minin, Enrico/J-6904-2013	Di Minin, Enrico/0000-0002-5562-318X	European Research Council Starting Grant [260393]; Academy of Finland Centre of Excellence Program [250444]; Academy of Finland [296524]	European Research Council Starting Grant(European Research Council (ERC)); Academy of Finland Centre of Excellence Program(Academy of Finland); Academy of Finland(Academy of Finland)	This work was supported by European Research Council Starting Grant, 260393, A.M.; Academy of Finland Centre of Excellence Program 2012-2017, 250444, A.M. and V.V.; Academy of Finland 2016-2019, 296524, E.M. https://erc.europa.eu/. http://www.aka.fi/en.	Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; BirdLife International N, 2013, BIRD SPEC DISTR WORL; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burke L., 2011, REEFS RISK REVISITED; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CEPF, BIOD HOTS; Clavero M, 2010, DIVERS DISTRIB, V16, P744, DOI 10.1111/j.1472-4642.2010.00680.x; Coad L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0281; Di Minin E, 2016, INTEGRATING BIODIVER; Di Minin E., 2014, QUICK INTRO ZONATION; Di Minin E, 2015, BIOSCIENCE, V65, P637, DOI 10.1093/biosci/biv064; Diamond J.M., 1984, P191; ESRI, 2012, ARCGIS REL 10 1; Evans MC, 2011, BIOSCIENCE, V61, P281, DOI 10.1525/bio.2011.61.4.8; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hijmans RJ, 2015, RASTER INTERNET; IUCN, 2016, GLOB STAND ID KEY BI, P26; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Joppa LN, 2016, SCIENCE, V352, P416, DOI 10.1126/science.aaf3565; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Leathwick JR, 2010, BIOL CONSERV, V143, P984, DOI 10.1016/j.biocon.2010.01.012; Lehtomaki J, 2015, ZONATOR INTERNET; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2016, GLOBAL PRIORITIES NA; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moilanen A, 2011, BIOL CONSERV, V144, P650, DOI 10.1016/j.biocon.2010.09.006; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Potapov P., 2017, LAST FRONTIERS WILDE, P1; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; R Core Team, 2015, R LANG ENV STAT COMP; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tulloch VJD, 2015, FRONT ECOL ENVIRON, V13, P91, DOI 10.1890/140022; UNEP-WCMC, 2001, WORLD WILD AR; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; Van Asselen S, 2013, GLOBAL CHANGE BIOL, V19, P3648, DOI 10.1111/gcb.12331; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9	56	16	17	9	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188397	10.1371/journal.pone.0188397	http://dx.doi.org/10.1371/journal.pone.0188397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182662	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000025
J	Davidson, R; Baas, BJ; Akiva, E; Holliday, GL; Polacco, BJ; LeVieux, JA; Pullara, CR; Zhang, YJ; Whitman, CP; Babbitt, PC				Davidson, Rebecca; Baas, Bert-Jan; Akiva, Eyal; Holliday, Gemma L.; Polacco, Benjamin J.; LeVieux, Jake A.; Pullara, Collin R.; Zhang, Yan Jessie; Whitman, Christian P.; Babbitt, Patricia C.			A global view of structure-function relationships in the tautomerase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-INHIBITORY FACTOR; TRANS-3-CHLOROACRYLIC ACID DEHALOGENASE; MALONATE SEMIALDEHYDE DECARBOXYLASE; SITE ARGININE RESIDUES; 4-OXALOCROTONATE TAUTOMERASE; CRYSTAL-STRUCTURE; FACTOR MIF; DIVERGENT EVOLUTION; ANGSTROM RESOLUTION; ENZYMATIC-ACTIVITY	The tautomerase superfamily (TSF) consists of more than 11,000 nonredundant sequences present throughout the biosphere. Characterized members have attracted much attention because of the unusual and key catalytic role of an N-terminal proline. These few characterized members catalyze a diverse range of chemical reactions, but the full scale of their chemical capabilities and biological functions remains unknown. To gain new insight into TSF structure-function relationships, we performed a global analysis of similarities across the entire superfamily and computed a sequence similarity network to guide classification into distinct subgroups. Our results indicate that TSF members are found in all domains of life, with most being present in bacteria. The eukaryotic members of the cis-3-chloroacrylic acid dehalogenase subgroup are limited to fungal species, whereas the macrophage migration inhibitory factor subgroup has wide eukaryotic representation (including mammals). Unexpectedly, we found that 346 TSF sequences lack Pro-1, of which 85% are present in the malonate semialdehyde decarboxylase subgroup. The computed network also enabled the identification of similarity paths, namely sequences that link functionally diverse subgroups and exhibit transitional structural features that may help explain reaction divergence. A structure-guided comparison of these linker proteins identified conserved transitions between them, and kinetic analysis paralleled these observations. Phylogenetic reconstruction of the linker set was consistent with these findings. Our results also suggest that contemporary TSF members may have evolved from a short 4-oxalocrotonate tautomerase-like ancestor followed by gene dupli-cation and fusion. Our new linker-guided strategy can be used to enrich the discovery of sequence/structure/function transitions in other enzyme superfamilies.	[Davidson, Rebecca; Akiva, Eyal; Holliday, Gemma L.; Polacco, Benjamin J.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Baas, Bert-Jan; Pullara, Collin R.; Whitman, Christian P.] Univ Texas Austin, Div Chem Biol & Med Chem, Coll Pharm, Austin, TX 78712 USA; [LeVieux, Jake A.; Zhang, Yan Jessie] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Zhang, Yan Jessie] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Whitman, CP (corresponding author), Univ Texas Austin, Div Chem Biol & Med Chem, Austin, TX 78712 USA.; Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	whitman@austin.utexas.edu; babbitt@cgl.ucsf.edu		Holliday, Gemma/0000-0002-6731-6398; Zhang, Yan/0000-0002-9360-5388; Babbitt, Patricia/0000-0003-0375-9015; Polacco, Benjamin/0000-0003-1570-9234	College of Natural Sciences at the University of Texas at Austin; Office of the Executive Vice President and Provost at the University of Texas at Austin; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, R01GM060595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	College of Natural Sciences at the University of Texas at Austin; Office of the Executive Vice President and Provost at the University of Texas at Austin; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Instrumentation and technical assistance were provided by the Macromolecular Crystallography Facility, with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin. The X-ray diffraction data were collected at the Advanced Light Sources (ALS) (Berkeley, CA). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231. We are indebted to Marieke Baas for carefully proofreading and formatting the manuscript and to Kathy Clement for help with generating graphics files for SSNs.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Almrud JJ, 2010, BIOORG CHEM, V38, P252, DOI 10.1016/j.bioorg.2010.07.002; Almrud JJ, 2005, BIOCHEMISTRY-US, V44, P14818, DOI 10.1021/bi051383m; Almrud JJ, 2002, BIOCHEMISTRY-US, V41, P12010, DOI 10.1021/bi020271h; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Azurmendi HF, 2004, BIOCHEMISTRY-US, V43, P4082, DOI 10.1021/bi030241u; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bloom J, 2016, EXPERT OPIN THER TAR, V20, P1463, DOI 10.1080/14728222.2016.1251582; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Burks EA, 2010, BIOCHEMISTRY-US, V49, P5016, DOI 10.1021/bi100502z; Chauhan N, 2015, ACTA TROP, V142, P71, DOI 10.1016/j.actatropica.2014.10.009; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Czerwinski RM, 2001, BIOCHEMISTRY-US, V40, P1984, DOI 10.1021/bi0024714; Czerwinski RM, 1999, BIOCHEMISTRY-US, V38, P12358, DOI 10.1021/bi9911177; de Jong RM, 2007, J BIOL CHEM, V282, P2440, DOI 10.1074/jbc.M608134200; de Jong RM, 2004, J BIOL CHEM, V279, P11546, DOI 10.1074/jbc.M311966200; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Harris TK, 1999, BIOCHEMISTRY-US, V38, P12343, DOI 10.1021/bi991116e; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huddleston JP, 2014, ARCH BIOCHEM BIOPHYS, V564, P189, DOI 10.1016/j.abb.2014.08.019; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; LeVieux JA, 2017, ARCH BIOCHEM BIOPHYS, V636, P50, DOI 10.1016/j.abb.2017.10.018; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Poelarends GJ, 2008, BIOCHEMISTRY-US, V47, P8139, DOI 10.1021/bi8007388; Poelarends GJ, 2007, BIOCHEMISTRY-US, V46, P9596, DOI 10.1021/bi7007189; Poelarends GJ, 2006, BIOCHEMISTRY-US, V45, P7700, DOI 10.1021/bi0600603; Poelarends GJ, 2004, J AM CHEM SOC, V126, P15658, DOI 10.1021/ja044304n; Poelarends GJ, 2004, BIOCHEMISTRY-US, V43, P7187, DOI 10.1021/bi049823h; Poelarends GJ, 2004, BIOCHEMISTRY-US, V43, P759, DOI 10.1021/bi0355948; Poelarends GJ, 2003, J BIOL CHEM, V278, P48674, DOI 10.1074/jbc.M306706200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sparkes A, 2017, IMMUNOBIOLOGY, V222, P473, DOI 10.1016/j.imbio.2016.10.006; Stamps SL, 2000, BIOCHEMISTRY-US, V39, P9671, DOI 10.1021/bi000373c; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P814, DOI 10.1021/bi9510789; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P803, DOI 10.1021/bi951077g; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Taylor AB, 1998, BIOCHEMISTRY-US, V37, P14692, DOI 10.1021/bi981607j; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; van der Meer JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10911; Wang SC, 2003, BIOCHEMISTRY-US, V42, P8762, DOI 10.1021/bi034598+; WHITMAN CP, 1992, J AM CHEM SOC, V114, P10104, DOI 10.1021/ja00052a002; Whitman CP, 2002, ARCH BIOCHEM BIOPHYS, V402, P1, DOI 10.1016/S0003-9861(02)00052-8; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yu DY, 2013, J IND MICROBIOL BIOT, V40, P159, DOI 10.1007/s10295-012-1207-9; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	72	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2342	2357		10.1074/jbc.M117.815340	http://dx.doi.org/10.1074/jbc.M117.815340			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29184004	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000425308300009
J	Li, TS; Li, MJ; Hou, LL; Guo, YM; Wang, L; Sun, GQ; Chen, L				Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Sun, Guiqin; Chen, Li			Identification and characterization of a core fucosidase from the bacterium Elizabethkingia meningoseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; glycobiology; glycoprotein; mass spectrometry (MS); mutagenesis; oligosaccharide; chemical rescue; core-1; 3-fucose; core-1; 3 fucosylation; core fucosidase	ALPHA-L-FUCOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS T-6; ARCHAEON SULFOLOBUS-SOLFATARICUS; HYDROLASE FAMILY 29; GLYCOSIDE HYDROLASE; SUBSTRATE-SPECIFICITY; BACTEROIDES-THETAIOTAOMICRON; HEPATOCELLULAR-CARCINOMA; BIFIDOBACTERIUM-BIFIDUM; HORSERADISH-PEROXIDASE	All reported -l-fucosidases catalyze the removal of nonreducing terminal l-fucoses from oligosaccharides or their conjugates, while having no capacity to hydrolyze core fucoses in glycoproteins directly. Here, we identified an -fucosidase from the bacterium Elizabethkingia meningoseptica with catalytic activity against core -1,3-fucosylated substrates, and we named it core fucosidase I (cFase I). Using site-specific mutational analysis, we found that three acidic residues (Asp-242, Glu-302, and Glu-315) in the predicted active pocket are critical for cFase I activity, with Asp-242 and Glu-315 acting as a pair of classic nucleophile and acid/base residues and Glu-302 acting in an as yet undefined role. These findings suggest a catalytic mechanism for cFase I that is different from known -fucosidase catalytic models. In summary, cFase I exhibits glycosidase activity that removes core -1,3-fucoses from substrates, suggesting cFase I as a new tool for glycobiology, especially for studies of proteins with core fucosylation.	[Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Chen, Li] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Chen, Li] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Hlth, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Sun, Guiqin] Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou 310053, Zhejiang, Peoples R China	Fudan University; Fudan University; Zhejiang Chinese Medical University	Chen, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China.; Chen, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Hlth, 130 Dongan Rd, Shanghai 200032, Peoples R China.; Sun, GQ (corresponding author), Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou 310053, Zhejiang, Peoples R China.	sunguiqin2001@163.com; lichen_bk@fudan.edu.cn	li, mengjie/GRS-3931-2022	Chen, Li/0000-0002-7006-4443	National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX09101046-004]; National Natural Science Foundation of China [31600644]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China Grant 2014ZX09101046-004 and the National Natural Science Foundation of China Grant 31600644. The authors declare that they have no conflicts of interest with the contents of this article.	Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Bridges CC, 2012, ARCH BIOCHEM BIOPHYS, V517, P20, DOI 10.1016/j.abb.2011.11.002; BUTTERS TD, 1991, BIOCHEM J, V279, P189, DOI 10.1042/bj2790189; Cao HN, 2014, J BIOL CHEM, V289, P25624, DOI 10.1074/jbc.M114.583286; Cobucci-Ponzano B, 2005, BIOCHEMISTRY-US, V44, P6331, DOI 10.1021/bi047495f; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Cobucci-Ponzano B, 2002, PROTEINS, V48, P98, DOI 10.1002/prot.10128; DAWSON G, 1977, ARCH BIOCHEM BIOPHYS, V184, P12, DOI 10.1016/0003-9861(77)90321-6; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; DICIOCCIO RA, 1982, J BIOL CHEM, V257, P714; Dupoiron S, 2015, J BIOL CHEM, V290, P6022, DOI 10.1074/jbc.M114.624593; Fan SQ, 2016, J BASIC MICROB, V56, P347, DOI 10.1002/jobm.201500582; FAZEL AR, 1989, AM J ANAT, V184, P76, DOI 10.1002/aja.1001840109; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; FUHR BJ, 1973, J AM CHEM SOC, V95, P6944, DOI 10.1021/ja00802a013; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Harmoko R, 2016, NEW PHYTOL, V212, P108, DOI 10.1111/nph.14031; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jitonnom J, 2014, J PHYS CHEM B, V118, P4771, DOI 10.1021/jp500652x; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; Lannoo N, 2015, PLANT SCI, V239, P67, DOI 10.1016/j.plantsci.2015.06.023; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Liu SW, 2009, BIOCHEMISTRY-US, V48, P110, DOI 10.1021/bi801529t; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; MacLeod AM, 1996, BIOCHEMISTRY-US, V35, P13165, DOI 10.1021/bi9610616; Marrero JA, 2004, GASTROENTEROLOGY, V127, pS113, DOI 10.1053/j.gastro.2004.09.024; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020; Palmberger D, 2014, BIOTECHNOL J, V9, P1206, DOI 10.1002/biot.201400061; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Phopin K, 2013, MOL REPROD DEV, V80, P273, DOI 10.1002/mrd.22164; Poltl G, 2007, GLYCOBIOLOGY, V17, P220, DOI [10.1093/glycob/cw1068, 10.1093/glycob/cwl068]; Rahman MZ, 2016, BIOSCI BIOTECH BIOCH, V80, P291, DOI 10.1080/09168451.2015.1079479; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rydberg EH, 2002, BIOCHEMISTRY-US, V41, P4492, DOI 10.1021/bi011821z; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; SCANLIN TF, 1979, CLIN CHIM ACTA, V91, P197, DOI 10.1016/0009-8981(79)90457-1; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Shaikh FA, 2013, BIOCHEMISTRY-US, V52, P5857, DOI 10.1021/bi400183q; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Sjogren J, 2014, FUTURE MICROBIOL, V9, P1039, DOI [10.2217/FMB.14.71, 10.2217/fmb.14.71]; Staudacher E, 1998, GLYCOCONJUGATE J, V15, P355, DOI 10.1023/A:1006969701231; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Sun G., 2015, GENOME ANNOUNC, V3; Sun GQ, 2015, J BIOL CHEM, V290, P7452, DOI 10.1074/jbc.M114.605493; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Tsai TI, 2017, ACS CHEM BIOL, V12, P63, DOI 10.1021/acschembio.6b00821; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Wang K, 2014, BRIT J CANCER, V110, P1811, DOI 10.1038/bjc.2014.102; WILLEMS PJ, 1988, AM J HUM GENET, V43, P756; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Wuhrer M, 2005, BBA-GEN SUBJECTS, V1723, P229, DOI 10.1016/j.bbagen.2005.02.013; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zeleny R, 2006, PHYTOCHEMISTRY, V67, P641, DOI 10.1016/j.phytochem.2006.01.021	71	11	12	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1243	1258		10.1074/jbc.M117.804252	http://dx.doi.org/10.1074/jbc.M117.804252			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29196602	Green Published, hybrid			2022-12-26	WOS:000423515000012
J	Oide, M; Okajima, K; Nakagami, H; Kato, T; Sekiguchi, Y; Oroguchi, T; Hikima, T; Yamamoto, M; Nakasako, M				Oide, Mao; Okajima, Koji; Nakagami, Hirofumi; Kato, Takayuki; Sekiguchi, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi			Blue light-excited LOV1 and LOV2 domains cooperatively regulate the kinase activity of full-length phototropin2 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PHOTORECEPTOR DOMAIN; INDUCED STRUCTURAL-CHANGES; CHLOROPLAST RELOCATION; CONFORMATIONAL-CHANGES; BINDING DOMAINS; ACTIVATION; RECEPTOR; PROTEIN; OXYGEN; NPL1	Phototropin2 (phot2) is a blue-light (BL) receptor that regulates BL-dependent activities for efficient photosynthesis in plants. phot2 comprises two BL-receiving light-oxygen-voltage-sensing domains (LOV1 and LOV2) and a kinase domain. BL-excited LOV2 is thought to be primarily responsible for the BL-dependent activation of the kinase. However, the molecular mechanisms by which small BL-induced conformational changes in the LOV2 domain are transmitted to the kinase remain unclear. Here, we used full-length wild-type and mutant phot2 proteins from Arabidopsis to study their molecular properties in the dark and under BL irradiation. Phosphorylation assays and absorption measurements indicated that the LOV1 domain assists the thermal relaxation of BL-excited LOV2 and vice versa. Using small-angle X-ray scattering and electron microscopy, we observed that phot2 forms a dimer and has a rod shape with a maximum length of 188 angstrom and a radius of gyration of 44 angstrom. Under BL, phot2 displayed large conformational changes that bent the rod shape. By superimposing the crystal structures of the LOV1 dimer, LOV2, and a homology model of the kinase to the observed changes, we inferred that the BL-dependent change consisted of positional shifts of both LOV2 and the kinase relative to LOV1. Furthermore, phot2 mutants lacking the photocycle in LOV1 or LOV2 still exhibited conformational changes under BL, suggesting that LOV1 and LOV2 cooperatively contribute to the conformational changes that activate the kinase. These results suggest that BL-activated LOV1 contributes to the kinase activity of phot2. We discuss the possible intramolecular interactions and signaling mechanisms in phot2.	[Oide, Mao; Okajima, Koji; Sekiguchi, Yuki; Oroguchi, Tomotaka; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoko Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Oide, Mao; Okajima, Koji; Sekiguchi, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi] RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan; [Nakagami, Hirofumi] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Nakagami, Hirofumi] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Kato, Takayuki] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan	Keio University; RIKEN; RIKEN; Max Planck Society; Osaka University	Okajima, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoko Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	okajima@phys.keio.ac.jp	Yamamoto, Masaki/B-7844-2015; Nakagami, Hirofumi/A-4122-2011	Yamamoto, Masaki/0000-0002-1311-1768; Nakagami, Hirofumi/0000-0003-2569-7062	Japan Society for the Promotion of Science (JSPS) [jp16H02218, jp22244054, jp22018027, jp20050030, jp1920402, jp26800227, jp17H04854, jp16K14682, jp15K18559]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [jp15076210, jp15H01647, jp17H05891, jp25120725, jp23120525, jp26104535]; Grants-in-Aid for Scientific Research [17H04854] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants jp16H02218, jp22244054, jp22018027, jp20050030, jp1920402 (to M. N.), jp26800227, jp17H04854 (to T. O.), jp16K14682 (to T. K.), and jp15K18559 (to K. O.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants jp15076210, jp15H01647, jp17H05891, jp25120725, jp23120525 (to M. N.), and jp26104535 (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aihara Y, 2008, PLANT J, V56, P364, DOI 10.1111/j.1365-313X.2008.03605.x; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Fujita S, 2013, CURR BIOL, V23, P1969, DOI 10.1016/j.cub.2013.08.006; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Guinier A., 1955, SMALL ANGLE SCATTERI; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kashojiya S, 2016, FEBS LETT, V590, P139, DOI 10.1002/1873-3468.12028; Kashojiya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124284; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Li FW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00637; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Oide M, 2016, J BIOL CHEM, V291, P19975, DOI 10.1074/jbc.M116.735787; Okajima K, 2016, J PLANT RES, V129, P149, DOI 10.1007/s10265-016-0783-6; Okajima K, 2014, J BIOL CHEM, V289, P413, DOI 10.1074/jbc.M113.515403; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suetsugu N, 2013, AM J BOT, V100, P60, DOI 10.3732/ajb.1200308; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Tseng TS, 2010, PLANT CELL, V22, P392, DOI 10.1105/tpc.109.066423	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					963	972		10.1074/jbc.RA117.000324	http://dx.doi.org/10.1074/jbc.RA117.000324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29196607	Green Published, hybrid			2022-12-26	WOS:000422864500017
J	Perez, JM; Chen, YH; Xiao, TS; Abbott, DW				Perez, Jessica M.; Chen, Yinghua; Xiao, Tsan S.; Abbott, Derek W.			Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPRESSION; RESPONSES; ALPHA; A20	Heightened and extended inflammation underlies the pathogenesis of many disorders, including inflammatory bowel disease, sepsis, and inflammatory arthritis. Ubiquitin networks help dictate the strength and duration of inflammatory signaling. In innate immunity, the itchy E3 ubiquitin protein ligase (ITCH)-A20 ubiquitin-editing complex inhibits receptor-interacting Ser/Thr kinase (RIPK) activation by removing Lys-63linked polyubiquitinated chains from key proteins in the nuclear factor kappa B (NF-kappa B) signaling pathway. The complex then attaches polyubiquitinated chains to these proteins to target them for lysosomal or proteasomal destruction. ITCHis phosphorylated and thereby inhibited by inhibitor of nuclear factor kappa B kinase subunit beta (IKK beta) to fine-tune the inflammatory response to the strength of the offending signal. However, the biochemical mechanism by which E3 ubiquitination is impaired by IKK-driven phosphorylation remains unclear. Here, we report that this phosphorylation impedes ITCH binding to its cognate E2 ubiquitin ligase, UbcH7. UsingCRISPR-Cas9geneticknockouttomimictheITCHUbcH7-inhibited state, we further show that genetic UbcH7 deficiency phenocopies ITCH phosphorylation in regulating RIPK2 ubiquitination. Weconclude that phosphorylation can disrupt the binding of an E3 ubiquitin ligase to an E2-conjugating enzyme, leading to prolonged inflammatory signaling. To our knowledge, this is the first report of E3 ubiquitin ligase phosphorylation inhibiting E3 ligase activity by impairing E2-E3 complex formation.	[Perez, Jessica M.; Xiao, Tsan S.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chen, Yinghua] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Abbott, DW (corresponding author), Room 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X	National Institutes of Health [R01GM086550, P01DK091222, F31GM108403A]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, P30DK097948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM108403, R01GM086550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM086550 (to D.W.A.), P01DK091222 (to D.W.A.), and F31GM108403A (to J.M.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Fraser JA, 2010, J BIOL CHEM, V285, P37762, DOI 10.1074/jbc.M110.143099; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Perez JM, 2015, CELL REP, V12, P537, DOI 10.1016/j.celrep.2015.06.050; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SMITH MF, 1994, J IMMUNOL, V153, P3584; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	29	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1100	1105		10.1074/jbc.RA117.000408	http://dx.doi.org/10.1074/jbc.RA117.000408			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29212706	Green Published, hybrid			2022-12-26	WOS:000422864500028
J	Ferro, A; Carbone, E; Zhang, J; Marzouk, E; Villegas, M; Siegel, A; Nguyen, D; Possidente, T; Hartman, J; Polley, K; Ingram, MA; Berry, G; Reynolds, TH; Possidente, B; Frederick, K; Ives, S; Lagalwar, S				Ferro, Austin; Carbone, Emily; Zhang, Jenny; Marzouk, Evan; Villegas, Monica; Siegel, Asher; Nguyen, Donna; Possidente, Thomas; Hartman, Jessilyn; Polley, Kailen; Ingram, Melissa A.; Berry, Georgia; Reynolds, Thomas H.; Possidente, Bernard; Frederick, Kimberley; Ives, Stephen; Lagalwar, Sarita			Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model	PLOS ONE			English	Article							COMPLEX-I; TRANSGENIC MICE; CAG REPEAT; PROTEIN; DISEASE; EXPRESSION; ONSET; PHOSPHORYLATION; LOCALIZATION; PROGRESSION	Mitochondrial dysfunction plays a significant role in neurodegenerative disease including ataxias and other movement disorders, particularly those marked by progressive degeneration in the cerebellum. In this study, we investigate the role of mitochondrial oxidative phosphorylation (OXPHOS) deficits in cerebellar tissue of a Purkinje cell-driven spinocerebellar ataxia type 1 (SCA1) mouse. Using RNA sequencing transcriptomics, OXPHOS complex assembly analysis and oxygen consumption assays, we report that in the presence of mutant polyglutamine-expanded ataxin-1, SCA1 mice display deficits in cerebellar OXPHOS complex I (NADH-coenzyme Q oxidoreductase). Complex I genes are upregulated at the time of symptom onset and upregulation persists into late stage disease; yet, functional assembly of complex I macromolecules are diminished and oxygen respiration through complex I is reduced. Acute treatment of postsymptomatic SCA1 mice with succinic acid, a complex II (succinate dehydrogenase) electron donor to bypass complex I dysfunction, ameliorated cerebellar OXPHOS dysfunction, reduced cerebellar pathology and improved motor behavior. Thus, exploration of mitochondrial dysfunction and its role in neurodegenerative ataxias, and warrants further investigation.	[Ferro, Austin; Carbone, Emily; Zhang, Jenny; Marzouk, Evan; Villegas, Monica; Nguyen, Donna; Possidente, Thomas; Hartman, Jessilyn; Polley, Kailen; Berry, Georgia; Possidente, Bernard; Lagalwar, Sarita] Skidmore Coll, Neurosci Program, Saratoga Springs, NY 12866 USA; [Siegel, Asher; Frederick, Kimberley] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA; [Ingram, Melissa A.] Univ Minnesota, Dept Lab Med & Pathol, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Reynolds, Thomas H.; Ives, Stephen] Skidmore Coll, Hlth & Exercise Sci Dept, Saratoga Springs, NY 12866 USA; [Possidente, Bernard] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Ferro, Austin] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA	Skidmore College; Skidmore College; University of Minnesota System; University of Minnesota Twin Cities; Skidmore College; Skidmore College; University of Minnesota System; University of Minnesota Twin Cities	Lagalwar, S (corresponding author), Skidmore Coll, Neurosci Program, Saratoga Springs, NY 12866 USA.	slagalwa@skidmore.edu	Siegel, Asher/ABD-8259-2021; Ives, Steve/GNH-0750-2022	Reynolds, Thomas/0000-0002-0290-528X; Carbone, Emily/0000-0002-6377-2847	National Science Foundation MRI [DBI-1337280]	National Science Foundation MRI(National Science Foundation (NSF))	The work was supported by National Science Foundation MRI (DBI-1337280) to Sarita Lagalwar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo-Molina A, 2013, NUTR CANC; Archer DF, 2013, MENOPAUSE, V20, P47, DOI 10.1097/gme.0b013e3182775fe9; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; Breuer ME, 2012, NEUROBIOL DIS; Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8; Budd SL, 1998, ESSAYS BIOCHEM, V33, P43, DOI 10.1042/bse0330043; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Burright EN, 1997, BRAIN PATHOL, V7, P965, DOI 10.1111/j.1750-3639.1997.tb00896.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Ebadi M, 2001, BIOL SIGNAL RECEPT, V10, P224; Ergoenuel PG, 2010, CZECH J FOOD SCI, V28, P202, DOI 10.17221/1379-CJFS; Ferro A, 2017, JOVE-J VIS EXP, DOI 10.3791/53758; Fonseca MD, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0126-1; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Hagenauer MH, 2011, HORM BEHAV, V60, P46, DOI 10.1016/j.yhbeh.2011.03.001; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lagalwar Sarita, 2013, Methods Mol Biol, V1010, P201, DOI 10.1007/978-1-62703-411-1_13; Lai B, 2005, EXP NEUROL, V194, P484, DOI 10.1016/j.expneurol.2005.03.005; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Leach RM, 2001, J PHYSIOL-LONDON, V536, P211, DOI 10.1111/j.1469-7793.2001.00211.x; Liebowitz MR, 2007, J CLIN PSYCHIAT, V68, P1663, DOI 10.4088/JCP.v68n1105; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Martin MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nie Y., 2015, BIO PROTOC, V5; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; Nowak G, 2008, J PHARMACOL EXP THER, V324, P1155, DOI 10.1124/jpet.107.130872; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Peskov AB, 2005, B EXP BIOL MED+, V140, P312, DOI 10.1007/s10517-005-0476-y; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sandhir R, 2010, NEUROCHEM INT, V57, P579, DOI 10.1016/j.neuint.2010.07.005; Saratikov A. S., 2000, Eksperimental'naya i Klinicheskaya Farmakologiya, V63, P56; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Stucki DM, 2016, FREE RADICAL BIO MED, V97, P427, DOI 10.1016/j.freeradbiomed.2016.07.005; Sugino T, 1999, NEUROSCI LETT, V259, P9, DOI 10.1016/S0304-3940(98)00875-1; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	61	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188425	10.1371/journal.pone.0188425	http://dx.doi.org/10.1371/journal.pone.0188425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211771	Green Submitted, Green Published, gold			2022-12-26	WOS:000417212200031
J	Baczkiewicz, A; Szczecinska, M; Sawicki, J; Stebel, A; Buczkowska, K				Baczkiewicz, Alina; Szczecinska, Monika; Sawicki, Jakub; Stebel, Adam; Buczkowska, Katarzyna			DNA barcoding, ecology and geography of the cryptic species of Aneura pinguis and their relationships with Aneura maxima and Aneura mirabilis (Metzgeriales, Marchantiophyta)	PLOS ONE			English	Article							INTEGRATIVE TAXONOMY; PLASTID GENOME; GENE LOSSES; LIVERWORT; JUNGERMANNIOPSIDA; DELIMITATION; SPECIATION; COMPLEX; MARKERS; BRYOPHYTES	Aneura pinguis is a thalloid liverwort species with broad geographical distribution. It is composed of cryptic species, however, the number of cryptic species within A. pinguis is not known. Five cpDNA regions (matK, rbcL, rpoC1, trnH-psbA and trnL-trnF) and the entire nuclear ITS region were studied in 130 samples of A. pinguis from different geographical regions. The relationships between the cryptic species of A. pinguis, A. maxima and A. mirabilis were analyzed. All of the examined samples were clustered into 10 clades corresponding to 10 cryptic species of A. pinguis (marked A to J). Aneura mirabilis and A. maxima were nested among different cryptic species of A. pinguis, which indicates that A. pinguis is a paraphyletic taxon. Subgroups were found in cryptic species A, B, C and E. As single barcodes, all tested DNA regions had 100% discriminant power and fulfilled DNA barcode criteria for species identification; however, the only combination detected in all subgroups was trnL-trnF with trnH-psbA or ITS2. The distances between cryptic species were 11- to 35-fold higher than intraspecific distances. In all analyzed DNA regions, the distances between most pairs of cryptic A. pinguis species were higher than between A. maxima and A. mirabilis. All cryptic species of A. pinguis clearly differed in their habitat preferences, which suggests that habitat adaptation could be the main driving force behind cryptic speciation within this taxon.	[Baczkiewicz, Alina; Buczkowska, Katarzyna] Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland; [Szczecinska, Monika; Sawicki, Jakub] Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland; [Stebel, Adam] Med Univ Silesia, Dept Pharmaceut Bot, Katowice, Poland	Adam Mickiewicz University; University of Warmia & Mazury; Medical University Silesia	Baczkiewicz, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland.	alinbacz@amu.edu.pl	Szczecinska, Monika/J-2400-2012; Sawicki, Jakub/H-4432-2012	Sawicki, Jakub/0000-0002-4759-8113; Szczecinska, Monika/0000-0002-5377-4304; Stebel, Adam/0000-0003-2198-4216	Polish National Science Centre [2011/01/B/NZ8/00364, 2013/09/B/NZ8/03274]	Polish National Science Centre	This work was supported by the Polish National Science Centre, grants no. 2011/01/B/NZ8/00364 (AB, KB, JS) and 2013/09/B/NZ8/03274 (AB, KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baczkiewicz A., 2005, BIOL LETT, V42, P61; Baczkiewicz A, 2016, BIODIV RES CONSERV, V41, P1, DOI DOI 10.1515/BIORC-2016-0001; Baczkiewicz A, 2008, CRYPTOGAMIE BRYOL, V29, P3; Baczkiewicz A, 2016, CRYPTOGAMIE BRYOL, V37, P3, DOI 10.7872/cryb/v37.iss1.2016.3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Buczkowska K, 2005, VARIABILITY EVOLUTIO, P97; Buczkowska K., 2006, BIOL LETT, V43, P51; Buczkowska K, 2006, CRYPTOGAMIE BRYOLOGI, V27, P1; Buczkowska K, 2016, BIOCHEM SYST ECOL, V68, P27, DOI 10.1016/j.bse.2016.06.013; Buczkowska K, 2012, PLANT SYST EVOL, V298, P549, DOI 10.1007/s00606-011-0565-5; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Damsholt K, 2002, ILLUSTRATED FLORA NO, p[654, 656]; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feldberg K, 2010, MOL PHYLOGENET EVOL, V55, P293, DOI 10.1016/j.ympev.2009.11.009; Furuki T, ANEURA CRATERIFORMIS; Hassel K, 2013, MOL ECOL RESOUR, V13, P1047, DOI 10.1111/1755-0998.12074; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Heinrichs J, 2015, TAXON, V64, P216, DOI 10.12705/642.5; Heinrichs J, 2011, AM J BOT, V98, P1252, DOI 10.3732/ajb.1100115; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lang AS, 2014, POLAR BIOL, V37, P1157, DOI 10.1007/s00300-014-1509-7; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Mayden R. L., 1997, V54, P381; Mayr E, SYSTEMATICS ORIGIN S; Medina R, 2012, TAXON, V61, P1180, DOI 10.1002/tax.616002; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Preussing M, 2010, TAXON, V59, P1424, DOI 10.1002/tax.595009; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Schuster RM., 1966, HEPATICAE ANTHOCEROT; Schuster RM, 1987, J HATTORI BOT LAB, V62, P299; Schuster RM, 1992, E HUNDREDTH MERIDIAN, V5; Singh D, 2016, J BRYOL, V38, P351; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053134; Szweykowski J., 2006, BIODIVERSITY POLAND, V4, P13; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; Wachowiak W, 2007, BOT J LINN SOC, V155, P273, DOI 10.1111/j.1095-8339.2007.00692.x; Wawrzyniak R, 2014, PHYTOCHEMISTRY, V105, P115, DOI 10.1016/j.phytochem.2014.06.010; Wickett NJ, 2008, J MOL EVOL, V67, P111, DOI 10.1007/s00239-008-9133-1; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wickett NJ, 2008, BOT J LINN SOC, V156, P1, DOI 10.1111/j.1095-8339.2007.00743.x; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	59	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188837	10.1371/journal.pone.0188837	http://dx.doi.org/10.1371/journal.pone.0188837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206876	gold, Green Published, Green Submitted			2022-12-26	WOS:000417110700028
J	Silva, DN; Oria, AP; Araujo, NL; Martins, E; Muramoto, C; Liborio, FD; Estrela-Lima, A				Silva, Danielle Nascimento; Oria, Arianne Pontes; Araujo, Nayone Lantyer; Martins-Filho, Emanoel; Muramoto, Caterina; Liborio, Fernanda de Azevedo; Estrela-Lima, Alessandra			Morphological study of the eye and adnexa in capuchin monkeys (Sapajus sp.)	PLOS ONE			English	Article							ANATOMICAL VARIATIONS; PRIMATES; ORIGINS; ORBIT	The objective of this study was to describe the anatomic and histologic features of the Sapajus sp. eye, comparing similarities and differences of humans and other species of non-human primates for biomedical research purposes. Computed tomography (CT) of adnexa, eye and orbit live animal, as well as formolized pieces of the same structures of Sapajus sp. for anatomical and histological study were also performed. The anatomical description of the eye and adnexa was performed using the techniques of topographic dissection and exenteration. Histological fragments were fixated in buffered formalin 10%, processed by the routine paraffin inclusion technique, stained with hematoxylin-eosin and special stains. CT scan evaluation showed no differences between the live animal and the formolized head on identification of visual apparatus structures. Anatomic and histologic evaluation revealed rounded orbit, absence of the supraorbital foramen and frontal notch, little exposure of the sclera, with slight pigmentation of the exposed area and marked pigmentation at the sclerocorneal junction. Masson's Trichrome revealed the Meibomian glands, the corneal epithelium and Bowman's membrane; in the choroid, melanocytes and Bruch's membrane were observed; and in the retina, cones and rods as well as, optic nerve, the lamina cribrosa of the nerve fibers bundles. Toluidine blue highlighted the membranes: Bowman, Descemet and the endothelium; in the choroid: melanocytes; and in the retina: nuclear layers and retinal pigment epithelium. In view of the observed results Sapajus sp. is an important experimental model for research in the ophthalmology field, which has been shown due to the high similarity of its anatomical and histological structures with the human species.	[Silva, Danielle Nascimento; Oria, Arianne Pontes; Araujo, Nayone Lantyer; Estrela-Lima, Alessandra] Univ Fed Bahia, Postgrad Program Anim Sci Trop, Salvador, BA, Brazil; [Oria, Arianne Pontes; Muramoto, Caterina; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat Pathol & Vet Clin, Salvador, BA, Brazil; [Martins-Filho, Emanoel] Fdn Res Support State Bahia, Reg Sci & Technol Dev Program, Salvador, BA, Brazil; [Liborio, Fernanda de Azevedo] Brazilian Inst Environm & Renewable Nat Resources, Screening Ctr Wild Anim, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Estrela-Lima, A (corresponding author), Univ Fed Bahia, Postgrad Program Anim Sci Trop, Salvador, BA, Brazil.; Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat Pathol & Vet Clin, Salvador, BA, Brazil.	alestrela@gmail.com	Estrela-Lima, Alessandra/AAL-2745-2021; Oriá, Arianne Pontes/AAB-7059-2019; Filho, Emanoel Ferreira Martins/AAK-7178-2021	Estrela-Lima, Alessandra/0000-0002-9879-7999; Oriá, Arianne Pontes/0000-0001-5093-6841; Filho, Emanoel Ferreira Martins/0000-0002-0542-5468; Araujo, Nayone/0000-0002-3305-3147				Agthong S, 2005, J ORAL MAXIL SURG, V63, P800, DOI 10.1016/j.joms.2005.02.016; Altavini TS, 2012, INT J PRIMATOL, V33, P1467, DOI 10.1007/s10764-012-9638-8; Ankel-Simons F, 2007, PRIMATE ANATOMY INTR, P470; [Anonymous], 2014, TRATADO ANIMAIS SELV; ARAO T, 1968, ANAT REC, V162, P53, DOI 10.1002/ar.1091620106; Archana Sarma, 1998, INDIAN J VET ANATOMY, V10, P5; Aviv RI, 2005, CLIN RADIOL, V60, P279, DOI 10.1016/j.crad.2004.05.017; Banzato T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-53; Beer GM, 1998, PLAST RECONSTR SURG, V102, P334, DOI 10.1097/00006534-199808000-00006; Bicca-Marques JC, 2005, AM J PRIMATOL, V65, P141, DOI 10.1002/ajp.20104; Borthakur S., 2000, Indian Journal of Veterinary Anatomy, V12, P1; Bron AJ., 1997, WOLFFS ANATOMY EYE O, V8; Chastain JB, 2006, OTOLARYNG CLIN N AM, V39, P855, DOI 10.1016/j.otc.2006.07.003; Daniel GB, 1999, CLIN TECH SMALL AN P, V14, P160, DOI 10.1016/S1096-2867(99)80032-2; Diesem C, 1975, ANATOMIA ANIMAIS DOM, P207; Diesem C, 1975, SISSON GROSSMAN ANAT, P207; Dua HS, 2013, OPHTHALMOLOGY, V120, P1778, DOI 10.1016/j.ophtha.2013.01.018; Elias M. G., 2004, Int. J. Morphol., V22, P273, DOI 10.4067/S0717-95022004000400006; Ettl A, 2000, SURV OPHTHALMOL, V44, P303, DOI 10.1016/S0039-6257(99)00115-0; Fernandez JRR, 2013, VET OPHTHALMOL, V16, P94, DOI 10.1111/vop.12070; Ferreira RGF, 2012, ACTA SCI MED, V5, P2; Gartner LP, 2014, COLOR ATLAS TEXT HIS, P454; Gasser K, 2011, VET OPHTHALMOL, V14, P26, DOI 10.1111/j.1463-5224.2010.00836.x; Getty R, 1975, SISSON GROSSMAN ANAT, V5th; Gilroy AM, 2014, ATLAS ANATOMIA BASEA; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; Junqueira L., 2004, HISTOLOGIA BASICA; Kawana K, 2004, BRIT J OPHTHALMOL, V88, P466, DOI 10.1136/bjo.2003.030361; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Knapp S, 2007, VET OPHTHALMOL, V10, P357, DOI 10.1111/j.1463-5224.2007.00568.x; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Krebs W., 1991, PRIMATE RETINA CHORO; Lange RR, 2012, VET OPHTHALMOL, V15, P376, DOI 10.1111/j.1463-5224.2012.00998.x; Leite A. G. B., 2013, Ars Veterinaria, V29, P42; Martin RD, 2012, CURR BIOL, V22, pR785, DOI 10.1016/j.cub.2012.07.015; McMinn RMH, 2005, ATLAS COLORIDO ANATO; Meekins JM, 2015, VET OPHTHALMOL, V19, P1; Merindano DM, 2002, EUR J ANAT, V6, P133; Montiani-Ferreira F, 2008, VET OPHTHALMOL, V11, P197, DOI 10.1111/j.1463-5224.2008.00620.x; NATORI Y, 1995, NEUROSURGERY, V36, P762, DOI 10.1227/00006123-199504000-00018; Penninck D, 2001, CLIN TECH SMALL AN P, V16, P22, DOI 10.1053/svms.2001.22802; Pereira CB, 1979, MANUAL CRANIOMETRIC; Perrett DI., 1990, COMP PERCEPTION, P187; Pissinatti A, 2014, HUMAN PRIMATES SCI U; Prophet E. B., 1992, LAB METHODS HISTOTEC; Raposo ACS, 2015, J MED PRIMATOL, V44, P381, DOI 10.1111/jmp.12200; Ross C, 1996, AM J PRIMATOL, V40, P205, DOI 10.1002/(SICI)1098-2345(1996)40:3<205::AID-AJP1>3.0.CO;2-1; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; Ross CF, 2000, ANNU REV ANTHROPOL, V29, P147, DOI 10.1146/annurev.anthro.29.1.147; Samuelson DA, 2013, VET OPHTHALMOL, P39; Sarma K, 2002, INDIAN J ANIM SCI, V72, P13; Sarma Kamal, 2006, Int. J. Morphol., V24, P449, DOI 10.4067/S0717-95022006000400025; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Saylam C, 2003, J CRANIOFAC SURG, V14, P10, DOI 10.1097/00001665-200301000-00003; Silva JV, 2013, ANATOMICAL FUNCTIONA, P5; Silva JV, 2013, DISCIPLINE OPHTHALMO, P5; Silveira LCL, 2003, PROG BRAIN RES, V144, P21, DOI 10.1016/S0079-6123(03)14400-2; Slatter DH, FUNDAMENTO OFTALMOLO; Sobotta J., 2007, SOBOTTA ATLAS HISTOL; Sobotta J, 2006, SOBOTTA ATLAS ANATOM, V1; TENAZA RR, 1989, AM J PRIMATOL, V17, P81, DOI 10.1002/ajp.1350170108; The Association for Research in Vision and Ophthalmology, 1985, NAT I HLTH PUBL; Torres LB, 2010, AM J PRIMATOL, V72, P1055, DOI 10.1002/ajp.20864; Turvey TA, 2012, ORAL MAXIL SURG CLIN, V24, P525, DOI 10.1016/j.coms.2012.08.003; Wichmann W, 2004, EUR J RADIOL, V49, P8, DOI 10.1016/j.ejrad.2003.11.001	65	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0186569	10.1371/journal.pone.0186569	http://dx.doi.org/10.1371/journal.pone.0186569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206882	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700001
J	Tahtali, D; Bohmann, F; Kurka, N; Rostek, P; Todorova-Rudolph, A; Buchkremer, M; Abruscato, M; Hartmetz, AK; Kuhlmann, A; Henke, C; Stegemann, A; Menon, S; Misselwitz, B; Reihs, A; Weidauer, S; Thonke, S; Meyding-Lamade, U; Singer, O; Steinmetz, H; Pfeilschifter, W				Tahtali, Damla; Bohmann, Ferdinand; Kurka, Natalia; Rostek, Peter; Todorova-Rudolph, Anelia; Buchkremer, Martin; Abruscato, Mario; Hartmetz, Ann-Kathrin; Kuhlmann, Andrea; Henke, Christian; Stegemann, Andre; Menon, Sanjay; Misselwitz, Bjeorn; Reihs, Anke; Weidauer, Stefan; Thonke, Sven; Meyding-Lamade, Uta; Singer, Oliver; Steinmetz, Helmuth; Pfeilschifter, Waltraud			Implementation of stroke teams and simulation training shortened process times in a regional stroke network-A network-wide prospective trial	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CREW RESOURCE-MANAGEMENT; THROMBOLYSIS; HOSPITALS; THERAPY; TRENDS	Background To meet the requirements imposed by the time-dependency of acute stroke therapies, it is necessary 1) to initiate structural and cultural changes in the breadth of stroke-ready hospitals and 2) to find new ways to train the personnel treating patients with acute stroke. We aimed to implement and validate a composite intervention of a stroke team algorithm and simulation-based stroke team training as an effective quality initiative in our regional interdisciplinary neurovascular network consisting of 7 stroke units. Methods We recorded door-to-needle times of all consecutive stroke patients receiving thrombolysis at seven stroke units for 3 months before and after a 2 month intervention which included setting up a team-based stroke workflow at each stroke unit, a train-the-trainer seminar for stroke team simulation training and a stroke team simulation training session at each hospital as well as a recommendation to take up regular stroke team trainings. Results The intervention reduced the network-wide median door-to-needle time by 12 minutes from 43,0 (IQR 29,8-60,0, n = 122) to 31,0 (IQR 24,0-42,0, n = 112) minutes (p < 0.001) and substantially increased the share of patients receiving thrombolysis within 30 minutes of hospital arrival from 41.5% to 59.6% (p < 0.001). Stroke team training participants stated a significant increase in knowledge on the topic of acute stroke care and in the perception of patient safety. The overall course concept was regarded as highly useful by most participants from different professional backgrounds. Conclusions The composite intervention of a binding team-based algorithm and stroke team simulation training showed to be well-transferable in our regional stroke network. We provide suggestions and materials for similar campaigns in other stroke networks.	[Tahtali, Damla; Bohmann, Ferdinand; Kurka, Natalia; Singer, Oliver; Steinmetz, Helmuth; Pfeilschifter, Waltraud] Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany; [Rostek, Peter] Univ Hosp Frankfurt, NICU Nursing Staff, Frankfurt, Germany; [Todorova-Rudolph, Anelia; Buchkremer, Martin] Vitos Weil Lahn, Dept Neurol, Weilmunster, Germany; [Abruscato, Mario; Thonke, Sven] Klinikum Hanau, Dept Neurol, Hanau, Germany; [Hartmetz, Ann-Kathrin; Kuhlmann, Andrea; Meyding-Lamade, Uta] Krankenhaus NW Frankfurt, Dept Neurol, Frankfurt, Germany; [Henke, Christian] Helios HSK Wiesbaden, Dept Neurol, Wiesbaden, Germany; [Stegemann, Andre; Weidauer, Stefan] Sankt Katharinen Krankenhaus, Dept Neurol, Frankfurt, Germany; [Menon, Sanjay] Klinikum Aschaffenburg Alzenau, Dept Neurol, Aschaffenburg, Germany; [Misselwitz, Bjeorn; Reihs, Anke] GQH, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Krankenhaus Nordwest	Pfeilschifter, W (corresponding author), Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de			Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Boehringer Ingelheim supported this study with a research grant of 10.000,00 Euros to WP. The funder had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Flin R, 2015, BEST PRACT RES-CLIN, V29, P27, DOI 10.1016/j.bpa.2015.02.002; Foerch C, 2008, DTSCH ARZTEBL INT, V105, P467, DOI 10.3238/arztebl.2008.0467; Gaba DM, 2000, BRIT MED J, V320, P785, DOI 10.1136/bmj.320.7237.785; Gal J, CLIN EMERGENCY MED I; Goyal M, 2016, RADIOLOGY, V279, P888, DOI 10.1148/radiol.2016160204; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Strbian D, 2015, STROKE, V46, P1275, DOI 10.1161/STROKEAHA.114.007170; Tahtali D, 2016, NERVENARZT, V87, P1322, DOI 10.1007/s00115-016-0162-5; Tahtali D, 2017, JOVE-J VIS EXP, DOI 10.3791/55138	17	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188231	10.1371/journal.pone.0188231	http://dx.doi.org/10.1371/journal.pone.0188231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206838	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700009
J	Neureiter, E; Hajfani, L; Ahnis, A; Mierke, A; Rose, M; Danzer, G; Klapp, BF				Neureiter, Elisabeth; Hajfani, Loreen; Ahnis, Anne; Mierke, Annett; Rose, Matthias; Danzer, Gerhard; Klapp, Burghard F.			An introduction to the 'Psycho-PhysiologicalStress- Test' (PPST)-A standardized instrument for evaluating stress reactions	PLOS ONE			English	Article								Using a standardized instrument to evaluate patients' stress reactions has become more important in daily clinical routines. Different signs or symptoms of stress are often unilaterally explored: the physiological, psychological or social aspects of stress disorders are each viewed on a single dimension. However, all dimensions afflict patients who have persistent health problems due to chronic stress. Therefore, it is important to use a multidimensional approach to acquire data. The 'Psycho-Physiological-Stress-Test' (PPST) was established to achieve a comprehensive understanding of stress and was further developed at the Charite A-Universitatsmedizin Berlin in collaboration with the Psychological Department of Freie Universitat Berlin. The PPST includes a series of varying stress phases, embedded in two periods of rest. Physiological and psychological parameters are simultaneously measured throughout the test session. Specifically, the PPST activates the sympathetic stress axis, which is measured by heart rate, blood pressure, respiration depth and rate, electro dermal activation and muscle tension (frontalis, masseter, trapezius). Psychological data are simultaneously collected, and include performance, motivation, emotion and behavior. After conducting this diagnostic test, it is possible to identify individual stress patterns that can be discussed with the individual patient to develop and recommend (outpatient) treatment strategies. This paper introduces the PPST as a standardized way to evaluate stress reactions by presenting the results from a sample of psychosomatic inpatients (n = 139) who were treated in Charite A-Universitatsmedizin Berlin, Germany. We observed that the varying testing conditions provoked adjusted changes in the different physiological parameters and psychological levels.	[Neureiter, Elisabeth; Hajfani, Loreen; Ahnis, Anne; Mierke, Annett; Rose, Matthias; Danzer, Gerhard; Klapp, Burghard F.] Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, Berlin, Germany; [Neureiter, Elisabeth; Danzer, Gerhard] Alpen Adria Univ Klagenfurt, Klagenfurt, Austria; [Danzer, Gerhard] Med Univ Brandenburg, Div Gen Internal & Psychosomat Med, Campus Ruppiner Kliniken, Neuruppin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Klagenfurt	Neureiter, E (corresponding author), Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, Berlin, Germany.	elisabeth.neureiter@charite.de		Neureiter, Elisabeth/0000-0002-9441-8963				Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Burch AE, 2014, INT J PSYCHOPHYSIOL, V94, P1, DOI 10.1016/j.ijpsycho.2014.07.002; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Fairburn CG, 1999, BEHAV RES THER, V37, P1, DOI 10.1016/S0005-7967(98)00102-8; Feher R., 2013, THESIS; Fliege H., 2001, DIAGNOSTICA, P510; FREDRIKSON M, 1989, J PSYCHOSOM RES, V33, P753, DOI 10.1016/0022-3999(89)90091-3; Gerhardt M., 2004, THESIS; Gromen A., 2002, THESIS; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Horhold M., 1994, PSYCHOPHYSIOLOGIE BE; Iliceto P, 2013, STRESS, V16, P143, DOI 10.3109/10253890.2012.689896; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kirschbaum C., 1991, PERSPECTIVES PROMISE, P67, DOI [10.1007/978-1-4899-3674-5_7, DOI 10.1007/978-1-4899-3674-5_7]; Klapp B. F., 2010, UEXKULL PSYCHOSOMATI, P43; Kolotylova T, 2010, PSYCHOTHER PSYCH MED, V60, P64, DOI 10.1055/s-0028-1103297; Kreibig SD, 2013, PSYCHOPHYSIOLOGY, V50, P799, DOI 10.1111/psyp.12064; Lazarus R.S., 1984, EMOTION ADAPTATION; LAZARUS RS, 1963, ADMIN SCI QUART, V8, P192, DOI 10.2307/2390899; LAZARUS RS, 1974, INT J PSYCHIAT MED, V5, P321, DOI 10.2190/T43T-84P3-QDUR-7RTP; Mutsuura H, 2009, APPL PSYCHOPHYS BIOF, V34, P291, DOI 10.1007/s10484-009-9110-5; POLLAK MH, 1994, PSYCHOSOM MED, V56, P271, DOI 10.1097/00006842-199405000-00015; Reid S, 2002, BRIT J PSYCHIAT, V180, P248, DOI 10.1192/bjp.180.3.248; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Selye H, 1975, Compr Ther, V1, P9; SELYE H, 1973, AM SCI, V61, P692; Sugaya N, 2012, INT J PSYCHOPHYSIOL, V84, P39, DOI 10.1016/j.ijpsycho.2012.01.006; Tureba A., 2013, BRAIN BEHAV IMMUN, P11; WATERINK W, 1994, BIOL PSYCHOL, V37, P183, DOI 10.1016/0301-0511(94)90001-9; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187859	10.1371/journal.pone.0187859	http://dx.doi.org/10.1371/journal.pone.0187859			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194437	Green Published, gold, Green Submitted			2022-12-26	WOS:000416867800009
J	Lekkerkerk, WSN; Haenen, A; van der Sande, MAB; Leenstra, T; de Greeff, S; Timen, A; Tjon-a-Tsien, A; Richardus, JH; van de Sande-Bruinsma, N; Vos, MC				Lekkerkerk, W. S. N.; Haenen, A.; van der Sande, M. A. B.; Leenstra, T.; de Greeff, S.; Timen, A.; Tjon-a-Tsien, A.; Richardus, J. H.; van de Sande-Bruinsma, N.; Vos, M. C.			Newly identified risk factors for MRSA carriage in The Netherlands	PLOS ONE			English	Article							RESISTANT-STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; PREVALENCE; CARE	Objectives To elucidate new risk factors for MRSA carriers without known risk factors (MRSA of unknown origin; MUO). These MUO carriers are neither pre-emptively screened nor isolated as normally dictated by the Dutch Search & Destroy policy, thus resulting in policy failure. Methods We performed a prospective case control study to determine risk factors for MUO acquisition/carriage (Dutch Trial Register: NTR2041). Cases were MUO carriers reported by participating medical microbiological laboratories to the RIVM from September 1 st 2011 until September 1 st 2013. Controls were randomly selected from the community during this period. Results Significant risk factors for MUO in logistic multivariate analysis were antibiotic use in the last twelve months, aOR 8.1 (5.6 - 11.7), screened as contact in a contact tracing but not detected as a MRSA carrier at that time, aOR 4.3 (2.1 - 8.8), having at least one foreign parent, aOR 2.4 (1.4 - 3.9) and receiving ambulatory care, aOR 2.3 (1.4 - 3.7). Our found risk factors explained 83% of the MUO carriage. Conclusions Identifying new risk factors for MRSA carriers remains crucial for countries that apply a targeted screening approach as a Search and Destroy policy or as vertical infection prevention measure.	[Lekkerkerk, W. S. N.; Vos, M. C.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Lekkerkerk, W. S. N.; Haenen, A.; van der Sande, M. A. B.; Leenstra, T.; de Greeff, S.; Timen, A.; van de Sande-Bruinsma, N.] Natl Ctr Hlth & Environm, RIVM, Bilthoven, Netherlands; [van der Sande, M. A. B.] UMCU, Julius Ctr, Utrecht, Netherlands; [van der Sande, M. A. B.] Inst Trop Med, Antwerp, Belgium; [Tjon-a-Tsien, A.; Richardus, J. H.] Municipal Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands; [Richardus, J. H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Unilever; Utrecht University; Utrecht University Medical Center; Institute of Tropical Medicine (ITM); Erasmus University Rotterdam; Erasmus MC	Vos, MC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	m.vos@erasmusmc.nl	van der Sande, Marianne/AAQ-3573-2021; Richardus, Jan Hendrik/AAE-1278-2021; Haenen, Anja/E-1621-2016; Timen, Aura/GLV-4130-2022	Richardus, Jan Hendrik/0000-0003-0564-6313; van der Sande, Marianne AB/0000-0002-4778-6739	Netherlands Organisation for Health Research and Development (ZonMw) [125020010]; ZonMw [125020010]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); ZonMw(Netherlands Organization for Health Research and Development)	This study was financed by The Netherlands Organisation for Health Research and Development (ZonMw; https://www.zonmw.nl/en/) (125020010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Anna Groenheide, Annelies van Ginkel, Yolanda van Weert, Dineke Frentz and Sjoukje Woudt for their supportive work in this study. Furthermore we would like to thank the participants, as well as the medical microbiologists, infection preventionists and other personnel of the following medical microbiological laboratories in The Netherlands that helped make this national study a success: Academic Medical Center, University of Amsterdam, Amsterdam, Admiraal de Ruyter Ziekenhuis, Goes/Vlissingen, ATAL-Medical Diagnostic Centre, Amsterdam, Atrium Medical Center Parkstad, Heerlen, Bronovo Hospital, The Hague, De Heel Zaans Medisch Centrum, Zaandam, Deventer Hospital, Deventer, Diaconessenhuis Leiden, Leiden, Diakonessenhuis Utrecht, Utrecht, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Gelderse Vallei Hospital, Ede, Gelre Hospital, Apeldoorn, Groene Hart Ziekenhuis, Gouda, Haga Hospital, The Hague, Usselland Hospital, Capelle aan den Ussel, Ikazia Hospital, Rotterdam, Isala Klinieken, Zwolle, Jeroen Bosch Hospital, 's-Hertogenbosch, Laboratory for Infectious Diseases, Groningen, Laboratory for Pathology and Medical Microbiology (PAMM), Veldhoven, Laurentius Hospital, Roermond, Maasstad Hospital, Rotterdam, Maastricht University Medical Center, Maastricht, Medical Center Alkmaar, Alkmaar, Medical Center Leeuwarden, Izore Center for Infectious Diseases Friesland, Leeuwarden, Orbis Medical Center, Sittard-Geleen, Regional Public Health Laboratory Kennemerland, Haarlem, Reinier de Graaf Groep, Delft, Rijnland Hospital, Leiderdorp, Rijnstate Hospital, Arnhem, SALTRO, Utrecht, SHL-group, Etten-Leur, Slingeland Hospital, Doetinchem, St. Antonius Hospital, Nieuwegein, St. Franciscus Gasthuis, Rotterdam, St. Jans Gasthuis, Weert, St. Jansdal Hospital, Harderwijk, Tergooi Hospitals Hilversum, Hilversum, UMC Utrecht, Utrecht, University Medical Center Groningen, Groningen, VieCuri Medical Center, Venlo, Vlietland Hospital, Schiedam, Westfries Gasthuis, Hoorn, Ziekenhuis ZeeuwsVlaanderen, Terneuzen, Zuwe Hofpoort Hospital, Woerden, The Netherlands. This study was financed by ZonMw (125020010) and listed in the Dutch Trial Register (NTR2041). Data were presented at the International Symposium on Staphylococci and Staphylococcal infections 2016, Seoul, South Korea. Poster S01-02.	Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Central Bureau for Statistics (CBS), 2016, EUR LEAST ANT PROV N; Couderc C, 2014, CLIN INFECT DIS, V59, P206, DOI 10.1093/cid/ciu236; Davies PR, 2013, EMERG INFECT DIS, V19, P1551, DOI [10.3201/eid1909.121577, 10.3201/eid1909.130876]; de Greeff SC MJ, 2017, NETHMAP MARAN 2017; Dutch Workinggroup of Infection Prevention, 2012, WIP GUID MRSA WERKGR; Dutch Workinggroup of Infection Prevention, 2007, WIP GUID MRSA 2007; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Larsen AR, 2008, J CLIN MICROBIOL, V46, P62, DOI 10.1128/JCM.01381-07; Lekkerkerk WS, 2015, J INFECT; Lekkerkerk WSN, 2011, CLIN MICROBIOL INFEC; Lo WT, 2008, PEDIATR INFECT DIS J, V27, P713, DOI 10.1097/INF.0b013e31816f63b5; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Paget J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139589; Psoter KJ, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0449-8; Ravensbergen SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176481; Reinheimer C, 2015, EURO SURVEILL, V21; RIVM, 2016, HRMO MRSA SCREEN IS; Soltani B, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.20025; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; van Rijen MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065594; Vos MC, 2009, INFECT CONT HOSP EP, V30, P977, DOI 10.1086/605921; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188502	10.1371/journal.pone.0188502	http://dx.doi.org/10.1371/journal.pone.0188502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190731	Green Published, gold			2022-12-26	WOS:000416841900064
J	Popowicz, ND; Lansley, SM; Cheah, HM; Kay, ID; Carson, CF; Waterer, GW; Paton, JC; Brown, JS; Lee, YCG				Popowicz, Natalia D.; Lansley, Sally M.; Cheah, Hui M.; Kay, Ian D.; Carson, Christine F.; Waterer, Grant W.; Paton, James C.; Brown, Jeremy S.; Lee, Y. C. Gary			Human pleural fluid is a potent growth medium for Streptococcus pneumoniae	PLOS ONE			English	Article							IRON UPTAKE; PARAPNEUMONIC EMPYEMA; ABC TRANSPORTER; VIRULENCE; PNEUMOLYSIN; MICE; PSAA; MECHANISMS; AUTOLYSIN; CHILDREN	Empyema is defined by the presence of bacteria and/or pus in pleural effusions. However, the biology of bacteria within human pleural fluid has not been studied. Streptococcus pneumoniae is the most common cause of pediatric and frequent cause of adult empyema. We investigated whether S. pneumoniae can proliferate within human pleural fluid and if growth is affected by the cellular content of the fluid and/or characteristics of pneumococcal surface proteins. Invasive S. pneumoniae isolates (n = 24) and reference strain recovered from human blood or empyema were inoculated (1.5x10(6) CFU/mL) into sterile human malignant pleural fluid samples (n = 11). All S. pneumoniae (n = 25) strains proliferated rapidly, increasing by a median of 3009 (IQR 1063-9846) from baseline at 24hrs in all pleural effusions tested. Proliferation was greater than in commercial pneumococcal culture media and concentrations were maintained for 48hrs without autolysis. A similar magnitude of proliferation was observed in pleural fluid before and after removal of its cellular content, p = 0.728. S. pneumoniae (D39 strain) wild-type, and derivatives (n = 12), each with mutation(s) in a different gene required for full virulence were inoculated into human pleural fluid (n = 8). S. pneumoniae with pneumococcal surface antigen A (triangle psaA) mutation failed to grow (2207-fold lower than wild-type), p< 0.001, however growth was restored with manganese supplementation. Growth of other common respiratory pathogens (n = 14) across pleural fluid samples (n = 7) was variable and inconsistent, with some strains failing to grow. We establish for the first time that pleural fluid is a potent growth medium for S. pneumoniae and proliferation is dependent on the PsaA surface protein and manganese.	[Popowicz, Natalia D.] Sir Charles Gairdner Hosp, Pharm Dept, Perth, WA, Australia; [Popowicz, Natalia D.; Carson, Christine F.; Waterer, Grant W.; Lee, Y. C. Gary] Univ Western Australia, Div Med, Perth, WA, Australia; [Popowicz, Natalia D.; Lansley, Sally M.; Cheah, Hui M.; Lee, Y. C. Gary] Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia; [Kay, Ian D.] Royal Perth Hosp, PathWest Lab Med, Dept Microbiol & Infect Dis, Perth, WA, Australia; [Waterer, Grant W.] Royal Perth Hosp, Resp Dept, Perth, WA, Australia; [Paton, James C.] Univ Adelaide, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA, Australia; [Brown, Jeremy S.] UCL, Ctr Inflammat & Tissue Repair, Resp Med, London, England; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; Royal Perth Hospital; University of Western Australia; University of Adelaide; University of London; University College London; University of Western Australia	Lee, YCG (corresponding author), Univ Western Australia, Div Med, Perth, WA, Australia.; Lee, YCG (corresponding author), Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia.; Lee, YCG (corresponding author), Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia.	Gary.lee@uwa.edu.au	Carson, Christine F/F-1521-2013; Waterer, Grant/AAG-2385-2021; CHeah, Hui Min/AAU-3478-2020; Popowicz, Natalia/M-7505-2018; Lee, Y C Gary/H-5264-2014	Carson, Christine F/0000-0003-3669-1651; Popowicz, Natalia/0000-0003-0200-1819; Brown, Jeremy/0000-0002-5650-5361; Lee, Yun Chor Gary/0000-0002-0036-511X; Cheah, Hui Min/0000-0003-1292-4561	NHMRC; New South Wales Dust Disease Board (DDB); Sir Charles Gairdner Research Advisory Committee; Institute for Respiratory Health Westcare Alan King Grants; Cancer Council of Western Australia; Department of Health's NIHR Biomedical Research Centre's funding scheme	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Dust Disease Board (DDB); Sir Charles Gairdner Research Advisory Committee; Institute for Respiratory Health Westcare Alan King Grants; Cancer Council of Western Australia(Cancer Council Western Australia); Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR))	YCGL is a National Health & Medical Research Council (NHMRC) Career Development Fellow and receives project grant funding from the NHMRC, New South Wales Dust Disease Board (DDB), Sir Charles Gairdner Research Advisory Committee, Institute for Respiratory Health Westcare Alan King Grants and the Cancer Council of Western Australia. JSB is partially funded from the Department of Health's NIHR Biomedical Research Centre's funding scheme. JCP is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Brown LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146785; Burgos J, 2013, CURR OPIN PULM MED, V19, P350, DOI 10.1097/MCP.0b013e3283606ab5; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Finley C, 2008, CAN RESPIR J, V15, P85, DOI 10.1155/2008/975312; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Grijalva CG, 2011, THORAX, V66, P663, DOI 10.1136/thx.2010.156406; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Proesmans M, 2014, EUR J PEDIATR, V173, P1339, DOI 10.1007/s00431-014-2319-1; Strachan RE, 2011, EMERG INFECT DIS, V17, P1839, DOI 10.3201/eid1710.101825; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; TALKINGTON DF, 1991, INFECT IMMUN, V59, P1285, DOI 10.1128/IAI.59.4.1285-1289.1991; Thomas R, 2016, CHEST, V149, P1494, DOI 10.1016/j.chest.2016.01.001; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Wilkosz S, 2012, AM J RESP CELL MOL, V46, P180, DOI 10.1165/rcmb.2011-0182OC; World Health Organization, 2004, REV GLOB BURD DIS 20	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188833	10.1371/journal.pone.0188833	http://dx.doi.org/10.1371/journal.pone.0188833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190798	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900137
J	Hsieh, CH; Lu, CH; Chen, WT; Ma, BL; Chao, CY				Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Chen, Wei-Ting; Ma, Bo-Lun; Chao, Chih-Yu			Application of non-invasive low strength pulsed electric field to EGCG treatment synergistically enhanced the inhibition effect on PANC-1 cells	PLOS ONE			English	Article							GREEN TEA POLYPHENOL; PANCREATIC-CANCER; EPIGALLOCATECHIN-3-GALLATE EGCG; IRREVERSIBLE ELECTROPORATION; APOPTOSIS; MECHANISMS; PREVENTION; ABLATION; BCL-2	Traditional therapies for pancreatic cancer are usually expensive and likely to cause side effects, and most patients have the risk of recurrence and suffering pain. Here, we investigated combination treatment of epigallocatechin-3-gallate (EGCG) and non-invasive low strength pulsed electric field (PEF) on the human pancreatic cell line PANC-1. Cells were cultured in various concentrations of EGCG and exposed to trains of PEF. The results showed that the low strength PEF alone or single treatment with low concentration of EGCG did not obviously affect the cell proliferation and migration in PANC-1. However, the EGCG-induced inhibitions of cell viability and migration ability in PANC-1 were dramatically enhanced by the further exposure of low strength PEF (60 V/cm). In particular, the same combination treatment caused less inhibition of cell viability in non-malignant HEK293 cells. We also found the combination treatment significantly decreased the ratio of Bcl-2/Bax protein and increased caspase activity in PANC-1 cells, resulting in the promotion of apoptotic responses, evidenced by chromatin condensation. The findings of the present study reveal the synergistic reactions in the combination treatment may severely disturb mitochondria, enhance the intrinsic pathway transduction, and effectively induce apoptosis; moreover, the migration and invasion of PANC-1 cancer cells were also significantly suppressed. Since normal cells are less sensitive to this combination treatment, and the non-invasive PEF could be modified to focus on a specific location, this treatment may serve as a promising method for anti-cancer therapy.	[Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Chen, Wei-Ting; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Chen, Wei-Ting; Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan; [Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/GMX-1452-2022; Hsieh, Chih-Hsiung/AFI-4085-2022		Ministry of Science and Technology of the Republic of China [MOST105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [NTU-ICRP-103R7560-2]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan)	This work has been supported by grants from Ministry of Science and Technology (MOST105-2112-M-002-006-MY3; C.Y. Chao) and Ministry of Education (NTU-ICRP-103R7560-2; C. Y. Chao) of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhonsle S, 2016, J VASC INTERV RADIOL, V27, P1913, DOI 10.1016/j.jvir.2016.07.012; Bozzuto G, 2015, INT J NANOMED, V10, P975, DOI 10.2147/IJN.S68861; Brand R, 2004, DM-DIS MON, V50, P545, DOI 10.1016/j.disamonth.2004.09.001; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Donghao L, 2015, 34 CHIN CONTR C CCC; Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679; Fischer R, 2012, SAUDI J GASTROENTERO, V18, P118, DOI 10.4103/1319-3767.93815; Fish Raymond M, 2009, Eplasty, V9, pe44; Frelinger AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160933; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; Huang FT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087897; Ivorra A, 2010, SER BIOMED ENG, P23, DOI 10.1007/978-3-642-05420-4_2; Ji SJ, 2006, ARCH PHARM RES, V29, P363, DOI 10.1007/BF02968585; Korchak HM, 1982, BIOCH BIOPHYS RES CO, V108; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Kotnik T, 2000, IEEE T BIO-MED ENG, V47, P1074, DOI 10.1109/10.855935; Leone M, 2003, CANCER RES, V63, P8118; Matsuki N, 2008, CANCER LETT, V269, P93, DOI 10.1016/j.canlet.2008.04.019; Matsuki N, 2010, ONCOL REP, V23, P1425, DOI 10.3892/or_00000780; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Mi Y, 2007, 2007 EMBS 2007 29 AN; Miklavcic D, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-10; Mir Lluis M., 2008, V423, P3, DOI 10.1007/978-1-59745-194-9_1; Mittal L, 2017, BIOCHEM BIOPH RES CO, V491, P1015, DOI 10.1016/j.bbrc.2017.08.002; Nagata H, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0773-0; Napotnik TB, 2016, BIOELECTROCHEMISTRY, V110, P1, DOI 10.1016/j.bioelechem.2016.02.011; Novac BM, 2014, IEEE T PLASMA SCI, V42, P216, DOI 10.1109/TPS.2013.2293915; Nuccitelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134364; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Robinson VS, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa630a; Ryan P, 2007, J INORG BIOCHEM, V101, P585, DOI 10.1016/j.jinorgbio.2006.12.001; Saif MW, 2014, EXPERT REV CLIN PHAR, V7, P487, DOI 10.1586/17512433.2014.910451; Saif MW, 2011, J PANCREAS, V12, P316; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Singh A, 2013, BIOMOLECULES, V3, P168, DOI 10.3390/biom3010168; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sundararajan R, 2009, MOL BIOTECHNOL, V41, P69, DOI 10.1007/s12033-008-9107-y; Vignes M, 2006, BRAIN RES, V1110, P102, DOI 10.1016/j.brainres.2006.06.062; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yao CG, 2004, IEEE T PLASMA SCI, V32, P1626, DOI 10.1109/TPS.2004.832621; Zeng L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00061; 罗非君, 2001, Chinese Journal of Cancer Research, V13, P235, DOI 10.1007/s11670-001-0038-4	48	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188885	10.1371/journal.pone.0188885	http://dx.doi.org/10.1371/journal.pone.0188885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186186	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900069
J	Shimoda, N; Lee, J; Kodama, M; Kakei, S; Masakado, Y				Shimoda, Naoshi; Lee, Jongho; Kodama, Mitsuhiko; Kakei, Shinji; Masakado, Yoshihisa			Quantitative evaluation of age-related decline in control of preprogramed movement	PLOS ONE			English	Article							STEP-TRACKING MOVEMENTS; VISUAL FEEDBACK; MUSCLE-ACTIVITY; ARM MOVEMENTS; WRIST; HUMANS	In this paper, we examined the age-related changes in control of preprogramed movement, with emphasis on its accuracy. Forty-nine healthy subjects participated in this study, and were divided into three groups depending on their ages: the young group (20-39 years) (n = 16), the middle-age group (40-59 years) (n = 16), and the elderly group (60-79 years) (n = 17). We asked the subjects to perform step-tracking movements of the wrist joint with a manipulandum, and recorded the movements. We evaluated the accuracy of control of pre-programed movement in the three groups in terms of the primary submovement, which was identified as the first segment of the step-tracking movement based on the bell-shaped velocity profile, and calculated the distance between the end position of the primary sub movement and the target (i.e. error). The error in the young group was found to be significantly smaller than that in the middle-age and elderly groups, i.e., the error was larger for the higher age groups. These results suggest that young subjects have better control of pre-programed movement than middle-age or elderly subjects. Finally, we examined the temporal property of the primary submovement and its age-related changes. The duration of the primary submovement tended to be longer for the aged groups, although significance was reached only for the elderly group. In particular, the ratio of the duration of the primary submovement to total movement time tended to be lower for the aged groups, suggesting that the proportion of additional movements that are required to compensate for the incomplete control in the preprogramed movement, which are under feedback control, was higher for the aged groups. Consequently, our results indicate that the distance between the end point of the primary submovement and the target center (i.e. error) in the step-tracking movement is a useful parameter to evaluate the age-related changes in control of preprogramed movement.	[Shimoda, Naoshi; Kodama, Mitsuhiko; Masakado, Yoshihisa] Tokai Univ, Sch Med, Dept Rehabil Med, Hiratsuka, Kanagawa, Japan; [Lee, Jongho; Kakei, Shinji] Tokyo Metropolitan Inst Med Sci, Movement Disorders Project, Tokyo, Japan	Tokai University; Tokyo Metropolitan Institute of Medical Science	Shimoda, N (corresponding author), Tokai Univ, Sch Med, Dept Rehabil Med, Hiratsuka, Kanagawa, Japan.	shimoda.naoshi@tokai-u.jp						ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Bellgrove MA, 1998, J GERONTOL A-BIOL, V53, pM222, DOI 10.1093/gerona/53A.3.M222; COOKE JD, 1989, NEUROBIOL AGING, V10, P159, DOI 10.1016/0197-4580(89)90025-0; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fradet L, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-28; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; Helsen WF, 2016, AGE, V38, DOI 10.1007/s11357-016-9908-z; HOFFMAN DS, 1990, J NEUROSCI, V10, P142; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kambara H, 2013, J NEUROPHYSIOL, V109, P2145, DOI 10.1152/jn.00542.2011; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132983; Lee J, 2008, IEEE ENG MED BIO, P181, DOI 10.1109/IEMBS.2008.4649120; Lee Jongho, 2007, Rinsho Byori, V55, P912; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Pratt J, 1996, J MOTOR BEHAV, V28, P149, DOI 10.1080/00222895.1996.9941741; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Roon D, 2008, CHILD DEV, V79, P852, DOI 10.1111/j.1467-8624.2008.01163.x; Walker N., 1997, J GERONTOL B-PSYCHOL, V52, P40; Welsh TN, 2007, HUM MOVEMENT SCI, V26, P892, DOI 10.1016/j.humov.2007.04.004; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	31	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188657	10.1371/journal.pone.0188657	http://dx.doi.org/10.1371/journal.pone.0188657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186168	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900051
J	Langemeyer, L; Perz, A; Kummel, D; Ungermann, C				Langemeyer, Lars; Perz, Angela; Kuemmel, Daniel; Ungermann, Christian			A guanine nucleotide exchange factor (GEF) limits Rab GTPase-driven membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; guanine nucleotide exchange factor (GEF); lysosome; membrane fusion; Rab; GDI; Mon1-Ccz1; Ypt7; Rab7; GDI	GDP DISSOCIATION INHIBITOR; VACUOLE DOCKING; COMPLEX; DISPLACEMENT; HOPS; IDENTIFICATION; PRENYLATION; MECHANISM; PROTEINS; ACTIVATION	The identity of organelles in the endomembrane system of any eukaryotic cell critically depends on the correctly localized Rab GTPase, which binds effectors and thus promotes membrane remodeling or fusion. However, it is still unresolved which factors are required and therefore define the localization of the correct fusion machinery. Using SNARE-decorated proteoliposomes that cannot fuse on their own, we now demonstrate that full fusion activity can be achieved by just four soluble factors: a soluble SNARE (Vam7), a guanine nucleotide exchange factor (GEF, Mon1-Ccz1), a Rab-GDP dissociation inhibitor (GDI) complex (prenylated Ypt7-GDI), and a Rab effector complex (HOPS). Our findings reveal that the GEF Mon1-Ccz1 is necessary and sufficient for stabilizing prenylated Ypt7 on membranes. HOPS binding to Ypt7-GTP then drives SNARE-mediated fusion, which is fully GTP-dependent. We conclude that an entire fusion cascade can be controlled by a GEF.	[Langemeyer, Lars; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany; [Kuemmel, Daniel] Univ Osnabruck, Struct Biochem, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Ungermann, C (corresponding author), Univ Osnabruck, Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de			Department of Biology/Chemistry of the University of Osnabruck;  [SFB 944];  [P11];  [P18]	Department of Biology/Chemistry of the University of Osnabruck; ; ; 	This work was supported by SFB 944 Project P11 (to C.U.) and Project P18 (to D.K.) and an incentive award of the Department of Biology/Chemistry of the University of Osnabruck (to L.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Cui Y, 2014, PLANT CELL, V26, P2080, DOI 10.1105/tpc.114.123141; Dennis MK, 2016, J CELL BIOL, V214, P293, DOI 10.1083/jcb.201605090; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Goody RS, 2017, BIOL CHEM, V398, P565, DOI 10.1515/hsz-2016-0274; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hegedus K, 2016, MOL BIOL CELL, V27, P3132, DOI 10.1091/mbc.E16-03-0205; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lachmann Jens, 2011, Small GTPases, V2, P182; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18101; Lurick A, 2017, MOL BIOL CELL, V28, P322, DOI 10.1091/mbc.E16-11-0764; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Oesterlin LK, 2012, P NATL ACAD SCI USA, V109, P5621, DOI 10.1073/pnas.1121161109; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Orr A, 2015, MOL BIOL CELL, V26, P305, DOI 10.1091/mbc.E14-08-1298; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Singh MK, 2014, CURR BIOL, V24, P1383, DOI 10.1016/j.cub.2014.05.005; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; Zick M., 2016, MOL BIOL CELL, V27, P1, DOI [10.1091/mbc.E15-06-0352, DOI 10.1091/MBC.E15-06-035226715420]; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zick M, 2012, MOL BIOL CELL, V23, P3429, DOI 10.1091/mbc.E12-04-0279; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	52	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					731	739		10.1074/jbc.M117.812941	http://dx.doi.org/10.1074/jbc.M117.812941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184002	hybrid, Green Published			2022-12-26	WOS:000419915400026
J	Cheng, B; Knaack, C; Forkert, ND; Schnabel, R; Gerloff, C; Thomalla, G				Cheng, Bastian; Knaack, Christian; Forkert, Nils Daniel; Schnabel, Renate; Gerloff, Christian; Thomalla, Goetz			Stroke subtype classification by geometrical descriptors of lesion shape	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; UNDETERMINED SOURCE; EMBOLIC STROKE; PATTERNS; VOLUME; VALIDITY; INFARCTS; MRI	Background and purpose Inference of etiology from lesion pattern in acute magnetic resonance imaging is valuable for management and prognosis of acute stroke patients. This study aims to assess the value of three-dimensional geometrical lesion-shape descriptors for stroke-subtype classification, specifically regarding stroke of cardioembolic origin. Methods Stroke Etiology was classified according to ASCOD in retrospectively selected patients with acute stroke. Lesions were segmented on diffusion-weighed datasets, and descriptors of lesion shape quantified: surface area, sphericity, bounding box volume, and ratio between bounding box and lesion volume. Morphological measures were compared between stroke subtypes classified by ASCOD and between patients with embolic stroke of cardiac and non-cardiac source. Results 150 patients (mean age 77 years; 95% CI, 65-80 years; median NIHSS 6, range 0-22) were included. Group comparison of lesion shape measures demonstrated that lesions caused by small-vessel disease were smaller and more spherical compared to other stroke subtypes. No significant differences of morphological measures were detected between patients with cardioembolic and non-cardioembolic stroke. Conclusion Stroke lesions caused by small vessel disease can be distinguished from other stroke lesions based on distinctive morphological properties. However, within the group of embolic strokes, etiology could not be inferred from the morphology measures studied in our analysis.	[Cheng, Bastian; Knaack, Christian; Gerloff, Christian; Thomalla, Goetz] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Forkert, Nils Daniel] Hotchkiss Brains Inst, Dept Radiol, Calgary, AB, Canada; [Schnabel, Renate] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cheng, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	b.cheng@uke.de	Schnabel, Renate B/ABE-6668-2021; Forkert, Nils Daniel/K-6273-2012	Schnabel, Renate B/0000-0001-7170-9509; Forkert, Nils Daniel/0000-0003-2556-3224; Gerloff, Christian/0000-0002-6484-8882	Deutsche Stiftung fur Herzforschung (German Heart Research Foundation) [F 24/16]	Deutsche Stiftung fur Herzforschung (German Heart Research Foundation)	We disclose that this work has been funded by the Deutsche Stiftung fur Herzforschung (German Heart Research Foundation) via grant no. F 24/16 (Recipient: Bastian Cheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2015, STROKE, V46, pE114, DOI 10.1161/STROKEAHA.114.007773; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Alhadramy O, 2010, STROKE, V41, P2596, DOI 10.1161/STROKEAHA.109.570382; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Arboix A, 2012, CURR CARDIOL REV, V8, P54, DOI 10.2174/157340312801215791; Asdaghi N, 2014, STROKE, V45, P2952, DOI 10.1161/STROKEAHA.114.005211; Ay H, 2014, STROKE, V45, P3589, DOI 10.1161/STROKEAHA.114.007362; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bernstein RA, 2015, CEREBROVASC DIS, V40, P91, DOI 10.1159/000437018; Bhatt A, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/172074; Depuydt S, 2014, J NEUROL SCI, V337, P151, DOI 10.1016/j.jns.2013.11.039; Forkert ND, 2014, METHOD INFORM MED, V53, P1; Frindel C, 2015, STROKE, V46, P976, DOI 10.1161/STROKEAHA.114.008046; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; Hart RG, 2014, ANN INTERNAL MED REV; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Herve D, 2005, STROKE, V36, P2384, DOI 10.1161/01.STR.0000185678.26296.38; Jorgensen HS, 1996, STROKE, V27, P1765, DOI 10.1161/01.STR.27.10.1765; Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004; Kang DW, 2003, ARCH NEUROL-CHICAGO, V60, P1730, DOI 10.1001/archneur.60.12.1730; Kim YD, 2011, EUR NEUROL, V66, P145, DOI 10.1159/000330563; Kishore A, 2014, STROKE, V45, P520, DOI 10.1161/STROKEAHA.113.003433; Kolominsky-rabas PL, 2001, EPIDEMIOLOGY ISCHEMI, P2735; Lee BI, 2001, CEREBROVASC DIS, V12, P145, DOI 10.1159/000047697; Novotny V, 2016, ACUTE CEREBRAL INFAR, P1; Ogata T, 2011, STROKE, V42, P1596, DOI 10.1161/STROKEAHA.110.609016; Olivot JM, 2009, STROKE, V40, P3245, DOI 10.1161/STROKEAHA.109.558635; Perera KS, 2016, STROKE, V47, P2197, DOI 10.1161/STROKEAHA.116.013378; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wessels T, 2005, STROKE, V36, P757, DOI 10.1161/01.STR.0000158908.48022.d7; Wessels T, 2006, CONTRIBUTION DIFFUSI	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0185063	10.1371/journal.pone.0185063	http://dx.doi.org/10.1371/journal.pone.0185063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216218	gold, Green Submitted, Green Published			2022-12-26	WOS:000417337800001
J	Woods, C; Fernee, C; Browne, M; Zakrzewski, S; Dickinson, A				Woods, Christopher; Fernee, Christianne; Browne, Martin; Zakrzewski, Sonia; Dickinson, Alexander			The potential of statistical shape modelling for geometric morphometric analysis of human teeth in archaeological research	PLOS ONE			English	Article							TOOTH WEAR; SEXUAL-DIMORPHISM; PERMANENT MOLARS; MORPHOLOGY; ENAMEL; COVARIATION; TOMOGRAPHY; INFERENCES; PHENOTYPE; HOMININS	This paper introduces statistical shape modelling (SSM) for use in osteoarchaeology research. SSM is a full field, multi-material analytical technique, and is presented as a supplementary geometric morphometric (GM) tool. Lower mandibular canines from two archaeological populations and one modern population were sampled, digitised using micro-CT, aligned, registered to a baseline and statistically modelled using principal component analysis (PCA). Sample material properties were incorporated as a binary enamel/dentin parameter. Results were assessed qualitatively and quantitatively using anatomical landmarks. Finally, the technique's application was demonstrated for inter-sample comparison through analysis of the principal component (PC) weights. It was found that SSM could provide high detail qualitative and quantitative insight with respect to archaeological inter-and intra-sample variability. This technique has value for archaeological, biomechanical and forensic applications including identification, finite element analysis (FEA) and reconstruction from partial datasets.	[Woods, Christopher; Browne, Martin; Dickinson, Alexander] Univ Southampton, Bioengn Sci Res Grp, Highfield Campus, Southampton, Hants, England; [Fernee, Christianne; Zakrzewski, Sonia] Univ Southampton, Dept Archaeol, Ave Campus, Southampton, Hants, England	University of Southampton; University of Southampton	Dickinson, A (corresponding author), Univ Southampton, Bioengn Sci Res Grp, Highfield Campus, Southampton, Hants, England.	alex.dickinson@soton.ac.uk	Browne, Martin/M-8229-2013; Zakrzewski, Sonia/AAA-9200-2022; Dickinson, Alex/D-2693-2012	Browne, Martin/0000-0001-5184-050X; Zakrzewski, Sonia/0000-0003-1796-065X; Dickinson, Alex/0000-0002-9647-1944	Royal Academy of Engineering [RF/130]; InnovateUK [KTP 8930]; Arts and Humanities Research Council (AHRC) PhD Studentship [AH/L503939/1]; EPSRC [EP-H01506X]	Royal Academy of Engineering(Royal Academy of Engineering - UK); InnovateUK(UK Research & Innovation (UKRI)Innovate UK); Arts and Humanities Research Council (AHRC) PhD Studentship(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors were funded by the following research grants: AD - Royal Academy of Engineering (Grant RF/130) - http://www.raeng.org.uk; AD/CW - InnovateUK (Grant KTP 8930) -https://www.gov.uk/government/organisations/innovate-uk; CF - Arts and Humanities Research Council (AHRC) PhD Studentship (Grant AH/L503939/1) - http//www.ahrc.ac.uk. Facilities funding for the MuVis Centre were provided by EPSRC grant EP-H01506X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SA., 1984, COMP STUDY TOOTH ROO; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Al-Gunaid T, 2012, MESIODISTAL TOOTH WI; Al-Shahrani I, 2014, FRONT PHYSIOL, P5; [Anonymous], 2016, HDB FORENSIC ANTHR A; Arambawatta Kapila, 2009, J Oral Sci, V51, P623; Ashar N Md, 2012, DENT CROWN ARCH SIZE; Babalola K, 2008, MICCAI, V2008, P401; Bah MT, 2015, MED ENG PHYS, V37, P995, DOI 10.1016/j.medengphy.2015.08.004; Bailey SE, 2016, AM J PHYS ANTHROPOL, V159, P93, DOI 10.1002/ajpa.22842; Baldwin MA, 2010, COMPUT METH PROG BIO, V97, P232, DOI 10.1016/j.cmpb.2009.07.005; Ballester MAG, 2004, MED IMAGE ANAL, V8, P361, DOI 10.1016/j.media.2004.06.012; Bardsley PF, 2008, CLIN ORAL INVEST, V12, pS15, DOI 10.1007/s00784-007-0184-2; Barratt DC, 2008, MED IMAGE ANAL, V12, P358, DOI 10.1016/j.media.2007.12.006; Bastir M, 2010, J HUM EVOL, V58, P68, DOI 10.1016/j.jhevol.2009.08.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Bookstein FL, 1998, ACTA ZOOL ACAD SCI H, V44, P7; Bredbenner TL, 2010, J BIOMECH, V43, P1780, DOI 10.1016/j.jbiomech.2010.02.015; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Bryan R., 2010, LARGE SCALE MULTIFEM; Bryan R, 2010, MED ENG PHYS, V32, P57, DOI 10.1016/j.medengphy.2009.10.008; Buchaillard SI, 2007, COMPUT BIOL MED, V37, P1461, DOI 10.1016/j.compbiomed.2007.01.003; Butler PM, 1939, STUDIES MAMMALIAN DE; Cameriere R, 2004, J FORENSIC SCI, V49, P1, DOI DOI 10.1520/JFS2003259; Cooke SB, 2015, ANAT REC, V298, P5, DOI 10.1002/ar.23065; Cootes T. F., 2004, TECHNICAL REPORT; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Crevecoeur I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084652; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; Davies RH, 2001, BIENN INT C INF PROC; Dreier F. G., 1994, INT J OSTEOARCHAEOL, V4, P137; Efeoglu N, 2005, J DENT, V33, P561, DOI 10.1016/j.jdent.2004.12.001; Elewa AM., 2010, MORPHOMETRICS NONMOR; Elliot J, 1989, APPL XRAY MICROTOMOG, VV; Fearne J, 2004, BRIT DENT J, V196, P634, DOI 10.1038/sj.bdj.4811282; Fernee CL, 2017, AM J PHYS ANTHROPOL, V162, P179; Fornai C, 2016, QUATERN INT, V398, P175, DOI 10.1016/j.quaint.2015.11.102; GARN SM, 1966, J DENT RES, V45, P1819, DOI 10.1177/00220345660450064301; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Gomez-Robles A, 2012, EVOLUTION, V66, P1024, DOI 10.1111/j.1558-5646.2011.01508.x; Goose DH, 1963, DENT ANTHR, V125, P148; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Guatelli-Steinberg D, 2013, TEETH MORPHOGENESIS, P69; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; Harris MD, 2013, J ORTHOP RES, V31, P1620, DOI 10.1002/jor.22389; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Howells W., 1968, CRANIUM MAXILLARY DE, V2; Huang TTY, 2007, J DENT, V35, P737, DOI 10.1016/j.jdent.2007.06.001; Humphries SM, 2016, MED BIOL ENG COMPUT, V54, P899, DOI 10.1007/s11517-015-1445-x; Irish J.D., 2015, COMPANION DENT ANTHR; Johnston T, 1996, ENDOD DENT TRAUMATOL, V12, P277; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAMBE T, 1991, FORENSIC SCI INT, V50, P97, DOI 10.1016/0379-0738(91)90138-9; Kanazawa E, 2015, NEW DIRECTIONS DENT; Kato A., 2011, DENT ANTHR, V24, P1; Kenyhercz MW, 2014, AM J PHYS ANTHROPOL, V153, P269, DOI 10.1002/ajpa.22429; Kondo S, 2004, HOMO, V55, P53, DOI 10.1016/j.jchb.2003.10.001; Lamecker H, 2002, MICCAI, V2002, P421; Lasker GW, 1957, J FORENSIC SCI, V2, P401; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Liu W, 2010, SCI CHINA EARTH SCI, V53, P1141, DOI 10.1007/s11430-010-4013-0; Liu Y, 2010, ANGLE ORTHOD, V80, P160, DOI 10.2319/121608-639.1; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; MOLNAR S, 1983, AM J PHYS ANTHROPOL, V61, P51, DOI 10.1002/ajpa.1330610106; Morita W, 2016, J ANAT, V229, P343, DOI 10.1111/joa.12482; MOSHFEGHI M, 1994, IEEE T IMAGE PROCESS, V3, P128, DOI 10.1109/83.277895; Nelson SJ, 2014, WHEELERS DENT ANATOM; Nicolella DP, 2012, COMPUT METHOD BIOMEC, V15, P101, DOI 10.1080/10255842.2010.515984; Oi T, 2004, INT ENDOD J, V37, P46, DOI 10.1111/j.1365-2591.2004.00757.x; Perinetti G., 2018, S EUR J ORTHOD DENTO, V5, P3; Pilloud M.A., 2016, BIOL DISTANCE ANAL F; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Polychronis G, 2014, J ANAT, V225, P220, DOI 10.1111/joa.12202; Polychronis G, 2013, AM J PHYS ANTHROPOL, V152, P186, DOI 10.1002/ajpa.22340; Querol LB, 2006, LECT NOTES COMPUT SC, V4190, P405; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rao C, 2013, MED ENG PHYS, V35, P1450, DOI 10.1016/j.medengphy.2013.03.021; Rizk Oliver T., 2008, CAMBRIDGE STUD BIOEV, P317; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rossi M, 2004, NUCL INSTRUM METH B, V213, P747, DOI 10.1016/S0168-583X(03)01697-5; Sarkalkan N, 2014, BONE, V60, P129, DOI 10.1016/j.bone.2013.12.006; Schatz D, 2001, DENT TRAUMATOL, V17, P167, DOI 10.1034/j.1600-9657.2001.170406.x; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Scott G, 2008, TECHNIQUE APPL DENT; Scott G.R., 2013, ANTHR PERSPECTIVES T; Singleton M, 2011, ANAT REC, V294, P322, DOI 10.1002/ar.21315; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; SMITH P, 1986, AM J PHYS ANTHROPOL, V70, P339, DOI 10.1002/ajpa.1330700309; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Star H, 2011, J FORENSIC SCI, V56, pS77, DOI 10.1111/j.1556-4029.2010.01633.x; Strauss RE, 2010, MORPHOMETRICS NONMOR, P73, DOI [10.1007/978-3-540-95853-6_4, DOI 10.1007/978-3-540-95853-6_4]; Teaford M.F., 2007, DEV FUNCTION EVOLUTI; Thompson AR, 2015, AM J PHYS ANTHROPOL, V158, P341, DOI 10.1002/ajpa.22791; Townsend G, 2012, NEW APPROACHES DENT; Ungar PS, 2009, FRONT ORAL BIOL, V13, P38, DOI 10.1159/000242388; van Reenen Frans, 1982, TEETH FORM FUNCTION, P182; Vodanovic M, 2007, J ARCHAEOL SCI, V34, P905, DOI 10.1016/j.jas.2006.09.004; Vollmer J, 1999, COMPUTER GRAPHICS FO; Vos F, 2004, PATT REC 2004 ICPR 2; WALKER PL, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P169; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Weber GW, 2015, QUATERN INT, V30, pe16; WOLPOFF MH, 1971, METRIC TRENDS HOMINI; Wong FSL, 2004, ARCH ORAL BIOL, V49, P937, DOI 10.1016/j.archoralbio.2004.05.011; Yang F, 2006, FORENSIC SCI INT, V159, pS78, DOI 10.1016/j.forsciint.2006.02.031; Yong R, 2014, AUST DENT J, V59, P34, DOI 10.1111/adj.12156; Zanolli C., 2015, BRIEF COMMUNICATION; Zanolli C, 2015, AM J PHYS ANTHROPOL, V157, P666, DOI 10.1002/ajpa.22748; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	119	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186754	10.1371/journal.pone.0186754	http://dx.doi.org/10.1371/journal.pone.0186754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216199	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000417337800006
J	Alahmari, DM; Chan, KYY; Stojanovska, V; LaRosa, D; Barton, SK; Nitsos, I; Zahra, V; Barbuto, J; Farrell, M; Yamaoka, S; Pearson, JT; Polglase, GR				Alahmari, Dhafer M.; Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Farrell, Michael; Yamaoka, Shigeo; Pearson, James T.; Polglase, Graeme R.			Diffusion tensor imaging detects ventilation-induced brain injury in preterm lambs	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL ENERGY FAILURE; WHITE-MATTER INJURY; HYPOXIA-ISCHEMIA; MR SPECTROSCOPY; DYSMYELINATION; CONSEQUENCES; OUTCOMES; PALSY; BIRTH	Purpose Injurious mechanical ventilation causes white matter (WM) injury in preterm infants through inflammatory and haemodynamic pathways. The relative contribution of each of these pathways is not known. We hypothesised that in vivo magnetic resonance imaging (MRI) can detect WM brain injury resulting from mechanical ventilation 24 h after preterm delivery. Further we hypothesised that the combination of inflammatory and haemodynamic pathways, induced by umbilical cord occlusion (UCO) increases brain injury at 24 h. Methods Fetuses at 124 +/- 2 days gestation were exposed, instrumented and either ventilated for 15 min using a high tidal-volume (V-T) injurious strategy with the umbilical cord intact (INJ; inflammatory pathway only), or occluded (INJ+UCO; inflammatory and haemodynamic pathway). The ventilation groups were compared to lambs that underwent surgery but were not ventilated (Sham), and lambs that did not undergo surgery (unoperated control; Cont). Fetuses were placed back in utero after the 15 min intervention and ewes recovered. Twenty-four hours later, lambs were delivered, placed on a protective ventilation strategy, and underwent MRI of the brain using structural, diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS) techniques. Results Absolute MRS concentrations of creatine and choline were significantly decreased in INJ+UCO compared to Cont lambs (P = 0.03, P = 0.009, respectively); no significant differences were detected between the INJ or Sham groups and the Cont group. Axial diffusivities in the internal capsule and frontal WM were lower in INJ and INJ+UCO compared to Cont lambs (P = 0.05, P = 0.04, respectively). Lambs in the INJ and INJ+UCO groups had lower mean diffusivities in the frontal WM compared to Cont group (P = 0.04). DTI colour mapping revealed lower diffusivity in specific WM regions in the Sham, INJ, and INJ+UCO groups compared to the Cont group, but the differences did not reach significance. INJ+UCO lambs more likely to exhibit lower WM diffusivity than INJ lambs. Conclusions Twenty-four hours after injurious ventilation, DTI and MRS showed increased brain injury in the injuriously ventilated lambs compared to controls. DTI colour mapping threshold approach provides evidence that the haemodynamic and inflammatory pathways have additive effects on the progression of brain injury compared to the inflammatory pathway alone.	[Alahmari, Dhafer M.; Farrell, Michael] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Alahmari, Dhafer M.; Farrell, Michael] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic, Australia; [Alahmari, Dhafer M.; Farrell, Michael; Pearson, James T.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Alahmari, Dhafer M.] King Saud Med City, Dept Diagnost Imaging, Riyadh, Saudi Arabia; [Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Yamaoka, Shigeo; Polglase, Graeme R.] Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Clayton, Vic, Australia; [Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Yamaoka, Shigeo; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Pearson, James T.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Suita, Osaka, Japan	Monash University; Monash University; Monash University; King Saud Medical City; Hudson Institute of Medical Research; Monash University; Monash University; Monash University; National Cerebral & Cardiovascular Center - Japan	Polglase, GR (corresponding author), Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Clayton, Vic, Australia.; Polglase, GR (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia.	graeme.polglase@monash.edu	Farrell, Michael/H-4571-2019; Pearson, James/B-4631-2012	Farrell, Michael/0000-0003-4126-8911; Barton, Samantha/0000-0001-7601-0238; Chan, Kyra/0000-0003-1355-5470; Pearson, James/0000-0002-3318-5406; Polglase, Graeme/0000-0002-8906-614X	National Institutes of Health [R01HD072848-04]; National Heart Foundation of Australia; National Health and Medical Research Council (NH&MRC) Career Development Fellowship [1105526]; National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship [1110040]; Victorian Government's Operational Infrastructure Support Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council (NH&MRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship; Victorian Government's Operational Infrastructure Support Program	This research was supported by the National Institutes of Health (R01HD072848-04), a joint National Heart Foundation of Australia and National Health and Medical Research Council (NH&MRC) Career Development Fellowship (1105526), National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship (SKB; 1110040) and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmari DM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00070; Alahmari DM, 2017, IMAGING MED, V9, P67, DOI [10.14303/Imaging-Medicine.1000061, DOI 10.14303/IMAGING-MEDICINE.1000061]; Alkan A, 2003, MAGN RESON IMAGING, V21, P77, DOI 10.1016/S0730-725X(02)00625-2; Barton SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112402; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Brown NC, 2009, J PEDIATR-US, V155, P32, DOI 10.1016/j.jpeds.2009.01.038; Cheong JLY, 2006, AM J NEURORADIOL, V27, P1546; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Duerden EG, 2015, AM J NEURORADIOL, V36, P1565, DOI 10.3174/ajnr.A4312; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hoch SE, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3710; Huppi P KR, 1998, REGIONAL MATURATION, VI, P94; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; LETH H, 1995, ACTA PAEDIATR, V84, P495, DOI 10.1111/j.1651-2227.1995.tb13681.x; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Nitsos I, 2014, REPROD SCI, V21, P658, DOI 10.1177/1933719111399928; Penrice J, 1997, PEDIATR RES, V41, P443, DOI 10.1203/00006450-199703000-00024; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; Polglase GR, 2004, PEDIATR RES, V56, P932, DOI 10.1203/01.PDR.0000145254.66447.C0; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Roelants-Van Rijn AM, 2001, PEDIATR RES, V49, P356, DOI 10.1203/00006450-200103000-00009; ROTHMAN DL, 1991, MAGN RESON MED, V21, P302, DOI 10.1002/mrm.1910210215; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Skiold B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095804; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van der Graaf M, 2010, EUR BIOPHYS J BIOPHY, V39, P527, DOI 10.1007/s00249-009-0517-y; Volpe JJ, 1998, ARCH NEUROL-CHICAGO, V55, P297, DOI 10.1001/archneur.55.3.297; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Wise-Faberowski L, 2014, BRAIN SCI, V4, P295, DOI 10.3390/brainsci4020295; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188737	10.1371/journal.pone.0188737	http://dx.doi.org/10.1371/journal.pone.0188737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211751	gold, Green Published			2022-12-26	WOS:000417212200046
J	Kuhn, CE; Chumbley, K; Fritz, L; Johnson, D				Kuhn, Carey E.; Chumbley, Kathryn; Fritz, Lowell; Johnson, Devin			Estimating dispersal rates of Steller sea lion (Eumetopias jubatus) mother-pup pairs from a natal rookery using mark-resight data	PLOS ONE			English	Article							MATERNAL ATTENDANCE PATTERNS; MOVEMENT PATTERNS; ALASKA; ABUNDANCE; ISLAND; POPULATION; SURVIVAL; BEHAVIOR; COUNTS; FEMALE	To monitor population trends of Steller sea lions (Eumetopias jubatus) in Alaska, newborn pups are counted during aerial surveys. These surveys are scheduled to occur after the majority of pups are born, but before pups begin to spend significant time in the water. Some studies have reported dispersal of mother-pup pairs away from breeding beaches during the pupping season (July), which may influence survey results. Using a multistate mark-recapture model with state uncertainty, we estimated the amount of dispersal during the pupping season based on observations of permanently marked sea lions. Research was conducted at land-based observation sites on Marmot Island, Alaska, between 2000 and 2013. Both marked adult females with dependent pups and marked pups were observed at two rookery beaches from May to July. Cumulative dispersal rates were minimal (< 1%) prior to the planned start of the aerial survey (23 June) and increased to 11.2% by the planned survey completion date (10 July). The increased cumulative dispersal rate during the remainder of the observation period (end of July) suggests potential bias in surveys that occur beyond 10 July, however surveys past this date are rare (< 10% between 1973 and 2016). As a result, movements of mother-pup pairs during the pupping season are not likely to influence aerial survey estimates.	[Kuhn, Carey E.; Chumbley, Kathryn; Fritz, Lowell; Johnson, Devin] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kuhn, CE (corresponding author), NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Carey.Kuhn@noaa.gov						BERKSON JM, 1985, CAN J FISH AQUAT SCI, V42, P873, DOI 10.1139/f85-111; Burkanov V, 2011, J MAMMAL, V92, P352, DOI 10.1644/10-MAMM-A-194.1; Calkins DG, 1982, POPULATION ASSESSMEN; CHUMBLEY K, 1997, NMFSAFSC77 NOAA US D; Davis RW, 2006, LOW WAKE FI, P13; Fritz L., 2016, NMFSAFSC321 NOAA US; Fritz L, 2017, COUNTS ALASKA STELLE; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; GALES NJ, 1992, WILDLIFE RES, V19, P405, DOI 10.1071/WR9920405; Gales NJ, 1999, WILDLIFE RES, V26, P35, DOI 10.1071/WR98022; Gentry RL, 1970, THESIS; Harris J. D., 2016, THESIS; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hastings KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176840; Hastings KK, 2016, MAR MAMMAL SCI, V32, P777, DOI 10.1111/mms.12288; Hastings KK, 2009, J WILDLIFE MANAGE, V73, P1040, DOI 10.2193/2007-208; HIGGINS LV, 1988, MAR MAMMAL SCI, V4, P44, DOI 10.1111/j.1748-7692.1988.tb00181.x; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; Hood WR, 1997, CAN J ZOOL, V75, P1241, DOI 10.1139/z97-146; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Johanos TC, 2014, MAR MAMMAL SCI, V30, P1165, DOI 10.1111/mms.12084; Johnson DS, 2014, METHODS ECOL EVOL, V5, P1110, DOI 10.1111/2041-210X.12231; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; Kenyon K. W., 1961, Journal of Mammalogy, V43, P223; Kuhn CE, 2017, ENDANGER SPECIES RES, V32, P213, DOI 10.3354/esr00796; Laake J.L., 2013, 201304 AFSC NOAA, P34; Laake JL, 2013, METHODS ECOL EVOL, V4, P885, DOI 10.1111/2041-210X.12065; LING JK, 1969, PAC SCI, V23, P399; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Lowry MS, 1999, MAR MAMMAL SCI, V15, P143, DOI 10.1111/j.1748-7692.1999.tb00786.x; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Merrick R, 1988, NMFSFNWC143 NOAA US; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Merrick RL, 1996, NMFSAFSC68 NOAA, P21; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; National Marine Fisheries Service, 1997, FED REGISTER, V62, P24345; NMFS (National Marine Fisheries Service), 2013, STAT REV E DIST POP; NMFS (National Marine Fisheries Service), 2008, REC PLAN STELL SEA L; Pitcher KW, 2005, CAN J ZOOL, V83, P1214, DOI 10.1139/Z05-098; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Sandegren FE, 1970, THESIS; Snyder GM, 2001, MAR MAMMAL SCI, V17, P136, DOI 10.1111/j.1748-7692.2001.tb00984.x; Stirling I., 1983, Special Publication American Society of Mammalogists, P489; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Westlake RL, 1997, MAR MAMMAL SCI, V13, P207, DOI 10.1111/j.1748-7692.1997.tb00628.x; Wilson K, 2012, MAR MAMMAL SCI, V28, pE58, DOI 10.1111/j.1748-7692.2011.00485.x; Young JK, 2007, MAR MAMMAL SCI, V23, P926, DOI 10.1111/j.1748-7692.2007.00138.x	50	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189061	10.1371/journal.pone.0189061	http://dx.doi.org/10.1371/journal.pone.0189061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211808	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200062
J	Lu, TM; Lee, TS; Lin, SJ; Chan, WL; Hsu, CP				Lu, Tse-Min; Lee, Tzong-Shyuan; Lin, Shing-Jong; Chan, Wan-Leong; Hsu, Chiao-Po			The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X	PLOS ONE			English	Article							ADVERSE CARDIOVASCULAR EVENTS; NORMAL CORONARY ANGIOGRAMS; OXIDE SYNTHASE INHIBITOR; ENDOTHELIAL DYSFUNCTION; L-ARGININE; ANGINA-PECTORIS; ARTERY-DISEASE; RISK; PLASMA	Background The pathophysiology of cardiac syndrome X is multifactorial and endothelial dysfunction has been implicated as important contributing factor. Asymmetric dimethylarginine (ADMA), characterized as a circulating endogenous inhibitor of nitric oxide synthase, may have been implicated as an important contributing factor for the development of endothelial dysfunction. In this study, we aim to assess the predictive power of ADMA for long-term prognosis in patients with cardiac syndrome X. Methods and results We enrolled 239 consecutive patients with cardiac syndrome X diagnosed by coronary angiography. The mean age was 58.7 +/- 10.1 years. The patients were grouped into tertiles according to the plasma ADMA levels: <0.38 mu mol/l (tertile I), 0.38-0.44 mu mol/l (tertile II), and >0.44 mu mol/l (tertile III). All patients were followed up for a mean period of 6.5 +/- 1.5 years (median: 6.3 years, inter-quartile range: 5.7-8.0 years). During the follow-up period, major adverse events (MAE) were observed in 15 patients (6.3%), including 13 deaths. The plasma ADMA levels in patients who developed MAE were significantly higher than those who did not (0.48 +/- 0.06 mu mol/l vs. 0.42 +/- 0.08 mu mol/l, p = 0.005). In multivariate Cox regression analysis adjusted for age, eGFR and LVEF, ADMA tertile I and II were identify to be associated with a significantly lower risk of MAE compared to ADMA tertile III (p = 0.017). By considering the plasma ADMA level as a continuous variable, the plasma ADMA level remained a significant independent predictor for outcomes of MAE, and the relative risk of MACE increased by 50% when plasma ADMA level increased by 1 SD of value (p = 0.018). Conclusions In patients with cardiac syndrome X, elevated plasma ADMA levels appeared to be an independent predictor of long-term adverse clinical outcomes.	[Lu, Tse-Min; Lin, Shing-Jong; Chan, Wan-Leong] Taipei Vet Gen Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lu, Tse-Min; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Hlth Care Ctr, Taipei, Taiwan; [Lu, Tse-Min; Hsu, Chiao-Po] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Tzong-Shyuan] Natl Yang Ming Univ, Dept Physiol, Taipei, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Hsu, Chiao-Po] Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hsu, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hsu, CP (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.	hsucp@vghtpe.gov.tw	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062				Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Cannon RO, 2009, J AM COLL CARDIOL, V54, P877, DOI 10.1016/j.jacc.2009.03.080; Chen C, 2017, CIRC J, V81, P3, DOI 10.1253/circj.CJ-16-1002; Crea F, 2014, EUR HEART J, V35, P1101, DOI 10.1093/eurheartj/eht513; EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hsu CP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0156-1; Hurst T, 2006, AM J MED, V119, P560, DOI 10.1016/j.amjmed.2005.07.009; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; Lamendola P, 2010, INT J CARDIOL, V140, P197, DOI 10.1016/j.ijcard.2008.11.026; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Okyay K, 2007, CORONARY ARTERY DIS, V18, P539, DOI 10.1097/MCA.0b013e3282f08ece; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Piatti PM, 2003, CIRCULATION, V107, P429, DOI 10.1161/01.CIR.0000046489.24563.79; Schnabel Renate, 2005, Circ Res, V97, pe53, DOI 10.1161/01.RES.0000181286.44222.61; Sen Nihat, 2009, Atherosclerosis, V204, pe82, DOI 10.1016/j.atherosclerosis.2008.09.029; Singh M, 2010, INT J CARDIOL, V142, P113, DOI 10.1016/j.ijcard.2009.11.021; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Vermeltfoort IAC, 2010, CLIN RES CARDIOL, V99, P475, DOI 10.1007/s00392-010-0159-1	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188995	10.1371/journal.pone.0188995	http://dx.doi.org/10.1371/journal.pone.0188995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206850	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700037
J	Broquetas, T; Garcia-Retortillo, M; Hernandez, JJ; Puigvehi, M; Canete, N; Coll, S; Cabrero, B; Gimenez, MD; Solaa, R; Carrioon, JA				Broquetas, Teresa; Garcia-Retortillo, Montserrat; Jose Hernandez, Juan; Puigvehi, Marc; Canete, Nuria; Coll, Susana; Cabrero, Beatriz; Dolors Gimenez, Maria; Sola, Ricard; Carrion, Jose A.			Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SURFACE-ANTIGEN LEVELS; NATURAL-HISTORY; PEGINTERFERON ALPHA-2A; SUSTAINED RESPONSE; VIRUS; TENOFOVIR; THERAPY; ANTIVIRALS; REDUCTION	Background HBeAg-negative chronic hepatitis B patients require long-term nucleos(t) ide analogues (NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with higher probability of seroclearance. The aim of our study was to evaluate qHBsAg in HBeAg-negative patients receiving NAs to predict a reduction of HBsAg levels and seroclearance. Methods Retrospective analysis of qHBsAg in HBeAg-negative patients before and at years 1, 3, 5, 8 and over of NAs treatment. Results From 1999 to 2015, HBsAg was quantified in 358 serum samples from 95 HBeAg-negative patients. Low qHBsAg (< 120 IU/mL) was identified at baseline or during follow-up in 14% of patients and HBsAg loss in 4%. No baseline variables predicted seroclearance and only treatment duration predicted low qHBsAg. The annual decline of qHBsAg was -0.102 log IU/mL and the median time to HBsAg loss was 6.04 years. The decline was greater in patients achieving low HBsAg levels (-0.257) than in those who did not (-0.057)(p<0.001). The diagnostic accuracy (ROC curve, 95% CI) of qHBsAg delta at year 3 was 0.89 (0.81 +/- 0.97), with cut-off >0.3 log IU/mL showing a positive and negative predictive value of 42% and 100% to identify patients achieving low levels of HBsAg. Conclusions Reduction of qHBsAg is slow in HBeAg-negative patients receiving NAs, although low levels or faster qHBsAg decline may occur in 14%. A qHBsAg reduction >0.3 log IU/mL at year 3 can identify patients with a higher probability of achieving low levels and HBsAg seroclearance.	[Broquetas, Teresa; Garcia-Retortillo, Montserrat; Puigvehi, Marc; Canete, Nuria; Coll, Susana; Cabrero, Beatriz; Dolors Gimenez, Maria; Sola, Ricard; Carrion, Jose A.] Univ Autonoma Barcelona, Hosp del Mar, Dept Med, Liver Sect,Gastroenterol Dept, Barcelona, Spain; [Broquetas, Teresa; Garcia-Retortillo, Montserrat; Puigvehi, Marc; Canete, Nuria; Coll, Susana; Cabrero, Beatriz; Dolors Gimenez, Maria; Sola, Ricard; Carrion, Jose A.] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Jose Hernandez, Juan] LRC, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Carrioon, JA (corresponding author), Univ Autonoma Barcelona, Hosp del Mar, Dept Med, Liver Sect,Gastroenterol Dept, Barcelona, Spain.; Carrioon, JA (corresponding author), Hosp del Mar Med Res Inst IMIM, Barcelona, Spain.	95565@parcdesalutmar.cat	Carrión, Jose A. A/GPW-5566-2022; Carrion, Jose A/M-2086-2017	Carrión, Jose A. A/0000-0001-7191-6081; Carrion, Jose A/0000-0001-7191-6081; Coll, Susanna/0000-0002-0395-9685; GARCIA-RETORTILLO, MONTSERRAT/0000-0001-6783-7604; Nuria, Canete Hidalgo/0000-0001-9501-7590; BROQUETAS, TERESA/0000-0002-5935-3076; Puigvehi, Marc/0000-0002-3694-3241	Institut de Salud Carlos III, Ministerio de Economia y Competitividad [PI14/00540]; Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa	Institut de Salud Carlos III, Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa	JAC has received a grant from Institut de Salud Carlos III, Ministerio de Economia y Competitividad (PI14/00540), co-funded by Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2003, J HEPATOL; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Boglione L, 2013, LIVER INT, V33, P580, DOI 10.1111/liv.12091; Boucle S, 2016, CLIN LIVER DIS, V20, P737, DOI 10.1016/j.cld.2016.07.001; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chen CH, 2014, J HEPATOL; Chen CH, 2014, WORLD J GASTROENTERO, V20, P7686, DOI 10.3748/wjg.v20.i24.7686; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Jang JW, 2011, ALIMENT PHARM THER, V34, P1337, DOI 10.1111/j.1365-2036.2011.04888.x; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Manesis EK, 2011, J HEPATOL, V55, P61, DOI 10.1016/j.jhep.2010.10.027; Marcellin P, 2016, ALIMENT PHARM THER, V44, P957, DOI 10.1111/apt.13779; Marcellin P, 2014, J HEPATOL, V61, P1228, DOI 10.1016/j.jhep.2014.07.019; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Papatheodoridis G, 2016, HEPATOLOGY, V63, P1481, DOI 10.1002/hep.28438; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Riveiro-Barciela M, 2017, DIGEST DIS SCI, V62, P784, DOI 10.1007/s10620-017-4448-7; Seto WK, 2013, HEPATOLOGY, V58, P923, DOI 10.1002/hep.26376; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; Soriano V, 2017, EXPERT OPIN INV DRUG, V26, P843, DOI 10.1080/13543784.2017.1333105; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Zoulim F, 2015, J HEPATOL, V62, P56, DOI 10.1016/j.jhep.2014.08.031; Zoutendijk R, 2011, J INFECT DIS, V204, P415, DOI 10.1093/infdis/jir282	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188303	10.1371/journal.pone.0188303	http://dx.doi.org/10.1371/journal.pone.0188303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190670	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900046
J	Kasai, T; Tatebe, H; Kondo, M; Ishii, R; Ohmichi, T; Yeung, WTE; Morimoto, M; Chiyonobu, T; Terada, N; Allsop, D; Nakagawa, M; Mizuno, T; Tokuda, T				Kasai, Takashi; Tatebe, Harutsugu; Kondo, Masaki; Ishii, Ryotaro; Ohmichi, Takuma; Yeung, Wing Tung Esther; Morimoto, Masafumi; Chiyonobu, Tomohiro; Terada, Naoto; Allsop, David; Nakagawa, Masanori; Mizuno, Toshiki; Tokuda, Takahiko			Increased levels of plasma total tau in adult Down syndrome	PLOS ONE			English	Article							REGULATED KINASE 1A; ALZHEIMERS-DISEASE; DEMENTIA; BIOMARKERS; MORTALITY; PATHOLOGY; PROTEINS	Down syndrome (DS) is the most prevalent chromosomal abnormality. Early-onset dementia with the pathology of Alzheimer's disease (AD) frequently develops in DS. Reliable blood biomarkers are needed to support the diagnosis for dementia in DS, since positron emission tomography or cerebrospinal fluid sampling is burdensome, particularly for patients with DS. Plasma t-tau is one of the established biomarkers for the diagnosis of AD, suggesting the potential value of t-tau as a biomarker for dementia in DS. The aim of this study was to assess and compare plasma levels of t-tau in adults with DS and in an age-matched control population. In this study, plasma levels of t-tau in 21 patients with DS and 22 control participants were measured by an ultrasensitive immunoassay technology, the single-molecule immunoarray (Simoa) method. We observed significantly increased plasma t-tau levels in the DS group (mean +/- standard deviation (SD) = 0.643 +/- 0.493) compared to those in the control group (mean +/- SD = 0.470 +/- 0.232): P = 0.0050. Moreover, age dependent correlation of plasma t-tau was only found in the DS group, and not in the control group. These findings suggest that elevated plasma t-tau levels reflect AD pathology and therefore have potential as an objective biomarker to detect dementia in adult DS.	[Kasai, Takashi; Tatebe, Harutsugu; Kondo, Masaki; Ishii, Ryotaro; Ohmichi, Takuma; Yeung, Wing Tung Esther; Nakagawa, Masanori; Mizuno, Toshiki; Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare, Kyoto, Japan; [Yeung, Wing Tung Esther] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Morimoto, Masafumi; Chiyonobu, Tomohiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Chiyonobu, Tomohiro; Nakagawa, Masanori] Kyoto Prefectural Univ Med, North Med Ctr, Kyoto, Japan; [Terada, Naoto] Hananoki Med Welf Ctr, Kyoto, Japan; [Allsop, David] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Maastricht University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Lancaster University; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020; Ishii, Ryotaro/K-4595-2019; Allsop, David/B-9725-2008	Allsop, David/0000-0002-0513-5575; Chiyonobu, Tomohiro/0000-0001-6678-060X	Japan Agency for Medical Research and Development (AMED)	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by a grant from Japan Agency for Medical Research and Development (AMED) to Takahiko Tokuda.	Annus T, 2016, ALZHEIMERS DEMENT, V12, P538, DOI 10.1016/j.jalz.2015.07.490; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V54, P1301; Chiu MJ, 2013, ACS CHEM NEUROSCI, V4, P1530, DOI 10.1021/cn400129p; Coppus A, 2006, J INTELL DISABIL RES, V50, P768, DOI 10.1111/j.1365-2788.2006.00842.x; Coppus AMW, 2012, NEUROBIOL AGING, V33, P1988, DOI 10.1016/j.neurobiolaging.2011.08.007; Coppus AMW, 2008, J AM GERIATR SOC, V56, P2311, DOI 10.1111/j.1532-5415.2008.01999.x; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319; Deb S, 2007, BRIT J PSYCHIAT, V190, P440, DOI 10.1192/bjp.bp.106.024984; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Esbensen AJ, 2010, INT REV RES MENT RET, V39, P107, DOI 10.1016/S0074-7750(10)39004-5; Hamlett ED, 2017, ALZHEIMERS DEMENT, V13, P541, DOI 10.1016/j.jalz.2016.08.012; Holland AJ, 1998, BRIT J PSYCHIAT, V172, P493, DOI 10.1192/bjp.172.6.493; Holland AJ, 2000, J INTELL DISABIL RES, V44, P138, DOI 10.1046/j.1365-2788.2000.00263.x; Jin NN, 2015, J BIOL CHEM, V290, P15219, DOI 10.1074/jbc.M115.645507; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kazemi M, 2016, INT J MOL CELL MED, V5, P125; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Lee NC, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00316; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Portelius E, 2014, NEURODEGENER DIS, V14, P98, DOI 10.1159/000358800; Rafii Michael S, 2015, Front Behav Neurosci, V9, P239, DOI 10.3389/fnbeh.2015.00239; Rafii MS, 2016, JORNAL PREVENTION AL, V4, P290; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Sparks D Larry, 2012, Am J Neurodegener Dis, V1, P99; Suzuki H, 1997, B SPEC ED, V21, P139; Tokuda T, 1997, ANN NEUROL, V41, P271, DOI 10.1002/ana.410410220; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Xu JC, 2013, EMBO J, V32, P2788, DOI 10.1038/emboj.2013.220; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128	35	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188802	10.1371/journal.pone.0188802	http://dx.doi.org/10.1371/journal.pone.0188802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190730	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900128
J	Pinsky, M; Rauch, M; Abbas, A; Sharabi-Nov, A; Tamir, S; Gutman, R				Pinsky, Mariel; Rauch, Maayan; Abbas, Atallah; Sharabi-Nov, Adi; Tamir, Snait; Gutman, Roee			Long-lived weight-reduced alpha MUPA mice show higher and longer maternal-dependent postnatal leptin surge	PLOS ONE			English	Article							HIGH-FAT DIET; BODY-WEIGHT; PLASMINOGEN-ACTIVATOR; HYPOTHALAMIC NEURONS; PREVENTS OBESITY; TRANSGENIC MICE; ENERGY-BALANCE; BREAST-MILK; RATS; EXPRESSION	We investigated whether long-lived weight-reduced alpha MUPA mice differ from their wild types in postnatal body composition and leptin level, and whether these differences are affected by maternal-borne factors. Newborn alpha MUPA and wild type mice had similar body weight and composition up to the third postnatal week, after which alpha MUPA mice maintained lower body weight due to lower fat-free mass. Both strains showed a surge in leptin levels at the second postnatal week, initiating earlier in alpha MUPA mice, rising higher and lasting longer than in the wild types, mainly in females. Leptin level in dams' serum and breast milk, and in their pup's stomach content were also higher in alpha MUPA than in the WT during the surge peak. Leptin surge preceded the strain divergence in body weight, and was associated with an age-dependent decrease in the leptin: fat mass ratio-suggesting that postnatal sex and strain differences in leptin ontogeny are strongly influenced by processes independent of fat mass, such as production and secretion, and possibly outside fat tissues. Dam removal elevated corticosterone level in female pups from both strains similarly, yet mitigated the leptin surge only in alpha MUPA-eliminating the strain differences in leptin levels. Overall, our results indicate that alpha MUPA's postnatal leptin surge is more pronounced than in the wild type, more sensitive to maternal deprivation, less related to pup's total adiposity, and is associated with a lower post-weaning fat-free mass. These strain-related postnatal differences may be related to alpha MUPA's higher milk-borne leptin levels. Thus, our results support the use of alpha MUPA mice in future studies aimed to explore the relationship between maternal (i.e. milk-borne) factors, postnatal leptin levels, and post-weaning body composition and energy homeostasis.	[Pinsky, Mariel; Rauch, Maayan; Abbas, Atallah; Gutman, Roee] MIGAL Galilee Res Inst, Unit Integrat Physiol LIP, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel; [Pinsky, Mariel; Tamir, Snait; Gutman, Roee] MIGAL Galilee Res Inst, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel; [Sharabi-Nov, Adi; Tamir, Snait] Tel Hai Coll, Fac Sci & Technol, Dept Nutr Sci, Upper Galilee, Israel; [Sharabi-Nov, Adi; Gutman, Roee] Ziv Med Ctr, Res Wing, Safed, Israel; [Gutman, Roee] Tel Hai Coll, Fac Sci & Technol, Dept Anim Sci, Upper Galilee, Israel	Tel Hai Academy College; Ziv Medical Center; Tel Hai Academy College	Gutman, R (corresponding author), MIGAL Galilee Res Inst, Unit Integrat Physiol LIP, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel.; Gutman, R (corresponding author), MIGAL Galilee Res Inst, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel.; Gutman, R (corresponding author), Ziv Med Ctr, Res Wing, Safed, Israel.; Gutman, R (corresponding author), Tel Hai Coll, Fac Sci & Technol, Dept Anim Sci, Upper Galilee, Israel.	roeeg@migal.org.il		Gutman, Roee/0000-0002-3282-6558	European Unions Seventh Framework Programme FP7-REGPOT-1 [316157]	European Unions Seventh Framework Programme FP7-REGPOT-1	The research leading to these results has received funding from the European Unions Seventh Framework Programme FP7-REGPOT-2012-2013-1, Agreement no. 316157. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Beierle EA, 2004, PEDIATR RES, V56, P250, DOI 10.1203/01.PDR.0000132753.81333.39; Beltrand J, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/296935; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Bikle DD, 2015, BONE, V80, P79, DOI 10.1016/j.bone.2015.04.036; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouyer K, 2013, J NEUROSCI, V33, P840, DOI 10.1523/JNEUROSCI.3215-12.2013; Briffa JF, 2015, AM J PHYSIOL-ENDOC M, V308, pE335, DOI 10.1152/ajpendo.00312.2014; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Cottrell EC, 2011, ENDOCRINOLOGY, V152, P476, DOI 10.1210/en.2010-0911; Cottrell EC, 2010, VITAM HORM, V82, P201, DOI 10.1016/S0083-6729(10)82011-4; Cravo CD, 2002, HORM METAB RES, V34, P400, DOI 10.1055/s-2002-33473; Del Bigio MR, 1999, INT J DEV NEUROSCI, V17, P387, DOI 10.1016/S0736-5748(99)00031-3; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Devaskar SU, 1997, BIOCHEM BIOPH RES CO, V238, P44, DOI 10.1006/bbrc.1997.7237; Ellis PJI, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-49; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Froy O, 2011, INT J OBESITY, V35, P226, DOI 10.1038/ijo.2010.125; Froy O, 2008, REJUV RES, V11, P467, DOI 10.1089/rej.2008.0669; Froy O, 2009, MECH AGEING DEV, V130, P154, DOI 10.1016/j.mad.2008.10.006; Granado M, 2011, ENDOCRINOLOGY, V152, P4116, DOI 10.1210/en.2011-1233; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Kim DH, 2013, INT J OBESITY, V37, P853, DOI 10.1038/ijo.2012.141; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Knight BS, 2007, J PHYSIOL-LONDON, V581, P873, DOI 10.1113/jphysiol.2006.126573; Konieczna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081906; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Lasar D, 2013, BBA-MOL CELL BIOL L, V1831, P960, DOI 10.1016/j.bbalip.2013.01.016; Lorenzini A, 2014, J GERONTOL A-BIOL, V69, P410, DOI 10.1093/gerona/glt108; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Miskin R, 2006, TRANSGENIC RES, V15, P241, DOI 10.1007/s11248-006-0006-3; Miskin R, 2005, MECH AGEING DEV, V126, P255, DOI 10.1016/j.mad.2004.08.018; Miskin R, 1997, J GERONTOL A-BIOL, V52, pB118, DOI 10.1093/gerona/52A.2.B118; MISKIN R, 1990, EUR J BIOCHEM, V190, P31, DOI 10.1111/j.1432-1033.1990.tb15541.x; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Muranishi Y, 2016, BIOTECHNIQUES, V60, P47, DOI 10.2144/000114373; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Nozhenko Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145376; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Palou A, 2009, ADV EXP MED BIOL, V646, P95, DOI 10.1007/978-1-4020-9173-5_10; Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005; Pico C, 2007, GENES NUTR, V2, P139, DOI 10.1007/s12263-007-0038-1; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Pico C, 2011, AM J CLIN NUTR, V94, p1830S, DOI 10.3945/ajcn.110.000752; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Rayner DV, 1997, AM J PHYSIOL-REG I, V273, pR446, DOI 10.1152/ajpregu.1997.273.1.R446; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Salzmann C, 2004, ENDOCRINOLOGY, V145, P1810, DOI 10.1210/en.2003-1514; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schroeder M, 2009, AM J PHYSIOL-REG I, V296, pR224, DOI 10.1152/ajpregu.90697.2008; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Steckler R, 2015, J GERONTOLOGY A; Sun B, 2014, ENDOCRINOLOGY, V155, P3421, DOI 10.1210/en.2014-1051; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Tirosh O, 2003, EXP GERONTOL, V38, P955, DOI 10.1016/S0531-5565(03)00151-7; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Vickers MH, 2012, BEST PRACT RES CL EN, V26, P677, DOI 10.1016/j.beem.2012.03.005; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Viveros MP, 2010, HORM BEHAV, V57, P405, DOI 10.1016/j.yhbeh.2010.01.009; Willingham K, 2014, JOVE-J VIS EXP, DOI 10.3791/51007; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zeltser LM, 2015, FRONT NEUROENDOCRIN, V39, P17, DOI 10.1016/j.yfrne.2015.07.002; Zhang Y, 2005, CURR TOP DEV BIOL, V66, P161, DOI 10.1016/S0070-2153(05)66005-X; Zhang YY, 2001, PHYSIOL GENOMICS, V4, P189, DOI 10.1152/physiolgenomics.2001.4.3.189	76	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188658	10.1371/journal.pone.0188658	http://dx.doi.org/10.1371/journal.pone.0188658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190757	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900094
J	Bao, WQ; Wuyun, TN; Li, TZ; Liu, HM; Jiang, ZM; Zhu, XC; Du, HY; Bai, YE				Bao, Wenquan; Wuyun, Tana; Li, Tiezhu; Liu, Huimin; Jiang, Zhongmao; Zhu, Xuchun; Du, Hongyan; Bai, Yu-e			Genetic diversity and population structure of Prunus mira (Koehne) from the Tibet plateau in China and recommended conservation strategies	PLOS ONE			English	Article							PERSICA L. BATSCH; MICROSATELLITE MARKERS; HABITAT FRAGMENTATION; RAPD MARKERS; ISSR MARKERS; SSR MARKERS; PEACH; INDIVIDUALS; ALTITUDES; SOFTWARE	Prunus mira Koehne, an important economic fruit crop with high breeding and medicinal values, and an ancestral species of many cultivated peach species, has recently been declared an endangered species. However, basic information about genetic diversity, population structure, and morphological variation is still limited for this species. In this study, we sampled 420 P. mira individuals from 21 wild populations in the Tibet plateau to conduct a comprehensive analysis of genetic and morphological characteristics. The results of molecular analyses based on simple sequence repeat (SSR) markers indicated moderate genetic diversity and inbreeding (A = 3.8, Ae = 2.5, He = 0.52, Ho = 0.44, l = 0.95, F-ls = 0.17) within P. mira populations. STRUCTURE, GENELAND, and phylogenetic analyses assigned the 21 populations to three genetic clusters that were moderately correlated with geographic altitudes, and this may have resulted from significantly different climatic and environmental factors at different altitudinal ranges. Significant isolation-by-distance was detected across the entire distribution of P. mira populations, but geographic altitude might have more significant effects on genetic structure than geographic distance in partial small-scale areas. Furthermore, clear genetic structure, high genetic differentiation, and restricted gene flow were detected between pairwise populations from different geographic groups, indicating that geographic barriers and genetic drift have significant effects on P. mira populations. Analyses of molecular variance based on the SSR markers indicated high variation (83.7% and 81.7%), whereas morphological analyses revealed low variation (1.30%-36.17%) within the populations. Large and heavy fruits were better adapted than light fruits and nutlets to poor climate and environmental conditions at high altitudes. Based on the results of molecular and morphological analyses, we classified the area into three conservation units and proposed several conservation strategies for wild P. mira populations in the Tibet plateau.	[Bao, Wenquan; Wuyun, Tana; Li, Tiezhu; Liu, Huimin; Jiang, Zhongmao; Zhu, Xuchun; Du, Hongyan] Chinese Acad Forestry, Nontimber Forest Res & Dev Ctr, Zhengzhou, Henan, Peoples R China; [Bao, Wenquan; Bai, Yu-e] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Peoples R China	Chinese Academy of Forestry; Paulownia R&D Center of State Administration of Forestry & Grassland, CAF; Inner Mongolia Agricultural University	Wuyun, TN (corresponding author), Chinese Acad Forestry, Nontimber Forest Res & Dev Ctr, Zhengzhou, Henan, Peoples R China.	tanatanan@163.com		Wuyun, Tana/0000-0003-1227-0158	National Science and Technology Pillar Program [2013BAD14B02]	National Science and Technology Pillar Program	This research was supported by the National Science and Technology Pillar Program during the 12th Five-year Plan Period (2013BAD14B02) to Tana Wuyun.	Abebe TD, 2010, HEREDITAS, V147, P154, DOI 10.1111/j.1601-5223.2010.02173.x; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Allendorf FW., 2009, CONSERV GENET; Bemmels JB, 2016, MOL ECOL, V25, P4889, DOI 10.1111/mec.13804; Berlin S, 2014, TREE GENET GENOMES, V10, P1595, DOI 10.1007/s11295-014-0782-5; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Cantini C, 2001, J AM SOC HORTIC SCI, V126, P205, DOI 10.21273/JASHS.126.2.205; Cao LJ, 2016, DIVERS DISTRIB, V22, P1276, DOI 10.1111/ddi.12486; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; Dettori MT, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1098-0; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Dong GZ, 1991, Q BY PRODUCT SPEC CH, V3, P44; Doyle J. J., 1987, PHYTOCHEM B, P11; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang JP, 2008, CHINA FOR SCI TECHNL, V22, P53; Ge Li-Wen, 2013, Ying Yong Sheng Tai Xue Bao, V24, P319; Gillies ACM, 1999, HEREDITY, V83, P722, DOI 10.1038/sj.hdy.6886260; Guan FC, 2014, HORTSCIENCE, V49, P1017, DOI 10.21273/HORTSCI.49.8.1017; Guo GuoNan, 2006, Journal of Fruit Science, V23, P664; Guo JY, 2002, RAPD ANAL GERMPLASM, P1; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HAMRICK JL, 1990, ISOZYMES PLANT BIOL, P87; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jia J, 2016, PLANT MOL BIOL REP, V34, P327, DOI 10.1007/s11105-015-0924-4; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Leimu R, 2010, ANN NY ACAD SCI, V1195, P84, DOI 10.1111/j.1749-6632.2010.05450.x; Li TF, 2014, PLANT SYST EVOL, V300, P475, DOI 10.1007/s00606-013-0896-5; Liu L., 2013, J ANHUI AGR SCI, V41, P13740; [卢杰 Lu Jie], 2013, [自然资源学报, Journal of Natural Resources], V28, P1977; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Mbora DNM, 2010, CONSERV GENET, V11, P1725, DOI 10.1007/s10592-010-0065-0; Mourad M, 2010, TREE GENET GENOMES, V6, P689, DOI DOI 10.1007/s11295-010-0284-z; NEI M, 1978, GENETICS, V89, P583; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng M, 2015, BIOCHEM SYST ECOL, V62, P98, DOI 10.1016/j.bse.2015.06.026; Pinheiro LR, 2012, PLANT SYST EVOL, V298, P1815, DOI 10.1007/s00606-012-0682-9; Pluess AR, 2005, OECOLOGIA, V144, P55, DOI 10.1007/s00442-005-0047-y; Raggi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124709; Ramakrishnan M, 2016, GENET RESOUR CROP EV, V63, P361, DOI 10.1007/s10722-015-0255-1; Rohlf F.J., 1994, EXETER SOFTWARE SETA; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sosinski B, 2000, THEOR APPL GENET, V101, P421, DOI 10.1007/s001220051499; Tahan O, 2009, BIOCHEM SYST ECOL, V37, P146, DOI 10.1016/j.bse.2009.02.006; Testolin R, 2000, GENOME, V43, P512, DOI 10.1139/gen-43-3-512; Tian Y, 2015, BIOTECHNOL BIOTEC EQ, V29, P1053, DOI 10.1080/13102818.2015.1064780; Wang Y, 2002, GENOME, V45, P319, DOI 10.1139/G01-153; Wang Z, 2014, CLIN INTERV AGING, V9, P1, DOI [10.2147/CIA.S41356, 10.1186/1556-276X-9-643]; Xie H, 2006, THEOR APPL GENET, V112, P366, DOI 10.1007/s00122-005-0138-5; Xing C, 2015, PLANT SYST EVOL, V301, P1055, DOI 10.1007/s00606-014-1136-3; Yamamoto T, 2002, MOL ECOL NOTES, V2, P298, DOI 10.1046/j.1471-8286.2002.00242.x; Yeh FC, 1995, J HERED, V86, P454, DOI 10.1093/oxfordjournals.jhered.a111620; Yu E DJ, 1979, TAXONOMY FRUIT TREES; Zeng X., 2016, ANHUI AGR SCI B, V22, P12	63	11	12	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188685	10.1371/journal.pone.0188685	http://dx.doi.org/10.1371/journal.pone.0188685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186199	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900052
J	Marin-Garcia, I; Chavez-Burbano, P; Guerra, V; Rabadan, J; Perez-Jimenez, R				Marin-Garcia, Ignacio; Chavez-Burbano, Patricia; Guerra, Victor; Rabadan, Jose; Perez-Jimenez, Rafael			Considerations on Visible Light Communication security by applying the Risk Matrix methodology for risk assessment	PLOS ONE			English	Article							TECHNOLOGY; ISSUES; MODELS; VLC	Visible Light Communications (VLC) is a cutting edge technology for data communication that is being considered to be implemented in a wide range of applications such as Inter vehicle communication or Local Area Network (LAN) communication. As a novel technology, some aspects of the implementation of VLC have not been deeply considered or tested. Among these aspects, security and its implementation may become an obstacle for VLCs broad usage. In this article, we have used the well-known Risk Matrix methodology to determine the relative risk that several common attacks have in a VLC network. Four examples: a War Driving, a Queensland alike Denial of Service, a Preshared Key Cracking, and an Evil Twin attack, illustrate the utilization of the methodology over a VLC implementation. The used attacks also covered the different areas delimited by the attack taxonomy used in this work. By defining and determining which attacks present a greater risk, the results of this work provide a lead into which areas should be invested to increase the safety of VLC networks.	[Marin-Garcia, Ignacio; Chavez-Burbano, Patricia] Escuela Super Politecn Litoral ESPOL, Fac Ingn Elect & Comp, Telemat Engn Dept, Guayaquil, Ecuador; [Guerra, Victor; Rabadan, Jose; Perez-Jimenez, Rafael] Univ Las Palmas Gran Canaria, Inst Desarrollo Tecnol & Innovac Comunicac IDeTIC, Las Palmas Gran Canaria, Las Palmas, Spain; [Marin-Garcia, Ignacio; Chavez-Burbano, Patricia] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Las Palmas, Spain	Escuela Superior Politecnica del Litoral; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Marin-Garcia, I (corresponding author), Escuela Super Politecn Litoral ESPOL, Fac Ingn Elect & Comp, Telemat Engn Dept, Guayaquil, Ecuador.; Marin-Garcia, I (corresponding author), Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Las Palmas, Spain.	imaringa@espol.edu.ec	Guerra, Victor/L-3133-2017; Marin-Garcia, Ignacio/N-8995-2019; Chavez-Burbano, Patricia/AAH-1406-2020; PEREZ-JIMENEZ, RAFAEL/AAA-8455-2021; Borges, Jose A Rabadan/M-5992-2014; Chavez-Burbano, Patricia X/G-7310-2017	Guerra, Victor/0000-0002-6264-7577; Marin-Garcia, Ignacio/0000-0002-8743-8528; Chavez-Burbano, Patricia/0000-0001-5169-9833; PEREZ-JIMENEZ, RAFAEL/0000-0002-8849-592X; Borges, Jose A Rabadan/0000-0002-9994-4495; Chavez-Burbano, Patricia X/0000-0001-5169-9833				Al-Kinani A., 2016, P IEEE 83 VEH TECHN, P1; [Anonymous], 2000, MILSTD882D; [Anonymous], 2011, OPTICAL COMMUNICATIO, DOI DOI 10.1109/IEEESTD.2011.6016195; Bazzi A, 2016, COMPUT COMMUN, V93, P39, DOI 10.1016/j.comcom.2016.07.004; Blinowski G, 2015, IFAC PAPERSONLINE, V48, P234, DOI 10.1016/j.ifacol.2015.07.039; Brynjolfsson E, 2000, J ECON PERSPECT, V14, P23, DOI 10.1257/jep.14.4.23; Burbeck K, 2003, P WORK PROGR SESS 24; Burchardt H, 2014, IEEE COMMUN MAG, V52, P98, DOI 10.1109/MCOM.2014.6852089; Cai X, 2016, PLOS ONE, V11, P1; Classen Jiska, 2015, arXiv; Elgala H, 2011, IEEE COMMUN MAG, V49, P56, DOI 10.1109/MCOM.2011.6011734; Feng LF, 2016, IEEE NETWORK, V30, P77, DOI 10.1109/MNET.2016.1500236RP; Gao HY, 2011, IEEE INTERNET COMPUT, V15, P56, DOI 10.1109/MIC.2011.50; Gislason D., 2008, ZIGBEE WIRELESS NETW; Goodspeed T., 2009, IN BLACK HAT USA; Haas H, 2016, J LIGHTWAVE TECHNOL, V34, P1533, DOI 10.1109/JLT.2015.2510021; Hussein AT, 2015, J LIGHTWAVE TECHNOL, V33, DOI 10.1109/JLT.2015.2495165; IEEE, 2015, IEEE STAND LOW RAT W; Joshi JBD, 2001, COMMUN ACM, V44, P38, DOI 10.1145/359205.359224; Jung SY, 2011, IEEE T CONSUM ELECTR, V57, P1592, DOI 10.1109/TCE.2011.6131130; Kurose J, 2013, COMPUTER NETWOTKING; Li XS, 2009, 2009 INTERNATIONAL FORUM ON INFORMATION TECHNOLOGY AND APPLICATIONS, VOL 2, PROCEEDINGS, P480, DOI 10.1109/IFITA.2009.542; Li ZP, 2013, IN C IND ENG ENG MAN, P1699, DOI 10.1109/IEEM.2013.6962700; Lu FQ, 2014, 2014 11TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P599, DOI 10.1109/WCICA.2014.7052781; Ma L, 2013, J LOSS PREVENT PROC, V26, P1183, DOI 10.1016/j.jlp.2013.05.001; Mahdy A, 2004, IEEE WCNC, P2399, DOI 10.1109/WCNC.2004.1311464; Marin-Garcia I, 2015, I SYMP CONSUM ELECTR, P297, DOI 10.1109/ICCE.2015.7066421; Marin-Garcia I., 2016, 2016 10 INT S COMM S, P1, DOI [10.1109/CSNDSP.2016.7573963, DOI 10.1109/CSNDSP.2016.7573963]; Mostafa Ayman, 2015, 2015 IEEE Photonics Society Summer Topical Meeting Series (SUM), P39, DOI 10.1109/PHOSST.2015.7248182; Mostafa A, 2014, IEEE ICC, P3342, DOI 10.1109/ICC.2014.6883837; Dao NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160375; Ni HH, 2010, SAFETY SCI, V48, P1269, DOI 10.1016/j.ssci.2010.04.005; Obraczka K, 2000, GLOB TELECOMM CONF, P421, DOI 10.1109/GLOCOM.2000.892040; OFlynn C, 2016, 20161047 CRYPT EPRIN, V2016, P1047; Prasad R., 2012, 2012 IEEE International Conference on Ultra-Wideband (ICUWB2012), P41, DOI 10.1109/ICUWB.2012.6340468; Rabadan J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17020330; Sewaiwar A, 2015, OPT EXPRESS, V23, P13015, DOI 10.1364/OE.23.013015; Sha Fu, 2011, 2011 IEEE 3rd International Conference on Communication Software and Networks (ICCSN 2011), P474, DOI 10.1109/ICCSN.2011.6013875; Shang YL, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042804; Stanton JM, 2005, COMPUT SECUR, V24, P124, DOI 10.1016/j.cose.2004.07.001; Tanenbaum A., 2011, COMPUTER NETWORKS; Theoharidou M, 2012, RISK ASSESSMENT METH, P443; Uysal M, 2017, IEEE COMMUN MAG, V55, P212, DOI 10.1109/MCOM.2017.1600872CM; vandenBrand D, 1996, INT J ENVIRON POLLUT, V6, P388; Wang TQ, 2013, J LIGHTWAVE TECHNOL, V31, P3302, DOI 10.1109/JLT.2013.2281592; Zillner T., 2015, ZIGBEE EXPLOITED GOO	46	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188759	10.1371/journal.pone.0188759	http://dx.doi.org/10.1371/journal.pone.0188759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186184	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900058
J	Crevecoeur, S; Vincent, WF; Comte, J; Matveev, A; Lovejoy, C				Crevecoeur, Sophie; Vincent, Warwick F.; Comte, Jerome; Matveev, Alex; Lovejoy, Connie			Diversity and potential activity of methanotrophs in high methane-emitting permafrost thaw ponds	PLOS ONE			English	Article							COMMUNITY COMPOSITION; BACTERIAL PRODUCTION; SEASONAL-VARIATION; HUDSON-BAY; SP NOV.; OXIDATION; LAKE; SOILS; PMOA; TEMPERATURE	Lakes and ponds derived from thawing permafrost are strong emitters of carbon dioxide and methane to the atmosphere, but little is known about the methane oxidation processes in these waters. Here we investigated the distribution and potential activity of aerobic methanotrophic bacteria in thaw ponds in two types of eroding permafrost landscapes in subarctic Que A bec: peatlands and mineral soils. We hypothesized that methanotrophic community composition and potential activity differ regionally as a function of the landscape type and permafrost degradation stage, and locally as a function of depth-dependent oxygen conditions. Our analysis of pmoA transcripts by Illumina amplicon sequencing and quantitative PCR showed that the communities were composed of diverse and potentially active lineages. Type I methanotrophs, particularly Methylobacter, dominated all communities, however there was a clear taxonomic separation between the two landscape types, consistent with environmental control of community structure. In contrast, methanotrophic potential activity, measured by pmoA transcript concentrations, did not vary with landscape type, but correlated with conductivity, phosphorus and total suspended solids. Methanotrophic potential activity was also detected in low-oxygen bottom waters, where it was inversely correlated with methane concentrations, suggesting methane depletion by methanotrophs. Methanotrophs were present and potentially active throughout the water column regardless of oxygen concentration, and may therefore be resilient to future mixing and oxygenation regimes in the warming subarctic.	[Crevecoeur, Sophie; Vincent, Warwick F.; Comte, Jerome; Matveev, Alex; Lovejoy, Connie] Univ Laval, CEN, Dept Biol, Quebec City, PQ, Canada; [Crevecoeur, Sophie; Vincent, Warwick F.; Comte, Jerome; Matveev, Alex; Lovejoy, Connie] Univ Laval, Takuvik Joint Int Lab, Quebec City, PQ, Canada; [Crevecoeur, Sophie; Comte, Jerome; Lovejoy, Connie] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Lovejoy, Connie] Univ Laval, Quebec Ocean, Quebec City, PQ, Canada; [Crevecoeur, Sophie] Univ Quebec, Dept Biol, Montreal, PQ, Canada; [Comte, Jerome] Environm & Climate Change Canada, Canada Ctr Inland Waters, Water Sci & Technol Watershed Hydrol & Ecol Res, Burlington, ON, Canada	Laval University; Laval University; Laval University; Laval University; University of Quebec; University of Quebec Montreal; Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW)	Crevecoeur, S (corresponding author), Univ Laval, CEN, Dept Biol, Quebec City, PQ, Canada.; Crevecoeur, S (corresponding author), Univ Laval, Takuvik Joint Int Lab, Quebec City, PQ, Canada.; Crevecoeur, S (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada.; Crevecoeur, S (corresponding author), Univ Quebec, Dept Biol, Montreal, PQ, Canada.	sophie.crevecoeur@gmail.com	Matveev, Alex/H-7380-2017; Vincent, Warwick/AAH-6152-2019; Lovejoy, Connie/A-3756-2008	Matveev, Alex/0000-0003-4103-9131; Vincent, Warwick/0000-0001-9055-1938; Lovejoy, Connie/0000-0001-8027-2281; Comte, Jerome/0000-0002-7936-4290	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair program; Network of Centres of Excellence ArcticNet; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Network of Centres of Excellence ArcticNet; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) including the Discovery Frontiers grant ADAPT, the Canada Research Chair program, the Network of Centres of Excellence ArcticNet, and support from the Fonds de Recherche du Quebec-Nature et Technologies (FRQNT) to Centre d'Etude Nordiques (CEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Bastviken D, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000608; Beck DAC, 2013, PEERJ, V1, DOI 10.7717/peerj.23; Bengtson P, 2009, FEMS MICROBIOL ECOL, V70, P356, DOI 10.1111/j.1574-6941.2009.00751.x; Berthelet M, 1996, FEMS MICROBIOL LETT, V138, P17; Bhiry N, 2006, ECOSCIENCE, V13, P56, DOI 10.2980/1195-6860(2006)13[56:ROCIVA]2.0.CO;2; Bhiry N, 2011, ECOSCIENCE, V18, P182, DOI 10.2980/18-3-3469; Blees J, 2014, LIMNOL OCEANOGR, V59, P311, DOI 10.4319/lo.2014.59.2.0311; Borjesson G, 2004, FEMS MICROBIOL ECOL, V48, P305, DOI 10.1016/j.femsec.2004.02.006; Bowman J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P266, DOI 10.1007/0-387-30745-1_15; Bragina A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01955; Calmels F, 2008, GEOMORPHOLOGY, V97, P287, DOI 10.1016/j.geomorph.2007.08.013; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carini S, 2005, ENVIRON MICROBIOL, V7, P1127, DOI 10.1111/j.1462-2920.2005.00786.x; Chen Y, 2008, ENVIRON MICROBIOL, V10, P446, DOI 10.1111/j.1462-2920.2007.01466.x; Comte J, 2016, BIOGEOSCIENCES, V12, P10233; Comte J, 2016, ECOGRAPHY, V39, P609, DOI 10.1111/ecog.01667; Comte J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00112; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Crevecoeur S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31312; Crevecoeur S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00192; Culpepper MA, 2012, CRIT REV BIOCHEM MOL, V47, P483, DOI 10.3109/10409238.2012.697865; Dedysh S. N., 2002, Mikrobiologiya, V71, P741; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dedysh SN, 2015, INT J SYST EVOL MICR, V65, P3618, DOI 10.1099/ijsem.0.000465; Degelmann DM, 2010, APPL ENVIRON MICROB, V76, P3228, DOI 10.1128/AEM.02730-09; Deshpande BN, 2017, ARCT SCI, V3, P406, DOI 10.1139/as-2016-0048; Deshpande BN, 2016, BIOGEOSCIENCES, V13, P4411, DOI 10.5194/bg-13-4411-2016; Deshpande BN, 2015, LIMNOL OCEANOGR, V60, P1656, DOI 10.1002/lno.10126; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Dunfield PF, 2009, ENCY LIFE SCI, P1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EPP MA, 1993, J GEOPHYS RES-ATMOS, V98, P18413, DOI 10.1029/93JD01667; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Freitag TE, 2010, FEMS MICROBIOL ECOL, V73, P157, DOI 10.1111/j.1574-6941.2010.00871.x; FRENZEL P, 1990, FEMS MICROBIOL ECOL, V73, P149, DOI 10.1016/0378-1097(90)90661-9; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galand PE, 2008, J MARINE SYST, V74, P774, DOI 10.1016/j.jmarsys.2007.12.001; GILBERT B, 1995, BIOL FERT SOILS, V20, P93, DOI 10.1007/BF00336586; Graef C, 2011, ENV MICROBIOL REP, V3, P466, DOI 10.1111/j.1758-2229.2010.00237.x; Grossart HP, 1998, AQUAT MICROB ECOL, V15, P127, DOI 10.3354/ame015127; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; He R, 2012, APPL ENVIRON MICROB, V78, P4715, DOI 10.1128/AEM.00853-12; Hernandez ME, 2015, PEERJ, V3, DOI 10.7717/peerj.801; Holmes AJ, 1999, APPL ENVIRON MICROB, V65, P3312; Hunt DE, 2013, APPL ENVIRON MICROB, V79, P177, DOI 10.1128/AEM.02155-12; Josse J, 2016, J STAT SOFTW, V70; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P1195, DOI 10.4319/lo.2006.51.2.1195; Kankaala P, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000336; Khalil MAK, 1998, J GEOPHYS RES-ATMOS, V103, P25233, DOI 10.1029/98JD01116; Kip N, 2011, APPL ENVIRON MICROB, V77, P5643, DOI 10.1128/AEM.05017-11; Knief C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01346; Kolb S, 2003, APPL ENVIRON MICROB, V69, P2423, DOI 10.1128/AEM.69.5.2423-2429.2003; Lajeunesse P, 2003, CAN J EARTH SCI, V40, P65, DOI 10.1139/E02-085; Laurion I, 2010, LIMNOL OCEANOGR, V55, P115, DOI 10.4319/lo.2010.55.1.0115; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Liebner S, 2013, APPL ENVIRON MICROB, V79, P701, DOI 10.1128/AEM.02292-12; Liu JJ, 2014, MICROB BIOTECHNOL, V7, P64, DOI 10.1111/1751-7915.12097; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P3877, DOI 10.1128/AEM.02960-10; Martineau C, 2010, APPL ENVIRON MICROB, V76, P5773, DOI 10.1128/AEM.03094-09; Martinez-Cruz K, 2015, BIOGEOSCIENCES, V12, P4595, DOI 10.5194/bg-12-4595-2015; Matveev A, 2016, LIMNOL OCEANOGR, V61, pS150, DOI 10.1002/lno.10311; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; McDonald IR, 1997, FEMS MICROBIOL LETT, V156, P205, DOI 10.1016/S0378-1097(97)00425-4; Milucka J, 2015, ISME J, V9, P1991, DOI 10.1038/ismej.2015.12; Mohanty SR, 2007, FEMS MICROBIOL ECOL, V62, P24, DOI 10.1111/j.1574-6941.2007.00370.x; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Northington RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159642; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Omelchenko MV, 1996, MICROBIOLOGY+, V65, P339; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; OSHKIN IY, 2014, ISME J, V9, P1; Oswald K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132574; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Peltoniemi K, 2016, SOIL BIOL BIOCHEM, V97, P144, DOI 10.1016/j.soilbio.2016.03.007; Przytulska A, 2016, BIOGEOSCIENCES, V13, P13, DOI 10.5194/bg-13-13-2016; Putkinen A, 2014, FEMS MICROBIOL ECOL, V88, P596, DOI 10.1111/1574-6941.12327; Reeburgh W. S., 1993, P1; Reeburgh W.S., 2003, TREATISE GEOCHEM, V4, P347; Reiche M, 2011, LIMNOL OCEANOGR, V56, P1386, DOI 10.4319/lo.2011.56.4.1386; Reim A, 2012, ISME J, V6, P2128, DOI 10.1038/ismej.2012.57; Rossi PG, 2013, AQUAT MICROB ECOL, V69, P231, DOI 10.3354/ame01634; Serkebaeva YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063994; Siljanen HMP, 2012, FEMS MICROBIOL ECOL, V80, P548, DOI 10.1111/j.1574-6941.2012.01321.x; Stackhouse BT, 2015, J GEOPHYS RES-BIOGEO, V120, P1764, DOI 10.1002/2015JG003004; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Trimmer M, 2015, ISME J, V9, P2304, DOI 10.1038/ismej.2015.98; Tuomivirta TT, 2009, RES MICROBIOL, V160, P751, DOI 10.1016/j.resmic.2009.09.008; Urmann K, 2009, FEMS MICROBIOL ECOL, V69, P202, DOI 10.1111/j.1574-6941.2009.00708.x; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; VECHERSKAYA MS, 1993, CURR MICROBIOL, V27, P181, DOI 10.1007/BF01576018; Vonk JE, 2015, BIOGEOSCIENCES, V12, P7129, DOI 10.5194/bg-12-7129-2015; Walter KM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000569; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P109, DOI 10.1099/ijs.0.63728-0; Wik M, 2016, NAT GEOSCI, V9, P99, DOI 10.1038/NGEO2578; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; Zhang T, 2011, BIOGEOSCIENCES, V8, P2805, DOI 10.5194/bg-8-2805-2011	102	41	42	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188223	10.1371/journal.pone.0188223	http://dx.doi.org/10.1371/journal.pone.0188223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182670	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000015
J	Mayoral-Varo, V; Calcabrini, A; Sanchez-Bailon, MP; Martin-Perez, J				Mayoral-Varo, Vitor; Calcabrini, Annarica; Pilar Sanchez-Bailon, Maria; Martin-Perez, Jorge			miR205 inhibits stem cell renewal in SUM159PT breast cancer cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DOWN-REGULATION; MYC EXPRESSION; MIR-205; SRC; INVASION; TAZ; METASTASIS; INDUCTION; MIGRATION	miR205 has a dual activity, as tumor suppressor and as oncogene. Here we analyzed the impact of miR205 ectopic expression in the initial tumorigenic processes of SUM159PT, a triple negative breast cancer cell line with low endogenous levels of miR205. In SUM159PT, miR205 inhibited expression of its targets VEGFA, ErbB3, Zeb1, Fyn and Lyn A/B; it reduced cell proliferation, and Myc/cyclin D1 levels, while increased p27 kip1 expression. miR205 abolished anchorage-independent growth, inhibited migration and invasion, Srckinases/Stat3 axis activation, and levels of secreted MMP9. miR205 also reduced expression of CD44 and TAZ, E2A. E12, Twist, Snail1 and CK5, associated with epithelial-mesenchymal transition (EMT). Importantly, we show that miR205 inhibited SUM159PT cancerstem cell renewal, expression in mammospheres of CD44 and ALDH1 stem-cell markers, TAZ, and E2A. E12. All these effects of miR205 were reverted by Anti-miR205 co-expression, demonstrating its specificity. Thus, all these results strongly suggest that ectopic expression of miR205 in SUM159PT affected several parameters associated with initial steps of tumorigenesis.	[Mayoral-Varo, Vitor; Calcabrini, Annarica; Pilar Sanchez-Bailon, Maria; Martin-Perez, Jorge] CSIC UAM, Inst Invest Biomed A Sols, Dept Canc Biol, 4 Arturo Duperier, Madrid, Spain; [Calcabrini, Annarica] Ist Super Sanita, Natl Ctr Drug Res & Evaluat, Viale Regina Elena 299, Rome, Italy; [Pilar Sanchez-Bailon, Maria] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England	Consejo Superior de Investigaciones Cientificas (CSIC); Istituto Superiore di Sanita (ISS); University of Birmingham	Martin-Perez, J (corresponding author), CSIC UAM, Inst Invest Biomed A Sols, Dept Canc Biol, 4 Arturo Duperier, Madrid, Spain.	jmartin@iib.uam.es	Martin-Perez, Jorge/A-3522-2008; , Victor/H-3115-2015; Calcabrini, Annarica/C-9897-2015	Martin-Perez, Jorge/0000-0002-2292-0057; BAILON PRADO, MARIA JULISA/0000-0001-9628-9176; , Victor/0000-0001-6972-2368; Calcabrini, Annarica/0000-0002-9600-1117	Ministerio de Economia y Competitividad from Spain [SAF2012-38048, SAF2016-75991-R]	Ministerio de Economia y Competitividad from Spain(Spanish Government)	These studies have been supported by grants from Ministerio de Economia y Competitividad from Spain (SAF2012-38048 and SAF2016-75991-R) to J. M-P, as well as a fellowship to Maria Pilar Sanchez-Bailon.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Berber U, 2014, J BREAST CANCER, V17, P143, DOI 10.4048/jbc.2014.17.2.143; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; CAMPANERO MR, 1991, EUR J IMMUNOL, V21, P3045, DOI 10.1002/eji.1830211222; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Diaz-Martin J, 2015, ENDOCR-RELAT CANCER, V22, P443, DOI 10.1530/ERC-14-0456; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Jitariu AA, 2017, ONCOTARGET, V8, P46652, DOI 10.18632/oncotarget.16938; Jung HY, 2015, CELL STEM CELL, V16, P1, DOI 10.1016/j.stem.2014.12.005; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li YW, 2015, CELL CYCLE, V14, P146, DOI 10.4161/15384101.2014.967106; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Marlow R, 2013, CANCER RES, V73, P6886, DOI 10.1158/0008-5472.CAN-13-0991; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; McCubrey James A., 2014, Advances in Biological Regulation, V56, P81, DOI 10.1016/j.jbior.2014.05.003; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Qin AY, 2013, EUR J CELL BIOL, V92, P54, DOI 10.1016/j.ejcb.2012.11.002; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Su CM, 2015, J NUTR BIOCHEM, V26, P675, DOI 10.1016/j.jnutbio.2015.01.005; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	45	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188637	10.1371/journal.pone.0188637	http://dx.doi.org/10.1371/journal.pone.0188637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182685	Green Submitted, gold, Green Published			2022-12-26	WOS:000416402000047
J	Thanapati, S; Ganu, MA; Tripathy, AS				Thanapati, Subrat; Ganu, Mohini A.; Tripathy, Anuradha S.			Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTION; T-CELLS; CYTOLYTIC FUNCTION; HEPATITIS-B; EXPRESSION; ARTHRITIS; INTERFERON; EPIDEMIC; DISEASE	The role of natural killer (NK; CD3(-)CD56(+))/NKT (CD3(+)CD56(+))-like cells in chikungunya virus (CHIKV) disease progression/recovery remains unclear. Here, we investigated the expression profiles and function of NK and NKT-like cells from 35 chronic chikungunya patients, 30 recovered individuals, and 69 controls. Percentage of NKT-like cells was low in chronic chikungunya patients. NKp30(+), CD244(+), DNAM-1(+), and NKG2D(+) NK cell percent-ages were also lower (MFI and/or percentage), while those of CD94(+) and NKG2A(+) NKT-like cells were higher (MFI and/or percentage) in chronic patients than in recovered subjects. IFN-gamma and TNF-alpha expression on NKT-like cells was high in the chronic patients, while only IFN-gamma expression on NK cells was high in the recovered individuals. Furthermore, percentage of perforin(+) NK cells was low in the chronic patients. Lower cytotoxic activity was observed in the chronic patients than in the controls. CD107a expression on NK and NKT-like cells post anti-CD94/anti-NKG2A blocking was comparable among the patients and controls. Upregulated inhibitory and downregulated activating NK receptor expressions on NK/NKT-like cells, lower perforin(+) and CD107a(+) NK cells are likely responsible for inhibiting the NK and NKT-like cell function in the chronic stage of chikungunya. Therefore, deregulation of NKR expression might underlie CHIKV-induced chronicity.	[Thanapati, Subrat; Tripathy, Anuradha S.] Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India; [Ganu, Mohini A.] Sanjeevan Hosp, Latur, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Tripathy, AS (corresponding author), Natl Inst Virol, Hepatitis Grp, Pune, Maharashtra, India.	anuradhastripathy@hotmail.com			University Grant Commission, New Delhi, India	University Grant Commission, New Delhi, India(University Grants Commission, India)	We thank Director, National Institute of Virology, for all the encouragement. Special thanks are due to Mr. Prasad Babar, Mr. Vasant Walkoli, Mr. Bipin Tilekar, Mr. Sarang Kamble, Mr. Dasharath, Mr. Prakash Sarje, Mr. Prakash B. Jawalkar, Ms. Neeta Thorat and Mr. Shirish Vaidya for technical help. We thank Ms. Shruti Kulkarni for her timely help. Mr. Subrat Thanapati would like to thank the University Grant Commission, New Delhi, India for providing the Senior Research Fellowship.	Alsharifi M, 2006, EUR J IMMUNOL, V36, P887, DOI 10.1002/eji.200535342; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Brandstadter JD, 2011, J INNATE IMMUN, V3, P274, DOI 10.1159/000324176; Braud VM, 2003, TRENDS IMMUNOL, V24, P162, DOI 10.1016/S1471-4906(03)00064-4; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Conroy MJ, 2015, J VIRAL HEPATITIS, V22, P335, DOI 10.1111/jvh.12299; Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015; Das R, 2014, MED MICROBIOL IMMUN, V203, P303, DOI 10.1007/s00430-014-0338-1; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Fu GF, 2010, CELL IMMUNOL, V265, P37, DOI 10.1016/j.cellimm.2010.06.011; Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13; Heeg M, 2012, HEPATOLOGY, V56, P1197, DOI 10.1002/hep.25858; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Jiang YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863625; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KENNEDY AC, 1980, J RHEUMATOL, V7, P231; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Silva MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32288; Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5; SINGH V K, 1987, Journal of Experimental Pathology (New York), V3, P19; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; SMEE DF, 1990, ANTIVIR RES, V13, P91, DOI 10.1016/0166-3542(90)90025-3; Solet J. L., 2007, PLOS BIOL, V77, P727; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005; Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177; Thanapati S, 2017, HUM IMMUNOL, V78, P370, DOI 10.1016/j.humimm.2017.02.006; Thanapati S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00895; Tripathy AS, 2011, J VIRAL HEPATITIS, V18, pE415, DOI 10.1111/j.1365-2893.2011.01457.x; Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759; Watzl C, 2010, CURRPROTOC IMMUNOL	47	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188342	10.1371/journal.pone.0188342	http://dx.doi.org/10.1371/journal.pone.0188342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182664	gold, Green Published, Green Submitted			2022-12-26	WOS:000416402000021
J	Derouiche, S; Takayama, Y; Murakami, M; Tominaga, M				Derouiche, Sandra; Takayama, Yasunori; Murakami, Masataka; Tominaga, Makoto			TRPV4 heats up ANO1-dependent exocrine gland fluid secretion	FASEB JOURNAL			English	Article						calcium; ion channels; saliva; tears	CA2+-ACTIVATED CL-CHANNEL; CATION CHANNEL; EVOKED ACTIVATION; SALIVARY; TEMPERATURE; MODULATION; MECHANISM; PATHWAY; ENTRY; AQP5	Several ion channels and transporters regulate fluid secretion in salivary and lacrimal glands. In salivary glands, the major anion channel involved in fluid secretion is the calcium-activated chloride channel anoctamin 1 (ANO1). Several members of the transient receptor potential (TRP) channel superfamily regulate ANO1 activity. Here, we report a functional interaction between thermosensitive TRP vanilloid (TRPV)4 and ANO1 in acinar cells isolated from mouse salivary and lacrimal glands. TRPV4 activation induced chloride currents and shrinkage of acinar cells by increasing intracellular calcium concentrations. The chloride currents evoked by a TRPV4-specific activator (GSK1016790A) were identified as ANO1-mediated currents. Moreover, TRPV4 activation by an inositol 1,4,5-trisphosphate (IP3)-dependent mechanism was found to contribute to the muscarinic pathway of fluid secretion. Muscarinic stimulation of saliva and tear secretion was down-regulated in both TRPV4-deficient mice and in acinar cells treated with a TRPV4-specific antagonist (HC-067047). Furthermore, the temperature dependence of muscarinic salivation was shown to depend mainly on TRPV4. Our results suggest that TRPV4 interacts with IP3 receptors and ANO1 to regulate the muscarinic pathway that mediates salivation and lacrimation.	[Derouiche, Sandra; Takayama, Yasunori; Tominaga, Makoto] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi, Japan; [Takayama, Yasunori; Murakami, Masataka; Tominaga, Makoto] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Murakami, Masataka] Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Tominaga, Makoto] Juntendo Univ, Inst Environm & Gender Specif Med, Urayasu, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Juntendo University	Derouiche, S; Tominaga, M (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	derosand@nips.ac.jp; tominaga@nips.ac.jp	Takayama, Yasunori/AAG-1133-2021		Japanese Society for the Promotion of Science; Japanese National Institute for Physiological Sciences in Japan; Ministry of Education, Culture, Sports, Science and Technology [15H02501, 15H05928]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese National Institute for Physiological Sciences in Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank K. Mikoshiba (RIKEN Brain Science Institute, Saitama, Japan) and K. Shibasaki (Gunma University, Maebashi, Japan) for the generous gifts of the IP<INF>3</INF> receptor and TRPV4 antibodies, respectively. This work was supported by grants from the Japanese Society for the Promotion of Science and the Japanese National Institute for Physiological Sciences in Japan (to S.D.) and by Grants 15H02501 and 15H05928 from Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (to M.T.). The authors declare no conflict of interest.	Ambudkar IS, 2012, CURR MED CHEM, V19, P5774; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Catalan MA, 2015, P NATL ACAD SCI USA, V112, P2263, DOI 10.1073/pnas.1415739112; COMPTON J, 1981, ARCH ORAL BIOL, V26, P555, DOI 10.1016/0003-9969(81)90017-0; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Fernandes J, 2008, J GEN PHYSIOL, V131, pi2, DOI DOI 10.1085/JGP1315OIA2; Fujita-Yoshigaki J, 2005, CELL TISSUE RES, V320, P455, DOI 10.1007/s00441-005-1076-x; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hosoi K, 2016, PFLUG ARCH EUR J PHY, V468, P519, DOI 10.1007/s00424-015-1749-6; Jin X, 2016, J PHYSIOL-LONDON, V594, P19, DOI 10.1113/jphysiol.2014.275107; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; MARTY A, 1984, J PHYSIOL-LONDON, V357, P293, DOI 10.1113/jphysiol.1984.sp015501; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mukaibo K., 2013, OPEN J STOMATOLOGY, V3, P83; MURAKAMI M, 1990, J PHYSIOL-LONDON, V426, P127, DOI 10.1113/jphysiol.1990.sp018130; Nakahari T, 1998, J MEMBRANE BIOL, V161, P287, DOI 10.1007/s002329900335; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Novak I, 2010, J PHYSIOL-LONDON, V588, P3615, DOI 10.1113/jphysiol.2010.190017; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Putney JW, 2014, CELL CALCIUM, V55, P290, DOI 10.1016/j.ceca.2014.01.001; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Sobhan U, 2013, CELL TISSUE RES, V354, P507, DOI 10.1007/s00441-013-1691-x; Sokabe Takaaki, 2010, Commun Integr Biol, V3, P619, DOI 10.4161/cib.3.6.13461; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Tominaga M, 2014, CHANNELS, V8, DOI 10.4161/chan.29001; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xing J, 2014, J PHYSIOL-LONDON, V592, P927, DOI 10.1113/jphysiol.2013.267740; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yu DF, 2012, AM J PHYSIOL-CELL PH, V303, pC767, DOI 10.1152/ajpcell.00195.2012; Zhang Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1365, DOI 10.1152/ajpgi.00366.2012	49	20	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1841	1854		10.1096/fj.201700954R	http://dx.doi.org/10.1096/fj.201700954R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29187363				2022-12-26	WOS:000429051400009
J	Mizumura, K; Justice, MJ; Schweitzer, KS; Krishnan, S; Bronova, I; Berdyshev, EV; Hubbard, WC; Pewzner-Jung, Y; Futerman, AH; Choi, AMK; Petrache, I				Mizumura, Kenji; Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Bronova, Irina; Berdyshev, Evgeny V.; Hubbard, Walter C.; Pewzner-Jung, Yael; Futerman, Anthony H.; Choi, Augustine M. K.; Petrache, Irina			Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure	FASEB JOURNAL			English	Article						ceramide; sphingosine; cell death; cell survival; inflammation	OBSTRUCTIVE PULMONARY-DISEASE; CERAMIDE SYNTHASE 2; SELECTIVE AUTOPHAGY; INDUCED EMPHYSEMA; PROTEIN; APOPTOSIS; STRESS; DEATH; MICE; PATHOGENESIS	The mechanisms by which lung structural cells survive toxic exposures to cigarette smoke (CS) are not well defined but may involve proper disposal of damaged mitochondria by macro-autophagy (mitophagy), processes that may be influenced by pro-apoptotic ceramide (Cer) or its precursor dihydroceramide (DHC). Human lung epithelial and endothelial cells exposed to CS exhibited mitochondrial damage, signaled by phosphatase and tensin homolog-induced putative kinase 1 (PINK1) phosphorylation, autophagy, and necroptosis. Although cells responded to CS by rapid inhibition of DHC desaturase, which elevated DHC levels, palmitoyl (C16)-Cer also increased in CS-exposed cells. Where as DHC augmentation triggered autophagy without cell death, the exogenous administration of C16-Cer was sufficient to trigger necroptosis. Inhibition of Cer-generating acid sphingomyelinase reduced both CS-induced PINK1 phosphorylation and necroptosis. When exposed to CS, Pink1-deficient (Pink1(-/-)) mice, which are protected from airspace enlargement compared with wild-type littermates, had blunted C16-Cer elevations and less lung necroptosis. CS-exposed Pink1(-/-) mice also exhibited significantly increased levels of lignoceroyl (C24)-DHC, along with increased expression of Cer synthase 2 (CerS2), the enzyme responsible for its production. This suggested that a combination of high C24-DHC and low C16-Cer levels might protect against CS-induced necroptosis. Indeed, CerS2(-/-) mice, which lack C24-DHC at the expense of increased C16-Cer, were more susceptible to CS, developing airspace enlargement following only 1 month of exposure. These results implicate DHCs, in particular, C24-DHC, as protective against CS toxicity by enhancing autophagy, where as C16-Cer accumulation contributes to mitochondrial damage and PINK1-mediated necroptosis, which may be amplified by the inhibition of C24-DHC-producing CerS2.	[Mizumura, Kenji; Choi, Augustine M. K.] New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA; [Mizumura, Kenji] Nihon Univ, Sch Med, Div Resp Med, Tokyo, Japan; [Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Petrache, Irina] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Petrache, Irina] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Schweitzer, Kelly S.; Bronova, Irina; Berdyshev, Evgeny V.; Petrache, Irina] Natl Jewish Hlth, Denver, CO USA; [Bronova, Irina; Berdyshev, Evgeny V.] Univ Illinois, Dept Med, Chicago, IL USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Clin Pharmacol, Baltimore, MD USA; [Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel	Cornell University; NewYork-Presbyterian Hospital; Nihon University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Jewish Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Weizmann Institute of Science	Petrache, I (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, 1400 Jackson St,J203, Denver, CO 80206 USA.	petrachei@njhealth.org	Petrache, Irina/AAZ-9648-2020; Pewzner, Faivish/I-6225-2017	Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115; Mizumura, Kenji/0000-0001-8532-9670	U.S. National Institute of Health, National Heart, Lung, and Blood Institute [RO1HL077328, F31HL126459, P01HL114501, R01HL132198]; Binational Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328, F31HL126459, R01HL132198, P01HL114501] Funding Source: NIH RePORTER	U.S. National Institute of Health, National Heart, Lung, and Blood Institute; Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the support from U.S. National Institute of Health, National Heart, Lung, and Blood Institute Grants RO1HL077328 (to I.P.), F31HL126459 (to M.J.J.), and P01HL114501 and R01HL132198 (to A.M.K.C.); and support from the Binational Science Foundation (to I.P. and A.H.F.). K.M. and M.J.J. are cofirst authors on this manuscript. The authors declare no conflicts of interest.	Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276; Arena G, 2017, J PATHOL, V241, P251, DOI 10.1002/path.4815; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Elias JA, 2005, NAT MED, V11, P471, DOI 10.1038/nm0505-471; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kamocki K, 2013, AM J RESP CELL MOL, V48, P87, DOI 10.1165/rcmb.2012-0254OC; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Mizumura K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00244; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2016, ANNU REV PHYSIOL, V78, P463, DOI 10.1146/annurev-physiol-021115-105221; Petrache I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062968; Petrusca DN, 2014, AM J RESP CELL MOL, V50, P513, DOI 10.1165/rcmb.2013-0023OC; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	33	39	39	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1880	1890		10.1096/fj.201700571R	http://dx.doi.org/10.1096/fj.201700571R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196503	Green Published			2022-12-26	WOS:000429051400012
J	Li, XY; Zhang, Y; Wang, XX; Jin, C; Wang, YQ; Sun, TC; Li, J; Tang, JX; Batool, A; Deng, SL; Chen, SR; Cheng, CY; Liu, YX				Li, Xiao-Yu; Zhang, Yan; Wang, Xiu-Xia; Jin, Cheng; Wang, Yu-Qian; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia; Deng, Shou-Long; Chen, Su-Ren; Cheng, C. Yan; Liu, Yi-Xun			Regulation of blood-testis barrier assembly in vivo by germ cells	FASEB JOURNAL			English	Article						tight junction; testosterone; claudin 3	SPERMATOGONIAL STEM-CELLS; C-KIT; SERTOLI; PROLIFERATION; EXPRESSION; ANDROGENS; RAT	The assembly of the blood-testis barrier (BTB) during postnatal development is crucial to support meiosis. However, the role of germcells in BTB assembly remains unclear. Herein, Kit(W)/Kit(WV) micewere used as a study model. These mice were infertile, failing to establish a functional BTB to support meiosis due to c-Kit mutation. Tra nsplantation of undifferentiated spermatogonia derived from normal mice into the testis of Kit(W)/Kit(WV) mice triggered functional BTB assembly, displaying cyclic remodeling during the epithelial cycle. Also, transplanted germ cells were capable of inducing Leydig cell testosterone production, which could enhance the expression of integral membrane protein claudin 3 in Sertoli cells. Early spermatocytes were shown to play a vital role in directing BTB assembly by expressing claudin 3, which likely created a transient adhesion structure to mediate BTB and cytoskeleton assembly in adjacent Sertoli cells. In summary, the positive modulation of germcells on somatic cell function provides useful information regarding somatic-germ cell interactions.	[Li, Xiao-Yu; Zhang, Yan; Wang, Xiu-Xia; Jin, Cheng; Wang, Yu-Qian; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia; Deng, Shou-Long; Chen, Su-Ren; Liu, Yi-Xun] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Li, Xiao-Yu; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yan] Changsha Reprod Med Hosp, Changsha, Hunan, Peoples R China; [Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Population Council	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA.; Liu, YX (corresponding author), Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	liuyx@ioz.ac.cn	Deng, Shou-Long/GWV-0452-2022; deng, shoulong/GWV-0293-2022; Chen, Su-Ren/S-1025-2017	Chen, Su-Ren/0000-0002-9337-5412; Cheng, C Yan/0000-0003-3117-3791; deng, shou-long/0000-0003-1187-3037; Li, Xiaoyu/0000-0002-0241-6152	Major Research Plan 973 Project [2012CB944702]; Natural Science Foundation of China [31501161, 31501953, 31471352, 31471400, 81270662, 31171380]; Clinical Capability Construction Project for Liaoning Provincial Hospitals [LNCCC-C09-2015, LNCCC-D50-2015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034] Funding Source: NIH RePORTER	Major Research Plan 973 Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Capability Construction Project for Liaoning Provincial Hospitals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Major Research Plan 973 Project (2012CB944702), Natural Science Foundation of China (31501161, 31501953, 31471352, 31471400, 81270662, and 31171380), Clinical Capability Construction Project for Liaoning Provincial Hospitals (LNCCC-C09-2015, LNCCC-D50-2015), and Academician Workstation Support (Shenyang, Changsha, and Shandong). The authors declare no conflicts of interest.	BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; BESMER P, 1993, DEVELOPMENT, P125; BYERS S, 1991, AM J ANAT, V191, P35, DOI 10.1002/aja.1001910104; Chakraborty P, 2014, MOL ENDOCRINOL, V28, P1055, DOI 10.1210/me.2013-1134; Chihara M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107847; DYM M, 1977, BIOL REPROD, V17, P390, DOI 10.1095/biolreprod17.3.390; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kubota H, 2009, BIOL REPROD, V81, P293, DOI 10.1095/biolreprod.109.075960; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; SU L, 2014, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.26460; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Takashima S, 2011, CELL STEM CELL, V9, P463, DOI 10.1016/j.stem.2011.08.011; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Zhang Y, 2012, CELL RES, V22, P773, DOI 10.1038/cr.2012.17	26	21	23	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1653	1664		10.1096/fj.201700681R	http://dx.doi.org/10.1096/fj.201700681R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29183964	Green Published			2022-12-26	WOS:000427246000042
J	Lavrsen, K; Dabelsteen, S; Vakhrushev, SY; Levann, AMR; Haue, AD; Dylander, A; Mandel, U; Hansen, L; Frodin, M; Bennett, EP; Wandall, HH				Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Frodin, Morten; Bennett, Eric P.; Wandall, Hans H.			De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell adhesion; colon cancer; differentiation; glycobiology; GalNAc; GalNAc-Ts; genetic engineering; glycoproteomics; tissue model	ALPHA-D-GALACTOSAMINE; ACETYL-D-GALACTOSAMINE; TRANSFERASE GENE FAMILY; O-LINKED GLYCOSYLATION; BOVINE UDP-GALNAC; PANCREATIC-CANCER; COLORECTAL-CANCER; BREAST-CANCER; POOR-PROGNOSIS; CDNA CLONING	Aberrant expression of O-glycans is a hallmark of epithelial cancers. Mucin-type O-glycosylation is initiated by a large family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) that target different proteins and are differentially expressed in cells and organs. Here, we investigated the expression patterns of all of the GalNAc-Ts in colon cancer by analyzing transcriptomic data. We found that GalNAc-T6 was highly up-regulated in colon adenocarcinomas but absent in normal-appearing adjacent colon tissue. These results were verified by immunohistochemistry, suggesting that GalNAc-T6 plays a role in colon carcinogenesis. To investigate the function of GalNAc-T6 in colon cancer, we used precise gene targeting to produce isogenic colon cancer cell lines with a knockout/rescue system for GALNT6. GalNAc-T6 expression was associated with a cancer-like, dysplastic growth pattern, whereas GALNT6 knockout cells showed a more normal differentiation pattern, reduced proliferation, normalized cell-cell adhesion, and formation of crypts in tissue cultures. O-Glycoproteomic analysis of the engineered cell lines identified a small set of GalNAc-T6-specific targets, suggesting that this isoform has unique cellular functions. In support of this notion, the genetically and functionally closely related GalNAc-T3 homolog did not show compensatory functionality for effects observed for GalNAc-T6. Taken together, these data strongly suggest that aberrant GalNAc-T6 expression and site-specific glycosylation is involved in oncogenic transformation.	[Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Bennett, Eric P.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Bennett, Eric P.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Odontol, DK-2200 Copenhagen N, Denmark; [Frodin, Morten] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.; Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Odontol, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Vakhrushev, Sergey Y/A-7638-2014; Bennett, Eric/AAG-6120-2020	Vakhrushev, Sergey Y/0000-0002-0418-5765; Bennett, Eric/0000-0002-4976-0647; Haue, Amalie Dahl/0000-0001-7656-7976; Mandel, Ulla/0000-0001-7012-9836; Rudjord-Levann, Asha M./0000-0002-9966-0345; Wandall, Hans H./0000-0003-0240-9232; Frodin, Morten/0000-0003-3691-9820; Dabelsteen, Sally/0000-0002-4279-8060	Danish Research Councils Grant [1331-00133B]; Programme of Excellence Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO from the University of Copenhagen; Danish National Research Foundation [DNRF107]; Lundbeck Foundation	Danish Research Councils Grant; Programme of Excellence Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO from the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by Danish Research Councils Grant 1331-00133B (to K. L., S. D., and H. H. W.), Programme of Excellence 2016 Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO2016 from the University of Copenhagen (to K. L. and H. H. W.), Danish National Research Foundation Grant DNRF107, and The Lundbeck Foundation (to K. L. and H. H. W.). H. H. W. is a consultant and owns stock in GO therapeutics.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Adachi T, 1997, J IMMUNOL, V159, P2645; Andergassen U, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/792672; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Ashley N, 2013, CANCER RES, V73, P5798, DOI 10.1158/0008-5472.CAN-13-0454; Baldus SE, 2000, CANCER-AM CANCER SOC, V88, P1536, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1536::AID-CNCR6>3.3.CO;2-N; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergmann H, 2012, IMMUNOL CELL BIOL, V90, P839, DOI 10.1038/icb.2012.51; Berois N, 2006, J HISTOCHEM CYTOCHEM, V54, P317, DOI 10.1369/jhc.5A6783.2005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CHING CK, 1993, GUT, V34, P1722, DOI 10.1136/gut.34.12.1722; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; DAVID L, 1992, APMIS, V100, P162; Ding MX, 2012, ASIAN PAC J CANCER P, V13, P5653, DOI 10.7314/APJCP.2012.13.11.5653; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Ferreira JA, 2013, MOL ONCOL, V7, P719, DOI 10.1016/j.molonc.2013.03.001; Freire T, 2006, INT J CANCER, V119, P1383, DOI 10.1002/ijc.21959; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harada Yoshikazu, 2015, Tumour Biol, V36, P10003, DOI 10.1007/s13277-015-4211-7; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; HOMA FL, 1993, J BIOL CHEM, V268, P12609; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Inoue T, 2007, MODERN PATHOL, V20, P267, DOI 10.1038/modpathol.3800700; Ishikawa M, 2005, PATHOBIOLOGY, V72, P139, DOI 10.1159/000084117; Ishikawa M, 2004, J SURG ONCOL, V86, P28, DOI 10.1002/jso.20042; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; Kariya Y, 2014, BIOCHEM J, V463, P93, DOI 10.1042/BJ20140060; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Lavrsen K, 2013, GLYCOCONJUGATE J, V30, P227, DOI 10.1007/s10719-012-9437-7; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Li Z, 2011, BRIT J CANCER, V104, P1882, DOI 10.1038/bjc.2011.166; Liesche F, 2016, MOL MED REP, V13, P4309, DOI 10.3892/mmr.2016.5044; LYUBSKY S, 1988, AM J CLIN PATHOL, V89, P160, DOI 10.1093/ajcp/89.2.160; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miyahara N, 2004, CLIN CANCER RES, V10, P2090, DOI 10.1158/1078-0432.CCR-1024-03; Mochizuki Y, 2013, THYROID, V23, P1553, DOI 10.1089/thy.2012.0613; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; Ozaki H, 2012, CLIN EXP METASTAS, V29, P229, DOI 10.1007/s10585-011-9445-1; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Patani Neill, 2008, Cancer Genomics & Proteomics, V5, P333; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Pedersen JW, 2014, INT J CANCER, V134, P2180, DOI 10.1002/ijc.28538; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Peng LB, 2014, J MOL HISTOL, V45, P555, DOI 10.1007/s10735-014-9577-0; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pinto R, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx371; Potapenko IO, 2015, MOL ONCOL, V9, P861, DOI 10.1016/j.molonc.2014.12.013; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shibao K, 2002, CANCER, V94, P1939, DOI 10.1002/cncr.10423; Steentoft Catharina, 2013, Methods Mol Biol, V1022, P387, DOI 10.1007/978-1-62703-465-4_29; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Sutherlin ME, 1997, CANCER RES, V57, P4744; Takeda K, 2011, ANTICANCER RES, V31, P263; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarhan YE, 2016, NEOPLASIA, V18, P265, DOI 10.1016/j.neo.2016.03.005; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Trecesson SD, 2011, J BIOL CHEM, V286, P12825, DOI 10.1074/jbc.M110.186437; Um JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6423; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Vester-Christensen Malene Bech, 2013, Methods Mol Biol, V1022, P403, DOI 10.1007/978-1-62703-465-4_30; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wandall HH, 2007, ORAL ONCOL, V43, P301, DOI 10.1016/j.oraloncology.2006.03.005; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang ZQ, 2014, ONCOTARGET, V5, P544, DOI 10.18632/oncotarget.1652; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yamamoto S, 2004, PATHOBIOLOGY, V71, P12, DOI 10.1159/000072957; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Zhang L, 2014, J PATHOL, V234, P60, DOI 10.1002/path.4375; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	112	46	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1298	1314		10.1074/jbc.M117.812826	http://dx.doi.org/10.1074/jbc.M117.812826			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29187600	hybrid, Green Published			2022-12-26	WOS:000423515000016
J	Offenbacher, AR; Iavarone, AT; Klinman, JP				Offenbacher, Adam R.; Iavarone, Anthony T.; Klinman, Judith P.			Hydrogen-deuterium exchange reveals long-range dynamical allostery in soybean lipoxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme inhibitor; fatty acid; hydrogen exchange mass spectrometry; inhibition mechanism; SLO; allostery; hydrogen-deuterium exchange (HDX); lipoxygenase	MONOUNSATURATED FATTY-ACIDS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CONFORMATIONAL DYNAMICS; SUBSTRATE-SPECIFICITY; HUMAN 15-LIPOXYGENASE; STRUCTURAL DYNAMICS; CALCIUM ACTIVATION; MEMBRANE-BINDING; PROTEIN MOTIONS	In lipoxygenases, the topologically conserved C-terminal domain catalyzes the oxidation of polyunsaturated fatty acids, generating an assortment of biologically relevant signaling mediators. Plant and animal lipoxygenases also contain a 100-150-amino acid N-terminal C2-like domain that has been implicated in interactions with isolated fatty acids and at the phospholipid bilayer. These interactions may lead to increased substrate availability and contribute to the regulation of active-site catalysis. Because of a lack of structural information, a molecular understanding of this lipid-protein interaction remains unresolved. Herein, we employed hydrogen-deuterium exchange MS (HDXMS) to spatially resolve changes in protein conformation upon interaction of soybean lipoxygenase with a fatty acid surrogate, oleyl sulfate (OS), previously shown to act at a site separate from the substrate-binding site. Specific, OS-induced conformational changes are detected both at the N-terminal domain and within the substrate portal nearly 30 angstrom away. Combining previously measured kinetic properties in the presence of OS with its impact on the K-d for linoleic acid substrate binding, we conclude that OS binding brings about an increase in rate constants for both the ingress and egress of substrate. We discuss the role of OS-induced changes in protein flexibility in the context of changes in the mechanism of substrate acquisition.	[Offenbacher, Adam R.; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Offenbacher, Adam R.] East Carolina Univ, Dept Chem, Greenville, NC 27858 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of North Carolina; East Carolina University	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu		Offenbacher, Adam/0000-0001-6990-7178	National Institutes of Health [GM113432, GM118117]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113432, R35GM118117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grants GM113432 (to A. R. O.) and GM118117 (to J. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Clapp CH, 2001, J AM CHEM SOC, V123, P747, DOI 10.1021/ja0032071; Clapp CH, 2006, BIOCHEMISTRY-US, V45, P15884, DOI 10.1021/bi0619425; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Di Venere A, 2003, J BIOL CHEM, V278, P18281, DOI 10.1074/jbc.M212122200; Droege KD, 2017, BIOCHEMISTRY-US, V56, P5065, DOI 10.1021/acs.biochem.7b00559; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gaffney BJ, 2012, BIOPHYS J, V103, P2134, DOI 10.1016/j.bpj.2012.10.002; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Hu SS, 2014, J AM CHEM SOC, V136, P8157, DOI 10.1021/ja502726s; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Konermann L, 2014, ANALYST, V139, P6078, DOI 10.1039/c4an01307g; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Liu YH, 2008, BIOCHEMISTRY-US, V47, P6342, DOI 10.1021/bi800463q; Liu YH, 2006, FEBS LETT, V580, P5137, DOI 10.1016/j.febslet.2006.08.042; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mogul R, 2000, BIOCHEMISTRY-US, V39, P4801, DOI 10.1021/bi992805t; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Offenbacher AR, 2017, ACS CENTRAL SCI, V3, P570, DOI 10.1021/acscentsci.7b00142; Offenbacher AR, 2016, TETRAHEDRON LETT, V57, P4537, DOI 10.1016/j.tetlet.2016.08.071; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; RESTREPO F, 1973, J FOOD SCI, V38, P779, DOI 10.1111/j.1365-2621.1973.tb02074.x; Ruddat VC, 2003, BIOCHEMISTRY-US, V42, P4172, DOI 10.1021/bi020698o; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Sowole MA, 2014, ANAL CHEM, V86, P6715, DOI 10.1021/ac501849n; Tatulian SA, 1998, BIOCHEMISTRY-US, V37, P15481, DOI 10.1021/bi981062t; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; VANDERHEIJDT LM, 1995, EUR J BIOCHEM, V231, P186, DOI 10.1111/j.1432-1033.1995.tb20685.x; VANDERHEIJDT LM, 1992, EUR J BIOCHEM, V207, P793, DOI 10.1111/j.1432-1033.1992.tb17110.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Wecksler AT, 2009, BIOCHEMISTRY-US, V48, P8721, DOI 10.1021/bi9009242; Wecksler AT, 2009, BIOORGAN MED CHEM, V17, P6534, DOI 10.1016/j.bmc.2009.08.005; Wennman A, 2016, J BIOL CHEM, V291, P8130, DOI 10.1074/jbc.M115.707380; Whitehouse M W, 2006, Inflammopharmacology, V14, P99, DOI 10.1007/s10787-006-1523-7; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006	64	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1138	1148		10.1074/jbc.M117.817197	http://dx.doi.org/10.1074/jbc.M117.817197			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191828	hybrid, Green Published			2022-12-26	WOS:000423515000003
J	Canini, L; Imamura, M; Kawakami, Y; Uprichard, SL; Cotler, SJ; Dahari, H; Chayama, K				Canini, Laetitia; Imamura, Michio; Kawakami, Yoshiiku; Uprichard, Susan L.; Cotler, Scott J.; Dahari, Harel; Chayama, Kazuaki			HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients	PLOS ONE			English	Article							SOFOSBUVIR COMBINATION THERAPIES; CHRONIC HEPATITIS-C; PROTEASE INHIBITOR; PLUS ASUNAPREVIR; NULL RESPONDERS; DUAL THERAPY; CIRRHOSIS; REGIMENS; TIME	Background & aims High cure rates are achieved in HCV genotype-1b patients treated with daclatasvir and asunaprevir, DCV/ASV. Here we analyzed early HCV kinetics in genotype-1b infected Japanese subjects treated with DCV/ASV and retrospectively projected, using mathematical modeling, whether shorter treatment durations might be effective. Methods HCV RNA levels were measured frequently during DCV/ASV therapy in 95 consecutively treated patients at a single center in Japan. Mathematical modeling was used to predict the time to cure, i.e, <1 virus copy in the extracellular body fluid. Patients with HCV<15 IU/ml at week 1 (n = 27) were excluded from modeling analysis due to insufficient HCV RNA data points. Results Eighty nine of the 95 included patients (94%) achieved cure, 3 (3%) relapsed due to treatment-emergent resistance, and 3 (3%) completed therapy but were lost during follow up. Model fits from 68 patients with sufficient data points indicate that after a short pharmacological delay (15.4 min [relative standard error, rse = 26%]), DCV/ASV effectiveness in blocking HCV production was 0.999 [rse similar to 0%], HCV half-life in blood was t(1/2) = 1.7 hr [rse = 21%], and HCV-infected cell loss rate was 0.391/d [rse = 5%]. Modeling predicted that 100% and 98.5% of patients who had HCV< 15 IU/ml at days 14 and 28 might have been cured with 6 and 8 weeks of therapy, respectively. There was a trend (p = 0.058) between younger age and shorter time to cure. Conclusion Modeling early HCV kinetics under DCV/ASV predicts that most patients would achieve cure with short treatment durations, suggesting that 24 weeks of DCV/ASV treatment can be significantly shortened.	[Canini, Laetitia; Uprichard, Susan L.; Cotler, Scott J.; Dahari, Harel] Loyola Univ, Med Ctr, Dept Med, Program Expt & Theoret Modeling,Div Hepatol, Maywood, IL 60153 USA; [Canini, Laetitia] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Imamura, Michio; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Loyola University Chicago; University of Edinburgh; Hiroshima University	Dahari, H (corresponding author), Loyola Univ, Med Ctr, Dept Med, Program Expt & Theoret Modeling,Div Hepatol, Maywood, IL 60153 USA.; Chayama, K (corresponding author), Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan.	hdahari@luc.edu; chayama@mba.ocn.ne.jp	Canini, Laetitia/K-1278-2019	Canini, Laetitia/0000-0001-7643-1219; Chayama, Kazuaki/0000-0002-5530-5341	U.S. National Institute of Health (NIH) [R01 -A1078881, R01GM121600]; UK Biotechnology and Biological Sciences Research Council [1698:BB/L001330/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121600] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported in part by the U.S. National Institute of Health (NIH) grants R01 -A1078881 and R01GM121600 and by the UK Biotechnology and Biological Sciences Research Council (grant reference 1698:BB/L001330/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Dahari H, 2016, J HEPATOL, V65, P462, DOI 10.1016/j.jhep.2016.05.028; Dahari H, 2016, J HEPATOL, V64, P1232, DOI 10.1016/j.jhep.2016.02.022; Dahari H, 2015, LIVER INT, V35, P289, DOI 10.1111/liv.12692; Gambato M, 2016, J HEPATOL, V64, pS795, DOI 10.1016/S0168-8278(16)01550-6; Goyal A, 2017, ANTIVIR RES, V144, P281, DOI 10.1016/j.antiviral.2017.06.019; Hayes CN, 2017, EXPERT REV GASTROENT, V11, P103, DOI 10.1080/17474124.2017.1270205; Hayes CN, 2015, J FORMOS MED ASSOC, V114, P204, DOI 10.1016/j.jfma.2014.09.001; Ikeda K, 2000, HEPATOL RES, V18, P252, DOI 10.1016/S1386-6346(00)00074-7; Kao JH, 2017, J GASTROEN HEPATOL, V32, P966, DOI 10.1111/jgh.13709; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Maasoumy B, 2016, J HEPATOL, V65, P473, DOI 10.1016/j.jhep.2016.04.006; Malespin M, 2017, THER ADV GASTROENTER, V10, P68, DOI 10.1177/1756283X16672392; Morio K, 2017, J GASTROEN HEPATOL, V32, P645, DOI 10.1111/jgh.13511; Rong LB, 2012, B MATH BIOL, V74, P1789, DOI 10.1007/s11538-012-9736-y; Sansone N, 2014, HEPATOLOGY, V60, p1165A; Sulkowski MS, 2017, LIVER INT, V37, P836, DOI 10.1111/liv.13335; Nguyen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03591-2; Toyota J, 2017, J GASTROENTEROL, V52, P385, DOI 10.1007/s00535-016-1245-6; WHO &VERBAR; Guidelines for the screening, CAR TREATM PERS CHRO	21	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187409	10.1371/journal.pone.0187409	http://dx.doi.org/10.1371/journal.pone.0187409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216198	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800007
J	Poplova, M; Sovka, P; Cifra, M				Poplova, Michaela; Sovka, Pavel; Cifra, Michal			Poisson pre-processing of nonstationary photonic signals: Signals with equality between mean and variance	PLOS ONE			English	Article							NEUTROPHILS IN-VITRO; PHOTOCOUNT STATISTICS; CHEMILUMINESCENCE; FLUCTUATIONS; LIGHT; EMISSION; SENSOR; IONS	Photonic signals are broadly exploited in communication and sensing and they typically exhibit Poisson-like statistics. In a common scenario where the intensity of the photonic signals is low and one needs to remove a nonstationary trend of the signals for any further analysis, one faces an obstacle: due to the dependence between the mean and variance typical for a Poisson-like process, information about the trend remains in the variance even after the trend has been subtracted, possibly yielding artifactual results in further analyses. Commonly available detrending or normalizing methods cannot cope with this issue. To alleviate this issue we developed a suitable pre-processing method for the signals that originate from a Poisson-like process. In this paper, a Poisson pre-processing method for nonstationary time series with Poisson distribution is developed and tested on computer-generated model data and experimental data of chemiluminescence from human neutrophils and mung seeds. The presented method transforms a nonstationary Poisson signal into a stationary signal with a Poisson distribution while preserving the type of photocount distribution and phase-space structure of the signal. The importance of the suggested pre-processing method is shown in Fano factor and Hurst exponent analysis of both computer-generated model signals and experimental photonic signals. It is demonstrated that our pre-processing method is superior to standard detrending-based methods whenever further signal analysis is sensitive to variance of the signal.	[Poplova, Michaela; Cifra, Michal] Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 18251 8, Czech Republic; [Poplova, Michaela; Sovka, Pavel] Czech Tech Univ, Fac Elect Engn, Tech 2, Prague 16627 6, Czech Republic	Czech Academy of Sciences; Institute of Photonics & Electronics of the Czech Academy of Sciences; Czech Technical University Prague	Cifra, M (corresponding author), Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 18251 8, Czech Republic.	cifra@ufe.cz	Cifra, Michal/D-4416-2013	Cifra, Michal/0000-0002-8853-9523	Czech Science Foundation [GA13-29294S]; Czech Technical University in Prague [SGS15/198/OHK3/3T/13]; Czech Academy of Sciences [SAV-15-22]; Slovak Academy of Sciences [SAV-15-22]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Technical University in Prague; Czech Academy of Sciences(Czech Academy of Sciences); Slovak Academy of Sciences(Slovak Academy of Sciences)	The authors acknowledge the support from the Czech Science Foundation (grant no. GA13-29294S) to M.C. and a grant from the Czech Technical University in Prague (grant no. SGS15/198/OHK3/3T/13). M.C. and M.P. participate in COST Actions BM1309, CA15211 and project no. SAV-15-22 between Czech and Slovak Academies of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from the Czech Science Foundation (grant no. GA13-29294S) and a grant from the Czech Technical University in Prague (grant no. SGS15/198/OHK3/3T/13). M.C. and M.P. participate in COST Actions BM1309, CA15211 and project no. SAV-15-22 between Czech and Slovak Academies of Sciences. Honorata Nawrocka-Bogusz is acknowledged for introducing the neutrophil isolation method to us.	[Anonymous], 1936, J R STAT SOC B, DOI DOI 10.2307/2983678; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Azzari L, 2016, IEEE SIGNAL PROC LET, V23, P1086, DOI 10.1109/LSP.2016.2580600; Bajpai RP, 2008, INDIAN J EXP BIOL, V46, P420; Bajpai RP, 2013, J PHOTOCH PHOTOBIO B, V129, P6, DOI 10.1016/j.jphotobiol.2013.09.002; Bendat J. S., 1966, MEASUREMENT ANAL BIN; Bland EJ, 2001, MOL BIOTECHNOL, V19, P125, DOI 10.1385/MB:19:2:125; Bryce RM, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00315; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Cifra M, 2015, J LUMIN, V164, P38, DOI 10.1016/j.jlumin.2015.03.020; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Feder J., 2013, FRACTALS; Freltas M, 2008, CLIN BIOCHEM, V41, P570, DOI 10.1016/j.clinbiochem.2007.12.021; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Guan Y, 2009, STAT PROBABIL LETT, V79, P1621, DOI 10.1016/j.spl.2009.04.010; Guderian A, 1999, CHEM PHYS LETT, V312, P440, DOI 10.1016/S0009-2614(99)00931-8; Halvorson RA, 2010, ENVIRON SCI TECHNOL, V44, P7749, DOI 10.1021/es101228z; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Iranifam M, 2010, LUMINESCENCE, V25, P409, DOI 10.1002/bio.1203; Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a; King MR, 2010, NUMERICAL STAT METHO; Kobayashi M, 1998, PHYS REV E, V57, P2129, DOI 10.1103/PhysRevE.57.2129; Kobayashi M, 2000, APPL OPTICS, V39, P183, DOI 10.1364/AO.39.000183; Larose D.T., 2015, DATA MINING PREDICTI, V2nd ed.; Malchus N, 2010, J FLUORESC, V20, P19, DOI 10.1007/s10895-009-0517-4; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; Manolakis DG, 2005, STAT ADAPTIVE SIGNAL, V46; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; Nawrocka-Bogusz H, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012023; Neely A, 2009, ACS NANO, V3, P2834, DOI 10.1021/nn900813b; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Piliarik M, 2009, BIOSENS BIOELECTRON, V24, P1399, DOI 10.1016/j.bios.2008.08.012; Poniedzialek B, 2013, ELECTROMAGN BIOL MED, V32, P333, DOI 10.3109/15368378.2012.721845; Rafieiolhosseini N, 2016, J PHOTOCH PHOTOBIO B, V162, P50, DOI 10.1016/j.jphotobiol.2016.06.001; Ramanujan VK, 2014, METHODS, V66, P222, DOI 10.1016/j.ymeth.2013.08.027; Ramanujan VK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2928154; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Rigler R., 2012, FLUORESCENCE CORRELA, V65; SAMUNI A, 1991, FREE RADICAL BIO MED, V10, P305, DOI 10.1016/0891-5849(91)90037-4; Shao YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00835; Sperling J, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023820; Teich M. C., 1989, Quantum Optics, V1, P153, DOI 10.1088/0954-8998/1/2/006; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; van Wijk E, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012021; Van Wijk EPA, 2008, INDIAN J EXP BIOL, V46, P345; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V99, P133, DOI 10.1016/j.jphotobiol.2010.03.008; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V84, P46, DOI 10.1016/j.jphotobiol.2006.01.010; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188622	10.1371/journal.pone.0188622	http://dx.doi.org/10.1371/journal.pone.0188622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216207	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800031
J	Adikusuma, F; Pfitzner, C; Thomas, PQ				Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton			Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; MOUSE MODEL; RNA; CAS9; NUCLEASES; CRISPR-CAS9; SPECIFICITY; GENERATION; NICKASES; SYSTEM	CRISPR/Cas9 technology enables efficient, rapid and cost-effective targeted genomic modification in a wide variety of cellular contexts including cultured cells. Some applications such as generation of double knock-outs, large deletions and paired-nickase cleavage require simultaneous expression of two gRNAs. Although single plasmids that enable multiplex expression of gRNAs have been developed, these require multiple rounds of cloning and/or PCR for generation of the desired construct. Here, we describe a series of vectors that enable generation of customized dual-gRNA expression constructs via an easy onestep golden gate cloning reaction using two annealed oligonucleotide inserts with different overhangs. Through nucleofection of mouse embryonic stem cells, we demonstrate highly efficient cleavage of the target loci using the dual-guide plasmids, which are available as Cas9-nuclease or Cas9-nickase expression constructs, with or without selection markers. These vectors are a valuable addition to the CRISPR/Cas9 toolbox and will be made available to all interested researchers via the Addgene plasmid repository.	[Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adikusuma, Fatwa] Diponegoro Univ, Fac Med, Ctr Biomed Res, Semarang, Central Java, Indonesia; [Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Thomas, Paul Quinton] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Adelaide; Diponegoro University; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Thomas, PQ (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Adikusuma, Fatwa/ABA-2989-2020	Adikusuma, Fatwa/0000-0003-2163-0514; Pfitzner, Chandran/0000-0001-6151-5479				Adikusuma F, 2017, MOL THER, V25, P1736, DOI 10.1016/j.ymthe.2017.05.021; Adikusuma F, 2017, GENETICS, V206, P1495, DOI 10.1534/genetics.117.202549; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083	28	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187236	10.1371/journal.pone.0187236	http://dx.doi.org/10.1371/journal.pone.0187236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211736	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200015
J	Agarwal, S; Ying, J; Boucher, KM; Agarwal, JP				Agarwal, Shailesh; Ying, Jian; Boucher, Kenneth M.; Agarwal, Jayant P.			The association between socioeconomic factors and breast cancer-specific survival varies by race	PLOS ONE			English	Article							RACIAL DISPARITIES; TUMOR MICROENVIRONMENT; AFRICAN-AMERICAN; WHITE WOMEN; OUTCOMES; POPULATION; ETHNICITY; IMPACT	Although racial disparity is well described for oncologic outcomes, factors associated with survival within racial groups remains unexplored. The objective of this study is to determine whether breast cancer survival among White or Black patients is associated with differing patient factors. Women diagnosed with breast cancer from 1998 through 2012 were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazard logistic regression was used to estimate cause-specific survival in the combined cohort, and separate cohorts of Black or White patients only. Main outcomes included cause-specific survival in cohorts of Black only, White only, or all patients adjusted for demographic and oncologic factors. A total of 406,907 Black (10.8%) or White (89.2%) patients diagnosed with breast cancer from 1998 through 2012 were isolated. Cancer-specific survival analysis of the combined cohort showed significantly decreased hazard ratio (H.R.) in patients from the higher economic quartiles (Q1: 1.0 (ref), Q2: 0.95 (p<0.01), Q3: 0.94 (p<0.01), Q4: 0.87 (p<0.001)). Analysis of the White only cohort showed a similar relationship with income (Q1: 1.0 (ref), Q2: 0.95 (p<0.01), Q3: 0.95 (p<0.01), Q4: 0.86 (p<0.001)). However, analysis of the Black only cohort did not show a relationship with income (Q1: 1.0 (ref), Q2: 1.04 (p = 0.34), Q3: 0.97 (p = 0.53), Q4: 1.04 (p = 0.47)). A test of interaction confirmed that the association between income and cancer-specific survival is dependent on patient race, both with and without adjustment for demographic and oncologic characteristics (p<0.01). While median county income is positively associated with cancer-specific survival among White patients, this is not the case with Black patients. Similar findings were noted for education level. These findings suggest that the association between socioeconomic status and breast cancer survival commonly reported in the literature is specific to White patients. These findings provide insight into differences between White and Black patients in cancer-specific survival.	[Agarwal, Shailesh] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Ying, Jian; Boucher, Kenneth M.] Univ Utah, Biostat Core, Huntsman Canc Inst, Salt Lake City, UT USA; [Agarwal, Jayant P.] Univ Utah, Dept Surg, Div Plast Surg, Salt Lake City, UT 84112 USA	University of Michigan System; University of Michigan; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Agarwal, JP (corresponding author), Univ Utah, Dept Surg, Div Plast Surg, Salt Lake City, UT 84112 USA.	jay.agarwal@hsc.utah.edu						Conway K, 2015, CANCER EPIDEM BIOMAR, V24, P921, DOI 10.1158/1055-9965.EPI-14-1228; Deshmukh SK, 2017, CANCER LETT, V396, P21, DOI 10.1016/j.canlet.2017.03.010; Deshmukh SK, 2017, CARCINOGENESIS, V38, P757, DOI 10.1093/carcin/bgx037; Evans-Knowell A, 2017, ADV CANCER RES, V133, P51, DOI 10.1016/bs.acr.2016.08.003; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Keenan T, 2015, J CLIN ONCOL, V33, P3621, DOI 10.1200/JCO.2015.62.2126; Kish Jonathan K., 2014, Journal of the National Cancer Institute Monographs, P236, DOI 10.1093/jncimonographs/lgu020; Komenaka IK, 2010, J NATL CANCER I, V102, P1178, DOI 10.1093/jnci/djq215; Koru-Sengul T, 2016, BREAST CANCER RES TR, V158, P113, DOI 10.1007/s10549-016-3847-3; Silber JH, 2014, ANN INTERN MED, V161, P845, DOI 10.7326/M14-0900; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Singal V, 2012, J CANCER RES CLIN, V138, P715, DOI 10.1007/s00432-012-1156-8; Vidal G, 2017, CANCER MED-US, V6, P1776, DOI 10.1002/cam4.1117; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364; Zeng C, 2015, JAMA ONCOL, V1, P88, DOI DOI 10.1001/JAMA0NC0L.2014.161	15	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187018	10.1371/journal.pone.0187018	http://dx.doi.org/10.1371/journal.pone.0187018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211739	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200011
J	Gray, TA; Dumville, JC; Christie, J; Cullum, NA				Gray, Trish A.; Dumville, Jo C.; Christie, Janice; Cullum, Nicky A.			Rapid research and implementation priority setting for wound care uncertainties	PLOS ONE			English	Article							NOMINAL GROUP TECHNIQUE; TACKLING TREATMENT UNCERTAINTIES; DECISION-MAKING; RESEARCH QUESTIONS; CLINICAL-RESEARCH; MANAGEMENT; HEALTH; PARTNERSHIP; EDUCATION; PATIENT	Introduction People with complex wounds are more likely to be elderly, living with multimorbidity and wound related symptoms. A variety of products are available for managing complex wounds and a range of healthcare professionals are involved in wound care, yet there is a lack of good evidence to guide practice and services. These factors create uncertainty for those who deliver and those who manage wound care. Formal priority setting for research and implementation topics is needed to more accurately target the gaps in treatment and services. We solicited practitioner and manager uncertainties in wound care and held a priority setting workshop to facilitate a collaborative approach to prioritising wound care-related uncertainties. Methods We recruited healthcare professionals who regularly cared for patients with complex wounds, were wound care specialists or managed wound care services. Participants submitted up to five wound care uncertainties in consultation with their colleagues, via an online survey and attended a priority setting workshop. Submitted uncertainties were collated, sorted and categorised according professional group. On the day of the workshop, participants were divided into four groups depending on their profession. Uncertainties submitted by their professional group were viewed, discussed and amended, prior to the first of three individual voting rounds. Participants cast up to ten votes for the uncertainties they judged as being high priority. Continuing in the professional groups, the top 10 uncertainties from each group were displayed, and the process was repeated. Groups were then brought together for a plenary session in which the final priorities were individually scored on a scale of 0-10 by participants. Priorities were ranked and results presented. Nominal group technique was used for generating the final uncertainties, voting and discussions. Results Thirty-three participants attended the workshop comprising; 10 specialist nurses, 10 district nurses, seven podiatrists and six managers. Participants had been qualified for a mean of 20.7 years with a mean of 16.8 years of wound care experience. One hundred and thirty-nine uncertainties were submitted electronically and a further 20 were identified on the day of the workshop following lively, interactive group discussions. Twenty-five uncertainties from the total of 159 generated made it to the final prioritised list. These included six of the 20 new uncertainties. The uncertainties varied in focus, but could be broadly categorised into three themes: service delivery and organisation, patient centred care and treatment options. Specialist nurses were more likely to vote for service delivery and organisation topics, podiatrists for patient centred topics, district nurses for treatment options and operational leads for a broad range. Conclusions This collaborative priority setting project is the first to engage front-line clinicians in prioritising research and implementation topics in wound care. We have shown that it is feasible to conduct topic prioritisation in a short time frame. This project has demonstrated that with careful planning and rigor, important questions that are raised in the course of clinicians' daily decision making can be translated into meaningful research and implementation initiatives that could make a difference to service delivery and patient care.	[Gray, Trish A.; Dumville, Jo C.; Christie, Janice; Cullum, Nicky A.] Univ Manchester, Sch Hlth Sci, Div Nursing Midwifery & Social Work, Manchester, Lancs, England; [Cullum, Nicky A.] Cent Manchester Univ Hosp NHS Fdn Trust, Res & Innovat Div, Manchester, Lancs, England	University of Manchester; University of Manchester	Gray, TA (corresponding author), Univ Manchester, Sch Hlth Sci, Div Nursing Midwifery & Social Work, Manchester, Lancs, England.	Trish.Gray@manchester.ac.uk	Gray, Trish/O-8790-2014; Christie, Janice/O-9320-2014; Cullum, Nicky/AAT-5888-2020; Dumville, Jo/O-7867-2014	Gray, Trish/0000-0002-8088-0698; Christie, Janice/0000-0001-6176-6075; Cullum, Nicky/0000-0003-2631-123X; Dumville, Jo/0000-0002-6546-3685	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester; National Institute for Health Research [NF-SI-0512-10028] Funding Source: researchfish	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester. The NIHR CLAHRC Greater Manchester is a partnership between providers and commissioners from the NHS, industry and the third sector, as well as clinical and research staff from the University of Manchester. NC received funding for the project, details of which can be found at http://clahrc-gm.nihr.ac.uk/our-work/wound-care/. NC, JD and TG are partially supported by the funding. The views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor JM, 2013, BRIT J DERMATOL, V168, P577, DOI 10.1111/bjd.12040; Bell-Syer Sally E M, 2007, Adv Skin Wound Care, V20, P283, DOI 10.1097/01.ASW.0000269316.68757.0e; Blevins D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-76; Boddy C, 2012, QUAL MARK RES, V15, P6, DOI 10.1108/13522751211191964; Bratzke LC, 2015, INT J NURS STUD, V52, P744, DOI 10.1016/j.ijnurstu.2014.10.010; Buckley Brian S, 2010, Nurs Times, V106, P36; Carney O, 1996, J ADV NURS, V23, P1024, DOI 10.1046/j.1365-2648.1996.09623.x; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2013, J ROY SOC MED, V106, P482, DOI 10.1177/0141076813493063; Chalmers I, 2009, OBSTET GYNECOL, V114, P1341, DOI 10.1097/AOG.0b013e3181c3020d; Cheung C, 2010, ADV SKIN WOUND CARE, V23, P39, DOI 10.1097/01.ASW.0000363487.01977.a9; Chitama D, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-46; Cooke J, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0014-y; Cowan K, 2010, J AMBUL CARE MANAG, V33, P241, DOI 10.1097/JAC.0b013e3181e62cda; Cowman S, 2012, J CLIN NURS, V21, P344, DOI 10.1111/j.1365-2702.2011.03950.x; Crowe Sally, 2015, Res Involv Engagem, V1, P2, DOI 10.1186/s40900-015-0003-x; Cullum N, 2016, PROGRAMME GRANTS APP, V4; Dalheim A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-367; Deane KHO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006434; Dowsett C, 2014, J WOUND CARE, V23, P552, DOI 10.12968/jowc.2014.23.11.552; Elwyn G, 2010, J EVAL CLIN PRACT, V16, P627, DOI 10.1111/j.1365-2753.2009.01262.x; Forsman H, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-46; Friman A, 2014, PRIM HEALTH CARE RES, V15, P386, DOI 10.1017/S1463423613000303; Gadsby R, 2012, DIABETIC MED, V29, P1321, DOI 10.1111/j.1464-5491.2012.03755.x; Gillespie BM, 2015, J ADV NURS, V71, P1238, DOI 10.1111/jan.12598; Hall J, 2014, WOUND REPAIR REGEN, V22, P694, DOI 10.1111/wrr.12230; Harvey N, 2012, INT J NURS PRACT, V18, P188, DOI 10.1111/j.1440-172X.2012.02017.x; Hastings Clare, 2014, Nurs Manage, V45, P9, DOI 10.1097/01.NUMA.0000452006.79838.67; Hodgson R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-19; Jacob E, 2017, J ADV NURS, V73, P1982, DOI 10.1111/jan.13306; Kelly S, 2015, AGE AGEING, V44, P985, DOI 10.1093/ageing/afv143; Knight SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162136; Layton A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008085; Lophatananon A, 2011, BJU INT, V108, P1040, DOI 10.1111/j.1464-410X.2011.10609.x; Madden M., 2016, RES INVOLVEMENT ENGA, V2, P1, DOI [10.1186/s40900-016-0026-y, DOI 10.1186/S40900-016-0026-Y]; McMillan SS, 2016, INT J CLIN PHARM; Naimoli JF, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0041-3; Norris R, 2012, J WOUND CARE, V21, P216, DOI 10.12968/jowc.2012.21.5.216; Petit-Zeman S, 2010, LANCET, V376, P667, DOI 10.1016/S0140-6736(10)60712-X; Pollock A, 2014, J HEALTH SERV RES PO, V19, P12, DOI 10.1177/1355819613500665; Rangan A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010412; Renner R, 2014, ACTA DERM-VENEREOL, V94, P50, DOI 10.2340/00015555-1635; Rowe F, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004905; Sibbald SL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-43; Squires JE, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-21; Stone PW, 2002, APPL NURS RES, V15, P197, DOI 10.1053/apnr.2002.34181; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Thomas RH, 2010, J NEUROL NEUROSUR PS, V81, P918, DOI 10.1136/jnnp.2009.192716; Tong A, 2008, NEPHROL DIAL TRANSPL, V23, P3206, DOI 10.1093/ndt/gfn207; Tong A, 2015, AM J KIDNEY DIS, V66, P212, DOI 10.1053/j.ajkd.2015.02.341; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; van der Veer SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128228; Vedhara K, 2010, DIABETOLOGIA, V53, P1590, DOI 10.1007/s00125-010-1743-7; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Vowden K, 2005, INTERNURSECOM S2, V10, pS6; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; West C, 2012, NURS EDUC TODAY, V32, P576, DOI 10.1016/j.nedt.2011.07.002; Whiffin Charlotte Jane, 2013, Br J Nurs, V22, P831; Woo Kevin Y, 2012, Surg Technol Int, V22, P57	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188958	10.1371/journal.pone.0188958	http://dx.doi.org/10.1371/journal.pone.0188958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206884	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700033
J	Jeong, HJ; Abhiraman, GC; Story, CM; Ingram, JR; Dougan, SK				Jeong, Hee-Jin; Abhiraman, Gita C.; Story, Craig M.; Ingram, Jessica R.; Dougan, Stephanie K.			Generation of Ca2+-independent sortase A mutants with enhanced activity for protein and cell surface labeling	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; LIGATION; TRANSPEPTIDASE; PEPTIDES; WALL	Sortase A, a calcium-dependent transpeptidase derived from Staphylococcus aureus, is used in a broad range of applications, such as the conjugation of fluorescent dyes and other moieties to proteins or to the surface of eukaryotic cells. In vivo and cell-based applications of sortase have been somewhat limited by the large range of calcium concentrations, as well as by the often transient nature of protein-protein interactions in living systems. In order to use sortase A for cell labeling applications, we generated a new sortase A variant by combining multiple mutations to yield an enzyme that was both calcium-independent and highly active. This variant has enhanced activity for both N-and C-terminal labeling, as well as for cell surface modification under physiological conditions.	[Jeong, Hee-Jin; Abhiraman, Gita C.; Ingram, Jessica R.; Dougan, Stephanie K.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Jeong, Hee-Jin; Ingram, Jessica R.; Dougan, Stephanie K.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Story, Craig M.] Gordon Coll, Dept Biol, Wenham, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Dougan, SK (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Dougan, SK (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	Stephanie_Dougan@dfci.harvard.edu	Jeong, Hee-Jin/AGR-3650-2022	Abhiraman, Gita/0000-0002-0546-4133	Dana-Farber Center for Cancer Immunology Research; Harvard PRISE program; Claudia Adams Barr Foundation; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	Dana-Farber Center for Cancer Immunology Research; Harvard PRISE program; Claudia Adams Barr Foundation; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	HJJ was funded by a fellowship from the Dana-Farber Center for Cancer Immunology Research. GCA was funded by the Harvard PRISE program. SKD and JRI were funded by the Claudia Adams Barr Foundation. SKD was funded by the Dana-Farber Cancer Institute/Novartis Drug Discovery Program.	Antos John M, 2017, Curr Protoc Protein Sci, V89, DOI 10.1002/cpps.38; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Chen I, 2011, GEN STRATEGY EVOLUTI; Chen L, 2016, SCI REP NATURE PUBLI, P1; Dougan SK, 2013, CANCER IMMUNOL RES, V1, P99, DOI 10.1158/2326-6066.CIR-13-0047; Frese MA, 2009, CHEMBIOCHEM; Glasgow JE, 2016, J AM CHEM SOC, V138, P7496, DOI 10.1021/jacs.6b03836; Hirakawa H, 2015, BIOTECHNOLOGY J; Hirakawa H, 2012, BIOTECHNOLOGY AND; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Ingram JR, 2017, NATURE COMMUNICATION, P1; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Milo R., 2015, CELL BIOL NUMBERS; Nguyen GKT, 2016, NAT PROTOC, V11, P1977, DOI 10.1038/nprot.2016.118; Pishesha N, 2017, P NATL ACAD SCI USA, V114, P3157, DOI 10.1073/pnas.1701746114; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Popp MW, 2011, SORTASE CATALYZED TR; Rashidian M, 2015, ACS CENTRAL SCI, V1, P142, DOI 10.1021/acscentsci.5b00121; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Shi JH, 2014, P NATL ACAD SCI USA, V111, P10131, DOI 10.1073/pnas.1409861111; Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x; Swee LK, 2015, ACS CHEM BIOL, V10, P460, DOI 10.1021/cb500462t; Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Vincke C, 2012, INTRO HEAVY CHAIN AN, P15; Witte MD, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.026; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109; Wu Q, 2017, ACS CHEM BIOL; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883	31	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189068	10.1371/journal.pone.0189068	http://dx.doi.org/10.1371/journal.pone.0189068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200433	Green Published, Green Submitted, gold			2022-12-26	WOS:000417033200027
J	Lopez-Torrecillas, F; Lopez-Quirantes, EM; Maldonado, A; Albein-Urios, N; Rueda, MD; Verdejo-Garcia, A				Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio; Albein-Urios, Natalia; del Mar Rueda, Ma; Verdejo-Garcia, Antonio			Decisional balance and processes of change in community-recruited with moderate-high versus mild severity of cannabis dependence	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; NICOTINE DEPENDENCE; SMOKING-CESSATION; FAGERSTROM TEST; ALCOHOL-USE; SCALE SDS; BEHAVIORS; USERS; RELIABILITY; RELAPSERS	Decisional Balance and Processes of Change are generally addressed in motivational interventions for the treatment of cannabis use disorders. However, specific aspects of these multifaceted constructs, with greater relevance for severe cannabis users, need to be ascertained to enable better interventions. This study aimed to compare the different facets of decisional balance and processes of change between mild and severe cannabis users in a community-based sample of young undergraduates. Thirty-one severe cannabis users and 31 mild cannabis users, indicated with the Severity of Dependence Scale, were assessed using the Decisional Balance Questionnaire (DBQ) and the Processes of Change Questionnaire (PCQ). We found that severe cannabis users had higher scores in the DBQ dimensions of Utilitarian Gains for the Self, Utilitarian Gains for Significant Others, and Selfapproval, as well as in the total subscale of Gains but not Losses. The group of severe cannabis users also had higher scores in the PCQ dimensions of Self-revaluations and Counter-conditioning. Our results pinpoint specific dimensions of Decisional Balance and Processes of Change that are endorsed by severe cannabis users. This knowledge could be applied to inform motivational interventions targeting severe cannabis users.	[Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio] Univ Granada, Dept Expt Psychol, Learning Emot & Decis Grp, Granada, Spain; [Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio] Univ Granada, Ctr Res Mind Brain & Behav CIMCYC, Granada, Spain; [Albein-Urios, Natalia] Deakin Univ, Sch Psychol, Burwood, Vic, Australia; [del Mar Rueda, Ma] Univ Granada, Dept Stat & Operat Res, Granada, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia	University of Granada; University of Granada; Deakin University; University of Granada; Monash University	Lopez-Torrecillas, F (corresponding author), Univ Granada, Dept Expt Psychol, Learning Emot & Decis Grp, Granada, Spain.; Lopez-Torrecillas, F (corresponding author), Univ Granada, Ctr Res Mind Brain & Behav CIMCYC, Granada, Spain.	fcalopez@ugr.es	Albein-Urios, Natalia/A-4514-2016; Verdejo-Garcia, Antonio/AAV-1147-2021; Lopez-Torrecillas, Francisca/C-8267-2018; Maldonado, Antonio/E-9540-2018; Rueda, Maria del Mar/F-9571-2015	Albein-Urios, Natalia/0000-0001-7841-018X; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Maldonado, Antonio/0000-0001-5903-3833; lopez-torrecillas, francisca/0000-0002-4541-5184; Rueda, Maria del Mar/0000-0002-2903-8745				Becona E, 1998, PSYCHOL REP, V83, P1455, DOI 10.2466/pr0.1998.83.3f.1455; Brown JL, 2013, CURR HIV-AIDS REP, V10, P356, DOI 10.1007/s11904-013-0174-8; Bruijnzeel AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153327; Cataldo JK, 2010, ONCOLOGY-BASEL, V78, P289, DOI 10.1159/000319937; Cooper K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19560; Cuenca-Royo AM, 2012, ADDICT BEHAV, V37, P709, DOI 10.1016/j.addbeh.2012.02.012; D'Amico EJ, 2015, J CONSULT CLIN PSYCH, V83, P68, DOI 10.1037/a0038155; Davis ML, 2015, EVAL HEALTH PROF, V38, P94, DOI 10.1177/0163278714529970; Elliott JC, 2011, PSYCHOL ADDICT BEHAV, V25, P90, DOI 10.1037/a0021743; Enzi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119150; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), ANN REP 2015; Girle R, 2004, ARGUMENTATION LIB, V9, P55; Gokbayrak NS, 2015, ADDICT BEHAV, V42, P176, DOI 10.1016/j.addbeh.2014.11.022; Gonzalez-Pinto A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160949; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hides L, 2007, ADDICTION, V102, P35, DOI 10.1111/j.1360-0443.2006.01669.x; Koenders L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152482; Longmire-Avital B, 2010, ANN BEHAV MED, V40, P176, DOI 10.1007/s12160-010-9194-4; Lorenzetti V, 2016, FRONT BEHAV NEUROSCI, V10; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Migneault JP, 1999, SUBST USE MISUSE, V34, P1325, DOI 10.3109/10826089909029387; Norman GJ, 1998, ADDICT BEHAV, V23, P139, DOI 10.1016/S0306-4603(97)00039-7; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Redding CA, 2011, SUBST USE MISUSE, V46, P1664, DOI 10.3109/10826084.2011.565853; Rohsenow D., 1992, 26 ANN CONV ASS ADV; Sun X, 2007, ADDICT BEHAV, V32, P2707, DOI 10.1016/j.addbeh.2007.04.005; Tejero A., 2003, INSTRUMENTOS 150 NIC, P23; Tejero A, 1994, DROGODEPENDENCIAS IN, P163; Troup LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149764; Trujols J, 1997, ADICCIONES, V9, P331; van Winkel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137625; Velasquez MM, 2009, J CONSULT CLIN PSYCH, V77, P657, DOI 10.1037/a0015519; VELICER WF, 1985, J PERS SOC PSYCHOL, V48, P1279, DOI 10.1037/0022-3514.48.5.1279	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188476	10.1371/journal.pone.0188476	http://dx.doi.org/10.1371/journal.pone.0188476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29206230	Green Published, gold			2022-12-26	WOS:000417033200008
J	De Silva, NH; Akazawa, T; Wijewardana, V; Inoue, N; Oyamada, M; Ohta, A; Tachibana, Y; Wijesekera, DPH; Kuwamura, M; Nishizawa, Y; Itoh, K; Izawa, T; Hatoya, S; Hasegawa, T; Yamate, J; Inaba, T; Sugiura, K				De Silva, Nadeeka H.; Akazawa, Takashi; Wijewardana, Viskam; Inoue, Norimitsu; Oyamada, Maremichi; Ohta, Atsuko; Tachibana, Yuki; Wijesekera, Daluthgamage Patsy H.; Kuwamura, Mitsuru; Nishizawa, Yasuko; Itoh, Kazuyuki; Izawa, Takeshi; Hatoya, Shingo; Hasegawa, Tetsuya; Yamate, Jyoji; Inaba, Toshio; Sugiura, Kikuya			Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand	PLOS ONE			English	Article							SUPPRESSOR-CELLS; PHASE-II; HEPATOCELLULAR-CARCINOMA; CANCER-IMMUNOTHERAPY; METASTATIC MELANOMA; CLINICAL-TRIAL; BEARING MICE; IFN; CYCLOPHOSPHAMIDE; VACCINATION	Although dendritic cell (DC)-based immunotherapy shows little toxicity, improvements should be necessary to obtain satisfactory clinical outcome. Using interferon-gamma injection along with DCs, we previously obtained significant clinical responses against small or early stage malignant tumors in dogs. However, improvement was necessary to be effective to largely developed or metastatic tumors. To obtain effective methods applicable to those tumors, we herein used a DC-targeting Toll-like receptor ligand, h11c, and examined the therapeutic effects in murine subcutaneous and visceral tumor models and also in the clinical treatment of canine cancers. In murine experiments, most and significant inhibition of tumor growth and extended survival was observed in the group treated with the combination of h11c-activated DCs in combination with interferon-gamma and a cyclooxygenase2 inhibitor. Both monocytic and granulocytic myeloid-derived suppressor cells were significantly reduced by the combined treatment. Following the successful results in mice, the combined treatment was examined against canine cancers, which spontaneously generated like as those in human. The combined treatment elicited significant clinical responses against a nonepithelial malignant tumor and a malignant fibrous histiocytoma. The treatment was also successful against a bone-metastasis of squamous cell carcinoma. In the successful cases, the marked increase of tumor-responding T cells and decrease of myeloid-derived suppressor cells and regulatory T cells was observed in their peripheral blood. Although the combined treatment permitted the growth of lung cancer of renal carcinoma-metastasis, the marked elevated and long-term maintaining of the tumor-responding T cells was observed in the patient dog. Overall, the combined treatment gave rise to emphatic amelioration in DC-based cancer therapy.	[De Silva, Nadeeka H.; Wijewardana, Viskam; Ohta, Atsuko; Tachibana, Yuki; Wijesekera, Daluthgamage Patsy H.; Hatoya, Shingo; Inaba, Toshio; Sugiura, Kikuya] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Adv Pathobiol, Izumisano, Japan; [Akazawa, Takashi; Inoue, Norimitsu] Osaka Int Canc Inst, Dept Tumor Immunol, Osaka, Japan; [Oyamada, Maremichi; Hasegawa, Tetsuya] Kakogawa Anim Hosp, Kakogawa, Hyogo, Japan; [Kuwamura, Mitsuru; Izawa, Takeshi; Yamate, Jyoji] Osaka Prefecture Univ, Dept Integrated Struct Biosci, Grad Sch Life & Environm Sci, Izumisano, Japan; [Nishizawa, Yasuko; Itoh, Kazuyuki] Nozaki Tokushukai, Res Inst, Daito, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Sugiura, K (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Adv Pathobiol, Izumisano, Japan.	sugiura@vet.osakafu-u.ac.jp	Hatoya, Shingo/ABE-5457-2020; Hatoya, Shingo/ABE-7060-2020	Hatoya, Shingo/0000-0001-5944-1394; Hatoya, Shingo/0000-0001-5944-1394; Sugiura, Kikuya/0000-0003-3366-237X; Izawa, Takeshi/0000-0003-3236-6050; Wijewardana, Viskam/0000-0002-5787-8792	Japan Society for the Promotion of Science [23380174]; Grants-in-Aid for Scientific Research [15K15560] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Science Research (B) No. 23380174 from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Akazawa T, 2007, FEBS LETT, V581, P3334, DOI 10.1016/j.febslet.2007.06.019; Akazawa T, 2014, INT J CANCER, V135, P2847, DOI 10.1002/ijc.28939; Akazawa T, 2010, CANCER SCI, V101, P1596, DOI 10.1111/j.1349-7006.2010.01583.x; Alfaro C, 2011, J IMMUNOL, V187, P6130, DOI 10.4049/jimmunol.1102209; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; de Rosa F, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-209; Edele F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105266; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gao DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093886; Goulart MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033274; Guo QM, 2012, INT IMMUNOPHARMACOL, V12, P425, DOI 10.1016/j.intimp.2011.12.016; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Jackson AM, 2008, INT J CANCER, V123, P623, DOI 10.1002/ijc.23530; Kodama K, 2009, SURG TODAY, V39, P194, DOI 10.1007/s00595-008-3826-3; Kohler C, 2007, CELL TISSUE RES, V330, P291, DOI 10.1007/s00441-007-0474-7; Koizumi S, 2012, CELL IMMUNOL, V276, P153, DOI 10.1016/j.cellimm.2012.05.002; Liu CC, 2008, CANCER IMMUNOL IMMUN, V57, P479, DOI 10.1007/s00262-007-0386-0; Matsushita H, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0030-4; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mito K, 2010, CANCER RES, V70, P7093, DOI 10.1158/0008-5472.CAN-10-0600; Mizuno T, 2009, J VET MED SCI, V71, P1561, DOI 10.1292/jvms.001561; Ning YL, 2016, INT J CANCER, V138, P2713, DOI 10.1002/ijc.30002; Ochoa MT, 2003, IMMUNOLOGY, V108, P10, DOI 10.1046/j.1365-2567.2003.01563.x; Oshita C, 2012, ONCOL REP, V28, P1131, DOI 10.3892/or.2012.1956; Palmer DH, 2009, HEPATOLOGY, V49, P124, DOI 10.1002/hep.22626; Ribas A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-89; Ridolfi L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-135; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Tada F, 2012, INT J ONCOL, V41, P1601, DOI 10.3892/ijo.2012.1626; Toh HC, 2009, CLIN CANCER RES, V15, P7726, DOI 10.1158/1078-0432.CCR-09-1537; Trapani JA, 2001, GENOME BIOL, V2; Yamamoto E, 2010, HISTOL HISTOPATHOL, V25, P995, DOI 10.14670/HH-25.995; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	35	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188738	10.1371/journal.pone.0188738	http://dx.doi.org/10.1371/journal.pone.0188738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190690	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900113
J	Feng, Y; Xu, CP; Li, CX; Lin, JF; Wang, ZF; Zhang, YJ; Jiang, JM; Lu, YY				Feng, Yan; Xu, Changping; Li, Cixiu; Lin, Junfen; Wang, Zhongfa; Zhang, Yanjun; Jiang, Jianmin; Lu, Yiyu			Replication capacity and adaptability of a severe fever with thrombocytopenia syndrome virus at different temperatures	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; SOUTH-KOREA; BUNYAVIRUS; SENSITIVITY; CHINA	Severe fever with thrombocytopenia syndrome (SFTS) is an emerging disease caused by the SFTS virus (SFTSV). Although fever and thrombocytopenia are the typical manifestations of SFTS, a specific SFTS case with no fever was observed in Zhejiang, China. In this report, we aimed to explore the probable reason for the absence of fever by analyzing the genetic characteristics and temperature sensitivity (ts) of the SFTSV strain ZJ2013-06, which was isolated from the specific case. Phylogenetically, different clusters of SFTSV strains circulated in Zhejiang. ZJ2013-06 was farthest from ZJ2014-02, an isolate belonging to a Chinese dominant cluster, and nearest to the coastal strain NB24/CHN/2013. Ts tests, performed on Vero cells at 37 degrees C and 39 degrees C, indicated that ZJ2013-06 had restricted replication at 39 degrees C. Its viral loads were substantially reduced at 39 degrees C compared with that at 37 degrees C (approximately 100-fold reduction) and were significantly lower than that of ZJ2014-02 at 39 degrees C (P < 0.01). By adaptive culture at 39 degrees C, the induced strain ZJ2013-06-P7 was obtained. Owing to a reverse mutation (S1616), ZJ2013-06-P7 lost the ts of the original strain, displaying similar replication processes with NB24/CHN/2013. The results indicated that the amino acid residue 1616 was related to the ts characteristics of ZJ2013-06. Our study revealed that ZJ2013-06 was temperature-sensitive and may be related to the absence of fever in our case.	[Feng, Yan; Xu, Changping; Li, Cixiu; Lin, Junfen; Zhang, Yanjun; Jiang, Jianmin; Lu, Yiyu] Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Wang, Zhongfa] Zhoushan Entry Exit Inspect & Quarantine Bur, Zhoushan, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Jiang, JM; Lu, YY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	jmjiang@cdc.zj.cn; luyiyuzjhz@aliyun.com		Li, Ci-Xiu/0000-0001-6911-9489	Science Technology Department of Zhejiang Province [2012C13016-2]	Science Technology Department of Zhejiang Province	This work was financially supported by a Key Program Grant from the Science Technology Department of Zhejiang Province (2012C13016-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by a Key Program Grant from the Science Technology Department of Zhejiang Province (2012C13016-2). The authors gratefully acknowledge Drs. Fengjiao Hu, Hongxia Ni, and Hongjun Dong from Ningbo Municipal CDC, as well as the staff at Huzhou and Taizhou Municipal CDCs in Zhejiang province, China for the collection and shipment of clinical specimens and for the isolation of viruses.	Choi SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005264; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Feng Cen, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P612; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Hu JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166611; Kato H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165207; Liu JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151677; Liu MM, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0661-9; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; MIYAMURA K, 1976, INTERVIROLOGY, V7, P192, DOI 10.1159/000149952; Nishiyama S, 2016, J VIROL, V90, P3735, DOI 10.1128/JVI.02241-15; Ohagi Y, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/918135; Sakata M, 2011, VACCINE, V29, P1107, DOI 10.1016/j.vaccine.2010.11.074; Schinkel SCB, 2017, VIRUS RES, V227, P104, DOI 10.1016/j.virusres.2016.10.003; Shin J, 2015, EMERG INFECT DIS, V21, P1704, DOI 10.3201/eid2110.141928; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wen HL, 2014, EMERG INFECT DIS, V20, P1, DOI 10.3201/eid2001.120532; Ye L, 2015, INT J INFECT DIS, V33, P199, DOI 10.1016/j.ijid.2015.02.003; Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]	26	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188462	10.1371/journal.pone.0188462	http://dx.doi.org/10.1371/journal.pone.0188462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190712	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900058
J	Huang, YK; Yen, CL; Shiu, SI; Lee, SW; Chang, PY; Yeh, HZ; Lee, TY				Huang, Yao-Kuang; Yen, Chieh-Ling; Shiu, Sz-Iuan; Lee, Shou-Wu; Chang, Pi-Yi; Yeh, Hong-Zen; Lee, Teng-Yu			Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; TRANSARTERIAL CHEMOEMBOLIZATION; EXTRAHEPATIC METASTASIS; SURVIVAL; DIAGNOSIS; PROGNOSIS; FAILURE	Targeted therapy is currently the standard treatment for advanced hepatocellular carcinoma (HCC), but an effective treatment after the discontinuation of sorafenib therapy remains uncertain. We aim to investigate the survival benefits of transcatheter arterial chemoembolization (TACE) after stopping sorafenib therapy. We retrospectively analyzed all patients with advanced HCC, who had received palliative TACE after terminating sorafenib therapy, from January 2008 to June 2016. Patients who were in the terminal stage (Child-Pugh class C or performance status 3-4), who received a liver transplantation, or who had received any HCC treatment other than TACE, were excluded. Finally, 28 patients were recruited as the TACE group, and were randomly matched 1: 1 by age, gender, Child-Pugh class, extrahepatic metastasis, and portal vein thrombosis with 28 controls who only received supportive care. For avoiding any immortal time bias, the index date of outcome follow-up was also matched. Cumulative incidences of, and hazard ratios (HRs) for, patient mortality were analyzed. The baseline demographic data between the TACE group and the control group were similar, but the 1-year overall survival rate in the TACE group was significantly higher than that of the control group (41.2%, 95% confidence interval [CI]: 19.4-63.0% vs. 24.5%, 95% CI: 6.3-42.7%; p < 0.01). In multivariate analysis, after adjusting for alpha-fetoprotein > 400ng/mL, Child-Pugh class B, and tumor extension > 50% of liver volume, TACE was independently associated with a decreased mortality risk(HR 0.19, 95% CI: 0.08-0.42). In addition, tumor extension > 50% of the liver was another independent prognostic factor associated with an increased mortality risk (HR 2.99, 95% CI: 1.31-6.82). Multivariate stratified analyses verified the association of TACE with a decreased mortality rate in each patient subgroup (all HR < 1.0). By controlling intrahepatic tumor growth, TACE may be a treatment option for use in improving patient survival in advanced HCC, after the termination of sorafenib therapy.	[Huang, Yao-Kuang; Yen, Chieh-Ling; Shiu, Sz-Iuan; Lee, Shou-Wu; Yeh, Hong-Zen; Lee, Teng-Yu] Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung, Taiwan; [Lee, Shou-Wu; Lee, Teng-Yu] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Chang, Pi-Yi] Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; Taichung Veterans General Hospital	Lee, TY (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung, Taiwan.; Lee, TY (corresponding author), Chung Shan Med Univ, Dept Med, Taichung, Taiwan.	tylee@vghtc.gov.tw	Huang, Yao-Kuang/AAK-5137-2021; Shiu, Sz-Iuan/AAE-1560-2022; Shiu, Sz-Iuan/AAK-3359-2020; Lee, Teng-Yu/H-4312-2019	Huang, Yao-Kuang/0000-0003-2699-2207; Shiu, Sz-Iuan/0000-0003-4385-5095; Shiu, Sz-Iuan/0000-0003-4385-5095; Lee, Teng-Yu/0000-0002-4097-4315	Taichung Veterans General Hospital, Taiwan [100DHA0500062]	Taichung Veterans General Hospital, Taiwan	This work was supported in part by Taichung Veterans General Hospital (100DHA0500062), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Georgiades CS, 2005, J VASC INTERV RADIOL, V16, P1653, DOI 10.1097/01.RVI.0000182185.47500.7A; Giannini EG, 2015, HEPATOLOGY, V61, P184, DOI 10.1002/hep.27443; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Lee IC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000688; Lee JE, 2014, WORLD J GASTROENTERO, V20, P235, DOI 10.3748/wjg.v20.i1.235; Lee TY, 2016, HEPATOLOGY, V63, P1517, DOI 10.1002/hep.28266; Leng JJ, 2016, ANZ J SURG, V86, P816, DOI 10.1111/ans.12803; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Niu ZJ, 2012, MED ONCOL, V29, P2992, DOI 10.1007/s12032-011-0145-0; Ogasawara S, 2011, HEPATOL INT, V5, P850, DOI 10.1007/s12072-010-9249-4; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Shariff SZ, 2008, J AM SOC NEPHROL, V19, P841, DOI 10.1681/ASN.2007121354; Silva JP, 2017, HPB, V19, P659, DOI 10.1016/j.hpb.2017.04.016; [TACE/TARE/HAI group Local ablation group Surgery group Staging group Diagnosis group Surveillance group], 2017, J FORMOS ME IN PRESS; Tan CH, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/519783; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; Xue TC, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-60; Yau T, 2012, INVEST NEW DRUG, V30, P2384, DOI 10.1007/s10637-012-9808-8; Yoo DJ, 2011, J GASTROEN HEPATOL, V26, P145, DOI 10.1111/j.1440-1746.2010.06341.x; Yoo JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113926; Zhao Y, 2016, J GASTROINTEST SURG, V20, P2002, DOI 10.1007/s11605-016-3285-x; Zhao Y, 2013, ASIA-PAC J CLIN ONCO, V9, P357, DOI 10.1111/ajco.12081; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188999	10.1371/journal.pone.0188999	http://dx.doi.org/10.1371/journal.pone.0188999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190692	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900186
J	Jansen, CHP; Perera, D; Wiethoff, AJ; Phinikaridou, A; Razavi, RM; Rinaldi, A; Marber, MS; Greil, GF; Nagel, E; Maintz, D; Redwood, S; Botnar, RM; Makowski, MR				Jansen, Christian H. P.; Perera, Divaka; Wiethoff, Andrea J.; Phinikaridou, Alkystis; Razavi, Reza M.; Rinaldi, Aldo; Marber, Mike S.; Greil, Gerald F.; Nagel, Eike; Maintz, David; Redwood, Simon; Botnar, Rene M.; Makowski, Marcus R.			Contrast-enhanced magnetic resonance imaging for the detection of ruptured coronary plaques in patients with acute myocardial infarction	PLOS ONE			English	Article							VESSEL WALL; HYPERINTENSE PLAQUE; TAKAYASUS-ARTERITIS; DISEASE; ATHEROSCLEROSIS; TOMOGRAPHY; BURDEN; MRI	Purpose X-ray coronary angiography (XCA) is the current gold standard for the assessment of lumen encroaching coronary stenosis but XCA does not allow for early detection of rupture-prone vulnerable plaques, which are thought to be the precursor lesions of most acute myocardial infarctions (AMI) and sudden death. The aim of this study was to investigate the potential of delayed contrast-enhanced magnetic resonance coronary vessel wall imaging (CE-MRCVI) for the detection of culprit lesions in the coronary arteries. Methods 16 patients (13 male, age 61.9 +/- 8.6 years) presenting with sub-acute MI underwent CE-MRCVI within 24-72h prior to invasive XCA. CE-MRCVI was performed using a T1-weighted 3D gradient echo inversion recovery sequence (3D IR TFE) 40 +/- 4 minutes following the administration of 0.2 mmol/kg gadolinium-diethylenetriamine-pentaacetic acid (DTPA) on a 3T MRI scanner equipped with a 32-channel cardiac coil. Results 14 patients were found to have culprit lesions (7x LAD, 1xLCX, 6xRCA) as identified by XCA. Quantitative CE-MRCVI correctly identified the culprit lesion location with a sensitivity of 79% and excluded culprit lesion formation with a specificity of 99%. The contrast to noise ratio (CNR) of culprit lesions (9.7 +/- 4.1) significantly exceeded CNR values of segments without culprit lesions (2.9 +/- 1.9, p<0.001). Conclusion CE-MRCVI allows the selective visualization of culprit lesions in patients immediately after myocardial infarction (MI). The pronounced contrast uptake in ruptured plaques may represent a surrogate biomarker of plaque activity and/or vulnerability.	[Jansen, Christian H. P.; Wiethoff, Andrea J.; Phinikaridou, Alkystis; Razavi, Reza M.; Greil, Gerald F.; Nagel, Eike; Botnar, Rene M.; Makowski, Marcus R.] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Jansen, Christian H. P.; Perera, Divaka; Razavi, Reza M.; Marber, Mike S.; Nagel, Eike; Botnar, Rene M.; Makowski, Marcus R.] BHF Ctr Excellence, London, England; [Jansen, Christian H. P.; Perera, Divaka; Razavi, Reza M.; Marber, Mike S.; Nagel, Eike; Botnar, Rene M.; Makowski, Marcus R.] NIHR Biomed Res Ctr, London, England; [Jansen, Christian H. P.; Perera, Divaka; Razavi, Reza M.; Marber, Mike S.; Nagel, Eike; Botnar, Rene M.; Makowski, Marcus R.] Kings Coll London, London, England; [Perera, Divaka; Rinaldi, Aldo; Marber, Mike S.; Redwood, Simon] Guys & St Thomas Hosp, Cardiovasc Ctr, London, England; [Wiethoff, Andrea J.] Philips Healthcare, Guildford, Surrey, England; [Razavi, Reza M.; Nagel, Eike; Botnar, Rene M.] Wellcome Trust Res Labs, London, England; [Razavi, Reza M.; Nagel, Eike; Botnar, Rene M.] EPSRC Med Engn Ctr, London, England; [Maintz, David] Univ Munster, Dept Radiol, Munster, Germany; [Botnar, Rene M.] Pontificia Univ Catolica Chile, Escuela Ingn, Santiago, Chile; [Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Philips; Philips Healthcare; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Munster; Pontificia Universidad Catolica de Chile; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jansen, CHP (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London, England.; Jansen, CHP (corresponding author), BHF Ctr Excellence, London, England.; Jansen, CHP (corresponding author), NIHR Biomed Res Ctr, London, England.; Jansen, CHP (corresponding author), Kings Coll London, London, England.	dr.c.jansen@icloud.com	Phinikaridou, Alkystis/AAA-9607-2020; Nagel, Eike/C-6903-2008; Makowski, Marcus R/Q-7957-2018; marber, michael/AAW-7916-2021; Maintz, David/ABG-3220-2020; Botnar, Rene Michael/AAZ-2112-2020; Botnar, Rene/E-6875-2012	Phinikaridou, Alkystis/0000-0002-5687-8504; Nagel, Eike/0000-0002-6044-950X; Marber, Michael/0000-0002-3463-7128; Rinaldi, christopher/0000-0002-3930-1957; Perera, Divaka/0000-0001-6362-1291; Razavi, Reza/0000-0003-1065-3008; Botnar, Rene/0000-0003-2811-2509; Botnar, Rene/0000-0002-9447-4367	British Heart Foundation [PG/10/044/28343]; BHF Centre of Excellence [RE/08/03]; Centre of Excellence in Medical Engineering (Welcome Trust); entre of Excellence in Medical Engineering (EPSRC) [WT 088641/Z/09/Z]; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; NIHR Healthcare Technology Co-operative for Cardiovascular Disease at Guy's and St Thomas' NHS Foundation Trust; Deutsche Forschungsgemeinschaft (DFG) [594331/41/91]; British Heart Foundation [RG/12/1/29262, PG/10/44/28343] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); BHF Centre of Excellence; Centre of Excellence in Medical Engineering (Welcome Trust); entre of Excellence in Medical Engineering (EPSRC); Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; NIHR Healthcare Technology Co-operative for Cardiovascular Disease at Guy's and St Thomas' NHS Foundation Trust; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); British Heart Foundation(British Heart Foundation)	The authors acknowledge financial support from the British Heart Foundation www.bhf.org.uk/) (PG/10/044/28343) and the BHF Centre of Excellence (https://www.bhf.org.uk/ research/where-we-fund-research/centres-of-research-excellence) (RE/08/03). The Division of Imaging Sciences receives also support from the Centre of Excellence in Medical Engineering (funded by the Welcome Trust and EPSRC; grant number WT 088641/Z/09/Z) (htfps.//www.epsrc.ac.uk/) and the Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, and by the NIHR Healthcare Technology Co-operative for Cardiovascular Disease at Guy's and St Thomas' NHS Foundation Trust. The views expressed are those of the author (s) and not necessarily those of the NHS, the NIHR or the Department of Health. The author MRM is grateful for the financial support from the Deutsche Forschungsgemeinschaft (http://ww.dtg.de/) (DFG, 594331/41/91).	[Anonymous], 2010, PUBLIC LIB SCI, V5; [Anonymous], 1999, MECH PROGRESSION NAT, V82, P265; Bley TA, 2005, AM J ROENTGENOL, V184, P283, DOI 10.2214/ajr.184.1.01840283; Botnar RM, 2000, CIRCULATION, V102, P2582; Choe YH, 2000, AM J ROENTGENOL, V175, P505, DOI 10.2214/ajr.175.2.1750505; Desai MY, 2005, AM J ROENTGENOL, V184, P1427, DOI 10.2214/ajr.184.5.01841427; Ehara S, 2012, EUR HEART J-CARD IMG, V13, P394, DOI 10.1093/ehjci/jer305; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fayad ZA, 2000, CIRCULATION, V102, P506; FUSTER V, 1992, CIRCULATION, V86, P1; Hussain T, 2013, CIRC-CARDIOVASC IMAG, V6, P91, DOI 10.1161/CIRCIMAGING.112.975797; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; Jansen CHP, 2011, CIRCULATION; Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Makowski MR, 2011, NAT MED, V17, P383, DOI 10.1038/nm.2310; Miao CL, 2009, J AM COLL CARDIOL, V53, P1708, DOI 10.1016/j.jacc.2008.12.063; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188292	10.1371/journal.pone.0188292	http://dx.doi.org/10.1371/journal.pone.0188292			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190694	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900044
J	Johnson, ML; Dasgupta, T; Gopichandran, N; Field, SL; Orsi, NM				Johnson, Michelle L.; Dasgupta, Tathagata; Gopichandran, Nadia; Field, Sarah L.; Orsi, Nicolas M.			A Bayesian view of murine seminal cytokine networks	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; UTERINE EPITHELIAL-CELLS; IMMUNOSUPPRESSIVE FACTOR; LEPTIN LEVELS; PLASMA; PREGNANCY; EXPRESSION; OBESE; SEMEN; IDENTIFICATION	It has long been established that active agents in seminal fluid are key to initiating and coordinating mating-induced immunomodulation. This is in part governed by the actions of a network of cytokine interactions which, to date, remain largely undefined, and whose interspecific evolutionary conservation is unknown. This study applied Bayesian methods to illustrate the interrelationships between seminal profiles of interleukin (IL)-1alpha, IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-17, eotaxin, granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interferon (IFN)-gamma, keratinocyte-derived chemokine (KC), monocyte chemoattractant protein (MCP-1), macrophage inflammatory protein (MIP-1) alpha, MIP-1beta, regulated on activation normal T cell expressed and secreted (RANTES), tumour necrosis factor (TNF)-alpha, leptin, inducible protein (IP)-10 and vascular endothelial growth factor (VEGF) in a rat model. IL-2, IL-9, IL-12 (p70), IL-13, IL-18, eotaxin, IFN-gamma, IP-10, KC, leptin, MCP-1, MIP-1alpha and TNF-alpha were significantly higher in serum, whilst IL-1beta, IL-5, IL-6, IL-10, IL-17, G-CSF and GM-CSF were significantly higher in seminal fluid. When compared to mouse profiles, only G-CSF was present at significantly higher levels in the seminal fluid in both species. Bayesian modelling highlighted key shared features across mouse and rat networks, namely TNF-alpha as the terminal node in both serum and seminal plasma, and MCP-1 as a central coordinator of seminal cytokine networks through the intermediary of KC and RANTES. These findings reveal a marked interspecific conservation of seminal cytokine networks.	[Johnson, Michelle L.; Orsi, Nicolas M.] Univ Leeds, Leeds Inst Canc & Pathol, Dept Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Dasgupta, Tathagata] Sleker, Brookline, MA USA; [Dasgupta, Tathagata] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Gopichandran, Nadia; Field, Sarah L.] Ostara Biomed Ltd, Liverpool, Merseyside, England	University of Leeds; Harvard University; Harvard Medical School	Orsi, NM (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Dept Pathol & Tumour Biol, Leeds, W Yorkshire, England.	n.m.orsi@leeds.ac.uk		Johnson, Michelle/0000-0002-6252-610X	National Institute for Health Research [CL-2016-02-003] Funding Source: researchfish; National Centre for the Replacement [NC/S01404/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement		Almabhouh FA, 2015, ANDROLOGIA, V47, P751, DOI 10.1111/and.12325; Cardoso E, 1993, Minerva Endocrinol, V18, P109; Croft M, 2017, NAT REV RHEUMATOL; Denison FC, 1999, MOL HUM REPROD, V5, P220, DOI 10.1093/molehr/5.3.220; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Field SL, 2015, REPRODUCTION, V150, P127, DOI 10.1530/REP-15-0087; Field SL, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0226-3; Frink M, 2007, AM J PHYSIOL-REG I, V292, pR1110, DOI 10.1152/ajpregu.00650.2006; Gopichandran N, 2006, REPRODUCTION, V131, P613, DOI 10.1530/rep.1.00959; Kayisli UA, 2002, AM J REPROD IMMUNOL, V47, P213, DOI 10.1034/j.1600-0897.2002.01075.x; Kelly RW, 1997, HUM REPROD, V12, P677, DOI 10.1093/humrep/12.4.677; KELLY RW, 1995, HUM REPROD, V10, P1686, DOI 10.1093/oxfordjournals.humrep.a136156; Knudsen E, 2002, EUR J HAEMATOL, V69, P284, DOI 10.1034/j.1600-0609.2002.02657.x; KOCH E, 1985, J REPROD FERTIL, V74, P39, DOI 10.1530/jrf.0.0740039; Lampiao F, 2008, ASIAN J ANDROL, V10, P799, DOI 10.1111/j.1745-7262.2008.00421.x; Li Hongjun, 2004, Zhonghua Nan Ke Xue, V10, P486; LIANG ZG, 1993, ANDROLOGIA, V25, P279; Maccioni M, 2001, J REPROD IMMUNOL, V50, P133, DOI 10.1016/S0165-0378(01)00060-2; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Miao DS, 1996, J REPROD IMMUNOL, V30, P97, DOI 10.1016/0165-0378(96)00957-6; Mounzih K, 1997, ENDOCRINOLOGY, V138, P1190, DOI 10.1210/en.138.3.1190; Mulet T, 2003, INT J BIOCHEM CELL B, V35, P104, DOI 10.1016/S1357-2725(02)00092-4; Naz RK, 2000, AM J REPROD IMMUNOL, V44, P197, DOI 10.1111/j.8755-8920.2000.440402.x; O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160; Orsi NM, 2006, ANIM REPROD SCI, V96, P54, DOI 10.1016/j.anireprosci.2005.11.010; Ota K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070470; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; REES RC, 1986, CLIN EXP IMMUNOL, V63, P687; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 2003, J REPROD IMMUNOL, V59, P253, DOI 10.1016/S0165-0378(03)00052-4; Robertson SA, 1996, BIOL REPROD, V54, P183, DOI 10.1095/biolreprod54.1.183; ROBERTSON SA, 1992, BIOL REPROD, V46, P1069, DOI 10.1095/biolreprod46.6.1069; Robertson SA, 2001, SEMIN IMMUNOL, V13, P243, DOI 10.1006/smim.2000.0320; SAXENA S, 1988, J REPROD IMMUNOL, V13, P133, DOI 10.1016/0165-0378(88)90057-5; Scheerlinck JPY, 1999, VET IMMUNOL IMMUNOP, V72, P39, DOI 10.1016/S0165-2427(99)00115-4; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503; STRATH M, 1985, J CELL SCI, V74, P207; TARTER TH, 1986, J IMMUNOL, V136, P2862; Wood GW, 1997, MOL REPROD DEV, V46, P62, DOI 10.1002/(SICI)1098-2795(199701)46:1<62::AID-MRD10>3.0.CO;2-5; Xie ZF, 2005, CHINESE MED J-PEKING, V118, P6; Zhang Jiyun, 2004, Zhonghua Nan Ke Xue, V10, P851; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188897	10.1371/journal.pone.0188897	http://dx.doi.org/10.1371/journal.pone.0188897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190674	Green Published, gold			2022-12-26	WOS:000416841900163
J	Mathavan, K; Khedgikar, V; Bartolo, V; Alfandari, D				Mathavan, Ketan; Khedgikar, Vikram; Bartolo, Vanessa; Alfandari, Dominique			The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration	PLOS ONE			English	Article							SOLUBLE-E-CADHERIN; GROWTH-FACTOR RECEPTOR; N-CADHERIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; XENOPUS; ADHESION; PROTEOLYSIS; ADAM13; ACTIN	During development, a multi-potent group of cells known as the cranial neural crest (CNC) migrate to form craniofacial structures. Proper migration of these cells requires proteolysis of cell adhesion molecules, such as cadherins. In Xenopus laevis, preventing extracellular cleavage of cadherin-11 impairs CNC migration. However, overexpression of the soluble cleavage product (EC1-3) is capable of rescuing this phenotype. The mechanism by which EC1-3 promotes CNC migration has not been investigated until now. Here we show that EC1-3 stimulates phosphorylation of Akt, a target of PI3K, in X. laevis CNC. Through immunoprecipitation experiments, we determined that EC1-3 interacts with all ErbB receptors, PDGFR alpha, and FGFR1. Of these receptors, only ErbB2 was able to produce an increase in Akt phosphorylation upon treatment with a recombinant EC1-3. This increase was abrogated by mubritinib, an inhibitor of ErbB2. We were able to recapitulate this decrease in Akt phosphorylation in vivo by knocking down ErbB2 in CNC cells. Knockdown of the receptor also significantly reduced CNC migration in vivo. We confirmed the importance of ErbB2 and ErbB receptor signaling in CNC migration using mubritinib and canertinib, respectively. Mubritinib and the PI3K inhibitor LY294002 significantly decreased cell migration while canertinib nearly prevented it altogether. These data show that ErbB2 and Akt are important for CNC migration and implicate other ErbB receptors and Akt-independent signaling pathways. Our findings provide the first example of a functional interaction between the extracellular domain of a type II classical cadherin and growth factor receptors.	[Mathavan, Ketan; Khedgikar, Vikram; Bartolo, Vanessa; Alfandari, Dominique] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Alfandari, D (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	alfandar@vasci.umass.edu		alfandari, dominique/0000-0002-0557-1246	National Institutes of Health, U.S. Public Health Service [RO1-DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER	National Institutes of Health, U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health, U.S. Public Health Service, Grant RO1-DE016289 to D.A.	Abbruzzese G, 2016, DEV BIOL, V415, P383, DOI 10.1016/j.ydbio.2015.07.018; Abbruzzese G, 2015, J CELL SCI, V128, P1139, DOI 10.1242/jcs.163063; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099; Bahm I, 2017, DEVELOPMENT; Borchers A, 2001, DEVELOPMENT, V128, P3049; Brouxhon SM, 2014, ONCOGENE, V33, P225, DOI 10.1038/onc.2012.563; Brouxhon SM, 2014, MOL CARCINOGEN, V53, P893, DOI 10.1002/mc.22048; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Cousin H, 2011, DEV CELL, V20, P256, DOI 10.1016/j.devcel.2010.12.009; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Dell'Albani P, 1998, J NEUROSCI RES, V54, P191, DOI 10.1002/(SICI)1097-4547(19981015)54:2<191::AID-JNR7>3.3.CO;2-#; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Inge LJ, 2011, EXP CELL RES, V317, P838, DOI 10.1016/j.yexcr.2010.12.025; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Khedgikar V, 2017, ELIFE, V6, DOI 10.7554/eLife.26898; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kulesa PM, 2010, DEV BIOL, V344, P543, DOI 10.1016/j.ydbio.2010.04.010; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moriyama Y, 2011, BIOCHEM BIOPH RES CO, V404, P974, DOI 10.1016/j.bbrc.2010.12.093; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Neuner R, 2009, MECH DEVELOP, V126, P240, DOI 10.1016/j.mod.2008.10.010; Nie SY, 2006, DEV DYNAM, V235, P301, DOI 10.1002/dvdy.20623; Noe V, 2001, J CELL SCI, V114, P111; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; PARADIES NE, 1993, J NEUROSCI RES, V36, P33, DOI 10.1002/jnr.490360105; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Scarpa E, 2015, DEV CELL, V34, P421, DOI 10.1016/j.devcel.2015.06.012; Schiffmacher AT, 2016, J CELL BIOL, V215, P735, DOI 10.1083/jcb.201604006; Schiffmacher AT, 2014, MOL BIOL CELL, V25, P41, DOI 10.1091/mbc.E13-08-0459; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Wicki A, 2016, PHYSIOL REV, V96, P805, DOI 10.1152/physrev.00024.2015; WILSON P, 1991, DEVELOPMENT, V112, P289; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	63	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188963	10.1371/journal.pone.0188963	http://dx.doi.org/10.1371/journal.pone.0188963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190819	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900179
J	Moura, MD; Diniz, HHL; Droguett, EL; da Cunha, BS; Lins, ID; Simoni, VR				Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier; Simoni, Vicente Ribeiro			Embedding resilience in the design of the electricity supply for industrial clients	PLOS ONE			English	Article							CRITICAL INFRASTRUCTURES; POWER GRIDS; NETWORKS; METRICS; DISRUPTION; FRAMEWORK; RISK; OPTIMIZATION; ROBUSTNESS; SELECTION	This paper proposes an optimization model, using Mixed-Integer Linear Programming (MILP), to support decisions related to making investments in the design of power grids serving industrial clients that experience interruptions to their energy supply due to disruptive events. In this approach, by considering the probabilities of the occurrence of a set of such disruptive events, the model is used to minimize the overall expected cost by determining an optimal strategy involving pre- and post-event actions. The pre-event actions, which are considered during the design phase, evaluate the resilience capacity (absorption, adaptation and restoration) and are tailored to the context of industrial clients dependent on a power grid. Four cases are analysed to explore the results of different probabilities of the occurrence of disruptions. Moreover, two scenarios, in which the probability of occurrence is lowest but the consequences are most serious, are selected to illustrate the model's applicability. The results indicate that investments in pre-event actions, if implemented, can enhance the resilience of power grids serving industrial clients because the impacts of disruptions either are experienced only for a short time period or are completely avoided.	[Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier] Univ Fed Pernambuco, Ctr Risk Anal & Environm Modeling CEERMA, Recife, PE, Brazil; [Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier] Univ Fed Pernambuco, Dept Prod Engn, Recife, PE, Brazil; [Droguett, Enrique Lopez] Univ Chile, Mech Engn Dept, Santiago, Chile; [Droguett, Enrique Lopez] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Simoni, Vicente Ribeiro] Co Hidro Eletr Sao Francisco Chesf, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidad de Chile; University System of Maryland; University of Maryland College Park	Droguett, EL (corresponding author), Univ Fed Pernambuco, Ctr Risk Anal & Environm Modeling CEERMA, Recife, PE, Brazil.; Droguett, EL (corresponding author), Univ Fed Pernambuco, Dept Prod Engn, Recife, PE, Brazil.; Droguett, EL (corresponding author), Univ Chile, Mech Engn Dept, Santiago, Chile.; Droguett, EL (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	elopezdroguett@ing.uchile.cl	Lins, Isis/L-6094-2013; Droguett, Enrique/AAC-9758-2019; Moura, Márcio das Chagas/L-3246-2013	Moura, Márcio das Chagas/0000-0001-5486-2093; Lins, Isis Didier/0000-0002-4090-5109; Lopez Droguett, Enrique/0000-0002-0790-8439				Ambulkar S, 2015, J OPER MANAG, V33-34, P111, DOI 10.1016/j.jom.2014.11.002; [Anonymous], 2014, INT J PROD ECON, V157, P89; [Anonymous], 2015, ESEA FLEX B, V35, P1; Banos R, 2011, WATER RESOUR MANAG, V25, P2351, DOI 10.1007/s11269-011-9812-3; Barker K, 2013, RELIAB ENG SYST SAFE, V117, P89, DOI 10.1016/j.ress.2013.03.012; Bartos M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/114008; Bhatia U, 2015, PLOS ONE, V10, P1; Bode C, 2011, ACAD MANAGE J, V54, P833, DOI 10.5465/AMJ.2011.64870145; Campbell R.J., 2012, WEATHER RELATED POWE; Cardoso SR, 2015, OMEGA-INT J MANAGE S, V56, P53, DOI 10.1016/j.omega.2015.03.008; Carvalho R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090265; Chen LC, 2012, TRANSPORT SCI, V46, P109, DOI 10.1287/trsc.1110.0376; Chopra SS, 2014, J ENVIRON MANAGE, V141, P86, DOI 10.1016/j.jenvman.2013.12.038; CNI-National Confederation of Industry, 2016, SPEC REP IND EN IND, P1; Correio Brazilience, 2012, IND CALC LOSS 6 MILL; Cuadra L, 2015, ENERGIES, V8, P9211, DOI 10.3390/en8099211; Dewenter T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015005; Dixit V, 2016, COMPUT IND ENG, V93, P205, DOI 10.1016/j.cie.2015.12.029; Espinoza S, 2016, ELECTR POW SYST RES, V136, P352, DOI 10.1016/j.epsr.2016.03.019; Fang YP, 2017, RELIAB ENG SYST SAFE, V159, P161, DOI 10.1016/j.ress.2016.10.028; Faturechi R, 2014, TRANSPORT RES B-METH, V70, P47, DOI 10.1016/j.trb.2014.08.007; Faturechi R, 2014, COMPUT OPER RES, V43, P335, DOI 10.1016/j.cor.2013.10.009; Filippini R, 2014, RELIAB ENG SYST SAFE, V125, P82, DOI 10.1016/j.ress.2013.09.010; Francis R, 2014, RELIAB ENG SYST SAFE, V121, P90, DOI 10.1016/j.ress.2013.07.004; Ganin AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19540; Garg A, 2015, ENERG POLICY, V81, P226, DOI 10.1016/j.enpol.2014.12.007; Ghanem DA, 2016, ENERG POLICY, V92, P171, DOI 10.1016/j.enpol.2016.02.003; Haimes YY, 2009, RISK ANAL, V29, P498, DOI 10.1111/j.1539-6924.2009.01216.x; Henry D, 2012, RELIAB ENG SYST SAFE, V99, P114, DOI 10.1016/j.ress.2011.09.002; Hillier FS, 2015, INTRO OPERATIONS RES, V10th; Hokstad P., 2012, RISK INTERDEPENDENCI; Hosseini S, 2016, RELIAB ENG SYST SAFE, V145, P47, DOI 10.1016/j.ress.2015.08.006; Johansson J, 2013, RELIAB ENG SYST SAFE, V120, P27, DOI 10.1016/j.ress.2013.02.027; Kjolle GH, 2012, RELIAB ENG SYST SAFE, V105, P80, DOI 10.1016/j.ress.2012.02.006; Koc Y, 2014, IEEE INT C NETW SENS, P386, DOI 10.1109/ICNSC.2014.6819657; Kwasinski A, 2016, ENERGIES, V9, DOI 10.3390/en9020093; Labaka L, 2015, RELIAB ENG SYST SAFE, V141, P92, DOI 10.1016/j.ress.2015.03.009; Levalle RR, 2015, COMPUT IND ENG, V90, P67, DOI 10.1016/j.cie.2015.08.017; Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227; Lundberg J, 2015, RELIAB ENG SYST SAFE, V141, P22, DOI 10.1016/j.ress.2015.03.013; Mari SI, 2014, SUSTAINABILITY-BASEL, V6, P6666, DOI 10.3390/su6106666; Mattsson LG, 2015, TRANSPORTATION RES A; McDonald J. D., 2007, ELECT POWER SUBSTATI; Mendonca D, 2015, RELIAB ENG SYST SAFE, V141, P83, DOI 10.1016/j.ress.2015.03.017; Miller-Hooks E, 2012, COMPUT OPER RES, V39, P1633, DOI 10.1016/j.cor.2011.09.017; Nan C, 2017, RELIAB ENG SYST SAFE, V157, P35, DOI 10.1016/j.ress.2016.08.013; Nezamoddini N, 2017, ELECTR POW SYST RES, V143, P329, DOI 10.1016/j.epsr.2016.08.046; Omer M, 2009, IEEE SYST J, V3, P295, DOI 10.1109/JSYST.2009.2022570; Ouyang M, 2014, RELIAB ENG SYST SAFE, V121, P43, DOI 10.1016/j.ress.2013.06.040; Panteli M, 2015, ELECTR POW SYST RES, V127, P259, DOI 10.1016/j.epsr.2015.06.012; Pepyne DL, 2007, J SYST SCI SYST ENG, V16, P202, DOI 10.1007/s11518-007-5044-8; Prieto F, 2014, INT J ELEC POWER, V54, P10, DOI 10.1016/j.ijepes.2013.06.033; Raby A, 2015, INT J DISAST RISK RE, V14, P332, DOI 10.1016/j.ijdrr.2015.08.009; Ramirez-Marquez JE, 2012, COMPUT IND ENG, V63, P235, DOI 10.1016/j.cie.2012.02.016; Reed DA, 2009, IEEE SYST J, V3, P174, DOI 10.1109/JSYST.2009.2017396; Roege PE, 2014, ENERG POLICY, V72, P249, DOI 10.1016/j.enpol.2014.04.012; Rokstad MM, 2015, RELIAB ENG SYST SAFE, V142, P148, DOI 10.1016/j.ress.2015.05.014; Salami O, 2011, MATH COMPUT MODEL, V53, P2219, DOI 10.1016/j.mcm.2010.08.027; Sawik T, 2013, OMEGA-INT J MANAGE S, V41, P259, DOI 10.1016/j.omega.2012.05.003; Shukla A, 2011, INT J PHYS DISTR LOG, V41, P623, DOI 10.1108/09600031111147844; Tang C., 2006, INT J LOGIST-RES APP, V9, P33, DOI [10.1080/13675560500405584, DOI 10.1080/13675560500405584]; Turnquist Mark, 2013, Environment Systems & Decisions, V33, P104, DOI 10.1007/s10669-012-9428-z; Utne IB, 2011, RELIAB ENG SYST SAFE, V96, P671, DOI 10.1016/j.ress.2010.12.006; Vugrin ED, 2010, SUSTAINABLE AND RESILIENT CRITICAL INFRASTRUCTURE SYSTEMS: SIMULATION, MODELING, AND INTELLIGENT ENGINEERING, P77, DOI 10.1007/978-3-642-11405-2_3; Wang XR, 2015, 2015 7TH INTERNATIONAL WORKSHOP ON RELIABLE NETWORKS DESIGN AND MODELING (RNDM) PROCE4EDINGS, P208, DOI 10.1109/RNDM.2015.7325231; Wei DQ, 2012, PHYSICA A, V391, P2771, DOI 10.1016/j.physa.2011.12.030; Zhang GH, 2008, 2008 THIRD INTERNATIONAL CONFERENCE ON ELECTRIC UTILITY DEREGULATION AND RESTRUCTURING AND POWER TECHNOLOGIES, VOLS 1-6, P1554, DOI 10.1109/DRPT.2008.4523652; Zhang M, 2016, RESOURCES CONSERVATI; Zhang X, 2015, J TRANSP GEOGR, V46, P35, DOI 10.1016/j.jtrangeo.2015.05.006; Zhao S, 2017, RELIAB ENG SYST SAFE, V164, P84, DOI 10.1016/j.ress.2017.02.009	70	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188875	10.1371/journal.pone.0188875	http://dx.doi.org/10.1371/journal.pone.0188875			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190777	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900155
J	Rooney, MF; Porter, RK; Katz, LM; Hill, EW				Rooney, Mary F.; Porter, Richard K.; Katz, Lisa M.; Hill, Emmeline W.			Skeletal muscle mitochondrial bioenergetics and associations with myostatin genotypes in the Thoroughbred horse	PLOS ONE			English	Article							INDUCED MUSCULAR INJURY; COENZYME-Q DEFICIENCY; CEREBELLAR-ATAXIA; PROTEIN ABUNDANCE; EXERCISE; Q(10); SUPPLEMENTATION; EXPRESSION; COMPLEX; MSTN	Variation in the myostatin (MSTN) gene has been reported to be associated with race distance, body composition and skeletal muscle fibre composition in the horse. The aim of the present study was to test the hypothesis that MSTN variation influences mitochondrial phenotypes in equine skeletal muscle. Mitochondrial abundance and skeletal muscle fibre types were measured in whole muscle biopsies from the gluteus medius of n = 82 untrained (21 +/- 3 months) Thoroughbred horses. Skeletal muscle fibre type proportions were significantly (p < 0.01) different among the three MSTN genotypes and mitochondrial content was significantly (p < 0.01) lower in the combined presence of the C-allele of SNP g.66493737C>T (C) and the SINE insertion 227 bp polymorphism (I). Evaluation of mitochondrial complex activities indicated higher combined mitochondrial complex I+III and II+III activities in the presence of the C-allele / I allele (p <= 0.05). The restoration of complex I+III and complex II+III activities following addition of exogenous coenzyme Q(1) (ubiquinone(1)) (CoQ(1)) in vitro in the TT/NN (homozygous T allele/homozygous no insertion) cohort indicated decreased coenzyme Q in these animals. In addition, decreased gene expression in two coenzyme Q (CoQ) biosynthesis pathway genes (COQ4, p <= 0.05; ADCK3, p <= 0.01) in the TT/NN horses was observed. This study has identified several mitochondrial phenotypes associated with MSTN genotype in untrained Thoroughbred horses and in addition, our findings suggest that nutritional supplementation with CoQ may aid to restore coenzyme Q activity in TT/NN horses.	[Rooney, Mary F.; Hill, Emmeline W.] Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin 4, Ireland; [Rooney, Mary F.; Porter, Richard K.] Trinity Coll Dublin, TBSI, Sch Biochem & Immunol, Dublin 2, Ireland; [Katz, Lisa M.] Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland	University College Dublin; Trinity College Dublin; University College Dublin	Hill, EW (corresponding author), Univ Coll Dublin, UCD Sch Agr & Food Sci, Dublin 4, Ireland.	Emmeline.Hill@ucd.ie	Porter, Richard/HGF-0546-2022	Porter, Richard/0000-0001-9854-5161	Science Foundation Ireland [11/PI/1166]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This publication has emanated from research conducted with the financial support of Science Foundation Ireland (http//www.sfi.ie/) under Grant Number 11/PI/1166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Bergamini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033712; Bhagavan HN, 2007, MITOCHONDRION, V7, pS78, DOI 10.1016/j.mito.2007.03.003; Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x; Bonetti A, 2000, J SPORT MED PHYS FIT, V40, P51; Borekova M, 2008, CZECH J FOOD SCI, V26, P229, DOI 10.17221/1122-CJFS; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Braun B, 1991, Int J Sport Nutr, V1, P353; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063; Cooke M, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-8; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Davey GP, 1996, J NEUROCHEM, V66, P1617; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; Dominique JE, 2006, EXP CELL RES, V312, P2401, DOI 10.1016/j.yexcr.2006.04.012; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Farge G, 2002, BIOCHIMIE, V84, P1189, DOI 10.1016/S0300-9084(02)00038-X; FOLKERS K, 1995, BBA-MOL BASIS DIS, V1271, P281, DOI 10.1016/0925-4439(95)00040-B; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Greene HM, 1995, J EQUINE VET SCI, V15, P388, DOI 10.1016/S0737-0806(07)80482-5; Hatefi Y, 1978, Methods Enzymol, V53, P27; Hemmings KM, 2009, J ANIM SCI, V87, P3915, DOI 10.2527/jas.2009-2067; Hill EW, 2012, J APPL PHYSIOL, V112, P86, DOI 10.1152/japplphysiol.00793.2011; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Horohov DW, 2012, J EQUINE VET SCI, V32, P805, DOI 10.1016/j.jevs.2012.03.017; INGJER F, 1979, J PHYSIOL-LONDON, V294, P419, DOI 10.1113/jphysiol.1979.sp012938; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; JONES JH, 1989, J APPL PHYSIOL, V67, P862, DOI 10.1152/jappl.1989.67.2.862; JONES JH, 1993, ANNU REV PHYSIOL, V55, P547, DOI 10.1146/annurev.physiol.55.1.547; KAYAR SR, 1989, PFLUG ARCH EUR J PHY, V413, P343, DOI 10.1007/BF00584481; King T.E., 1967, METHODS ENZYMOL, P216, DOI DOI 10.1016/0076-6879(67)10043-8; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kon M, 2008, BRIT J NUTR, V100, P903, DOI 10.1017/S0007114508926544; Kon M, 2007, EXERC IMMUNOL REV, V13, P76; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Ledwith A, 2004, EQUINE VET EDUC, V16, P62, DOI 10.1111/j.2042-3292.2004.tb00268.x; Li CC, 2016, J APPL PHYSIOL, V121, P299, DOI 10.1152/japplphysiol.01077.2015; LINNANE AW, 1995, BBA-MOL BASIS DIS, V1271, P191, DOI 10.1016/0925-4439(95)00027-2; Linnane AW, 2002, FREE RADICAL RES, V36, P445, DOI 10.1080/10715760290021306; Littarru GP, 2010, NUTRITION, V26, P250, DOI 10.1016/j.nut.2009.08.008; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; MATHIEU O, 1981, RESP PHYSIOL, V44, P113, DOI 10.1016/0034-5687(81)90079-7; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003; Mizuno K, 2008, NUTRITION, V24, P293, DOI 10.1016/j.nut.2007.12.007; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; MORISCO C, 1993, CLIN INVESTIGATOR, V71, pS134; Ogata T, 1958, ACTA MED, P216; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Petersen JL, 2014, ANIMAL GENETICS; Ploquin C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1000, DOI 10.1152/ajpendo.00652.2011; Powers WJ, 2007, NEUROBIOL DIS, V27, P99, DOI 10.1016/j.nbd.2007.04.008; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rivero JLL, 1999, J MUSCLE RES CELL M, V20, P211, DOI 10.1023/A:1005461214800; Rooney MF, 2016, BIOCH BIOPHYSICA A S, V1857, pe31; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014; Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serrano AL, 2000, PFLUG ARCH EUR J PHY, V441, P263, DOI 10.1007/s004240000408; Sinatra ST, 2014, J EQUINE VET SCI, V34, P265, DOI 10.1016/j.jevs.2013.06.001; Sinatra ST, 2013, J EQUINE VET SCI, V33, P71, DOI 10.1016/j.jevs.2012.05.001; SLATER EC, 1987, EUR J BIOCHEM, V166, P489, DOI 10.1111/j.1432-1033.1987.tb13542.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNIDER IP, 1992, INT J SPORT NUTR, V2, P272, DOI 10.1123/ijsn.2.3.272; Spurney CF, 2011, MUSCLE NERVE, V44, P174, DOI 10.1002/mus.22047; Tozaki T, 2010, ANIM GENET, V41, P28, DOI 10.1111/j.1365-2052.2010.02095.x; Tozaki T, 2011, J VET MED SCI, V73, P1617, DOI 10.1292/jvms.11-0295; Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van den Hoven R, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0428-3; Vinogradov A D, 1979, Methods Enzymol, V55, P118; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wharton DC., 1967, METHOD ENZYMOL, P245; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	90	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0186247	10.1371/journal.pone.0186247	http://dx.doi.org/10.1371/journal.pone.0186247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190290	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900007
J	Zhang, T; Huang, LY; Wang, YX; Wang, WS; Zhao, XQ; Zhang, SL; Zhang, J; Hu, FY; Fu, BY; Li, ZK				Zhang, Ting; Huang, Liyu; Wang, Yinxiao; Wang, Wensheng; Zhao, Xiuqin; Zhang, Shilai; Zhang, Jing; Hu, Fengyi; Fu, Binying; Li, Zhikang			Differential transcriptome profiling of chilling stress response between shoots and rhizomes of Oryza longistaminata using RNA sequencing	PLOS ONE			English	Article							COMPREHENSIVE EXPRESSION ANALYSIS; IMPROVES DROUGHT TOLERANCE; COLD TOLERANCE; GENE-EXPRESSION; ABIOTIC STRESS; ABSCISIC-ACID; NEGATIVE REGULATOR; OSDREB GENES; GRAIN-YIELD; RICE PLANTS	Rice (Oryza sativa) is very sensitive to chilling stress at seedling and reproductive stages, whereas wild rice, O. longistaminata, tolerates non-freezing cold temperatures and has overwintering ability. Elucidating the molecular mechanisms of chilling tolerance (CT) in O. longistaminata should thus provide a basis for rice CT improvement through molecular breeding. In this study, high-throughput RNA sequencing was performed to profile global transcriptome alterations and crucial genes involved in response to long-term low temperature in O. longistaminata shoots and rhizomes subjected to 7 days of chilling stress. A total of 605 and 403 genes were respectively identified as up-and down-regulated in O. longistaminata under 7 days of chilling stress, with 354 and 371 differentially expressed genes (DEGs) found exclusively in shoots and rhizomes, respectively. GO enrichment and KEGG pathway analyses revealed that multiple transcriptional regulatory pathways were enriched in commonly induced genes in both tissues; in contrast, only the photosynthesis pathway was prevalent in genes uniquely induced in shoots, whereas several key metabolic pathways and the programmed cell death process were enriched in genes induced only in rhizomes. Further analysis of these tissue-specific DEGs showed that the CBF/DREB1 regulon and other transcription factors (TFs), including AP2/EREBPs, MYBs, and WRKYs, were synergistically involved in transcriptional regulation of chilling stress response in shoots. Different sets of TFs, such as OsERF922, OsNAC9, OsWRKY25, and WRKY74, and eight genes encoding antioxidant enzymes were exclusively activated in rhizomes under long-term low-temperature treatment. Furthermore, several cis-regulatory elements, including the ICE1-binding site, the GATA element for phytochrome regulation, and the W-box for WRKY binding, were highly abundant in both tissues, confirming the involvement of multiple regulatory genes and complex networks in the transcriptional regulation of CT in O. longistaminata. Finally, most chilling-induced genes with alternative splicing exclusive to shoots were associated with photosynthesis and regulation of gene expression, while those enriched in rhizomes were primarily related to stress signal transduction; this indicates that tissue-specific transcriptional and post-transcriptional regulation mechanisms synergistically contribute to O. longistaminata long-term CT. Our findings provide an overview of the complex regulatory networks of CT in O. longistaminata.	[Zhang, Ting; Huang, Liyu; Wang, Yinxiao; Wang, Wensheng; Zhao, Xiuqin; Fu, Binying; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Huang, Liyu; Zhang, Shilai; Zhang, Jing; Hu, Fengyi] Yunnan Univ, Sch Agr, Kunming, Yunnan, Peoples R China; [Huang, Liyu; Zhang, Shilai; Zhang, Jing; Hu, Fengyi] Yunnan Univ, Res Ctr Perennial Rice Engn & Technol, Kunming, Yunnan, Peoples R China; [Fu, Binying; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen, Peoples R China; [Zhang, Ting] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Yunnan University; Yunnan University; Chinese Academy of Agricultural Sciences; Icahn School of Medicine at Mount Sinai	Fu, BY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.; Fu, BY (corresponding author), Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen, Peoples R China.	fubinying@caas.cn	zhang, ting/ABG-5784-2020	zhang, ting/0000-0001-9231-1604	National Natural Science Foundation of China [U1302264]; Shenzhen Peacock Plan [20130415095710361]; Chinese Academy Agricultural Science Innovative Team Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Plan; Chinese Academy Agricultural Science Innovative Team Award	This work was supported by grants from the National Natural Science Foundation of China (U1302264), the Shenzhen Peacock Plan (20130415095710361) and the Chinese Academy Agricultural Science Innovative Team Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (U1302264), the Shenzhen Peacock Plan (20130415095710361) and the Chinese Academy Agricultural Science Innovative Team Award. We thank Barbara Goodson, PhD, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.	Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Aoyama T, 2003, J PLANT RES, V116, P221, DOI 10.1007/s10265-003-0094-6; Balibrea ME, 1997, J PLANT PHYSIOL, V151, P221, DOI 10.1016/S0176-1617(97)80156-3; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Bonnecarrere V, 2011, PLANT SCI, V180, P726, DOI 10.1016/j.plantsci.2011.01.023; Casaretto JA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2659-5; Chen JQ, 2008, BIOTECHNOL LETT, V30, P2191, DOI 10.1007/s10529-008-9811-5; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Cominelli E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-162; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Degenhardt J, 1996, PLANT CELL, V8, P31, DOI 10.1105/tpc.8.1.31; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Du H, 2015, J INTEGR PLANT BIOL, V57, P954, DOI 10.1111/jipb.12313; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El-kereamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052030; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ghosh T, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1138192; Gichuhi E., 2012, P 2012 JKUAT SCI TEC, P723; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; He G.C., 1996, J WUHAN U NAT SCI ED, V42, P252; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huner NPA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00018; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 1991, RICE GENET NEWSL, Vl7, P121; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Li QX, 1988, SW CHINA J AGR SCI, V11, P5; Liang XX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02643-x; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086895; Liu JQ, 2016, PLANT PHYSIOL, V171, P1427, DOI 10.1104/pp.15.01921; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lv Y, 2017, PLANT PHYSIOL, V173, P1475, DOI 10.1104/pp.16.01725; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Mao DH, 2015, THEOR APPL GENET, V128, P1359, DOI 10.1007/s00122-015-2511-3; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Mishra M, 2013, OMICS, V17, P439, DOI 10.1089/omi.2012.0074; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagele T, 2013, NEW PHYTOL, V198, P777, DOI 10.1111/nph.12201; Nevo R, 2012, PLANT J, V70, P157, DOI 10.1111/j.1365-313X.2011.04876.x; OQUIST G, 1993, PLANT PHYSIOL, V101, P245, DOI 10.1104/pp.101.1.245; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Park MR, 2010, PLANT CELL ENVIRON, V33, P2209, DOI 10.1111/j.1365-3040.2010.02221.x; Phukan UJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00150; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Qian BJ, 2012, J SCI FOOD AGR, V92, P159, DOI 10.1002/jsfa.4557; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Satake T, 1986, NEW FRONTIERS BREEDI, P221; Schlappi MR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00957; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Serra TS, 2013, PLANT MOL BIOL, V82, P439, DOI 10.1007/s11103-013-0073-9; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Shukla N, 2012, PLANT PHYSIOL BIOCH, V54, P78, DOI 10.1016/j.plaphy.2012.02.001; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh A, 2012, PLANT SIGNAL BEHAV, V7, P847, DOI 10.4161/psb.20385; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Sun LJ, 2015, INT J MOL SCI, V16, P4306, DOI 10.3390/ijms16024306; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Tarkowski LP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00203; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vijayakumar H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081211; Virdi AS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00809; Wang D, 2016, RICE, V9, DOI 10.1186/s12284-016-0133-2; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Washburn JD, 2013, BIOENERG RES, V6, P822, DOI 10.1007/s12155-013-9305-8; Xie GS, 2009, FEBS LETT, V583, P2734, DOI 10.1016/j.febslet.2009.07.057; Xu GY, 2011, PLANTA, V234, P47, DOI 10.1007/s00425-011-1386-z; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yan HD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03435-z; Yanagisawa S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24447; Yang Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0257-0; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Yin XM, 2015, J PLANT BIOL, V58, P68, DOI 10.1007/s12374-014-0349-x; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhang F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-461; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang ZL, 2009, PLANT MOL BIOL, V70, P139, DOI 10.1007/s11103-009-9463-4	96	17	20	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188625	10.1371/journal.pone.0188625	http://dx.doi.org/10.1371/journal.pone.0188625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190752	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900086
J	Castan, A; Fernandez-Calleja, V; Hernandez, P; Krimer, DB; Schvartzman, JB; Fernandez-Nestosa, MJ				Castan, Alicia; Fernandez-Calleja, Vanessa; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.; Fernandez-Nestosa, Maria-Jose			Analysis of DNA topology of EBV minichromosomes in HEK 293 cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INTERTWINED CATENATED DIMERS; REPLICATION FORKS; RECOMBINANT PLASMIDS; GEL-ELECTROPHORESIS; NUCLEAR ANTIGEN-1; LATENT ORIGIN; ORIP; INITIATION; BINDING	Simian Virus 40 (SV40) and Epstein-Barr Virus (EBV) are frequently used as model systems to study DNA replication. Their genomes are both circular duplex DNAs organized in a single replicon where replication initiates at a precise site upon binding of a specific protein: the large tumor (T) antigen for SV40 and the Epstein-Barr Nuclear Antigen 1 (EBNA-1) for EBV. Despite the abundant information available on the genetics and biochemistry of the replication process in these systems, little is known about the changes in DNA topology that take place as molecules are transfected into eukaryotic cells, assembled into chromatin and bind initiator proteins to start replication. Here we used high-resolution two-dimensional agarose gel electrophoresis to demonstrate that in Human Embryonic Kidney (HEK) 293 cells, mini chromosomes of almost the same mass carrying either the SV40 or the EBV replication origin showed similar topological features. The patterns were very similar regardless of the initiator proteins. We also showed that in a hybrid minichromosome, pEco3'Delta, that initiates replication from the SV40 origin, the presence of EBNA-1 and its putative binding to the EBV "family of repeats" induces no significant topological change. These observations challenge the idea that binding of EBNA-1 to oriP could induce negative supercoiling and favor a model suggesting that it binds to oriP in a two-step process where only the second step causes structural changes in a transient cell cycle specific manner.	[Castan, Alicia; Fernandez-Calleja, Vanessa; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.] Ctr Invest Biol CSIC, Dept Cellular & Mol Biol, Ramiro de Maeztu 9, Madrid, Spain; [Fernandez-Nestosa, Maria-Jose] Natl Univ Asuncion, Sci & Appl Comp Lab, Polytech Sch, Sl, San Lorenzo, Paraguay	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad Nacional de Asuncion	Schvartzman, JB (corresponding author), Ctr Invest Biol CSIC, Dept Cellular & Mol Biol, Ramiro de Maeztu 9, Madrid, Spain.; Fernandez-Nestosa, MJ (corresponding author), Natl Univ Asuncion, Sci & Appl Comp Lab, Polytech Sch, Sl, San Lorenzo, Paraguay.	schvartzman@cib.csic.es; mjfernes@hotmail.com	Fernández De Nestosa, María José/GXZ-5768-2022; Schvartzman, Jorge B/J-9171-2014; Krimer, Dora/J-9176-2014	Krimer, Dora/0000-0001-9972-3994; Pablo, Hernandez/0000-0002-8113-1277; SCHVARTZMAN, JORGE B/0000-0002-1856-6278	Paraguayan CONACYTPROCIENCIA program [14-INV-062]; Spanish Ministerio de Economia y Competitividad [BFU2014-56835]	Paraguayan CONACYTPROCIENCIA program; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Grant 14-INV-062 from the Paraguayan CONACYTPROCIENCIA program to MJFN; Grant BFU2014-56835 from the Spanish Ministerio de Economia y Competitividad to JBS.	Avolio-Hunter TM, 2003, VIROLOGY, V315, P398, DOI 10.1016/S0042-6822(03)00561-0; Bashaw JM, 2001, J VIROL, V75, P10603, DOI 10.1128/JVI.75.22.10603-10611.2001; Bates A. D., 2005, DNA TOPOLOGY; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; CEREGHINI S, 1984, EMBO J, V3, P1243, DOI 10.1002/j.1460-2075.1984.tb01959.x; Dean FB, 1996, CURR BIOL, V6, P931, DOI 10.1016/S0960-9822(02)00629-2; DEPAMPHILIS ML, 1993, ANNU REV BIOCHEM, V62, P29; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; DULBECCO R, 1963, P NATL ACAD SCI USA, V50, P236, DOI 10.1073/pnas.50.2.236; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; FRAPPIER L, 1991, P NATL ACAD SCI USA, V88, P10875, DOI 10.1073/pnas.88.23.10875; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Hammerschmidt W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013029; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; HSIEH DJ, 1993, EMBO J, V12, P4933, DOI 10.1002/j.1460-2075.1993.tb06187.x; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Leight ER, 2001, J VIROL, V75, P10709; Mayan-Santos MD, 2007, ELECTROPHORESIS, V28, P3845, DOI 10.1002/elps.200700294; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Meinke G, 2007, PLOS BIOL, V5, P144, DOI 10.1371/journal.pbio.0050023; Mirkin SM, 2002, DNA TOPOLOGY FUNDAME; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; ORLOWSKI R, 1991, J VIROL, V65, P677, DOI 10.1128/JVI.65.2.677-686.1991; PLATT THK, 1993, J VIROL, V67, P1739, DOI 10.1128/JVI.67.3.1739-1745.1993; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Santamaria D, 1998, J BIOL CHEM, V273, P33386, DOI 10.1074/jbc.273.50.33386; Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026; Schvartzman JB, 2013, METHODS MOL BIOL, V1054, P121, DOI 10.1007/978-1-62703-565-1_7; Schvartzman JB, 2012, METHODS, V57, P170, DOI 10.1016/j.ymeth.2012.03.013; SHEN CKJ, 1986, P NATL ACAD SCI USA, V83, P1641, DOI 10.1073/pnas.83.6.1641; STILLMAN B, 1994, J BIOL CHEM, V269, P7047; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SU W, 1991, P NATL ACAD SCI USA, V88, P10870, DOI 10.1073/pnas.88.23.10870; SUGDEN B, 1985, MOL CELL BIOL, V5, P410, DOI 10.1128/MCB.5.2.410; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wang J., 2009, NGLING DOUBLE HELIX; Willis NA, 2014, NATURE, V510, P556, DOI 10.1038/nature13295; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806	45	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188172	10.1371/Journal.pone.0188172	http://dx.doi.org/10.1371/Journal.pone.0188172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186176	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900025
J	Jiang, N; Jin, H; Li, Y; Ge, XN; Han, J; Guo, X; Zhou, L; Yang, HC				Jiang, Nan; Jin, Huan; Li, Yi; Ge, Xinna; Han, Jun; Guo, Xin; Zhou, Lei; Yang, Hanchun			Identification of a novel linear B-cell epitope in nonstructural protein 11 of porcine reproductive and respiratory syndrome virus that are conserved in both genotypes	PLOS ONE			English	Article							EARED PIG-DISEASE; REPLICATIVE ENDORIBONUCLEASE; MONOCLONAL-ANTIBODY; MOLECULAR-BIOLOGY; PATHOGENICITY; STRAIN; NSP11; BRITTANY; VR-2332; ISOLATE	Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important pathogens, that hinder the development of global pork industry. Its nonstructural protein 11 (nsp11), with the nidoviral uridylate-specific endoribonuclease (NendoU) domain, is essential for PRRSV genome replication and it also contributes to host innate immunity suppression. However, the immunogenicity and immune structure of PRRSV nsp11 have not been well investigated yet. In this study, a monoclonal antibody (mAb), designated 3F9, that against nsp11 was generated. Subsequently, a series of partially overlapped fragments, covered the nsp11(40-223aa), were expressed to test the reactivity with mAb 3F9, and the (DCREY115)-D-111 was found to be the core unit of the B-cell epitope recognized by mAb 3F9. Further investigation indicated that both genotype 1 and genotype 2 PRRSV can be recognized by mAb 3F9, due to the (DCREY115)-D-111 is conserved in both genotype virus. Meanwhile, this epitope, localized at the surface of nsp11 in 3D structure, is confirmed to be able to induce humoral immune response in PRRSV infected pigs. These findings do not only provide an mAb tool to further investigate the function of nsp11, they also indicate the diagnostic potential for this epitope.	[Jiang, Nan; Jin, Huan; Li, Yi; Ge, Xinna; Han, Jun; Guo, Xin; Zhou, Lei; Yang, Hanchun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China; [Jiang, Nan; Jin, Huan; Li, Yi; Ge, Xinna; Han, Jun; Guo, Xin; Zhou, Lei; Yang, Hanchun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Zhou, L (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol, Minist Agr, Beijing, Peoples R China.; Zhou, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	Leosj@cau.edu.cn		Zhou, Lei/0000-0002-8837-3965	National Natural Science Foundation of China [31330077]; Earmarked fund for Modern Agroindustry Technology Research System of China from the Ministry of Agriculture of People's Republic of China [CARS-36]; National Key Technology R&D Program of China from the Chinese Ministry of Science and Technology [2015BAD12B01-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked fund for Modern Agroindustry Technology Research System of China from the Ministry of Agriculture of People's Republic of China; National Key Technology R&D Program of China from the Chinese Ministry of Science and Technology	This study was found by Key project of National Natural Science Funds from National Natural Science Foundation of China with Award Number 31330077 (to HY); Earmarked fund for Modern Agroindustry Technology Research System of China from the Ministry of Agriculture of People's Republic of China with Award Number CARS-36 (to HY); National Key Technology R&D Program of China from the Chinese Ministry of Science and Technology with Award Number 2015BAD12B01-2 (to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA E, 1992, VET REC, V130, P83, DOI 10.1136/vr.130.4.83-a; ALBINA E, 1992, VET REC, V130, P58, DOI 10.1136/vr.130.3.58; Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; Bi CH, 2017, ARCH VIROL, V162, P2239, DOI 10.1007/s00705-017-3355-8; Cao JZ, 2012, VIRUS RES, V167, P247, DOI 10.1016/j.virusres.2012.05.006; Chen J, 2015, VIRUSES-BASEL, V7, P5539, DOI 10.3390/v7102893; Chen NH, 2011, J GEN VIROL, V92, P880, DOI 10.1099/vir.0.027995-0; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; He Q, 2015, VIRUS RES, V201, P32, DOI 10.1016/j.virusres.2015.02.014; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; MORIN M, 1991, VET REC, V129, P252, DOI 10.1136/vr.129.11.252-b; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Ramirez E, 2008, TRANSBOUND EMERG DIS, V55, P115, DOI 10.1111/j.1865-1682.2007.00991.x; Shi XB, 2011, MOL IMMUNOL, V48, P1568, DOI 10.1016/j.molimm.2011.03.004; Shi YJ, 2016, J VIROL, V90, P4579, DOI 10.1128/JVI.03065-15; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Ulferts R, 2011, RNA BIOL, V8, P295, DOI 10.4161/rna.8.2.15196; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Vanhee M, 2010, VIRAL IMMUNOL, V23, P403, DOI 10.1089/vim.2010.0025; Wang C, 2015, DNA CELL BIOL, V34, P728, DOI 10.1089/dna.2015.2929; Wang XC, 2016, VIRUS RES, V225, P40, DOI 10.1016/j.virusres.2016.09.006; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yan YL, 2007, VIRUS RES, V126, P207, DOI 10.1016/j.virusres.2007.03.002; Zhang MF, 2017, J VIROL, V91, DOI [10.1128/JVI.01309-16, 10.1128/jvi.01309-16]; Zhang ZB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0782-9; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188946	10.1371/journal.pone.0188946	http://dx.doi.org/10.1371/journal.pone.0188946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186182	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900071
J	Takeuchi, Y; Soda, R; Diway, B; Kuda, TA; Nakagawa, M; Nagamasu, H; Nakashizuka, T				Takeuchi, Yayoi; Soda, Ryoji; Diway, Bibian; Kuda, Tinjan ak.; Nakagawa, Michiko; Nagamasu, Hidetoshi; Nakashizuka, Tohru			Biodiversity conservation values of fragmented communally reserved forests, managed by indigenous people, in a human modified landscape in Borneo	PLOS ONE			English	Article							TREE SPECIES-DIVERSITY; SMALL PATCHES; LAND-USE; AGRICULTURE; COMMUNITY; BENEFITS	This study explored the conservation values of communally reserved forests (CRFs), which local indigenous communities deliberately preserve within their area of shifting cultivation. In the current landscape of rural Borneo, CRFs are the only option for conservation because other forested areas have already been logged or transformed into plantations. By analyzing their alpha and beta diversity, we investigated how these forests can contribute to restore regional biodiversity. Although CRFs were fragmented and some had been disturbed in the past, their tree species diversity was high and equivalent to that of primary forests. The species composition of intact forests and forests disturbed in the past did not differ clearly, which indicates that past logging was not intensive. All CRFs contained unique and endangered species, which are on the IUCN Red List, Sarawak protected plants, or both. On the other hand, the forest size structure differed between disturbed and intact CRFs, with the disturbed CRFs consisting of relatively smaller trees. Although the beta diversity among CRFs was also high, we found a high contribution of species replacement (turnover), but not of richness difference, in the total beta diversity. This suggests that all CRFs have a conservation value for restoring the overall regional biodiversity. Therefore, for maintaining the regional species diversity and endangered species, it would be suitable to design a conservation target into all CRFs.	[Takeuchi, Yayoi] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Soda, Ryoji] Osaka City Univ, Fac Literature & Human Sci, Sumiyoshi Ku, Osaka, Japan; [Diway, Bibian; Kuda, Tinjan ak.] Sarawak Forestry Corp, Bot Res Ctr Semenggoh, Kuching, Sarawak, Malaysia; [Nakagawa, Michiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Nagamasu, Hidetoshi] Kyoto Univ, Kyoto Univ Museum, Sakyo Ku, Kyoto, Japan; [Nakashizuka, Tohru] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kuda, Tinjan ak.] Int Trop Timber Org, Forest Dept HQ, Kuching, Sarawak, Malaysia; [Nakashizuka, Tohru] Res Inst Human & Nat, Kyoto, Japan	National Institute for Environmental Studies - Japan; Osaka Metropolitan University; Nagoya University; Kyoto University; Tohoku University; Jabatan Hutan Sarawak; Research Institute for Humanity & Nature (RIHN)	Takeuchi, Y (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	takeuchi.yayoi@nies.go.jp	Nakashizuka, Tohru/AAO-1081-2020	TAKEUCHI, YAYOI/0000-0002-8402-7854	JSPS KAKENHI [22221010, 16K00641]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Numbers 22221010 (YT, RS) and 16K00641 (YT). http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Ashton P., 2015, FORESTS TROPICAL ASI; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bhagwat SA, 2014, FOREST ECOL MANAG, V329, P393, DOI 10.1016/j.foreco.2013.11.017; Birch JC, 2014, ECOSYST SERV, V8, P118, DOI 10.1016/j.ecoser.2014.03.005; Brandt JS, 2013, BIOL CONSERV, V166, P34, DOI 10.1016/j.biocon.2013.06.014; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Cannon CH, 1998, SCIENCE, V281, P1366, DOI 10.1126/science.281.5381.1366; CBD, 1992, CONV BIOL DIV RIO JA; CITES, 2015, CONV INT TRAD END SP; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; de Jong W, 2002, FOREST PRODUCTS LOCA; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Gao H, 2013, BIODIVERS CONSERV, V22, P531, DOI 10.1007/s10531-012-0427-7; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Majid-Cooke F., 2006, ASIA PACIFIC ENV MON, V1; McGill B, 2015, NATURE, V520, P38, DOI 10.1038/520038a; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Mulyoutami E, 2009, FOREST ECOL MANAG, V257, P2054, DOI 10.1016/j.foreco.2009.01.042; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Pardo-De-Santayana M, 2015, NATURE, V518, P487, DOI 10.1038/518487a; R Development Core Team, 2014, R LANG ENV STAT COMP; Sarawak Forestry Corporation, PROT PLANTS; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sutlive VH, 2001, ENCY IBAN STUSIES IB; Takeuchi Y, 2013, FOREST ECOL MANAG, V289, P416, DOI 10.1016/j.foreco.2012.10.027; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; World Conservation Monitoring Centre, 2016, IUCN RED LIST THREAT	37	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187273	10.1371/journal.pone.0187273	http://dx.doi.org/10.1371/journal.pone.0187273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186138	gold, Green Submitted, Green Published			2022-12-26	WOS:000416484900004
J	Pathan-Chhatbar, S; Taft, MH; Reindl, T; Hundt, N; Latham, SL; Manstein, DJ				Pathan-Chhatbar, Salma; Taft, Manuel H.; Reindl, Theresia; Hundt, Nikolas; Latham, Sharissa L.; Manstein, Dietmar J.			Three mammalian tropomyosin isoforms have different regulatory effects on nonmuscle myosin-2B and filamentous beta-actin in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TROPOMYOSIN; CYTOPLASMIC MYOSINS; MOLECULAR MOTORS; SMOOTH-MUSCLE; N-TERMINUS; F-ACTIN; BINDING; COMPLEX; IIB; CYTOSKELETON	The metazoan actin cytoskeleton supports a wide range of contractile and transport processes. Recent studies have shown how the dynamic association with specific tropomyosin isoforms generates actin filament populations with distinct functional properties. However, critical details of the associated molecular interactions remain unclear. Here, we report the properties of actomyosin-tropomyosin complexes containing filamentous beta-actin, nonmuscle myosin-2B (NM-2B) constructs, and either tropomyosin isoform Tpm1.8cy (b.-.b.d), Tpm1.12br (b.-.b.c), or Tpm3.1cy(b.-.a.d). Our results show the extent to which the association of filamentous beta-actin with these different tropomyosin cofilaments affects the actin-mediated activation of NM-2B and the release of the ATP hydrolysis products ADP and phosphate from the active site. Phosphate release gates a transition from weak to strong F-actin-binding states. The release of ADP has the opposite effect. These changes in dominant rate-limiting steps have a direct effect on the duty ratio, the fraction of time that NM-2B spends in strongly F-actin-bound states during ATP turnover. The duty ratio is increased similar to 3-fold in the presence of Tpm1.12 and 5-fold for both Tpm1.8 and Tpm3.1. The presence of Tpm1.12 extends the time required per ATP hydrolysis cycle 3.7-fold, whereas it is shortened by 27 and 63% in the presence of Tpm1.8 and Tpm3.1, respectively. The resulting Tpm isoform-specific changes in the frequency, duration, and efficiency of actomyosin interactions establish a molecular basis for the ability of these complexes to support cellular processes with widely divergent demands in regard to force production, capacity to move processively, and speed of movement.	[Pathan-Chhatbar, Salma; Taft, Manuel H.; Reindl, Theresia; Hundt, Nikolas; Latham, Sharissa L.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Manstein, Dietmar J.] Hannover Med Sch, Div Struct Biochem, D-30625 Hannover, Germany; [Hundt, Nikolas] Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3TA, England	Hannover Medical School; Hannover Medical School; University of Oxford	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Taft, Manuel/O-1396-2019; Manstein, Dietmar J./AAG-2640-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J. J/M-1034-2013; Latham, Sharissa/B-2353-2016	Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Reindl, Theresia/0000-0001-9633-1899; Latham, Sharissa/0000-0003-1128-5315	Deutsche Forschungsgemeinschaft [MA1081/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA1081/21-1 (to D.J.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ampe C, 2017, HANDB EXP PHARMACOL, V235, P1, DOI 10.1007/164_2016_43; Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; Barua B, 2014, BIOCHEMISTRY-US, V53, P4015, DOI 10.1021/bi500162z; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CHO YJ, 1991, P NATL ACAD SCI USA, V88, P10153, DOI 10.1073/pnas.88.22.10153; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Clayton JE, 2015, CYTOSKELETON, V72, P131, DOI 10.1002/cm.21213; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; Currier MA, 2017, MOL CANCER THER, V16, P1555, DOI 10.1158/1535-7163.MCT-16-0873; Curthoys NM, 2014, MOL CELL NEUROSCI, V58, P11, DOI 10.1016/j.mcn.2013.10.011; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Diensthuber RP, 2011, FEBS LETT, V585, P767, DOI 10.1016/j.febslet.2011.01.042; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Erdmann T, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052403; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Geeves M, 2011, BIOPHYS J, V100, P2679, DOI 10.1016/j.bpj.2011.04.020; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Greenfield NJ, 2009, BIOCHEMISTRY-US, V48, P1272, DOI 10.1021/bi801861k; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Hundt N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20554; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Kee AJ, 2016, TRAFFIC, V17, P80, DOI 10.1111/tra.12342; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; Manstein DJ, 2016, TRAFFIC, V17, P872, DOI 10.1111/tra.12399; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MCLACHLAN AD, 1976, J MOL BIOL, V106, P1017, DOI 10.1016/0022-2836(76)90349-1; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Muller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070636; Munnich S, 2014, FEBS LETT, V588, P4754, DOI 10.1016/j.febslet.2014.11.007; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nelson SR, 2011, METHODS MOL BIOL, V778, P111, DOI 10.1007/978-1-61779-261-8_8; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shutova MS, 2014, CURR BIOL, V24, P1958, DOI 10.1016/j.cub.2014.07.070; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Stam S, 2015, BIOPHYS J, V108, P1997, DOI 10.1016/j.bpj.2015.03.030; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Walklate J, 2016, J EXP BIOL, V219, P168, DOI 10.1242/jeb.124594; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WEGNER A, 1980, FEBS LETT, V119, P245, DOI 10.1016/0014-5793(80)80263-8; WEIGT C, 1991, BIOCHEMISTRY-US, V30, P10700, DOI 10.1021/bi00108a014; Wolfenson H, 2016, NAT CELL BIOL, V18, P33, DOI 10.1038/ncb3277	70	25	25	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					863	875		10.1074/jbc.M117.806521	http://dx.doi.org/10.1074/jbc.M117.806521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191834	Green Published, hybrid			2022-12-26	WOS:000422864500009
J	Chakraborty, J; Langdon-Embry, L; Cunanan, KM; Escalon, JG; Allen, PJ; Lowery, MA; O'Reilly, EM; Gonen, M; Do, RG; Simpson, AL				Chakraborty, Jayasree; Langdon-Embry, Liana; Cunanan, Kristen M.; Escalon, Joanna G.; Allen, Peter J.; Lowery, Maeve A.; O'Reilly, Eileen M.; Gonen, Mithat; Do, Richard G.; Simpson, Amber L.			Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients	PLOS ONE			English	Article							ADENOCARCINOMA; CLASSIFICATION; GEMCITABINE; INFORMATION; RESECTION; PATTERNS; FEATURES	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate between resectable patients with occult metastatic disease from those with potentially curable disease. Identification of patients with poor prognosis via early classification would help in initial management including the use of neoadjuvant chemotherapy or radiation, or in the choice of postoperative adjuvant therapy. PDAC ranges in appearance from homogeneously isoattenuating masses to heterogeneously hypovascular tumors on CT images; hence, we hypothesize that heterogeneity reflects underlying differences at the histologic or genetic level and will therefore correlate with patient outcome. We quantify heterogeneity of PDAC with texture analysis to predict 2-year survival. Using fuzzy minimum-redundancy maximum-relevance feature selection and a naive Bayes classifier, the proposed features achieve an area under receiver operating characteristic curve (AUC) of 0.90 and accuracy (Ac) of 82.86% with the leave-one-image-out technique and an AUC of 0.80 and Ac of 75.0% with three-fold cross-validation. We conclude that texture analysis can be used to quantify heterogeneity in CT images to accurately predict 2-year survival in patients with pancreatic cancer. From these data, we infer differences in the biological evolution of pancreatic cancer subtypes measurable in imaging and identify opportunities for optimized patient selection for therapy.	[Chakraborty, Jayasree; Langdon-Embry, Liana; Allen, Peter J.; Simpson, Amber L.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Cunanan, Kristen M.; Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Escalon, Joanna G.; Do, Richard G.] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Lowery, Maeve A.; O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Simpson, Amber L.] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Simpson, AL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Simpson, AL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10021 USA.	simpsonl@mskcc.org	lowery, maeve/AAG-2575-2019; Gonen, Mithat/E-4826-2012; Chakraborty, Jayasree/Q-2424-2019	lowery, maeve/0000-0003-1354-7606; Gonen, Mithat/0000-0001-8683-8477; O'Reilly, Eileen M./0000-0002-8076-9199; Chakraborty, Jayasree/0000-0003-4434-8861	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Cycle for Survival	NIH/NCI Cancer Center Support Grant; Cycle for Survival	This work was supported in part by NIH/NCI P30 CA008748 Cancer Center Support Grant and Cycle for Survival (cycleforsurvival.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2009, LECT NOTES COMPUT SC, V5575, P61, DOI 10.1007/978-3-642-02230-2_7; Al-Ani A, 2012, COMM COM INF SC, V322, P430; Al-Hawary MM, 2014, GASTROENTEROLOGY, V146, P291, DOI 10.1053/j.gastro.2013.11.004; Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; American Cancer Society, 2014, CANC FACTS FIG 2014; Andriulli A, 2012, ANN SURG ONCOL, V19, P1644, DOI 10.1245/s10434-011-2110-8; Antonelli M., 2013, LECT NOTES COMPUTER, V8256, P36, DOI DOI 10.1007/978-3-319-03200-9_4; Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Banik S, 2013, INT J COMPUT ASS RAD, V8, P121, DOI 10.1007/s11548-012-0681-x; Bilici A, 2014, WORLD J GASTROENTERO, V20, P10802, DOI 10.3748/wjg.v20.i31.10802; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Buczkowski S, 1998, PATTERN RECOGN, V31, P411, DOI 10.1016/S0031-3203(97)00054-X; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Chakraborty J., 2016, SPIE MED IMAGING 201; Chakraborty J, 2013, INT CONF BIOMED, P111, DOI 10.1109/BMEI.2013.6746917; Chakraborty J, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.3.033010; Costa A. F., 2012, 2012 XXV SIBGRAPI - Conference on Graphics, Patterns and Images (SIBGRAPI 2012), P39, DOI 10.1109/SIBGRAPI.2012.15; DUDA RO, 2001, PATTERN CLASSIFICATI; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Hallemeier Christopher L, 2011, Am J Clin Oncol, V34, P567, DOI 10.1097/COC.0b013e3181f946fc; Hanania AN, 2016, ONCOTARGET, V7, P85776, DOI 10.18632/oncotarget.11769; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Howlader N., 2016, SEER CANC STAT REV; Khushaba RN, 2011, IEEE T BIO-MED ENG, V58, P121, DOI 10.1109/TBME.2010.2077291; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Li DN, 2015, SEMIN ONCOL, V42, P134, DOI 10.1053/j.seminoncol.2014.12.012; Liu L, 2014, IEEE T IMAGE PROCESS, V23, P3071, DOI 10.1109/TIP.2014.2325777; Lloyd Mark C, 2010, J Pathol Inform, V1, P29, DOI 10.4103/2153-3539.74186; Lowery MA, 2012, PHARMACOGENOMICS J, V12, P1, DOI 10.1038/tpj.2011.52; Mehta Rakesh, 2013, Proceedings of the 2nd International Conference on Pattern Recognition Applications and Methods. ICPRAM 2013, P497; Midya A, 2015, I S BIOMED IMAGING, P411, DOI 10.1109/ISBI.2015.7163899; O'Reilly EM, 2014, ANN SURG, V260, P142, DOI 10.1097/SLA.0000000000000251; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pang Kwok Kuen, 2003, J Chin Med Assoc, V66, P655; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pietikainen M, 2011, COMPUT IMAGING VIS, V40, P13, DOI 10.1007/978-0-85729-748-8_2; Prigarin S. M., 2013, INT J BIOMATH, V2, P167; Puleo F, 2015, WORLD J GASTROENTERO, V21, P2281, DOI 10.3748/wjg.v21.i8.2281; Spiteri M, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.044502; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Urayama S, 2015, WORLD J GASTROENTERO, V21, P1707, DOI 10.3748/wjg.v21.i6.1707; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Winter JM, 2012, ANN SURG ONCOL, V19, P169, DOI 10.1245/s10434-011-1900-3; Xu CP, 2014, J CANCER RES CLIN, V140, P549, DOI 10.1007/s00432-013-1572-4; Yang XF, 2012, MED PHYS, V39, P5732, DOI 10.1118/1.4747526; Yoon SH, 2011, RADIOLOGY, V259, P442, DOI 10.1148/radiol.11101133	52	48	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188022	10.1371/journal.pone.0188022	http://dx.doi.org/10.1371/journal.pone.0188022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216209	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800017
J	Carlin, DE; Paull, EO; Graim, K; Wong, CK; Bivol, A; Ryabinin, P; Ellrott, K; Sokolov, A; Stuart, JM				Carlin, Daniel E.; Paull, Evan O.; Graim, Kiley; Wong, Christopher K.; Bivol, Adrian; Ryabinin, Peter; Ellrott, Kyle; Sokolov, Artem; Stuart, Joshua M.			Prophetic Granger Causality to infer gene regulatory networks	PLOS ONE			English	Article							COEXPRESSION NETWORK; EXPRESSION; TOPOLOGY; INHIBITION; ALGORITHM; DISCOVERY; REVEALS; PATHWAY; MODELS; YAP	We introduce a novel method called Prophetic Granger Causality (PGC) for inferring gene regulatory networks (GRNs) from protein-level time series data. The method uses an L1-penalized regression adaptation of Granger Causality to model protein levels as a function of time, stimuli, and other perturbations. When combined with a data-independent network prior, the framework outperformed all other methods submitted to the HPN-DREAM 8 breast cancer network inference challenge. Our investigations reveal that PGC provides complementary information to other approaches, raising the performance of ensemble learners, while on its own achieves moderate performance. Thus, PGC serves as a valuable new tool in the bioinformatics toolkit for analyzing temporal datasets. We investigate the general and cell-specific interactions predicted by our method and find several novel interactions, demonstrating the utility of the approach in charting new tumor wiring.	[Carlin, Daniel E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Paull, Evan O.; Graim, Kiley; Wong, Christopher K.; Bivol, Adrian; Ryabinin, Peter; Sokolov, Artem; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ellrott, Kyle] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR USA	University of California System; University of California San Diego; University of California System; University of California Santa Cruz; Oregon Health & Science University	Sokolov, A; Stuart, JM (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	Artem.Sokolov@gmail.com; jstuart@ucsc.edu		Sokolov, Artem/0000-0002-8056-0504; Stuart, Joshua/0000-0002-2171-565X; Ellrott, Kyle/0000-0002-6573-5900; Graim, Kiley/0000-0002-4569-8444	National Cancer Institute [U24-CA143858, 1R01CA180778]; National Human Genome Research Institute [5U54HG006097]; National Institute for General Medical Sciences [5R01GM109031]; National Science Foundation Office of Cyberinfrastructure [0845783]; West Coast Prostate Cancer Dream Team by Stand Up to Cancer/ AACR/Prostate Cancer Foundation [SU2C-AACR-DT0812]; Movember Foundation; NATIONAL CANCER INSTITUTE [R01CA180778, U24CA210990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Office of Cyberinfrastructure; West Coast Prostate Cancer Dream Team by Stand Up to Cancer/ AACR/Prostate Cancer Foundation; Movember Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Cancer Institute U24-CA143858, National Cancer Institute 1R01CA180778, National Human Genome Research Institute 5U54HG006097, National Institute for General Medical Sciences 5R01GM109031,and a National Science Foundation Office of Cyberinfrastructure 0845783. Supported by the West Coast Prostate Cancer Dream Team supported by Stand Up to Cancer/ AACR/Prostate Cancer Foundation SU2C-AACR-DT0812 (O.N.W. co-PI). This research Grant is made possible by the generous support of the Movember Foundation. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam R, 2015, MOL BIOSYST, V11, P942, DOI 10.1039/c4mb00413b; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Cheng DH, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P382, DOI 10.1145/2623330.2623709; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kiani NA, 2016, SEMIN CELL DEV BIOL, V51, P44, DOI 10.1016/j.semcdb.2016.01.012; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Liu F, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005024; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Nair A, 2015, MOL BIOSYST, V11, P2449, DOI 10.1039/c5mb00122f; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Petryszak R, 2013, NUCLEIC ACIDS RES; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Rau A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1513; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tam GHF, 2013, IET SYST BIOL, V7, P195, DOI 10.1049/iet-syb.2012.0063; Vaske CJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000274; Yao S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0710-1; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Young WC, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-47; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang XJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1315; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou C, 2015, INT J DATA MIN BIOIN, V12, P328, DOI 10.1504/IJDMB.2015.069658	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0170340	10.1371/journal.pone.0170340	http://dx.doi.org/10.1371/journal.pone.0170340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211761	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200001
J	Holtman, GA; Lisman-van Leeuwen, Y; Kollen, BJ; Norbruis, OF; Escher, JC; Walhout, LC; Kindermann, A; de Rijke, YB; van Rheenen, PF; Berger, MY				Holtman, Gea A.; Lisman-van Leeuwen, Yvonne; Kollen, Boudewijn J.; Norbruis, Obbe F.; Escher, Johanna C.; Walhout, Laurence C.; Kindermann, Angelika; de Rijke, Yolanda B.; van Rheenen, Patrick F.; Berger, Marjolein Y.			Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care	PLOS ONE			English	Article							RECURRENT ABDOMINAL-PAIN; FECAL CALPROTECTIN; PREDICTION MODELS; IMPUTATION; VALUES; ACCURACY; MARKERS; EVENTS; IBD	Background In children with symptoms suggestive of inflammatory bowel disease (IBD) who present in primary care, the optimal test strategy for identifying those who require specialist care is unclear. We evaluated the following three test strategies to determine which was optimal for referring children with suspected IBD to specialist care: 1) alarm symptoms alone, 2) alarm symptoms plus c-reactive protein, and 3) alarm symptoms plus fecal calprotectin. Methods A prospective cohort study was conducted, including children with chronic gastrointestinal symptoms referred to pediatric gastroenterology. Outcome was defined as IBD confirmed by endoscopy, or IBD ruled out by either endoscopy or unremarkable clinical 12 month follow-up with no indication for endoscopy. Test strategy probabilities were generated by logistic regression analyses and compared by area under the receiver operating characteristic curves (AUC) and decision curves. Results We included 90 children, of whom 17 (19%) had IBD (n = 65 from primary care physicians, n = 25 from general pediatricians). Adding fecal calprotectin to alarm symptoms increased the AUC significantly from 0.80 (0.67-0.92) to 0.97 (0.93-1.00), but adding c-reactive protein to alarm symptoms did not increase the AUC significantly (p > 0.05). Decision curves confirmed these patterns, showing that alarm symptoms combined with fecal calprotectin produced the diagnostic test strategy with the highest net benefit at reasonable threshold probabilities. Conclusion In primary care, when children are identified as being at high risk for IBD, adding fecal calprotectin testing to alarm symptoms was the optimal strategy for improving risk stratification.	[Holtman, Gea A.; Lisman-van Leeuwen, Yvonne; Kollen, Boudewijn J.; Berger, Marjolein Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Norbruis, Obbe F.] Isala Hosp, Dept Pediat, Zwolle, Netherlands; [Escher, Johanna C.; Walhout, Laurence C.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Gastroenterol, Rotterdam, Netherlands; [Kindermann, Angelika] Acad Med Ctr, Dept Pediat Gastroenterol, Emma Childrens Hosp, Amsterdam, Netherlands; [de Rijke, Yolanda B.] Univ Med Ctr, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands; [van Rheenen, Patrick F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Gastroenterol, Groningen, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Holtman, GA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	g.a.holtman@umcg.nl	de Rijke, Yolanda/AAQ-5497-2020	/0000-0003-3867-2665; Lisman-van Leeuwen, Yvonne/0000-0003-4126-526X	Netherlands Fonds NutsOhra [0802-099]; University Medical Centre Groningen doelmatigheidsonderzoek [689 302]	Netherlands Fonds NutsOhra; University Medical Centre Groningen doelmatigheidsonderzoek	This study was funded by a grant from the Netherlands Fonds NutsOhra (grant number 0802-099) and a grant from the University Medical Centre Groningen doelmatigheidsonderzoek (grant number 689 302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH Program AIHW General Practice Statistics and Classification Unit, 2004, Aust Fam Physician, V33, P968; de Ridder Lissy, 2010, Ned Tijdschr Geneeskd, V154, pA1898; Degraeuwe PLJ, 2015, J PEDIATR GASTR NUTR, V60, P339, DOI 10.1097/MPG.0000000000000615; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Lorenzo C, 2005, J PEDIATR GASTR NUTR, V40, P249, DOI 10.1097/01.MPG.0000154661.39488.AC; Gieteling MJ, 2008, J PEDIATR GASTR NUTR, V47, P316, DOI 10.1097/MPG.0b013e31815bc1c1; Gieteling MJ, 2011, ANN FAM MED, V9, P337, DOI 10.1370/afm.1268; Gieteling MJ., 2012, HUISARTS WET, V55, P404; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Holtman GA, 2016, ANN FAM MED, V14, P437, DOI 10.1370/afm.1949; Holtman GA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2126; Holtman GA, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-179; Kim SC, 2004, GASTROENTEROLOGY, V126, P1550, DOI 10.1053/j.gastro.2004.03.022; Knottnerus JA, 1997, BRIT MED J, V315, P1109; Kokkonen J, 2004, ACTA PAEDIATR, V93, P880, DOI [10.1080/08035250410024907, 10.1111/j.1651-2227.2004.tb02684.x]; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Naaktgeboren CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i402; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Oord T, 2014, SCAND J CLIN LAB INV, V74, P254, DOI 10.3109/00365513.2013.879732; Oostenbrink R, 2003, J CLIN EPIDEMIOL, V56, P501, DOI 10.1016/S0895-4356(03)00080-5; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pels LPM, 2010, J PEDIATR GASTR NUTR, V51, P708, DOI 10.1097/MPG.0b013e3181da4d8b; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Spee LAA, 2013, SCAND J PRIM HEALTH, V31, P197, DOI 10.3109/02813432.2013.844405; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thomson S, 2011, INT PROFILES HLTH CA; Van de Vijver E, 2012, ARCH DIS CHILD, V97, P1014, DOI 10.1136/archdischild-2011-301206; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van Tilburg ML, 2006, GASTROENTEROL NURS, V29, P50, DOI 10.1097/00001610-200601000-00009; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6; Vink G, 2014, STAT NEERL, V68, P61, DOI 10.1111/stan.12023; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189111	10.1371/journal.pone.0189111	http://dx.doi.org/10.1371/journal.pone.0189111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211800	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200065
J	Shinomiya, H; Shinomiya, H; Kubo, M; Saito, Y; Yoshida, M; Ando, M; Teshima, M; Otsuki, N; Kiyota, N; Sasaki, R; Nibu, K				Shinomiya, Hirotaka; Shinomiya, Hitomi; Kubo, Mie; Saito, Yuki; Yoshida, Masafumi; Ando, Mizuo; Teshima, Masanori; Otsuki, Naoki; Kiyota, Naomi; Sasaki, Ryohei; Nibu, Kenichi			Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE 2; HUMAN-PAPILLOMAVIRUS; ALCOHOL-CONSUMPTION; RISK; NECK; HEAD; DRINKING; SURVIVAL	Background Half of Japanese possess a polymorphism of aldehyde dehydrogenase 2(ALDH2), while few white individuals possess this mutation. The purpose of this study was to investigate the possibility of ALDH2 polymorphism as a prognostic factor for oropharyngeal cancer (OPC) among Japanese population. Methods We analyzed 82 Japanese patients with OPC treated between 2006 and 2011. The median observation period was 50 months. P16-staining and ALDH2 polymorphisms were investigated. To examine the frequencies of second primary pharyngeal and esophageal cancers (SPPEC), 37 Japanese patients with OPC treated at Tokyo University Hospital were included for statistical analysis. Results Statistically significant differences were noted in OS among sex, age, N classification, and p16 (p = 0.045, 0.024, 0.020, 0.007, respectively). In addition, OS and DSS rates of the patients with heterozygous ALDH2 tended to be worse than those of the patients with homozygous ALDH2 (p = 0.21, 0.086, respectively). Of note, OS and DSS of the patients with p16-negative OPC and heterozygous ALDH2 was significant poorer than those of the patients with p16-positive OPC (p = 0.002, 0.006, respectively), while there was no significant difference in OS and DSS between patients with p16-positive OPC and patients with p16-negative OPC and homozygous ALDH2. Conclusions ALDH2 polymorphism might be a promising prognostic factor for Japanese patients with p16-negative OPC.	[Shinomiya, Hirotaka; Shinomiya, Hitomi; Kubo, Mie; Teshima, Masanori; Otsuki, Naoki; Nibu, Kenichi] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan; [Saito, Yuki; Yoshida, Masafumi; Ando, Mizuo] Univ Tokyo, Dept Head & Neck Surg Otolaryngol, Tokyo, Japan; [Kiyota, Naomi] Kobe Univ, Grad Sch Med, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan; [Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiat Oncol, Kobe, Hyogo, Japan	Kobe University; University of Tokyo; Kobe University; Kobe University	Shinomiya, H; Nibu, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan.	hshino@med.kobe-u.ac.jp; nibu@med.kobe-u.ac.jp	Kiyota, Naomi/K-3226-2016; Otsuki, Naoki/AAH-2468-2020; Shinomiya, Hirotaka/AAF-5067-2020	Kiyota, Naomi/0000-0001-8021-6116; Shinomiya, Hirotaka/0000-0003-1667-7545; Ando, Mizuo/0000-0002-0754-2545; Otsuki, Naoki/0000-0002-9682-2548; Saito, Yuki/0000-0002-4825-7783	Japan Agency for Medical Research and Development [16ck0106223h001];  [26861379];  [16H0548];  [16H05481]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); ; ; 	This work is partly supported by Grant-in-Aid for Scientific Research (26861379, H. S. & 16H0548, 16H05481 K.N) and Japan Agency for Medical Research and Development (16ck0106223h001, K.N.).	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Chang JS, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0327-y; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hama T, 2014, ONCOLOGY-BASEL, V87, P173, DOI 10.1159/000360991; Ji YB, 2011, ORAL ONCOL, V47, P583, DOI 10.1016/j.oraloncology.2011.04.007; Kawakita D, 2016, J EPIDEMIOL, V26, P292, DOI 10.2188/jea.JE20140240; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Li QD, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-74; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Saito Y, 2014, JPN J CLIN ONCOL, V44, P564, DOI 10.1093/jjco/hyu042; Saito Y, 2013, CANCER-AM CANCER SOC, V119, P2005, DOI 10.1002/cncr.28015; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Ye B, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-12; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187992	10.1371/journal.pone.0187992	http://dx.doi.org/10.1371/journal.pone.0187992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206831	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700007
J	Wollison, BM; Thai, E; Mckinney, A; Ward, A; Clapp, A; Clinton, C; Nag, A; Thorner, AR; Gastier-Foster, JM; Crompton, BD				Wollison, Bruce M.; Thai, Edwin; Mckinney, Aimee; Ward, Abigail; Clapp, Andrea; Clinton, Catherine; Nag, Anwesha; Thorner, Aaron R.; Gastier-Foster, Julie M.; Crompton, Brian D.			Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; SEQUENCING DATA; LUNG-CANCER; PLASMA; MUTATIONS; GENES; HETEROGENEITY; RESISTANCE; FRAMEWORK; VARIANTS	Objectives Liquid biopsy technologies allow non-invasive tumor profiling for patients with solid tumor malignancies by sequencing circulating tumor DNA. These studies may be useful in risk-stratification, monitoring for relapse, and understanding tumor evolution. The quality of DNA obtained for these studies is improved when blood samples are collected in tubes that stabilizing white blood cells (WBC). However, ongoing germline research in pediatric oncology generally requires obtaining blood samples in EDTA tubes, which do not contain a WBC-stabilizing preservative. In this study, we explored whether blood samples collected in WBC-stabilizing tubes could be used for both liquid biopsy and germline studies simultaneously, minimizing blood collection volumes for pediatric patients. Methods Blood was simultaneously collected from three patients in both EDTA and Streck Cell-Free DNA BCT (R) tubes. Germline DNA was extracted from all blood samples and subjected to whole-exome sequencing and microarray profiling. Results Quality control metrics of DNA quality, sequencing library preperation and whole-exome sequencing alignment were virtually identical regardless of the sample collection method. There was no discernable difference in patterns of variant calling for paired samples by either whole-exome sequencing or microarray analysis. Conclusion Our study demonstrates that high-quality genomic studies may be performed from germline DNA obtained in Streck tubes. Therefore, these tubes may be used to simultaneously obtain samples for both liquid biopsy and germline studies in pediatric patients when the volume of blood available for research studies may be limited.	[Wollison, Bruce M.; Thai, Edwin; Clapp, Andrea; Nag, Anwesha; Thorner, Aaron R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mckinney, Aimee; Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH USA; [Ward, Abigail; Clinton, Catherine; Crompton, Brian D.] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Crompton, Brian D.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Crompton, BD (corresponding author), Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA.; Crompton, BD (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.	briand_crompton@dfci.harvard.edu		Crompton, Brian/0000-0001-9404-6621	NIH [K08 - 5K08CA188073-03]; Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies; Go 4 the Goal Foundation Grant; NATIONAL CANCER INSTITUTE [K08CA188073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies; Go 4 the Goal Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K08 - 5K08CA188073-03 (BDC), Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies (BDC), and Go 4 the Goal Foundation Grant (BDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Cherukuri PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2107-y; Chicard M, 2016, CLIN CANCER RES, V22, P5564, DOI 10.1158/1078-0432.CCR-16-0500; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Couch F. J., 2017, JAMA ONCOL; Curras-Freixes M, 2017, J MOL DIAGN; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Denis MG, 2015, CLIN CHEM, V61, P886, DOI 10.1373/clinchem.2015.238352; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gadd S, 2017, NAT GENET, V49, P1487, DOI 10.1038/ng.3940; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gray ES, 2015, ONCOTARGET, V6, P42008, DOI 10.18632/oncotarget.5788; Hayashi M, 2016, CANCER-AM CANCER SOC, V122, P3015, DOI 10.1002/cncr.30144; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Kline CN, 2017, NEURO-ONCOLOGY, V19, P699, DOI 10.1093/neuonc/now254; Krumbholz M, 2016, CLIN CANCER RES, V22, P4356, DOI 10.1158/1078-0432.CCR-15-3028; Kurihara S, 2015, J PEDIATR SURG, V50, P2094, DOI 10.1016/j.jpedsurg.2015.08.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linderman MD, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-20; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Pratt VM, 2016, J MOL DIAGN, V18, P109, DOI 10.1016/j.jmoldx.2015.08.005; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rothwell DG, 2016, MOL ONCOL, V10, P566, DOI 10.1016/j.molonc.2015.11.006; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Toro PV, 2015, CLIN BIOCHEM, V48, P993, DOI 10.1016/j.clinbiochem.2015.07.097; Trubicka J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3211-y; Van Allen EM, 2016, ONCOTARGET, V7, P52888, DOI 10.18632/oncotarget.9184; Warton K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-476; Yanagita M, 2016, CLIN CANCER RES, V22, P6010, DOI 10.1158/1078-0432.CCR-16-0909; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	35	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188835	10.1371/journal.pone.0188835	http://dx.doi.org/10.1371/journal.pone.0188835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206863	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700026
J	Casarin, S; Berceli, SA; Garbey, M				Casarin, Stefano; Berceli, Scott A.; Garbey, Marc			Linking gene dynamics to vascular hyperplasia - Toward a predictive model of vein graft adaptation	PLOS ONE			English	Article							INTERNAL MAMMARY ARTERY; FLUID SHEAR-STRESS; SAPHENOUS-VEIN; BLOOD-FLOW; BYPASS-SURGERY; NEOINTIMAL HYPERPLASIA; SYSTEMS BIOLOGY; FAILURE; PREVENTION; ELEMENT	Reductionist approaches, where individual pieces of a process are examined in isolation, have been the mainstay of biomedical research. While these methods are effective in highly compartmentalized systems, they fail to account for the inherent plasticity and non-linearity within the signaling structure. In the current manuscript, we present the computational architecture for tracking an acute perturbation in a biologic system through a multiscale model that links gene dynamics to cell kinetics, with the overall goal of predicting tissue adaptation. Given the complexity of the genome, the problem is mad'e tractable by clustering temporal changes in gene expression into unique patterns. These cluster elements form the core of an integrated network that serves as the driving force for the response of the biologic system. This modeling approach is illustrated using the clinical scenario of vein bypass graft adaptation. Vein segments placed in the arterial circulation for treatment of advanced occlusive disease can develop an aggressive hyperplastic response that narrows the lumen, reduces blood flow, and induces in situ thrombosis. Reducing this hyperplastic response has been a long-standing but unrealized goal of biologic researchers in the field. With repeated failures of single target therapies, the redundant response pathways are thought to be a fundamental issue preventing progress towards a solution. Using the current framework, we demonstrate how theoretical genomic manipulations can be introduced into the system to shift the adaptation to a more beneficial phenotype, where the hyperplastic response is mitigated and the risk of thrombosis reduced. Utilizing our previously published rabbit vein graft genomic data, where grafts were harvested at time points ranging from 2 hours to 28 days and under differential flow conditions, and a customized clustering algorithm, five gene clusters that differentiated the low flow (i.e., pro-hyperplastic) from high flow (i.e., anti-hyperplastic) response were identified. The current analysis advances these general associations to create a model that identifies those genes sets most likely to be of therapeutic benefit. Using this approach, we examine the range of potential opportunities for intervention via gene cluster over-expression or inhibition, delivered in isolation or combination, at the time of vein graft implantation.	[Casarin, Stefano; Garbey, Marc] Univ La Rochelle, LASIE UMR CNRS 7356, La Rochelle, France; [Casarin, Stefano; Garbey, Marc] Houston Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Casarin, Stefano; Garbey, Marc] Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA; [Berceli, Scott A.] Malcom Randall VAMC, Gainesville, FL USA; [Berceli, Scott A.] Univ Florida, Dept Surg, Gainesville, FL USA	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; State University System of Florida; University of Florida	Casarin, S (corresponding author), Univ La Rochelle, LASIE UMR CNRS 7356, La Rochelle, France.; Casarin, S (corresponding author), Houston Methodist Hosp, Res Inst, Houston, TX 77030 USA.; Casarin, S (corresponding author), Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA.	scasarin@houstonmethodist.org		Casarin, Stefano/0000-0002-7416-2366	 [NIH - U01HL119178-01]		Grant NIH - U01HL119178-01 has supported in full this research.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Berceli SA, 2009, VASCULAR, V17, pS2, DOI 10.2310/6670.2008.00083; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; de Korte CL, 2000, CIRCULATION, V102, P617, DOI 10.1161/01.CIR.102.6.617; DOBRIN PB, 1995, HYPERTENSION, V26, P38, DOI 10.1161/01.HYP.26.1.38; DOBRIN PB, 1989, SURGERY, V105, P393; Facciotti MT, 2004, CURR GENOMICS, V5, P527, DOI 10.2174/1389202043348850; Fernandez CM, 2004, ANN BIOMED ENG, V32, P1484, DOI 10.1114/B:ABME.0000049033.65547.cf; FILLINGER MF, 1994, J VASC SURG, V19, P970, DOI 10.1016/S0741-5214(94)70208-X; GALT SW, 1993, J VASC SURG, V17, P563, DOI 10.1016/0741-5214(93)90156-G; Garbey M, 2013, J THEOR BIOL, V336, P209, DOI 10.1016/j.jtbi.2013.07.006; Gendrau M, 2010, HDB METAHEURISTICS; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Harskamp RE, 2013, ANN SURG, V257, P824, DOI 10.1097/SLA.0b013e318288c38d; Hwang M., 2011, THESIS; Jiang ZH, 2004, AM J PHYSIOL-HEART C, V286, pH240, DOI 10.1152/ajpheart.00760.2003; Jiang ZH, 2007, AM J PHYSIOL-HEART C, V293, pH482, DOI 10.1152/ajpheart.01372.2006; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klein B, 2017, ANN BIOMED ENG, V45, P644, DOI 10.1007/s10439-016-1725-0; KOHLER TR, 1991, CIRC RES, V69, P1557, DOI 10.1161/01.RES.69.6.1557; KOPPLE KD, 1967, J AM CHEM SOC, V89, P6193, DOI 10.1021/ja01000a035; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; LYTLE BW, 1985, J THORAC CARDIOV SUR, V89, P248; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mann M J, 2000, Curr Cardiol Rep, V2, P29, DOI 10.1007/s11886-000-0022-5; Mitchell M., 1996, INTRO GENETIC ALGORI; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Moyers-Gonzalez M, 2008, J FLUID MECH, V617, P327, DOI 10.1017/S002211200800428X; Oshima M, 2001, COMPUT METHOD APPL M, V191, P661, DOI 10.1016/S0045-7825(01)00307-3; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Parussini L, 2017, J COMPUT PHYS, V336, P36, DOI 10.1016/j.jcp.2017.01.047; Popp MP, 2007, MOL VIS, V13, P164; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; Saswata D, 2013, JAMA-J AM MED ASSOC, V310, P2086, DOI DOI 10.1001/jama.2013.281718; Schachner T, 2006, J THORAC CARDIOV SUR, V131, P1065, DOI 10.1016/j.jtcvs.2005.11.043; Tran-Son-Tay R, 2008, ANN BIOMED ENG, V36, P1083, DOI 10.1007/s10439-008-9495-y; WALTS AE, 1987, AM HEART J, V114, P718, DOI 10.1016/0002-8703(87)90780-0; Wang YQ, 2012, BRIEF BIOINFORM, V13, P162, DOI 10.1093/bib/bbr032; Zhang LS, 2004, ARTERIOSCL THROM VAS, V24, P470, DOI 10.1161/01.ATV.0000116865.98067.31; ZWOLAK RM, 1987, J VASC SURG, V5, P126, DOI 10.1067/mva.1987.avs0050126	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187606	10.1371/journal.pone.0187606	http://dx.doi.org/10.1371/journal.pone.0187606			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190638	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900018
J	Khumpirapang, N; Pikulkaew, S; Mullertz, A; Rades, T; Okonogi, S				Khumpirapang, Nattakanwadee; Pikulkaew, Surachai; Mullertz, Anette; Rades, Thomas; Okonogi, Siriporn			Self-microemulsifying drug delivery system and nanoemulsion for enhancing aqueous miscibility of Alpinia galanga oil	PLOS ONE			English	Article							L.; ZEBRAFISH; ABSORPTION; ANESTHESIA; SURFACTANT; STABILITY; EMULSIONS; EXPOSURE; ETHANOL; REGION	Alpinia galanga oil (AGO) possesses various activities but low aqueous solubility limits its application particularly in aquatic animals. AGO has powerful activity on fish anesthesia. Ethanol used for enhancing water miscible of AGO always shows severe side effects on fish. The present study explores the development of self-microemulsifying drug delivery systems (SMEDDS) and nanoemulsions (NE) to deliver AGO for fish anesthesia with less or no alcohol. Pseudoternary phase diagrams were constructed to identify the best SMEDDS-AGO formulation, whereas NE-AGO were developed by means of high-energy emulsification. The mean droplet size of the best SMEDDS-AGO was 82 +/- 0.5 nm whereas that of NE-AGO was 48 +/- 1.6 nm. The anesthetic effect of the developed SMEDDS-AGO and NE-AGO in koi (Cyprinus carpio) was evaluated and compared with AGO ethanolic solution (EtOH-AGO). It was found that the time of induction the fish to reach the surgical stage of anesthesia was dose dependent. NE-AGO showed significantly higher activity than SMEDDS-AGO and EtOH-AGO, respectively. EtOH-AGO caused unwanted hyperactivity in the fish. This side effect did not occur in the fish anesthetized with SMEDDS-AGO and NE-AGO. In conclusion, SMEDDS and NE are promising delivery systems for AGO.	[Khumpirapang, Nattakanwadee] Chiang Mai Univ, Grad Sch, Interdisciplinary Program Nanosci & Nanotechnol, Chiang Mai, Thailand; [Pikulkaew, Surachai] Chiang Mai Univ, Dept Food Anim Clin, Fac Vet Med, Chiang Mai, Thailand; [Mullertz, Anette; Rades, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Okonogi, Siriporn] Chiang Mai Univ, Dept Pharmaceut Sci, Fac Pharm, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; University of Copenhagen; Chiang Mai University	Okonogi, S (corresponding author), Chiang Mai Univ, Dept Pharmaceut Sci, Fac Pharm, Chiang Mai, Thailand.	okng2000@gmail.com	Okonogi, Siriporn/AAB-7172-2022; Müllertz, Anette/ABF-6935-2021; Rades, Thomas/ABE-9953-2021; pikulkaew, surachai/GSM-8561-2022; pikulkaew, surachai/AAO-5512-2021	Müllertz, Anette/0000-0003-3020-8892; Rades, Thomas/0000-0002-7521-6020; Khumpirapang, Nattakanwadee/0000-0001-9069-4509; pikulkaew, surachai/0000-0002-9922-7357	Thailand Research Fund (TRF) via the Research and Researchers for Industries (RRI) [PHD56I0040]; Research and Researchers for Industries, Thailand [PHD56I0040]	Thailand Research Fund (TRF) via the Research and Researchers for Industries (RRI); Research and Researchers for Industries, Thailand	This study is financially supported by the Thailand Research Fund (TRF) via the Research and Researchers for Industries (RRI) grant no. PHD56I0040.; The authors are grateful for the financial support from the Research and Researchers for Industries, Thailand (grant no. PHD56I0040). We also thank Bioneer:FARMA, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, the National Research Council of Thailand, and the Research Center of Pharmaceutical Nanotechnology, Chiang Mai University, Thailand for the equipment and facility support.	Aboalnaja KO, 2016, EXPERT OPIN DRUG DEL, V13, P1327, DOI 10.1517/17425247.2016.1162154; Bernardi DS, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-44; Bernstein PS, 1997, AM J OPHTHALMOL, V124, P843, DOI 10.1016/S0002-9394(14)71705-2; Capek I, 2004, ADV COLLOID INTERFAC, V107, P125, DOI 10.1016/S0001-8686(03)00115-5; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Chaiyana W, 2010, INT J PHARMACEUT, V401, P32, DOI 10.1016/j.ijpharm.2010.09.005; Chalchat JC, 2008, FOOD CHEM, V110, P501, DOI 10.1016/j.foodchem.2008.02.018; Charles D. J., 1992, Journal of Essential Oil Research, V4, P81; Chaudhary A., 2012, J ADV PHARM ED RES, V2, P32, DOI DOI 10.4103/2231-4040.90872; Chudiwal A. K., 2010, Indian Journal of Natural Products and Resources, V1, P143; CORDES EH, 1974, CHEM REV, V74, P581, DOI 10.1021/cr60291a004; Donsi F, 2011, LWT-FOOD SCI TECHNOL, V44, P1908, DOI 10.1016/j.lwt.2011.03.003; Eid AM, 2014, INT J NANOMED, V9, P4685, DOI 10.2147/IJN.S66180; Gardeli C, 2008, FOOD CHEM, V107, P1120, DOI 10.1016/j.foodchem.2007.09.036; Grzanna R, 2005, J MED FOOD, V8, P125, DOI 10.1089/jmf.2005.8.125; Ho HO, 1996, J PHARM SCI, V85, P138, DOI 10.1021/js950352h; Holm R, 2003, EUR J PHARM SCI, V20, P91, DOI 10.1016/S0928-0987(03)00174-X; Jantan I. B., 2004, J ESSENT OIL RES, V16, P174, DOI DOI 10.1080/; Kawabata Y, 2011, INT J PHARMACEUT, V420, P1, DOI 10.1016/j.ijpharm.2011.08.032; Krishnan S, 2005, CARBOHYD POLYM, V61, P95, DOI 10.1016/j.carbpol.2005.02.020; Krone PH, 1997, CELL MOL LIFE SCI, V53, P122, DOI 10.1007/PL00000574; Mahae N., 2009, Kasetsart Journal, Natural Sciences, V43, P358; Marinova KG, 1996, LANGMUIR, V12, P2045, DOI 10.1021/la950928i; Mathur P, 2011, BEHAV BRAIN RES, V217, P128, DOI 10.1016/j.bbr.2010.10.015; McClements DJ, 2011, SOFT MATTER, V7, P2297, DOI 10.1039/c0sm00549e; Mehyar GF, 2014, J FOOD SCI, V79, pC1939, DOI 10.1111/1750-3841.12652; Okonogi S, 2012, DRUG DISCOV THER, V6, P249, DOI 10.5582/ddt.2012.v6.5.249; Oonmetta-aree H, 2006, LWT-FOOD SCI TECHNOL, V39, P1214, DOI 10.1016/j.lwt.2005.06.015; Oprean R, 2001, J PHARMACEUT BIOMED, V24, P1163, DOI 10.1016/S0731-7085(00)00578-1; Pikulkaew S, 2017, DRUG DISCOV THER, V11, P186, DOI 10.5582/ddt.2017.01035; Prakatthagomol W, 2011, DRUG DISCOV THER, V5, P84, DOI 10.5582/ddt.2011.v5.2.84; Raina VK, 2003, FLAVOUR FRAG J, V18, P18, DOI 10.1002/ffj.1136; Raina VK, 2002, FLAVOUR FRAG J, V17, P358, DOI 10.1002/ffj.1105; Saeio K, 2011, DRUG DISCOV THER, V5, P246, DOI 10.5582/ddt.2011.v5.5.246; Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029; Saupe A, 2006, INT J PHARM, V314, P56, DOI 10.1016/j.ijpharm.2006.01.022; Solans C, 2012, CURR OPIN COLLOID IN, V17, P246, DOI 10.1016/j.cocis.2012.07.003; Srivastava B, 2008, WORLD J MICROB BIOT, V24, P693, DOI 10.1007/s11274-007-9526-0; Tenjarla S, 1999, CRIT REV THER DRUG, V16, P461; Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006; Wang XY, 2008, FOOD CHEM, V108, P419, DOI 10.1016/j.foodchem.2007.10.086; Wang YJ, 2011, DRUG DEV IND PHARM, V37, P1225, DOI 10.3109/03639045.2011.565774; Yang XG, 1999, J AGR FOOD CHEM, V47, P1657, DOI 10.1021/jf9808224; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zhang HJ, 2003, ARCH PHARM RES, V26, P768, DOI 10.1007/BF02976689; Zhao Y, 2010, INT J PHARMACEUT, V383, P170, DOI 10.1016/j.ijpharm.2009.08.035	46	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188848	10.1371/journal.pone.0188848	http://dx.doi.org/10.1371/journal.pone.0188848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190663	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900142
J	Navia, B; Lopez-Sobaler, AM; Villalobos, T; Aranceta-Bartrina, J; Gil, A; Gonzalez-Gross, M; Serra-Majem, L; Varela-Moreiras, G; Ortega, RM				Navia, Beatriz; Lopez-Sobaler, Ana M.; Villalobos, Tania; Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis; Varela-Moreiras, Gregorio; Ortega, Rosa M.			Breakfast habits and differences regarding abdominal obesity in a cross-sectional study in Spanish adults: The ANIBES study	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; ENERGY-INTAKE; SKIPPING BREAKFAST; METABOLIC SYNDROME; DIET QUALITY; RISK-FACTORS; HEALTH; ASSOCIATIONS; CONSUMPTION	Background Previous studies have indicated that breakfast has a protective effect against obesity. The aim of this study was to describe the breakfast habits of the Spanish adult population and to assess the possible association between breakfast frequency and the presence of abdominal obesity, in a cross-sectional analysis of the ANIBES Study. Methods A representative sample of 1655 Spanish adults (aged 39 +/- 12 y; (mean +/- sd)) from the ANIBES Study was investigated. The final field work was carried out from mid-September to November (three months) 2013. Collected data included a dietary data collected by a 3-days food record, and health, socioeconomic, physical activity and anthropometric (weight, height and waist circumference) data. Abdominal obesity was defined as having a waist-to-height ratio >= 0.5. The adults were also classified into three groups based on the number of days they ate breakfast (never (0/3 days), sometimes (1-2/3 days) and always (3/3 days)). Logistic regression analyses were used to evaluate the association between breakfast and abdominal obesity. Results In total, 3.6% of adults skipped breakfast and 14.1% ate breakfast sometimes. Having always breakfast was negatively associated with abdominal obesity [OR = 0.738 (0.558-0.975) p = 0.033]. The odds of abdominal obesity after full adjustment (age, gender, and educational and activity level) were 1.5 times higher for those who skipped breakfast when compared to those who always have breakfast. By correcting the model considered for other variables, the odds among smokers decreased when they have breakfast sometimes [OR = 0.032 (0.003-0.387) p = 0.007] and always [OR = 0.023 (0.002-0.270) p = 0.003] comparing with smokers who skip breakfast. Conclusion Breakfast frequency could be negatively associated with abdominal obesity, especially among smokers.	[Navia, Beatriz; Lopez-Sobaler, Ana M.; Villalobos, Tania; Ortega, Rosa M.] Univ Complutense Madrid, Fac Pharm, Dept Nutr, VALORNUT Res Grp, Madrid, Spain; [Aranceta-Bartrina, Javier] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis] Inst Salud Carlos III ISCIII, CIBERobn, CIBER Fisiopatol Obesidad & Nutr CB12 03 30038, Madrid, Spain; [Gil, Angel] Univ Granada, Inst Nutr & Food Sci, Dept Biochem & Mol Biol 2, Granada, Spain; [Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Med Sch, Las Palmas Gran Canaria, Spain; [Varela-Moreiras, Gregorio] CEU San Pablo Univ, Fac Pharm, Dept Pharmaceut & Hlth Sci, Madrid, Spain; [Varela-Moreiras, Gregorio] Spanish Nutr Fdn FEN, Madrid, Spain	Complutense University of Madrid; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Granada; Universidad Politecnica de Madrid; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; San Pablo CEU University	Ortega, RM (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Nutr, VALORNUT Res Grp, Madrid, Spain.	gvarela@ceu.es; rortega@ucm.es	Gonzalez-Gross, Marcela/W-8000-2018; López-Sobaler, Ana M/I-3589-2016; Ortega, Rosa M/S-5760-2016; Gil, Angel/ABA-7621-2020; Serra-Majem, Lluis/I-6708-2019	López-Sobaler, Ana M/0000-0002-4133-1450; Ortega, Rosa M/0000-0003-3837-9450; Gil, Angel/0000-0001-7663-0939; Serra-Majem, Lluis/0000-0002-9658-9061; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Coca Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	Coca Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	ANIBES Study was financially supported by Coca Cola Iberia through an agreement with the Spanish Nutrition Foundation (FEN). The funding sponsors had no role in the study design, data collection, analysis or interpretation of the data; the writing of the manuscript; or the decision to publish the results.; The authors would like to thank Coca-Cola Iberia for its support and thank you to IPSOS for its technical advice, particularly Rafael Urrialde and Javier Ruiz.	Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Azadbakht L, 2013, NUTRITION, V29, P420, DOI 10.1016/j.nut.2012.07.008; Barr SI, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0151-3; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Chen JY, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0348-1; Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307; Chung SJ, 2015, NUTR RES PRACT, V9, P288, DOI 10.4162/nrp.2015.9.3.288; Davy Brenda M, 2004, South Med J, V97, P571, DOI 10.1097/00007611-200406000-00012; de la Hunty A, 2013, OBESITY FACTS, V6, P70, DOI 10.1159/000348878; Deshmukh-Taskar P, 2013, PUBLIC HEALTH NUTR, V16, P2073, DOI 10.1017/S1368980012004296; Deshmukh-Taskar PR, 2010, J AM COLL NUTR, V29, P407, DOI 10.1080/07315724.2010.10719858; di Giuseppe R, 2012, NUTR METAB CARDIOVAS, V22, P347, DOI 10.1016/j.numecd.2010.07.006; Drewnowski A, 1999, EUR J CLIN NUTR, V2015, P1035, DOI DOI 10.1038/EJCN.2015.38; Dwyer J, 2014, J ACAD NUTR DIET, V114, pS5, DOI 10.1016/j.jand.2014.10.005; Ferreira-Hermosillo A, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-32; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126; Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285; Keski-Rahkonen AM., 2003, EUR J CLIN NUTR MED, V5736; Lopez-Sobaler AM, 2003, EUR J CLIN NUTR, V57, pS49, DOI 10.1038/sj.ejcn.1601815; Lopez-Sobaler AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169027; Lopez-Sobaler AM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8341487; Malinauskas BM, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-11; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Marin-Guerrero AC, 2008, BRIT J NUTR, V100, P1142, DOI 10.1017/S0007114508966137; Mielgo-Ayuso J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149969; Min C, 2011, NUTR RES PRACT, V5, P455, DOI 10.4162/nrp.2011.5.5.455; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moreiras O., 2011, FOOD COMPOSITION TAB; Navia B, 2003, EUR J CLIN NUTR, V57, pS90, DOI 10.1038/sj.ejcn.1601807; Nurul-Fadhilah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059297; O'Neil CE, 2014, J ACAD NUTR DIET, V114, pS8, DOI 10.1016/j.jand.2014.08.022; O'Neil CE, 2014, J ACAD NUTR DIET, V114, pS27, DOI 10.1016/j.jand.2014.08.021; Odegaard AO, 2013, DIABETES CARE, V36, P3100, DOI 10.2337/dc13-0316; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ortega ARM, 2013, NUTR HOSP S, V28, P56, DOI DOI 10.3305/NH.2013.28.SUP5.6918; Ortega RM, 2014, NUTR HOSP, V30, P29; Papaetis GS, 2015, ARCH MED SCI, V11, P463, DOI 10.5114/aoms.2015.52350; Peters BSE, 2012, J HUM NUTR DIET, V25, P69, DOI 10.1111/j.1365-277X.2011.01166.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reeves S, 2013, APPETITE, V60, P51, DOI 10.1016/j.appet.2012.09.024; Ruiz E, 2015, NUTRIENTS, V7, P4739, DOI 10.3390/nu7064739; Ruiz E, 2015, NUTRIENTS, V7, P970, DOI 10.3390/nu7020970; Shafiee G, 2013, J PEDIAT-BRAZIL, V89, P575, DOI 10.1016/j.jped.2013.03.020; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; Song WO, 2005, J AM DIET ASSOC, V105, P1373, DOI 10.1016/j.jada.2005.06.002; Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037; Sweeney Nancy M, 2005, J Sch Nurs, V21, P100; Thompson-McCormick JJ, 2010, ASIA PAC J CLIN NUTR, V19, P372; Moreiras GV, 2015, NUTR HOSP, V31, P101, DOI 10.3305/nh.2015.31.sup3.8758; Vik FN, 2016, PREV MED, V91, P197, DOI 10.1016/j.ypmed.2016.08.013	54	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188828	10.1371/journal.pone.0188828	http://dx.doi.org/10.1371/journal.pone.0188828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190719	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900135
J	Pavlikova, Z; Hola, D; Vlasakova, B; Prochazka, Ta; Munzbergova, Z				Pavlikova, Zuzana; Hola, Dana; Vlasakova, Blanka; Prochazka, Tomas; Munzbergova, Zuzana			Physiological and fitness differences between cytotypes vary with stress in a grassland perennial herb	PLOS ONE			English	Article							CHLOROPHYLL-A; PLOIDY LEVEL; ASTER-AMELLUS; TETRAPLOID POPULATIONS; PHENOTYPIC PLASTICITY; DROUGHT-STRESS; WATER-STRESS; PHOTOSYNTHETIC CHARACTERISTICS; STOMATAL CHARACTERISTICS; LONICERA-JAPONICA	Background and aims Understanding the consequences of polyploidization is a major step towards assessing the importance of this mode of speciation. Most previous studies comparing different cytotypes, however, did so only within a single environment and considered only one group of traits. To take a step further, we need to explore multiple environments and a wide range of traits. The aim of this study was to assess response of diploid and autotetraploid individuals of Knautia arvensis (Dipsacaceae) to two stress conditions, shade or drought. Methods We studied eleven photosynthetic, morphological and fitness parameters of the plants over three years in a common garden under ambient conditions and two types of stress. Key results The results indicate strong differences in performance and physiology between cytotypes in ambient conditions. Interestingly, higher fitness in diploids contrasted with more efficient photosynthesis in tetraploids in ambient conditions. However, stress, especially drought, strongly reduced fitness and disrupted function of the photosystems in both cytotypes reducing the between cytotype differences. The results indicate that drought stress reduced function of the photosynthetic processes in both cytotypes but particularly in tetraploids, while fitness reduction was stronger in diploids. Conclusions The photosynthesis related traits show higher plasticity in polyploids as theoretically expected, while the fitness related traits show higher plasticity in diploids especially in response to drought. This suggests that between cytotype comparisons need to consider multiple traits and multiple environments to understand the breath of possible responses of different cytotypes to stress. They also show that integrating results based on different traits is not straightforward and call for better mechanistic understanding of the relationships between species photosynthetic activity and fitness. Still, considering multiple environments and multiple species traits is crucial for understanding the drivers of niche differentiation between cytotypes in future studies.	[Pavlikova, Zuzana; Vlasakova, Blanka; Prochazka, Tomas; Munzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Hola, Dana] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic; [Vlasakova, Blanka; Munzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, Dept Populat Ecol, Pruhonice, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.; Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Populat Ecol, Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Holá, Dana/H-9344-2016; Münzbergová, Zuzana/F-6321-2013	Holá, Dana/0000-0002-2080-8774; Münzbergová, Zuzana/0000-0002-4026-6220; Vlasakova, Blanka/0000-0001-9288-5448	GACR [P505-13-32048S];  [RVO 67985939]	GACR(Grant Agency of the Czech Republic); 	The study was supported by GACR P505-13-32048S (www.gacr.cz, to ZM). Institutional research project RVO 67985939 (www.cas.cz) also partly supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli M, 2013, ACTA PHYSIOL PLANT, V35, P2075, DOI 10.1007/s11738-013-1242-9; Alavi-Samani S.M., 2013, JMED HERBS, V4, P109; Alix K, 2017, ANN BOT; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Baczek-Kwinta R, 2011, PHOTOSYNTHETICA, V49, P87, DOI 10.1007/s11099-011-0013-3; Beck SL, 2003, BOT J LINN SOC, V141, P177, DOI 10.1046/j.1095-8339.2003.00132.x; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; Burton TL, 2000, EVOLUTION, V54, P1182, DOI 10.1111/j.0014-3820.2000.tb00553.x; Cai ZQ, 2011, IND CROP PROD, V34, P1235, DOI 10.1016/j.indcrop.2011.03.021; del Pozo JC, 2015, J EXP BOT, V66, P6991, DOI 10.1093/jxb/erv432; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Cerna L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116992; Chandra A, 2009, ACTA PHYSIOL PLANT, V31, P1003, DOI 10.1007/s11738-009-0317-0; Chen LZ, 2007, PLANTA, V225, P603, DOI 10.1007/s00425-006-0381-2; Clausen J., 1945, EXPT STUDIES NATURE; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Devkota A, 2011, INT AGROPHYS, V25, P211; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eliasova A, 2014, BIOL J LINN SOC, V113, P57, DOI 10.1111/bij.12318; Eliasova A, 2014, ANN BOT-LONDON, V113, P159, DOI 10.1093/aob/mct252; Eligova A., 2017, J PLANT RES; Ellenberg H., 1992, ZEIGERWERTE GEFASSPL; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; FRYDRYCH J, 1970, PHOTOSYNTHETICA, V4, P139; GARBUTT K, 1983, NEW PHYTOL, V93, P129, DOI 10.1111/j.1469-8137.1983.tb02698.x; Gibson D. J., 2009, GRASSES GRASSLAND EC; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Gotelli NJ, 2013, ECOSIMR 1 00; Guo W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01329; Hijmans RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P485, DOI 10.1111/j.1466-8238.2007.00308.x; Hulber K, 2011, ALPINE BOT, V121, P123, DOI 10.1007/s00035-011-0091-7; Jedmowski C, 2013, ACTA PHYSIOL PLANT, V35, P345, DOI 10.1007/s11738-012-1077-9; JIANG HF, 1993, AGRON J, V85, P221, DOI 10.2134/agronj1993.00021962008500020011x; Khazaei H, 2010, GENET RESOUR CROP EV, V57, P307, DOI 10.1007/s10722-009-9471-x; KIK C, 1993, ACTA BOT NEERL, V42, P73; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Levy AA, 2004, BIOL J LINN SOC, V82, P607, DOI 10.1111/j.1095-8312.2004.00346.x; Li WD, 2011, BIOL PLANTARUM, V55, P279, DOI 10.1007/s10535-011-0039-1; Li Wan-Liang, 1996, American Journal of Botany, V83, P15, DOI 10.2307/2445949; Li WD, 2009, FUNCT PLANT BIOL, V36, P783, DOI 10.1071/FP09022; Liu SY, 2011, SCI HORTIC-AMSTERDAM, V127, P411, DOI 10.1016/j.scienta.2010.10.012; MACEIRA NO, 1993, NEW PHYTOL, V124, P321, DOI 10.1111/j.1469-8137.1993.tb03822.x; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Majdi M, 2010, HORTSCIENCE, V45, P16, DOI 10.21273/HORTSCI.45.1.16; Mandakova T, 2008, PLANT SYST EVOL, V274, P155, DOI 10.1007/s00606-008-0040-0; Mandakova T, 2006, ANN BOT-LONDON, V98, P845, DOI 10.1093/aob/mcl165; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mishra MK, 1997, ANN BOT-LONDON, V80, P689, DOI 10.1006/anbo.1997.0491; Mraz P, 2014, ANN BOT-LONDON, V114, P289, DOI 10.1093/aob/mcu105; Munzbergova Z, 2013, HEREDITY, V110, P123, DOI 10.1038/hdy.2012.87; Munzbergova Z, 2007, BIOL J LINN SOC, V92, P211, DOI 10.1111/j.1095-8312.2007.00820.x; Munzbergova Z, 2015, BIOL J LINN SOC, V115, P270, DOI 10.1111/bij.12482; Munzbergova Z, 2011, PERSPECT PLANT ECOL, V13, P151, DOI 10.1016/j.ppees.2011.03.002; Muntzing A., 1936, HEREDITAS, V21, P263, DOI DOI 10.1111/J.1601-5223.1936.TB03204.X; Munzbergova Z, 2017, ANN BOT; Munzbergova Z, 2006, OIKOS, V115, P443, DOI 10.1111/j.2006.0030-1299.15286.x; Na YW, 2014, HORTIC ENVIRON BIOTE, V55, P280, DOI 10.1007/s13580-014-0006-9; Nuismer SL, 2005, EVOLUTION, V59, P1928; Oukarroum A, 2007, ENVIRON EXP BOT, V60, P438, DOI 10.1016/j.envexpbot.2007.01.002; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Pavlikova Z, 2017, SYNTHETIC POLYPLOIDS; Petit C, 1997, J ECOL, V85, P657, DOI 10.2307/2960536; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Razmjoo K., 2008, International Journal of Agriculture and Biology, V10, P451; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SANO Y, 1980, BOT MAG TOKYO, V93, P171, DOI 10.1007/BF02489319; Schlaepfer DR, 2010, OECOLOGIA, V163, P661, DOI 10.1007/s00442-010-1595-3; Soltis DE, 2003, AM J BOT, V90, P1596, DOI 10.3732/ajb.90.11.1596; Soltis DE, 2014, AM J BOT, V101, P1057, DOI 10.3732/ajb.1400178; Soltis PS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0351; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Stepanek J., 1997, KVETENA ESKE REPUBLI, V5, P543; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Sugiyama Shu-ichi, 2006, Grassland Science, V52, P155, DOI 10.1111/j.1744-697X.2006.00062.x; SULTAN SE, 1993, EVOLUTION, V47, P1009, DOI 10.1111/j.1558-5646.1993.tb02132.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thompson KA, 2015, J ECOL, V103, P733, DOI 10.1111/1365-2745.12384; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Van Laere K, 2011, ACTA PHYSIOL PLANT, V33, P1149, DOI 10.1007/s11738-010-0643-2; WARNER DA, 1993, PHOTOSYNTH RES, V35, P135, DOI 10.1007/BF00014744; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Yang PM, 2014, PHOTOSYNTHETICA, V52, P193, DOI 10.1007/s11099-014-0020-2; Yang XM, 2006, EUPHYTICA, V152, P217, DOI 10.1007/s10681-006-9203-7; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zhang L, 2010, PHOTOSYNTHETICA, V48, P87, DOI 10.1007/s11099-010-0012-9; Zivcak M, 2008, PLANT SOIL ENVIRON, V54, P133, DOI 10.17221/392-PSE; [No title captured]	95	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188795	10.1371/journal.pone.0188795	http://dx.doi.org/10.1371/journal.pone.0188795			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190749	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900125
J	Ringstad, G; Lindstrom, EK; Vatnehol, SAS; Mardal, KA; Emblem, KE; Eide, PK				Ringstad, Geir; Lindstrom, Erika Kristina; Vatnehol, Svein Are Sirirud; Mardal, Kent-Andre; Emblem, Kyrre Eeg; Eide, Per Kristian			Non-invasive assessment of pulsatile intracranial pressure with phase-contrast magnetic resonance imaging	PLOS ONE			English	Article							CEREBROSPINAL-FLUID FLOW; AQUEDUCTAL STROKE VOLUME; CHIARI MALFORMATION; CSF FLOW; CEREBRAL AQUEDUCT; CINE MRI; HYDROCEPHALUS; MANAGEMENT; GRADIENT; SURGERY	Invasive monitoring of pulsatile intracranial pressure can accurately predict shunt response in patients with idiopathic normal pressure hydrocephalus, but may potentially cause complications such as bleeding and infection. We tested how a proposed surrogate parameter for pulsatile intracranial pressure, the phase-contrast magnetic resonance imaging derived pulse pressure gradient, compared with its invasive counterpart. In 22 patients with suspected idiopathic normal pressure hydrocephalus, preceding invasive intracranial pressure monitoring, and any surgical shunt procedure, we calculated the pulse pressure gradient from phase-contrast magnetic resonance imaging derived cerebrospinal fluid flow velocities obtained at the upper cervical spinal canal using a simplified Navier-Stokes equation. Repeated measurements of the pulse pressure gradient were also undertaken in four healthy controls. Of 17 shunted patients, 16 responded, indicating high proportion of "true" normal pressure hydrocephalus in the patient cohort. However, there was no correlation between the magnetic resonance imaging derived pulse pressure gradient and pulsatile intracranial pressure (R = -.18, P = .43). Pulse pressure gradients were also similar in patients and healthy controls (P = .26), and did not differ between individuals with pulsatile intracranial pressure above or below established thresholds for shunt treatment (P = .97). Assessment of pulse pressure gradient at level C2 was therefore not found feasible to replace invasive monitoring of pulsatile intracranial pressure in selection of patients with idiopathic normal pressure hydrocephalus for surgical shunting. Unlike invasive, overnight monitoring, the pulse pressure gradient from magnetic resonance imaging comprises short-term pressure fluctuations only. Moreover, complexity of cervical cerebrospinal fluid flow and -pulsatility at the upper cervical spinal canal may render the pulse pressure gradient a poor surrogate marker for intracranial pressure pulsations.	[Ringstad, Geir] Natl Hosp Norway, Dept Radiol & Nucl Med, Oslo Univ Hosp, Oslo, Norway; [Ringstad, Geir; Vatnehol, Svein Are Sirirud; Eide, Per Kristian] Univ Oslo, Fac Med, Oslo, Norway; [Lindstrom, Erika Kristina; Mardal, Kent-Andre] Univ Oslo, Fac Math & Nat Sci, Dept Math, Oslo, Norway; [Vatnehol, Svein Are Sirirud; Emblem, Kyrre Eeg] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Eide, Per Kristian] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Ringstad, G (corresponding author), Natl Hosp Norway, Dept Radiol & Nucl Med, Oslo Univ Hosp, Oslo, Norway.; Ringstad, G (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	gringsta@ous-hf.no	Mardal, Kent-Andre/G-8296-2018; Emblem, Kyrre/H-6691-2012	Mardal, Kent-Andre/0000-0002-4946-1110; Vatnehol, Svein Are Sirirud/0000-0002-7900-0534; Emblem, Kyrre/0000-0002-6580-9519; Ringstad, Geir/0000-0003-0919-4510	South Eastern Norway Regional Health Authority [2013069]	South Eastern Norway Regional Health Authority	Kyrre Eeg Emblem received Grant #2013069 from South Eastern Norway Regional Health Authority (http://www.helse-sorost.no/fag/forskning-og-innovasjon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PKE has a financial interest (shares) in the software company (dPCom AS, Oslo) manufacturing the software (Sensometrics Software) used for analysis of the ICP recordings. For the remaining authors none were declared. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Alperin N, 2015, J MAGN RESON IMAGING, V42, P1158, DOI 10.1002/jmri.24882; Alperin N, 2014, NEUROSURGERY, V75, P515, DOI 10.1227/NEU.0000000000000507; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Cheng S, 2014, J BIOMECH, V47, P2826, DOI 10.1016/j.jbiomech.2014.04.027; Daouk J, 2017, ACTA RADIOL, V58, P977, DOI 10.1177/0284185116676655; Dixon GR, 2002, MAYO CLIN PROC, V77, P509, DOI 10.4065/77.6.509; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Eide PK, 2016, WORLD NEUROSURG, V86, P186, DOI 10.1016/j.wneu.2015.09.067; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Eide PK, 2015, WORLD NEUROSURGERY; Fric R, 2015, ACTA NEUROCHIR, V157, P1411, DOI 10.1007/s00701-015-2465-x; Glick RP, 2006, NEUROSURGERY, V59, P1052, DOI 10.1227/01.NEU.0000245586.23710.EF; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Haughton V, 2014, AM J NEURORADIOL, V35, P1864, DOI 10.3174/ajnr.A4023; Jaeger M, 2016, J CLIN NEUROSCI, V33, P169, DOI 10.1016/j.jocn.2016.03.029; Kahlon B, 2007, NEUROSURGERY, V60, P124, DOI 10.1227/01.NEU.0000249208.04344.A3; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lorenz R, 2014, MAGN RESON MED, V72, P33, DOI 10.1002/mrm.24885; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Mase M, 2005, ACT NEUR S, V95, P303; Muehlmann M, 2013, INVEST RADIOL, V48, P543, DOI 10.1097/RLI.0b013e31828ad504; Pahlavian SH, 2015, ANN BIOMED ENG, V43, P2911, DOI 10.1007/s10439-015-1355-y; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Ringstad G, 2015, AM J NEURORADIOL, V36, P1623, DOI 10.3174/ajnr.A4340; Roldan A, 2009, AM J NEURORADIOL, V30, P941, DOI 10.3174/ajnr.A1489; Rutkowska G, 2012, AM J NEURORADIOL, V33, P1756, DOI 10.3174/ajnr.A3047; Sharma AK, 2008, CLIN NEUROL NEUROSUR, V110, P363, DOI 10.1016/j.clineuro.2007.12.021	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188896	10.1371/journal.pone.0188896	http://dx.doi.org/10.1371/journal.pone.0188896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190788	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900162
J	Wang, G; Wu, M; Maloneyhuss, MA; Wojcik, J; Durham, AC; Mason, NJ; Roth, DB				Wang, Guannan; Wu, Ming; Maloneyhuss, Martha A.; Wojcik, John; Durham, Amy C.; Mason, Nicola J.; Roth, David B.			Actionable mutations in canine hemangiosarcoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; PLCG1 MUTATIONS; CANCER MUTANTS; P53; PIK3CA; REVEALS; HAPLOINSUFFICIENCY; ANGIOSARCOMA	Background Angiosarcomas (AS) are rare in humans, but they are a deadly subtype of soft tissue sarcoma. Discovery sequencing in AS, especially the visceral form, is hampered by the rarity of cases. Most diagnostic material exists as archival formalin fixed, paraffin embedded tissue which serves as a poor source of high quality DNA for genome-wide sequencing. We approached this problem through comparative genomics. We hypothesized that exome sequencing a histologically similar tumor, hemangiosarcoma (HSA), that occurs in approximately 50,000 dogs per year, may lead to the identification of potential oncogenic drivers and druggable targets that could also occur in angiosarcoma. Methods Splenic hemangiosarcomas are common in dogs, which allowed us to collect a cohort of archived matched tumor and normal tissue samples suitable for whole exome sequencing. Mapping of the reads to the latest canine reference genome (Canfam3) demonstrated that >99% of the targeted exomal regions were covered, with >80% at 20X coverage and >90% at 10X coverage. Results and conclusions Sequence analysis of 20 samples identified somatic mutations in PIK3CA, TP53, PTEN, and PLCG1, all of which correspond to well-known tumor drivers in human cancer, in more than half of the cases. In one case, we identified a mutation in PLCG1 identical to a mutation observed previously in this gene in human visceral AS. Activating PIK3CA mutations present novel therapeutic targets, and clinical trials of targeted inhibitors are underway in human cancers. Our results lay a foundation for similar clinical trials in canine HSA, enabling a precision medicine approach to this disease.	[Wang, Guannan; Wojcik, John; Roth, David B.] Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Ming] Illumina, San Diego, CA USA; [Maloneyhuss, Martha A.; Durham, Amy C.; Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Illumina; University of Pennsylvania; University of Pennsylvania	Roth, DB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA.	rothd@uphs.upenn.edu			Abramson Cancer Center's sarcoma program (Abramson Cancer Center, University of Pennsylvania); University of Pennsylvania; Abramson Family Cancer Center Paul Calabresi Career Development Award for Clinical Oncology (K12) [PAR-13-201]; Illumina; Abramson Cancer Center's sarcoma program; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Abramson Cancer Center's sarcoma program (Abramson Cancer Center, University of Pennsylvania); University of Pennsylvania; Abramson Family Cancer Center Paul Calabresi Career Development Award for Clinical Oncology (K12); Illumina; Abramson Cancer Center's sarcoma program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the generous support of a grant from the Abramson Cancer Center's sarcoma program (Abramson Cancer Center, University of Pennsylvania) and my Start-up funds (University of Pennsylvania). Start up funds helped defray the costs of exome sequencing. JW is supported by the Abramson Family Cancer Center Paul Calabresi Career Development Award for Clinical Oncology (K12; PAR-13-201). Illumina provided salary support for MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We acknowledge the generous support of a grant from the Abramson Cancer Center's sarcoma program. We are grateful to Dr. Rebecca Linn (Children's Hospital of Philadelphia) for observing that PIK3CA mutations are found in human segmental overgrowth syndromes.; JW is supported by the Abramson Family Cancer Center Paul Calabresi Career Development Award for Clinical Oncology (K12; PAR-13-201).	Adachi M, 2016, CAN J VET RES, V80, P209; Andersen NJ, 2015, INT J ONCOL, V47, P71, DOI 10.3892/ijo.2015.2989; Antonescu C, 2014, MODERN PATHOL, V27, pS30, DOI 10.1038/modpathol.2013.176; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Dickerson EB, 2005, VET PATHOL, V42, P618, DOI 10.1354/vp.42-5-618; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Gkeka P, 2014, PLOS COMPUT BIOL, V10; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grossman TR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002344; Huang SC, 2016, AM J SURG PATHOL, V40, P645, DOI 10.1097/PAS.0000000000000582; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; James CD, 1999, INT J ONCOL, V15, P547; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Keppler-Noreuil KM, 2016, AM J MED GENET C, V172, P402, DOI 10.1002/ajmg.c.31531; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Loconte DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123092; Manso R, 2015, HAEMATOLOGICA, V100, pE25, DOI 10.3324/haematol.2014.113696; Martin SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155189; Mullany LK, 2015, NEOPLASIA, V17, P789, DOI 10.1016/j.neo.2015.10.003; Murai A, 2012, J COMP PATHOL, V147, P430, DOI 10.1016/j.jcpa.2012.05.002; Murai A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-128; Murali R, 2015, ONCOTARGET, V6, P36041, DOI 10.18632/oncotarget.5936; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naka N, 1996, J SURG ONCOL, V61, P170, DOI 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8; Naka N, 1997, INT J CANCER, V71, P952, DOI 10.1002/(SICI)1097-0215(19970611)71:6<952::AID-IJC7>3.3.CO;2-N; Nisa L, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0660-5; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; Tate G, 2007, CANCER GENET CYTOGEN, V178, P160, DOI 10.1016/j.cancergencyto.2007.07.017; Thomas R, 2014, CHROMOSOME RES, V22, P305, DOI 10.1007/s10577-014-9406-z; Tonomura N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004922; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yang D, 2007, MOL CELL BIOCHEM, V304, P219, DOI 10.1007/s11010-007-9503-9; Zhang LN, 2013, ONCOTARGETS THER, V6, P497, DOI 10.2147/OTT.S41643	45	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188667	10.1371/journal.pone.0188667	http://dx.doi.org/10.1371/journal.pone.0188667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190660	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900097
J	Chen, Y; Zhou, WD; Roh, T; Estes, MK; Kaplan, DL				Chen, Ying; Zhou, Wenda; Roh, Terrence; Estes, Mary K.; Kaplan, David L.			In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ON-A-CHIP; STEM-CELLS; REGENERATIVE MEDICINE; SILK FIBROIN; DIFFERENTIATION; CULTURE; PHYSIOLOGY; SCAFFOLDS; PATHOPHYSIOLOGY	There is a need for functional in vitro 3D human intestine systems that can bridge the gap between conventional cell culture studies and human trials. The successful engineering in vitro of human intestinal tissues relies on the use of the appropriate cell sources, biomimetic scaffolds, and 3D culture conditions to support vital organ functions. We previously established a compartmentalized scaffold consisting of a hollow space within a porous bulk matrix, in which a functional and physiologically relevant intestinal epithelium system was generated using intestinal cell lines. In this study, we adopt the 3D scaffold system for the cultivation of stem cell-derived human small intestinal enteriods (HIES) to engineer an in vitro 3D model of a nonstransformed human small intestinal epithelium. Characterization of tissue properties revealed a mature HIE-derived epithelium displaying four major terminally differentiated epithelial cell types (enterocytes, Goblet cells, Paneth cells, enteroendocrine cells), with tight junction formation, microvilli polarization, digestive enzyme secretion, and low oxygen tension in the lumen. Moreover, the tissue model demonstrates significant antibacterial responses to E. coli infection, as evidenced by the significant upregulation of genes involved in the innate immune response. Importantly, many of these genes are activated in human patients with inflammatory bowel disease (IBD), implicating the potential application of the 3D stem-cell derived epithelium for the in vitro study of host-microbe-pathogen interplay and IBD pathogenesis.	[Chen, Ying; Zhou, Wenda; Roh, Terrence; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Estes, Mary K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Tufts University; Baylor College of Medicine; Baylor College of Medicine	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu		Roh, Terrence/0000-0001-6831-1153	NIH [U19A1116497, P41EB002520]; Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116497, U19AI131126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the NIH (U19A1116497, P41EB002520) and the Gates Foundation for support of this work.	Abbott RD, 2016, ADV HEALTHC MATER, V5, P1667, DOI 10.1002/adhm.201600211; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Arrowsmith J, 2012, NAT REV DRUG DISCOV, V11, P17, DOI 10.1038/nrd3630; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Balimane PV, 2005, DRUG DISCOV TODAY, V10, P335, DOI 10.1016/S1359-6446(04)03354-9; BOHLEN HG, 1980, AM J PHYSIOL, V239, pH489, DOI 10.1152/ajpheart.1980.239.4.H489; Brown M, 2014, CLIN EXP IMMUNOL, V178, P28, DOI 10.1111/cei.12381; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Castellanos-Gonzalez A, 2013, INFECT IMMUN, V81, P1996, DOI 10.1128/IAI.01131-12; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13708; Costello CM, 2014, BIOTECHNOL BIOENG, V111, P1222, DOI 10.1002/bit.25180; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Deng XD, 2013, APPL MICROBIOL BIOT, V97, P6943, DOI 10.1007/s00253-013-4975-x; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.TEB.2012.0723, 10.1089/ten.teb.2012.0723]; Foster Jane A, 2013, Cerebrum, V2013, P9; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168; Holmberg FEO, 2017, EMBO MOL MED, V9, P558, DOI 10.15252/emmm.201607260; Hosseinkhani M, 2014, WORLD J PLAST SURG, V3, P3; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Kauffman AL, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00079; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Liu FK, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00334; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Martinez-Medina Margarita, 2014, World J Gastrointest Pathophysiol, V5, P213, DOI 10.4291/wjgp.v5.i3.213; Morgan ME, 2014, MUCOSAL IMMUNOL, V7, P1266, DOI 10.1038/mi.2014.16; Nalle SC, 2015, MUCOSAL IMMUNOL, V8, P720, DOI 10.1038/mi.2015.40; Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; RePass MAD, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00731-16; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Schweinlin M, 2016, TISSUE ENG PART C-ME, V22, P873, DOI [10.1089/ten.tec.2016.0101, 10.1089/ten.TEC.2016.0101]; Sideri A, 2015, CELL MOL GASTROENTER, V1, P420, DOI 10.1016/j.jcmgh.2015.03.003; Sidoroff M, 2010, WORLD J GASTROENTERO, V16, P2901, DOI 10.3748/wjg.v16.i23.2901; Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686; Spoettl T, 2007, INFLAMM BOWEL DIS, V13, P727, DOI 10.1002/ibd.20107; Spurrier RG, 2013, CLIN GASTROENTEROL H, V11, P354, DOI 10.1016/j.cgh.2013.01.028; Sun DX, 2002, PHARMACEUT RES, V19, P1400, DOI 10.1023/A:1020483911355; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI 10.1517/17425255.4.4.395 ; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Vasseur F, 2012, INFLAMM BOWEL DIS, V18, P430, DOI 10.1002/ibd.21817; Villar-Suarez V, 2004, J BIOMED BIOTECHNOL, P86; Villenave R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169412; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022; Yu JJ, 2014, DRUG DISCOV TODAY, V19, P1587, DOI 10.1016/j.drudis.2014.05.003; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995	62	56	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187880	10.1371/journal.pone.0187880	http://dx.doi.org/10.1371/journal.pone.0187880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186150	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900014
J	McPeake, J; Shaw, M; Iwashyna, TJ; Daniel, M; Devine, H; Jarvie, L; Kinsella, J; MacTavish, P; Quasim, T				McPeake, Joanne; Shaw, Martin; Iwashyna, Theodore J.; Daniel, Malcolm; Devine, Helen; Jarvie, Lyndsey; Kinsella, John; MacTavish, Pamela; Quasim, Tara			Intensive Care Syndrome: Promoting Independence and Return to Employment (InS:PIRE). Early evaluation of a complex intervention	PLOS ONE			English	Article							FUNCTIONAL DISABILITY; PEER SUPPORT; REHABILITATION; SURVIVORS; DISCHARGE; OUTCOMES	Background Many patients suffer significant physical, social and psychological problems in the months and years following critical care discharge. At present, there is minimal evidence of any effective interventions to support this patient group following hospital discharge. The aim of this project was to understand the impact of a complex intervention for ICU survivors. Methods Quality improvement project conducted between September 2014 and June 2016, enrolling 49 selected patients from one ICU in Scotland. To evaluate the impact of this programme outcomes were compared to an existing cohort of patients from the same ICU from 2008-2009. Patients attended a five week peer supported rehabilitation programme. This multidisciplinary programme included pharmacy, physiotherapy, nursing, medical, and psychology input. The primary outcome in this evaluation was the EQ-5D, a validated measure of health-related quality of life. The minimally clinically important difference (MCID) in the EQ-5D is 0.08. We also measured change in self-efficacy over the programme duration. Based on previous research, this study utilised a 2.4 (6%) point change in self-efficacy scores as a MCID. Results 40 patients (82%) completed follow-up surveys at 12 months. After regression adjustment for those factors known to impact recovery from critical care, there was a 0.07-0.16 point improvement in quality of life for those patients who took part in the intervention compared to historical controls from the same institution, depending on specific regression strategy used. Self-efficacy scores increased by 2.5 points (6.25%) over the duration of the five week programme (p = 0.003), and was sustained at one year post intervention. In the year following ICU, 15 InS:PIRE patients returned to employment or volunteering roles (88%) compared with 11 (46%) in the historical control group (p = 0.15). Conclusions and relevance This historical control study suggests that a complex intervention may improve quality of life and self-efficacy in survivors of ICU. A larger, multi-centre study is needed to investigate this intervention further.	[McPeake, Joanne; Shaw, Martin; Kinsella, John; MacTavish, Pamela; Quasim, Tara] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [McPeake, Joanne; Daniel, Malcolm; Devine, Helen; Jarvie, Lyndsey; Kinsella, John; Quasim, Tara] Glasgow Royal Infirm, NHS Greater Glasgow & Clyde, Intens Care Unit, Glasgow, Lanark, Scotland; [Shaw, Martin] Glasgow Royal Infirm, NHS Greater Glasgow & Clyde, Clin Phys Dept, Glasgow, Lanark, Scotland; [Iwashyna, Theodore J.] VA Ann Arbor Hlth Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Iwashyna, Theodore J.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA	University of Glasgow; University of Glasgow; University of Glasgow; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	McPeake, J (corresponding author), Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland.; McPeake, J (corresponding author), Glasgow Royal Infirm, NHS Greater Glasgow & Clyde, Intens Care Unit, Glasgow, Lanark, Scotland.	joanne.mcpeake@glasgow.ac.uk	Daniel, Malcolm/AFL-1547-2022	Quasim, Tara/0000-0002-9872-3623; McPeake, Joanne/0000-0001-8206-6801	CNO Scotland Fellowship; Health Foundation; US Department of Veterans Affairs, Health Services Research Development [IIR 13-079]	CNO Scotland Fellowship; Health Foundation; US Department of Veterans Affairs, Health Services Research Development(US Department of Veterans Affairs)	JMcP is supported by a CNO Scotland Fellowship and the Health Foundation. TJI's work was supported, in part, by US Department of Veterans Affairs, Health Services Research & Development, IIR 13-079. MD, HD, PMacT, JK and TQ are supported by the Health Foundation. This study does not necessarily represent the official views of the US Government or Department of Veterans Affairs. The Health Foundation is a charitable organisation. They had no role in the design, collection, analysis, interpretation of data or in the writing of this manuscript. They had no role in the decision to submit the manuscript for publication.	[Anonymous], 2021, LANG ENV STAT COMP; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P92, DOI 10.1136/jech.2008.077354; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Battle CE, 2013, CRIT CARE, V17, DOI 10.1186/cc12746; Bland M., 2000, INTRO STAT; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Cameron LD, 2007, PSYCHO-ONCOLOGY, V16, P171, DOI 10.1002/pon.1050; CUTHBERTSON BH, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B3723; Davis T, 2014, J BURN CARE RES, V35, P416, DOI 10.1097/BCR.0000000000000011; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Deacon Kate S, 2012, Intensive Crit Care Nurs, V28, P114, DOI 10.1016/j.iccn.2011.11.008; Denehy L, 2013, CRIT CARE, V17, DOI 10.1186/cc12835; Diamond A, 2013, REV ECON STAT, V95, P932, DOI 10.1162/REST_a_00318; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Harrell FE, 2001, REGRESSION MODELING; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Intensive Care Society, 2009, LEV CRIT CAR AD PAT; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Lone NI, 2013, CRIT CARE MED, V41, P1832, DOI 10.1097/CCM.0b013e31828a409c; McPeake J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009944; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Mikkelsen ME, 2016, AACN ADV CRIT CARE, V27, P221, DOI 10.4037/aacnacc2016667; Moody A, 2004, THORAX, V59, P1; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Orwelius L, 2010, CRIT CARE, V14, DOI 10.1186/cc8967; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Quasim Tara, 2015, J Intensive Care Soc, V16, P31, DOI 10.1177/1751143714556238; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Scottish Government, 2012, NAT STAT PUBL SCOTL; Szende A., 2006, EQ 5D VALUE SETS INV; Tsay SL, 2002, INT J NURS STUD, V39, P245, DOI 10.1016/S0020-7489(01)00030-X; Vainiola T, 2010, INTENS CARE MED, V36, P2090, DOI 10.1007/s00134-010-1979-1; Vincent E, 2011, CHEST, V140, P1534, DOI 10.1378/chest.10-2649; Wade DM, 2012, CRIT CARE, V16, DOI 10.1186/cc11677; Walker Wendy, 2015, J Intensive Care Soc, V16, P37, DOI 10.1177/1751143714554896; Walsh TS, 2015, JAMA INTERN MED, V175, P901, DOI 10.1001/jamainternmed.2015.0822; Welch CA, 2010, J CRIT CARE, V25, P382, DOI 10.1016/j.jcrc.2009.11.003	41	37	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188028	10.1371/journal.pone.0188028	http://dx.doi.org/10.1371/journal.pone.0188028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186177	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900021
J	Sorensen, AIV; Toft, N; Boklund, A; Espinosa-Gongora, C; Graesboll, K; Larsen, J; Halasa, T				Sorensen, Anna Irene Vedel; Toft, Nils; Boklund, Anette; Espinosa-Gongora, Carmen; Graesboll, Kaare; Larsen, Jesper; Halasa, Tariq			A mechanistic model for spread of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) within a pig herd	PLOS ONE			English	Article							NASAL CARRIAGE; SOIL SURFACES; COLONIZATION; TRANSMISSION; ZINC; CONTAMINATION; SELECTION; EXPOSURE; IMPACT; CC398	Before an efficient control strategy for livestock-associated methicillin resistant Staphylococcus aureus (LA-MRSA) in pigs can be decided upon, it is necessary to obtain a better understanding of how LA-MRSA spreads and persists within a pig herd, once it is introduced. We here present a mechanistic stochastic discrete-event simulation model for spread of LA-MRSA within a farrow-to-finish sow herd to aid in this. The model was individual- based and included three different disease compartments: susceptible, intermittent or persistent shedder of MRSA. The model was used for studying transmission dynamics and within-farm prevalence after different introductions of LA-MRSA into a farm. The spread of LA-MRSA throughout the farm mainly followed the movement of pigs. After spread of LA-MRSA had reached equilibrium, the prevalence of LA-MRSA shedders was predicted to be highest in the farrowing unit, independent of how LA-MRSA was introduced. LA-MRSA took longer to spread to the whole herd if introduced in the finisher stable, rather than by gilts in the mating stable. The more LA-MRSA positive animals introduced, the shorter time before the prevalence in the herd stabilised. Introduction of a low number of intermittently shedding pigs was predicted to frequently result in LA-MRSA fading out. The model is a potential decision support tool for assessments of short and long term consequences of proposed intervention strategies or surveillance options for LA-MRSA within pig herds.	[Sorensen, Anna Irene Vedel; Toft, Nils; Boklund, Anette; Espinosa-Gongora, Carmen; Graesboll, Kaare; Halasa, Tariq] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Larsen, Jesper] Statens Serum Inst, Microbiol & Infect Control, Copenhagen, Denmark	Technical University of Denmark; Statens Serum Institut	Sorensen, AIV (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark.	anvso@vet.dtu.dk	Larsen, Jesper/AAJ-3161-2021; Boklund, Anette/HGE-8502-2022	Larsen, Jesper/0000-0003-0582-0457; Halasa, Tariq/0000-0003-1112-0254; Espinosa-Gongora, Carmen/0000-0002-9536-0548; Graesboll, Kaare/0000-0002-6258-8212; Boklund, Anette/0000-0001-6359-3403; Sorensen, Anna Irene Vedel/0000-0002-3877-4592	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency [33010-NIFA-14-612]	Ministry of Environment and Food of Denmark through The Danish Agrifish Agency	This study was supported by a grant from the Ministry of Environment and Food of Denmark through The Danish Agrifish Agency (J. no. 33010-NIFA-14-612) (www.agrifish.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, VET MICROBIOL, V142, P455, DOI 10.1016/j.vetmic.2009.10.021; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bangerter PD, 2016, VET MICROBIOL, V183, P125, DOI 10.1016/j.vetmic.2015.12.007; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85; Broens EM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-58; Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010; Burns A, 2014, VET MICROBIOL, V174, P504, DOI 10.1016/j.vetmic.2014.10.009; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014; Crombe F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00057; Crombe F, 2012, APPL ENVIRON MICROB, V78, P1631, DOI 10.1128/AEM.07356-11; Cuny C, 2015, ANTIBIOTICS-BASEL, V4, P521, DOI 10.3390/antibiotics4040521; Danish Agriculture & Food Council, 2016, STAT 2015 PIGM; Danish Pig Research Centre, 2010, PROGR HOLDDR; Danish Veterinary and Food Administration, 2017, RES SCREEN HUSD MRSA, P1; DANMAP. DANMAP, 2016, 2015 US ANT AG OCC A; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Espinosa-Gongora C, 2015, APPL ENVIRON MICROB, V81, P1251, DOI 10.1128/AEM.03392-14; European Centre for Disease Prevention and Control (ECDC), 2015, ANN EP REP 2014 ANT; Federation of Veterinarians of Europe, 2014, FVE POS PAP US ZINC; Friese A, 2013, APPL ENVIRON MICROB, V79, P2759, DOI 10.1128/AEM.03939-12; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Gibbons JF, 2013, VET MICROBIOL, V162, P771, DOI 10.1016/j.vetmic.2012.10.001; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Grontvedt CA, 2016, CLIN INFECT DIS, V63, P1431, DOI 10.1093/cid/ciw552; Guardabassi L, 2013, J GLOB ANTIMICROB RE, V1, P55, DOI 10.1016/j.jgar.2013.03.011; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Halasa T, 2009, LIVEST SCI, V124, P295, DOI 10.1016/j.livsci.2009.02.019; Hybschmann GK, 2011, PREV VET MED, V98, P190, DOI 10.1016/j.prevetmed.2010.10.005; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jessen O., 2016, LANDSGENNEMSNIT PROD; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Larsen J, 2016, ANTIMICROB AGENTS CH, V60, P4401, DOI 10.1128/AAC.00426-16; Leonard FC, 2008, VET J, V175, P27, DOI 10.1016/j.tvjl.2006.11.008; Moodley A, 2011, VET MICROBIOL, V152, P420, DOI 10.1016/j.vetmic.2011.05.025; Nemeghaire S, 2013, AVIAN PATHOL, V42, P342, DOI 10.1080/03079457.2013.805183; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; R Core Team, 2015, R LANG ENV STAT COMP, V55, P275; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Skallerup P, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0599-y; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P79, DOI 10.1111/zph.12167; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; Verhegghe M, 2013, ZOONOSES PUBLIC HLTH, V60, P366, DOI 10.1111/zph.12007; Verhegghe M, 2014, GENETIC DIVERSITY LI, P1; Verhegghe M, 2013, VET MICROBIOL, V162, P679, DOI 10.1016/j.vetmic.2012.09.014; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188429	10.1371/journal.pone.0188429	http://dx.doi.org/10.1371/journal.pone.0188429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182655	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000027
J	Onelli, E; Moscatelli, A; Gagliardi, A; Zaninelli, M; Bini, L; Baldi, A; Caccianiga, M; Reggi, S; Rossi, L				Onelli, Elisabetta; Moscatelli, Alessandra; Gagliardi, Assunta; Zaninelli, Mauro; Bini, Luca; Baldi, Antonella; Caccianiga, Marco; Reggi, Serena; Rossi, Luciana			Retarded germination of Nicotiana tabacum seeds following insertion of exogenous DNA mimics the seed persistent behavior	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CLASS-I BETA-1,3-GLUCANASE; STORAGE PROTEINS; MOLECULAR CHAPERONES; DISULFIDE-ISOMERASE; ASPARTIC PROTEINASE; TOBACCO SEEDS; ENDOPLASMIC-RETICULUM; DORMANCY RELEASE; GENE-EXPRESSION	Tobacco seeds show a coat-imposed dormancy in which the seed envelope tissues (testa and endosperm) impose a physical constraint on the radicle protrusion. The germination-limiting process is represented by the endosperm rupture which is induced by cell-wall weakening. Transgenic tobacco seeds, obtained by insertion of exogenous genes codifying for seed-based oral vaccines (F18 and VT2eB), showed retarded germination with respect to the wild type and modified the expression of endogenous proteins. Morphological and proteomic analyses of wild type and transgenic seeds revealed new insights into factors influencing seed germination. Our data showed that the interference of exogenous DNA influences the germination rather than the dormancy release, by modifying the maturation process. Dry seeds of F18 and VT2eB transgenic lines accumulated a higher amount of reserve and stress-related proteins with respect to the wild type. Moreover, the storage proteins accumulated in tobacco F18 and VT2eB dry seeds have structural properties that do not enable the early limited proteolysis observed in the wild type. Morphological observations by electron and light microscopy revealed a retarded mobilization of the storage material from protein and lipid bodies in transgenic seeds, thus impairing water imbibition and embryo elongation. In addition, both F18 and VT2eB dry seeds are more rounded than the wild type. Both the morphological and biochemical characteristics of transgenic seeds mimic the seed persistent profile, in which their roundness enables them to be buried in the soil, while the higher content of storage material enables the hypocotyl to elongate more and the cotyledons to emerge.	[Onelli, Elisabetta; Moscatelli, Alessandra; Caccianiga, Marco] Univ Milan, Dept Biosci, Milan, Italy; [Gagliardi, Assunta; Bini, Luca] Univ Siena, Dept Life Sci, Lab Funct Prote, Siena, Italy; [Zaninelli, Mauro] Univ Telemat San Raffaele Roma, Dept Human Sci & Qual Life Promot, Rome, Italy; [Baldi, Antonella; Rossi, Luciana] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Reggi, Serena] Plantechno Srl, Vicomoscano, Cremona, Italy; [Gagliardi, Assunta] Univ Trento, CIBIO, Trento, Italy	University of Milan; University of Siena; Universita Telematica San Raffaele; University of Milan; University of Trento	Moscatelli, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alessandra.moscatelli@unimi.it	Rossi, Luciana/I-5142-2012; Zaninelli, Mauro/D-4626-2018; Moscatelli, alessandra/B-1138-2017	Rossi, Luciana/0000-0003-1178-4683; Zaninelli, Mauro/0000-0001-8800-1777; Moscatelli, alessandra/0000-0003-0912-5697	Linea B, VESPA Department, University of Milan; Plantechno SRL	Linea B, VESPA Department, University of Milan; Plantechno SRL	This study was funded by Linea B, VESPA Department, University of Milan. Plantechno SRL provided support in the form of salary for author [SR], but did not have any additional role in study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Barba-Espin G, 2011, PLANT CELL ENVIRON, V34, P1907, DOI 10.1111/j.1365-3040.2011.02386.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BELOZERSKY MA, 1989, PLANTA, V177, P321, DOI 10.1007/BF00403589; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerabolini B, 2003, SEED SCI RES, V13, P75, DOI 10.1079/SSR2002126; Cervantes E, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5691825; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Cohen J, 2002, SCIENCE, V296, P2164, DOI 10.1126/science.296.5576.2164; Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9; Cuming AC, 1999, SEED PROTEINS, P753; DURE L, 1983, PLANT MOL BIOL, V2, P199, DOI 10.1007/BF01578379; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Funes G, 1999, SEED SCI RES, V9, P341, DOI 10.1017/S0960258599000355; Gao F, 2013, PLANT BIOTECHNOL J, V11, P921, DOI 10.1111/pbi.12083; Gardarin A, 2013, WEED RES, V55, P14; Gardarin A, 2011, ECOL MODEL, V222, P626, DOI 10.1016/j.ecolmodel.2010.10.005; Gendreau E, 2008, J EXP BOT, V59, P203, DOI 10.1093/jxb/erm296; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hua ShuiJin, 2012, African Journal of Agricultural Research, V7, P2475; Jiang LW, 2001, J CELL BIOL, V155, P991, DOI 10.1083/jcb.200107012; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; Jung YuJin, 2014, Plant Breeding and Biotechnology, V2, P370, DOI 10.9787/PBB.2014.2.4.370; Kalemba E.M., 2007, BIOL LETT, V44, P3; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Kimura S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0460-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Lal SK, 1998, PLANT PHYSIOL, V118, P1285, DOI 10.1104/pp.118.4.1285; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Leishman MR, 1998, FUNCT ECOL, V12, P480, DOI 10.1046/j.1365-2435.1998.00215.x; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Leubner-Metzger G, 2003, SEED SCI RES, V13, P17, DOI 10.1079/SSR2002121; Leubner-Metzger G, 2002, PLANTA, V215, P959, DOI 10.1007/s00425-002-0837-y; Leubner-Metzger G, 2001, J EXP BOT, V52, P1753, DOI 10.1093/jexbot/52.362.1753; Li QB, 2001, PLANT PHYSIOL, V125, P1633, DOI 10.1104/pp.125.4.1633; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Long RL, 2015, BIOL REV, V90, P31, DOI 10.1111/brv.12095; Lubaretz O, 2002, PLANTA, V215, P220, DOI 10.1007/s00425-002-0745-1; Lytle BL, 2009, PROTEINS, V76, P237, DOI 10.1002/prot.22396; MADISON JT, 1981, ANN BOT-LONDON, V47, P65, DOI 10.1093/oxfordjournals.aob.a086001; Manz B, 2005, PLANT PHYSIOL, V138, P1538, DOI 10.1104/pp.105.061663; MEEKSWAGNER DR, 1989, PLANT CELL, V1, P25, DOI 10.1105/tpc.1.1.25; Moles AT, 2000, OIKOS, V89, P541, DOI 10.1034/j.1600-0706.2000.890313.x; Moscatelli A, 2015, BIOL OPEN, V4, P378, DOI 10.1242/bio.201410249; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Mutlu A, 1998, PHYTOCHEMISTRY, V47, P1453, DOI 10.1016/S0031-9422(97)00834-0; Mutlu A, 1999, SEED SCI RES, V9, P75, DOI 10.1017/S0960258599000082; Myernic JA, 1996, TRENDS PLANT SCI, V2, P180; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; NEALE AD, 1990, PLANT CELL, V2, P673, DOI 10.1105/tpc.2.7.673; NESSLER CL, 1985, PLANT PHYSIOL, V79, P499, DOI 10.1104/pp.79.2.499; NESSLER CL, 1992, PLANT MOL BIOL, V20, P749, DOI 10.1007/BF00046460; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Onda Y, 2011, PLANT CELL, V23, P210, DOI 10.1105/tpc.110.079509; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Penfield S, 2004, PLANT CELL, V16, P2705, DOI 10.1105/tpc.104.024711; QI QG, 1994, PLANTA, V194, P193, DOI 10.1007/BF01101678; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Reggi S, 2005, PLANT MOL BIOL, V57, P101, DOI 10.1007/s11103-004-6832-x; Rossi L, 2011, IJAS S, V1, P19; Rossi L, 2014, VET RES COMMUN, V38, P39, DOI 10.1007/s11259-013-9583-9; Rossi L, 2013, J VET SCI, V14, P263, DOI 10.4142/jvs.2013.14.3.263; RUNEBERGROOS P, 1994, PLANT PHYSIOL, V105, P321, DOI 10.1104/pp.105.1.321; Sadiq I, 2011, J PLANT PHYSIOL, V168, P2234, DOI 10.1016/j.jplph.2011.07.009; Satoh-Cruz M, 2010, PLANT CELL PHYSIOL, V51, P1581, DOI 10.1093/pcp/pcq098; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Sharma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148449; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Soskic V, 1999, BIOCHEMISTRY-US, V38, P1757, DOI 10.1021/bi982093r; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tan-Wilson AL, 2012, PHYSIOL PLANTARUM, V145, P140, DOI 10.1111/j.1399-3054.2011.01535.x; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thompson K, 2001, SEED SCI RES, V11, P345; Nguyen PT, 2015, J EXP BOT, V66, P6399, DOI 10.1093/jxb/erv348; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Voll LM, 2009, NEW PHYTOL, V184, P607, DOI 10.1111/j.1469-8137.2009.02998.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Witzel K, 2010, PLANT CELL ENVIRON, V33, P211, DOI 10.1111/j.1365-3040.2009.02071.x; Yan DW, 2014, PLANT CELL PHYSIOL, V55, P1521, DOI 10.1093/pcp/pcu089; Yeh CH, 2002, PLANT PHYSIOL, V128, P661, DOI 10.1104/pp.010594; Yuen CYL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0869-2; ZURNIEDEN U, 1995, PLANTA, V196, P530	113	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187929	10.1371/journal.pone.0187929	http://dx.doi.org/10.1371/journal.pone.0187929			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216220	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800015
J	Muniz-Talavera, H; Schmidt, JV				Muniz-Talavera, Hilmarie; Schmidt, Jennifer V.			The mouse Jhy gene regulates ependymal cell differentiation and ciliogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; PRIMARY CILIARY DYSKINESIA; ADHERENS JUNCTIONS; PLANAR POLARITY; VENTRICULAR ZONE; RADIAL GLIA; N-CADHERIN; HYDROCEPHALUS FORMATION; ABNORMAL NEUROGENESIS; CATENIN COMPLEX	During the first postnatal week of mouse development, radial glial cells lining the ventricles of the brain differentiate into ependymal cells, undergoing a morphological change from pseudostratified cuboidal cells to a flattened monolayer. Concomitant with this change, multiple motile cilia are generated and aligned on each nascent ependymal cell. Proper ependymal cell development is crucial to forming the brain tissue:CSF barrier, and to the establishment of ciliary CSF flow, but the mechanisms that regulate this differentiation event are poorly understood. The Jhy(lacZ) mouse line carries an insertional mutation in the Jhy gene (formerly 4931429I11Rik), and homozygous Jhy(lacZ/lacZ) mice develop a rapidly progressive juvenile hydrocephalus, with defects in ependymal cilia morphology and ultrastructure. Here we show that beyond just defective motile cilia, Jhy(lacZ/lacZ) mice display abnormal ependymal cell differentiation. Ventricular ependyma in Jhy(lacZ/lacZ) mice retain an unorganized and multi-layered morphology, representative of undifferentiated ependymal (radial glial) cells, and they show altered expression of differentiation markers. Most Jhy(lacZ/lacZ) ependymal cells do eventually acquire some differentiated ependymal characteristics, suggesting a delay, rather than a block, in the differentiation process, but ciliogenesis remains perturbed. Jhy(lacZ/lacZ) ependymal cells also manifest disruptions in adherens junction formation, with altered N-cadherin localization, and have defects in the polarized organization of the apical motile cilia that do form. Functional studies showed that cilia of Jhy(lacZ/lacZ) mice have severely reduced motility, a potential cause for the development of hydrocephalus. This work shows that JHY does not only control ciliogenesis, but is a crucial component of the ependymal differentiation process, with ciliary defects likely a consequence of altered ependymal differentiation.	[Muniz-Talavera, Hilmarie; Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, S Ashland Ave, Chicago, IL 60680 USA; [Muniz-Talavera, Hilmarie] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schmidt, Jennifer V.] Shark Res Inst, Sci Res, Crystal Beach, TX 77550 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; St Jude Children's Research Hospital	Schmidt, JV (corresponding author), Univ Illinois, Dept Biol Sci, S Ashland Ave, Chicago, IL 60680 USA.; Schmidt, JV (corresponding author), Shark Res Inst, Sci Res, Crystal Beach, TX 77550 USA.	jennifer@sharks.org			National Institutes of Health [NS065188, S10RR025629]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (NS065188) to JVS, and (S10RR025629) to Peter Toth.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Appelbe OK, 2013, DEV BIOL, V382, P172, DOI 10.1016/j.ydbio.2013.07.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas D, 2006, EUR J NEUROSCI, V24, P1020, DOI 10.1111/j.1460-9568.2006.05002.x; Bertocchi Cristina, 2012, J Signal Transduct, V2012, P125295, DOI 10.1155/2012/125295; Boutin C, 2014, P NATL ACAD SCI USA, V111, pE3129, DOI 10.1073/pnas.1404988111; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Clare DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5888; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; DIDIER M, 1986, CELL TISSUE RES, V245, P343; Etienne-Manneville S, 2011, SEMIN CELL DEV BIOL, V22, P850, DOI 10.1016/j.semcdb.2011.07.023; Batiz LF, 2011, ACTA NEUROPATHOL, V121, P721, DOI 10.1007/s00401-011-0799-x; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jacquet BV, 2011, J NEUROSCI, V31, P9368, DOI 10.1523/JNEUROSCI.0171-11.2011; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kishimoto N, 2012, DIFFERENTIATION, V83, pS86, DOI 10.1016/j.diff.2011.10.007; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Ladoux B, 2015, INTEGR BIOL-UK, V7, P1109, DOI 10.1039/c5ib00070j; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Lavado A, 2011, DEVELOPMENT, V138, P5291, DOI 10.1242/dev.067470; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; Lindqvist M, 2010, J CELL SCI, V123, P472, DOI 10.1242/jcs.048074; McEwen Abbye E, 2012, Subcell Biochem, V60, P171, DOI 10.1007/978-94-007-4186-7_8; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Nagaoka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06940; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; O'Callaghan Chris, 2012, Cilia, V1, P8, DOI 10.1186/2046-2530-1-8; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Oliver C, 2013, J NEUROPATH EXP NEUR, V72, P846, DOI 10.1097/NEN.0b013e3182a2d5fe; Orsulic S, 1999, J CELL SCI, V112, P1237; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Rappl A, 2008, J CELL SCI, V121, P4089, DOI 10.1242/jcs.027995; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Rubenstein JL, 2013, COMPREHENSIVE DEV NE, P974; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Shibata T, 1997, J NEUROSCI, V17, P9212; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Stocker AM, 2015, CELL ADHES MIGR, V9, P167, DOI 10.1080/19336918.2015.1027478; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Wallingford JB, 2010, CURR OPIN CELL BIOL, V22, P597, DOI 10.1016/j.ceb.2010.07.011; Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7; Zhou J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002516	76	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0184957	10.1371/journal.pone.0184957	http://dx.doi.org/10.1371/journal.pone.0184957			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211732	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200003
J	Vacquie-Garcia, J; Lydersen, C; Biuw, M; Haug, T; Fedak, MA; Kovacs, KM				Vacquie-Garcia, Jade; Lydersen, Christian; Biuw, Martin; Haug, Tore; Fedak, Mike A.; Kovacs, Kit M.			Hooded seal Cystophora cristata foraging areas in the Northeast Atlantic Ocean-Investigated using three complementary methods	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; HARP PAGOPHILUS-GROENLANDICUS; TRACKED KING PENGUINS; DRIFT ICE WATERS; DIVING BEHAVIOR; HABITAT USE; SATELLITE TELEMETRY; SEXUAL SEGREGATION; EAST-COAST; MOVEMENTS	Identifying environmental characteristics that define the ecological niche of a species is essential to understanding how changes in physical conditions might affect its distribution and other aspects of its ecology. The present study used satellite relay data loggers (SRDLs) to study habitat use by Northeast Atlantic hooded seals (N = 20; 9 adult females, 3 adult males, and 8 juveniles). Three different methods were used in combination to achieve maximum insight regarding key foraging areas for hooded seals in this region, which have decline by 85% in recent decades: 1) first passage time (FPT); 2) vertical transit rate and; 3) change in dive drift rate. Generalized additive mixed models (GAMM) were applied to each method to determine whether specific habitat characteristics were associated with foraging. Separate models were run for the post-molting and the post-breeding seasons; sex and age classes were included in the GAMMs. All three methods highlighted a few common geographic areas as being important foraging zones; however, there were also some different areas identified by the different methods, which highlights the importance of using multiple indexes when analyzing tracking and diving data to study foraging behavior. Foraging occurred most commonly in relatively shallow areas with high Sea Surface Temperatures (SST), corresponding to continental shelf areas with Atlantic Water masses. All age and sex classes overlapped spatially to some extent, but the different age and sex groups showed differences in the bathymetry of their foraging areas as well as in their vertical use of the water column. When foraging, pups dove in the upper part of the water column in relatively deep areas. Adult females foraged relatively shallowly in deep water areas too, though in shallower areas than pups. Adult males foraged close to the bottom in shallower areas.	[Vacquie-Garcia, Jade; Lydersen, Christian; Biuw, Martin; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Biuw, Martin; Haug, Tore] Inst Marine Res, Tromso, Norway; [Fedak, Mike A.] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland	Norwegian Polar Institute; Institute of Marine Research - Norway; University of St Andrews	Vacquie-Garcia, J (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	jadevacquiegarcia@gmail.com	Fedak, Michael A/B-3987-2009; Biuw, Martin/AAF-9895-2021	Fedak, Michael A/0000-0002-9569-1128; Biuw, Martin/0000-0001-8051-3399; VACQUIE GARCIA, Jade/0000-0002-3126-3423	Norwegian Research Council within Norwegian International Polar Year programme [176477/S30]; Norwegian Polar Institute	Norwegian Research Council within Norwegian International Polar Year programme; Norwegian Polar Institute	This work was funded by the Norwegian Research Council (grant number 176477/S30), within the Norwegian International Polar Year programme and the Norwegian Polar Institute.	Amente C, 2009, NGDC24 NOAA NESDIS; Andersen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103072; Andersen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080438; Andersen JM, 2013, ICES J MAR SCI, V70, P173, DOI 10.1093/icesjms/fss133; Andersen Julie M., 2009, Journal of Northwest Atlantic Fishery Science, V42, P1; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bajzak CE, 2009, MAR ECOL PROG SER, V385, P285, DOI 10.3354/meps08015; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2000, J EXP BIOL, V203, P2323; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; BENHAMOU S, 1989, ANIM BEHAV, V38, P375, DOI 10.1016/S0003-3472(89)80030-2; Bennett KA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P911, DOI 10.1086/656925; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Blanchet MA, 2014, AQUAT BIOL, V21, P167, DOI 10.3354/ab00580; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; BOWEN WD, 1985, CAN J ZOOL, V63, P2841, DOI 10.1139/z85-424; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burns JM, 2015, PHYSIOL BIOCHEM ZOOL, V88, P167, DOI 10.1086/680015; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Enoksen S, 2017, POLAR BIOL, V40, P931, DOI 10.1007/s00300-016-2002-2; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fedak M, 2000, AM ZOOL, V40, P1013; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Folkow LP, 2010, POLAR BIOL, V33, P433, DOI 10.1007/s00300-009-0718-y; Folkow LP, 1996, POLAR BIOL, V16, P179, DOI 10.1007/BF02329206; Folkow LP, 1999, POLAR BIOL, V22, P61, DOI 10.1007/s003000050391; Folkow LP, 1995, DEV MAR BIO, V4, P193; Freitas C, 2013, PACKAGE ARGOSFILTER; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Geiseler SJ, 2013, J EXP BIOL, V216, P1793, DOI 10.1242/jeb.082099; Guinet C, 1997, MAR ECOL PROG SER, V150, P11, DOI 10.3354/meps150011; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hamilton CD, 2016, MAR ECOL PROG SER, V545, P261, DOI 10.3354/meps11598; Hammill M.O., 2000, Journal of Northwest Atlantic Fishery Science, V26, P1, DOI 10.2960/J.v26.a1; HAMMILL MO, 1993, POLAR BIOL, V13, P307; Hammill MO, 1960, ABUNDANCE NW ATLANTI, P19; Haug T, 2004, POLAR RES, V23, P35, DOI 10.1111/j.1751-8369.2004.tb00127.x; Haug T, 2007, MAR BIOL RES, V3, P123, DOI 10.1080/17451000701358531; Henriksen S, NORWEGIAN RED LIST S; Hindell MA, 1999, CAN J ZOOL, V77, P1807, DOI 10.1139/cjz-77-11-1807; *ICES, 2008, REP WORK GROUP WID D; Johnson D, 2013, CRAWL FIT CONTINUOUS; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Kapel Finn O., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V26, P87; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kirkman SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152370; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Kovacs K.M., 2016, CYSTOPHORA CRISTATA; Kovacs KM, 1996, CAN J ZOOL, V74, P1521, DOI 10.1139/z96-166; Lagoy H, 2012, MAR BIOL RES, V8, P5; LeBoeuf BJ, 1996, CAN J ZOOL, V74, P1632; Lestyk KC, 2009, J COMP PHYSIOL B, V179, P985, DOI 10.1007/s00360-009-0378-9; McIntyre T, 2010, MAR ECOL PROG SER, V412, P293, DOI 10.3354/meps08680; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Ng P, 2007, STAT MODEL, V7, P315, DOI 10.1177/1471082X0700700403; Noren SR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P782; Nottestad L, 2016, ICES J MAR SCI, V73, P359, DOI 10.1093/icesjms/fsv218; Oritsiand T., 1959, FAUNA OSLO, V12, P70; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Photopoulou T., 2015, ANIMAL BIOTELEMETRY, V3, P21, DOI DOI 10.1186/S40317-015-0053-8; R Development Core Team, R LANG ENV STAT COMP; Rasmussen B., 1960, Fisken og Havet, VNo. 1, P1; Rey AR, 2010, J ORNITHOL, V151, P933, DOI 10.1007/s10336-010-0531-y; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Sergeant D.E., 1974, Polarforschung, V44, P1; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; Thums M, 2008, J EXP MAR BIOL ECOL, V363, P75, DOI 10.1016/j.jembe.2008.06.024; TRIVELPIECE WZ, 1986, AUK, V103, P777, DOI 10.1093/auk/103.4.777; Tucker S, 2009, MAR ECOL PROG SER, V384, P287, DOI 10.3354/meps08000; Vacquie-Garcia J, 2015, MAR ECOL PROG SER, V541, P265, DOI 10.3354/meps11511; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; Wolf JBW, 2005, BEHAV ECOL SOCIOBIOL, V59, P293, DOI 10.1007/s00265-005-0042-7; Zuur AF, 2007, STAT BIOL HEALTH, P163	95	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187889	10.1371/journal.pone.0187889	http://dx.doi.org/10.1371/journal.pone.0187889			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211797	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000417212200021
J	Bao, AH; Che, KF; Bozinovski, S; Ji, J; Gregory, JA; Georen, SK; Adner, M; Cardell, LO; Linden, A				Bao, Aihua; Che, Karlhans Fru; Bozinovski, Steven; Ji, Jie; Gregory, Joshua A.; Georen, Susanna Kumlien; Adner, Mikael; Cardell, Lars-Olaf; Linden, Anders			Recombinant human IL-26 facilitates the innate immune response to endotoxin in the bronchoalveolar space of mice in vivo	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; EPITHELIAL-CELLS; OZONE EXPOSURE; INFLAMMATION; INTERLEUKIN-26; EXPRESSION; IL-17	Interleukin (IL)-26 is released in response to bacterial endotoxin (LPS) in the bronchoalveolar space of humans in vivo and it may potentiate neutrophil chemotaxis by enhanced IL-26 receptor stimulation. However, the effects of extracellular IL-26 protein on the innate immune response in the lungs in vivo remain unknown. Here, we characterized these effects of IL-26 on a wide range of aspects of the innate immune response to LPS in different compartments of the lungs in vivo over time. We administrated recombinant human (rh) IL-26 protein in the bronchoalveolar space using intranasal instillation in a mouse in vivo model, with and without prior instillation of LPS. We verified gene expression of the IL-26 receptor complex in mouse lungs and observed that, after instillation of LPS, rhIL-26 increases the phosphorylation of STAT3, a signaling molecule of the IL-26 receptor complex. We also observed that rhIL-26 exerted additional stimulatory and inhibitory actions that are compartment- and time-dependent, resulting in alterations of cytokines, proteinases, tissue inflammation and the accumulation of innate effector cells. Without the prior instillation of LPS, rhIL-26 exerted time-dependent effects on total gelatinase activity but few other effects. Most important, after instillation of LPS, rhIL-26 cleared inflammatory cells from local tissue and increased the accumulation of innate effector cells in the bronchoalveolar space. Tentatively, rhIL-26 may facilitate the innate immune response towards the bronchoalveolar space in vivo and represents a potential target for therapy in lung disorders involving the innate immune response.	[Bao, Aihua; Che, Karlhans Fru; Ji, Jie; Linden, Anders] Karolinska Inst, Unit Lung & Airway Res, Inst Environm Med, Stockholm, Sweden; [Bao, Aihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Resp Med, Shanghai, Peoples R China; [Bozinovski, Steven] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Gregory, Joshua A.; Georen, Susanna Kumlien; Adner, Mikael; Cardell, Lars-Olaf] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Gregory, Joshua A.; Adner, Mikael] Inst Environm Med, Unit Expt Asthma & Allergy Res, Stockholm, Sweden; [Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Linden, Anders] Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden	Karolinska Institutet; Shanghai Jiao Tong University; Royal Melbourne Institute of Technology (RMIT); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Linden, A (corresponding author), Karolinska Inst, Unit Lung & Airway Res, Inst Environm Med, Stockholm, Sweden.; Linden, A (corresponding author), Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden.	anders.linden@ki.se		Linden, Anders/0000-0003-1258-2928; Bozinovski, Steven/0000-0001-6533-8641; Kumlien Georen, Susanna/0000-0001-7292-9255	Swedish Heart-Lung Foundation; Swedish Institute; Swedish Research Council; King Gustaf V's and Queen Victoria's Freemason Research Fund; federal funding from Karolinska Institutet; ALF; LUA; Chinese Scholarship Council; Shanghai Municipal Commission of Health and Family Planning grant	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V's and Queen Victoria's Freemason Research Fund; federal funding from Karolinska Institutet(Karolinska Institutet); ALF; LUA; Chinese Scholarship Council(China Scholarship Council); Shanghai Municipal Commission of Health and Family Planning grant	This study was funded by the Swedish Heart-Lung Foundation (AL), the Swedish Institute (AL), the Swedish Research Council (AL and LOC), King Gustaf V's and Queen Victoria's Freemason Research Fund (AL), federal funding from Karolinska Institutet (AL) and from ALF (SLL) and LUA (VGR) grants (AL for both). This publication is a result of Aihua Bao's postdoctoral research work at Karolinska Institutet, made possible by the support of Chinese Scholarship Council (AB and AL) and the Swedish Institute, as well as the Shanghai Municipal Commission of Health and Family Planning grant (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Swedish Heart-Lung Foundation (AL), the Swedish Institute (AL), the Swedish Research Council (AL and LOC), King Gustaf V's and Queen Victoria's Freemason Research Fund (AL), federal funding from Karolinska Institutet (AL) and from ALF (SLL) and LUA (VGR) grants (AL for both). This publication is a result of Aihua Bao's postdoctoral research work at Karolinska Institutet, made possible by the support of Chinese Scholarship Council (AB and AL) and the Swedish Institute, as well as the Shanghai Municipal Commission of Health and Family Planning grant (AB).	Bao AH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0126-x; Bao AH, 2013, FRONT BIOSCI-LANDMRK, V18, P838, DOI 10.2741/4147; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Che KF, 2014, AM J RESP CRIT CARE, V190, P1022, DOI 10.1164/rccm.201404-0689OC; Che KF, 2017, MOL MED, V23, P247, DOI 10.2119/molmed.2016.00064; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Laan M, 1999, J IMMUNOL, V162, P2347; Linden Anders, 2007, Sci STKE, V2007, pre4, DOI 10.1126/stke.3982007re4; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Ohnuma K, 2015, J IMMUNOL, V194, P3697, DOI 10.4049/jimmunol.1402785; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peters M, 2016, AM J RESP CELL MOL B; Ramezanpour M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9798206; Smith ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075032; Srisodsai A, 2004, J BIOL CHEM, V279, P54358, DOI 10.1074/jbc.M405331200; Tachiiri A, 2003, GENES IMMUN, V4, P153, DOI 10.1038/sj.gene.6363934; Tengvall S, 2016, J INNATE IMMUN, V8, P15, DOI 10.1159/000434646; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	27	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188909	10.1371/journal.pone.0188909	http://dx.doi.org/10.1371/journal.pone.0188909			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206862	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700030
J	Kiware, SS; Chitnis, N; Tatarsky, A; Wu, S; Castellanos, HMS; Gosling, R; Smith, D; Marshall, JM				Kiware, Samson S.; Chitnis, Nakul; Tatarsky, Allison; Wu, Sean; Castellanos, Hector Manuel Sanchez; Gosling, Roly; Smith, David; Marshall, John M.			Attacking the mosquito on multiple fronts: Insights from the Vector Control Optimization Model (VCOM) for malaria elimination	PLOS ONE			English	Article							TRANSMISSION	Background Despite great achievements by insecticide-treated nets (ITNs) and indoor residual spraying (IRS) in reducing malaria transmission, it is unlikely these tools will be sufficient to eliminate malaria transmission on their own in many settings today. Fortunately, field experiments indicate that there are many promising vector control interventions that can be used to complement ITNs and/or IRS by targeting a wide range of biological and environmental mosquito resources. The majority of these experiments were performed to test a single vector control intervention in isolation; however, there is growing evidence and consensus that effective vector control with the goal of malaria elimination will require a combination of interventions. Method and findings We have developed a model of mosquito population dynamic to describe the mosquito life and feeding cycles and to optimize the impact of vector control intervention combinations at suppressing mosquito populations. The model simulations were performed for the main three malaria vectors in sub-Saharan Africa, Anopheles gambiae s.s, An. arabiensis and An. funestus. We considered areas having low, moderate and high malaria transmission, corresponding to entomological inoculation rates of 10, 50 and 100 infective bites per person per year, respectively. In all settings, we considered baseline ITN coverage of 50% or 80% in addition to a range of other vector control tools to interrupt malaria transmission. The model was used to sweep through parameters space to select the best optimal intervention packages. Sample model simulations indicate that, starting with ITNs at a coverage of 50% (An. gambiae s.s. and An. funestus) or 80% (An. arabiensis) and adding interventions that do not require human participation (e.g. larviciding at 80% coverage, endectocide treated cattle at 50% coverage and attractive toxic sugar baits at 50% coverage) may be sufficient to suppress all the three species to an extent required to achieve local malaria elimination. Conclusion The Vector Control Optimization Model (VCOM) is a computational tool to predict the impact of combined vector control interventions at the mosquito population level in a range of eco-epidemiological settings. The model predicts specific combinations of vector control tools to achieve local malaria elimination in a range of eco-epidemiological settings and can assist researchers and program decision-makers on the design of experimental or operational research to test vector control interventions. A corresponding graphical user interface is available for national malaria control programs and other end users.	[Kiware, Samson S.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania; [Kiware, Samson S.] Marquette Univ, Math Stat & Comp Sci Dept, Milwaukee, WI 53233 USA; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Tatarsky, Allison] Univ Basel, Basel, Switzerland; [Tatarsky, Allison; Gosling, Roly] Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Wu, Sean; Castellanos, Hector Manuel Sanchez; Marshall, John M.] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Wu, Sean; Castellanos, Hector Manuel Sanchez; Marshall, John M.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Castellanos, Hector Manuel Sanchez] Tecnol Monterrey, Sch Med, Atizapan De Zaragoza, Estado De Mexic, Mexico; [Smith, David] Univ Washington, Dept Global Hlth, Seattle, WA USA	Ifakara Health Institute; Marquette University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tecnologico de Monterrey; University of Washington; University of Washington Seattle	Kiware, SS (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania.; Kiware, SS (corresponding author), Marquette Univ, Math Stat & Comp Sci Dept, Milwaukee, WI 53233 USA.	skiware@ihi.or.tz	Smith, David L/L-8850-2013; Smith, David/GQQ-8257-2022	Smith, David L/0000-0003-4367-3849; Kiware, Samson/0000-0001-7252-520X	Wellcome Trust Training Fellowship grant [107599/Z/15/Z]; UC-MEXUS grant; University of California, San Francisco, Group Health Group Malaria Elimination Initiative through Parker Foundation	Wellcome Trust Training Fellowship grant; UC-MEXUS grant; University of California, San Francisco, Group Health Group Malaria Elimination Initiative through Parker Foundation	SSK acknowledges financial support from a Wellcome Trust Training Fellowship grant # 107599/Z/15/Z. HS and JM acknowledges financial support from UC-MEXUS grant. This work was supported by the University of California, San Francisco, Group Health Group Malaria Elimination Initiative through funding from The Parker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Control mCGoV, 2011, PLOS MED, V8; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; DYE C, 1986, Parasitology Today, V2, P203; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Imbahale SS, 2012, BMC PUBLIC HEALTH, V12, P1; Karunamoorthi K, 2011, CLIN MICROBIOL INFEC, V17, P1608, DOI 10.1111/j.1469-0691.2011.03664.x; Killeen G.F., 2012, MAL J, V1, P1; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2014, MALARIA J, V13, P1, DOI DOI 10.1186/1475-2875-13-330; Killeen GF, 2013, PARASITE VECTOR, V6, P1; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kiware SS, 2012, BIOL LETTERS, V8, P874, DOI 10.1098/rsbl.2012.0352; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C., 1998, COCHRANE DATABASE SY; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Muller GC, 2010, MALARIA J, V9, P1; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Poche RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0883-0; R Core T, 2013, R LANG ENV STAT COMP; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell T. L., 2011, MALARIA J, V10, P1; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Tusting LS, 2013, MOSQUITO LARVAL SOUR; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; WEATHERSBEE AA, 1991, J AM MOSQUITO CONTR, V7, P238; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Wilson AL, 2014, ARE TOPICAL INSECT R, V13, P1; Yakob L., 2016, Parasite Epidemiology and Control, V1, P2, DOI 10.1016/j.parepi.2015.12.001; Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150	47	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187680	10.1371/journal.pone.0187680	http://dx.doi.org/10.1371/journal.pone.0187680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194440	Green Published, gold, Green Accepted			2022-12-26	WOS:000416867800007
J	Nagata, Y; Kiyono, T; Okamura, K; Goto, Y; Matsuo, M; Ikemoto-Uezumi, M; Hashimoto, N				Nagata, Yuki; Kiyono, Tohru; Okamura, Kikuo; Goto, Yu-ichi; Matsuo, Masafumi; Ikemoto-Uezumi, Madoka; Hashimoto, Naohiro			Interleukin-1beta (IL-1 beta)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1 beta on human dystrophic myogenic cells	PLOS ONE			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; MOLECULAR SIGNATURE; PROGENITOR CELLS; CYCLIN D1; P38 MAPK; DIFFERENTIATION; EXPRESSION; REGENERATION	Duchenne muscular dystrophy (DMD) is a severe X-linked recessive muscle disorder caused by mutations in the dystrophin gene. Nonetheless, secondary processes involving perturbation of muscle regeneration probably exacerbate disease progression, resulting in the fatal loss of muscle in DMD patients. A dysfunction of undifferentiated myogenic cells is the most likely cause for the reduction of regenerative capacity of muscle. To clarify molecular mechanisms in perturbation of the regenerative capacity of DMD muscle, we have established several NCAM (CD56)-positive immortalized human dystrophic and non-dystrophic myogenic cell lines from DMD and healthy muscles. A pro-inflammatory cytokine, IL-1 beta, promoted cell cycle progression of non-dystrophic myogenic cells but not DMD myogenic cells. In contrast, IL-1 beta upregulated the Notch ligand Jagged1 gene in DMD myogenic cells but not in non-dystrophic myogenic cells. Knockdown of Jagged1 in DMD myogenic cells restored the IL-1 beta-promoted cell cycle progression. Conversely, enforced expression of Jagged1-blocked IL-1 beta promoted proliferation of non-dystrophic myogenic cells. In addition, IL-1 beta prevented myogenic differentiation of DMD myogenic cells depending on Jagged1 but not of non-dystrophic myogenic cells. These results demonstrate that Jagged1 induced by IL-1 beta in DMD myogenic cells modified the action of IL-1 beta and reduced the ability to proliferate and differentiate. IL-1 beta induced Jagged1 gene expression may be a feedback response to excess stimulation with this cytokine because high IL-1 beta (200-1000 pg/ml) induced Jagged1 gene expression even in non-dystrophic myogenic cells. DMD myogenic cells are likely to acquire the susceptibility of the Jagged1 gene to IL-1 beta under the microcircumstances in DMD muscles. The present results suggest that Jagged1 induced by IL-1 beta plays a crucial role in the loss of muscle regeneration capacity of DMD muscles. The IL-1 beta/Jagged1 pathway may be a new therapeutic target to ameliorate exacerbation of muscular dystrophy in a dystrophin-independent manner.	[Nagata, Yuki; Ikemoto-Uezumi, Madoka; Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Dept Regenerat Med, Oobu, Aichi, Japan; [Kiyono, Tohru] Natl Canc Ctr Res Inst, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tsukiji, Tokyo, Japan; [Okamura, Kikuo] Natl Ctr Geriatr & Gerontol, Dept Urol, Oobu, Aichi, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci Nervous & Muscular Disorders, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo, Japan; [Matsuo, Masafumi] Kobegakuin Univ, Fac Rehabil, Dept Rehabil Med, Nishi Ku, Ikawadani Cho, Kobe, Hyogo, Japan; [Okamura, Kikuo] Higashinagoya Natl Hosp, Dept Clin Res, Meito Ku, Nagoya, Aichi, Japan; [Ikemoto-Uezumi, Madoka] Tokyo Metropolitan Geriatr Hosp, Gerontol Motor Syst, Res Team Geriatr Med, Itabashi Ku, Tokyo, Japan; [Ikemoto-Uezumi, Madoka] Inst Gerontol, Itabashi Ku, Tokyo, Japan	National Center for Geriatrics & Gerontology; National Cancer Center - Japan; National Center for Geriatrics & Gerontology; National Center for Neurology & Psychiatry - Japan; Kobe Gakuin University	Hashimoto, N (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Regenerat Med, Oobu, Aichi, Japan.	nao@ncgg.go.jp		Ikemoto-Uezumi, Madoka/0000-0003-2771-9851	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan [25-5, 28-6]; National Center for Geriatrics and Gerontology (NCGG), Japan [28-24, 28-39];  [15K10426]	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan; National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology); 	This work was supported by Grants-in Aid for Scientific Research (KAKENHI,15K10426), Japan, Intramural Research Grant (25-5, 28-6) for Neurological and Psychiatric Disorders of NCNP, Japan, and The Research Funding for Longevity Sciences (28-24, 28-39) from National Center for Geriatrics and Gerontology (NCGG), Japan.	Agley CC, 2013, J CELL SCI, V126, P5610, DOI 10.1242/jcs.132563; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; CASHMAN NR, 1987, ANN NEUROL, V21, P481, DOI 10.1002/ana.410210512; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Church JE, 2014, EXP PHYSIOL, V99, P675, DOI 10.1113/expphysiol.2013.077255; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; HASHIMOTO N, 1995, EUR J BIOCHEM, V227, P379, DOI 10.1111/j.1432-1033.1995.tb20400.x; Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395; Hashimoto N., 2008, RECENT ADV SKELETAL, P1; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hashimoto N, 2006, BIOCHEM BIOPH RES CO, V348, P1383, DOI 10.1016/j.bbrc.2006.08.006; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; MILLER SC, 1988, MOL CELL BIOL, V8, P2295, DOI 10.1128/MCB.8.6.2295; Miyoshi Hiroyuki, 2004, Methods Mol Biol, V246, P429; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Oexle K, 2001, NEUROPEDIATRICS, V32, P123, DOI 10.1055/s-2001-16613; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Spencer MJ, 2001, NEUROMUSCULAR DISORD, V11, P556, DOI 10.1016/S0960-8966(01)00198-5; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188821	10.1371/journal.pone.0188821	http://dx.doi.org/10.1371/journal.pone.0188821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194448	Green Published, Green Submitted, gold			2022-12-26	WOS:000416867800015
J	Bernardi, A; Kirschner, KN; Faller, R				Bernardi, Austen; Kirschner, Karl N.; Faller, Roland			Structural analysis of human glycoprotein butyrylcholinesterase using atomistic molecular dynamics: The importance of glycosylation site ASN(241)	PLOS ONE			English	Article							NERVE AGENT TOXICITY; SIDE-CHAIN; ACETYLCHOLINESTERASE; INHIBITION; SIMULATION; PROTECTION; TETRAMER; BINDING; WATER	Human butyrylcholinesterase (BChE) is a glycoprotein capable of bioscavenging toxic compounds such as organophosphorus (OP) nerve agents. For commercial production of BChE, it is practical to synthesize BChE in non-human expression systems, such as plants or animals. However, the glycosylation profile in these systems is significantly different from the human glycosylation profile, which could result in changes in BChE's structure and function. From our investigation, we found that the glycan attached to ASN(241) is both structurally and functionally important due to its close proximity to the BChE tetramerization domain and the active site gorge. To investigate the effects of populating glycosylation site ASN(24)1, monomeric human BChE glycoforms were simulated with and without site ASN(241) glycosylated. Our simulations indicate that the structure and function of human BChE are significantly affected by the absence of glycan 241.	[Bernardi, Austen; Faller, Roland] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; [Kirschner, Karl N.] Bonn Rhein Sieg Univ Appl Sci, St Augustin, Germany	University of California System; University of California Davis; Hochschule Bonn Rhein Sieg	Faller, R (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.	rfaller@ucdavis.edu		Faller, Roland/0000-0001-9946-3846; Bernardi, Austen/0000-0001-6217-7037; Kirschner, Karl/0000-0002-4581-920X	US Defense Threat Reduction Agency [HDTRA1-15-0054]; Defense Threat Reduction Agency (DTRA) [HDTRA1-15-0054]	US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the US Defense Threat Reduction Agency (www.dtra.mil) under grant #HDTRA1-15-0054.; We thank Somen Nandi, Vincent Ustach, Karen McDonald, Carlito Lebrilla, and Xi Chen for many fruitful discussions. AB also thanks Martin Schenk and Dirk Reith at Hochschule Bonn-Rhein-Sieg, Germany for their hospitality during his visit. Funding for this project was provided by the Defense Threat Reduction Agency (DTRA, #HDTRA1-15-0054). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of DTRA.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Cheatham TE III, 2017, AMBER 2017; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Hamza A, 2005, J PHYS CHEM B, V109, P4776, DOI 10.1021/jp0447136; Hanson J, 2017, BIOINFORMATICS, V33, P685, DOI 10.1093/bioinformatics/btw678; HEFFRON PF, 1979, BRIT J PHARMACOL, V66, P323, DOI 10.1111/j.1476-5381.1979.tb13683.x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kolarich D, 2008, PROTEOMICS, V8, P254, DOI 10.1002/pmic.200700720; Lenz DE, 2007, TOXICOLOGY, V233, P31, DOI 10.1016/j.tox.2006.11.066; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; Lockridge O, 2015, PHARMACOL THERAPEUT, V148, P34, DOI 10.1016/j.pharmthera.2014.11.011; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Maxwell DM, 2006, ARCH TOXICOL, V80, P756, DOI 10.1007/s00204-006-0120-2; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03; Pan YM, 2009, J PHYS CHEM B, V113, P6543, DOI 10.1021/jp8114995; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P2465, DOI 10.1016/0006-2952(93)90228-O; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; vanderSpoel D, 1997, BIOPHYS J, V72, P2032, DOI 10.1016/S0006-3495(97)78847-7; Vyas S, 2010, CHEM-BIOL INTERACT, V187, P241, DOI 10.1016/j.cbi.2010.04.004; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Woods R., 2005, GLYCOPROTEIN BUILDER; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187994	10.1371/journal.pone.0187994	http://dx.doi.org/10.1371/journal.pone.0187994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190644	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900027
J	Meyer, SL; Jongbloed, MR; Ho, SY; Bartelings, MM; McCarthy, KP; Uemura, H; Ebels, T				Meyer, Sophie L.; Jongbloed, Monique R.; Ho, Siew Y.; Bartelings, Margot M.; McCarthy, Karen P.; Uemura, Hideki; Ebels, Tjark			Intracardiac anatomical relationships and potential for streaming in double inlet left ventricles	PLOS ONE			English	Article							LONG-TERM SURVIVAL; UNOPERATED SINGLE VENTRICLE; CONGENITAL HEART-DISEASE; VENTRICULOARTERIAL CONNECTION; UNIVENTRICULAR HEART; SUBAORTIC STENOSIS; TRICUSPID-ATRESIA; FONTAN SURGERY; FOLLOW-UP; OPERATION	The aim of this study was to gain better understanding of the variable anatomical features of double inlet left ventricle hearts without cavopulmonary connection that would potentially facilitate favorable streaming. Thirty-nine post-mortem specimens of double inlet left ventricle without cavopulmonary connection were investigated. The focus was on anatomical characteristics that could influence the flow and separation of deoxygenated and oxygenated blood in the ventricles. Elements of interest were the ventriculoarterial connection, the spatial relationship of the ventricles, the position and size of the great arteries, the ventricular septal defect, the presence of relative outflow tract stenosis and the relationship of the inflow and outflow tracts. The most common anatomy was a discordant ventriculoarterial connection with an anatomically left-sided morphologically right ventricle (n = 12, 31%). When looking at the pulmonary trunk/aorta ratio, 21 (72%) hearts showed no pulmonary stenosis relative to the aorta. The ventricular septal defect created a relative subpulmonary or subaortic stenosis in 13 (41%) cases. Sixteen (41%) hearts had a parallel relationship of the inflow and outflow tracts, facilitating separation of deoxygenated and oxygenated blood streams. On the other end of the spectrum were 10 (25%) hearts with a perpendicular relationship, which might lead to maximum mixing of the blood streams. The relationship of the inflow and outflow tracts as well as the presence of (sub-) pulmonary stenosis might play a crucial role in the distribution of blood in double inlet left ventricle hearts. Additional in vivo studies will be necessary to confirm this postulation.	[Meyer, Sophie L.; Ebels, Tjark] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiothorac Surg, Groningen, Netherlands; [Jongbloed, Monique R.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jongbloed, Monique R.; Bartelings, Margot M.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Ho, Siew Y.; McCarthy, Karen P.; Uemura, Hideki] Imperial Coll London, Royal Brompton Hosp, Cardiac Morphol Unit, Natl Heart & Lung Inst, London, England	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; Royal Brompton Hospital	Meyer, SL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiothorac Surg, Groningen, Netherlands.	s.l.meyer@umcg.nl	Jongbloed, Monique/AAA-4239-2022	Jongbloed, Monique/0000-0002-9132-0418; Ebels, Tjark/0000-0002-7124-0058; Meyer, Sophie/0000-0002-5459-4305				Ammash NM, 1996, AM J CARDIOL, V77, P542, DOI 10.1016/S0002-9149(97)89356-3; ANDERSON RH, 1984, PEDIATR CARDIOL, V5, P281, DOI 10.1007/BF02424973; CHAMBERS WN, 1961, CIRCULATION, V23, P91, DOI 10.1161/01.CIR.23.1.91; d'Udekem Y, 2014, CIRCULATION, V130, pS32, DOI 10.1161/CIRCULATIONAHA.113.007764; Downing TE, 2017, J THORAC CARDIOV SUR, V154, P243, DOI 10.1016/j.jtcvs.2017.01.056; FRANKLIN RCG, 1990, J AM COLL CARDIOL, V16, P1455, DOI 10.1016/0735-1097(90)90392-3; FREEDOM RM, 1986, CIRCULATION, V73, P758, DOI 10.1161/01.CIR.73.4.758; Frescura C, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00062; HABERICH F. J., 1965, ANN N Y ACAD SCI, V127, P459, DOI 10.1111/j.1749-6632.1965.tb49419.x; Hillman SS, 2014, J EXP BIOL, V217, P2844, DOI 10.1242/jeb.105536; Kathiria NN, 2015, MAGN RESON IMAGING C, V23, P35, DOI 10.1016/j.mric.2014.09.005; Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559; MACARTNEY FJ, 1976, CIRCULATION, V53, P543, DOI 10.1161/01.CIR.53.3.543; MATITIAU A, 1992, J AM COLL CARDIOL, V19, P142, DOI 10.1016/0735-1097(92)90065-U; MOCELLIN R, 1979, HERZ, V4, P242; Munson B. R., 2002, FUNDAMENTALS FLUID M; Ohuchi H, 2016, J CARDIOL, V68, P181, DOI 10.1016/j.jjcc.2016.04.001; Poterucha JT, 2016, HEART, V102, P216, DOI 10.1136/heartjnl-2015-308440; Potter M., 2015, MECH FLUIDS; Pundi KN, 2015, J AM COLL CARDIOL, V66, P1700, DOI 10.1016/j.jacc.2015.07.065; RAHIMTOOLA SH, 1966, CIRCULATION, V34, P14, DOI 10.1161/01.CIR.34.1.14; Restaino G, 2004, INT J CARDIOVAS IMAG, V20, P221, DOI 10.1023/B:CAIM.0000021881.57609.b4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHARMA HL, 1961, J MORPHOL, V109, P323, DOI 10.1002/jmor.1051090307; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Uemura H, 2008, ANN THORAC SURG, V86, P1321, DOI 10.1016/j.athoracsur.2008.06.050; Vyas Himeshkumar, 2007, Curr Treat Options Cardiovasc Med, V9, P391, DOI 10.1007/s11936-007-0059-5; WILKINSON JL, 1979, HERZ, V4, P107; Wolff D, 2014, EUR J CARDIO-THORAC, V45, P602, DOI 10.1093/ejcts/ezt461	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188048	10.1371/journal.pone.0188048	http://dx.doi.org/10.1371/journal.pone.0188048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190641	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900031
J	Promis, A; Allen, RB				Promis, Alvaro; Allen, Robert B.			Tree seedlings respond to both light and soil nutrients in a Patagonian evergreen-deciduous forest	PLOS ONE			English	Article							BELOW-GROUND COMPETITION; TIERRA-DEL-FUEGO; GROWTH NOTHOFAGUS-BETULOIDES; ROOT COMPETITION; SHADE TOLERANCE; WOODY-PLANTS; TEMPERATE; SURVIVAL; ALLOCATION; GAPS	Seedlings of co-occurring species vary in their response to resource availability and this has implications for the conservation and management of forests. Differential shade-tolerance is thought to influence seedling performance in mixed Nothofagus betuloides-Nothofagus pumilio forests of Patagonia. However, these species also vary in their soil nutrient requirements. To determine the effects of light and soil nutrient resources on small seedlings we examined responses to an experimental reduction in canopy tree root competition through root trenching and restricting soil nutrient depletion through the addition of fertilizer. To understand the effect of light these treatments were undertaken in small canopy gaps and nearby beneath undisturbed canopy with lower light levels. Seedling diameter growth was greater for N. pumilio and height growth was greater for N. betuloides. Overall, diameter and height growth were greater in canopy gaps than beneath undisturbed canopy. Such growths were also greater with fertilizer and root trenching treatments, even beneath undisturbed canopy. Seedling survival was lower under such treatments, potentially reflecting thinning facilitated by resource induced growth. Finally, above-ground biomass did not vary among species although the less shade tolerant N. pumilio had higher below-ground biomass and root to shoot biomass ratio than the more shade tolerant N. betuloides. Above-and below-ground biomass were higher in canopy gaps so that the root to shoot biomass ratio was similar to that beneath undisturbed canopy. Above-ground biomass was also higher with fertilizer and root trenching treatments and that lowered the root to shoot biomass ratio. Restricting soil nutrient depletion allowed seedlings of both species to focus their responses above-ground. Our results support a view that soil nutrient resources, as well as the more commonly studied light resources, are important to seedlings of Nothofagus species occurring on infertile soils.	[Promis, Alvaro] Univ Chile, Dept Silviculture & Nat Conservancy, Santiago, Chile	Universidad de Chile	Promis, A (corresponding author), Univ Chile, Dept Silviculture & Nat Conservancy, Santiago, Chile.	alvaro.promis@gmail.com	Promis, Alvaro/B-3016-2010	Promis, Alvaro/0000-0002-1596-4940	Chilean Commission for Scientific and Technological Research [11100093]; Landcare Research, New Zealand; German Academic Exchange Service through the Re-invitation Programme for Former Scholarships Holders	Chilean Commission for Scientific and Technological Research; Landcare Research, New Zealand; German Academic Exchange Service through the Re-invitation Programme for Former Scholarships Holders	This study was supported by funds from the Chilean Commission for Scientific and Technological Research (Project Fondecyt No. 11100093) and Landcare Research, New Zealand. Also, the first author gratefully acknowledges a grant by the German Academic Exchange Service through the Re-invitation Programme for Former Scholarships Holders to support a stay at the University of Freiburg in Germany which allowed completion of the statistical analyses for this paper.	Allen RB, 1997, CAN J FOREST RES, V27, P323, DOI 10.1139/x96-183; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BERENDSE F, 1983, J ECOL, V71, P379, DOI 10.2307/2259721; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Canham CD, 1999, OECOLOGIA, V121, P1, DOI 10.1007/s004420050900; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Carswell FE, 2012, FOREST ECOL MANAG, V269, P188, DOI 10.1016/j.foreco.2011.12.027; Cavieres LA, 2005, FOREST ECOL MANAG, V204, P237, DOI 10.1016/j.foreco.2004.09.004; Clinton PW, 2002, CAN J FOREST RES, V32, P344, DOI 10.1139/X01-188; Coomes DA, 1998, ECOLOGY, V79, P768, DOI 10.1890/0012-9658(1998)079[0768:ROJTTA]2.0.CO;2; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Cruz G, 2007, CARACTERIZACION SILV, P25; Davis MR, 2004, CAN J FOREST RES, V34, P2037, DOI [10.1139/x04-067, 10.1139/X04-067]; Frangi JL, 1997, CAN J FOREST RES, V27, P1095, DOI 10.1139/cjfr-27-7-1095; Frederiksen P., 1988, FOLIA GEOGRAPHICA DA, VXVIII, P159; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Grime J. P., 1979, Plant strategies and vegetation processes.; Grubb PJ, 1994, PHYTOCOENOLOGIA, V24, P495, DOI 10.1127/phyto/24/1994/495; Gutiurrez E., 1991, OECOLOGIA AQUATICA, V10, P351; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; INGESTAD T, 1979, PHYSIOL PLANTARUM, V45, P373, DOI 10.1111/j.1399-3054.1979.tb02599.x; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lewis SL, 2000, ECOLOGY, V81, P2525, DOI 10.1890/0012-9658(2000)081[2525:EOAABC]2.0.CO;2; Pastur GJM, 2011, ANN FOREST SCI, V68, P587, DOI 10.1007/s13595-011-0059-1; Nouhra E, 2013, MYCORRHIZA, V23, P487, DOI 10.1007/s00572-013-0490-2; Park A, 2014, CRIT REV PLANT SCI, V33, P251, DOI 10.1080/07352689.2014.858956; Peltzer DA, 2001, J ECOL, V89, P519, DOI 10.1046/j.1365-2745.2001.00570.x; Pisano E, 1977, ANALES I PATAGONIA, V8, P121; Platt KH, 2004, NEW ZEAL J ECOL, V28, P289; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; POPMA J, 1988, OECOLOGIA, V75, P625, DOI 10.1007/BF00776429; Promis A, 2010, ALLG FORST JAGDZTG, V181, P53; Promis A, 2009, INT J BIOMETEOROL, V53, P355, DOI 10.1007/s00484-009-0222-7; REBERTUS AJ, 1993, J VEG SCI, V4, P641, DOI 10.2307/3236129; Romanya J, 2005, GEODERMA, V124, P169, DOI 10.1016/j.geoderma.2004.04.011; RUNKLE JR, 1995, ECOLOGY, V76, P2107, DOI 10.2307/1941685; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Seiwa K, 2007, ANN BOT-LONDON, V99, P537, DOI 10.1093/aob/mcl283; Sokal, 2000, BIOMETRY PRINCIPLES; Tomlinson KW, 2013, ANN BOT-LONDON, V112, P575, DOI 10.1093/aob/mct132; Tuhkanen Sakari, 1992, Acta Botanica Fennica, V145, P1; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2016, PLANT ECOL DIVERS, V9, P237, DOI 10.1080/17550874.2016.1210262; Veblen Thomas T., 1996, P293; Walters MB, 2000, ECOLOGY, V81, P1887, DOI 10.1890/0012-9658(2000)081[1887:SSNSAG]2.0.CO;2; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Waring RH, 1995, FOREST ECOSYSTEMS CO; Wilson BC, 2006, NEW FOREST, V31, P417, DOI 10.1007/s11056-005-0878-8	49	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188686	10.1371/journal.pone.0188686	http://dx.doi.org/10.1371/journal.pone.0188686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190657	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900100
J	Oh, SH; Kim, JW; Kim, Y; Lee, MN; Kook, MS; Choi, EY; Im, SY; Koh, JT				Oh, Sin-Hye; Kim, Jung-Woo; Kim, Yuri; Lee, Mi Nam; Kook, Min-Suk; Choi, Eun Young; Im, Suhn-Young; Koh, Jeong-Tae			The extracellular matrix protein Edil3 stimulates osteoblast differentiation through the integrin alpha 5 beta 1/ERK/Runx2 pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTOR; BONE-FORMATION; IN-VITRO; FIBRONECTIN; OSTEOGENESIS; EXPRESSION; DOMAIN; ALPHA-V-BETA-3; PROLIFERATION	Epidermal growth factor-like repeats and discoidin I-like domain 3 (Edil3) is an extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif that binds integrin. Recently, Edil3 has been implicated in various biological processes, including angiogenesis and cellular differentiation. It can inhibit inflammatory bone destruction. The objective of this study was to explore the role of Edil3 in osteoblast differentiation and its underlying molecular mechanisms. In wild-type mice, high expression levels of Edil3 mRNA were observed in isolated calvaria and tibia/femur bones. Immunohistochemical analysis showed that Edil3 protein was localized along periosteum and calcified regions surrounding bone tissues. When murine calvaria-derived MC3T3-E1 cells were cultured in osteogenic medium containing 50 mu g/ml ascorbic acid and 5 mM beta-glycerophosphate, Edil3 mRNA and protein expression levels were increased. Treatment with Edil3 protein in growth media increased expression levels of alkaline phosphatase and osteocalcin gene and phosphorylation level of extracellular signal-regulated kinase (ERK). Edil3 treatment with osteogenic medium induced mineralization. Treatment with a neutralizing antibody against alpha 5 beta 1 and MEK inhibitor U0126 inhibited Edil3-enhanced osteogenic marker gene expression and mineral deposition. Edil3 increased protein expression levels of transcription factor runt-related transcription factor2 (Runx2). Edil3-induced Runx2 protein expression was suppressed by pretreatment with U0126. Taken together, these results suggest that Edil3 may stimulate osteoblast differentiation and matrix mineralization by increasing expression of Runx2 through alpha 5 beta 1 integrin /ERK pathway.	[Oh, Sin-Hye; Kim, Jung-Woo; Kim, Yuri; Lee, Mi Nam; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea; [Oh, Sin-Hye; Im, Suhn-Young] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Gwangju, South Korea; [Kook, Min-Suk] Chonnam Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Gwangju, South Korea; [Choi, Eun Young] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; University of Ulsan	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2011-0030121]; Chonnam National University Hospital Biomedical Research Institute [CRI 13905-24]	National Research Foundation of Korea (NRF) - Korea Government (MSIP); Chonnam National University Hospital Biomedical Research Institute	This study was supported by the National Research Foundation of Korea (NRF) Grants funded by the Korea Government (MSIP) (No. 2011-0030121) and Chonnam National University Hospital Biomedical Research Institute (CRI 13905-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoka Y, 2002, MICROVASC RES, V64, P148, DOI 10.1006/mvre.2002.2414; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; CLOVER J, 1992, J CELL SCI, V103, P267; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Garcia JR, 2016, J BIOMED MATER RES A, V104, P889, DOI 10.1002/jbm.a.35626; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Globus RK, 1998, J CELL SCI, V111, P1385; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hidai C, 2007, CELL TISSUE RES, V330, P83, DOI 10.1007/s00441-007-0456-9; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Khader SA, 2012, NAT IMMUNOL, V13, P433, DOI 10.1038/ni.2290; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Lee M, 2016, P IEEE VIRT REAL ANN, P11, DOI 10.1109/VR.2016.7504683; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rezaee M, 2002, AM J PHYSIOL-HEART C, V282, pH1924, DOI 10.1152/ajpheart.00921.2001; Savontaus M, 2004, Orthod Craniofac Res, V7, P216, DOI 10.1111/j.1601-6343.2004.00304.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0; Tomlinson RE, 2014, J BONE MINER RES, V29, P1970, DOI 10.1002/jbmr.2223; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Zhang P, 2012, INT J MOL MED, V29, P1083, DOI 10.3892/ijmm.2012.934; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	43	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188749	10.1371/journal.pone.0188749	http://dx.doi.org/10.1371/journal.pone.0188749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182679	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000055
J	Li, HH; Yang, K; Wang, WJ; Niu, YB; Li, J; Dong, YH; Liu, YF; Wang, CC; Wang, L; Liang, HH				Li, Huanhuan; Yang, Kai; Wang, Wenjia; Niu, Yingbo; Li, Jun; Dong, Yuhui; Liu, Yingfang; Wang, Chih-chen; Wang, Lei; Liang, Huanhuan			Crystal and solution structures of human protein-disulfide isomerase-like protein of the testis (PDILT) provide insight into its chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; molecular chaperone; protein structure; small-angle X-ray scattering (SAXS); X-ray crystallography	X-RAY-SCATTERING; MHC CLASS-I; BIOLOGICAL MACROMOLECULES; ENDOPLASMIC-RETICULUM; FOLDING CATALYST; QUALITY-CONTROL; BINDING SITE; B' DOMAIN; RESOLUTION; SYSTEM	Protein-disulfide isomerase-like protein of the testis (PDILT), a member of the protein-disulfide isomerase family, is a chaperone essential for the folding of spermatogenesis-specific proteins in male postmeiotic germ cells. However, the structural mechanisms that regulate the chaperone function of PDILTs are unknown. Here, we report the structures of human PDILT (hPDILT) determined by X-ray crystallography to 2.4 resolution and small-angle X-ray scattering (SAXS). Distinct from previously reported U-like structures of related PDI family proteins, our structures revealed that hPDILT folds into a compact L-like structure in crystals and into an extended chain-like structure in solution. The hydrophobic regions and the hydrophobic pockets in hPDILT, which are important for substrate recognition, were clearly delineated in the crystal structure. Moreover, our results of the SAXS analysis and of structure-based substitutions and truncations indicated that the C-terminal tail in hPDILT is required for suppression of aggregation of denatured proteins, suggesting that the tail is crucial for the chaperone activity of PDILT. Taken together, our findings have identified the critical regions and conformational changes of PDILT that enable and control its activity. These results advance our understanding of the structural mechanisms involved in the chaperone activity of PDILT.	[Li, Huanhuan; Li, Jun; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yang, Kai; Niu, Yingbo; Wang, Chih-chen; Wang, Lei] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Wenjia; Dong, Yuhui] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Li, Huanhuan; Yang, Kai; Niu, Yingbo; Li, Jun; Wang, Chih-chen; Wang, Lei] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Yingfang] Sun Yat Sen Univ, Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Huanhuan] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; Sun Yat Sen University	Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Wang, L (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Wang, L (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.; Liang, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China.	wanglei@moon.ibp.ac.cn; hhliang@moon.ibp.ac.cn	Yang, Kai S./AAC-9906-2021	Yang, Kai S./0000-0002-1890-4169; Wang, Lei/0000-0002-5071-5800; Dong, Yuhui/0000-0002-4422-4685	National Natural Science Foundation of China [31530015, 31571163, 31370775]; National Key R&D Program of China [2016YFA0500200, 2017YFA0504000]; Strategic Priority Research Program, CAS Grant [XDB08000000]; Frontier Sciences Project, CAS Grant [QYZDYSSW-SMC018]; Youth Innovation Promotion Association CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program, CAS Grant; Frontier Sciences Project, CAS Grant; Youth Innovation Promotion Association CAS	This work was supported by National Natural Science Foundation of China Grants 31530015, 31571163, and 31370775, National Key R&D Program of China Grants 2016YFA0500200 and 2017YFA0504000, the Strategic Priority Research Program, CAS Grant XDB08000000, Frontier Sciences Project, CAS Grant QYZDYSSW-SMC018, and Youth Innovation Promotion Association CAS (to L. W). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bastos-Aristizabal S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04464; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Diwaker D, 2015, VIRAL IMMUNOL, V28, P153, DOI 10.1089/vim.2014.0095; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Lipton SA, 2007, INT REV NEUROBIOL, V82, P1, DOI 10.1016/S0074-7742(07)82001-0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smulders RHPH, 1996, J BIOL CHEM, V271, P29060, DOI 10.1074/jbc.271.46.29060; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; van Lith M, 2007, MOL BIOL CELL, V18, P2795, DOI 10.1091/mbc.E07-02-0147; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Watanabe S, 2017, P NATL ACAD SCI USA, V114, pE3224, DOI 10.1073/pnas.1621426114	52	6	7	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1192	1202		10.1074/jbc.M117.797290	http://dx.doi.org/10.1074/jbc.M117.797290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29203529	Green Published, hybrid			2022-12-26	WOS:000423515000008
J	Morgan, GJ; Burkhardt, DH; Kelly, JW; Powers, ET				Morgan, Gareth J.; Burkhardt, David H.; Kelly, Jeffery W.; Powers, Evan T.			Translation efficiency is maintained at elevated temperature in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK RESPONSE; TRANSCRIPTION FACTOR SIGMA(32); SIGNAL RECOGNITION PARTICLE; RIBOSOME PROFILING REVEALS; CODON USAGE BIAS; GENE-EXPRESSION; MESSENGER-RNA; GENOME-WIDE; TRIGGER FACTOR; IN-VIVO	Cellular protein levels are dictated by the balance between gene transcription, mRNA translation, and protein degradation, among other factors. Translation requires the interplay of several RNA hybridization processes, which are expected to be temperature-sensitive. We used ribosome profiling to monitor translation in Escherichia coli at 30 degrees C and to investigate how this changes after 10-20 min of heat shock at 42 degrees C. Translation efficiencies are robustly maintained after thermal heat shock and after mimicking the heat-shock response transcriptional program at 30 degrees C by overexpressing the heat shock sigma factor encoded by the rpoH gene. We compared translation efficiency, the ratio of ribosome footprint reads to mRNA reads for each gene, to parameters derived from gene sequences. Genes with stable mRNA structures, non-optimal codon use, and those whose gene product is cotranslationally translocated into the inner membrane are generally less highly translated than other genes. Comparison with other published datasets suggests a role for translational elongation in coupling mRNA structures to translation initiation. Genome-wide calculations of the temperature dependence of mRNA structure predict that relatively few mRNAs show a melting transition between 30 and 42 degrees C, consistent with the observed lack of changes in translation efficiency. We developed a linear model with six parameters that can predict 38% of the variation in translation efficiency between genes, which may be useful in interpreting transcriptome data.	[Morgan, Gareth J.; Kelly, Jeffery W.; Powers, Evan T.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Morgan, Gareth J.; Kelly, Jeffery W.; Powers, Evan T.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Burkhardt, David H.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Burkhardt, David H.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Powers, ET (corresponding author), 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	epowers@scripps.edu			National Institutes of Health from NIGMS [GM101644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, R01GM101644] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM101644 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Avcilar-Kucukgoze I, 2016, NUCLEIC ACIDS RES, V44, P8324, DOI 10.1093/nar/gkw697; Bartholomaus A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0069; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Borujeni AE, 2017, NUCLEIC ACIDS RES, V45, P5437, DOI 10.1093/nar/gkx061; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diaz-Mejia JJ, 2009, FEMS MICROBIOL REV, V33, P66, DOI 10.1111/j.1574-6976.2008.00141.x; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gorochowski TE, 2015, NUCLEIC ACIDS RES, V43, P3022, DOI 10.1093/nar/gkv199; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Guimaraes JC, 2014, NUCLEIC ACIDS RES, V42, P4791, DOI 10.1093/nar/gku126; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Li GW, 2015, CURR OPIN MICROBIOL, V24, P66, DOI 10.1016/j.mib.2015.01.001; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lim B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001735; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NATH K, 1970, J BIOL CHEM, V245, P2889; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; OHTAKA Y, 1963, SCIENCE, V142, P493, DOI 10.1126/science.142.3591.493; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Schrader JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004463; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMAS MS, 1987, J MOL BIOL, V196, P333, DOI 10.1016/0022-2836(87)90694-2; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WIKSTROM PM, 1992, J MOL BIOL, V224, P949, DOI 10.1016/0022-2836(92)90462-S; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Yura T, 2007, P NATL ACAD SCI USA, V104, P17638, DOI 10.1073/pnas.0708819104; Zhang X, 2014, ACS CHEM BIOL, V9, P1945, DOI 10.1021/cb5004477; Zhang YQ, 2017, GENOM PROTEOM BIOINF, V15, P324, DOI 10.1016/j.gpb.2017.04.005	77	20	20	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					777	793		10.1074/jbc.RA117.000284	http://dx.doi.org/10.1074/jbc.RA117.000284			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29183994	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000422864500003
J	Robertson, BA; Rathbone, L; Cirillo, G; D'Eath, RB; Bateson, M; Boswell, T; Wilson, PW; Dunn, IC; Smulders, TV				Robertson, Barbara-Anne; Rathbone, Lucy; Cirillo, Giselda; D'Eath, Richard B.; Bateson, Melissa; Boswell, Timothy; Wilson, Peter W.; Dunn, Ian C.; Smulders, Tom V.			Food restriction reduces neurogenesis in the avian hippocampal formation	PLOS ONE			English	Article							CHICKADEES POECILE-GAMBELI; MESSENGER-RNA EXPRESSION; CELL-PROLIFERATION RATES; ADULT NEUROGENESIS; DENTATE GYRUS; DIETARY RESTRICTION; BROILER BREEDERS; SPATIAL MEMORY; MOUNTAIN CHICKADEES; GLUCOCORTICOID-RECEPTOR	The mammalian hippocampus is particularly vulnerable to chronic stress. Adult neurogenesis in the dentate gyrus is suppressed by chronic stress and by administration of glucocorticoid hormones. Post-natal and adult neurogenesis are present in the avian hippocampal formation as well, but much less is known about its sensitivity to chronic stressors. In this study, we investigate this question in a commercial bird model: the broiler breeder chicken. Commercial broiler breeders are food restricted during development to manipulate their growth curve and to avoid negative health outcomes, including obesity and poor reproductive performance. Beyond knowing that these chickens are healthier than fully-fed birds and that they have a high motivation to eat, little is known about how food restriction impacts the animals' physiology. Chickens were kept on a commercial food-restricted diet during the first 12 weeks of life, or released from this restriction by feeding them ad libitum from weeks 7-12 of life. To test the hypothesis that chronic food restriction decreases the production of new neurons (neurogenesis) in the hippocampal formation, the cell proliferation marker bromodeoxyuridine was injected one week prior to tissue collection. Corticosterone levels in blood plasma were elevated during food restriction, even though molecular markers of hypothalamic- pituitary-adrenal axis activation did not differ between the treatments. The density of new hippocampal neurons was significantly reduced in the food-restricted condition, as compared to chickens fed ad libitum, similar to findings in rats at a similar developmental stage. Food restriction did not affect hippocampal volume or the total number of neurons. These findings indicate that in birds, like in mammals, reduction in hippocampal neurogenesis is associated with chronically elevated corticosterone levels, and therefore potentially with chronic stress in general. This finding is consistent with the hypothesis that the response to stressors in the avian hippocampal formation is homologous to that of the mammalian hippocampus.	[Robertson, Barbara-Anne; Cirillo, Giselda; Bateson, Melissa; Boswell, Timothy; Smulders, Tom V.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Robertson, Barbara-Anne; Cirillo, Giselda; Bateson, Melissa; Boswell, Timothy; Smulders, Tom V.] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Robertson, Barbara-Anne; Rathbone, Lucy; Smulders, Tom V.] Newcastle Univ, Sch Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [D'Eath, Richard B.] Scotlands Rural Coll, Anim Behav & Welf Grp, Easter Bush, Scotland; [Boswell, Timothy] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Wilson, Peter W.; Dunn, Ian C.] Univ Edinburgh, Roslin Inst, Edinburgh, Easter Bush, Scotland	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Scotland's Rural College; Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Smulders, TV (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.; Smulders, TV (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.; Smulders, TV (corresponding author), Newcastle Univ, Sch Psychol, Newcastle Upon Tyne, Tyne & Wear, England.	Tom.smulders@ncl.ac.uk	Smulders, Tom/G-3955-2011; Bateson, Melissa/AAE-7075-2022; Dunn, Ian/C-7689-2013	Smulders, Tom/0000-0002-6673-7596; Bateson, Melissa/0000-0002-0861-0191; D'Eath, Rick/0000-0002-1801-254X; Dunn, Ian/0000-0003-3630-0120	Department for the Environment, Food and Rural Affairs (Defra) [AW1141]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K003534/1]; BBSRC [BB/L000288/1, BBS/E/D/30002276, BB/K003534/1, BBS/E/D/20320000, BB/L000199/1, BBS/E/D/20221655, BBS/E/D/05191132] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K003534/1, BBS/E/D/20320000, BBS/E/D/20221655, BBS/E/D/05191132, BB/L000199/1, BB/L000288/1, BBS/E/D/30002276] Funding Source: researchfish	Department for the Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the following funders: Department for the Environment, Food and Rural Affairs (Defra), Grant number: AW1141 to RBD, MB, TB, ICD and TVS; The Biotechnology and Biological Sciences Research Council (BBSRC), Grant number: BB/K003534/1 to TVS, RBD and TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that Defra requires to see the manuscript before submission.	Abellan A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00059; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Allen TA, 2013, P NATL ACAD SCI USA, V110, P10379, DOI 10.1073/pnas.1301199110; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Atoji Y, 2004, J COMP NEUROL, V475, P426, DOI 10.1002/cne.20186; Atoji Y, 2006, REV NEUROSCIENCE, V17, P3; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; Barnea A, 2011, EUR J NEUROSCI, V34, P884, DOI 10.1111/j.1460-9568.2011.07851.x; Biegler R, 2001, P NATL ACAD SCI USA, V98, P6941, DOI 10.1073/pnas.121034798; BOUILLE C, 1973, NEUROENDOCRINOLOGY, V13, P264, DOI 10.1159/000122211; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Bureau C, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-430, 10.3201/eid1508.080772]; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cardoso A, 2016, NEUROBIOL LEARN MEM, V133, P214, DOI 10.1016/j.nlm.2016.07.013; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; D'Eath RB, 2009, ANIM BEHAV, V77, P275, DOI 10.1016/j.anbehav.2008.10.028; de Andrade JS, 2013, BEHAV BRAIN RES, V250, P81, DOI 10.1016/j.bbr.2013.04.031; De Jong IC, 2011, WORLD POULTRY SCI J, V67, P73, DOI 10.1017/S0043933911000067; Decuypere E, 2006, WORLD POULTRY SCI J, V62, P443, DOI [10.1017/S0043933906001073, 10.1079/WPS2005107]; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Dickens MJ, 2011, GEN COMP ENDOCR, V170, P569, DOI 10.1016/j.ygcen.2010.11.018; Dixon LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102322; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Dunn IC, 2015, J NEUROENDOCRINOL, V27, P681, DOI 10.1111/jne.12295; Dunn IC, 2013, J NEUROENDOCRINOL, V25, P920, DOI 10.1111/jne.12088; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Giachetto PF, 2003, PESQUI AGROPECU BRAS, V38, P697, DOI 10.1590/S0100-204X2003000600005; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gould E, 1997, DEV BRAIN RES, V103, P91, DOI 10.1016/S0165-3806(97)00079-5; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 1997, J NEUROSCI, V17, P2492; HARVEY S, 1984, J EXP ZOOL, V232, P633, DOI 10.1002/jez.1402320332; Herold C, 2015, HIPPOCAMPUS, V25, P1193, DOI 10.1002/hipo.22463; Ho YC, 2010, NEUROSCIENCE, V171, P153, DOI 10.1016/j.neuroscience.2010.08.062; HOCKING PM, 1993, BRIT POULTRY SCI, V34, P793, DOI 10.1080/00071669308417638; Hocking PM, 2004, POULTRY SCI, V83, P2044, DOI 10.1093/ps/83.12.2044; HOCKING PM, 1993, BRIT POULTRY SCI, V34, P443, DOI 10.1080/00071669308417600; Hodgson ZG, 2007, P ROY SOC B-BIOL SCI, V274, P239, DOI 10.1098/rspb.2006.3704; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Krause JS, 2015, J NEUROENDOCRINOL, V27, P66, DOI 10.1111/jne.12237; LaDage LD, 2010, P ROY SOC B-BIOL SCI, V277, P1071, DOI 10.1098/rspb.2009.1769; Lattin CR, 2013, AUK, V130, P591, DOI 10.1525/auk.2013.13043; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee J, 2002, J NEUROCHEM, V81, P57; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Lukoyanov NV, 2002, BEHAV BRAIN RES, V134, P283, DOI 10.1016/S0166-4328(02)00036-0; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; Mench JA, 2002, WORLD POULTRY SCI J, V58, P23, DOI 10.1079/WPS20020004; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nikolakopoulou AM, 2006, EUR J NEUROSCI, V24, P2631, DOI 10.1111/j.1460-9568.2006.05133.x; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Pravosudov VV, 2001, P ROY SOC B-BIOL SCI, V268, P363, DOI 10.1098/rspb.2000.1401; Pravosudov VV, 2005, J NEUROBIOL, V62, P31, DOI 10.1002/neu.20065; Pravosudov VV, 2005, J NEUROBIOL, V62, P82, DOI 10.1002/neu.20069; Puelles L., 2009, CHICK BRAIN STEREOTA; Rattenborg NC, 2011, BEHAV BRAIN RES, V222, P236, DOI 10.1016/j.bbr.2011.03.030; Saaltink DJ, 2014, CELL MOL LIFE SCI, V71, P2499, DOI 10.1007/s00018-014-1568-5; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sapolsky RM, 2015, NAT NEUROSCI, V18, P1344, DOI 10.1038/nn.4109; Saraulli D, 2017, CURR NEUROPHARMACOL, V15, P519, DOI 10.2174/1570159X14666160412150223; SAVORY CJ, 1993, ANIM WELFARE, V2, P131; Shahbazi M, 2011, GEN COMP ENDOCR, V174, P354, DOI 10.1016/j.ygcen.2011.09.017; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Smulders TV, 2017, BRAIN BEHAV EVOLUT, V90, P81, DOI 10.1159/000477654; Smulders TV, 2000, J NEUROBIOL, V43, P244, DOI 10.1002/(SICI)1097-4695(20000605)43:3<244::AID-NEU3>3.0.CO;2-#; Striedter GF, 2016, J COMP NEUROL, V524, P496, DOI 10.1002/cne.23803; Sufka KJ, 2006, BEHAV PHARMACOL, V17, P681, DOI 10.1097/FBP.0b013e3280115fac; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tarr BA, 2009, DEV NEUROBIOLOGY; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wu MV, 2014, HIPPOCAMPUS, V24, P751, DOI 10.1002/hipo.22265	97	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189158	10.1371/journal.pone.0189158	http://dx.doi.org/10.1371/journal.pone.0189158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211774	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200072
J	Gong, CC; Chen, HS; He, WX; Zhang, ZL				Gong, Congcong; Chen, Haisong; He, Weixiong; Zhang, Zhanliang			Improved multi-objective clustering algorithm using particle swarm optimization	PLOS ONE			English	Article								Multi-objective clustering has received widespread attention recently, as it can obtain more accurate and reasonable solution. In this paper, an improved multi-objective clustering framework using particle swarm optimization (IMCPSO) is proposed. Firstly, a novel particle representation for clustering problem is designed to help PSO search clustering solutions in continuous space. Secondly, the distribution of Pareto set is analyzed. The analysis results are applied to the leader selection strategy, and make algorithm avoid trapping in local optimum. Moreover, a clustering solution-improved method is proposed, which can increase the efficiency in searching clustering solution greatly. In the experiments, 28 datasets are used and nine state-of-the-art clustering algorithms are compared, the proposed method is superior to other approaches in the evaluation index ARI.	[Gong, Congcong; Chen, Haisong; He, Weixiong; Zhang, Zhanliang] PLA Univ Sci & Technol, Nanjing, Jiangsu, Peoples R China	Army Engineering University of PLA	Chen, HS (corresponding author), PLA Univ Sci & Technol, Nanjing, Jiangsu, Peoples R China.	haisong_chen@outlook.com			National Natural Science Foundation of China [61473263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially sponsored by the National Natural Science Foundation of China (61473263). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by National Natural Science Foundation of China (61473263).	Abubaker A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130995; Alcala-Fdez J, 2011, J MULT-VALUED LOG S, V17, P255; Alvarezbenitez JE, 2013, 3 INT C EMO 2005 GUA; Armano G, 2016, MULTIOBJECTIVE CLUST, P184; Aupetit M, 2003, EUR S ART NEUR NETW; Cheng SX, 2016, APPL SOFT COMPUT, V47, P370, DOI 10.1016/j.asoc.2016.06.012; Coello CAC, 2002, 2002 CEC 02 P 2002 C; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Cui X, 2005, SWARM INT S 2005 SIS; Eckley DC, 2013, COMPUT ENVIRON URBAN, V37, P70, DOI 10.1016/j.compenvurbsys.2012.06.004; Ester M., 1996, INT C KNOWL DISC DAT; Frank A., 2010, UCI MACHINE LEARNING; Freitas AA, 2007, REV EVOLUTIONARY ALG, P371; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Garcia S, 2009, J HEURISTICS, V15, P617, DOI 10.1007/s10732-008-9080-4; Garcia-Piquer A, 2015, INFORM SCIENCES, V320, P12, DOI 10.1016/j.ins.2015.04.041; Han J, 2011, DATA MINING CONCEPTS, V5, P1; Handl J, 2004, LECT NOTES COMPUT SC, V3242, P1081; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; Hashemi SN, 2015, EARTH SCI INFORM, V8, P367, DOI 10.1007/s12145-014-0163-5; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Inkaya T, 2015, PATTERN RECOGN LETT, V52, P17, DOI 10.1016/j.patrec.2014.09.007; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kasprzak EM, 2001, STRUCT MULTIDISCIP O, V22, P208, DOI 10.1007/s001580100138; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kovacs L, 2011, IEEE INT S COMP INT; Li L, 2017, INFORM SCIENCES, V375, P30, DOI 10.1016/j.ins.2016.08.043; Omran MGH, 2007, INTELL DATA ANAL, V11, P583, DOI 10.3233/IDA-2007-11602; Omran MGH, 2006, PATTERN ANAL APPL, V8, P332, DOI 10.1007/s10044-005-0015-5; Phoong SM, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P729; Poli R, 2007, SWARM INTELLIGENCE, V1; Rana S, 2011, ARTIF INTELL REV, V35, P211, DOI 10.1007/s10462-010-9191-9; Rao ARM, 2011, J REINF PLAST COMP, V30, P1703, DOI 10.1177/0731684411417198; Raquel CR, 2005, GEN EV COMP C GECCO; Ruiz C, 2009, INT C ROUGH SETS FUZ; Santana RA, 2009, INT C INT SYST DES A; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Shen HY, 2005, ADV NATURAL COMPUTAT, P439; Shi Y, 1997, IEEE INT C EV COMP P; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Szilagyi SM, 2014, COMPUT BIOL MED, V48, P94, DOI 10.1016/j.compbiomed.2014.02.016; Van dM, 2003, 2003 CEC 03 2003 C; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yan H, 2006, 2006 WCICA 2006 6 WO; Yang F, 2013, EXPERT SYSTEMS APPL, V40, P9847	46	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188815	10.1371/journal.pone.0188815	http://dx.doi.org/10.1371/journal.pone.0188815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206880	Green Submitted, gold, Green Published			2022-12-26	WOS:000417110700025
J	Martin, S; Choi, CTM				Martin, Sebastien; Choi, Charles T. M.			A novel post-processing scheme for two-dimensional electrical impedance tomography based on artificial neural networks	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION	Objective Electrical Impedance Tomography (EIT) is a powerful non-invasive technique for imaging applications. The goal is to estimate the electrical properties of living tissues by measuring the potential at the boundary of the domain. Being safe with respect to patient health, non-invasive, and having no known hazards, EIT is an attractive and promising technology. However, it suffers from a particular technical difficulty, which consists of solving a nonlinear inverse problem in real time. Several nonlinear approaches have been proposed as a replacement for the linear solver, but in practice very few are capable of stable, high-quality, and real-time EIT imaging because of their very low robustness to errors and inaccurate modeling, or because they require considerable computational effort. Methods In this paper, a post-processing technique based on an artificial neural network (ANN) is proposed to obtain a nonlinear solution to the inverse problem, starting from a linear solution. While common reconstruction methods based on ANNs estimate the solution directly from the measured data, the method proposed here enhances the solution obtained from a linear solver. Conclusion Applying a linear reconstruction algorithm before applying an ANN reduces the effects of noise and modeling errors. Hence, this approach significantly reduces the error associated with solving 2D inverse problems using machine-learning-based algorithms.	[Martin, Sebastien; Choi, Charles T. M.] Natl Chiao Tung Univ, Dept Elect & Comp Engn, Hsinchu, Taiwan; [Choi, Charles T. M.] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Martin, Sebastien; Choi, Charles T. M.] Natl Chiao Tung Univ, Dept Elect & Comp Engn, Neural Engn & Interface Lab, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Choi, CTM (corresponding author), Natl Chiao Tung Univ, Dept Elect & Comp Engn, Hsinchu, Taiwan.; Choi, CTM (corresponding author), Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan.; Choi, CTM (corresponding author), Natl Chiao Tung Univ, Dept Elect & Comp Engn, Neural Engn & Interface Lab, Hsinchu, Taiwan.	c.t.choi@ieee.org		Choi, Charles T./0000-0002-4551-2603; Martin, Sebastien/0000-0003-4119-3382	Ministry of Science and Technology of Taiwan [102-2221-E-009-038-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	Partial funding from research grant 102-2221-E-009-038-MY3 from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; ADLER A, 1994, IEEE T MED IMAGING, V13, P594, DOI 10.1109/42.363109; Adler A, 1996, IEEE T MED IMAGING, V15, P170, DOI 10.1109/42.491418; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Ammari H, 2004, RECONSTRUCTION SMALL; Astala K, 2010, APPL COMPUT HARMON A, V29, P2, DOI 10.1016/j.acha.2009.08.001; Bayford RH, 2006, ANNU REV BIOMED ENG, V8, P63, DOI 10.1146/annurev.bioeng.8.061505.095716; Borsic A, 2010, IEEE T MED IMAGING, V29, P44, DOI 10.1109/TMI.2009.2022540; Calderon AP, 1980, INVERSE BOUNDARY VAL, P65; Carbonetto P, 1992, INTUITION PRIMAL DUA, P1; CHEN TP, 1995, IEEE T NEURAL NETWOR, V6, P904, DOI 10.1109/72.392252; Cheney M, 1999, SIAM REV, V41, P85, DOI 10.1137/S0036144598333613; Cheney M., 1990, International Journal of Imaging Systems and Technology, V2, P66, DOI 10.1002/ima.1850020203; Egmont-Petersen M, 2002, PATTERN RECOGN, V35, P2279, DOI 10.1016/S0031-3203(01)00178-9; Fortier N., 1993, Journal of Visual Communication and Image Representation, V4, P157, DOI 10.1006/jvci.1993.1014; GhasemAzar M, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1-3, P868; Holder D. S, 2005, ELECT IMPEDANCE TOMO; Isaacson D, 2006, PHYSIOL MEAS, V27, pS43, DOI 10.1088/0967-3334/27/5/S04; Jin KH, 2017, IEEE T IMAGE PROCESS, V26, P4509, DOI 10.1109/TIP.2017.2713099; Kwon O, 2002, IEEE T BIO-MED ENG, V49, P160, DOI 10.1109/10.979355; Lampinen J., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P3942, DOI 10.1109/IJCNN.1999.830787; Lionheart WRB, 1999, ANN NY ACAD SCI, V873, P466, DOI 10.1111/j.1749-6632.1999.tb09495.x; Martin S, POSTPROCESSING METHO; Martin S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07727-2; Martin S, 2016, PHYSIOL MEAS, V37, P801, DOI 10.1088/0967-3334/37/6/801; Mayer M, 2006, PHYSIOL MEAS, V27, pS93, DOI 10.1088/0967-3334/27/5/S08; McEwan A, 2007, PHYSIOL MEAS, V28, pS197, DOI 10.1088/0967-3334/28/7/S15; Miao LW, 2014, IEEE T INSTRUM MEAS, V63, P2903, DOI 10.1109/TIM.2014.2326765; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Ramirez M. P. T., 2010, 2010 7th International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE 2010) (Formerly known as ICEEE), P274, DOI 10.1109/ICEEE.2010.5608621; Sharma OP, 2013, INT J SOFT COMPUTING, V2, P220; Singh D, 2016, IEEE T MAGN, V52, DOI 10.1109/TMAG.2016.2590384; Stasiak M, 2007, ENG ANAL BOUND ELEM, V31, P713, DOI 10.1016/j.enganabound.2006.12.003; Tu C. -Y, 2015, DEV HIGH RESOLUTION; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Uhlmann G, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123011; Wu SG, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1-3, P120; Zhou Z, 2015, PHYSIOL MEAS, V36, P1193, DOI 10.1088/0967-3334/36/6/1193	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188993	10.1371/journal.pone.0188993	http://dx.doi.org/10.1371/journal.pone.0188993			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206856	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700036
J	Wang, P; Tuvblad, C; Younan, D; Franklin, M; Lurmann, F; Wu, J; Baker, LA; Chen, JC				Wang, Pan; Tuvblad, Catherine; Younan, Diana; Franklin, Meredith; Lurmann, Fred; Wu, Jun; Baker, Laura A.; Chen, Jiu-Chiuan			Socioeconomic disparities and sexual dimorphism in neurotoxic effects of ambient fine particles on youth IQ: A longitudinal analysis	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AGE-RELATED-CHANGES; FLUID INTELLIGENCE; PRENATAL EXPOSURE; YOUNG ADULTHOOD; AIR-POLLUTION; WHITE-MATTER; CHILD IQ; BRAIN-DEVELOPMENT; ADOLESCENCE	Mounting evidence indicates that early-life exposure to particulate air pollutants pose threats to children's cognitive development, but studies about the neurotoxic effects associated with exposures during adolescence remain unclear. We examined whether exposure to ambient fine particles (PM2.5) at residential locations affects intelligence quotient (IQ) during pre-/early- adolescence (ages 9-11) and emerging adulthood (ages 18-20) in a demographicallydiverse population (N = 1,360) residing in Southern California. Increased ambient PM2.5 levels were associated with decreased IQ scores. This association was more evident for Performance IQ (PIQ), but less for Verbal IQ, assessed by the Wechsler Abbreviated Scale of Intelligence. For each inter-quartile (7.73 mu g/m(3)) increase in one-year PM2.5 preceding each assessment, the average PIQ score decreased by 3.08 points (95% confidence interval = [-6.04, -0.12]) accounting for within-family/within-individual correlations, demographic characteristics, family socioeconomic status (SES), parents' cognitive abilities, neighborhood characteristics, and other spatial confounders. The adverse effect was 150% greater in low SES families and 89% stronger in males, compared to their counterparts. Better understanding of the social disparities and sexual dimorphism in the adverse PM2.5-IQ effects may help elucidate the underlying mechanisms and shed light on prevention strategies.	[Wang, Pan] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA 90095 USA; [Tuvblad, Catherine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tuvblad, Catherine] Orebro Univ, Sch Law Psychol & Social Work, Orebro, Sweden; [Younan, Diana; Franklin, Meredith; Chen, Jiu-Chiuan] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Lurmann, Fred] Sonoma Technol Inc, Petaluma, CA USA; [Wu, Jun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of California System; University of California Los Angeles; University of Southern California; Orebro University; University of Southern California; University of California System; University of California Irvine	Wang, P (corresponding author), Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA 90095 USA.	panwang@ucla.edu			National Institute of Environmental Health Sciences [R21 ES022369]; National Institute of Mental Health [R01 MH058354]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (grant R21 ES022369 to JC), https.//www.niehs.nih.gov/. The USC RFAB Twin Study is funded by the National Institute of Mental Health (grant R01 MH058354 to LB), https://www.nimh.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author FL worked at Sonoma Technology Inc. while engaged in this research. Sonoma provided support in the form of salaries for author FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of FL is articulated in the 'author contributions' section.	Allen JL, 2014, TOXICOL SCI, V140, P160, DOI 10.1093/toxsci/kfu059; Baker LA, 2013, TWIN RES HUM GENET, V16, P336, DOI 10.1017/thg.2012.127; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Bellinger DC, 2016, ENVIRON INT, V94, P103, DOI 10.1016/j.envint.2016.05.014; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006; Cattell R. B., 1971, ABILITIES THEIR STRU; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Chiu YHM, 2016, ENVIRON INT, V87, P56, DOI 10.1016/j.envint.2015.11.010; CHRISTIAN K, 2001, ENV EFFECTS COGNITIV, P287; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; Guxens M, 2016, EPIDEMIOLOGY ISEE; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Harris MH, 2015, ENVIRON HEALTH PERSP, V123, P1072, DOI 10.1289/ehp.1408803; Herlitz A, 2013, DEV NEUROPSYCHOL, V38, P167, DOI 10.1080/87565641.2012.759580; Hoekstra RA, 2007, LEARN INDIVID DIFFER, V17, P97, DOI 10.1016/j.lindif.2007.05.005; Jedrychowski WA, 2015, ENVIRON SCI POLLUT R, V22, P3631, DOI 10.1007/s11356-014-3627-8; Johnson S. B., 2016, PEDIATRICS, V137, P2015; Kaufman A.S., 2005, ASSESSING ADOLESCENT; Knezevic A, OVERLAPPING CONFIDEN; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lovasi GS, 2014, J CHILD FAM STUD, V23, P785, DOI 10.1007/s10826-013-9731-4; Lynn R., 2006, IQ GLOBAL INEQUALITY; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2013, DEVELOPMENTAL SCI, V16, P653, DOI 10.1111/desc.12077; Perera F, 2012, ENVIRON RES, V114, P40, DOI 10.1016/j.envres.2011.12.011; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Peterson BS, 2015, JAMA PSYCHIAT, V72, P531, DOI 10.1001/jamapsychiatry.2015.57; Porta D., 2015, EPIDEMIOLOGY; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Sirivelu MP, 2006, ENVIRON HEALTH PERSP, V114, P870, DOI 10.1289/ehp.8619; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tsukue N, 2004, J HEALTH SCI, V50, P174, DOI 10.1248/jhs.50.174; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Ijzendoorn MH, 2005, PSYCHOL BULL, V131, P301, DOI 10.1037/0033-2909.131.2.301; Vishnevetsky J, 2015, NEUROTOXICOL TERATOL, V49, P74, DOI 10.1016/j.ntt.2015.04.002; Vuoksimaa E, 2012, PSYCHONEUROENDOCRINO, V37, P1791, DOI 10.1016/j.psyneuen.2012.03.013; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weiss B, 2002, ENVIRON HEALTH PERSP, V110, P387, DOI 10.1289/ehp.02110s3387; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; WHO, 2016, AD DEV2011; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107	59	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188731	10.1371/journal.pone.0188731	http://dx.doi.org/10.1371/journal.pone.0188731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206872	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700020
J	Zhang, H; Diao, HX; Jia, LX; Yuan, YJ; Thamm, DH; Wang, HA; Jin, YP; Pei, SM; Zhou, B; Yu, F; Zhao, LN; Cheng, N; Du, HC; Huang, Y; Zhang, D; Lin, DG				Zhang, Hong; Diao, Hongxiu; Jia, Lixin; Yuan, Yujing; Thamm, Douglas H.; Wang, Huanan; Jin, Yipeng; Pei, Shimin; Zhou, Bin; Yu, Fang; Zhao, Linna; Cheng, Nan; Du, Hongchao; Huang, Ying; Zhang, Di; Lin, Degui			Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CARBONIC-ANHYDRASE-IX; MAMMARY-CARCINOMA 4T1; DENDRITIC CELLS; SALMONELLA-TYPHIMURIUM; IN-VIVO; TARGETED THERAPY; TUMOR-GROWTH; POOR SURVIVAL; HYPOXIA	A variety of bacteria have been used as agents and vectors for antineoplastic therapy. A series of mechanisms, including native bacterial toxicity, sensitization of the immune system and competition for nutrients, may contribute to antitumor effects. However, the antitumor effects of Proteus species have been minimally studied, and it is not clear if bacteria can alter tumor hypoxia as a component of their antineoplastic effect. In the present study, Proteus mirabilis bacteria were evaluated for the ability to proliferate and accumulate in murine tumors after intravenous injection. To further investigate the efficacy and safety of bacterial injection, mice bearing 4T1 tumors were treated with an intravenous dose of 5x10(7) CFU Proteus mirabilis bacteria via the tail vein weekly for three treatments. Histopathology, immunohistochemistry (IHC) and western analysis were then performed on excised tumors. The results suggested Proteus mirabilis localized preferentially to tumor tissues and remarkably suppressed the growth of primary breast cancer and pulmonary metastasis in murine 4T1 models. Results showed that the expression of NKp46 and CD11c was significantly increased after bacteria treatment. Furthermore, tumor expression of carbonic anhydrase IX (CA IX) and hypoxia inducible factor-1a (HIF-1a), surrogates for hypoxia, was significantly lower in the treated group than the control group mice as assessed by IHC and western analysis. These findings demonstrated that Proteus mirabilis may a promising bacterial strain for used against primary tumor growth and pulmonary metastasis, and the immune system and reduction of tumor hypoxia may contribute to the antineoplastic and antimetastatic effects observed.	[Zhang, Hong; Diao, Hongxiu; Jia, Lixin; Yuan, Yujing; Jin, Yipeng; Yu, Fang; Zhao, Linna; Cheng, Nan; Du, Hongchao; Huang, Ying; Zhang, Di; Lin, Degui] China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China; [Thamm, Douglas H.] Colorado State Univ, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Wang, Huanan] Zhejiang Univ, Dept Vet, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Pei, Shimin] Hainan Univ, Dept Vet Med, Haikou, Hainan, Peoples R China; [Zhou, Bin] Zhejiang Agr & Forestry Univ, Coll Anim Sci & Technol, Hangzhou, Zhejiang, Peoples R China	China Agricultural University; Colorado State University; Zhejiang University; Hainan University; Zhejiang A&F University	Zhang, D; Lin, DG (corresponding author), China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China.	dzhangdvm@cau.edu.cn; csama@sina.com	Thamm, Douglas H/I-5976-2013; Thamm, Douglas/AAG-3672-2020	Thamm, Douglas H/0000-0002-8914-7767; 	National Natural Science Foundation of China [3157130419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), grant number No. 3157130419, which DL received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Peixoto RCA, 2015, TUMOR BIOL, V36, P3325, DOI 10.1007/s13277-014-2966-x; Barbe S, 2005, FEMS MICROBIOL LETT, V246, P67, DOI 10.1016/j.femsle.2005.03.037; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034676; Beketic-Oreskovic L, 2011, PATHOL ONCOL RES, V17, P593, DOI 10.1007/s12253-010-9355-6; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Browder T, 2000, CANCER RES, V60, P1878; Chen JX, 2012, CANCER SCI, V103, P325, DOI 10.1111/j.1349-7006.2011.02147.x; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coley WB, 1906, AM J MED SCI, V131, P375; Coutermarsh-Ott SL, 2017, ONCOTARGET, V8, P33601, DOI 10.18632/oncotarget.16830; Cuenca AG, 2014, J IMMUNOL, V192, P6111, DOI 10.4049/jimmunol.1302895; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Douglas H., 2005, CLIN CANC RES OFFICI, V11, P7; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Fang J, 2014, J PHARM SCI-US, V103, P3235, DOI 10.1002/jps.24083; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gieling RG, 2013, BIOORGAN MED CHEM, V21, P1470, DOI 10.1016/j.bmc.2012.09.062; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Heap JT, 2014, ONCOTARGET, V5, P1761, DOI 10.18632/oncotarget.1761; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Hye-Jin, 2010, J CELL SCI, V124, P1077; Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598; Jeong J.-M., 2014, BOUND VALUE PROBL, V255, P1, DOI DOI 10.1016/J.CHI.2014.01.017; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; Kaya AO, 2012, J BUON, V17, P663; Kim EJ, 2011, BREAST CANCER RES TR, V130, P61, DOI 10.1007/s10549-010-1299-8; Krick EL, 2012, AM J VET RES, V73, P112, DOI 10.2460/ajvr.73.1.112; Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MURATA TOYOICHIRO, 1965, LIFE SCI, V4, P1055; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; OLTMANN LF, 1979, FEBS LETT, V106, P43, DOI 10.1016/0014-5793(79)80691-2; Parks SK, 2016, MOL ASPECTS MED, V47-48, P3, DOI 10.1016/j.mam.2015.12.001; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Roberts N.J., 2014, SCI TRANSL MED, V6, P249, DOI DOI 10.1126/SCITRANSLMED.3008982; SAKAMOTO K, 1988, JPN J CANCER RES, V79, P109, DOI 10.1111/j.1349-7006.1988.tb00017.x; Schaffer JN, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0017-2013; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Shafey SABHME, 2013, EUROPEAN SCI J, V9, P14; Sznol M, 2000, J CLIN INVEST, V105, P1027, DOI 10.1172/JCI9818; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; van der Groep P, 2004, BREAST CANCER RES TR, V88, pS152; Vanderheyde N, 2001, J IMMUNOL, V167, P3565, DOI 10.4049/jimmunol.167.7.3565; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yan LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131518; Yu HJ, 2016, THERANOSTICS, V6, P14, DOI 10.7150/thno.13515; Zhang T, 2015, NANOMEDICINE-UK, V10, P573, DOI 10.2217/nnm.14.141; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	69	12	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188960	10.1371/journal.pone.0188960	http://dx.doi.org/10.1371/journal.pone.0188960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206859	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700034
J	Chua, MMJ; Lee, M; Dominguez, I				Chua, Melissa M. J.; Lee, Migi; Dominguez, Isabel			Cancer-type dependent expression of CK2 transcripts	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; MALIGNANT PLEURAL MESOTHELIOMA; UNFAVORABLE PROGNOSTIC MARKER; GENE-EXPRESSION; MULTIPLE-MYELOMA; ALPHA-SUBUNIT; IN-VIVO; BARRETTS METAPLASIA	A multitude of proteins are aberrantly expressed in cancer cells, including the oncogenic serine-threonine kinase CK2. In a previous report, we found increases in CK2 transcript expression that could explain the increased CK2 protein levels found in tumors from lung and bronchus, prostate, breast, colon and rectum, ovarian and pancreatic cancers. We also found that, contrary to the current notions about CK2, some CK2 transcripts were downregulated in several cancers. Here, we investigate all other cancers using Oncomine to determine whether they also display significant CK2 transcript dysregulation. As anticipated from our previous analysis, we found cancers with all CK2 transcripts upregulated (e.g. cervical), and cancers where there was a combination of upregulation and/or downregulation of the CK2 transcripts (e.g. sarcoma). Unexpectedly, we found some cancers with significant downregulation of all CK2 transcripts (e.g. testicular cancer). We also found that, in some cases, CK2 transcript levels were already dysregulated in benign lesions (e.g. Barrett's esophagus). We also found that CK2 transcript upregulation correlated with lower patient survival in most cases where data was significant. However, there were two cancer types, glioblastoma and renal cell carcinoma, where CK2 transcript upregulation correlated with higher survival. Overall, these data show that the expression levels of CK2 genes is highly variable in cancers and can lead to different patient outcomes.	[Chua, Melissa M. J.; Lee, Migi; Dominguez, Isabel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Dominguez, I (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	isdoming@bu.edu		Lee, Migi/0000-0002-6571-267X; /0000-0001-9617-4141; Chua, Melissa/0000-0002-2832-4002	National Institutes of General Medical Sciences [1R01GM098367]; Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); Boston University Undergraduate Research Opportunities Program (UROP); National Institutes of General Medical Sciences (NIGMS) [1R01GM098367]	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); Boston University Undergraduate Research Opportunities Program (UROP); National Institutes of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part with funding from the National Institutes of General Medical Sciences; 1R01GM098367 [http://www.nigms.nih.gov/]. M.C. was supported by a Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); and M.L. was supported by a fellowship from the Boston University Undergraduate Research Opportunities Program (UROP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Dominguez lab for discussions. We thank Janice Weinberg and Na Wang, Biostatistics Consultants in the Department of Medicine, for their help with statistical analysis. We thank Kevan Hartshorn, Anurag Singh, Barbara Guerra and Sam Thiangalingam for their comments to the manuscript. This work was partially supported with funding from the National Institutes of General Medical Sciences (NIGMS); 1R01GM098367. M.C. was supported by a Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); and M.L. was supported by a fellowship from the Boston University Undergraduate Research Opportunities Program (UROP). Data from WHO, NCI, CDC, ACS, Oncomine and Kaplan Meier Plotter are cited as per their requirements.	Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Ahmed K, 2000, J CELL BIOCHEM, P130; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; [Anonymous], **DROPPED REF**, Patent No. 2001.016009606.x; Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Bai XY, 2009, NUCLEIC ACIDS RES, V37, P2699, DOI 10.1093/nar/gkp094; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bian YS, 2015, INT J BIOL SCI, V11, P411, DOI 10.7150/ijbs.10745; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bilous N, 2005, EXP ONCOL, V27, P325; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Cannon CM, 2017, HUM GENE THER CL DEV, V28, P80, DOI 10.1089/humc.2017.008; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; [陈勃 Chen Bo], 2012, [南方医科大学学报, Journal of Southern Medical University], V32, P1491; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Choi SE, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00006-17; Choi YL, 2007, ONCOGENE, V26, P1245, DOI 10.1038/sj.onc.1209898; Chua MMJ, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010018; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Cozza G, 2016, EXPERT OPIN THER TAR, V20, P319, DOI 10.1517/14728222.2016.1091883; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Deffenbacher KE, 2012, BLOOD, V119, P3757, DOI 10.1182/blood-2011-05-349662; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Dubois N, 2016, INT J ONCOL, V48, P2445, DOI 10.3892/ijo.2016.3490; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Faust RA, 1999, INT J BIOCHEM CELL B, V31, P941, DOI 10.1016/S1357-2725(99)00050-3; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; Ferrer-Font L, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010024; Filhol O., 2013, ROLE CK2 CONTROL CEL; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Guerra B, 1999, FEBS LETT, V462, P353, DOI 10.1016/S0014-5793(99)01553-7; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Guo M, 2014, ASIAN PAC J CANCER P, V15, P7425, DOI 10.7314/APJCP.2014.15.17.7425; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Jeppesen DK, 2014, PROTEOMICS, V14, P699, DOI 10.1002/pmic.201300452; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kim HS, 2014, FEBS J, V281, P851, DOI 10.1111/febs.12652; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Krick R, 2006, BIOCHEM BIOPH RES CO, V341, P343, DOI 10.1016/j.bbrc.2005.12.190; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee YS, 2014, HELICOBACTER, V19, P465, DOI 10.1111/hel.12144; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Litchfield DW, 2001, MOL CELL BIOCHEM, V227, P21, DOI 10.1023/A:1013188101465; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Macias Alvarez L., 2013, WILEY IUBMB SERIES B; Maia S, 2005, CANCER RES, V65, P10050, DOI 10.1158/0008-5472.CAN-05-1574; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; Manni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075280; Gomes AM, 2014, HAEMATOLOGICA, V99, P1062, DOI 10.3324/haematol.2013.096438; MARIDOR G, 1991, J BIOL CHEM, V266, P2362; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Massimi P, 2000, VIROLOGY, V276, P388, DOI 10.1006/viro.2000.0514; Michiels S, 2016, ANN ONCOL, V27, P2160, DOI 10.1093/annonc/mdw307; Morrison C, 2004, AM J PATHOL, V165, P565, DOI 10.1016/S0002-9440(10)63321-4; Nitta RT, 2015, ONCOGENE, V34, P3688, DOI 10.1038/onc.2014.299; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637; Pascual V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146276; Pencheva N, 2017, CELL REP, V20, P48, DOI 10.1016/j.celrep.2017.06.036; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Peng XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005591; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pizzi M, 2015, ONCOTARGET, V6, P6544, DOI 10.18632/oncotarget.3446; Posch C, 2016, J INVEST DERMATOL, V136, P1330, DOI 10.1016/j.jid.2016.03.006; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Quade BJ, 2004, GENE CHROMOSOME CANC, V40, P97, DOI 10.1002/gcc.20018; Rabjerg M, 2017, ONCOTARGET, V8, P1613, DOI 10.18632/oncotarget.13693; Rabjerg M, 2016, APMIS, V124, P372, DOI 10.1111/apm.12519; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; ROELANTS C, 2015, DYSR EXPR PROT KIN, V12, P241; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SELDIN DC, 1995, CURR OPIN IMMUNOL, V7, P665, DOI 10.1016/0952-7915(95)80075-1; Sengupta A, 2006, J GENE MED, V8, P1251, DOI 10.1002/jgm.959; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-8; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Takahashi K, 2017, ONCOL REP, V37, P1141, DOI 10.3892/or.2016.5310; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Trembley J.H., 2013, CK2 SUPPRESSION APOP, P219; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Tubi LQ, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-78; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zhang SL, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0093-6; Zhang XL, 2016, ONCOTARGET, V7, P87361, DOI 10.18632/oncotarget.13571; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265; Zhou BY, 2016, J BIOL CHEM, V291, P17804, DOI 10.1074/jbc.M115.712885	151	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188854	10.1371/journal.pone.0188854	http://dx.doi.org/10.1371/journal.pone.0188854			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206231	Green Published, gold, Green Submitted			2022-12-26	WOS:000417033200016
J	Osthushenrich, T; Frisch, M; Herzog, E				Osthushenrich, Tanja; Frisch, Matthias; Herzog, Eva			Genomic selection of crossing partners on basis of the expected mean and variance of their derived lines	PLOS ONE			English	Article							GENETIC VARIANCE; MAIZE; PREDICTION; LOCI; POPULATIONS; PERFORMANCE	In a line or a hybrid breeding program superior lines are selected from a breeding pool as parental lines for the next breeding cycle. From a cross of two parental lines, new lines are derived by single-seed descent (SSD) or doubled haploid (DH) technology. However, not all possible crosses between the parental lines can be carried out due to limited resources. Our objectives were to present formulas to characterize a cross by the mean and variance of the genotypic values of the lines derived from the cross, and to apply the formulas to predict means and variances of flowering time traits in recombinant inbred line families of a publicly available data set in maize. We derived formulas which are based on the expected linkage disequilibrium (LD) between two loci and which can be used for arbitrary mating systems. Results were worked out for SSD and DH lines derived from a cross after an arbitrary number of intermating generations. The means and variances were highly correlated with results obtained by the simulation software PopVar. Compared with these simulations, computation time for our closed formulas was about ten times faster. The means and variances for flowering time traits observed in the recombinant inbred line families of the investigated data set showed correlations of around 0.9 for the means and of 0.46 and 0.65 for the standard deviations with the estimated values. We conclude that our results provide a framework that can be exploited to increase the efficiency of hybrid and line breeding programs by extending genomic selection approaches to the selection of crossing partners.	[Osthushenrich, Tanja; Frisch, Matthias; Herzog, Eva] Justus Liebig Univ, Inst Agron & Plant Breeding 2, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany	Justus Liebig University Giessen	Herzog, E (corresponding author), Justus Liebig Univ, Inst Agron & Plant Breeding 2, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	eva.herzog@uni-giessen.de	Frisch, Matthias/R-1564-2019	Frisch, Matthias/0000-0003-4234-8972				Bernardo R, 2006, CROP SCI, V46, P1972, DOI 10.2135/cropsci2006.01-0057; Bernardo R, 2014, CROP SCI, V54, P2586, DOI 10.2135/cropsci2014.01.0088; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; Falconer D. S., 1996, INTRO QUANTITATIVE G; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frisch M, 2007, GENETICS, V176, P477, DOI 10.1534/genetics.106.065433; Haldane JBS, 1919, J GENET, V8, P299; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Hofheinz N, 2012, THEOR APPL GENET, V125, P1639, DOI 10.1007/s00122-012-1940-5; Lian L, 2015, CROP SCI, V55, P1181, DOI 10.2135/cropsci2014.10.0729; Maurer HP, 2008, EUPHYTICA, V161, P133, DOI 10.1007/s10681-007-9493-4; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meuwissen THE, 2001, GENETICS, V157, P1819; Mohammadi M, 2015, CROP SCI, V55, P2068, DOI 10.2135/cropsci2015.01.0030; Schnell F. W., 1975, Bericht uber die Arbeitstagung 1975 der "Arbeitsgemeinschaft der Saatzuchtleiter"., P243; Tiede T, 2015, POPVAR GENOMIC BREED; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zenke-Philippi C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2580-y; Zhong SQ, 2007, GENETICS, V177, P567, DOI 10.1534/genetics.107.075358	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188839	10.1371/journal.pone.0188839	http://dx.doi.org/10.1371/journal.pone.0188839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200436	gold, Green Submitted, Green Published			2022-12-26	WOS:000417033200014
J	Bollinger, JL; Collins, KE; Patel, R; Wellman, CL				Bollinger, Justin L.; Collins, Kaitlyn E.; Patel, Rushi; Wellman, Cara L.			Behavioral stress alters corticolimbic microglia in a sex- and brain region-specific manner	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; PREFRONTAL CORTEX; DENDRITIC MORPHOLOGY; GENDER-DIFFERENCES; PYRAMIDAL NEURONS; DIFFERENT STATES; INDUCED ATROPHY; IN-VIVO; ACTIVATION; NEUROINFLAMMATION	Women are more susceptible to numerous stress-linked psychological disorders (e.g., depression) characterized by dysfunction of corticolimbic brain regions critical for emotion regulation and cognitive function. Although sparsely investigated, a number of studies indicate sex differences in stress effects on neuronal structure, function, and behaviors associated with these regions. We recently demonstrated a basal sex difference in-and differential effects of stress on-microglial activation in medial prefrontal cortex (mPFC). The resident immune cells of the brain, microglia are implicated in synaptic and dendritic plasticity, and cognitive-behavioral function. Here, we examined the effects of acute (3h/day, 1 day) and chronic (3h/day, 10 days) restraint stress on microglial density and morphology, as well as immune factor expression in orbitofrontal cortex (OFC), basolateral amygdala (BLA), and dorsal hippocampus (DHC) in male and female rats. Microglia were visualized, classified based on their morphology, and stereologically counted. Microglia-associated transcripts (CD40, iNOS, Arg1, CX3CL1, CX3CR1, CD200, and CD200R) were assessed in brain punches from each region. Expression of genes linked with cellular stress, neuroimmune state, and neuron-microglia communication varied between unstressed male and female rats in a region-specific manner. In OFC, chronic stress upregulated a wider variety of immune factors in females than in males. Acute stress increased microglia-associated transcripts in BLA in males, whereas chronic stress altered immune factor expression in BLA more broadly in females. In DHC, chronic stress increased immune factor expression in males but not females. Moreover, acute and chronic stress differentially affected microglial morphological activation state in male and female rats across all brain regions investigated. In males, chronic stress altered microglial activation in a pattern consistent with microglial involvement in stress-induced dendritic remodeling across OFC, BLA, and DHC. Together, these data suggest the potential for microglia-mediated sex differences in stress effects on neural structure, function, and behavior.	[Bollinger, Justin L.; Collins, Kaitlyn E.; Patel, Rushi; Wellman, Cara L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bollinger, Justin L.; Wellman, Cara L.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Bollinger, Justin L.; Wellman, Cara L.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wellman, CL (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.; Wellman, CL (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.; Wellman, CL (corresponding author), Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA.	wellmanc@indiana.edu		Bollinger, Justin/0000-0002-1424-8694; Wellman, Cara/0000-0002-3064-4259	Indiana University; National Institute of Mental Health [T32MH103213]; National Institute of Child Health and Human Development [T32HD049336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH103213] Funding Source: NIH RePORTER	Indiana University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Indiana University, the National Institute of Mental Health (T32MH103213, JLB), and the National Institute of Child Health and Human Development (T32HD049336, JLB) for their generous support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gene expression techniques were made possible by equipment provided in the Center for the Integrative Study of Animal Behavior's Mechanisms of Behavior Laboratory and the Center for Genomics and Bioinformatics Genomics Core Facility.	Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bekhbat M, 2017, BRAIN BEHAV IMMUNITY; Bijlsma EY, 2011, NEUROSCIENCE, V173, P82, DOI 10.1016/j.neuroscience.2010.11.026; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cox FF, 2012, BRAIN BEHAV IMMUN, V26, P789, DOI 10.1016/j.bbi.2011.10.004; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Delpech JC, 2015, NEUROPHARMACOLOGY, V96, P19, DOI 10.1016/j.neuropharm.2014.12.034; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Garrett JE, 2009, NEUROSCIENCE, V162, P195, DOI 10.1016/j.neuroscience.2009.04.057; Grillo CA, 2015, NEUROSCIENCE, V284, P430, DOI 10.1016/j.neuroscience.2014.09.047; Habib P, 2014, J STEROID BIOCHEM MO; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Kitraki E, 2004, NEUROSCIENCE, V125, P47, DOI 10.1016/j.neuroscience.2003.12.024; Konkle ATM, 2003, BRAIN RES, V992, P227, DOI 10.1016/j.brainres.2003.08.047; Kopp BL, 2013, PHYSIOL BEHAV, V122, P246, DOI 10.1016/j.physbeh.2013.05.030; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Lehmann ML, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0672-x; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Michels M, 2015, MOL MED, V21, P219, DOI 10.2119/molmed.2015.00070; Mika A, 2012, BEHAV NEUROSCI, V126, P605, DOI 10.1037/a0029642; Milior G., 2015, BRAIN BEHAV IMMUNITY; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mitra R, 2005, NEUROSCI LETT, V383, P278, DOI 10.1016/j.neulet.2005.04.037; Moench KM, 2017, NEUROSCIENCE, V357, P145, DOI 10.1016/j.neuroscience.2017.05.049; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Pan Y, 2014, BRAIN BEHAV IMMUN, V41, P90, DOI 10.1016/j.bbi.2014.04.007; Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Solomon MB, 2009, PHYSIOL BEHAV, V97, P250, DOI 10.1016/j.physbeh.2009.02.033; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2002, J NEUROSCI, V22, P6810; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wei J, 2014, MOL PSYCHIATR, V19, P588, DOI 10.1038/mp.2013.83; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2017, BIOL PSYCHIAT; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	69	46	47	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187631	10.1371/journal.pone.0187631	http://dx.doi.org/10.1371/journal.pone.0187631			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194444	gold, Green Published, Green Submitted			2022-12-26	WOS:000416867800006
J	Andersen, S; Richardsen, E; Rakaee, M; Bertilsson, H; Bremnes, R; Borset, M; Busund, LT; Slordahl, T				Andersen, Sigve; Richardsen, Elin; Rakaee, Mehrdad; Bertilsson, Helena; Bremnes, Roy; Borset, Magne; Busund, Lill-Tove; Slordahl, Tobias			Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; PRL-3 PHOSPHATASE; GASTRIC-CANCER; BREAST-CANCER; METASTASIS; PROTEIN; OVEREXPRESSION; MIGRATION; GROWTH; SUPPRESSES	Background Prostate cancer (PC) stratification needs new prognostic tools to reduce overtreatment. Phosphatase of regenerating liver (PRL-3) is a phosphatase found at high levels in several cancer types, where its expression is associated with survival. A recent PC cell line study has shown it to be involved in PC growth and migration. Methods We used a monoclonal antibody to evaluate the expression of PRL-3 in PC tissue of patients in an unselected cohort of 535 prostatectomy patients. We analyzed associations between PRL-3 expression and biochemical failure-free survival (BFFS), clinical failure-free survival (CFFS) and PC death-free survival (PCDFS). Results Cytoplasmic PRL-3 staining in tumor cells was significantly correlated to expression of molecules in the VEGFR-axis, but not to the clinicopathological variables. High PRL-3 was not significantly associated with survival in the univariate analysis for BFFS (p = 0.131), but significantly associated with CFFS (p = 0.044) and PCDFS (p = 0.041). In multivariate analysis for the various end points, PRL-3 came out as an independent and significant indicator of poor survival for BFFS (HR = 1.53, CI95% 1.10-2.13, p = 0.012), CFFS (HR = 2.41, CI95% 1.17-4.98, p = 0.017) and PCDFS (HR = 3.99, CI95% 1.21-13.1, p = 0.023). Conclusions PRL-3 is independently associated with all PC endpoints in this study. Since high PRL-3 expression also correlates with poor prognosis in other cancers and functional studies in PC support these findings, PRL-3 emerges as a potential treatment target in PC.	[Andersen, Sigve; Bremnes, Roy] Arctic Univ Norway, UiT, Dept Clin Med, Translat Canc Res Grp, Tromso, Norway; [Andersen, Sigve; Bremnes, Roy] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Richardsen, Elin; Rakaee, Mehrdad; Busund, Lill-Tove] Arctic Univ Norway, UiT, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Richardsen, Elin; Busund, Lill-Tove] Univ Hosp North Norway, Dept Pathol, Tromso, Norway; [Bertilsson, Helena; Borset, Magne; Slordahl, Tobias] NTNU Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Bertilsson, Helena] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Urol, Trondheim, Norway; [Borset, Magne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Immunol & Transfus Med, Trondheim, Norway; [Slordahl, Tobias] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Hematol, Trondheim, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Andersen, S (corresponding author), Arctic Univ Norway, UiT, Dept Clin Med, Translat Canc Res Grp, Tromso, Norway.; Andersen, S (corresponding author), Univ Hosp North Norway, Dept Oncol, Tromso, Norway.	sigve.andersen@uit.no	Borset, Magne/AAY-1713-2021; Rakaee, Mehrdad/GMX-0729-2022	Rakaee, Mehrdad/0000-0002-9080-0153	NTNU Norwegian University of Science and Technology, Trondheim, Norway; Kreftforeningen; HelseNord RHF	NTNU Norwegian University of Science and Technology, Trondheim, Norway; Kreftforeningen; HelseNord RHF	Funders are NTNU Norwegian University of Science and Technology, Trondheim, Norway, Kreftforeningen and HelseNord RHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi P, 2016, MOL CANC RES; Ahn JH, 2006, BIOORG MED CHEM LETT, V16, P2996, DOI 10.1016/j.bmcl.2006.02.060; Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Andersen S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-49; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Choi SK, 2006, NAT PROD RES, V20, P341, DOI 10.1080/14786410500463312; Da N, 2009, WORLD J GASTROENTERO, V15, P1499, DOI 10.3748/wjg.15.1499; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; den Hollander P, 2016, CANCER RES, V76, P1942, DOI 10.1158/0008-5472.CAN-14-0673; Dong Q, 2016, J ORAL PATHOL MED, V45, P111, DOI 10.1111/jop.12331; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Feik E, 2013, PROSTATE, V73, P1413, DOI 10.1002/pros.22688; Ferlay, 2016, CANC TODAY; Gari HH, 2016, ONCOTARGET, V7, P15757, DOI 10.18632/oncotarget.7462; Gronberg H, 2015, LANCET ONCOL, V16, P1667, DOI 10.1016/S1470-2045(15)00361-7; Guo K, 2012, ONCOTARGET, V3, P158; Han Y, 2012, J NANOMATER, V2012, P10; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Lee JD, 2016, EXP THER MED, V12, P2974, DOI 10.3892/etm.2016.3722; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Liang F, 2008, J BIOL CHEM, V283, P10339, DOI 10.1074/jbc.M708285200; Ma YX, 2011, MED ONCOL, V28, P775, DOI 10.1007/s12032-010-9514-3; Mayinuer A, 2013, ANN SURG ONCOL, V20, P305, DOI 10.1245/s10434-012-2395-2; Min G, 2013, BIOORG MED CHEM LETT, V23, P3769, DOI 10.1016/j.bmcl.2013.04.092; Min Li, 2015, Asian Pac J Cancer Prev, V16, P2819; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Miskad UA, 2007, VIRCHOWS ARCH, V450, P303, DOI 10.1007/s00428-006-0361-8; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Moon MK, 2010, ARCH PHARM RES, V33, P1747, DOI 10.1007/s12272-010-1106-4; Ooki A, 2009, ONCOL REP, V21, P1467, DOI 10.3892/or_00000376; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Ren TT, 2009, PATHOL ONCOL RES, V15, P555, DOI 10.1007/s12253-009-9153-1; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Rubio T, 2016, BIOCHEM SOC T, V44, P1305, DOI 10.1042/BST20160146; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Salamoun JM, 2016, ORG BIOMOL CHEM, V14, P6398, DOI 10.1039/c6ob00946h; Shin Y, 2013, MAR DRUGS, V11, P2472, DOI 10.3390/md11072472; Stadlbauer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134336; Thura M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87607; Ustaalioglu BBO, 2012, CLIN TRANSL ONCOL, V14, P911, DOI 10.1007/s12094-012-0880-5; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Vandsemb EN, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0830-z; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wang Z, 2009, ANN SURG ONCOL, V16, P208, DOI 10.1245/s10434-008-0214-6; Xing XF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-309; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Xu YJ, 2010, PATHOL ONCOL RES, V16, P169, DOI 10.1007/s12253-009-9200-y; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17046; Zhou J, 2009, INT J CANCER, V124, P1879, DOI 10.1002/ijc.24096	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189000	10.1371/journal.pone.0189000	http://dx.doi.org/10.1371/journal.pone.0189000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190795	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900187
J	Ma, L; Wang, L; Shan, YT; Nafees, M; Ihab, E; Zhang, RH; Wang, FJ; Yin, W				Ma, Lin; Wang, Lan; Shan, Yating; Nafees, Muhammad; Ihab, Elshoura; Zhang, Ruhui; Wang, Fangjun; Yin, Wu			Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; DRUG-RESISTANCE; PIVOTAL ROLE; CELLS; CD133; CHEMORESISTANCE; IDENTIFICATION; PROMOTES; MARKERS; LNX	Cancer stem-like cells (CSCs) have been reported to play major roles in tumorigenesis, tumor relapse, and metastasis after therapy against colorectal carcinoma (CRC). Therefore, identification of colorectal CSC regulators could provide promising targets for CRC. Ligand-of-Numb protein X1 (LNX1) is one E3 ubiquitin ligase which mediates the ubiquitination and degradation of Numb. Although several studies indicate LNX1 could be a potential suppressor of cancer diseases, the functions of LNX1 in mediating cancer stemness remain poorly understood. In this study, LNX1 was identified as a negative regulator of cancer stemness in CRC, which was downregulated in colonospheres or side population (SP) cells. Furthermore, the coxsackievirus and adenovirus receptor (CXADR) was found to be one critical downstream mediator of cancer stemness regulated by LNX1. Interestingly, the anti-breast cancer drug tamoxifen was found to be an agonist of LNX1 and suppress cancer stemness in CRC. In sum, this study provided the evidences that LNX1 signaling plays important roles in regulating the stemness of colon cancer cells.	[Ma, Lin; Shan, Yating; Ihab, Elshoura; Zhang, Ruhui; Yin, Wu] Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Lan] Southeast Univ, Dept Resp Med, Affiliated Jiangyin Hosp, Jiangyin, Peoples R China; [Nafees, Muhammad] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing, Jiangsu, Peoples R China; [Wang, Fangjun] Southeast Univ, Dept Gastroenterol, Affiliated Jiangyin Hosp, Jiangyin, Peoples R China	Nanjing University; Southeast University - China; Nanjing University; Southeast University - China	Yin, W (corresponding author), Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.; Wang, FJ (corresponding author), Southeast Univ, Dept Gastroenterol, Affiliated Jiangyin Hosp, Jiangyin, Peoples R China.	dizzy163@163.com; wyin@nju.edu.cn		Muhammad, Nafees/0000-0001-8594-4243	Natural Science Fund of China [31071250, 81673462, 81473293, 91540119, J1103521]; Fundamental Research Funds for the Central Universities; Six talent peaks project in Jiangsu Province [YY-012]; Key development project of Jiangsu Province [BE2017712]; Key project of Wuxi Municipal Commission of Health and Family Planning [Z201509]; Jiangsu Province [QNRC2016136]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Six talent peaks project in Jiangsu Province; Key development project of Jiangsu Province; Key project of Wuxi Municipal Commission of Health and Family Planning; Jiangsu Province	This project was sponsored by Natural Science Fund of China (31071250, 81673462, 81473293, 91540119, and J1103521), the Fundamental Research Funds for the Central Universities. Six talent peaks project in Jiangsu Province to WY. (YY-012). Key development project of Jiangsu Province (BE2017712). Key project of Wuxi Municipal Commission of Health and Family Planning (Z201509), and the young talent's subsidy project of Jiangsu Province (QNRC2016136) to Fangjun Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was sponsored by Natural Science Fund of China (31071250, 81673462, 81473293, 91540119, and J1103521), the Fundamental Research Funds for the Central Universities. Six talent peaks project in Jiangsu Province to Y.W. (YY-012). Key development project of Jiangsu Province (BE2017712). Key project of Wuxi Municipal Commission of Health and Family Planning (Z201509), and the young talent's subsidy project of Jiangsu Province (QNRC2016136) to Wang fangjun The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2017, SEMIN CANCER BIOL, V44, P25, DOI 10.1016/j.semcancer.2017.03.003; Albini A, 2015, CONNECT TISSUE RES, V56, P414, DOI 10.3109/03008207.2015.1066780; Behbod F, 2015, METHODS MOL BIOL, V1293, P73, DOI 10.1007/978-1-4939-2519-3_4; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Chen JJ, 2015, IEEE INT CONF COMM, P1, DOI 10.1109/ICCW.2015.7247066; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Choi JE, 2017, ONCOL REP, V38, P1695, DOI 10.3892/or.2017.5790; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; El Khoury F, 2016, INT J ONCOL, V49, P2558, DOI 10.3892/ijo.2016.3725; Eun K, 2017, BMB REP, V50, P117, DOI 10.5483/BMBRep.2017.50.3.222; Fanali C, 2014, WORLD J GASTROENTERO, V20, P923, DOI 10.3748/wjg.v20.i4.923; Gilbertson RJ, 2012, NATURE, V488, P462, DOI 10.1038/nature11480; Hale JS, 2014, STEM CELLS, V32, P1746, DOI 10.1002/stem.1716; Higa S, 2007, BIOCHEM BIOPH RES CO, V354, P686, DOI 10.1016/j.bbrc.2007.01.036; Hu TT, 2015, CELL BIOCHEM FUNCT, V33, P443, DOI 10.1002/cbf.3130; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kantara C, 2015, LAB INVEST, V95, P100, DOI 10.1038/labinvest.2014.133; Kawada M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40400; Kawamoto H, 2010, CELL TRANSPLANT, V19, P857, DOI 10.3727/096368910X508988; Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019; Kugimiya N, 2015, J CELL MOL MED, V19, P1569, DOI 10.1111/jcmm.12531; Lee SY, 2017, MOL CELLS, V40, P515, DOI 10.14348/molcells.2017.0089; Liu YS, 2013, BIOMED PHARMACOTHER, V67, P791, DOI 10.1016/j.biopha.2013.08.001; Mashima T, 2017, YAKUGAKU ZASSHI, V137, P129, DOI 10.1248/yakushi.16-00229-1; Medema JP, 2017, NEW ENGL J MED, V377, P888, DOI 10.1056/NEJMcibr1706541; Navarro-Alvarez N, 2010, CELL TRANSPLANT, V19, P865, DOI 10.3727/096368910X508997; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang CX, 2012, ONCOL REP, V28, P1301, DOI 10.3892/or.2012.1951; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Xie ZY, 2014, ONCOL RES TREAT, V37, P666, DOI 10.1159/000368842; Zhang Huan-Le, 2016, Shengli Xuebao, V68, P171, DOI 10.13294/j.aps.2016.0027	41	7	7	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188665	10.1371/journal.pone.0188665	http://dx.doi.org/10.1371/journal.pone.0188665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190716	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900096
J	McCormack, SW; Witzel, U; Watson, PJ; Fagan, MJ; Groning, F				McCormack, Steven W.; Witzel, Ulrich; Watson, Peter J.; Fagan, Michael J.; Groning, Flora			Inclusion of periodontal ligament fibres in mandibular finite element models leads to an increase in alveolar bone strains	PLOS ONE			English	Article							ORTHODONTIC TOOTH MOVEMENT; TRABECULAR BONE; COMPUTED-TOMOGRAPHY; BIOMECHANICAL STRESS; FEMORAL-HEAD; BITE FORCE; VOLUME 44; ISSUE 10; LOADS; SIMPLIFICATIONS	Alveolar bone remodelling is vital for the success of dental implants and orthodontic treatments. However, the underlying biomechanical mechanisms, in particular the function of the periodontal ligament (PDL) in bone loading and remodelling, are not well understood. The PDL is a soft fibrous connective tissue that joins the tooth root to the alveolar bone and plays a critical role in the transmission of loads from the tooth to the surrounding bone. However, due to its complex structure, small size and location within the tooth socket it is difficult to study in vivo. Finite element analysis (FEA) is an ideal tool with which to investigate the role of the PDL, however inclusion of the PDL in FE models is complex and time consuming, therefore consideration must be given to how it is included. The aim of this study was to investigate the effects of including the PDL and its fibrous structure in mandibular finite element models. A high-resolution model of a human molar region was created from micro-computed tomography scans. This is the first time that the fibrous structure of the PDL has been included in a model with realistic tooth and bone geometry. The results show that omission of the PDL creates a more rigid model, reducing the strains observed in the mandibular corpus which are of interest when considering mandibular functional morphology. How the PDL is modelled also affects the strains. The inclusion of PDL fibres alters the strains in the mandibular bone, increasing the strains in the tooth socket compared to PDL modelled without fibres. As strains in the alveolar bone are thought to play a key role in bone remodelling during orthodontic tooth movement, future FE analyses aimed at improving our understanding and management of orthodontic treatment should include the fibrous structure of the PDL.	[McCormack, Steven W.; Watson, Peter J.; Fagan, Michael J.] Univ Hull, Sch Engn & Comp Sci, Med & Biol Engn Res Grp, Kingston Upon Hull, N Humberside, England; [Witzel, Ulrich] Ruhr Univ Bochum, Fak Maschinenbau, Univ Str 150, Bochum, Germany; [Groning, Flora] Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med Res Programme, Aberdeen, Scotland	University of Hull; Ruhr University Bochum; University of Aberdeen	Groning, F (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med Res Programme, Aberdeen, Scotland.	f.groening@abdn.ac.uk	Groning, Flora/C-2220-2012	Groning, Flora/0000-0002-8127-4112	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I008462/1]; Marie Curie Actions Integration Grant [FP7-PEOPLE PERG7-GA-2010-268430]; BBSRC [BB/I008462/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008462/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Actions Integration Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk; BB/I008462/1) (FG and MJF) and Marie Curie Actions Integration Grant (ec.europa.eu/research/mariecurieactions; FP7-PEOPLE PERG7-GA-2010-268430) (FG and MJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sukhun J, 2007, J BIOMED MATER RES A, V80A, P234, DOI 10.1002/jbm.a.30894; ATMARAM GH, 1981, J DENT RES, V60, P873, DOI 10.1177/00220345810600050301; BAUMRIND S, 1969, AMER J ORTHODONTICS, V55, P12, DOI 10.1016/S0002-9416(69)90170-5; BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Bourauel C, 1999, J Orofac Orthop, V60, P136, DOI 10.1007/BF01298963; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V133, P681, DOI 10.1016/j.ajodo.2006.05.038; Cattaneo PM, 2005, J DENT RES, V84, P428, DOI 10.1177/154405910508400506; Chen JN, 2014, J BIOMECH, V47, P1689, DOI 10.1016/j.jbiomech.2014.02.030; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; CURREY JD, 1968, J THEOR BIOL, V20, P91, DOI 10.1016/0022-5193(68)90094-5; Daegling DJ, 2000, AM J PHYS ANTHROPOL, V112, P541, DOI 10.1002/1096-8644(200008)112:4<541::AID-AJPA8>3.0.CO;2-Z; Daegling DJ, 1997, J HUM EVOL, V33, P705, DOI 10.1006/jhev.1997.0164; Dalstra M, 2015, J BIOMECH, V48, P801, DOI 10.1016/j.jbiomech.2014.12.014; Dalstra M, 2006, Orthod Craniofac Res, V9, P199; Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7; Dorow Christina, 2002, J Orofac Orthop, V63, P94, DOI 10.1007/s00056-002-0107-4; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Fajardo RJ, 2007, ANAT REC, V290, P422, DOI 10.1002/ar.20493; Fill Ted S, 2011, J Dent Biomech, V2011, P312980, DOI 10.4061/2011/312980; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Groning F, 2012, J BIOMECH, V45, P1749, DOI 10.1016/j.jbiomech.2011.10.042; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Grosse IR, 2012, J BIOMECH, V45, P1750, DOI 10.1016/j.jbiomech.2012.01.047; HERT J, 1969, Folia Morphologica (Prague), V17, P389; Hohmann A, 2011, AM J ORTHOD DENTOFAC, V139, P775, DOI 10.1016/j.ajodo.2009.11.014; HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102; HYLANDER WL, 1985, AM ZOOL, V25, P315; Jones M L, 2001, J Orthod, V28, P29; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; Kohnke P., 2009, THEORY REFERENCE MEC; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572; LISKOVA M, 1971, Folia Morphologica (Prague), V19, P301; Mac Donald BJ., 2007, PRACTICAL STRESS ANA; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; McCormack SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102387; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Melsen B, 1999, ANGLE ORTHOD, V69, P151; Meyer BN, 2010, AM J ORTHOD DENTOFAC, V137, P354, DOI 10.1016/j.ajodo.2008.03.029; Middleton J, 1996, AM J ORTHOD DENTOFAC, V109, P155, DOI 10.1016/S0889-5406(96)70176-2; de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005; Naveh GRS, 2012, ARCH ORAL BIOL, V57, P1575, DOI 10.1016/j.archoralbio.2012.07.006; Naveh GRS, 2012, J STRUCT BIOL, V177, P477, DOI 10.1016/j.jsb.2011.11.019; O'Connor CF, 2005, AM J PHYS ANTHROPOL, V127, P129, DOI 10.1002/ajpa.20025; Provatidis CG, 2000, MED ENG PHYS, V22, P359, DOI 10.1016/S1350-4533(00)00055-2; Qian HH, 2001, AM J ORTHOD DENTOFAC, V120, P272, DOI 10.1067/mod.2001.116085; Ralph WJ, 1998, J ORAL REHABIL, V15, P499; Ramos A, 2011, EXP MECH, V51, P1053, DOI 10.1007/s11340-010-9403-x; Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Ryan TM, 2002, J HUM EVOL, V43, P241, DOI 10.1006/jhev.2002.0575; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schroeder H.E., 2000, ORALE STRUKTURBIOLOG, V5th; Schwarz A.M., 1932, INT J ORTHODONTIA OR, V18, P331, DOI [10.1016/S0099-6963(32)80074-8, DOI 10.1016/S0099-6963(32)80074-8]; SLOAN P, 1979, J ROY SOC MED, V72, P188, DOI 10.1177/014107687907200308; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; van Driel WD, 2000, P I MECH ENG H, V214, P497, DOI 10.1243/0954411001535525; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Witzel U, 1998, TARGET, V1, P10; Yasar F, 2005, DENTOMAXILLOFAC RAD, V34, P261, DOI 10.1259/dmfr/85149245; Zhao LP, 2001, P ANN INT IEEE EMBS, V23, P2509, DOI 10.1109/IEMBS.2001.1017289	72	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188707	10.1371/journal.pone.0188707	http://dx.doi.org/10.1371/journal.pone.0188707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190785	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900105
J	Robineau, O; Velter, A; Barin, F; Boelle, PY				Robineau, Olivier; Velter, Annie; Barin, Francis; Boelle, Pierre-Yves			HIV transmission and pre-exposure prophylaxis in a high risk MSM population: A simulation study of location-based selection of sexual partners	PLOS ONE			English	Article							UNITED-STATES; RACIAL DISPARITIES; COST-EFFECTIVENESS; BISEXUAL MEN; WHITE MEN; PREVALENCE; INFECTION; EPIDEMIC; BEHAVIOR; VENUES	Objective In France, indications for pre-exposure prophylaxis (PrEP) for HIV prevention are based on individual-level risk factors for HIV infection. However, the risk of HIV infection may also depend on characteristics of sexual partnerships. Here we study how place-based selection of partners change transmission and the overall efficiency of PrEP. Methods We used the PREVAGAY survey of sexual behavior and HIV serostatus in men who have sex with men (MSM) in a Parisian district to look for associations between sexual network characteristics and HIV infection. We then simulated HIV transmission in a high-risk MSM population. We used information about venues visited to meet casual sexual partners (clubs, backrooms or saunas) to define sexual networks. We then simulated HIV transmission in these networks and assessed the impact of PrEP in this population. Results In the PREVAGAY study, we found that HIV serostatus changed with the type of venues visited, in addition to other individual risk factors. In simulations, we found similar differences in HIV incidence when the choice of venues visited was not random. The use of PrEP allowed reducing incidence, irrespective of the venues visited by PrEP users. However, with the same amount of PrEP, the number of infections adverted could almost double depending on network structure and venues visited by PrEP users. Conclusion This study shows that characteristics of the sexual network structure can strongly impact the effectiveness of PrEP interventions. These should be considered further to refine individual risk assessment and maximize the effect of individual-based prevention policies.	[Robineau, Olivier; Boelle, Pierre-Yves] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,U1136, Paris, France; [Robineau, Olivier] Ctr Hosp Gustave Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Robineau, Olivier] Univ Lille 2, Dept Malad Infect, Lille, France; [Velter, Annie] Sante Publ France, St Maurice, France; [Barin, Francis] Univ Tours, INSERM, UMR966, Tours, France; [Barin, Francis] Ctr Hosp Reg Univ, Ctr Natl Ref VIH, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Robineau, O (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,U1136, Paris, France.; Robineau, O (corresponding author), Ctr Hosp Gustave Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France.; Robineau, O (corresponding author), Univ Lille 2, Dept Malad Infect, Lille, France.	olivier.robineau82@gmail.com			Agence publique francaise de recherches sur le sida et les hepatites virales	Agence publique francaise de recherches sur le sida et les hepatites virales	PYB received grant from Agence publique francaise de recherches sur le sida et les hepatites virales: www.anrs.fr.	[Anonymous], 2016, DIAGN TREATM CAR KEY; Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Beymer MR, 2017, SEX TRANSM DIS, V44, P49, DOI 10.1097/OLQ.0000000000000535; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Carnegie NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043048; Cassels S, 2008, JAIDS-J ACQ IMM DEF, V47, pS34, DOI 10.1097/QAI.0b013e3181605da3; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Cremin I, LANCET HIV; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; deWit JBF, 1997, INT J STD AIDS, V8, P130, DOI 10.1258/0956462971919552; Doherty IA, 2006, SEX TRANSM DIS, V33, P368, DOI 10.1097/01.olq.0000194586.66409.7a; Gilead Sciences Inc, 2017, ANN M STOCKH W SAN F; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Goodreau SM, 2017, LANCET HIV, V4, pE311, DOI 10.1016/S2352-3018(17)30067-X; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grov C, 2007, AIDS BEHAV, V11, P915, DOI 10.1007/s10461-006-9199-y; Grov C, 2013, ARCH SEX BEHAV, V42, P291, DOI 10.1007/s10508-011-9854-x; Grov C, 2012, AIDS EDUC PREV, V24, P102, DOI 10.1521/aeap.2012.24.2.102; Grov C, 2010, AIDS EDUC PREV, V22, P496, DOI 10.1521/aeap.2010.22.6.496; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Handcock MS, STATISTICS, V26; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Jenness SM, 2016, SEX TRANSM INFECT, V92, P619, DOI 10.1136/sextrans-2015-052476; Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439; Jenness SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169484; Jenness SM, 2016, J INFECT DIS, V214, P1800, DOI 10.1093/infdis/jiw223; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; Kasaie P, 1999, J ACQ IMMUN DEF SYND, V2017; Kerr ZY, 2015, ARCH SEX BEHAV, V44, P443, DOI 10.1007/s10508-014-0352-9; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Le Vu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039872; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Madge S, 2008, HIV MED, V9, P208, DOI 10.1111/j.1468-1293.2008.00548.x; Marcus U, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009107; McCormack S., 2015, LANCET, V9; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Mitchell KM, 2014, J THEOR BIOL, V355, P140, DOI 10.1016/j.jtbi.2014.04.005; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM., 2017, 9 INT AIDS C AIDS 20; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; Omori R, 2017, AIDS, V31, P1721, DOI [10.1097/QAD.0000000000001542, 10.1097/qad.0000000000001542]; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Prise en charge medicale des personnes vivant avec le VIH, PRIS CHARG MED PERS; Punyacharoensin N, 2016, LANCET HIV, V3, pE94, DOI 10.1016/S2352-3018(15)00056-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rusow JA, 2017, AIDS BEHAV, V21, P1149, DOI 10.1007/s10461-016-1630-4; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Stromgren M, 2017, EPIDEMIOL INFECT, V145, P2582, DOI 10.1017/S0950268817001169; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Velter A, 2013, AIDS BEHAV, V17, P1266, DOI 10.1007/s10461-012-0303-1; Weinstein M, 2017, AIDS, V31, P2303, DOI 10.1097/QAD.0000000000001626	65	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189002	10.1371/journal.pone.0189002	http://dx.doi.org/10.1371/journal.pone.0189002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190784	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900189
J	Shao, S; Xiang, C; Qin, KR; Aziz, AUR; Liao, XL; Liu, B				Shao, Shuai; Xiang, Cheng; Qin, Kairong; Aziz, Aziz Ur Rehman; Liao, Xiaoling; Liu, Bo			Visualizing the spatiotemporal map of Rac activation in bovine aortic endothelial cells under laminar and disturbed flows	PLOS ONE			English	Article							SHEAR-STRESS; NEUTROPHIL CHEMOTAXIS; MEMBRANE-FLUIDITY; LIVING CELLS; MICROTUBULES; MIGRATION; DYNAMICS; ROLES; RHO; TRANSLOCATION	Disturbed flow can eliminate the alignment of endothelial cells in the direction of laminar flow, and significantly impacts on atherosclerosis in collateral arteries near the bifurcation and high curvature regions. While shear stress induced Rac polarity has been shown to play crucial roles in cell polarity and migration, little is known about the spatiotemporal map of Rac under disturbed flow, and the mechanism of flow-induced cell polarity still needs to be elucidated. In this paper, disturbed flow or laminar flow with 15 dyn/cm(2) of average shear stress was applied on bovine aortic endothelial cells (BAECs) for 30 minutes. A genetically-encoded PAK-PBD-GFP reporter was transfected into BAECs to visualize the real-time activation of Rac in living cell under fluorescence microscope. The imaging of the fluorescence intensity was analyzed by Matlab and the normalized data was converted into 3D spatiotemporal map. Then the changes of data upon chemical interference were fitted with logistic curve to explore the rule and mechanism of Rac polarity under laminar or disturbed flow. A polarized Rac activation was observed at the downstream edge along the laminar flow, which was enhanced by benzol alcohol-enhanced membrane fluidity but inhibited by nocodazole- disrupted microtubules or cholesterol-inhibited membrane fluidity, while no obvious polarized Rac activation could be found upon disturbed flow application. It is concluded that disturbed flow inhibits the flow-induced Rac polarized activation, which is related to the interaction of cell membrane and cytoskeleton, especially the microtubules.	[Shao, Shuai; Qin, Kairong; Aziz, Aziz Ur Rehman; Liu, Bo] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China; [Shao, Shuai] Univ Jyvaskyla, Fac Informat Technol, Dept Math, Math Informat Technol, Jyvaskyla, Finland; [Xiang, Cheng] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Liao, Xiaoling] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Chongqing, Peoples R China	Dalian University of Technology; University of Jyvaskyla; National University of Singapore; Chongqing University of Science & Technology	Liu, B (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China.	lbo@dlut.edu.cn		Aziz, Aziz ur Rehman/0000-0003-3706-393X	National Natural Science Foundation of China (NSFC) [31670867, 31670961, 11532004]; Natural Science Key Foundation Project of CQ in China [CSTC2015JCYJBX0003]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Key Foundation Project of CQ in China	This work was supported in part by grants from National Natural Science Foundation of China (NSFC No. 31670867, No. 31670961, No.11532004), and Natural Science Key Foundation Project of CQ in China (CSTC2015JCYJBX0003).	Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Barakat AI, 2003, CELL BIOCHEM BIOPHYS, V38, P323, DOI 10.1385/CBB:38:3:323; Butler PJ, 2001, FASEB J, V15, P216, DOI 10.1096/fj.01-0434fje; Butler PJ, 2001, AM J PHYSIOL-CELL PH, V280, pC962, DOI 10.1152/ajpcell.2001.280.4.C962; Chen CN, 2006, BLOOD, V107, P1933, DOI 10.1182/blood-2005-08-3137; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; CHOI HW, 2004, C P IEEE ENG MED BIO, V26, P5065; Collins Caitlin, 2014, Small GTPases, V5, pe28650, DOI 10.4161/sgtp.28650; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Kato T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097749; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; KELLER HU, 1984, EXP CELL RES, V153, P173, DOI 10.1016/0014-4827(84)90459-2; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Liu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07008; Liu B, 2011, CARDIOVASC RES, V91, P124, DOI 10.1093/cvr/cvr033; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; Magalhaes MAO, 2007, J LEUKOCYTE BIOL, V82, P559, DOI 10.1189/jlb.0207126; Moissoglu K, 2014, J CELL SCI, V127, P2565, DOI 10.1242/jcs.149088; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Omelchenko T, 2002, P NATL ACAD SCI USA, V99, P10452, DOI 10.1073/pnas.152339899; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wang C, 2012, J BIOMECH, V45, P1212, DOI 10.1016/j.jbiomech.2012.01.045; Wang XX, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/066002; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189088	10.1371/journal.pone.0189088	http://dx.doi.org/10.1371/journal.pone.0189088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190756	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900199
J	Stefan, KL; Fink, A; Surana, NK; Kasper, DL; Dasgupta, S				Stefan, Kailyn L.; Fink, Avner; Surana, Neeraj K.; Kasper, Dennis L.; Dasgupta, Suryasarathi			Type I interferon signaling restrains IL-10R(+) colonic macrophages and dendritic cells and leads to more severe Salmonella colitis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTERLEUKIN-10 RECEPTOR; INFLAMMATORY RESPONSE; INFECTION; BACTERIA; INNATE; PATHOGENESIS; ACTIVATION; IMMUNITY; ROLES	Type I interferons (IFN alpha, IFN beta) are key regulators of innate and adaptive immunity, modulating the severity of both viral and bacterial infections. While type I IFN signaling leads to improved outcomes in viral infections, its role in bacterial infections is more contextual and depends on the specific pathogen and route of infection. Given the limited evidence on whether type I IFN signaling affects enteric bacterial pathogens, we investigated the role of this signaling pathway in Salmonella enterica serovar Typhimurium (S. typhimurium) - induced colitis. Comparing mice deficient in IFNAR1- the common receptor for IFNa and IFN beta-with wild-type mice, we found that type I IFN signaling leads to more rapid death, more severe colonic inflammation, higher serum levels of pro-inflammatory cytokines, and greater bacterial dissemination. Specific ablation of plasmacytoid dendritic cells (pDCs), which are prominent producers of type I IFNs in antiviral responses, did not alter survival after infection. This result established that pDCs do not play a major role in the pathogenesis of S. typhimurium colitis. Flow cytometric analysis of macrophages and conventional dendritic cells (cDCs) during active colitis demonstrated an increase in CD11c(-) macrophages and CD103(+) cDCs in the colon of Ifnar1(-/-) animals. Interestingly, cells expressing the antiinflammatory cytokine receptor IL-10R are more abundant within these subsets in Ifnar1-/ than in wild-type mice. Moreover, blockade of IL-10R in Ifnar1(-/-) mice increased their susceptibility to S. typhimurium colitis, suggesting that altered numbers of these immunoregulatory cells may underlie the difference in disease severity. This cross-talk between type I IFN and IL-10R signaling pathways may represent a key host cellular mechanism to investigate further in order to unravel the balance between pathogenic inflammation and homeostasis of the colon. Taken together, our data clearly demonstrate that type I IFN signaling is pathogenic in S. typhimurium colitis.	[Stefan, Kailyn L.; Fink, Avner; Surana, Neeraj K.; Kasper, Dennis L.; Dasgupta, Suryasarathi] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Surana, Neeraj K.] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA USA; [Fink, Avner] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Jerusalem, Israel; [Dasgupta, Suryasarathi] Takeda Calif Inc, Div Immunol, San Diego, CA 92121 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Hebrew University of Jerusalem; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Dasgupta, S (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.; Dasgupta, S (corresponding author), Takeda Calif Inc, Div Immunol, San Diego, CA 92121 USA.	Surya.Dasgupta@gmail.com			NIAID NIH HHS [T32 AI007061, K08 AI108690] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI108690, T32AI007061] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Dhariwala MO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00545; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gomes MTR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00130; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Michea P, 2013, EUR J IMMUNOL, V43, P1264, DOI 10.1002/eji.201242990; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Naves R, 2013, J IMMUNOL, V191, P2967, DOI 10.4049/jimmunol.1300419; Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222; Pitts MG, 2016, J IMMUNOL, V196, P3109, DOI 10.4049/jimmunol.1502192; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Williams NL, 2015, MICROBES INFECT, V17, P311, DOI 10.1016/j.micinf.2014.12.007; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188600	10.1371/journal.pone.0188600	http://dx.doi.org/10.1371/journal.pone.0188600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190678	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900081
J	Praphasiri, P; Ditsungnoen, D; Sirilak, S; Rattanayot, J; Areerat, P; Dawood, FS; Lindblade, KA				Praphasiri, Prabda; Ditsungnoen, Darunee; Sirilak, Supakit; Rattanayot, Jarawee; Areerat, Peera; Dawood, Fatimah S.; Lindblade, Kim A.			Predictors of seasonal influenza vaccination among older adults in Thailand	PLOS ONE			English	Article							VULNERABLE ELDERS SURVEY; RISK; HOSPITALIZATION; VACCINES; SERVICES; SENIORS; PEOPLE; DEATH; BIAS	Background In advance of a large influenza vaccine effectiveness (VE) cohort study among older adults in Thailand, we conducted a population-based, cross-sectional survey to measure vaccine coverage and identify factors associated with influenza vaccination among older Thai adults that could bias measures of vaccine effectiveness. Method We selected adults >= 65 years using a two-stage, stratified, cluster sampling design. Functional status was assessed using the 10-point Vulnerable Elders Survey (VES); scores >= 3 indicated vulnerability. Questions about attitudes towards vaccination were based on the Health Belief Model. The distance between participants' households and the nearest vaccination clinic was calculated. Vaccination status was determined using national influenza vaccination registry. Prevalence ratios (PR) and 95% confidence intervals (Cis) were calculated using log-binomial multivariable models accounting for the sampling design. Result We enrolled 581 participants, of whom 60% were female, median age was 72 years, 41% had at least one chronic underlying illness, 24% met the criteria for vulnerable, and 23% did not leave the house on a daily basis. Influenza vaccination rate was 34%. In multivariable models, no variable related to functional status was associated with vaccination. The strongest predictors of vaccination were distance to the nearest vaccination center (PR 3.0, 95% CI 1.7-5.1 for participants in the closest quartile compared to the furthest), and high levels of a perception of benefits of influenza vaccination (PR 2.8, 95% CI 1.4-5.6) and cues to action (PR 2.7, 95% CI 1.5-5.1). Conclusion Distance to vaccination clinics should be considered in analyses of influenza VE studies in Thailand. Strategies that emphasize benefits of vaccination and encourage physicians to recommend annual influenza vaccination could improve influenza vaccine uptake among older Thai adults. Outreach to more distant and less mobile older adults may also be required to improve influenza vaccination coverage.	[Praphasiri, Prabda; Ditsungnoen, Darunee; Lindblade, Kim A.] Thailand MOPH US CDC Collaborat, Influenza Program, Nonthaburi, Thailand; [Sirilak, Supakit] Thailand Minist Publ Hlth, Tech Hlth Off, Nonthaburi, Thailand; [Rattanayot, Jarawee] Natl Hlth Secur Off, Bangkok, Thailand; [Areerat, Peera] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand; [Dawood, Fatimah S.; Lindblade, Kim A.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Praphasiri, P (corresponding author), Thailand MOPH US CDC Collaborat, Influenza Program, Nonthaburi, Thailand.	hpu3@cdc.gov		Praphasiri, Prabda/0000-0003-4593-0247; Lindblade, Kim/0000-0002-5593-0470	Centers for Disease Control and Prevention (CDC); Ministry of Public Health, Thailand [5-U01 GH000152-03]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Ministry of Public Health, Thailand	This survey was supported by the Centers for Disease Control and Prevention (CDC) and awarded to the Ministry of Public Health, Thailand in cooperative agreement 5-U01 GH000152-03. SS acquired the funding. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ang LW, 2014, EMERG INFECT DIS, V20, P1652, DOI 10.3201/eid2010.131768; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, NAKHON PHANOM PROVIN; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Dawood FS, 2014, INFLUENZA OTHER RESP, V8, P463, DOI 10.1111/irv.12233; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fleiss J.L., 2004, DETERMINING SAMPLE S; Groenwold RHH, 2008, INT J EPIDEMIOL, V37, P1422, DOI 10.1093/ije/dyn173; Havers FP, 2016, CLIN INFECT DIS; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Lipsitch M, 2016, INT J EPIDEMIOL, V45, P2060, DOI 10.1093/ije/dyw124; Min LC, 2006, J AM GERIATR SOC, V54, P507, DOI 10.1111/j.1532-5415.2005.00615.x; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; Newall AT, 2008, VACCINE, V26, P2135, DOI 10.1016/j.vaccine.2008.01.051; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Payaprom Y, 2010, J PUBLIC HEALTH-UK, V32, P26, DOI 10.1093/pubmed/fdp086; Prakongsai P, 2006, APPL ASSET INDEX MEA; Remschmidt C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1154-y; RIDDIOUGH MA, 1981, PUBLIC HEALTH REP, V96, P528; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Worasathit R, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0137-6	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188422	10.1371/journal.pone.0188422	http://dx.doi.org/10.1371/journal.pone.0188422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186159	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900036
J	Kuo, A; Lee, MY; Yang, K; Gross, RW; Sessa, WC				Kuo, Andrew; Lee, Monica Y.; Yang, Kui; Gross, Richard W.; Sessa, William C.			Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin-stimulated, cAMP-mediated lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; MASS-SPECTROMETRY; PLASMA-MEMBRANE; SHOTGUN LIPIDOMICS; PULMONARY DEFECTS; MICE; ADIPOCYTES; PROTEIN; IDENTIFICATION; ABNORMALITIES	Lipid droplets (LD) are dynamic organelles involved in intracellular lipid metabolism in almost all eukaryotic cells, and LD-associated proteins tightly regulate their dynamics. One LD coat protein is caveolin-1 (Cav-1), an essential component for caveola assembly in highly differentiated cells, including adipocytes, smooth muscle cells, and endothelial cells (EC). However, the role of Cav-1 in LD dynamics is unclear. Here we report that EC lacking Cav-1 exhibit impaired LD formation. The decreased LD formation is due to enhanced lipolysis and not caused by reduced triglyceride synthesis or fatty acid uptake. Mechanistically, the absence of Cav-1 increased cAMP/PKA signaling in EC, as indicated by elevated phosphorylation of hormone-sensitive lipase and increased lipolysis. Unexpectedly, we also observed enhanced autocrine production of prostaglandin I-2 (PGI(2), also called prostacyclin) in Cav-1KOEC, and this PGI(2) increase appeared to stimulate cAMP/PKA pathways, contributing to the enhanced lipolysis in Cav-1 KO cells. Our results reveal an unanticipated role of Cav-1 in regulating lipolysis in non-adipose tissue, indicating that Cav-1 is required for LD metabolism in EC and that it regulates cAMP-dependent lipolysis in part via the autocrine production of PGI(2).	[Kuo, Andrew; Lee, Monica Y.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06510 USA; [Lee, Monica Y.; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Kuo, Andrew] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Med & Dev Biol, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Yale University; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL)	Sessa, WC (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06510 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938	National Institutes of Health [R01 HL64793, R01 HL61371, P01 HL1070295, R01 HL118639]; MERIT award from the American Heart Association; Leducq Fondation (MIRVAD Network); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639, R01HL064793, R01HL061371, R01HL133178, R35HL139945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MERIT award from the American Heart Association; Leducq Fondation (MIRVAD Network); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, and P01 HL1070295; a MERIT award from the American Heart Association and the Leducq Fondation (MIRVAD Network) (to W.C.S.), and National Institutes of Health Grant R01 HL118639 (to R.W.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Blouin CM, 2008, BIOCHEM BIOPH RES CO, V376, P331, DOI 10.1016/j.bbrc.2008.08.154; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chen YY, 2016, FIFTEENTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, P1; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kuo A, 2017, CIRC RES, V120, P1289, DOI 10.1161/CIRCRESAHA.116.310498; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; Midgett C, 2011, CURR MOL MED, V11, P517, DOI 10.2174/156652411800615144; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Shiroto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087871; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang K, 2015, ANAL BIOANAL CHEM, V407, P5199, DOI 10.1007/s00216-015-8640-3; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	35	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					973	983		10.1074/jbc.RA117.000980	http://dx.doi.org/10.1074/jbc.RA117.000980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203526	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000422864500018
J	Kriebel, R; Khabbazian, M; Sytsma, KJ				Kriebel, Ricardo; Khabbazian, Mohammad; Sytsma, Kenneth J.			A continuous morphological approach to study the evolution of pollen in a phylogenetic context: An example with the order Myrtales	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; DIVERGENCE TIMES; STABILIZING SELECTION; MORPHOMETRIC-ANALYSIS; REPRODUCTIVE-BIOLOGY; MOLECULAR PHYLOGENY; FLOWERING PLANTS; TRAIT EVOLUTION; GENOME SIZE; GENUS	The study of pollen morphology has historically allowed evolutionary biologists to assess phylogenetic relationships among Angiosperms, as well as to better understand the fossil record. During this process, pollen has mainly been studied by discretizing some of its main characteristics such as size, shape, and exine ornamentation. One large plant clade in which pollen has been used this way for phylogenetic inference and character mapping is the order Myrtales, composed by the small families Alzateaceae, Crypteroniaceae, and Penaeaceae (collectively the "AP clade"), as well as the large families Combretaceae, Lythraceae, Melastomataceae, Myrtaceae, Onagraceae and Vochysiaceae. In this study, we present a novel way to study pollen evolution by using quantitative size and shape variables. We use morphometric and morphospace methods to evaluate pollen change in the order Myrtales using a time-calibrated, supermatrix phylogeny. We then test for conservatism, divergence, and morphological convergence of pollen and for correlation between the latitudinal gradient and pollen size and shape. To obtain an estimate of shape, Myrtales pollen images were extracted from the literature, and their outlines analyzed using elliptic Fourier methods. Shape and size variables were then analyzed in a phylogenetic framework under an Ornstein-Uhlenbeck process to test for shifts in size and shape during the evolutionary history of Myrtales. Few shifts in Myrtales pollen morphology were found which indicates morphological conservatism. Heterocolpate, small pollen is ancestral with largest pollen in Onagraceae. Convergent shifts in shape but not size occurred in Myrtaceae and Onagraceae and are correlated to shifts in latitude and biogeography. A quantitative approach was applied for the first time to examine pollen evolution across a large time scale. Using phylogenetic based morphometrics and an OU process, hypotheses of pollen size and shape were tested across Myrtales. Convergent pollen shifts and position in the latitudinal gradient support the selective role of harmomegathy, the mechanism by which pollen grains accommodate their volume in response to water loss.	[Kriebel, Ricardo; Sytsma, Kenneth J.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Khabbazian, Mohammad] Columbia Univ, Dept Stat, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University	Kriebel, R (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	kriebelr@gmail.com		Kriebel, Ricardo/0000-0002-1138-7533	US National Science Foundation's Dimensions of Biodiversity program [DEB-1046355]; Hofmeister Fund, Botany Department, University of Wisconsin, Madison	US National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Hofmeister Fund, Botany Department, University of Wisconsin, Madison	US National Science Foundation's Dimensions of Biodiversity program (awards DEB-1046355) provided the time commitment of Kriebel and Sytsma. Additional support came from the Hofmeister Fund, Botany Department, University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Khanbeygi Z., 2011, Iranian Journal of Botany, V17, P158; ALMEDA F, 1993, BRITTONIA, V45, P187, DOI 10.2307/2807100; APSA, 2007, AUSTR POLL SPOR ATL; Barth O. M., 1975, Memorias do Instituto Oswaldo Cruz, V73, P101, DOI 10.1590/S0074-02761975000100007; Barth OM, 2014, REV BIOL TROP, V62, P1209, DOI 10.15517/rbt.v62i3.12323; BEARDSELL DV, 1993, AUST J BOT, V41, P511, DOI 10.1071/BT9930511; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Beaulieu JM, 2013, EVOLUTION, V67, P3132, DOI 10.1111/evo.12180; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Berger BA, 2016, MOL PHYLOGENET EVOL, V95, P116, DOI 10.1016/j.ympev.2015.10.001; Blackmore S, 1984, POLLEN SPORES FORM F, P137; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bonhomme V, 2013, PLANT SYST EVOL, V299, P811, DOI 10.1007/s00606-013-0762-5; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; BROWN C A, 1967, Review of Palaeobotany and Palynology, V3, P163, DOI 10.1016/0034-6667(67)90050-4; Bush MB, 2007, J BIOGEOGR, V34, P377, DOI 10.1111/j.1365-2699.2006.01645.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Campos D. Cos, 1964, POLLEN SPORES, V6, P303; Carrno-Oliveira R, 2009, ACTA BOT BRAS, V23, P780, DOI 10.1590/S0102-33062009000300018; Chantaranothai P, 1997, GRANA, V36, P146, DOI 10.1080/00173139709362602; Chartier M, 2014, NEW PHYTOL, V204, P841, DOI 10.1111/nph.12969; Chen WH, 2007, ACTA PHYTOTAXON SIN, V45, P587, DOI 10.1360/aps050006; Chong SML, 2014, PHILIPP J CROP SCI, V39, P1; Conti E, 1997, SYST BOT, V22, P629, DOI 10.2307/2419432; Conti E, 2004, EVOLUTION, V58, P1874; Cressler CE, 2015, SYST BIOL, V64, P953, DOI 10.1093/sysbio/syv043; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; DAGHLIAN CP, 1985, AM J BOT, V72, P1039, DOI 10.2307/2443446; DAHLGREN R, 1984, ANN MO BOT GARD, V71, P633, DOI 10.2307/2399158; De Frenne P, 2013, J ECOL, V101, P784, DOI 10.1111/1365-2745.12074; Eberle J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098536; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Ejsmond MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00147.1; Fiz O, 2008, SYST BOT, V33, P326, DOI 10.1600/036364408784571482; Furness CA, 2012, INT J PLANT SCI, V173, P1055, DOI 10.1086/667614; Furness CA, 2010, INT J PLANT SCI, V171, P713, DOI 10.1086/654848; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; GRAHAM A, 1987, AM J BOT, V74, P829, DOI 10.2307/2443864; GRAHAM A, 1990, AM J BOT, V77, P159, DOI 10.1002/j.1537-2197.1990.tb13543.x; GRAHAM A, 1985, AM J BOT, V72, P1012, DOI 10.2307/2443444; GRAHAM A, 1968, AM J BOT, V55, P1080, DOI 10.2307/2440476; GRAHAM SA, 1977, SYST BOT, V2, P61, DOI 10.2307/2418502; Graham SA, 2010, ANN MO BOT GARD, V97, P34, DOI 10.3417/2007028; Gressler Eliana, 2006, Braz. J. Bot., V29, P509, DOI 10.1590/S0100-84042006000400002; Grimsson F, 2012, PLANT SYST EVOL, V298, P671, DOI 10.1007/s00606-011-0578-0; Grimsson F, 2012, INT J PLANT SCI, V173, P297, DOI 10.1086/663968; GROSS CL, 1993, BIOTROPICA, V25, P468, DOI 10.2307/2388870; Guers J., 1974, TRAVAUX DOCUMENTS GE, V16, P86; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harder LD, 1998, BIOL J LINN SOC, V64, P513, DOI 10.1111/j.1095-8312.1998.tb00347.x; Ho LST, 2014, METHODS ECOL EVOL, V5, P1133, DOI 10.1111/2041-210X.12285; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hsieh Tsung-Hsin, 1999, Taiwania, V44, P529; JOHNSON LAS, 1984, ANN MO BOT GARD, V71, P700, DOI 10.2307/2399159; Katifori E, 2010, P NATL ACAD SCI USA, V107, P7635, DOI 10.1073/pnas.0911223107; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KERI C, 1992, GRANA, V31, P119, DOI 10.1080/00173139209430731; Kerkhoff AJ, 2014, P NATL ACAD SCI USA, V111, P8125, DOI 10.1073/pnas.1308932111; Khabbazian M, 2016, METHODS ECOL EVOL, V7, P811, DOI 10.1111/2041-210X.12534; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Knight C.A, 2010, J BOT; Ksepka DT, 2011, BIOL LETTERS, V7, P801, DOI 10.1098/rsbl.2011.0356; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LADD PG, 1994, BOT J LINN SOC, V115, P165, DOI 10.1006/bojl.1994.1040; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lee S, 1979, KOREAN J BOT, V22, P115; Leslie AB, 2015, EVOLUTION, V69, P1573, DOI 10.1111/evo.12670; Lindbladh MS, 2002, AM J BOT, V89, P1459, DOI 10.3732/ajb.89.9.1459; Linder HP, 2014, J BIOGEOGR, V41, P1313, DOI 10.1111/jbi.12312; Liu YS, 2008, GRANA, V47, P262, DOI 10.1080/00173130802457255; LUMER C, 1980, BRITTONIA, V32, P512, DOI 10.2307/2806163; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Makbul S, 2008, ACTA BIOL CRACOV BOT, V50, P51; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Mangiafico SS, 2015, R COMPANION HDB BIOL; Mayr G, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0223; Miller M.A., 2010, P GAT COMP ENV WORKS; MULLER J, 1981, REV PALAEOBOT PALYNO, V35, P93, DOI 10.1016/0034-6667(81)90016-6; MULLER J, 1979, ANN MO BOT GARD, V66, P593, DOI 10.2307/2398913; MULLER J, 1975, Blumea, V22, P275; Muller J, 1976, 4 INT PAL C LUCKN, V1, P194; Narayan R, 1985, J GENET, V64, P101; Narayan RKJ, 1998, ANN BOT-LONDON, V82, P57, DOI 10.1006/anbo.1998.0752; NOWICKE JW, 1984, ANN MO BOT GARD, V71, P35, DOI 10.2307/2399056; Palazzesi L, 2012, BIOL J LINN SOC, V107, P67, DOI 10.1111/j.1095-8312.2012.01910.x; Parham JF, 2011, SYSTEMATIC BIOL; PATEL V, 1983, AM J BOT, V70, P469, DOI 10.2307/2443255; PATEL VC, 1984, ANN MO BOT GARD, V71, P858, DOI 10.2307/2399170; PAYNE WW, 1981, REV PALAEOBOT PALYNO, V35, P39, DOI 10.1016/0034-6667(81)90013-0; Pires JC, 2008, ANN MO BOT GARD, V95, P275, DOI 10.3417/2007176; Premathilake R, 2001, GRANA, V40, P256, DOI 10.1080/00173130152987508; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2013, NATURE COMMUNICATION, V4, P55; RAVEN PH, 1979, NEW ZEAL J BOT, V17, P575, DOI 10.1080/0028825X.1979.10432572; RAVEN PH, 1984, ANN MO BOT GARD, V71, P631; RENNER S S, 1989, Memoirs of the New York Botanical Garden, V50, P1; RENNER SS, 1989, ANN MO BOT GARD, V76, P496, DOI 10.2307/2399497; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; ROBBINS RR, 1979, AM J BOT, V66, P538, DOI 10.2307/2442503; Rose JP, 2016, AM J BOT, V103, P652, DOI 10.3732/ajb.1500394; Roubik D.W., 1991, MONOGRAPHS SYSTEMATI, V36; Santos FAR, 1997, POLIBOTANICA, V5, P1; Sauquet H, 2003, INT J PLANT SCI, V164, P613, DOI 10.1086/375424; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schols P, 2005, SYST BOT, V30, P750, DOI 10.1600/036364405775097743; Schols P., 2004, Phyloinformatics, V1, P1; SCOTLAND RW, 1990, GRANA, V29, P37, DOI 10.1080/00173139009429975; Siver PA, 2013, GEOBIOLOGY, V11, P127, DOI 10.1111/gbi.12023; SKVARLA J J, 1978, Pollen et Spores, V20, P5; Skvarla JJ, 2005, TAXON, V54, P121, DOI 10.2307/25065308; Skvarla John J, 1975, Am J Bot, V62, P6, DOI 10.1002/j.1537-2197.1975.tb12334.x; SLATER AT, 1991, AUST J BOT, V39, P229, DOI 10.1071/BT9910229; Smith SA, 2012, BIOINFORMATICS, V28, P2689, DOI 10.1093/bioinformatics/bts492; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sytsma KJ, 2014, BIOL J LINN SOC, V113, P29, DOI 10.1111/bij.12297; Sytsma KJ, 2004, INT J PLANT SCI, V165, pS85, DOI 10.1086/421066; Thangaraja A, 2008, AFR J PLANT SCI, V2, P140; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Thornhill AH, 2015, MOL PHYLOGENET EVOL, V93, P29, DOI 10.1016/j.ympev.2015.07.007; Thornhill AH, 2012, REV PALAEOBOT PALYNO, V176, P1, DOI 10.1016/j.revpalbo.2012.03.003; Thornhill AH, 2012, AUST SYST BOT, V25, P171, DOI 10.1071/SB11019; Thornhill AH, 2012, AUST J BOT, V60, P225, DOI 10.1071/BT11176; Thornhill AH, 2012, AUST J BOT, V60, P260, DOI 10.1071/BT11177; Thornhill AH, 2012, AUST J BOT, V60, P200, DOI 10.1071/BT11175; Thornhill AH, 2012, AUST J BOT, V60, P165, DOI 10.1071/BT11174; Thornhill AH, 2012, MOL PHYLOGENET EVOL, V63, P15, DOI 10.1016/j.ympev.2011.12.003; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TING WILLIAM S., 1966, POLLEN SPORES, V8, P9; TOBE H, 1983, ANN MO BOT GARD, V70, P71, DOI 10.2307/2399008; Tomizono S., 2013, BOXPLOTDBL DOUBLE BO; Torres C, 2000, SEX PLANT REPROD, V12, P365, DOI 10.1007/s004970000030; van der Hammen T, 1966, LEIDSE GEOLOGISCHE M, V35, P105; VANDERHAM RWJM, 1989, BLUMEA, V34, P21; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Cruz-Barros Maria Amélia Vitorino da, 2007, Hoehnea, V34, P531; Volkova OA, 2013, PLANT SYST EVOL, V299, P1769, DOI 10.1007/s00606-013-0832-8; Wang WM, 2004, REV PALAEOBOT PALYNO, V131, P117, DOI 10.1016/j.revpalbo.2004.03.005; Wang Yu-Fa, 2001, Taiwania, V46, P167; Welsh M, 2010, PLANT SYST EVOL, V285, P83, DOI 10.1007/s00606-009-0259-4; Wiens JJ, 2001, SYST BIOL, V50, P689, DOI 10.1080/106351501753328811; Wilf P, 2015, NEW PHYTOL, V207, P283, DOI 10.1111/nph.13114; Wodehouse RP., 1935, POLLEN GRAINS; Wronska-Pilarek D, 2005, ACTA SOC BOT POL, V74, P297; Wronska-Pilarek D, 2011, PLANT SYST EVOL, V295, P55, DOI 10.1007/s00606-011-0462-y	153	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187228	10.1371/journal.pone.0187228	http://dx.doi.org/10.1371/journal.pone.0187228			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211730	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200014
J	Watson, CH; Coriakula, J; Ngoc, DTT; Flasche, S; Kucharski, AJ; Lau, CL; Thieu, NTV; de Waroux, OL; Rawalai, K; Van, TT; Taufa, M; Baker, S; Nilles, EJ; Kama, M; Edmunds, WJ				Watson, Conall H.; Coriakula, Jeremaia; Dung Tran Thi Ngoc; Flasche, Stefan; Kucharski, Adam J.; Lau, Colleen L.; Nga Tran Vu Thieu; de Waroux, Olivier le Polain; Rawalai, Kitione; Tan Trinh Van; Taufa, Mere; Baker, Stephen; Nilles, Eric J.; Kama, Mike; Edmunds, W. John			Social mixing in Fiji: Who-eats-with-whom contact patterns and the implications of age and ethnic heterogeneity for disease dynamics in the Pacific Islands	PLOS ONE			English	Article							MEDICAL-RESEARCH; TYPHOID-FEVER; TRANSMISSION; SPREAD; EPIDEMIOLOGY; INFECTIONS; PARAMETERS; NETWORKS; OUTBREAK; BEHAVIOR	Empirical data on contact patterns can inform dynamic models of infectious disease transmission. Such information has not been widely reported from Pacific islands, nor strongly multi-ethnic settings, and few attempts have been made to quantify contact patterns relevant for the spread of gastrointestinal infections. As part of enteric fever investigations, we conducted a cross-sectional survey of the general public in Fiji, finding that within the 9,650 mealtime contacts reported by 1,814 participants, there was strong like-with-like mixing by age and ethnicity, with higher contact rates amongst iTaukei than non-iTaukei Fijians. Extra-domiciliary lunchtime contacts follow these mixing patterns, indicating the overall data do not simply reflect household structures. Inter-ethnic mixing was most common amongst school-age children. Serological responses indicative of recent Salmonella Typhi infection were found to be associated, after adjusting for age, with increased contact rates between meal-sharing iTaukei, with no association observed for other contact groups. Animal ownership and travel within the geographical division were common. These are novel data that identify ethnicity as an important social mixing variable, and use retrospective mealtime contacts as a socially acceptable metric of relevance to enteric, contact and respiratory diseases that can be collected in a single visit to participants. Application of these data to other island settings will enable communicable disease models to incorporate locally relevant mixing patterns in parameterisation.	[Watson, Conall H.; Flasche, Stefan; Kucharski, Adam J.; de Waroux, Olivier le Polain; Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Coriakula, Jeremaia; Tan Trinh Van] Fiji Natl Univ, Sch Med, Suva, Fiji; [Dung Tran Thi Ngoc; Nga Tran Vu Thieu; Baker, Stephen] Hosp Trop Dis, Oxford Univ Clin Res Unit Vietnam, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Lau, Colleen L.] Australian Natl Univ, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia; [Rawalai, Kitione] Project HEAVEN, Suva, Fiji; [Taufa, Mere; Kama, Mike] Minist Hlth & Med Serv, Fiji Ctr Communicable Dis Control, Suva, Fiji; [Baker, Stephen] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Kama, Mike] World Hlth Org Western Pacific Region, Div Pacific Tech Support, Suva, Fiji	University of London; London School of Hygiene & Tropical Medicine; Fiji National University (FNU); Australian National University; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Watson, CH (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.	conall.watson@lshtm.ac.uk	Lau, Colleen L/F-5974-2012; Nilles, Eric/ABA-4757-2021	Lau, Colleen L/0000-0001-8288-4169; Nilles, Eric/0000-0001-7044-5257; Flasche, Stefan/0000-0002-5808-2606; le Polain de Waroux, Olivier/0000-0003-3458-2945; Coriakula, Jeremaia/0000-0002-9973-0980; Watson, Conall/0000-0002-2469-791X; Baker, Stephen/0000-0003-1308-5755	World Health Organization Western Pacific Region; UK Medical Research Council [MR/J003999/1]; Chadwick Trust; Australian National Health and Medical Research Council (NHMRC) Fellowship [1109035]; Global Change Institute at The University of Queensland [607562]; Wellcome Trust [100087/Z/12/Z]; Royal Society [100087/Z/12/Z]; Medical Research Council [1263989] Funding Source: researchfish	World Health Organization Western Pacific Region; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chadwick Trust; Australian National Health and Medical Research Council (NHMRC) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Global Change Institute at The University of Queensland; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Fieldwork was funded by the World Health Organization Western Pacific Region as part of typhoid and leptospirosis control. CHW is supported by the UK Medical Research Council (grant MR/J003999/1) and the Chadwick Trust. CLL was supported by an Australian National Health and Medical Research Council (NHMRC) Fellowship (1109035), and a research grant from the Global Change Institute (607562) at The University of Queensland. SB is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). EJN was an employee of the WHO. The other funders had no role in the design of the study, preparation of the manuscript or decision to publish.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2016, AUSTR OCEANIA FRENCH; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bakach I, 2015, T ROY SOC TROP MED H, V109, P679, DOI 10.1093/trstmh/trv075; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bates SJ, 2007, AM J EPIDEMIOL, V166, P1088, DOI 10.1093/aje/kwm184; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cornell S., 2007, ETHNICITY RACE MAKIN; Craig A, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2012.3.4.007, 10.5365/WPSAR.2012.3.4.007]; Cvjetanovic B, 1978, TYPHOID FEVER ENDEMI, P45; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Eames KT, 2010, HEAL TECHNOL ASSESS, V14; Edmunds WJ, 1997, P R SOC B, V264; Feachem R, 1983, SANITATION DIS; Fiji Bureau of Statistics, 2012, FIJ 2007 CENS POP HO; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Hens N., 2012, MODELING INFECT DIS; Hethcote H, 1984, LECT NOTES BIOMATH, P111; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Ibuka Y, 2015, J EPIDEMIOL COMMUNIT; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405; Lau CL, 2012, AM J TROP MED HYG, V86, P309, DOI 10.4269/ajtmh.2012.11-0398; Lauritsen J.M., 2005, EPIDATA ENTRY COMPRE; Marks M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003988; McKenzie K, 1996, BRIT MED J, V312, P1054; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Moss R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005018; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OSBORNE NG, 1992, JAMA-J AM MED ASSOC, V267, P275, DOI 10.1001/jama.267.2.275; Phimpraphai W, 2017, ACTA TROP, V169, P150, DOI 10.1016/j.actatropica.2017.02.001; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2014, P R SOC B; Reller ME, 2003, CLIN INFECT DIS, V37, P141, DOI 10.1086/375590; Rolls DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1237-9; Romani L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003452; Schmitt Robert C., 2001, HAWAIIAN J HIST, V35, P1; Shanks GD, 2016, AM J TROP MED HYG, V95, P273, DOI 10.4269/ajtmh.16-0169; Steer AC, 2008, EPIDEMIOL INFECT, V136, P621, DOI 10.1017/S095026880700917X; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; TAYLOR R, 1983, MED J AUSTRALIA, V2, P389, DOI 10.5694/j.1326-5377.1983.tb122536.x; Taylor R, 2013, AUST NZ J PUBL HEAL, V37, P509, DOI 10.1111/1753-6405.12116; Temple B, 2012, TROP MED INT HEALTH, V17, P197, DOI 10.1111/j.1365-3156.2011.02897.x; Thompson CN, 2014, TROP MED INT HEALTH, V19, P1284, DOI 10.1111/tmi.12367; van Hoek AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076180; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Watson CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005786; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186911	10.1371/journal.pone.0186911	http://dx.doi.org/10.1371/journal.pone.0186911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211731	Green Published, gold, Green Accepted			2022-12-26	WOS:000417212200010
J	Hsu, SD; Lee, SY; Lin, KT; Lin, CS; Chien, WC; Chen, CJ; Chung, CH; Chang, WK				Hsu, Sheng-Der; Lee, Shih-Yu; Lin, Kuen-Tze; Lin, Chun-Shu; Chien, Wu-Chien; Chen, Cheng-Jueng; Chung, Chi-Hsiang; Chang, Wei-Kuo			Risk of infertility following pelvic angiographic embolization in female patients with pelvic fractures: A nationwide population-based cohort study in Taiwan	PLOS ONE			English	Article							INTERNAL ILIAC ARTERY; POSTPARTUM HEMORRHAGE; GLUTEAL NECROSIS; TRAUMA; PREGNANCY; FERTILITY; CANCER	Pelvic angiographic embolization is an effective procedure to provide haemostasis in patients with pelvic fractures. However, management with repeated follow-up radiographs may result in infertility. The study aimed to evaluate the risk of infertility following pelvic fracture treated with pelvic angiographic embolization in female patients. We used data from the National Health Insurance Research Database (NHIRD) provided by the Bureau of National Health Insurance of the Department of Health in Taiwan from the period of 1997 +/- 2010. A total of 36 and 18,029 patients were included in the case and control cohorts, respectively. The risk estimations for the case and control cohorts were compared using a Cox's proportional hazards regression model. The significance level was set at < 0.05. After adjusting for possible confounding factors, the incidence of infertility in the case cohort was nearly 30.7-fold higher than that in the control cohort (adjust hazard ratio [HR] = 30.7, 95% confidence interval [CI] = 10.643 +/- 70.109). Patients between 15 +/- 35 years of age had a much higher incidence of infertility in the case cohort than in the control cohort (adjusted HR = 49.9, 95% CI = 15.177 +/- 64.099). Taken together, pelvic fractures in female patients treated with arter-ioembolization for haemostasis might be associated with a higher risk of infertility in Taiwan. Physicians should be aware of the link and inform patients of this risk prior to arterioembolization.	[Hsu, Sheng-Der; Chen, Cheng-Jueng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Traumat & Gen Surg, Taipei, Taiwan; [Lee, Shih-Yu] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Lin, Kuen-Tze; Lin, Chun-Shu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chang, Wei-Kuo] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chang, WK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.	weikuohome@hotmail.com	Chung, Chi-Hsiang/AAY-3386-2021	Hsu, Sheng-Der/0000-0001-9698-8954; Lee, Shih-Yu/0000-0002-4713-6410; Chang, Wei-Kuo/0000-0002-5738-2797				Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; [Anonymous], 1992, World Health Organ Tech Rep Ser, V820, P1; Auerbach AD, 2012, J ORTHOP TRAUMA, V26, P290, DOI 10.1097/BOT.0b013e31821f9574; Barton SE, 2013, LANCET ONCOL, V14, P873, DOI 10.1016/S1470-2045(13)70251-1; Chauleur C, 2008, HUM REPROD, V23, P1553, DOI 10.1093/humrep/den122; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; COLLINS JA, 1992, INT J GYNECOL OBSTET, V39, P267, DOI 10.1016/0020-7292(92)90257-J; Copeland CE, 1997, J ORTHOP TRAUMA, V11, P73, DOI 10.1097/00005131-199702000-00001; Croce MA, 2007, J AM COLL SURGEONS, V204, P935, DOI 10.1016/j.jamcollsurg.2007.01.059; Giannoudis PV, 2007, J TRAUMA, V63, P875, DOI 10.1097/01.ta.0000242259.67486.15; HARE WSC, 1983, RADIOLOGY, V146, P47, DOI 10.1148/radiology.146.1.6849068; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Huang WY, 2012, RADIOTHER ONCOL, V104, P338, DOI 10.1016/j.radonc.2012.08.015; Lin KT, 2015, HEAD NECK-J SCI SPEC, V37, P413, DOI 10.1002/hed.23617; Liu FX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001462; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; Suzuki T, 2005, ARCH ORTHOP TRAUM SU, V125, P448, DOI 10.1007/s00402-005-0827-1; Takahira N, 2001, INJURY, V32, P27, DOI 10.1016/S0020-1383(00)00098-X; THONNEAU P, 1992, HUM REPROD, V7, P55, DOI 10.1093/oxfordjournals.humrep.a137557; THONNEAU P, 1993, INT J FERTIL, V38, P37; van Vugt AB, 2006, J BONE JOINT SURG BR, V88B, P427, DOI 10.1302/0301-620x.88b4.16693	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0174733	10.1371/journal.pone.0174733	http://dx.doi.org/10.1371/journal.pone.0174733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194450	gold, Green Published, Green Submitted			2022-12-26	WOS:000416867800001
J	Adams, WR				Adams, Warwick R.			High-accuracy detection of early Parkinson's Disease using multiple characteristics of finger movement while typing	PLOS ONE			English	Article							PET	Parkinson's Disease (PD) is a progressive neurodegenerative movement disease affecting over 6 million people worldwide. Loss of dopamine-producing neurons results in a range of both motor and non-motor symptoms, however there is currently no definitive test for PD by non-specialist clinicians, especially in the early disease stages where the symptoms may be subtle and poorly characterised. This results in a high misdiagnosis rate (up to 25% by non-specialists) and people can have the disease for many years before diagnosis. There is a need for a more accurate, objective means of early detection, ideally one which can be used by individuals in their home setting. In this investigation, keystroke timing information from 103 subjects (comprising 32 with mild PD severity and the remainder non-PD controls) was captured as they typed on a computer keyboard over an extended period and showed that PD affects various characteristics of hand and finger movement and that these can be detected. A novel methodology was used to classify the subjects' disease status, by utilising a combination of many keystroke features which were analysed by an ensemble of machine learning classification models. When applied to two separate participant groups, this approach was able to successfully discriminate between early-PD subjects and controls with 96% sensitivity, 97% specificity and an AUC of 0.98. The technique does not require any specialised equipment or medical supervision, and does not rely on the experience and skill of the practitioner. Regarding more general application, it currently does not incorporate a second cardinal disease symptom, so may not differentiate PD from similar movement-related disorders.	[Adams, Warwick R.] Charles Sturt Univ, Sch Comp & Math, Bathurst, NSW, Australia	Charles Sturt University	Adams, WR (corresponding author), Charles Sturt Univ, Sch Comp & Math, Bathurst, NSW, Australia.	warwick@harvest.com.au		Adams, Warwick/0000-0003-1533-0961				ANGEL RW, 1970, BRAIN, V93, P1, DOI 10.1093/brain/93.1.1; [Anonymous], 2015, NAT STAT ETH COND HU; Bartmann D, 2007, INT J INF SECUR PRIV, V1, P1, DOI 10.4018/jisp.2007040101; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Choi JH, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7932185; Das RK, 2014, IETE J RES, V60, P229, DOI 10.1080/03772063.2014.914686; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Frid A, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE SCIENCE, TECHNOLOGY AND ENGINEERING (SWSTE), P50, DOI 10.1109/SWSTE.2014.17; Gage H, 2003, J NEUROL NEUROSUR PS, V74, P163, DOI 10.1136/jnnp.74.2.163; Giancardo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09678; Giancardo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep34468; Giot Romain, 2012, International Journal of Information Technology and Management, V11, P35, DOI 10.1504/IJITM.2012.044062; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Grosset D, 2009, CLINICIANS DESK REFE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kalman YM, 2011, 6 MED C INF SYST MCI; Kang S. J., 2015, ADV SCI TECHNOLOGY L, V116, P209; Keogh E., 2017, ENCY MACHINE LEARNIN, DOI [10.1007/978-1-4899-7687-1_192, DOI 10.1007/978-1-4899-7687-1_192]; Kingma DP., 2014, ADAM METHOD STOCHAST; Low KA, 2002, BRAIN, V125, P1980, DOI 10.1093/brain/awf206; Maetzler W, 2016, MOV DISORD; Pagan FL, 2012, AM J MANAG CARE, V18, pS176; Pal PK, 2001, PARKINSONISM RELAT D, V7, P305, DOI 10.1016/S1353-8020(00)00048-1; Parkinsons Australia, 2013, PARK DESCR INC THEOR; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Ruegg C., 2017, MATH NET NUMERICS; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Scikit-Learn Developers, 2016, CROSS VAL EV EST PER; Teh PS, 2011, PATTERN ANAL APPL, V14, P23, DOI 10.1007/s10044-009-0167-9; Toth C, 2004, MOVEMENT DISORD, V19, P151, DOI 10.1002/mds.10685; Tumer K., 1996, Connection Science, V8, P385, DOI 10.1080/095400996116839; Vapnik, 1996, NAT STAT LEARN THEOR; Yokoe M, 2009, PARKINSONISM RELAT D, V15, P440, DOI 10.1016/j.parkreldis.2008.11.003; Yu HF, 2011, MACH LEARN, V85, P41, DOI 10.1007/s10994-010-5221-8; Zhong Y., 2015, RECENT ADV USER AUTH, V2, P1, DOI [DOI 10.15579/GCSR.V0L2.CH1, 10.15579/gcsr.vol2.ch1, DOI 10.15579/GCSR.VOL2.CH1]	45	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188226	10.1371/journal.pone.0188226	http://dx.doi.org/10.1371/journal.pone.0188226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190695	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900040
J	Boin, F; Torchia, MLG; Borrello, I; Noonan, KA; Neil, M; Soloski, MJ; Cimbro, R				Boin, Francesco; Torchia, Maria Letizia Giardino; Borrello, Ivan; Noonan, Kimberly A.; Neil, Matthew; Soloski, Mark J.; Cimbro, Raffaello			Flow cytometric discrimination of seven lineage markers by using two fluorochromes	PLOS ONE			English	Article							CD8(+) T-CELLS; DIFFERENTIAL EXPRESSION; HELPER-CELLS; ACTIVATION	Flow cytometry is the primary immunological technique used to analyze multiple parameters on complex cell populations. We present a staining method that identifies major human mononuclear lymphoid and myeloid populations (CD4+ and CD8+ T cells, gamma delta T cells, B cells, NK cells and monocytes), using only two fluorochromes and a minimal number of cells. Our approach increases the number of markers recordable on most flow cytometers allowing for a deeper and more comprehensive immunophenotyping.	[Boin, Francesco; Neil, Matthew; Soloski, Mark J.; Cimbro, Raffaello] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA; [Torchia, Maria Letizia Giardino] Natl Canc Inst, Lab Immune Cell Biol, NIH, Bethesda, MD USA; [Borrello, Ivan; Noonan, Kimberly A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Boin, Francesco] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA; [Torchia, Maria Letizia Giardino] Medimmune LLC, Oncol Res, Gaithersburg, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of California System; University of California San Francisco; AstraZeneca; Medimmune	Cimbro, R (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA.	rcimbro1@jhmi.edu	Boin, Francesco/AAI-1471-2021	Boin, Francesco/0000-0003-4840-3063; Cimbro, Raffaello/0000-0002-6251-5160; Neil, Matthew/0000-0003-0972-0859	National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR053503]; Stabler Foundation; National Institute of Allergy and Infectious Disease [T32AI007247]; Nina Ireland Program for Lung Health, (NIPLH)	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stabler Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nina Ireland Program for Lung Health, (NIPLH)	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, https://www.niams.nih.gov/, award number P30-AR053503; The Stabler Foundation, www.stablerfoundation.org; National Institute of Allergy and Infectious Disease, www.niaid.nih.gov, T32AI007247; Nina Ireland Program for Lung Health, (NIPLH), https://pulmonary.ucsf.edu/ireland/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bocsi J, 2014, CYTOM PART A, V85A, P781, DOI 10.1002/cyto.a.22505; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bradford JA, 2004, CYTOM PART A, V61A, P142, DOI 10.1002/cyto.a.20037; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Fujimiya Y, 1997, CLIN CANCER RES, V3, P633; Ginaldi L, 1996, J CLIN PATHOL, V49, P539, DOI 10.1136/jcp.49.7.539; Lambert C, 2004, CYTOM PART B-CLIN CY, V61B, P45, DOI 10.1002/cyto.b.20005; Mahnke YD, 2013, CYTOM PART A, V83A, P439, DOI 10.1002/cyto.a.22269; MANSOUR I, 1990, CYTOMETRY, V11, P636, DOI 10.1002/cyto.990110512; Noonan KA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7014; Park J, 2012, ANN LAB MED, V32, P171, DOI 10.3343/alm.2012.32.3.171; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Speiser DE, 2001, EUR J IMMUNOL, V31, P459, DOI 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Zola H, LEUKOCYTE STROMAL CE	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188916	10.1371/journal.pone.0188916	http://dx.doi.org/10.1371/journal.pone.0188916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190813	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900168
J	Conceicao, T; de Lencastre, H; Aires-De-Sousa, M				Conceicao, Teresa; de Lencastre, Herminia; Aires-de-Sousa, Marta			Carriage of Staphylococcus aureus among Portuguese nursing students: A longitudinal cohort study over four years of education	PLOS ONE			English	Article							METHICILLIN-RESISTANT; NASAL CARRIAGE; MEDICAL-STUDENTS; HOSPITALS; CLONES; EPIDEMIOLOGY; BACTERIA; PATTERNS; SPREAD	Background Staphylococcus aureus is a major human pathogen that can colonize healthy people mainly in the anterior nares. The aim of the present study was to evaluate S. aureus nasal colonization over time among Portuguese nursing students, including methicillin-resistant S. aureus (MRSA). Methods and findings In this longitudinal cohort study, we collected 280 nasal swabs from nursing students at 14 time points over four years of schooling (2012-2016). The isolates were characterized by pulsed-field gel electrophoresis (PFGE), spa typing, multilocus sequence typing (MLST), and SCCmec typing for MRSA. Among 47 students, 20 (43%) carried methicillin-susceptible S. aureus (MSSA) at admission, but none was colonized with MRSA. A total of 19 students (40%) became colonized after exposure during the nursing training, out of which five carried MRSA. Overall, 39 students (83%) had S. aureus detected at least once during the study period. Among the 97 MSSA isolates, most (65%) belonged to four clones: PFGE A-ST30 (21%), B-ST72 (20%), C-ST508 (13%), and D-ST398 (11%). Three of the five MRSA carriers were colonized with the predominant clone circulating in Portuguese hospitals (ST22-IVh) and two with ST3162-II. Colonization of nursing students was highly dynamic with continuous appearance of strains with distinct PFGE types in the same individual. Conclusions A considerable proportion of students became colonized by S. aureus, including MRSA, during the nursing education, evidencing this population represents an important reservoir of S. aureus. Therefore, education on infection control measures in nursing schools is of major importance.	[Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Genet, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Aires-de-Sousa, Marta] Escola Super Saude da Cruz Vermelha Portuguesa, Lisbon, Portugal	Universidade Nova de Lisboa; Rockefeller University	Aires-De-Sousa, M (corresponding author), Escola Super Saude da Cruz Vermelha Portuguesa, Lisbon, Portugal.	msousa@esscvp.eu	Conceicao, Teresa/M-3449-2014	Conceicao, Teresa/0000-0002-9818-2767; Aires-de-Sousa, Marta/0000-0001-5036-2446; /0000-0001-6816-8932	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/DTP-EPI/0842/2014]; FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT, Portugal [SFRH/BPD/72422/2010]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT, Portugal(Portuguese Foundation for Science and Technology)	This work was partly supported by project PTDC/DTP-EPI/0842/2014 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal and by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI). TC was supported by grant SFRH/BPD/72422/2010 from FCT, Portugal.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Akpinar RB, 2009, J CLIN NURS, V18, P426, DOI 10.1111/j.1365-2702.2008.02514.x; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Almeida ST, 2015, EUR J CLIN MICROBIOL, V34, P593, DOI 10.1007/s10096-014-2267-8; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Bellows C, 2013, BRAZ J INFECT DIS, V17, P118, DOI 10.1016/j.bjid.2012.08.018; Berthelot P, 2004, INFECT CONT HOSP EP, V25, P364, DOI 10.1086/503498; Bettin A, 2012, BRAZ J INFECT DIS, V16, P329, DOI 10.1016/j.bjid.2012.06.017; Carmona-Torre F, 2017, LANCET INFECT DIS, V17, P477, DOI 10.1016/S1473-3099(17)30188-3; Chen CS, 2012, INT J INFECT DIS, V16, pE799, DOI 10.1016/j.ijid.2012.07.004; Conceicao T, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.010; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P253, DOI 10.1089/mdr.2000.6.253; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Duggan JM, 2008, INFECT CONT HOSP EP, V29, P534, DOI 10.1086/588164; Dulon M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-363; ECDC, 2017, SURV ANT RES EUR 201; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Gualdoni GA, 2012, GMS KRANKENHHYG INTE, V7, P1; Guclu E, 2007, EUR ARCH OTO-RHINO-L, V264, P85, DOI 10.1007/s00405-006-0160-5; Hawkins G, 2011, J HOSP INFECT, V77, P285, DOI 10.1016/j.jhin.2010.09.038; Higuchi Wataru, 2007, Journal of Infection and Chemotherapy, V13, P63, DOI 10.1007/s10156-006-0492-5; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krishnamurthy V, 2014, J CLIN DIAGN RES, V8, pDC4, DOI 10.7860/JCDR/2014/8409.4638; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Orlin I, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0175-2; Rioux C, 2007, INFECT CONT HOSP EP, V28, P733, DOI 10.1086/516664; Rohde Rodney E, 2014, Clin Lab Sci, V27, P21; Syafinaz A M, 2012, Med J Malaysia, V67, P636; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Vranic SM, 2012, MED GLAS, V9, P325; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	33	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188855	10.1371/journal.pone.0188855	http://dx.doi.org/10.1371/journal.pone.0188855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190721	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900144
J	Hong, S; Chang, Y; Jung, HS; Yun, KE; Shin, H; Ryu, S				Hong, Sungwoo; Chang, Yoosoo; Jung, Hyun-Suk; Yun, Kyung Eun; Shin, Hocheol; Ryu, Seungho			Relative muscle mass and the risk of incident type 2 diabetes: A cohort study	PLOS ONE			English	Article							METABOLICALLY-HEALTHY OBESITY; NUTRITION EXAMINATION SURVEY; FATTY LIVER-DISEASE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; BODY-COMPOSITION; BIOIMPEDANCE ANALYSIS; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; OLDER-ADULTS	Aims The association between relative muscle mass (RMM) and incidence of type 2 diabetes (T2DM) is largely unknown. We examined whether RMM predicted development of T2DM in an apparently young healthy population. Methods This cohort study was comprised of 113,913 men and 89,854 women, free of T2DM at baseline, who underwent a health checkup examination and were followed-up annually or biennially for an average of 2.9 years. We used skeletal muscle mass index (SMI) as an indicator of RMM. SMI (%) [total skeletal muscle mass (kg)/body weight (kg)x100] was estimated using a bioelectrical impedance analyzer. The study outcome was incident T2DM, defined as fasting serum glucose >= 126 mg/dL, HbA1C >= 6.5%, or use of medication for T2DM. Results During 589,098.8 person-years of follow-up, 4,264 individuals developed T2DM (incidence rate, 7.2 per 1000 person-years). Median age (range) at baseline was 39.1 years (18.1 - 87.1). RMM was negatively associated with incidence of T2DM in a dose-response manner. The multivariate-adjusted hazard ratios (95% CIs) for incident T2DM comparing quartiles 3, 2 and 1 of RMM to the highest quartile were 1.32 (1.14-1.52), 1.63 (1.42-1.86), and 2.21 (1.94-2.51), respectively, for males and 1.18 (0.88-1.58), 1.46 (1.11-1.91), and 1.96 (01.51-2.53) for females (P for trend <0.001; 0.011). This association was stronger in younger or premenopausal subjects. Conclusions RMM was negatively associated with development of T2DM in a large sample of young and middle-aged Korean adults. Further research is required to determine whether preservation of muscle mass through intervention affects the risk of T2DM.	[Hong, Sungwoo; Chang, Yoosoo; Jung, Hyun-Suk; Yun, Kyung Eun; Shin, Hocheol; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Ctr Cohort Studies, Total Healthcare Ctr,Sch Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Family Med, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Ctr Cohort Studies, Total Healthcare Ctr,Sch Med, Seoul, South Korea.; Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea.; Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea.	yoosoo.chang@gmail.com; sh703.yoo@gmail.com		Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646	Kangbuk Samsung Health Study	Kangbuk Samsung Health Study(Samsung)	This study was made possible with the support of the Kangbuk Samsung Health Study and was a cohort study of Korean men and women.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Alizadehkhaiyat O, 2014, EUR J APPL PHYSIOL, V114, P177, DOI 10.1007/s00421-013-2764-y; [Anonymous], 2014, INDIAN J ENDOCRINOL, DOI DOI 10.4103/2230-8210.141388; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Broadwin J, 2001, J AM GERIATR SOC, V49, P1641, DOI 10.1111/j.1532-5415.2001.49273.x; Bunout D, 2011, AUSTRALAS J AGEING, V30, P89, DOI 10.1111/j.1741-6612.2010.00448.x; Chang Y, 2016, AM J GASTROENTEROL, V111, P1133, DOI 10.1038/ajg.2016.178; Chang Y, 2016, ANN INTERN MED, V164, P305, DOI 10.7326/M15-1323; Chang Y, 2014, J AM COLL CARDIOL, V63, P2679, DOI 10.1016/j.jacc.2014.03.042; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kim KS, 2014, GERIATR GERONTOL INT, V14, P115, DOI 10.1111/ggi.12189; Koster A, 2015, CLIN GERIATR MED, V31, P41, DOI 10.1016/j.cger.2014.08.020; Larsen BA, 2016, J CLIN ENDOCR METAB, V101, P1847, DOI 10.1210/jc.2015-3643; Li JJ, 2016, METABOLISM, V65, P883, DOI 10.1016/j.metabol.2016.03.011; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9; Mizgier ML, 2014, OBES REV, V15, P587, DOI 10.1111/obr.12166; Moon SS, 2014, ENDOCR J, V61, P61, DOI 10.1507/endoc; Moore MC, 2003, BEST PRACT RES CL EN, V17, P343, DOI 10.1016/S1521-690X(03)00036-8; Morley JE, 2014, J AM MED DIR ASSOC, V15, P853, DOI 10.1016/j.jamda.2014.10.001; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2015, J HEPATOL, V63, P1229, DOI 10.1016/j.jhep.2015.07.010; */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081; Scott D, 2016, MED J AUSTRALIA, V205, P329, DOI 10.5694/mja16.00446; SINACORE DR, 1993, PHYS THER, V73, P878, DOI 10.1093/ptj/73.12.878; Srikanthan P, 2016, AM J CARDIOL, V117, P1355, DOI 10.1016/j.amjcard.2016.01.033; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	41	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188650	10.1371/journal.pone.0188650	http://dx.doi.org/10.1371/journal.pone.0188650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190709	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900092
J	Puls, TJ; Tan, XH; Whittington, CF; Voytik-Harbin, SL				Puls, T. J.; Tan, Xiaohong; Whittington, Catherine F.; Voytik-Harbin, Sherry L.			3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; TUMOR-MICROENVIRONMENT; INVASION; DESMOPLASIA; EXPRESSION; BIOMARKERS; TRANSPORT; STIFFNESS; PROMOTES	Pancreatic cancer, one of the deadliest cancers, is characterized by high rates of metastasis and intense desmoplasia, both of which are associated with changes in fibrillar type I collagen composition and microstructure. Epithelial to mesenchymal transition (EMT), a critical step of metastasis, also involves a change in extracellular matrix (ECM) context as cells detach from basement membrane (BM) and engage interstitial matrix (IM). The objective of this work was to develop and apply an in-vitro three-dimensional (3D) tumor-ECM model to define how ECM composition and biophysical properties modulate pancreatic cancer EMT. Three established pancreatic ductal adenocarcinoma (PDAC) lines were embedded within 3D matrices prepared with type I collagen Oligomer (IM) at various fibril densities to control matrix stiffness or Oligomer and Matrigel combined at various ratios while maintaining constant matrix stiffness. Evaluation of cell morphology and protein expression at both the cellular-and population-levels revealed a spectrum of matrix-driven EMT phenotypes that were dependent on ECM composition and architecture as well as initial PDAC phenotype. In general, exposure to fibrillar IM was sufficient to drive EMT, with cells displaying spindle-shaped morphology and mesenchymal markers, and non-fibrillar BM promoted more epithelial behavior. When cultured within low density Oligomer, only a subpopulation of epithelial BxPC-3 cells displayed EMT while mesenchymal MiaPaCa-2 cells displayed more uniform spindle-shaped morphologies and mesenchymal marker expression. Interestingly, as IM fibril density increased, associated changes in spatial constraints and matrix stiffness resulted in all PDAC lines growing as tight clusters; however mesenchymal marker expression was maintained. Collectively, the comparison of these results to other in-vitro tumor models highlights the role of IM fibril microstructure in guiding EMT heterogeneity and showcases the potential of standardized 3D matrices such as Oligomer to serve as robust platforms for mechanistic study of metastasis and creation of predictive drug screening models.	[Puls, T. J.; Tan, Xiaohong; Whittington, Catherine F.; Voytik-Harbin, Sherry L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Whittington, Catherine F.] Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA; [Voytik-Harbin, Sherry L.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Eli Lilly; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Voytik-Harbin, SL (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Voytik-Harbin, SL (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	harbins@purdue.edu		Whittington, Catherine/0000-0002-5821-4437	Birck Nanotechnology Graduate Research Fellowship; Lilly Innovation Fellowship Award; Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program; Eli Lilly	Birck Nanotechnology Graduate Research Fellowship; Lilly Innovation Fellowship Award; Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program; Eli Lilly(Eli Lilly)	This study was supported by a Birck Nanotechnology Graduate Research Fellowship (TJP), a Lilly Innovation Fellowship Award (CFW), and the Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program (SLVH). Eli Lilly provided support in the form of salary for CFW and research supplies, but did not have any additional role in the study design, data collection or analysis. Because of this affiliation, CFW's mentors at Eli Lilly provided editorial review of the manuscript, and Eli Lilly gave internal approval for publication.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; ASTM International, 2014, ASTM STAND F3089 STA; Bailey JL, 2011, BIOPOLYMERS, V95, P77, DOI 10.1002/bip.21537; Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Bidarra SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27072; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Blum KM, 2016, BIOMATER SCI-UK, V4, P711, DOI 10.1039/c5bm00443h; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Brookes S, 2017, LARYNGOSCOPE; Carey SP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42088; Cassereau L, 2015, J BIOTECHNOL, V193, P66, DOI 10.1016/j.jbiotec.2014.11.008; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086; Hamed SS, 2013, CANCER CHEMOTH PHARM, V72, P553, DOI 10.1007/s00280-013-2226-6; Han B, 2016, CANCER LETT, V380, P319, DOI 10.1016/j.canlet.2015.12.003; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Herrera-Perez M, 2015, TISSUE ENG PT A, V21, P2572, DOI [10.1089/ten.tea.2014.0504, 10.1089/ten.TEA.2014.0504]; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017083; Ki CS, 2014, BIOMATERIALS, V35, P9668, DOI 10.1016/j.biomaterials.2014.08.014; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kreger ST, 2010, BIOPOLYMERS, V93, P690, DOI 10.1002/bip.21431; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee DW, 2014, ANAL CHEM, V86, P535, DOI 10.1021/ac402546b; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Mandal M, 2016, INTEGR BIOL-UK, V8, P167, DOI 10.1039/c5ib00219b; Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Menke A, 2001, CANCER RES, V61, P3508; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morris HT, 2015, BRIT J CANCER, V112, P613, DOI 10.1038/bjc.2014.658; Multhaupt HAB, 2016, ADV DRUG DELIVER REV, V97, P28, DOI 10.1016/j.addr.2015.10.013; National Cancer Institute, 2014, SCI FRAM PANCR DUCT; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sapudom J, 2015, BIOMATERIALS, V52, P367, DOI 10.1016/j.biomaterials.2015.02.022; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Taubenberger AV, 2016, ACTA BIOMATER, V36, P73, DOI 10.1016/j.actbio.2016.03.017; Teixido C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053645; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; van der Zee JA, 2012, BRIT J CANCER, V107, P1153, DOI 10.1038/bjc.2012.373; Walsh LA, 2011, MATRIX BIOL, V30, P243, DOI 10.1016/j.matbio.2011.03.007; Wei SC, 2015, CELL CYCLE, V14, P2387, DOI 10.1080/15384101.2015.1063296; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Whatcott CJ., 2012, DESMOPLASIA CHEMORES; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Whittington CF, 2013, MICROSC MICROANAL, V19, P1323, DOI 10.1017/S1431927613001931; Whittington CF, 2013, MACROMOL BIOSCI, P1; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	81	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188870	10.1371/journal.pone.0188870	http://dx.doi.org/10.1371/journal.pone.0188870			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190794	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900150
J	Azizi, M; Ghourchian, H; Yazdian, F; Dashtestani, F; AlizadehZeinabad, H				Azizi, Marzieh; Ghourchian, Hedayatollah; Yazdian, Fatemeh; Dashtestani, Fariba; AlizadehZeinabad, Hojjat			Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231	PLOS ONE			English	Article							APOPTOSIS; FLUORESCENCE; STRESS; BOVINE; SPECTROSCOPY; TOXICITY; DELIVERY; RELEASE	Purpose The aim of this study was to design a new nanocomposite that would have high cytotoxicity against invasive breast cancer cells and minimum side effects on normal cells. Methods An albumin nano-carrier for delivery of CuNPs was developed. The ACuNPs formation was characterized by TEM, DLS and UV-Vis, fluorescence and circular dichroism spectroscopy. The cytotoxic efficacy of the ACuNPs against human breast cancer cells (MDA-MB 231) and normal cells (MCF-10A) was compared using a standard MTT assay. The mechanism of cell death induced by ACuNPs was considered by inverted and fluorescent microscopy, flow cytometry and gel electrophoresis. The effects of compounds on ROS generations in MDA-MB 231 cells were also studied. Results It was found that the resulted ACuNPs with a diameter of 62.7 nm and zeta potential of about-10.76 mV, are suitable for extravasation into tumor cells. In ACuNPs, the 90% of the secondary structure and almost all the tertiary structure of albumin remained intact. Comparing to CuNPs, ACuNPs could significantly suppress the viability of cancer cells while they were less toxic on normal cells. Compared with the untreated cells, the MDA-MB 231 cell line showed higher levels of ROS production after treatment with ACuNPs. The increase in ROS production after 24 hours indicated that ACuNPs induce apoptosis. Conclusions The ACuNPs characteristics such as intact structure of albumin, high toxicity against cancer cells comparing to normal cells and apoptosis induction as the mechanism of cell death, revealed that this nanocomposite is a good candidate to be used as a chemotherapeutic agent against invasive breast cancer cells.	[Azizi, Marzieh; Ghourchian, Hedayatollah; Dashtestani, Fariba; AlizadehZeinabad, Hojjat] Univ Tehran, IBB, Tehran, Iran; [Ghourchian, Hedayatollah] Univ Tehran, Nanobiomed Ctr Excellence, Nanosci & Nanotechnol Res Ctr, Tehran, Iran; [Yazdian, Fatemeh] Univ Tehran, Fac New Sci & Technol, Tehran, Iran	University of Tehran; University of Tehran; University of Tehran	Ghourchian, H (corresponding author), Univ Tehran, IBB, Tehran, Iran.; Ghourchian, H (corresponding author), Univ Tehran, Nanobiomed Ctr Excellence, Nanosci & Nanotechnol Res Ctr, Tehran, Iran.	ghourchian@ut.ac.ir	Dashtestani, Fariba/AAF-5328-2020; Alizadeh Zeinabad, Hojjat/ABH-2284-2021	Dashtestani, Fariba/0000-0003-0497-7487; Alizadeh Zeinabad, Hojjat/0000-0003-1575-1803				Ahamed M, 2016, COLLOID SURFACE B, V142, P46, DOI 10.1016/j.colsurfb.2016.02.043; Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323; Ahmad J, 2015, ENVIRON TOXICOL, V30, P137, DOI 10.1002/tox.21879; Azad VJ, 2017, J BIOMOL STRUCT DYN, V35, P2565, DOI 10.1080/07391102.2016.1222972; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Brodska A B, 2011, OXIDATIVE MED CELLUL, V2011; Christian P, 2010, J MATER CHEM, V20, P1135, DOI 10.1039/b920301j; Dashtestani F, 2015, MICROCHIM ACTA, V182, P1045, DOI 10.1007/s00604-014-1424-1; Diaz-Visurraga J, 2012, INT J NANOMED, V7, P3597, DOI 10.2147/IJN.S32648; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; FISHER GA, 1995, HEMATOL ONCOL CLIN N, V9, P363, DOI 10.1016/S0889-8588(18)30099-6; Franco-Molina MA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-148; Golla K, 2013, J CANCER, V4, P644, DOI 10.7150/jca.7093; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Hannun YA, 1997, BLOOD, V89, P1845, DOI 10.1182/blood.V89.6.1845; Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19; Hospes M, 2013, PHOTOCH PHOTOBIO SCI, V12, P479, DOI 10.1039/c2pp25222h; Hu R, 2009, J PHYS CHEM C, V113, P2676, DOI 10.1021/jp8076672; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karlsson HL, 2013, TOXICOLOGY, V313, P59, DOI 10.1016/j.tox.2013.07.012; Kheirollahi A, 2014, N-S ARCH PHARMACOL, V387, P1199, DOI 10.1007/s00210-014-1038-5; Kim TH, 2011, INT J PHARMACEUT, V403, P285, DOI 10.1016/j.ijpharm.2010.10.041; Lampiasi N, 2009, MOL PHARMACOL, V76, P290, DOI 10.1124/mol.109.055418; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; LeBel CP, 1992, CHEM RES TOXICOL, V5; Liu HT, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105707; Madu CO, 2009, PHARMACEUTICAL PERSPECTIVES OF CANCER THERAPEUTICS, P1, DOI 10.1007/978-1-4419-0131-6_1; Meshkini A, 2012, EXP TOXICOL PATHOL, V64, P357, DOI 10.1016/j.etp.2010.09.010; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Minocha S, 2012, SMALL, V8, P3289, DOI 10.1002/smll.201200478; Mirtsching B, 2011, CLIN BREAST CANCER, V11, P121, DOI 10.1016/j.clbc.2011.03.007; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OBRIEN RW, 1990, FARADAY DISCUSS, V90, P301, DOI 10.1039/dc9909000301; Pabbathi A, 2013, CHEMPHYSCHEM, V14, P2441, DOI 10.1002/cphc.201300313; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poor M, 2014, J LUMIN, V145, P767, DOI 10.1016/j.jlumin.2013.08.059; Rashid M.U., 2013, DHAKA U J PHARMA SC, V12, P29, DOI DOI 10.3329/DUJPS.V12I1.16297; Safavi M, 2012, EUR J MED CHEM, V58, P573, DOI 10.1016/j.ejmech.2012.10.043; Sankar R, 2014, MAT SCI ENG C-MATER, V44, P234, DOI 10.1016/j.msec.2014.08.030; Sastry M, 1997, COLLOID SURFACE A, V127, P221, DOI 10.1016/S0927-7757(97)00087-3; Satchell PG, 2003, INT ENDOD J, V36, P237, DOI 10.1046/j.1365-2591.2003.00657.x; Trajkovska M., 2013, NAT CELL BIOL, V15, P729, DOI DOI 10.1038/ncb2809; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Wang ZM, 2013, BBA-GEN SUBJECTS, V1830, P5356, DOI 10.1016/j.bbagen.2013.06.032; Wartlick H, 2004, J CONTROL RELEASE, V96, P483, DOI 10.1016/j.jconrel.2004.01.029; Yanase K, 2014, J MOL LIQ; ZEINABAD HA, 2016, SCI REPORTS, V6; Zhao XC, 2010, J PHYS CHEM B, V114, P5625, DOI 10.1021/jp100903x	48	72	73	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188639	10.1371/Journal.pone.0188639	http://dx.doi.org/10.1371/Journal.pone.0188639			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186208	Green Published, gold			2022-12-26	WOS:000416484900048
J	Rudobeck, E; Bellone, JA; Szucs, A; Bonnick, K; Mehrotra-Carter, S; Badaut, J; Nelson, GA; Hartman, RE; Vlkolinsky, R				Rudobeck, Emil; Bellone, John A.; Szucs, Attila; Bonnick, Kristine; Mehrotra-Carter, Shalini; Badaut, Jerome; Nelson, Gregory A.; Hartman, Richard E.; Vlkolinsky, Roman			Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; LONG-TERM POTENTIATION; NEURAL STEM-CELLS; SYNAPTIC PLASTICITY; IONIZING-RADIATION; MUTANT PRESENILIN-1; PARTICLE RADIATION; WILD-TYPE; SIMULATED MICROGRAVITY; PERSISTENT REDUCTION	Space radiation represents a significant health risk for astronauts. Ground-based animal studies indicate that space radiation affects neuronal functions such as excitability, synaptic transmission, and plasticity, and it may accelerate the onset of Alzheimer's disease (AD). Although protons represent the main constituent in the space radiation spectrum, their effects on AD-related pathology have not been tested. We irradiated 3 month-old APP/PSEN1 transgenic (TG) and wild type (WT) mice with protons (150 MeV; 0.1-1.0 Gy; whole body) and evaluated functional and biochemical hallmarks of AD. We performed behavioral tests in the water maze (WM) before irradiation and in the WM and Barnes maze at 3 and 6 months post-irradiation to evaluate spatial learning and memory. We also performed electrophysiological recordings in vitro in hippocampal slices prepared 6 and 9 months post irradiation to evaluate excitatory synaptic transmission and plasticity. Next, we evaluated amyloid 3 (A(3) deposition in the contralateral hippocampus and adjacent cortex using immunohistochemistry. In cortical homogenates, we analyzed the levels of the presynaptic marker synaptophysin by Western blotting and measured pro-inflammatory cytokine levels (INF alpha, IL-beta, IL-6, CXCL10 and CCL2) by bead-based multiplex assay. TG mice performed significantly worse than WT mice in the WM. Irradiation of TG mice did not affect their behavioral performance, but reduced the amplitudes of population spikes and inhibited paired-pulse facilitation in CA1 neurons. These electrophysiological alterations in the TG mice were qualitatively different from those observed in WT mice, in which irradiation increased excitability and synaptic efficacy. Irradiation increased A beta deposition in the cortex of TG mice without affecting cytokine levels and increased synaptophysin expression in WT mice (but not in the TG mice). Although irradiation with protons increased A beta deposition, the complex functional and biochemical results indicate that irradiation effects are not synergistic to AD pathology.	[Rudobeck, Emil; Bonnick, Kristine; Mehrotra-Carter, Shalini; Nelson, Gregory A.; Vlkolinsky, Roman] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Bellone, John A.; Hartman, Richard E.] Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA USA; [Szucs, Attila] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Badaut, Jerome] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92350 USA; [Szucs, Attila] Eotvos Lorand Univ, MTA ELTE NAP B Neuronal Cell Biol Res Grp, Budapest, Hungary; [Mehrotra-Carter, Shalini] Loma Linda Univ, Sch Allied Hlth Profess, Loma Linda, CA 92350 USA; [Badaut, Jerome] Univ Bordeaux, Aquitaine Inst Cognit & Integrat Neurosci, CNRS, UMR5287, Bordeaux, France	Loma Linda University; Loma Linda University; University of California System; University of California San Diego; Loma Linda University; Eotvos Lorand University; Loma Linda University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Vlkolinsky, R (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA.	rvlkolinsky@llu.edu		Vlkolinsky, Roman/0000-0002-9786-0407; Rudobeck, Emil/0000-0001-7949-4282	National Astronautics and Space Administration (NASA) grant [NNX11AE41G]; National Research, Development and Innovation Office of Hungary [KTIA_NAP_13-2014-0018];  [NNX15AI22G]	National Astronautics and Space Administration (NASA) grant; National Research, Development and Innovation Office of Hungary; 	This work was funded by National Astronautics and Space Administration (NASA) grant NNX11AE41G (R. VIkolinsky), and in part by grant NNX15AI22G (G. A. Nelson). A. SzLics was partially supported by the National Research, Development and Innovation Office of Hungary under grant KTIA_NAP_13-2014-0018.	Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Begum N, 2012, J RADIAT RES, V53, P815, DOI 10.1093/jrr/rrs036; Behl C, 2005, SUB CELL BIOCHEM, V38, P65; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Bellone JA, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.19; Bellone JA, 2015, RADIAT RES, V184, P193, DOI 10.1667/RR13903.1; Blakely EA, 2000, HEALTH PHYS, V79, P495, DOI 10.1097/00004032-200011000-00006; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Britten RA, 2016, RADIAT RES, V185, P332, DOI 10.1667/RR14120.1; Britten RA, 2014, RADIAT RES, V182, P292, DOI 10.1667/RR3766.1; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; CARLSON LD, 1957, RADIAT RES, V7, P190, DOI 10.2307/3570466; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; Chmielewski NN, 2016, ENVIRON MOL MUTAGEN, V57, P364, DOI 10.1002/em.22006; Cucinotta FA, 2015, HEALTH PHYS, V108, P131, DOI 10.1097/HP.0000000000000255; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Cuttler JM, 2016, CASE REPORT DOSE RES, V14; Denisova NA, 2002, RADIAT RES, V158, P725, DOI 10.1667/0033-7587(2002)158[0725:BSABRI]2.0.CO;2; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Dorostkar MM, 2015, ACTA NEUROPATHOL, V130, P1, DOI 10.1007/s00401-015-1449-5; Ermini FV, 2008, AM J PATHOL, V172, P1520, DOI 10.2353/ajpath.2008.060520; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; GOBBEL GT, 1992, RADIAT RES, V130, P236, DOI 10.2307/3578281; Gold LH, 1996, ADV EXP MED BIOL, V402, P199; Gridley DS, 2006, RADIAT RES, V165, P78, DOI 10.1667/RR3490.1; Gridley DS, 2002, AM J PHYSIOL-REG I, V282, pR677, DOI 10.1152/ajpregu.00435.2001; Gridley DS, 2001, IN VIVO, V15, P209; Gylys KH, 2004, NEUROCHEM INT, V44, P125, DOI 10.1016/S0197-0186(03)00146-3; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Hermann D, 2009, NEUROSCIENCE, V162, P1081, DOI 10.1016/j.neuroscience.2009.05.044; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kempf SJ, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9092; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lee SH, 2017, BRAIN STRUCT FUNCT, V222, P2345, DOI 10.1007/s00429-016-1345-3; Li L, 2014, J NEUROCHEM, V131, P86, DOI 10.1111/jnc.12769; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Limoli CL, 2006, RAD ENV BIOPHYS; Machida M, 2010, RADIAT RES, V174, P618, DOI 10.1667/RR1988.1; Malm Tarja, 2011, Int J Alzheimers Dis, V2011, P517160, DOI 10.4061/2011/517160; Mao XW, 2016, RADIAT RES, V185, P647, DOI 10.1667/RR14267.1; Mao XW, 2010, RADIAT RES, V173, P486, DOI 10.1667/RR1728.1; Mao XW, 2006, TECHNOL CANCER RES T, V5, P127, DOI 10.1177/153303460600500206; Marples B, 2016, RADIOTHER ONCOL, V118, P579, DOI 10.1016/j.radonc.2016.01.010; Marty VN, 2014, RADIAT RES, V182, P653, DOI 10.1667/RR13647.1; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Muller N, 1997, NERVENARZT, V68, P11, DOI 10.1007/s001150050092; MURPHY GM, 1991, NEUROSCI LETT, V131, P100, DOI 10.1016/0304-3940(91)90346-U; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nelson GA, 2016, RADIAT RES, V185, P349, DOI 10.1667/RR14311.1; Nelson TE, 2011, BRAIN BEHAV IMMUN, V25, pS106, DOI 10.1016/j.bbi.2011.02.013; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Olichney JM, 2000, ARCH NEUROL-CHICAGO, V57, P869, DOI 10.1001/archneur.57.6.869; Parihar VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400256; Parihar VK, 2015, BRAIN STRUCT FUNCT, V220, P1161, DOI 10.1007/s00429-014-0709-9; Parihar VK, 2015, ANTIOXID REDOX SIGN, V22, P78, DOI 10.1089/ars.2014.5929; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Pawlowski TL, 2009, BRAIN RES, V1256, P101, DOI 10.1016/j.brainres.2008.12.039; PHILPOTT DE, 1985, SCAN ELECTRON MICROS, P1177; Pozueta J, 2013, NEUROSCIENCE, V251, P51, DOI 10.1016/j.neuroscience.2012.05.050; Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016; Qi XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165891; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2016, RADIAT RES, V185, P20, DOI 10.1667/RR14222.1; Ramirez-Lugo L, 2009, J ALZHEIMERS DIS, V18, P281, DOI 10.3233/JAD-2009-1141; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Roder S, 2003, NEUROSCIENCE, V120, P705, DOI 10.1016/S0306-4522(03)00381-6; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosenberg PB, 2006, INT REV PSYCHIATR, V17, P503, DOI 10.1080/02646830500382037; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Rudobeck E, 2014, RADIAT RES, V181, P407, DOI 10.1667/RR13484.1; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Sahara N, 2010, FUTUR NEUROL, V5, P411, DOI 10.2217/FNL.10.10; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shukitt-Hale B, 2004, ADV SPACE RES-SERIES, V33, P1334, DOI 10.1016/j.asr.2003.10.038; Simon AM, 2009, NEUROBIOL DIS, V33, P369, DOI 10.1016/j.nbd.2008.11.005; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sokolova IV, 2015, RADIAT RES, V183, P208, DOI 10.1667/RR13785.1; Stover KR, 2012, BEHAV BRAIN RES, V231, P75, DOI 10.1016/j.bbr.2012.02.044; Sturchler-Pierrat C, 2000, ANN NY ACAD SCI, V920, P134; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tseng BP, 2014, ANTIOXID REDOX SIGN, V20, P1410, DOI 10.1089/ars.2012.5134; Vlkolinsky R, 2004, J NEUROIMMUNOL, V150, P37, DOI 10.1016/j.jneuroim.2004.01.011; Vlkolinsky R, 2010, RADIAT RES, V173, P342, DOI 10.1667/RR1825.1; Vlkolinsky R, 2008, RADIAT RES, V169, P523, DOI 10.1667/RR1228.1; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	122	20	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0186168	10.1371/journal.pone.0186168	http://dx.doi.org/10.1371/journal.pone.0186168			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186131	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900002
J	Buratta, S; Urbanelli, L; Sagini, K; Giovagnoli, S; Caponi, S; Fioretto, D; Mitro, N; Caruso, D; Emiliani, C				Buratta, Sandra; Urbanelli, Lorena; Sagini, Krizia; Giovagnoli, Stefano; Caponi, Silvia; Fioretto, Daniele; Mitro, Nico; Caruso, Donatella; Emiliani, Carla			Extracellular vesicles released by fibroblasts undergoing H-Ras induced senescence show changes in lipid profile	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; EXOSOME SECRETION; CELLS; MECHANISM; CANCER; TETRASPANINS; HEPATOCYTES; PLATELETS; CERAMIDE; PROTEIN	Cells release extracellular vesicles (EVs) in their environment and cellular lipids play an important role in their formation, secretion and uptake. Besides, there is also evidence that EV transferred lipids impact on recipient's cell signaling. Cellular senescence is characterized by a state of permanent proliferation arrest and represents a barrier towards the development of neoplastic lesions. A peculiar feature of senescence is the release of many soluble factors, the so-called Senescence-Associated Secretory Phenotype, which play a key role in triggering paracrine senescence signals. Recently, evidences have suggested that this phenotype includes not only soluble factors, but also EVs. To identify lipid signatures associated with H-Ras-induced senescence in EVs, we expressed active H-Ras (HRasV12) in human fibroblasts and investigated how it affects EV release and lipid composition. An enrichment of hydroxylated sphingomyelin, lyso-and ether-linked phospholipids and specific H-Ras-induced senescence signatures, e.g. sphingomyelin, lysophosphatidic acid and sulfatides, were found in EVs compared to cells. Furthermore, H-RasV12 expression in fibroblasts was associated with higher levels of tetraspanins involved in vesicle formation.	[Buratta, Sandra; Urbanelli, Lorena; Sagini, Krizia; Emiliani, Carla] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy; [Giovagnoli, Stefano] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy; [Caponi, Silvia] Univ Perugia, IOM, CNR, Unita Perugia,Dept Phys & Geol, Perugia, Italy; [Fioretto, Daniele] Univ Perugia, Dept Phys & Geol, Perugia, Italy; [Fioretto, Daniele; Emiliani, Carla] CEMIN, Perugia, Italy; [Mitro, Nico; Caruso, Donatella] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	University of Perugia; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Perugia; University of Perugia; University of Milan	Buratta, S; Urbanelli, L (corresponding author), Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy.	sandra.buratta@unipg.it; lorena.urbanelli@unipg.it	Giovagnoli, Stefano/J-7484-2019; SAGINI, Krizia/Z-1629-2019; Emiliani, Carla/G-3738-2010; giovagnoli, stefano/N-1064-2018; Caponi, Silvia/F-9821-2010	SAGINI, Krizia/0000-0003-3357-2171; Emiliani, Carla/0000-0002-6368-1515; giovagnoli, stefano/0000-0001-5043-7233; Caponi, Silvia/0000-0002-4219-3256; Mitro, Nico/0000-0002-5000-3619; Urbanelli, Lorena/0000-0003-0621-8476	Fondazione Cassa di Risparmio di Perugia grant [2016.0050.021]	Fondazione Cassa di Risparmio di Perugia grant	This work was supported by Fondazione Cassa di Risparmio di Perugia grant 2016.0050.021 to Prof. Carla Emiliani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Armeni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052151; Becker T, 2013, INTECHOPEN; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Brown W, 1993, DYNAMIC LIGHT SCATTE, V177; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Cermenati G, 2017, J STEROID BIOCHEM, V168, P60, DOI 10.1016/j.jsbmb.2017.02.002; Cermenati G, 2015, CELL METAB, V21, P571, DOI 10.1016/j.cmet.2015.02.016; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hirsova P, 2016, GASTROENTEROLOGY, V150, P956, DOI 10.1053/j.gastro.2015.12.037; Jethwa SA, 2016, J CELL SCI, V129, P3948, DOI 10.1242/jcs.184424; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Krishnamurthy J, J CLIN INVEST, V114, P1299; Laulagnier K, 2004, FEBS LETT, V572, P11, DOI 10.1016/j.febslet.2004.06.082; Lee SJ, 2014, J PROTEOME RES, V13, P1438, DOI 10.1021/pr400990k; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lydic TA, 2015, METHODS, V87, P83, DOI 10.1016/j.ymeth.2015.04.014; Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Phuyal S, 2015, J BIOL CHEM, V290, P4225, DOI 10.1074/jbc.M114.593962; Pienimaeki-Roemer A, 2015, TRANSFUSION, V55, P507, DOI 10.1111/trf.12874; Pienimaeki-Roemer A, 2013, TRANSFUSION, V53, P612, DOI 10.1111/j.1537-2995.2012.03775.x; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Record M, 2014, BIOCHIMIE, V96, P67, DOI 10.1016/j.biochi.2013.06.016; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Tetta C, 2013, ENDOCRINE, P4411; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; Urbanelli L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091408; Urbanelli Lorena, 2015, Recent Pat CNS Drug Discov, V10, P10; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Urbanelli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089485; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	49	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188840	10.1371/journal.pone.0188840	http://dx.doi.org/10.1371/journal.pone.0188840			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182668	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000059
J	Wei, C; Stock, L; Valanejad, L; Zalewski, ZA; Karns, R; Puymirat, J; Nelson, D; Witte, D; Woodgett, J; Timchenko, NA; Timchenko, L				Wei, Christina; Stock, Lauren; Valanejad, Leila; Zalewski, Zachary A.; Karns, Rebekah; Puymirat, Jack; Nelson, David; Witte, David; Woodgett, Jim; Timchenko, Nikolai A.; Timchenko, Lubov			Correction of GSK3 beta at young age prevents muscle pathology in mice with myotonic dystrophy type 1	FASEB JOURNAL			English	Article						CUG repeats; CUGBP1; glycogen synthase kinase 3 beta	RNA-BINDING PROTEIN; SKELETAL-MUSCLE; CUG REPEATS; NEUROMUSCULAR-JUNCTION; HELICASE P68/DDX5; MESSENGER-RNA; OVEREXPRESSION; MECHANISMS; EXPRESSION; MOUSE	Myotonic dystrophy type 1 (DM1) is a progressive neuromuscular disease caused by expanded CUG repeats, which misregulate RNA metabolism through several RNA-binding proteins, including CUG-binding protein/CUGBP1 elav-like factor 1 (CUGBP1/CELF1) and muscleblind 1 protein. Mutant CUG repeats elevate CUGBP1 and alter CUGBP1 activity via a glycogen synthase kinase 3 beta (GSK3 beta)-cyclin D3-cyclin D-dependent kinase 4 (CDK4) signaling pathway. Inhibition of GSK3 corrects abnormal activity of CUGBP1 in DM1 mice [human skeletal actin mRNA, containing long repeats (HSA(LR)) model]. Here, we show that the inhibition of GSK3 beta in young HSA(LR) mice prevents development of DM1 muscle pathology. Skeletal muscle in 1-yr-old HSA(LR) mice, treated at 1.5 mo for 6 wk with the inhibitors of GSK3, exhibits high fiber density, corrected atrophy, normal fiber size, with reduced central nuclei and normalized grip strength. Because CUG-GSK3 beta-cyclin D3-CDK4 converts the active form of CUGBP1 into a form of translational repressor, we examined the contribution of CUGBP1 in myogenesis using Celf1 knockout mice. We found that a loss of CUGBP1 disrupts myogenesis, affecting genes that regulate differentiation and the extracellular matrix. Proteins of those pathways are also misregulated in young HSA(LR) mice and in muscle biopsies of patients with congenital DM1. These findings suggest that the correction of GSK3-CUGBP1 pathway in young HSA(LR) mice might have a positive effect on the myogenesis over time.	[Wei, Christina; Stock, Lauren; Timchenko, Lubov] Cincinnati Childrens Hosp, Div Neurol, Cincinnati, OH USA; [Valanejad, Leila; Timchenko, Nikolai A.] Cincinnati Childrens Hosp, Dept Surg, Cincinnati, OH USA; [Karns, Rebekah] Cincinnati Childrens Hosp, Dept Bioinformat, Cincinnati, OH USA; [Witte, David] Cincinnati Childrens Hosp, Dept Pathol, Cincinnati, OH USA; [Zalewski, Zachary A.; Nelson, David] Baylor Coll Med, Dept Mol Genet, Houston, TX 77030 USA; [Puymirat, Jack] CHU Laval, Res Ctr, Quebec City, PQ, Canada; [Woodgett, Jim] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Baylor College of Medicine; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Timchenko, L (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neurol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	tubov.timchenko@cchmc.org	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR044387, AR052791, AR064488]; NIH National Cancer Institute [CA159942]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK102597]; Internal Development Funds from Cincinnati Children's Hospital Medical Center; NATIONAL CANCER INSTITUTE [R01CA159942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387, R01AR052791, R21AR064488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Internal Development Funds from Cincinnati Children's Hospital Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Mei Wang (Cincinnati Children's Hospital Medical Center) for the help with RT-PCR analysis. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR044387 and AR052791, AR064488 (to L.T.), NIH National Cancer Institute Grant CA159942, NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK102597 (to N.A.T.), and by Internal Development Funds from Cincinnati Children's Hospital Medical Center (to L.T. and N.A.T.). The authors declare no conflicts of interest.	Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berger DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019274; Bourgeois F, 2015, NEUROMUSCULAR DISORD, V25, P461, DOI 10.1016/j.nmd.2015.01.012; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Giudice J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35550; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Jones K, 2015, P NATL ACAD SCI USA, V112, P8041, DOI 10.1073/pnas.1422273112; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Latvanlehto A, 2010, J NEUROSCI, V30, P12230, DOI 10.1523/JNEUROSCI.5518-09.2010; Laurent FX, 2012, NUCLEIC ACIDS RES, V40, P3159, DOI 10.1093/nar/gkr1228; Lu TJ, 2013, P NATL ACAD SCI USA, V110, P19131, DOI 10.1073/pnas.1303687110; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Ogawa R, 2015, DEVELOPMENT, V142, P51, DOI 10.1242/dev.112557; Pettersson OJ, 2014, NUCLEIC ACIDS RES, V42, P7186, DOI 10.1093/nar/gku352; Ravel-Chapuis A, 2012, J CELL BIOL, V196, P699, DOI 10.1083/jcb.201108113; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; Timchenko L, 2013, INT J BIOCHEM CELL B, V45, P2280, DOI 10.1016/j.biocel.2013.06.010; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Vivian JL, 1999, DEV BIOL, V208, P44, DOI 10.1006/dbio.1998.9182; Wagatsuma A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/121254; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	37	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2073	2085		10.1096/fj.201700700R	http://dx.doi.org/10.1096/fj.201700700R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203592	Green Published			2022-12-26	WOS:000429051400028
J	Morales, TGP; Ratia, K; Wang, DS; Gogos, A; Bloem, L; Driver, TG; Federle, MJ				Morales, Tiara G. Perez; Ratia, Kiira; Wang, Duo-Sheng; Gogos, Artemis; Bloem, Laura; Driver, Tom G.; Federle, Michael J.			A novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO (vol 293, pg 931, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wang, Duo-Sheng/O-9846-2018	Wang, Duo-Sheng/0000-0002-3519-2386; Gogos, Artemis/0000-0002-0555-3814	National Institutes of Health Grant [UL1TR002003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125452, R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Laura Bloem was inadvertently omitted as an author. The author line should appear as shown above. Dr. Bloem's affiliation is the UICentre for Drug Discovery. Accordingly, the Acknowledgments section should read as follows. We thank Dr. Reid Wilkening for preparations of S. pyogenes and S. gordonii rPepO and Drs. Jason Hickok and Gregory R. J. Thatcher of the UICentre under the UIC Center for Clinical & Translational Sciences (National Institutes of Health Grant UL1TR002003), for valuable project discussions and compound library access. Dr. Bloem provided important contributions in decisions on the best compounds to pursue for this study and in the design and evaluation of results of a kinetic bioassay (Fig. 5).	Morales TGP, 2018, J BIOL CHEM, V293, P4580, DOI [10.1074/jbc.AAC118.002674, 10.1074/jbc.M117.810994]	1	5	5	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4580	4580		10.1074/jbc.AAC118.002674	http://dx.doi.org/10.1074/jbc.AAC118.002674			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29203527	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000428204300032
J	Harner, M; Wickner, W				Harner, Max; Wickner, William			Assembly of intermediates for rapid membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; protein complex; SNARE proteins; Saccharomyces cerevisiae; membrane reconstitution	TRANS-SNARE COMPLEXES; HOMOTYPIC VACUOLE FUSION; SACCHAROMYCES-CEREVISIAE; EFFECTOR COMPLEX; TRIGGER FUSION; HOPS CATALYZES; ALPHA-SNAP; T-SNARE; DOCKING; CHAPERONES	Membrane fusion is essential for intracellular protein sorting, cell growth, hormone secretion, and neurotransmission. Rapid membrane fusion requires tethering and Sec1-Munc18 (SM) function to catalyze R-, Qa-, Qb-, and Qc-SNARE complex assembly in trans, as well as SNARE engagement by the SNARE-binding chaperone Sec17/SNAP. The hexameric vacuolar HOPS (homotypic fusion and vacuole protein sorting) complex in the yeast Saccharomyces cerevisiae tethers membranes through its affinities for the membrane Rab GTPase Ypt7. HOPS also has specific affinities for the vacuolar SNAREs and catalyzes SNARE complex assembly, but the order of their assembly into a 4-SNARE complex is unclear. We now report defined assembly intermediates on the path to membrane fusion. We found that a prefusion intermediate will assemble with HOPS and the R, Qa, and Qc SNAREs, and that this assembly undergoes rapid fusion upon addition of Qb and Sec17. HOPS-tethered membranes and all four vacuolar SNAREs formed a complex that underwent an even more dramatic burst of fusion upon Sec17p addition. These findings provide initial insights into an ordered fusion pathway consisting of the following intermediates and events: 1) Rab- and HOPS-tethered membranes, 2) a HOPS:R:Qa:Qc trans-complex, 3) a HOPS:4-SNARE trans-complex, 4) an engagement with Sec17, and 5) the rapid lipid rearrangements during fusion. In conclusion, our results indicate that the R:Qa:Qc complex forms in the context of membrane, Ypt7, HOPS, and trans-SNARE assembly and serves as a functional intermediate for rapid fusion after addition of the Qb-SNARE and Sec17 proteins.	[Harner, Max; Wickner, William] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Harner, Max] Ludwig Maximilians Univ Munchen, Biomed Ctr Munich, Inst Cardiovasc Physiol & Pathophysiol, Grosshadernerstr 9, D-82152 Planegg Martinsried, Germany	Dartmouth College; University of Munich	Wickner, W (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@Dartmouth.edu		Harner, Max/0000-0002-5513-1046	National Institutes of Health [R35GM118037-01, 3R35GM118037-0191]; Deutsche Forschungsgemeinschaft [HA 7730/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM118037-01 and 3R35GM118037-0191 (to W. W.) and Deutsche Forschungsgemeinschaft Fellowship HA 7730/2-1 (to M. H.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gossing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066304; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Ma L, 2016, CELL REP, V15, P531, DOI 10.1016/j.celrep.2016.03.050; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Orr A, 2017, MOL BIOL CELL, V28, P975, DOI 10.1091/mbc.E16-10-0743; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Song HK, 2017, MOL BIOL CELL, V28, P2282, DOI 10.1091/mbc.E17-04-0218; Song HK, 2017, ELIFE, V6, DOI 10.7554/eLife.26646; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148; Zick M, 2016, MOL BIOL CELL, V27, P2590, DOI 10.1091/mbc.E16-04-0230; Zick M, 2015, P NATL ACAD SCI USA, V112, pE2290, DOI 10.1073/pnas.1506409112; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.01879; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419; Zick M, 2012, MOL BIOL CELL, V23, P3429, DOI 10.1091/mbc.E12-04-0279; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	38	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1346	1352		10.1074/jbc.RA117.000791	http://dx.doi.org/10.1074/jbc.RA117.000791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29208657	Green Published, hybrid			2022-12-26	WOS:000423515000020
J	Guo, Q; Wan, FY				Guo, Qing; Wan, Fangyi			Complete synchronization of the global coupled dynamical network induced by Poisson noises	PLOS ONE			English	Article							INDUCED REGIME SHIFTS; CHAOS; BIFURCATION; NEURON; SYSTEM; DELAYS; MODEL; P53	The different Poisson noise-induced complete synchronization of the global coupled dynamical network is investigated. Based on the stability theory of stochastic differential equations driven by Poisson process, we can prove that Poisson noises can induce synchronization and sufficient conditions are established to achieve complete synchronization with probability 1. Furthermore, numerical examples are provided to show the agreement between theoretical and numerical analysis.	[Guo, Qing; Wan, Fangyi] Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Wan, FY (corresponding author), Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China.	fwan@nwpu.edu.cn	Wan, Fang-Yi/N-4519-2019	Wan, Fang-Yi/0000-0002-4404-5820				Cao J, 2007, PHYSICA A, V385, P718, DOI 10.1016/j.physa.2007.06.043; CHUA LO, 1993, IEEE T CIRCUITS-I, V40, P732, DOI 10.1109/81.246149; Gao ZL, 2016, J APPL PROBAB, V53, P307, DOI 10.1017/jpr.2015.27; Garcia M.A., 1994, STOCH MODELS, V10, P335; Gihman I. I., 1972, STOCHASTIC DIFFERENT; Han QL, 2014, PHYSICA A, V408, P96, DOI 10.1016/j.physa.2014.04.015; HERZEL H, 1995, PHYS REV E, V52, P3238, DOI 10.1103/PhysRevE.52.3238; Kushner H. J, 1967, STOCHASTIC STABILITY; Lai CH, 1998, EUROPHYS LETT, V43, P376, DOI 10.1209/epl/i1998-00368-1; Lin W, 2006, CHAOS, V16, DOI 10.1063/1.2183734; Lin W, 2005, CHAOS, V15, DOI 10.1063/1.1938627; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; PIKOVSKY AS, 1994, PHYS REV LETT, V73, P2931, DOI 10.1103/PhysRevLett.73.2931; Qian Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12333-3; Qian Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032807; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Samhouri JF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1860; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Ting Y, 1999, SOOCHOW J MATH, V25, P145; Wang ST, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018103; Wang XF, 2002, IEEE T CIRCUITS-I, V49, P54, DOI 10.1109/81.974874; Wang XF, 2002, INT J BIFURCAT CHAOS, V12, P885, DOI 10.1142/S0218127402004802; Wu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174330; Xiao YZ, 2012, CHAOS, V22, DOI 10.1063/1.3677253; Xiao YZ, 2009, CHAOS, V19, DOI 10.1063/1.3080194; Xu Y, 2015, MATH METHOD APPL SCI, V38, P2120, DOI 10.1002/mma.3208; Xu Y, 2013, PHYSICA A, V392, P4739, DOI 10.1016/j.physa.2013.06.010; Xu Y, 2013, CHAOS, V23, DOI 10.1063/1.4775758; Xu Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056215; Yin CC, 2014, FRONT MATH CHINA, V9, P1453, DOI 10.1007/s11464-013-0186-5; Yin CC, 2014, ASTIN BULL, V44, P635, DOI 10.1017/asb.2014.12; Yin CC, 2011, STAT PROBABIL LETT, V81, P1841, DOI 10.1016/j.spl.2011.07.022; Yin CC, 2010, METHODOL COMPUT APPL, V12, P391, DOI 10.1007/s11009-008-9109-z; Yu Q., 2017, SCI REPORTS, V7, P5746; Zeng CH, 2015, ECOL COMPLEX, V22, P102, DOI 10.1016/j.ecocom.2015.02.005; Zeng CH, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/10/P10017; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025; Zeng JK, 2016, PHYSICA A, V462, P1273, DOI 10.1016/j.physa.2016.06.115; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; ZOU F, 1993, IEEE T CIRCUITS-I, V40, P166, DOI 10.1109/81.222797	42	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188632	10.1371/journal.pone.0188632	http://dx.doi.org/10.1371/journal.pone.0188632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216214	Green Published, Green Submitted, gold			2022-12-26	WOS:000417337800032
J	Kasangian, AA; Gherardi, G; Biagioli, E; Torri, V; Moretti, A; Bernardin, E; Cordovana, A; Farina, G; Bramati, A; Piva, S; Dazzani, MC; Paterno, E; La Verde, NM				Kasangian, Anaid Anna; Gherardi, Giorgio; Biagioli, Elena; Torri, Valter; Moretti, Anna; Bernardin, Elena; Cordovana, Andrea; Farina, Gabriella; Bramati, Annalisa; Piva, Sheila; Dazzani, Maria Chiara; Paterno, Emanuela; La Verde, Nicla Maria			The prognostic role of tumor size in early breast cancer in the era of molecular biology	PLOS ONE			English	Article							CARCINOMA	Background The prognosis of early breast cancer (EBC) depends on patient and tumor characteristics. The association between tumor size, the largest diameter in TNM staging, and prognosis is well recognized. According to TNM, tumors classified as T2, could have very different volumes; e.g. a tumor of 2.1 cm has a volume of 4500 mm(3), while a tumor of 4.9 cm has a volume of 60.000 mm(3) even belonging to the same class. The aim of the study is to establish if the prognostic role of tumor size, expressed as diameter and volume, has been overshadowed by other factors. Methods The primary objective is to evaluate the association between tumor dimensions and overall survival (OS)/disease free survival (DFS), in our institution from January 1st 2005 to September 30th 2013 in a surgical T1-T2 population. Volume was evaluated with the measurement of three half-diameters of the tumor (a, b and c), and calculated using the following formula: 4/3 pi x a x b x c. Results 341 patients with T1-T2 EBC were included. 86.5% were treated with conservative surgery. 85.1% had a Luminal subtype, 9.1% were Triple negative and 7.4% were HER2 positive. Median volume was 942 mm 3 (range 0.52 +/- 31.651.2). 44 patients (12.9%) relapsed and 23 patients died. With a median follow-up of 6.5 years, the univariate analysis for DFS showed an association between age, tumor size, volume, histological grading and molecular subtype. The multivariate analysis confirmed the statistically significant association only for molecular subtype (p 0.005), with a worse prognosis for Triple negative and HER2 positive subtypes compared with Luminal (HR: 2.65; 95% CI: 1.34-5.22). Likewise for OS, an association was shown by the multivariate analysis solely for molecular subtype (HER2 and Triple negative vs. Luminal. HR: 2.83; 95% CI: 1.46-5.49; p 0.002). Conclusions In our study, the only parameter that strongly influences survival is molecular subtype. These findings encourage clinicians to choose adjuvant treatment not based on dimensional criteria but on biological features.	[Kasangian, Anaid Anna; Bernardin, Elena; Cordovana, Andrea] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Breast Surg Unit, Milan, Italy; [Gherardi, Giorgio] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Pathol, Milan, Italy; [Biagioli, Elena; Torri, Valter] IRCCS Mario Negri Inst Pharmacol Res, Lab Methodol Biomed Res, Milan, Italy; [Moretti, Anna; Farina, Gabriella; Bramati, Annalisa; Piva, Sheila; Dazzani, Maria Chiara; Paterno, Emanuela; La Verde, Nicla Maria] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Oncol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Moretti, A (corresponding author), ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Oncol, Milan, Italy.	anna.moretti@asst-fbf-sacco.it	Biagioli, Elena/AAB-1999-2020; la verde, nicla/AAW-9398-2020; Torri, Valter/H-7550-2015	Biagioli, Elena/0000-0002-2066-3827; la verde, nicla/0000-0002-2884-1632; Torri, Valter/0000-0001-9541-9354				Boggs Drexell Hunter, 2015, J Gastrointest Cancer, V46, P131, DOI 10.1007/s12029-015-9699-y; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chang CC, 2002, HEAD NECK-J SCI SPEC, V24, P940, DOI 10.1002/hed.10151; Chang CC, 2001, J OTOLARYNGOL, V30, P231, DOI 10.2310/7070.2001.19764; Dempsey MF, 2005, AM J NEURORADIOL, V26, P770; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P1515, DOI 10.1043/1543-2165-133.10.1515; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Monetti F, 2004, LUNG CANCER-J IASLC, V43, P71, DOI 10.1016/j.lungcan.2003.07.005; Moon HG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143811; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Veronesi U, 2009, BREAST J, V15, P291, DOI 10.1111/j.1524-4741.2009.00719.x; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032	13	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189127	10.1371/journal.pone.0189127	http://dx.doi.org/10.1371/journal.pone.0189127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211792	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200067
J	Leong, C; Neumann, C; Ramasamy, S; Rout, B; Wee, LY; Bigliardi-Qi, M; Bigliardi, PL				Leong, Cheryl; Neumann, Christine; Ramasamy, Srinivas; Rout, Bhimsen; Wee, Lim Yi; Bigliardi-Qi, Mei; Bigliardi, Paul L.			Investigating endogenous mu-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand	PLOS ONE			English	Article							OPIATE RECEPTOR; BETA-ENDORPHIN; CHRONIC PRURITUS; NERVE-ENDINGS; IN-VITRO; H-3 CTOP; INTERNALIZATION; EXPRESSION; BINDING; ITCH	Opioids in skin function during stress response, regeneration, ageing and, particularly in regulating sensation. In chronic pruritus, topical treatment with Naltrexone changes mu-opioid receptor (mu-OR) localization to relieve itch. The molecular mechanisms behind the effects of Naltrexone on mu-OR function in reduction of itching behavior has not been studied. There is an immediate need to understand the endogenous complexity of mu-OR dynamics in normal and pathological skin conditions. Here we evaluate real-time behavior of mu-OR-Endomorphine complexes in the presence of agonist and antagonists. The mu-OR ligand Endomorphine-1 (EM) was conjugated to the fluorescent dye Tetramethylrhodamine (TAMRA) to investigate the effects of agonist and antagonists in N/TERT-1 keratinocytes. The cellular localization of the EM-TAMRA was followed through time resolved confocal microscopy and population analysis was performed by flow cytometry. The in vitro analyses demonstrate fast internalization and trafficking of the endogenous EM-TAMRA-mu-OR interactions in a qualitative manner. Competition with Endomorphine-1, Naltrexone and CTOP show both canonical and non-canonical effects in basal and differentiated keratinocytes. Acute and chronic treatment with Naltrexone and Endomorphine-1 increases EM-TAMRA binding to skin cells. Although Naltrexone is clinically effective in relieving itch, the mechanisms behind re-distribution of mu-ORs during clinical treatments are not known. Our study has given insight into cellular mechanisms of mu-OR ligand-receptor interactions after opioid agonist and antagonist treatments in vitro. These findings potentially offer opportunities in using novel treatment strategies for skin and peripheral sensory disorders.	[Leong, Cheryl; Neumann, Christine; Ramasamy, Srinivas; Rout, Bhimsen; Bigliardi-Qi, Mei; Bigliardi, Paul L.] ASTAR, Inst Med Biol, Singapore, Singapore; [Wee, Lim Yi] ASTAR, Inst Chem & Engn Sci, Singapore, Singapore; [Bigliardi, Paul L.] Univ Med Cluster, Natl Univ Hosp, Div Rheumatol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); National University of Singapore	Bigliardi-Qi, M; Bigliardi, PL (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.; Bigliardi, PL (corresponding author), Univ Med Cluster, Natl Univ Hosp, Div Rheumatol, Singapore, Singapore.	mei.bigliardi-qi@imb.a-star.edu.sg; paul.bigliardi@imb.a-star.edu.sg		Bigliardi, Paul Lorenz/0000-0003-4567-9080; Srinivas, Ramasamy/0000-0001-9528-1981	Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR)	Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	These studies were supported by funding from the Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR).	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Andoh T, 2004, J INVEST DERMATOL, V123, P196, DOI 10.1111/j.0022-202X.2004.22704.x; Andoh T, 2008, J PHARMACOL SCI, V106, P667, DOI 10.1254/jphs.08004SC; Arttamangkul S, 2000, MOL PHARMACOL, V58, P1570, DOI 10.1124/mol.58.6.1570; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Bigliardi PL, 2015, BRIT J PHARMACOL, V172, P501, DOI 10.1111/bph.12687; Bigliardi PL, 2007, J AM ACAD DERMATOL, V56, P979, DOI 10.1016/j.jaad.2007.01.007; Bigliardi PL, 2009, EXP DERMATOL, V18, P424, DOI 10.1111/j.1600-0625.2009.00844.x; Bigliardi PL, 1998, J INVEST DERMATOL, V111, P297, DOI 10.1046/j.1523-1747.1998.00259.x; Bigliardi PL, 2003, J INVEST DERMATOL, V120, P145, DOI 10.1046/j.1523-1747.2003.12018.x; Bigliardi PL, 2002, J RECEPT SIGNAL TR R, V22, P191, DOI 10.1081/RRS-120014595; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Bigliardi-Qi M, 2005, DERMATOLOGY, V210, P91, DOI 10.1159/000082563; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Bigliardi-Qi M, 2000, J INVEST DERMATOL, V114, P527, DOI 10.1046/j.1523-1747.2000.00801.x; Burford NT, 1998, EUR J PHARMACOL, V342, P123, DOI 10.1016/S0014-2999(97)01556-2; Cassano N, 2010, AM J CLIN DERMATOL, V11, P399, DOI 10.2165/11317620-000000000-00000; Castex-Rizzi N, 2014, BRIT J DERMATOL, V170, P12, DOI 10.1111/bjd.13106; Chuquilin M, 2016, J AM ACAD DERMATOL, V74, P197, DOI 10.1016/j.jaad.2015.04.060; Cohen AS, 2016, BIOCONJUGATE CHEM, V27, P427, DOI 10.1021/acs.bioconjchem.5b00516; Emmerson PJ, 1997, BIOCHEM PHARMACOL, V54, P1315, DOI 10.1016/S0006-2952(97)00374-2; GLINSKI W, 1995, ACTA DERM-VENEREOL, V75, P9; GLINSKI W, 1994, INT J DERMATOL, V33, P356, DOI 10.1111/j.1365-4362.1994.tb01068.x; GLINSKI W, 1994, BRIT J DERMATOL, V131, P260; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Halls ML, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9177; HAWKINS KN, 1989, J PHARMACOL EXP THER, V248, P73; HAWKINS KN, 1988, LIFE SCI, V42, P2541, DOI 10.1016/0024-3205(88)90322-0; Horner KA, 2004, BRAIN RES, V1028, P121, DOI 10.1016/j.brainres.2004.07.055; Ignatowski TA, 1998, J PHARMACOL EXP THER, V284, P298; Janecka A, 2004, CURR TOP MED CHEM, V4, P1, DOI 10.2174/1568026043451618; Karaji AG, 2005, INT IMMUNOPHARMACOL, V5, P1019, DOI 10.1016/j.intimp.2005.01.012; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Ko M.C., 2014, ITCH MECH TREATMENT; Lee CH, 2006, BRIT J DERMATOL, V154, P1100, DOI 10.1111/j.1365-2133.2006.07191.x; Lee J, 2016, CHILD YOUTH SERV REV, V63, P28, DOI 10.1016/j.childyouth.2016.02.003; Lengyel I, 2016, J PHYSIOL PHARMACOL, V67, P605; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Madsen BW, 2000, J NEUROSCI METH, V97, P123, DOI 10.1016/S0165-0270(00)00175-8; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Neumann C, 2015, J INVEST DERMATOL, V135, P471, DOI 10.1038/jid.2014.370; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P555, DOI 10.2340/00015555-1353; Nissen JB, 1997, ARCH DERMATOL RES, V289, P265, DOI 10.1007/s004030050191; Nissen JB, 1997, EXP DERMATOL, V6, P222, DOI 10.1111/j.1600-0625.1997.tb00166.x; Pereira MP, 2016, CURR PROBL DERMATOL, V50, P71, DOI 10.1159/000446046; Petaja-Repo UE, 2014, PHARMACOL RES, V83, P52, DOI 10.1016/j.phrs.2013.12.001; Phan NQ, 2010, J AM ACAD DERMATOL, V63, P680, DOI 10.1016/j.jaad.2009.08.052; Siemens W, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008320.pub3; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; SLOMINSKI A, 1991, ANN NY ACAD SCI, V642, P459; SLOMINSKI A, 1993, J LAB CLIN MED, V122, P658; Slominski A. T., 2012, ADV ANATOMY EMBRYOLO, V212, P115, DOI DOI 10.1007/978-3-642-19683-6_1; Slominski AT, 2015, J INVEST DERMATOL, V135, P333, DOI 10.1038/jid.2014.458; Slominski AT, 2011, J INVEST DERMATOL, V131, P613, DOI 10.1038/jid.2010.376; Stoddart LA, 2015, NEUROPHARMACOLOGY, V98, P48, DOI 10.1016/j.neuropharm.2015.04.033; Tominaga M, 2007, J INVEST DERMATOL, V127, P2228, DOI 10.1038/sj.jid.5700942; YAMAZAKI T, 1993, J MED CHEM, V36, P708, DOI 10.1021/jm00058a007; Yu X, 2003, J PHARMACOL EXP THER, V306, P447, DOI 10.1124/jpet.103.048694; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	60	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188607	10.1371/journal.pone.0188607	http://dx.doi.org/10.1371/journal.pone.0188607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211767	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200041
J	Vukovic, R; Milenkovic, T; Stojan, G; Vukovic, A; Mitrovic, K; Todorovic, S; Soldatovic, I				Vukovic, Rade; Milenkovic, Tatjana; Stojan, George; Vukovic, Ana; Mitrovic, Katarina; Todorovic, Sladjana; Soldatovic, Ivan			Pediatric siMS score: A new, simple and accurate continuous metabolic syndrome score for everyday use in pediatrics	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; SYNDROME RISK SCORE; BODY-MASS INDEX; PHYSICAL-ACTIVITY; AMERICAN CHILDREN; OBESE CHILDREN; QUEBEC-FAMILY; CVD RISK; ADOLESCENTS; PREVALENCE	Background The dichotomous nature of the current definition of metabolic syndrome (MS) in youth results in loss of information. On the other hand, the calculation of continuous MS scores using standardized residuals in linear regression (Z scores) or factor scores of principal component analysis (PCA) is highly impractical for clinical use. Recently, a novel, easily calculated continuous MS score called siMS score was developed based on the IDF MS criteria for the adult population. Objective To develop a Pediatric siMS score (PsiMS), a modified continuous MS score for use in the obese youth, based on the original siMS score, while keeping the score as simple as possible and retaining high correlation with more complex scores. Subjects and methods The database consisted of clinical data on 153 obese (BMI >= 95th percentile) children and adolescents. Continuous MS scores were calculated using Z scores and PCA, as well as the original siMS score. Four variants of PsiMS score were developed in accordance with IDF criteria for MS in youth and correlation of these scores with PCA and Z score derived MS continuous scores was assessed. Results PsiMS score calculated using formula: (2xWaist/Height) + (Glucose(mmol/l)/5.6) + (triglycerides( mmol/l)/1.7) + (Systolic BP/130)-(HDL(mmol/l)/1.02) showed the highest correlation with most of the complex continuous scores (0.792-0.901). The original siMS score also showed high correlation with continuous MS scores. Conclusion PsiMS score represents a practical and accurate score for the evaluation of MS in the obese youth. The original siMS score should be used when evaluating large cohorts consisting of both adults and children.	[Vukovic, Rade; Mitrovic, Katarina; Todorovic, Sladjana] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Dept Endocrinol, Belgrade, Serbia; [Milenkovic, Tatjana] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Belgrade, Serbia; [Stojan, George] Harvard Med Sch, BIDMC, Boston, MA USA; [Vukovic, Ana] Univ Belgrade, Sch Dent Med, Dept Pediat & Prevent Dent, Belgrade, Serbia; [Soldatovic, Ivan] Univ Belgrade, Inst Med Stat & Informat, Sch Med, Belgrade, Serbia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Belgrade; University of Belgrade	Soldatovic, I (corresponding author), Univ Belgrade, Inst Med Stat & Informat, Sch Med, Belgrade, Serbia.	soldatovic.ivan@gmail.com	Vukovic, Rade/H-3344-2019; Todorovic, Sladjana/GVS-4184-2022; Stojan, George/AAP-3878-2020	Vukovic, Rade/0000-0002-1592-4105; Stojan, George/0000-0001-5758-5052; Soldatovic, Ivan/0000-0003-4893-1683; Todorovic, Sladjana/0000-0002-9981-8923				Ahrens W, 2014, INT J OBESITY, V38, pS4, DOI 10.1038/ijo.2014.130; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DuBose KD, 2015, PEDIATR EXERC SCI, V27, P364, DOI [10.1123/pes.2014-01340, 10.1123/pes.2014-0134]; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Eisenmann JC, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-8; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Friend A, 2013, METAB SYNDR RELAT D, V11, P71, DOI 10.1089/met.2012.0122; Kahn R, 2007, CIRCULATION, V115, P1806, DOI 10.1161/CIRCULATIONAHA.106.658336; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Li CY, 2007, DIABETES CARE, V30, P1556, DOI 10.2337/dc06-2481; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Okosun IS, 2010, J CLIN HYPERTENS, V12, P636, DOI 10.1111/j.1751-7176.2010.00338.x; Olza J, 2015, ANN NUTR METAB, V66, P72, DOI 10.1159/000369981; Pandit D, 2011, INT J OBESITY, V35, P1318, DOI 10.1038/ijo.2011.138; Pirkola J, 2008, ARCH DIS CHILD, V93, P945, DOI 10.1136/adc.2007.132951; Pladevall M, 2006, DIABETES CARE, V29, P113, DOI 10.2337/diacare.29.1.113; Shi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138979; Soldatovic I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146143; Viitasalo A, 2014, DIABETOLOGIA, V57, P940, DOI 10.1007/s00125-014-3172-5; Villa Julia Khéde Dourado, 2015, Rev. paul. pediatr., V33, P187, DOI 10.1016/j.rpped.2014.11.001; Vukovic R, 2012, INT J OBESITY, V36, P1479, DOI 10.1038/ijo.2011.273; Vukovic R, 2015, J PEDIATR ENDOCR MET, V28, P903, DOI 10.1515/jpem-2014-0533; WHO, 2009, WHO ANTHR PERS COMP; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189232	10.1371/journal.pone.0189232	http://dx.doi.org/10.1371/journal.pone.0189232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211786	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200076
J	Warden, CH; Bettaieb, A; Min, E; Fisler, JS; Haj, FG; Stern, JS				Warden, Craig H.; Bettaieb, Ahmed; Min, Esther; Fisler, Janis S.; Haj, Fawaz G.; Stern, Judith S.			Chow fed UC Davis strain female Lepr fatty Zucker rats exhibit mild glucose intolerance, hypertriglyceridemia, and increased urine volume, all reduced by a Brown Norway strain chromosome 1 congenic donor region	PLOS ONE			English	Article							SUITABLE HOUSEKEEPING GENES; BODY-MASS INDEX; RENAL-DISEASE; KIDNEY-DISEASE; RT-PCR; OBESE; MOUSE; INJURY; IDENTIFICATION; NORMALIZATION	Our objective is to identify genes that influence the development of any phenotypes of type 2 diabetes (T2D) or kidney disease in obese animals. We use the reproductively isolated UC Davis fatty Zucker strain rat model in which the defective chromosome 4 leptin receptor (Lepr(faSte/faSte)) results in fatty obesity. We previously produced a congenic strain with the distal half of chromosome 1 from the Brown Norway strain (BN) on a Zucker (ZUC) background (BN.ZUC-D1Rat183-D1Rat90). Previously published studies in males showed that the BN congenic donor region protects from some phenotypes of renal dysfunction and T2D. We now expand our studies to include females and expand phenotyping to gene expression. We performed diabetes and kidney disease phenotyping in chow-fed females of the BN. ZUC-D1Rat183-D1Rat90 congenic strain to determine the specific characteristics of the UC Davis model. Fatty Lepr(faSte/faSte) animals of both BN and ZUC genotype in the congenic donor region had prediabetic levels of fasting blood glucose and blood glucose 2 hours after a glucose tolerance test. We observed significant congenic strain chromosome 1 genotype effects of the BN donor region in fatty females that resulted in decreased food intake, urine volume, glucose area under the curve during glucose tolerance test, plasma triglyceride levels, and urine glucose excretion per day. In fatty females, there were significant congenic strain BN genotype effects on non-fasted plasma urea nitrogen, triglyceride, and creatinine. Congenic region genotype effects were observed by quantitative PCR of mRNA from the kidney for six genes, all located in the chromosome 1 BN donor region, with potential effects on T2D or kidney function. The results are consistent with the hypothesis that the BN genotype chromosome 1 congenic region influences traits of both type 2 diabetes and kidney function in fatty UC Davis ZUC females and that there are many positional candidate genes.	[Warden, Craig H.] Univ Calif Davis, Dept Pediat Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Bettaieb, Ahmed] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Min, Esther; Fisler, Janis S.; Haj, Fawaz G.; Stern, Judith S.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Stern, Judith S.] Univ Calif Davis, Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Davis; University of California System; University of California Davis	Warden, CH (corresponding author), Univ Calif Davis, Dept Pediat Neurobiol Physiol & Behav, Davis, CA 95616 USA.	chwarden@ucdavis.edu			Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359] Funding Source: NIH RePORTER	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Nora Eccles Treadwell Foundation grant to JSS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2011, SEX DEPENDENT HEPATI; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bettaieb A, 2017, FEBS J, V284, P1970, DOI 10.1111/febs.14100; CHAN CP, 1982, AM J PHYSIOL, V242, pE19, DOI 10.1152/ajpendo.1982.242.1.E19; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dominguez JH, 2006, KIDNEY INT, V69, P1969, DOI 10.1038/sj.ki.5000406; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Fisler JS, 1997, J NUTR, V127, pS1909, DOI 10.1093/jn/127.9.1909S; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Fram EB, 2016, UROLOGY, V87, P52, DOI 10.1016/j.urology.2015.10.013; Gades MD, 1998, KIDNEY INT, V53, P130, DOI 10.1046/j.1523-1755.1998.00746.x; Gades MD, 1999, KIDNEY INT, V56, P1779, DOI 10.1046/j.1523-1755.1999.00731.x; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00564-3; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; Johnson PR, 1997, AM J CLIN NUTR, V66, P890, DOI 10.1093/ajcn/66.4.890; KASISKE BL, 1986, AM J CLIN NUTR, V44, P56, DOI 10.1093/ajcn/44.1.56; Kessler MA, 1997, ANAL BIOCHEM, V248, P180, DOI 10.1006/abio.1997.2113; Kessler MA, 1997, CLIN CHEM, V43, P996; Kim K, 2010, PHYSL GENOMICS; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Lazar J, 2013, PHYSIOL GENOMICS, V45, P720, DOI 10.1152/physiolgenomics.00089.2013; Liu TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141859; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Navaneethan SD, 2016, KIDNEY INT, V89, P675, DOI 10.1016/j.kint.2015.12.002; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Reznichenko A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-78; Sarahan KA, 2011, PHYSIOL GENOMICS, V43, P1049, DOI 10.1152/physiolgenomics.00134.2010; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stevenson FT, 2000, KIDNEY INT, V57, P1927, DOI 10.1046/j.1523-1755.2000.00042.x; Stevenson FT, 2001, OBES RES, V9, P492, DOI 10.1038/oby.2001.64; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Tan YC, 2011, BBA-MOL BASIS DIS, V1812, P1202, DOI 10.1016/j.bbadis.2011.03.002; Valente V, 2014, ANN NEUROSCI, V21, P62, DOI 10.5214/ans.0972.7531.210207; Vesentini Nicoletta, 2012, BMC Res Notes, V5, P124, DOI 10.1186/1756-0500-5-124; WARDEN CH, 1993, J CLIN INVEST, V92, P773, DOI 10.1172/JCI116649; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; Warden CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087770; Warden CH, 2012, PHYSIOL GENOMICS, V44, P1052, DOI 10.1152/physiolgenomics.00134.2011; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Xu M, 2016, EBIOMEDICINE, V6, P162, DOI 10.1016/j.ebiom.2016.02.032; Yazdi FT, 2015, PEERJ, V3, DOI 10.7717/peerj.856; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	57	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188175	10.1371/journal.pone.0188175	http://dx.doi.org/10.1371/journal.pone.0188175			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211750	Green Published, gold			2022-12-26	WOS:000417212200025
J	Tang, JJ; Zhang, S; Zou, YJ; Liu, F				Tang, Jinjun; Zhang, Shen; Zou, Yajie; Liu, Fang			An adaptive map-matching algorithm based on hierarchical fuzzy system from vehicular GPS data	PLOS ONE			English	Article							TRANSPORT; PATTERNS	An improved hierarchical fuzzy inference method based on C-measure map-matching algorithm is proposed in this paper, in which the C-measure represents the certainty or probability of the vehicle traveling on the actual road. A strategy is firstly introduced to use historical positioning information to employ curve-curve matching between vehicle trajectories and shapes of candidate roads. It improves matching performance by overcoming the disadvantage of traditional map-matching algorithm only considering current information. An average historical distance is used to measure similarity between vehicle trajectories and road shape. The input of system includes three variables: distance between position point and candidate roads, angle between driving heading and road direction, and average distance. As the number of fuzzy rules will increase exponentially when adding average distance as a variable, a hierarchical fuzzy inference system is then applied to reduce fuzzy rules and improve the calculation efficiency. Additionally, a learning process is updated to support the algorithm. Finally, a case study contains four different routes in Beijing city is used to validate the effectiveness and superiority of the proposed method.	[Tang, Jinjun] Cent S Univ, Sch Traff & Transportat Engn, Key Lab Smart Transport Hunan Prov, Changsha, Hunan, Peoples R China; [Zhang, Shen] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Heilongjiang, Peoples R China; [Zou, Yajie] Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China; [Liu, Fang] Inner Mongolia Agr Univ, Sch Energy & Transportat Engn, Hohhot, Peoples R China	Central South University; Harbin Institute of Technology; Tongji University; Inner Mongolia Agricultural University	Zou, YJ (corresponding author), Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China.	yajiezou@hotmail.com		Zou, Yajie/0000-0002-3505-168X	National Natural Science Foundation of China [71701215, 61573009, 71403068]; Foundation of Central South University [502045002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Central South University	This research was funded in part by the National Natural Science Foundation of China (grant nos. 71701215, 61573009 and 71403068), Foundation of Central South University (grant nos. 502045002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part by the National Natural Science Foundation of China (grant nos. 71701215 and 71403068), Foundation of Central South University (grant nos. 502045002).	[Anonymous], 2010, P 18 SIGSPATIAL INT, DOI DOI 10.1145/1869790.1869807; Blazquez CA, 2005, TRANSPORT RES REC, P68, DOI 10.3141/1935-08; Fu MY, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P613, DOI 10.1109/ITSC.2004.1398971; Greenfeld J., 2002, 81 ANN M TRANSP RES; Kim S, 2001, IEEE T IND ELECTRON, V48, P432, DOI 10.1109/41.915423; Li ZH, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P425; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Ochieng W. Y., 2004, BRAZILIAN J CARTOGRA, V55, P1; Phuyal B., 2002, I NAV ION ANN C PORT; Quddus MA, 2007, TRANSPORT RES C-EMER, V15, P312, DOI 10.1016/j.trc.2007.05.002; Quddus MA, 2006, J INTELL TRANSPORT S, V10, P103, DOI 10.1080/15472450600793560; RAJU GVS, 1991, INT J CONTROL, V54, P1201, DOI 10.1080/00207179108934205; Syed S, 2004, I NAV ION NAT TECHN; Tang JJ, 2017, IEEE T INTELL TRANSP, V18, P2340, DOI 10.1109/TITS.2016.2643005; Tang JJ, 2018, EXPERT SYST APPL, V91, P452, DOI 10.1016/j.eswa.2017.09.025; Tang JJ, 2016, IEEE T INTELL TRANSP, V17, P3318, DOI 10.1109/TITS.2016.2544140; Tang JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147263; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; White CE, 2000, TRANSPORT RES C-EMER, V8, P91, DOI 10.1016/S0968-090X(00)00026-7; Yan Y, 2017, PHYSICA A, V477, P149, DOI 10.1016/j.physa.2017.02.040; Yang D, 2003, 2003 IEEE INTELLIGENT TRANSPORTATION SYSTEMS PROCEEDINGS, VOLS. 1 & 2, P1246; YU HY, 2017, SENSORS BASEL, V17, DOI DOI 10.3390/S17071501; Zhang S, 2017, J TRANSP GEOGR, V61, P72, DOI 10.1016/j.jtrangeo.2017.04.009; Zhao Y., 1997, VEHICLE LOCATION NAV	26	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188796	10.1371/journal.pone.0188796	http://dx.doi.org/10.1371/journal.pone.0188796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206866	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700023
J	Jhun, BW; Jung, WJ; Hwang, NY; Park, HY; Jeon, K; Kang, ES; Koh, WJ				Jhun, Byung Woo; Jung, Woo Jin; Hwang, Na Young; Park, Hye Yun; Jeon, Kyeongman; Kang, Eun-Suk; Koh, Won-Jung			Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease	PLOS ONE			English	Article							SERUM ITRACONAZOLE LEVELS; CLINICAL CHARACTERISTICS; CYSTIC-FIBROSIS; ANTIBIOTIC-TREATMENT; PRACTICE GUIDELINES; TREATMENT OUTCOMES; AVIUM; DIAGNOSIS; THERAPY; ABSCESSUS	Nontuberculous mycobacterial lung disease (NTM-LD) is increasingly recognized as an important predisposing condition for the development of chronic pulmonary aspergillosis (CPA), but there are limited data on the risk factors for CPA development in NTM-LD patients. We reviewed the medical records of 566 patients who, at the time of diagnosis of NTM-LD, did not have CPA and who received >= 12 months of treatment for NTM-LD between January 2010 and June 2015. Of these patients, 41 (7.2%) developed CPA (NTM-CPA group), whereas the remaining 525 patients did not develop CPA (NTM group). The median time to the development of CPA was 18.0 months from treatment initiation for NTM-LD. The NTM-CPA group was older and had significantly higher proportions of males, current smokers, and patients with a low body mass index (< 18.5 kg/m(2)), when compared to the NTM group. Moreover, the NTM-CPA group was more likely to have a history of tuberculosis and chronic obstructive lung disease and to have used inhaled or systemic steroids. In the NTM-CPA group, more than 40% of patients had Mycobacterium abscessus complex (MABC) as the cause of NTM-LD, and the fibrocavitary form of NTM-LD was the most common; both associations were higher than in the NTM group. Overall, 17 (3%) patients died, and the NTM-CPA group had a higher mortality rate than did the NTM group (19.5% vs. 1.7%, respectively; P<0.001). In a multivariable analysis, old age, male gender, low body mass index, chronic obstructive lung disease, systemic steroids, MABC as the etiologic organism, and the fibrocavitary form of NTM-LD remained significant predictors of development of CPA. In conclusion, CPA occurred in 7.2% of patients after initiation of treatment for NTM-LD, and some risk factors were associated with CPA development. Given the worse prognosis, early diagnosis and treatment of CPA are important in patients with NTM-LD.	[Jhun, Byung Woo; Jung, Woo Jin; Park, Hye Yun; Jeon, Kyeongman; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Hwang, Na Young] Samsung Med Ctr, Dept Stat, Seoul, South Korea; [Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; Jeon, Kyeongman/F-5963-2019	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A01003959]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C2778]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A01003959) and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2778). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Fleshner M, 2016, INT J TUBERC LUNG D, V20, P582, DOI 10.5588/ijtld.15.0807; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2015, CHEST, V147, P1369, DOI 10.1378/chest.14-1297; Hafeez I, 2000, THORAX, V55, P717, DOI 10.1136/thorax.55.8.717; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kang YA, 2016, EXPERT REV RESP MED, V10, P557, DOI 10.1586/17476348.2016.1165611; Kobashi Y, 2006, RESPIROLOGY, V11, P809, DOI 10.1111/j.1440-1843.2006.00952.x; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02503-2016; Koh WJ, 2017, CLIN INFECT DIS, V64, P309, DOI 10.1093/cid/ciw724; Koh WJ, 2016, CHEST, V150, P1211, DOI 10.1016/j.chest.2016.05.003; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Kunst H, 2006, EUR RESPIR J, V28, P352, DOI 10.1183/09031936.06.00139005; Kwon YS, 2016, J KOREAN MED SCI, V31, P649, DOI 10.3346/jkms.2016.31.5.649; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Moon SM, 2017, J INFECT CHEMOTHER, V23, P658, DOI 10.1016/j.jiac.2017.02.004; Moon SM, 2015, ANTIMICROB AGENTS CH, V59, P663, DOI 10.1128/AAC.04075-14; Mussaffi H, 2005, EUR RESPIR J, V25, P324, DOI 10.1183/09031936.05.00058604; Nam HS, 2010, INT J INFECT DIS, V14, pE479, DOI 10.1016/j.ijid.2009.07.011; Noni M, 2014, MED MYCOL, V52, P715, DOI 10.1093/mmy/myu038; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; Stout JE, 2016, INT J INFECT DIS, V45, P123, DOI 10.1016/j.ijid.2016.03.006; Takeda K, 2016, MED MYCOL, V54, P120, DOI 10.1093/mmy/myv093; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Zoumot Z, 2014, RESPIROLOGY, V19, P714, DOI 10.1111/resp.12287	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188716	10.1371/journal.pone.0188716	http://dx.doi.org/10.1371/journal.pone.0188716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190796	Green Published, gold			2022-12-26	WOS:000416841900106
J	Li, Z; Wang, WW; Liu, D; Guo, YM				Li, Zhui; Wang, Weiwei; Liu, Dan; Guo, Yuming			Effects of Lactobacillus acidophilus on gut microbiota composition in broilers challenged with Clostridium perfringens	PLOS ONE			English	Article							CHAIN FATTY-ACID; NECROTIC ENTERITIS; INTESTINAL MICROBIOTA; CECAL MICROFLORA; CHICKENS; BUTYRATE; COMMUNITY; HEALTH; INFECTION; STRAINS	This study shows the effects of dietary supplementation with Lactobacillus acidophilus on the gut microbiota of broiler chickens challenged with Clostridium perfringens infection during a 21-day period according to pyrosequencing of the 16S ribosomal RNA gene. In a 2 x 2 factorial arrangement of treatments, 308 1-day-old male Arbor Acres broiler chicks were analyzed for the effects of the probiotic (groups without or with L. acidophilus supplementation), pathogen challenge (groups without or with C. perfringens), and the effects of interaction. The infection decreased the number of Observed species, Chao1, and ACE of ileal microbiota and increased Chao1 of cecal microbiota of broilers, whereas L. acidophilus supplementation decreased the Shannon index of the ileal microbiota. Shannon index and Simpson indices were lower in the ileal microbiota than in the cecal microbiota. In the ileal microbiota, the control group had higher relative abundance of Lachnospiraceae and Ruminococcaceae in comparison with the other groups; however, the relative abundance of Gamma proteobacteria was significantly higher in the challenge group than in the other groups. C. perfringens infection tended to increase lactate concentration and decreased concentrations of formate, acetate and propionate in the ileum; decreased isobutyrate concentration; and tended to decrease isovalerate concentration in the cecum. Besides, L. acidophilus supplementation increased the concentration of lactate and butyrate and decreased concentrations of formate and propionate in the ileum, and increased concentrations of lactate and valerate in the cecum. In conclusion, C. perfringens infection and/or dietary supplementation with L. acidophilus modulated the relative abundance of some bacteria taxa, and the L. acidophilus supplementation helped to restore the microbial community disrupted by C. perfringens infection.	[Li, Zhui; Wang, Weiwei; Liu, Dan; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Liu, D (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	liudan23@163.com			Natural Science foundation of China	Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science foundation of China (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonissen G, 2016, AVIAN PATHOL, V45, P308, DOI 10.1080/03079457.2016.1152625; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bull M, 2013, FEMS MICROBIOL LETT, V349, P77, DOI 10.1111/1574-6968.12293; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Dahiya JP, 2005, POULTRY SCI, V84, P1875, DOI 10.1093/ps/84.12.1875; Du E, 2015, J ANIM SCI TECHNOL, V24, P6; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Fasina YO, 2016, POULTRY SCI, V95, P247, DOI 10.3382/ps/pev329; Feng YN, 2010, VET MICROBIOL, V140, P116, DOI 10.1016/j.vetmic.2009.07.001; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Hofacre CL, 2003, J APPL POULTRY RES, V12, P60, DOI 10.1093/japr/12.1.60; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Jung TH, 2015, NUTR RES PRACT, V9, P343, DOI 10.4162/nrp.2015.9.4.343; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin CK, 2008, ANAEROBE, V14, P251, DOI 10.1016/j.anaerobe.2008.07.003; Liu D, 2012, AVIAN PATHOL, V41, P291, DOI 10.1080/03079457.2012.684089; Liu D, 2010, AVIAN PATHOL, V39, P17, DOI 10.1080/03079450903447404; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Meimandipour A, 2010, POULTRY SCI, V89, P470, DOI 10.3382/ps.2009-00495; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Peng Q, 2016, POULTRY SCI, V95, P893, DOI 10.3382/ps/pev435; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ren CC, 2016, SCI REPORTS, P6; Rinttila T, 2013, J APPL POULTRY RES, V22, P647, DOI 10.3382/japr.2013-00742; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shaufi MAM, 2015, GUT PATHOG, P7; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Sluis W. van der, 2000, World Poultry, V16, P42; Stanley D, 2014, PLOS ONE, V9; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Sun QJ, 2015, ANIM FEED SCI TECH, V207, P234, DOI 10.1016/j.anifeedsci.2015.06.021; Thomas S, 2017, CANCER RES, V77, P1783, DOI 10.1158/0008-5472.CAN-16-2929; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Tsai CC, 2005, INT J FOOD MICROBIOL, V102, P185, DOI 10.1016/j.ijfoodmicro.2004.12.014; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Walugembe M, 2015, POULTRY SCI, V94, P2351, DOI 10.3382/ps/pev242	58	42	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188634	10.1371/journal.pone.0188634	http://dx.doi.org/10.1371/journal.pone.0188634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190649	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900088
J	Martins, RT; Rezende, RD; Goncalves, JF; Lopes, A; Piedade, MTF; Cavalcante, HD; Hamada, N				Martins, Renato Tavares; Rezende, Renan de Souza; Goncalves Junior, Jose Francisco; Lopes, Aline; Fernandez Piedade, Maria Teresa; Cavalcante, Heloide de Lima; Hamada, Neusa			Effects of increasing temperature and, CO2 on quality of litter, shredders, and microorganisms in Amazonian aquatic systems	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; ORGANIC-MATTER DYNAMICS; LEAF-LITTER; ELEVATED CO2; CLIMATE-CHANGE; DECOMPOSITION; BREAKDOWN; STREAMS; TRICHOPTERA; INVERTEBRATES	Climate change may affect the chemical composition of riparian leaf litter and, aquatic organisms and, consequently, leaf breakdown. We evaluated the effects of different scenarios combining increased temperature and carbon dioxide (CO2) on leaf detritus of Hevea spruceana (Benth) Mull. and decomposers (insect shredders and microorganisms). We hypothesized that simulated climate change (warming and elevated CO2) would: i) decrease leaf-litter quality, ii) decrease survival and leaf breakdown by shredders, and iii) increase microbial leaf breakdown and fungal biomass. We performed the experiment in four microcosm chambers that simulated air temperature and CO2 changes in relation to a real-time control tracking current conditions in Manaus, Amazonas, Brazil. The experiment lasted seven days. During the experiment mean air temperature and CO2 concentration ranged from 26.96 +/- 0.98 degrees C and 537.86 +/- 18.36 ppmv in the control to 31.75 +/- 0.50 degrees C and 1636.96 +/- 17.99 ppmv in the extreme chamber, respectively. However, phosphorus concentration in the leaf litter decreased with warming and elevated CO2. Leaf quality (percentage of carbon, nitrogen, phosphorus, cellulose and lignin) was not influenced by soil flooding. Fungal biomass and microbial leaf breakdown were positively influenced by temperature and CO2 increase and reached their highest values in the intermediate condition. Both total and shredder leaf breakdown, and shredder survival rate were similar among all climatic conditions. Thus, low leaf-litter quality due to climate change and higher leaf breakdown under intermediate conditions may indicate an increase of riparian metabolism due to temperature and CO2 increase, highlighting the risk (e.g., decreased productivity) of global warming for tropical streams.	[Martins, Renato Tavares; Hamada, Neusa] INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Rezende, Renan de Souza] Univ Comunitaria Reg Chapeco, Programa Posgrad Ciencias Ambientais, Chapeco, SC, Brazil; [Goncalves Junior, Jose Francisco] Univ Brasilia, Inst Biol, Dept Ecol, AquaRiparia, Brasilia, DF, Brazil; [Lopes, Aline; Fernandez Piedade, Maria Teresa; Cavalcante, Heloide de Lima] Inst Nacl de Pesquisas da Amazonia, Grp MAUA Ecol Monitoramento & Uso Sustentavel Are, Manaus, Amazonas, Brazil; [Lopes, Aline] Univ Nilton Lins, Lab Ecol Posgrad Biol Urbana, Manaus, Amazonas, Brazil; [Martins, Renato Tavares] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Comunitaria Regional de Chapeco; Universidade de Brasilia; Institute Nacional de Pesquisas da Amazonia; Centro Universitario Nilton Lins; Universidade Federal de Goias	Martins, RT (corresponding author), INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.; Martins, RT (corresponding author), Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	martinsrt@gmail.com	Hamada, Neusa/E-3383-2013; Gonçalves Júnior, José/G-3910-2012; Lopes, Aline/G-5773-2012; Martins, Renato Tavares/F-4968-2014; Rezende, Renan de Souza/I-5165-2014; Martins, Renato Tavares/ABA-5075-2021; Piedade, Maria Teresa/C-5372-2013; Martins, Renato Tavares/GSD-8118-2022	Gonçalves Júnior, José/0000-0001-8191-2113; Lopes, Aline/0000-0001-5771-4643; Rezende, Renan de Souza/0000-0002-4129-0863; Piedade, Maria Teresa/0000-0002-7320-0498; Martins, Renato Tavares/0000-0003-3464-7905	Programa de Apoio a Fixacao de Doutores no Amazonas-FIXAM/AM (FAPEAM); Programa Nacional de Pos-Doutorado - PNPD/CAPES Programa de Pos-graduacao em Ecologia e Evolucao -PPGEE/UFG; National Institute for Research in Amazonia (INPA) through CNPq [151375/2014-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302957/2014-6, 310547/2016-4, 307849/2014-7]; CT-Hidro/Climatic Changes/Water Resources/CNPq [403949/2013-0]; INCT/ADAPTA-II (CNPq/FAPEAM) [465540/2014-7]	Programa de Apoio a Fixacao de Doutores no Amazonas-FIXAM/AM (FAPEAM); Programa Nacional de Pos-Doutorado - PNPD/CAPES Programa de Pos-graduacao em Ecologia e Evolucao -PPGEE/UFG; National Institute for Research in Amazonia (INPA) through CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CT-Hidro/Climatic Changes/Water Resources/CNPq; INCT/ADAPTA-II (CNPq/FAPEAM)	RTM and AL received a fellowships from Programa de Apoio a Fixacao de Doutores no Amazonas-FIXAM/AM (FAPEAM). RTM received a fellowship from Programa Nacional de Pos-Doutorado - PNPD/CAPES Programa de Pos-graduacao em Ecologia e Evolucao -PPGEE/UFG. RSR received a Post-Doctoral Scholarship from the National Institute for Research in Amazonia (INPA) through CNPq grant number 151375/2014-3. JFG, MTFP and NH received research grants (302957/2014-6, 310547/2016-4 and 307849/2014-7, respectively) from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). CT-Hidro/Climatic Changes/Water Resources/CNPq (Process 403949/2013-0), INCT/ADAPTA-II (CNPq/FAPEAM; Process 465540/2014-7), PELD MAUA (CNPq, FAPEAM) and INPA supported the invertebrate samples, laboratory analyses and microcosm experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim EACC, 2015, J LIMNOL, V74, P248, DOI 10.4081/jlimnol.2014.982; [Anonymous], 2013, SECAS AMAZONIA CAUSA; Barlocher F, 2013, MICROB ECOL, V66, P30, DOI 10.1007/s00248-013-0202-7; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Canhoto C, 2016, FUNGAL ECOL, V19, P201, DOI 10.1016/j.funeco.2015.09.011; Chen HJ, 2005, AQUAT BOT, V82, P250, DOI 10.1016/j.aquabot.2005.02.013; Cook B, 2012, EARTH INTERACT, V16, DOI 10.1175/2011EI398.1; Wittmann AD, 2007, AQUAT BOT, V86, P197, DOI 10.1016/j.aquabot.2006.10.001; Villanueva VD, 2011, HYDROBIOLOGIA, V678, P155, DOI 10.1007/s10750-011-0837-7; Ferreira V, 2015, CAN J FISH AQUAT SCI, V72, P206, DOI 10.1139/cjfas-2014-0119; Ferreira V, 2010, GLOBAL CHANGE BIOL, V16, P3284, DOI 10.1111/j.1365-2486.2009.02153.x; Ferreira WR, 2015, ANN LIMNOL-INT J LIM, V51, P115, DOI 10.1051/limn/2015004; Finlayson CM, 2005, ANN BOT-LONDON, V96, P541, DOI 10.1093/aob/mci209; Gessner Mark O., 2005, P115, DOI 10.1007/1-4020-3466-0_17; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gessner MO, METHODS STUDY LITTER, P189; Goncalves JF, 2017, HYDROBIOLOGIA, V792, P195, DOI 10.1007/s10750-016-3056-4; Graca MAS, 2014, OECOLOGIA, V174, P1021, DOI 10.1007/s00442-013-2825-2; Graca MAS, 2016, FUNGAL ECOL, V19, P182, DOI 10.1016/j.funeco.2015.08.001; Graca MAS, 2015, INT REV HYDROBIOL, V100, P1, DOI 10.1002/iroh.201401757; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Hasegawa S, 2016, GLOBAL CHANGE BIOL, V22, P1628, DOI 10.1111/gcb.13147; He ZL, 2014, ISME J, V8, P714, DOI 10.1038/ismej.2013.177; Holzenthal RW, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.654.9516; Hoosbeek MR, 2016, BIOGEOCHEMISTRY, V127, P89, DOI 10.1007/s10533-015-0169-1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IPCC, 2007, CLIM CHANG 2007 PHYS; Je SM, 2017, ECOL RES, P1; Khan FN, 2010, PAK J BOT, V42, P907; Lahive F, 2017, PHOTOSYNTHETICA; Leberfinger K, 2010, HYDROBIOLOGIA, V652, P247, DOI 10.1007/s10750-010-0337-1; Leonel BF, 2015, J MED ENTOMOL, V52, P866, DOI 10.1093/jme/tjv068; LeRoy CJ, 2014, FUND APPL LIMNOL, V184, P1, DOI 10.1127/1863-9135/2014/0505; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Lopes A, 2015, HYDROBIOLOGIA; Lopez OR, 1999, TREE PHYSIOL, V19, P925; Lower SS, 2003, OECOLOGIA, V136, P402, DOI 10.1007/s00442-003-1278-4; Malavolta E., 1997, AVALIA O ESTADO NUTR, V2nd; Martins RT, 2017, HYDROBIOLOGIA, V789, P31, DOI 10.1007/s10750-016-2689-7; Martins RT, 2015, FRESHW SCI, V34, P716, DOI 10.1086/681086; Martins RT, 2014, ZOOLOGIA-CURITIBA, V31, P337, DOI 10.1590/S1984-46702014000400005; Moretti MS, 2009, HYDROBIOLOGIA, V630, P199, DOI 10.1007/s10750-009-9792-y; Navarro FKSP, 2017, IHERINGIA SER ZOOL, V107, DOI 10.1590/1678-4766e2017017; Prather A.L., 2003, ZOOTAXA, V275, P1, DOI DOI 10.11646/Z00TAXA.275.1.1; Pyne MI, 2017, GLOBAL CHANGE BIOL, V23, P77, DOI 10.1111/gcb.13437; Rezende RD, 2016, BIOTROPICA, V48, P301, DOI 10.1111/btp.12308; Rezende RD, 2015, AUSTRAL ECOL, V40, P693, DOI 10.1111/aec.12236; Rezende RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097072; Riedl HL., 2013, RIPARIAN ECOLOGY CON, V1, P3, DOI [DOI 10.2478/REMC-2013-0002, 10.2478/remc-2013-0002]; Rothman JM, 2015, ECOLOGY, V96, P873, DOI 10.1890/14-0391.1; Shah JJF, 2017, GLOBAL CHANGE BIOL, V23, P3064, DOI 10.1111/gcb.13609; Navarro FKSP, 2013, BIOTA NEOTROP, V13, P28, DOI 10.1590/S1676-06032013000400002; Sorribas MV, 2016, CLIMATIC CHANGE, V136, P555, DOI 10.1007/s10584-016-1640-2; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Stocker T. F., 2013, WORK GROUP CONTR 5 A; SUBERKROPP K, 1995, ECOLOGY, V76, P1433, DOI 10.2307/1938146; Taniwaki RH, 2017, HYDROBIOLOGIA, V793, P41, DOI 10.1007/s10750-016-2907-3; Tank JL, 2010, J N AM BENTHOL SOC, V29, P118, DOI 10.1899/08-170.1; Tonin AM, 2014, HYDROBIOLOGIA, V740, P79, DOI 10.1007/s10750-014-1939-9; Top SM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00423; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Tripole Susana, 2008, LIMNETICA, V27, P29; Vidovix Thyago Augusto da Silva, 2013, EntomoBrasilis, V6, P39; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P216, DOI 10.1899/0887-3593(2006)25[216:DPBISA]2.0.CO;2; Wycherley PR, 1992, NATURAL RUBBER BIOL, P50; Xiong Jinbo, 2015, Sci Rep, V5, P9316, DOI 10.1038/srep09316; Ylla I, 2014, MICROB ECOL, V68, P132, DOI 10.1007/s00248-014-0406-5	67	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188791	10.1371/journal.pone.0188791	http://dx.doi.org/10.1371/journal.pone.0188791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190723	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900124
J	Park, JY; Lee, SW				Park, Jee Yoon; Lee, Sung Woo			A history of repetitive cesarean section is a risk factor of anemia in healthy perimenopausal women: The Korea National Health and Nutrition Examination Survey 2010-2012	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; MATERNAL ANEMIA; HEART-FAILURE; PREGNANCY; PREVALENCE; SUPPLEMENTATION; UTERINE; BLOOD	Background and objectives To determine whether the delivery method is associated with the rate of anemia in later life, using the data from the Korea National Health and Nutrition Examination Survey (KNHANES). Methods This study used data from the KNHANES 2010 -2012. Among 25,534 participants, 8,126 cases were included in this study after exclusion of males and other inappropriate data. The study population was divided into three groups according to the delivery modes: vaginal delivery (VD) only group, single cesarean delivery (SCD) group and repetitive cesarean delivery (RCD) group. The primary outcome was anemia and iron deficiency. Anemia was defined as hemoglobin < 12 g/dl in accordance with the World Health Organization criteria. Iron deficiency was defined as low transferrin saturation (TSAT) or ferritin levels. Multivariate analysis was used for determination of association between the delivery modes and anemia. Results The mean age was 53.4 years and the median time from the last delivery to the survey was 25 years. The VD only group was composed of 6,493 (79.9%) women, while 685 (8.4%) were classified as the SCD group and 948 (11.7%) were classified as a RCD group. The rates of anemia were 11.8%, 13.9%, and 19.7% in VD only group, SCD group, and RCD group, respectively. However, those groups were significantly different in many confounding factors. Therefore, to adjust those factors, multivariate analysis and subgroup analysis were followed. The odds of SCD for anemia and iron deficiency were not different from those of VD only. However, RCD was independently associated with anemia [Odds ratio(OR) 1.47, 95% Confidence interval (CI) 1.21-1.79,P < 0.001] and iron deficiency (OR 1.42, 95% CI 1.21-1.67, P < 0.001) compared to VD only. In the subgroup analysis, RCD was significantly associated with anemia in perimenopausal women, women with iron deficiency, those without any comorbidity and those without anemia- prone treatment. Conclusion Repetitive cesarean section may be a risk factor for future development of anemia in later life, especially in perimenopausal period. Therefore, evaluation and management of anemia in longer postpartum period should be considered for women who experience repetitive cesarean section.	[Park, Jee Yoon] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea; [Lee, Sung Woo] Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seoul, South Korea; [Lee, Sung Woo] Eulji Univ, Eulji Med Ctr, Dept Nephrol, Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Eulji University	Lee, SW (corresponding author), Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seoul, South Korea.; Lee, SW (corresponding author), Eulji Univ, Eulji Med Ctr, Dept Nephrol, Internal Med, Seoul, South Korea.	neplsw@gmail.com	Dangal, Ganesh/O-1989-2017; Park, Jee Yoon/ABC-3368-2021	Dangal, Ganesh/0000-0002-5834-5525; Lee, Sung Woo/0000-0002-4419-3938				American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039; Becuzzi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/815437; Bodnar LM, 2005, AM J OBSTET GYNECOL, V193, P36, DOI 10.1016/j.ajog.2004.12.009; Chen BH, 1998, WESTERN J MED, V169, P280; Cohen B J, 1980, Obstet Gynecol Surv, V35, P597; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Drukker L, 2015, TRANSFUSION, V55, P2799, DOI 10.1111/trf.13252; Ehrenthal DB, 2012, J WOMENS HEALTH, V21, P792, DOI 10.1089/jwh.2011.3248; Friedman AJ, 2012, J WOMENS HEALTH, V21, P1282, DOI 10.1089/jwh.2012.3713; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hamalainen H, 2003, CLIN NUTR, V22, P271, DOI 10.1016/S0261-5614(02)00209-1; Herzog CA, 2004, J CARD FAIL, V10, P467, DOI 10.1016/j.cardfail.2004.03.003; Hwang HS, 2010, J PERINAT MED, V38, P467, DOI [10.1515/JPM.2010.047, 10.1515/jpm.2010.047]; Jansen AJG, 2005, OBSTET GYNECOL SURV, V60, P663, DOI 10.1097/01.ogx.0000180909.31293.cf; Kanuri G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163817; Lee WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180165; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Malhotra M, 2002, INT J GYNECOL OBSTET, V79, P93, DOI 10.1016/S0020-7292(02)00225-4; Maraldi C, 2006, AGING CLIN EXP RES, V18, P485; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; MILMAN N, 1991, DAN MED BULL, V38, P471; Milman N, 2008, ANN HEMATOL, V87, P949, DOI 10.1007/s00277-008-0518-4; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Nash CM, 2015, J OBSTET GYNAECOL CA, V37, P439, DOI 10.1016/S1701-2163(15)30259-0; Okonko DO, 2011, J AM COLL CARDIOL, V58, P1241, DOI 10.1016/j.jacc.2011.04.040; Park YS, 2015, J PERINAT MED, V43, P741, DOI 10.1515/jpm-2014-0104; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Petranovic D, 2008, MED HYPOTHESES, V70, P70, DOI 10.1016/j.mehy.2007.04.029; Peyrin-Biroulet L, 2015, AM J CLIN NUTR, V102, P1585, DOI 10.3945/ajcn.114.103366; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Sifakis S, 2000, ANN NY ACAD SCI, V900, P125, DOI 10.1111/j.1749-6632.2000.tb06223.x; Silva EA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002458; Stafford I, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.049; United States Preventive Services Task Force, 1993, JAMA-J AM MED ASSOC, V270, P2846; WOOLF SH, 1993, JAMA-J AM MED ASSOC, V270, P2848	38	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188903	10.1371/journal.pone.0188903	http://dx.doi.org/10.1371/journal.pone.0188903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190715	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900165
J	Thiagarajan, D; Shea, KO; Sreejit, G; Ananthakrishnan, R; Quadri, N; Li, Q; Schmidt, AM; Gabbay, K; Ramasamy, R				Thiagarajan, Devi; Shea, Karen O'; Sreejit, Gopalkrishna; Ananthakrishnan, Radha; Quadri, Nosirudeen; Li, Qing; Schmidt, Ann Marie; Gabbay, Kenneth; Ramasamy, Ravichandran			Aldose reductase modulates acute activation of mesenchymal markers via the beta-catenin pathway during cardiac ischemia-reperfusion	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASE-2; ENDOTHELIAL-CELLS; INJURY; MATRIX-METALLOPROTEINASE-9; PROTECTS; INHIBITION; FIBROSIS; HEART	Aldose reductase (AR: human, AKR1B1; mouse, AKR1B3), the first enzyme in the polyol pathway, plays a key role in mediating myocardial ischemia/reperfusion (I/R) injury. In earlier studies, using transgenic mice broadly expressing human AKR1B1 to human-relevant levels, mice devoid of Akr1b3, and pharmacological inhibitors of AR, we demonstrated that AR is an important component of myocardial I/R injury and that inhibition of this enzyme protects the heart from I/R injury. In this study, our objective was to investigate if AR modulates the beta-catenin pathway and consequent activation of mesenchymal markers during I/R in the heart. To test this premise, we used two different experimental models: in vivo, Akr1b3 null mice and wild type C57BL/6 mice (WT) were exposed to acute occlusion of the left anterior descending coronary artery (LAD) followed by recovery for 48 hours or 28 days, and ex-vivo, WT and Akr1b3 null murine hearts were perfused using the Langendorff technique (LT) and subjected to 30 min of global (zero-flow) ischemia followed by 60 min of reperfusion. Our in vivo results reveal reduced infarct size and improved functional recovery at 48 hours in mice devoid of Akr1b3 compared to WT mice. We demonstrate that the cardioprotection observed in Akr1b3 null mice was linked to acute activation of the beta-catenin pathway and consequent activation of mesenchymal markers and genes linked to fibrotic remodeling. The increased activity of the beta-catenin pathway at 48 hours of recovery post-LAD was not observed at 28 days post-infarction, thus indicating that the observed increase in beta-catenin activity was transient in the mice hearts devoid of Akr1b3. In ex vivo studies, inhibition of beta-catenin blocked the cardioprotection observed in Akr1b3 null mice hearts. Taken together, these data indicate that AR suppresses acute activation of beta-catenin and, thereby, blocks consequent induction of mesenchymal markers during early reperfusion after myocardial ischemia. Inhibition of AR might provide a therapeutic opportunity to optimize cardiac remodeling after I/R injury.	[Thiagarajan, Devi; Shea, Karen O'; Sreejit, Gopalkrishna; Ananthakrishnan, Radha; Quadri, Nosirudeen; Li, Qing; Schmidt, Ann Marie; Ramasamy, Ravichandran] NYU, Langone Med Ctr, Dept Med, Diabet Res Program, New York, NY 10003 USA; [Gabbay, Kenneth] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	New York University; NYU Langone Medical Center; Baylor College of Medicine	Ramasamy, R (corresponding author), NYU, Langone Med Ctr, Dept Med, Diabet Res Program, New York, NY 10003 USA.	ramasr02@nyumc.org	sreejit, Gopalkrishna/AAF-4772-2020	Ramasamy, Ravichandran/0000-0002-3666-3346; sreejit, gopalkrishna/0000-0003-4616-8397	NIH [HL60901, AG026467]; Harry B & Aileen B. Gordon Foundation; Agar Corporation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry B & Aileen B. Gordon Foundation; Agar Corporation	This work was supported in part by grants from NIH - HL60901(RR & AMS), and AG026467 (RR & AMS), and the Harry B & Aileen B. Gordon Foundation (KHG), and the Agar Corporation (KHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Ananthakrishnan R, 2013, ARTIF CELL NANOMED B, V41, P428, DOI 10.3109/21691401.2012.762370; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Calderone V, 2010, J PHARM PHARMACOL, V62, P107, DOI 10.1211/jpp.62.01.0012; CAMICI P, 1989, PROG CARDIOVASC DIS, V32, P217, DOI 10.1016/0033-0620(89)90027-3; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chrobak I, 2013, J CELL PHYSIOL, V228, P1774, DOI 10.1002/jcp.24337; DeCoux A, 2014, J MOL CELL CARDIOL, V77, P64, DOI 10.1016/j.yjmcc.2014.09.016; Distler A, 2013, ANN RHEUM DIS, V72, P1575, DOI 10.1136/annrheumdis-2012-202275; Douglas IS, 2006, AM J RESP CELL MOL, V34, P274, DOI 10.1165/rcmb.2005-0277OC; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Euler G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00066; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Hu BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36436; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Inoue T, 2016, J CARDIOL, V67, P305, DOI 10.1016/j.jjcc.2015.09.002; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; Iyer RP, 2016, J MOL CELL CARDIOL, V100, P109, DOI 10.1016/j.yjmcc.2016.10.005; Jacob-Ferreira AL, 2013, ARCH BIOCHEM BIOPHYS, V540, P82, DOI 10.1016/j.abb.2013.09.019; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Lee SC, 2015, ONCOTARGET, V6, P27146, DOI 10.18632/oncotarget.4354; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lindsey ML, 2006, AM J PHYSIOL-HEART C, V290, pH232, DOI 10.1152/ajpheart.00457.2005; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nie L, 2014, AM J PHYSIOL-CELL PH, V307, pC859, DOI 10.1152/ajpcell.00081.2014; NISHIMURA C, 1994, CLIN CHEM, V40, P889; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 1999, CARDIOVASC RES, V42, P130, DOI 10.1016/S0008-6363(98)00303-4; Ruiz-Villalba A, 2015, J AM COLL CARDIOL, V65, P2057, DOI 10.1016/j.jacc.2015.03.520; SAUTNER T, 1995, EUR J SURG, V161, P97; Scholten D, 2011, AM J PATHOL, V179, P189, DOI 10.1016/j.ajpath.2011.03.049; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Son NHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046549; Thirunavukkarasu M, 2008, ANTIOXID REDOX SIGN, V10, P1475, DOI 10.1089/ars.2008.2042; Thirunavukkarasu M, 2015, J PHYSIOL BIOCHEM, V71, P623, DOI 10.1007/s13105-015-0426-8; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Warboys CM, 2014, CARDIOVASC RES, V104, P116, DOI 10.1093/cvr/cvu173; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Xin Yi, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P1194; Ye B, 2013, CARDIOVASC PATHOL, V22, P54, DOI 10.1016/j.carpath.2012.03.004; Yoshimoto Tetsuyuki, 1997, Hokkaido Journal of Medical Science, V72, P97; Zamilpa R, 2012, J MOL CELL CARDIOL, V53, P599, DOI 10.1016/j.yjmcc.2012.07.017; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhou SH, 2013, J ORTHOP RES, V31, P554, DOI 10.1002/jor.22244	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188981	10.1371/journal.pone.0188981	http://dx.doi.org/10.1371/journal.pone.0188981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190815	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900183
J	Thompson, KJ; Ingle, JN; Tang, XJ; Chia, N; Jeraldo, PR; Walther-Antonio, MR; Kandimalla, KK; Johnson, S; Yao, JZ; Harrington, SC; Suman, VJ; Wang, LW; Weinshilboum, RL; Boughey, JC; Kocher, JP; Nelson, H; Goetz, MP; Kalari, KR				Thompson, Kevin J.; Ingle, James N.; Tang, Xiaojia; Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Kandimalla, Karunya K.; Johnson, Stephen; Yao, Janet Z.; Harrington, Sean C.; Suman, Vera J.; Wang, Liewei; Weinshilboum, Richard L.; Boughey, Judy C.; Kocher, Jean-Pierre; Nelson, Heidi; Goetz, Matthew P.; Kalari, Krishna R.			A comprehensive analysis of breast cancer microbiota and host gene expression	PLOS ONE			English	Article							ESTROGEN METABOLITES; CONTAMINATION; HALLMARKS; DATABASE; TISSUE	The inflammatory tumoral-immune response alters the physiology of the tumor microenvironment, which may attenuate genomic instability. In addition to inducing inflammatory immune responses, several pathogenic bacteria produce genotoxins. However the extent of microbial contribution to the tumor microenvironment biology remains unknown. We utilized The Cancer Genome Atlas, (TCGA) breast cancer data to perform a novel experiment utilizing unmapped and mapped RNA sequencing read evidence to minimize laboratory costs and effort. Our objective was to characterize the microbiota and associate the microbiota with the tumor expression profiles, for 668 breast tumor tissues and 72 non-cancerous adjacent tissues. The prominent presence of Proteobacteria was increased in the tumor tissues and conversely Actinobacteria abundance increase in non-cancerous adjacent tissues. Further, geneset enrichment suggests Listeria spp to be associated with the expression profiles of genes involved with epithelial to mesenchymal transitions. Moreover, evidence suggests H. influenza may reside in the surrounding stromal material and was significantly associated with the proliferative pathways: G2M checkpoint, E2F transcription factors, and mitotic spindle assembly. In summary, further unraveling this complicated interplay should enable us to better diagnose and treat breast cancer patients.	[Thompson, Kevin J.; Tang, Xiaojia; Johnson, Stephen; Suman, Vera J.; Kocher, Jean-Pierre; Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Thompson, Kevin J.; Tang, Xiaojia; Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Johnson, Stephen; Yao, Janet Z.; Harrington, Sean C.; Kocher, Jean-Pierre; Kalari, Krishna R.] Mayo Clin, Dept Ctr Individualized Med, Rochester, MN 55905 USA; [Ingle, James N.; Goetz, Matthew P.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Boughey, Judy C.; Nelson, Heidi] Mayo Clin, Dept Surg, Rochester, MN USA; [Kandimalla, Karunya K.] Mayo Clin, Dept Pharmaceut, Rochester, MN USA; [Wang, Liewei; Weinshilboum, Richard L.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kalari, KR (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.; Kalari, KR (corresponding author), Mayo Clin, Dept Ctr Individualized Med, Rochester, MN 55905 USA.	Kalari.Krishna@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Kalari, Krishna/0000-0001-8944-8378; Tang, Xiaojia/0000-0003-2457-9953; Thompson, Kevin/0000-0002-9348-4686; Harrington, Jon/0000-0003-1293-5201; Walther-Antonio, Marina/0000-0002-5531-3712	Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) Career Enhancement Award [P50CA116201]; Mayo Clinic Center for Individualized Medicine; Division of Biostatistics and Informatics at the Mayo Clinic; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER	Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) Career Enhancement Award; Mayo Clinic Center for Individualized Medicine; Division of Biostatistics and Informatics at the Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) (P50CA116201) Career Enhancement Award, the Mayo Clinic Center for Individualized Medicine and by the Division of Biostatistics and Informatics at the Mayo Clinic.; Research reported in this publication was supported by the Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) (P50CA116201) Career Enhancement Award, the Mayo Clinic Center for Individualized Medicine and by the Division of Biostatistics and Informatics at the Mayo Clinic. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen Y, 2015, EDGER EMPIRICAL ANAL; Chen YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128955; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson J, 2012, T DISTRIBUTED STOCHA; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253; Flores R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039745; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Gierach Gretchen L, 2010, Breast Dis, V32, P5, DOI 10.3233/BD-2010-0319; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hanson B.A., 2016, HIVER 2D 3D HIVE PLO; Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Jensen MA, 2017, BLOOD, V130, P453, DOI 10.1182/blood-2017-03-735654; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Jin Y, 2010, BUS GENE NETWORK REC; Kampstra P, 2014, BEANPLOT VISUALIZATI; Kenney NJ, 1996, J MAMMARY GLAND BIOL, V1, P189, DOI 10.1007/BF02013642; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leek JT, 2015, SVA SURROGATE VARIAB; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Maechler M., 2022, CLUSTER CLUSTER ANAL; Mahoney Douglas W, 2013, BMC Res Notes, V6, P33, DOI 10.1186/1756-0500-6-33; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pevsner-Fischer M, 2016, WORLD J CLIN ONCOL, V7, P200, DOI 10.5306/wjco.v7.i2.200; Reichman H, 2016, TRENDS CANCER, V2, P664, DOI 10.1016/j.trecan.2016.10.002; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz A, 2013, EPADE EASY PLOTS; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smyth G, 2015, LIMMA LINEAR MODELS; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	61	68	71	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188873	10.1371/journal.pone.0188873	http://dx.doi.org/10.1371/journal.pone.0188873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190829	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900153
J	Lynch, CJ; Cawte, AD; Millar, CM; Rueda, D; Lane, DA				Lynch, Christopher J.; Cawte, Adam D.; Millar, Carolyn M.; Rueda, David; Lane, David A.			A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct	PLOS ONE			English	Article							IIA-VONWILLEBRAND DISEASE; INTRACELLULAR STORAGE; REGULATED SECRETION; FLUORESCENT PROTEIN; CANDIDATE MUTATION; ANEMONIA-SULCATA; GLYCOPROTEIN IB; SCISSILE BOND; CLEAVAGE; VWF	Rheological forces in the blood trigger the unfolding of von Willebrand factor (VWF) and its A2 domain, exposing the scissile bond for proteolysis by ADAMTS13. Under quiescent conditions, the scissile bond is hidden by the folded structure due to the stabilisation provided by the structural specialisations of the VWF A2 domain, a vicinal disulphide bond, a calcium binding site and a N1574-glycan.The reduced circulating high MW multimers of VWF in patients with type 2A von Willebrand disease (VWD) may be associated with mutations within the VWF A2 domain and this is attributed to enhanced ADAMTS13 proteolysis. We investigated 11 VWF A2 domain variants identified in patients with type 2A VWD. In recombinant full-length VWF, enhanced ADAMTS13 proteolysis was detected for all of the expressed variants in the presence of urea-induced denaturation. A subset of the FLVWF variants displayed enhanced proteolysis in the absence of urea. The mechanism of enhancement was investigated using a novel VWF A2 domain FRET construct. In the absence of induced unfolding, 7/8 of the expressed mutants exhibited a disrupted domain fold, causing spatial separation of the N- and C- termini. Three of the type 2A mutants were not secreted when studied within the VWF A2 domain FRET construct. Urea denaturation revealed for all 8 secreted mutants reduced unfolding cooperativity and stability of the VWF A2 domain. As folding stability was progressively disrupted, proteolysis by ADAMTS13 increased. Due to the range of folding stabilities and wide distribution of VWF A2 domain mutations studied, we conclude that these mutations disrupt regulated folding of the VWF A2 domain. They enhance unfolding by inducing separation of N- and C-termini, thereby promoting a more open conformation that reveals its binding sites for ADAMTS13 and the scissile bond.	[Lynch, Christopher J.; Millar, Carolyn M.; Lane, David A.] Imperial Coll London, Ctr Haematol, Dept Med, London, England; [Cawte, Adam D.; Rueda, David] Imperial Coll, Dept Med, Mol Virol, London, England; [Cawte, Adam D.; Rueda, David] Imperial Coll, MRC London Inst Med Sci, Single Mol Imaging Grp, London, England; [Millar, Carolyn M.] Imperial Coll Healthcare NHS Trust, Cane Rd, London, England; [Lynch, Christopher J.] Univ Oxford, RDM Div Cardiovasc Med, Roosevelt Dr, Oxford, England; [Lynch, Christopher J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Lane, DA (corresponding author), Imperial Coll London, Ctr Haematol, Dept Med, London, England.	d.lane@imperial.ac.uk	Rueda, David S./F-9065-2014	Rueda, David S./0000-0003-4657-6323; Lane, David/0000-0003-4283-3695; Lynch, Christopher/0000-0002-4534-4865	British Heart Foundation [FS/14/21/30733]; MRC London Institute of Medical Sciences [RCUK MC-A658-5TY10]; Wellcome Trust [206292/C/17/Z]; Leverhulme Trust [RPG-2016-214]; Imperial College London; MRC [MC_UP_1102/5] Funding Source: UKRI; Medical Research Council [MC_UP_1102/5, 1583062] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC London Institute of Medical Sciences(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Studentship from the British Heart Foundation (FS/14/21/30733) to DA Lane, https://www.bhf.org.uk/. NIHR Imperial College Biomedical Research Centre to CM Millar. The lab of David Rueda is funded by the MRC London Institute of Medical Sciences (RCUK MC-A658-5TY10), the Wellcome Trust (206292/C/17/Z), the Leverhulme Trust (RPG-2016-214) and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Aponte-Santamaria C, 2017, BIOPHYS J, V112, P57, DOI 10.1016/j.bpj.2016.11.3202; Baldauf C, 2009, J THROMB HAEMOST, V7, P2096, DOI 10.1111/j.1538-7836.2009.03640.x; Blenner MA, 2014, J BIOL CHEM, V289, P5565, DOI 10.1074/jbc.M113.511220; Casana P, 1999, AM J HEMATOL, V60, P309; Chen W, 2010, CELL MOL BIOENG, V3, P117, DOI 10.1007/s12195-010-0117-z; Chen W, 2009, CELL MOL BIOENG, V2, P75, DOI 10.1007/s12195-009-0051-0; Corrales I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; de Groot R, 2010, BLOOD, V116, P3064, DOI 10.1182/blood-2009-12-258780; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hampshire DJ, 2011, SEMIN THROMB HEMOST, V37, P470, DOI 10.1055/s-0031-1281031; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Hilbert L, 2004, HAEMATOLOGICA, V89, P1128; Interlandi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045207; Jacobi PM, 2012, BLOOD, V119, P4543, DOI 10.1182/blood-2011-06-360875; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jenkins PV, 1998, BLOOD, V91, P2032, DOI 10.1182/blood.V91.6.2032.2032_2032_2044; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; Lynch CJ, 2016, BLOOD, V127, P1711, DOI 10.1182/blood-2015-09-672014; Lynch CJ, 2014, BLOOD, V123, P2585, DOI 10.1182/blood-2013-11-538173; LYONS SE, 1992, J BIOL CHEM, V267, P4424; LYONS SE, 1994, BLOOD, V83, P1551; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; O'Brien LA, 2005, J THROMB HAEMOST, V3, P796, DOI 10.1111/j.1538-7836.2005.01219.x; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Quillin ML, 2005, BIOCHEMISTRY-US, V44, P5774, DOI 10.1021/bi047644u; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schneppenheim R, 2001, BEST PRACT RES CL HA, V14, P281, DOI 10.1053/beha.2001.0134; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; van den Heuvel E, 2009, J PEDIAT HEMATOL ONC, V31, P277, DOI 10.1097/MPH.0b013e31819d9119; Wang JW, 2012, J THROMB HAEMOST, V10, P2168, DOI 10.1111/j.1538-7836.2012.04891.x; Wang JW, 2011, J BIOL CHEM, V286, P24180, DOI 10.1074/jbc.M110.215194; Wilmann PG, 2005, J BIOL CHEM, V280, P2401, DOI 10.1074/jbc.C400484200; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Xu AJ, 2013, J BIOL CHEM, V288, P6317, DOI 10.1074/jbc.M112.422618; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Zagranichny VE, 2004, BIOCHEMISTRY-US, V43, P13598, DOI 10.1021/bi0488247; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	56	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188405	10.1371/journal.pone.0188405	http://dx.doi.org/10.1371/journal.pone.0188405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186156	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900034
J	Gelin, ML; Branch, LC; Thornton, DH; Novaro, AJ; Gould, MJ; Caragiulo, A				Gelin, Maria L.; Branch, Lyn C.; Thornton, Daniel H.; Novaro, Andres J.; Gould, Matthew J.; Caragiulo, Anthony			Response of pumas (Puma concolor) to migration of their primary prey in Patagonia	PLOS ONE			English	Article							LAMA-GUANICOE; MOUNTAIN LIONS; CAMERA TRAPS; SOCIAL-ORGANIZATION; DENSITY-ESTIMATION; CAPTURE-RECAPTURE; ACTIVITY PATTERNS; FEEDING ECOLOGY; HABITAT USE; POPULATION	Large-scale ungulate migrations result in changes in prey availability for top predators and, as a consequence, can alter predator behavior. Migration may include entire populations of prey species, but often prey populations exhibit partial migration with some individuals remaining resident and others migrating. Interactions of migratory prey and predators have been documented in North America and some other parts of the world, but are poorly studied in South America. We examined the response of pumas (Puma concolor) to seasonal migration of guanacos (Lama guanicoe) in La Payunia Reserve in northern Patagonia Argentina, which is the site of the longest known ungulate migration in South America. More than 15,000 guanacos migrate seasonally in this landscape, and some guanacos also are resident year-round. We hypothesized that pumas would respond to the guanaco migration by consuming more alternative prey rather than migrating with guanacos because of the territoriality of pumas and availability of alternative prey throughout the year at this site. To determine whether pumas moved seasonally with the guanacos, we conducted camera trapping in the summer and winter range of guanacos across both seasons and estimated density of pumas with spatial mark-resight (SMR) models. Also, we analyzed puma scats to assess changes in prey consumption in response to guanaco migration. Density estimates of pumas did not change significantly in the winter and summer range of guanacos when guanacos migrated to and from these areas, indicating that pumas do not follow the migration of guanacos. Pumas also did not consume more alternative native prey or livestock when guanaco availability was lower, but rather fed primarily on guanacos and some alternative prey during all seasons. Alternative prey were most common in the diet during summer when guanacos also were abundant on the summer range. The response of pumas to the migration of guanacos differs from sites in the western North America where entire prey populations migrate and pumas migrate with their prey or switch to more abundant prey when their primary prey migrates.	[Gelin, Maria L.; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Gelin, Maria L.; Branch, Lyn C.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Thornton, Daniel H.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Novaro, Andres J.] INIBIOMA Univ Nacl Comahue CONICET, Programa Estepa Patagon & Andina, Wildlife Conservat Soc, Junin De Los Andes, Neuquen, Argentina; [Gould, Matthew J.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Caragiulo, Anthony] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington State University; New Mexico State University; American Museum of Natural History (AMNH)	Branch, LC (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.; Branch, LC (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	branchl@ufl.edu		Gould, Matthew/0000-0002-9703-4690	Conservation Food and Health Foundation; Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund; Rufford Small Grants for Nature Conservation; IdeaWild; Tropical Conservation and Development Program, University of Florida; BEC.AR Argentina; School of Natural Resources and the Environment, University of Florida	Conservation Food and Health Foundation; Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund; Rufford Small Grants for Nature Conservation; IdeaWild; Tropical Conservation and Development Program, University of Florida; BEC.AR Argentina; School of Natural Resources and the Environment, University of Florida(University of Florida)	The authors gratefully acknowledge financial support and equipment from the Conservation Food and Health Foundation, Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund, Rufford Small Grants for Nature Conservation, IdeaWild, and the Tropical Conservation and Development Program, University of Florida. During this work, M. L. Gelin was supported by scholarships from BEC.AR Argentina and the School of Natural Resources and the Environment, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Argentinian program of the Wildlife Conservation Society and Direccion de Recursos Naturales Renovables de Mendoza for logistical support. We are grateful to Mariel Ruiz Blanco and Maria Jose Bolgeri for sharing their knowledge of La Payunia and for assistance throughout the fieldwork. We also thank all the volunteers on the project, and especially the following people for the many days they spent in the field: Uriel Menalled, Natanael Griffa, Bianca Bonaparte and park rangers Lucas Aros, Andres Castro, Anibal Soto, Edgardo Soto, Francisco Estive, Jairo Espinosa. Also, we are grateful to the park rangers of Malargue for providing lodging. We gratefully acknowledge financial support and equipment from the Conservation Food and Health Foundation, Pittsburgh Zoo & PPG Aquarium's PPG Conservation and Sustainability Fund, Rufford Small Grants for Nature Conservation, IdeaWild, and the Tropical Conservation and Development Program, University of Florida. During this work, M. L. Gelin was supported by scholarships from BEC.AR Argentina and the School of Natural Resources and the Environment, University of Florida. We thank John Goodrich and two anonymous reviewers for helpful comments on the manuscript.	Altrichter M, 2006, BIODIVERS CONSERV, V15, P2719, DOI 10.1007/s10531-005-0307-5; Arroyo-Arce S, 2014, REV BIOL TROP, V62, P1449, DOI 10.15517/rbt.v62i4.13314; Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; Ballard Warren B., 1997, Wildlife Monographs, V135, P1; Bolgeri María J, 2015, Mastozool. neotrop., V22, P255; Bolgeri MJ, 2015, THESIS; Branch LC, 1996, J MAMMAL, V77, P453; Candia R., 1993, MULTEQUINA, V2, P5; Caragiulo A, 2014, MITOCHONDR DNA, V25, P304, DOI 10.3109/19401736.2013.800486; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Chehebar C., 1989, Donana Acta Vertebrata, V16, P247; Donadio E, 2010, J ZOOL, V280, P33, DOI 10.1111/j.1469-7998.2009.00638.x; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford M.G., 2016, SECR 2 10 SPATIALLY; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Elbroch LM, 2017, J ZOOL, V302, P164, DOI 10.1111/jzo.12442; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083375; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Fernández Cynthia S, 2014, Mastozool. neotrop., V21, P331; Frame PF, 2008, ARCTIC, V61, P134; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; Guarda N, 2016, ORYX, V51, P1; HOFER H, 1993, ANIM BEHAV, V46, P559, DOI 10.1006/anbe.1993.1223; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; IRIARTE JA, 1991, REV CHIL HIST NAT, V64, P145; Keehner JR, 2015, BIOL CONSERV, V192, P101, DOI 10.1016/j.biocon.2015.09.006; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Laundre JW, 2010, WHAT WE KNOW PUMAS L, P76; LINDZEY FG, 1994, J WILDLIFE MANAGE, V58, P619, DOI 10.2307/3809674; Llambias EJ., 2008, DISTRITO VOLCANICO P, P263; LOFT ER, 1984, J WILDLIFE MANAGE, V48, P1317, DOI 10.2307/3801792; Logan K.A., 2001, DESERT PUMA EVOLUTIO; LOGAN KA, 1986, J WILDLIFE MANAGE, V50, P648, DOI 10.2307/3800975; Lyamuya RD, 2014, ORYX, V48, P378, DOI 10.1017/S0030605312001706; Marker Laurie, 2003, Cat News, V38, P24; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Moraga CA, 2015, ORYX, V49, P30, DOI 10.1017/S0030605312001238; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Mysterud A, 2013, ECOLOGY, V94, P1257, DOI 10.1890/12-0505.1; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Nelson AA, 2012, ECOL APPL, V22, P2293, DOI 10.1890/11-1829.1; Niedballa J, 2016, METHODS ECOL EVOL, V7, P1457, DOI 10.1111/2041-210X.12600; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Novaro A. J., 2005, LARGE CARNIVORES CON, P267; Novaro AJ, 2000, BIOL CONSERV, V92, P25, DOI 10.1016/S0006-3207(99)00065-8; Novaro AJ, 2006, TERCER INFORM AVANCE; Nunez-Regueiro MM, 2015, BIOL CONSERV, V187, P19, DOI 10.1016/j.biocon.2015.04.001; Ortega IM, 1995, REV CHIL HIST NAT, V68, P489; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Pierce BM, 1999, J MAMMAL, V80, P986, DOI 10.2307/1383269; Pierce BM, 2000, ECOLOGY, V81, P1533; Puig S, 1996, J ARID ENVIRON, V34, P215, DOI 10.1006/jare.1996.0103; Puig Silvia, 2003, Multequina, V12, P37; Quiroga VA, 2016, J NAT CONSERV, V31, P9, DOI 10.1016/j.jnc.2016.02.004; Rich LN, 2014, J MAMMAL, V95, P382, DOI 10.1644/13-MAMM-A-126; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Scheel, 1995, SERENGETI; Schroeder NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085960; Seidensticker J.C. IV., 1973, Wildlife Monogr, VNo. 35, P1; Silver S., 2004, ASSESSING JAGUAR ABU, P1; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Sollmann R, 2013, J APPL ECOL, V50, P961, DOI 10.1111/1365-2664.12098; Soria-Diaz L, 2010, ANIM BIOL, V60, P361, DOI 10.1163/157075610X523251; Stoner DC, 2006, J WILDLIFE MANAGE, V70, P1588, DOI 10.2193/0022-541X(2006)70[1588:CELIUI]2.0.CO;2; Sunquist ME, 2002, WILD CATS WORLD; Thornton DH, 2015, WILDLIFE RES, V42, P394, DOI 10.1071/WR15092; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Villepique JT, 2011, SOUTHWEST NAT, V56, P187, DOI 10.1894/F07-TAL.1; Walton Z, 2017, OIKOS, V126, P642, DOI 10.1111/oik.03374; WEINGART E L, 1973, American Midland Naturalist, V90, P508, DOI 10.2307/2424481; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Martinez JIZ, 2012, ORYX, V46, P106, DOI 10.1017/S0030605310001821; Zanon-Martinez JI, 2016, WILDLIFE RES, V43, P449, DOI 10.1071/WR16056; Zar J.H., 2010, BIOSTAT ANAL	83	14	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188877	10.1371/journal.pone.0188877	http://dx.doi.org/10.1371/journal.pone.0188877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211753	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200050
J	Lee, JH; Kim, TJ; Kim, ER; Hong, SN; Chang, DK; Choi, LH; Woo, HI; Lee, SY; Kim, YH				Lee, Ji Hyeon; Kim, Tae Jun; Kim, Eun Ran; Hong, Sung Noh; Chang, Dong Kyung; Choi, Li-Hwa; Woo, Hye In; Lee, Soo-Youn; Kim, Young-Ho			Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease	PLOS ONE			English	Article							THIOPURINE S-METHYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; JAPANESE PATIENTS; AZATHIOPRINE THERAPY; INDUCED LEUKOPENIA; PEDIATRIC-PATIENTS; METABOLITE LEVELS; 5-AMINOSALICYLIC ACID; 6-MERCAPTOPURINE; POLYMORPHISMS	The association between the 6-thioguanine nucleotide (6-TGN) level and clinical remission in Crohn's disease (CD) remains controversial. Thiopurine-induced leukopenia is a life-threatening complication of CD in Asians that was recently shown to strongly correlate with NUDT15 genetic variants. This study aimed to determine the relationship between thiopurine metabolite levels and therapeutic response, and to investigate the association of NUDT15, TPMT, and thiopurine metabolites with leukopenia in patients with CD. We enrolled 165 adult patients with CD undergoing thiopurine treatment. Clinical evaluation and laboratory examinations were carried out every 2-3 months. We measured thiopurine metabolites levels and genotyped NUDT15 and TPMT. During the median 12-month observational period, 95 (67.9%) patients exhibited clinical response and 45 (32.1%) did not respond to the treatment. The median 6-TGN level was significantly higher in responders than in non-responders (P < 0.001). The odds ratio of patients with a 6-TGN level >= 230 pmol/8 x 10(8) red blood cells for showing a clinical response was 4.63 (95% CI 1.62-11.9). NUDT15 variant types were strongly associated with developing leukopenia. Patients with NUDT15 homozygous variant genotype developed severe early leukopenia with an average reduction of 88.2% (range, 84-94%) from the baseline white blood cell count at 4 weeks. Our findings support the role of therapeutic drug monitoring in thiopurine maintenance treatment to optimize thiopurine therapy, especially, for non-responding CD patients. Thiopurine treatment should not be recommended to patients with NUDT15 homozygous variant genotype due to severe early leukopenia.	[Lee, Ji Hyeon; Kim, Tae Jun; Kim, Eun Ran; Hong, Sung Noh; Chang, Dong Kyung; Kim, Young-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Li-Hwa; Lee, Soo-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea; [Choi, Li-Hwa] Green Cross Labs, Dept Lab Med, Yongin, Gyeonggi, South Korea; [Woo, Hye In] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Lab Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.; Lee, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea.	suddenbz@skku.edu; bowelkim@gmail.com	Kim, Eun Ran/AAD-8003-2022	LEE, SOO-YOUN/0000-0001-7595-4042	grant of the Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0130]	grant of the Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI12C0130 to YHK).	Amin J, 2015, INFLAMM BOWEL DIS, V21, P445, DOI 10.1097/MIB.0000000000000197; Andoh A, 2008, J GASTROEN HEPATOL, V23, P1373, DOI 10.1111/j.1440-1746.2008.05419.x; Asada A, 2016, J GASTROENTEROL, V51, P22, DOI 10.1007/s00535-015-1142-4; Ban H, 2008, INTERNAL MED, V47, P1645, DOI 10.2169/internalmedicine.47.1268; Booth RA, 2011, ANN INTERN MED, V154, P814, DOI 10.7326/0003-4819-154-12-201106210-00009; Bradford K, 2011, WORLD J GASTROENTERO, V17, P4166, DOI 10.3748/wjg.v17.i37.4166; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Cuffari C, 2001, GUT, V48, P642, DOI 10.1136/gut.48.5.642; Dassopoulos T, 2014, ALIMENT PHARM THER, V39, P163, DOI 10.1111/apt.12555; de Graaf P, 2010, BRIT J PHARMACOL, V160, P1083, DOI 10.1111/j.1476-5381.2010.00731.x; Dervieux T, 2001, LEUKEMIA, V15, P1706, DOI 10.1038/sj.leu.2402259; Dewit O, 2011, CLIN BIOCHEM, V44, P1062, DOI 10.1016/j.clinbiochem.2011.06.079; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Duley JA, 2008, J GASTROEN HEPATOL, V23, P1317, DOI 10.1111/j.1440-1746.2008.05564.x; Duley JA, 2005, THER DRUG MONIT, V27, P647, DOI 10.1097/01.ftd.0000169061.52715.3e; Gao X, 2012, EUR J GASTROEN HEPAT, V24, P958, DOI 10.1097/MEG.0b013e3283545ae3; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Gilissen LPL, 2012, J CROHNS COLITIS, V6, P698, DOI 10.1016/j.crohns.2011.12.003; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P2769, DOI 10.1111/j.1572-0241.2006.00843.x; Gonzalez-Lama Y, 2011, ALIMENT PHARM THER, V34, P544, DOI 10.1111/j.1365-2036.2011.04756.x; Goodhand JR, 2013, ALIMENT PHARM THER, V38, P1097, DOI 10.1111/apt.12476; Gordon M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008414.pub2; Kim HT, 2017, PHARMACOGENET GENOM, V27, P197, DOI 10.1097/FPC.0000000000000274; Kim HY, 2015, PHARMACOGENET GENOM, V25, P143, DOI 10.1097/FPC.0000000000000117; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Komiyama T, 2008, J CROHNS COLITIS, V2, P315, DOI 10.1016/j.crohns.2008.05.002; Kwan LY, 2008, DIGEST LIVER DIS, V40, P425, DOI 10.1016/j.dld.2008.01.003; Lee MN, 2015, INFLAMM BOWEL DIS, V21, P2897, DOI 10.1097/MIB.0000000000000570; Lee MN, 2015, INFLAMM BOWEL DIS, V21, P1054, DOI 10.1097/MIB.0000000000000347; Lee YJ, 2016, EUR J GASTROEN HEPAT, V28, P475, DOI 10.1097/MEG.0000000000000564; Lewis LD, 1997, CLIN PHARMACOL THER, V62, P464, DOI 10.1016/S0009-9236(97)90125-9; Moreau AC, 2014, INFLAMM BOWEL DIS, V20, P464, DOI 10.1097/01.MIB.0000439068.71126.00; Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508; OBRIEN JJ, 1991, GASTROENTEROLOGY, V101, P39, DOI 10.1016/0016-5085(91)90457-V; Ohtsuka Y, 2010, J GASTROEN HEPATOL, V25, P1626, DOI 10.1111/j.1440-1746.2010.06364.x; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Shah SA, 2016, J GASTROENTEROL HEPA; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Wong FCK, 2016, HONG KONG MED J, V22, P185, DOI 10.12809/hkmj154783; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhu X, 2016, ALIMENT PHARM THER, V44, P967, DOI 10.1111/apt.13796	48	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188925	10.1371/journal.pone.0188925	http://dx.doi.org/10.1371/journal.pone.0188925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206869	gold, Green Published, Green Submitted			2022-12-26	WOS:000417110700032
J	Kunze, T; Peterson, ADH; Haueisen, J; Knosche, TR				Kunze, Tim; Peterson, Andre D. H.; Haueisen, Jens; Knoesche, Thomas R.			A model of individualized canonical microcircuits supporting cognitive operations	PLOS ONE			English	Article							NEURAL MASS MODEL; BIFURCATION-ANALYSIS; POTENTIAL GENERATION; MATHEMATICAL-MODEL; NEURONAL CIRCUITS; DYNAMIC BALANCE; CEREBRAL-CORTEX; VISUAL-CORTEX; IN-VIVO; NETWORKS	Major cognitive functions such as language, memory, and decision-making are thought to rely on distributed networks of a large number of basic elements, called canonical microcircuits. In this theoretical study we propose a novel canonical microcircuit model and find that it supports two basic computational operations: a gating mechanism and working memory. By means of bifurcation analysis we systematically investigate the dynamical behavior of the canonical microcircuit with respect to parameters that govern the local network balance, that is, the relationship between excitation and inhibition, and key intrinsic feedback architectures of canonical microcircuits. We relate the local behavior of the canonical microcircuit to cognitive processing and demonstrate how a network of interacting canonical microcircuits enables the establishment of spatiotemporal sequences in the context of syntax parsing during sentence comprehension. This study provides a framework for using individualized canonical microcircuits for the construction of biologically realistic networks supporting cognitive operations.	[Kunze, Tim; Haueisen, Jens; Knoesche, Thomas R.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Kunze, Tim; Haueisen, Jens] Ilmenau Univ Technol, Inst Biomed Engn & Informat, Ilmenau, Germany; [Peterson, Andre D. H.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Max Planck Society; Technische Universitat Ilmenau; University of Melbourne	Kunze, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.; Kunze, T (corresponding author), Ilmenau Univ Technol, Inst Biomed Engn & Informat, Ilmenau, Germany.	tkunze@cbs.mpg.de	Haueisen, Jens/B-7183-2011	Haueisen, Jens/0000-0003-3871-2890	Max Planck Society; DAAD-Go8-Germany joint research scheme [57061157]; Sir John Eccles Research Fellowship; Thuringian Ministry of Science [2015 FGR 0085]	Max Planck Society(Max Planck Society); DAAD-Go8-Germany joint research scheme; Sir John Eccles Research Fellowship; Thuringian Ministry of Science	This work was funded by the Max Planck Society and supported by the DAAD-Go8-Germany joint research scheme under the grant number 57061157. A.D.H.P was supported by a Sir John Eccles Research Fellowship. J.H. has received partly funding from the Thuringian Ministry of Science under grant number 2015 FGR 0085.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Bastos AM, 2015, NEUROIMAGE, V108, P460, DOI 10.1016/j.neuroimage.2014.12.081; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Beul SF, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00165; Bosman CA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00303; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Cain N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005045; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Engelborghs K, 2002, ACM T MATH SOFTWARE, V28, P1, DOI 10.1145/513001.513002; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Frazier Lyn, 1979, THESIS; Freeman WJ, 1975, MASS ACTION NERVOUS; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2015, TRENDS COGN SCI, V19, P329, DOI 10.1016/j.tics.2015.03.012; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garnier A, 2015, NEURAL COMPUT, V27, P329, DOI 10.1162/NECO_a_00696; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Goodfellow M, 2012, NEUROIMAGE, V59, P2644, DOI 10.1016/j.neuroimage.2011.08.060; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; Haeusler S, 2007, CEREB CORTEX, V17, P149, DOI 10.1093/cercor/bhj132; Haeusler S, 2009, J PHYSIOL-PARIS, V103, P73, DOI 10.1016/j.jphysparis.2009.05.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hesse J, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00166; Isa T, 2004, PROG BRAIN RES, V143, P299, DOI 10.1016/S0079-6123(03)43029-X; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Johnson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050276; Kunze T, 2016, NEUROIMAGE; Liley DTJ, 2002, NETWORK-COMP NEURAL, V13, P67, DOI 10.1088/0954-898X/13/1/303; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LOPESDAS.FH, 1974, KYBERNETIK, V15, P27, DOI 10.1007/BF00270757; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Malagarriga D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004007; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Markert H, 2007, BIOSYSTEMS, V89, P300, DOI 10.1016/j.biosystems.2006.04.027; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; Meffin H, 2004, J COMPUT NEUROSCI, V16, P159, DOI 10.1023/B:JCNS.0000014108.03012.81; Merlet I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057330; Miller KD, 2016, CURR OPIN NEUROBIOL, V37, P75, DOI 10.1016/j.conb.2016.01.008; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Peters JF, 2016, NEUROSCI LETT, V626, P99, DOI 10.1016/j.neulet.2016.03.052; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Pulvermuller F, 2014, BIOL CYBERN, V108, P573, DOI 10.1007/s00422-014-0603-9; Pulvermuller F, 2002, PROG NEUROBIOL, V67, P85, DOI 10.1016/S0301-0082(02)00014-X; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rolls ET, 2015, BRAIN RES, V1621, P316, DOI 10.1016/j.brainres.2014.09.021; Rowan MS, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00039; Royer S, 2000, J NEUROSCI, V20, P9034; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sammler D, 2010, BRAIN, V133, P2643, DOI 10.1093/brain/awq231; Schuaz A., 2002, CORTICAL AREAS UNITY, P377, DOI DOI 10.1201/9780203299296.CH16; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sigurdsson T, 2016, NEUROSCIENCE, V321, P42, DOI 10.1016/j.neuroscience.2015.06.059; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Spiegler A, 2010, NEUROIMAGE, V52, P1041, DOI 10.1016/j.neuroimage.2009.12.081; Touboul J, 2011, NEURAL COMPUT, V23, P3232, DOI 10.1162/NECO_a_00206; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; Wennekers T, 2006, J PHYSIOL-PARIS, V100, P16, DOI 10.1016/j.jphysparis.2006.09.007; Yildiz IB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003219; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Ziburkus J, 2013, J NEUROPHYSIOL, V109, P1296, DOI 10.1152/jn.00232.2012	80	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188003	10.1371/journal.pone.0188003	http://dx.doi.org/10.1371/journal.pone.0188003			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200435	Green Published, gold			2022-12-26	WOS:000417033200003
J	Copen, WA; Yoo, AJ; Rost, NS; Morais, LT; Schaefer, PW; Gonzalez, RG; Wu, O				Copen, William A.; Yoo, Albert J.; Rost, Natalia S.; Morais, Livia T.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Wu, Ona			In patients with suspected acute stroke, CT perfusion-based cerebral blood flow maps cannot substitute for DWI in measuring the ischemic core	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; NEONATAL-RAT BRAIN; COMPUTED-TOMOGRAPHY; ARTERY OCCLUSION; GLOBAL-ISCHEMIA; WATER DIFFUSION; INFARCT CORE; THRESHOLDS; VOLUME; MRI	Background Neuroimaging may guide acute stroke treatment by measuring the volume of brain tissue in the irreversibly injured "ischemic core." The most widely accepted core volume measurement technique is diffusion-weighted MRI (DWI). However, some claim that measuring regional cerebral blood flow (CBF) with CT perfusion imaging (CTP), and labeling tissue below some threshold as the core, provides equivalent estimates. We tested whether any threshold allows reliable substitution of CBF for DWI. Methods 58 patients with suspected stroke underwent DWI and CTP within six hours of symptom onset. A neuroradiologist outlined DWI lesions. In CBF maps, core pixels were defined by thresholds ranging from 0%-100% of normal, in 1% increments. Replicating prior studies, we used receiver operating characteristic (ROC) curves to select thresholds that optimized sensitivity and specificity in predicting DWI-positive pixels, first using only pixels on the side of the brain where infarction was clinically suspected ("unilateral" method), then including both sides ("bilateral"). We quantified each method and threshold's accuracy in estimating DWI volumes, using sums of squared errors (SSE). For the 23 patients with follow-up studies, we assessed whether CBF-derived volumes inaccurately exceeded follow-up infarct volumes. Results The areas under the ROC curves were 0.89 (unilateral) and 0.90 (bilateral). Various metrics selected optimum CBF thresholds ranging from 29%-32%, with sensitivities of 0.79-0.81, and specificities of 0.83-0.85. However, for the unilateral and bilateral methods respectively, volume estimates derived from all CBF thresholds above 28% and 22% were less accurate than disregarding imaging and presuming every patient's core volume to be zero. The unilateral method with a 30% threshold, which recent clinical trials have employed, produced a mean core overestimation of 65 mL (range: -82-191), and exceeded follow- up volumes for 83% of patients, by up to 191 mL. Conclusion CTP-derived CBF maps cannot substitute for DWI in measuring the ischemic core.	[Copen, William A.; Yoo, Albert J.; Morais, Livia T.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Wu, Ona] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Copen, William A.; Yoo, Albert J.; Rost, Natalia S.; Schaefer, Pamela W.; Gonzalez, R. Gilberto; Wu, Ona] Harvard Med Sch, Boston, MA 02115 USA; [Yoo, Albert J.] Texas Stroke Inst, Div Neurointervent, Ft Worth, TX USA; [Rost, Natalia S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Copen, WA (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Copen, WA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	wcopen@partners.org	Schaefer, Pamela/AAA-1323-2019	Wu, Ona/0000-0002-5509-9461	National Institutes of Health-National Institute of Neurological Disorders and Stroke [P50-NS051343, R01NS059775, R01NS082285, R01NS086905]	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Ona Wu is supported in part by National Institutes of Health-National Institute of Neurological Disorders and Stroke P50-NS051343, R01NS059775, R01NS082285, and R01NS086905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Anderson AW, 1996, MAGN RESON MED, V35, P162, DOI 10.1002/mrm.1910350206; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Bivard A, 2014, J NEURORADIOLOGY, V41, P307, DOI 10.1016/j.neurad.2013.11.006; Bivard A, 2011, CEREBROVASC DIS, V31, P238, DOI 10.1159/000321897; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boned S, 2017, J NEUROINTERV SURG, V9, P66, DOI 10.1136/neurintsurg-2016-012494; BUSZA AL, 1992, STROKE, V23, P1602, DOI 10.1161/01.STR.23.11.1602; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Chemmanam T, 2010, NEUROLOGY, V75, P1040, DOI 10.1212/WNL.0b013e3181f39ab6; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Copen WA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133566; d'Esterre CD, 2015, STROKE, V46, P3390, DOI 10.1161/STROKEAHA.115.009250; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; Duong TQ, 1998, MAGN RESON MED, V40, P1, DOI 10.1002/mrm.1910400102; Fiehler J, 2002, STROKE, V33, P79, DOI 10.1161/hs0102.100884; GE Healthcare Publications, 2011, CT PERFUSION 4D USER; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Grant PE, 2001, RADIOLOGY, V221, P43, DOI 10.1148/radiol.2211001523; Guadagno JV, 2006, STROKE, V37, P1741, DOI 10.1161/01.STR.0000232437.00621.86; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Jovin TG, 2017, INT J STROKE, V12, P641, DOI 10.1177/1747493017710341; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Kidwell CS, 2000, ANN NEUROL, V47, P462, DOI 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.3.CO;2-P; KOHNO K, 1995, MAGN RESON IMAGING, V13, P73, DOI 10.1016/0730-725X(94)00080-M; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Lin WL, 2003, STROKE, V34, P64, DOI 10.1161/01.STR.0000048151.28173.0D; MANCUSO A, 1995, MAGNET RESON MED, V34, P368, DOI 10.1002/mrm.1910340314; MINEMATSU K, 1992, STROKE, V23, P1304, DOI 10.1161/01.STR.23.9.1304; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Mui K, 2011, AM J NEURORADIOL, V32, P846, DOI 10.3174/ajnr.A2415; National Institutes of Health StrokeNet, 2015, END THER FOLL IM EV; NORRIS DG, 1994, NMR BIOMED, V7, P304, DOI 10.1002/nbm.1940070703; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rubin G, 1999, J Stroke Cerebrovasc Dis, V8, P404, DOI 10.1016/S1052-3057(99)80048-2; Sanak D, 2006, NEURORADIOLOGY, V48, P632, DOI 10.1007/s00234-006-0105-0; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; SCHUIER FJ, 1980, STROKE, V11, P593, DOI 10.1161/01.STR.11.6.593; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Touho H, 1996, SURG NEUROL, V46, P135, DOI 10.1016/0090-3019(95)00464-5; vanderToorn A, 1996, MAGN RESON MED, V36, P52, DOI 10.1002/mrm.1910360110; Wintermark M, 2002, STROKE, V33, P2025, DOI 10.1161/01.STR.0000023579.61630.AC; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	53	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188891	10.1371/journal.pone.0188891	http://dx.doi.org/10.1371/journal.pone.0188891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190675	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900159
J	Horvei, KD; Pedersen, HL; Fismen, S; Thiyagarajan, D; Schneider, A; Rekvig, OP; Winkler, TH; Seredkina, N				Horvei, Kjersti Daae; Pedersen, Hege Lynum; Fismen, Silje; Thiyagarajan, Dhivya; Schneider, Andrea; Rekvig, Ole Petter; Winkler, Thomas H.; Seredkina, Natalya			Lupus nephritis progression in Fc gamma RIIB-/- yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease	PLOS ONE			English	Article							ERYTHEMATOSUS; AUTOIMMUNITY; FCGR2B; GENE; EXPRESSION; DEFICIENT; SUSCEPTIBILITY; POLYMORPHISMS; ANTIBODIES; RECEPTORS	Fc gamma RIIB-/- yaa mice develop severe lupus glomerulonephritis due to lack of an inhibitory immune cell receptor combined with a Y-chromosome linked autoimmune accelerator mutation. In the present study, we have investigated nephritis development and progression in Fc gamma RIIB-/- yaa mice to find shared features with NZB/NZW F1 lupus prone mice and human disease. We sacrificed 25 male Fc gamma RIIB-/- yaa mice at various disease stages, and grouped them according to activity and chronicity indices for lupus nephritis. Glomerular morphology and localization of electron dense deposits containing IgG were further determined by immune electron microscopy. Renal DNase I and pro-inflammatory cytokine mRNA levels were measured by real-time quantitative PCR. DNase I protein levels was assessed by immunohistochemistry and zymography. Our results demonstrate early development of electron dense deposits containing IgG in Fc gamma RIIB-/- yaa mice, before detectable levels of serum anti-dsDNA antibodies. Similar to NZB/NZW F1, electron dense deposits in Fc gamma RIIB-/- yaa progressed from being confined to the mesangium in the early stage of lupus nephritis to be present also in capillary glomerular basement membranes. In the advanced stage of lupus nephritis, renal DNase I was lost on both transcriptional and protein levels, which has previously been shown in NZB/NZW F1 mice and in human disease. Although lupus nephritis appears on different genetic backgrounds, our findings suggest similar processes when comparing different murine models and human lupus nephritis.	[Horvei, Kjersti Daae; Pedersen, Hege Lynum; Fismen, Silje; Thiyagarajan, Dhivya; Rekvig, Ole Petter; Seredkina, Natalya] UIT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway; [Schneider, Andrea; Winkler, Thomas H.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Nikolaus Fiebiger Zentrum Mol Med, Erlangen, Germany; [Seredkina, Natalya] UIT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Stem Cell Aging & Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso; University of Erlangen Nuremberg; UiT The Arctic University of Tromso	Seredkina, N (corresponding author), UIT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway.; Seredkina, N (corresponding author), UIT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Stem Cell Aging & Canc Res Grp, Tromso, Norway.	natalya.seredkina@uit.no	Rekvig, Ole Petter/V-7113-2019	Horvei, Kjersti Daae/0000-0001-8291-3548; Pedersen, Hege Lynum/0000-0002-3768-9513	Northern Norway Regional Health Authority Medical Research Program [SFP1133-13]; Norwegian Extra Foundation for Health and Rehabilitation; University of Tromso	Northern Norway Regional Health Authority Medical Research Program; Norwegian Extra Foundation for Health and Rehabilitation; University of Tromso	This work has been made possible by the Northern Norway Regional Health Authority Medical Research Program (grant # SFP1133-13), the Norwegian Extra Foundation for Health and Rehabilitation, and the University of Tromso as a Milieu support given to OPR.	Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; APPEL GB, 1987, AM J MED, V83, P877, DOI 10.1016/0002-9343(87)90645-0; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Bastian HM, 2002, LUPUS, V11, P152, DOI 10.1191/0961203302lu158oa; Bethunaickan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077489; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bruin M, 2004, BRIT J HAEMATOL, V127, P561, DOI 10.1111/j.1365-2141.2004.05235.x; Buzder T, 2009, DNA CELL BIOL, V28, P435, DOI 10.1089/dna.2008.0850; Castellano G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0588-3; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Georg P, 2012, AUTOIMMUNITY, V45, P579, DOI 10.3109/08916934.2012.719955; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kawano S, 2013, EUR J IMMUNOL, V43, P770, DOI 10.1002/eji.201243057; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Lee J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004937; Lee SG, 2012, RHEUMATOL INT, V32, P2459, DOI 10.1007/s00296-011-1986-8; Lin QS, 2010, J AUTOIMMUN, V34, P356, DOI 10.1016/j.jaut.2009.08.011; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Ludwig S, 2009, INT J BIOCHEM CELL B, V41, P1079, DOI 10.1016/j.biocel.2008.09.030; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Niewold TB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948364; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; RUBINKELLEY VE, 1991, J AM SOC NEPHROL, V2, P13; Siriboonrit U, 2003, TISSUE ANTIGENS, V61, P374, DOI 10.1034/j.1399-0039.2003.00047.x; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tam LS, 2003, LUPUS, V12, P665, DOI 10.1191/0961203303lu446oa; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Wahl P, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017901.77985F; Ward MM, 2009, J RHEUMATOL, V36, P63, DOI 10.3899/jrheum.080625; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Yung S, 2017, CLIN SCI, V131, P49, DOI 10.1042/CS20160421; Zhou XJ, 2010, NEPHROL DIAL TRANSPL, V25, P97, DOI 10.1093/ndt/gfp374; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188863	10.1371/journal.pone.0188863	http://dx.doi.org/10.1371/journal.pone.0188863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190833	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900148
J	Sasaki, N; Ishi, K; Kudo, N; Nakayama, SMM; Nakamura, K; Morishita, K; Ohta, H; Ishizuka, M; Takiguchi, M				Sasaki, Noboru; Ishi, Kazuhiro; Kudo, Nobuki; Nakayama, Shouta M. M.; Nakamura, Kensuke; Morishita, Keitaro; Ohta, Hiroshi; Ishizuka, Mayumi; Takiguchi, Mitsuyoshi			Spatial and temporal profile of cisplatin delivery by ultrasound-assisted intravesical chemotherapy in a bladder cancer model	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; PULSED ULTRASOUND; TRANSPORTER CTR1; IN-VITRO; MICROBUBBLES; CELLS; SONOPORATION; PERMEABILITY; MANAGEMENT; THERAPY	Non-muscle invasive bladder cancer is one of the most common tumors of the urinary tract. Despite the current multimodal therapy, recurrence and progression of disease have been challenging problems. We hereby introduced a new approach, ultrasound-assisted intravesical chemotherapy, intravesical instillation of chemotherapeutic agents and microbubbles followed by ultrasound exposure. We investigated the feasibility of the treatment for nonmuscle invasive bladder cancer. In order to evaluate intracellular delivery and cytotoxic effect as a function to the thickness, we performed all experiments using a bladder cancer mimicking 3D culture model. Ultrasound-triggered microbubble cavitation increased both the intracellular platinum concentration and the cytotoxic effect of cisplatin at the thickness of 70 and 122 mu m of the culture model. The duration of enhanced cytotoxic effect of cisplatin by ultrasound-triggered microbubble cavitation was approximately 1 hr. Based on the distance and duration of delivery, we further tested the feasibility of repetition of the treatment. Triple treatment increased the effective distance by 1.6-fold. Our results clearly showed spatial and temporal profile of delivery by ultrasound-triggered microbubble cavitation in a tumor-mimicking structure. Furthermore, we demonstrated that the increase in intracellular concentration results in the enhancement of the cytotoxic effect in a structure with the certain thickness. Repetition of ultrasound exposure would be treatment of choice in future clinical application. Our results suggest ultrasound-triggered microbubble cavitation can be repeatable and is promising for the local control of non-muscle invasive bladder cancer.	[Sasaki, Noboru; Ishi, Kazuhiro; Ohta, Hiroshi; Takiguchi, Mitsuyoshi] Hokkaido Univ, Dept Clin Sci, Fac Vet Med, Sapporo, Hokkaido, Japan; [Kudo, Nobuki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Div Bioengn & Bioinformat, Sapporo, Hokkaido, Japan; [Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Dept Environm Vet Sci, Fac Vet Med, Sapporo, Hokkaido, Japan; [Nakamura, Kensuke; Morishita, Keitaro] Hokkaido Univ, Vet Teaching Hosp, Fac Vet Med, Sapporo, Hokkaido, Japan; [Nakamura, Kensuke] Miyazaki Univ, Org Promot Tenure Track, Miyazaki, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; University of Miyazaki	Takiguchi, M (corresponding author), Hokkaido Univ, Dept Clin Sci, Fac Vet Med, Sapporo, Hokkaido, Japan.	mtaki@vetmed.hokudai.ac.jp	Nakamura, Kensuke/H-4654-2019; SASAKI, NOBORU/HHS-3600-2022; Kudo, Nobuki/AAB-7034-2020	Nakamura, Kensuke/0000-0002-1010-3228; Kudo, Nobuki/0000-0003-3463-3714	Japan Society for the Promotion of Science [26292155, 16K18799]; Grants-in-Aid for Scientific Research [17H00864] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/index.html), Nos. 26292155 (MT) and 16K18799 (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate Mr. Takahiro Ichise for his technical assistant in platinum measurement by ICP-MS. This study was supported by the Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26292155, MT and 16K18799, NS).	Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Anderson CD, 2013, ULTRASOUND MED BIOL, V39, P2351, DOI 10.1016/j.ultrasmedbio.2013.07.002; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Azevedo R, 2015, J CONTROL RELEASE, V214, P40, DOI 10.1016/j.jconrel.2015.07.002; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Bouffioux C, 1992, J UROLOGY, V148, P279; Carson AR, 2012, CANCER RES, V72, P6191, DOI 10.1158/0008-5472.CAN-11-4079; Chen CH, 2012, UROL ONCOL-SEMIN ORI, V30, P421, DOI 10.1016/j.urolonc.2010.06.012; Cheng L, 2009, MODERN PATHOL, V22, pS70, DOI 10.1038/modpathol.2009.1; Dalbagni G, 2007, NAT CLIN PRACT UROL, V4, P254, DOI 10.1038/ncpuro0784; Delto JC, 2013, ONCOTARGET, V4, P269, DOI 10.18632/oncotarget.852; Douglass L, 2016, BLADDER CANCER, V2, P285, DOI 10.3233/BLC-160056; Eifler JB, 2015, CURR OPIN ONCOL, V27, P185, DOI 10.1097/CCO.0000000000000173; Escoffre JM, 2011, MOL PHARMACEUT, V8, P799, DOI 10.1021/mp100397p; Hadaschik BA, 2008, BJU INT, V101, P1347, DOI 10.1111/j.1464-410X.2008.07571.x; Hansel DE, 2013, EUR UROL, V63, P321, DOI 10.1016/j.eururo.2012.10.008; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Iwanaga K, 2007, CANCER GENE THER, V14, P354, DOI 10.1038/sj.cgt.7701026; Kindberg GM, 2003, CELL TISSUE RES, V312, P49, DOI 10.1007/s00441-003-0698-0; Kooiman K, 2011, J CONTROL RELEASE, V154, P35, DOI 10.1016/j.jconrel.2011.04.008; Kudo N, 2009, BIOPHYS J, V96, P4866, DOI 10.1016/j.bpj.2009.02.072; Lammertink B, 2015, INT J PHARMACEUT, V482, P92, DOI 10.1016/j.ijpharm.2014.12.013; Lammertink BHA, 2016, J CONTROL RELEASE, V238, P157, DOI 10.1016/j.jconrel.2016.07.049; Landon CD, 2013, INT J HYPERTHER, V29, P528, DOI 10.3109/02656736.2013.790563; Lentacker I, 2014, ADV DRUG DELIVER REV, V72, P49, DOI 10.1016/j.addr.2013.11.008; Lentacker I, 2010, MOL THER, V18, P101, DOI 10.1038/mt.2009.160; Liang ZD, 2009, MOL PHARMACOL, V76, P843, DOI 10.1124/mol.109.056416; MILBURN GHW, 1966, J CHEM SOC A, P1609, DOI 10.1039/j19660001609; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Sasaki N, 2015, INT J PHARMACEUT, V482, P118, DOI 10.1016/j.ijpharm.2015.01.039; Sasaki N, 2012, ULTRASOUND MED BIOL, V38, P109, DOI 10.1016/j.ultrasmedbio.2011.09.017; Sonoda S, 2007, CANCER BIOL THER, V6, P1276; Sontum PC, 1999, INVEST RADIOL, V34, P268, DOI 10.1097/00004424-199904000-00003; Stieger SM, 2007, RADIOLOGY, V243, P112, DOI 10.1148/radiol.2431060167; Suen WLL, 2016, ULTRASOUND MED BIOL, V42, P2650, DOI 10.1016/j.ultrasmedbio.2016.07.013; Tinkov S, 2010, J CONTROL RELEASE, V143, P143, DOI 10.1016/j.jconrel.2009.12.026; van Wamel A, 2006, J CONTROL RELEASE, V112, P149, DOI 10.1016/j.jconrel.2006.02.007; Yudina A, 2011, MOL IMAGING BIOL, V13, P239, DOI 10.1007/s11307-010-0346-5; Zeghimi A, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066007; Zhou Y, 2007, J ACOUST SOC AM, V122, P1191	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188093	10.1371/journal.pone.0188093	http://dx.doi.org/10.1371/journal.pone.0188093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190688	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900035
J	Zhai, DY; Zhu, SG; Zhang, W; Li, X; Zhu, YL				Zhai, Deng-Yue; Zhu, Shuang-Gen; Zhang, Wei; Li, Xue; Zhu, You-Ling			Infarct morphology assessment in patients with carotid artery/middle cerebral artery occlusion using fast fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH)	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IMAGING VESSEL SIGNS; MOYAMOYA-DISEASE; COLLATERAL FLOW; ASSOCIATION; MARKER; MRI	We aim to evaluate the value of fast fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) in assessing infarct morphology in patients with symptomatic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusions. Magnetic resonance (MR) diffusion-weighted imaging (DWI) FLAIR sequences, and carotid/cerebral magnetic resonance angiography of 102 patients with symptomatic ICA or MCA occlusions were evaluated. The location and score of FVH were determined using Olindo's method; patients were classified as having Low or High FVHs based on FVH score, and either Distal or Proximal FVH based on FVH location. The differences between infarct morphologies were analyzed. FVH were detectable in 62 patients with High FVH and in 40 patients with Low FVHs based on the Olindo's scale. There were no statistically significant differences in age, gender, hypertension, diabetes, hyperlipidemia, smoking history, and vascular occlusive site between High and Low FVHs patients, except for infarct morphology (P<0.01). Patients with Distal FVH presented with significant (P<0.01) perforating artery and border zone infarcts, whereas those with Proximal FVH had significant (P<0.01) large territorial infarcts. The scores and locations of FVH could be a predictive imaging marker for infarct morphology in patients with symptomatic ICA or MCA occlusion.	[Zhai, Deng-Yue; Li, Xue; Zhu, You-Ling] Anhui Med Univ, Dept Neurol, Affiliated Hosp 3, Hefei, Anhui, Peoples R China; [Zhu, Shuang-Gen] Peoples Hosp Longhua, Dept Neurol, Shenzhen, Guangdong, Peoples R China; [Zhang, Wei] Second Peoples Hosp Anhui Prov, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University	Zhu, YL (corresponding author), Anhui Med Univ, Dept Neurol, Affiliated Hosp 3, Hefei, Anhui, Peoples R China.	moonfallz@qq.com			Natural Science Foundation of Anhui Medical University [2013xkj048]; Anhui Provincial Natural Science Research Project [kj2013z119]; Innovation Technology Funding Project of Longhua District, Shenzhen, China [20150924A1030082]; Medical Scientific Research Foundation of Guangdong Province, China [B2016091]	Natural Science Foundation of Anhui Medical University; Anhui Provincial Natural Science Research Project; Innovation Technology Funding Project of Longhua District, Shenzhen, China; Medical Scientific Research Foundation of Guangdong Province, China	This project was supported by the Natural Science Foundation of Anhui Medical University (2013xkj048), Anhui Provincial Natural Science Research Project (kj2013z119). Innovation Technology Funding Project of Longhua District, Shenzhen, China (20150924A1030082), and Medical Scientific Research Foundation of Guangdong Province, China (B2016091).	Assouline E, 2005, CEREBROVASC DIS, V20, P6, DOI 10.1159/000086120; Bakshi R, 2001, ARCH NEUROL-CHICAGO, V58, P742, DOI 10.1001/archneur.58.5.742; Bangerter NK, 2006, J MAGN RESON IMAGING, V24, P1426, DOI 10.1002/jmri.20743; Chung PW, 2009, NEUROLOGY, V72, P1872, DOI 10.1212/WNL.0b013e3181a7120e; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hohenhaus M, 2012, CEREBROVASC DIS, V34, P63, DOI 10.1159/000339012; Huang XJ, 2012, EUR NEUROL, V68, P214, DOI 10.1159/000340021; Kawashima M, 2010, AM J NEURORADIOL, V31, P1713, DOI 10.3174/ajnr.A2124; Kim SE, 2016, STROKE, V47, P1548, DOI 10.1161/STROKEAHA.115.012285; Kim SJ, 2012, STROKE, V43, P386, DOI 10.1161/STROKEAHA.111.638106; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Lee KY, 2009, NEUROLOGY, V72, P1134, DOI 10.1212/01.wnl.0000345360.80382.69; Liebeskind DS, 2005, AM J NEURORADIOL, V26, P2432; Liu DZ, 2016, STROKE, V47, P2763, DOI 10.1161/STROKEAHA.116.013953; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; McNally JS, 2012, CIRC-CARDIOVASC IMAG, V5, P376, DOI 10.1161/CIRCIMAGING.111.967398; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Okuda T, 1998, BRIT J RADIOL, V71, P282, DOI 10.1259/bjr.71.843.9616237; Olindo S, 2012, ARCH NEUROL-CHICAGO, V69, P1462, DOI 10.1001/archneurol.2012.1310; Sanossian N, 2009, AM J NEURORADIOL, V30, P564, DOI 10.3174/ajnr.A1388; Schellinger PD, 2005, AM J NEURORADIOL, V26, P618; Shi ZQ, 2013, P NATL ACAD SCI USA, V110, P3137, DOI 10.1073/pnas.1215501110; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Toyoda K, 2001, AM J NEURORADIOL, V22, P1021	24	2	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188078	10.1371/journal.pone.0188078	http://dx.doi.org/10.1371/journal.pone.0188078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190679	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900033
J	Krause, DJ; Hinke, JT; Perryman, WL; Goebel, ME; LeRoi, DJ				Krause, Douglas J.; Hinke, Jefferson T.; Perryman, Wayne L.; Goebel, Michael E.; LeRoi, Donald J.			An accurate and adaptable photogrammetric approach for estimating the mass and body condition of pinnipeds using an unmanned aerial system	PLOS ONE			English	Article							SEALS HYDRURGA-LEPTONYX; SOUTHERN ELEPHANT SEAL; ANTARCTIC FUR SEALS; LEOPARD SEALS; AIRCRAFT SYSTEMS; MIROUNGA-LEONINA; PRYDZ BAY; FORAGING ENERGETICS; CHEMICAL RESTRAINT; WILDLIFE	Measurements of body size and mass are fundamental to pinniped population management and research. Manual measurements tend to be accurate but are invasive and logistically challenging to obtain. Ground-based photogrammetric techniques are less invasive, but inherent limitations make them impractical for many field applications. The recent proliferation of unmanned aerial systems (UAS) in wildlife monitoring has provided a promising new platform for the photogrammetry of free-ranging pinnipeds. Leopard seals (Hydrurga leptonyx) are an apex predator in coastal Antarctica whose body condition could be a valuable indicator of ecosystem health. We aerially surveyed leopard seals of known body size and mass to test the precision and accuracy of photogrammetry from a small UAS. Flights were conducted in January and February of 2013 and 2014 and 50 photogrammetric samples were obtained from 15 unrestrained seals. UAS-derived measurements of standard length were accurate to within 2.01 +/- 1.06%, and paired comparisons with ground measurements were statistically indistinguishable. An allometric linear mixed effects model predicted leopard seal mass within 19.40 kg (4.4% error for a 440 kg seal). Photogrammetric measurements from a single, vertical image obtained using UAS provide a noninvasive approach for estimating the mass and body condition of pinnipeds that may be widely applicable.	[Krause, Douglas J.; Hinke, Jefferson T.; Goebel, Michael E.] NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Perryman, Wayne L.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [LeRoi, Donald J.] Aerial Imaging Solut LLC, Old Lyme, CT USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Krause, DJ (corresponding author), NOAA, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.	douglas.krause@noaa.gov	, Jefferson/AAG-1702-2021	, Jefferson/0000-0002-3600-1414; Krause, Douglas J./0000-0002-2517-3106	NOAA Fisheries	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this study was provided by NOAA Fisheries.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ainley DG, 2005, ANTARCT SCI, V17, P335, DOI 10.1017/S0954102005002750; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson SS, 1987, S ZOOLOGICAL SOC LON; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baker WH, 1960, PHOTOGRAMMETRY; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell CM, 1997, MAR MAMMAL SCI, V13, P669, DOI 10.1111/j.1748-7692.1997.tb00090.x; Bester MN, 2002, ANTARCT SCI, V14, P123, DOI 10.1017/S0954102002000676; Boveng PL, 1998, ECOLOGY, V79, P2863, DOI 10.2307/176522; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; BRYDEN MM, 1968, NATURE, V220, P597, DOI 10.1038/220597a0; BRYDEN MM, 1969, GROWTH, V33, P69; Calder WA., 1984, SIZE FUNCTION LIFE H; Casaux R, 2009, POLAR BIOL, V32, P307, DOI 10.1007/s00300-008-0567-0; CASTELLINI MA, 1993, MAR MAMMAL SCI, V9, P48, DOI 10.1111/j.1748-7692.1993.tb00425.x; CASTELLINI MA, 1990, MAR MAMMAL SCI, V6, P75, DOI 10.1111/j.1748-7692.1990.tb00227.x; COSTA DP, 1991, AM ZOOL, V31, P111; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; de Bruyn P, 2009, AQUAT BIOL, P5; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Durban JW, 2015, J UNMANNED VEH SYST, V3, P131, DOI 10.1139/juvs-2015-0020; Durban JW, 2016, MAR MAMMAL SCI, V32, P1510, DOI 10.1111/mms.12328; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Fox J., 2018, R COMPANION APPL REG, VThird; GALES NJ, 1989, MAR MAMMAL SCI, V5, P228, DOI 10.1111/j.1748-7692.1989.tb00338.x; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Gentry RL., 1986, FUR SEALS MATERNAL S, DOI 10.1515/9781400854691; Gilbert J, 1977, ADAPTATIONS ANTARCTI, P703; Gilpatrick JW, 1996, NOAA TECHNICAL MEMOR; Goebel ME, 2014, AMLR 2010 11 FIELD S, P50; Goebel ME, 2015, POLAR BIOL, V38, P619, DOI 10.1007/s00300-014-1625-4; HALEY MP, 1991, MAR MAMMAL SCI, V7, P157, DOI 10.1111/j.1748-7692.1991.tb00562.x; Hanks J, 1981, DYNAMICS LARGE MAMMA, P47; Higgins DP, 2002, MAR MAMMAL SCI, V18, P483, DOI 10.1111/j.1748-7692.2002.tb01050.x; Hiruki LM, 1999, J ZOOL, V249, P97; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hodgson JC, 2016, CURR BIOL, V26, pR404, DOI 10.1016/j.cub.2016.04.001; Hodgson JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22574; Hofman R, 1977, ADAPTATIONS ANTARCTI, P769; Hofman RJ, 1975, DISTRIBUTION PATTERN; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Ireland D, 2006, MAR MAMMAL SCI, V22, P361, DOI 10.1111/j.1748-7692.2006.00039.x; Irvine LG, 2000, J ZOOL, V251, P463, DOI 10.1017/S0952836900008062; Jeglinski JWE, 2010, AQUAT MAMM, V36, P262, DOI 10.1578/AM.36.3.2010.262; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; KOOYMAN G L, 1990, Polar Record, V26, P103; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Krause D.J., 2015, ANIM BIOTELEM, V3, P1, DOI [10.1186/s40317-015-0059-2, DOI 10.1186/S40317-015-0059-2]; Krause DJ, 2016, MAR MAMMAL SCI, V32, P839, DOI 10.1111/mms.12309; Laws R. M., 1957, Saugetierkundliche Mitteilungen, V5, P49; Linchant J, 2015, MAMMAL REV, V45, P239, DOI 10.1111/mam.12046; Lumley T., 2009, LEAPS REGRESSION SUB; Lydersen C, 2012, POLAR BIOL, V35, P1555, DOI 10.1007/s00300-012-1195-2; McDonald BI, 2008, DEEP-SEA RES PT II, V55, P515, DOI 10.1016/j.dsr2.2007.11.002; McFadden Katherine W., 2006, Aquatic Mammals, V32, P31, DOI 10.1578/AM.32.1.2006.31; Meise K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101197; Merkel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067576; MERRICK RL, 1995, FISH B-NOAA, V93, P753; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; MITCHELL PJ, 1991, VET REC, V129, P332, DOI 10.1136/vr.129.15.332; Monson DH, 2000, OIKOS, V90, P457, DOI 10.1034/j.1600-0706.2000.900304.x; Perryman Wayne L., 2002, Journal of Cetacean Research and Management, V4, P155; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pussini N, 2015, MAR MAMMAL SCI, V31, P1549, DOI 10.1111/mms.12232; READ AJ, 1990, CAN J ZOOL, V68, P1962, DOI 10.1139/z90-276; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; ROGERS T, 1995, CAN J ZOOL, V73, P1001, DOI 10.1139/z95-119; Rogers TL, 2005, POLAR BIOL, V28, P456, DOI 10.1007/s00300-004-0703-4; Rogers TL, 1997, MAR MAMMAL SCI, V13, P293, DOI 10.1111/j.1748-7692.1997.tb00632.x; Rogers TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052542; Sasse DB, 2003, WILDLIFE SOC B, V31, P1015; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seals Laws R., 1984, ANTARCT ECOL, VII, P621; Shero MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091233; Shingleton AW., 2010, NAT ED KNOWL, V3, P2; Siniff D.B., 1985, P555; Slate E.H, 2014, GVLMA GLOBAL VALIDAT; Southwell C, 2008, DEEP-SEA RES PT I, V55, P519, DOI 10.1016/j.dsr.2008.01.005; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Sweeney KL, 2016, J UNMANNED VEH SYST, V4, P70, DOI 10.1139/juvs-2015-0010; Trillmich F., 1991, Ecological Studies, V88, P66; USHER PJ, 1969, ARCTIC, V22, P120; Van den Hoff J, 2005, J WILDLIFE MANAGE, V69, P1015, DOI 10.2193/0022-541X(2005)069[1015:EBMACO]2.0.CO;2; Venables WN., 2002, MODERN APPL STAT S, V4; Waite JN, 2007, CAN J FISH AQUAT SCI, V64, P296, DOI 10.1139/F07-014; Walker TR, 1998, ANTARCT SCI, V10, P75, DOI 10.1017/S0954102098000108; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Webb PM, 1998, J EXP BIOL, V201, P2349; Webb PW, 1975, HYDRODYNAMICS ENERGE; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whitehead K, 2014, J UNMANNED VEH SYST, V2, P86, DOI 10.1139/juvs-2014-0007; WILLIAMS TM, 1985, PHYSIOL ZOOL, V58, P576, DOI 10.1086/physzool.58.5.30158584; Wilson EA, 1902, REPORT COLLECTIONS N, P67; Wilson EA, 1905, VOYAGE DISCOVERY, VII, P469; WILSON S, 1974, BEHAVIOUR, V48, P37, DOI 10.1163/156853974X00246; Wolf P.R, 1983, ELEMENTS PHOTOGRAMME	102	55	59	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187465	10.1371/journal.pone.0187465	http://dx.doi.org/10.1371/journal.pone.0187465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186134	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900006
J	Mas, Y; Gracia, L; Ibarz, E; Gabarre, S; Pena, D; Herrera, A				Mas, Yolanda; Gracia, Luis; Ibarz, Elena; Gabarre, Sergio; Pena, Diego; Herrera, Antonio			Finite element simulation and clinical follow-up of lumbar spine biomechanics with dynamic fixations	PLOS ONE			English	Article							ADJACENT-SEGMENT DEGENERATION; LOW-BACK-PAIN; STABILIZATION SYSTEM; DISC DEGENERATION; INTERBODY FUSION; NEUTRALIZATION SYSTEM; IN-VITRO; DYNESYS; EPIDEMIOLOGY; DISEASE	Arthrodesis is a recommended treatment in advanced stages of degenerative disc disease. Despite dynamic fixations were designed to prevent abnormal motions with better physiological load transmission, improving lumbar pain and reducing stress on adjacent segments, contradictory results have been obtained. This study was designed to compare differences in the biomechanical behaviour between the healthy lumbar spine and the spine with DYNESYS and DIAM fixation, respectively, at L4-L5 level. Behaviour under flexion, extension, lateral bending and axial rotation are compared using healthy lumbar spine as reference. Three 3D finite element models of lumbar spine (healthy, DYNESYS and DIAM implemented, respectively) were developed, together a clinical follow-up of 58 patients operated on for degenerative disc disease. DYNESYS produced higher variations of motion with a maximum value for lateral bending, decreasing intradiscal pressure and facet joint forces at instrumented level, whereas screw insertion zones concentrated stress. DIAM increased movement during flexion, decreased it in another three movements, and produced stress concentration at the apophyses at instrumented level. Dynamic systems, used as single systems without vertebral fusion, could be a good alternative to degenerative disc disease for grade II and grade III of Pfirrmann.	[Mas, Yolanda; Gracia, Luis; Ibarz, Elena; Gabarre, Sergio] Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain; [Gracia, Luis; Ibarz, Elena; Herrera, Antonio] Aragon Inst Engn Res, Zaragoza, Spain; [Pena, Diego] Miguel Servet Univ Hosp, Spine Unit, Dept Orthopaed Surg & Traumatol, Zaragoza, Spain; [Pena, Diego; Herrera, Antonio] Aragon Hlth Res Inst, Zaragoza, Spain; [Herrera, Antonio] Univ Zaragoza, Sch Med, Dept Surg, Zaragoza, Spain	University of Zaragoza; Miguel Servet University Hospital; University of Zaragoza	Herrera, A (corresponding author), Aragon Inst Engn Res, Zaragoza, Spain.; Herrera, A (corresponding author), Aragon Hlth Res Inst, Zaragoza, Spain.; Herrera, A (corresponding author), Univ Zaragoza, Sch Med, Dept Surg, Zaragoza, Spain.	antonio.herrera@unizar.es	Ibarz, Elena/ABF-7630-2020; Herrera, Antonio/E-5532-2011	Herrera, Antonio/0000-0001-7877-4733; Gabarre, Sergio/0000-0002-2934-1525				Anesetti F, 2010, J NEUROSURG-SPINE, V13, P568, DOI 10.3171/2010.6.SPINE09885; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Bellini CM, 2007, J SPINAL DISORD TECH, V20, P423, DOI 10.1097/BSD.0b013e318031af6f; Bredin S, 2017, ORTHOP TRAUMATOL SUR; Buric J, 2011, ACTA NEUROCHIR SUPPL, V108, P177, DOI 10.1007/978-3-211-99370-5_26; Buric J, 2011, EUR SPINE J, V20, P1304, DOI 10.1007/s00586-011-1697-6; Caserta S, 2002, EUR SPINE J, V11, pS192, DOI 10.1007/s00586-002-0426-6; Cegonino J, 2015, J ORTHOP RES, V33, P993, DOI 10.1002/jor.22854; Chen CH, 2015, 2015 THIRD INTERNATIONAL CONFERENCE ON ROBOT, VISION AND SIGNAL PROCESSING (RVSP), P10, DOI 10.1109/RVSP.2015.11; Cheng BC, 2007, SPINE, V32, P2551, DOI 10.1097/BRS.0b013e318158cdbe; Chien CY, 2014, SPINE, V39, pE878, DOI 10.1097/BRS.0000000000000388; Chou WY, 2002, ARCH ORTHOP TRAUM SU, V122, P39, DOI 10.1007/s004020100314; Ciavarro C, 2012, J MAGN RESON IMAGING, V35, P1145, DOI 10.1002/jmri.23525; Disch AC, 2008, J SPINAL DISORD TECH, V21, P79, DOI 10.1097/BSD.0b013e3180577259; Erbulut DU, 2015, J NEUROSURG-SPINE, V23, P200, DOI 10.3171/2014.12.SPINE14419; Erbulut DU, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027060; Galbusera F, 2011, MED ENG PHYS, V33, P490, DOI 10.1016/j.medengphy.2010.11.018; Grob D, 2005, SPINE, V30, P324, DOI 10.1097/01.brs.0000152584.46266.25; Helgeson MD, 2013, SPINE J, V13, P342, DOI 10.1016/j.spinee.2012.12.009; Hemanta Dhungana, 2016, Chinese Medical Sciences Journal, V31, P185; Hirsch C, 2015, ORTHOP TRAUMATOL-SUR, V101, P215, DOI 10.1016/j.otsr.2014.11.016; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Ibarz E, 2013, ADV BIOSCIENCE BIOTE, V4, P547; Ibarz E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/705185; Jahng TA, 2013, SPINE J, V13, P85, DOI 10.1016/j.spinee.2012.11.014; Kadow T, 2015, CLIN ORTHOP RELAT R, V473, P1903, DOI 10.1007/s11999-014-3774-8; Kim HJ, 2015, SPINE J, V15, P1841, DOI 10.1016/j.spinee.2015.03.038; Kim Keung Nyun, 2009, Neurospine, V6, P175; Krappel F, 2017, EUR SPINE J, V26, P865, DOI 10.1007/s00586-016-4796-6; Lee CH, 2013, NEUROSURGERY, V73, P224, DOI 10.1227/NEU.0b013e31828e8ddc; Levin DA, 2007, BULL HOSP JT DIS, V65, P29; Liang JQ, 2014, J ORTHOPAEDIC SURG R, P9; Liu CL, 2011, EUR SPINE J, V20, P1850, DOI 10.1007/s00586-011-1817-3; Liu CL, 2010, J SPINAL DISORD TECH, V23, P410, DOI 10.1097/BSD.0b013e3181b63d89; Liu K, 2017, J ORTHOP SCI; Lu K, 2015, J NEUROSURG-SPINE, V23, P190, DOI 10.3171/2014.12.SPINE14666; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Minns RJ, 1997, SPINE, V22, P1819, DOI 10.1097/00007632-199708150-00004; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rigal J, 2017, EUR SPINE J, V26, P2045, DOI 10.1007/s00586-017-5146-z; Rohlmann A, 2007, EUR SPINE J, V16, P1223, DOI 10.1007/s00586-006-0292-8; Rohlmann A, 2010, J BIOMECH, V43, P2963, DOI 10.1016/j.jbiomech.2010.07.018; Schmoelz W, 2006, EUR SPINE J, V15, P1276, DOI 10.1007/s00586-005-0032-5; Schulte TL, 2008, EUR SPINE J, V17, P1057, DOI 10.1007/s00586-008-0667-0; Shih SL, 2012, J SPINAL DISORD TECH, V25, pE140, DOI 10.1097/BSD.0b013e31824e5e10; Shim CS, 2008, SPINE, V33, pE820, DOI 10.1097/BRS.0b013e3181894fb1; Sjovold SG, 2012, EUR SPINE J, V21, P1660, DOI 10.1007/s00586-012-2253-8; Song KJ, 2011, EUR SPINE J, V20, P1940, DOI 10.1007/s00586-011-1864-9; Stoll TM, 2002, EUR SPINE J, V11, pS170, DOI 10.1007/s00586-002-0438-2; Strube P, 2010, EUR SPINE J, V19, P2171, DOI 10.1007/s00586-010-1549-9; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Volkheimer D, 2015, EUR SPINE J, V24, P1882, DOI 10.1007/s00586-015-4040-9; Weber KT, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-015-0887-8; Weber KT, 2015, CURR REV MUSCULOSKE, V8, P18, DOI 10.1007/s12178-014-9253-8; Wilke HJ, 2008, EUR SPINE J, V17, P1049, DOI 10.1007/s00586-008-0657-2; Wong KCH, 2009, BMC MUSCULOSKEL DIS, P10; Wu AM, 2014, PLOS ONE, P9; Wu HT, 2017, J INT MED RES, V45, P1562, DOI 10.1177/0300060517708104; Zander T, 2006, CLIN BIOMECH, V21, P767, DOI 10.1016/j.clinbiomech.2006.04.001; Zhang CM, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0597-9	62	20	26	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188328	10.1371/journal.pone.0188328	http://dx.doi.org/10.1371/journal.pone.0188328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186157	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900030
J	Huo, TY; Canepa, R; Sura, A; Modave, F; Gong, Y				Huo, Tianyao; Canepa, Ronald; Sura, Andrei; Modave, Francois; Gong, Yan			Colorectal cancer stages transcriptome analysis	PLOS ONE			English	Article							COLON-CANCER; EXPRESSION; GENE; OVEREXPRESSION; APOPTOSIS; DATABASE; CELLS	Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths in the United States. The purpose of this study was to evaluate the gene expression differences in different stages of CRC. Gene expression data on 433 CRC patient samples were obtained from The Cancer Genome Atlas (TCGA). Gene expression differences were evaluated across CRC stages using linear regression. Genes with p <= 0.001 in expression differences were evaluated further in principal component analysis and genes with p <= 0.0001 were evaluated further in gene set enrichment analysis. A total of 377 patients with gene expression data in 20,532 genes were included in the final analysis. The numbers of patients in stage I through IV were 59, 147, 116 and 55, respectively. NEK4 gene, which encodes for NIMA related kinase 4, was differentially expressed across the four stages of CRC. The stage I patients had the highest expression of NEK4 genes, while the stage IV patients had the lowest expressions (p = 9*10(-6)). Ten other genes (RNF34, HIST3H2BB, NUDT6, LRCh4, GLB1L, HIST2H4A, TMEM79, AMIGO2, C20orf135 and SPSB3) had p value of 0.0001 in the differential expression analysis. Principal component analysis indicated that the patients from the 4 clinical stages do not appear to have distinct gene expression pattern. Network-based and pathway-based gene set enrichment analyses showed that these 11 genes map to multiple pathways such as meiotic synapsis and packaging of telomere ends, etc. Ten of these 11 genes were linked to Gene Ontology terms such as nucleosome, DNA packaging complex and protein-DNA interactions. The protein complex-based gene set analysis showed that four genes were involved in H2AX complex II. This study identified a small number of genes that might be associated with clinical stages of CRC. Our analysis was not able to find a molecular basis for the current clinical staging for CRC based on the gene expression patterns.	[Huo, Tianyao; Sura, Andrei; Modave, Francois] Univ Florida, Coll Med, Dept Hlth Outcomes & Policy, Gainesville, FL USA; [Canepa, Ronald] Univ Florida, Informat Technol & Serv, Gainesville, FL USA; [Gong, Yan] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA; [Gong, Yan] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL 32611 USA; [Gong, Yan] Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gong, Y (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.; Gong, Y (corresponding author), Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL 32611 USA.; Gong, Y (corresponding author), Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA.	gong@cop.ufl.edu		Canepa, Ronald/0000-0002-4756-1070	NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Konishi T, 2006, ONCOGENE, V25, P3160, DOI 10.1038/sj.onc.1209342; Konishi T, 2005, MOL CANCER THER, V4, P743, DOI 10.1158/1535-7163.MCT-05-0020; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lorenc Z, 2017, MED SCI MONITOR, V23, P1305, DOI 10.12659/MSM.901593; Marmol I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010197; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musulen E, 2013, HUM PATHOL, V44, P412, DOI 10.1016/j.humpath.2012.06.006; Nguyen CL, 2012, MOL CELL BIOL, V32, P3963, DOI 10.1128/MCB.00436-12; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; Rabenau KE, 2004, ONCOGENE, V23, P5056, DOI 10.1038/sj.onc.1207681; Reimers Marlies S, 2014, J Natl Cancer Inst, V106, DOI 10.1093/jnci/dju269; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tutlewska K, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-9; Vogel JD, 2017, DIS COLON RECTUM, V60, P999, DOI 10.1097/DCR.0000000000000926; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188697	10.1371/journal.pone.0188697	http://dx.doi.org/10.1371/journal.pone.0188697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182684	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000051
J	Nurrohman, H; Carneiro, KMM; Hellgeth, J; Saeki, K; Marshall, SJ; Marshall, GW; Habelitz, S				Nurrohman, Hamid; Carneiro, Karina M. M.; Hellgeth, John; Saeki, Kuniko; Marshall, Sally J.; Marshall, Grayson W.; Habelitz, Stefan			The role of protease inhibitors on the remineralization of demineralized dentin using the PILP method	PLOS ONE			English	Article							PLAY DISTINCT ROLES; MECHANICAL-PROPERTIES; COLLAGEN; CHLORHEXIDINE; MINERALIZATION; DEGRADATION	Mineralized and sound dentin matrices contain inactive preforms of proteolytic enzymes that may be activated during the demineralization cycle. In this study, we tested the hypothesis that protease inhibitors (PI) preserve demineralized collagen fibrils and other constituents of the dentin matrix and thereby affect the potential for remineralization. Artificial carious lesions with lesion depths of 140 mu m were created with acetate buffer (pH = 5.0, 66 hours), and remineralized using a polymer-induced-liquid-precursor (PILP) process (pH = 7.4, 14 days) containing poly(aspartic acid) (pAsp) as the process-directing agent. De-and remineralizing procedures were performed in the presence or absence of PI. Ultrastructure and mechanical recovery of demineralized dentin following PILP remineralization were examined and measured in water with atomic force microscopy (AFM) and nanoindentation. Nanomechanical properties of hydrated artificial lesions had a low elastic modulus (ER < 0.4 GPa) extending about 100 mu m into the lesion, followed by a sloped region of about 140 mu m depth where values reached those of normal dentin (18.0-20.0 GPa). Mapping of mineral content by both micro-FTIR and micro x-ray computed tomography correlated well with modulus profiles obtained by nanoindentation. Tissue demineralized in the presence of PI exhibited higher elastic moduli (average 2.8 GPa) across the lesion and comprised a narrow zone in the outer lesion with strongly increased modulus (up to 8 GPa; p < 0.05), which might be related to the preservation of non-collagenous proteins that appear to induce calcium phosphate mineral formation even under demineralizing physical-chemical conditions. However, mechanical aspects of remineralization through the elastic modulus change, and the micromorphological aspects with SEM and TEM observation were almost identical with PILP treatments being conducted in the presence or absence of PI. Thus, the application of the protease inhibitors (PI) seemed to be less effective in promoting the remineralization of demineralized dentin.	[Nurrohman, Hamid; Carneiro, Karina M. M.; Saeki, Kuniko; Marshall, Sally J.; Marshall, Grayson W.; Habelitz, Stefan] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Nurrohman, Hamid] AT Still Univ, Missouri Sch Dent & Oral Hlth, Kirksville, MO USA; [Carneiro, Karina M. M.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Hellgeth, John] Thermo Fisher Sci, San Jose, CA USA	University of California System; University of California San Francisco; A.T. Still University of Health Sciences; University of Toronto; Thermo Fisher Scientific	Marshall, GW; Habelitz, S (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA.	GW.Marshall@ucsf.edu; Stefan.habelitz@ucsf.edu	Carneiro, Karina M. M./AAD-8410-2019	Habelitz, Stefan/0000-0001-7201-5779; Marshall, Grayson W/0000-0001-8921-3253	NIH/NIDCR [2R01 DE016849]; Thermo-Fisher	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Thermo-Fisher	This study was supported by NIH/NIDCR2R01 DE016849 to SH, GWM. JH received salary support from Thermo-Fisher. The specific roles of these authors are articulated in the "author contributions" section.	Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; Carrilho MRO, 2007, J DENT RES, V86, P529, DOI 10.1177/154405910708600608; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08; Chen ZQ, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/390134; Chien YC, 2016, ARCH ORAL BIOL, V63, P93, DOI 10.1016/j.archoralbio.2015.10.001; de Souza AP, 2000, DENT MATER, V16, P103, DOI 10.1016/S0109-5641(99)00084-6; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Everts V, 1998, J BONE MINER RES, V13, P1420, DOI 10.1359/jbmr.1998.13.9.1420; Gendron R, 1999, CLIN DIAGN LAB IMMUN, V6, P437, DOI 10.1128/CDLI.6.3.437-439.1999; Gericke A, 2010, J DENT RES, V89, P355, DOI 10.1177/0022034510363250; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Habelitz S, 2002, J BIOMECH, V35, P995, DOI 10.1016/S0021-9290(02)00039-8; Habelitz S, NATURAL PROCESS BIOM, P13; Hebling J, 2005, J DENT RES, V84, P741, DOI 10.1177/154405910508400811; Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036; Kim DS, 2012, SCANNING, V34, P151, DOI 10.1002/sca.20291; Kim DS, 2011, J DENT, V39, P855, DOI 10.1016/j.jdent.2011.09.010; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; Montagner AF, 2014, J DENT RES, V93, P733, DOI 10.1177/0022034514538046; Niu LN, 2017, NAT MATER, V16, P370, DOI [10.1038/NMAT4789, 10.1038/nmat4789]; Nudelman F, 2013, J STRUCT BIOL, V183, P258, DOI 10.1016/j.jsb.2013.04.003; Nurrohman H, J MAT RES, V31, P321; Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025; Olszta MJ, 2003, CALCIFIED TISSUE INT, V72, P583, DOI 10.1007/s00223-002-1032-7; Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306; Saito T, 1998, J BONE MINER RES, V13, P265, DOI 10.1359/jbmr.1998.13.2.265; Sauro S, 2015, DENT MATER, V31, P759, DOI 10.1016/j.dental.2015.03.013; Scaffa PMC, 2012, J DENT RES, V91, P420, DOI 10.1177/0022034511435329; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001	32	9	9	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188277	10.1371/journal.pone.0188277	http://dx.doi.org/10.1371/journal.pone.0188277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182665	Green Published, gold			2022-12-26	WOS:000416402000019
J	Mangat, R; Borthwick, F; Haase, T; Jacome, M; Nelson, R; Kontush, A; Vine, DF; Proctor, SD				Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Kontush, Anatol; Vine, Donna F.; Proctor, Spencer D.			Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin	FASEB JOURNAL			English	Article						niacin/nicotinic acid; lipid metabolism; ApoB48; chylomicrons; lipoproteins	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; ACTIVATED RECEPTOR-ALPHA; ESTER TRANSFER PROTEIN; REVERSE CHOLESTEROL TRANSPORT; ISCHEMIC-HEART-DISEASE; POSTPRANDIAL DYSLIPIDEMIA; REMNANT CHOLESTEROL; GENE-EXPRESSION; INCREASES HDL	The intestine is involved in whole-body lipid and cholesterol homeostasis and secretes lipoproteins containing apolipoprotein(Apo) B48 and discrete ApoA-I into the mesenteric lymph. The lymphatic system has been proposed to have a significant role in the reverse cholesterol transport pathway associated with HDL-ApoA-I. In conditions of insulin resistance (IR), there is intestinal overproduction of chylomicrons containing ApoB48; however, there is limited data on the intestinal synthesis and secretion of HDL-ApoA-I. microRNA (miR)-223 has been shown to regulate peripheral HDL metabolism and may impact intestinal-derived HDL. Niacin (nicotinic acid; vitamin B3) is known to regulate lipid metabolism, but the role of niacin in modulating intestinal lipid and lipoprotein (ApoB48 and ApoA-I) metabolism is unknown. The aim of this study was to determine the secretion of intestinal lymphatic HDL-ApoA-I and the effect of dietary intervention with niacin on these pathways in a rodent model of IR. HDL was isolated from intestinal mesenteric lymph by density ultracentrifugation, and subsequent HDL miR analysis was developed in collaboration with Exiqon Services. Insulin-resistant rodents were fed chow or chow with niacin (1% w/w) for 6wk. Intestinal lymph HDL-ApoA-I and miR-223 expression were lower by at least 45 and 60%, respectively, and lymph HDL was associated with 85% higher triglyceride (TG) content in IR compared to non-IR control group. Niacin was found to increase secretion of lymph HDL and miR-223 by at least 50-60% and to deplete the TGs associated with HDL compared with the nontreated IR group. Niacin significantly increased peroxisome proliferator-activating nuclear receptor a and carnitine palmitoyltransferase I a mRNA and annulled Tnf-alpha mRNA expression in intestinal (jejunal) explants. Altered intestinal lymphatic HDL-ApoA-I and miR-223 metabolism in IR and modulation by niacin may provide insight into the intestinal-mediated regulation of the reverse cholesterol transport pathway.	[Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Grp Mol Cell Biol Lipids, Metab & Cardiovasc Dis Lab, Edmonton, AB, Canada; [Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Kontush, Anatol] Univ Paris 06, Salpetriere Univ Hosp, Natl Inst Hlth & Med Res, Paris, France	University of Alberta; University of Alberta; University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Proctor, SD (corresponding author), Univ Alberta, Metab & Cardiovasc Dis Lab, Alberta Diabet & Mazankowski Heart Inst, Grp Mol Cell Biol Lipids,J Li Ka Shing Ctr Hlth I, Edmonton, AB T6G 2P5, Canada.	spencer.proctor@ualberta.ca			investigator-initiated studies grant - Merck; University of Alberta Vitamin Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant	investigator-initiated studies grant - Merck; University of Alberta Vitamin Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Sandra Kelly, Sharon Sokolik, and Kendra Chow (University of Alberta) for their excellent technical assistance in the study. This work was supported, in part, by an investigator-initiated studies grant sponsored by Merck (to S.D.P.). Seed funds were also provided by a University of Alberta Vitamin Fund (to D.F.V.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to S.D.P. and D.F.V.). The authors declare no conflicts of interest.	Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Avramoglu RK, 2003, FRONT BIOSCI, V8, pD464, DOI 10.2741/1022; BISGAIER CL, 1983, ANNU REV PHYSIOL, V45, P625, DOI 10.1146/annurev.ph.45.030183.003205; Blenkiron C, 2014, ANN SURG, V260, P341, DOI 10.1097/SLA.0000000000000447; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; Borthwick F, 2014, ATHEROSCLEROSIS, V232, P141, DOI 10.1016/j.atherosclerosis.2013.10.031; Brunham LR, 2015, PROG LIPID RES, V58, P14, DOI 10.1016/j.plipres.2015.01.001; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; CHUNG BH, 1980, J LIPID RES, V21, P284; Colin S, 2013, EUR HEART J, V34, P2566, DOI 10.1093/eurheartj/ehs227; Dash S, 2015, ANNU REV NUTR, V35, P265, DOI 10.1146/annurev-nutr-071714-034338; FORESTER GP, 1983, J BIOL CHEM, V258, P5938; GLICKMAN RM, 1977, P NATL ACAD SCI USA, V74, P2569, DOI 10.1073/pnas.74.6.2569; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Haas MJ, 2003, BBA-GEN SUBJECTS, V1623, P120, DOI 10.1016/j.bbagen.2003.08.004; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; Hogue JC, 2007, J LIPID RES, V48, P1336, DOI 10.1194/jlr.M600548-JLR200; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Huang LH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00182; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Hutchins PM, 2015, CURR OPIN LIPIDOL, V26, P388, DOI 10.1097/MOL.0000000000000209; Iqbal J, 2014, J LIPID RES, V55, P2261, DOI 10.1194/jlr.M047951; Jacome-Sosa MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-60; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lu J, 2011, BRIT J NUTR, V105, P1572, DOI 10.1017/S0007114510005453; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mooradian AD, 2004, DIABETES, V53, P513, DOI 10.2337/diabetes.53.3.513; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Pang J, 2012, CURR OPIN LIPIDOL, V23, P303, DOI 10.1097/MOL.0b013e328354c790; Pont F, 2002, INT J OBESITY, V26, P1151, DOI 10.1038/sj.ijo.0802070; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; SHIAU YF, 1985, AM J PHYSIOL, V248, pG164, DOI 10.1152/ajpgi.1985.248.2.G164; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Siripurkpong P, 2009, J NUTR BIOCHEM, V20, P261, DOI 10.1016/j.jnutbio.2008.02.010; Smith D, 1997, ANN CLIN BIOCHEM, V34, P185, DOI 10.1177/000456329703400210; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; Varbo A, 2014, PHARMACOL THERAPEUT, V141, P358, DOI 10.1016/j.pharmthera.2013.11.008; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vine DF, 2007, ATHEROSCLEROSIS, V190, P282, DOI 10.1016/j.atherosclerosis.2006.03.013; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; Wang Y, 2012, MOL NUTR FOOD RES, V56, P1234, DOI 10.1002/mnfr.201100517; Wang Y, 2009, J NUTR, V139, P2049, DOI 10.3945/jn.109.109488; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Xiao CT, 2012, BBA-MOL CELL BIOL L, V1821, P736, DOI 10.1016/j.bbalip.2011.09.019; Yuana Y, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23262; Zhang LH, 2012, J LIPID RES, V53, P941, DOI 10.1194/jlr.M020917; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	58	3	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1602	1612		10.1096/fj.201600298RR	http://dx.doi.org/10.1096/fj.201600298RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29183962				2022-12-26	WOS:000427246000038
J	Flynn, JD; McGlinchey, RP; Walker, RL; Lee, JC				Flynn, Jessica D.; McGlinchey, Ryan P.; Walker, Robert L., III; Lee, Jennifer C.			Structural features of alpha-synuclein amyloid fibrils revealed by Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; PARKINSONS-DISEASE; SECONDARY STRUCTURE; IN-VITRO; THIOFLAVINE-T; MUTANT FORMS; A-SYNUCLEIN; AGGREGATION; MUTATION; INSIGHTS	Parkinson's disease (PD) is associated with the formation of alpha-synuclein amyloid fibrils. Elucidating the role of these beta-sheet-rich fibrils in disease progression is crucial; however, collecting detailed structural information on amyloids is inherently difficult because of their insoluble, non-crystalline, and polymorphic nature. Here, we show that Raman spectroscopy is a facile technique for characterizing structural features of alpha-synuclein fibrils. Combining Raman spectroscopy with aggregation kinetics and transmission electron microscopy, we examined the effects of pH and ionic strength as well as four PD-related mutations (A30P, E46K, G51D, and A53T) on alpha-synuclein fibrils. Raman spectral differences were observed in the amide-I, amide-III, and fingerprint regions, indicating that secondary structure and tertiary contacts are influenced by pH and to a lesser extent by NaCl. Faster aggregation times appear to facilitate unique fibril structure as determined by the highly reproducible amide-I band widths, linking aggregation propensity and fibril polymorphism. Importantly, Raman spectroscopy revealed molecular-level perturbations of fibril conformation by the PD-related mutations that are not apparent through transmission electron microscopy or limited proteolysis. The amide-III band was found to be particularly sensitive, with G51D exhibiting the most distinctive features, followed by A53T and E46K. Relating to a cellular environment, our data would suggest that fibril polymorphs can be formed in different cellular compartments and potentially result in distinct phenotypes. Our work sets a foundation toward future cellular Raman studies of amyloids.	[Flynn, Jessica D.; McGlinchey, Ryan P.; Walker, Robert L., III; Lee, Jennifer C.] NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, JC (corresponding author), NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	Flynn, Jessica/G-1693-2017; Lee, Jennifer/E-9658-2015	Flynn, Jessica/0000-0002-9310-4882; Lee, Jennifer/0000-0003-0506-8349	National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006236] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Carey PR, 2006, ANNU REV PHYS CHEM, V57, P527, DOI 10.1146/annurev.physchem.57.032905.104521; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kurouski D, 2015, ANALYST, V140, P4967, DOI 10.1039/c5an00342c; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Louros NN, 2017, J STRUCT BIOL, V199, P140, DOI 10.1016/j.jsb.2017.06.002; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; McColl LH, 2003, J AM CHEM SOC, V125, P10019, DOI 10.1021/ja021464v; McGlinchey RP, 2017, BIOCHEMISTRY-US, V56, P3881, DOI 10.1021/acs.biochem.7b00360; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Mensch C, 2017, J RAMAN SPECTROSC, V48, P910, DOI 10.1002/jrs.5149; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petrucci S, 2016, PARKINSONISM RELAT D, V22, pS16, DOI 10.1016/j.parkreldis.2015.08.015; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ranjan P, 2017, ACS CHEM NEUROSCI, V8, P2235, DOI 10.1021/acschemneuro.7b00149; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rygula A, 2013, J RAMAN SPECTROSC, V44, P1061, DOI 10.1002/jrs.4335; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Stefanis L, 2014, COLD SPRING HARB PER, V4, P1; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105	53	54	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					767	776		10.1074/jbc.M117.812388	http://dx.doi.org/10.1074/jbc.M117.812388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191831	hybrid, Green Published			2022-12-26	WOS:000422864500002
J	Bhide, GP; Zapater, JL; Colley, KJ				Bhide, Gaurang P.; Zapater, Joseph L.; Colley, Karen J.			Autopolysialylation of polysialyltransferases is required for polysialylation and polysialic acid chain elongation on select glycoprotein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural cell adhesion molecule; neuropilin-2; polysialic acid; polysialyltransferase; synaptic cell adhesion molecule; sialic acid; sialyltransferase; glycoprotein biosynthesis; glycosylation; glycosyltransferase	CELL-ADHESION MOLECULE; SWISS-MODEL; ST8SIA IV; N-CAM; AMINO-ACIDS; SYNCAM 1; PROTEIN; NEUROPILIN-2; BIOSYNTHESIS; SEQUENCES	Polysialic acid (polySia) is a large glycan polymer that is added to some glycoproteins by two polysialyltransferases (polySTs), ST8Sia-II and ST8Sia-IV. As polySia modulates cell adhesion and signaling, immune cell function, and tumor metastasis, it is of interest to determine how the polySTs recognize their select substrates. We have recently identified residues within the ST8Sia-IV polybasic region (PBR) that are required for neural cell adhesion molecule (NCAM) recognition and subsequent polysialylation. Here, we compared the PBR sequence requirements for NCAM, neuropilin-2 (NRP-2), and synaptic cell adhesion molecule 1 (SynCAM 1) for polysialylation by their respective polySTs. We found that the polySTs use unique but overlapping sets of PBR residues for substrate recognition, that the NCAM-recognizing PBR sites in ST8Sia-II and ST8Sia-IV include homologous residues, but that the ST8Sia-II site is larger, and that fewer PBR residues are involved in NRP-2 and SynCAM 1 recognition than in NCAM recognition. Noting that the two sites for ST8Sia-IV autopolysialylation flank the PBR, we evaluated the role of PBR residues in autopolysialylation and found that the requirements for polyST autopolysialylation and substrate polysialylation overlap. These data together with the evaluation of the polyST autopolysialylation mechanism enabled us to further identify PBR residues potentially playing dual roles in substrate recognition and in polySia chain polymerization. Finally, we found that ST8Sia-IV autopolysialylation is required for NRP-2 polysialylation and that ST8Sia-II autopolysialylation promotes the polymerization of longer polySia chains on SynCAM 1, suggesting a critical role for polyST autopolysialylation in substrate selection and polySia chain elongation.	[Bhide, Gaurang P.; Zapater, Joseph L.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA; [Zapater, Joseph L.] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu		Bhide, Gaurang/0000-0002-6120-3747	National Institutes of Health [RO1 GM101949]; NIGMS [F31 GM096739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM096739, R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM101949 (to K. J. C.) and NIGMS Fellowship F31 GM096739 (to J. L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhide GP, 2017, BIOCHEMISTRY-US, V56, P1504, DOI 10.1021/acs.biochem.6b01221; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Bhide GP, 2016, J BIOL CHEM, V291, P9444, DOI 10.1074/jbc.M116.714329; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brenachot X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00245; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Galuska CE, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6020027; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang RB, 2017, CURR TOP MED CHEM, V17, P2359, DOI 10.2174/1568026617666170414150730; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiermaier E, 2016, SCIENCE, V351, P186, DOI 10.1126/science.aad0512; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Rollenhagen M, 2012, J BIOL CHEM, V287, P35170, DOI 10.1074/jbc.M112.375642; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Toikka J, 1998, J BIOL CHEM, V273, P28557, DOI 10.1074/jbc.273.44.28557; Volkers G, 2015, NAT STRUCT MOL BIOL, V22, P627, DOI 10.1038/nsmb.3060; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Werneburg S, 2016, GLIA, V64, P1314, DOI 10.1002/glia.23004; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; Zhou GP, 2015, PROTEIN PEPTIDE LETT, V22, P137, DOI 10.2174/0929866521666141019192221; ZUBER C, 1992, J BIOL CHEM, V267, P9965	46	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					701	716		10.1074/jbc.RA117.000401	http://dx.doi.org/10.1074/jbc.RA117.000401			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183999	hybrid, Green Published			2022-12-26	WOS:000419915400024
J	Langrand-Escure, J; Rivoirard, R; Oriol, M; Tinquaut, F; Rancoule, C; Chauvin, F; Magne, N; Bourmaud, A				Langrand-Escure, Julien; Rivoirard, Romain; Oriol, Mathieu; Tinquaut, Fabien; Rancoule, Chloe; Chauvin, Frank; Magne, Nicolas; Bourmaud, Aurelie			Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review	PLOS ONE			English	Review							CLINICAL-TRIALS; END-POINTS; TASK-FORCE; CANCER; DESIGN; RECOMMENDATIONS; SUCCESS; ISSUES	Background Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation. Surprisingly the attrition ratio in Phase III trials in oncology is significantly higher than in any other medical specialty. This suggests phase II trials in oncology fail to achieve their goal. Objective The present study aims at estimating the quality of reporting in published oncology phase II clinical trials. Data sources A literature review was conducted among all phase II and phase II/III clinical trials published during a 5-year period (2010-2015). Study eligibility criteria All articles electronically published by three randomly-selected oncology journals with Impact-Factors>4 were included: Journal of Clinical Oncology, Annals of Oncology and British Journal of Cancer. Intervention Quality of reporting was assessed using the Key Methodological Score. Results 557 articles were included. 315 trials were single-arm studies (56.6%), 193 (34.6%) were randomized and 49 (8.8%) were non-randomized multiple-arm studies. The Methodological Score was equal to 0 (lowest level), 1, 2, 3 (highest level) respectively for 22 (3.9%), 119 (21.4%), 270 (48.5%) and 146 (26.2%) articles. The primary end point is almost systematically reported (90.5%), while sample size calculation is missing in 66% of the articles. 3 variables were independently associated with reporting of a high standard: presence of statistical design (p-value < 0.001), multicenter trial (p-value = 0.012), per-protocol analysis (p-value < 0.001). Limitations Screening was mainly performed by a sole author. The Key Methodological Score was based on only 3 items, making grey zones difficult to translate. Conclusions & implications of key findings This literature review highlights the existence of gaps concerning the quality of reporting. It therefore raised the question of the suitability of the methodology as well as the quality of these trials, reporting being incomplete in the corresponding articles.	[Langrand-Escure, Julien; Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Frank; Bourmaud, Aurelie] Lucien Neuwirth Canc Inst, Publ Hlth Dept, Ctr Hygee, St Priest En Jarez, France; [Langrand-Escure, Julien; Rancoule, Chloe; Magne, Nicolas] Lucien Neuwirth Canc Inst, Radiotherapy Dept, St Priest En Jarez, France; [Rivoirard, Romain] Lucien Neuwirth Canc Inst, Oncol Dept, St Priest En Jarez, France; [Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Frank; Bourmaud, Aurelie] INSERM 1408 CIC EC, St Etienne, France; [Chauvin, Frank; Bourmaud, Aurelie] Lyon 1 Univ, HESPER 7425, EA Hlth Serv Performance Res, Lyon, France	Institut de Cancerologie de la Loire; Institut de Cancerologie de la Loire; Institut de Cancerologie de la Loire; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourmaud, A (corresponding author), Lucien Neuwirth Canc Inst, Publ Hlth Dept, Ctr Hygee, St Priest En Jarez, France.; Bourmaud, A (corresponding author), INSERM 1408 CIC EC, St Etienne, France.; Bourmaud, A (corresponding author), Lyon 1 Univ, HESPER 7425, EA Hlth Serv Performance Res, Lyon, France.	Aurelie.bourmaud@icloire.fr		Bourmaud, Aurelie/0000-0002-2228-6471				Adjei AA, 2009, CLIN CANCER RES, V15, P1866, DOI 10.1158/1078-0432.CCR-08-2035; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Booth CM, 2008, EUR J CANCER, V44, P25, DOI 10.1016/j.ejca.2007.07.031; Brown SR, 2011, BRIT J CANCER, V105, P194, DOI 10.1038/bjc.2011.235; Cannistra SA, 2009, J CLIN ONCOL, V27, P3073, DOI 10.1200/JCO.2009.23.1811; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913; Grellety T, 2014, ANN ONCOL, V25, P536, DOI 10.1093/annonc/mdt550; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramar A, 1996, BRIT J CANCER, V74, P1317, DOI 10.1038/bjc.1996.537; Lee JJ, 2005, J CLIN ONCOL, V23, P4450, DOI 10.1200/JCO.2005.03.197; Mariani L, 2000, J CLIN ONCOL, V18, P429, DOI 10.1200/JCO.2000.18.2.429; Mathoulin-Pelissier C, METHODES BIOSTATISTI; Medioni JR, 2000, B CANCER, V87, P551; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Nickolich M, 2014, CLIN LUNG CANCER, V15, P207, DOI 10.1016/j.cllc.2013.12.001; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P44, DOI 10.1007/s00262-004-0567-z; Parulekar WR, 2002, ANN ONCOL, V13, P139, DOI 10.1093/annonc/mdf651; Penel N, 2010, B CANCER, V97, P55, DOI 10.1684/bdc.2010.1016; Perrone F, 2003, LANCET ONCOL, V4, P305, DOI 10.1016/S1470-2045(03)01078-7; Piedbois P, 2007, B CANCER, V94, P953; Ratain MJ, 2008, EUR J CANCER, V44, P8, DOI 10.1016/j.ejca.2007.09.011; Ratain MJ, 2009, EUR J CANCER, V45, P275, DOI 10.1016/j.ejca.2008.10.029; Riechelmann R, 2008, J CLIN ONCOL; Rubinstein LV, 2005, J CLIN ONCOL, V23, P7199, DOI 10.1200/JCO.2005.01.149; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Seymour L, 2010, CLIN CANCER RES, V16, P1764, DOI 10.1158/1078-0432.CCR-09-3287; Thezenas S, 2004, EUR J CANCER, V40, P1244, DOI 10.1016/j.ejca.2004.01.008; Tuma RS, 2008, J NATL CANCER I, V100, P164, DOI 10.1093/jnci/djn006; Walter T, 2012, NEUROENDOCRINOLOGY, V96, P238, DOI 10.1159/000337662	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0185536	10.1371/journal.pone.0185536	http://dx.doi.org/10.1371/journal.pone.0185536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216190	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800002
J	Flick, RJ; Munthali, A; Simon, K; Hosseinipour, M; Kim, MH; Mlauzi, L; Kazembe, PN; Ahmed, S				Flick, Robert J.; Munthali, Adamson; Simon, Katherine; Hosseinipour, Mina; Kim, Maria H.; Mlauzi, Lameck; Kazembe, Peter N.; Ahmed, Saeed			Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-ASSOCIATED TUBERCULOSIS; SETTINGS; EPIDEMIC; OUTBREAK; THERAPY; AFRICA; RISK	Transmission of Mycobacterium tuberculosis (TB) in health settings threatens health care workers and people living with HIV in sub-Saharan Africa. Nosocomial transmission is reduced with implementation of infection control (IC) guidelines. The objective of this study is to describe implementation of TB IC measures in Malawi. We conducted a cross-sectional study utilizing anonymous health worker questionnaires, semi-structured interviews with facility managers, and direct observations at 17 facilities in central Malawi. Of 592 health care workers surveyed, 34% reported that all patients entering the facility were screened for cough and only 8% correctly named the four most common signs and symptoms of TB in adults. Of 33 managers interviewed, 7 (21%) and 1 (3%) provided the correct TB screening questions for use in adults and children, respectively. Of 592 health workers, only 2.4% had been screened for TB in the previous year. Most (90%) reported knowing their HIV status, 53% were tested at their facility of employment, and half reported they would feel comfortable receiving ART or TB treatment at their facility of employment. We conclude that screening is infrequently conducted and knowledge gaps may undercut its effectiveness. Further, health care workers do not routinely access TB and HIV diagnostic and treatment services at their facility of employment.	[Flick, Robert J.; Munthali, Adamson; Simon, Katherine; Kim, Maria H.; Kazembe, Peter N.; Ahmed, Saeed] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Flick, Robert J.; Hosseinipour, Mina] Univ North Carolina Project Malawi, Lilongwe, Malawi; [Flick, Robert J.] Univ Colorado, Sch Med, Denver, CO USA; [Simon, Katherine; Kim, Maria H.; Kazembe, Peter N.; Ahmed, Saeed] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Texas Childrens Hosp, Houston, TX 77030 USA; [Hosseinipour, Mina] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Mlauzi, Lameck] Malawi Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi	Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ahmed, S (corresponding author), Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi.; Ahmed, S (corresponding author), Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Texas Childrens Hosp, Houston, TX 77030 USA.	sahmed@tingathe.org		Flick, Robert/0000-0002-8155-6398	United States Agency for International Development [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA) [K01 TW009644]; Doris Duke Charitable Foundation (New York, NY, USA); NIH - Fogarty International Center [R25 TW009340]; USAID [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health [K01 TW009644]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA); Doris Duke Charitable Foundation (New York, NY, USA)(Doris Duke Charitable Foundation (DDCF)); NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); USAID(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was made possible by the Tingathe Program supported by the United States Agency for International Development cooperative agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA) under award number K01 TW009644. RF was supported by the Doris Duke Charitable Foundation (New York, NY, USA) and NIH Research Training Grant number R25 TW009340 funded by the Fogarty International Center.; This publication was made possible by support from USAID cooperative agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health under award number K01 TW009644. RF was supported by the Doris Duke Charitable Foundation (New York, NY, USA) and NIH Research Training Grant number R25 TW009340 funded by the Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of the funders, including the National Institutes of Health, USAID and the United States Government. This study was presented in part at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada and was awarded the IAS TB/HIV Research Prize.	Ahmed S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19305; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Atukunda R., 2013, GLOBAL J MED PUBLIC, V2, P1; Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Daley CL, 1992, NEW ENGL J MED, P326; DIPERRI G, 1989, LANCET, V2, P1502; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Eyob G, 2002, INT J TUBERC LUNG D, V6, P85; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Government of Malawi Ministry of Health, 2009, GUID LIN INF PREV CO; Government of Malawi Ministry of Health, MAL HLTH INF MAN SYS; Government of Malawi Ministry of Health UNICEF UNFPA World Health Organization AMDD, 2010, MASL 20110 EMONC NEE; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P526; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Kanyerere HS, 2003, INT J TUBERC LUNG D, V7, P489; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kim MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072421; Kranzer K, 2010, SAMJ S AFR MED J, V100, P224, DOI 10.7196/SAMJ.3903; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Malawi Ministry of Health Department of HIV & AIDS, 2015, INT HIV PROGR REP OC; Malawi National Statistical Office, 2014, 2014 MAL POP; MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002; Namakhoma I, 2010, AIDS CARE, V22, P68, DOI 10.1080/09540121003607241; Nardell EA, 2016, INDOOR AIR, V26, P79, DOI 10.1111/ina.12232; SEPKOWITZ KA, 1994, ANN INTERN MED, V120, P71, DOI 10.7326/0003-4819-120-1-199401010-00012; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; UNAIDS, 2013, GLOBAL REPORT UNAIDS; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2015, GLOB TUB REP 2015; ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189140	10.1371/journal.pone.0189140	http://dx.doi.org/10.1371/journal.pone.0189140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211793	gold, Green Submitted, Green Published			2022-12-26	WOS:000417212200068
J	Ghith, N; Frolich, A; Merlo, J				Ghith, Nermin; Frolich, Anne; Merlo, Juan			The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; CARE; SURVIVAL; RATES; HOSPITALIZATION; PERFORMANCE; SWEDEN; RISK; READMISSION	Purpose To evaluate the general contextual effect (GCE) of the hospital department on one-year mortality in Swedish and Danish patients with heart failure (HF) by applying a multilevel analysis of individual heterogeneity. Methods Using the Swedish patient register, we obtained data on 36,943 patients who were 45-80 years old and admitted for HF to the hospital between 2007 and 2009. From the Danish Heart Failure Database (DHFD), we obtained data on 12,001 patients with incident HF who were 18 years or older and treated at hospitals between June 2010 and June2013. For each year, we applied two-step single and multilevel logistic regression models. We evaluated the general effects of the department by quantifying the intra-class correlation coefficient (ICC) and the increment in the area under the receiver operating characteristic curve (AUC) obtained by adding the random effects of the department in a multilevel logistic regression analysis. Results One-year mortality for Danish incident HF patients was low in the three audit years (around 11.1% - 13.1%) and departments performed homogeneously (ICC approximate to 1.5% -3.5%). The discriminatory accuracy of a model including age and gender was rather high (AUC approximate to 0.71-0.73) but the increment in AUC after adding the department random effects into these models was only about 0.011-0.022 units in the three years. One-year mortality in Swedish patients with first hospitalization for heart failure, was relatively higher for 2007-2009 (approximate to 21.3% -22%) and departments performed homogeneously ICC approximate to 1.5% - 3%). The discriminatory accuracy of a model including age, gender and patient risk score was rather high (AUC approximate to 0.726-0.728) but the increment in AUC after adding the department random effects was only about 0.010-0.017 units in the three years. Conclusion Using the DHFD standard benchmark for one-year mortality, Danish departments had a good, homogeneous performance. In reference to literature, Swedish departments had a homogeneous performance and the mortality rates for patients with first hospitalization for heart failure were similar to those reported since 2000. Considering this, if health authorities decide to further reduce mortality rates, a comprehensive quality strategy should focus on all Swedish hospitals. Yet, a complementary assessment for the period after the study period is required to confirm whether department performance is still homogeneous or not to determine the most appropriate action.	[Ghith, Nermin; Frolich, Anne] Bispebjerg & Frederiksberg Univ Hosp, Dept Clin Epidemiol, Res Unit Chron Condit, Copenhagen, Denmark; [Ghith, Nermin; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden	University of Copenhagen; Bispebjerg Hospital; Lund University	Ghith, N (corresponding author), Bispebjerg & Frederiksberg Univ Hosp, Dept Clin Epidemiol, Res Unit Chron Condit, Copenhagen, Denmark.; Ghith, N (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.	nermin_m.ghith@med.lu.se	Ghith, Nermin/B-3163-2013; Merlo, Juan/E-2136-2011	Ghith, Nermin/0000-0002-5863-5442; Merlo, Juan/0000-0001-8379-9708	University of Copenhagen; Association of Hospitals in Copenhagen; Swedish Research Council (VR) [2013-2484]	University of Copenhagen; Association of Hospitals in Copenhagen; Swedish Research Council (VR)(Swedish Research Council)	This work was supported by grants from the University of Copenhagen and the Association of Hospitals in Copenhagen for Nermin Ghith as a PHD candidate and by the Swedish Research Council (VR) [#2013-2484, Juan Merlo]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arah OA, 2006, INT J QUAL HEALTH C, V18, P5, DOI 10.1093/intqhc/mzl024; Ash AS, 2012, STAT ISSUES ASSESSIN; Austin PC, 2016, MEDIAN HAZARD RATIO; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Browne WJ., 2013, MCMC ESTIMATIN MLWIN; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Ding VY, 2013, HEALTH SERV OUTCOME, V13, P1, DOI 10.1007/s10742-012-0099-5; Diya L, 2014, J R STAT SOC A STAT, V177, P237, DOI 10.1111/rssa.12012; Elliott MN, 2005, ANAL CASE MIX STRATE; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Ghith N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148187; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Hayes AF, 2006, HUM COMMUN RES, V32, P385, DOI 10.1111/j.1468-2958.2006.00281.x; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Mehta HB, 2016, J SURG RES, V204, P326, DOI 10.1016/j.jss.2016.05.008; Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P323, DOI 10.1136/jech.55.5.323; Merlo J, 2001, LAKARTIDNINGEN, V98, P4838; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Nakano A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-391; Nezlek JB, 2008, SOC PERSONAL PSYCHOL, V2, P842, DOI 10.1111/j.1751-9004.2007.00059.x; Normand SLT, 2016, ANNU REV STAT APPL, V3, P21, DOI 10.1146/annurev-statistics-022513-115617; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; O'Brien SM, 2016, CIRC-CARDIOVASC QUAL, V9, P560, DOI 10.1161/CIRCOUTCOMES.116.002756; OECD, 2013, OECD REV HLTH CAR QU; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rasbash J, 2013, MLWIN 2; Rasbash J, 2015, USERS GUIDE MLWIN; Romano P. S., 2010, SELECTING QUALITY RE; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Schjodt I, 2016, CLIN EPIDEMIOL, V8, P497, DOI 10.2147/CLEP.S99504; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thorvaldsen T, 2016, EUR J HEART FAIL, V18, P503, DOI 10.1002/ejhf.496; Urbanoski KA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-63; Wagner P, 2015, INT J EPIDEMIOL, V44, P49; Wagner P, 2014, 20 IEA WORLD C EP 17	53	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189050	10.1371/journal.pone.0189050	http://dx.doi.org/10.1371/journal.pone.0189050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211785	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200059
J	Lin, C; Fesi, BD; Marquis, M; Bosak, NP; Lysenko, A; Koshnevisan, MA; Duke, FF; Theodorides, ML; Nelson, TM; McDaniel, AH; Avigdor, M; Arayata, CJ; Shaw, L; Bachmanov, AA; Reed, DR				Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Lysenko, Anna; Koshnevisan, Mohammed Amin; Duke, Fujiko F.; Theodorides, Maria L.; Nelson, Theodore M.; McDaniel, Amanda H.; Avigdor, Mauricio; Arayata, Charles J.; Shaw, Lauren; Bachmanov, Alexander A.; Reed, Danielle R.			Adiposity QTL Adip20 decomposes into at least four loci when dissected using congenic strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-FAT DISTRIBUTION; OBESITY QTLS; CANDIDATE GENE; DIETARY OBESITY; MOUSE STRAINS; F-2 INTERCROSS; KNOCKOUT MICE; INBRED MICE; GENOME-WIDE	An average mouse in midlife weighs between 25 and 30 g, with about a gram of tissue in the largest adipose depot (gonadal), and the weight of this depot differs between inbred strains. Specifically, C57BL/6ByJ mice have heavier gonadal depots on average than do 129P3/J mice. To understand the genetic contributions to this trait, we mapped several quantitative trait loci (QTLs) for gonadal depot weight in an F-2 intercross population. Our goal here was to fine-map one of these QTLs, Adip20 (formerly Adip5), on mouse chromosome 9. To that end, we analyzed the weight of the gonadal adipose depot from newly created congenic strains. Results from the sequential comparison method indicated at least four rather than one QTL; two of the QTLs were less than 0.5 Mb apart, with opposing directions of allelic effect. Different types of evidence (missense and regulatory genetic variation, human adiposity/body mass index orthologues, and differential gene expression) implicated numerous candidate genes from the four QTL regions. These results highlight the value of mouse congenic strains and the value of this sequential method to dissect challenging genetic architecture.	[Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Lysenko, Anna; Koshnevisan, Mohammed Amin; Duke, Fujiko F.; Theodorides, Maria L.; Nelson, Theodore M.; McDaniel, Amanda H.; Avigdor, Mauricio; Arayata, Charles J.; Shaw, Lauren; Bachmanov, Alexander A.; Reed, Danielle R.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Lin, Cailu/E-5316-2011; Bachmanov, Alexander A./AAH-8857-2020	Lin, Cailu/0000-0001-8909-7758; Bachmanov, Alexander A./0000-0002-2861-3322	National Institutes of Health [R01 DK094759, R01 DK058797, P30 DC011735, OD018125, RR025607, RR026752, G20 OD020296]; institutional funds from the Monell Chemical Senses Center; National Institutes of Health provided genotyping services	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional funds from the Monell Chemical Senses Center; National Institutes of Health provided genotyping services	The National Institutes of Health grants R01 DK094759, R01 DK058797, P30 DC011735, OD018125, RR025607, RR026752, G20 OD020296 and institutional funds from the Monell Chemical Senses Center funded this work including genotyping and the purchase of equipment. The Center for Inherited Disease Research through the auspices of the National Institutes of Health provided genotyping services.	[Anonymous], 2015, MUS MUSC LAB MOUS GE; [Anonymous], 2015, SIFT WEB SERVER PRED; [Anonymous], 2016, DBSNP SINGLE NUCLEOT; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Brockmann GA, 1998, GENETICS, V150, P369; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Cheverud JM, 1996, GENETICS, V142, P1305; Cinti S, 1999, ADIPOSE ORGAN; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; de Ledesma AMR, 2006, MAMM GENOME, V17, P111, DOI 10.1007/s00335-005-0107-y; Delignette-Muller ML., 2014, FITDISTRPLUS HELP FI; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DIETRICH W, 1992, GENETICS, V131, P423; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; EISEN EJ, 1990, J ANIM SCI, V68, P3557; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Farber CR, 2007, GENETICS, V175, P349, DOI 10.1534/genetics.106.063693; Fesi B, 2013, KROC LECT S U PENNS; Fontenla M., OPTREES OPTIMAL TREE; Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; GWAS Catalog, 2015, GWAS CAT NHGRI EBI C; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Hayakawa T, 2001, COLOR ATLAS SECTIONA; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Ishikawa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170652; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jerez-Timaure NC, 2004, OBES RES, V12, P1408, DOI 10.1038/oby.2004.177; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keightley PD, 1998, GENETICS, V148, P1931; Keightley PD, 1998, HEREDITY, V81, P630, DOI 10.1046/j.1365-2540.1998.00450.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; McDaniel AH, 2006, MAMM GENOME, V17, P1078, DOI 10.1007/s00335-006-0055-1; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Oey H, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0047-z; Ogino T, 2000, GENOMICS, V70, P19, DOI 10.1006/geno.2000.6349; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Pond C.M., 1998, FATS LIFE; Raab RM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-40; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Reed DR, 2006, MAMM GENOME, V17, P1065, DOI 10.1007/s00335-006-0054-2; Reed DR, 2011, PHYSIOL BEHAV, V103, P523, DOI 10.1016/j.physbeh.2011.04.006; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; SKaI J, 2016, CRAN2016; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Suto J, 1998, MAMM GENOME, V9, P506, DOI 10.1007/s003359900809; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; WEST DB, 1994, MAMM GENOME, V5, P546, DOI 10.1007/BF00354928; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wickham H CW, 2016, CRAN2016; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yick CY, 2013, EUR RESPIR J, V42, P662, DOI 10.1183/09031936.00115412; York B, 1997, MAMM GENOME, V8, P726, DOI 10.1007/s003359900554; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao W, 2004, PHYSIOL GENOMICS, V19, P218, DOI 10.1152/physiolgenomics.00129.2004; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325	88	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188972	10.1371/journal.pone.0188972	http://dx.doi.org/10.1371/journal.pone.0188972			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194435	Green Submitted, Green Published, gold			2022-12-26	WOS:000416867800017
J	Jo, A; Hoi, H; Zhou, H; Gupta, M; Montemagno, CD				Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Gupta, Manisha; Montemagno, Carlo D.			Single-molecule study of full-length NaChBac by planar lipid bilayer recording	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; PHOSPHOLIPID-VESICLES; FUNCTIONAL-ANALYSIS; MEMBRANE-PROTEINS; RECONSTITUTION	Planar lipid bilayer device, alternatively known as BLM, is a powerful tool to study functional properties of conducting membrane proteins such as ion channels and porins. In this work, we used BLM to study the prokaryotic voltage-gated sodium channel (Nav) NaChBac in a well-defined membrane environment. Navs are an essential component for the generation and propagation of electric signals in excitable cells. The successes in the biochemical, biophysical and crystallographic studies on prokaryotic Navs in recent years has greatly promoted the understanding of the molecular mechanism that underlies these proteins and their eukaryotic counterparts. In this work, we investigated the single-molecule conductance and ionic selectivity behavior of NaChBac. Purified NaChBac protein was first reconstituted into lipid vesicles, which is subsequently incorporated into planar lipid bilayer by fusion. At single-molecule level, we were able to observe three distinct long-lived conductance substates of NaChBac. Change in the membrane potential switches on the channel mainly by increasing its opening probability. In addition, we found that individual NaChBac has similar permeability for Na+, K+, and Ca2+. The single-molecule behavior of the full-length protein is essentially highly stochastic. Our results show that planar lipid bilayer device can be used to study purified ion channels at single-molecule level in an artificial environment, and such studies can reveal new protein properties that are otherwise not observable in in vivo ensemble studies.	[Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Montemagno, Carlo D.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Gupta, Manisha; Montemagno, Carlo D.] Ingenu Lab, Edmonton, AB, Canada; [Gupta, Manisha] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Montemagno, Carlo D.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Montemagno, Carlo D.] Southern Illinois Univ, Carbondale, IL 62901 USA	University of Alberta; University of Alberta; National Research Council Canada; Southern Illinois University System; Southern Illinois University	Hoi, H; Montemagno, CD (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Hoi, H; Montemagno, CD (corresponding author), Ingenu Lab, Edmonton, AB, Canada.; Montemagno, CD (corresponding author), Natl Inst Nanotechnol, Edmonton, AB, Canada.; Montemagno, CD (corresponding author), Southern Illinois Univ, Carbondale, IL 62901 USA.	hiofan@ualberta.ca; chancellor@siu.edu			Alberta Innovates [20090279/PSI14420-2011]; AITF iCORE chairship [16326-2014]	Alberta Innovates; AITF iCORE chairship	This work was funded by Alberta Innovates (Grant # 20090279/PSI14420-2011) and an AITF iCORE chairship to C.D.M (grant #16326-2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; COHEN FS, 1982, SCIENCE, V217, P458, DOI 10.1126/science.6283637; COHEN FS, 1993, METHOD ENZYMOL, V220, P50, DOI 10.1016/0076-6879(93)20073-C; COHEN FS, 1989, J GEN PHYSIOL, V93, P201, DOI 10.1085/jgp.93.2.201; Gutsmann T, 2015, NAT PROTOC, V10, P188, DOI 10.1038/nprot.2015.003; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Kelly ML, 2003, MEMBR SCI T, V7, P699, DOI 10.1016/S0927-5193(03)80049-9; Kuszak AJ, 2015, J BIOL CHEM, V290, P26204, DOI 10.1074/jbc.M115.642173; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li Y, 2015, PROTEIN CELL, V6, P413, DOI 10.1007/s13238-015-0152-6; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MONTAL M, 1981, Q REV BIOPHYS, V14, P1, DOI 10.1017/S0033583500002079; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Patti JT, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325103; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Saha SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131286; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Siontorou CG, 2017, MEMBRANES-BASEL, V7, DOI 10.3390/membranes7030038; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Sula A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14205; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188861	10.1371/journal.pone.0188861	http://dx.doi.org/10.1371/journal.pone.0188861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190805	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900147
J	Panezai, J; Ghaffar, A; Altamash, M; Sundqvist, KG; Engstrom, PE; Larsson, A				Panezai, Jeneen; Ghaffar, Ambereen; Altamash, Mohammad; Sundqvist, Karl-Gosta; Engstrom, Per-Erik; Larsson, Anders			Correlation of serum cytokines, chemokines, growth factors and enzymes with periodontal disease parameters	PLOS ONE			English	Article							HOST-RESPONSE; CELLS; EXPRESSION; NEUROTROPHINS; PATHOGENESIS; MECHANISMS; APOPTOSIS; IMMUNITY; SUBSETS; DOMAIN	Background Periodontal disease (PD) is characterized by inflammatory tissue destruction in tooth supporting apparatus. Many studies indicate that the underlying pathogenesis is in concordance with rheumatoid arthritis (RA) sharing immune-inflammatory events affect both diseases. The aim of this study was to investigate serum cytokines, chemokines, growth factors, enzymes and costimulatory proteins in association with periodontal conditions in PD and RA subjects. Materials & methods Periodontal examination was performed in RA (n = 38), PD (n = 38) and healthy subjects (n = 14). Bleeding on probing (BOP) and probing pocket depth (PPD) were measured. Marginal bone loss (MBL) for premolars and molars was measured on digital panoramic radiographs. PD was defined as present if the PPD was >= 5mm in >= 3 different sites. Serum samples were collected from all subjects. A multiplex proximity extension assay (PEA) was used to analyze the samples for simultaneous measurement of 92 cytokines. Cytokines with >= 60% quantitative results were included. Results A significant positive correlation was seen for ST1A1, FGF-19 and NT-3 whereas EN-RAGE, DNER, CX3CL1 and TWEAK associated inversely with BOP, PPD >= 5mm and MBL but positively with number of teeth. Several CD markers (CD244, CD40, CDCP1, LIF-R, IL-10RA, CD5 and CD6) were found to be associated with BOP, shallow and deep pockets, MBL and number of teeth, either directly or inversely. Most chemokines (CCL8, CX3CL1, CXCL10, CXCL11, CCL11, CCL4, CCL20, CXCL5, CXCL6, and CCL23) were positively associated with number of teeth and some inversely related to MBL (CCL8, CXCL10). Proteins with enzymatic activity (ST1A1, HGF and CASP-8) were directly related to the severity of periodontal conditions and inversely related to number of teeth. Aside from FGF-19, other growth factors were also directly associated with MBL (HGF), number of teeth (VEGF-A, LAP TGF-beta-1) and, inversely to, shallow pockets (LAP TGF-beta-1, TGFA and Beta-NGF). Out of 33 cytokines, 32 associated inversely with shallow pockets, whereas only CD40 associated positively. Associations between cytokines and periodontal parameters in the RA group were comparatively less. Statistical analyses were adjusted for multivariate effects using the Benjamini-Hochberg false discovery rate method. Conclusion Systemic inflammatory burden, via known and novel markers, is associated with periodontal conditions in PD and RA subjects. Shallow pockets are not associated with a higher inflammatory state.	[Panezai, Jeneen; Altamash, Mohammad] Altamash Inst Dent Med, Dept Periodontol, Karachi, Pakistan; [Panezai, Jeneen; Engstrom, Per-Erik] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Ghaffar, Ambereen] Rheumatol Clin, Habib Med Ctr, Karachi, Pakistan; [Sundqvist, Karl-Gosta] Karolinska Univ Hosp, Div Clin Immunol, Dept Lab Med, Stockholm, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Panezai, J (corresponding author), Altamash Inst Dent Med, Dept Periodontol, Karachi, Pakistan.; Panezai, J (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden.	jeneen.panezai@ki.se			Altamash Institute of Dental Medicine	Altamash Institute of Dental Medicine	This research received internal funding from the Altamash Institute of Dental Medicine. The corresponding author Jeneen Panezai received a salary from the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFAR B, 1992, J PERIODONTAL RES, V27, P126, DOI 10.1111/j.1600-0765.1992.tb01814.x; Airila-Mansson S, 2004, ACTA ODONTOL SCAND, V62, P111, DOI 10.1080/00016350410005861; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ANDERSON SG, 1970, B WORLD HEALTH ORGAN, V42, P311; Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; COHEN S, 1974, CELL IMMUNOL, V12, P150, DOI 10.1016/0008-8749(74)90066-5; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Delima AJ, 2002, J INFECT DIS, V186, P511, DOI 10.1086/341778; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; DUMONDE DC, 1969, NATURE, V224, P38, DOI 10.1038/224038a0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Foell D, 2003, RHEUMATOLOGY, V42, P1383, DOI 10.1093/rheumatology/keg385; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V139, P506, DOI 10.1111/j.1365-2249.2005.02675.x; Hughes F J, 1995, Oral Dis, V1, P259; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jauregui CE, 2013, INFECT IMMUN, V81, P2288, DOI 10.1128/IAI.00264-13; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; KASAKURA S, 1965, NATURE, V208, P794, DOI 10.1038/208794a0; Kinane DF, 2011, J CLIN PERIODONTOL, V38, P44, DOI 10.1111/j.1600-051X.2010.01682.x; Krintel SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038539; Kuan WP, 2010, J RHEUMATOL, V37, P257, DOI 10.3899/jrheum.090769; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Lonn J, 2014, J PERIODONTOL, V85, P113, DOI 10.1902/jop.2013.130003; Matteucci E, 2003, ONCOGENE, V22, P4062, DOI 10.1038/sj.onc.1206519; McInnes IB, 2003, ARTHRITIS RES THER, V5, P288, DOI 10.1186/ar1017; Menkin V, 1944, SCIENCE, V100, P337, DOI 10.1126/science.100.2598.337; Mori G, 2009, INT J IMMUNOPATH PH, V22, P95, DOI 10.1177/039463200902200111; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; NAKANISHI T, 1994, BIOCHEM BIOPH RES CO, V198, P891, DOI 10.1006/bbrc.1994.1127; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Raman C, 2002, IMMUNOL RES, V26, P255, DOI 10.1385/IR:26:1-3:255; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; Shimada M, 2001, JPN J PHARMACOL, V1, P371; Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Vinader V, 2012, FUTURE MED CHEM, V4, P845, DOI [10.4155/FMC.12.49, 10.4155/fmc.12.49]	45	24	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188945	10.1371/journal.pone.0188945	http://dx.doi.org/10.1371/journal.pone.0188945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190740	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900176
J	Rahmanian, A; Jamali, M; Lankarani, KB; Ghahramani, S				Rahmanian, Abdolkarim; Jamali, Mohammad; Lankarani, Kamran Bagheri; Ghahramani, Sulmaz			Aneurysmal subarachnoid haemorrhage (aSAH): Five consecutive years' experience of Fars province, Iran	PLOS ONE			English	Article							RISK-FACTORS; INTRACRANIAL ANEURYSMS; CASE-FATALITY; SUDDEN-DEATH; RUPTURE; PROBABILITY; PREVALENCE	Objective Subarachnoid haemorrhage (SAH), caused by the rupture of intracranial aneurysms, is a devastating event with high rates of morbidity and mortality. Aneurysmal subarachnoid haemorrhage (aSAH) plays a critical role in the potential loss of life as its sufferers are usually of a young age. We aimed to investigate the incidence of aSAH along with the patients' characteristics over five consecutive years in Fars, a large province located in Southern Iran. Methods In this prospective study, anonymous data of all patients diagnosed with aSAH in Fars province were collected after patient admission and surgery. Data from the last national census in 2011 were used to calculate the incidence. The data were analysed using SPSS software version 18 using independent sample t test, chi square test and ANOVA. The significance level was set at 0.05. Results The number of aSAH cases identified in Fars, Iran, each year varied between 78 (2011) and 98 (2015) for a total of 421 aSAH cases within the 5-year study period. The annual aSAH incidence estimates showed no differences and were 1.65 [95% confidence interval (CI): 1.58-1.72], 1.70 (95% CI: 1.68-1.72), 1.71 (95% CI: 1.63-1.78), 1.82 (95% CI: 1.74-1.9), and 2.05 (95% CI: 1.97-2.13) per 100,000 persons, respectively, for the five consecutive years from 21 March 2011 to 20 March 2016. Hypertension was the most common risk factor, and was found in 198 (48%) aSAH patients. Ninety-four (22.5%) patients had moderate hydrocephalus on admission. Middle cerebral artery and anterior communicating artery were the most common sites of aneurysms. On admission, 351 (83%) patients had a Glasgow Coma Scale score > 7, 197 (47%) presented with Hunt and Hess score of 1, and 365 (87%) had a Fisher score of <= 3. Multiple aneurysms were found in 59 (14%) of the 421 cases and the most common risk factors in multiple aneurysms were hypertension in 30 (51%) and smoking in 26 (44%) cases. Survival data were available only on patients diagnosed in year 2015, and the six-month survival rate was 89.8%. Conclusions This study revealed that although the incidence of aSAH remained stable, the survival of aSAH patients who reached the hospital alive and were operated on, improved in Shiraz (the six-month survival rate was 89.8% in year 2015). The incidence and survival study on aSAH in other geographic areas of Iran as a multi-centre study is recommended. There is a need to inform primary healthcare workers regarding the possibility of aSAH in a patient with signs of the sentinel headache.	[Rahmanian, Abdolkarim; Jamali, Mohammad] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Lankarani, Kamran Bagheri; Ghahramani, Sulmaz] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science	Ghahramani, S (corresponding author), Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran.	suli.ghahraman@gmail.com	Lankarani, Kamran B/P-5336-2019; jamali, mohammad/AAN-4369-2020; Ghahramani, Sulmaz/S-3942-2019; Lankarani, Kamran Bagheri/P-2066-2017; lankarani, kamran b/D-5901-2012; Ghahramani, Sulmaz/S-7384-2017	Lankarani, Kamran B/0000-0002-7524-9017; jamali, mohammad/0000-0001-8391-9175; Ghahramani, Sulmaz/0000-0002-4161-5146; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Ghahramani, Sulmaz/0000-0002-4161-5146				Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Rooij NK, 2007, J NEUROLOGY NEUROSUR; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Gudmundsson G, 1973, STROKE, V4, P764, DOI 10.1161/01.STR.4.5.764; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718; Isaksen J, 2002, J NEUROL NEUROSUR PS, V73, P185, DOI 10.1136/jnnp.73.2.185; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Lindekleiv HM, 2011, ACTA NEUROL SCAND, V123, P34, DOI 10.1111/j.1600-0404.2010.01336.x; Menghini VV, 1998, NEUROLOGY, V51, P405, DOI 10.1212/WNL.51.2.405; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ohkuma H, 2003, STROKE, V34, P96, DOI 10.1161/01.STR.0000048161.57536.42; Rahmanian A, 2012, SURG NEUROLOGY INT, V3; Rakei S, 2008, IRAN RED CRESCENT ME, V2008, P228; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tromp G, 2014, ANN MED, V46, P597, DOI 10.3109/07853890.2014.949299; Winn HR, 2017, YOUMANS NEUROLOGICAL; Wood MJ, 2005, J CLIN NEUROSCI, V12, P770, DOI 10.1016/j.jocn.2004.10.006; Zabihyan S, 2011, WORLD NEUROSURG, V76, P372, DOI 10.1016/j.wneu.2011.08.029; Ziemba-Davis M, 2014, J STROKE CEREBROVASC, V23, P1073, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.010	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189005	10.1371/journal.pone.0189005	http://dx.doi.org/10.1371/journal.pone.0189005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190810	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900190
J	Shirai, YM; Tsunoyama, TA; Hiramoto-Yamaki, N; Hirosawa, KM; Shibata, ACE; Kondo, K; Tsurumune, A; Ishidate, F; Kusumi, A; Fujiwara, TK				Shirai, Yuki M.; Tsunoyama, Taka A.; Hiramoto-Yamaki, Nao; Hirosawa, Koichiro M.; Shibata, Akihiro C. E.; Kondo, Kenichi; Tsurumune, Atsushi; Ishidate, Fumiyoshi; Kusumi, Akihiro; Fujiwara, Takahiro K.			Cortical actin nodes: Their dynamics and recruitment of podosomal proteins as revealed by super-resolution and single-molecule microscopy	PLOS ONE			English	Article							UNDERGO HOP DIFFUSION; PLASMA-MEMBRANE; 3-DIMENSIONAL STRUCTURE; TRACKING; ORGANIZATION; ARCHITECTURE; RECEPTOR; CELLS; COMPARTMENTS; INVADOPODIA	Electron tomography of the plasma membrane (PM) identified several layers of cortical actin meshwork running parallel to the PM cytoplasmic surface throughout the PM. Here, cortical actin structures and dynamics were examined in living cells, using super-resolution microscopy, with (x, y)- and z-resolutions of similar to 140 and similar to 400 nm, respectively, and single-molecule imaging. The super-resolution microscopy identified sub-micron-sized actin clusters that appeared identical by both phalloidin post-fixation staining and Lifeact-mGFP expression followed by fixation, and therefore, these actin clusters were named "actin-pl-clusters". In live cells, the actin-pl-clusters visualized by Lifeact-mGFP linked two or more actin filaments in the fine actin meshwork, acting as a node of the meshwork, and dynamically moved on/along the meshwork in a myosin II-dependent manner. Their formation depended on the Arp2/3 activities, suggesting that the movements could involve both the myosin motor activity and actin polymerization-depolymerization. The actin-pl-clusters differ from the actin nodes/asters found previously after latrunculin treatments, since myosin II and filamin A were not colocalized with the actin-pl-clusters, and the actin-pl-clusters were much smaller than the previously reported nodes/asters. The Lifeact linked to a fluorescently-labeled transmembrane peptide from syntaxin4 (Lifeact-TM) expressed in the PM exhibited temporary immobilization in the PM regions on which actin-pl-clusters and stress fibers were projected, showing that >= 66% of actin-pl-clusters and 89% of stress fibers were located in close proximity (within 3.5 nm) to the PM cytoplasmic surface. Podosome-associated cytoplasmic proteins, Tks4, Tks5, cortactin, and N-WASP, were transiently recruited to actin-pl-clusters, and thus, we propose that actin-pl-clusters also represent "actin podosome-like clusters".	[Shirai, Yuki M.; Shibata, Akihiro C. E.; Kusumi, Akihiro] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan; [Shirai, Yuki M.; Hiramoto-Yamaki, Nao; Hirosawa, Koichiro M.; Shibata, Akihiro C. E.; Ishidate, Fumiyoshi; Kusumi, Akihiro; Fujiwara, Takahiro K.] Kyoto Univ, Ctr Mesobio Single Mol Imaging CeMI, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Tsunoyama, Taka A.; Kusumi, Akihiro] Okinawa Inst Sci & Technol, Membrane Cooperat Unit, Okinawa, Japan; [Kondo, Kenichi] Olympus Corp, Tokyo, Japan; [Tsurumune, Atsushi] Nikon Instech, Tokyo, Japan; [Hirosawa, Koichiro M.] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan; [Shibata, Akihiro C. E.] Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Kyoto University; Kyoto University; Okinawa Institute of Science & Technology Graduate University; Olympus Corporation; Gifu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kusumi, A (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan.; Kusumi, A; Fujiwara, TK (corresponding author), Kyoto Univ, Ctr Mesobio Single Mol Imaging CeMI, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan.; Kusumi, A (corresponding author), Okinawa Inst Sci & Technol, Membrane Cooperat Unit, Okinawa, Japan.	akihiro.kusumi@oist.jp; tfujiwara@icems.kyoto-u.ac.jp	Fujiwara, Takahiro/G-2755-2012	Fujiwara, Takahiro/0000-0001-5576-759X; Shibata, Akihiro/0000-0003-1394-7220	Japan Society for the Promotion of Science [16H04775, 24247029, 16H06386, 26115707, 15H01212]; Core Research for Evolutional Science and Technology (CREST) project of Japan Science and Technology Agency (JST) [JPMJCR14W2]; World Premiere Research Center Initiative (WPI) of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) project of Japan Science and Technology Agency (JST); World Premiere Research Center Initiative (WPI) of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/). (Kiban B to T. K. F. [16H04775] and Kiban A and S to A. K. [24247029 and 16H06386, respectively]). Grants-in-Aid for Innovative Areas from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/) to T. K. F. (26115707 and 15H01212), a grant from Core Research for Evolutional Science and Technology (CREST) project of http://www.jst.go.jp/kisoken/crest/"Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics" of Japan Science and Technology Agency (JST) to A. K. (JPMJCR14W2). WPI-iCeMS of Kyoto University is supported by the World Premiere Research Center Initiative (WPI) of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government (http://www.mext.go.jp/).	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Atkins P., 2006, PHYS CHEM; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Co C, 2007, CELL, V454, P42; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; Dudin O, 2015, J CELL BIOL, V208, P897, DOI 10.1083/jcb.201411124; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fritzsche M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14347; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Fujiwara TK, 2016, MOL BIOL CELL, V27, P1101, DOI 10.1091/mbc.E15-04-0186; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hayashi S, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.082501; Hayashi S, 2015, MOL BIOL CELL, V26, P1743, DOI 10.1091/mbc.E14-08-1287; Hiramoto-Yamaki N, 2014, TRAFFIC, V15, P583, DOI 10.1111/tra.12163; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kalay Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032948; Kiuchi T, 2015, NAT METHODS, V12, P743, DOI [10.1038/nmeth.3466, 10.1038/NMETH.3466]; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Koster DV, 2016, P NATL ACAD SCI USA, V113, pE1645, DOI 10.1073/pnas.1514030113; Komura N, 2016, NAT CHEM BIOL, V12, P402, DOI 10.1038/nchembio.2059; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Luo W, 2016, PLOS ONE, V11, P1; Luo WW, 2013, J CELL BIOL, V202, P1057, DOI 10.1083/jcb.201210123; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morone N, 2010, METHODS MOL BIOL, V657, P275, DOI 10.1007/978-1-60761-783-9_22; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nagase T, 2008, DNA RES, V15, P137, DOI 10.1093/dnares/dsn004; NAKAGAWA Y, 1979, PATTERN RECOGN, V11, P191, DOI 10.1016/0031-3203(79)90006-2; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pfaff M, 2001, J CELL SCI, V114, P2775; Poulter NS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8254; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Riedl J, 2010, NAT METHODS, V5, P1; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Schachtner H, 2013, BLOOD, V121, P2542, DOI 10.1182/blood-2012-07-443457; Shibata ACE, 2012, CYTOSKELETON, V69, P380, DOI 10.1002/cm.21032; Stolting M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035340; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]	62	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188778	10.1371/journal.pone.0188778	http://dx.doi.org/10.1371/journal.pone.0188778			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190677	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900122
J	Puig, J; Blasco, G; Daunis-i-Estadella, P; van Eendendburg, C; Carrillo-Garcia, M; Aboud, C; Hernandez-Perez, M; Serena, J; Biarnes, C; Nael, K; Liebeskind, DS; Thomalla, G; Menon, BK; Demchuk, A; Wintermark, M; Pedraza, S; Castellanos, M				Puig, Josep; Blasco, Gerard; Daunis-i-Estadella, Pepus; van Eendendburg, Cecile; Carrillo-Garcia, Maria; Aboud, Carlos; Hernandez-Perez, Maria; Serena, Joaquin; Biarnes, Carles; Nael, Kambiz; Liebeskind, David S.; Thomalla, Goetz; Menon, Bijoy K.; Demchuk, Andrew; Wintermark, Max; Pedraza, Salvador; Castellanos, Mar			High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BRAIN-BARRIER PERMEABILITY; COMPUTED-TOMOGRAPHY PERFUSION; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; RISK-FACTORS; MULTICENTER; THERAPY; ANGIOGRAPHY; PARAMETERS	Objective Blood-brain barrier (BBB) permeability has been proposed as a predictor of hemorrhagic transformation (HT) after tissue plasminogen activator (tPA) administration; however, the reliability of perfusion computed tomography (PCT) permeability imaging for predicting HT is uncertain. We aimed to determine the performance of high-permeability region size on PCT (HPrsPCT) in predicting HT after intravenous tPA administration in patients with acute stroke. Methods We performed a multimodal CT protocol (non-contrast CT, PCT, CT angiography) to prospectively study patients with middle cerebral artery occlusion treated with tPA within 4.5 hours of symptom onset. HT was graded at 24 hours using the European-Australasian Acute Stroke Study II criteria. ROC curves selected optimal volume threshold, and multivariate logistic regression analysis identified predictors of HT. Results The study included 156 patients (50% male, median age 75.5 years). Thirty-seven (23,7%) developed HT [12 (7,7%), parenchymal hematoma type 2 (PH-2)]. At admission, patients with HT had lower platelet values, higher NIHSS scores, increased ischemic lesion volumes, larger HPrs-PCT, and poorer collateral status. The negative predictive value of HPrs-PCT at a threshold of 7mL/100g/min was 0.84 for HT and 0.93 for PH-2. The multiple regression analysis selected HPrs-PCT at 7mL/100g/min combined with platelets and baseline NIHSS score as the best model for predicting HT (AUC 0.77). HPrs-PCT at 7mL/100g/min was the only independent predictor of PH-2 (OR 1, AUC 0.68, p = 0.045). Conclusions HPrs-PCT can help predict HT after tPA, and is particularly useful in identifying patients at low risk of developing HT.	[Puig, Josep; Blasco, Gerard; Biarnes, Carles; Pedraza, Salvador] Hosp Univ Dr Josep Trueta, Girona Biomed Res Inst, IDIBGI, Dept Radiol,Res Unit Diagnost Imaging Inst IDI, Girona, Spain; [Daunis-i-Estadella, Pepus] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain; [van Eendendburg, Cecile; Serena, Joaquin] Dr Josep Trueta Univ Hosp, Dept Neurol, IDIBGI, Girona, Spain; [Carrillo-Garcia, Maria] Morales Meseguer Univ Hosp, Dept Radiol, Murcia, Spain; [Aboud, Carlos] La Fe Univ Hosp, Dept Radiol, Valencia, Spain; [Hernandez-Perez, Maria] Germans Trias i Pujol Univ Hosp, Stroke Unit, Badalona, Spain; [Nael, Kambiz] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Liebeskind, David S.] Neurovasc Imaging Res Core, Los Angeles, CA USA; [Liebeskind, David S.] UCLA, Stroke Ctr, Los Angeles, CA USA; [Thomalla, Goetz] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Menon, Bijoy K.; Demchuk, Andrew] Univ Calgary, Hotchkiss Brain Inst, Calgary Stroke Program, Calgary, AB, Canada; [Wintermark, Max] Stanford Univ, Dept Radiol, Neuroradiol Div, Palo Alto, CA 94304 USA; [Castellanos, Mar] A Coruna Univ Hosp, Dept Neurol, Biomed Res Inst, La Coruna, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; Stanford University; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Castellanos, M (corresponding author), A Coruna Univ Hosp, Dept Neurol, Biomed Res Inst, La Coruna, Spain.	Maria.del.Mar.Castellanos.Rodrigo@sergas.es	pedraza, salvador/AAC-1728-2019; MENON, BIJOY K/B-7718-2014; Daunis-i-Estadella, Pepus/B-9082-2011; Demchuk, Andrew M/E-1103-2012	pedraza, salvador/0000-0003-2517-4413; Daunis-i-Estadella, Pepus/0000-0001-6134-9255; Demchuk, Andrew M/0000-0002-4930-7789; Castellanos, Maria del Mar/0000-0003-3116-1352; Blasco, Gerard/0000-0002-5302-0625; Hernandez-Perez, Maria/0000-0001-8279-7954	Instituto de Investigacion Carlos III [PI10/01309, PI13/02258]; ERDF: European Regional Development Fund; Spanish Stroke Research Network (INVICTUS) - Instituto de Salud Carlos III [RD12/0014/0001, RD16/0019/0004]; Spanish Ministry of Health; Alberta Innovates [201300690] Funding Source: researchfish	Instituto de Investigacion Carlos III(Instituto de Salud Carlos III); ERDF: European Regional Development Fund; Spanish Stroke Research Network (INVICTUS) - Instituto de Salud Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Alberta Innovates	This work was partially supported by grants from the Spanish Ministry of Health, Instituto de Investigacion Carlos III (PI10/01309 and PI13/02258), the ERDF: European Regional Development Fund and the Spanish Stroke Research Network (INVICTUS), also financed by the Instituto de Salud Carlos III (RD12/0014/0001 and RD16/0019/0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aviv RI, 2009, RADIOLOGY, V250, P867, DOI 10.1148/radiol.2503080257; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bennink E, 2015, MED PHYS, V42, P4610, DOI 10.1118/1.4923751; Bhatt A, 2008, NEUROSURGERY, V63, P874, DOI 10.1227/01.NEU.0000333259.11739.AD; Bisdas S, 2007, J NEURORADIOLOGY, V34, P101, DOI 10.1016/j.neurad.2007.02.003; Bisdas S, 2007, ACTA RADIOL, V48, P341, DOI 10.1080/02841850601182170; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; Horsch AD, 2016, CLIN NEURORADIOL, V26, P415, DOI 10.1007/s00062-015-0375-1; Jain AR, 2013, AM J NEURORADIOL, V34, P1895, DOI 10.3174/ajnr.A3502; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Lansberg MG, 2007, CEREBROVASC DIS, V24, P1, DOI 10.1159/000103110; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Medcalf RL, 2012, INT J STROKE, V7, P419, DOI 10.1111/j.1747-4949.2012.00783.x; Ozkul-Wermester O, 2014, EUR NEUROL, V72, P45, DOI 10.1159/000358297; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Souza LCS, 2012, CEREBROVASC DIS, V33, P8, DOI 10.1159/000331914; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Verro P, 2007, CLIN NEUROL NEUROSUR, V109, P138, DOI 10.1016/j.clineuro.2006.07.002; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Yassi N, 2013, STROKE, V44, P3039, DOI 10.1161/STROKEAHA.113.002396; Yen P, 2016, WORLD J RADIOL, V8, P594, DOI 10.4329/wjr.v8.i6.594	30	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188238	10.1371/journal.pone.0188238	http://dx.doi.org/10.1371/journal.pone.0188238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182658	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000016
J	Wilson, DL; Coyle, JR; Thomas, EA				Wilson, Daniel L.; Coyle, Jeremy R.; Thomas, Evan A.			Ensemble machine learning and forecasting can achieve 99% uptime for rural handpumps	PLOS ONE			English	Article							MAINTENANCE	Broken water pumps continue to impede efforts to deliver clean and economically-viable water to the global poor. The literature has demonstrated that customers' health benefits and willingness to pay for clean water are best realized when clean water infrastructure performs extremely well (> 99% uptime). In this paper, we used sensor data from 42 Afridevbrand handpumps observed for 14 months in western Kenya to demonstrate how sensors and supervised ensemble machine learning could be used to increase total fleet uptime from a best-practices baseline of about 70% to > 99%. We accomplish this increase in uptime by forecasting pump failures and identifying existing failures very quickly. Comparing the costs of operating the pump per functional year over a lifetime of 10 years, we estimate that implementing this algorithm would save 7% on the levelized cost of water relative to a sensor-less scheduled maintenance program. Combined with a rigorous system for dispatching maintenance personnel, implementing this algorithm in a real-world program could significantly improve health outcomes and customers' willingness to pay for water services.	[Wilson, Daniel L.] Univ Calif Berkeley, Civil & Environm Engn, Berkeley, CA 94720 USA; [Coyle, Jeremy R.] Univ Calif Berkeley, Biostat, Berkeley, CA 94720 USA; [Thomas, Evan A.] Portland State Univ, Mech Engn, Portland, OR 97207 USA; [Wilson, Daniel L.; Coyle, Jeremy R.; Thomas, Evan A.] SweetSense Inc, Portland, OR 97201 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Portland State University	Thomas, EA (corresponding author), Portland State Univ, Mech Engn, Portland, OR 97207 USA.; Thomas, EA (corresponding author), SweetSense Inc, Portland, OR 97201 USA.	evthomas@pdx.edu		Wilson, Daniel/0000-0002-5142-0529; Thomas, Evan/0000-0003-3095-8407; Coyle, Jeremy/0000-0002-9874-6649	National Science Foundation's Small Business Innovative Research program [1621444]; NSF through SweetSense Inc.	National Science Foundation's Small Business Innovative Research program; NSF through SweetSense Inc.	This work was funded by the National Science Foundation's Small Business Innovative Research program, under award number 1621444 (https://nsf.gov/awardsearch/) to SweetSense Inc. The NSF as funder provided support in the form of salaries through SweetSense Inc. for authors DW, JC, ET, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are also affiliated with the universities listed. The authors were not compensated for this work by their universities. The specific roles of these authors are articulated in the author contributions section.	Ahmad R, 2012, COMPUT IND ENG, V63, P135, DOI 10.1016/j.cie.2012.02.002; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bishop Christopher M., 2006, PATTERN RECOGNITION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]; Byington CS, 2004, AEROSP CONF PROC, P3551; Clasen TF, 2012, TROP MED INT HEALTH, V17, P1178, DOI 10.1111/j.1365-3156.2012.03052.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Foster T, 2013, ENVIRON SCI TECHNOL, V47, P12037, DOI 10.1021/es402086n; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gross P, 2006, 21 NAT C ART INT AAA, P1; Harvey P. A., 2007, Community Development Journal, V42, P365, DOI 10.1093/cdj/bsl001; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Higgs PA, 2004, 7 BIENN C ENG S DES, P1; Koehler J, 2015, WORLD DEV, V74, P397, DOI 10.1016/j.worlddev.2015.05.020; Liddle E. S., 2017, Waterlines, V36, P140, DOI 10.3362/1756-3488.16-00022; Lockwood H., 2011, SUPPORTING RURAL WAT; MALIK MAK, 1979, AIIE T, V11, P221, DOI 10.1080/05695557908974463; Nagel C, 2015, ENVIRON SCI TECHNOL, V49, P14292, DOI 10.1021/acs.est.5b04077; Rural Water Supply Network (RWSN), 2009, HANDP DAT 2009 SEL C; Si XS, 2011, EUR J OPER RES, V213, P1, DOI 10.1016/j.ejor.2010.11.018; Usher JS, 1998, IIE TRANS, V30, P1121, DOI 10.1023/A:1007524100829; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309	23	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188808	10.1371/journal.pone.0188808	http://dx.doi.org/10.1371/journal.pone.0188808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182673	gold, Green Published, Green Submitted			2022-12-26	WOS:000416402000058
J	Lee, KH; Hwang, JA; Kim, SO; Kim, JH; Shin, SC; Kim, EE; Lee, KS; Rhee, K; Jeon, BH; Bang, JK; Cha-Molstad, H; Soung, NK; Jang, JH; Ko, SK; Lee, HG; Ahn, JS; Kwon, YT; Kim, BY				Lee, Kyung Ho; Hwang, Jeong-Ah; Kim, Sun-Ok; Kim, Jung Hee; Shin, Sang Chul; Kim, Eunice EunKyeong; Lee, Kyung S.; Rhee, Kunsoo; Jeon, Byeong Hwa; Bang, Jeong Kyu; Cha-Molstad, Hyunjoo; Soung, Nak-Kyun; Jang, Jae-Hyuk; Ko, Sung-Kyun; Lee, Hee Gu; Ahn, Jong Seog; Kwon, Yong Tae; Kim, Bo Yeon			Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; BOX DOMAIN; METASTASIS; CENTROSOME; PLASTICITY; INVASION; GROWTH; PHENIX	Elevated expression of human enhancer filamentation 1 (HEF1;also known as NEDD9 or Cas-L) is an essential stimulus for the metastatic process of various solid tumors. This process requires HEF1 localization to focal adhesions (FAs). Although the association of HEF1 with FAs is considered to play a role in cancer cell migration, the mechanism targeting HEF1 to FAs remains unclear. Moreover, up-regulation of Polo-like kinase 1 (Plk1) positively correlates with human cancer metastasis, yet how Plk1 deregulation promotes metastasis remains elusive. Here, we report that casein kinase 1 delta (CK1 delta) phosphorylates HEF1 at Ser-780 and Thr-804 and that these phosphorylation events promote a physical interaction between Plk1 and HEF1. We found that this interaction is critical for HEF1 translocation to FAs and for inducing migration of HeLa cells. Plk1-docking phosphoepitopes were mapped/ confirmed in HEF1 by various methods, including X-ray crystallography, and mutated for functional analysis in HeLa cells. In summary, our results reveal the role of a phosphorylation-dependent HEF1-Plk1 complex in HEF1 translocation to FAs to induce cell migration. Our findings provide critical mechanistic insights into the HEF1-Plk1 complex-dependent localization of HEF1 to FAs underlying the metastatic process and may therefore contribute to the development of new cancer therapies.	[Lee, Kyung Ho; Hwang, Jeong-Ah; Kim, Sun-Ok; Cha-Molstad, Hyunjoo; Soung, Nak-Kyun; Jang, Jae-Hyuk; Ko, Sung-Kyun; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, World Class Inst, 30 Yeongudanji Ro, Cheongwon 28116, Chungbuk, South Korea; [Kim, Jung Hee; Shin, Sang Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Hwarangno 14-Gil 5, Seoul 02792, South Korea; [Lee, Kyung S.] NCI, Ctr Canc Res, Lab Metab, Bethesda, MD 20892 USA; [Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea; [Hwang, Jeong-Ah; Jeon, Byeong Hwa] Chungnam Natl Univ, Coll Med, Dept Physiol, Res Inst Med Sci, Daejeon 35015, South Korea; [Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang 28119, South Korea; [Lee, Hee Gu] Korea Res Inst Biosci & Biotechnol, Genome Struct Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul 03080, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Science & Technology (KIST); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Chungnam National University; Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul 03080, South Korea.; Lee, KH; Kim, BY (corresponding author), KRIBB, Anticanc Agent Res Ctr, World Class Inst, 30 Yeongudanji Ro, Cheongwon 28116, Chungbuk, South Korea.	leekh@kribb.re.kr; yok5@snu.ac.kr; bykim@kribb.re.kr	Jeon, Byeong Hwa/D-4160-2012	Jeon, Byeong Hwa/0000-0002-3347-2739; Ko, Sung-Kyun/0000-0002-8202-1205	R&D Convergence Program of the National Research Council of Science and Technology (NST) of the Republic of Korea [CAP-16-03-KRIBB]; International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea [NRF-2016R1A2B3011389]; KRIBB Research Initiative Program; NATIONAL CANCER INSTITUTE [ZIABC011518] Funding Source: NIH RePORTER	R&D Convergence Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea; KRIBB Research Initiative Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R&D Convergence Program Grant CAP-16-03-KRIBB and the International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea. This work was also supported by Basic Science Research Program Grant NRF-2016R1A2B3011389 of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea and the KRIBB Research Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Jia JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14626; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Knecht R, 1999, CANCER RES, V59, P2794; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rizki A, 2007, CANCER RES, V67, P11106, DOI 10.1158/0008-5472.CAN-07-2348; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	41	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					847	862		10.1074/jbc.M117.802587	http://dx.doi.org/10.1074/jbc.M117.802587			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191835	Green Published, hybrid			2022-12-26	WOS:000422864500008
J	Yamamura, H; Nishimura, K; Hagihara, Y; Suzuki, Y; Imaizumi, Y				Yamamura, Hisao; Nishimura, Kaori; Hagihara, Yumiko; Suzuki, Yoshiaki; Imaizumi, Yuji			TMEM16A and TMEM16B channel proteins generate Ca2+-activated Cl- current and regulate melatonin secretion in rat pineal glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; SMOOTH-MUSCLE-CELLS; MURINE PORTAL-VEIN; LARGE-CONDUCTANCE; CA2+ CHANNELS; K+ CHANNELS; ANOCTAMIN 1; EXPRESSION; NOREPINEPHRINE; MODULATION	Pinealocytes regulate circadian rhythm by synthesizing and secreting melatonin. These cells generate action potentials; however, the contribution of specific ion channels to melatonin secretion from pinealocytes remains unclear. In this study, the involvement and molecular identity of Ca2+-activated Cl- (Cl-Ca) channels in the regulation of melatonin secretion were examined in rat pineal glands. Treatment with the ClCa channel blockers, niflumic acid or T16A(inh)-A01, significantly reduced melatonin secretion in pineal glands. After pineal K+ currents were totally blocked under whole-cell patch clamp conditions, depolarization and subsequent repolarization induced a slowly activating outward current and a substantial inward tail current, respectively. Both of these current changes were dependent on intracellular Ca2+ concentration and inhibited by niflumic acid and T16A(inh)-A01. Quantitative real-time PCR, Western blotting, and immunocytochemical analyses revealed that TMEM16A and TMEM16B were highly expressed in pineal glands. siRNA knockdown of TMEM16A and/or TMEM16B showed that both channels contribute to Cl-Ca currents in pinealocytes. Conversely, co-expression of TMEM16A and TMEM16B channels or the expression of this tandem channel in HEK293 cells mimicked the electrophysiological characteristics of Cl-Ca currents in pinealocytes. Moreover, bimolecular fluorescence complementation, FRET, and co-immunoprecipitation experiments suggested that TMEM16A and TMEM16B can form heteromeric channels, as well as homomeric channels. In conclusion, pineal Cl-Ca channels are composed of TMEM16A and TMEM16B subunits, and these fluxes regulate melatonin secretion in pineal glands.	[Yamamura, Hisao; Nishimura, Kaori; Hagihara, Yumiko; Suzuki, Yoshiaki; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi 4678603, Japan	Nagoya City University	Yamamura, H (corresponding author), 3-1 Tanabedori Mizuhoku, Nagoya, Aichi 4678603, Japan.	yamamura@phar.nagoya-cu.ac.jp	Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; 	Japan Society for the Promotion of Science [17H05537, 26293021, 25460104, 16K08278]; Grants-in-Aid for Scientific Research [16K08278] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative strate their involvement in melatonin secretion in rat pineal Areas 17H05537 (to H.Y.), Grant-in-Aid for Scientific Research (B) 26293021 (to Y.I.), and Grants-in-Aid for Scientific Research (C) 25460104 and 16K08278 (to H.Y.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Adomaviciene A, 2013, J PHYSIOL-LONDON, V591, P3487, DOI 10.1113/jphysiol.2013.251660; AGUAYO LG, 1988, J PHYSIOL-LONDON, V405, P397, DOI 10.1113/jphysiol.1988.sp017339; Bernstein K, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.018; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASTELLANO A, 1989, PFLUG ARCH EUR J PHY, V413, P644, DOI 10.1007/BF00581815; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Darvish N, 1998, J NEUROPHYSIOL, V79, P2546, DOI 10.1152/jn.1998.79.5.2546; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; FRESCHI JE, 1986, BRAIN RES, V368, P366, DOI 10.1016/0006-8993(86)90583-4; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Kitamura K, 2001, JPN J PHARMACOL, V85, P351, DOI 10.1254/jjp.85.351; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Lee SY, 2006, AM J PHYSIOL-CELL PH, V290, pC1060, DOI 10.1152/ajpcell.00343.2005; Letz B, 1997, J PHYSIOL-LONDON, V499, P329, DOI 10.1113/jphysiol.1997.sp021930; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maurya DK, 2014, DEV NEUROBIOL, V74, P657, DOI 10.1002/dneu.22159; Mizutani H, 2016, AM J PHYSIOL-CELL PH, V310, pC740, DOI 10.1152/ajpcell.00342.2015; Mizutani H, 2014, AM J PHYSIOL-CELL PH, V306, pC1008, DOI 10.1152/ajpcell.00014.2014; Ohshiro J, 2014, J PHARMACOL SCI, V125, P107, DOI 10.1254/jphs.14015SC; Ohshiro J, 2014, BIOCHEM BIOPH RES CO, V443, P518, DOI 10.1016/j.bbrc.2013.11.117; Ohya S, 2001, PFLUG ARCH EUR J PHY, V441, P611, DOI 10.1007/s004240000463; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Phansuwan-Pujito P, 1999, MICROSC RES TECHNIQ, V46, P281, DOI 10.1002/(SICI)1097-0029(19990815/01)46:4/5<281::AID-JEMT5>3.0.CO;2-N; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; REUSS S, 1984, EXP BRAIN RES, V55, P455; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186252; Suzuki Y, 2016, J BIOL CHEM, V291, P24247, DOI 10.1074/jbc.M116.743302; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Yamada H, 1998, J NEUROSCI, V18, P2056; Yamada H, 1998, J NEUROSCI, V18, P4946; Yamamura H, 2015, J PHARMACOL SCI, V128, P1, DOI 10.1016/j.jphs.2015.04.004; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zemkova H, 2011, ENDOCRINOLOGY, V152, P3842, DOI 10.1210/en.2011-1180; Zhao L, 2016, EXP THER MED, V11, P1755, DOI 10.3892/etm.2016.3158	49	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					995	1006		10.1074/jbc.RA117.000326	http://dx.doi.org/10.1074/jbc.RA117.000326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187602	Green Published, hybrid			2022-12-26	WOS:000422864500020
J	Abdalla, Z; Walsh, T; Thakker, N; Ward, CM				Abdalla, Zahra; Walsh, Tanya; Thakker, Nalin; Ward, Christopher M.			Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; E-CADHERIN; EXPRESSION; TRANSITION; VIMENTIN; CATENIN; PROTEIN; HEAD	Oral squamous cell carcinoma (OSCC) is a highly aggressive cancer that is associated with poor 5-year patient survival. Disease treatment is further compounded by the difficulty in predicting pre-cancerous tissues that will progress to OSCC and the high recurrence rates following surgical resection. Here we have assessed expression of the oral epithelial markers E-cadherin, EMP1 and 5T4 and the pro-invasive N-cadherin proteins using fully characterised antibodies and quantitative immunofluorescence microscopy in normal tissue (NT), fibroepithelial polyp (FEP), low-grade dysplasia (LGD), high-grade dysplasia (HGD), T1 OSCC and T4 OSCC biopsies. Decreased E-cadherin expression was associated with FEP, LGD and HGD biopsies, demonstrating that loss of E-cadherin is an early event within abnormal epithelium and occurs in the absence of an E-to N-cadherin switch, the latter of which was only observed in T4 OSCC. Furthermore, loss of E-cadherin and EMP1 is an indicator of LGD (p = 0.0006) and loss of E-cadherin, EMP1 and 5T4 an indicator of HGD (p = 0.0006). Expression patterns of E-cadherin, EMP1 and N-cadherin could predict abnormal epithelium in LGD, HGD, T1 and T4 OSCC biopsies (z-value = 0 for all disease grades) and allowed classification of LGD (z = 1.47), HGD (z = 2.138), T1 (z = 1.05) and T4 OSCC (z = 1.49) biopsies. Therefore, these markers provide a useful means to predict abnormal epithelium in patient biopsies. Linear regression and coefficient of determination analysis revealed positive correlation with a NT>LGD>HGD disease transition but low correlation with a putative HGD>T1OSCC>T4 OSCC disease transition. Furthermore, expression of E-cadherin, EMP1, 5T4 and N-cadherin in pathologically normal surgical safety margins of LGD, HGD and T1 OSCC patient biopsies revealed significant differences to NT and the use of safety margins or FEP as 'normal tissue' controls introduced Type II errors in all patient cohorts. This work forms the basis for further investigation of the role of E-cadherin loss in abnormal epithelium and in the development of automated analyses for use in cancer diagnostics.	[Abdalla, Zahra; Walsh, Tanya; Ward, Christopher M.] Manchester Dent Sch, Stem Cell Res Grp, Manchester, Lancs, England; [Thakker, Nalin] Manchester Royal Infirm, Dept Histopathol, Manchester, Lancs, England	University of Manchester; University of Manchester	Ward, CM (corresponding author), Manchester Dent Sch, Stem Cell Res Grp, Manchester, Lancs, England.	christopher.ward@manchester.ac.uk		Thakker, Nalin/0000-0002-8664-1508; Walsh, Tanya/0000-0001-7003-8854; Ward, Christopher/0000-0001-7389-4488	United Kingdom Biotechnology and Biological Sciences Research Council [BB/K020277/1]; Engineering and Physical Sciences Research Council [EP/H046070/1]; Biotechnology and Biological Sciences Research Council [BB/K020277/1] Funding Source: researchfish; BBSRC [BB/K020277/1] Funding Source: UKRI; EPSRC [EP/H046070/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (BB/K020277/1) and the Engineering and Physical Sciences Research Council (EP/H046070/1) to Christopher M Ward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (BB/K020277/1) and the Engineering and Physical Sciences Research Council (EP/H046070/1).	Bangsow T, 2008, J CEREBR BLOOD F MET, V28, P1249, DOI 10.1038/jcbfm.2008.19; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Colucci S, 1997, ORAL ONCOL, V33, P240, DOI 10.1016/S0964-1955(97)00027-4; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Kaur J, 2013, PLOS ONE, V8; Kyrodimou M, 2014, CLIN ORAL INVEST, V18, P199, DOI 10.1007/s00784-013-0937-z; Liu W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-685; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; NEES M, 1993, CANCER RES, V53, P4189; Noutomi Y, 2006, J PATHOL, V210, P67, DOI 10.1002/path.2015; Ogbureke KUE, 2010, CANCER-AM CANCER SOC, V116, P1709, DOI 10.1002/cncr.24938; Omura K, 2014, INT J CLIN ONCOL, V19, P423, DOI 10.1007/s10147-014-0689-z; Shaw RJ, 2013, ANN SURG ONCOL, V20, P2796, DOI 10.1245/s10434-012-2713-8; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SLAUGHTER DP, 1946, SURGERY, V20, P133; Slaughter DP, 1944, SURG GYNECOL OBSTET, V79, P89; Soncin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021463; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Sridevi Ugrappa, 2015, Eur J Dent, V9, P364, DOI 10.4103/1305-7456.163238; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; von Zeidler SV, 2014, BMC CANC, V14; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Zhou JP, 2015, INT J CLIN EXP PATHO, V8, P3150	28	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187449	10.1371/journal.pone.0187449	http://dx.doi.org/10.1371/journal.pone.0187449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216196	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800008
J	Kim, HJ; Seo, YH; Kim, BH				Kim, Hyung Jin; Seo, Yeong Ho; Kim, Byeong Hee			New intraocular pressure measurement method using reflected pneumatic pressure from cornea deformed by air puff of ring-type nozzle	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETRY; DYNAMIC CONTOUR TONOMETRY; NORMAL-TENSION GLAUCOMA; REBOUND TONOMETER	In this study, a non-contact type intraocular pressure (IOP) measuring system using reflected pneumatic pressure is proposed to overcome the disadvantages of existing measurement systems. A ring-type nozzle, a key component in the proposed system, is designed via computational fluid analysis. It predicts the reflected pneumatic pressure based on the nozzle exit angle and inner and outer diameters of the nozzle, which are 30 degrees, 7 mm, and 9 mm, respectively. Performance evaluation is conducted using artificial eyes fabricated using polydimethylsiloxane with the specifications of human eyes. The IOP of the fabricated artificial eyes is adjusted to 10, 30, and 50 mm Hg, and the reflected pneumatic pressure is measured as a function of the distance between the ring-type nozzle and artificial eye. The measured reflected pneumatic pressure is high when the measurement distance is short and eye pressure is low. The cornea of an artificial eye is significantly deformed at a low IOP, and the applied pneumatic pressure is more concentrated in front of the ring-type nozzle because of the deformed cornea. Thus, the reflected pneumatic pressure at a low IOP has more inflows into the pressure sensor inserted inside the nozzle. The sensitivity of the output based on the IOP at measurement distances between 3-5 mm is -0.0027, -0.0022, -0.0018, -0.0015, and -0.0012. Sensitivity decreases as the measurement distance increases. In addition, the reflected pneumatic pressure owing to the misalignment at the measurement distances of 3-5 mm is not affected within a range of 0.5 mm. Therefore, the measurement range is acceptable up to a 1 mm diameter from the center of an artificial eye. However, the accuracy gradually decreases as the reflected pneumatic pressure from a misalignment of 1 mm or more decreases by 26% or more.	[Kim, Hyung Jin; Seo, Yeong Ho; Kim, Byeong Hee] Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chunchon, South Korea	Kangwon National University	Kim, BH (corresponding author), Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chunchon, South Korea.	khb@kangwon.ac.kr			Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Trade, Industry and Energy [20154030200950]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [20153010024470]	Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Trade, Industry and Energy; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by the Human Resources Development program (No. 20154030200950) of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Trade, Industry and Energy. This work was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20153010024470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM., 1999, PRINCIPLES PRACTICE; Asman P, 2003, ACTA OPHTHALMOL, V81, P424; Caffier PP, 2003, EUR J APPL PHYSIOL, V89, P319, DOI 10.1007/s00421-003-0807-5; Chien W-Z, 1947, LARGE DEFLECTION CIR; Chitnis G, 2013, IEEE T BIO-MED ENG, V60, P250, DOI 10.1109/TBME.2012.2205248; Farhood QK, 2013, CLIN OPHTHALMOL, V7, P23, DOI 10.2147/OPTH.S38418; Fernandes P, 2005, OPHTHAL PHYSL OPT, V25, P436, DOI 10.1111/j.1475-1313.2005.00327.x; Gisler C, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.1.4; Glaucoma Rosenberg L., 1995, AM FAM PHYSICIAN, V52, P2289; Goel M, 2010, OPEN OPHTHALMOLOGY J, V4; Hamilton KE, 2008, OPTOMETRY VISION SCI, V85, P445, DOI 10.1097/OPX.0b013e3181783a70; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Kageyama M, 2011, J GLAUCOMA, V20, P63, DOI 10.1097/IJG.0b013e3181d12dc4; Kaufmann C, 2004, INVEST OPHTH VIS SCI, V45, P3118, DOI 10.1167/iovs.04-0018; Khawaja AP, 2014, OPHTHALMOLOGY, V121, P1501, DOI 10.1016/j.ophtha.2014.02.009; Kim HJ, 2016, THESIS; Kim KH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035022; Kontiola AI, 2000, ACTA OPHTHALMOL SCAN, V78, P142, DOI 10.1034/j.1600-0420.2000.078002142.x; Koseki N, 1999, J GLAUCOMA, V8, P117; Ohnell H, 2016, OPHTHALMOLOGY, V123, P1173, DOI 10.1016/j.ophtha.2016.01.039; Pache M, 2005, GRAEF ARCH CLIN EXP, V243, P763, DOI 10.1007/s00417-005-1124-y; Rodriguez-Matas JF, 2015, PLOS ONE, V10; Schlote T, 2005, KLIN MONATSBL AUGENH, V222, P123, DOI 10.1055/s-2005-857881; Shah Sunil, 2006, Cont Lens Anterior Eye, V29, P257, DOI 10.1016/j.clae.2006.09.006; SHIELDS MB, 1980, SURV OPHTHALMOL, V24, P211, DOI 10.1016/0039-6257(80)90042-9; Singh P., IOSR J DENT MED SCI, V13, P67; Spoerl E, 2011, J REFRACT SURG, V27, P452, DOI 10.3928/1081597X-20110106-01; Stevens Sue, 2007, Community Eye Health, V20, P74; Suman S, 2014, J GLAUCOMA, V23, P633, DOI 10.1097/IJG.0b013e318285fefd; Tojo N, 2014, J GLAUCOMA, V23, pE138, DOI 10.1097/IJG.0000000000000026; Valbon BF, 2013, ARQ BRAS OFTALMOL, V76, P229, DOI 10.1590/S0004-27492013000400008	31	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186738	10.1371/journal.pone.0186738	http://dx.doi.org/10.1371/journal.pone.0186738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216189	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800005
J	Rourke, OLC; Butts, DA				Rourke, Oliver L. C.; Butts, Daniel A.			Cortical computations via transient attractors	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; NEURAL-NETWORKS; PERSISTENT ACTIVITY; SUSTAINED ACTIVITY; PREFRONTAL CORTEX; MODEL; NEURONS; DYNAMICS; SYSTEMS	The ability of sensory networks to transiently store information on the scale of seconds can confer many advantages in processing time-varying stimuli. How a network could store information on such intermediate time scales, between typical neurophysiological time scales and those of long-term memory, is typically attributed to persistent neural activity. An alternative mechanism which might allow for such information storage is through temporary modifications to the neural connectivity which decay on the same second-long time scale as the underlying memories. Earlier work that has explored this method has done so by emphasizing one attractor from a limited, pre-defined set. Here, we describe an alternative, a Transient Attractor network, which can learn any pattern presented to it, store several simultaneously, and robustly recall them on demand using targeted probes in a manner reminiscent of Hopfield networks. We hypothesize that such functionality could be usefully embedded within sensory cortex, and allow for a flexibly-gated short-term memory, as well as conferring the ability of the network to perform automatic de-noising, and separation of input signals into distinct perceptual objects. We demonstrate that the stored information can be refreshed to extend storage time, is not sensitive to noise in the system, and can be turned on or off by simple neuromodulation. The diverse capabilities of transient attractors, as well as their resemblance to many features observed in sensory cortex, suggest the possibility that their actions might underlie neural processing in many sensory areas.	[Rourke, Oliver L. C.; Butts, Daniel A.] Univ Maryland, Program Appl Math Stat & Sci Computat, College Pk, MD 20742 USA; [Butts, Daniel A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Butts, Daniel A.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Rourke, OLC (corresponding author), Univ Maryland, Program Appl Math Stat & Sci Computat, College Pk, MD 20742 USA.	orourke@math.umd.edu	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317	National Science Foundation [IIS-1350990]	National Science Foundation(National Science Foundation (NSF))	This work supported by National Science Foundation grant IIS-1350990, URL: https://www.nsf.gov/.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Barak O, 2014, CURR OPIN NEUROBIOL, V25, P20, DOI 10.1016/j.conb.2013.10.008; Becker S., 1992, LEARNING CATEGORIZE; BEER RD, 1995, ADAPT BEHAV, V3, P469, DOI 10.1177/105971239500300405; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; BUHMANN J, 1986, BIOL CYBERN, V54, P319, DOI 10.1007/BF00318428; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Dubreuil AM, 2016, J COMPUT NEUROSCI, V40, P157, DOI 10.1007/s10827-016-0590-z; Erickson MA, 2010, J COGNITIVE NEUROSCI, V22, P2530, DOI 10.1162/jocn.2009.21375; Fiebig F, 2017, SPIKING WORKING MEMO, V37, P83; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Itskov V, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00040; Kaminski J, 2017, NAT NEUROSCI, V20, P590, DOI 10.1038/nn.4509; Kandel ER, 2014, PRINCIPLES NEURAL SC, P1248; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; Lansner A, 2003, THEOR BIOSCI, V122, P19, DOI 10.1078/1431-7613-00072; Leavitt ML, 2017, TRENDS NEUROSCI, V40, P328, DOI 10.1016/j.tins.2017.04.004; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Maex R, 2009, NEURAL NETWORKS, V22, P1105, DOI 10.1016/j.neunet.2009.07.022; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Martinez-Trujillo, 2015, MECH SENSORY WORKING, VXXV, P43, DOI 10.1016/B978-0-12-801371-7.00005-3; McDougal RA, 2011, EXCITATORY INHIBITOR; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Petrides M, 2000, J NEUROSCI, V20, P7496; Sandberg A, 2003, NETWORK-COMP NEURAL, V14, P789, DOI 10.1088/0954-898X/14/4/309; Schneegans S., 2008, HDB COGNITIVE SCI, P241, DOI [10.1016/B978-0-08-046616-3.00013-X, DOI 10.1016/B978-0-08-046616-3.00013-X]; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shamma S, 2013, ADV EXP MED BIOL, V787, P535, DOI 10.1007/978-1-4614-1590-9_59; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Verduzco-Flores S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006399; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Zylberberg J, 2017, ANNU REV NEUROSCI, V40, P603, DOI 10.1146/annurev-neuro-070815-014006	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188562	10.1371/journal.pone.0188562	http://dx.doi.org/10.1371/journal.pone.0188562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216222	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800030
J	Lind, O; Milton, I; Andersson, E; Jensen, P; Roth, LSV				Lind, Olle; Milton, Ida; Andersson, Elin; Jensen, Per; Roth, Lina S. V.			High visual acuity revealed in dogs	PLOS ONE			English	Article							GANGLION-CELLS; DOMESTIC DOGS	Humans have selectively bred and used dogs over a period of thousands of years, and more recently the dog has become an important model animal for studies in ethology, cognition and genetics. These broad interests warrant careful descriptions of the senses of dogs. Still there is little known about dog vision, especially what dogs can discriminate in different light conditions. We trained and tested whippets, pugs, and a Shetland sheepdog in a two-choice discrimination set-up and show that dogs can discriminate patterns with spatial frequencies between 5.5 and 19.5 cycle per degree (cpd) in the bright light condition (43 cd m(-2)). This is a higher spatial resolution than has been previously reported although the individual variation in our tests was large. Humans tested in the same set-up reached acuities corresponding to earlier studies, ranging between 32.1 and 44.2 cpd. In the dim light condition (0.0087 cd m(-2)) the acuity of dogs ranged between 1.8 and 3.5 cpd while in humans, between 5.9 and 9.9 cpd. Thus, humans make visual discrimination of objects from roughly a threefold distance compared to dogs in both bright and dim light.	[Lind, Olle] Lund Univ, Cognit Sci, Lund, Sweden; [Milton, Ida; Andersson, Elin; Jensen, Per; Roth, Lina S. V.] Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, Linkoping, Sweden	Lund University; Linkoping University	Roth, LSV (corresponding author), Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, Linkoping, Sweden.	lina.roth@liu.se	Roth, Lina S.V./J-6272-2019	Roth, Lina S V/0000-0002-3297-1130	European Research Council Advanced Research Grant GENEWELL [322206]; Swedish Research Council [637-2013-388]	European Research Council Advanced Research Grant GENEWELL; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding is acknowledged from the European Research Council Advanced Research Grant GENEWELL (grant no 322206 to PJ; http://erc.europa.eu) and from the Swedish Research Council (grant with diarienr. 637-2013-388 to OL; http./vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090390; DeValois RL, 1990, SPATIAL VISION; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10; Harmening WM, 2009, J VISION, V9, DOI 10.1167/9.7.13; Harrington F.H., 2003, WOLVES BEHAV ECOLOGY; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; Johnson H. M., 1914, J ANIM BEHAV, V4, P340; Kingdom F, 2009, PALAMEDES MATLAB ROU; Land MF, 2002, ANIMAL EYES; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Miklosi A., 2015, DOG BEHAV EVOLUTION; Murphy CJ, 1997, AM J VET RES, V58, P414; NEUHAUS W, 1967, Z VERGL PHYSIOL, V57, P137, DOI 10.1007/BF00303069; ODOM JV, 1983, AM J PHYSIOL, V245, pR637, DOI 10.1152/ajpregu.1983.245.5.R637; Ofri R., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P111; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; Pongracz P, 2017, BEHAV PROCESS, V140, P53, DOI 10.1016/j.beproc.2017.04.002; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; RODIECK RW, 1973, VERTEBRATE RETINA PR; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Zaine Isabela, 2014, Psychol. Neurosci., V7, P199, DOI 10.3922/j.psns.2014.014	25	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188557	10.1371/journal.pone.0188557	http://dx.doi.org/10.1371/journal.pone.0188557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206864	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700013
J	Shendre, A; Wiener, HW; Irvin, MR; Aouizerat, BE; Overton, ET; Lazar, J; Liu, CL; Hodis, HN; Limdi, NA; Weber, KM; Gange, SJ; Zhi, DG; Floris-Moore, MA; Ofotokun, I; Qi, QB; Hanna, DB; Kaplan, RC; Shrestha, S				Shendre, Aditi; Wiener, Howard W.; Irvin, Marguerite R.; Aouizerat, Bradley E.; Overton, Edgar T.; Lazar, Jason; Liu, Chenglong; Hodis, Howard N.; Limdi, Nita A.; Weber, Kathleen M.; Gange, Stephen J.; Zhi, Degui; Floris-Moore, Michelle A.; Ofotokun, Ighovwerha; Qi, Qibin; Hanna, David B.; Kaplan, Robert C.; Shrestha, Sadeep			Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; AFRICAN-AMERICANS; INFECTED PATIENTS; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; GENE POLYMORPHISMS; LOCAL ANCESTRY; VARIANTS	Cardiovascular disease (CVD) is a major comorbidity among HIV-infected individuals. Common carotid artery intima-media thickness (cCIMT) is a valid and reliable subclinical measure of atherosclerosis and is known to predict CVD. We performed genome-wide association (GWA) and admixture analysis among 682 HIV-positive and 288 HIV-negative Black, non-Hispanic women from the Women's Interagency HIV study (WIHS) cohort using a combined and stratified analysis approach. We found some suggestive associations but none of the SNPs reached genome-wide statistical significance in our GWAS analysis. The top GWAS SNPs were rs2280828 in the region intergenic to mediator complex subunit 30 and exostosin glycosyltransferase 1 (MED30 broken vertical bar EXT1) among all women, rs2907092 in the catenin delta 2 (CTNND2) gene among HIV-positive women, and rs7529733 in the region intergenic to family with sequence similarity 5, member C and regulator of G-protein signaling 18 (FAM5C broken vertical bar RGS18) genes among HIV-negative women. The most significant local European ancestry associations were in the region intergenic to the zinc finger and SCAN domain containing 5D gene and NADH: ubiquinone oxidoreductase complex assembly factor 1 (ZSCAN5D broken vertical bar NDUF1) pseudogene on chromosome 19 among all women, in the region intergenic to vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 (VN1R6P broken vertical bar ZNF845) gene on chromosome 19 among HIV-positive women, and in the region intergenic to the SEC23-interacting protein and phosphatidic acid phosphatase type 2 domain containing 1A (SEC23IP broken vertical bar PPAPDC1A) genes located on chromosome 10 among HIV-negative women. A number of previously identified SNP associations with cCIMT were also observed and included rs2572204 in the ryanodine receptor 3 (RYR3) and an admixture region in the secretion-regulating guanine nucleotide exchange factor (SERGEF) gene. We report several SNPs and gene regions in the GWAS and admixture analysis, some of which are common across HIV-positive and HIV-negative women as demonstrated using meta-analysis, and also across the two analytic approaches (i.e., GWA and admixture). These findings suggest that local European ancestry plays an important role in genetic associations of cCIMT among black women from WIHS along with other environmental factors that are related to CVD and may also be triggered by HIV. These findings warrant confirmation in independent samples.	[Shendre, Aditi; Wiener, Howard W.; Irvin, Marguerite R.; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Aouizerat, Bradley E.] NYU, Bluestone Ctr Clin Res, New York, NY USA; [Aouizerat, Bradley E.] NYU, Dept Oral & Maxillofacial Surg, New York, NY USA; [Overton, Edgar T.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Lazar, Jason] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Liu, Chenglong] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Hodis, Howard N.] Univ Southern Calif, Atherosclerosis Res Unit, Los Angeles, CA USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Weber, Kathleen M.] Cook Cty Hlth & Hosp Syst, Hektoen Inst Med, Chicago, IL USA; [Gange, Stephen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Floris-Moore, Michelle A.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Ofotokun, Ighovwerha] Emory Univ, Dept Med Infect Dis, Atlanta, GA 30322 USA; [Ofotokun, Ighovwerha] Grady Healthcare Syst, Atlanta, GA USA; [Qi, Qibin; Hanna, David B.; Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Shendre, Aditi] Indianapolis Univ Purdue Univ Indianapolis, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN USA; [Zhi, Degui] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; New York University; New York University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of Southern California; University of Alabama System; University of Alabama Birmingham; John H Stroger Junior Hospital Cook County; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; Yeshiva University; Albert Einstein College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health Science Center Houston	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	sshrestha@uab.edu	Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X; Liu, Chenglong/0000-0001-8235-8513; Shendre, Aditi/0000-0003-4123-7613; Deloukas, Panos/0000-0001-9251-070X; Overton, Edgar/0000-0002-4013-536X	WIHS: UAB-MS WIHS [U01-AI-103401]; Atlanta WIHS [U01-AI-103408]; Bronx WIHS [U01-A I-035004]; Brooklyn WIHS [U01-AI-031834]; Chicago WIHS [U01-A I-034993]; Metropolitan Washington WIHS [U01-AI-034994]; Miami WIHS [U01-AI-103397]; UNC WIHS [U01-AI-103390]; Connie Wofsy Women's HIV Study, Northern California [U01-AI-034989]; WIHS Data Management and Analysis Center [U01-AI-042590]; Southern California WIHS [U01-HD-032632]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; UCSFCTSA [UL1-TR000004]; Atlanta CTSA [UL1-TR000454]; WIHS [R56HL125061];  [1R01HL126543];  [1R21HL120394];  [1R01HL083760];  [1R01HL095140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL129892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	WIHS: UAB-MS WIHS; Atlanta WIHS; Bronx WIHS; Brooklyn WIHS; Chicago WIHS; Metropolitan Washington WIHS; Miami WIHS; UNC WIHS; Connie Wofsy Women's HIV Study, Northern California; WIHS Data Management and Analysis Center; Southern California WIHS; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); UCSFCTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); WIHS; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-A I-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen and Audrey French), U01-A I-034993; Metropolitan Washington WIHS (Seble Kassaye), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt,Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Joel Milam), U01-HD-032632 (WIHSI-WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSFCTSA) and UL1-TR000454 (Atlanta CTSA). The cardiovascular substudies in WIHS are also supported by 1R01HL126543, 1R21HL120394, 1R01HL083760, 1R01HL095140. The analysis in this study was supported by the pilot project funds from WIHS (Pilot project PI: Shrestha) and R56HL125061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bhuiyan AR, 2007, J AM SOC HYPERTENS, V1, P362, DOI 10.1016/j.jash.2007.06.006; Bis JC, 2014, CIRC-CARDIOVASC GENE, V7, P359, DOI 10.1161/CIRCGENETICS.113.000116; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chen YC, 2015, INT J CARDIOL, V189, P264, DOI 10.1016/j.ijcard.2015.04.034; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Coll B, 2005, AIDS, V19, P1877, DOI 10.1097/01.aids.0000183516.22266.dd; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; Connelly JJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-33; Debette S, 2009, STROKE, V40, P2212, DOI 10.1161/STROKEAHA.108.537159; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Delaney JAC, 2010, AIDS, V24, P2201, DOI 10.1097/QAD.0b013e32833d2132; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dumont J, 2007, ARTERIOSCL THROM VAS, V27, P2120, DOI 10.1161/ATVBAHA.107.150458; Dumont J, 2007, J MED GENET, V44, P526, DOI 10.1136/jmg.2006.047449; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Fox ER, 2013, CIRC-CARDIOVASC GENE, V6, P37, DOI 10.1161/CIRCGENETICS.111.962365; Frasco MA, 2012, AIDS, V26, P2097, DOI 10.1097/QAD.0b013e3283593602; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; GeneCards, PATHW INT PLPP4 GEN; Gomez F, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0196-x; Goodarzi MO, 2009, ATHEROSCLEROSIS, V205, P503, DOI 10.1016/j.atherosclerosis.2008.12.038; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Heinritz W, 2009, ANN HUM GENET, V73, P283, DOI 10.1111/j.1469-1809.2009.00508.x; Hessler N, 2016, STROKE, V47, P2904, DOI 10.1161/STROKEAHA.116.013943; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Iemitsu M, 2014, EUR J APPL PHYSIOL, V114, P1421, DOI 10.1007/s00421-014-2862-5; Kanters SDJM, 1997, STROKE, V28, P665, DOI 10.1161/01.STR.28.3.665; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mackinnon MJ, 2016, MOL BIOL EVOL; Manolio TA, 2004, ARTERIOSCL THROM VAS, V24, P1567, DOI 10.1161/01.ATV.0000138789.11433.c1; Markus HS, 2013, STROKE, V44, P1220, DOI 10.1161/STROKEAHA.111.000217; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Melton PE, 2013, CIRC-CARDIOVASC GENE, V6, P211, DOI 10.1161/CIRCGENETICS.113.000079; MITTAL CK, 1994, BIOCHEM BIOPH RES CO, V203, P8, DOI 10.1006/bbrc.1994.2141; Mooij HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001274; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Natarajan P, 2016, CIRC-CARDIOVASC GENE, V9, P511, DOI 10.1161/CIRCGENETICS.116.001572; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Oramasionwu CU, 2013, POPUL HEALTH MANAG, V16, P201, DOI 10.1089/pop.2012.0043; Oramasionwu Christine U, 2012, Open AIDS J, V6, P29, DOI 10.2174/1874613601206010029; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pollex Rebecca L, 2006, Curr Atheroscler Rep, V8, P206, DOI 10.1007/s11883-006-0075-z; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin HZ, 2012, GENET EPIDEMIOL, V36, P235, DOI 10.1002/gepi.21616; Qin HZ, 2010, BIOINFORMATICS, V26, P2961, DOI 10.1093/bioinformatics/btq560; Rahman TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023248; Ruiz A, 2014, J BIOL CHEM, V289, P27665, DOI 10.1074/jbc.M114.570341; Sato J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107236; Schiano C, 2014, BBA-GENE REGUL MECH, V1839, P444, DOI 10.1016/j.bbagrm.2014.04.012; Seaberg EC, 2010, STROKE, V41, P2163, DOI 10.1161/STROKEAHA.110.583856; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Shendre A, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001569; Shendre A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004739; Shendre A, 2014, ATHEROSCLEROSIS, V233, P666, DOI 10.1016/j.atherosclerosis.2014.01.035; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Shrestha S, 2012, AIDS, V26, P1571, DOI 10.1097/QAD.0b013e328355359f; Shrestha S, 2010, AIDS, V24, P583, DOI 10.1097/QAD.0b013e3283353c9e; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stein JH, 2013, AIDS, V27, P929, DOI 10.1097/QAD.0b013e32835ce27e; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2013, CURR HIV-AIDS REP, V10, P199, DOI 10.1007/s11904-013-0168-6; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; Wang LY, 2012, CIRC-CARDIOVASC GENE, V5, P234, DOI 10.1161/CIRCGENETICS.111.961763; Wassel CL, 2011, OBESITY, V19, P840, DOI 10.1038/oby.2010.229; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yazdanpanah M, 2006, DIABETES, V55, P2922, DOI 10.2337/db06-0302; Yorgov Daniel, 2014, BMC Proc, V8, pS6, DOI 10.1186/1753-6561-8-S1-S6; Zhang JQ, 2014, GENET EPIDEMIOL, V38, P502, DOI 10.1002/gepi.21835; Zhao JY, 2013, ATHEROSCLEROSIS, V226, P238, DOI 10.1016/j.atherosclerosis.2012.10.048	87	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188725	10.1371/journal.pone.0188725	http://dx.doi.org/10.1371/journal.pone.0188725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206233	Green Published, Green Submitted, gold			2022-12-26	WOS:000417033200013
J	Alegiani, AC; MacLean, S; Braass, H; Siemonsen, S; Gerloff, C; Fiehler, J; Cho, TH; Derex, L; Hermier, M; Berthezene, Y; Nighoghossian, N; Thomalla, G				Alegiani, Anna Christina; MacLean, Simon; Braass, Hanna; Siemonsen, Susanne; Gerloff, Christian; Fiehler, Jens; Cho, Tae-Hee; Derex, Laurent; Hermier, Marc; Berthezene, Yves; Nighoghossian, Norbert; Thomalla, Goetz			Comprehensive analysis of early fractional anisotropy changes in acute ischemic stroke	PLOS ONE			English	Article							WATER DIFFUSION; ONSET; TIME	Background and purpose Cerebral ischemia leads to a rapid decrease of the apparent diffusion coefficient. For fractional anisotropy both increase and decrease have been reported in acute ischemic stroke. Aim of this study was to characterize early water diffusion changes in a homogenous group of acute stroke patients and to clarify the issue of early fractional anisotropy changes and their relation to time from symptom onset. Methods MRI data of patients with acute ischemic stroke examined by diffusion tensor imaging within 8h after symptom were analyzed. We calculated fractional anisotropy, eigenvalues and the isotropic and anisotropic components of the diffusion tensor. The values were calculated as ratios between the ischemic lesion and a mirror region in the unaffected side and correlated with clinical parameters. Results We included 63 patients: 49% female, mean age 69 +/- 14 years, median NIHSS on admission 9 (IQR 4 +/- 14). For the whole sample, mean fractional anisotropy was increased (ratio: 1.083 +/- 0.168), while all other diffusion parameters were decreased. Both the isotropic and anisotropic component of the diffusion tensor were decreased with a more pronounced decrease of the isotropic component (ratios: isotropic = 0.730 +/- 0.106, anisotropic = 0.788 +/- 0.127; p < 0.001). There was no correlation of fractional anisotropy with time from symptom onset. Looking at individual patients, fractional anisotropy was increased in 70%. There were no differences in clinical characteristics between patients with increased and decreased fractional anisotropy. Conclusion Fractional anisotropy increase in acute stroke results from a more pronounced decrease of the isotropic diffusion component and is not related to time from symptom onset. Thus, fractional anisotropy is not helpful as a surrogate marker of lesion age in the very first hours of stroke.	[Alegiani, Anna Christina; MacLean, Simon; Braass, Hanna; Gerloff, Christian; Thomalla, Goetz] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Siemonsen, Susanne; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany; [Cho, Tae-Hee; Derex, Laurent; Nighoghossian, Norbert] Univ Lyon, Dept Stroke Med, Lyon, France; [Hermier, Marc; Berthezene, Yves] Univ Lyon, Dept Neuroradiol, Lyon, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Alegiani, AC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	a.alegiani@uke.uni-hamburg.de	Derex, Laurent/AAQ-1034-2020; Berthezene, yves/I-5689-2014; Derex, Laurent/AAK-5890-2020; Cho, Tae-Hee/GOJ-9942-2022; Carmen, Team3/Y-7384-2019; Cho, Tae-Hee/I-5491-2014	Derex, Laurent/0000-0002-0909-8900; Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Cho, Tae-Hee/0000-0001-8677-2447; Gerloff, Christian/0000-0002-6484-8882	European Union Grant I-KNOW [027294]	European Union Grant I-KNOW	This work was supported by European Union Grant I-KNOW No 027294; Recipients: Jens Fiehler and Norbert Nighoghossian sponsoring of data acquisition and sources for analysis.	Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Carrera E, 2011, STROKE, V42, P1602, DOI 10.1161/STROKEAHA.110.606970; Fiehler J, 2002, STROKE, V33, P79, DOI 10.1161/hs0102.100884; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Harris AD, 2004, J MAGN RESON IMAGING, V20, P193, DOI 10.1002/jmri.20116; Herve D, 2005, J NEUROL NEUROSUR PS, V76, P200, DOI 10.1136/jnnp.2004.041012; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Marrale M, 2016, CLIN NEURORADIOL, V26, P391, DOI 10.1007/s00062-015-0469-9; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Ozsunar Y, 2004, AM J NEURORADIOL, V25, P699; Puig J, 2013, STROKE, V44, P1162, DOI 10.1161/STROKEAHA.111.678110; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	18	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188318	10.1371/journal.pone.0188318	http://dx.doi.org/10.1371/journal.pone.0188318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190762	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900047
J	Hromic-Jahjefendic, A; Jozic, NJ; Kazazic, S; Branilovic, MG; Karacic, Z; Schrittwieser, JH; Das, KMP; Tomin, M; Oberer, M; Gruber, K; Abramic, M; Tomic, S				Hromic-Jahjefendic, Altijana; Jozic, Nina Jajcanin; Kazazic, Sasa; Branilovic, Marina Grabar; Karacic, Zrinka; Schrittwieser, Jorg H.; Das, Krishna Mohan Padmanabha; Tomin, Marko; Oberer, Monika; Gruber, Karl; Abramic, Marija; Tomic, Sanja			A novel Porphyromonas gingivalis enzyme: An atypical dipeptidyl peptidase III with an ARM repeat domain	PLOS ONE			English	Article							PERIODONTAL-DISEASE; MOLECULAR-DYNAMICS; HYDROGEN-EXCHANGE; CANCER RISK; SCATTERING; MECHANISM; IV; IDENTIFICATION; PARAMETERS; PREDICTION	Porphyromonas gingivalis, an asaccharolytic Gram-negative oral anaerobe, is a major pathogen associated with adult periodontitis, a chronic infective disease that a significant percentage of the human population suffers from. It preferentially utilizes dipeptides as its carbon source, suggesting the importance of dipeptidyl peptidase (DPP) types of enzyme for its growth. Until now DPP IV, DPP5, 7 and 11 have been extensively investigated. Here, we report the characterization of DPP III using molecular biology, biochemical, biophysical and computational chemistry methods. In addition to the expected evolutionarily conserved regions of all DPP III family members, PgDPP III possesses a C-terminal extension containing an Armadillo (ARM) type fold similar to the AlkD family of bacterial DNA glycosylases, implicating it in alkylation repair functions. However, complementation assays in a DNA repair-deficient Escherichia coli strain indicated the absence of alkylation repair function for PgDPP III. Biochemical analyses of recombinant PgDPP III revealed activity similar to that of DPP III from Bacteroides thetaiotaomicron, and in the range between activities of human and yeast counterparts. However, the catalytic efficiency of the separately expressed DPP III domain is similar to 1000-fold weaker. The structure and dynamics of the ligand-free enzyme and its complex with two different diarginyl arylamide substrates was investigated using small angle X-ray scattering, homology modeling, MD simulations and hydrogen/deuterium exchange (HDX). The correlation between the experimental HDX and MD data improved with simulation time, suggesting that the DPP III domain adopts a semi-closed or closed form in solution, similar to that reported for human DPP III. The obtained results reveal an atypical DPP III with increased structural complexity: its superhelical C-terminal domain contributes to peptidase activity and influences DPP III interdomain dynamics. Overall, this research reveals multifunctionality of PgDPP III and opens direction for future research of DPP III family proteins.	[Hromic-Jahjefendic, Altijana; Das, Krishna Mohan Padmanabha; Oberer, Monika; Gruber, Karl] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Jozic, Nina Jajcanin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Kazazic, Sasa] Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia; [Branilovic, Marina Grabar; Karacic, Zrinka; Tomin, Marko; Abramic, Marija; Tomic, Sanja] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia; [Schrittwieser, Jorg H.] Karl Franzens Univ Graz, Inst Chem, Graz, Austria	University of Graz; University of Oxford; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Graz	Abramic, M; Tomic, S (corresponding author), Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia.	abramic@irb.hr; sanja.tomic@irb.hr	Kazazic, Sasa/AAE-4524-2022; Schrittwieser, Joerg/I-1011-2019; Das, Krishna Mohan Padmanabha/AAV-3476-2020; Branilović, Marina Grabar/ABG-1855-2020; Kazazic, Sasa/AAO-7920-2020; Hromic-Jahjefendic, Altijana/CAG-0216-2022; Gruber, Karl/GPP-6706-2022; Branilovic, Marina Grabar/AAF-8093-2019	Kazazic, Sasa/0000-0002-6185-2229; Schrittwieser, Joerg/0000-0002-5780-3221; Das, Krishna Mohan Padmanabha/0000-0002-0116-4256; Gruber, Karl/0000-0002-3485-9740; Grabar Branilovic, Marina/0000-0001-5742-4830; Karacic, Zrinka/0000-0001-9643-4118; Oberer, Monika/0000-0003-2525-9513; Hromic-Jahjefendic, Altijana/0000-0001-7222-8678	Croatian Science Foundation; PhD program "Molecular Enzymology" - Austrian Science Funds (EWE) [W901]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Croatian Science Foundation; PhD program "Molecular Enzymology" - Austrian Science Funds (EWE); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work has been supported by Croatian Science Foundation under the project "7235 Flexibility, activity and structure correlations in the dipeptidyl peptidase III family" and by the PhD program "Molecular Enzymology", funded by the Austrian Science Funds (EWE) under project W901.	ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2000, BIOL CHEM, V381, P1233, DOI 10.1515/BC.2000.151; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertrand KA, 2017, INT J CANCER, V140, P1020, DOI 10.1002/ijc.30518; Bezerra GA, 2012, P NATL ACAD SCI USA, V109, P6525, DOI 10.1073/pnas.1118005109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case RDA, 2015, AMBER 2015; Chen J.-M., 2004, HDB PROTEOLYTIC ENZY, P809; Cvitesic A, 2016, J ENZYM INHIB MED CH, V31, P40, DOI 10.1080/14756366.2016.1186021; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Gul IS, 2017, CELL MOL LIFE SCI, V74, P525, DOI 10.1007/s00018-016-2319-6; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P2653, DOI 10.1001/jama.2016.6295; Jajcanin-Jozic N, 2010, BIOCHIMIE, V92, P89, DOI 10.1016/j.biochi.2009.09.014; Jajcannin-Jozic N, 2013, BIOL CHEM, V394, P767, DOI 10.1515/hsz-2012-0347; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kumagai Y, 2005, INFECT IMMUN, V73, P2655, DOI 10.1128/IAI.73.5.2655-2664.2005; Kumagai Y, 2003, MICROBIOL IMMUNOL, V47, P735, DOI 10.1111/j.1348-0421.2003.tb03443.x; Kumar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23787; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Leira Y, 2017, EUR J EPIDEMIOL, V32, P43, DOI 10.1007/s10654-016-0170-6; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Momen-Heravi F, 2017, INT J CANCER, V140, P646, DOI 10.1002/ijc.30486; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nemoto TK, 2016, JPN DENT SCI REV, V52, P22, DOI 10.1016/j.jdsr.2015.08.002; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Park IH, 2015, J CHEM INF MODEL, V55, P1914, DOI 10.1021/acs.jcim.5b00185; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Potempa J, 1998, HDB PROTEOLYTIC ENZY, P762; Rea D, 2004, ACTA CRYSTALLOGR D, V60, P1871, DOI 10.1107/S0907444904017639; Read RC, 1998, TOPLEY WILSONS PRINC, V3, P319; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shay K, 2005, SPEC CARE DENT, V25, P179, DOI 10.1111/j.1754-4505.2005.tb01647.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Tomic A, 2016, PHYS CHEM CHEM PHYS, V18, P27245, DOI 10.1039/c6cp04580d; Tomic A, 2015, MOL BIOSYST, V11, P3068, DOI 10.1039/c5mb00465a; Tomic A, 2014, DALTON T, V43, P15503, DOI 10.1039/c4dt02003k; Tomic A, 2012, J CHEM INF MODEL, V52, P1583, DOI 10.1021/ci300141k; Tomic A, 2011, J MOL RECOGNIT, V24, P804, DOI 10.1002/jmr.1115; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Williams RC, 2000, PERIODONTOL 2000, V23, P9, DOI 10.1034/j.1600-0757.2000.2230101.x; Zeng XT, 2016, J PERIODONTOL, V87, P1158, DOI 10.1902/jop.2016.150597; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	72	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188915	10.1371/journal.pone.0188915	http://dx.doi.org/10.1371/journal.pone.0188915			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190734	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900167
J	Ito, M; Hayashi, K; Minamisawa, T; Homma, S; Koido, S; Shiba, K				Ito, Masaki; Hayashi, Kazumi; Minamisawa, Tamiko; Homma, Sadamu; Koido, Shigeo; Shiba, Kiyotaka			Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; DENDRITIC CELLS; ENDOTOXIN; ADJUVANT; CD40; DIFFERENTIATION; RECOGNITION; BACTERIAL; IMMUNITY	Adjuvants are indispensable for achieving a sufficient immune response from vaccinations. From a functional viewpoint, adjuvants are classified into two categories: "physical adjuvants" increase the efficacy of antigen presentation by antigen-presenting cells (APC) and "signal adjuvants" induce the maturation of APC. Our previous study has demonstrated that a physical adjuvant can be encrypted into proteinous antigens by creating artificial proteins from combinatorial assemblages of epitope peptides and those peptide sequences having propensities to form certain protein structures (motif programming). However, the artificial antigens still require a signal adjuvant to maturate the APC; for example, co-administration of the Toll-like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPLA) was required to induce an in vivo immunoreaction. In this study, we further modified the previous artificial antigens by appending the peptide motifs, which have been reported to have agonistic activity for TLR4, to create "adjuvant-free" antigens. The created antigens with triple TLR4 agonistic motifs in their C-terminus have activated NF-kappa B signaling pathways through TLR4. These proteins also induced the production of the inflammatory cytokine TNF-alpha, and the expression of the co-stimulatory molecule CD40 in APC, supporting the maturation of APC in vitro. Unexpectedly, these signal adjuvant-encrypted proteins have lost their ability to be physical adjuvants because they did not induce cytotoxic T lymphocytes (CTL) in vivo, while the parental proteins induced CTL. These results confirmed that the manifestation of a motif's function is context-dependent and simple addition does not always work for motifprograming. Further optimization of the molecular context of the TLR4 agonistic motifs in antigens should be required to create adjuvant-free antigens.	[Ito, Masaki; Hayashi, Kazumi; Homma, Sadamu] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Oncol, Tokyo, Japan; [Ito, Masaki; Minamisawa, Tamiko; Shiba, Kiyotaka] Japanese Fdn Canc Res, Canc Inst, Div Prot Engn, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Jikei University; Japanese Foundation for Cancer Research; Jikei University	Ito, M (corresponding author), Jikei Univ, Sch Med, Res Ctr Med Sci, Div Oncol, Tokyo, Japan.; Ito, M; Shiba, K (corresponding author), Japanese Fdn Canc Res, Canc Inst, Div Prot Engn, Tokyo, Japan.	mito@jikei.ac.jp; kshiba@jfcr.or.jp	Shiba, Kiyotaka/I-9588-2014	Shiba, Kiyotaka/0000-0001-6459-0204; ito, masaki/0000-0002-2149-0614	JSPS KAKENHI [JP26430172, JP12936891, 15K09050]; Grants-in-Aid for Scientific Research [26430172] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP26430172 (to M.I.), JSPS KAKENHI Grant Number JP12936891 (to K. S.), JSPS KAKENHI Grant Number 15K09050 (to S.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Iijima N, 2003, IMMUNOLOGY, V110, P197, DOI 10.1046/j.1365-2567.2003.01723.x; Ito M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110425; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; O'Hagan DT, 2015, VACCINE, V33, pB14, DOI 10.1016/j.vaccine.2015.01.088; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Saxena RK, 2003, J BIOSCIENCES, V28, P129, DOI 10.1007/BF02970143; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shanmugam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030839; Shiba K, 2010, CHEM SOC REV, V39, P117, DOI 10.1039/b719081f	19	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188934	10.1371/journal.pone.0188934	http://dx.doi.org/10.1371/journal.pone.0188934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190754	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900172
J	Pillebout, E; Jamin, A; Ayari, H; Housset, P; Pierre, M; Sauvaget, V; Viglietti, D; Deschenes, G; Monteiro, RC; Berthelot, L				Pillebout, Evangeline; Jamin, Agnes; Ayari, Hamza; Housset, Pierre; Pierre, Melissa; Sauvaget, Virginia; Viglietti, Denis; Deschenes, Georges; Monteiro, Renato C.; Berthelot, Laureline		HSPrognosis Grp	Biomarkers of IgA vasculitis nephritis in children	PLOS ONE			English	Article							HENOCH-SCHONLEIN PURPURA; DISEASE PROGRESSION; RENAL INVOLVEMENT; SERUM-LEVELS; LIPOCALIN 2; NEPHROPATHY; GLYCOSYLATION; INTERLEUKIN-6; ANTIBODIES; DEPOSITION	Henoch-Schoonlein purpura is a systemic vasculitis characterized by IgA deposits, which target the skin, joints, and kidneys, among other organs. In children, prognosis is often good but little is known about biomarkers of pediatric nephritis. We hypothesized that biological markers, including cytokines, immunoglobulins, IgA-immune complexes, IgA glycosylation and neutrophil gelatinase-associated lipocalin (NGAL), may discriminate IgA vasculitis (IgAV) pediatric patients with renal involvement from those without renal involvement. Fifty children at the time of IgAV rash between 2010 and 2015 were prospectively enrolled and compared to 21 controls. All patients were assessed for clinical and biological parameters at the time of diagnosis, including the levels of cytokines, immunoglobulins, immune complexes, IgA glycosylation and NGAL in serum and urine. Among IgAV patients, 33 patients exhibited nephritis (IgAV-N) and 17 children were without nephritis (IgAV-woN). The serum level of galactose-deficient (Gd)-IgA1 (p<0.01) and the urinary concentrations of IgA, IgG, IgM, IL-6, IL-8, IL-10, IgA-IgG complexes and IgA-sCD89 complexes (p<0.001 for all) were higher in the IgAV-N patients than in the IgAV-woN patients. Among those markers, urinary IgA and IgM had the highest AUC (0.86 and 0.87 respectively, p<0.0001). This prospective cohort study furthers our understanding of the pathophysiology of IgAV. We identified biomarkers that are able to distinguish patients initially with or without nephritis. To conclude, serum Gd-IgA1 and urinary IgA, IgG, IgM, IL-6, IL-8, IL-10, and IgA-IgG and IgA-sCD89 complexes could identify IgAV pediatric patients with renal involvement at the time of diagnosis.	[Pillebout, Evangeline; Jamin, Agnes; Ayari, Hamza; Housset, Pierre; Pierre, Melissa; Sauvaget, Virginia; Deschenes, Georges; Monteiro, Renato C.; Berthelot, Laureline] CRI, INSERM 1149, Paris, France; [Pillebout, Evangeline; Jamin, Agnes; Ayari, Hamza; Housset, Pierre; Pierre, Melissa; Sauvaget, Virginia; Deschenes, Georges; Monteiro, Renato C.; Berthelot, Laureline] Bichat Med Fac, Lab Excellence, Inflamex, Paris, France; [Pillebout, Evangeline; Jamin, Agnes; Ayari, Hamza; Housset, Pierre; Pierre, Melissa; Sauvaget, Virginia; Deschenes, Georges; Monteiro, Renato C.; Berthelot, Laureline] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Pillebout, Evangeline; Jamin, Agnes; Ayari, Hamza; Housset, Pierre; Pierre, Melissa; Sauvaget, Virginia; Deschenes, Georges; Monteiro, Renato C.; Berthelot, Laureline] CNRS, ERL8252, Paris, France; [Pillebout, Evangeline; Viglietti, Denis] St Louis Hop, AP HP, Dept Nephrol, Paris, France; [Deschenes, Georges] Robert Debre Hosp, AP HP, Dept Pediat Nephrol, DHU Fire, Paris, France; [Monteiro, Renato C.] Hop Xavier Bichat, AP HP, Dept Immunol, DHU Fire, Paris, France; [Berthelot, Laureline] Univ Nantes, INSERM, UMR 1064, CRTI, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Pillebout, E; Monteiro, RC; Berthelot, L (corresponding author), CRI, INSERM 1149, Paris, France.; Pillebout, E; Monteiro, RC; Berthelot, L (corresponding author), Bichat Med Fac, Lab Excellence, Inflamex, Paris, France.; Monteiro, RC; Berthelot, L (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Pillebout, E; Monteiro, RC; Berthelot, L (corresponding author), CNRS, ERL8252, Paris, France.; Pillebout, E (corresponding author), St Louis Hop, AP HP, Dept Nephrol, Paris, France.; Berthelot, L (corresponding author), Univ Nantes, INSERM, UMR 1064, CRTI, Nantes, France.	evangeline.pillebout@aphp.fr; renato.monteiro@inserm.fr; laureline.berthelot@inserm.fr	Berthelot, Laureline/T-1096-2017; Viglietti, Denis/J-3595-2019; Berthelot, Laureline/AAE-6262-2022; Monteiro, Renato C/U-8633-2017	Berthelot, Laureline/0000-0002-9306-9247; Berthelot, Laureline/0000-0002-9306-9247; Monteiro, Renato C/0000-0001-5202-5646; Jamin, Agnes/0000-0002-6210-4046	Assistance Publique Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM (grant RCT); Fondation pour la Recherche Medicale (FRM) [DMP20101120408]	Assistance Publique Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM (grant RCT); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This study was financially supported by Assistance Publique Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement) and together by INSERM (grant RCT 2010). Fondation pour la Recherche Medicale (FRM) supported this study (grant number DMP20101120408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are most grateful to the study participants, their parents and to the clinicians of the HSPrognostic Group. This study was financially supported by Assistance Publique Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement),by INSERM (grant RCT 2010). and by Fondation pour la Recherche Medicale (FRM, grant number DMP20101120408).	Allen AC, 1998, NEPHROL DIAL TRANSPL, V13, P930, DOI 10.1093/ndt/13.4.930; Audemard-Verger A, 2015, AUTOIMMUN REV, V14, P579, DOI 10.1016/j.autrev.2015.02.003; Belli AA, 2014, EUR J DERMATOL, V24, P81, DOI 10.1684/ejd.2013.2243; Berthelot L, 2017, NEPHROL DIAL TRANSPL; Berthelot L, 2015, KIDNEY INT, V88, P815, DOI 10.1038/ki.2015.158; Berthelot L, 2012, J EXP MED, V209, P793, DOI 10.1084/jem.20112005; Besbas N, 1997, SCAND J RHEUMATOL, V26, P456, DOI 10.3109/03009749709065719; Carlo DVG, 2008, IMMUNOPHARM IMMUNOT, V30, P623, DOI 10.1080/08923970801973646 ; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101026; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; DAVIN JC, 1994, PEDIATR NEPHROL, V8, P169, DOI 10.1007/BF00865470; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Du Y, 2014, EXP THER MED, V7, P1130, DOI 10.3892/etm.2014.1595; El Karoui K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10330; Fretzayas A, 2009, PEDIATR INT, V51, P381, DOI 10.1111/j.1442-200X.2008.02762.x; Harada K, 2002, NEPHRON, V92, P824, DOI 10.1159/000065465; Kimura S, 2013, CLIN EXP DERMATOL, V38, P730, DOI 10.1111/ced.12089; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Lau KK, 2007, PEDIATR NEPHROL, V22, P2067, DOI 10.1007/s00467-007-0623-y; Lin Chih-Yang, 2006, Journal of Microbiology Immunology and Infection, V39, P476; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Oh HJ, 2012, KIDNEY INT, V82, P1304, DOI 10.1038/ki.2012.302; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Pan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115261; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Poterucha TJ, 2014, J CUTAN PATHOL, V41, P582, DOI 10.1111/cup.12295; QUIROS AB, 1994, EUR J PEDIATR, V153, P103, DOI 10.1007/BF01959218; Robert T, 2015, TRENDS MOL MED, V21, P762, DOI 10.1016/j.molmed.2015.10.003; Saulsbury FT, 2007, LANCET, V369, P976, DOI 10.1016/S0140-6736(07)60474-7; Saulsbury FT, 1998, BRIT J RHEUMATOL, V37, P570; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Takeuchi S, 2010, J AM ACAD DERMATOL, V63, P1026, DOI 10.1016/j.jaad.2009.11.690; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Vuong MT, 2010, KIDNEY INT, V78, P1281, DOI 10.1038/ki.2010.314; Ye Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127767; Yuksel S, 2015, PEDIATR NEPHROL, V30, P969, DOI 10.1007/s00467-014-3026-x	36	50	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188718	10.1371/journal.pone.0188718	http://dx.doi.org/10.1371/journal.pone.0188718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190714	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900108
J	Pineda-Rodriguez, B; Toscano-Tejeida, D; Garcia-Vences, E; Rodriguez-Barrera, R; Flores-Romero, A; Castellanos-Canales, D; Ospina, GG; Castillo-Carvajal, L; Melendez-Herrera, E; Ibarra, A				Pineda-Rodriguez, Beatriz; Toscano-Tejeida, Diana; Garcia-Vences, Elisa; Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Castellanos-Canales, Daniela; Gutierrez Ospina, Gabriel; Castillo-Carvajal, Laura; Melendez-Herrera, Esperanza; Ibarra, Antonio			Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury	PLOS ONE			English	Article							REGULATORY T-CELLS; TRAUMATIC BRAIN-INJURY; MYELIN BASIC-PROTEIN; ADULT NEUROGENESIS; NEUROPATHIC PAIN; NKT CELLS; IN-VIVO; METHYLPREDNISOLONE; NEUROINFLAMMATION; PATHOPHYSIOLOGY	The inflammatory response is probably one of the main destructive events occurring after spinal cord injury (SCI). Its progression depends mostly on the autoimmune response developed against neural constituents. Therefore, modulation or inhibition of this self-reactive reaction could help to reduce tissue destruction. Anterior chamber associated immune deviation (ACAID) is a phenomenon that induces immune-tolerance to antigens injected into the eye A s anterior chamber, provoking the reduction of such immune response. In the light of this notion, induction of ACAID to neural constituents could be used as a potential prophylactic therapy to promote neuroprotection. In order to evaluate this approach, three experiments were performed. In the first one, the capability to induce ACAID of the spinal cord extract (SCE) and the myelin basic protein (MBP) was evaluated. Using the delayed type hypersensibility assay (DTH) we demonstrated that both, SCE and MBP were capable of inducing ACAID. In the second experiment we evaluated the effect of SCE-induced ACAID on neurological and morphological recovery after SCI. In the results, there was a significant improvement of motor recovery, nociceptive hypersensitivity and motoneuron survival in rats with SCE-induced ACAID. Moreover, ACAID also up-regulated the expression of genes encoding for anti-inflammatory cytokines and FoxP3 but down-regulated those for pro-inflamatory cytokines. Finally, in the third experiment, the effect of a more simple and practical strategy was evaluated: MBP-induced ACAID, we also found significant neurological and morphological outcomes. In the present study we demonstrate that the induction of ACAID against neural antigens in rats, promotes neuroprotection after SCI.	[Pineda-Rodriguez, Beatriz; Toscano-Tejeida, Diana; Garcia-Vences, Elisa; Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Castellanos-Canales, Daniela; Castillo-Carvajal, Laura; Ibarra, Antonio] Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte,Ave Univ Anahuac 46, Anahuac, Huixquilucan Es, Mexico; [Gutierrez Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Ciudad De Mexico, Mexico; [Melendez-Herrera, Esperanza] Univ Michoacana, Inst Invest Recursos Nat, Dept Zool, Lab Ecofisiol Anim, Morelia, Michoacan, Mexico; [Ibarra, Antonio] Proyecto CAMINA AC, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Michoacana de San Nicolas de Hidalgo	Ibarra, A (corresponding author), Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte,Ave Univ Anahuac 46, Anahuac, Huixquilucan Es, Mexico.; Ibarra, A (corresponding author), Proyecto CAMINA AC, Ciudad De Mexico, Mexico.	jose.ibarra@anahuac.mx		Castillo Carvajal, Laura Catalina/0000-0002-1531-2504; garcia vences, edna elisa/0000-0001-7588-3846; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	National Council of Science and Technology (CONACyT) [178544]; nonprofit foundation Proyecto Camina AC	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); nonprofit foundation Proyecto Camina AC	This work was supported by the National Council of Science and Technology (CONACyT; Grant 178544; https://www.conacyt.gob.mx). Al is the author who received the funding. The nonprofit foundation Proyecto Camina AC provided financial support in the form of research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0625-4; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Chamberlain JD, 2015, INJURY EPIDEMIOLOGY, V2, P1, DOI DOI 10.1186/S40621-014-0032-1; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Crowley MG, 2017, J NEUROSURG SCI, V61, P291, DOI 10.23736/S0390-5616.16.03921-7; Cui Y, 2009, INVEST OPHTH VIS SCI, V50, P5811, DOI 10.1167/iovs.09-3389; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Faunce DE, 2002, J IMMUNOL, V169, P31, DOI 10.4049/jimmunol.169.1.31; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garcia E, 2012, J NEUROSCI RES, V90, P656, DOI 10.1002/jnr.22771; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ibarra A, 2013, NEUROSCI LETT, V554, P59, DOI 10.1016/j.neulet.2013.08.048; Ibarra A, 2003, BRAIN RES, V979, P165, DOI 10.1016/S0006-8993(03)02898-1; Ibarra A, 2010, NEUROSCI LETT, V476, P62, DOI 10.1016/j.neulet.2010.04.003; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; KAPLAN HJ, 1975, TRANSPLANTATION, V19, P302, DOI 10.1097/00007890-197504000-00005; KARTHIGASAN J, 1992, J MOL NEUROSCI, V3, P185, DOI 10.1007/BF03380137; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Legos JJ, 2001, NEUROSURGERY, V49, P1427, DOI 10.1097/00006123-200112000-00022; Lin CY, 2012, J NEUROTRAUM, V29, P589, DOI 10.1089/neu.2011.2059; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Martinon S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0267-6; Meng H, 2015, DRUG RES, V65, P437, DOI 10.1055/s-0034-1389949; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Nakamura T, 2003, J IMMUNOL, V171, P1266, DOI 10.4049/jimmunol.171.3.1266; Nawaz S, 2013, GLIA, V61, P1364, DOI 10.1002/glia.22520; Neal JM, 2015, REGION ANESTH PAIN M, V40, P506, DOI 10.1097/AAP.0000000000000297; Niederkorn Jerry Y, 2007, Chem Immunol Allergy, V92, P27, DOI 10.1159/000099251; Niederkorn JY, 2009, EXPERT REV CLIN IMMU, V5, P137, DOI 10.1586/1744666X.5.2.137; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Pais R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043182; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rodriguez-Barrera R, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0331-2; Saganova K, 2009, CELL MOL NEUROBIOL, V29, P1045, DOI 10.1007/s10571-009-9395-1; Stonesifer C, 2017, PROG NEUROBIOL, V158, P94, DOI 10.1016/j.pneurobio.2017.07.004; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Teng YD, 1998, EUR J NEUROSCI, V10, P798, DOI 10.1046/j.1460-9568.1998.00100.x; Toscano-Tejeida D, 2016, MED HYPOTHESES, V88, P38, DOI 10.1016/j.mehy.2016.01.006; Wang YF, 2003, OCUL IMMUNOL INFLAMM, V11, P39, DOI 10.1076/ocii.11.1.39.15578; Zajarias-Fainsod D, 2012, EUR SPINE J, V21, P964, DOI 10.1007/s00586-011-2060-7; Zhang HN, 2008, IMMUNOLOGY, V124, P304, DOI 10.1111/j.1365-2567.2007.02769.x; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188506	10.1371/journal.pone.0188506	http://dx.doi.org/10.1371/journal.pone.0188506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190648	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900065
J	Fu, C; Bai, HT; Zhu, JQ; Niu, ZH; Wang, Y; Li, JN; Yang, XY; Bai, YS				Fu, Chuan; Bai, Haotian; Zhu, Jiaqi; Niu, Zhihao; Wang, Yu; Li, Jianan; Yang, Xiaoyu; Bai, Yunshen			Enhanced cell proliferation and osteogenic differentiation in electrospun PLGA/hydroxyapatite nanofibre scaffolds incorporated with graphene oxide	PLOS ONE			English	Article							DELIVERY; POLY(LACTIDE-CO-GLYCOLIDE); NANOCOMPOSITES; FIBERS; ACID	One of the goals of bone tissue engineering is to mimic native ECM in architecture and function, creating scaffolds with excellent biocompatibility, osteoinductive ability and mechanical properties. The aim of this study was to fabricate nanofibrous matrices by electrospinning a blend of poly (L-lactic-co-glycolic acid) (PLGA), hydroxyapatite (HA), and grapheme oxide (GO) as a favourable platform for bone tissue engineering. The morphology, biocompatibility, mechanical properties, and biological activity of all nanofibrous matrices were compared. The data indicate that the hydrophilicity and protein adsorption rate of the fabricated matrices were significantly increased by blending with a small amount of HA and GO. Furthermore, GO significantly boosted the tensile strength of the nanofibrous matrices, and the PLGA/GO/HA nanofibrous matrices can serve as mechanically stable scaffolds for cell growth. For further test in vitro, MC3T3-E1 cells were cultured on the PLGA/HA/GO nanofbrous matrices to observe various cellular activities and cell mineralization. The results indicated that the PLGA/GO/HA nanofibrous matrices significantly enhanced adhesion, and proliferation in MCET3-E1 cells and functionally promoted alkaline phosphatase (ALP) activity, the osteogenesis-related gene expression and mineral deposition. Therefore, the PLGA/HA/GO composite nanofibres are excellent and versatile scaffolds for applications in bone tissue regeneration.	[Fu, Chuan; Bai, Haotian; Zhu, Jiaqi; Li, Jianan; Yang, Xiaoyu; Bai, Yunshen] Jilin Univ, Hosp 2, Dept Orthoped Surg, Changchun, Jilin, Peoples R China; [Niu, Zhihao] Hosp Tianjin, Ctr 3, Dept Hepatobiliary Surg, Tianjin, Peoples R China; [Wang, Yu] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun, Jilin, Peoples R China	Jilin University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Yang, XY; Bai, YS (corresponding author), Jilin Univ, Hosp 2, Dept Orthoped Surg, Changchun, Jilin, Peoples R China.	yangxiaoyu88@sina.com; bysjl2017@163.com	yu, wang/AAC-7847-2021		National Natural Science Foundation of China [81672263, 31572217]; Jilin Scientific and Technological Development Program [20160101027JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Scientific and Technological Development Program	This study was supported by the National Natural Science Foundation of China, No. 81672263, No. 31572217 as well as the Jilin Scientific and Technological Development Program (20160101027JC).	Armentano I, 2008, J MATER SCI-MATER M, V19, P2377, DOI 10.1007/s10856-007-3276-2; BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8; Cai B, 2015, APPL SURF SCI, V356, P844, DOI 10.1016/j.apsusc.2015.08.178; Cheng J, 2015, J BIOACT COMPAT POL, V30, P289, DOI 10.1177/0883911515569918; Cheng LY, 2013, J MATER CHEM B, V1, P4428, DOI 10.1039/c3tb20441c; Chou WJ, 2008, COMPOS SCI TECHNOL, V68, P2208, DOI 10.1016/j.compscitech.2008.04.008; Cui LG, 2015, J BIONIC ENG, V12, P117, DOI 10.1016/S1672-6529(14)60106-2; Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Ducheyne P, 2012, NAT MATER, V11, P652, DOI 10.1038/nmat3392; Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023; Gao TL, 2016, RSC ADV, V6, P20202, DOI 10.1039/c5ra27914c; Gao TL, 2015, MACROMOL BIOSCI, V15, P1070, DOI 10.1002/mabi.201500069; Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035; Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019; Kandziora F, 2004, SPINE, V29, P1845, DOI 10.1097/01.brs.0000137060.79732.78; Kim OS, 2014, IEEE T ANTENN PROPAG, V62, P3839, DOI 10.1109/TAP.2014.2317489; Kim SE, 2014, ACS MACRO LETT, V3, P585, DOI 10.1021/mz500112d; Kim SB, 2006, ANAL BIOCHEM, V359, P147, DOI 10.1016/j.ab.2006.07.013; Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029; Li H, 2015, ACS APPL MATER INTER, V7, P14708, DOI 10.1021/acsami.5b05109; Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862; Ma HB, 2012, CHINESE SCI BULL, V57, P3051, DOI 10.1007/s11434-012-5336-3; Mehrasa M, 2015, INT J BIOL MACROMOL, V79, P687, DOI 10.1016/j.ijbiomac.2015.05.050; Patila M, 2016, INT J BIOL MACROMOL, V84, P227, DOI 10.1016/j.ijbiomac.2015.12.023; Ruan J, 2016, ADV FUNCT MATER, V26, P1085, DOI 10.1002/adfm.201504141; Shao WL, 2016, MAT SCI ENG C-MATER, V62, P823, DOI 10.1016/j.msec.2016.01.078; Shen H, 2012, ACS APPL MATER INTER, V4, P6317, DOI 10.1021/am3019367; Shin YC, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0081-9; Tang YF, 2016, COMPOS SCI TECHNOL, V125, P100, DOI 10.1016/j.compscitech.2016.02.005; Tayton E, 2014, J BIOMED MATER RES A, V102, P2613, DOI 10.1002/jbm.a.34926; Varela JN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-14; Wang H, 2014, INT J NANOMED, V9, P1433, DOI 10.2147/IJN.S58783; Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008; Wang ZL, 2016, BIOMACROMOLECULES, V17, P818, DOI 10.1021/acs.biomac.5b01543; Wang ZL, 2015, RSC ADV, V5, P96725, DOI 10.1039/c5ra19183a; Yoon O. J., COMPOSITES APPL SC A; Zhai P, 2015, MAT SCI ENG C-MATER, V56, P251, DOI 10.1016/j.msec.2015.06.015; Zhou Q., 2016, SCI REPORTS, V6, P10, DOI DOI 10.1038/SREP36373	39	61	63	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188352	10.1371/journal.pone.0188352	http://dx.doi.org/10.1371/journal.pone.0188352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186202	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900031
J	Lopez, G; Braggio, D; Zewdu, A; Casadei, L; Batte, K; Bid, HK; Koller, D; Yu, P; Iwenofu, OH; Strohecker, A; Choy, E; Lev, D; Pollock, R				Lopez, Gonzalo; Braggio, Danielle; Zewdu, Abeba; Casadei, Lucia; Batte, Kara; Bid, Hemant Kumar; Koller, David; Yu, Peter; Iwenofu, Obiajulu Hans; Strohecker, Anne; Choy, Edwin; Lev, Dina; Pollock, Raphael			Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACTIVITY IN-VITRO; PANCREATIC-CANCER; HDAC INHIBITOR; TRICHOSTATIN-A; CELL-GROWTH; CHEMOTHERAPY; RESISTANT; MGCD0103; VORINOSTAT	Leiomyosarcoma (LMS) is a malignant soft tissue sarcoma (STS) with a dismal prognosis following metastatic disease. Chemotherapeutic intervention has demonstrated to have modest clinical efficacy with no curative potential in LMS patients. Previously, we demonstrated pan-HDAC inhibition to have a superior effect in various complex karyotypic sarcomas. In this study, our goal is to evaluate the therapeutic efficacy of mocetinostat alone and in combination with gemcitabine in LMS. Human leiomyosarcoma (LMS) cell lines were used for in vitro and in vivo studies. Compounds tested included the class I HDAC inhibitor, mocetinostat, and nucleoside analog, gemcitabine. MTS and clonogenic assays were used to evaluate the effect of mocetinostat on LMS cell growth. Cleaved caspase 3/7 analysis was used to determine the effects of mocetinostat on apoptosis. Compusyn software was used to determine in vitro synergy studies for the combination of mocetinostat plus gemcitabine. A LMS xenograft model in SCID mice was used to test the impact of mocetinostat alone, gemcitabine alone and the combination of mocetinostat plus gemcitabine. Mocetinostat abrogated LMS cell growth and clonogenic potential, and enhanced apoptosis in LMS cell lines. The combination of mocetinostat plus gemcitabine exhibited a synergistic effect in LMS cells in vitro. Similarly, mocetinostat combined with gemcitabine resulted in superior anti-LMS effects in vivo. Mocetinostat reduced the expression of gemcitabine-resistance markers RRM1, RRM2, and increased the expression of gemcitabine-sensitivity marker, hENT1, in LMS cells. LMS are aggressive, metastatic tumors with poor prognosis where effective therapeutic interventions are wanting. Our studies demonstrate the potential utility of mocetinostat combined with gemcitabine for the treatment of LMS.	[Lopez, Gonzalo; Braggio, Danielle; Zewdu, Abeba; Casadei, Lucia; Batte, Kara; Koller, David; Yu, Peter; Strohecker, Anne] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Bid, Hemant Kumar] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Iwenofu, Obiajulu Hans] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Choy, Edwin] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Lev, Dina] Sheba Med Ctr, Surg B, Tel Aviv, Israel; [Pollock, Raphael] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Chaim Sheba Medical Center; University System of Ohio; Ohio State University	Pollock, R (corresponding author), Ohio State Univ, Dept Surg, Columbus, OH 43210 USA.	raphael.pollock@osumc.edu		CASADEI, Lucia/0000-0002-5731-8197; Pollock, Raphael/0000-0002-0443-1583	NIH SARC SPORE grant [U54CA168512]; National Leiomyosarcoma Foundation grant [GRT00041181/60052311]	NIH SARC SPORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Leiomyosarcoma Foundation grant	This work was supported by NIH SARC SPORE grant (U54CA168512), funding recipient RP; and National Leiomyosarcoma Foundation grant (GRT00041181/60052311), funding recipient GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerpohl O, 2007, BRIT J CANCER, V96, P73, DOI 10.1038/sj.bjc.6603511; Ansari D, 2014, ANTICANCER RES, V34, P5269; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Boumber Y, 2011, EXPERT OPIN INV DRUG, V20, P823, DOI 10.1517/13543784.2011.577737; Buggy JJ, 2006, MOL CANCER THER, V5, P1309, DOI 10.1158/1535-7163.MCT-05-0442; Candelaria M, 2010, MED ONCOL, V27, P1133, DOI 10.1007/s12032-009-9349-y; Candelaria M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029181; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chatterjee S, 2016, GYNECOL ONCOL, V141, P51; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Dovzhanskiy DI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-226; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HEINEMANN V, 1988, CANCER RES, V48, P4024; Henderson SE, 2016, NEOPLASIA, V18, P765, DOI 10.1016/j.neo.2016.10.003; Hensley ML, 2008, GYNECOL ONCOL, V109, P329, DOI 10.1016/j.ygyno.2008.03.010; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Hosokawa M, 2015, ONCOL LETT, V10, P761, DOI 10.3892/ol.2015.3253; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Iwahashi S, 2011, INT J CLIN ONCOL, V16, P671, DOI 10.1007/s10147-011-0246-y; Iwahashi S, 2011, ONCOL REP, V26, P1057, DOI 10.3892/or.2011.1407; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klein JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079502; Lee HS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41615; Lee J, 2012, CLIN MED INSIGHTS-ON, V6, DOI 10.4137/CMO.S7194; Look KY, 2004, GYNECOL ONCOL, V92, P644, DOI 10.1016/j.ygyno.2003.11.023; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Merimsky O, 1998, EUR J CANCER, V34, P1296; Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013; Piacentini P, 2006, VIRCHOWS ARCH, V448, P797, DOI 10.1007/s00428-006-0173-x; Rundall BK, 2005, SURGERY, V138, P360, DOI 10.1016/j.surg.2005.06.016; Sakamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145985; Sampson ER, 2011, J ORTHOP RES, V29, P623, DOI 10.1002/jor.21274; Samulitis BK, 2015, CANCER BIOL THER, V16, P43, DOI 10.4161/15384047.2014.986967; Schniewind Bodo, 2006, J Carcinog, V5, P25, DOI 10.1186/1477-3163-5-25; Seddon B, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-015-0029-8; Shang MJ, 2015, TUMOR BIOL, V36, P9015, DOI 10.1007/s13277-015-3537-5; Siu LL, 2008, J CLIN ONCOL, V26, P1940, DOI 10.1200/JCO.2007.14.5730; Sung V, 2011, CANCER SCI, V102, P1201, DOI 10.1111/j.1349-7006.2011.01921.x; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang R, 2001, GENE CHROMOSOME CANC, V31, P54, DOI 10.1002/gcc.1118; Wang ZJ, 2016, CANCER MED-US, V5, P3437, DOI 10.1002/cam4.956; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xue K, 2016, J CANCER RES CLIN, V142, P379, DOI 10.1007/s00432-015-2026-y	47	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188859	10.1371/journal.pone.0188859	http://dx.doi.org/10.1371/journal.pone.0188859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186204	Green Submitted, Green Published, gold			2022-12-26	WOS:000416484900067
J	Dierick, F; Nivard, AL; White, O; Buisseret, F				Dierick, Frederic; Nivard, Anne-Laure; White, Olivier; Buisseret, Fabien			Fractal analyses reveal independent complexity and predictability of gait	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; LONG-RANGE CORRELATIONS; TIME-SERIES; STRIDE-INTERVAL; HUMAN WALKING; TEMPORAL ORGANIZATION; NONLINEAR DYNAMICS; BACKWARD WALKING; VARIABILITY; DISEASE	Locomotion is a natural task that has been assessed for decades and used as a proxy to highlight impairments of various origins. So far, most studies adopted classical linear analyses of spatio-temporal gait parameters. Here, we use more advanced, yet not less practical, non-linear techniques to analyse gait time series of healthy subjects. We aimed at finding more sensitive indexes related to spatio-temporal gait parameters than those previously used, with the hope to better identify abnormal locomotion. We analysed large-scale stride interval time series and mean step width in 34 participants while altering walking direction (forward vs. backward walking) and with or without galvanic vestibular stimulation. The Hurst exponent a and the Minkowski fractal dimension D were computed and interpreted as indexes expressing predictability and complexity of stride interval time series, respectively. These holistic indexes can easily be interpreted in the framework of optimal movement complexity. We show that a and D accurately capture stride interval changes in function of the experimental condition. Walking forward exhibited maximal complexity (D) and hence, adaptability. In contrast, walking backward and/ or stimulation of the vestibular system decreased D. Furthermore, walking backward increased predictability (a) through a more stereotyped pattern of the stride interval and galvanic vestibular stimulation reduced predictability. The present study demonstrates the complementary power of the Hurst exponent and the fractal dimension to improve walking classification. Our developments may have immediate applications in rehabilitation, diagnosis, and classification procedures.	[Dierick, Frederic; Nivard, Anne-Laure; Buisseret, Fabien] Haute Ecole Louvain Hainaut HELHa, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Rue Trieu Kaisin 136, B-6061 Montignies Sur Sambre, Belgium; [Dierick, Frederic] Catholic Univ Louvain, Fac Sci Motricite, Louvain La Neuve, Belgium; [White, Olivier] Univ Bourgogne, INSERM, Cognit Act & Sensorimotor Plast U1093, Campus Univ,BP 27877, F-21078 Dijon, France; [White, Olivier] Univ East Anglia, Sch Hlth Sci, Acquired Brain Injury Rehabil Alliance, Norwich, Norfolk, England; [Buisseret, Fabien] Univ Mons, UMONS Res Inst Complex Syst, Serv Phys Nucl & Subnucl, Pl Parc 20, B-7000 Mons, Belgium	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of East Anglia; University of Mons	Buisseret, F (corresponding author), Haute Ecole Louvain Hainaut HELHa, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Rue Trieu Kaisin 136, B-6061 Montignies Sur Sambre, Belgium.; Buisseret, F (corresponding author), Univ Mons, UMONS Res Inst Complex Syst, Serv Phys Nucl & Subnucl, Pl Parc 20, B-7000 Mons, Belgium.	buisseretf@helha.be	White, Olivier/AAJ-6914-2020	White, Olivier/0000-0002-9119-1329; Dierick, Frederic/0000-0003-2061-0968				Ahn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073239; Ahn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047963; Balter SGT, 2004, ACTA OTO-LARYNGOL, V124, P262, DOI 10.1080/00016480310015245; Bent LR, 2004, J NEUROPHYSIOL, V92, P1269, DOI 10.1152/jn.01260.2003; Blouin JS, 2011, J APPL PHYSIOL, V111, P1484, DOI 10.1152/japplphysiol.00621.2011; Bollens B, 2014, ANN BIOMED ENG, V42, P742, DOI 10.1007/s10439-013-0961-9; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Crevecoeur F, 2010, J NEUROSCI METH, V192, P163, DOI 10.1016/j.jneumeth.2010.07.017; Dakin CJ, 2013, J NEUROPHYSIOL, V110, P86, DOI 10.1152/jn.00843.2012; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; FALCONER KJ, 1995, P AM MATH SOC, V123, P1115, DOI 10.2307/2160708; Fitzpatrick RC, 1999, J PHYSIOL-LONDON, V517, P931, DOI 10.1111/j.1469-7793.1999.0931s.x; Fritz NE, 2013, GAIT POSTURE, V37, P593, DOI 10.1016/j.gaitpost.2012.09.022; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gates DH, 2007, PHYSICA A, V380, P259, DOI 10.1016/j.physa.2007.02.061; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Gneiting T, 2004, SIAM REV, V46, P269, DOI 10.1137/S0036144501394387; Gneiting T, 2012, STAT SCI, V27, P247, DOI 10.1214/11-STS370; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hoogkamer W, 2014, EXERC SPORT SCI REV, V42, P23, DOI 10.1249/JES.0000000000000000; Jahn K, 2000, NEUROREPORT, V11, P1745, DOI 10.1097/00001756-200006050-00029; Kantz H., 2004, NONLINEAR TIME SERIE; Katsavelis D, 2010, NONLIN DYNAM PSYCHOL, V14, P165; Kennedy PM, 2005, NEUROREPORT, V16, P1097, DOI 10.1097/00001756-200507130-00013; Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Mandelbrot B.B, 1975, OBJETS FRACTALS FORM; Moon Y, 2016, HUM MOVEMENT SCI, V47, P197, DOI 10.1016/j.humov.2016.03.010; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; POZZO T, 1990, EXP BRAIN RES, V82, P97; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Scinicariello AP, 2001, BIOL CYBERN, V84, P475, DOI 10.1007/PL00007991; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; Warlop T, 2016, J REHABIL MED, V48, P865, DOI 10.2340/16501977-2158; West BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051917; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99	51	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188711	10.1371/journal.pone.0188711	http://dx.doi.org/10.1371/journal.pone.0188711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN9ZL	29182659	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000416402000054
J	Hietamaki, J; Hero, M; Holopainen, E; Kansakoski, J; Vaaralahti, K; Iivonen, AP; Miettinen, PJ; Raivio, T				Hietamaki, Johanna; Hero, Matti; Holopainen, Elina; Kansakoski, Johanna; Vaaralahti, Kirsi; Iivonen, Anna-Pauliina; Miettinen, Paivi J.; Raivio, Taneli			GnRH receptor gene mutations in adolescents and young adults presenting with signs of partial gonadotropin deficiency	PLOS ONE			English	Article							IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; FUNCTIONAL HYPOTHALAMIC AMENORRHEA; HOMOZYGOUS R262Q MUTATION; HORMONE RECEPTOR; DELAYED PUBERTY; CONSTITUTIONAL DELAY; DIAGNOSIS; REVERSAL; GROWTH; TESTOSTERONE	Biallelic, partial loss-of-function mutations in GNRHR cause a wide spectrum of reproductive phenotypes from constitutional delay of growth and puberty to complete congenital hypogonadotropic hypogonadism. We studied the frequency of GNRHR, FGFR1, TAC3, and TACR3 mutations in nine adolescent and young adult females with clinical cues consistent with partial gonadotropin deficiency (stalled puberty, unexplained secondary amenorrhea), and describe phenotypic features and molecular genetic findings of monozygotic twin brothers with stalled puberty. Two girls out of nine (22%, 95% CI 6-55%) carried biallelic mutations in GNRHR. The girl with compound heterozygous c. 317A>G p.(Gln106Arg) and c. 924_926delCTT p.(Phe309del) GNRHR mutations displayed incomplete puberty and clinical signs of hypoestrogenism. The patient carrying a homozygous c. 785G> A p.(Arg262Gln) mutation presented with signs of hypoestrogenism and unexplained secondary amenorrhea. None of the patients exhibited mutations in FGFR1, TAC3, or TACR3. The twin brothers, compound heterozygous for GNRHR mutations c. 317A> G p.(Gln106Arg) and c. 785G>A p.(Arg262Gln), presented with stalled puberty and were discordant for weight, and the heavier of them had lower testosterone levels. These results suggest that genetic testing of the GNRHR gene should be offered to adolescent females with low-normal gonadotropins and unexplained stalled puberty or menstrual dysfunction. In male patients with partial gonadotropin deficiency, excess adipose tissue may suppress hypothalamic-pituitary-gonadal axis.	[Hietamaki, Johanna; Hero, Matti; Kansakoski, Johanna; Vaaralahti, Kirsi; Iivonen, Anna-Pauliina; Miettinen, Paivi J.; Raivio, Taneli] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland; [Hietamaki, Johanna; Hero, Matti; Holopainen, Elina; Kansakoski, Johanna; Vaaralahti, Kirsi; Iivonen, Anna-Pauliina; Miettinen, Paivi J.; Raivio, Taneli] Helsinki Univ Hosp, Helsinki, Finland; [Hietamaki, Johanna; Kansakoski, Johanna; Vaaralahti, Kirsi; Iivonen, Anna-Pauliina; Raivio, Taneli] Univ Helsinki, Dept Physiol, Fac Med, Helsinki, Finland; [Holopainen, Elina] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Miettinen, Paivi J.] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Miettinen, Paivi J.] Univ Helsinki, Biomedicum Stem Cell Ctr, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Hietamaki, J; Raivio, T (corresponding author), Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland.; Hietamaki, J; Raivio, T (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Hietamaki, J; Raivio, T (corresponding author), Univ Helsinki, Dept Physiol, Fac Med, Helsinki, Finland.	johanna.hietamaki@helsinki.fi; taneli.raivio@helsinki.fi	Iivonen, Anna-Pauliina/D-1506-2018	Iivonen, Anna-Pauliina/0000-0001-7781-5361; Miettinen, Paivi/0000-0002-5184-9616; Holopainen, Elina/0000-0003-3572-1337	Academy of Finland [268356]; Foundation for Pediatric Research [7495]; Sigrid Juselius Foundation [2613]; Finnish Medical Foundation [011115]	Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Medical Foundation	This work was supported by The Academy of Finland (268356), http://www.aka.fi/en/; Foundation for Pediatric Research (7495), http://www.lastentautientutkimussaatio.fi/; Sigrid Juselius Foundation (2613), http://sigridjuselius.fi/en/main-page/; and the Finnish Medical Foundation (011115), http://www.laaketieteensaatio.fi/fin/in_english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneduzzi D, 2014, FERTIL STERIL, V102, P838, DOI 10.1016/j.fertnstert.2014.05.044; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Caburet S, 2017, EUR J ENDOCRINOL, V176, pK9, DOI 10.1530/EJE-16-0968; Caronia LM, 2011, NEW ENGL J MED, V364, P215, DOI 10.1056/NEJMoa0911064; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Coutant R, 2010, J CLIN ENDOCR METAB, V95, P5225, DOI 10.1210/jc.2010-1535; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dewailly D, 2002, FERTIL STERIL, V77, P1288, DOI 10.1016/S0015-0282(02)03102-3; Dwyer AA, 2016, EUR J ENDOCRINOL, V174, pR267, DOI 10.1530/EJE-15-1033; Gianetti E, 2012, J CLIN ENDOCR METAB, V97, pE1798, DOI 10.1210/jc.2012-1264; Gordon CM, 2017, J CLIN ENDOCR METAB, V102, P1413, DOI 10.1210/jc.2017-00131; HANSEN P F, 1952, Acta Med Scand Suppl, V266, P457; Harrington J, 2012, J CLIN ENDOCR METAB, V97, P3056, DOI 10.1210/jc.2012-1598; Howard SR, 2016, EMBO MOL MED, V8, P626, DOI 10.15252/emmm.201606250; Kim HG, 2010, FRONT HORM RES, V39, P94, DOI 10.1159/000312696; Laitinen EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039450; Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin L, 2006, J CLIN ENDOCR METAB, V91, P5117, DOI 10.1210/jc.2006-0807; Mayo Foundation for Medical Education and Research, TEST ID EEST ESTR SE; Mogri M, 2013, CLIN ENDOCRINOL, V78, P593, DOI 10.1111/cen.12018; Noel SD, 2011, MOL CELL ENDOCRINOL, V346, P91, DOI 10.1016/j.mce.2011.06.022; Ojajarvi P., 1982, THESIS, P2985; Palmert MR, 2012, NEW ENGL J MED, V366, P443, DOI 10.1056/NEJMcp1109290; Peacock A, 2012, ARCH DIS CHILD, V97, P554, DOI 10.1136/adc.2009.160853; Pietilaien KH, 2004, TWIN RES, V7, P421; Pitteloud N, 2001, J CLIN ENDOCR METAB, V86, P2470, DOI 10.1210/jc.86.6.2470; Quintos JB, 2009, J PEDIATR ENDOCR MET, V22, P181; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; Shaw ND, 2011, J CLIN ENDOCR METAB, V96, pE566, DOI 10.1210/jc.2010-2292; Sidhoum VF, 2014, J CLIN ENDOCR METAB, V99, P861, DOI 10.1210/jc.2013-2809; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Thodberg HH, 2009, IEEE T MED IMAGING, V28, P52, DOI 10.1109/TMI.2008.926067; Tommiska J, 2014, EUR J MED GENET, V57, P345, DOI 10.1016/j.ejmg.2014.04.002; Tommiska J, 2013, CLIN ENDOCRINOL, V78, P316, DOI 10.1111/j.1365-2265.2012.04493.x; Vaaralahti K, 2011, FERTIL STERIL, V95, P2756, DOI 10.1016/j.fertnstert.2010.12.059; Vandewalle S, 2014, J CLIN ENDOCR METAB, V99, P2977, DOI 10.1210/jc.2014-1452; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wickman S, 2001, J CLIN ENDOCR METAB, V86, P4887, DOI 10.1210/jc.86.10.4887	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188750	10.1371/journal.pone.0188750	http://dx.doi.org/10.1371/journal.pone.0188750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182666	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000056
J	Wang, B; Zhao, PP; Zhou, Y; Meng, LS; Zhu, WH; Jiang, CS; Wang, LY; Cai, YS; Lu, SM; Hou, WK				Wang, Bo; Zhao, Panpan; Zhou, Yan; Meng, Liesu; Zhu, Wenhua; Jiang, Congshan; Wang, Linyu; Cai, Yongsong; Lu, Shemin; Hou, Weikun			Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; MOUSE MODEL; GM-CSF; MICE; INFLAMMATION; RECEPTOR; JOINTS; DIFFERENTIATION	The objective of this study was to identify the key changed subtype of T helper cells (Th cells) and their cytokines in pristane-induced arthritis (PIA) in rats. The severity of arthritis was evaluated by body weight, clinical score, the perimeter of ankle and mid-paw and histological assessment of ankle joints. Cytokines of Th1, Th2 and Th17 were determined in the spleen and inguinal lymph nodes at 28 days after pristane injection by real-time qPCR. The mRNA levels of IL-22 receptors, IL-22R1 and IL-22BP, in the spleen were quantified by realtime qPCR. Additionally, IL-22 expression in synovial membrane was detected by Western blotting, and serum IL-22 concentration was determined by ELISA. Correlation between IL-22 concentration and clinical score was analyzed. By screening the cytokines of Th1, Th2 and Th17 expression profile, we found that the mRNA levels of Th17 cytokines were significantly increased in PIA rats. Particularly, a significant increase in the protein expression of IL-22 was determined in synovial membrane and serum from PIA rats, and correlated with clinical score. We conclude that IL-22 expression level was increased and correlated with disease severity, which indicated that IL-22 may play an important role in development of PIA, and was helpful to explorer the pathogenesis of rheumatoid arthritis.	[Wang, Bo; Wang, Linyu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian, Shaanxi, Peoples R China; [Wang, Bo; Zhao, Panpan; Zhou, Yan; Meng, Liesu; Zhu, Wenhua; Jiang, Congshan; Cai, Yongsong; Lu, Shemin; Hou, Weikun] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian, Shaanxi, Peoples R China; [Wang, Bo; Wang, Linyu] Key Lab Tumor Precis Med Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Zhou, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Dermatol, Xian, Shaanxi, Peoples R China; [Cai, Yongsong; Hou, Weikun] Xi An Jiao Tong Univ, Xian Honghui Hosp, Joint Surg, Osteonecrosis & Joint Reconstruct Ward,Hlth Sci C, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Hou, WK (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian, Shaanxi, Peoples R China.; Hou, WK (corresponding author), Xi An Jiao Tong Univ, Xian Honghui Hosp, Joint Surg, Osteonecrosis & Joint Reconstruct Ward,Hlth Sci C, Xian, Shaanxi, Peoples R China.	houweikun@xjtu.edu.cn	Lu, Shemin/AAI-6479-2021; wang, lin/HHM-2225-2022; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Lu, Shemin/0000-0001-8250-850X; Zhou, Yan/0000-0002-9384-8793; Jiang, Congshan/0000-0002-7457-6243; Zhu, Wenhua/0000-0002-2820-2427	National Natural Science Foundation of China; Postdoctoral Foundation of Shaanxi Province; Science and Technique Foundation of Shaanxi Province; Science Foundation of the First Affiliated Hospital of Xi'an Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of Shaanxi Province; Science and Technique Foundation of Shaanxi Province; Science Foundation of the First Affiliated Hospital of Xi'an Jiaotong University	This work was supported by grants from National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Postdoctoral Foundation of Shaanxi Province (http://postdoc.shaanxi.gov.cn/), Science and Technique Foundation of Shaanxi Province (http://www.sninfo.gov.cn/), Science Foundation of the First Affiliated Hospital of Xi'an Jiaotong University (http://www.dyyy.xjtu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Behrens F, 2007, ANN RHEUM DIS, V66, P1151, DOI 10.1136/ard.2006.068320; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; El-Zayadi AA, 2017, RHEUMATOLOGY, V56, P488, DOI 10.1093/rheumatology/kew384; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Hou W, 2010, CLIN EXP RHEUMATOL, V28, P532; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Justa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093279; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Marijnissen RJ, 2011, ARTHRITIS RHEUM-US, V63, P2939, DOI 10.1002/art.30469; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Panayi GS, 2006, NAT CLIN PRACT RHEUM, V2, P58, DOI 10.1038/ncprheum0094; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pineda MA, 2014, ARTHRITIS RHEUMATOL, V66, P1492, DOI 10.1002/art.38392; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sarkar S, 2013, ARTHRITIS RHEUM-US, V65, P960, DOI 10.1002/art.37849; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep11296; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Szekanecz Zoltan, 2009, Front Biosci (Elite Ed), V1, P44; Tuncel J, 2016, EUROPEAN J IMMUNOLOG; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526; Yang XY, 2013, J CLIN IMMUNOL, V33, P767, DOI 10.1007/s10875-013-9878-1; Yau ACY, 2016, DIS MODEL MECH, V9, P1111, DOI 10.1242/dmm.026435; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou XR, 2011, J CLIN IMMUNOL, V31, P395, DOI 10.1007/s10875-011-9508-8; Zhu WH, 2017, CLIN IMMUNOL, V175, P56, DOI 10.1016/j.clim.2016.11.017	60	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188199	10.1371/journal.pone.0188199	http://dx.doi.org/10.1371/journal.pone.0188199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182672	gold, Green Published, Green Submitted			2022-12-26	WOS:000416402000013
J	Fiebig, T; Litschko, C; Freiberger, F; Bethe, A; Berger, M; Gerardy-Schahn, R				Fiebig, Timm; Litschko, Christa; Freiberger, Friedrich; Bethe, Andrea; Berger, Monika; Gerardy-Schahn, Rita			Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; GLYCOCONJUGATE VACCINE; CONJUGATE VACCINE; POLYSACCHARIDE; CARBOHYDRATE; POLYSIALYLTRANSFERASE; TETRASACCHARIDE; PERSPECTIVE; POLYMERASE; MECHANISM	Neisseria meningitidis serogroups A and X are among the leading causes of bacterial meningitis in the African meningitis belt. Glycoconjugate vaccines, consisting of an antigenic carrier protein coupled to the capsular polysaccharide of the bacterial pathogen, are the most effective strategy for prevention of meningococcal disease. However, the distribution of effective glycoconjugate vaccines in this region is limited by the high cost of cultivating pathogens and purification of their capsular polysaccharides. Moreover, chemical approaches to synthesize oligosaccharide antigens have proven challenging. In the current study, we present a chemoenzymatic approach for generating tailored oligosaccharide fractions ready for activation and coupling to the carrier protein. In a first step, the elongation modes of recombinant capsular polymerases from Neisseria meningitidis serogroups A (CsaB) and X (CsxA) were characterized. We observed that CsaB is a distributive enzyme, and CsxA is a processive enzyme. Sequence comparison of these two stealth family proteins revealed a C-terminal extension in CsxA, which conferred processivity because of the existence of a second product-binding site. Deletion of the C-terminal domain converted CsxA into a distributive enzyme, allowing facile control of product length by adjusting the ratio of donor to acceptor sugars. Solid-phase fixation of the engineered capsular polymerases enabled rapid production of capsular polysaccharides with high yield and purity. In summary, the tools developed here provide critical steps toward reducing the cost of conjugate vaccine production, which will increase access in regions with the greatest need. Our work also facilitates efforts to study the relationship between oligosaccharide size and antigenicity.	[Fiebig, Timm; Litschko, Christa; Freiberger, Friedrich; Bethe, Andrea; Berger, Monika; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Hannover Medical School	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de		Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	LOM from Medizinische Hochschule Hannover (Hannover Medical School)	LOM from Medizinische Hochschule Hannover (Hannover Medical School)	This work was supported by LOM (impact-oriented funding) funds to the Institute of Clinical Biochemistry from Medizinische Hochschule Hannover (Hannover Medical School). T.F., M.B., A.B., F.F., and R.G.-S. have submitted patent applications for glycoconjugate vaccines against NmA and NmX.	Adamo R, 2017, ACCOUNTS CHEM RES, V50, P1270, DOI 10.1021/acs.accounts.7b00106; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P145; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; Berti F, 2013, ACS CHEM BIOL, V8, P1653, DOI 10.1021/cb400423g; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; Fallarini S, 2015, ACS INFECT DIS, V1, P487, DOI 10.1021/acsinfecdis.5b00071; Fiebig T, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.17; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Gao Q, 2013, ACS CHEM BIOL, V8, P2561, DOI 10.1021/cb400463u; Harale KR, 2017, ORG CHEM FRONT, V4, P2348, DOI 10.1039/c7qo00468k; Harale KR, 2015, RSC ADV, V5, P41332, DOI 10.1039/c5ra02993g; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814; Kulkarni PS, 2015, CLIN INFECT DIS, V61, pS483, DOI 10.1093/cid/civ500; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Litschko C, 2015, J BIOL CHEM, V290, P24355, DOI 10.1074/jbc.M115.678094; Maurice J, 2015, LANCET, V385, P2241, DOI 10.1016/S0140-6736(15)61050-9; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Micoli F, 2013, P NATL ACAD SCI USA, V110, P19077, DOI 10.1073/pnas.1314476110; Morelli L, 2014, BEILSTEIN J ORG CHEM, V10, P2367, DOI 10.3762/bjoc.10.247; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; Romanow A, 2014, J BIOL CHEM, V289, P33945, DOI 10.1074/jbc.M114.597773; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Schumann B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5347; SEPPALA I, 1989, J IMMUNOL, V143, P1259; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036	43	22	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					953	962		10.1074/jbc.RA117.000488	http://dx.doi.org/10.1074/jbc.RA117.000488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187601	Green Published, hybrid			2022-12-26	WOS:000422864500016
J	Giannakou, A; Sicko, RJ; Zhang, W; Romitti, P; Browne, ML; Caggana, M; Brody, LC; Jelliffe-Pawlowski, L; Shaw, GM; Kay, DM; Mills, JL				Giannakou, Andreas; Sicko, Robert J.; Zhang, Wei; Romitti, Paul; Browne, Marilyn L.; Caggana, Michele; Brody, Lawrence C.; Jelliffe-Pawlowski, Laura; Shaw, Gary M.; Kay, Denise M.; Mills, James L.			Copy number variants in Ebstein anomaly	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AVIAN PREGASTRULA EPIBLAST; 2ND HEART FIELD; CARDIAC MYOGENESIS; TRICUSPID-VALVE; SKELETAL ABNORMALITIES; DILATED CARDIOMYOPATHY; DEFINITIVE ENDODERM; ACTIVIN-A; IN-VITRO	Background Ebstein anomaly (EA) is a rare congenital defect characterized by apical displacement of the septal tricuspid leaflets and atrialization of the right ventricle. The etiology of EA is unclear; however, recurrence in families and the association of EA with genetic syndromes and copy number variants (CNVs) suggest a genetic component. Objective We performed a population-based study to search for recurrent and novel CNVs in a previously unreported set of EA cases. Methods We genotyped 60 EA cases identified from all live births (2,891,076) from selected California counties (1991-2010) using the Illumina HumanOmni 2.5-8 array. We identified 38 candidate CNVs in 28 (46%) cases and prioritized and validated 11 CNVs based on the genes included. Results Five CNVs (41%) overlapped or were close to genes involved in early myocardial development, including NODAL, PDLIM5, SIX1, ASF1A and FGF12. We also replicated a previous association of EA with CNVs at 1p34.1 and AKAP12. Finally, we identified four CNVs overlapping or in close proximity to the transcription factors HES3, TRIM71, CUX1 and EIF4EBP2. Conclusions This study supports the relationship of genetic factors to EA and demonstrates that defects in cardiomyocytes and myocardium differentiation may play a role. Abnormal differentiation of cardiomyocytes and how genetic factors contribute should be examined for their association with EA.	[Giannakou, Andreas; Zhang, Wei; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Sicko, Robert J.; Caggana, Michele; Kay, Denise M.] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY USA; [Romitti, Paul] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Browne, Marilyn L.] SUNY Albany, Dept Epidemiol & Biostat, Sch Publ Hlth, Rensselaer, NY USA; [Brody, Lawrence C.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Jelliffe-Pawlowski, Laura] Univ Calif San Francisco, Calif San Francisco Sch Med, San Francisco, CA 94143 USA; [Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center; University of Iowa; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Francisco; Stanford University	Mills, JL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	jamesmills@nih.gov		Sicko, Robert/0000-0001-7521-9742; Shaw, Gary/0000-0001-7438-4914; Mills, James/0000-0003-4496-332X; Kay, Denise/0000-0002-9928-2698; Romitti, Paul/0000-0001-5393-9984	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [HHSN2752011000011, HHSN27500005]; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD contract) [N01-DK-73431]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008951] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD contract); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (contract numbers HHSN2752011000011 and HHSN27500005; NICHD contract N01-DK-73431). This study was internally funded by the investigators' institution. No outside funding was involved and the investigators had total control over data collection and analysis, decision to publish and preparation of the manuscript.; This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; BALAJI S, 1991, BRIT HEART J, V66, P26; Bettinelli AL, 2013, AM J MED GENET A, V161, P3187, DOI 10.1002/ajmg.a.36182; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Boghossian NS, 2016, AM J MED GENET A, V170, P622, DOI 10.1002/ajmg.a.37493; Booker OJ, 2015, ECHOCARDIOGR-J CARD, V32, P69, DOI 10.1111/echo.12486; Bowman A, 2017, NUCLEIC ACIDS RES, V45, P643, DOI 10.1093/nar/gkw892; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dilg D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161096; DONEGAN CC, 1968, AM HEART J, V75, P375, DOI 10.1016/0002-8703(68)90095-1; Fesslova V, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/368067; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Fost CHA, 2005, SWISS MED WKLY, V135, P269; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GUERON M, 1966, AM J CARDIOL, V18, P105, DOI 10.1016/0002-9149(66)90202-5; Guillory AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074784; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Hennessey JA, 2013, HEART RHYTHM, V10, P1886, DOI 10.1016/j.hrthm.2013.09.064; Hutson MR, 2006, DEV BIOL, V295, P486, DOI 10.1016/j.ydbio.2006.02.052; Ito J, 2015, CELL SIGNAL, V27, P2425, DOI 10.1016/j.cellsig.2015.09.007; Ito J, 2013, BIOCHEM BIOPH RES CO, V435, P483, DOI 10.1016/j.bbrc.2013.05.016; Jost CHA, 2005, MAYO CLIN PROC, V80, P361, DOI 10.4065/80.3.361; Katoh M, 2007, INT J ONCOL, V31, P461; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Laitenberger G, 2008, PEDIATR CARDIOL, V29, P1104, DOI 10.1007/s00246-007-9150-7; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Lupo PJ, 2011, AM J MED GENET A, V155A, P1007, DOI 10.1002/ajmg.a.33883; MANGIACAPRA FJ, 1995, CELL TISSUE RES, V282, P227, DOI 10.1007/s004410050475; Margalit-Stashefski Ruti, 1998, Harefuah, V134, P762; Martinez-Jacobo L, 2013, MOL SYNDROMOL, V4, P285, DOI 10.1159/000353510; Matsui H, 2005, DEV DYNAM, V233, P1419, DOI 10.1002/dvdy.20477; Mu YX, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001950; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Osada SI, 1999, DEVELOPMENT, V126, P3229; Oxenius A, 2013, CARDIOL YOUNG, V23, P27, DOI 10.1017/S1047951112000224; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Postma AV, 2011, CIRC-CARDIOVASC GENE, V4, P43, DOI 10.1161/CIRCGENETICS.110.957985; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Rigler SL, 2015, GENET MED, V17, P348, DOI 10.1038/gim.2014.112; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; SCHULMAN J, 1993, PUBLIC HEALTH REP, V108, P91; Shimasaki N, 2004, PEDIATR CARDIOL, V25, P411, DOI 10.1007/s00246-003-0271-3; Sicko RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165174; SIMCHA A, 1971, BRIT HEART J, V33, P46; Sinkovec M, 2005, INT J CARDIOL, V102, P297, DOI 10.1016/j.ijcard.2004.05.033; Song ZZ, 2010, INT J CARDIOL, V143, pE30, DOI 10.1016/j.ijcard.2008.12.024; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; SUGI Y, 1995, DEV BIOL, V168, P567, DOI 10.1006/dbio.1995.1102; SUMNER RG, 1964, CIRCULATION, V30, P578, DOI 10.1161/01.CIR.30.4.578; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Trost D, 1999, DEUT MED WOCHENSCHR, V124, P3, DOI 10.1055/s-2008-1062601; Uyan C, 2002, INT J CARDIOVAS IMAG, V18, P435, DOI 10.1023/A:1021153504393; Vitelli F, 2006, DEV BIOL, V295, P559, DOI 10.1016/j.ydbio.2006.03.044; Walsh R, 2010, CARDIOLOGY, V115, P49, DOI 10.1159/000252808; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; Yuan SM, 2016, PEDIAT NEONATOLOGY; ZUBERBUHLER JR, 1979, J THORAC CARDIOV SUR, V77, P202	68	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188168	10.1371/journal.pone.0188168	http://dx.doi.org/10.1371/journal.pone.0188168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216221	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800018
J	Kim, M; Kim, M; Yoo, HJ; Lee, E; Chae, JS; Lee, SH; Lee, JH				Kim, Minjoo; Kim, Minkyung; Yoo, Hye Jin; Lee, Eunji; Chae, Jey Sook; Lee, Sang-Hyun; Lee, Jong Ho			A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients	PLOS ONE			English	Article							APOLIPOPROTEIN A5 GENE; PULSE-WAVE VELOCITY; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; MARKED HYPERTRIGLYCERIDEMIA; PLASMA; RISK; C.553G-GREATER-THAN-T; ASSOCIATION; POPULATION	Hypertriglyceridemia is recognized as an independent risk factor for coronary artery disease. The apolipoprotein A5 gene (APOA5) is a key regulator of triglyceride levels. We aimed to evaluate the associations of single nucleotide polymorphisms (SNPs) in APOA5, including -1131T>C and c.553G>T, with hypertriglyceridemia, apoA5 concentrations, atherogenic LDL cholesterol levels, and arterial stiffness in hypertriglyceridemic patients. The study population included 599 hypertriglyceridemic patients (case) and 1,549 untreated normotriglyceridemic subjects (control). We genotyped two APOA5 variants, -1131T>C (rs662799) and c.553G>T (rs2075291). The frequencies of the CC genotype of -1131T>C (0.165) and the T allele of c.553G>T (0.119) were significantly higher in hypertriglyceridemic patients than in normotriglyceridemic subjects (0.061 and 0.070, respectively; all p< 0.001). In the control and case groups, both the -1131T>C and c.553G>T variants were associated with higher triglyceride and lower HDL cholesterol levels. Controls with the -1131CC variant had lower apoA5 concentrations than controls with the -1131TT variant. Similar effects of the -1131T>C variant on apoA5 were observed in the cases. In the hypertriglyceridemic group, the -1131T>C variant was associated with a smaller LDL particle size, higher levels of oxidized LDL and malondialdehyde, and higher brachial-ankle pulse wave velocity. The -1131T>C and c.553G>T polymorphisms were associated with hypertriglyceridemia in the study population, but only the -1131T>C polymorphism directly affected apoA5 concentrations. Hypertriglyceridemic patients carrying the APOA5 -1131T>C polymorphism exhibited increased atherogenic LDL levels and arterial stiffness, probably due to an effect of the -1131T>C polymorphism on apoA5 concentrations.	[Kim, Minjoo; Kim, Minkyung; Chae, Jey Sook; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea; [Yoo, Hye Jin; Lee, Eunji; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea; [Lee, Eunji; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea; [Lee, Sang-Hyun] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Family Practice, Goyang, South Korea	Yonsei University; Yonsei University; Yonsei University; NHIS Ilsan Hospital	Lee, JH (corresponding author), Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea.	jhleeb@yonsei.ac.kr			Bio-Synergy Research Project of the Ministry of Science [NRF-2012M3A9C4048762]; Mid-career Researcher Program of the Ministry of Science [NRF-2016R1A2B4011662]; ICT and Future Planning through National Research Foundation of the Republic of Korea	Bio-Synergy Research Project of the Ministry of Science; Mid-career Researcher Program of the Ministry of Science; ICT and Future Planning through National Research Foundation of the Republic of Korea	This study was funded by the Bio-Synergy Research Project (NRF-2012M3A9C4048762) and the Mid-career Researcher Program (NRF-2016R1A2B4011662) of the Ministry of Science and by ICT and Future Planning through the National Research Foundation of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas-Padilla Maria Cristina, 2007, Am J Ther, V14, P172, DOI 10.1097/01.pap.0000249914.75895.48; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Corella D, 2007, J MOL MED-JMM, V85, P119, DOI 10.1007/s00109-006-0147-0; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Dorfmeister B, 2008, ARTERIOSCL THROM VAS, V28, P1866, DOI 10.1161/ATVBAHA.108.172866; Elosua R, 2006, J LIPID RES, V47, P990, DOI 10.1194/jlr.M500446-JLR200; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Guardiola M, 2015, ATHEROSCLEROSIS, V240, P98, DOI 10.1016/j.atherosclerosis.2015.03.008; He HJ, 2016, GENET TEST MOL BIOMA, V20, P758, DOI 10.1089/gtmb.2016.0047; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang YJ, 2012, CLIN CHIM ACTA, V413, P246, DOI 10.1016/j.cca.2011.09.045; Hung CS, 2009, NUTR METAB CARDIOVAS, V19, P241, DOI 10.1016/j.numecd.2008.07.006; Jang Y, 2009, CLIN CHIM ACTA, V402, P83, DOI 10.1016/j.cca.2008.12.024; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kim EJ, 2007, J HUM HYPERTENS, V21, P141, DOI 10.1038/sj.jhh.1002120; Kim M, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0063-4; Kim OY, 2013, CLIN EXP HYPERTENS, V35, P382, DOI 10.3109/10641963.2012.739232; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KH, 2010, METABOLISM, V59, P1583, DOI 10.1016/j.metabol.2010.02.008; Matsunaga A, 2007, CIRC J, V71, P746, DOI 10.1253/circj.71.746; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Sharma V, 2014, ARTERIOSCL THROM VAS, V34, P2254, DOI 10.1161/ATVBAHA.114.304027; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Xie SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129488; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhao TF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-120	39	7	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186693	10.1371/journal.pone.0186693	http://dx.doi.org/10.1371/journal.pone.0186693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211729	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200008
J	Lin, WC; Chang, CW; Chen, MJ; Chu, CH; Shih, SC; Hsu, TC; Wang, HY				Lin, Wei-Chen; Chang, Chen-Wang; Chen, Ming-Jen; Chu, Cheng-Hsin; Shih, Shou-Chuan; Hsu, Tzu-Chi; Wang, Horng-Yang			Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOODY DIARRHEA; TAIWAN SOCIETY; FIRST ATTACKS; MANAGEMENT	Ulcerative colitis (UC) is a chronic inflammation of the large bowel characterized by diarrhea and a negative stool culture. However, several enteropathogens have been implicated as causative agents in UC. The differentiation between chronic infectious colitis (IC) and UC with concurrent infection is difficult owing to their similar clinical presentations. The study aimed to explore the presentations and diagnostic clues that enable differentiation between UC with concomitant infections and chronic IC. The study included 17 UC patients with a bacterial infection and 46 with chronic IC. The UC patients (47 +/- 19 years) were younger than the chronic IC patients (58 +/- 20 years) (P = 0.022). Bloody diarrhea was more common in UC than in chronic IC (58.8% vs 10.9%, P < 0.001). Previous antibiotic usage was a risk factor for chronic IC (5.9% vs 32.6%, P = 0.031). Malignancy was a common comorbidity of chronic IC (5.9% vs 34.8%, P = 0.022). UC patients had lower antibiotic response rates than chronic IC patients (60.0% vs 87.2%, P = 0.026). Aeromonas species and Clostridium difficile were common in both groups. Histological features of cryptitis and crypt abscess were useful in the diagnosis of UC (P = 0.052 and P = 0.016, respectively). Bloody diarrhea in a young adult, decreased response to antibiotic treatment, and results of endoscopy with biopsy are important features in the diagnosis of UC with bacterial infection.	[Lin, Wei-Chen; Chang, Chen-Wang; Chen, Ming-Jen; Chu, Cheng-Hsin; Shih, Shou-Chuan; Wang, Horng-Yang] Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Hsu, Tzu-Chi] Mackay Mem Hosp, Div Colon & Rectal Surg, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital	Lin, WC (corresponding author), Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan.	b8801040@gmail.com	Chu, Chu/T-6038-2019					Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Chi CY, 2017, J MICROBIOL IMMUNOL, VS1684-1182, P30085; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Haffajee J, 2003, AM J GASTROENTEROL, V98, pS174; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Juckett G, 2011, AM FAM PHYSICIAN, V84, P1119; Kaiser L, 2012, BEST PRACT RES CL GA, V26, P563, DOI 10.1016/j.bpg.2012.11.001; Lin WC, 2016, J AM GERIATR SOC, V64, pE95, DOI 10.1111/jgs.14427; Lobaton T, 2015, INFLAMM BOWEL DIS, V21, P71, DOI 10.1097/MIB.0000000000000247; Mota MI, 2010, REV ARGENT MICROBIOL, V42, P114, DOI 10.1590/S0325-75412010000200009; Ohkusa T, 2010, AM J GASTROENTEROL, V105, P1820, DOI 10.1038/ajg.2010.84; Ricciardi R, 2009, DIS COLON RECTUM, V52, P40, DOI 10.1007/DCR.0b013e31819733fd; Sartor RB, 1996, CURR OPIN GASTROEN, V12, P327, DOI 10.1097/00001574-199607000-00003; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; SCHUMACHER G, 1993, SCAND J GASTROENTERO, V28, P1077, DOI 10.3109/00365529309098313; SCHUMACHER G, 1994, SCAND J GASTROENTERO, V29, P265, DOI 10.3109/00365529409090475; Shetty S, 2011, HISTOPATHOLOGY, V59, P850, DOI 10.1111/j.1365-2559.2011.04019.x; Talan DA, 2001, CLIN INFECT DIS, V32, P573, DOI 10.1086/318718; Tanaka M, 1999, SCAND J GASTROENTERO, V34, P55; Tremaine WJ, 2007, CLIN GASTROENTEROL H, V5, P310, DOI 10.1016/j.cgh.2006.12.030; Villafuerte-Galvez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046690; Wei SC, 2017, INTEST RES, V15, P266, DOI 10.5217/ir.2017.15.3.266; Wilks S., 1875, LECTURES PATHOLOGICA, P408; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896	26	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189377	10.1371/journal.pone.0189377	http://dx.doi.org/10.1371/journal.pone.0189377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211811	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200077
J	Alkishe, AA; Peterson, AT; Samy, AM				Alkishe, Abdelghafar A.; Peterson, A. Townsend; Samy, Abdallah M.			Climate change influences on the potential geographic distribution of the disease vector tick Ixodes ricinus	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; BORNE ENCEPHALITIS; BORRELIA-BURGDORFERI; SPECIES DISTRIBUTIONS; HIGHER ALTITUDES; IMPACT; EPIDEMIOLOGY; CONSTRAINTS; PREVALENCE; PATHOGENS	Background Ixodes ricinus is a species of hard tick that transmits several important diseases in Europe and North Africa, including Lyme borreliosis and tick-borne encephalitis. Climate change is affecting the geographic distributions and abundances of arthropod vectors, which in turn influence the geographic distribution and epidemiology of associated vector-borne diseases. To date, few studies have investigated effects of climate change on the spatial distribution of I. ricinus at continental extents. Here, we assessed the potential distribution of I. ricinus under current and future climate conditions to understand how climate change will influence the geographic distribution of this important tick vector in coming decades. Method We used ecological niche modeling to estimate the geographic distribution of I. ricinus with respect to current climate, and then assessed its future potential distribution under different climate change scenarios. This approach integrates occurrence records of I. ricinus with six relevant environmental variables over a continental extent that includes Europe, North Africa, and the Middle East. Future projections were based on climate data from 17 general circulation models (GCMs) under 2 representative concentration pathway emissions scenarios (RCPs), for the years 2050 and 2070. Result The present and future potential distributions of I. ricinus showed broad overlap across most of western and central Europe, and in more narrow zones in eastern and northern Europe, and North Africa. Potential expansions were observed in northern and eastern Europe. These results indicate that I. ricinus populations could emerge in areas in which they are currently lacking, posing increased risks to human health in those areas. However, the future of I. ricinus ticks in some important regions such the Mediterranean was unclear owing to high uncertainty in model predictions.	[Alkishe, Abdelghafar A.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Alkishe, Abdelghafar A.] Univ Tripoli, Fac Sci, Zool Dept, Tripoli, Libya; [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Entomol Dept, Cairo, Egypt	University of Kansas; Egyptian Knowledge Bank (EKB); Ain Shams University	Alkishe, AA (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.; Alkishe, AA (corresponding author), Univ Tripoli, Fac Sci, Zool Dept, Tripoli, Libya.; Samy, AM (corresponding author), Ain Shams Univ, Fac Sci, Entomol Dept, Cairo, Egypt.	al.keesh@ku.edu; samy@sci.asu.edu.eg	Samy, Abdallah/B-4375-2010; Alkishe, Abdelghafar/AAM-6814-2020	Samy, Abdallah/0000-0003-3978-1134; Alkishe, Abdelghafar/0000-0003-2927-514X	Ministry of Higher Education, Libya; Graduate Fulbright Egyptian Mission Program (EFMP); Egyptian Fulbright Mission Program [EFMP]	Ministry of Higher Education, Libya; Graduate Fulbright Egyptian Mission Program (EFMP); Egyptian Fulbright Mission Program [EFMP]	AAA was supported by the Ministry of Higher Education, Libya. AMS was supported by the Graduate Fulbright Egyptian Mission Program (EFMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the University of Kansas Ecological Niche Modeling (KU ENM) Group, and the Surveillance, Ecology, and Epidemiology Research Group, Cairo, Egypt. Thanks to the Ministry of Higher Education, Libya, for supporting AAA during his studies at the University of Kansas; AMS was funded by the Egyptian Fulbright Mission Program [EFMP]. Special thanks to the staff of the Zoology Department, Faculty of Science, University of Tripoli, Tripoli, Libya; for their continuous support during the study. Thanks to Gengping Zhu and Katie Allen for assistance with data analysis. Thanks to Arwa Elaagip who hosted AMS during his work on this project at Khartoum University, Sudan.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Daniel M, 2004, INT J MED MICROBIOL, V293, P55, DOI 10.1016/S1433-1128(04)80009-3; Danielova V, 2008, INT J MED MICROBIOL, V298, P68, DOI 10.1016/j.ijmm.2008.02.005; Derdakova M, 2005, ANN AGR ENV MED, V12, P165; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Estrada-Pena A, 2007, J MED ENTOMOL, V44, P1130, DOI 10.1603/0022-2585(2007)44[1130:CNOTSI]2.0.CO;2; Estrada-Pena A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1474-9; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Filippova Natalia Aleksandrovna, 2002, Acta Zoologica Lituanica, V12, P215, DOI 10.1080/13921657.2002.10512509; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gray J. S., 1991, Review of Medical and Veterinary Entomology, V79, P323; Gray JS, 2008, INT J MED MICROBIOL, V298, P19, DOI 10.1016/j.ijmm.2007.09.005; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jore S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-11; Kovalev SY, 2016, TICKS TICK-BORNE DIS, V7, P113, DOI 10.1016/j.ttbdis.2015.09.005; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindgren E, 2006, LYME BORRELIOSIS EUR; Materna J., 2005, Central European Journal of Public Health, V13, P24; Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; MILNE A, 1949, PARASITOLOGY, V39, P173, DOI 10.1017/S0031182000083736; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Paulauskas A, 2016, J VECTOR ECOL, V41, P244, DOI 10.1111/jvec.12219; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porretta Daniele, 2013, Parasites & Vectors, V6, P1; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Ruiz-Fons F, 2012, APPL ENVIRON MICROB, V78, P2669, DOI 10.1128/AEM.06564-11; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Schwarz A, 2009, INT J HYG ENVIR HEAL, V212, P87, DOI 10.1016/j.ijheh.2007.12.001; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zeman P, 2010, TICKS TICK-BORNE DIS, V1, P129, DOI 10.1016/j.ttbdis.2010.05.003; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	48	84	84	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189092	10.1371/journal.pone.0189092	http://dx.doi.org/10.1371/journal.pone.0189092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206879	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700048
J	Andryushchenko, VA; Chekmarev, SF				Andryushchenko, Vladimir A.; Chekmarev, Sergei F.			Turbulence in protein folding: Vorticity, scaling and diffusion of probability flows	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BETA-SHEET MINIPROTEIN; TRP-CAGE; ENERGY LANDSCAPE; MECHANISMS; MODEL; THERMODYNAMICS; PERSPECTIVE; INTEGRATION; KINETICS	Recently, when studying folding of a SH3 domain, we discovered that the flows of transitions between protein states can be surprisingly similar to turbulent fluid flows. This similarity was not restricted by a vortex pattern of the flow fields but extended to a spatial correlation of flow fluctuations, resulting, in particular, in the structure functions such as in the Kolmogorov theory of homogeneous and isotropic turbulence. Here, we undertake a detailed analysis of spatial distribution of folding flows and their similarity to turbulent fluid flows. Using molecular dynamics simulations, we study folding of another benchmark system-Trp-cage miniprotein, which has different content of secondary structure elements and mechanism of folding. Calculating the probability fluxes of transitions in a three-dimensional space of collective variables, we have found that similar to the SH3 domain, the structure functions of the second and third orders correspond to the Kolmogorov functions. The spatial distributions of the probability fluxes are self-similar with a fractal dimension, and the fractal index decreases toward the native state, indicating that the flow becomes more turbulent as the native state is approached. We also show that the process of folding can be viewed as Brownian diffusion in the space of probability fluxes. The diffusion coefficient plays a role of the key parameter that defines the structures functions, similar to the rate of dissipation of kinetic energy in hydrodynamic turbulence. The obtained results, first, show that the very complex dynamics of protein folding allows a simple characterization in terms of scaling and diffusion of probability fluxes, and, secondly, they suggest that the turbulence phenomena similar to hydrodynamic turbulence are not specific of folding of a particular protein but are common to protein folding.	[Andryushchenko, Vladimir A.; Chekmarev, Sergei F.] RAS, SB, Inst Thermophys, Novosibirsk, Russia; [Andryushchenko, Vladimir A.; Chekmarev, Sergei F.] Novosibirsk State Univ, Dept Phys, Novosibirsk, Russia	Russian Academy of Sciences; S.S. Kutateladze Institute of Thermophysics, Siberian Division of the Russian Academy of Sciences; Novosibirsk State University	Chekmarev, SF (corresponding author), RAS, SB, Inst Thermophys, Novosibirsk, Russia.; Chekmarev, SF (corresponding author), Novosibirsk State Univ, Dept Phys, Novosibirsk, Russia.	chekmarev@itp.nsc.ru	Chekmarev, Sergei F/N-4255-2017	Chekmarev, Sergei F/0000-0002-5603-8193	Russian Science Foundation [14-1400325]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, Grant number 14-1400325, SCh, http://grant.rscf.ru/.	Andryushchenko VA, 2016, EUR BIOPHYS J BIOPHY, V45, P229, DOI 10.1007/s00249-015-1089-7; Barenghi CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35701; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chekmarev SF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018107; Chekmarev SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121640; Chekmarev SF, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824133; Chowdhury S, 2004, J PHYS CHEM B, V108, P13855, DOI 10.1021/jp0478920; Darmofal DL, 1996, J COMPUT PHYS, V123, P182, DOI 10.1006/jcph.1996.0015; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Eyink GL, 1996, J STAT PHYS, V83, P385, DOI 10.1007/BF02183738; Ferrara P, 2000, J PHYS CHEM B, V104, P5000, DOI 10.1021/jp994157t; Ferrara P, 2002, PROTEINS, V46, P24, DOI 10.1002/prot.10001; Frisch U., 1995, TURBULENCE LEGACY AN; Gardiner C. W., 1983, HDB STOCHASTIC METHO; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; GRAHAM R, 1977, Z PHYS B CON MAT, V26, P397, DOI 10.1007/BF01570750; Han W, 2013, J PHYS CHEM B, V117, P13367, DOI 10.1021/jp404331d; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Juraszek J, 2006, P NATL ACAD SCI USA, V103, P15859, DOI 10.1073/pnas.0606692103; Kalgin IV, 2015, J PHYS CHEM B, V119, P1380, DOI 10.1021/jp5112795; Kalgin IV, 2014, J PHYS CHEM B, V118, P4287, DOI 10.1021/jp412729r; Kalgin IV, 2013, J PHYS CHEM B, V117, P6092, DOI 10.1021/jp401742y; Kalgin IV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011920; Kalgin IV, 2009, J PHYS CHEM B, V113, P12759, DOI 10.1021/jp903325z; KOLMOGOROV AN, 1991, P ROY SOC LOND A MAT, V434, P9, DOI 10.1098/rspa.1991.0075; KOLMOGOROV AN, 1991, P R SOC-MATH PHYS SC, V434, P15, DOI 10.1098/rspa.1991.0076; Landau L.D., 1987, PHYS TODAY; Lesieur M, 2008, FLUID MECH APPL, V84, P1; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Moon FC., 1992, CHAOTIC FRACTAL DYNA; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Nemirovskii SK, 2013, PHYS REP, V524, P85, DOI 10.1016/j.physrep.2012.10.005; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Richardson L.F., 1922, WEATHER PREDICTION N, DOI DOI 10.1017/CBO9780511618291; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; TOMITA K, 1974, PROG THEOR PHYS, V51, P1731, DOI 10.1143/PTP.51.1731; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Yaglom A. M, 1975, STAT FLUID MECH 2; Zakharov V., 1992, KOLMOGOROV SPECTRA T; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	47	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188659	10.1371/journal.pone.0188659	http://dx.doi.org/10.1371/journal.pone.0188659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206845	gold, Green Submitted, Green Published			2022-12-26	WOS:000417110700016
J	Ordonez, A; Kennedy, EV; Diaz-Pulido, G				Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo			Reduced spore germination explains sensitivity of reef-building algae to climate change stressors	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; OCEAN ACIDIFICATION; PARTIAL-PRESSURE; LOWERED PH; RESPONSES; CO2; TEMPERATURE; CALCIFICATION; RECRUITMENT; SETTLEMENT	Reduced seawater pH and changes in carbonate chemistry associated with ocean acidification (OA) decrease the recruitment of crustose coralline algae (CCAcf.), an important coralreef builder. However, it is unclear whether the observed decline in recruitment is driven by impairment of spore germination, or post-settlement processes (e.g. space competition). To address this, we conducted an experiment using a dominant CCA, Porolithon cf. onkodes to test the independent and combined effects of OA, warming, and irradiance on its germination success and early development. Elevated CO2 negatively affected several processes of spore germination, including formation of the germination disc, initial growth, and germling survival. The magnitude of these effects varied depending on the levels of temperature and irradiance. For example, the combination of high CO2 and high temperature reduced formation of the germination disc, but this effect was independent of irradiance levels, while spore abnormalities increased under high CO2 and high temperature particularly in combination with low irradiance intensity. This study demonstrates that spore germination of CCA is impacted by the independent and interactive effects of OA, increasing seawater temperature and irradiance intensity. For the first time, this provides a mechanism for how the sensitivity of critical early life history processes to global change may drive declines of adult populations of key marine calcifiers.	[Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan Campus, Brisbane, Qld, Australia; [Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Nathan Campus, Brisbane, Qld, Australia; [Diaz-Pulido, Guillermo] ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	Griffith University; Griffith University	Diaz-Pulido, G (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan Campus, Brisbane, Qld, Australia.; Diaz-Pulido, G (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan Campus, Brisbane, Qld, Australia.; Diaz-Pulido, G (corresponding author), ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	g.diaz-pulido@griffith.edu.au	Diaz-Pulido, Guillermo/B-3648-2013; Kennedy, Emma V/M-3193-2014	Kennedy, Emma V/0000-0003-1821-9740; Diaz-Pulido, Guillermo/0000-0002-0901-3727	Australian Research Council [DP-120101778]; Great Barrier Reef Foundation	Australian Research Council(Australian Research Council); Great Barrier Reef Foundation	This project was funded by the Australian Research Council (DP-120101778) and the Great Barrier Reef Foundation through grants awarded to GDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey W.H., 1975, Atoll Res Bull, VNo. 187, P1; Adey W.H., 1982, SMITHSONIAN CONTRIBU, V15; ADEY WH, 1970, J PHYCOL, V6, P269, DOI 10.1111/j.0022-3646.1970.00269.x; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bertness M.D., 2001, MARINE COMMUNITY ECO; BOSENCE DWJ, 1983, J GEOL SOC LONDON, V140, P365, DOI 10.1144/gsjgs.140.3.0365; Bradassi F, 2013, MAR BIOL, V160, P2261, DOI 10.1007/s00227-013-2260-2; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHIHARA M, 1974, J PHYCOL, V10, P266, DOI 10.1111/j.1529-8817.1974.tb02712.x; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2014, J EXP MAR BIOL ECOL, V453, P28, DOI 10.1016/j.jembe.2013.12.013; Connell SD, 2010, P R SOC B; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Dean AJ, 2015, CORAL REEFS, V34, P581, DOI 10.1007/s00338-015-1263-5; Diaz-Pulido G, 2005, J EXP MAR BIOL ECOL, V317, P13, DOI 10.1016/j.jembe.2004.11.013; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G, 2016, CORAL REEFS, P1; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Greer SP, 2002, J PHYCOL, V38, P116, DOI 10.1046/j.1529-8817.2002.00178.x; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harvey A.S., 2005, CORALLINE ALGAE CENT; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Ichiki Shigeo, 2000, Phycological Research, V48, P115, DOI 10.1046/j.1440-1835.2000.00193.x; Irvine LM, 1994, SEAWEEDS BRIT IS 2 B, V1; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Johnson MD, 2014, PEERJ, V2, DOI 10.7717/peerj.411; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jones W. E., 1973, MBAI SPECIAL PUBLICA, V1, P293; Kamenos NA, 2004, J EXP MAR BIOL ECOL, V313, P241, DOI 10.1016/j.jembe.2004.08.007; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Littler M. M, 1972, OCEANOGR MAR BIOL, V10, P103; LITTLER MM, 1975, J ECOL, V63, P117, DOI 10.2307/2258846; LUNING K, 1984, HELGOLANDER MEERESUN, V38, P305, DOI 10.1007/BF01997486; Maneveldt GW, 2014, TAXONOMIC REV BASED, V190, P34; Marcos Alvarez A, 2016, THESIS; Martin S, 2013, ECOL EVOL, V3, P676, DOI 10.1002/ece3.475; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; McCoy SJ, 2014, NAT CLIM CHANGE, V4, P719, DOI 10.1038/NCLIMATE2273; MEDFORD JI, 1992, PLANT CELL, V4, P631, DOI 10.1105/tpc.4.6.631; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Noisette F, 2013, J EXP MAR BIOL ECOL, V448, P179, DOI 10.1016/j.jembe.2013.07.006; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Pfister CA, 2016, P R SOC B, V283; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Ragazzola F, 2012, GLOBAL CHANGE BIOL, V18, P2804, DOI 10.1111/j.1365-2486.2012.02756.x; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ringeltaube P, 2005, BOT MAR, V43, P409; Roleda MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140394; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Rosler A, 2016, J PHYCOL, V52, P412, DOI 10.1111/jpy.12404; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; Santelices B, 1999, J PHYCOL, V35, P1127, DOI 10.1046/j.1529-8817.1999.3561127.x; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Short JA, 2015, ESTUAR COAST SHELF S, V164, P463, DOI 10.1016/j.ecss.2015.08.006; SOROKIN C, 1962, NATURE, V194, P496, DOI 10.1038/194496a0; Stocker T. F., 2013, CLIMATE CHANGE 2013; Underwood AJ, 1996, EXPT ECOLOGY; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	78	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189122	10.1371/journal.pone.0189122	http://dx.doi.org/10.1371/journal.pone.0189122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206887	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700050
J	Cortes-Hernandez, P; Dominguez-Ramirez, L				Cortes-Hernandez, Paulina; Dominguez-Ramirez, Lenin			Role of cis-trans proline isomerization in the function of pathogenic enterobacterial Periplasmic Binding Proteins	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SIDE-CHAIN; ARGININE; LYSINE; TRANSPORTER; HISTIDINE; SOFTWARE; MOTIONS; SYSTEMS	Periplasmic Binding Proteins (PBPs) trap nutrients for their internalization into bacteria by ABC transporters. Ligand binding triggers PBP closure by bringing its two domains together like a Venus flytrap. The atomic determinants that control PBP opening and closure for nutrient capture and release are not known, although it is proposed that opening and ligand release occur while in contact with the ABC transporter for concurrent substrate translocation. In this paper we evaluated the effect of the isomerization of a conserved proline, located near the binding site, on the propensity of PBPs to open and close. ArgT/LAO from Salmonella typhimurium and HisJ from Escherichia coli were studied through molecular mechanics at two different temperatures: 300 and 323 K. Eight microseconds were simulated per protein to analyze protein opening and closure in the absence of the ABC transporter. We show that when the studied proline is in trans, closed empty LAO and HisJ can open. In contrast, with the proline in cis, opening transitions were much less frequent and characterized by smaller changes. The proline in trans also renders the open trap prone to close over a ligand. Our data suggest that the isomerization of this conserved proline modulates the PBP mechanism: the proline in trans allows the exploration of conformational space to produce trap opening and closure, while in cis it restricts PBP movement and could limit ligand release until in productive contact with the ABC transporter. This is the first time that a proline isomerization has been related to the control of a large conformational change like the PBP flytrap mechanism.	[Cortes-Hernandez, Paulina] IMSS, Ctr Invest Biomed Oriente CIBIOR, Puebla, Mexico; [Dominguez-Ramirez, Lenin] Univ Amer Puebla UDLAP, Chem & Biol Sci, Puebla, Mexico	Universidad Americas Puebla (UDLAP)	Dominguez-Ramirez, L (corresponding author), Univ Amer Puebla UDLAP, Chem & Biol Sci, Puebla, Mexico.	julio.dominguez@udlap.mx	Cortes-Hernandez, Paulina/GLQ-5915-2022; Dominguez-Ramirez, Lenin/AAG-9864-2020; Cortes-Hernandez, Paulina/ABC-1133-2020	Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Cortes-Hernandez, Paulina/0000-0001-8226-1703	NVIDIA Corporation; CONACyT Basic Science grant [CB2014-2429]	NVIDIA Corporation; CONACyT Basic Science grant	NVIDIA Corporation provided material support for this study by donating the Tesla K40 GPU used for this research. Lenin Dominguez-Ramirez is supported by a CONACyT Basic Science grant (CB2014-2429). We, the authors, declare that the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chu BCH, 2014, PROTEINS, V82, P386, DOI 10.1002/prot.24396; Chu BCH, 2013, J BIOL CHEM, V288, P31409, DOI 10.1074/jbc.M113.490441; Dodge RW, 1996, BIOCHEMISTRY-US, V35, P1548, DOI 10.1021/bi952348q; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hardin C, 1999, PROTEINS, V34, P281; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P26323; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Pang A, 2005, PROTEINS, V61, P809, DOI 10.1002/prot.20672; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schmidpeter PAM, 2015, BBA-GEN SUBJECTS, V1850, P1973, DOI 10.1016/j.bbagen.2014.12.019; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412; Yang AYC, 2008, J COMPUT AID MOL DES, V22, P799, DOI 10.1007/s10822-008-9215-6; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004	38	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188935	10.1371/journal.pone.0188935	http://dx.doi.org/10.1371/journal.pone.0188935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190818	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900173
J	Li, Z; Sun, DY; Zhu, RQ; Lin, ZH				Li, Ze; Sun, Duoyong; Zhu, Renqi; Lin, Zihan			Detecting event-related changes in organizational networks using optimized neural network models	PLOS ONE			English	Article							ALGORITHM	Organizational external behavior changes are caused by the internal structure and interactions. External behaviors are also known as the behavioral events of an organization. Detecting event-related changes in organizational networks could efficiently be used to monitor the dynamics of organizational behaviors. Although many different methods have been used to detect changes in organizational networks, these methods usually ignore the correlation between the internal structure and external events. Event-related change detection considers the correlation and could be used for event recognition based on social network modeling and supervised classification. Detecting event-related changes could be effectively useful in providing early warnings and faster responses to both positive and negative organizational activities. In this study, event-related change in an organizational network was defined, and artificial neural network models were used to quantitatively determine whether and when a change occurred. To achieve a higher accuracy, Back Propagation Neural Networks (BPNNs) were optimized using Genetic Algorithms (GAs) and Particle Swarm Optimization (PSO). We showed the feasibility of the proposed method by comparing its performance with that of other methods using two cases. The results suggested that the proposed method could identify organizational events based on a correlation between the organizational networks and events. The results also suggested that the proposed method not only has a higher precision but also has a better robustness than the previously used techniques.	[Li, Ze; Sun, Duoyong; Zhu, Renqi; Lin, Zihan] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Li, Z (corresponding author), Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China.	plalize@nudt.edu.cn			National Natural Science Foundation of China [71473263]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20134307110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (Grant no. 71473263) to Duoyong Sun. The Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20134307110020) to Duoyong Sun.	[Anonymous], 2004, WASHINGTON POST; ARTIS JJ, 2009, J JAY ARTIS TRANSNAT; Asur S, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1631162.1631164; Ball B, 2011, CONTEMP SOCIOL, V84, P109; Brelger R, 2004, DYNAMIC SOCIAL NETWO, P423; Carley KM, 2009, ORA USERS GUIDE 2009; Carrington PJ, 2005, MODELS METHODS SOCIA, P118; Clauset A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048633; Crenshaw M, 1998, P NATL ACAD SCI USA, V98, P15056; Dandy GC, 1996, WATER RESOUR RES, V32, P449, DOI 10.1029/95WR02917; Du B, 2016, CATCH ME IF YOU CAN, P87; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Gao Y, 2014, NETWORK TRAFFIC PRED; Gupta M, 2012, COMMUNITY TREND OUTL, P692; Heard NA, 2010, ANN APPL STAT, V4, P645, DOI 10.1214/10-AOAS329; Huayu S., 2008, J TIANJIN U TECHNOL, V5, P13; Li S, 2016, DETECTING WEAK CHANG; Liu B, 2007, IEEE T SYST MAN CY B, V37, P18, DOI 10.1109/TSMCB.2006.883272; Mannes A, 2013, INDIAN MUJAHIDEEN CO; Mcculloh I, 2008, DETECTING CHANGE LON; McCulloh I, 2007, SOCIAL NETWORK MONIT; Medina R, 2008, GEOSPATIAL ANAL DYNA; Meng X, 2007, BP NETWORK OPTIMIZED, P1630; Najgebauer A., 2008, J TELECOMMUNICATIONS, V2008, P14; Peel L, 2015, AAAI CONF ARTIF INTE, P2914; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Priebe C. Y., 2005, Computational & Mathematical Organization Theory, V11, P229, DOI 10.1007/s10588-005-5378-z; Qiu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155133; Raghavan V, 2013, ANN APPL STAT, V7, P2402, DOI 10.1214/13-AOAS682; Rong FU, 2009, RENEWABLE ENERGY RES; Sarevska M., 2004, GENERALIZATION CAPAB; Shazwani S, 2016, PLOS ONE, V11; Shetty J., 2004, ENRON EMAIL DATASET; Silva J, 2008, 2008 42ND ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1-3, P636, DOI 10.1109/CISS.2008.4558601; Sliva A, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P253, DOI 10.1007/978-3-211-09442-6_15; Snijders T, 2000, SIMULATION STAT INFE, P493; Subrahmanian VS, 2013, JAPANESE J ED PSYCHO, V37, P67; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Vigliotti MG, 2015, SOC NETWORKS, V41, P18, DOI 10.1016/j.socnet.2014.12.001; Wang JZ, 2010, ENERGY, V35, P1671, DOI 10.1016/j.energy.2009.12.015; Wu Bin, 2011, Journal of Software, V22, P1488, DOI 10.3724/SP.J.1001.2011.03841; Xue A, 2011, TERRORIST ORG BEHAV, P332; Zhao Xin, 2009, Computer Engineering and Applications, V45, P53, DOI 10.3778/j.issn.1002-8331.2009.26.015	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188733	10.1371/journal.pone.0188733	http://dx.doi.org/10.1371/journal.pone.0188733			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190799	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900111
J	Merino, I; Porter, SB; Johnston, BD; Clabots, C; Shaw, E; Horcajada, JP; Canton, R; Ruiz-Garbajosa, P; Johnson, JR				Merino, Irene; Porter, Stephen B.; Johnston, Brian D.; Clabots, Connie; Shaw, Evelyn; Pablo Horcajada, Juan; Canton, Rafael; Ruiz-Garbajosa, Patricia; Johnson, James R.		ITUBRAS-GEIH Grp	Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; H30-RX SUBCLONES; UNITED-STATES; E. COLI; URINARY; ST131; INFECTIONS; STRAINS; TRAITS	Objective To assess experimental virulence among sequence type 131 (ST131) Escherichia coli bloodstream isolates in relation to virulence genotype and subclone. Methods We analysed 48 Spanish ST131 bloodstream isolates (2010) by PCR for ST131 subclone status (H30Rx, H30 non-Rx, or non-H30), virulence genes (VGs), and O-type. Then we compared these traits with virulence in a murine sepsis model, as measured by illness severity score (ISS) and rapid lethality (mean ISS >= 4). Results Of the 48 study isolates, 65% were H30Rx, 21% H30 non-Rx, and 15% non-H30; 44% produced ESBLs, 98% were O25b, and 83% qualified as extraintestinal pathogenic E. coli (ExPEC). Of 49 VGs, ibeA and iss were associated significantly with non-H30 isolates, and sat, iha and malX with H30 isolates. Median VG scores differed by subclone, i.e., 12 (H30Rx), 10 (H30 non-Rx), and 11 (non-H30) (p < 0.01). Nearly 80% of isolates represented a described virotype. In mice, H30Rx and non-H30 isolates were more virulent than H30 non-Rx isolates (according to ISS [p = 0.03] and rapid lethality [p = 0.03]), as were ExPEC isolates compared with non-ExPEC isolates (median ISS, 4.3 vs. 2.7: p = 0.03). In contrast, most individual VGs, VG scores, VG profiles, and virotypes were not associated with mouse virulence. Conclusions ST131 subclone and ExPEC status, but not individual VGs, VG scores or profiles, or virotypes, predicted mouse virulence. Given the lower virulence of non-Rx H30 isolates, hyper-virulence probably cannot explain the ST131-H30 clade's epidemic emergence.	[Merino, Irene; Canton, Rafael; Ruiz-Garbajosa, Patricia] Hosp Univ Ramon y Cajal, IRYCIS, Serv Microbiol, Madrid, Spain; [Merino, Irene; Shaw, Evelyn; Canton, Rafael; Ruiz-Garbajosa, Patricia] Spanish Network Res Infect Dis REIPI, Madrid, Spain; [Porter, Stephen B.; Clabots, Connie; Johnson, James R.] Minneapolis Vet Hlth Care Syst, Minneapolis, MN USA; [Johnston, Brian D.; Johnson, James R.] Univ Minnesota, Minneapolis, MN USA; [Shaw, Evelyn] Hosp Univ Bellvitge, IDIBELL, Serv Enfermedades Infecciosas, Barcelona, Spain; [Pablo Horcajada, Juan] CEXS Univ Pompeu Fabra, Hosp del Mar, Med Res Inst Hosp del Mar IMIM, Barcelona, Spain	Hospital Universitario Ramon y Cajal; University of Minnesota System; University of Minnesota Twin Cities; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Ruiz-Garbajosa, P (corresponding author), Hosp Univ Ramon y Cajal, IRYCIS, Serv Microbiol, Madrid, Spain.; Ruiz-Garbajosa, P (corresponding author), Spanish Network Res Infect Dis REIPI, Madrid, Spain.	pruizg@salud.madrid.org	Merino, Irene/P-5874-2017; Horcajada, Juan P./AAU-7717-2021; CANTON, RAFAEL/ABF-6353-2020; Cantón, Rafael/AAP-8669-2021	Merino, Irene/0000-0001-5841-7392; Horcajada, Juan P./0000-0001-9873-5459; Canton, Rafael/0000-0003-1675-3173; Shaw, Evelyn/0000-0002-1882-1259	Instituto de Salud Carlos III of Spain [PI13/02092]; Spanish Network for Research in Infectious Diseases or REIPI [RD12/0015/0004, RD16/0016/0011]; European Development Regional Fund (ERDF); REIPI [RD12/0015/0004]; Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC, IMV); Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]; Veterans Affairs [I01CX000920] Funding Source: NIH RePORTER	Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases or REIPI; European Development Regional Fund (ERDF)(European Commission); REIPI; Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC, IMV); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Instituto de Salud Carlos III of Spain (www.isciii.es) with the grant PI13/02092; and Spanish Network for Research in Infectious Diseases or REIPI (www.reipi.org): RD12/0015/0004 and RD16/0016/0011; and co-financed by the European Development Regional Fund (ERDF), "A Way to Achieve Europe". IMV is supported by a research contract from the REIPI (RD12/0015/0004). Part of this work was supported by a grant from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC 2014, IMV). This material also is based partly upon work supported by Office of Research and Development, Medical Research Service, Department of Veterans Affairs, grant # 1 I01 CX000192 01 (JRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghoribi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101547; Ben Zakour NL, 2016, MBIO, V7, P1, DOI DOI 10.3391/mbi.2016.7.1.01; Blanco J, 2013, J CLIN MICROBIOL, V51, P3358, DOI 10.1128/JCM.01555-13; Burgess MJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv011; Ciesielczuk H, 2015, VIRULENCE, V6, P145, DOI 10.4161/21505594.2014.988095; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Dahbi G, 2014, INT J MED MICROBIOL, V304, P1247, DOI 10.1016/j.ijmm.2014.10.002; Horcajada JP, 2013, CLIN MICROBIOL INFEC, V19, P962, DOI 10.1111/1469-0691.12089; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2014, J CLIN MICROBIOL, V52, P1358, DOI 10.1128/JCM.03502-13; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Johnson JR, 2004, J INFECT DIS, V190, P1739, DOI 10.1086/425018; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Lahlaoui H, 2014, MED MALADIES INFECT, V44, P400, DOI 10.1016/j.medmal.2014.03.010; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Merino I, 2016, J ANTIMICROB CHEMOTH, V71, P2125, DOI 10.1093/jac/dkw133; Mora A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087025; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Olesen B, 2014, ANTIMICROB AGENTS CH, V58, P6886, DOI 10.1128/AAC.03679-14; Park Hae-Kyung, 2011, Journal of Bacteriology and Virology, V41, P245; Peirano G, 2014, EMERG INFECT DIS, V20, P1928, DOI 10.3201/eid2011.141388; Peirano G, 2014, ANTIMICROB AGENTS CH, V58, P3762, DOI 10.1128/AAC.02428-14; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Vimont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046547	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188838	10.1371/journal.pone.0188838	http://dx.doi.org/10.1371/journal.pone.0188838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190804	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900139
J	Sasabe, E; Tomomura, A; Tomita, R; Sento, S; Kitamura, N; Yamamoto, T				Sasabe, Eri; Tomomura, Ayumi; Tomita, Riki; Sento, Shinya; Kitamura, Naoya; Yamamoto, Tetsuya			Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma	PLOS ONE			English	Article							EPH RECEPTORS; CANCER-CELLS; SOLID TUMORS; NECK; HEAD; EXPRESSION; GROWTH; PHOSPHORYLATION; ANGIOGENESIS; INHIBITION	Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the head and neck and frequently metastasizes to cervical lymph nodes. Aggressive local invasion and metastasis of OSCC are significant factors for poor prognosis. In this study, we investigated whether ephrin-B2 expressed in OSCC contributed to tumor progression and lymph node metastasis. Clinical specimens from patients with OSCC had robust ephrin-B2-positive tumor cells and ephrin-B2 protein level was associated with clinical stage, lymph node metastasis, and poor survival outcomes. We also determined that ephrin-B2 protein level was increased in OSCC cell lines compared to normal human oral keratinocytes and that its levels were associated with the migratory and invasive potential of OSCC cell lines. Transfection of an EFNB2-specific small interfering RNA (siRNA) into SAS-L1 cells significantly reduced proliferation, attachment, migration, and invasion through phosphorylation of the epidermal growth factor receptor, FAK, ERK1/2, p38, AKT, and JNK1/2 pathways. Furthermore, knockdown of EFNB2 significantly suppressed adhesion and transmigration of SAS-L1 cells toward human lymphatic endothelial cells. In addition, the growth rate of tumor xenografts and cervical lymph node metastases of OSCC were suppressed by local injection of EFNB2 siRNA. These results suggest that ephrin-B2 overexpression and activation of the ephrin-B2 reverse signaling pathway in tumor microenvironment in OSCC facilitates progression and lymph node metastasis via enhancement of malignant potential and interaction with surrounding cells.	[Sasabe, Eri; Tomomura, Ayumi; Tomita, Riki; Sento, Shinya; Kitamura, Naoya; Yamamoto, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Oko Cho, Nankoku, Kochi, Japan	Kochi University	Sasabe, E (corresponding author), Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Oko Cho, Nankoku, Kochi, Japan.	yoshieri@kochi-u.ac.jp		Sasabe, Eri/0000-0001-6865-1772	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23792353]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23792353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Chiu YW, 2016, LAB INVEST, V96, P296, DOI 10.1038/labinvest.2015.151; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Daar IO, 2012, SEMIN CELL DEV BIOL, V23, P65, DOI 10.1016/j.semcdb.2011.10.012; Ferguson BD, 2014, GROWTH FACTORS, V32, P202, DOI 10.3109/08977194.2014.980904; Fujimoto R., 2004, J JPN ORAL MUCO MEMB, V8, P1, DOI [10.6014/jjomm1995.8.1, DOI 10.6014/jjomm1995.8.1]; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kimura M, 2009, INT J ONCOL, V34, P321, DOI 10.3892/ijo_00000154; Koo BS, 2015, ONCOGENE, V34, P2317, DOI 10.1038/onc.2014.174; Liao CT, 2012, ORAL ONCOL, V48, P329, DOI 10.1016/j.oraloncology.2011.10.017; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; Meyer S, 2005, INT J ONCOL, V27, P1197; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Okura M, 2009, ORAL ONCOL, V45, P908, DOI 10.1016/j.oraloncology.2009.03.013; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Oweida A, 2017, MOL CARCINOGEN, V56, P1189, DOI 10.1002/mc.22574; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Rutkowski R, 2012, INT J CANCER, V131, pE614, DOI 10.1002/ijc.27392; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shintani S, 2002, ORAL ONCOL, V38, P664, DOI 10.1016/S1368-8375(01)00131-2; SINHA UK, 2003, ENT-EAR NOSE THROAT, V82, P869; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei S, 2010, DEV CELL, V19, P345, DOI 10.1016/j.devcel.2010.07.012; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752; Yavrouian EJ, 2008, ARCH OTOLARYNGOL, V134, P985, DOI 10.1001/archotol.134.9.985	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188965	10.1371/journal.pone.0188965	http://dx.doi.org/10.1371/journal.pone.0188965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190834	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900180
J	Webb, M; Davies, M; Ashra, N; Bodicoat, D; Brady, E; Webb, D; Moulton, C; Ismail, K; Khunti, K				Webb, M'Balu; Davies, Melanie; Ashra, Nuzhat; Bodicoat, Danielle; Brady, Emer; Webb, David; Moulton, Calum; Ismail, Khalida; Khunti, Kamlesh			The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; EXPERIMENTAL HYPERLEPTINEMIA; ABDOMINAL OBESITY; LEPTIN LEVELS; TNF-ALPHA; RISK; METAANALYSIS; PREDICTOR	Introduction Depression has been shown to be associated with elevated leptin levels, low-grade inflammation and insulin resistance. These derangements are often measured in mixed gender cohorts despite the different body compositions and hormonal environments of men and women and gender-specific prevalence and responses to depression. Methods A cross-sectional analysis was carried out on a cohort of 639 participants from the ADDITION-Leicester dataset to assess differences in markers of diabetes risk, cardiovascular risk and inflammation in depressed and non-depressed individuals. Depressive symptoms were determined using the WHO (Five) well-being index. Multivariate linear and logistic regression analyses were adjusted for age, sex, ethnicity, body mass index, smoking, social deprivation and activity levels for continuous and binary variables respectively. Further analysis included stratifying the data by gender as well as assessing the interaction between depression and gender by including an interaction term in the model. Results Women with depressive symptoms had a 5.3% larger waist circumference (p = 0.003), 28.7% higher HOMA IR levels (p = 0.026), 6.6% higher log-leptin levels (p = 0.01) and 22.37% higher TNF-alpha levels (p = 0.015) compared with women without. Conversely, depressive symptoms in men were associated with 7.8% lower body fat %(p = 0.015) but 48.7% higher CRP levels (p = 0.031) compared to men without. However, interaction analysis failed to show a significant difference between men and women. Conclusions Depressive symptoms are associated with metabolic derangements. Whilst women tended to show elevations in biomarkers related to an increased risk of type 2 diabetes (HOMA IR, leptin and TNF-alpha), men showed a marked increase in the cardiovascular disease risk biomarker CRP. However, perhaps due to the cohort size, interaction analysis did not show a significant gender difference.	[Webb, M'Balu; Davies, Melanie; Bodicoat, Danielle; Brady, Emer; Webb, David; Khunti, Kamlesh] Univ Hosp Leicester, Natl Inst Hlth Res, Biomed Res Ctr Leicester, Leicester, Leics, England; [Webb, M'Balu; Davies, Melanie; Brady, Emer; Khunti, Kamlesh] Univ Hosp Leicester, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester, Leics, England; [Davies, Melanie; Ashra, Nuzhat; Bodicoat, Danielle; Webb, David; Khunti, Kamlesh] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England; [Moulton, Calum; Ismail, Khalida] Kings Coll London, Dept Psychol Med, Weston Educ Ctr, London, England	University Hospitals of Leicester NHS Trust; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of London; King's College London	Webb, M (corresponding author), Univ Hosp Leicester, Natl Inst Hlth Res, Biomed Res Ctr Leicester, Leicester, Leics, England.; Webb, M (corresponding author), Univ Hosp Leicester, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester, Leics, England.	balu.webb@uhl-tr.nhs.uk	/ABC-9527-2021	Ashra, Nuzhat/0000-0002-5818-0628; Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371; Ismail, Khalida/0000-0001-6084-449X; Moulton, Calum/0000-0003-0880-4495; Webb, David/0000-0002-3932-3339	NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM)	NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM)	The authors received no specific funding for this work, however this work was supported by the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC - EM).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Cordas G, 2015, NEUROENDOCRINOLOGY, V101, P82, DOI 10.1159/000371803; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dortland AKBV, 2013, PSYCHOSOM MED, V75, P83, DOI 10.1097/PSY.0b013e318274d30f; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Elovainio M, 2009, PSYCHOSOM MED, V71, P423, DOI 10.1097/PSY.0b013e31819e333a; Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gayoso-Diz P, 2011, DIABETES RES CLIN PR, V94, P146, DOI 10.1016/j.diabres.2011.07.015; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Goebel MU, 2000, PSYCHOSOM MED, V62, P591, DOI 10.1097/00006842-200007000-00019; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Grossniklaus DA, 2012, EUR J CARDIOVASC NUR, V11, P423, DOI 10.1016/j.ejcnurse.2011.03.008; Hafner S, 2011, PSYCHONEUROENDOCRINO, V36, P200, DOI 10.1016/j.psyneuen.2010.07.009; HARING H, 1986, BIOCHEM J, V234, P59; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; KIRSCH DM, 1983, BIOCHEM J, V216, P737, DOI 10.1042/bj2160737; Konttinen H, 2010, AM J CLIN NUTR, V92, P1031, DOI 10.3945/ajcn.2010.29732; Kraus T, 2001, NEUROENDOCRINOLOGY, V73, P243, DOI 10.1159/000054641; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Machleidt F, 2013, J CLIN ENDOCR METAB, V98, pE491, DOI 10.1210/jc.2012-3009; Madrigal JLM, 2002, NEUROPSYCHOPHARMACOL, V26, P155, DOI 10.1016/S0893-133X(01)00292-5; Mantzoros CS, 1998, OBES RES, V6, P179, DOI 10.1002/j.1550-8528.1998.tb00335.x; MCDONALD EM, 1987, LANCET, V2, P1175; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Milaneschi Y, 2012, J CLIN PSYCHIAT, V73, P1205, DOI 10.4088/JCP.11m07552; Mohr DC, 2001, ARCH NEUROL-CHICAGO, V58, P1081, DOI 10.1001/archneur.58.7.1081; Morris AA, 2012, PSYCHOSOM MED, V74, P483, DOI 10.1097/PSY.0b013e31824f5de0; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nielsen ST, 2013, DIABETES-METAB RES, V29, P655, DOI 10.1002/dmrr.2441; Office of the Deputy Prime Minister, 2007, ENGLISH INDICES DEPR; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Samuelsson Anne-Maj, 2013, Hypertension, V62, P627, DOI 10.1161/HYPERTENSIONAHA.111.00691; Shen QH, 2011, BIOL RES NURS, V13, P175, DOI 10.1177/1099800410384501; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; Uher R, 2014, AM J PSYCHIAT, V171, P1278, DOI 10.1176/appi.ajp.2014.14010094; Vaccarino V, 2008, PSYCHOSOM MED, V70, P40, DOI 10.1097/PSY.0b013e31815c1b85; Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Warnke I, 2016, J AFFECT DISORDERS, V193, P295, DOI 10.1016/j.jad.2016.01.006; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Weber-Hamann B, 2002, PSYCHOSOM MED, V64, P274, DOI 10.1097/00006842-200203000-00010; World Health Organisation, 2008, DEF DIAGN DIAB MELL	62	30	31	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187448	10.1371/journal.pone.0187448	http://dx.doi.org/10.1371/journal.pone.0187448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190710	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900014
J	Yadav, K; Patel, P; Srivastava, AK; Ganapathi, TR				Yadav, Karuna; Patel, Prashanti; Srivastava, Ashish Kumar; Ganapathi, T. R.			Overexpression of native ferritin gene MusaFer1 enhances iron content and oxidative stress tolerance in transgenic banana plants	PLOS ONE			English	Article							EXPRESSION PROFILES; NITRIC-OXIDE; ARABIDOPSIS-THALIANA; MINERAL-COMPOSITION; ZINC ACCUMULATION; SOYBEAN FERRITIN; MESSENGER-RNA; RICE; HOMEOSTASIS; RESPONSES	Iron is an indispensable element for plant growth and defense and hence it is essential to improve the plant's ability to accumulate iron. Besides, it is also an important aspect for human health. In view of this, we attempted to increase the iron content in banana cultivar Rasthali using MusaFer1 as a candidate gene. Initially, the expression of all five genes of the MusaFer family (MusaFer1-5) was quantified under iron-excess and -deficient conditions. The supplementation of 250 and 350 mu M iron enhanced expression of all MusaFer genes; however, MusaFer1 was increased maximally by 2- and 4-fold in leaves and roots respectively. Under iron deficient condition, all five MusaFer genes were downregulated, indicating their iron dependent regulation. In MusaFer1 overexpressing lines, iron content was increased by 2- and 3-fold in leaves and roots respectively, as compared with that of untransformed lines. The increased iron was mainly localized in the epidermal regions of petiole. The analysis of MusaFer1 promoter indicated that it might control the expression of iron metabolism related genes and also other genes of MusaFer family. MusaFer1 overexpression led to downregulated expression of MusaFer3, MusaFer4 and MusaFer5 in transgenic leaves which might be associated with the plant's compensatory mechanism in response to iron flux. Other iron metabolism genes like Ferric reductase (FRO), transporters (IRT, VIT and YSL) and chelators (NAS, DMAS and NAAT) were also differentially expressed in transgenic leaf and root, suggesting the multifaceted impact of MusaFer1 towards iron uptake and organ distribution. Additionally, MusaFer1 overexpression increased plant tolerance against methyl viologen and excess iron which was quantified in terms of photosynthetic efficiency and malondialdehyde content. Thus, the study not only broadens our understanding about iron metabolism but also highlights MusaFer1 as a suitable candidate gene for iron fortification in banana.	[Yadav, Karuna; Patel, Prashanti; Ganapathi, T. R.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay, Maharashtra, India; [Srivastava, Ashish Kumar] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Stress Physiol & Biotechnol Sect, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay, Maharashtra, India.	trgana@barc.gov.in		Srivastava, Ashish Kumar/0000-0001-9863-528X	DBT-BIRAC	DBT-BIRAC	The authors received funding from DBT-BIRAC for conducting this work.	Badigannavar A, 2016, CROP J, V4, P61, DOI 10.1016/j.cj.2015.07.002; Beasley JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177061; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Bruce BD, 2001, BIOCH BIOPHYSIC 1212, P1541; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Camaschella C, 2016, POSTGRADUATE HAEMATOLOGY, 7TH EDITION, P21; CHANDRA RK, 1990, ANN NY ACAD SCI, V587, P9, DOI 10.1111/j.1749-6632.1990.tb00128.x; Cheng Z, 2002, ZHONGGUO SHUIDAO KEX, V17, P85; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; Dixit P, 2010, PLANT CELL ENVIRON, V33, P1697, DOI 10.1111/j.1365-3040.2010.02174.x; Drakakaki G, 2005, PLANT MOL BIOL, V59, P869, DOI 10.1007/s11103-005-1537-3; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Gaymard F, 1996, BIOCHEM J, V318, P67, DOI 10.1042/bj3180067; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Hardisson A, 2001, FOOD CHEM, V73, P153, DOI 10.1016/S0308-8146(00)00252-1; Huang X, 2004, PLANTA, V218, P938, DOI 10.1007/s00425-003-1178-1; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jin CW, 2009, PLANT PHYSIOL, V150, P272, DOI 10.1104/pp.109.136721; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Kanobe MN, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00196; Kennedy BC, 2016, FETAL DEV, P295; Liu HJ, 2017, CHEMOSPHERE, V171, P240, DOI 10.1016/j.chemosphere.2016.12.081; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Masuda H, 2013, FRONTIERS PLANT SCI, V4; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; Srivastava S, 2009, J EXP BOT, V60, P3419, DOI 10.1093/jxb/erp181; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Wuytswinkel O, 1999, PLANT J, V17, P93, DOI 10.1046/j.1365-313X.1999.00349.x; Vasconcelos M, 2003, PLANT SCI, V164, P371, DOI 10.1016/S0168-9452(02)00421-1; Wall MM, 2006, J FOOD COMPOS ANAL, V19, P434, DOI 10.1016/j.jfca.2006.01.002; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098; Wang Minqi, 2013, FEATURES TREATMENT S, P4; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Xing CH, 2008, J ZHEJIANG UNIV-SC B, V9, P261, DOI 10.1631/jzus.B0710627	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188933	10.1371/journal.pone.0188933	http://dx.doi.org/10.1371/journal.pone.0188933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190821	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900171
J	Elisia, I; Lam, V; Hofs, E; Li, MY; Hay, M; Cho, B; Brooks-Wilson, A; Rosin, M; Bu, L; Jia, W; Krystal, G				Elisia, Ingrid; Lam, Vivian; Hofs, Elyse; Li, Michael Yu; Hay, Mariah; Cho, Brandon; Brooks-Wilson, Angela; Rosin, Miriam; Bu, Luke; Jia, William; Krystal, Gerald			Effect of age on chronic inflammation and responsiveness to bacterial and viral challenges	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; INDUCED ACTIVATION; INTERFERON-GAMMA; GENE-EXPRESSION; RECEPTOR-ALPHA; T-CELLS; HEPARIN; BLOOD	To identify reliable biomarkers of age-related changes in chronic inflammation and responsiveness to bacterial and viral challenges, we evaluated endogenous and ex vivo stimulated levels of 18 inflammatory markers, using whole blood collected in EDTA and sodium heparin tubes from 41 healthy volunteers, i.e., 11 men + 10 women aged 20-35 and 10 men + 10 women aged 50-77. These studies revealed significant differences in the levels of inflammatory markers when blood was collected in EDTA versus sodium heparin and age related differences in these biomarkers were confirmed with blood collected in EDTA from 120 healthy volunteers in 3 age categories, ie, 20 men + 20 women, aged 20-35, 36-49 and 5077. Studies with unstimulated blood samples, to measure levels of chronic inflammation, revealed a significant increase with age in IL-12p70, CRP and PGE2, consistent with the concept of "inflammaging", and a decrease in G-CSF in both men and women. Interestingly, in response to E. co/istimulation, PGE2 levels were markedly reduced in the 50-77 year old cohort while they were increased following Herpes Simplex virus-1 (HSV-1) stimulation, along with IL-8. In addition, unlike E. coli, HSV-1 potently stimulated IFNa production, but levels were dramatically reduced in the older cohort, consistent with a reduced ability to generate an anti-viral response. We also found platelets and CD8(+) T cells were reduced with age while CD4(+) T cells were significantly increased, resulting in a substantially higher CD4/CD8 ratio in the older cohort. Surprisingly, however, we found that the older cohort exhibited more T cell proliferation and IFNy production in response to anti-CD3(+)anti-CD28 stimulation. Importantly, there was considerable person-to-person variation in these inflammatory markers in all age groups, making possible comparisons between a person's "inflammage" and chronological age. These assays should help to identify individuals at high risk of auto immune disorders and cancer.	[Elisia, Ingrid; Lam, Vivian; Hofs, Elyse; Li, Michael Yu; Hay, Mariah; Cho, Brandon; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Rosin, Miriam] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Bu, Luke; Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency; University of British Columbia	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada.	gkrystal@bccrc.ca	JIA, WILLIAM/AAE-4322-2020; Brooks-Wilson, Angela/E-9399-2012	Brooks-Wilson, Angela/0000-0003-1009-6408; Krystal, Gerald/0000-0002-1961-6281	Lotte & John Hecht Memorial Foundation [3693]; BC Cancer Foundation; BC Cancer Agency	Lotte & John Hecht Memorial Foundation; BC Cancer Foundation; BC Cancer Agency	The research was supported by the Lotte & John Hecht Memorial Foundation, grant number 3693 (http://www.hecht.org/), with core support from the BC Cancer Foundation and the BC Cancer Agency, to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABB J, 1984, BLUT, V48, P285; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Beharka AA, 2001, J GERONTOL A-BIOL, V56, pB81, DOI 10.1093/gerona/56.2.B81; Bernstein ED, 1998, AGE, V21, P137, DOI 10.1007/s11357-998-0024-6; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Born J, 1995, MECH AGEING DEV, V84, P113, DOI 10.1016/0047-6374(95)01638-4; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; Brondum L, 2016, SCAND J CLIN LAB INV, V76, P601, DOI 10.1080/00365513.2016.1230882; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; CLARK JA, 1994, MECH AGEING DEV, V77, P127, DOI 10.1016/0047-6374(94)90020-5; Coch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071057; Dorresteijn MJ, 2010, INNATE IMMUN-LONDON, V16, P248, DOI 10.1177/1753425909339923; Duvigneau JC, 2007, J IMMUNOL METHODS, V324, P38, DOI 10.1016/j.jim.2007.04.012; El-Omar EM, 2001, NATURE, V412, P99, DOI 10.1038/35083631; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Feldman M, 2014, RHEUMATOLOGY CURRENT, V4; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Frasca D, 2016, BIOGERONTOLOGY, V17, P7, DOI 10.1007/s10522-015-9578-8; Gardner EM, 2002, BIOGERONTOLOGY, V3, P271, DOI 10.1023/A:1020151401826; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; GOODWIN JS, 1979, J CLIN INVEST, V64, P434, DOI 10.1172/JCI109480; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Hasan M, 1999, J IMMUNOL, V162, P1064; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Hochart H, 2008, THROMB HAEMOSTASIS, V99, P570, DOI 10.1160/TH07-06-0424; Hooper KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179184; Howie SEM, 2011, BLOOD, V118, P5718, DOI 10.1182/blood-2011-09-381137; JACKOLA DR, 1994, AGING-CLIN EXP RES, V6, P25, DOI 10.1007/BF03324210; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kilinc MO, 2006, J IMMUNOL, V177, P6962, DOI 10.4049/jimmunol.177.10.6962; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee MC, 2017, J IMMUNOL, V198, P3565, DOI 10.4049/jimmunol.1602127; Li C, 2015, INT CONF INFO SCI, P10, DOI 10.1109/ICIST.2015.7288911; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Lowe DB, 2011, IMMUNOTHERAPY-UK, V3, P1265, DOI [10.2217/IMT.11.113, 10.2217/imt.11.113]; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Miles SA, 2009, ADV DRUG DELIVER REV, V61, P275, DOI 10.1016/j.addr.2008.12.011; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Monti D, 2017, MECH AGEING DEV, V165, P129, DOI 10.1016/j.mad.2016.12.008; Newhall KJ, 2010, CLIN CHEM, V56, P1483, DOI 10.1373/clinchem.2006.144618; Obermann HL, 2012, IMMUNITY, V36, P159, DOI 10.1016/j.immuni.2012.02.003; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Pera A, 2015, MATURITAS, V82, P50, DOI 10.1016/j.maturitas.2015.05.004; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; SABA HI, 1984, AM J HEMATOL, V17, P295, DOI 10.1002/ajh.2830170310; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Sansoni P, 1997, MECH AGEING DEV, V96, P127, DOI 10.1016/S0047-6374(97)01887-3; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; Silva D, 2013, ACTA TROP, V127, P75, DOI 10.1016/j.actatropica.2013.04.002; Sloan RP, 2007, J APPL PHYSIOL, V103, P1007, DOI 10.1152/japplphysiol.00147.2007; Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taleb K, 2017, J IMMUNOL, V198, P1156, DOI 10.4049/jimmunol.1502638; Turnis ME, 2010, IMMUNOTHERAPY-UK, V2, P847, DOI 10.2217/IMT.10.56; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wu D, 1998, AM J PHYSIOL-CELL PH, V275, pC661, DOI 10.1152/ajpcell.1998.275.3.C661; Wu DY, 2004, BRAIN BEHAV IMMUN, V18, P487, DOI 10.1016/j.bbi.2004.05.003; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471; Yen CJ, 2000, J BIOMED SCI, V7, P317; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	89	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188881	10.1371/journal.pone.0188881	http://dx.doi.org/10.1371/journal.pone.0188881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186188	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900068
J	Neige, C; Masse-larie, H; Gagne, M; Bouyer, LJ; Mercier, C				Neige, Cecilia; Masse-Alarie, Hugo; Gagne, Martin; Bouyer, Laurent J.; Mercier, Catherine			Modulation of corticospinal output in agonist and antagonist proximal arm muscles during motor preparation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; REACTION-TIME-TASK; CORTICOMOTOR EXCITABILITY; POSTSPIKE FACILITATION; INHIBITORY MECHANISMS; EVOKED-POTENTIALS; CORTEX; SUPPRESSION; MOVEMENT; HUMANS	Previous studies have shown modulation of corticospinal output of the agonist muscle when a known-movement is prepared but withheld until a response signal appearance, reflecting motor preparation processes. However, modulation in the antagonist muscles has not been described, despite the fact that reaching movements require precise coordination between the activation of agonist and antagonist muscles. In this study, participants performed an instructed-delay reaction time (RT) task, with randomized elbow flexion and extension movements. The aim was to assess the time course modulation of corticospinal output in two antagonist muscles, by simultaneously quantified the amplitude of motor evoked potentials (MEPs) in biceps brachii and triceps brachii, and the amplitude and direction of elbow movements evoked by transcranial magnetic stimulation (TMS). Depending on the prepared movement direction, a specific modulation of corticospinal output was observed, MEPs and TMS-evoked movements amplitude being relatively greater for extension compared to flexion. At the end of motor preparation, a decrease in MEPs amplitude was observed for both biceps brachii and triceps brachii, regardless of the prepared movement direction. In contrast, the probability of evoking movement in the flexion direction and the amplitude of TMS-evoked movement decreased at the end of preparation for flexion, but not for extension. Together, these results confirm the existence of inhibitory processes at the end of the motor preparation, probably to avoid a premature motor response. Moreover, they provide evidence of differences in the corticospinal control of elbow flexor and extensor muscles with patterns of modulation that are not necessarily reciprocal during motor preparation.	[Neige, Cecilia; Masse-Alarie, Hugo; Gagne, Martin; Bouyer, Laurent J.; Mercier, Catherine] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Neige, Cecilia; Bouyer, Laurent J.; Mercier, Catherine] Laval Univ, Dept Rehabil, Quebec City, PQ, Canada	Laval University; Laval University	Mercier, C (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Mercier, C (corresponding author), Laval Univ, Dept Rehabil, Quebec City, PQ, Canada.	catherine.mercier@rea.ulaval.ca	Bouyer, Laurent J/A-9255-2010; Neige, Cécilia/Z-4350-2019; Bouyer, Laurent/L-6471-2019	Bouyer, Laurent J/0000-0003-2034-4516; Neige, Cécilia/0000-0003-0652-6372; Bouyer, Laurent/0000-0003-2034-4516; Mercier, Catherine/0000-0002-2037-6916; Masse-Alarie, Hugo/0000-0003-4472-9656	Canadian Institute for Health Research (CIHR) [MOP-125869]; Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Fonds de Recherche Quebec-Sante (FRQS)	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Fonds de Recherche Quebec-Sante (FRQS)	This study was funded by the Canadian Institute for Health Research (CIHR) [grant number MOP-125869] ttp://www.cihr-irsc.gc.ca/e/193.html. CN was supported by a studentship from the Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS). CM was supported by salary grants from the Fonds de Recherche Quebec-Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; Bestmann S, 2016, NEUROSCIENTIST, V22, P392, DOI 10.1177/1073858415592594; Burle B, 2002, PSYCHOPHYSIOLOGY, V39, P207, DOI 10.1017/S0048577201392119; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cohen O, 2010, CURR OPIN NEUROBIOL, V20, P696, DOI 10.1016/j.conb.2010.09.001; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; DIFABIO RP, 1987, PHYS THER, V67, P43, DOI 10.1093/ptj/67.1.43; Duque J, 2017, TRENDS NEUROSCI, V40, P219, DOI 10.1016/j.tins.2017.02.006; Duque J, 2014, NEUROPSYCHOLOGIA, V65, P287, DOI 10.1016/j.neuropsychologia.2014.08.006; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Federico P, 2017, J PHYSIOL-LONDON, V595, P233, DOI 10.1113/JP272266; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Gerachshenko T, 2007, EXP BRAIN RES, V183, P531, DOI 10.1007/s00221-007-1071-4; Hasbroucq T, 1997, COGNITIVE BRAIN RES, V5, P185, DOI 10.1016/S0926-6410(96)00069-9; Hoshiyama M, 1996, MUSCLE NERVE, V19, P125, DOI 10.1002/(SICI)1097-4598(199602)19:2<125::AID-MUS1>3.0.CO;2-G; Jones-Lush LM, 2010, NEUROSCIENCE, V165, P774, DOI 10.1016/j.neuroscience.2009.10.065; KASSER RJ, 1985, J NEUROPHYSIOL, V53, P959, DOI 10.1152/jn.1985.53.4.959; Komeilipoor N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41249; Lebon F, 2015, CEREB CORTEX, P1; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; Mars RB, 2007, EXP BRAIN RES, V182, P125, DOI 10.1007/s00221-007-1055-4; McMillan S, 2004, EXP BRAIN RES, V156, P80, DOI 10.1007/s00221-003-1772-2; McMillan S, 2006, EXP BRAIN RES, V172, P230, DOI 10.1007/s00221-005-0331-4; McMorland AJC, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00082; Mitsuhashi K, 2007, TOHOKU J EXP MED, V212, P221, DOI 10.1620/tjem.212.221; Mogk JPM, 2014, CLIN NEUROPHYSIOL, V125, P2046, DOI 10.1016/j.clinph.2014.02.007; Morgante F, 2011, J NEUROL, V258, P263, DOI 10.1007/s00415-010-5742-x; Nuzzo J, 2016, J NEUROPHYSIOL; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park MC, 2004, J NEUROPHYSIOL, V92, P2968, DOI 10.1152/jn.00649.2003; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Riehle A, 2005, FRON NEUROS, P213; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Sinclair C, 2009, EXP BRAIN RES, V194, P103, DOI 10.1007/s00221-008-1684-2; Touge T, 1998, ELECTROMYOGR MOTOR C, V109, P489, DOI 10.1016/S0924-980X(98)00050-2; Vallence AM, 2012, J NEUROPHYSIOL, V107, P3417, DOI 10.1152/jn.01118.2010; WADMAN W J, 1979, Journal of Human Movement Studies, V5, P3; Wong AL, 2015, NEUROSCIENTIST, V21, P385, DOI 10.1177/1073858414541484; Yamanaka K, 2002, EXP BRAIN RES, V142, P301, DOI 10.1007/s00221-001-0943-2; Yu WS, 2010, J NEUROPHYSIOL, V103, P278, DOI 10.1152/jn.00797.2009	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188801	10.1371/journal.pone.0188801	http://dx.doi.org/10.1371/journal.pone.0188801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186189	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900062
J	Zang, XJ; Zheng, X; Hou, YL; Hu, MM; Wang, H; Bao, XQ; Zhou, F; Wang, GJ; Hao, HP				Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Bao, Xiaoqiang; Zhou, Fang; Wang, Guangji; Hao, Haiping			Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice	FASEB JOURNAL			English	Article						tryptophan metabolism; neuroimmune interaction; glial activation	ARYL-HYDROCARBON RECEPTOR; LY6C(HI) MONOCYTES; BRAIN; TRYPTOPHAN; CNS; STIMULATION; INHIBITION; MICROBIOTA; PERIPHERY; RESPONSES	Elevated kynurenine (Kyn) production from tryptophan (Trp) metabolism is a biomarker of immune dysregulation in depression, but its mechanistic contributions to the behavioral symptoms are poorly defined. In this study, Kyn was shown to be ametabolic regulator of proinflammatory monocytes that orchestrated peripheral immune activation and neuroinflammation in depressive mice. Kyn-induced depressive behavior was paralleled by brain infiltration of proinflammatory monocytes and astrocytic activation. Kyn enhanced chemokine (C-C motif) ligand-2-mediated chemotaxis of monocytes and their proinflammatory capability on cocultured astrocytes in vitro, which involved the activation of aryl hydrocarbon receptor (AhR) signaling. Kyn augmented, whereas pharmacological AhR blockade rescued, systemic inflammation-induced monocyte trafficking, neuroimmune disturbance, and depressive-like behavior in mice. The behavior-exacerbating effects of the Kyn-AhR axis were dampened with prior depletion of functional monocytes in the periphery. The findings in our study extend understanding of an immunologic effect of Kyn that links Trp metabolism and inflammatory signaling in depression pathology, with potential therapeutic implications for depressive disorders.	[Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Lab Metab Regulat & Drug Target Discovery, Nanjing, Jiangsu, Peoples R China; [Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Jiangsu Prov Key Lab Drug Metab, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiao; Hao, Haiping] China Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Bao, Xiaoqiang] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Anim Expt Ctr, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China.; Hao, HP (corresponding author), China Pharmaceut Univ, Sch Pharm, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Zheng, Xiao/GQZ-5063-2022; Hao, Haiping/L-8265-2019	Hao, Haiping/0000-0003-2522-7546; Wang, Hong/0000-0002-6192-3082; Wang, Guangji/0000-0002-0777-3896	National Natural Science Foundation of China [81503142, 81430091, 81325025]; Natural Science Foundation of Jiangsu Province [BK20141035, BK2012026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. An Kang (Nanjing University of Chinese Medicine, Nanjing, China) and Wenxia Bai (Nanjing Technical University, Nanjing, China) for technical support and advice. This work was supported by National Natural Science Foundation of China Grants 81503142 (to X.Z.) and 81430091 and 81325025 (to H.H.), and Natural Science Foundation of Jiangsu Province Grants BK20141035 (to X.Z.) and BK2012026 (to H.H.). The authors declare no conflicts of interest.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Alcocer-Gomez E, 2016, MOL NEUROBIOL, V53, P4874, DOI 10.1007/s12035-015-9408-7; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Breda C, 2016, P NATL ACAD SCI USA, V113, P5435, DOI 10.1073/pnas.1604453113; Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008; Cuartero MI, 2014, CIRCULATION, V130, P2040, DOI 10.1161/CIRCULATIONAHA.114.011394; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Hoshi M, 2014, INFECT IMMUN, V82, P4487, DOI 10.1128/IAI.02113-14; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Kawasaki H, 2014, ALLERGY, V69, P445, DOI 10.1111/all.12346; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; McKim DB, 2016, BIOL PSYCHIAT, V79, P803, DOI 10.1016/j.biopsych.2015.07.010; Menard C, 2017, NEUROPSYCHOPHARMACOL, V42, P62, DOI 10.1038/npp.2016.90; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Novikov O, 2016, MOL PHARMACOL, V90, P674, DOI 10.1124/mol.116.105361; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Parrott JM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.200; Pino Paula A, 2011, J Vis Exp, DOI 10.3791/2348; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Strasser B, 2017, CURR TOP BEHAV NEURO, V31, P95, DOI 10.1007/7854_2016_23; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Weber MD, 2017, NEUROPSYCHOPHARMACOL, V42, P46, DOI 10.1038/npp.2016.102; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69; Wurfel BE, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.88; Xue J, 2016, GASTROENTEROLOGY, V151, P1206, DOI 10.1053/j.gastro.2016.09.064; Zheng X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19406; Zheng X, 2015, DRUG DISCOV TODAY, V20, P562, DOI 10.1016/j.drudis.2015.03.015; Zhou YF, 2013, BLOOD, V121, P3195, DOI 10.1182/blood-2012-08-453597; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	43	28	29	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1944	1956		10.1096/fj.201700853R	http://dx.doi.org/10.1096/fj.201700853R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29183965				2022-12-26	WOS:000429051400017
J	Ahsendorf, T; Muller, FJ; Topkar, V; Gunawardena, J; Eils, R				Ahsendorf, Tobias; Mueller, Franz-Josef; Topkar, Ved; Gunawardena, Jeremy; Eils, Roland			Transcription factors, coregulators, and epigenetic marks are linearly correlated and highly redundant	PLOS ONE			English	Article							HUMAN CELL-TYPES; CHROMATIN-STATE; ERYTHROID-DIFFERENTIATION; HISTONE MODIFICATIONS; GENE-EXPRESSION; FACTOR-BINDING; X-RECEPTOR; REPRESSOR; COMPLEX; PROMOTER	The DNA microstates that regulate transcription include sequence-specific transcription factors (TFs), coregulatory complexes, nucleosomes, histone modifications, DNA methylation, and parts of the three-dimensional architecture of genomes, which could create an enormous combinatorial complexity across the genome. However, many proteins and epigenetic marks are known to colocalize, suggesting that the information content encoded in these marks can be compressed. It has so far proved difficult to understand this compression in a systematic and quantitative manner. Here, we show that simple linear models can reliably predict the data generated by the ENCODE and Roadmap Epigenomics consortia. Further, we demonstrate that a small number of marks can predict all other marks with high average correlation across the genome, systematically revealing the substantial information compression that is present in different cell lines. We find that the linear models for activating marks are typically cell line-independent, while those for silencing marks are predominantly cell line-specific. Of particular note, a nuclear receptor corepressor, transducin beta-like 1 X-linked receptor 1 (TBLR1), was highly predictive of other marks in two hematopoietic cell lines. The methodology presented here shows how the potentially vast complexity of TFs, coregulators, and epigenetic marks at eukaryotic genes is highly redundant and that the information present can be compressed onto a much smaller subset of marks. These findings could be used to efficiently characterize cell lines and tissues based on a small number of diagnostic marks and suggest how the DNA microstates, which regulate the expression of individual genes, can be specified.	[Ahsendorf, Tobias; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Baden Wurttembe, Germany; [Ahsendorf, Tobias; Eils, Roland] Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Baden Wurttembe, Germany; [Ahsendorf, Tobias; Topkar, Ved; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany; [Topkar, Ved] Harvard Univ, Boston, MA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Baden Wurttembe, Germany.; Eils, R (corresponding author), Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Baden Wurttembe, Germany.	r.eils@dkfz.de	Eils, Roland/B-6121-2009; Müller, Franz-Josef/E-3336-2010	Eils, Roland/0000-0002-0034-4036; Müller, Franz-Josef/0000-0001-9478-8430				Ahsendorf T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0102-4; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; [Anonymous], 2014, R LANG ENV STAT COMP; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Baron MH, 2013, BLOOD, V122, P3701, DOI 10.1182/blood-2013-10-531673; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Bresnick E.H., 2012, NUC ACIDS RES; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Clabby ML, 2003, J BIOL CHEM, V278, P5760, DOI 10.1074/jbc.M208173200; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139280; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gupta AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003170; Hadjiagapiou C, 2005, AM J PHYSIOL-GASTR L, V288, pG1118, DOI 10.1152/ajpgi.00312.2004; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kihara-Negishi F, 2005, BIOCHEM BIOPH RES CO, V335, P477, DOI 10.1016/j.bbrc.2005.07.098; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kuang Z, 2014, NAT STRUCT MOL BIOL, V21, P854, DOI 10.1038/nsmb.2881; Lee CC, 2012, J BIOL CHEM, V287, P2798, DOI 10.1074/jbc.M111.258947; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li JY, 2015, AM J CLIN EXP UROL, V3, P13; Perner J, 2014, NUCLEIC ACIDS RES, V42, P13689, DOI 10.1093/nar/gku1234; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Ridinger-Saison M, 2013, CELL DEATH DIFFER, V20, P1268, DOI 10.1038/cdd.2013.88; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186324	10.1371/journal.pone.0186324	http://dx.doi.org/10.1371/journal.pone.0186324			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216191	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800003
J	Davies, G; Lobanova, L; Dawicki, W; Groot, G; Gordon, JR; Bowen, M; Harkness, T; Arnason, T				Davies, Gerald; Lobanova, Liubov; Dawicki, Wojciech; Groot, Gary; Gordon, John R.; Bowen, Matthew; Harkness, Troy; Arnason, Terra			Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer	PLOS ONE			English	Article							OVEREXPRESSED P53 PROTEIN; MULTIPLE-DRUG RESISTANCE; INDUCIBLE FACTOR-I; MULTIDRUG-RESISTANCE; DEACETYLASE INHIBITORS; CELL-DEATH; PHOSPHORYLATION; DOXORUBICIN; SERINE-392; PHENOTYPE	Multiple drug resistant (MDR) malignancy remains a predictable and often terminal event in cancer therapy, and affects individuals with many cancer types, regardless of the stage at which they were originally diagnosed or the interval from last treatment. Protein biomarkers of MDR are not globally used for clinical decision-making, but include the overexpression of drug-efflux pumps (ABC transporter family) such as MDR-1 and BCRP, as well as HIF1 alpha, a stress responsive transcription factor found elevated within many MDR tumors. Here, we present the important in vitro discovery that the development of MDR (in breast cancer cells) can be prevented, and that established MDR could be resensitized to therapy, by adjunct treatment with metformin. Metformin is prescribed globally to improve insulin sensitivity, including in those individuals with Type 2 Diabetes Mellitus (DM2). We demonstrate the effectiveness of metformin in resensitizing MDR breast cancer cell lines to their original treatment, and provide evidence that metformin may function through a mechanism involving post-translational histone modifications via an indirect histone deacetylase inhibitor (HDACi) activity. We find that metformin, at low physiological concentrations, reduces the expression of multiple classic protein markers of MDR in vitro and in preliminary in vivo models. Our demonstration that metformin can prevent MDR development and resensitize MDR cells to chemotherapy in vitro, provides important medical relevance towards metformin's potential clinical use against MDR cancers.	[Davies, Gerald; Lobanova, Liubov; Harkness, Troy; Arnason, Terra] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Dawicki, Wojciech; Gordon, John R.; Bowen, Matthew; Arnason, Terra] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Groot, Gary] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Arnason, T (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada.; Arnason, T (corresponding author), Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada.	terra.arnason@usask.ca		Groot, Gary/0000-0002-8307-5125	Canadian Breast Cancer Foundation; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; Department of Medicine, University of Saskatchewan	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Department of Medicine, University of Saskatchewan	Funded by Canadian Breast Cancer Foundation (TH and TA), Saskatchewan Health Research Foundation (TH, TA, JRG, GG), Canadian Foundation for Innovation (TH and TA), and Department of Medicine, University of Saskatchewan (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason T, 2015, CANCERS, V7, P2063, DOI 10.3390/cancers7040877; Asensio-Lopez MC, 2014, FREE RADICAL BIO MED, V67, P19, DOI 10.1016/j.freeradbiomed.2013.11.003; Bang S, 2014, MOL ENDOCRINOL, V28, P1186, DOI 10.1210/me.2014-1134; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chan TS, 2017, ONCOTARGETS THER, V10, P347, DOI 10.2147/OTT.S93528; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, pT19, DOI 10.1530/ERC-14-0185; Comerford KM, 2002, CANCER RES, V62, P3387; Cooper AC, 2015, J CANCER RES CLIN, V141, P1523, DOI 10.1007/s00432-015-1909-2; Coyle C, 2016, ANN ONCOL, V27, P2184, DOI 10.1093/annonc/mdw410; Davies GF, 2010, CANCER LETT, V288, P236, DOI 10.1016/j.canlet.2009.07.011; Davies GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084611; Davies GF, 2009, DRUG DES DEV THER, V3, P79; Davies GF, 2005, LEUKEMIA LYMPHOMA, V46, P1199, DOI 10.1080/10428190500102555; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Duo J, 2013, DNA CELL BIOL, V32, P156, DOI 10.1089/dna.2012.1926; (FDA) Food and drug administration, METF HYDR TABL; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fox EM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00145; Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284; Furihata M, 2002, J PATHOL, V197, P82, DOI 10.1002/path.1082; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Guo QQ, 2016, MOL MED REP, V13, P2590, DOI 10.3892/mmr.2016.4830; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Hatoum D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/548436; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Katz TA, 2014, ANN MED, V46, P397, DOI 10.3109/07853890.2014.923740; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kim J, 2017, IUBMB LIFE, V69, P459, DOI 10.1002/iub.1633; Kim J, 2016, ONCOL REP, V35, P2553, DOI 10.3892/or.2016.4675; Laubach JP, 2017, EXPERT REV HEMATOL, V10, P229, DOI 10.1080/17474086.2017.1280388; Lee JO, 2012, J BIOL CHEM, V287, P44121, DOI 10.1074/jbc.M112.361386; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Ling SB, 2014, MOL MED REP, V10, P2891, DOI 10.3892/mmr.2014.2614; Long JP, 2016, WORLD J CLIN ONCOL, V7, P122, DOI 10.5306/wjco.v7.i1.122; Loubiere C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05052-2; MA J, 2014, BMC CANCER, V14; Ma SJ, 2016, ONCOTARGET, V7, P66202, DOI 10.18632/oncotarget.11033; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Matsumoto M, 2004, ONCOLOGY-BASEL, V67, P143, DOI 10.1159/000081001; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Montemurro F, 2016, EXPERT REV ANTICANC, V16, P211, DOI 10.1586/14737140.2016.1128327; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Nounou MI, 2015, BREAST CANCER-BASIC, V9, P17, DOI 10.4137/BCBCR.S29420; Ocana A, 2017, ONCOTARGET, V8, P22218, DOI 10.18632/oncotarget.14731; Patani N, 2014, MOL CELL ENDOCRINOL, V382, P683, DOI 10.1016/j.mce.2013.09.038; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2015, CLIN SCI, V129, P1037, DOI 10.1042/CS20150451; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Strober W, 2015, CURR PROTOC IMMUNOL, V111; Sukhai M, 2000, J PHARM PHARM SCI, V3, P268; Tampio M, 2008, TOXICOL LETT, V178, P152, DOI 10.1016/j.toxlet.2008.03.006; Tarrado-Castellarnau M, 2016, ONCOTARGET, V7, P62726, DOI 10.18632/oncotarget.10911; Velez J, 2016, ONCOTARGET, V7, P51435, DOI 10.18632/oncotarget.9843; Wan GX, 2016, ONCOTARGET, V7, P35437, DOI 10.18632/oncotarget.8881; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Yang T, 2015, J BREAST CANCER, V18, P264, DOI 10.4048/jbc.2015.18.3.264; Yousef M, 2017, CANCERS, V9, DOI 10.3390/cancers9050045; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhou G, 2016, CURR MOL MED, V16, P83, DOI 10.2174/1566524016666151222145551; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu H, 2013, J BIOL CHEM, V288, P16495, DOI 10.1074/jbc.M112.443580; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	72	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187191	10.1371/journal.pone.0187191	http://dx.doi.org/10.1371/journal.pone.0187191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211738	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200012
J	Ivic, N; Bilokapic, S; Halic, M				Ivic, Nives; Bilokapic, Silvija; Halic, Mario			Preparative two-step purification of recombinant H1.0 linker histone and its domains	PLOS ONE			English	Article							TERMINAL DOMAIN; NUCLEOSOME STRUCTURE; CRYSTAL-STRUCTURE; CHROMATIN; BINDING; DNA; AFFINITY; PHOSPHORYLATION; EXPRESSION; CHAPERONE	H1 linker histones are small basic proteins that have a key role in the formation and maintenance of higher-order chromatin structures. Additionally, many examples have shown that linker histones play an important role in gene regulation, modulated by their various sub-types and posttranslational modifications. Obtaining high amounts of very pure linker histones, especially for efficient antibody production, remains a demanding and challenging procedure. Here we present an easy and fast method to purify human linker histone H1.0 overexpressed in Escherichia coli, as well as its domains: N-terminal/globular domain and C-terminal intrinsically disordered domain. This purification protocol relies on a simple affinity chromatography step followed by cation exchange due to the highly basic properties of histone proteins. Therefore, this protocol can also be applied to other linker histones. Highly pure proteins in amounts sufficient for most biochemical experiments can be obtained. The functional quality of purified H1.0 histone and its domains has been confirmed by pull-down, gel-mobility shift assays and the nuclear import assay.	[Ivic, Nives; Bilokapic, Silvija; Halic, Mario] Univ Munich LMU, Dept Biochem, Gene Ctr, Munich, Germany; [Ivic, Nives] Rudjer Boskovic Inst, Dept Phys Chem, Zagreb, Croatia	University of Munich; Rudjer Boskovic Institute	Bilokapic, S (corresponding author), Univ Munich LMU, Dept Biochem, Gene Ctr, Munich, Germany.	bilokapic@genzentrum.lmu.de	Halic, Mario/X-2163-2018; Bilokapic, Silvija/H-5108-2018	Halic, Mario/0000-0002-0061-7372	Gene Center; BioSysNet; ERC-smallRNAhet [309584]; European Union Seventh Framework Programme [291823]; NEWFELPRO [26]	Gene Center; BioSysNet; ERC-smallRNAhet; European Union Seventh Framework Programme(European Commission); NEWFELPRO	This work was supported by the core funding of Gene Center, BioSysNet, and ERC-smallRNAhet-309584. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7 2007-2013) under grant agreement no 291823 Marie Curie FP7-PEOPLE-2011-COFUND (The new International Fellowship Mobility Programme for Experienced Researchers in Croatia- NEWFELPRO). This article has been prepared as a part of a project "Importins-H1 complex" which has received funding through NEWFELPRO project under grant agreement no 26.; We would like to thank Joseph Bartho for reading the manuscript. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7 2007-2013) under grant agreement no 291823 Marie Curie FP7-PEOPLE-2011-COFUND (The new International Fellowship Mobility Programme for Experienced Researchers in Croatia-NEWFELPRO). This article has been prepared as a part of a project "Structural characterization of importin beta:importin7:H1 complex (Importins-H 1 complex)" which has received funding through NEWFELPRO project under grant agreement no 26.	Bernier M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10152; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Cassany Aurelia, 2008, V464, P181; Caterino TL, 2011, MOL CELL BIOL, V31, P2341, DOI 10.1128/MCB.05145-11; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; GERCHMAN SE, 1994, PROTEIN EXPRES PURIF, V5, P242, DOI 10.1006/prep.1994.1037; Happel N, 2009, CELL CYCLE, V8, P2226, DOI 10.4161/cc.8.14.8982; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hayashihara K, 2010, MOL BIOTECHNOL, V44, P148, DOI 10.1007/s12033-009-9223-3; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Ivic N, 2016, CROAT CHEM ACTA, V89, DOI 10.5562/cca2806; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jakel S, 1999, IMPORTIN HETERODIMER, V18, P2411; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104029; Lee YT, 2015, PROTEIN EXPRES PURIF, V110, P89, DOI 10.1016/j.pep.2015.02.007; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Oberg C, 2012, BIOCHEM BIOPH RES CO, V420, P321, DOI 10.1016/j.bbrc.2012.02.157; Pyo SH, 2001, PROTEIN EXPRES PURIF, V23, P38, DOI 10.1006/prep.2001.1471; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Roque A, 2005, J BIOL CHEM, V280, P32141, DOI 10.1074/jbc.M505636200; Shintomi K, 2005, P NATL ACAD SCI USA, V102, P8210, DOI 10.1073/pnas.0500822102; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Ulrich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053360; van Holde KE., 1989, SPRINGER SERIES MOL; Vyas P, 2012, J BIOL CHEM, V287, P11778, DOI 10.1074/jbc.M111.312819; Wellman SE, 1997, BIOTECHNOL APPL BIOC, V26, P117; White AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19122; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110; Zhou BR, 2015, STRUCTURAL MECHANISM, V59, P628	42	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189040	10.1371/journal.pone.0189040	http://dx.doi.org/10.1371/journal.pone.0189040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206861	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700040
J	van Eldik, W; den Adel, B; Monshouwer-Kloots, J; Salvatori, D; Maas, S; van der Made, I; Creemers, EE; Frank, D; Frey, N; Boontje, N; van der Velden, J; Steendijk, P; Mummery, C; Passier, R; Beqqali, A				van Eldik, Willemijn; den Adel, Brigit; Monshouwer-Kloots, Jantine; Salvatori, Daniela; Maas, Saskia; van der Made, Ingeborg; Creemers, Esther E.; Frank, Derk; Frey, Norbert; Boontje, Nicky; van der Velden, Jolanda; Steendijk, Paul; Mummery, Christine; Passier, Robert; Beqqali, Abdelaziz			Z-disc protein CHAPb induces cardiomyopathy and contractile dysfunction in the postnatal heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; INDUCED CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; VENTRICULAR CONDUCTION; EXPRESSION; ATRIAL; DISRUPTION; FAILURE; MOUSE; CONNEXIN43	Aims The Z-disc is a crucial structure of the sarcomere and is implicated in mechanosensation/ transduction. Dysregulation of Z-disc proteins often result in cardiomyopathy. We have previously shown that the Z-disc protein Cytoskeletal Heart-enriched Actin-associated Protein (CHAP) is essential for cardiac and skeletal muscle development. Furthermore, the CHAP gene has been associated with atrial fibrillation in humans. Here, we studied the misregulated expression of CHAP isoforms in heart disease. Methods and results Mice that underwent transverse aortic constriction and calcineurin transgenic (Tg) mice, both models of experimental heart failure, displayed a significant increase in cardiac expression of fetal isoform CHAPb. To investigate whether increased expression of CHAPb postnatally is sufficient to induce cardiomyopathy, we generated CHAPb Tg mice under the control of the cardiac-specific alpha MHC promoter. CHAPb Tg mice displayed cardiac hypertrophy, interstitial fibrosis and enlargement of the left atrium at three months, which was more pronounced at the age of six months. Hypertrophy and fibrosis were confirmed by evidence of activation of the hypertrophic gene program (Nppa, Nppb, Myh7) and increased collagen expression, respectively. Connexin40 and 43 were downregulated in the left atrium, which was associated with delayed atrioventricular conduction. Tg hearts displayed both systolic and diastolic dysfunction partly caused by impaired sarcomere function evident from a reduced force generating capacity of single cardiomyocytes. This co-incided with activation of the actin signalling pathway leading to the formation of stress fibers. Conclusion This study demonstrated that the fetal isoform CHAPb initiates progression towards cardiac hypertrophy, which is accompanied by delayed atrioventricular conduction and diastolic dysfunction. Moreover, CHAP may be a novel therapeutic target or candidate gene for screening in cardiomyopathies and atrial fibrillation.	[van Eldik, Willemijn; den Adel, Brigit; Monshouwer-Kloots, Jantine; Salvatori, Daniela; Maas, Saskia; Mummery, Christine; Passier, Robert; Beqqali, Abdelaziz] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands; [van Eldik, Willemijn] ICIN, Utrecht, Netherlands; [Salvatori, Daniela; Maas, Saskia] Leiden Univ, Med Ctr, Cent Lab Anim Facil, Leiden, Netherlands; [van der Made, Ingeborg; Creemers, Esther E.; Beqqali, Abdelaziz] Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands; [Frank, Derk; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, UKSH, Kiel, Germany; [Boontje, Nicky; van der Velden, Jolanda] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Lab Physiol, Amsterdam, Netherlands; [Steendijk, Paul] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Kiel; Schleswig Holstein University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Beqqali, A (corresponding author), Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands.; Beqqali, A (corresponding author), Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands.	a.beqqali@icloud.com	Frey, Norbert/A-9695-2010; Beqqali, Abdelaziz/F-8568-2013; Steendijk, Paul/ABF-8636-2021; Frey, Norbert/M-7749-2019	Beqqali, Abdelaziz/0000-0003-1390-5821; Steendijk, Paul/0000-0002-8454-4499; Frey, Norbert/0000-0001-7611-378X; van der Velden, Jolanda/0000-0001-5224-5788; Mummery, Christine/0000-0002-4549-6535; Creemers, Esther/0000-0002-9001-3854	Netherlands Heart Foundation [2006B209]; European Community's Sixth Framework Programme [LSHM-CT-2005-018630]	Netherlands Heart Foundation(Netherlands Heart Foundation); European Community's Sixth Framework Programme	This study was supported by the Netherlands Heart Foundation grant 2006B209 (WE), and by European Community's Sixth Framework Programme contract (HeartRepair) LSHM-CT-2005-018630 (AB).	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Bevilacqua LM, 2000, J INTERV CARD ELECTR, V4, P459, DOI 10.1023/A:1009800328836; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Henkens IR, 2007, AM J PHYSIOL-HEART C, V293, pH1300, DOI 10.1152/ajpheart.01359.2006; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kindermann M, 2008, TRENDS CARDIOVAS MED, V18, P280, DOI 10.1016/j.tcm.2008.12.003; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kraja AT, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001778; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lubitz SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006284; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Perez MV, 2009, AM HEART J, V158, P622, DOI 10.1016/j.ahj.2009.08.002; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; van Eldik W, 2011, INT J DEV BIOL, V55, P649, DOI 10.1387/ijdb.103207wv; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Weeland CJ, 2015, J MOL CELL CARDIOL, V81, P107, DOI 10.1016/j.yjmcc.2015.02.008; Wei L, 2004, FASEB J, V18, P857, DOI 10.1096/fj.03-0664fje; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	47	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189139	10.1371/journal.pone.0189139	http://dx.doi.org/10.1371/journal.pone.0189139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206857	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700051
J	Zuo, Y; Xie, WF; Pang, Y; Li, TS; Li, QW; Li, YY				Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying			Bacterial community composition in the gut content of Lampetra japonica revealed by 16S rRNA gene pyrosequencing	PLOS ONE			English	Article							SEA LAMPREY; MICROBIOTA; EVOLUTION; IMMUNITY; DIVERSIFICATION; RECEPTORS; DEAMINASE; RESPONSES; DISEASE; SHAPES	The composition of the bacterial communities in the hindgut contents of Lampetrs japonica was surveyed by Illumina MiSeq of the 16S rRNA gene. An average of 32385 optimized reads was obtained from three samples. The rarefaction curve based on the operational taxonomic units tended to approach the asymptote. The rank abundance curve representing the species richness and evenness was calculated. The composition of microbe in six classification levels was also analyzed. Top 20 members in genera level were displayed as the classification tree. The abundance of microorganisms in different individuals was displayed as the pie charts at the branch nodes in the classification tree. The differences of top 50 genera in abundance between individuals of lamprey are displayed as a heatmap. The pairwise comparison of bacterial taxa abundance revealed that there are no significant differences of gut microbiota between three individuals of lamprey at a given rarefied depth. Also, the gut microbiota derived from L. japonica displays little similarity with other aquatic organism of Vertebrata after UPGMA analysis. The metabolic function of the bacterial communities was predicted through KEGG analysis. This study represents the first analysis of the bacterial community composition in the gut content of L. japonica. The investigation of the gut microbiota associated with L. japonica will broaden our understanding of this unique organism.	[Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying] Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China; [Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying] Liaoning Normal Univ, Lamprey Res Ctr, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University	Li, QW; Li, YY (corresponding author), Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China.; Li, QW; Li, YY (corresponding author), Liaoning Normal Univ, Lamprey Res Ctr, Dalian, Peoples R China.	liqw@263.net; liyingying16@163.com	Xie, Wen-Fang/AFM-0704-2022		Natural Science Foundation of China [31500106]; China Postdoctoral Science Foundation [2016M590233]; General Scientific Research Foundation of Liaoning Educational Committee [L201683674]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); General Scientific Research Foundation of Liaoning Educational Committee	The research was supported by the Natural Science Foundation of China (No. 31500106), the China Postdoctoral Science Foundation (No. 2016M590233), and the General Scientific Research Foundation of Liaoning Educational Committee (No. L201683674), all to Yingying Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang CW, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0660-4; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ghanbari M, 2013, INTECH, V81, P100; Havenaar R., 1992, SELECTION STRAINS PR, P209, DOI DOI 10.1007/978-94-011-2364-8_9; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kuraku S, 2009, JAWLESS FISHES CYCLO; Li H, 2014, AQUACULTURE RES, V46; Li YY, 2016, ANTON LEEUW INT J G, V109, P979, DOI 10.1007/s10482-016-0699-0; McCurley N, 2012, CURR GENOMICS, V13, P86, DOI 10.2174/138920212799860670; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xiao Y, 2015, MICROB ECOL, V69, P492, DOI 10.1007/s00248-014-0492-4; Yang HL, 2014, DIS AQUAT ORGAN, V111, P119, DOI 10.3354/dao02772	32	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188919	10.1371/journal.pone.0188919	http://dx.doi.org/10.1371/journal.pone.0188919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206846	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700031
J	Colabella, C; Corte, L; Roscini, L; Shapaval, V; Kohler, A; Tafintseva, V; Tascini, C; Cardinali, G				Colabella, Claudia; Corte, Laura; Roscini, Luca; Shapaval, Volha; Kohler, Achim; Tafintseva, Valeria; Tascini, Carlo; Cardinali, Gianluigi			Merging FT-IR and NGS for simultaneous phenotypic and genotypic identification of pathogenic Candida species	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INTERNAL TRANSCRIBED SPACER; RAPID IDENTIFICATION; RELIABLE IDENTIFICATION; BASIDIOMYCETOUS YEASTS; RIBOSOMAL DNA; BACTERIAL; DIFFERENTIATION; FUNGI; TOOL	The rapid and accurate identification of pathogen yeast species is crucial for clinical diagnosis due to the high level of mortality and morbidity induced, even after antifungal therapy. For this purpose, new rapid, high-throughput and reliable identification methods are required. In this work we described a combined approach based on two high-throughput techniques in order to improve the identification of pathogenic yeast strains. Next Generation Sequencing (NGS) of ITS and D1/D2 LSU marker regions together with FTIR spectroscopy were applied to identify 256 strains belonging to Candida genus isolated in nosocomial environments. Multivariate data analysis (MVA) was carried out on NGS and FT-IR datasets, separately. Strains of Candida albicans, C. parapsilosis, C. glabrata and C. tropicalis, were identified with high-throughput NGS sequencing of ITS and LSU markers and then with FTIR. Inter-and intra-species variability was investigated by consensus principal component analysis (CPCA) which combines high-dimensional data of the two complementary analytical approaches in concatenated PCA blocks normalized to the same weight. The total percentage of correct identification reached around 97.4% for C. albicans and 74% for C. parapsilosis while the other two species showed lower identification rates. Results suggested that the identification success increases with the increasing number of strains actually used in the PLS analysis. The absence of reliable FT-IR libraries in the current scenario is the major limitation in FTIR-based identification of strains, although this metabolomics fingerprint represents a valid and affordable aid to rapid and high-throughput to clinical diagnosis. According to our data, FT-IR libraries should include some tens of certified strains per species, possibly over 50, deriving from diverse sources and collected over an extensive time period. This implies a multidisciplinary effort of specialists working in strain isolation and maintenance, molecular taxonomy, FT-IR technique and chemo-metrics, data management and data basing.	[Colabella, Claudia; Corte, Laura; Roscini, Luca; Cardinali, Gianluigi] Univ Perugia, Dept Pharmaceut Sci Microbiol, Perugia, Italy; [Shapaval, Volha; Kohler, Achim; Tafintseva, Valeria] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Tascini, Carlo] Azienda Osped Colli, Osped Cotugno, Naples, Italy; [Cardinali, Gianluigi] Univ Perugia, Dept Chem Biol & Biotechnol, CEMIN, Perugia, Italy	University of Perugia; Norwegian University of Life Sciences; University of Perugia	Cardinali, G (corresponding author), Univ Perugia, Dept Pharmaceut Sci Microbiol, Perugia, Italy.; Cardinali, G (corresponding author), Univ Perugia, Dept Chem Biol & Biotechnol, CEMIN, Perugia, Italy.	gianluigi.cardinali@unipg.it	Tafintseva, Valeria/Q-9556-2019; Corte, Laura/I-5498-2012; Tascini, Carlo/L-5942-2017; Cardinali, Gianluigi/B-8622-2011	Tafintseva, Valeria/0000-0001-6015-0893; Corte, Laura/0000-0002-4723-7254; Tascini, Carlo/0000-0001-9625-6024; Kohler, Achim/0000-0001-5759-1989; Colabella, Claudia/0000-0002-2156-4150; Cardinali, Gianluigi/0000-0002-4522-7925	Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato"	Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato"	GC, CT and LC received funding for this work by Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato" (URL: http://www.itfellowshipprogram.it).	Adamowicz Sarah J, 2015, Genome, V58, P151, DOI 10.1139/gen-2015-0094; Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; [Anonymous], STUDIES MYCOLOGY; Antonielli L.V., 2011, OPEN APPL INFORM J, V5, P11, DOI DOI 10.2174/1874136301005010011; Baayen RP, 2001, PHYTOPATHOLOGY, V91, P1037, DOI 10.1094/PHYTO.2001.91.11.1037; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Buchl NR, 2008, YEAST, V25, P787, DOI 10.1002/yea.1633; Cardinali G, 2001, ANN MICROBIOL, V51, P121; Corte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26860; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEAK T, 1993, J FOOD PROTECT, V56, P777, DOI 10.4315/0362-028X-56.9.777; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Erukhimovitch V., 2005, J AGR TECHNOL, V1, P145; Essendoubi M, 2005, BBA-GEN SUBJECTS, V1724, P239, DOI 10.1016/j.bbagen.2005.04.019; Essendoubi M, 2007, J MICROBIOL METH, V71, P325, DOI 10.1016/j.mimet.2007.09.018; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fischer G, 2006, J MICROBIOL METH, V64, P63, DOI 10.1016/j.mimet.2005.04.005; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Howlett BJ, 1997, MICROBIOL RES, V152, P261, DOI 10.1016/S0944-5013(97)80038-9; Irinyi L, 2015, MED MYCOL, V53, P313, DOI 10.1093/mmy/myv008; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kohler A, 2008, BIOMEDICAL VIBRATION, P333; Kohler A, 2007, MODERN CONCEPTS BIOM, P333; Kohler A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118052; Kummerle M, 1998, APPL ENVIRON MICROB, V64, P2207; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; MANTEL N, 1967, CANCER RES, V27, P209; Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Orsini F, 2000, J MICROBIOL METH, V42, P17, DOI 10.1016/S0167-7012(00)00168-8; Oust A, 2004, FEMS MICROBIOL LETT, V239, P111, DOI 10.1016/j.femsle.2004.08.024; Putignani L, 2011, MOL BIOSYST, V7, P620, DOI 10.1039/c0mb00138d; Sandt C, 2003, J CLIN MICROBIOL, V41, P954, DOI 10.1128/JCM.41.3.954-959.2003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schoch CL, 2009, SYST BIOL; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shapaval V, 2013, ANALYST, V138, P4129, DOI 10.1039/c3an00304c; Shapaval V, 2013, J APPL MICROBIOL, V114, P788, DOI 10.1111/jam.12092; Shapaval V, 2010, J BIOPHOTONICS, V3, P512, DOI 10.1002/jbio.201000014; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; Timmins EM, 1998, J CLIN MICROBIOL, V36, P367, DOI 10.1128/JCM.36.2.367-374.1998; Toubas D, 2007, ANAL BIOANAL CHEM, V387, P1729, DOI 10.1007/s00216-006-1005-1; Vu D, STUDIES MYCOLOGY; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhao HJ, 2004, APPL ENVIRON MICROB, V70, P6619, DOI 10.1128/AEM.70.11.6619-6627.2004; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723	60	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188104	10.1371/journal.pone.0188104	http://dx.doi.org/10.1371/journal.pone.0188104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206226	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000417033200004
J	Koeniger, N; Kurze, C; Phiancharoen, M; Koeniger, G				Koeniger, Nikolaus; Kurze, Christoph; Phiancharoen, Mananya; Koeniger, Gudrun			"Up" or "down" that makes the difference. How giant honeybees (Apis dorsata) see the world	PLOS ONE			English	Article							GENUS-APIS; RECOGNITION; PREDATORS	A. dorsata builds its large exposed comb high in trees or under ledges of high rocks. The "open" nest of A. dorsata, shielded (only!) by multiple layers of bees, is highly vulnerable to any kind of direct contact or close range attacks from predators. Therefore, guard bees of the outer layer of A. dorsata's nest monitor the vicinity for possible hazards and an effective risk assessment is required. Guard bees, however, are frequently exposed to different objects like leaves, twigs and other tree litter passing the nest from above and falling to the ground. Thus, downward movement of objects past the nest might be used by A. dorsata to classify these visual stimuli near the nest as "harmless". To test the effect of movement direction on defensive responses, we used circular black discs that were moved down or up in front of colonies and recorded the number of guard bees flying towards the disc. The size of the disc (diameter from 8 cm to 50 cm) had an effect on the number of guard bees responding, the bigger the plate the more bees started from the nest. The direction of a disc's movement had a dramatic effect on the attraction. We found a significantly higher number of attacks, when discs were moved upwards compared to downward movements (GLMM (estimate +/- s.e.) 1.872 +/- 0.149, P < 0.001). Our results demonstrate for the first time that the vertical direction of movement of an object can be important for releasing defensive behaviour. Upward movement of dark objects near the colony might be an innate releaser of attack flights. At the same time, downward movement is perceived as a "harmless" stimulus.	[Koeniger, Nikolaus; Kurze, Christoph; Koeniger, Gudrun] Martin Luther Univ Halle Wittenberg, Inst Biol Zool, Mol Ecol, Halle, Germany; [Kurze, Christoph] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Phiancharoen, Mananya] King Mongkuts Univ Technol Thonburi, Bangkok, Thailand	Martin Luther University Halle Wittenberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Mongkuts University of Technology Thonburi	Koeniger, N (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol Zool, Mol Ecol, Halle, Germany.	nikolaus.koeniger@zoologie.uni-halle.de						ALEXANDER BA, 1991, ANN ENTOMOL SOC AM, V84, P137, DOI 10.1093/aesa/84.2.137; Blumstein DT, 2006, ETHOLOGY, V112, P209, DOI 10.1111/j.1439-0310.2006.01209.x; Brown GE, 2011, ANIM BEHAV, V81, P1249, DOI 10.1016/j.anbehav.2011.03.013; Fuchs S, 2011, HONEYBEES OF ASIA, P369, DOI 10.1007/978-3-642-16422-4_17; Griffin AS, 2001, ANIM BEHAV, V62, P577, DOI 10.1006/anbe.2001.1781; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger Gerald, 2010, Communicative & Integrative Biology, V3, P179; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; KOENIGER N, 1979, J INSECT PHYSIOL, V25, P467, DOI 10.1016/S0022-1910(79)80004-9; KOENIGER N, 1972, NATURWISSENSCHAFTEN, V59, P169, DOI 10.1007/BF00637365; Koeniger N., 1975, P153; Koeniger N, 2015, BEES DEV J, V115, P6; Koeniger N., 2010, HONEY BEES BORNEO EX; Koeniger N, 2011, HONEYBEES OF ASIA, P23, DOI 10.1007/978-3-642-16422-4_2; Morse R.A, 1969, PHILIPPINE ASS ENTOM, V1, P1; OLDROYD BP, 2006, ASIAN HONEY BEES; R Development Core Team, 2016, R LANG ENV STAT COMP; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Seeley TD., 1985, HONEYBEE ECOLOGY, DOI [10.1515/9781400857876, DOI 10.1515/9781400857876]; Skaug H, 2012, GLMMADMB GEN LINEAR; Webb JK, 2010, BEHAV ECOL, V21, P72, DOI 10.1093/beheco/arp152	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0185325	10.1371/journal.pone.0185325	http://dx.doi.org/10.1371/journal.pone.0185325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190297	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900004
J	Menshikov, IS; Shklover, AV; Babkina, TS; Myagkov, MG				Menshikov, Ivan S.; Shklover, Alexsandr V.; Babkina, Tatiana S.; Myagkov, Mikhail G.			From rationality to cooperativeness: The totally mixed Nash equilibrium in Markov strategies in the iterated Prisoner's Dilemma	PLOS ONE			English	Article							QUANTAL RESPONSE EQUILIBRIUM; BEHAVIOR; GAMES; SIZE; NEIGHBORHOOD	In this research, the social behavior of the participants in a Prisoner's Dilemma laboratory game is explained on the basis of the quantal response equilibrium concept and the representation of the game in Markov strategies. In previous research, we demonstrated that social interaction during the experiment has a positive influence on cooperation, trust, and gratefulness. This research shows that the quantal response equilibrium concept agrees only with the results of experiments on cooperation in Prisoner's Dilemma prior to social interaction. However, quantal response equilibrium does not explain of participants' behavior after social interaction. As an alternative theoretical approach, an examination was conducted of iterated Prisoner's Dilemma game in Markov strategies. We built a totally mixed Nash equilibrium in this game; the equilibrium agrees with the results of the experiments both before and after social interaction.	[Menshikov, Ivan S.; Shklover, Alexsandr V.; Babkina, Tatiana S.] State Univ, Moscow Inst Phys & Technol, Dept Control & Appl Math, Moscow, Moscow Region, Russia; [Menshikov, Ivan S.] Russian Acad Sci, Fed Res Ctr Comp Sci & Control, Dorodnicyn Comp Ctr, Dept Math Modeling Econ Syst, Moscow, Moscow Region, Russia; [Babkina, Tatiana S.] Skolkovo Inst Sci & Technol, Ctr Design Mfg & Mat, Moscow, Moscow Region, Russia; [Babkina, Tatiana S.; Myagkov, Mikhail G.] Tomsk State Univ, Lab Expt Methods Cognit & Social Sci, Tomsk, Tomsk Region, Russia; [Myagkov, Mikhail G.] Univ Oregon, Dept Polit Sci, Eugene, OR 97403 USA	Moscow Institute of Physics & Technology; Federal Research Center "Computer Science & Control" of RAS; Russian Academy of Sciences; Dorodnitsyn Computing Centre, RAS; Skolkovo Institute of Science & Technology; Tomsk State University; University of Oregon	Babkina, TS (corresponding author), State Univ, Moscow Inst Phys & Technol, Dept Control & Appl Math, Moscow, Moscow Region, Russia.; Babkina, TS (corresponding author), Skolkovo Inst Sci & Technol, Ctr Design Mfg & Mat, Moscow, Moscow Region, Russia.; Babkina, TS (corresponding author), Tomsk State Univ, Lab Expt Methods Cognit & Social Sci, Tomsk, Tomsk Region, Russia.	t.babkina@skoltech.ru	Myagkov, Mikhail G./G-6049-2017; Menshikov, Ivan S/B-6381-2018; Babkina, Tatiana/J-6732-2015	Babkina, Tatiana/0000-0002-0504-2643	Russian Foundation for Basic Research [16-0100633]; Skolkovo Institute of Science and Technology; Tomsk State University competitiveness improvement program	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Skolkovo Institute of Science and Technology; Tomsk State University competitiveness improvement program	The research was supported by the grant in Russian Foundation for Basic Research, http:// www.rfbr.ru/rffi/eng. The grant number is 16-0100633. The recipient of funding is I.S. Menshikov. Also the conducting of the experiments was supported by Skolkovo Institute of Science and Technology. This research was supported by The Tomsk State University competitiveness improvement program.; We thank Rinat Yaminov for writing the programing code for experiments, Anna Sedush and Alexander Chaban for technical help in conducting experiments at Tomsk State University, Olga Menshikova for thoughtful comments and advices. This research was supported by The Tomsk State University competitiveness improvement program.	Akin E., 2013, ARXIV12110969V2; Axelrod R., 1987, DYNAMICS NORMS, P1; Babkina T., 2016, CEUR WORK P CEUR WORK P, V1627, P13; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; Berkman ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119685; BERNHEIM BD, 1987, J ECON THEORY, V42, P1, DOI 10.1016/0022-0531(87)90099-8; BOYD R, 1987, NATURE, V327, P58, DOI 10.1038/327058a0; Campbell R., 1985, PARADOXES RATIONALIT; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Choi S, 2012, REV ECON DES, V16, P135, DOI 10.1007/s10058-012-0122-x; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Englmaier F, 2010, GAME ECON BEHAV, V69, P312, DOI 10.1016/j.geb.2009.12.007; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Goeree JK, 2005, EXP ECON, V8, P347, DOI 10.1007/s10683-005-5374-7; Goeree JK, 2000, EUR ECON REV, V44, P1079, DOI 10.1016/S0014-2921(99)00048-3; Goeree JK, 2002, J ECON THEORY, V104, P247, DOI 10.1006/jeth.2001.2914; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Karandikar R, 1998, J ECON THEORY, V80, P292, DOI 10.1006/jeth.1997.2379; Lukinova E., 2015, WORLD ACAD SCI ENG T, V7; Lukinova E, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00060; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; McKelvey RD, 2000, J ECON BEHAV ORGAN, V42, P523, DOI 10.1016/S0167-2681(00)00102-5; McKelvey RD, 1993, UANTAL RESPONSE EQU; McWilliams A, 2006, CORPORATE SOCIAL RES, V43, P1; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Milinski M, 1998, P NATL ACAD SCI USA, V95, P13755, DOI 10.1073/pnas.95.23.13755; Myerson Roger., 1978, INT J GAME THEORY, V7, P73, DOI DOI 10.1007/BF01753236; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Ostrom E., 2003, TRUST RECIPROCITY IN; Peshkovskaya AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175492; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; ROBERTS RW, 1992, ACCOUNT ORG SOC, V17, P595, DOI 10.1016/0361-3682(92)90015-K; Roth A. E., 1977, Mathematics of Operations Research, V2, P64, DOI 10.1287/moor.2.1.64; SELTEN R, 1986, J ECON BEHAV ORGAN, V7, P47, DOI 10.1016/0167-2681(86)90021-1; STARR JA, 1990, STRATEGIC MANAGE J, V11, P79; Tumennasan N, 2013, GAME ECON BEHAV, V77, P138, DOI 10.1016/j.geb.2012.10.004; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; WHEELER RM, 1986, IEEE T AUTOMAT CONTR, V31, P519, DOI 10.1109/TAC.1986.1104342; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Zhang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074540; Zhang FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124371; Zhuang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105391	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0180754	10.1371/journal.pone.0180754	http://dx.doi.org/10.1371/journal.pone.0180754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190280	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900001
J	Mundre, RS; Koka, P; Dhanaraj, P; Khatri, N; Vig, S; Chandramohan, Y; Dhanasekaran, A				Mundre, Reddy Sailaja; Koka, Pavani; Dhanaraj, Prakash; Khatri, Nitin; Vig, Sanjana; Chandramohan, Yamini; Dhanasekaran, Anuradha			Synergistic role of 5-azacytidine and ascorbic acid in directing cardiosphere derived cells to cardiomyocytes in vitro by downregulating Wnt signaling pathway via phosphorylation of beta-catenin	PLOS ONE			English	Article							CARDIAC STEM-CELLS; PROGENITOR CELLS; DIFFERENTIATION; HEART; TRANSPLANTATION; MULTIPLE; POTENCY; AXIN	Background Cardiosphere derived cells (CDCs) represent a valuable source in stem cell based therapy for cardiovascular diseases, yet poor differentiation rate hinders the transplantation efficiency. The aim of this study is to check the ability of 5-Azacytidine (Aza) alone and in combination with ascorbic acid (Aza+AA) in delineating CDCs to cardiomyogenesis and the underlying Wnt signaling mechanism in induced differentiation. Methods CDCs were treated with Aza and Aza+AA for a period of 14 days to examine the expression of cardiac specific markers and Wnt downstream regulators by immunofluorescence, real time PCR and western blot. Results Results revealed that Aza+AA induced efficient commitment of CDCs to cardiomyogenic lineage. Immunofluorescence analysis showed significant augment for Nkx 2.5, GATA 4 and a-Sarcomeric actinin markers in Aza+AA group than control group (p = 0.0118, p = 0.009 and p = 0.0091, respectively). Relative upregulation of cardiac markers, Nkx 2.5 (p = 0.0156), GATA 4 (p = 0.0087) and down regulation of Wnt markers, beta-catenin (p = 0.0107) and Cyclin D1 (p = 0. 0116) in Aza+AA group was revealed by RNA expression analysis. Moreover, the Aza+AA induced prominent expression of GATA 4, a-Sarcomeric actinin and phospho beta-catenin while non phospho beta-catenin and Cyclin D1 expression was significantly suppressed as displayed in protein expression analysis. Generation of spontaneous beating in Aza+AA treated CDCs further reinforced that Aza+AA accelerates the cardiomyogenic potential of CDCs. Conclusion Combined treatment of Aza along with AA implicit in inducing cardiomyogenic potential of CDCs and is associated with down regulating Wnt signaling pathway. Altogether, CDCs represent a valuable tool for the treatment of cardiovascular disorders.	[Mundre, Reddy Sailaja; Koka, Pavani; Dhanaraj, Prakash; Khatri, Nitin; Vig, Sanjana; Chandramohan, Yamini; Dhanasekaran, Anuradha] Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India	Anna University; Anna University Chennai	Dhanasekaran, A (corresponding author), Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India.	anu@annauniv.edu	Dhanasekaran, Anuradha/AAF-3160-2022; Dhanasekaran, Anuradha/AFH-8265-2022	Vig, Sanjana/0000-0001-7939-6500; Dhanasekaran, Anuradha/0000-0002-0195-9681	Department of Science and Technology, New Delhi, India under DST-INSPIRE Fellowship [DST/INSPIRE Fellowship/2012/143]; MHRDCEMA [5-3/2015-TS VII]; BUILDER [BT/PR12153/INF/22/200/2014]	Department of Science and Technology, New Delhi, India under DST-INSPIRE Fellowship(Department of Science & Technology (India)); MHRDCEMA; BUILDER	The authors are thankful to Department of Science and Technology, New Delhi, India for the financial support under DST-INSPIRE Fellowship (No: DST/INSPIRE Fellowship/2012/143) granted to RSM. We acknowledge the financial support from MHRDCEMA F.NO-5-3/2015-TS VII and BUILDER program BT/PR12153/INF/22/200/2014 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875; Arminan A, 2009, STEM CELLS DEV, V18, P907, DOI 10.1089/scd.2008.0292; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bonios M, 2011, J AM SOC ECHOCARDIOG, V24, P808, DOI 10.1016/j.echo.2011.03.003; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gao Q, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/162024; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Hoyos I, 2016, PLOS ONE, V11; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Parvin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107453; Qian Q, 2012, STEM CELLS DEV, V21, P67, DOI 10.1089/scd.2010.0519; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tan JJ, 2011, CURR PROTOC STEM C C, V2C; Tateishi K, 2007, BIOCHEM BIOPH RES CO, V352, P635, DOI 10.1016/j.bbrc.2006.11.096; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Vliet P, 2008, NETH HEART J, V16, P163, DOI 10.1007/BF03086138; Weiser B, 2009, CELLS TISSUES ORGANS, V189, P373, DOI 10.1159/000154270; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105; Zhang Yihua, 2009, Interact Cardiovasc Thorac Surg, V9, P943, DOI 10.1510/icvts.2009.211490	47	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188805	10.1371/journal.pone.0188805	http://dx.doi.org/10.1371/journal.pone.0188805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190771	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900130
J	Coalson, GA; Byrd, CT				Coalson, Geoffrey A.; Byrd, Courtney T.			Nonword repetition in adults who stutter: The effects of stimuli stress and auditory orthographic cues	PLOS ONE			English	Article							LANGUAGE HISTORY QUESTIONNAIRE; LONG-TERM KNOWLEDGE; SPEECH PRODUCTION; WORKING-MEMORY; YOUNG-CHILDREN; SYLLABLE-FREQUENCY; PHONEME ELISION; LEXICAL ACCESS; SERIAL-RECALL; STRATEGY USE	Purpose Adults who stutter (AWS) are less accurate in their immediate repetition of novel phonological sequences compared to adults who do not stutter (AWNS). The present study examined whether manipulation of the following two aspects of traditional nonword repetition tasks unmask distinct weaknesses in phonological working memory in AWS: (1) presentation of stimuli with less-frequent stress patterns, and (2) removal of auditory-orthographic cues immediately prior to response. Method Fifty-two participants (26 AWS, 26 AWNS) produced 12 bisyllabic nonwords in the presence of corresponding auditory-orthographic cues (i.e., immediate repetition task), and the absence of auditory-orthographic cues (i.e., short-term recall task). Half of each cohort (13 AWS, 13 AWNS) were exposed to the stimuli with high-frequency trochaic stress, and half (13 AWS, 13 AWNS) were exposed to identical stimuli with lower-frequency iambic stress. Results No differences in immediate repetition accuracy for trochaic or iambic nonwords were observed for either group. However, AWS were less accurate when recalling iambic non words than trochaic nonwords in the absence of auditory-orthographic cues. Conclusions Manipulation of two factors which may minimize phonological demand during standard non word repetition tasks increased the number of errors in AWS compared to AWNS. These findings suggest greater vulnerability in phonological working memory in AWS, even when producing nonwords as short as two syllables.	[Coalson, Geoffrey A.] Louisiana State Univ, Dept Commun Sci & Disorders, Baton Rouge, LA 70803 USA; [Byrd, Courtney T.] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA	Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Austin	Coalson, GA (corresponding author), Louisiana State Univ, Dept Commun Sci & Disorders, Baton Rouge, LA 70803 USA.	gcoals1@lsu.edu		Coalson, Geoffrey/0000-0003-1179-2499	Michael and Tami Lang Stuttering Institute; Emanuel Bodner Developmental Stuttering Laboratory; Louisiana State University Council of Research; ASH Foundation New Century Scholars Doctoral Scholarship; National Stuttering Association Canadeo Family Research Award; Manship Summer Research Award; Louisiana Board of Regents Research Competitiveness Subprogram and Pilot Funding for New Research	Michael and Tami Lang Stuttering Institute; Emanuel Bodner Developmental Stuttering Laboratory; Louisiana State University Council of Research; ASH Foundation New Century Scholars Doctoral Scholarship; National Stuttering Association Canadeo Family Research Award; Manship Summer Research Award; Louisiana Board of Regents Research Competitiveness Subprogram and Pilot Funding for New Research	This study was funded by the endowed support of the Michael and Tami Lang Stuttering Institute and Dr. Jennifer and Emanuel Bodner Developmental Stuttering Laboratory. This study was also funded in part by the Louisiana State University Council of Research, the ASH Foundation New Century Scholars Doctoral Scholarship, the National Stuttering Association Canadeo Family Research Award, the Manship Summer Research Award, and the Louisiana Board of Regents Research Competitiveness Subprogram and Pilot Funding for New Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Speech-Language-Hearing Association, 1997, GUID AUD SCREEN; Anderson JD, 2008, J SPEECH LANG HEAR R, V51, P851, DOI 10.1044/1092-4388(2008/062); Anderson JD, 2007, J SPEECH LANG HEAR R, V50, P229, DOI 10.1044/1092-4388(2007/018); Anderson JD, 2006, J FLUENCY DISORD, V31, P177, DOI 10.1016/j.jfludis.2006.05.001; Anderson JD, 2010, J FLUENCY DISORD, V35, P216, DOI 10.1016/j.jfludis.2010.04.003; [Anonymous], DISCOVERING STAT USI; Archibald LMD, 2009, J ACOUST SOC AM, V125, P1712, DOI 10.1121/1.3076200; Arndt J, 2001, LANG SPEECH HEAR SER, V32, P68, DOI 10.1044/0161-1461(2001/006); Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bajaj A, 2007, J FLUENCY DISORD, V32, P218, DOI 10.1016/j.jfludis.2007.03.002; BOSSHARDT HG, 1993, J SPEECH HEAR RES, V36, P286, DOI 10.1044/jshr.3602.286; BOSSHARDT HG, 1990, J SPEECH HEAR RES, V33, P776, DOI 10.1044/jshr.3304.776; Boucher VJ, 2006, LANG SPEECH, V49, P495, DOI 10.1177/00238309060490040301; Byrd CT, 2007, AM J SPEECH-LANG PAT, V16, P43, DOI 10.1044/1058-0360(2007/006); Byrd CT, 2015, J FLUENCY DISORD, V44, P17, DOI 10.1016/j.jfludis.2015.01.004; Byrd CT, 2012, J FLUENCY DISORD, V37, P188, DOI 10.1016/j.jfludis.2012.03.003; Byrd CT, 2016, P INT FLUENC ASS 8 W; Chiat S, 2007, J SPEECH LANG HEAR R, V50, P429, DOI 10.1044/1092-4388(2007/030); Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; Cholin J, 2011, J EXP PSYCHOL LEARN, V37, P109, DOI 10.1037/a0021322; Coalson GA, 2015, J SPEECH LANG HEAR R, V58, P601, DOI 10.1044/2015_JSLHR-S-14-0111; Coalson GA, 2012, CLIN LINGUIST PHONET, V26, P646, DOI 10.3109/02699206.2012.682696; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; Damian MF, 2003, J MEM LANG, V49, P119, DOI 10.1016/S0749-596X(03)00008-1; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Dunlosky J, 2007, Q J EXP PSYCHOL, V60, P1227, DOI 10.1080/17470210600926075; Gallon N, 2007, CLIN LINGUIST PHONET, V21, P435, DOI 10.1080/02699200701299982; GATHERCOLE SE, 1995, MEM COGNITION, V23, P83, DOI 10.3758/BF03210559; Gathercole SE, 2001, Q J EXP PSYCHOL-A, V54, P1, DOI 10.1080/02724980042000002; Gathercole SE, 1997, CHILDRENS TEST NONWO; Goffman L, 1999, J SPEECH LANG HEAR R, V42, P1499, DOI 10.1044/jslhr.4206.1499; Goffman L, 1999, J SPEECH LANG HEAR R, V42, P1003, DOI 10.1044/jslhr.4204.1003; Gupta P, 2003, Q J EXP PSYCHOL-A, V56, P1213, DOI 10.1080/02724980343000071; Hakim HB, 2004, J FLUENCY DISORD, V29, P179, DOI 10.1016/j.jfludis.2004.06.001; Hennessey NW, 2008, J FLUENCY DISORD, V33, P180, DOI 10.1016/j.jfludis.2008.06.001; Howell P, 2006, CLIN LINGUIST PHONET, V20, P703, DOI 10.1080/02699200500390990; Jones RM, 2012, J SPEECH LANG HEAR R, V55, P1862, DOI 10.1044/1092-4388(2012/12-0014); Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Li P, 2006, BEHAV RES METHODS, V38, P202, DOI 10.3758/BF03192770; Li P, 2014, BILING-LANG COGN, V17, P673, DOI 10.1017/S1366728913000606; LUDLOW CL, 1997, SPEECH PROD MOT, V1146, P221; McNamara DS, 2001, MEM COGNITION, V29, P10, DOI 10.3758/BF03195736; Morgan JL, 2014, Q J EXP PSYCHOL, V67, P220, DOI 10.1080/17470218.2013.799216; Namasivayam AK, 2011, J MOTOR BEHAV, V43, P477, DOI 10.1080/00222895.2011.628347; Nippold MA, 2012, AM J SPEECH-LANG PAT, V21, P183, DOI 10.1044/1058-0360(2012/11-0078); Ntourou K, 2011, AM J SPEECH-LANG PAT, V20, P163, DOI 10.1044/1058-0360(2011/09-0102); Ozdemir R, 2007, COGNITION, V105, P457, DOI 10.1016/j.cognition.2006.10.006; Pelczarski KM, 2014, J FLUENCY DISORD, V39, P12, DOI 10.1016/j.jfludis.2013.10.003; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Raudenbush SW, 2001, PSYCHOL METHODS, P378; Reeves C, 2000, J EXP PSYCHOL LEARN, V26, P1638, DOI 10.1037//0278-7393.26.6.1638; Riley G., 2009, STUTTERING SEVERITY, V4th; Roy P, 2004, J SPEECH LANG HEAR R, V47, P223, DOI 10.1044/1092-4388(2004/019); Sasisekaran J, 2006, J FLUENCY DISORD, V31, P1, DOI 10.1016/j.jfludis.2005.11.005; Sasisekaran J, 2006, J FLUENCY DISORD, V31, P284, DOI 10.1016/j.jfludis.2006.08.001; Sasisekaran J, 2014, J FLUENCY DISORD, V41, P55, DOI 10.1016/j.jfludis.2014.02.004; Sasisekaran J, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-1371754; Sasisekaran J, 2013, J FLUENCY DISORD, V38, P275, DOI 10.1016/j.jfludis.2013.06.001; Smith A, 2016, SEMIN SPEECH LANG, V37, P291, DOI 10.1055/s-0036-1587703; Smith A, 2012, J FLUENCY DISORD, V37, P344, DOI 10.1016/j.jfludis.2012.06.001; Smith A, 2010, J FLUENCY DISORD, V35, P1, DOI 10.1016/j.jfludis.2009.12.001; Spencer C, 2014, J FLUENCY DISORD, V41, P32, DOI 10.1016/j.jfludis.2014.06.001; Thorn ASC, 2005, COGNITIVE PSYCHOL, V50, P133, DOI 10.1016/j.cogpsych.2004.07.001; Torgesen J.K., 1999, COMPREHENSIVE TEST P; *US DEP HHS, 1996, INT CLASS DIS 9 REV; Vallar G, 2002, HDB MEMORY DISORDERS, P24; Vincent I, 2012, J FLUENCY DISORD, V37, P91, DOI 10.1016/j.jfludis.2012.01.001; Vitevitch MS, 1997, LANG SPEECH, V40, P47, DOI 10.1177/002383099704000103; Vitevitch MS, 2003, MEM COGNITION, V31, P491, DOI 10.3758/BF03196091; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Wagner R.K., 2013, CTOPP 2 COMPREHENSIV; Weber-Fox C, 2004, J SPEECH LANG HEAR R, V47, P1244, DOI 10.1044/1092-4388(2004/094); Wechsler D., 1997, WECHSLER ADULT INTEL; Wheeldon LR, 2002, LANG COGNITIVE PROC, V17, P503, DOI 10.1080/01690960143000308	75	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188111	10.1371/journal.pone.0188111	http://dx.doi.org/10.1371/journal.pone.0188111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186179	gold, Green Published			2022-12-26	WOS:000416484900022
J	Jiang, CH; Zhang, N; Gao, J; Hu, ZL				Jiang, Changhui; Zhang, Na; Gao, Juan; Hu, Zhanli			Geometric calibration of a stationary digital breast tomosynthesis system based on distributed carbon nanotube X-ray source arrays	PLOS ONE			English	Article							CONE-BEAM TOMOGRAPHY; COMPUTED-TOMOGRAPHY; MICRO-CT; PARAMETERS	Stationary digital breast tomosynthesis (sDBT) with distributed X-ray sources based on carbon nanotube (CNT) field emission cathodes has been recently proposed as an approach that can prevent motion blur produced by traditional DBT systems. In this paper, we simulate a geometric calibration method based on a proposed multi-source CNT X-ray sDBT system. This method is a projection matrix-based approach with seven geometric parameters, all of which can be obtained from only one projection datum of the phantom. To our knowledge, this study reports the first application of this approach in a CNT-based multi-beam X-ray sDBT system. The simulation results showed that the extracted geometric parameters from the calculated projection matrix are extremely close to the input values and that the proposed method is effective and reliable for a square sDBT system. In addition, a traditional cone-beam computed tomography (CT) system was also simulated, and the uncalibrated and calibrated geometric parameters were used in image reconstruction based on the filtered back-projection (FBP) method. The results indicated that the images reconstructed with calibrated geometric parameters have fewer artifacts and are closer to the reference image. All the simulation tests showed that this geometric calibration method is optimized for sDBT systems but can also be applied to other application-specific CT imaging systems.	[Jiang, Changhui; Zhang, Na; Gao, Juan; Hu, Zhanli] Chinese Acad Sci, Shenzhen Inst Adv Technol, Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Jiang, Changhui; Zhang, Na] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, ZL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	zl.hu@siat.ac.cn	gao, juan/GXV-1381-2022		National Natural Science Foundation of China [81401410, 81527804, 11575285]; Natural Science Foundation of Guangdong Province in China [2017A030313743]; Shenzhen Overseas High-Level Talent Peacock Team of China [KQTD2016053117113327]; Basic Research Program of Shenzhen in China [JCYJ20160608153434110, JCYJ20150831154213680]; Applied Science and Technology Project of Guangdong Province in China [20156020233014]; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province [20146030301013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province in China(National Natural Science Foundation of Guangdong Province); Shenzhen Overseas High-Level Talent Peacock Team of China; Basic Research Program of Shenzhen in China; Applied Science and Technology Project of Guangdong Province in China; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province	This work was supported in part by the National Natural Science Foundation of China (81401410, 81527804,11575285), the Natural Science Foundation of Guangdong Province in China (2017A030313743), the Shenzhen Overseas High-Level Talent Peacock Team of China (KQTD2016053117113327), the Basic Research Program of Shenzhen in China (JCYJ20160608153434110, JCYJ20150831154213680), the Applied Science and Technology Project of Guangdong Province in China (20156020233014), the Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (20146030301013).	Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Bassett LW, 2005, DIAGNOSIS DIS BREAST; Ben Tekaya I, 2013, IEEE T NUCL SCI, V60, P3937, DOI 10.1109/TNS.2013.2279675; Bronnikov AV, 1999, OPT ENG, V38, P381, DOI 10.1117/1.602100; Cho YB, 2005, MED PHYS, V32, P968, DOI 10.1118/1.1869652; Ford JC, 2011, MED PHYS, V38, P2829, DOI 10.1118/1.3589130; Gennaro G, 2010, EUR RADIOL, V20, P1545, DOI 10.1007/s00330-009-1699-5; GULLBERG GT, 1987, PHYS MED BIOL, V32, P1581, DOI 10.1088/0031-9155/32/12/005; GULLBERG GT, 1990, MED PHYS, V17, P264, DOI 10.1118/1.596505; Hu ZL, 2011, IEEE T INF TECHNOL B, V15, P655, DOI 10.1109/TITB.2011.2159012; Jenkins C, 2008, STATIONARY DIGITAL B, pA9131; Khoury R, 2009, J INSTRUM, V4, DOI 10.1088/1748-0221/4/07/P07016; Ladikos A, 2012, GEOMETRIC CALIBRATIO; Li XH, 2010, MED PHYS, V37, P3844, DOI 10.1118/1.3431996; Meng YZ, 2013, IEEE T MED IMAGING, V32, P278, DOI 10.1109/TMI.2012.2224360; Noo F, 2000, PHYS MED BIOL, V45, P3489, DOI 10.1088/0031-9155/45/11/327; Panetta D, 2008, PHYS MED BIOL, V53, P3841, DOI 10.1088/0031-9155/53/14/009; Qian X, 2009, MED PHYS, V36, P4389, DOI 10.1118/1.3213520; Quan EZ, 2007, I S BIOMED IMAGING, P221, DOI 10.1109/ISBI.2007.356828; Rafferty EA, 2007, RADIOL CLIN N AM, V45, P831, DOI 10.1016/j.rcl.2007.06.005; Robert N, 2009, PHYS MED BIOL, V54, P7239, DOI 10.1088/0031-9155/54/24/001; ROUGEE A, 1993, COMPUT MED IMAG GRAP, V17, P295, DOI 10.1016/0895-6111(93)90020-N; Sun Y, 2006, NDT&E INT, V39, P499, DOI 10.1016/j.ndteint.2006.03.002; von Smekal L, 2004, MED PHYS, V31, P3242, DOI 10.1118/1.1803792; Yang K, 2006, MED PHYS, V33, P1695, DOI 10.1118/1.2198187; Yang Y, 2016, NUCL SCI TECHNIQUES, V27	26	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188367	10.1371/journal.pone.0188367	http://dx.doi.org/10.1371/journal.pone.0188367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186172	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900032
J	Zhu, C; Ji, XY; Zhang, HT; Zhou, Q; Cao, XL; Tang, M; Si, Y; Yan, H; Li, L; Liang, TB; Feng, XH; Zhao, B				Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Li, Li; Liang, Tingbo; Feng, Xin-Hua; Zhao, Bin			Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anaphase-promoting complex; LATS2; USP9X; ubiquitination; deubiquitination; protein stability; tumor suppressor gene; signal transduction; Hippo pathway	ORGAN SIZE CONTROL; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC DUCTAL ADENOCARCINOMA; PROTEIN-INTERACTION NETWORK; CELL-CYCLE EXIT; PROMOTES APOPTOSIS; SIGNALING PATHWAY; TEAD/TEF FAMILY; YAP ONCOPROTEIN; GROWTH-CONTROL	The Hippo pathway plays important roles in controlling organ size and in suppressing tumorigenesis through large tumor suppressor kinase 1/2 (LATS1/2)-mediated phosphorylation of YAP/TAZ transcription co-activators. The kinase activity of LATS1/2 is regulated by phosphorylation in response to extracellular signals. Moreover, LATS2 protein levels are repressed by the ubiquitin-proteasome system in conditions such as hypoxia. However, the mechanism that removes the ubiquitin modification from LATS2 and thereby stabilizes the protein is not well understood. Here, using tandem affinity purification (TAP), we found that anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase complex, and USP9X, a deubiquitylase, specifically interact with LATS2. We also found that although APC1 co-localizes with LATS2 to intracellular vesicle structures, it does not regulate LATS2 protein levels and activity. In contrast, USP9X ablation drastically diminished LATS2 protein levels. We further demonstrated that USP9X deubiquitinates LATS2 and thus prevents LATS2 degradation by the proteasome. Furthermore, in pancreatic cancer cells, USP9X loss activated YAP and enhanced the oncogenic potential of the cells. In addition, the tumorigenesis induced by the USP9X ablation depended not only on LATS2 repression, but also on YAP/TAZ activity. We conclude that USP9X is a deubiquitylase of the Hippo pathway kinase LATS2 and that the Hippo pathway functions as a downstream signaling cascade that mediates USP9X's tumor-suppressive activity.	[Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Feng, Xin-Hua; Zhao, Bin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Feng, Xin-Hua; Zhao, Bin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310058, Zhejiang, Peoples R China; [Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Canc Prevent & Intervent, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Li] Hangzhou Normal Univ, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Hangzhou Normal University	Zhao, B (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.edu.cn		, Huan/0000-0003-3370-0479	National Key R&D Program of China [2017YFA0504502]; National Natural Science Foundation of China Key Project [81730069]; Excellent Young Scholars Project [31422036]; General Project [31471316]; International Collaboration Project [31661130150]; 111 Project [B13026]; Qianjiang Scholar Plan of Hangzhou; Thousand Young Talents Plan of China; Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship; Academy of Medical Sciences (AMS) [NAF003\\1004] Funding Source: researchfish	National Key R&D Program of China; National Natural Science Foundation of China Key Project(National Natural Science Foundation of China (NSFC)); Excellent Young Scholars Project; General Project; International Collaboration Project; 111 Project(Ministry of Education, China - 111 Project); Qianjiang Scholar Plan of Hangzhou; Thousand Young Talents Plan of China; Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This work was supported by National Key R&D Program of China Grant 2017YFA0504502, National Natural Science Foundation of China Key Project Grant 81730069, Excellent Young Scholars Project Grant 31422036, General Project Grant 31471316, International Collaboration Project Grant 31661130150, 111 Project Grant B13026, the Qianjiang Scholar Plan of Hangzhou, the Thousand Young Talents Plan of China, and the Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship (to B. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Aylon Y, 2009, ONCOGENE, V28, P4469, DOI 10.1038/onc.2009.270; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chen Q, 2015, GENE DEV, V29, P1285, DOI 10.1101/gad.264234.115; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dai XM, 2015, CELL RES, V25, P1175, DOI 10.1038/cr.2015.101; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Nguyen HT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.1; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Q, 2014, DEV CELL, V31, P291, DOI 10.1016/j.devcel.2014.09.012; Li SX, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.38; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Masuda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118662; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Toloczko A, 2017, CANCER RES, V77, P4921, DOI 10.1158/0008-5472.CAN-16-3413; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yeung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061027; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110	64	31	32	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1178	1191		10.1074/jbc.RA117.000392	http://dx.doi.org/10.1074/jbc.RA117.000392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29183995	hybrid, Green Published			2022-12-26	WOS:000423515000007
J	Anantharaju, PG; Reddy, DB; Padukudru, MA; Chitturi, CMK; Vimalambike, MG; Madhunapantula, SV				Anantharaju, Preethi G.; Reddy, Deepa B.; Padukudru, Mahesh A.; Chitturi, Ch. M. Kumari; Vimalambike, Manjunath G.; Madhunapantula, SubbaRao V.			Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC)	PLOS ONE			English	Article							NF-KAPPA-B; SUBEROYLANILIDE HYDROXAMIC ACID; CYCLE ARREST; TRANSFORMED-CELLS; GENE-EXPRESSION; TRICHOSTATIN-A; DNA-DAMAGE; APOPTOSIS; GROWTH; SAHA	Recent studies from our group and many others have shown the ability of histone deacetylase (HDAC) inhibitors for retarding the growth of carcinomas of cervix, colon and rectum in vitro. A search for naturally occurring HDAC inhibitors continues due to the adverse effects associated with known HDAC inhibitors like SAHA and TSA. Therefore in the current study, naturally occurring cinnamic acids derivatives were screened for HDAC inhibitory effect using in silico docking method which identified cinnamic acids as potential candidates. Cinnamic acids (CA) are naturally occurring phenolic compounds known to exhibit anticancer properties. However, it is not clearly known whether the anticancer properties of CA derivatives are due to the inhibition of oncogenic HDACs, if so how the efficacy varies among various CA derivatives. Hence, the HDAC inhibitory potential of CA derivatives containing increasing number of hydroxylic groups or methoxy moieties was determined using Discovery Studio software and the most potent CA derivatives tested ex vivo (biochemical assay) as well as in vitro (using cell based assay). Among CA derivatives tested, dihydroxy cinnamic acid (DHCA, commonly known as caffeic acid) exhibited better interactions with HDAC2 (compared to other isoforms) in silico and inhibited its activity ex vivo as well as in vitro. Targeted reduction of HDAC activity using DHCA induced death of cancer cells by (a) generating reactive oxygen species, (b) arresting cells in S and G2/M phases; and (c) induction of caspase-3 mediated apoptosis. In conclusion, we demonstrated that DHCA inhibited cancer cell growth by binding to HDAC followed by the induction of apoptosis.	[Anantharaju, Preethi G.; Madhunapantula, SubbaRao V.] Jagadguru Sri Shivarathreeshwara Univ, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Dept Biochem, Mysuru, Karnataka, India; [Reddy, Deepa B.; Chitturi, Ch. M. Kumari] Womens Univ, Sri Padmavati Mahila Visvavidyalayam, Dept Appl Microbiol, Tirupati, Andhra Pradesh, India; [Padukudru, Mahesh A.] Jagadguru Sri Shivarathreeshwara Univ, JSS Med Coll, Dept Pulm Med, Mysuru, Karnataka, India; [Vimalambike, Manjunath G.] Jagadguru Sri Shivarathreeshwara Univ, JSS Med Coll, Dept Pathol, Mysuru, Karnataka, India	JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; Sri Padmavati Mahila Vishwavidyalayam; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru	Madhunapantula, SV (corresponding author), Jagadguru Sri Shivarathreeshwara Univ, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Dept Biochem, Mysuru, Karnataka, India.	madhunapantulas@yahoo.com	Madhunapantula, SubbaRao V./B-1590-2015	Madhunapantula, SubbaRao V./0000-0001-9167-9271	University Grants Commission, Government of India [F117.1/201415/MANF201415JAIKAR3409]; Department of Science and Technology (DST)-Fund for the Improvement of Science and Technology infrastructure (FIST)	University Grants Commission, Government of India(University Grants Commission, India); Department of Science and Technology (DST)-Fund for the Improvement of Science and Technology infrastructure (FIST)	PGA would like to acknowledge University Grants Commission, Government of India for providing Maulana Azad National Fellowship (F117.1/201415/MANF201415JAIKAR3409). PGA also would like to acknowledge Department of Science and Technology (DST)-Fund for the Improvement of Science and Technology infrastructure (FIST) supported Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR) laboratory, Department of Biochemistry, JSS Medical College, JSS University for allowing me to carry out research studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PGA would like to acknowledge University Grants Commission, Government of India for providing Maulana Azad National Fellowship (F117.1/201415/MANF201415JAIKAR3409). PGA also would like to acknowledge Department of Science and Technology (DST)-Fund for the Improvement of Science and Technology infrastructure (FIST) supported Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR) laboratory, Department of Biochemistry, JSS Medical College, JSS University for allowing me to carry out research studies.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anantharaju PG, 2017, CANC BIOL THER; Anantharaju PG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0217-2; Bassett SA, 2014, NUTRIENTS, V6, P4273, DOI 10.3390/nu6104273; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bora-Tatar G, 2009, BIOORGAN MED CHEM, V17, P5219, DOI 10.1016/j.bmc.2009.05.042; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Chueh AC, 2017, CLIN CANCER RES, V23, P5573, DOI 10.1158/1078-0432.CCR-17-0466; Cohen Idan, 2011, Genes Cancer, V2, P631, DOI 10.1177/1947601911417176; Du L, 2014, J NAT PROD, V77, P1753, DOI 10.1021/np500387h; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Hrgovic I, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2807-y; Huang LL, 2000, MOL MED, V6, P849, DOI 10.1007/BF03401823; Ishihama K, 2007, J CLIN PATHOL, V60, P1205, DOI 10.1136/jcp.2005.029165; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Karthik S, 2015, BIOMED PHARMACOTHER, V69, P337, DOI 10.1016/j.biopha.2014.12.023; Karthik S, 2014, BIOMED PHARMACOTHER, V68, P327, DOI 10.1016/j.biopha.2014.01.002; Kim YB, 2000, J ANTIBIOT, V53, P1191, DOI 10.7164/antibiotics.53.1191; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li GC, 2006, INT J UROL, V13, P581, DOI 10.1111/j.1442-2042.2006.01344.x; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Madhunapantula SV, 2008, MOL CANCER THER, V7, P1297, DOI 10.1158/1535-7163.MCT-07-2267; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McDermott J, 2014, DRUG TODAY, V50, P337, DOI 10.1358/dot.2014.50.5.2138703; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Parbin S, 2014, J HISTOCHEM CYTOCHEM, V62, P11, DOI 10.1369/0022155413506582; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Richardson PG, 2013, BLOOD, V122, P2331, DOI 10.1182/blood-2013-01-481325; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Rosato RR, 2008, MOL CANCER THER, V7, P3285, DOI 10.1158/1535-7163.MCT-08-0385; Sachweh MCC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.61; Senawong T, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-232; Shailasree S, 2015, MOL NEUROBIOL, V51, P119, DOI 10.1007/s12035-014-8700-2; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Singh BN, 2011, FUTURE ONCOL, V7, P1415, DOI [10.2217/fon.11.124, 10.2217/FON.11.124]; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sova M, 2012, MINI-REV MED CHEM, V12, P749, DOI 10.2174/138955712801264792; Thurn KT, 2011, FUTURE ONCOL, V7, P263, DOI 10.2217/FON.11.2; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Usha T, 2014, J BIOMED RES, V28, P406, DOI 10.7555/JBR.28.20130110; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Zheng L, 2014, INT J CANCER, V135, P1721, DOI 10.1002/ijc.28810; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhou XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030340	64	44	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0186208	10.1371/journal.pone.0186208	http://dx.doi.org/10.1371/journal.pone.0186208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190639	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900006
J	Fernandez-Pernas, P; Rodriguez-Lesende, I; de la Fuente, A; Mateos, J; Fuentes, I; De Toro, J; Blanco, FJ; Arufe, MC				Fernandez-Pernas, Pablo; Rodriguez-Lesende, Ivan; de la Fuente, Alexandre; Mateos, Jesus; Fuentes, Isaac; De Toro, Javier; Blanco, Fco J.; Arufe, M. C.			CD105(+)-mesenchymal stem cells migrate into osteoarthritis joint: An animal model	PLOS ONE			English	Article							ESTROGEN REPLACEMENT THERAPY; CARTILAGE REPAIR; DIFFERENTIATION; RECRUITMENT; INCREASES; INJECTION; DEFECT	Mesenchymal stem cells are being the focus of connective tissue technology and regenerative medicine, presenting a good choice cell source for improving old and well recognized techniques of cartilage defect repair. For instance, the autologous chondrocyte transplantation using new concepts of regenerative medicine. The present study investigated the risk of xenogenicity of human synovial membrane-derived MSCs, injected into the monkeys using intravenous and intra-articular administration. The animal models used were adult monkeys Rhesus which had been injured into the left knee to create an Osteoarthritis (OA) animal model. CD105(+)-MSCs were injected twice into the OA monkeys with an interval of one week between them. The animals were euthanized one month after treatment. Immunohistochemistry analysis of different organs: spleen, heart, fat, liver, gut, pancreas, lung, skeletal muscle and kidney from the animals revealed that CD105(+)-MSCs migrated towards the injured knee joint. MSCs naive were found statistically significant increased in the injured knee in front of healthy one. CD105(+)-MSCs were negatives for CD68 and the area where CD105(+)-MSCs were found presented SDF-1 increased levels in front of healthy knee. We concluded that a characterized MSCs subset could be a safe alternative for cell therapy in clearly localized pathologies.	[Fernandez-Pernas, Pablo; Rodriguez-Lesende, Ivan; de la Fuente, Alexandre; Fuentes, Isaac; De Toro, Javier; Arufe, M. C.] UDC, Grp Terapia Celular & Med Regenerat TCMR CHUAC,CH, Dept Ciencias Biomed Med & Fisioterapia,Fac Oza,S, CIBER BBN ISCIII,Inst Invest Biomed A Coruna INIB, As Xubias, A Coruna, Spain; [Mateos, Jesus; Blanco, Fco J.] UDC, Grp Invest Prote ProteoRed PBR2, Inst Invest Biomed A Coruna INIBIC, CHUAC,SERGAS,ISCIII Serv Reumatol, As Xubias, A Coruna, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Arufe, MC (corresponding author), UDC, Grp Terapia Celular & Med Regenerat TCMR CHUAC,CH, Dept Ciencias Biomed Med & Fisioterapia,Fac Oza,S, CIBER BBN ISCIII,Inst Invest Biomed A Coruna INIB, As Xubias, A Coruna, Spain.; Blanco, FJ (corresponding author), UDC, Grp Invest Prote ProteoRed PBR2, Inst Invest Biomed A Coruna INIBIC, CHUAC,SERGAS,ISCIII Serv Reumatol, As Xubias, A Coruna, Spain.	fblagar@sergas.es; maria.arufe@udc.es	del Carmen Arufe Gonda, María/L-2942-2019; Boquete, Isaac Manuel Fuentes/C-8865-2015; Mateos, Jesús/N-3610-2014; de toro, javier/ABH-4217-2020; Blanco, Francisco J./C-3192-2014; arufe gonda, maria/N-3189-2014	del Carmen Arufe Gonda, María/0000-0003-3725-0743; Boquete, Isaac Manuel Fuentes/0000-0003-1056-4507; Mateos, Jesús/0000-0002-1782-6779; Blanco, Francisco J./0000-0001-9821-7635; arufe gonda, maria/0000-0003-3725-0743; de-Toro, Javier/0000-0001-6131-1273	Catedra Bioiberica de la Universidad de A Coruna; Instituto de Salud Carlos III-Ministerio Economia y Competitividad Union Europea-Fondo Europeo de Desarrollo Regional (FEDER) 'Una manera de hacer Europa' [PI11/02799]	Catedra Bioiberica de la Universidad de A Coruna; Instituto de Salud Carlos III-Ministerio Economia y Competitividad Union Europea-Fondo Europeo de Desarrollo Regional (FEDER) 'Una manera de hacer Europa'	This study was supported by grants from Catedra Bioiberica de la Universidad de A Coruna and Instituto de Salud Carlos III-Ministerio Economia y Competitividad No Expediente PI11/02799 Union Europea-Fondo Europeo de Desarrollo Regional (FEDER) 'Una manera de hacer Europa'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[艾昊 Ai Hao], 2011, [中国实验血液学杂志, Journal of Experimental Hematology], V19, P169; Araki S, 2015, ACTA ORTHOP, V86, P119, DOI 10.3109/17453674.2014.958807; Arufe MC, 2009, J CELL BIOCHEM, V108, P145, DOI 10.1002/jcb.22238; Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004; Castagnini Francesco, 2016, J Exp Orthop, V3, P3, DOI 10.1186/s40634-016-0038-4; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Ghadge SK, 2010, PHARM THER; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Gyongyosi M, 2010, THROMB HAEMOSTASIS, V104, P376, DOI 10.1160/TH09-08-0558; Ham KD, 2004, OSTEOARTHR CARTILAGE, V12, P160, DOI 10.1016/j.joca.2003.08.002; Ham KD, 2002, ARTHRITIS RHEUM-US, V46, P1956, DOI 10.1002/art.10406; Hopper N, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/323454; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Karlsson C, 2009, J ANAT; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Krawetz RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043616; Li JM, 2014, BRAIN RES, V1579, P1, DOI 10.1016/j.brainres.2014.07.016; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; Mak J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23076; Mateos J, 2013, STEM CELL RES, V11, P1137, DOI 10.1016/j.scr.2013.07.004; Mobasheri A, 2009, HISTOL HISTOPATHOL, V24, P347, DOI 10.14670/HH-24.347; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Niemeyer P, 2010, TISSUE ENG PT A, V16, P33, DOI [10.1089/ten.tea.2009.0190, 10.1089/ten.TEA.2009.0190]; Ryu JS, 2014, BIOCHEM BIOPH RES CO, V447, P715, DOI 10.1016/j.bbrc.2014.04.077; Salamon A, 2013, EXP CELL RES, V319, P2856, DOI 10.1016/j.yexcr.2013.09.008; Shimomura K, 2014, TISSUE ENG PT A, V20, P2291, DOI 10.1089/ten.tea.2013.0414; Taichman RS, 2002, CANCER RES, V62, P1832; Wang YW, 2012, STEM CELLS DEV, V21, P1401, DOI 10.1089/scd.2011.0441	30	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188072	10.1371/journal.pone.0188072	http://dx.doi.org/10.1371/journal.pone.0188072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190645	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900032
J	Stalvey, MS; Havasi, V; Tuggle, KL; Wang, DZ; Birket, S; Rowe, SM; Sorscher, EJ				Stalvey, Michael S.; Havasi, Viktoria; Tuggle, Katherine L.; Wang, Dezhi; Birket, Susan; Rowe, Steve M.; Sorscher, Eric J.			Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHILDREN; MICE; OSTEOPENIA; MOUSE; CHONDROCYTES; RETARDATION; HEIGHT; HUMANS	Background Reduced growth and osteopenia are common in individuals with cystic fibrosis (CF). Additionally, improved weight and height are associated with better lung function and overall health in the disease. Mechanisms for this reduction in growth are not understood. We utilized a new CFTR knockout rat to evaluate growth in young CF animals, via femur length, microarchitecture of bone and growth plate, as well as serum IGF-I concentrations. Methods Femur length was measured in wild-type (WT) and SD-CFTR (tm1sage) (Cftr-/-) rats, as a surrogate marker for growth. Quantitative bone parameters in Cftr-/-and WT rats were measured by micro computed tomography (micro-CT). Bone histomorphometry and cartilaginous growth plates were analyzed. Serum IGF-I concentrations were also compared. Results Femur length was reduced in both Cftr-/- male and female rats compared to WT. Multiple parameters of bone microarchitecture (of both trabecular and cortical bone) were adversely affected in Cftr-/- rats. There was a reduction in overall growth plate thichkness in both male and female Cftr-/- rats, as well as hypertrophic zone thickness and mean hypertrophic cell volume in male rats, indicating abnormal growth characteristics at the plate. Serum IGF-I concentrations were severely reduced in Cftr-/- rats compared to WT littermates. Conclusions Despite absence of overt lung or pancreatic disease, reduced growth and bone content were readily detected in young Cftr-/- rats. Reduced size of the growth plate and decreased IGF-I concentrations suggest the mechanistic basis for this phenotype. These findings appear to be intrinsic to the CFTR deficient state and independent of significant clinical confounders, providing substantive evidence for the importance of CFTR on maintinaing normal bone growth.	[Stalvey, Michael S.; Havasi, Viktoria] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Stalvey, Michael S.; Havasi, Viktoria; Tuggle, Katherine L.; Birket, Susan; Rowe, Steve M.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Tuggle, Katherine L.] Cyst Fibrosis Fdn, Bethesda, MD USA; [Wang, Dezhi] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Birket, Susan; Rowe, Steve M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Sorscher, Eric J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cystic Fibrosis Foundation; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Stalvey, MS (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.; Stalvey, MS (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.	mstalvey@peds.uab.edu	Havasi, Viktoria/B-1309-2009	Sorscher, Eric J./0000-0001-9341-3354; Stalvey, Michael/0000-0003-4257-5710	U.S. National Institutes of Health, NIDDK (Bethesda, MD) [K08DK094784]; NIH [DK072482]; CFF [R464-CR11]; NIH Nutrition & Obesity Research Center [P30DK056336]; Diabetes Research Center [P30DK079626]	U.S. National Institutes of Health, NIDDK (Bethesda, MD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF; NIH Nutrition & Obesity Research Center; Diabetes Research Center	This study was funded in part by by a grant from the U.S. National Institutes of Health, NIDDK (Bethesda, MD) grant K08DK094784 (MSS), NIH DK072482 (MSS) and CFF (R464-CR11) (EJS) to the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the UAB Small Animal Phenotyping Core (supported by the NIH Nutrition & Obesity Research Center P30DK056336 and Diabetes Research Center P30DK079626) for microCT analysis, and the UAB Histomophometry and Molecular Analysis Core for the histological analsysis. We would also like to thank the UAB CF Animal Model Core for providing additional animals for our study. UAB Pediatric Research Office provided assistance with statistical analysis.	Assael BM, 2009, PEDIATR PULM, V44, P209, DOI 10.1002/ppul.21001; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Cystic Fibrosis Foundation Patient Registry, 2016, 2015 ANN DAT REP; Dif F, 2004, BONE, V35, P595, DOI 10.1016/j.bone.2004.05.021; Frisch J, 2017, J CELL MOL MED; Grinspoon S, 2002, J CLIN ENDOCR METAB, V87, P2883, DOI 10.1210/jc.87.6.2883; Haston CK, 2008, AM J RESP CRIT CARE, V177, P309, DOI 10.1164/rccm.200705-659OC; Hodges CA, 2008, ENDOCRINOLOGY, V149, P2790, DOI 10.1210/en.2007-1581; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; Konstan MW, 2017, J CYST FIBROS, V16, P158, DOI 10.1016/j.jcf.2016.11.005; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; Le Henaff C, 2015, J BIOL CHEM, V290, P18009, DOI 10.1074/jbc.M115.646208; Le Henaff C, 2014, AM J PATHOL, V184, P1132, DOI 10.1016/j.ajpath.2013.12.027; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Leung D, JAMA PEDIAT IN PRESS; Liang HT, 2010, CLIN EXP PHARMACOL P, V37, P506, DOI 10.1111/j.1440-1681.2009.05319.x; Locatelli V, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/235060; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Midyett LK, 2010, J CLIN ENDOCR METAB, V95, P611, DOI 10.1210/jc.2009-0570; Paradis J, 2010, J CYST FIBROS, V9, P239, DOI 10.1016/j.jcf.2010.05.001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pashuck TD, 2009, PEDIATR RES, V65, P311, DOI 10.1203/PDR.0b013e3181961e80; Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107; Rosa RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105170; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Stalvey MS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2522; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Stalvey MS, 2013, CURR OPIN ENDOCRINOL, V20, P547, DOI 10.1097/01.med.0000436191.87727.ec; Stalvey MS, 2012, PEDIATR PULM, V47, P252, DOI 10.1002/ppul.21546; Switzer M, 2009, J PEDIATR ENDOCR MET, V22, P417; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Vieni G, 2013, CLIN NUTR, V32, P382, DOI 10.1016/j.clnu.2012.08.017; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Zhang Z.J., 2015, J SENSORS, V2015, P10, DOI DOI 10.1109/LED.2015.2483760; Zhang ZM, 2013, J PEDIATR-US, V163, P376, DOI 10.1016/j.jpeds.2013.02.026	39	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188497	10.1371/journal.pone.0188497	http://dx.doi.org/10.1371/journal.pone.0188497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190650	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900061
J	Grassi, M; Meneghetti, C; Toffalini, E; Borella, E				Grassi, Massimo; Meneghetti, Chiara; Toffalini, Enrico; Borella, Erika			Auditory and cognitive performance in elderly musicians and nonmusicians	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; LIFE-SPAN; OLD-AGE; INTRUSION ERRORS; GAP DETECTION; HEARING-LOSS; BROCAS AREA; DISCRIMINATION; EXPERIENCE	Musicians represent a model for examining brain and behavioral plasticity in terms of cognitive and auditory profile, but few studies have investigated whether elderly musicians have better auditory and cognitive abilities than nonmusicians. The aim of the present study was to examine whether being a professional musician attenuates the normal age-related changes in hearing and cognition. Elderly musicians still active in their profession were compared with nonmusicians on auditory performance (absolute threshold, frequency intensity, duration and spectral shape discrimination, gap and sinusoidal amplitude-modulation detection), and on simple (short-term memory) and more complex and higher-order (working memory [WM] and visuospatial abilities) cognitive tasks. The sample consisted of adults at least 65 years of age. The results showed that older musicians had similar absolute thresholds but better supra-threshold discrimination abilities than nonmusicians in four of the six auditory tasks administered. They also had a better WM performance, and stronger visuospatial abilities than nonmusicians. No differences were found between the two groups' short-term memory. Frequency discrimination and gap detection for the auditory measures, and WM complex span tasks and one of the visuospatial tasks for the cognitive ones proved to be very good classifiers of the musicians. These findings suggest that life-long music training may be associated with enhanced auditory and cognitive performance, including complex cognitive skills, in advanced age. However, whether this music training represents a protective factor or not needs further investigation.	[Grassi, Massimo; Meneghetti, Chiara; Toffalini, Enrico; Borella, Erika] Univ Padua, Dept Gen Psychol, Via Venezia 8, Padua, Italy	University of Padua	Grassi, M; Borella, E (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 8, Padua, Italy.	massimo.grassi@unipd.it; erika.borella@unipd.it	Meneghetti, Chiara/D-1691-2014; Grassi, Massimo/I-8234-2012	Meneghetti, Chiara/0000-0002-4232-4244; Toffalini, Enrico/0000-0002-1404-5133; Meneghetti, Chiara/0000-0002-1838-7958; , ERIKA/0000-0001-8943-2958; Grassi, Massimo/0000-0002-3784-2784	University of Padova [CPDA123458]	University of Padova	This study was conducted when Massimo Grassi was supported by the grant CPDA123458 ("Progetto di ricerca di Ateneo") awarded by the University of Padova.	Alain C, 2014, HEARING RES, V308, P162, DOI 10.1016/j.heares.2013.06.008; Amer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071630; Andrews MW, 1998, PSYCHOL AGING, V13, P462, DOI 10.1037/0882-7974.13.3.462; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barrett KC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00713; Bidelman GM, 2015, J NEUROSCI, V35, P1240, DOI 10.1523/JNEUROSCI.3292-14.2015; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Bopp KL, 2009, PSYCHOL AGING, V24, P968, DOI 10.1037/a0017731; Borella E, 2008, ACTA PSYCHOL, V128, P33, DOI 10.1016/j.actpsy.2007.09.008; Borella E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00099; Borella E, 2014, DEV PSYCHOL, V50, P384, DOI 10.1037/a0033818; Borella E, 2013, ARCH CLIN NEUROPSYCH, V28, P331, DOI 10.1093/arclin/act020; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Cazzolato A, 2015, GIORNALE ITALIANO PS, V42, P249, DOI [10.1421/79848.10.1093/arclin/act020, DOI 10.1421/79848.10.1093/ARCLIN/ACT020]; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Clinard CG, 2010, HEARING RES, V264, P48, DOI 10.1016/j.heares.2009.11.010; Cornoldi C, 2003, VISUO SPATIAL WORKIN, DOI [10.1002/acp.1008, DOI 10.1002/ACP.1008]; Corsi P. M., 1972, HUMAN MEMORY MED TEM; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Beni R, 1998, Q J EXP PSYCHOL-A, V51, P305, DOI 10.1080/713755761; De Beni R., 2014, BATTERIA VISUOSPAZIA; de Ribaupierre A, 2000, CONTROL OF HUMAN BEHAVIOR, MENTAL PROCESSES, AND CONSCIOUSNESS, P147; Deguchi C, 2012, BRAIN RES, V1455, P75, DOI 10.1016/j.brainres.2012.03.034; Della Sala S., 1997, VISUAL PATTERNS TEST; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Fitzgibbons PJ, 2010, SPRINGER HANDB AUDIT, V34, P111, DOI 10.1007/978-1-4419-0993-0_5; FITZGIBBONS PJ, 1994, J SPEECH HEAR RES, V37, P662, DOI 10.1044/jshr.3703.662; Fitzgibbons PJ, 1995, J ACOUST SOC AM, V98, P3140, DOI 10.1121/1.413803; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Gallina P., 2006, TEND NUOVE, V3, P229, DOI [10.1450/ 22126, DOI 10.1450/22126, 10.1450/22126]; Galton F., 1983, INQUIRY HUMAN FACULT; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Ghisletta P, 2006, J GERONTOL B-PSYCHOL, V61, pP253, DOI 10.1093/geronb/61.5.P253; Grassi M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00059; Grassi M, 2009, BEHAV RES METHODS, V41, P20, DOI 10.3758/BRM.41.1.20; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; Halliday LF, 2011, ATTEN PERCEPT PSYCHO, V73, P1329, DOI 10.3758/s13414-011-0148-0; HALPERN AR, 1995, PSYCHOL AGING, V10, P325, DOI 10.1037/0882-7974.10.3.325; Hanna-Pladdy B, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00198; Hanna-Pladdy B, 2011, NEUROPSYCHOLOGY, V25, P378, DOI 10.1037/a0021895; He NJ, 1998, J ACOUST SOC AM, V103, P553, DOI 10.1121/1.421127; He NJ, 1999, J ACOUST SOC AM, V106, P966, DOI 10.1121/1.427109; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hofer SM, 2003, PSYCHOL AGING, V18, P285, DOI 10.1037/0882-7974.18.2.285; Humes LE, 2016, EAR HEARING, V37, p52S, DOI 10.1097/AUD.0000000000000303; Humes LE, 2010, HEARING RES, V264, P30, DOI 10.1016/j.heares.2009.09.010; Humes LE, 2009, ATTEN PERCEPT PSYCHO, V71, P860, DOI 10.3758/APP.71.4.860; Humes LE, 2005, EAR HEARING, V26, P109, DOI 10.1097/00003446-200504000-00001; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jakobson LS, 2008, MUSIC PERCEPT, V26, P41, DOI 10.1525/MP.2008.26.1.41; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kumar UA, 2011, J AM ACAD AUDIOL, V22, P5, DOI 10.3766/jaaa.22.1.2; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; LOOSEN F, 1994, PERCEPT PSYCHOPHYS, V56, P221, DOI 10.3758/BF03213900; Mammarella IC, 2013, LEARN INDIVID DIFFER, V25, P99, DOI 10.1016/j.lindif.2013.01.014; Mazelova J, 2003, EXP GERONTOL, V38, P87, DOI 10.1016/S0531-5565(02)00155-9; McAdams S, 1999, J ACOUST SOC AM, V105, P882, DOI 10.1121/1.426277; Mehr SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082007; Meinz EJ, 2000, PSYCHOL AGING, V15, P297, DOI 10.1037/0882-7974.15.2.297; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Moreno S, 2011, MUSIC PERCEPT, V29, P165, DOI 10.1525/MP.2011.29.2.165; Morrow DG, 2009, AGING NEUROPSYCHOL C, V16, P33, DOI 10.1080/13825580802195641; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Orsini A, 2003, WAIS R E TERZA; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Parbery-Clark A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018082; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Patston LLM, 2007, LATERALITY, V12, P262, DOI 10.1080/13576500701251981; Pietsch S, 2012, LEARN INDIVID DIFFER, V22, P159, DOI 10.1016/j.lindif.2011.11.012; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Robert C, 2009, MEM COGNITION, V37, P336, DOI 10.3758/MC.37.3.336; Sarkamo T, 2014, GERONTOLOGIST, V54, P634, DOI 10.1093/geront/gnt100; Schellenberg EG, 2010, PSYCHOL MUSIC, V38, P209, DOI 10.1177/0305735609339473; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Schneider BA., 2000, HDB AGING COGNITION; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Sheft S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134330; Shrivastav MN, 2006, J ACOUST SOC AM, V119, P1131, DOI 10.1121/1.2151794; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Smayda KE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00682; Soranzo A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00712; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strait DL, 2014, HEARING RES, V308, P109, DOI 10.1016/j.heares.2013.08.004; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; TAKAHASHI GA, 1992, J SPEECH HEAR RES, V35, P1410, DOI 10.1044/jshr.3506.1410; Talamini F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186773; Talamini F, 2016, MUSIC PERCEPT, V34, P183, DOI 10.1525/MP.2016.34.2.183; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Travis F, 2011, CONSCIOUS COGN, V20, P1256, DOI 10.1016/j.concog.2011.03.020; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; WECHSLER D, 1981, CONTEMP EDUC PSYCHOL, V6, P82, DOI 10.1016/0361-476X(81)90035-7; Weiss AH, 2014, J VISION, V14, DOI 10.1167/14.9.18; Witkin, 1971, MANUAL GROUP EMBEDDE; Zendel BR, 2013, J COGNITIVE NEUROSCI, V25, P503, DOI 10.1162/jocn_a_00329; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816; Zhu W, 2010, NESUG P HLTH CARE LI	116	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187881	10.1371/journal.pone.0187881	http://dx.doi.org/10.1371/journal.pone.0187881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186146	Green Published, gold, Green Submitted			2022-12-26	WOS:000416484900015
J	Schmitt, P; Culloch, R; Lieber, L; Molander, S; Hammar, L; Kregting, L				Schmitt, Pal; Culloch, Ross; Lieber, Lilian; Molander, Sverker; Hammar, Linus; Kregting, Louise			A tool for simulating collision probabilities of animals with marine renewable energy devices	PLOS ONE			English	Article							RISK	The mathematical problem of establishing a collision probability distribution is often not trivial. The shape and motion of the animal as well as of the the device must be evaluated in a four-dimensional space (3D motion over time). Earlier work on wind and tidal turbines was limited to a simplified two-dimensional representation, which cannot be applied to many new structures. We present a numerical algorithm to obtain such probability distributions using transient, three-dimensional numerical simulations. The method is demonstrated using a sub-surface tidal kite as an example. Necessary pre- and post-processing of the data created by the model is explained, numerical details and potential issues and limitations in the application of resulting probability distributions are highlighted.	[Schmitt, Pal; Culloch, Ross; Lieber, Lilian; Kregting, Louise] Queens Univ Belfast, Marine Res Grp, Belfast, Antrim, North Ireland; [Molander, Sverker] Chalmers Univ Technol, Environm Syst Anal Energy & Environm, Gothenburg, Sweden; [Hammar, Linus] Swedish Agcy Marine & Water Management, Gothenburg, Sweden	Queens University Belfast; Chalmers University of Technology	Schmitt, P (corresponding author), Queens Univ Belfast, Marine Res Grp, Belfast, Antrim, North Ireland.	p.schmitt@qub.ac.uk	Molander, Sverker/E-1462-2012; Lieber, Lilian/AAW-6214-2020; Lieber, Lilian/U-8245-2017; Schmitt, Pal/N-7711-2019	Molander, Sverker/0000-0002-9081-8847; Lieber, Lilian/0000-0002-4833-9594; Lieber, Lilian/0000-0002-4833-9594; Schmitt, Pal/0000-0001-8455-952X	European Union [654438]; Swedish Energy Agency [42233-1]	European Union(European Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This project has received funding from the European Union's Horizon 2020 (https://ec.europa.eu./programmes/horizon2020/) research and innovation programme under grant agreement No 654438, and from the Swedish Energy Agency under grant number 42233-1 (http://wwv.energarwadigheten se/en/). The funders had no role in study design, data collection and analysis,	Alarcon-Rodriguez JR, 2004, ADV SPACE RES-SERIES, V34, P1120, DOI 10.1016/j.asr.2003.01.015; Bai XZ, 2016, ADV SPACE RES, V58, P950, DOI 10.1016/j.asr.2016.05.050; Benjamins S, 2015, REV MARINE MEGAFAUNA, P1; Bevelhimer M, 2016, INFORMING TIDAL TURB; Bocci F, 2012, EUR J PHYS, V33, P1321, DOI 10.1088/0143-0807/33/5/1321; Copping A, 2017, INT J MAR ENERGY, V19, P110, DOI 10.1016/j.ijome.2017.07.004; Cotter E, 2016, 4 MAR EN TECHN S MET; CURTIS RG, 1986, J OPER RES SOC, V37, P397, DOI 10.2307/2582567; Forbush D, 2016, INT J MAR ENERGY, V16, P150, DOI 10.1016/j.ijome.2016.06.001; Hammar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117756; Hastie GD, 2014, HUMANIT SEA, P127, DOI 10.1007/978-94-017-8002-5_10; Keenan G, 2011, SEAGEN ENV MONITORIN; Lidtke AA, 2017, ACTA ASTRONAUT, V131, P10, DOI 10.1016/j.actaastro.2016.11.012; Lieber L, 2014, P 2 INT C ENV INT MA; Lin MP, 2017, ADV SPACE RES, V59, P2398, DOI 10.1016/j.asr.2017.02.023; Macaulay J, 2017, J ACOUST SOC AM, V141, P1120, DOI 10.1121/1.4976077; R Core Team, 2021, R LANGUAGE ENV STAT; Savidge G, 2014, HUMANIT SEA, P153, DOI 10.1007/978-94-017-8002-5_12; Schweizer PE, 2011, ESTIMATION RISKS COL; Shen HX, 2016, RENEW ENERG, V97, P746, DOI 10.1016/j.renene.2016.06.026; Viehman HA, 2015, ESTUAR COAST, V38, pS241, DOI 10.1007/s12237-014-9767-8; Whittaker T, 2012, PHILOS T R SOC A, V370, P345, DOI 10.1098/rsta.2011.0152; Wilkinson L, 2014, INT C OFFSH REN EN 2; Williamson BJ, 2016, IEEE J OCEANIC ENG, V41, P67, DOI 10.1109/JOE.2015.2410851; Wilson B, 2007, REPORT SCOTTISH EXEC, P1; Wood J, 2015, PREPARED PNNL DOE S; Zambrano C., 2016, WTE16 D 2 WORKSH WAV	27	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188780	10.1371/journal.pone.0188780	http://dx.doi.org/10.1371/journal.pone.0188780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186183	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900059
J	Ende-Verhaar, YM; Kroft, LJM; Mos, ICM; Huisman, MV; Klok, FA				Ende-Verhaar, Yvonne M.; Kroft, Lucia J. M.; Mos, Inge C. M.; Huisman, Menno V.; Klok, Frederikus A.			Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; RISK STRATIFICATION; NORMOTENSIVE PATIENTS; DYSFUNCTION; ANGIOGRAPHY; DIAGNOSIS; HYPERTENSION; BIOMARKERS; GUIDELINES; MANAGEMENT	Background Right ventricular (RV) dysfunction caused by acute pulmonary embolism (PE) is associated with poor short-and long-term prognosis. RV dilatation as a proxy for RV dysfunction can be assessed by calculating the right-to-left ventricle diameter (RV/LV) ratio on standard computed tomography pulmonary angiography (CTPA) images. It is unknown whether dedicated training is required to accurately and reproducibly measure RV/LV ratio therefore we aimed to assess these parameters in residents in internal medicine without experience in CTPA reading. Methods CTPA images of 100 patients with PE were assessed by three residents after single instruction, and one experienced thoracic radiologist. Maximum diameters were evaluated in the axial view by measuring the distance between the ventricular endocardium and the interventricular septum, perpendicular to the long axis of the heart. RV dilatation was defined as a ratio of >= 1.0. Interobserver accuracy and reproducibility was determined using Kappa statistics, Bland-Altman analysis and Spearman's rank correlation. Results The kappa statistic for the presence of RV dilatation of the residents compared to the experienced radiologist ranged from 0.83-0.94. The average interobserver difference in calculated RV/LV ratio's (+/- SD) between the three residents was: -0.01 (SD0.11), 0.07 (SD0.14) and 0.06 (SD0.18) with an overall mean RV/LV diameter ratio of 1.04. In line with this, Spearman's rank correlation coefficients were 0.92, 0.88 and 0.85 respectively indicating very good correlation (p<0.01 for all). Conclusion After simple instruction, RV/LV diameter ratio assessment on CTPA images by clinical residents is accurate and reproducible, which is of help in identifying PE patients at risk.	[Ende-Verhaar, Yvonne M.; Mos, Inge C. M.; Huisman, Menno V.; Klok, Frederikus A.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Kroft, Lucia J. M.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ende-Verhaar, YM (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.	Y.M.Ende-Verhaar@lumc.nl	Klok, Erik/U-4870-2019	Klok, Erik/0000-0001-9961-0754				Aribas A, 2014, JPN J RADIOL, V32, P451, DOI 10.1007/s11604-014-0327-8; Becattini C, 2014, EUR RESPIR J, V43, P1678, DOI 10.1183/09031936.00147813; Becattini C, 2011, EUR HEART J, V32, P1657, DOI 10.1093/eurheartj/ehr108; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cok G, 2013, JPN J RADIOL, V31, P172, DOI 10.1007/s11604-012-0164-6; Coutance G, 2011, CRIT CARE, V15, DOI 10.1186/cc10119; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Javadrashid R, 2015, EUR RADIOL, V25, P147, DOI 10.1007/s00330-014-3383-7; Jimenez D, 2012, J THROMB THROMBOLYS, V34, P187, DOI 10.1007/s11239-012-0709-7; Kang DK, 2011, AM J CARDIOL, V108, P133, DOI 10.1016/j.amjcard.2011.03.009; Kang DK, 2010, AM J ROENTGENOL, V194, P1500, DOI 10.2214/AJR.09.3717; Klok FA, 2016, J THROMB HAEMOST, V14, P121, DOI 10.1111/jth.13175; Klok FA, 2010, J THROMB HAEMOST, V8, P853, DOI 10.1111/j.1538-7836.2010.03780.x; Konstantinides S, 2012, EUR HEART J, V33, P3014, DOI 10.1093/eurheartj/ehs258; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kumamaru KK, 2012, J THORAC IMAG, V27, P331, DOI 10.1097/RTI.0b013e3182350a35; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Ouriel K, 2017, VASCULAR, V25, P54, DOI 10.1177/1708538116645056; Ozsu S, 2010, THROMB RES, V126, P486, DOI 10.1016/j.thromres.2010.08.021; Park JR, 2012, INT J CARDIOVAS IMAG, V28, P979, DOI 10.1007/s10554-011-9912-4; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Stein PD, 2008, AM J MED, V121, P34, DOI 10.1016/j.amjmed.2007.06.032; van der Bijl N, 2011, CHEST, V140, P1008, DOI 10.1378/chest.10-3174; Wittenberg R, 2012, EUR J RADIOL, V81, P218, DOI 10.1016/j.ejrad.2011.01.041	25	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188862	10.1371/journal.pone.0188862	http://dx.doi.org/10.1371/journal.pone.0188862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182657	Green Submitted, gold, Green Published			2022-12-26	WOS:000416402000061
J	Hammes, V; Nusse, O; Isselstein, J; Kayser, M				Hammes, Verena; Nuesse, Olaf; Isselstein, Johannes; Kayser, Manfred			Using C-13 in cattle hair to trace back the maize level in the feeding regime-A field test	PLOS ONE			English	Article							STABLE-ISOTOPE COMPOSITION; FARMING SYSTEMS; CARBON ISOTOPES; FATTY-ACIDS; TAIL-HAIR; DIET; BEEF; MILK; QUALITY; GRASS	Sections from cattle hair serve as an isotopic archive-they contain information on the cattle diet from different time periods. We tested the reliability of C-13 signatures (delta C-13) in cattle tail switch hair to retrospectively trace back the annual dietary proportion of maize of different production systems without having to sample and analyze the feed. Furthermore, we investigated if differences in dietary proportion of maize during summer and winter feeding can be detected in a single tail switch hair by sampling hair only once a year. We sampled hair and obtained information on management and annual composition of diets on 23 cattle farms in northern Germany. Farms differed in dietary proportions of maize, grass and concentrates as well as in grazing regime (year-round grazing, summer grazing, no grazing). We found that the annual mean delta C-13 values (delta(CY)-C-13) of two hair sections that contain the isotopic information of summer and winter feeding is a robust indicator for the annual proportion of maize in cattle diet on a farm. The grazing regimes could clearly be distinguished by analyzing seasonal mean delta C-13 values (delta(CS)-C-13). We could also demonstrate short term changes in the diet changes by means of delta(CS)-C-13. We conclude that the method can be used in different cattle production systems to check on dietary proportions of maize for a period of one year before sampling of hair.	[Hammes, Verena; Nuesse, Olaf; Kayser, Manfred] Georg August Univ Goettingen, Dept Crop Sci, Grassland Sci, Vechta, Germany; [Isselstein, Johannes] Georg August Univ Goettingen, Dept Crop Sci, Grassland Sci, Gottingen, Germany; [Isselstein, Johannes] Georg August Univ Goettingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; University of Gottingen	Hammes, V (corresponding author), Georg August Univ Goettingen, Dept Crop Sci, Grassland Sci, Vechta, Germany.	vhammes@uni-goettingen.de			German Federal Ministry of Education and Research (BMBF) [FKZ 033L029]; German Research Foundation; Gottingen University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This project (Nachhaltiges Landmanagement im Norddeutschen Tiefland, FKZ 033L029) was supported by the German Federal Ministry of Education and Research (BMBF) https://www.bmbf.de. Centre Stable Isotopes (KOSI, University of Goettingen) for analysis of the isotope samples. Furthermore we acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.; This project (Nachhaltiges Landmanagement im Norddeutschen Tiefland, FKZ 033L029) was supported by the German Federal Ministry of Education and Research (BMBF). We are grateful to Nicole Wrage-Monnig (University of Rostock) and Barbara Hohlmann (University of Goettingen) for assistance with theoretical and practical questions concerning sampling and analysis. We would also like to take this opportunity to thank Reinhard Langel and colleagues from the Competence Centre Stable Isotopes (KOSI, University of Goettingen) for analysis of the isotope samples. Furthermore we acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Goettingen University.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Arens NC, 2000, PALEOBIOLOGY, V26, P137, DOI 10.1666/0094-8373(2000)026&lt;0137:CCPFRT&gt;2.0.CO;2; Auerswald K, 2015, J AGR FOOD CHEM, V63, P10500, DOI 10.1021/acs.jafc.5b03646; Auerswald K, 2011, RAPID COMMUN MASS SP, V25, P3741, DOI 10.1002/rcm.5284; Aurousseau B, 2004, MEAT SCI, V66, P531, DOI 10.1016/S0309-1740(03)00156-6; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bahar B, 2005, RAPID COMMUN MASS SP, V19, P1937, DOI 10.1002/rcm.2007; Becker T. H., 2015, Grassland and forages in high output dairy farming systems. Proceedings of the 18th Symposium of the European Grassland Federation, Wageningen, The Netherlands, 15-17 June 2015, P84; Bedoin F., 2012, THESIS; Bockstaller C, 1997, EUR J AGRON, V7, P261, DOI 10.1016/S1161-0301(97)00041-5; BULLOUGH W. S., 1958, BIOLOGY HAIR GROWTH, P171; Camin F, 2015, RAPID COMMUN MASS SP, V29, P415, DOI 10.1002/rcm.7117; De Smet S, 2004, RAPID COMMUN MASS SP, V18, P1227, DOI 10.1002/rcm.1471; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Erasmus SW, 2016, FOOD CHEM, V192, P997, DOI 10.1016/j.foodchem.2015.07.121; FISHER DD, 1985, AM J VET RES, V46, P2235; Gregory PJ, 2000, AGR ECOSYST ENVIRON, V82, P3, DOI 10.1016/S0167-8809(00)00212-7; Halberg N, 1999, AGR ECOSYST ENVIRON, V76, P17, DOI 10.1016/S0167-8809(99)00055-9; Herrmann A, 2013, BIOENERG RES, V6, P372, DOI 10.1007/s12155-012-9227-x; Hocquette JF, 2012, MEAT SCI, V92, P197, DOI 10.1016/j.meatsci.2012.04.007; JONES RJ, 1981, SEARCH, V12, P85; Kaplan JO, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001403; Karoui R, 2007, FOOD CHEM, V102, P621, DOI 10.1016/j.foodchem.2006.05.042; Kelly ML, 1998, J DAIRY SCI, V81, P1630, DOI 10.3168/jds.S0022-0302(98)75730-3; Kelly S. D., 2001, Lipid Technology, V13, P140; Klapp E., 1971, WIESEN UND WEIDEN; Klaus VH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078134; Knobbe N, 2006, ANAL BIOANAL CHEM, V386, P104, DOI 10.1007/s00216-006-0644-6; Kornexl BE, 1997, Z LEBENSM UNTERS F A, V205, P19, DOI 10.1007/s002170050117; KTBL, 2009, FAUSTZ LANDW; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Molkentin J, 2009, J AGR FOOD CHEM, V57, P785, DOI 10.1021/jf8022029; O'Connell TC, 1999, AM J PHYS ANTHROPOL, V108, P409, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;409::AID-AJPA3&gt;3.0.CO;2-E; Offermann F, 2010, LANDBAUFORSCHUNG-GER, V60, P157; Opara LU, 2001, OUTLOOK AGR, V30, P239, DOI 10.5367/000000001101293724; Osorio MT, 2011, J AGR FOOD CHEM, V59, P3295, DOI 10.1021/jf1040959; Rehheul D, 2017, GRASS FORAGE SCI; Rogers KM, 2015, J AGR FOOD CHEM, V63, P8372, DOI 10.1021/acs.jafc.5b01975; Schneider S, 2014, ISOT ENVIRON HEALT S, V51, P33; Schnyder H, 2006, GLOBAL CHANGE BIOL, V12, P1315, DOI 10.1111/j.1365-2486.2006.01169.x; Schuler M, 2016, TAG 60 JAHR ARB GRUN, P23; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Touzeau A, 2014, J ARCHAEOL SCI, V46, P114, DOI 10.1016/j.jas.2014.03.005; VANSCOTT EJ, 1957, J INVEST DERMATOL, V29, P197, DOI 10.1038/jid.1957.87; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; White CD, 1999, PALAEOGEOGR PALAEOCL, V147, P209, DOI 10.1016/S0031-0182(98)00168-0; Wittmer MHOM, 2010, BASIC APPL ECOL, V11, P83, DOI 10.1016/j.baae.2009.10.007; Yanagi Y, 2012, FOOD CHEM, V134, P502, DOI 10.1016/j.foodchem.2012.02.107; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zazzo A, 2015, RAPID COMMUN MASS SP, V29, P1357, DOI 10.1002/rcm.7228	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188926	10.1371/journal.pone.0188926	http://dx.doi.org/10.1371/journal.pone.0188926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182681	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000064
J	Guo, Q; Liao, SH; Zhu, ZL; Li, Y; Li, FD; Xu, C				Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao			Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell signaling; kinesin; structural biology; X-ray crystallography; ankyrin domain	REPEAT; BINDING; GROWTH; MOTIF; TRANSDUCTION; MUTATIONS; GENE	A well-controlled microtubule organization is essential for intracellular transport, cytoskeleton maintenance, and cell development. KN motif and ankyrin repeat domain-containing protein 1 (KANK1), a member of KANK family, recruits kinesin family member 21A (KIF21A) to the cell cortex to control microtubule growth via its C-terminal ankyrin domain. However, how the KANK1 ankyrin domain recognizes KIF21A and whether other KANK proteins can also bind KIF21A remain unknown. Here, using a combination of structural, site-directed mutagenesis, and biochemical studies, we found that a stretch of approximate to 22 amino acids in KIF21A is sufficient for binding to KANK1 and its close homolog KANK2. We further solved the complex structure of the KIF21A peptide with either the KANK1 ankyrin domain or the KANK2 ankyrin domain. In each complex, KIF21A is recognized by two distinct pockets of the ankyrin domain and adopts helical conformations upon binding to the ankyrin domain. The elucidated KANK structures may advance our understanding of the role of KANK1 as a scaffolding molecule in controlling microtubule growth at the cell periphery.	[Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Chinese Acad Sci, Hefei Sci Ctr CAS, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Liao, SH; Xu, C (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Liao, SH; Xu, C (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.; Liao, SH; Xu, C (corresponding author), Chinese Acad Sci, Hefei Sci Ctr CAS, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China.	ajsod@mail.ustc.edu.cn; xuchaor@ustc.edu.cn	Liao, Shanhui/N-1628-2018; Xu, Chao/G-3885-2010	Liao, Shanhui/0000-0002-5083-667X; Xu, Chao/0000-0003-0444-7080	National Natural Science Foundation of China [31570737, 31770806, 31500601]; Thousand Young Talent program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Young Talent program	This work was supported by National Natural Science Foundation of China Grants 31570737 and 31770806 (to C. X.) and 31500601 (to S. L.) and the "Thousand Young Talent program" (to C. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Allison SJ, 2015, NAT REV NEPHROL, V11, P387, DOI [10.1038/nrneph.2015.86, 10.1038/nrneph.2015.79]; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher D, 2015, DEV CELL, V32, P31, DOI 10.1016/j.devcel.2014.11.031; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ihara S, 2011, NAT CELL BIOL, V13, P641, DOI 10.1038/ncb2233; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liu HY, 2016, ELIFE, V5, DOI 10.7554/eLife.12856; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nie JY, 2015, STRUCTURE, V23, P700, DOI 10.1016/j.str.2015.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Xu C, 2016, GENE DEV, V30, P2376, DOI 10.1101/gad.288340.116; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	41	8	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					557	566		10.1074/jbc.M117.817494	http://dx.doi.org/10.1074/jbc.M117.817494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183992	hybrid, Green Published			2022-12-26	WOS:000419915400012
J	Nadanaka, S; Kinouchi, H; Kitagawa, H				Nadanaka, Satomi; Kinouchi, Hiroki; Kitagawa, Hiroshi			Chondroitin sulfate-mediated N-cadherin/-catenin signaling is associated with basal-like breast cancer cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-catenin (B-catenin); breast cancer; cadherin; cell invasion; chondroitin sulfate; extracellular matrix; glycobiology; glycosaminoglycan; proteoglycan; sulfotransferase	E-DISACCHARIDE EXPRESSION; BETA-CATENIN; HEPARAN-SULFATE; GENE-EXPRESSION; GROWTH-FACTOR; CLEAVAGE; BIOSYNTHESIS; MIGRATION; ADHESION; BINDING	Tumor metastasis involves cancer cell invasion across basement membranes and interstitial tissues. The initial invasion step consists of adherence of the tumor cell to the extracellular matrix (ECM), and this binding transduces a variety of signals from the ECM to the tumor cell. Accordingly, it is critical to establish the mechanisms by which extracellular cues influence the intracellular activities that regulate tumor cell invasion. Here, we found that invasion of the basal-like breast cancer cell line BT-549 is enhanced by the ECM component chondroitin sulfates (CSs). CSs interacted with and induced proteolytic cleavage of N-cadherin in the BT-549 cells, yielding a C-terminal intracellular N-cadherin fragment that formed a complex with -catenin. Of note, the cleavage of N-cadherin increased cytoplasmic and nuclear -catenin levels; induced the matrix metalloproteinase 9 (MMP9) gene, a target of -catenin nuclear signaling; and augmented the invasion potential of the cells. We also found that CS-induced N-cadherin proteolysis requires caveolae-mediated endocytosis. An inhibitor of that process, nystatin, blocked both the endocytosis and proteolytic cleavage of N-cadherin induced by CS and also suppressed BT-549 cell invasion. Knock-out of chondroitin 4-O-sulfotransferase-1 (C4ST-1), a key CS biosynthetic enzyme, suppressed activation of the N-cadherin/-catenin pathway through N-cadherin endocytosis and significantly decreased BT-549 cell invasion. These results suggest that CSs produced by C4ST-1 might be useful therapeutic targets in the management of basal-like breast cancers.	[Nadanaka, Satomi; Kinouchi, Hiroki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [23110003];  [16H05088];  [25460080]; Grants-in-Aid for Scientific Research [17K07353] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas 23110003 (to H. K.), Scientific Research (B) 16H05088 (to H. K.), and (C) 25460080 (to S. N.), and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.), from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Iida J, 2015, EXP CELL RES, V330, P358, DOI 10.1016/j.yexcr.2014.11.002; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Ma R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0425-0; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; McCusker Catherine D, 2009, Commun Integr Biol, V2, P155; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2016, BIOCHEM BIOPH RES CO, V480, P234, DOI 10.1016/j.bbrc.2016.10.035; Nadanaka S, 2014, J BIOL CHEM, V289, P15231, DOI 10.1074/jbc.M113.545343; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Ueda Y, 2002, INT J CANCER, V99, P681, DOI 10.1002/ijc.10418; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Willis CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103966; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	58	39	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					444	465		10.1074/jbc.M117.814509	http://dx.doi.org/10.1074/jbc.M117.814509			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183998	Green Published, hybrid			2022-12-26	WOS:000419915400004
J	Nadarajah, S; Zhang, YY				Nadarajah, Saralees; Zhang, Yuanyuan			Wrapped: An R package for circular data	PLOS ONE			English	Article							ASYMMETRIC LAPLACE DISTRIBUTION; DIRECTIONAL-DATA; T-DISTRIBUTION; PARTICLE-SIZE; DISTRIBUTIONS; MODELS; REGRESSION; CIRCLE; SPHERE; FAMILY	The Wrapped package computes the probability density function, cumulative distribution function, quantile function and also generates random samples for many univariate wrapped distributions. It also computes maximum likelihood estimates, standard errors, confidence intervals and measures of goodness of fit for nearly fifty univariate wrapped distributions. Numerical illustrations of the package are given.	[Nadarajah, Saralees; Zhang, Yuanyuan] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England	University of Manchester	Nadarajah, S (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	mbbsssn2@manchester.ac.uk						Aas K., 2006, J FINANC ECON, V4, P275, DOI DOI 10.1093/jjfinec/nbj006; Adnan MAS, 2013, J STAT MANAG SYST, V16, P1, DOI 10.1080/09720510.2013.777578; Agostinelli C, 2017, CIRCULAR STAT; Akkaya AD, 2008, TEST-SPAIN, V17, P282, DOI 10.1007/s11749-006-0032-8; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 1994, CONTINUOUS UNIVARIAT; [Anonymous], 2001, LAPLACE DISTRIBUTION; AZZALINI A, 1985, SCAND J STAT, V12, P171; Azzalini A, 2003, J R STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; Azzalini A., 2016, SKEW NORMAL SKEW T D; Azzalini A., 1986, STATISTICA, V46, P199, DOI [10.6092/ISSN.1973-2201/711, DOI 10.6092/ISSN.1973-2201/711]; BARNDORFFNIELSEN O, 1977, P ROY SOC LOND A MAT, V353, P401, DOI 10.1098/rspa.1977.0041; BREITENBERGER E, 1963, BIOMETRIKA, V50, P81; Chen W, 2016, FITS; Chubaty A, 2016, SPATIALLY EXPLICIT D; Coelho CA, 2007, J STAT THEORY PRACT, V1, P1, DOI 10.1080/15598608.2007.10411821; Computes Pdf Cdf Quantile, 2017, RAND NUMB PROV EST U; de Moivre A., 1738, DOCTRINE CHANCES; Delignette-Muller M, 2017, PARAMETRIC DISTRIBUT; Fernandez C, 1998, J AM STAT ASSOC, V93, P359, DOI 10.2307/2669632; FIELLER NRJ, 1992, J R STAT SOC C-APPL, V41, P127; FISHER NI, 1989, AUST J EARTH SCI, V36, P91, DOI 10.1080/14400958985270081; Franke J, 2016, SCAND J STAT, V43, P139, DOI 10.1111/sjos.12169; Gauss C.F., 1809, THEORIA MOTVS CORPOR; GENTER FC, 1985, CAN J STAT, V13, P37, DOI 10.2307/3315165; Geraci M, 2007, BIOSTATISTICS, V8, P140, DOI 10.1093/biostatistics/kxj039; Girija S.V.S., 2014, INT J MATH ARCH, V5, P168; Gumbel EJ, 1954, APPL MATH SERIES, V33; Gupta A. K., 2004, HDB BETA DISTRIBUTIO; Jacob S, 2013, J STAT THEORY APPL, V12, P348, DOI 10.2991/jsta.2013.12.4.3; Jammalamadaka SR, 2004, COMMUN STAT-THEOR M, V33, P2059, DOI 10.1081/STA-200026570; Jayakumar K., 2012, OPEN J STAT, V2, P106, DOI DOI 10.4236/OJS.2012.21011; Johnson N., 1954, TRABAJOS ESTADISTICA, V5, P283, DOI DOI 10.1007/BF03005988; Johnson NL, 1995, CONTINUOUS UNIVARIAT; Jones M., 2005, APPL STAT, V54, P546; Jones MC, 2009, BIOMETRIKA, V96, P761, DOI 10.1093/biomet/asp053; Joshi S, 2017, WRAPPED LINDLEY DIST; Lund U, 2001, CIRCULAR STAT TOPICS; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Marinho P, 2016, MODELS GEN PURPOSE O; MCDONALD JB, 1995, J ECONOMETRICS, V66, P133, DOI 10.1016/0304-4076(94)01612-4; Michelot T, 2017, MARKOV MODELS; Mineo A., 2014, HOUTINES ROUTINES EX; Oliveira M, 2015, NONPARAMETIC CIRCULA; Paolella M., 1997, TAIL ESTIMATION COND; Pewsey A, 2000, COMMUN STAT-THEOR M, V29, P2459, DOI 10.1080/03610920008832616; Pewsey A, 2008, COMPUT STAT DATA AN, V52, P1516, DOI 10.1016/j.csda.2007.04.017; Pewsey A, 2007, AUST NZ J STAT, V49, P79, DOI 10.1111/j.1467-842X.2006.00465.x; R Development Core Team, 2017, R LANG ENV STAT COMP; Rao JS., 2001, TOPICS CIRCULAR STAT; Reed WJ, 2006, STAT IND TECHNOL, P61, DOI 10.1007/0-8176-4487-3_4; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Roy S, 2012, STAT PROBABIL LETT, V82, P77, DOI 10.1016/j.spl.2011.08.023; Sarma R, 2011, J STAT COMPUT SIM, V81, P579, DOI 10.1080/00949650903436547; Schulz J, 2015, J COMPUT GRAPH STAT, V24, P539, DOI 10.1080/10618600.2014.914947; Scott D, 2015, NORMAL LAPLACE DISTR; Sengupta A, 2014, COMMUN STAT-THEOR M, V43, P2563, DOI 10.1080/03610926.2013.800883; Sousa T, 2015, GEVSTABLEGARCH ARMA; Thavaneswaran A, 2016, INT J STAT PROBABILI, V5, P1; Theodossiou P, 1998, MANAGE SCI, V44, P1650, DOI 10.1287/mnsc.44.12.1650; Uesu K, 2015, J MULTIVARIATE ANAL, V134, P146, DOI 10.1016/j.jmva.2014.11.004; van Staden PJ, 2015, STAT PROBABIL LETT, V96, P109, DOI 10.1016/j.spl.2014.09.001; Wang FP, 2014, J AM STAT ASSOC, V109, P1565, DOI 10.1080/01621459.2014.934454; Yu KM, 2005, COMMUN STAT-THEOR M, V34, P1867, DOI 10.1080/03610920500199018	64	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188512	10.1371/journal.pone.0188512	http://dx.doi.org/10.1371/journal.pone.0188512			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216219	Green Published, gold, Green Submitted			2022-12-26	WOS:000417337800028
J	Berry, RS; Xiong, MJ; Greenbaum, A; Mortaji, P; Nofchissey, RA; Schultz, F; Martinez, C; Luo, L; Morris, KT; Hanson, JA				Berry, Ryan S.; Xiong, Meng-Jun; Greenbaum, Alissa; Mortaji, Parisa; Nofchissey, Robert A.; Schultz, Fred; Martinez, Cathleen; Luo, Li; Morris, Katherine T.; Hanson, Joshua A.			High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer	PLOS ONE			English	Article							EOSINOPHILS; EXPRESSION	Conflicting reports regarding whether high tumor-associated neutrophils (TAN) are associated with outcomes in colorectal cancer (CRC) exist. Previous investigators have counted TAN using non-neutrophil-specific immunohistochemistry (IHC) stains. We examined whether TAN levels as determined by multi-field manual counting would predict prognosis. IRB approval was obtained and two pathologists, blinded to stage/outcome, counted TAN in 20 high power fields (HPF) per specimen. TAN score was defined as the mean of these counts. High TAN was defined as at or greater than the median score for that stage. Demographics, tumor characteristics, and overall survival (OS) were obtained from the records and examined for association with TAN score. IHC for arginase expression was performed in a subset of samples. 221 patients were included. Stage II patients with high TAN scores had an OS of 232 months as compared to those with low TAN (OS = 85 months, p = 0.03). The survival benefit persisted in multivariable analysis (HR 0.48, CI 0.25-0.91, p = 0.026) controlling for age and sex. Women had increased survival as compared to men, and there were no significant prognostic associations with TAN count in stage III/IV patients, although there were only 12 stage IV patients. Arginase staining did not provide additional information. Stage II colorectal cancer patients with high TAN live nearly 3 times longer than those with low TAN. Women with stage II disease and high TAN counts appear to be driving the survival benefit seen in the stage II patients and have increased overall survival in all stages.	[Berry, Ryan S.] Geisinger Med Ctr, Dept Dermatol, Danville, PA 17822 USA; [Berry, Ryan S.] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA; [Xiong, Meng-Jun; Schultz, Fred; Martinez, Cathleen; Hanson, Joshua A.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Greenbaum, Alissa] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Mortaji, Parisa] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Morris, Katherine T.] Univ Oklahoma, Dept Surg, Oklahoma City, OK USA; [Luo, Li] Univ New Mexico, Div Epidemiol Biostat & Prevent Med, Dept Internal Med, Albuquerque, NM 87131 USA	Geisinger Medical Center; Geisinger Medical Center; University of New Mexico; University of New Mexico; University of New Mexico; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of New Mexico	Morris, KT (corresponding author), Univ Oklahoma, Dept Surg, Oklahoma City, OK USA.	kmorris4@ouhsc.edu		Xiong, Meng-Jun/0000-0002-1940-3972	National Institute of Health [5U54GM104944-03]; Mentored Research Scholar Grant from the American Cancer Society [MRSG-15-136-01-CCE]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scholar Grant from the American Cancer Society	Funded by National Institute of Health 5U54GM104944-03 (KTM), and Mentored Research Scholar Grant, MRSG-15-136-01-CCE from the American Cancer Society (KTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Barry TS, 2003, AM J SURG PATHOL, V27, P1513, DOI 10.1097/00000478-200312000-00003; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Harbaum L, 2015, MODERN PATHOL, V28, P403, DOI 10.1038/modpathol.2014.104; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jang TJ, 2013, KOREAN J PATHOL, V47, P340, DOI 10.4132/KoreanJPathol.2013.47.4.340; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kansal R, 2002, AM J CLIN PATHOL, V117, P29; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lerdkiattikorn P, 2014, EXPERT REV PHARM OUT, P1; Lindskog EB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-948; Niccoli G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002554; Pepe MS, 2015, CANCER EPIDEM BIOMAR, V24, P944, DOI 10.1158/1055-9965.EPI-14-1227; Rao HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030806; Sionov R.V., 2014, CANC MICROENVIRON; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Wikberg ML, 2017, HUMAN PATHOLOGY; Yang L, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000266; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655	25	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188799	10.1371/journal.pone.0188799	http://dx.doi.org/10.1371/journal.pone.0188799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211768	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200049
J	Goldstein, B; Moses, R; Sammons, N; Birkved, M				Goldstein, Benjamin; Moses, Rebekah; Sammons, Norman; Birkved, Morten			Potential to curb the environmental burdens of American beef consumption using a novel plant-based beef substitute	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENTS; AGRICULTURAL LAND; FOOD CHOICES; MEAT; IMPACTS; LIVESTOCK; OPPORTUNITIES; FOOTPRINT; EXPANSION	The food demands of the United States (US) impart significant environmental pressures. The high rate of consumption of beef has been shown to be the largest driver of food-borne greenhouse gas emissions, water use and land occupation in the US diet. The environmental benefits of substituting animal products with vegetal foods are well documented, but significant psychological barriers persist in reducing meat consumption. Here we use life cycle assessment to appraise the environmental performance of a novel vegetal protein source in the mean US diet where it replaces ground beef, and in vegetarian and vegan diets where it substitutes for legumes, tofu and other protein sources. We find that relative to the mean US diet, vegetarian and vegan diets significantly reduce per-capita food-borne greenhouse gas emission (32% and 67%, respectively), blue water use (70% and 75%, respectively) and land occupation (70% and 79%, respectively), primarily in the form of rangeland. The substitution of 10%, 25% and 50% of ground beef with plant-based burger (PBB) at the national scale results in substantial reductions in annual US dietary greenhouse gas emissions (4.55-45.42 Mt CO2 equivalents), water consumption (1.30-12.00 km(3)) and land occupation (22300-190100 km(2)). Despite PBB's elevated environmental pressures compared to other vegetal protein sources, we demonstrate that minimal risk exists for the disservices of PBB substitution in non-meat diets to outweigh the benefits of ground-beef substitution in the omnivorous American diet. Demand for plant-based oils in PBB production has the potential to increase land use pressures in biodiversity hotspots, though these could be obviated through responsible land stewardship. Although the apparent environmental benefits of the PBB are contingent on actual uptake of the product, this study demonstrates the potential for non-traditional protein substitutes to play a role in a transition towards more sustainable consumption regimes in the US and potentially abroad.	[Goldstein, Benjamin; Birkved, Morten] Tech Univ Denmark, Quantitat Sustainabil Assessment Div, Dept Management Engn, Lyngby, Denmark; [Moses, Rebekah; Sammons, Norman] Impossible Foods, Redwood City, CA USA	Technical University of Denmark	Goldstein, B (corresponding author), Tech Univ Denmark, Quantitat Sustainabil Assessment Div, Dept Management Engn, Lyngby, Denmark.	bgol@dtu.dk	Birkved, Morten/AAA-4736-2020; Goldstein, Benjamin Paul/N-2745-2015; Birkved, Morten/O-8585-2018	Goldstein, Benjamin Paul/0000-0003-0055-1323; Birkved, Morten/0000-0001-6989-1647	Impossible Foods	Impossible Foods	Impossible Foods provided support in the form of salaries for authors RM and NS, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The CEO of Impossible Foods had minor say on the final decision to publish, but this did not affect the manner in which data collection, calculations, results interpretation or manuscript drafting were performed.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Barlow J, 2016, BIORESOURCE TECHNOL, V220, P360, DOI 10.1016/j.biortech.2016.08.091; Baroni L, 2007, EUR J CLIN NUTR, V61, P279, DOI 10.1038/sj.ejcn.1602522; Boucher D., 2011, ROOT PROBLEM WHATS D; Boyd W, 2001, TECHNOL CULT, V42, P631, DOI 10.1353/tech.2001.0150; Capper JL, 2011, J ANIM SCI, V89, P4249, DOI 10.2527/jas.2010-3784; Cattlemen's Beef Board and Cattlemen's Beef Association, 2016, BEEF RETAIL MARK; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Cunningham J, 2009, VEG J, V29; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Davis J, 2010, FOOD RES INT, V43, P1874, DOI 10.1016/j.foodres.2009.08.017; de Boer J, 2007, FOOD QUAL PREFER, V18, P985, DOI 10.1016/j.foodqual.2007.04.002; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Dumont B, 2013, ANIMAL, V7, P1028, DOI 10.1017/S1751731112002418; Edenhofer O., 2014, CONTRIBUTION WORKING; Eshel G, 2016, ENVIRON SCI TECHNOL, V50, P8164, DOI 10.1021/acs.est.6b01006; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Fellet M, 2015, ACS CENTRAL SCI, V1, P347, DOI 10.1021/acscentsci.5b00307; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fraser R., 2017, US Patent, Patent No. [9700067B2, 9700067]; Frieden T, 2013, ANTIBIOTIC RESISTANC, V23, P11; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Gerber PJ, 2013, TACKING CLIMATE CHAN; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibbs HK, 2016, CONSERV LETT, V9, P32, DOI 10.1111/conl.12175; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Gliessman S, 2015, AGROECOLOGY: THE ECOLOGY OF SUSTAINABLE FOOD SYSTEMS, 3RD EDITION, pXI; Goldstein B, 2016, FOOD POLICY, V59, P139, DOI 10.1016/j.foodpol.2016.01.006; Haddad EH, 2003, AM J CLIN NUTR, V78, p626S, DOI 10.1093/ajcn/78.3.626S; Harnisch J, 2005, SAFEGUARDING OZONE L, P118; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20878, DOI 10.1073/pnas.1321844111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Jalava M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074016; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; Magat SS, 2007, COCONUT PRODUCTIVITY, P23; Matthews K, 2013, ALTERNATIVE BEEF PRO; Mattick CS, 2015, ENVIRON SCI TECHNOL, V49, P11941, DOI 10.1021/acs.est.5b01614; Meier T, 2013, ENVIRON SCI TECHNOL, V47, P877, DOI 10.1021/es302152v; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Munoz I, 2010, INT J LIFE CYCLE ASS, V15, P794, DOI 10.1007/s11367-010-0188-z; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Noojipady Praveen, 2015, Ecosystem Health and Sustainability, V1, P27, DOI 10.1890/EHS15-0020.1; OECD, 2016, MEAT CONS; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Pelletier N, 2010, AGR SYST, V103, P380, DOI 10.1016/j.agsy.2010.03.009; Peters CJ, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000116; Piazza J, 2015, APPETITE, V91, P114, DOI 10.1016/j.appet.2015.04.011; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rothgerber H., 2012, PSYCHOL MEN MASCULIN, V14; Sammons N, 2016, P 2016 LCA FOOD C DU; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Shepon A, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/10/105002; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Sneeringer S, 2015, ERR200; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Steinfeld H, 2013, GREENHOUSE GAS EMISS; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; The United States Geological Survey, 2016, USGS WAT SCI SCH; Thomson KJ, 2003, LAND USE POLICY, V20, P375, DOI 10.1016/S0264-8377(03)00047-4; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tuomisto HL, 2011, ENVIRON SCI TECHNOL, V45, P6117, DOI 10.1021/es200130u; U.S. Department of Agriculture (USDA), 2016, FOOD AV PER CAP DAT; U. S. Department of Health and Human Services and U. S. Department of Agriculture, 2015, 2015 2020 DIET GUID; United States Department of Agriculture-Economic Research Service, 2016, CATTL BEEF TRAD; United States Environmental Protection Agency, 2008, AV ANN EM FUEL CONS; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; Van Kernebeek HRJ, 2016, INT J LIFE CYCLE ASS, V21, P677, DOI 10.1007/s11367-015-0923-6; Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f; Wells HF, 2008, EC INFORM B NUMBER, V33, P1; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	89	40	42	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189029	10.1371/journal.pone.0189029	http://dx.doi.org/10.1371/journal.pone.0189029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211775	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200057
J	Berzaczy, D; Mayerhoefer, ME; Azizi, AA; Haug, AR; Senn, D; Beitzke, D; Weber, M; Traub-Weidinger, T				Berzaczy, Dominik; Mayerhoefer, Marius E.; Azizi, Amedeo A.; Haug, Alexander R.; Senn, Daniela; Beitzke, Dietrich; Weber, Michael; Traub-Weidinger, Tatjana			Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; DIFFUSION-WEIGHTED MRI; F-18-FDG PET/CT; DIAGNOSIS	Purpose To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. Materials and methods Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). Results A total of 12 (6 male/6 female, mean age was 16.2 +/- 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -. 441) and ADCmin (r = -. 477), which proved to be statistically significant (p =.005 and p =.002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -. 311) and ADCmin (r: -. 300) and did not reach statistical significance (p =.054 and p =.057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r =.353; p =.027) and a strong one for SUVmean (r =.879; p =.001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r =.827; p <.001 and r =.721; p <.001) but differed significantly (p <.001). Conclusions We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST.	[Berzaczy, Dominik; Mayerhoefer, Marius E.; Beitzke, Dietrich; Weber, Michael] Med Univ Vienna, Div Gen & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Azizi, Amedeo A.] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Haug, Alexander R.; Senn, Daniela; Traub-Weidinger, Tatjana] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Berzaczy, D (corresponding author), Med Univ Vienna, Div Gen & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	dominik.berzaczy@meduniwien.ac.at	Mayerhoefer, Marius/AAD-2156-2021; Weber, Michael/L-9836-2016	Mayerhoefer, Marius/0000-0001-8786-8686; Traub-Weidinger, Tatjana/0000-0003-1118-926X; Azizi, Amedeo/0000-0002-1347-6644; Weber, Michael/0000-0002-8507-2219; Haug, Alexander/0000-0002-8308-6174	Austrian Science Fund (FWF) [KLIF 382]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), project number KLIF 382 to Marius E. Mayerhoefer. https://www.fwf.ac.at/en/.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Azizi AA, 2017, PEDIAT BLOOD CANC; Benz MR, 2010, CANCER-AM CANCER SOC, V116, P451, DOI 10.1002/cncr.24755; Chirindel A, 2015, J NUCL MED, V56, P379, DOI 10.2967/jnumed.114.142372; Chirindel A, 2015, CLIN NUCL MED, V40, pE17, DOI 10.1097/RLU.0000000000000446; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; Derlin T, 2013, CLIN NUCL MED, V38, pE19, DOI 10.1097/RLU.0b013e318266ce84; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2002, CANCER RES, V62, P1573; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Mayerhoefer ME, 2016, CLIN NUCL MED, V41, P837, DOI 10.1097/RLU.0000000000001395; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pemov A, 2017, ONCOGENE, V36, P3168, DOI 10.1038/onc.2016.464; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Salamon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143305; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Schaarschmidt BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122545; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Tovmassian D, 2016, INT J SURG ONCOL, V2016, DOI 10.1155/2016/6162182; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Van Der Gucht A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151809; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; Yap YS, 2014, ONCOTARGET, V5, P5873, DOI 10.18632/oncotarget.2194	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189093	10.1371/journal.pone.0189093	http://dx.doi.org/10.1371/journal.pone.0189093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206885	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700049
J	Suresh, S; Abdurehman, L; Osmani, AH; Osmani, SA				Suresh, Subbulakshmi; Abdurehman, Leymaan; Osmani, Aysha H.; Osmani, Stephen A.			Tools for retargeting proteins within Aspergillus nidulans	PLOS ONE			English	Article							CONNECTIVITY; LOCALIZATION; MANIPULATION; CONSTRUCTION; VERSATILE; COMPLEX; MARKER	Endogenously tagging proteins with green fluorescent protein (GFP) enables the visualization of the tagged protein using live cell microscopy. GFP-tagging is widely utilized to study biological processes in model experimental organisms including filamentous fungi such as Aspergillus nidulans. Many strains of A. nidulans have therefore been generated with different proteins endogenously tagged with GFP. To further enhance experimental approaches based upon GFP-tagging, we have adapted the GFP Binding Protein (GBP) system for A. nidulans. GBP is a genetically encoded Llama single chain antibody against GFP which binds GFP with high affinity. Using gene replacement approaches, it is therefore possible to link GBP to anchor proteins, which will then retarget GFP-tagged proteins away from their normal location to the location of the anchor-GBP protein. To facilitate this approach in A. nidulans, we made four base plasmid cassettes that can be used to generate gene replacement GBP-tagging constructs by utilizing fusion PCR. Using these base cassettes, fusion PCR, and gene targeting approaches, we generated strains with SPA10-GBP and Tom20-GBP gene replacements. These strains enabled test targeting of GFP-tagged proteins to septa or to the surface of mitochondria respectively. SPA10-GBP is shown to effectively target GFP-tagged proteins to both forming and mature septa. Tom20-GBP has a higher capacity to retarget GFP-tagged proteins being able to relocate all Nup49-GFP from its location within nuclear pore complexes (NPCs) to the cytoplasm in association with mitochondria. Notably, removal of Nup49-GFP from NPCs causes cold sensitivity as does deletion of the nup49 gene. The cassette constructs described facilitate experimental approaches to generate precise protein-protein linkages in fungi. The A. nidulans SPA10-GBP and Tom20-GBP strains can be utilized to modulate other GFP-tagged proteins of interest.	[Suresh, Subbulakshmi; Abdurehman, Leymaan; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Suresh, Subbulakshmi] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	University System of Ohio; Ohio State University; Rockefeller University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Suresh, Subbulakshmi/AAE-8714-2019; Osmani, Stephen A./AAS-3904-2021					Borg S, 2015, MBIO, V6, DOI 10.1128/mBio.02117-14; Chen YH, 2017, J CELL SCI, V130, P1003, DOI 10.1242/jcs.198457; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; De Souza CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090911; De Souza CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058008; Harris SD, 1997, FUNGAL GENET BIOL, V22, P1, DOI 10.1006/fgbi.1997.0990; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Lai JL, 2012, P NATL ACAD SCI USA, V109, P15781, DOI 10.1073/pnas.1207467109; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Markossian S, 2015, MOL BIOL CELL, V26, P605, DOI 10.1091/mbc.E14-09-1359; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Shen KF, 2014, MOL BIOL CELL, V25, P763, DOI 10.1091/mbc.E13-12-0718; Suelmann R, 2000, CELL MOTIL CYTOSKEL, V45, P42, DOI 10.1002/(SICI)1097-0169(200001)45:1<42::AID-CM4>3.0.CO;2-C; Suresh S, 2017, J CELL BIOL, V216, P2813, DOI 10.1083/jcb.201610019; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; Toews MW, 2004, CURR GENET, V45, P383, DOI 10.1007/s00294-004-0495-7; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zhang Y, 2017, MOL MICROBIOL, V106, P285, DOI 10.1111/mmi.13763	26	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0189077	10.1371/journal.pone.0189077	http://dx.doi.org/10.1371/journal.pone.0189077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194456	Green Submitted, Green Published, gold			2022-12-26	WOS:000416867800019
J	Krause, ET; Kruger, O; Hoffman, JI				Krause, E. Tobias; Krueger, Oliver; Hoffman, Joseph I.			The influence of inherited plumage colour morph on morphometric traits and breeding investment in zebra finches (Taeniopygia guttata)	PLOS ONE			English	Article							LIFETIME REPRODUCTIVE SUCCESS; MELANOCORTIN 1 RECEPTOR; POPULATION-STRUCTURE; EARLY NUTRITION; COMMON BUZZARD; MC1R; FITNESS; POLYMORPHISM; MAINTENANCE; EVOLUTION	Melanin-based plumage polymorphism occurs in many wild bird populations and has been linked to fitness variation in several species. These fitness differences often arise as a consequence of variation in traits such as behaviour, immune responsiveness, body size and reproductive investment. However, few studies have controlled for genetic differences between colour morphs that could potentially generate artefactual associations between plumage colouration and trait variation. Here, we used zebra finches (Taeniopygia guttata) as a model system in order to evaluate whether life-history traits such as adult body condition and reproductive investment could be influenced by plumage morph. To maximise any potential differences, we selected wild-type and white plumage morphs, which differ maximally in their extent of melanisation, while using a controlled three-generation breeding design to homogenise the genetic background. We found that F-2 adults with white plumage colouration were on average lighter and had poorer body condition than wild-type F-2 birds. However, they appeared to compensate for this by reproducing earlier and producing heavier eggs relative to their own body mass. Our study thus reveals differences in morphological and life history traits that could be relevant to fitness variation, although further studies will be required to evaluate fitness effects under natural conditions as well as to characterise any potential fitness costs of compensatory strategies in white zebra finches.	[Krause, E. Tobias; Krueger, Oliver; Hoffman, Joseph I.] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany; [Krause, E. Tobias] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany	University of Bielefeld; Friedrich Loeffler Institute	Krause, ET (corresponding author), Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.; Krause, ET (corresponding author), Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany.	tobias.krause@fli.de	Krause, E. Tobias/A-9900-2009; Hoffman, Joseph i/K-7725-2012	Krause, E. Tobias/0000-0002-8327-3711; Hoffman, Joseph i/0000-0001-5895-8949	German Science Foundation (DFG) [KR 2089/2-1]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	German Science Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	OK was funded by the German Science Foundation (DFG) through a Heisenberg-Professorship (KR 2089/2-1). We acknowledge support for the Article Processing Charge from the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the animal caretakers from the Department of Animal Behaviour, Bielefeld University. Two anonymous reviewers provided helpful comments to an earlier version of the manuscript. We acknowledge support for the Article Processing Charge from the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Adam I, 2014, JOVE-J VIS EXP, DOI 10.3791/51429; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; Bolund E, 2009, P R SOC B, V276, P707, DOI 10.1098/rspb.2008.1251; Boswell T, 2005, PEPTIDES, V26, P1733, DOI 10.1016/j.peptides.2004.11.039; Brazill-Boast J, 2013, EVOL ECOL, V27, P1189, DOI 10.1007/s10682-013-9651-1; Bredenkotter M, 2003, BRAIN RES, V978, P155, DOI 10.1016/S0006-8993(03)02803-8; Brommer JE, 2005, P ROY SOC B-BIOL SCI, V272, P935, DOI 10.1098/rspb.2005.3052; Caspers BA, 2013, ANIM BEHAV, V86, P85, DOI 10.1016/j.anbehav.2013.04.015; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Chakarov N, 2013, MOL ECOL, V22, P5430, DOI 10.1111/mec.12493; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Crawley M.J., 2007, R BOOK; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eckmeier D, 2008, J COMP PHYSIOL A, V194, P871, DOI 10.1007/s00359-008-0358-7; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Gilby AJ, 2009, EMU, V109, P222, DOI 10.1071/MU09013; Griffith SC, 2017, ETHOLOGY, V123, P1, DOI 10.1111/eth.12576; Gross J., 2015, NORTEST TESTS NORMAL; Hoffman JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096881; Hoffman JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086519; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; Immelmann K., 1959, Zool Jb (Abt Syst), V86, P437; Immelmann K., 1969, ZEBRAFINK TAENIOPYGI; Karell P, 2011, J EVOLUTION BIOL, V24, P1783, DOI 10.1111/j.1420-9101.2011.02308.x; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; Krause ET, 2017, ANIM BEHAV, V128, P103, DOI 10.1016/j.anbehav.2017.04.003; Krause ET, 2016, EMU, V116, P333, DOI 10.1071/MU15088; Krause ET, 2016, APPL ANIM BEHAV SCI, V182, P80, DOI 10.1016/j.applanim.2016.06.003; Krause ET, 2014, EVOL ECOL, V28, P263, DOI 10.1007/s10682-013-9674-7; Krause ET, 2011, ANIM BEHAV, V81, P1295, DOI 10.1016/j.anbehav.2011.03.021; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; MANN NI, 1991, ANIM BEHAV, V42, P285, DOI 10.1016/S0003-3472(05)80560-3; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MARIATH HA, 1982, Z TIERPSYCHOL, V60, P135; Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Navarro D., 2015, LEARNING STAT R TUTO; Peters L, 2016, ECOL EVOL, V6, P5705, DOI 10.1002/ece3.2290; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; ROHWER S, 1983, AUK, V100, P971, DOI 10.1093/auk/100.4.971; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P937, DOI 10.1098/rspb.2000.1093; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Schmelz M, 2015, J COMP PSYCHOL, V129, P356, DOI 10.1037/a0039646; Tritos NA, 1999, NEUROPEPTIDES, V33, P339, DOI 10.1054/npep.1999.0055; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; VOS DR, 1993, BEHAVIOUR, V126, P137, DOI 10.1163/156853993X00380; Xu HY, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S109; Zann RA., 1996, ZEBRA FINCH SYNTHESI	66	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188582	10.1371/journal.pone.0188582	http://dx.doi.org/10.1371/journal.pone.0188582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190647	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900078
J	Mcgee, D; Smith, A; Poncil, S; Patterson, A; Bernstein, AI; Racicot, K				Mcgee, Devin; Smith, Arianna; Poncil, Sharra; Patterson, Amanda; Bernstein, Alison I.; Racicot, Karen			Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth	PLOS ONE			English	Article							VIRAL-INFECTION; PREGNANCY; EPIDEMIOLOGY; INFLAMMATION; MORTALITY; LABOR	Preterm birth (PTB), or birth before 37 weeks gestation, is the leading cause of neonatal mortality worldwide. Cervical viral infections have been established as risk factors for PTB in women, although the mechanism leading to increased risk is unknown. Using a mouse model of pregnancy, we determined that intra-vaginal HSV2 infection caused increased rates of preterm birth following an intra-vaginal bacterial infection. HSV2 infection resulted in histological changes in the cervix mimicking cervical ripening, including significant collagen remodeling and increased hyaluronic acid synthesis. Viral infection also caused aberrant expression of estrogen and progesterone receptor in the cervical epithelium. Further analysis using human ectocervical cells demonstrated a role for Src kinase in virus-mediated changes in estrogen receptor and hyaluronic acid expression. In conclusion, HSV2 affects proteins involved in tissue hormone responsiveness, causes significant changes reminiscent of premature cervical ripening, and increases risk of preterm birth. Studies such as this improve our chances of identifying clinical interventions in the future.	[Mcgee, Devin; Smith, Arianna; Poncil, Sharra; Patterson, Amanda; Racicot, Karen] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, Grand Rapids, MI 49503 USA; [Bernstein, Alison I.] Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine	Racicot, K (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, Grand Rapids, MI 49503 USA.	Karen.racicot@hc.msu.edu	Bernstein, Alison I/H-9702-2019; Patterson, Amanda/L-8421-2019; Smith, Arianna L/AAD-2267-2019	Bernstein, Alison I/0000-0002-5589-4318; Patterson, Amanda/0000-0001-8407-5437; Smith, Arianna L/0000-0003-0025-3932	Eunice Kennedy Shriver National Institute of Child Health and Human Development [T32HD087166]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD087166] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development T32HD087166 (Arianna Smith).	Akgul Y, 2014, J CLIN INVEST, V124, P5481, DOI 10.1172/JCI78765; Akgul Y, 2012, ENDOCRINOLOGY, V153, P3493, DOI 10.1210/en.2011-1950; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Andersson S, 2008, J CLIN ENDOCR METAB, V93, P2366, DOI 10.1210/jc.2007-2813; Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x; Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Dimes Mo, 2012, BORN TOO SOON GLOBAL; Gibson CS, 2008, BJOG-INT J OBSTET GY, V115, P492, DOI 10.1111/j.1471-0528.2007.01653.x; Gibson CS, 2011, J MATERN-FETAL NEO M, V24, P847, DOI 10.3109/14767058.2010.531324; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Lawn JE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa2563; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Li DK, 2014, AM J EPIDEMIOLOGY; Manenaroo M, 1999, MOL ENDOCRINOL, V13, P981; Mosbah A, 2017, J MATERN-FETAL NEO M, P1; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nakubulwa S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0292-7; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Rubens CE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009871; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Subramaniam A, 2016, OBSTET GYNECOL, V127, P233, DOI 10.1097/AOG.0000000000001247; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844; Zuo Z, 2011, AM J CLIN PATHOL, V136, P260, DOI 10.1309/AJCP93JMIUEKRPIW	30	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188645	10.1371/journal.pone.0188645	http://dx.doi.org/10.1371/journal.pone.0188645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190738	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900091
J	Bosmans, JE; Coupe, VMH; Knottnerus, BJ; Geerlings, SE; van Charante, EPM; ter Riet, G				Bosmans, Judith E.; Coupe, Veerle M. H.; Knottnerus, Bart J.; Geerlings, Suzanne E.; van Charante, Eric P. Moll; ter Riet, Gerben			Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care	PLOS ONE			English	Article							CYSTITIS; MANAGEMENT; RESISTANCE; SYMPTOMS; VALIDITY; PLACEBO; TRIAL	Background Uncomplicated Urinary Tract Infections (UTIs) are common in primary care resulting in substantial costs. Since antimicrobial resistance against antibiotics for UTIs is rising, accurate diagnosis is needed in settings with low rates of multidrug-resistant bacteria. Objective To compare the cost-effectiveness of different strategies to diagnose UTIs in women who contacted their general practitioner (GP) with painful and/or frequent micturition between 2006 and 2008 in and around Amsterdam, The Netherlands. Methods This is a model-based cost-effectiveness analysis using data from 196 women who underwent four tests: history, urine stick, sediment, dipslide, and the gold standard, a urine culture. Decision trees were constructed reflecting 15 diagnostic strategies comprising different parallel and sequential combinations of the four tests. Using the decision trees, for each strategy the costs and the proportion of women with a correct positive or negative diagnosis were estimated. Probabilistic sensitivity analysis was used to estimate uncertainty surrounding costs and effects. Uncertainty was presented using cost-effectiveness planes and acceptability curves. Results Most sequential testing strategies resulted in higher proportions of correctly classified women and lower costs than parallel testing strategies. For different willingness to pay thresholds, the most cost-effective strategies were: 1) performing a dipstick after a positive history for thresholds below 10 per additional correctly classified patient, 2) performing both a history and dipstick for thresholds between 10 and 17 per additional correctly classified patient, 3) performing a dipstick if history was negative, followed by a sediment if the dipstick was negative for thresholds between 17 and 118 per additional correctly classified patient, 4) performing a dipstick if history was negative, followed by a dipslide if the dipstick was negative for thresholds above 118 per additional correctly classified patient. Conclusion Depending on decision makers' willingness to pay for one additional correctly classified woman, the strategy consisting of performing a history and dipstick simultaneously (ceiling ratios between 10 and 17) or performing a sediment if history and subsequent dipstick are negative (ceiling ratios between 17 and 118) are the most cost-effective strategies to diagnose a UTI.	[Bosmans, Judith E.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Coupe, Veerle M. H.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Knottnerus, Bart J.; van Charante, Eric P. Moll; ter Riet, Gerben] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Geerlings, Suzanne E.] Acad Med Ctr, Dept Internal Med Infect Dis, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bosmans, JE (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands.	j.e.bosmans@vu.nl	Knottnerus, Bart/AAV-5136-2021; Riet, Gerben ter/A-6943-2011; Knottnerus, Bart J/E-5824-2012; van Charante, Eric Moll/L-4856-2019	Knottnerus, Bart/0000-0001-7266-1746; Riet, Gerben ter/0000-0002-2231-7637; Knottnerus, Bart J/0000-0001-7266-1746; van Charante, Eric Moll/0000-0002-1489-5218; Coupe, Veerle/0000-0002-9553-9791; Bosmans, Judith/0000-0002-1443-1026				Bachmann LM, 2009, J CLIN EPIDEMIOL, V62, P357, DOI 10.1016/j.jclinepi.2008.02.007; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Chomarat M, 2000, INT J ANTIMICROB AG, V16, P483, DOI 10.1016/S0924-8579(00)00281-8; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; European Confederation of Laboratory Medicine, 2000, Scand J Clin Lab Invest Suppl, V231, P1; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Gonzalez CM, 1999, WORLD J UROL, V17, P372, DOI 10.1007/s003450050163; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; Hakkaart-vanRoijen L, 2011, GEACTUALISEERDE VERS; Heytens S, 2011, J WOMENS HEALTH, V20, P1117, DOI 10.1089/jwh.2010.2302; Hooton TM, 2004, CLIN INFECT DIS, V39, P75, DOI 10.1086/422145; Jacob-Tacken KHM, 2005, HEALTH ECON, V14, P435, DOI 10.1002/hec.948; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Knottnerus BJ, 2013, ANN FAM MED, V11, P442, DOI 10.1370/afm.1513; Little P, 2006, BRIT J GEN PRACT, V56, P606; McIsaac WJ, 2002, ARCH INTERN MED, V162, P600, DOI 10.1001/archinte.162.5.600; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Postma MJ, 2008, SEX TRANSM INFECT, V84, P152, DOI 10.1136/sti.2007.028043; Richards D, 2005, BMJ-BRIT MED J, V331, P143, DOI 10.1136/bmj.38496.452581.8F; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; van Pinxteren B, 2013, HUISARTS WET, V56, P270; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; Winkens R, 2003, FAM PRACT, V20, P410, DOI 10.1093/fampra/cmg412; WINKENS RAG, 1995, FAM PRACT, V12, P290, DOI 10.1093/fampra/12.3.290; *Z IND, 2006, G STAND	30	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188818	10.1371/journal.pone.0188818	http://dx.doi.org/10.1371/journal.pone.0188818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186185	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900064
J	Hsiao, CT; Liu, YT; Liao, YC; Hsu, TY; Lee, YC; Soong, BW				Hsiao, Cheng-Tsung; Liu, Yo-Tsen; Liao, Yi-Chu; Hsu, Ting-Yi; Lee, Yi-Chung; Soong, Bing-Wen			Mutational analysis of ITPR1 in a Taiwanese cohort with cerebellar ataxias	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GENE DELETION; MISSENSE MUTATION; SCA15; VARIANTS; FAMILIES; LOCALIZATION; ANTIBODIES; PHENOTYPE; DIAGNOSIS	Background The inositol 1,4,5-triphosphate (IP3) receptor type 1 gene (ITPR1) encodes the IP3 receptor type 1 (IP3R1), which modulates intracellular calcium homeostasis and signaling. Mutations in ITPR1 have been implicated in inherited cerebellar ataxias. The aim of this study was to investigate the role of ITPR1 mutations, including both large segmental deletion and single nucleotide mutations, in a Han Chinese cohort with inherited cerebellar ataxias in Taiwan. Methodology and principal findings Ninety-three unrelated individuals with molecularly unassigned spinocerebellar ataxia selected from 585 pedigrees with autosomal dominant cerebellar ataxias, were recruited into the study with elaborate clinical evaluations. The quantitative PCR technique was used to survey large segmental deletion of ITPR1 and a targeted sequencing approach was applied to sequence all of the 61 exons and the flanking regions of ITPR1. A novel ITPR1 mutation, c.7721T>C (p.V2574A), was identified in a family with dominantly inherited cerebellar ataxia. The proband has an adult-onset non-progressive pure cerebellar ataxia and her daughter is afflicted with a childhood onset cerebellar ataxia with intellectual sub normalities. Conclusion ITPR1 mutation is an uncommon cause of inherited cerebellar ataxia, accounting for 0.2% (1/585) of patients with dominantly inherited cerebellar ataxias in Taiwan. This study broadens the mutational spectrum of ITPR1 and also emphasizes the importance of considering ITPR1 mutations as a potential cause of inherited cerebellar ataxias.	[Hsiao, Cheng-Tsung] Taipei Vet Gen Hosp, Div Neurol, Dept Internal Med, Taoyuan Branch, Taoyuan, Taiwan; [Hsiao, Cheng-Tsung; Liu, Yo-Tsen; Liao, Yi-Chu; Hsu, Ting-Yi; Lee, Yi-Chung; Soong, Bing-Wen] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei, Taiwan; [Hsiao, Cheng-Tsung] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei, Taiwan; [Liu, Yo-Tsen; Liao, Yi-Chu; Hsu, Ting-Yi; Lee, Yi-Chung; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Yi-Chung; Soong, Bing-Wen] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Soong, Bing-Wen] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Soong, BW (corresponding author), Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei, Taiwan.; Soong, BW (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.; Soong, BW (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan.; Soong, BW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan.	bwsoong@ym.edu.tw	Lee, Yi-Chung/GZK-7162-2022	Liao, Yi-Chu/0000-0002-9644-2086; Lee, Yi-Chung/0000-0003-0102-164X	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-010-049-MY3]; Taipei Veterans General Hospital [V103C-109, V104E9-006, V105C-048, V105E9-006-MY2-1, V105D9-006-MY2-2]; Brain Research Center, National Yang-Ming University, Republic of China [104AC-B19]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center, National Yang-Ming University, Republic of China	The study was funded by the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-010-049-MY3), Taipei Veterans General Hospital (V103C-109, V104E9-006, V105C-048, V105E9-006-MY2-1, V105D9-006-MY2-2), and the Brain Research Center, National Yang-Ming University (104AC-B19), Republic of China.	Barresi S, 2016, CLIN GENET; Bezprozvanny I, 2011, NEUROCHEM RES, V36, P1186, DOI 10.1007/s11064-010-0393-y; Castrioto A, 2011, EUR J NEUROL, V18, P1263, DOI 10.1111/j.1468-1331.2011.03366.x; Di Gregorio E, 2010, CEREBELLUM, V9, P115, DOI 10.1007/s12311-009-0154-0; Dudding TE, 2004, NEUROLOGY, V63, P2288, DOI 10.1212/01.WNL.0000147299.80872.D1; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Ganesamoorthy D, 2009, CLIN CHEM, V55, P1415, DOI 10.1373/clinchem.2009.124958; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023; Hara K, 2008, NEUROLOGY, V71, P547, DOI 10.1212/01.wnl.0000311277.71046.a0; Hsiao CT, 2014, J NEUROL SCI, V347, P322, DOI 10.1016/j.jns.2014.10.042; Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67; Jarius S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0356-y; Jarius S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0206-3; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knight MA, 2003, NEUROBIOL DIS, V13, P147, DOI 10.1016/S0969-9961(03)00029-9; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YC, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000068; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Lee YC, 2011, MOVEMENT DISORD, V26, P2081, DOI 10.1002/mds.23809; Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81; McEntagart M, 2016, AM J HUM GENET, V98, P981, DOI 10.1016/j.ajhg.2016.03.018; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Novak MJU, 2010, MOVEMENT DISORD, V25, P2176, DOI 10.1002/mds.23223; Obayashi M, 2012, J HUM GENET, V57, P202, DOI 10.1038/jhg.2012.5; Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sasaki M, 2015, J NEUROL, V262, P1278, DOI 10.1007/s00415-015-7705-8; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schnekenberg RP, 2015, BRAIN, V138, P1817, DOI 10.1093/brain/awv117; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shadrina M I, 2016, Cerebellum Ataxias, V3, P2, DOI 10.1186/s40673-016-0040-8; Synofzik M, 2011, J MED GENET, V48, P407, DOI 10.1136/jmg.2010.087023; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; van Dijk T, 2017, AM J MED GENET A, V173, P207, DOI 10.1002/ajmg.a.37962; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; Yamazaki H, 2011, BIOCHEM BIOPH RES CO, V410, P754, DOI 10.1016/j.bbrc.2011.06.043	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187503	10.1371/journal.pone.0187503	http://dx.doi.org/10.1371/journal.pone.0187503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186133	gold, Green Submitted, Green Published			2022-12-26	WOS:000416484900007
J	Palacios-Cena, D; Hernandez-Barrera, V; Jimenez-Trujillo, I; Serrano-Urrea, R; Fernandez-de-las-Penas, C; Carrasco-Garrido, P				Palacios-Cena, Domingo; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Serrano-Urrea, Ramon; Fernandez-de-las-Penas, Cesar; Carrasco-Garrido, Pilar			Time trends in antibiotic consumption in the elderly: Ten-year follow-up of the Spanish National Health Survey and the European Health Interview Survey for Spain (2003-2014)	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; POPULATION-BASED SURVEY; NURSING-HOMES; OLDER-ADULTS; PRIMARY-CARE; PRESCRIPTION; PREVALENCE; MEDICINES; DENMARK; PEOPLE	Background The purposes of this study were: firstly, to estimate time trends in the prevalence of prescription antibiotic consumption between 2003 and 2014; secondly, to identify the factors associated with the probability of consuming antibiotics during this period in elderly persons in Spain. Methods We analyzed data collected from the Spanish National Health Survey in 2003 (n = 21,650), 2006 (n = 29,478), and 2012 (n = 20,007) and from the European Health Interview Survey for Spain in 2009 (n = 22,188) and 2014 (n = 22,842). Antibiotic consumption was the dependent variable. We also analyzed sociodemographic features, self-perceived health status, lifestyle habits, comorbid diseases, and disabilities using logistic regression models. Results The prevalence of antibiotic consumption increased from 2003 to 2014 in both sexes. The variables that predicted antibiotic consumption (men; women) were secondary education (OR 1.38; OR 1.31), visits to a general practitioner (OR 2.05; OR 2.15), hospitalization (OR 1.91; OR 1.83), therapy with > 4 non-antibiotic drugs (OR 3.36; OR 5.84), instrumental activities of daily living (OR 1.50; OR 1.24), and activities of daily living (OR 1.39; OR 1.35). In contrast, age > 85 years was associated with low antibiotic consumption in both men (OR 0.81) and women (OR 0.88). Conclusions The prevalence of antibiotic prescription has increased in Spain in the last decade. Our study identified several factors that appear to affect antibiotic consumption in elderly persons, with potential implications for healthcare providers.	[Palacios-Cena, Domingo; Fernandez-de-las-Penas, Cesar] Univ Rey Juan Carlos, ITPSE Res Grp, Dept Physiotherapy Occupat Therapy Rehabil & Phys, Madrid, Spain; [Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel] Univ Rey Juan Carlos, Med & Surg, Psychol Prevent Med & Publ Hlth, Med Microbiol & Immunol & Nursing Dept, Madrid, Spain; [Serrano-Urrea, Ramon] Univ Castilla La Mancha, Fac Comp Sci Engn, Dept Math, Albacete, Castilla La Man, Spain; [Carrasco-Garrido, Pilar] Univ Rey Juan Carlos, ITPSE Res Group, Psychol Prevent Med & Publ Hlth, Med & Surg,Med Microbiol & Immunol & Nursing Dept, Madrid, Spain	Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad de Castilla-La Mancha; Universidad Rey Juan Carlos	Palacios-Cena, D (corresponding author), Univ Rey Juan Carlos, ITPSE Res Grp, Dept Physiotherapy Occupat Therapy Rehabil & Phys, Madrid, Spain.	domingo.palacios@urjc.es	Jimenez-Trujillo, Isabel/AAP-7746-2021; PALACIOS-CEÑA, DOMINGO/B-6944-2015	Jimenez-Trujillo, Isabel/0000-0002-9394-6799; PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Hernandez-Barrera, Valentin/0000-0001-5790-1959	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") [PI13/00369]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa")	This study was funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant No. PI13/00369, Institute de Salud Carlos III) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afekouh H, 2015, MED MALADIES INFECT, V45, P427, DOI 10.1016/j.medmal.2015.09.010; Bagger K, 2015, EUR J GEN PRACT, V21, P118, DOI 10.3109/13814788.2014.1001361; Barroso C, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0346-4; Beckett CL, 2015, CLIN MICROBIOL INFEC, V21, P3, DOI 10.1016/j.cmi.2014.08.018; Bradley SF, 2016, CLIN GERIATR MED, V32, P443, DOI 10.1016/j.cger.2016.02.009; Cardoso T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-375; Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121; Cooper JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009235; da Costa FA, 2017, INT J CLIN PHARM-NET, V39, P104, DOI 10.1007/s11096-016-0405-3; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; European Centre for Disease Prevention and Control, SUMM LAT DAT ANT CON; Haeseker MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051860; Instituto Nacional de Estadistica, SPAN NAC HLTH SURV 2; Instituto Nacional de Estadistica, 2009, EUR HLTH INT SURV SP; Instituto Nacional de Estadistica, SPAN NAT HLTH SURV 2; Lallana-Alvarez MJ, 2012, ENFERM INFEC MICR CL, V30, P591, DOI 10.1016/j.eimc.2012.03.004; Kliemann BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167885; Knox K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3441; Kourlaba G, 2016, EURO SURVEILL, V21; Kuhn KG, 2014, SCAND J INFECT DIS, V46, P599, DOI 10.3109/00365548.2014.912347; Lago JA, PHARM EXPENDITURE SP; Malo S, 2014, BASIC CLIN PHARMACOL, V115, P231, DOI 10.1111/bcpt.12211; Malo-Fumanal S, 2014, ENFERM INFEC MICR CL, V32, P412, DOI 10.1016/j.eimc.2013.10.002; Marra F, 2010, CAN J INFECT DIS MED, V21, pE99, DOI 10.1155/2010/965268; McClean P, 2011, J ANTIMICROB CHEMOTH, V66, P1609, DOI 10.1093/jac/dkr183; Nessighaoui H, 2016, THERAPIE, V71, P275, DOI 10.1016/j.therap.2016.02.021; Palacios-Cena D, 2013, MATURITAS, V76, P326, DOI 10.1016/j.maturitas.2013.07.016; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Pan DST, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0547-3; Schroeck JL, 2015, ANTIMICROB AGENTS CH, V59, P3848, DOI 10.1128/AAC.00652-15; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Sigurdardottir NR, 2015, SCAND J PRIM HEALTH, V33, P269, DOI 10.3109/02813432.2015.1114349; Stearns CR, 2009, ACAD EMERG MED, V16, P934, DOI 10.1111/j.1553-2712.2009.00522.x; Touboul-Lundgren P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2254-8; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; World Health Organization, ANT RES GLOB REP SUR; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717; Zimmerman S, 2014, J AM GERIATR SOC, V62, P907, DOI 10.1111/jgs.12784	38	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0185869	10.1371/journal.pone.0185869	http://dx.doi.org/10.1371/journal.pone.0185869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186144	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900001
J	Chauta, A; Whitehead, S; Amaya-Marquez, M; Poveda, K				Chauta, Alexander; Whitehead, Susan; Amaya-Marquez, Marisol; Poveda, Katja			Leaf herbivory imposes fitness costs mediated by hummingbird and insect pollinators	PLOS ONE			English	Article							PALICOUREA-PADIFOLIA RUBIACEAE; ECOLOGICAL COSTS; FLORAL CHARACTERS; PLANT; EVOLUTION; NECTAR; ATTRACTIVENESS; PSYCHOTRIEAE; VOLATILES; IMPACTS	Plant responses induced by herbivore damage can provide fitness benefits, but can also have important costs due to altered interactions with mutualist pollinators. We examined the effects of plant responses to herbivory in a hummingbird-pollinated distylous shrub, Palicourea angustifolia. Through a series of field experiments we investigated whether damage from foliar herbivores leads to a reduction in fruit set, influences floral visitation, or alters floral traits that may influence pollinator preference or pollinator efficiency. Foliar herbivory by a generalist grasshopper led to reduced fruit set in branches that were directly damaged as well as in adjacent undamaged branches on the same plant. Furthermore, herbivory resulted in reduced floral visitation from two common hummingbird species and two bee species. An investigation into the potential mechanisms behind reduced floral visitation in induced plants showed that foliar herbivore damage resulted in shorter styles and lower nectar volumes. This reduction in style length could reduce pollen deposition between different floral morphs that is required for optimal pollination in a distylous plant. We did not detect any differences in the volatile blends released by damaged and undamaged branches, suggesting that foliar herbivore-induced changes in floral morphology and rewards, and not volatile blends, are the primary mechanism mediating changes in visitation. Our results provide novel mechanisms for how plant responses induced by foliar herbivores can lead to ecological costs.	[Chauta, Alexander] Univ Nacl Colombia, Dept Biol, Ciudad Univ, Bogota, Colombia; [Whitehead, Susan; Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Amaya-Marquez, Marisol] Univ Nacl Colombia, Inst Ciencias Nat, Ciudad Univ, Bogota, Colombia; [Chauta, Alexander] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA	Universidad Nacional de Colombia; Cornell University; Universidad Nacional de Colombia; Cornell University	Chauta, A (corresponding author), Univ Nacl Colombia, Dept Biol, Ciudad Univ, Bogota, Colombia.; Chauta, A (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	jachautam@unal.edu.co		Whitehead, Susan/0000-0002-7089-4594; Amaya- Marquez, Marisol/0000-0001-6135-8063	Programa Jovenes investigadores e innovadores, Colciencias	Programa Jovenes investigadores e innovadores, Colciencias	This work was supported by Programa Jovenes investigadores e innovadores-2012, Colciencias.	Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Aldea M, 2005, PLANT CELL ENVIRON, V28, P402, DOI 10.1111/j.1365-3040.2005.01279.x; BARRETT SCH, 1990, TRENDS ECOL EVOL, V5, P144, DOI 10.1016/0169-5347(90)90220-8; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bronstein Judith L., 2007, P75, DOI 10.1017/CBO9780511542701.005; Diaz-Uriarte R, 2015, PACKAGE VARSELRF; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Gehring CA, 2002, ECOL STU AN, V157, P295; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; Hernandez A, 2007, ECOSCIENCE, V14, P8, DOI 10.2980/1195-6860(2007)14[8:DPTIDP]2.0.CO;2; Herrera CM, 2002, P NATL ACAD SCI USA, V99, P16823, DOI 10.1073/pnas.252362799; Hilty SL, 2001, GUIA AVES COLOMBIA; Hothorn AT, 2015, PACKAGE MULTCOMP; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; KARBAN R, 1997, INDUCED RESPONSES HE; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Knudsen JT, 2004, BOT J LINN SOC, V146, P191, DOI 10.1111/j.1095-8339.2004.00329.x; Krupnick GA, 1999, ECOLOGY, V80, P125, DOI 10.1890/0012-9658(1999)080[0125:TCOFHF]2.0.CO;2; Lehtila K, 1997, OECOLOGIA, V111, P396, DOI 10.1007/s004420050251; Leonard A.S., 2011, EVOLUTION PLANT POLL, P261, DOI DOI 10.1016/J.ANBEHAV.2012.01.007; Lopes S, 2004, BIOCHEM SYST ECOL, V32, P1187, DOI 10.1016/j.bse.2004.04.015; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Massinga PH, 2005, ANN BOT-LONDON, V95, P389, DOI 10.1093/aob/mci040; Mothershead K, 2000, ECOLOGY, V81, P30, DOI 10.2307/177131; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Ornelas JF, 2004, AM J BOT, V91, P1052, DOI 10.3732/ajb.91.7.1052; OSTLIE KR, 1984, ENVIRON ENTOMOL, V13, P1675, DOI 10.1093/ee/13.6.1675; Porras MF, 2007, REV COLOMB ENTOMOL, V33, P70; Poveda K, 2003, OECOLOGIA, V135, P601, DOI 10.1007/s00442-003-1228-1; R Team Core, 2014, R LANG ENV STAT COMP; Ranganathan Y, 2010, PLANT BIOLOGY, V12, P735, DOI 10.1111/j.1438-8677.2009.00278.x; RENNER S, 1983, BIOTROPICA, V15, P251, DOI 10.2307/2387649; Rivera-Diaz O, 2012, GUIA CAMPO PLANTAS C; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; STEPHENSON AG, 1982, J CHEM ECOL, V8, P1025, DOI 10.1007/BF00987883; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; Strauss SY, 1996, AM NAT, V147, P1098, DOI 10.1086/285896; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; TAMM S, 1986, OECOLOGIA, V70, P20, DOI 10.1007/BF00377107; Taylor CM, 1997, ANN MO BOT GARD, V84, P224, DOI 10.2307/2400003; Taylor CM, 2000, NOVON, V10, P78, DOI 10.2307/3393191; Torres I, 2008, ECOSCIENCE, V15, P65, DOI 10.2980/1195-6860(2008)15[65:AATEIA]2.0.CO;2; Valois-Cuesta H, 2006, BIODIVERSIDAD, P40; Whitehead SR, 2011, J ECOL, V99, P964, DOI 10.1111/j.1365-2745.2011.01819.x; Zuur A. F., 2013, BEGINNERS GUIDE GLM	52	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188408	10.1371/journal.pone.0188408	http://dx.doi.org/10.1371/journal.pone.0188408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211805	gold, Green Submitted, Green Published			2022-12-26	WOS:000417212200030
J	Denslow, A; Switalska, M; Jarosz, J; Papiernik, D; Porshneva, K; Nowak, M; Wietrzyk, J				Denslow, Agnieszka; Switalska, Marta; Jarosz, Joanna; Papiernik, Diana; Porshneva, Kseniia; Nowak, Marcin; Wietrzyk, Joanna			Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models	PLOS ONE			English	Article							PLATELET ACTIVATION; P-SELECTIN; CANCER; CELLS; BREAST; INHIBITION; CARCINOMA; SURVIVAL; ANGIOGENESIS; ANTIOXIDANT	Clopidogrel, a thienopyridine derivative with antiplatelet activity, is widely prescribed for patients with cardiovascular diseases. In addition to antiplatelet activity, antiplatelet agents possess anticancer and antimetastatic properties. Contrary to this, results of some studies have suggested that the use of clopidogrel and other thienopyridines accelerates the progression of breast, colorectal, and prostate cancer. Therefore, in this study, we aimed to evaluate the efficacy of clopidogrel and various anticancer agents as a combined treatment using mouse models of breast, colorectal, and prostate cancer. Metastatic dissemination, selected parameters of platelet morphology and biochemistry, as well as angiogenesis were assessed. In addition, body weight, blood morphology, and biochemistry were evaluated to test toxicity of the studied compounds. According to the results, clopidogrel increased antitumor and/or antimetastatic activity of chemotherapeutics such as 5-fluorouracil, cyclophosphamide, and mitoxantrone, whereas it decreased the anticancer activity of doxorubicin, cisplatin, and tamoxifen. The mechanisms of such divergent activities may be based on the modulation of tumor vasculature via factors, such as transforming growth factor beta 1 released from platelets. Moreover, clopidogrel increased the toxicity of docetaxel and protected against mitoxantrone-induced toxicity, which may be due to the modulation of hepatic enzymes and protection of the vasculature, respectively. These results demonstrate that antiplatelet agents can be useful but also dangerous in anticancer treatment and therefore use of thienopyridines in patients undergoing chemotherapy should be carefully evaluated.	[Denslow, Agnieszka; Switalska, Marta; Jarosz, Joanna; Papiernik, Diana; Porshneva, Kseniia; Wietrzyk, Joanna] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland; [Nowak, Marcin] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences	Wietrzyk, J (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland.	wietrzyk@iitd.pan.wroc.pl	Wietrzyk, Joanna/O-4392-2018; Nowak, Marcin/A-8768-2017	Wietrzyk, Joanna/0000-0003-4980-6606; Nowak, Marcin/0000-0002-2468-107X; Switalska, Marta/0000-0001-7920-2251; Jarosz, Joanna/0000-0002-9287-6207	European Union; National Center for Research and Development under Polish Strategic Framework Program STRATEGMED [STRATEGMED1/233226/11/NCBR/2015]; Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW); European Regional Development Fund within the Innovative Economy Program [POIG.01.01.02-00-069/09]	European Union(European Commission); National Center for Research and Development under Polish Strategic Framework Program STRATEGMED; Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW); European Regional Development Fund within the Innovative Economy Program	This study was supported by the European Union from the resources of the European Regional Development Fund within the Innovative Economy Program (grant coordinated by the JCET-UJ, No. POIG.01.01.02-00-069/09) and The National Center for Research and Development under the Polish Strategic Framework Program STRATEGMED (grant coordinated by JCET-UJ No. STRATEGMED1/233226/11/NCBR/2015). The publication was supported by Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW) for years 2014-2018. The funding bodies did not participate in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.	Agergaard K, 2017, CLIN PHARM THER; Battinelli EM, 2014, BLOOD, V123, P101, DOI 10.1182/blood-2013-02-485011; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bergmann TK, 2016, BRIT J CLIN PHARMACO, V81, P313, DOI 10.1111/bcp.12795; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Chiodoni C, 2006, J EXP MED, V203, P2441, DOI 10.1084/jem.20060844; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Choe KS, 2010, CANCER-AM CANCER SOC, V116, P1820, DOI 10.1002/cncr.24890; Coupland LA, 2012, CANCER RES, V72, P4662, DOI 10.1158/0008-5472.CAN-11-4010; Damiani RM, 2016, ARCH TOXICOL, V90, P2063, DOI 10.1007/s00204-016-1759-y; Danckwardt S, 2013, J MOL MED, V91, P1257, DOI 10.1007/s00109-013-1074-5; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Erez N, 2011, INT J CANCER, V128, P2536, DOI 10.1002/ijc.26032; Finsterer J, 2015, EXPERT OPIN DRUG MET, V11, P15, DOI 10.1517/17425255.2015.973401; Floyd JS, 2010, ARCH INTERN MED, V170, P1078, DOI 10.1001/archinternmed.2010.154; Ford NF, 2016, J CLIN PHARMACOL, V56, P1474, DOI 10.1002/jcph.769; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gawron-Skarbek A, 2014, NUTR METAB CARDIOVAS, V24, pE21, DOI 10.1016/j.numecd.2014.02.011; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Han Hui, 2014, ScientificWorldJournal, V2014, P878209, DOI 10.1155/2014/878209; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Herbert J-M, 1998, PLATELETS, V9, P251; Hicks BM, 2015, PHARMACOEPIDEM DR S, V24, P830, DOI 10.1002/pds.3807; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Jakubowski A, 2005, PROSTAG LEUKOTR ESS, V72, P139, DOI 10.1016/j.plefa.2004.10.011; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; Kenmotsu H, 2015, CANCER SCI, V106, P497, DOI 10.1111/cas.12647; Kispert SE, 2014, AM J PHYSIOL-CELL PH, V307, pC951, DOI 10.1152/ajpcell.00218.2014; Kotronias RA, 2016, DRUG SAFETY, P1; Krzeminski P, 2007, FEBS J, V274, P1970, DOI 10.1111/j.1742-4658.2007.05741.x; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Leader A, 2017, AM J MED, V130, P826, DOI 10.1016/j.amjmed.2017.01.022; Lee PC, 2016, ANN SURG ONCOL, V23, pS874, DOI 10.1245/s10434-016-5520-9; Lukasik M, 2011, THROMB RES, V128, pE73, DOI 10.1016/j.thromres.2011.06.016; Mannori G, 2000, CLIN EXP METASTAS, V18, P89, DOI 10.1023/A:1026548700247; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; Medina C, 2006, J PHARMACOL EXP THER, V317, P739, DOI 10.1124/jpet.105.098384; Mezouar S, 2015, INT J CANCER, V136, P462, DOI 10.1002/ijc.28997; Milczarek M, 2013, ANTICANCER RES, V33, P433; Mir O, 2009, ANN ONCOL, V20, P736, DOI 10.1093/annonc/mdn698; Miyashita T, 2015, J SURG RES, V193, P289, DOI 10.1016/j.jss.2014.07.037; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Oshiro C, 2009, PHARMACOGENET GENOM, V19, P979, DOI 10.1097/FPC.0b013e3283335277; Pajtasz-Piasecka E, 2004, FOLIA BIOL-PRAGUE, V50, P7; Pandey A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/44/445101; Panis C, 2013, ANTICANCER RES, V33, P737; Radziwon-Balicka A, 2012, BRIT J PHARMACOL, V167, P787, DOI 10.1111/j.1476-5381.2012.01991.x; Sarangi S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0567-y; Schrottmaier WC, 2015, THROMB HAEMOSTASIS, V114, P478, DOI 10.1160/TH14-11-0943; Serebruany VL, 2009, AM J MED, V122, P407, DOI 10.1016/j.amjmed.2008.11.023; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Symeonidis D, 2012, WORLD J GASTRO ENDOS, V4, P409, DOI 10.4253/wjge.v4.i9.409; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Van Kolen K, 2006, FEBS J, V273, P1843, DOI 10.1111/j.1742-4658.2006.05205.x; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Zahno A, 2013, FREE RADICAL BIO MED, V65, P208, DOI 10.1016/j.freeradbiomed.2013.06.007	63	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188740	10.1371/journal.pone.0188740	http://dx.doi.org/10.1371/journal.pone.0188740			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206871	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700021
J	Hsieh, AR; Chen, DP; Chattopadhyay, AS; Li, YJ; Chang, CC; Fann, CSJ				Hsieh, Ai-Ru; Chen, Dao-Peng; Chattopadhyay, Amrita Sengupta; Li, Ying-Ju; Chang, Chien-Ching; Fann, Cathy S. J.			A non-threshold region-specific method for detecting rare variants in complex diseases	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GAMETIC DISEQUILIBRIUM; LINKAGE DISEQUILIBRIUM; MISSING HERITABILITY; ASSOCIATION ANALYSIS; COMMON; TESTS; SUSCEPTIBILITY; SEQUENCE; STRATEGIES	A region-specific method, NTR (non-threshold rare) variant detection method, was developed D it does not use the threshold for defining rare variants and accounts for directions of effects. NTR also considers linkage disequilibrium within the region and accommodates common and rare variants simultaneously. NTR weighs variants according to minor allele frequency and odds ratio to combine the effects of common and rare variants on disease occurrence into a single score and provides a test statistic to assess the significance of the score. In the simulations, under different effect sizes, the power of NTR increased as the effect size increased, and the type I error of our method was controlled well. Moreover, NTR was compared with several other existing methods, including the combined multivariate and collapsing method (CMC), weighted sum statistic method (WSS), sequence kernel association test (SKAT), and its modification, SKAT-O. NTR yields comparable or better power in simulations, especially when the effects of linkage disequilibrium between variants were at least moderate. In an analysis of diabetic nephropathy data, NTR detected more confirmed disease-related genes than the other aforementioned methods. NTR can thus be used as a complementary tool to help in dissecting the etiology of complex diseases.	[Hsieh, Ai-Ru] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Dao-Peng; Chattopadhyay, Amrita Sengupta; Li, Ying-Ju; Chang, Chien-Ching; Fann, Cathy S. J.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	China Medical University Taiwan; Academia Sinica - Taiwan	Fann, CSJ (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	csjfann@ibms.sinica.edu.tw	Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276; HSIEH, AIRU/0000-0003-3900-9101	National Science Council and Institute of Biomedical Sciences; China Medical University of Taiwan [MOST102-2314-B-001 -003 -MY2, CMU103-N-15, CMU105-N-23]; National Core Facility Program for Biotechnology of National Science council, Taiwan; Academia Sinica of Taiwan	National Science Council and Institute of Biomedical Sciences; China Medical University of Taiwan(China Medical University); National Core Facility Program for Biotechnology of National Science council, Taiwan; Academia Sinica of Taiwan(Academia Sinica - Taiwan)	We are grateful to the National Science Council and Institute of Biomedical Sciences, Academia Sinica of Taiwan and China Medical University of Taiwan for funding (MOST102-2314-B-001 -003 -MY2 to CSJF, CMU103-N-15 and CMU105-N-23 to AH).; We thank the National Center for Genome Medicine at Academia Sinica, Taiwan, for technical/bioinformatics support. This Center was supported by grants from the National Core Facility Program for Biotechnology of National Science council, Taiwan. We are also grateful to the National Science Council and Institute of Biomedical Sciences, Academia Sinica of Taiwan and China Medical University of Taiwan for funding (MOST102-2314-B-001 -003 -MY2, CMU103-N-15 and CMU105-N-23).	Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Ayres KL, 2001, GENETICS, V157, P413; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fan Ruixue, 2011, BMC Proc, V5 Suppl 9, pS17, DOI 10.1186/1753-6561-5-S9-S17; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Hatunic M, 2009, DIABETES RES CLIN PR, V83, P316, DOI 10.1016/j.diabres.2008.12.004; HEDRICK PW, 1987, GENETICS, V117, P331; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofker MH, 2014, BBA-MOL BASIS DIS, V1842, P1889, DOI 10.1016/j.bbadis.2014.05.002; Kotlinowski J, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8492353; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Legry V, 2008, INT J OBESITY, V32, P421, DOI 10.1038/sj.ijo.0803705; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2010, AM J HUM GENET, V87, P790, DOI 10.1016/j.ajhg.2010.10.025; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nicolae DL, 2016, ANNU REV GENOM HUM G, V17, P117, DOI 10.1146/annurev-genom-083115-022609; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pengelly RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1854-0; Peralta JM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S86; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Shen LX, 2016, NEUROSCI BULL, V32, P183, DOI 10.1007/s12264-016-0011-3; Swan EJ, 2015, DIABETIC MED, V32, P1104, DOI 10.1111/dme.12763; Toma MI, 2013, GENE CHROMOSOME CANC, V52, P265, DOI 10.1002/gcc.22026; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wen SH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-875; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yuan A, 2012, BIOINFORM BIOL INSIG, V6, P1, DOI 10.4137/BBI.S8852; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zhang GY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2312-8; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188566	10.1371/journal.pone.0188566	http://dx.doi.org/10.1371/journal.pone.0188566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190701	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900075
J	Kuznik, A; Iliyasu, G; Lamorde, M; Mahmud, M; Musa, BM; Nashabaru, I; Obaro, S; Mohammed, I; Habib, AG				Kuznik, Andreas; Iliyasu, Garba; Lamorde, Mohammed; Mahmud, Mustapha; Musa, Baba M.; Nashabaru, Ibrahim; Obaro, Stephen; Mohammed, Idris; Habib, Abdulrazaq G.			Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, Wand Y with a quadrivalent conjugate vaccine in the African meningitis belt	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; GROUP-A; BACTERIAL-MENINGITIS; BURKINA-FASO; EPIDEMIC; NIGER; INFECTION; COUNTRIES; DISEASE	Background Neisseria meningitidis constitutes a major public health problem among countries in the African meningitis belt. Following regional vaccination campaigns for serogroup A and subsequent increases in protection against this serogroup, non-A serogroups such as C and W now pose significant epidemic threats, particularly in young children. Objective To evaluate the cost-effectiveness of broadening coverage from conjugate serogroup A to quadrivalent ACWY vaccination. Methods We developed a 40-year Markov state transition model with annual cycles to simulate costs and clinical outcomes in children aged 1 to 10 in the 26 countries of the African meningitis belt. The incidence of CWY meningitis cases among an unvaccinated population was held constant at inter-epidemic rates of 50 per 100,000/year and 150 per 100,000/year. The country-specific cost and probability of access to meningitis care, vaccine efficacy, the mortality risk among treated and untreated meningitis cases, the risk of clinical sequelae and their respective disability weights were based on published sources. Vaccination cost was based on international prices lists, presented in 2014 US$. Results At an incidence rate of 50 per 100,000/year, routine conjugate vaccination is highly costeffective in 14 out of 26 countries with a cost/DALY averted ranging from US$ 555-US$ 787. At the higher incidence rate of 150 per 100,000/year, quadrivalent vaccination is cost-effective in all 26 countries with a cost/DALY averted ranging from US$ 105-US$ 250. The annual incidence rate at which routine conjugate quadrivalent vaccination is expected to be economically justifiable ranges from 13 per 100,000/year in Nigeria to 142 per 100,000/year in Burundi. Conclusion Routine quadrivalent conjugate vaccination against Neisseria meningitidis is cost-effective at incidence rates well below the epidemic threshold among children living in the African meningitis belt.	[Kuznik, Andreas] Regeneron Pharmaceut, Tarrytown, NY USA; [Kuznik, Andreas; Iliyasu, Garba; Musa, Baba M.; Nashabaru, Ibrahim; Habib, Abdulrazaq G.] Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Nigeria; [Kuznik, Andreas; Lamorde, Mohammed] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Mahmud, Mustapha; Habib, Abdulrazaq G.] Natl Primary Hlth Care Dev Agcy, Natl Immunizat Tech Advisory Grp, Abuja, Nigeria; [Obaro, Stephen] Univ Nebraska Med Ctr, Div Pediat Infect Dis, Omaha, NE USA; [Mohammed, Idris] Fed Teaching Hosp, Dept Med, Infect Dis Unit, Gombe, Nigeria	Regeneron; Bayero University; Makerere University; University of Nebraska System; University of Nebraska Medical Center	Habib, AG (corresponding author), Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Nigeria.; Habib, AG (corresponding author), Natl Primary Hlth Care Dev Agcy, Natl Immunizat Tech Advisory Grp, Abuja, Nigeria.	abdulrazaq_habib@yahoo.co.uk		Kuznik, Andreas/0000-0002-8634-8360; Musa, Baba/0000-0002-9159-3635; Lamorde, Mohammed/0000-0003-2218-6822	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	Regeneron Pharmaceuticals provided support in the form of salaries for author Andreas Kuznik but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P633; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bovier PA, 1999, SOC SCI MED, V48, P1205, DOI 10.1016/S0277-9536(98)00419-5; BROOME CV, 1983, B WORLD HEALTH ORGAN, V61, P325; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Chow J, 2016, PLOS CURRENTS OUTBRE; Colombini A, 2015, CLIN INFECT DIS, V61, pS473, DOI 10.1093/cid/civ600; CROWE BA, 1989, J INFECT DIS, V159, P686, DOI 10.1093/infdis/159.4.686; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; EVANSJONES LG, 1977, ARCH DIS CHILD, V52, P320, DOI 10.1136/adc.52.4.320; Flexner S, 1913, J EXP MED, V17, P553, DOI 10.1084/jem.17.5.553; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Hayden MH, 2013, AM J TROP MED HYG, V89, P265, DOI 10.4269/ajtmh.12-0515; Hepkema H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065036; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597; Maurice J, 2015, LANCET, V385, P2241, DOI 10.1016/S0140-6736(15)61050-9; MOHAMMED I, 1984, J INFECTION, V9, P190, DOI 10.1016/S0163-4453(84)91429-4; Mohammed I, 2000, T ROY SOC TROP MED H, V94, P265, DOI 10.1016/S0035-9203(00)90316-X; Patel M, 2011, EVIDENCE BASED CHILD, V6, P916; Portnoy A, 2015, VACCINE, V33, pA240, DOI 10.1016/j.vaccine.2014.11.061; Round A, 1999, J PUBLIC HEALTH MED, V21, P8, DOI 10.1093/pubmed/21.1.8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sidikou F, 2016, LANCET INFECT DIS; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; The World Bank, 2015, GNI PER CAP ATL METH; World Health Organization, 2011, COST EFF THRESH; World Health Organization, 1995, WEEKLY EPIDEMIOLOGIC, V70, P136; World Health Organization, 2013, REV VACC PRIC DAT, P20	31	5	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188595	10.1371/journal.pone.0188595	http://dx.doi.org/10.1371/journal.pone.0188595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190699	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900080
J	Morfeld, KA; Brown, JL				Morfeld, Kari A.; Brown, Janine L.			Metabolic health assessment of zoo elephants: Management factors predicting leptin levels and the glucose-to-insulin ratio and their associations with health parameters	PLOS ONE			English	Article							SERUM LEPTIN; WEIGHT-LOSS; BODY-FAT; OBESITY; STRESS; ADIPONECTIN; SENSITIVITY; EXERCISE; RESISTIN; TISSUE	Screening for metabolic-related health problems can enhance animal welfare, so the purpose of this study was to conduct the first metabolic health assessment of zoo elephants and use epidemiological methods to determine how factors in the captive environment were associated with metabolic hormone concentrations. In addition, we examined relationships between metabolic status and several fitness parameters: foot health, musculoskeletal health, reproductive cyclicity, and body condition. Two blood samples were collected 2 weeks apart from 87 Asian (Elephas maximus) and 105 African (Loxodonta africana) elephants managed by zoos accredited by the Association of Zoos and Aquariums for analysis of serum leptin, insulin, glucose and the glucose-to-insulin ratio (G:I). In females, mean (SD) leptin concentrations and the G:l were lower (P<0.05) in Asian (3.93 +/- 2.21 ng/ml and 110 86 units) compared to African (4.37 +/- 2.89 ng/ml and 208 +/- 133 units) elephants, respectively. For males, mean leptin and the G:l were 4.99 +/- 3.61 ng/ml and 253 +/- 181 units for Asian, and 3.72 +/- 2.00 ng/ml and 326 +/- 231 units for African elephants, respectively, with no differences between species (P>0.05). As mean leptin concentration increased there was an increase in the odds of a female being non-cycling (P = 0.0083). The G:l was associated inversely with body condition (P = 0.0002); as the G:1 increased there was a decreased risk of BCS = 4 or 5 as compared to the ideal, or BCS = 3. Neither leptin nor G:l were predictive of foot or musculoskeletal health scores. Factors related to walking and feeding practices were most influential in predicting metabolic status, whereas social and housing factors showed smaller, but significant effects. The metabolic health benefits of walking were detected if the time spent in staff-directed walking was 7 hours or more per week. The most protective feeding practices included implementing a random rather than predictable feeding schedule and limiting the number of methods presentation methods. Results indicate that leptin levels and G:l can be used as predictors of both ovarian cycle function and body condition, and are affected by zoo management in elephants.	[Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE 68502 USA; [Morfeld, Kari A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Morfeld, Kari A.] Omahas Henry Doorly Zoo & Aquarium, Omaha, NE 68107 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Morfeld, KA (corresponding author), Lincoln Childrens Zoo, Lincoln, NE 68502 USA.; Morfeld, KA (corresponding author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.; Morfeld, KA (corresponding author), Omahas Henry Doorly Zoo & Aquarium, Omaha, NE 68107 USA.	karimorfeld@yahoo.com			National Leadership Grant from the Institute of Museum and Library Services [LG-25-10-0033-10]; Morris Animal Foundation Grant [D14Z0-075]	National Leadership Grant from the Institute of Museum and Library Services; Morris Animal Foundation Grant	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) Grant number: LG-25-10-0033-10. Funding support was also provided by a Morris Animal Foundation Grant (www.morrisariimaltouridation.org) to the Smithsonian National Zoological Park Grant number: D14Z0-075. Employers provided financial support in the form of authors' salaries as follows: Lincoln Children's Zoo (KM); Smithsonian National Zoological Park (KM, JLB). The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2008, CLIN NUTR, V27, P545, DOI 10.1016/j.clnu.2008.01.005; Bailey SR, 2007, JAVMA-J AM VET MED A, V231, P1365, DOI 10.2460/javma.231.9.1365; Banks WA, 2001, J CLIN ENDOCR METAB, V86, P4315, DOI 10.1210/jc.86.9.4315; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S; Bray George A., 1997, Human Reproduction (Oxford), V12, P26; Brown JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145673; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Clubb R., 2002, REPORT COMMISSIONED; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Diez JJ, 2005, CLIN ENDOCRINOL, V62, P242, DOI 10.1111/j.1365-2265.2005.02207.x; DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009; Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fors H, 1999, J CLIN ENDOCR METAB, V84, P3586, DOI 10.1210/jc.84.10.3586; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; GARCIA MC, 1986, AM J VET RES, V47, P570; Garnsworthy PC, 2008, J DAIRY SCI, V91, P3824, DOI 10.3168/jds.2008-1032; German AJ, 2009, DOMEST ANIM ENDOCRIN, V37, P214, DOI 10.1016/j.domaniend.2009.07.001; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152490; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HARTZ AJ, 1979, INT J OBESITY, V3, P57; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P788, DOI 10.1152/japplphysiol.01219.2001; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150331; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Houck R., 1993, CURRENT THERAPY, V3, P453; Irvine L. M., 2003, CURR OBSTET GYNAECOL, V13, P179, DOI [DOI 10.1016/S0957-5847(03)00005-2, 10.1016/S0957-5847(03)00005-2]; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P271, DOI 10.1016/S0749-0739(02)00006-8; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Lin EJD, 2015, PSYCHONEUROENDOCRINO, V51, P318, DOI 10.1016/j.psyneuen.2014.10.007; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Meehan CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146703; Mikota S.K., 1994, W BLOOMFIELD; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Nonogaki K, 2007, ENDOCRINOLOGY, V148, P4658, DOI 10.1210/en.2007-0296; Ostlund RE, 1996, J CLIN ENDOCR METAB, V81, P3909, DOI 10.1210/jc.81.11.3909; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; PASQUALI R, 1993, CLIN ENDOCRINOL, V39, P1, DOI 10.1111/j.1365-2265.1993.tb01744.x; Pickup JC, 2000, CLIN ENDOCRINOL, V52, P107, DOI 10.1046/j.1365-2265.2000.00921.x; Prado-Oviedo NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154750; Ralston SL, 2002, VET CLIN N AM-EQUINE, V18, P295, DOI 10.1016/S0749-0739(02)00014-7; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Treiber KH, 2006, JAVMA-J AM VET MED A, V228, P1538, DOI 10.2460/javma.228.10.1538; Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016; Wadha PS, 1986, AM J CLIN NUTR, V5, P551; YKIJARVINEN H, 1992, ENDOCR REV, V13, P415, DOI 10.1210/er.13.3.415	59	12	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188701	10.1371/journal.pone.0188701	http://dx.doi.org/10.1371/journal.pone.0188701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186207	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900053
J	Bodhini, D; Gaal, S; Shatwan, I; Ramya, K; Ellahi, B; Surendran, S; Sudha, V; Anjana, MR; Mohan, V; Lovegrove, JA; Radha, V; Vimaleswaran, KS				Bodhini, Dhanasekaran; Gaal, Szilvia; Shatwan, Israa; Ramya, Kandaswamy; Ellahi, Basma; Surendran, Shelini; Sudha, Vasudevan; Anjana, Mohan R.; Mohan, Viswanathan; Lovegrove, Julie A.; Radha, Venkatesan; Vimaleswaran, Karani Santhanakrishnan			Interaction between TCF7L2 polymorphism and dietary fat intake on high density lipoprotein cholesterol	PLOS ONE			English	Article							BODY-MASS INDEX; URBAN-RURAL EPIDEMIOLOGY; TYPE-2 DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; LIFE-STYLE FACTORS; POSTPRANDIAL LIPEMIA; COMMON VARIANTS; FIBER INTAKE; OBESITY; RISK	Recent evidence suggests that lifestyle factors influence the association between the Melanocortin 4 receptor (MC4R) and Transcription Factor 7-Like 2 (TCF7L2) gene variants and cardio-metabolic traits in several populations; however, the available research is limited among the Asian Indian population. Hence, the present study examined whether the association between the MC4R single nucleotide polymorphism (SNP) (rs17782313) and two SNPs of the TCF7L2 gene (rs12255372 and rs7903146) and cardio-metabolic traits is modified by dietary factors and physical activity. This cross sectional study included a random sample of normal glucose tolerant (NGT) (n = 821) and participants with type 2 diabetes (T2D) (n = 861) recruited from the urban part of the Chennai Urban Rural Epidemiology Study (CURES). A validated food frequency questionnaire (FFQ) was used for dietary assessment and self-reported physical activity measures were collected. The threshold for significance was set at P = 0.00023 based on Bonferroni correction for multiple testing [(0.05/210 (3 SNPs x 14 outcomes x 5 lifestyle factors)]. After Bonferroni correction, there was a significant interaction between the TCF7L2 rs12255372 SNP and fat intake (g/day) (P-interaction = 0.0001) on high-density lipoprotein cholesterol (HDL-C), where the 'T' allele carriers in the lowest tertile of total fat intake had higher HDL-C (P = 0.008) and those in the highest tertile (P = 0.017) had lower HDL-C compared to the GG homozygotes. In a secondary analysis of SNPs with the subtypes of fat, there was also a significant interaction between the SNP rs12255372 and polyunsaturated fatty acids (PUFA, g/day) (P-interaction < 0.0001) on HDL-C, where the minor allele carriers had higher HDL-C in the lowest PUFA tertile (P = 0.024) and those in the highest PUFA tertile had lower HDL-C (P = 0.028) than GG homozygotes. In addition, a significant interaction was also seen between TCF7L2 SNP rs12255372 and fibre intake (g/ day) on HDL-C (P-interaction < 0.0001). None of the other interactions between the SNPs and lifestyle factors were statistically significant after correction for multiple testing. Our findings indicate that the association between TCF7L2 SNP rs12255372 and HDL-C may be modified by dietary fat intake in this Asian Indian population.	[Bodhini, Dhanasekaran; Ramya, Kandaswamy; Radha, Venkatesan] Madras Diabet Res Fdn, Dept Mol Genet, Madras, Tamil Nadu, India; [Gaal, Szilvia; Shatwan, Israa; Surendran, Shelini; Lovegrove, Julie A.; Vimaleswaran, Karani Santhanakrishnan] Univ Reading, Hugh Sinclair Unit Human Nutr, Reading, Berks, England; [Gaal, Szilvia; Shatwan, Israa; Surendran, Shelini; Lovegrove, Julie A.; Vimaleswaran, Karani Santhanakrishnan] Univ Reading, Dept Food & Nutr Sci, ICMR, Reading, Berks, England; [Ellahi, Basma] Univ Chester, Fac Hlth & Social Care, Chester, Cheshire, England; [Sudha, Vasudevan] Madras Diabet Res Fdn, Dept Foods Nutr & Dietet Res, Madras, Tamil Nadu, India; [Anjana, Mohan R.; Mohan, Viswanathan] Madras Diabet Res Fdn, Dept Diabetol, Madras, Tamil Nadu, India; [Anjana, Mohan R.; Mohan, Viswanathan] WHO Collaborating Ctr Noncommunicable Dis Prevent, Dr Mohans Diabet Specialties Ctr, Madras, Tamil Nadu, India	Madras Diabetes Research Foundation; University of Reading; University of Reading; University of Chester; Madras Diabetes Research Foundation; Madras Diabetes Research Foundation	Vimaleswaran, KS (corresponding author), Univ Reading, Hugh Sinclair Unit Human Nutr, Reading, Berks, England.; Vimaleswaran, KS (corresponding author), Univ Reading, Dept Food & Nutr Sci, ICMR, Reading, Berks, England.	v.karani@reading.ac.uk	Shatwan, Israa/AAS-8199-2021; Dhanasekaran, Bodhini/AAZ-6533-2020	Shatwan, Israa/0000-0003-0222-9135; Dhanasekaran, Bodhini/0000-0001-7194-0639; Surendran, Shelini/0000-0001-9723-1937; Karani, Vimal/0000-0002-8485-8930	British Nutrition Foundation; Lady Tata Memorial Trust, Mumbai; Chennai Wellingdon Corporate Foundation [CURES-148]	British Nutrition Foundation; Lady Tata Memorial Trust, Mumbai; Chennai Wellingdon Corporate Foundation	The study was supported by the British Nutrition Foundation and Lady Tata Memorial Trust, Mumbai. The Chennai Wellingdon Corporate Foundation supported the CURES field studies (CURES-148).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson JW, 2004, J AM COLL NUTR, V23, P5, DOI 10.1080/07315724.2004.10719338; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Anjana RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-26; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Brown L, 1999, AM J CLIN NUTR, V69, P30; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Choi H, 2012, NUTR RES, V32, P100, DOI 10.1016/j.nutres.2011.12.013; Corella D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052344; Deepa M, 2003, J Assoc Physicians India, V51, P863; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Hindy G, 2012, DIABETOLOGIA, V55, P2646, DOI 10.1007/s00125-012-2634-x; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mattei J, 2012, AM J CLIN NUTR, V96, P1129, DOI 10.3945/ajcn.112.038125; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Mohan V, 2006, J Assoc Physicians India, V54, P685; Mohan V, 2007, DIABETES OBES METAB, V9, P337, DOI 10.1111/j.1463-1326.2006.00612.x; Norby FL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151932; Phillips CM, 2012, J NUTR BIOCHEM, V23, P239, DOI 10.1016/j.jnutbio.2010.11.020; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rasmussen O, 1996, AM J CLIN NUTR, V63, P249, DOI 10.1093/ajcn/63.2.249; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Research ICoM, 2010, NUTR REQ REC DIET AL; Riccardi G., 2006, Scandinavian Journal of Food & Nutrition, V50, P99, DOI 10.1080/17482970600783067; Silva FM, 2013, NUTR REV, V71, P790, DOI 10.1111/nure.12076; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Sudha V, 2006, INT J FOOD SCI NUTR, V57, P481, DOI 10.1080/09637480600969220; Sull JW, 2013, ENDOCRINE, V44, P675, DOI 10.1007/s12020-013-9909-y; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Thomsen C, 2003, AM J CLIN NUTR, V77, P605, DOI 10.1093/ajcn/77.3.605; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Vasan SK, 2012, OBESITY, V20, P2268, DOI 10.1038/oby.2012.64; Vimaleswaran KS, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0098-6; Vimaleswaran KS, 2012, HUM MOL GENET, V21, P4537, DOI 10.1093/hmg/dds283; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Warodomwichit D, 2009, J NUTR, V139, P439, DOI 10.3945/jn.108.096461; Wirstrom T, 2013, AM J CLIN NUTR, V97, P179, DOI 10.3945/ajcn.112.045583; Yanai Hidekatsu, 2014, J Clin Med Res, V6, P321, DOI 10.14740/jocmr1884w; Zhang L, 2009, J ATHEROSCLER THROMB, V16, P463, DOI 10.5551/jat.No1347; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188382	10.1371/journal.pone.0188382	http://dx.doi.org/10.1371/journal.pone.0188382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182660	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000416402000023
J	Marrama, G; Kriwet, J				Marrama, Giuseppe; Kriwet, Juergen			Principal component and discriminant analyses as powerful tools to support taxonomic identification and their use for functional and phylogenetic signal detection of isolated fossil shark teeth	PLOS ONE			English	Article							MORPHOLOGICAL DIVERSIFICATION; MULTIVARIATE-ANALYSIS; EOCENE; FISHES; CHONDRICHTHYES; BOLCA; MORPHOSPACE; NICHE; GENUS	Identifying isolated teeth of fossil selachians only based on qualitative characters is sometimes hindered by similarity in their morphology, resulting often in heated taxonomic debates. On the other hand, the use of quantitative characters (i.e. measurements) has been often neglected or underestimated in characterization and identification of fossil teeth of selachians. Here we show that, employing a robust methodological protocol based on principal component and discriminant analyses on a sample of 175 isolated fossil teeth of lamniform sharks, the traditional morphometrics can be useful to support and complement the classic taxonomic identification made on qualitative features. Furthermore, we show that discriminant analysis can be successfully useful to assign indeterminate isolated shark teeth to a certain taxon. Finally, the degree of separation of the clusters might be used to predict functional and probably also phylogenetic signals in lamniform shark teeth. However, this needs to be tested in the future employing teeth of more extant and extinct lamniform sharks and it must be pointed out that this approach does not replace in any way the qualitative analysis, but it is intended to complement and support it.	[Marrama, Giuseppe; Kriwet, Juergen] Univ Vienna, Dept Palaeontol, Vienna, Austria	University of Vienna	Marrama, G (corresponding author), Univ Vienna, Dept Palaeontol, Vienna, Austria.	giuseppe.marrama@univie.ac.at	Marramà, Giuseppe/J-2605-2019; Marramà, Giuseppe/L-4093-2019	Marramà, Giuseppe/0000-0002-7856-5605; Kriwet, Jurgen/0000-0002-6439-8455	Austrian Federal Ministry of Science, Research and Economy [Ernst Mach grant] [ICM-2016-03318]; University of Vienna	Austrian Federal Ministry of Science, Research and Economy [Ernst Mach grant]; University of Vienna	The research was supported by the Austrian Federal Ministry of Science, Research and Economy [Ernst Mach grant ICM-2016-03318 to G.M.]. Open access funding was provided by University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Roberto Zorzin and Anna Vaccari (Museo Civico di Storia Naturale di Verona), Massimo Cerato (Museo dei Fossili di Bolca), Mariagabriella Fornasiero (Museo di Geologia e Paleontologia dell'Universita di Padova), Emma Bernard (Natural History Museum, London), Anja Palandacic (Naturhistorisches Museum, Vienna), Susanne Futing and Wolfram Eckloff (Museum fur Natur and Umwelt, Lubeck) for the facilities and access to fossil material under their care. Thanks are also due to Stefano Castelli (Universita degli Studi di Padova), Joseph Cawley and Iris Fuchs (University of Vienna) and Kevin Webb (Natural History Museum, London) for some of the photographs. The manuscript has been greatly improved by the valuable reviews of Charlie J. Underwood (University of London) and Giorgio Carnevale (University degli Studi di Torino), and editorial comments from Fabrizio Frontalini. Open access funding was provided by University of Vienna.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Adnet S, 2006, ACTA PALAEONTOL POL, V51, P477; Agassiz L., 1833, RECHERCHES POISSONS; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Apuan Dennis A., 2010, Egyptian Academic Journal of Biological Sciences B Zoology, V2, P27; Arbour JH, 2014, METHODS ECOL EVOL, V5, P16, DOI 10.1111/2041-210X.12128; Bartolini Lucenti S, 2016, QUATERNARY SCI REV, V162, P12; Belben RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178294; Bock W.J., 2004, J ZOOLOGICAL SYSTEMA, V42, P172; Bose R, 2013, P NATL A SCI INDIA B, V83, P533, DOI 10.1007/s40011-013-0179-5; Brito Paulo M., 2004, P101; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Cappetta H., 1987, HDB PALEOICHTHYOLOGY; Cappetta H., 2012, HDB PALAEOICHTHYOLOG; Cappetta Henri, 2005, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V75, P237; Cavin L, 2007, PALAEOGEOGR PALAEOCL, V245, P353, DOI 10.1016/j.palaeo.2006.08.010; Chiapella J, 2000, BOT J LINN SOC, V134, P495, DOI [10.1006/bojl.2000.0343, 10.1111/j.1095-8339.2000.tb00547.x]; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Compagno L.J.V., 2005, FIELD GUIDE SHARKS W; Compagno LJV, 1999, SHARKS, SKATES, AND RAYS, P1; Compagno LJV., 1984, FAO FISH SYNOP, P20; Csiky J, 2010, PRESLIA, V82, P247; Cucchi T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160997; Davis J.C., 1986, STAT DATA ANAL GEOLO; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; Farre M, 2013, ECOL INDIC, V29, P159, DOI 10.1016/j.ecolind.2012.12.005; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Frederich B, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1556; Frey L, 2016, PALAEONTOL ELECTRON, V19; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Froese R, 2017, WORLD WIDE WEB ELECT; Gotelli NJ, 2013, ECOSIMR 1 00; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper D.A., 1999, NUMERICAL PALAEOBIOL, DOI [10.5772/intechopen.73573, DOI 10.5772/INTECHOPEN.73573]; Hedrick BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069265; Herrera M, 1996, SMALL RUMINANT RES, V22, P39, DOI 10.1016/0921-4488(96)00863-2; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hovestadt Dirk C., 2010, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V17, P57; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Janekovi F, 2012, PRINCIPAL COMPONENT, P127; Kriwet J, 2015, ACTA PALAEONTOL POL, V60, P858, DOI 10.4202/app.00066.2014; Kucharczyk H, 2009, ACTA ZOOL ACAD SCI H, V55, P349; Legendre P., 2012, NUMERICAL ECOLOGY; Lilburn TG, 2004, INT J SYST EVOL MICR, V54, P7, DOI 10.1099/ijs.0.02749-0; Maisch Harry M., 2014, Paludicola, V9, P183; Marrama G, 2016, B SOC PALEONTOL ITAL, V55, P139, DOI 10.4435/BSPI.2016.13; Marrama G, PALAONTOL Z; MARRAMA G, 2016, PALAEOGEOGR PALAEOCL, V454, P228, DOI DOI 10.1016/J.PALAEO.2016.04.021; Marrama G, 2017, HIST BIOL; Marrama G, 2017, J SYST PALAEONTOL; Marrama G, 2017, ZOOL J LINN SOC-LOND, V181, P209, DOI 10.1093/zoolinnean/zlw029; Marrama G, 2017, RIV ITAL PALEONTOL S, V123, P219, DOI 10.13130/2039-4942/8328; Marrama G, 2016, B SOC PALEONTOL ITAL, V55, P11, DOI 10.4435/BSPI.2016.02; Marrama G, 2016, CRETACEOUS RES, V61, P34, DOI 10.1016/j.cretres.2015.12.022; Marrama G, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1014490; Martin AP, 2002, MOL PHYLOGENET EVOL, V23, P205, DOI 10.1016/S1055-7903(02)00001-5; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Naylor Gavin J. P., 1997, P199, DOI 10.1016/B978-012417540-2/50014-2; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Nyberg KG, 2006, J VERTEBR PALEONTOL, V26, P806, DOI 10.1671/0272-4634(2006)26[806:TTAOTG]2.0.CO;2; Purdy RW, 2007, J VERTEBR PALEONTOL, V27, P798, DOI 10.1671/0272-4634(2007)27[798:ODOTIL]2.0.CO;2; Reyment R.A., 1999, ASPECTS MULTIVARIATE; Robertson M. P., 2001, Diversity and Distributions, V7, P15, DOI 10.1046/j.1472-4642.2001.00094.x; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; Rojas C, 2008, MYCOLOGIA, V100, P843, DOI 10.3852/07-197; Sanguansat P, 2012, APPL PCA TAXONOMY RE, P111; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Shimada Kenshu, 2005, Paleontological Research, V9, P55, DOI 10.2517/prpsj.9.55; Siversson M, 2015, ACTA PALAEONTOL POL, V60, P339, DOI 10.4202/app.2012.0137; Smith DK, 1998, J VERTEBR PALEONTOL, V18, P126, DOI 10.1080/02724634.1998.10011039; Sokal RR, 1995, BIOMETRY PRINCIPLES; Takacs P., 2012, INT J LIMNOL, V48, P53; Underwood CJ, 2006, PALEOBIOLOGY, V32, P215, DOI 10.1666/04069.1; Valiranta M, 2007, ANN BOT FENN, V44, P213; Vela E, 2007, PLANT MOL BIOL REP, V25, P83, DOI 10.1007/s11105-007-0009-0; Walker JA, 2010, INTEGR COMP BIOL, V50, P1051, DOI 10.1093/icb/icq014; Wang MR, 2015, ECOL EVOL, V5, P567, DOI 10.1002/ece3.1386; Whitenack LB, 2010, J VERTEBR PALEONTOL, V30, P17, DOI 10.1080/02724630903409055; Wolff RL, 1997, TREES-STRUCT FUNCT, V12, P113; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; [No title captured]	83	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188806	10.1371/journal.pone.0188806	http://dx.doi.org/10.1371/journal.pone.0188806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182683	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000057
J	Haffner-Luntzer, M; Kovtun, A; Fischer, V; Prystaz, K; Hainzl, A; Kroeger, CM; Krikki, I; Brinker, TJ; Ignatius, A; Gatzka, M				Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Hainzl, Adelheid; Kroeger, Carsten M.; Krikki, Ioanna; Brinker, Titus J.; Ignatius, Anita; Gatzka, Martina			Loss of p53 compensates osteopenia in murine Mysm1 deficiency	FASEB JOURNAL			English	Article						bone; epigenetics; mesenchymal stem cell; osteoblasts	NEGATIVE REGULATOR; BONE; DIFFERENTIATION; HEMATOPOIESIS; PROLIFERATION; CONTRIBUTES; EXPRESSION; OSTERIX	Histone modifications critically contribute to the epigenetic orchestration of bone homeostasis-in part, by modifying the access of transcription factors to specific genes involved in the osteogenic differentiation process of bone marrow mesenchymal stem cells (MSCs) and osteoblasts. Based on our previous finding that histone H2A deubiquitinase 2A-DUB/Mysm1 interacts with the p53 axis in hematopoiesis and tissue development, we analyzed the molecular basis of the skeletal phenotype of Mysm1-deficient mice and dissected the underlying p53-dependent and -independent mechanisms. Visible morphologic, skeletal deformations of young Mysm1-deficient mice-including a kinked and truncated tail and shortened long bones-were associated with osteopenia of long bones. On the cellular level, Mysm1-deficient primary osteoblasts displayed reduced potential to differentiate into mature osteoblasts, as indicated by decreased expression of osteogenic markers. Reduced osteogenic differentiation capacity of Mysm1-deficient osteoblasts was accompanied by an impaired induction of osteogenic transcription factor Runx2. Osteogenic differentiation of Mysm1(-/-) MSCs, however, was not compromised in vitro. In line with defective hematopoietic development of Mysm1-deficient mice, Mysm1(-/-) osteoclasts had reduced resorption activity and were more prone to apoptosis in TUNEL assays. Skeletal alterations and osteopenia of Mysm1-deficient mice were phenotypically completely rescued by simultaneous ablation of p53 in p53(-/-)Mysm1(-/-) double-deficient mice-although p53 deficiency did not restore Runx2 expression in Mysm1(-/-) osteoblasts on the molecular level but, instead, enhanced proliferation and osteogenic differentiation of MSCs. In summary, our results demonstrate novel roles for Mysm1 in osteoblast differentiation and osteoclast formation, resulting in osteopenia in Mysm1-deficient mice that could be abrogated by the loss of p53 from increased osteogenic differentiation of Mysm1(-/-)p53(-/-) MSCs.	[Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Ignatius, Anita] Univ Ulm, Trauma Res Ctr, Ulm, Germany; [Hainzl, Adelheid; Kroeger, Carsten M.; Krikki, Ioanna; Gatzka, Martina] Univ Ulm, Dept Dermatol & Allerg Dis, James Franck Ring 11C,N27, D-89081 Ulm, Germany; [Brinker, Titus J.] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany; [Brinker, Titus J.] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany	Ulm University; Ulm University; Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gatzka, M (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, James Franck Ring 11C,N27, D-89081 Ulm, Germany.	martina.gatzka@uni-ulm.de	Vikman, Anna/F-1115-2017; Fischer, Verena/GVU-3636-2022; Ignatius, Anita/M-6012-2013; Haffner-Luntzer, Melanie/L-3562-2019	Ignatius, Anita/0000-0002-4782-1979; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Vikman, Anna/0000-0001-8531-9712; Fischer, Verena/0000-0001-7039-8008	German Research Foundation (DFG) [CRC1149]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by grants from the German Research Foundation (DFG) to A.I. (CRC1149) and M.G. The authors declare no conflicts of interest.	Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bahrami E, 2017, J ALLERGY CLIN IMMUN, V140, P1112, DOI 10.1016/j.jaci.2016.10.053; Belle JI, 2016, CELL DEATH DIFFER, V23, P759, DOI 10.1038/cdd.2015.140; Belle JI, 2015, BLOOD, V125, P2344, DOI 10.1182/blood-2014-05-574111; Coudert AE, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/372156; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Gatzka M, 2015, CELL DEATH DIFFER, V22, P1451, DOI 10.1038/cdd.2014.231; Hayase Y, 1997, EXP HEMATOL, V25, P19; He YL, 2015, STEM CELLS, V33, P1304, DOI 10.1002/stem.1925; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kemmler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131194; Le Guen T, 2015, J ALLERGY CLIN IMMUN, V136, P1619, DOI 10.1016/j.jaci.2015.06.008; Li P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22211; Liedert A, 2006, BIOCHEM BIOPH RES CO, V342, P1070, DOI 10.1016/j.bbrc.2006.02.063; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nijnik A, 2012, BLOOD, V119, P1370, DOI 10.1182/blood-2011-05-352666; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petrov JC, 2017, EXP HEMATOL, V47, P76, DOI 10.1016/j.exphem.2016.10.013; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rapp AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147465; Rauch DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015755; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tautzenberger A, 2011, BIOMATERIALS, V32, P1706, DOI 10.1016/j.biomaterials.2010.10.053; Tu QS, 2006, BIOCHEM BIOPH RES CO, V341, P1257, DOI 10.1016/j.bbrc.2006.01.092; Velletri T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.367; Wang T, 2013, BLOOD, V122, P2812, DOI 10.1182/blood-2013-03-489641; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Wilms C, 2017, ONCOTARGET, V8, P67287, DOI 10.18632/oncotarget.18617; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Zauli G, 2007, J BONE MINER RES, V22, P1621, DOI 10.1359/JBMR.070618; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	38	13	14	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1957	1968		10.1096/fj.201700871R	http://dx.doi.org/10.1096/fj.201700871R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203593				2022-12-26	WOS:000429051400018
J	Ranieri, M; Zahedi, K; Tamma, G; Centrone, M; Di Mise, A; Soleimani, M; Valenti, G				Ranieri, Marianna; Zahedi, Kamyar; Tamma, Grazia; Centrone, Mariangela; Di Mise, Annarita; Soleimani, Manoocher; Valenti, Giovanna			CaSR signaling down-regulates AQP2 expression via a novel microRNA pathway in pendrin and NaCl cotransporter knockout mice	FASEB JOURNAL			English	Article						water channel; miRNA-137; p38-MAPK; hypercalciuria	CALCIUM-SENSING RECEPTOR; RENAL COLLECTING DUCT; CL-COTRANSPORTER; AQUAPORIN-2 EXPRESSION; PLASMA-MEMBRANE; VASOPRESSIN; KIDNEY; MOUSE; PHOSPHORYLATION; CHANNEL	High concentrations of urinary calcium counteract vasopressin action via the activation of the calcium-sensing receptor (CaSR) that is expressed in the luminal membrane of collecting duct cells, which impairs the trafficking of aquaporin-2 (AQP2). Pendrin/NaCl cotransporter double-knockout (dKO) mice display significant calcium wasting and develop severe volume depletion, despite increased circulating vasopressin levels. We hypothesized that the CaSR-mediated impairment of AQP2 expression/trafficking underlies vasopressin resistance in dKO mice. Compared with wild-type mice, in renal inner medulla, dKO mice had reduced total AQP2 sensitive to proteasome inhibitors, higher levels of AQP2-pS261, ubiquitinated AQP2, and p38-MAPK, an enzyme that is activated by CaSR signaling and known to phosphorylate AQP2 at Ser261. CaSR inhibition with the calcilytic NPS2143 reversed these effects, which indicates that CaSR mediates the up-regulation of AQP2-pS261, ubiquitination, and degradation. Of note, dKO mice demonstrated significantly higher AQP2-targeting miRNA-137 that was reduced upon CaSR inhibition, supporting a critical role for CaSR in the down-regulation of AQP2 expression. Our data indicate that CaSR signaling reduces AQP2 abundance both via AQP2-targeting miRNA-137 and the p38-MAPK/AQP2-pS261/ubiquitination/proteasomal axis. These effects may contribute to the reduced renal concentrating ability that has been observed in dKO mice and underscore a physiologic mechanism of the CaSR-dependent regulation of AQP2 abundance via a novel microRNA pathway.	[Ranieri, Marianna; Tamma, Grazia; Centrone, Mariangela; Di Mise, Annarita; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4,Amendola 165-A, I-70125 Bari, Italy; [Valenti, Giovanna] Univ Bari, Ctr Excellence Comparat Genom, Bari, Italy; [Zahedi, Kamyar; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Zahedi, Kamyar; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH USA; [Zahedi, Kamyar; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH USA; [Tamma, Grazia; Valenti, Giovanna] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Valenti, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4,Amendola 165-A, I-70125 Bari, Italy.	giovanna.valenti@uniba.it	Zahedi, Kamyar/AAQ-3428-2021; Ranieri, Marianna/J-9421-2018; Di Mise, Annarita/AAP-4176-2020	Ranieri, Marianna/0000-0003-3118-5813; DI MISE, Annarita/0000-0002-8132-4917; Tamma, Grazia/0000-0002-8890-0278	"Intervento cofinanziato dal Fondo di Sviluppo e Coesione APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch"; Telethon [GGP13227]; Italian Space Agency (ASI) [2013-091-R.0]; Progetti di Rilevante Interesse Nazionale (PRIN) [01373409]; Merit Review Award [2IO1BX001000, 12111o18]	"Intervento cofinanziato dal Fondo di Sviluppo e Coesione APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch"(Regione Puglia); Telethon(Fondazione Telethon); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Merit Review Award(US Department of Veterans Affairs)	The authors thank Elena Ciani (University of Bari) for assistance with real-time PCR experiments. M.R. is a postdoctoral research fellow supported by "Intervento cofinanziato dal Fondo di Sviluppo e Coesione 2007-2013-APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch." This study was supported, in part, by Telethon funding (GGP13227) and by Italian Space Agency (ASI; 2013-091-R.0 to G.V.), by Progetti di Rilevante Interesse Nazionale (PRIN; 01373409 to G.T.), and by Merit Review Award 2IO1BX001000 (Grant 12111o18 to M.S.). The authors declare no conflicts of interest.	Abdullah HI, 2008, AM J PHYSIOL-RENAL, V295, pF1082, DOI 10.1152/ajprenal.90316.2008; Amlal H, 2010, AM J PHYSIOL-CELL PH, V299, pC33, DOI 10.1152/ajpcell.00033.2010; Boone M, 2011, AM J PHYSIOL-RENAL, V300, pF761, DOI 10.1152/ajprenal.00247.2010; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 1996, NEPHROL DIAL TRANSPL, V11, P1967, DOI 10.1093/oxfordjournals.ndt.a027081; Di Mise A, 2015, AM J PHYSIOL-RENAL, V308, pF1200, DOI 10.1152/ajprenal.00352.2014; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; Ellison DH, 2003, J AM SOC NEPHROL, V14, P538, DOI 10.1681/ASN.V142538; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Gkika D, 2006, J AM SOC NEPHROL, V17, P3020, DOI 10.1681/ASN.2006060676; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; Graca JAZ, 2016, AM J PHYSIOL-RENAL, V310, pF518, DOI 10.1152/ajprenal.00208.2015; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Maiti A, 2008, J BIOL CHEM, V283, P175, DOI 10.1074/jbc.M707269200; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Murer L, 2004, J AM SOC NEPHROL, V15, P2705, DOI 10.1097/01.ASN.0000139689.94776.7A; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033145; Puliyanda DP, 2003, BIOCHEM BIOPH RES CO, V303, P52, DOI 10.1016/S0006-291X(03)00215-8; Ranieri M, 2015, J CELL SCI, V128, P2350, DOI 10.1242/jcs.168096; Ranieri M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079113; Riccardi D, 2016, NAT REV NEPHROL, V12, P414, DOI 10.1038/nrneph.2016.59; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Sansoe G, 2010, J HEPATOL, V53, P856, DOI 10.1016/j.jhep.2010.05.021; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Soleimani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159804; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; Tamma G, 2003, J CELL SCI, V116, P3285, DOI 10.1242/jcs.00640; Tamma G, 2014, J BIOL CHEM, V289, P27807, DOI 10.1074/jbc.M114.586024; Tamma G, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-133; Tamma G, 2013, CELL PHYSIOL BIOCHEM, V32, P200, DOI 10.1159/000356639; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tfelt-Hansen J, 2005, GROWTH FACTORS, V23, P117, DOI 10.1080/08977190500126272; Trepiccione F, 2014, KIDNEY INT, V86, P757, DOI 10.1038/ki.2014.107; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Valenti G, 2010, CELL PHYSIOL BIOCHEM, V26, P901, DOI 10.1159/000323999; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Wall SM, 2008, CURR OPIN NEPHROL HY, V17, P18, DOI 10.1097/MNH.0b013e3282f29086; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282	66	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2148	2159		10.1096/fj.201700412RR	http://dx.doi.org/10.1096/fj.201700412RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29212817				2022-12-26	WOS:000429051400034
J	Hsu, SHC; Nadesan, P; Puviindran, V; Section, WBS; Kirsch, DG; Alman, BA				Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Section, William B. Stallcup; Kirsch, David G.; Alman, Benjamin A.			Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY-BASED IMMUNOTHERAPY; FACTOR-BINDING PROTEIN-3; PDGF ALPHA-RECEPTOR; FACTOR I RECEPTOR; ANTIGEN HMW-MAA; NG2 PROTEOGLYCAN; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; CELL-SURFACE; FACTORS IGFS	Sarcomas, and the mesenchymal precursor cells from which they arise, express chondroitin sulfate proteoglycan 4 (NG2/CSPG4). However, NG2/CSPG4's function and its capacity to serve as a therapeutic target in this tumor type are unknown. Here, we used cells from human tumors and a genetically engineered autochthonous mouse model of soft-tissue sarcomas (STSs) to determine NG2/CSPG4's role in STS initiation and growth. Inhibiting NG2/CSPG4 expression in established murine and human STSs decreased tumor volume by almost two-thirds and cell proliferation rate by 50%. NG2/CSPG4 antibody immunotherapy in human sarcomas established as xenografts in mice similarly decreased tumor volume, and expression of a lentivirus blocking NG2/CSPG4 expression inhibited tumor cell proliferation and increased the latency of engraftment. Gene profiling showed that Ng2/Cspg4 deletion altered the expression of genes regulating cell proliferation and apoptosis. Surprisingly, Ng2/Cspg4 deletion at the time of tumor initiation resulted in larger tumors. Gene expression profiling indicated substantial down-regulation of insulin-like growth factor binding protein (Igfbp) genes when Ng2/Cspg4 is depleted at tumor initiation, but not when Ng2/Cspg4 is depleted after tumor initiation. Such differences may have clinical significance, as therapeutic targeting of a signaling pathway such as NG2/CSPG4 may have different effects on cell behavior with tumor progression. NG2/CSPG4 depletion has divergent effects, depending on the developmental stage of sarcoma. In established tumors, IGF signaling is active, and NG2 inhibition targets cell proliferation and apoptosis.	[Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Alman, Benjamin A.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA; [Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Alman, Benjamin A.] Duke Univ, RegenerationNext Initiat, Durham, NC 27710 USA; [Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC 27710 USA; [Section, William B. Stallcup] Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA	Duke University; Duke University; Duke University; Sanford Burnham Prebys Medical Discovery Institute	Alman, BA (corresponding author), DUMC2888,200 Trent Dr,Orange Zone 5th Floor, Durham, NC 27710 USA.	ben.alman@duke.edu			NCI, National Institutes of Health [R01 CA183811]; NATIONAL CANCER INSTITUTE [R01CA183811] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant R01 CA183811. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benassi MS, 2009, J ORTHOP RES, V27, P135, DOI 10.1002/jor.20694; Borden EC, 2003, CLIN CANCER RES, V9, P1941; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Cattaruzza S, 2013, J MOL CELL BIOL, V5, P176, DOI 10.1093/jmcb/mjt010; Cattaruzza S, 2013, ANGIOGENESIS, V16, P309, DOI 10.1007/s10456-012-9316-7; Chang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030637; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Duan CM, 1999, J BIOL CHEM, V274, P37147, DOI 10.1074/jbc.274.52.37147; Fletcher CDM, 2014, MODERN PATHOL, V27, pS98, DOI 10.1038/modpathol.2013.172; Fottner C, 1999, HORM METAB RES, V31, P203, DOI 10.1055/s-2007-978720; Grako KA, 1999, J CELL SCI, V112, P905; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hollowood AD, 2000, INT J CANCER, V88, P336, DOI 10.1002/1097-0215(20001101)88:3<336::AID-IJC3>3.3.CO;2-1; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jin QR, 2014, CARCINOGENESIS, V35, P2232, DOI 10.1093/carcin/bgu129; Joo NE, 2008, CELL DEATH DIFFER, V15, P899, DOI 10.1038/cdd.2008.22; Joo NE, 2014, DNA CELL BIOL, V33, P854, DOI 10.1089/dna.2014.2399; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; KAGESHITA T, 1992, PIGM CELL RES, P132; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; King DM, 2009, CLIN ORTHOP RELAT R, V467, P2838, DOI 10.1007/s11999-009-0989-1; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lehnhardt M, 2009, LANGENBECK ARCH SURG, V394, P313, DOI 10.1007/s00423-008-0368-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Matushansky I, 2009, EXPERT REV ANTICANC, V9, P1135, DOI [10.1586/era.09.76, 10.1586/ERA.09.76]; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Mittelman A, 1995, CLIN CANCER RES, V1, P705; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nicolosi PA, 2015, THERANOSTICS, V5, P530, DOI 10.7150/thno.10824; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Petrovici Karin, 2010, Cancer Genomics & Proteomics, V7, P173; Poon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037940; Rivera Z, 2012, CLIN CANCER RES, V18, P5352, DOI 10.1158/1078-0432.CCR-12-0628; Sato S, 2016, CELL REP, V16, P917, DOI 10.1016/j.celrep.2016.06.058; Scotlandi K, 1996, CANCER RES, V56, P4570; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; VanderVen LTM, 1997, BRIT J CANCER, V75, P1631, DOI 10.1038/bjc.1997.278; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wagner S, 2008, CLIN CANCER RES, V14, P8178, DOI 10.1158/1078-0432.CCR-08-0371; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; Wang CYY, 2012, CANCER RES, V72, P1013, DOI 10.1158/0008-5472.CAN-11-2531; Wang J. -G., 2011, FRESHW FISH, V4, P6, DOI DOI 10.1371/J0URNAL.P0NE.0023062; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Wei QX, 2015, ONCOTARGET, V6, P40283, DOI 10.18632/oncotarget.5375; Williams AC, 2000, CANCER RES, V60, P22; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Yu L, 2011, IMMUNOL RES, V50, P294, DOI 10.1007/s12026-011-8232-z	59	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2466	2475		10.1074/jbc.M117.805051	http://dx.doi.org/10.1074/jbc.M117.805051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29196603	hybrid, Green Published			2022-12-26	WOS:000425308300019
J	Ha, BH; Boggon, TJ				Ha, Byung Hak; Boggon, Titus J.			The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; crystal structure; dimerization; protein kinase; PTEN-induced putative kinase (PINK1)	SIGNALING NETWORK; PROTEIN; PHOSPHORYLATION; SGK269/PEAK1; RECOGNITION; MECHANISMS; COMPLEX; LIVE	The pseudokinase group encompasses some 10% of protein kinases, but pseudokinases diverge from canonical kinases in key motifs. The two members of the small new kinase family 3 (NKF3) group are considered pseudokinases. These proteins, pseudopodium-enriched atypical kinase 1 (PEAK1, Sugen kinase 269, or SgK269) and pragmin (Sugen kinase 223 or SgK223), act as scaffolds in growth factor signaling pathways, and both contain a kinase fold with degraded kinase motifs at their C termini. These kinases may harbor regions that mediate oligomerization or control other aspects of signal transduction, but a lack of structural information has precluded detailed investigations into their functional roles. In this study, we determined the X-ray crystal structure of the PEAK1 pseudokinase domain to 2.3 resolution. The structure revealed that the PEAK1 kinase-like domain contains a closed nucleotide-binding cleft that in this conformation may deleteriously affect nucleotide binding. Moreover, we found that N- and C-terminal extensions create a highly unusual all -helical split-dimerization region, termed here the split helical dimerization (SHED) region. Sequence conservation analysis suggested that this region facilitates a dimerization mode that is conserved between PEAK1 and pragmin. Finally, we observed structural similarities between the PEAK1 SHED region and the C-terminal extension of the Parkinson's disease-associated kinase PINK1. In summary, PEAK1's kinase cleft is occluded, and its newly identified SHED region may promote an unexpected dimerization mode. Similarities of PEAK1 with the active kinase PINK1 may reclassify the latter as a member of the new kinase family 3 group.	[Ha, Byung Hak; Boggon, Titus J.] Yale Univ, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA; [Boggon, Titus J.] Yale Univ, Dept Mol Biophys & Biochem, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu			National Institutes of Health [R01NS085078, R01GM109487, R01GM114621, R01GM102262, S10OD018007]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM114621, R01GM102262, R01GM109487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01NS085078, R01GM109487, R01GM114621, R01GM102262, and S10OD018007. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agajanian M, 2015, BIOCHEM BIOPH RES CO, V465, P606, DOI 10.1016/j.bbrc.2015.08.071; Agajanian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135748; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bristow JM, 2013, J BIOL CHEM, V288, P123, DOI 10.1074/jbc.M112.410910; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Hamill S, 2016, MOL CELL, V62, P397, DOI 10.1016/j.molcel.2016.04.001; Hammaren HM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150226; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kelber JA, 2010, ONCOTARGET, V1, P219, DOI 10.18632/oncotarget.128; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2017, ELIFE, V6, DOI 10.7554/eLife.29985; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liu L, 2016, J BIOL CHEM, V291, P21571, DOI 10.1074/jbc.M116.748897; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Murphy JM, 2017, CURR OPIN STRUC BIOL, V47, P95, DOI 10.1016/j.sbi.2017.07.004; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ohara O, 2002, DNA RES, V9, P47, DOI 10.1093/dnares/9.2.47; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01279-9; Schubert AF, 2017, NATURE, V552, P51, DOI 10.1038/nature24645; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stiegler AL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00483-x; Strnadel J, 2017, CANCER RES, V77, P1997, DOI 10.1158/0008-5472.CAN-16-2594; Tactacan CM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0412-3; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	43	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1642	1650		10.1074/jbc.RA117.000751	http://dx.doi.org/10.1074/jbc.RA117.000751			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29212708	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000424201700016
J	Fattuoni, C; Pietrasanta, C; Pugni, L; Ronchi, A; Palmas, F; Barberini, L; Dessi, A; Pintus, R; Fanos, V; Noto, A; Mosca, F				Fattuoni, Claudia; Pietrasanta, Carlo; Pugni, Lorenza; Ronchi, Andrea; Palmas, Francesco; Barberini, Luigi; Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio; Mosca, Fabio			Urinary metabolomic analysis to identify preterm neonates exposed to histological chorioamnionitis: A pilot study	PLOS ONE			English	Article							EMPIRICAL ANTIBIOTIC-TREATMENT; HIGH-DIMENSIONAL BIOLOGY; EARLY-ONSET SEPSIS; CLINICAL CHORIOAMNIONITIS; INFANTS; BIRTH; MANAGEMENT; DISEASE; GUIDELINES; PATTERNS	Objective Chorioamnionitis is a leading cause of preterm birth worldwide, with higher incidence at lower gestational ages. An early and reliable diagnosis of histological chorioamnionitis (HCA) in preterm infants may be helpful in guiding postnatal management, especially the administration of prophylactic antibiotics to prevent early-onset sepsis. The main aim of this study was to investigate metabolomic analysis of urines collected in the first 24 hours of life as diagnostic tool of HCA. Methods Gestational age-, birth weight-, delivery mode-and sex-matched (1: 2) preterm neonates (< 35 weeks' gestation) born to mothers with or without HCA were enrolled from an observational study. Gas chromatography-mass spectrometry (GC-MS)-based metabolomic analysis was performed on urine samples non-invasively collected in the first 24 hours of life. Univariate analysis, partial least square discriminant analysis (PLS-DA) and its associated variable importance in projection (VIP) score were performed. The most affected metabolic pathways were examined by Metabolite Sets Enrichment Analysis (MSEA). Results Fifteen cases (mean GA 30.2 +/- 3.8 weeks, mean BW 1415 +/- 471.9 grams) and 30 controls (mean GA 30.2 +/- 2.9 weeks, mean BW 1426 +/- 569.8 grams) were enrolled. Following univariate analysis, 29 metabolites had a significantly different concentration between cases and controls. The supervised PLS-DA model confirmed a separation between the two groups. Only gluconic acid, an oxidation product of glucose, was higher in cases than in controls. All other VIP metabolites were more abundant in the control group. Glutamate metabolism, mitochondrial electron transport chain, citric acid cycle, galactose metabolism, and fructose and mannose degradation metabolism were the most significantly altered pathways (P < 0.01). Conclusions For the first time, urinary metabolomics was able to discriminate neonates born to mothers with and without HCA. The identification of specifically altered metabolic pathways may be helpful in understanding metabolic derangement following chorioamnionitis.	[Fattuoni, Claudia; Palmas, Francesco] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Pietrasanta, Carlo; Pugni, Lorenza; Ronchi, Andrea; Mosca, Fabio] Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Barberini, Luigi] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy; [Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio] AOUCA Univ Hosp Cagliari, Maternal Neonatal Dept, Neonatal Intens Care Unit, Puericulture Inst, Cagliari, Italy; [Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio] AOUCA Univ Hosp Cagliari, Neonatal Sect, Cagliari, Italy	University of Cagliari; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Cagliari	Pugni, L (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy.	lorenza.pugni@mangiagalli.it	Palmas, Francesco/AAV-8482-2021; pietrasanta, carlo/K-5786-2018; Fattuoni, Claudia/N-2843-2014; Fanos, Vassilios/AHI-0685-2022; Dessì, Angelica/AHD-9828-2022; Barberini, Luigi/Q-5870-2019; Barberini, Luigi/G-3669-2012; MOSCA, FABIO/C-5826-2017	Palmas, Francesco/0000-0001-8578-6871; pietrasanta, carlo/0000-0002-1019-4422; Fattuoni, Claudia/0000-0002-6956-7967; Barberini, Luigi/0000-0002-3815-0392; Barberini, Luigi/0000-0002-3815-0392; MOSCA, FABIO/0000-0001-6477-0299	Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia); Sardinia Regional Government (European Social Fund-Axis IV Human Resources)	Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia); Sardinia Regional Government (European Social Fund-Axis IV Human Resources)	Francesco Palmas was supported for his PhD scholarship by Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013-Axis IV Human Resources, Objective I.3, Line of Activity I.3.1.).	Abehsera D, 2014, PLACENTA, V35, P70, DOI 10.1016/j.placenta.2013.10.009; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Been JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046217; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Brady MT, 2013, PEDIATRICS, V132, P166, DOI 10.1542/peds.2013-1310; Buhimschi Irina A, 2013, Expert Opin Med Diagn, V7, P5, DOI 10.1517/17530059.2012.709232; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Cotten CM, 2015, CLIN PERINATOL, V42, P195, DOI 10.1016/j.clp.2014.10.007; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; De Angelis M, 2015, GUT MICROBES, V6, P207, DOI 10.1080/19490976.2015.1035855; Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868; Dudzik D, 2015, J PROTEOME RES, V14, P1432, DOI 10.1021/pr501087x; Fanos V, 2014, EARLY HUM DEV, V90, pS78, DOI 10.1016/S0378-3782(14)70024-6; Fanos V, 2013, EARLY HUM DEV, V89, pS58, DOI 10.1016/S0378-3782(13)70017-3; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kamath-Rayne BD, 2014, REPROD SCI, V21, P6, DOI 10.1177/1933719113485292; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Mukhopadhyay S, 2013, J PERINATOL, V33, P198, DOI 10.1038/jp.2012.96; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; Palmas F, 2016, J PEDIAT NEONAT INDI, V5; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Pugni L, 2016, J MATERN-FETAL NEO M, V29, P1525, DOI 10.3109/14767058.2015.1053862; Puopolo KM, 2013, CURR OPIN PEDIATR, V25, P161, DOI 10.1097/MOP.0b013e32835e1f96; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Soraisham AS, 2013, J PERINATOL, V33, P70, DOI 10.1038/jp.2012.49; Sung JH, 2017, BJOG-INT J OBSTET GY, V124, P775, DOI 10.1111/1471-0528.14176; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	44	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189120	10.1371/journal.pone.0189120	http://dx.doi.org/10.1371/journal.pone.0189120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211784	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200066
J	Schiavano, GF; Carloni, E; Andreoni, F; Magi, S; Chironna, M; Brandi, G; Amagliani, G				Schiavano, Giuditta Fiorella; Carloni, Elisa; Andreoni, Francesca; Magi, Silvia; Chironna, Maria; Brandi, Giorgio; Amagliani, Giulia			Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates	PLOS ONE			English	Article							MECHANISMS; MEROPENEM	Scope This study aimed to analyse the prevalence, antibiotic resistance and genetic relatedness of P. aeruginosa isolates obtained from potable and recreational water samples (n. 8,351) collected from different settings (swimming pools, n. 207; healthcare facilities, n 1,684; accommodation facilities, n. 1,518; municipal waterworks, n. 4,500; residential buildings, n. 235). Possible mechanisms underlying resistance to imipenem, with particular focus on those involving oprD-based uptake, were also explored. Methods and results Isolation and identification of Pseudomonas aeruginosa was performed according to the standardized procedure UNI EN ISO 16266:2008 followed by PCR confirmation. Antibiotic Susceptibility testing was conducted according to EUCAST standardized disk diffusion method. Genetic relatedness of strains was carried out by RAPD. The sequence of the oprD gene was analyzed by standard method. Fifty-three samples (0.63%) were positive for P. aeruginosa, of which 10/207 (4.83%) were from swimming pools. Five isolates (9.43%) were resistant to imipenem, one to Ticarcillin + Clavulanate, one to both Piperacillin and Ticarcillin + Clavulanate. The highest isolation rate of imipenem resistant P. aeruginosa was observed in swimming pool water. Identical RAPD profiles were found in isolates from the same location in the same year or even in different years. Conclusions Imipenem resistant strains were identified as carbapenemase-negative and resistance has been associated with inactivating mutations within the oprD gene, with a concomitant loss of porin. RAPD results proved that a water system can remain colonized by one strain for long periods and the contamination may be difficult to eradicate. This study has revealed the presence of P. aeruginosa in different water samples, including resistant strains, especially in swimming pools, and confirmed the role of porins as a contributing factor in carbapenem resistance in Gram-negative bacteria.	[Schiavano, Giuditta Fiorella; Brandi, Giorgio; Amagliani, Giulia] Univ Urbino Carlo Bo, Dept Biomol Sci, Toxicol Hygienist & Environm Sci Unit, Urbino, PU, Italy; [Carloni, Elisa; Andreoni, Francesca] Univ Urbino Carlo Bo, Sect Biotechnol, Dept Biomol Sci, Fano, PU, Italy; [Magi, Silvia] Dipartimento Prov ARPAM Pesaro, Serv Acque, Pesaro, Italy; [Chironna, Maria] Aldo Moro Univ Bari, Dept Biomed Sci & Human Oncol, Hyg Sect, Bari, Italy	University of Urbino; University of Urbino; Universita degli Studi di Bari Aldo Moro	Schiavano, GF (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Toxicol Hygienist & Environm Sci Unit, Urbino, PU, Italy.	giuditta.schiavano@uniurb.it	Francesca, Andreoni/G-7505-2012	Francesca, Andreoni/0000-0002-4857-8210; Schiavano, Giuditta Fiorella/0000-0002-1427-3486; chironna, maria/0000-0002-1043-1256; Carloni, Elisa/0000-0003-1178-9353				Amagliani G, 2013, MICROCHEM J, V110, P656, DOI 10.1016/j.microc.2013.08.001; Amagliani G, 2012, INT J ENVIRON HEAL R, V22, P60, DOI 10.1080/09603123.2011.588325; Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483; [Anonymous], 162662008 UNI EN ISO; ARMSTRONG JL, 1982, APPL ENVIRON MICROB, V44, P308, DOI 10.1128/AEM.44.2.308-316.1982; Bai XH, 2015, SCI TOTAL ENVIRON, V533, P24, DOI 10.1016/j.scitotenv.2015.06.082; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Berthelot P, 2005, PATHOL BIOL, V53, P341, DOI 10.1016/j.patbio.2004.09.006; Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z; Chalhoub H, 2016, INT J ANTIMICROB AG, V48, P740, DOI 10.1016/j.ijantimicag.2016.09.012; De Francesco MA, 2013, J INFECT PUBLIC HEAL, V6, P179, DOI 10.1016/j.jiph.2012.11.006; Cavalcanti FLD, 2015, MEM I OSWALDO CRUZ, V110, P1003, DOI 10.1590/0074-02760150233; European Centre for Disease Prevention and Control, 2017, ANN REP EUR ANT RES; Felfoldi T, 2010, ACTA MICROBIOL IMM H, V57, P165, DOI 10.1556/AMicr.57.2010.3.2; Figueira V, 2012, J WATER HEALTH, V10, P1, DOI 10.2166/wh.2011.002; Guida M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090919; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Huhulescu S, 2011, INFECTION, V39, P265, DOI 10.1007/s15010-011-0096-6; HUNTER PR, 1993, J APPL BACTERIOL, V74, P345, DOI 10.1111/j.1365-2672.1993.tb05137.x; Italian Republic, ACC STAT REG PROV AU; Kimata N, 2004, MICROBIAL ECOL, V47, P41, DOI 10.1007/s00248-003-1032-9; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Lefebvre A, 2017, J HOSP INFECT, V96, P238, DOI 10.1016/j.jhin.2016.12.007; Li H, 2012, INT J MED MICROBIOL, V302, P63, DOI 10.1016/j.ijmm.2011.10.001; LIVERMORE DM, 1992, ANTIMICROB AGENTS CH, V36, P2046, DOI 10.1128/AAC.36.9.2046; Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Ocampo-Sosa AA, 2012, ANTIMICROB AGENTS CH, V56, P1703, DOI 10.1128/AAC.05451-11; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Riera E, 2011, J ANTIMICROB CHEMOTH, V66, P2022, DOI 10.1093/jac/dkr232; Sanbongi Y, 2009, MICROBIOL IMMUNOL, V53, P361, DOI 10.1111/j.1348-0421.2009.00137.x; Sharma VK, 2016, CHEMOSPHERE, V150, P702, DOI 10.1016/j.chemosphere.2015.12.084; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Wolkowicz T, 2016, J GLOB ANTIMICROB RE, V7, P119, DOI 10.1016/j.jgar.2016.08.007; Wolter DJ, 2004, FEMS MICROBIOL LETT, V236, P137, DOI 10.1016/j.femsle.2004.05.039; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; YONEYAMA H, 1993, ANTIMICROB AGENTS CH, V37, P2385, DOI 10.1128/AAC.37.11.2385	40	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189172	10.1371/journal.pone.0189172	http://dx.doi.org/10.1371/journal.pone.0189172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211780	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200075
J	Spierenburg, EAJ; Smit, LAM; Krop, EJM; Heederik, D; Hylkema, MN; Wouters, IM				Spierenburg, Elisabeth A. J.; Smit, Lidwien A. M.; Krop, Esmeralda J. M.; Heederik, Dick; Hylkema, Machteld N.; Wouters, Inge M.			Occupational endotoxin exposure in association with atopic sensitization and respiratory health in adults: Results of a 5-year follow-up	PLOS ONE			English	Article							LUNG-FUNCTION DECLINE; ALLERGIC SENSITIZATION; DAIRY FARMERS	The objective of the present longitudinal study was to investigate the effects of occupational endotoxin exposure on respiratory health and atopic sensitization in adults. Health outcomes and personal endotoxin exposure estimates were determined for 234 farmers and agricultural workers both at baseline and 5 years later. A questionnaire was used to assess respiratory symptoms, spirometry tests were performed and total and specific IgE levels were measured in serum. A twofold increase in personal endotoxin exposure was associated with less hay fever (OR 0.68, 95% CI 0.54-0.87) and grass IgE positivity (OR 0.81, 95% CI 0.68-0.97) at both time points ("persistent" versus "never"). Although not statistically significant, a consistent protective pattern was observed for an increased loss of hay fever symptoms (OR 2.19, 95% CI 0.96-4.99) and grass IgE positivity (OR 1.24, 95% CI 0.76-2.02), and for less new-onset of hay fever (OR 0.87, 95% CI 0.65-1.17), grass IgE positivity (OR 0.83, 95% CI 0.61-1.12) and atopic sensitization (OR 0.75, 95% CI 0.55-1.02). Endotoxin exposure was not associated with changes in lung function. We showed that occupational endotoxin exposure is associated with a long-term protective effect on hay fever and grass IgE positivity. Results on longitudinal changes in hay fever, atopy and grass IgE positivity in adulthood were consistent with a protective effect of endotoxin exposure, but results need to be confirmed in larger cohorts. An effect of endotoxin exposure on lung function decline was not found.	[Spierenburg, Elisabeth A. J.; Smit, Lidwien A. M.; Krop, Esmeralda J. M.; Heederik, Dick; Wouters, Inge M.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Groningen, Netherlands	Utrecht University; University of Groningen; University of Groningen	Wouters, IM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	i.wouters@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Wouters, Inge M./0000-0001-7834-9390; Krop, Esmeralda/0000-0002-6009-1181; Heederik, Dick/0000-0002-4550-1437	Dutch Lung Foundation [3.2.09.036]	Dutch Lung Foundation	This work was supported by the Dutch Lung Foundation Grant Number 3.2.09.036, http://research.longfonds.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bolund AC, 2017, OCCUP ENV MED; Bolund ACS, 2015, OCCUP ENV MED; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Campbell BE, 2015, CLIN EXP ALLERGY, V45, P744, DOI 10.1111/cea.12429; Chaudemanche H, 2003, OCCUP ENVIRON MED, V60, P858, DOI 10.1136/oem.60.11.858; Depner M, 2015, J ALLERGY CLIN IMMUN; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; DOUWES J, 1995, APPL ENVIRON MICROB, V61, P1763, DOI 10.1128/AEM.61.5.1763-1769.1995; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elholm G, 2013, J ALLERGY CLIN IMMUN, V132, P1239, DOI 10.1016/j.jaci.2013.07.003; Gaint M, 2007, EUR RESPIR J, V30, P97, DOI 10.1183/09031936.00150405; Gehring U, 2004, ALLERGY, V59, P946, DOI 10.1111/j.1398-9995.2004.00551.x; Horak F, 2002, CLIN EXP ALLERGY, V32, P1155, DOI 10.1046/j.1365-2745.2002.01448.x; Iversen M, 2000, EUR RESPIR J, V16, P404, DOI 10.1034/j.1399-3003.2000.016003404.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pahwa Punam, 2003, Can Respir J, V10, P135; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Post W, 1998, OCCUP ENVIRON MED, V55, P349, DOI 10.1136/oem.55.5.349; Preller L, 1995, SCAND J WORK ENV HEA, V21, P504, DOI 10.5271/sjweh.67; Prior C, 2001, RESPIRATION, V68, P46, DOI 10.1159/000050462; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Robbe P, 2014, THORAX, V69, P630, DOI 10.1136/thoraxjnl-2013-204295; Senthilselvan A, 1997, CHEST, V111, P1733, DOI 10.1378/chest.111.6.1733; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Smit LAM, 2010, INT ARCH ALLERGY IMM, V152, P151, DOI 10.1159/000265536; Spierenburg EAJ, 2015, INT ARCH OCC ENV HEA, V88, P1165, DOI 10.1007/s00420-015-1047-9; Thaon I, 2011, EUR RESPIR J, V37, P767, DOI 10.1183/09031936.00122209; Thomsen GF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0021-3; Venier AG, 2006, AM J IND MED, V49, P231, DOI 10.1002/ajim.20278; Vercelli D, 2003, CURR OPIN ALLERGY CL, V3, P343, DOI 10.1097/01.all.0000092603.76804.e4; Vogelzang PFJ, 1998, AM J RESP CRIT CARE, V157, P15, DOI 10.1164/ajrccm.157.1.9703087	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189097	10.1371/journal.pone.0189097	http://dx.doi.org/10.1371/journal.pone.0189097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211772	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200064
J	Garcia-Garcia, ML; Calvo, C; Ruiz, S; Pozo, F; del Pozo, V; Remedios, L; Exposito, N; Tellez, A; Casas, I				Luz Garcia-Garcia, Maria; Calvo, Cristina; Ruiz, Sara; Pozo, Francisco; del Pozo, Victoria; Remedios, Laura; Exposito, Nadia; Tellez, Ana; Casas, Inmaculada			Role of viral coinfections in asthma development	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; THYMIC STROMAL LYMPHOPOIETIN; DENDRITIC CELLS INDUCE; IMPORTANT RISK-FACTOR; BRONCHIOLITIS; ALLERGY; INFANCY; QUESTIONNAIRE; VALIDATION; EXPRESSION	Background Viral respiratory infections, especially acute bronchiolitis, play a key role in the development of asthma in childhood. However, most studies have focused on respiratory syncytial virus or rhinovirus infections and none of them have compared the long-term evolution of single versus double or multiple viral infections. Objective Our aim was to compare the frequency of asthma development at 6-8 years in children with previous admission for bronchiolitis associated with single versus double or multiple viral infection. Patients & methods A cross-sectional study was performed in 244 children currently aged 6-8 years, previously admitted due to bronchiolitis between September 2008 and December 2011. A structured clinical interview and the ISAAC questionnaire for asthma symptoms for 6-7-year-old children, were answered by parents by telephone. Specimens of nasopharyngeal aspirate for virological study (polymerase chain reaction) and clinical data were prospectively taken during admission for bronchiolitis. Results Median current age at follow-up was 7.3 years (IQR: 6.7-8.1). The rate of recurrent wheezing was 82.7% in the coinfection group and 69.7% in the single-infection group, p = 0.06. The number of wheezing-related admissions was twice as high in coinfections than in single infections, p = 0.004. Regarding the ISAAC questionnaire, 30.8% of coinfections versus 15% of single infections, p = 0.01, presented "wheezing in the last 12 months", data that strongly correlate with current prevalence of asthma. "Dry cough at night" was also reported more frequently in coinfections than in single infections, p = 0.02. The strongest independent risk factors for asthma at 6-8 years of age were: age > 9 months at admission for bronchiolitis (OR: 3.484; CI95%: 1.459-8.317, p: 0.005), allergic rhinitis (OR: 5.910; 95% CI: 2.622- 13.318, p< 0.001), and viral coinfection-bronchiolitis (OR: 3.374; CI95%: 1.542-7.386, p: 0.01). Conclusions Asthma at 6-8 years is more frequent and severe in those children previously hospitalized with viral coinfection-bronchiolitis compared with those with single infection. Allergic rhinitis and older age at admission seem also to be strong independent risk factors for asthma development in children previously hospitalised because of bronchiolitis.	[Luz Garcia-Garcia, Maria; Ruiz, Sara; Remedios, Laura; Exposito, Nadia; Tellez, Ana] Severo Ochoa Hosp, Pediat Dept, Leganes, Spain; [Luz Garcia-Garcia, Maria; Ruiz, Sara; Remedios, Laura; Exposito, Nadia; Tellez, Ana] Alfonso X El Sabio Univ, Madrid, Spain; [Luz Garcia-Garcia, Maria; Calvo, Cristina] Alfonso X El Sabio Univ, Traslat Res Network Pediat Infect Dis RITIP, La Paz Hosp, Madrid, Spain; [Calvo, Cristina] Alfonso X El Sabio Univ, TEDDY Network, European Network Excellence Pediat Clin Res, La Paz Hosp, Madrid, Spain; [Calvo, Cristina] Alfonso X El Sabio Univ, La Paz Hosp, Pediat Dept, Madrid, Spain; [Pozo, Francisco; Casas, Inmaculada] Natl Microbiol Ctr ISCIII, Resp Virus & Influenza Unit, Madrid, Spain; [del Pozo, Victoria] Fdn Jimenez Diaz, IIS, CIBERES, Dept Immunol, Madrid, Spain	Severo Ochoa University Hospital; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacion Jimenez Diaz	Garcia-Garcia, ML (corresponding author), Severo Ochoa Hosp, Pediat Dept, Leganes, Spain.; Garcia-Garcia, ML (corresponding author), Alfonso X El Sabio Univ, Madrid, Spain.; Garcia-Garcia, ML (corresponding author), Alfonso X El Sabio Univ, Traslat Res Network Pediat Infect Dis RITIP, La Paz Hosp, Madrid, Spain.	marialuz.hso@gmail.com	Pozo, Francisco/F-4426-2012; Casas, Inmaculada/H-9442-2015; Casas, Inmaculada/X-7579-2019; Calvo, Cristina/T-5028-2018	Pozo, Francisco/0000-0003-1828-733X; Casas, Inmaculada/0000-0003-1840-1198; Casas, Inmaculada/0000-0003-1840-1198; Calvo, Cristina/0000-0002-6503-3423	Fondo de Investigaciones Sanitarias-Spanish Health Research Fund [PI12/0129]	Fondo de Investigaciones Sanitarias-Spanish Health Research Fund(Instituto de Salud Carlos III)	This study has been partially supported by Fondo de Investigaciones Sanitarias-Spanish Health Research Fund.Grant PI12/0129. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruvito L, 2015, CURR OPIN INFECT DIS, V28, P259, DOI 10.1097/QCO.0000000000000159; Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Berraies A, 2016, IMMUNOL LETT, V178, P85, DOI 10.1016/j.imlet.2016.08.004; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Calvo C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001788; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Fernandez CM, 2005, J INVEST ALLERG CLIN, V15, P201; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lauhkonen Eero, 2016, Acta Paediatr, V105, P1355, DOI 10.1111/apa.13537; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Lukkarinen H, 2014, J ALLERGY CLIN IMMUN, V133, P256, DOI 10.1016/j.jaci.2013.10.014; Lukkarinen M, 2013, PEDIAT ALLERG IMM-UK, V24, P237, DOI 10.1111/pai.12046; Garcia-Garcia ML, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006787; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; MCCONNOCHIE KM, 1983, AM J DIS CHILD, V137, P11, DOI 10.1001/archpedi.1983.02140270007003; Pattarini L, 2017, J EXP MED, V214, P1529, DOI 10.1084/jem.20150402; Pereira AM, 2015, PEDIAT ALLERG IMM-UK, V26, P618, DOI 10.1111/pai.12430; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Pite H, 2016, ALLERGY ASTHMA PROC, V37, P231, DOI 10.2500/aap.2016.37.3955; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Rossi GA, 2017, PEDIAT ALLERG IMM-UK, V28, P320, DOI 10.1111/pai.12716; Rossi GA, 2015, EUR RESPIR J, V45, P774, DOI 10.1183/09031936.00062714; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Tulah AS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-100; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	37	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							0189083	10.1371/journal.pone.0189083	http://dx.doi.org/10.1371/journal.pone.0189083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206851	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700046
J	Charara, M; Tovmasyan, A; Batinic-Haberle, I; Craik, J; Benov, L				Charara, Malak; Tovmasyan, Artak; Batinic-Haberle, Ines; Craik, James; Benov, Ludmil			Post-illumination cellular effects of photodynamic treatment	PLOS ONE			English	Article							LIPID-PEROXIDATION; PHOTO-TREATMENT; PROTEIN; APOPTOSIS; CELLS; OXIDATION; PATHWAYS; SURVIVAL; THERAPY; DAMAGE	Increased interest in clinical application of photodynamic therapy (PDT) in various medical fields poses a demand for better understanding of processes triggered by photo-treatment. Most of the work on PDT performed so far has focused on the immediate effects of photo-treatment. It is generally accepted that cellular damage occurs during light exposure and within a short period thereafter. If cells are not killed during the PDT, they might recover, depending on the extent of the photo-induced damage. Little is known, however, about the relationship between the properties of photosensitizers (PSs) and the delayed consequences of PDT. The aim of this work was to investigate cellular responses to sub-lethal photodynamic treatment and how toxicogenic potency may be affected by molecular features of the PS. Results demonstrated that for cationic porphyrin-based PSs, lipophilicity is the main factor determining the fate of the cells in the 24-hour post-illumination period. PSs with amphiphilic properties initiated oxidative reactions that continued in the dark, long after light exposure, and caused suppression of metabolism and loss of cell viability with concomitant changes in electrophoretic mobility of proteins, including caspases. Apoptotic activity was not stimulated in the post-illumination period. This study demonstrated that in PDT mediated by amphiphilic cationic metalloporphyrin PSs, even when immediate photo-damage is relatively mild, destructive oxidative processes initiated during PDT continue in the absence of light to substantially impair metabolism, and that post-illumination protein modification may modify utilization of cell death pathways.	[Charara, Malak; Craik, James; Benov, Ludmil] Kuwait Univ, Dept Biochem, Fac Med, Kuwait, Kuwait; [Tovmasyan, Artak; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Kuwait University; Duke University	Benov, L (corresponding author), Kuwait Univ, Dept Biochem, Fac Med, Kuwait, Kuwait.	lbenov@hsc.edu.kw	Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146	College of Graduate Studies; Kuwait University [YM09/13]; General Research Funds; HSC Omics [SRUL02/13]	College of Graduate Studies; Kuwait University; General Research Funds; HSC Omics	LB MC JC were supported by College of Graduate Studies and grants YM09/13 from Kuwait University. IBH was supported by General Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based on a M. Sc. Thesis submitted by Malak Charara to the College of Graduate Studies, Kuwait University. The authors thank Professor Yunus Luqmani, Faculty of Pharmacy, Kuwait University for providing the cell line used in this study. We are grateful to Ms. Milini Thomas, Ms. F. Sequeira, and the staff of HSC Omics (grant SRUL02/13), for excellent technical assistance.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al-Mutairi DA, 2007, BBA-GEN SUBJECTS, V1770, P1520, DOI 10.1016/j.bbagen.2007.06.006; Al-Mutairi DA, 2007, FREE RADICAL RES, V41, P89, DOI 10.1080/10715760600952869; Awad MM, 2016, APPL MICROBIOL BIOT, V100, P7679, DOI 10.1007/s00253-016-7632-3; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BACHOWSKI GJ, 1991, J PHOTOCH PHOTOBIO B, V9, P307, DOI 10.1016/1011-1344(91)80168-H; Benov L, 2001, PROTOPLASMA, V217, P33, DOI 10.1007/BF01289410; Benov Ludmil, 2015, Med Princ Pract, V24 Suppl 1, P14, DOI 10.1159/000362416; Benov L, 2012, AMINO ACIDS, V42, P117, DOI 10.1007/s00726-010-0640-1; Benov L, 2011, ANTI-CANCER AGENT ME, V11, P233, DOI 10.2174/187152011795255975; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Broekgaarden M, 2015, CANCER METAST REV, V34, P643, DOI 10.1007/s10555-015-9588-7; Chatterjee SR, 1997, CHEM-BIOL INTERACT, V108, P27, DOI 10.1016/S0009-2797(97)00092-6; Chatterjee SR, 1997, MOL CELL BIOCHEM, V166, P25, DOI 10.1023/A:1006840714583; Davies MJ, 2016, BIOCHEM J, V473, P805, DOI 10.1042/BJ20151227; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dean RT, 1997, BIOCHEM J, V324, P1; Ezzeddine R, 2013, J BIOL CHEM, V288, P36579, DOI 10.1074/jbc.M113.511642; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; Geiger PG, 1997, FREE RADICAL BIO MED, V23, P57, DOI 10.1016/S0891-5849(96)00587-4; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; Grebenova D, 2000, PHOTOCHEM PHOTOBIOL, V72, P16, DOI 10.1562/0031-8655(2000)072<0016:PCIHLC>2.0.CO;2; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; Kessel D, 1996, PHOTOCHEM PHOTOBIOL, V64, P601, DOI 10.1111/j.1751-1097.1996.tb03111.x; Lavie G, 1999, BRIT J CANCER, V79, P423, DOI 10.1038/sj.bjc.6690066; Lin D, 2008, ADV BIOACTIVATION RE; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Munshi A, 2005, METH MOLEC MED, V110, P21; Noodt BB, 1996, BRIT J CANCER, V74, P22, DOI 10.1038/bjc.1996.310; Odeh AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108238; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Sakharov DV, 2005, FEBS LETT, V579, P1255, DOI 10.1016/j.febslet.2005.01.024; Sakharov DV, 2003, EUR J BIOCHEM, V270, P4859, DOI 10.1046/j.1432-1033.2003.03885.x; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; THOMAS JP, 1989, CANCER RES, V49, P1682; Thomas M, 2015, FUTURE MICROBIOL, V10, P709, DOI [10.2217/fmb.14.148, 10.2217/FMB.14.148]; Tsaytler PA, 2008, J PROTEOME RES, V7, P3868, DOI 10.1021/pr800189q; VERWEIJ H, 1981, BIOCHIM BIOPHYS ACTA, V647, P87, DOI 10.1016/0005-2736(81)90297-2; Weijer R, 2017, CELL MOL LIFE SCI, V74, P1133, DOI 10.1007/s00018-016-2401-0; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965; ZELENIN AV, 1984, CYTOMETRY, V5, P348, DOI 10.1002/cyto.990050410	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188535	10.1371/journal.pone.0188535	http://dx.doi.org/10.1371/journal.pone.0188535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200431	Green Published, gold, Green Submitted			2022-12-26	WOS:000417033200009
J	Cassidy, J; Bruen, L; Rosini, E; Molla, G; Pollegioni, L; Paradisi, F				Cassidy, Jennifer; Bruen, Larah; Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano; Paradisi, Francesca			Engineering substrate promiscuity in halophilic alcohol dehydrogenase (HvADH2) by in silico design	PLOS ONE			English	Article							HALOFERAX-VOLCANII; THERMOANAEROBACTER-ETHANOLICUS; KINETIC-RESOLUTION; SECONDARY ALCOHOLS; EXTREME HALOPHILE; SWISS-MODEL; ADH2; IMMOBILIZATION; ALDEHYDES; ENZYMES	An alcohol dehydrogenase from the halophilic archaeon Haloferax volcanii (HvADH2) has been engineered by rational design to broaden its substrate scope towards the conversion of a range of aromatic substrates, including flurbiprofenol, that is an intermediate of the nonsteroidal anti-inflammatory drug, flurbiprofen. Wild-type HvADH2 showed minimal activity with flurbiprofenol (11.1 mU/mg). A homology model of HvADH2 was built and docking experiments with this substrate revealed that the biphenyl rings of flurbiprofenol formed strong interactions with residues F85 and F108, preventing its optimal binding in the active site. Mutations at position 85 however did not increase activity. Site directed mutagenesis at position F108 allowed the identification of three variants showing a significant (up to 2.3-fold) enhancement of activity towards flurbiprofenol, when compared to wild-type HvADH2. Interestingly, F108G variant did not show the classic inhibition in the presence of (R)-enantiomer when tested with rac-1-phenylethanol, underling its potential in racemic resolution of secondary alcohols.	[Cassidy, Jennifer; Bruen, Larah; Paradisi, Francesca] Univ Coll Dublin, Synth & Solid State Pharmaceut Ctr SSPC, Sch Chem, Dublin, Ireland; [Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy; [Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Politecn Milano, Prot Factory, Milan, Italy; [Paradisi, Francesca] Univ Nottingham, Sch Chem, Univ Pk, Nottingham, England	University College Dublin; University of Insubria; Polytechnic University of Milan; University of Insubria; University of Nottingham	Paradisi, F (corresponding author), Univ Coll Dublin, Synth & Solid State Pharmaceut Ctr SSPC, Sch Chem, Dublin, Ireland.; Paradisi, F (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham, England.	Francesca.Paradisi@nottingham.ac.uk	Cassidy, Jennifer HM/J-3356-2017; Rosini, Elena/H-3474-2012; Paradisi, Francesca/O-7556-2019	Rosini, Elena/0000-0001-8384-7992; Paradisi, Francesca/0000-0003-1704-0642; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Science Foundation Ireland through Synthesis and Solid State Pharmaceutical Centre [12/RC/2275]; European Cooperation in Science and Technology [ECOST-STSM-CM1303-010614-045245, COST Action CM1303]; Science Foundation Ireland through the Synthesis and Solid State Pharmaceutical Centre [12/RC/2275]	Science Foundation Ireland through Synthesis and Solid State Pharmaceutical Centre(Science Foundation Ireland); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Science Foundation Ireland through the Synthesis and Solid State Pharmaceutical Centre(Science Foundation Ireland)	Funded by Science Foundation Ireland through Synthesis and Solid State Pharmaceutical Centre (grant number 12/RC/2275) to FP and the European Cooperation in Science and Technology (COST Action CM1303 "SysBiocat" grant number ECOST-STSM-CM1303-010614-045245) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the support from Science Foundation Ireland through the Synthesis and Solid State Pharmaceutical Centre (12/RC/2275). We also acknowledge the support from the COST Action CM1303 "SysBiocat".	Alsafadi D, 2014, MOL BIOTECHNOL, V56, P240, DOI 10.1007/s12033-013-9701-5; Alsafadi D, 2013, EXTREMOPHILES, V17, P115, DOI 10.1007/s00792-012-0498-0; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cheng JH, 2002, ACTA CRYSTALLOGR A, V58, P102; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Friest JA, 2010, J AM CHEM SOC, V132, P5930, DOI 10.1021/ja910778p; Galletti P, 2010, ORG BIOMOL CHEM, V8, P4117, DOI 10.1039/c005098a; Giacomini D, 2007, CHEM COMMUN, P4038, DOI 10.1039/b712290j; Karume I, 2016, CHEMCATCHEM, V8, P1459, DOI 10.1002/cctc.201600160; Konst P, 2012, ANGEW CHEM INT EDIT, V51, P9914, DOI 10.1002/anie.201203219; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Liliensiek AK, 2013, MOL BIOTECHNOL, V55, P143, DOI 10.1007/s12033-013-9666-4; Nealon CM, 2016, ARCH BIOCHEM BIOPHYS, V606, P151, DOI 10.1016/j.abb.2016.08.002; Pedragosa-Moreau S, 2017, ADV SYNTH CATAL, V359, P485, DOI 10.1002/adsc.201601222; Quaglia D, 2013, PROCESS BIOCHEM, V48, P810, DOI 10.1016/j.procbio.2013.03.016; Savile C, 2012, US, Patent No. 8288141; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Swint-Kruse L, 2016, BIOPHYS J, V111, P10, DOI 10.1016/j.bpj.2016.05.030; Tanaka N, 2002, J MOL BIOL, V324, P519, DOI 10.1016/S0022-2836(02)01066-5; Timpson LM, 2013, APPL MICROBIOL BIOT, V97, P195, DOI 10.1007/s00253-012-4074-4; Timpson LM, 2012, EXTREMOPHILES, V16, P57, DOI 10.1007/s00792-011-0405-0; Wu X, 2013, APPL ENVIRON MICROB, V79, P2209, DOI 10.1128/AEM.03873-12; Zheng YG, 2017, APPL MICROBIOL BIOT, V101, P987, DOI 10.1007/s00253-016-8083-6; Ziegelmann-Fjeld KI, 2007, PROTEIN ENG DES SEL, V20, P47, DOI 10.1093/protein/gzl052	24	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187482	10.1371/journal.pone.0187482	http://dx.doi.org/10.1371/journal.pone.0187482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190711	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000416841900015
J	Foksinski, M; Zarakowska, E; Gackowski, D; Skonieczna, M; Gajda, K; Hudy, D; Szpila, A; Bialkowski, K; Starczak, M; Labejszo, A; Czyz, J; Rzeszowska-Wolny, J; Olinski, R				Foksinski, Marek; Zarakowska, Ewelina; Gackowski, Daniel; Skonieczna, Magdalena; Gajda, Karolina; Hudy, Dorota; Szpila, Anna; Bialkowski, Karol; Starczak, Marta; Labejszo, Anna; Czyz, Jaroslaw; Rzeszowska-Wolny, Joanna; Olinski, Ryszard			Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2 '-deoxycytidine level in cultured cancerous cell lines	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; OXIDATION; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; METHYLATION; DERIVATIVES; MECHANISMS	Active demethylation of 5-methylcytosine moiety in DNA occurs by its sequential oxidation to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxycytosine, catalysed by enzymes of the Ten-Eleven Translocation family proteins (TETs 1, 2 and 3). Here we analyzed for the first time all the intermediate products of DNA demethylation pathway in the form of deoxynucleosides (5-methyl-2'-deoxycytidine, 5-(hydroxymethyl)-2'-deoxycytidine, 5-formyl-2'-deoxycytidine and 5-carboxy-2'-deoxycytidine as well as 5-(hydroxymethyl)-2'-deoxyuridine) using automated isotope-dilution online two-dimensional ultra-performance liquid chromatography with tandem mass spectrometry. DNA was isolated from human malignant cell lines of colon adenocarcinoma (HCT 116), melanoma (Me45), myelogenous leukemia bone marrow blasts (K562), EBV-positive Burkitt's lymphoma lymphoblasts (Raji), EBV-negative Burkitt's lymphoma lymphoblasts (male-CA46 and female-ST486), as well as normal neonatal dermal fibroblasts (NHDF-Neo). The expression levels of TET1, TET2, TET3, SMUG1, and TDG genes were also assayed by RTqPCR. Our results show a global erasure of 5-hydroxymethyl-2'-deoxycytidine and 5-carboxy- 2'-deoxycytidine in DNA of cultured cells compared with DNA from primary malignant tissue. Moreover, malignant cells in culture have a quite different DNA epigenetic profile than cultured normal cells, and different types of malignant cells display different and characteristic profiles of DNA epigenetic marks. Similar analyses of a broader spectrum of epigenetic modifications, not restricted to 5-methyl-2'-deoxycytidine, could lead to better understanding of the mechanism(s) responsible for emergence of different types of cancer cells.	[Foksinski, Marek; Zarakowska, Ewelina; Gackowski, Daniel; Szpila, Anna; Bialkowski, Karol; Starczak, Marta; Labejszo, Anna; Olinski, Ryszard] Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Fac Pharm, Dept Clin Biochem, Bydgoszcz, Poland; [Skonieczna, Magdalena; Gajda, Karolina; Hudy, Dorota; Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Fac Automat Elect & Informat, Inst Automat Control, Biosyst Grp, Gliwice, Poland; [Skonieczna, Magdalena; Gajda, Karolina; Hudy, Dorota; Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Biotechnol Ctr, Gliwice, Poland; [Czyz, Jaroslaw] Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Dept Hematol, Fac Med, Bydgoszcz, Poland	Nicolaus Copernicus University; Silesian University of Technology; Silesian University of Technology; Nicolaus Copernicus University	Olinski, R (corresponding author), Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Fac Pharm, Dept Clin Biochem, Bydgoszcz, Poland.	ryszardo@cm.umk.pl	Bialkowski, Karol/E-2328-2014; Starczak, Marta/P-4773-2019; Foksinski, Marek/D-4942-2014; Gackowski, Daniel/G-5693-2012; Labejszo, Anna/G-4394-2019; Skonieczna, Magdalena/M-7012-2019; Zarakowska, Ewelina/G-7912-2014; Olinski, Ryszard/E-9607-2014	Bialkowski, Karol/0000-0002-3836-8076; Starczak, Marta/0000-0003-4098-7412; Foksinski, Marek/0000-0002-1338-8230; Gackowski, Daniel/0000-0002-7259-1511; Labejszo, Anna/0000-0001-7536-7809; Skonieczna, Magdalena/0000-0002-6263-9585; Szpila, Anna/0000-0002-1139-6157; Rzeszowska-Wolny, Joanna/0000-0002-5804-4757; Zarakowska, Ewelina/0000-0003-0508-7777; Gajda, Karolina/0000-0002-0447-3628; Hudy, Dorota/0000-0002-9110-2314; Olinski, Ryszard/0000-0001-9927-8755	Polish National Science Center [DEC-2012/07/B/NZ1/00008]	Polish National Science Center	This work was supported by grant DEC-2012/07/B/NZ1/00008 from the Polish National Science Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Crawford DJ, 2016, J AM CHEM SOC, V138, P730, DOI 10.1021/jacs.5b10554; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gackowski D, 2016, ANAL CHEM, V88, P12128, DOI 10.1021/acs.analchem.6b02900; Gackowski D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144859; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Kramer-Marek G, 2006, J PHOTOCH PHOTOBIO B, V84, P1, DOI 10.1016/j.jphotobiol.2005.12.011; Livak K. J., 1997, USER B, V2, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nestor CE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0576-y; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Niller HH, 2016, ADV EXP MED BIOL, V879, P107, DOI 10.1007/978-3-319-24738-0_6; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tang Y, 2015, ANAL CHEM, V87, P3445, DOI 10.1021/ac504786r; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xiong J, 2016, MOL CELL, V64, P913, DOI 10.1016/j.molcel.2016.10.013	20	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188856	10.1371/journal.pone.0188856	http://dx.doi.org/10.1371/journal.pone.0188856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190698	Green Published, gold			2022-12-26	WOS:000416841900145
J	Friel, S; Pescud, M; Malbon, E; Lee, A; Carter, R; Greenfield, J; Cobcroft, M; Potter, J; Rychetnik, L; Meertens, B				Friel, Sharon; Pescud, Melanie; Malbon, Eleanor; Lee, Amanda; Carter, Robert; Greenfield, Joanne; Cobcroft, Megan; Potter, Jane; Rychetnik, Lucie; Meertens, Beth			Using systems science to understand the determinants of inequities in healthy eating	PLOS ONE			English	Article							SOCIAL DETERMINANTS; PUBLIC-HEALTH; OBESITY; FOOD; POLICY; THINKING; DISPARITIES; PROMOTION; DIAGRAMS; EQUITY	Introduction Systems thinking has emerged in recent years as a promising approach to understanding and acting on the prevention and amelioration of non-communicable disease. However, the evidence on inequities in non-communicable diseases and their risks factors, particularly diet, has not been examined from a systems perspective. We report on an approach to developing a system oriented policy actor perspective on the multiple causes of inequities in healthy eating. Methods Collaborative conceptual modelling workshops were held in 2015 with an expert group of representatives from government, non-government health organisations and academia in Australia. The expert group built a systems model using a system dynamics theoretical perspective. The model developed from individual mind maps to pair blended maps, before being finalised as a causal loop diagram. Results The work of the expert stakeholders generated a comprehensive causal loop diagram of the determinants of inequity in healthy eating (the HE 2 Diagram). This complex dynamic system has seven sub-systems: (1) food supply and environment; (2) transport; (3) housing and the built environment; (4) employment; (5) social protection; (6) health literacy; and (7) food preferences. Discussion The HE 2 causal loop diagram illustrates the complexity of determinants of inequities in healthy eating. This approach, both the process of construction and the final visualisation, can provide the basis for planning the prevention and amelioration of inequities in healthy eating that engages with multiple levels of causes and existing policies and programs.	[Friel, Sharon; Pescud, Melanie; Malbon, Eleanor] Australian Natl Univ, Sch Regulat & Global Governance RegNet, Canberra, ACT, Australia; [Lee, Amanda; Rychetnik, Lucie] Sax Inst, Sydney, NSW, Australia; [Carter, Robert] Deakin Univ, Melbourne, Vic, Australia; [Greenfield, Joanne] ACT Hlth, Canberra, ACT, Australia; [Cobcroft, Megan] NSW Hlth, Sydney, NSW, Australia; [Potter, Jane; Meertens, Beth] Natl Heart Fdn Australia, Melbourne, Vic, Australia	Australian National University; University of Sydney; Deakin University	Friel, S (corresponding author), Australian Natl Univ, Sch Regulat & Global Governance RegNet, Canberra, ACT, Australia.	Sharon.friel@anu.edu.au		Lee, Amanda/0000-0001-6887-5426; Rychetnik, Lucie/0000-0001-6855-2897; Friel, Sharon/0000-0002-8345-5435; Carter, Rob/0000-0002-1586-5619	Australian Prevention Partnership Centre through the NHMRC [GNT9100001]; Australian Government Department of Health; New South Wales Ministry of Health; Australian Capital Territory Health; HCF; HCF Research Foundation	Australian Prevention Partnership Centre through the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); New South Wales Ministry of Health; Australian Capital Territory Health; HCF; HCF Research Foundation	This research was supported by The Australian Prevention Partnership Centre through the NHMRC partnership centre grant scheme (Grant ID: GNT9100001) with the Australian Government Department of Health, New South Wales Ministry of Health, Australian Capital Territory Health, HCF, and the HCF Research Foundation.	Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Bar-Yam Y, 2006, AM J PUBLIC HEALTH, V96, P459, DOI 10.2105/AJPH.2005.064444; Brimblecombe J, 2013, PUBLIC HEALTH NUTR, V16, P1159, DOI 10.1017/S1368980012004284; Burns C M, 2004, Rural Remote Health, V4, P311; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Commonwealth of Australia, 2013, STAT PREV HLTH 2013; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Finegood DT, 2012, OXFORD HDB SOCIAL SC; Forde I, 2008, LANCET, V372, P1694, DOI 10.1016/S0140-6736(08)61695-5; Foresight (Program) & Great Britain, 2007, TACKL OB FUT CHOIC P; Friel S, 2015, HEALTH PROMOT INT, V30, P77, DOI 10.1093/heapro/dav073; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP 2016 P, DOI 10.2499/9780896295841; Joffe M, 2006, AM J PUBLIC HEALTH, V96, P473, DOI 10.2105/AJPH.2005.063693; Leischow SJ, 2008, AM J PREV MED, V35, pS196, DOI 10.1016/j.amepre.2008.05.014; Levy DT, 2011, OBES REV, V12, P378, DOI 10.1111/j.1467-789X.2010.00804.x; Mabry PL, 2010, AM J PUBLIC HEALTH, V100, P1161, DOI 10.2105/AJPH.2010.198176; Malhi L, 2009, J HUNGER ENVIRON NUT, V4, P466, DOI 10.1080/19320240903346448; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Meadows D.H., 2008, THINKING SYSTEMS PRI; Mendez D, 2010, AM J PUBLIC HEALTH, V100, P1160, DOI 10.2105/AJPH.2010.199877; Midgley G, 2006, AM J PUBLIC HEALTH, V96, P466, DOI 10.2105/AJPH.2005.067660; Midgley G, 1997, SYST PRACTICE, V10, P37, DOI 10.1007/BF02557850; Milstein B, 2007, PREVENTING CHRONIC D, V4; Nestle M., 2013, FOOD POLITICS FOOD I, V3; Newell B., 2012, WORKING PAPER; Newell Barry, 2007, N S W Public Health Bull, V18, P214, DOI 10.1071/NB07028; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; Organization WH, 2009, GLOB HLTH RISKS MORT; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; Proust K, 2012, INT J ENV RES PUB HE, V9, P2134, DOI 10.3390/ijerph9062134; Richardson GP, 1997, SYST DYNAM REV, V13, P247, DOI 10.1002/(SICI)1099-1727(199723)13:3<247::AID-SDR128>3.0.CO;2-9; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Sabounchi NS, 2014, AM J PUBLIC HEALTH, V104, P1240, DOI 10.2105/AJPH.2014.301898; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Signal LN, 2013, HEALTH PROMOT INT, V28, P84, DOI 10.1093/heapro/das006; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Townsend N, 2013, PUBLIC HEALTH NUTR, V16, P1101, DOI 10.1017/S1368980011002655; Trochim WM, 2006, AM J PUBLIC HEALTH, V96, P538, DOI 10.2105/AJPH.2005.066001; Vensim, 2006, VENS PLE SOFTW; Weiler AM, 2015, HEALTH POLICY PLANN, V30, P1078, DOI 10.1093/heapol/czu109; World Health Organization, 2003, SOCIAL DETERMINANTS	54	54	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188872	10.1371/journal.pone.0188872	http://dx.doi.org/10.1371/journal.pone.0188872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190662	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900152
J	Lai, S; Cagetti, MG; Cocco, F; Cossellu, D; Meloni, G; Campus, G; Lingstrom, P				Lai, Stefano; Cagetti, Maria Grazia; Cocco, Fabio; Cossellu, Dina; Meloni, Gianfranco; Campus, Guglielmo; Lingstrom, Peter			Evaluation of the difference in caries experience in diabetic and non-diabetic children-A case control study	PLOS ONE			English	Article							ORAL-HEALTH; DENTAL-CARIES; GLYCEMIC CONTROL; PLAQUE-PH; TYPE-1; MELLITUS; ADOLESCENTS; CLASSIFICATION; STREPTOCOCCI; PREVALENCE	Aim To evaluate the caries prevalence and related variables in Type 1 diabetic and non-diabetic children and among the diabetic children according to their metabolic status. Methods Sixty-eight diabetic and 136 non-diabetic children, matching by gender and age (4-14 years) were enrolled. The diabetic children were divided: a) 20 children in good metabolic control (Hb1ac <= 7.5) and b) 48 children in bad metabolic control (Hb1ac > 7.5). Dietary and oral hygiene habits were investigated. Caries status was registered using the International Caries Detection and Assessment System. Oral microflora was analysed using the checker-board DNA-DNA hybridisation method. Plaque acidogenicity was recorded after a sucrose rinse. Results Sugared beverage and snack intake was higher in diabetic group compared to non-diabetic group (p = 0.03 and p = 0.04, respectively) and in subjects in bad metabolic control (p = 0.03 and p < 0.01, respectively). Oral hygiene habits were similar, except for the use of fluoridated adjuvants, higher in non-diabetic children (p = 0.04). No statistically significant differences were observed regarding caries figures, but a higher number of caries free subjects was found in diabetic subjects in good metabolic control (p<0.01). Significant difference for the main cariogenic bacteria was found between diabetic and non-diabetic subjects (p < 0.05). The pH values showed statistically significant differences between diabetic and non-diabetic subjects and between diabetic subjects in good and bad metabolic control (p < 0.01). Conclusions Diabetic children in good metabolic control might even be considered at low caries risk, while those in bad metabolic control showed an oral environment prone to a high caries risk.	[Lai, Stefano] Univ Sassari, Dept Biomed Sci, Med Sch, Sassari, Italy; [Cagetti, Maria Grazia; Cocco, Fabio; Campus, Guglielmo; Lingstrom, Peter] WHO, Collaborating Ctr Epidemiol & Prevent Dent, Milan, Italy; [Cagetti, Maria Grazia] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Cocco, Fabio; Cossellu, Dina; Campus, Guglielmo] Univ Sassari, Dent Sch, Dept Surg Microsurg & Med Sci, Sassari, Italy; [Meloni, Gianfranco] Univ Sassari, Clin Pediat, Dept Surg Microsurg & Med Sci, Sassari, Italy; [Lingstrom, Peter] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Dept Cariol, Gothenburg, Sweden	University of Sassari; World Health Organization; University of Milan; University of Sassari; University of Sassari; University of Gothenburg	Campus, G (corresponding author), WHO, Collaborating Ctr Epidemiol & Prevent Dent, Milan, Italy.; Campus, G (corresponding author), Univ Sassari, Dent Sch, Dept Surg Microsurg & Med Sci, Sassari, Italy.	gcampus@uniss.it	Campus, Guglielmo/AAB-5248-2020; Cocco, Fabio/L-9152-2014; Meloni, Gianfranco G.F./E-9426-2012; Cagetti, Maria Grazia/AAD-1507-2021	Cocco, Fabio/0000-0003-1126-6157; Meloni, Gianfranco G.F./0000-0002-0604-8924; Cagetti, Maria Grazia/0000-0002-2704-0585				Acerini C, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12182; Aitken-Saavedra Juan, 2015, J Clin Exp Dent, V7, pe501, DOI 10.4317/jced.52329; Akpata ES, 2012, PEDIATR DENT, V34, P468; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bonate PL, 1998, PHARMACEUT RES, V15, P405, DOI 10.1023/A:1011968129921; Bratthall D, 1996, EUR J ORAL SCI, V104, P416, DOI 10.1111/j.1600-0722.1996.tb00104.x; Campus G, 2011, CARIES RES, V45, P393, DOI 10.1159/000330234; Carlen A, 2010, CARIES RES, V44, P341, DOI 10.1159/000315273; Carta G, 2014, COMMUNITY DENT HLTH, V31, P123, DOI 10.1922/CDH_3300Carta06; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Couper JJ, 2014, PEDIATR DIABETES, V15, P18, DOI 10.1111/pedi.12188; Creeth JE, 2016, J DENT, V55, P61, DOI 10.1016/j.jdent.2016.10.003; El-Tekeya M, 2012, PEDIATR DENT, V34, P510; Green A, 2000, LANCET, V355, P873; Innes N P T, 2016, Adv Dent Res, V28, P49, DOI 10.1177/0022034516639276; Ismail AF, 2015, DIABETES RES CLIN PR, V108, P369, DOI 10.1016/j.diabres.2015.03.003; Jasim H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39073; Karjalainen KM, 1997, CARIES RES, V31, P13, DOI 10.1159/000262367; Leite RS, 2013, AM J MED SCI, V345, P271, DOI 10.1097/MAJ.0b013e31828bdedf; LINGSTROM P, 1993, J DENT RES, V72, P865, DOI 10.1177/00220345930720050601; López María Elena, 2003, Braz. Dent. J., V14, P26, DOI 10.1590/S0103-64402003000100005; Losasso Carmen, 2015, Front Nutr, V2, P30, DOI 10.3389/fnut.2015.00030; Miko S, 2010, BRIT DENT J, V208, DOI 10.1038/sj.bdj.2010.290; Miralles Lucia, 2006, Med Oral Patol Oral Cir Bucal, V11, pE256; Mitrakul K, 2013, EUR ARCH PAEDIATR DE, V14, P83, DOI 10.1007/s40368-013-0017-8; Mitrakul K, 2011, J CLIN PEDIATR DENT, V36, P161, DOI 10.17796/jcpd.36.2.d7r750u227j85813; Nansel TR, 2016, AM J CLIN NUTR, V104, P81, DOI 10.3945/ajcn.115.126136; Negrato CA, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-3; Neuhouser ML, 2009, J AM DIET ASSOC, V109, P1587, DOI 10.1016/j.jada.2009.06.365; Nordstrom A, 2017, ACTA ODONTOL SCAND, V75, P483, DOI 10.1080/00016357.2017.1344876; Orbak R, 2008, YONSEI MED J, V49, P357, DOI 10.3349/ymj.2008.49.3.357; Pitts NB, 2013, COMMUNITY DENT ORAL, V41, pe41, DOI 10.1111/cdoe.12025; Prathibha KM, 2013, J CLIN DIAGN RES, V7, P1592, DOI 10.7860/JCDR/2013/5749.3232; Rai K, 2011, J CLIN PEDIATR DENT, V36, P181, DOI 10.17796/jcpd.36.2.x436ln878221g364; Rewers MJ, 2014, PEDIATR DIABETES, V15, P102, DOI 10.1111/pedi.12190; Saes Busato I M, 2010, ORAL SURG ORAL MED O, V109, pe51, DOI DOI 10.1016/J.TRIPLE0.2009.10.037; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Singh-Husgen P, 2016, CLIN ORAL INVEST, V20, P841, DOI 10.1007/s00784-015-1564-7; Singh-Husgen P, 2015, CLIN ORAL INVESTIG; Siudikiene J, 2008, CARIES RES, V42, P354, DOI 10.1159/000151582; Tagelsir A, 2011, INT J PAEDIATR DENT, V21, P13, DOI 10.1111/j.1365-263X.2010.01094.x; Tanzer J M, 2001, J Dent Educ, V65, P1028; Twetman S, 2002, CARIES RES, V36, P31, DOI 10.1159/000057587; TWETMAN S, 1989, ORAL MICROBIOL IMMUN, V4, P165, DOI 10.1111/j.1399-302X.1989.tb00245.x; Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837; Wall-Manning GM, 2002, J MICROBIOL METH, V51, P301, DOI 10.1016/S0167-7012(02)00106-9; Wheeler ML, 2012, DIABETES CARE, V35, P434, DOI 10.2337/dc11-2216	49	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188451	10.1371/journal.pone.0188451	http://dx.doi.org/10.1371/journal.pone.0188451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190700	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900057
J	Pale, M; Nacoto, A; Tivane, A; Nguenha, N; Machalele, L; Gundane, F; Muteto, D; Chilundo, J; Mavale, S; Sema-Baltazar, C; Pires, G; Augusto, O; Mussaa, T; Gudo, E				Pale, Mirela; Nacoto, Afonso; Tivane, Almiro; Nguenha, Neuza; Machalele, Loira; Gundane, Felix; Muteto, Delcio; Chilundo, Josina; Mavale, Sandra; Sema-Baltazar, Cynthia; Pires, Germano; Augusto, Orvalho; Mussa, Tufaria; Gudo, Eduardo			Respiratory syncytial and influenza viruses in children under 2 years old with severe acute respiratory infection (SARI) in Maputo, 2015	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; TRACT INFECTION; YOUNG-CHILDREN; SOUTH-AFRICA; GLOBAL BURDEN; RISK-FACTORS; EPIDEMIOLOGY; AGE; DEATHS; MOZAMBIQUE	Introduction Although respiratory syncytial virus (RSV) and influenza virus (influenza) infections are one of the leading causes of Severe Acute Respiratory Infections (SARI) and death in young children worldwide, little is known about the burden of these pathogens in Mozambique. Material and methods From January 2015 to January 2016, nasopharyngeal swabs from 450 children, aged <= 2 years, who had been admitted to the Pediatric Department of the Maputo Central Hospital (HCM) in Mozambique, suffering with SARI were enrolled and tested for influenza and RSV using a real-time PCR assay. Results Influenza and RSV were detected in 2.4% (11/450) and 26.7% (113/424) of the participants. Children with influenza were slightly older than those infected with RSV (10 months in influenza- infected children compared to 3 months in RSV-infected children); male children were predominant in both groups (63.6% versus 54.9% in children with influenza and RSV, respectively). There was a trend towards a higher frequency of influenza (72.7%) and RSV (93.8%) cases in the dry season. Bronchopneumonia, bronchitis and respiratory distress were the most common diagnoses at admission. Antibiotics were administered to 27,3% and 15,9% of the children with influenza and RSV, respectively. Two children, of whom, one was positive for RSV (aged 6 months) and another was positive for Influenza (aged 3 months) died; both were children of HIV seropositive mothers and had bronchopneumonia. Conclusions Our data demonstrated that RSV, and less frequently influenza, occurs in children with SARI in urban/sub-urban settings from southern Mozambique. The occurrence of deaths in small children suspected of being HIV-infected, suggests that particular attention should be given to this vulnerable population. Our data also provide evidence of antibiotics prescription in children with respiratory viral infection, which represents an important public health problem and calls for urgent interventions.	[Pale, Mirela; Nacoto, Afonso; Tivane, Almiro; Nguenha, Neuza; Machalele, Loira; Gundane, Felix; Muteto, Delcio; Sema-Baltazar, Cynthia; Pires, Germano; Mussa, Tufaria; Gudo, Eduardo] Minist Hlth, Natl Inst Hlth, Dept Technol Platforms, Maputo, Mozambique; [Chilundo, Josina; Mavale, Sandra] Maputo Cent Hosp, Pediat Dept, Maputo, Mozambique; [Augusto, Orvalho; Mussa, Tufaria] Eduardo Mondlane Univ, Fac Med, Dept Microbiol, Maputo, Mozambique	Eduardo Mondlane University	Pale, M (corresponding author), Minist Hlth, Natl Inst Hlth, Dept Technol Platforms, Maputo, Mozambique.	mirelapale@gmail.com	Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Sema Baltazar, Cynthia/0000-0001-8901-2240; Mussa, Tufaria/0000-0002-9635-3585	Centre for Diseases Control and Prevention [1U51IP000825-01]; World Health Organization	Centre for Diseases Control and Prevention; World Health Organization(World Health Organization)	This study was funded by Centre for Diseases Control and Prevention (Grant #1U51IP000825-01) and by the World Health Organization.	Ahmed JA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-7; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Byington CL, 2002, ARCH PEDIAT ADOL MED, V156, P1230, DOI 10.1001/archpedi.156.12.1230; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; El Kholy AA, 2014, J INFECT DEV COUNTR, V8, P1285, DOI 10.3855/jidc.4682; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1988, J PEDIATR-US, V113, P266; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lafond KE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001977; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McMorrow ML, 2015, J INFECT DIS, V212, P853, DOI 10.1093/infdis/jiv100; Moyes J, 2013, J INFECT DIS, V208, pS217, DOI 10.1093/infdis/jit479; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nyawanda BO, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1532-0; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Oladokun R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1572-5; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Resch Bernhard, 2012, World J Clin Pediatr, V1, P8, DOI 10.5409/wjcp.v1.i3.8; Resch B, 2011, PEDIATR INFECT DIS J, V30, P797, DOI 10.1097/INF.0b013e318215cf3e; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Schacht CD, 2015, FACTORS INFLUENCING; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Shi T, 2015, J GLOB HEALTH, V5, P203, DOI 10.7189/jogh.05.020416; Simusika P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0779-1; Suntarattiwong Piyarat, 2011, J Med Assoc Thai, V94 Suppl 3, pS164; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; UNAIDS, 2015, AIDSINFO 2015; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; WHO, 2016, WORLD HLTH STAT 2011; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606	41	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0186735	10.1371/journal.pone.0186735	http://dx.doi.org/10.1371/journal.pone.0186735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190684	gold, Green Submitted, Green Published			2022-12-26	WOS:000416841900009
J	Thomas, DM; Bell, B; Papillon, S; Delaplain, P; Lim, J; Golden, J; Bowling, J; Wang, J; Wang, L; Grishin, AV; Ford, HR				Thomas, Debi M.; Bell, Brandon; Papillon, Stephanie; Delaplain, Patrick; Lim, Joanna; Golden, Jamie; Bowling, Jordan; Wang, Jin; Wang, Larry; Grishin, Anatoly V.; Ford, Henri R.			Colonization with Escherichia coli EC 25 protects neonatal rats from necrotizing enterocolitis	PLOS ONE			English	Article							CRONOBACTER-SAKAZAKII; PRETERM INFANTS; PATHOGENESIS; MODEL; BIFIDOBACTERIA; PROBIOTICS; MICROBIOTA; APOPTOSIS; BACTERIA; INJURY	Necrotizing enterocolitis (NEC) is a significant cause of morbidity and mortality in premature infants; yet its pathogenesis remains poorly understood. To evaluate the role of intestinal bacteria in protection against NEC, we assessed the ability of naturally occurring intestinal colonizer E. coli EC25 to influence composition of intestinal microbiota and NEC pathology in the neonatal rat model. Experimental NEC was induced in neonatal rats by formula feeding/hypoxia, and graded histologically. Bacterial populations were characterized by plating on blood agar, scoring colony classes, and identifying each class by sequencing 16S rDNA. Binding of bacteria to, and induction of apoptosis in IEC-6 enterocytes were examined by plating on blood agar and fluorescent staining for fragmented DNA. E. coli EC 25, which was originally isolated from healthy rats, efficiently colonized the intestine and protected from NEC following introduction to newborn rats with formula at 10 6 or 10 8 cfu. Protection did not depend significantly on EC25 inoculum size or load in the intestine, but positively correlated with the fraction of EC25 in the microbiome. Introduction of EC25 did not prevent colonization with other bacteria and did not significantly alter bacterial diversity. EC25 neither induced cultured enterocyte apoptosis, nor protected from apoptosis induced by an enteropathogenic strain of Cronobacter muytjensii. Our results show that E. coli EC25 is a commensal strain that efficiently colonizes the neonatal intestine and protects from NEC.	[Thomas, Debi M.; Bell, Brandon; Papillon, Stephanie; Delaplain, Patrick; Lim, Joanna; Golden, Jamie; Bowling, Jordan; Wang, Jin; Grishin, Anatoly V.; Ford, Henri R.] Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA; [Delaplain, Patrick; Golden, Jamie; Bowling, Jordan; Grishin, Anatoly V.; Ford, Henri R.] Univ Southern Calif, Dept Surg, Los Angeles, CA 90007 USA; [Wang, Larry] Childrens Hosp Los Angeles, Div Pathol, Los Angeles, CA 90027 USA; [Thomas, Debi M.] Univ Calif Davis, Dept Surg, Sacramento, CA USA; [Papillon, Stephanie] Howard Univ Hosp, Dept Surg, Washington, DC USA; [Lim, Joanna] UCSF East Bay Surg Program, San Francisco, CA USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of California System; University of California Davis; Howard University	Grishin, AV (corresponding author), Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA.; Grishin, AV (corresponding author), Univ Southern Calif, Dept Surg, Los Angeles, CA 90007 USA.	agrishin@chla.usc.edu			National Institutes of Health [R01 AI 014032]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health, R01 AI 014032 to Henri R. Ford. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Laura Illingworth for expert technical assistance. This study was supported by NIH R01 grant AI 014032 to H.R.F.	Awaisheh SS, 2013, J FOOD SCI, V78, pM1416, DOI 10.1111/1750-3841.12209; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Bertelli C, 2015, CLIN INFECT DIS, V60, P924, DOI 10.1093/cid/ciu946; Buccigrossi V, 2013, CURR OPIN GASTROEN, V29, P31, DOI 10.1097/MOG.0b013e32835a3500; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Caplan M, 2011, SEMIN FETAL NEONAT M, V16, P264, DOI 10.1016/j.siny.2011.03.004; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; Carlisle EM, 2011, J PEDIATR SURG, V46, P577, DOI 10.1016/j.jpedsurg.2010.12.018; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Downard CD, 2012, J PEDIATR SURG, V47, P2111, DOI 10.1016/j.jpedsurg.2012.08.011; Dvorak K, 2013, AM J PHYSIOL-GASTR L, V305, pG585, DOI 10.1152/ajpgi.00483.2012; Emami CN, 2009, SURG INFECT, V10, P407, DOI 10.1089/sur.2009.054; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Garrity G.M., 2004, BERGEYS MANUAL SYSTE, V2nd, DOI [10.1007/bergeysoutline200405, DOI 10.1007/BERGEYSOUTLINE200405]; Grishin A, 2013, SEMIN PEDIATR SURG, V22, P69, DOI 10.1053/j.sempedsurg.2013.01.002; Heineman John, 2012, Curr Gastroenterol Rep, V14, P343, DOI 10.1007/s11894-012-0274-4; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Janda JM, 2002, J CLIN MICROBIOL, V40, P1887, DOI 10.1128/JCM.40.6.1887-1891.2002; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Leach ST, 2015, DIG DIS SCI; Li D, 2013, J CLIN PHARM THER, V38, P445, DOI 10.1111/jcpt.12084; Liu Q, 2012, J SURG RES, V176, P437, DOI 10.1016/j.jss.2011.10.030; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; McMurtry VE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0075-8; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Miniello V L, 2010, Minerva Pediatr, V62, P105; Mirpuri J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051955; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; MUSEMECHE CA, 1986, J PEDIATR SURG, V21, P536, DOI 10.1016/S0022-3468(86)80228-7; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2014, CLIN PERINATOL, V41, P967, DOI 10.1016/j.clp.2014.08.014; Peter CS, 1999, EUR J PEDIATR, V158, P67, DOI 10.1007/s004310051012; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Schroeder B, 2006, DIGEST DIS SCI, V51, P724, DOI 10.1007/s10620-006-3198-8; Stewart CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073465; Waligora-Dupriet AJ, 2005, PEDIATR RES, V58, P629, DOI 10.1203/01.PDR.0000180538.13142.84; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013	38	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188211	10.1371/journal.pone.0188211	http://dx.doi.org/10.1371/journal.pone.0188211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190745	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900039
J	Bullock, KK; Shaffer, CL; Brooks, AW; Secka, O; Forsyth, MH; McClain, MS; Cover, TL				Bullock, Kennady K.; Shaffer, Carrie L.; Brooks, Andrew W.; Secka, Ousman; Forsyth, Mark H.; McClain, Mark S.; Cover, Timothy L.			Genetic signatures for Helicobacter pylori strains of West African origin	PLOS ONE			English	Article							GASTRIC-CANCER; BIOLOGICAL-ACTIVITY; CAGA; EVOLUTION; DIVERSITY; VIRULENCE; RISK; EPIDEMIOLOGY; COEVOLUTION; PARADIGM	Helicobacter pylori is a genetically diverse bacterial species that colonizes the stomach in about half of the human population. Most persons colonized by H. pylori remain asymptomatic, but the presence of this organism is a risk factor for gastric cancer. Multiple populations and subpopulations of H. pylori with distinct geographic distributions are recognized. Genetic differences among these populations might be a factor underlying geographic variation in gastric cancer incidence. Relatively little is known about the genomic features of African H. pyloristrains compared to other populations of strains. In this study, we first analyzed the genomes of H. pylori strains from seven globally distributed populations or subpopulations and identified encoded proteins that exhibited the highest levels of sequence divergence. These included secreted proteins, an LPS glycosyltransferase, fucosyltransferases, proteins involved in molybdopterin biosynthesis, and Clp protease adaptor (CIpS). Among proteins encoded by the cag pathogenicity island, CagA and CagQ exhibited the highest levels of sequence diversity. We then identified proteins in strains of Western African origin (classified as hspWAfrica by MLST analysis) with sequences that were highly divergent compared to those in other populations of strains. These included ATP-dependent Clp protease, CIpS, and proteins of unknown function. Three of the divergent proteins sequences identified in West African strains were characterized by distinct insertions or deletions up to 8 amino acids in length. These polymorphisms in rapidly evolving proteins represent robust genetic signatures for H. pylori strains of West African origin.	[Bullock, Kennady K.; McClain, Mark S.; Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Shaffer, Carrie L.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Brooks, Andrew W.] Vanderbilt Univ, Sch Med, Vanderbilt Genet Inst, Nashville, TN 37212 USA; [Secka, Ousman] Med Res Council Unit Gambia, Banjul, Gambia; [Forsyth, Mark H.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; University of Kentucky; Vanderbilt University; University of London; London School of Hygiene & Tropical Medicine; William & Mary; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Cover, TL (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.; Cover, TL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.; Cover, TL (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	timothy.l.cover@vanderbilt.edu	Shaffer, Carrie/X-6106-2019; McClain, Mark S/A-6942-2009; Cover, Timothy/I-3814-2015	McClain, Mark S/0000-0002-9857-4883; Brooks, Andrew/0000-0002-9237-5349; Shaffer, Carrie L./0000-0002-7457-7422; Forsyth, Mark/0000-0001-8653-6508; Cover, Timothy/0000-0001-8503-002X	National Institutes of Health [A1118932, A1039657, CM 16087]; U.S. Department of Veterans Affairs [2101BX000627]; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118932, R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health A1118932, A1039657, CM 16087 (TC); and U.S. Department of Veterans Affairs 2101BX000627 (TC).	[Anonymous], 1994, IARC MONOGRAPHS EVAL; Asombang AW, 2014, WORLD J GASTROENTERO, V20, P3875, DOI 10.3748/wjg.v20.i14.3875; Baltrus DA, 2009, GENOME DYNAM, V6, P75, DOI 10.1159/000235764; Belogolova E, 2013, CELL MICROBIOL, V15, P1896, DOI 10.1111/cmi.12158; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Chiou PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071208; Cover TL, 2016, MBIO, V7, DOI 10.1128/mBio.01869-15; Cover TL, 2013, GUT MICROBES, V4, P482, DOI 10.4161/gmic.26262; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Duncan SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055120; Duncan SS, 2012, J BACTERIOL, V194, P1593, DOI 10.1128/JB.06340-11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fischer W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-310; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fox JG, 2014, TOXICOL PATHOL, V42, P162, DOI 10.1177/0192623313512564; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Frick-Cheng AE, 2016, MBIO, V7, DOI 10.1128/mBio.02001-15; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kodaman N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00290; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kumar N, 2015, NUCLEIC ACIDS RES, V43, P324, DOI 10.1093/nar/gku1271; Linz B, 2007, RES MICROBIOL, V158, P737, DOI 10.1016/j.resmic.2007.09.006; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu W, 2014, J BACTERIOL, V196, P1073, DOI 10.1128/JB.01021-13; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004; Montano V, 2015, GENETICS, V200, P947, DOI 10.1534/genetics.115.176404; Moodley Y, 2009, GENOME DYNAM, V6, P62, DOI 10.1159/000235763; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Munoz-Ramirez ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00050; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Secka O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109466; Secka O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027954; Snider CA, 2015, J PROTEOMIC IN PRESS; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Suzuki M, 2011, J BIOL CHEM, V286, P29964, DOI 10.1074/jbc.M111.263715; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tegtmeyer N, 2017, MOL MICROBIOL; Thorell K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006546; van Vliet AHM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw296; Yahara K, 2013, MOL BIOL EVOL, V30, P1454, DOI 10.1093/molbev/mst055; Yao Jiqiang, 2007, In Silico Biology, V7, P195	60	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188804	10.1371/journal.pone.0188804	http://dx.doi.org/10.1371/journal.pone.0188804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186206	Green Submitted, Green Published, gold			2022-12-26	WOS:000416484900063
J	Abdel-Rahman, O				Abdel-Rahman, Omar			Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; AMERICAN JOINT COMMITTEE; SURVIVAL; MORTALITY; CARCINOMA; MODEL	Background The American Joint Committee on Cancer (AJCC) staging system (8th edition) for prostate cancer has been published. The current study seeks to validate the prognostic performance of the changes in the new system among clinically staged prostate cancer patients registered within the surveillance, epidemiology and end results (SEER) database. Methods SEER database (2004-2014) has been accessed through SEER*Stat program and AJCC 7th and 8th edition stages were calculated utilizing T, N and M stages as well as baseline prostatic specific antigen (PSA) and grade group. Cancer-specific and overall survival analyses according to 6th, 7th and 8th editions were conducted through Kaplan-Meier analysis. Moreover, multivariate analysis was conducted through a Cox proportional hazard model. Results A total of 110499 patients with prostate cancer were identified in the period from 2004-2014. For cancer-specific survival according to 8th AJCC, all pair wise P values for comparison were significant (<0.01) except for stage IIA vs. IIB; while for overall survival according to 8th AJCC, all pair wise P values for comparison were significant (<0.02) except for stage IIIA vs. IIIB. Results of c-index assessment for cancer-specific survival for the three AJCC editions were as follows: c-index for AJCC 6th edition was 0.816; c-index for AJCC 7th edition was 0.897; c-index for AJCC 8th edition was 0.907. For stage IVB prostate cancer (i.e. M1 disease), further sub-staging was proposed according to M1 sub-stage (i.e. M1a, M1b and M1c). Pair wise comparison between these proposed sub-stages was conducted for both cancer-specific and overall survival. For both cancer-specific and overall survival, all pair wise P values for comparisons were <0.0001. Conclusion Compared to older staging systems (6th and 7th), the 8th system is more discriminatory. Further sub-classification of stage IV disease is suggested.	[Abdel-Rahman, Omar] Ain Shams Univ, Clin Oncol Dept, Fac Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	Abdel-Rahman, O (corresponding author), Ain Shams Univ, Clin Oncol Dept, Fac Med, Cairo, Egypt.	Omar.abdelrhman@med.asu.edu.eg		Abdel-Rahman Abdelsalam, Omar M/0000-0002-5117-2502				Abdel-Rahman O., 2017, CLIN ONCOL R COLL RA; Abdel-Rahman O., THER ADV UROL; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; [Anonymous], DAT INC SEER 18 REGS; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Buyyounouski MK, 2017, CA CANC J CLIN; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Gillessen S, 2015, ANN ONCOL; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Gravis G, 2015, EUR UROL, V68, P196, DOI 10.1016/j.eururo.2014.09.022; Halabi S, 2013, JNCI-J NATL CANCER I; Halabi S, 2014, J CLIN ONCOL, V32, P671, DOI 10.1200/JCO.2013.52.3696; Izumi K, 2015, PROSTATE, V75, P1034, DOI 10.1002/pros.22985; Kattan MW, 2016, CA-CANCER J CLIN, V66, P370, DOI 10.3322/caac.21339; Muralidhar V, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0470-0; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Rusthoven CG, 2014, UROLOGIC ONCOLOGY SE; Schymura MJ, 2014, CANCER-AM CANCER SOC, V120, P3758, DOI 10.1002/cncr.29052; Shukla ME, 2015, CLIN GENITOURIN CANC, V13, P17, DOI 10.1016/j.clgc.2014.07.003; Wong MH, 2014, ANN ACAD MED SINGAP, V43, P484; Zaorsky NG, 2012, CANCER-AM CANCER SOC, V118, P5535, DOI 10.1002/cncr.27597	22	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188450	10.1371/journal.pone.0188450	http://dx.doi.org/10.1371/journal.pone.0188450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182656	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000030
J	Mettang, M; Reichel, SN; Lattke, M; Palmer, A; Abaei, A; Rasche, V; Huber-Lang, M; Baumann, B; Wirth, T				Mettang, Melanie; Reichel, Stephanie Nadine; Lattke, Michael; Palmer, Annette; Abaei, Alireza; Rasche, Volker; Huber-Lang, Markus; Baumann, Bernd; Wirth, Thomas			IKK2/NF-kappa B signaling protects neurons after traumatic brain injury	FASEB JOURNAL			English	Article						neuroinflammation; apoptosis neurological outcome; neurodegeneration; conditional mouse model	NF-KAPPA-B; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; REDUCES INFLAMMATION; FUNCTIONAL RECOVERY; ACTIVATION; EXPRESSION; EPIDEMIOLOGY; MICE	Traumatic brain injury (TBI) is the leading cause of death in young adults. After the initial injury, a poorly understood secondary phase, including a strong inflammatory response determines the final outcome of TBI. The inhibitor of NF-kappa B kinase (IKK)/NF-kappa B signaling system is the key regulator of inflammation and also critically involved in regulation of neuronal survival and synaptic plasticity. We addressed the neuron-specific function of IKK2/NF-kappa B signaling pathway in TBI using an experimental model of closed-head injury (CHI) in combination with mouse models allowing conditional regulation of IKK/NF-kappa B signaling in excitatory forebrain neurons. We found that repression of IKK2/NF-kappa B signaling in neurons increases the acute posttraumatic mortality rate, worsens the neurological outcome, and promotes neuronal cell death by apoptosis, thus resulting in enhanced proinflammatory gene expression. As a potential mechanism, we identified elevated levels of the proapoptotic mediators Bax and Bad and enhanced expression of stress response genes. This phenotype is also observed when neuronal IKK/NF-kappa B activity is inhibited just before CHI. In contrast, neuron-specific activation of IKK/NF-kappa B signaling does not alter the TBI outcome. Thus, this study demonstrates that physiological neuronal IKK/NF-kappa B signaling is necessary and sufficient to protect neurons from trauma consequences.	[Mettang, Melanie; Reichel, Stephanie Nadine; Lattke, Michael; Baumann, Bernd; Wirth, Thomas] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Abaei, Alireza; Rasche, Volker] Ulm Univ, Core Facil Small Anim Magnet Resonance Imaging, Ulm, Germany; [Lattke, Michael] Francis Crick Inst, Neural Stem Cell Biol Lab, London, England; [Palmer, Annette; Huber-Lang, Markus] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany	Ulm University; Ulm University; Francis Crick Institute; Ulm University	Wirth, T (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	thomas.wirth@uni-ulm.de	Wirth, Thomas/X-7172-2019; Huber-Lang, Markus/AAJ-2209-2020; Lattke, Michael/AAE-5079-2020; Rasche, Volker/P-6523-2016	Lattke, Michael/0000-0001-5533-8592; Rasche, Volker/0000-0001-8844-3583	German research foundation [CRC1149]	German research foundation(German Research Foundation (DFG))	The authors thank Petra Weihrich, Melanie Gerstenlauer, Annika Gnann, Ute Leschik (all from the Institute of Physiological Chemistry, Ulm University), and Sonja Braumuller (Institute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm) for excellent technical assistance. This work was supported by the German research foundation (CRC1149/Project A03 to T.W. and CRC1149/Project Z03). Melanie Mettang and Stephanie N. Reichel are members of the International Graduate School in Molecular Medicine Ulm (IGradU). The authors declare no conflicts of interest.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Acarin L, 1998, NEUROREPORT, V9, P2869, DOI 10.1097/00001756-199808240-00035; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cucchiara B, 2001, J NEUROL SCI, V187, P81, DOI 10.1016/S0022-510X(01)00529-9; Duckworth EAM, 2006, BRAIN RES, V1088, P167, DOI 10.1016/j.brainres.2006.02.103; Engelmann C, 2014, NEURAL REGEN RES, V9, P707, DOI 10.4103/1673-5374.131572; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gabriel C, 1999, MOL BRAIN RES, V65, P61, DOI 10.1016/S0169-328X(98)00330-1; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kaltschmidt B., 2015, BRAIN FRONT MOL NEUR, V8, P69, DOI DOI 10.3389/FNM0L.2015.00069; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Lagraoui M, 2017, BRAIN BEHAV IMMUN, V61, P96, DOI 10.1016/j.bbi.2016.12.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lattke M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0157-0; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Ledoux AC, 2014, BIOCHEM SOC T, V42, P76, DOI 10.1042/BST20130156; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maqbool A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-40; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pennypacker KR, 2001, EXP NEUROL, V172, P307, DOI 10.1006/exnr.2001.7817; Pennypacker KR, 2000, ACTA NEUROBIOL EXP, V60, P515; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmidt-Strassburger U, 2012, FASEB J, V26, P4990, DOI 10.1096/fj.12-208587; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Widera D, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.041804; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Yuan YM, 2015, BRAIN BEHAV IMMUN, V48, P287, DOI 10.1016/j.bbi.2015.04.008	77	49	51	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1916	1932		10.1096/fj.201700826R	http://dx.doi.org/10.1096/fj.201700826R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29187362	Green Published			2022-12-26	WOS:000429051400015
J	Murray, J; Whitson, RH; Itakura, K				Murray, Jennifer; Whitson, Robert H.; Itakura, Keiichi			Reduced prostaglandin I-2 signaling in Arid5b(-/-) primary skeletal muscle cells attenuates myogenesis	FASEB JOURNAL			English	Article						myoblast; differentiation; prostacyclin; migration; cell fusion	MYOBLAST MIGRATION; SATELLITE CELLS; STEM-CELLS; IN-VITRO; FUSION; DIFFERENTIATION; PROLIFERATION; PROTEINS; PATHWAY; MICE	The AT-rich interaction domain (ARID) family of proteins regulates gene expression, development, and differentiation. Although Arid5b has important functions in adipogenesis and chondrogenesis, the role of Arid5b in skeletal muscle myogenesis has not been investigated. Therefore, we isolated primary skeletal muscle cells from Arid5b(+/+) and Arid5b(-/-) mice and characterized differentiation in these cells. We found that Arid5b(-/-) primary skeletal muscle cells showed differentiation defects and impaired sarcomeric assembly. Microarray analysis revealed down-regulation of the prostanoid biosynthesis pathway in Arid5b(-/-) myoblasts, including the genes encoding cyclooxygenase (COX)-1 (Ptgs1) and prostaglandin (PG) I synthase (Ptgis). Down-regulation of COX-1 and PGI synthase was confirmed by real-time PCR and Western blot analyses. Correspondingly, the production of PGI(2), as measured by ELISA, was reduced in Arid5b(-/-) cells relative to Arid5b(+/+) cells. Boyden chamber assays showed that migration was increased but chemotaxis was impaired in Arid5b(-/-) cells. Myoblast fusion was also inhibited in Arid5b(-/-) cells compared with Arid5b(+/+) cells. Treatment with the PGI(2) analog iloprost rescued the defects in myotube formation, migration, and fusion. These results demonstrate that Arid5b has a novel and essential role in skeletal muscle differentiation by regulating PGI(2) production.	[Murray, Jennifer; Whitson, Robert H.; Itakura, Keiichi] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Murray, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jmurray@coh.org			U.S. National Institutes of Health (NIH) National Cancer Institute [P30CA033572]; Genentech; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded, in part, by Genentech royalties to K.I. Research reported in this publication included work performed in the Analytical Cytometry Core and the Integrative Genomics Core, supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (P30CA033572). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bondesen BA, 2007, FASEB J, V21, P3338, DOI 10.1096/fj.06-7070com; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Hata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3850; Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085; Jansen KM, 2008, CELL DEATH DIFFER, V15, P1619, DOI 10.1038/cdd.2008.90; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Korotkova M, 2014, NAT REV RHEUMATOL, V10, P295, DOI 10.1038/nrrheum.2014.2; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mackey AL, 2013, J APPL PHYSIOL, V115, P900, DOI 10.1152/japplphysiol.00044.2013; Markworth JF, 2011, AM J PHYSIOL-CELL PH, V300, pC671, DOI 10.1152/ajpcell.00549.2009; MCLENNAN IS, 1991, J ANAT, V174, P115; Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Otis JS, 2005, EXP CELL RES, V310, P417, DOI 10.1016/j.yexcr.2005.08.009; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schoenfeld BJ, 2012, SPORTS MED, V42, P1017, DOI 10.2165/11635190-000000000-00000; Shen W, 2006, J APPL PHYSIOL, V101, P1215, DOI 10.1152/japplphysiol.01331.2005; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; VANDENBURGH HH, 1990, AM J PHYSIOL, V259, pC232, DOI 10.1152/ajpcell.1990.259.2.C232; Whitson RH, 1999, BIOCHEM BIOPH RES CO, V258, P326, DOI 10.1006/bbrc.1999.0643; Whitson RH, 2003, BIOCHEM BIOPH RES CO, V312, P997, DOI 10.1016/j.bbrc.2003.11.026; Yamakawa T, 2008, MOL ENDOCRINOL, V22, P441, DOI 10.1210/me.2007-0271; ZALIN RJ, 1987, EXP CELL RES, V172, P265, DOI 10.1016/0014-4827(87)90386-7; ZALIN RJ, 1975, FEBS LETT, V53, P33, DOI 10.1016/0014-5793(75)80675-2	36	4	4	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1868	1879		10.1096/fj.201700453RR	http://dx.doi.org/10.1096/fj.201700453RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196500	Green Published, hybrid			2022-12-26	WOS:000429051400011
J	Romey-Glusing, R; Li, Y; Hoffmann, J; von Frieling, J; Knop, M; Pfefferkorn, R; Bruchhaus, I; Fink, C; Roeder, T				Romey-Gluesing, Renja; Li, Yang; Hoffmann, Julia; von Frieling, Jakob; Knop, Mirjam; Pfefferkorn, Roxana; Bruchhaus, Iris; Fink, Christine; Roeder, Thomas			Nutritional regimens with periodically recurring phases of dietary restriction extend lifespan in Drosophila	FASEB JOURNAL			English	Article						lifespan extension; sex differences; insulin; metabolic rate; impl2	INSULIN-PRODUCING NEURONS; CALORIC RESTRICTION; METABOLIC-RATE; CAENORHABDITIS-ELEGANS; VOLUNTARY EXERCISE; FEMALE DROSOPHILA; GENE-EXPRESSION; BLOOD-PRESSURE; BODY-WEIGHT; PROTEIN	Nutritional interventions such as caloric and dietary restriction increase lifespan in various animal models. To identify alternative and less demanding nutritional interventions that extend lifespan, we subjected fruit flies (Drosophila melanogaster) to weekly nutritional regimens that involved alternating a conventional diet with dietary restriction. Short periods of dietary restriction (up to 2 d) followed by longer periods of a conventional diet yielded minimal increases in lifespan. We found that 3 or more days of contiguous dietary restriction (DR) was necessary to yield a lifespan extension similar to that observed with persistent DR. Female flies were more responsive to these interventions than males. Physiologic changes known to be associated with prolonged DR, such as reduced metabolic rates, showed the same time course as lifespan extension. Moreover, concurrent transcriptional changes indicative of reduced insulin signaling were identified with DR. These physiologic and transcriptional changes were sustained, as they were detectable several days after switching to conventional diets. Taken together, diets with longer periods of DR extended lifespan concurrently with physiologic and transcriptional changes that may underlie this increase in lifespan.	[Romey-Gluesing, Renja; Li, Yang; Hoffmann, Julia; von Frieling, Jakob; Knop, Mirjam; Pfefferkorn, Roxana; Fink, Christine; Roeder, Thomas] Univ Kiel, Inst Zool, Dept Mol Physiol, Botanischen Garten 1-9, D-24118 Kiel, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Fink, Christine; Roeder, Thomas] ARCN, German Ctr Lung Res DZL, Grosshansdorf, Germany; [Romey-Gluesing, Renja] Univ Hamburg, Dept Biol, Hamburg, Germany; [Li, Yang] Ocean Univ China, Dept Marine Geosci, Qingdao, Peoples R China; [Hoffmann, Julia] Amedon GmbH, Lubeck, Germany	University of Kiel; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; Ocean University of China	Roeder, T (corresponding author), Univ Kiel, Inst Zool, Dept Mol Physiol, Botanischen Garten 1-9, D-24118 Kiel, Germany.	troeder@zoologie.uni-kiel.de	Roeder, Thomas/B-9016-2011; Fink, Christine/ABF-7102-2021	Roeder, Thomas/0000-0002-3489-3834; Fink, Christine/0000-0003-0083-2168	Deutsche Forschungsgemeinschaft [CRC1182]; BMB+F (Vision Epifood)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMB+F (Vision Epifood)	The authors thank Britta Laubenstein and Christiane Sandberg (Kiel University) for excellent technical help; the Bloomington Drosophila Stock Center for fly stocks, and Sangbin Park and Seung Kim (Stanford University, CA, USA) for the dILP2-tagged flies and the reagents to perform the initial experiments. This work was supported by the Deutsche Forschungsgemeinschaft (CRC1182, Project C2) and the BMB+F (Vision Epifood). The authors declare no conflicts of interest.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; ANDERSSON B, 1988, ACTA MED SCAND, V223, P485; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Bruce KD, 2013, EXP GERONTOL, V48, P1129, DOI [10.1016/j.exger.2013.02.003, 10.1016/j.exge]; Brzek P, 2012, J EXP BIOL, V215, P3191, DOI 10.1242/jeb.065318; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; El-Kholy S, 2015, CELL TISSUE RES, V361, P669, DOI 10.1007/s00441-015-2137-4; Fink C, 2013, APPL ENVIRON MICROB, V79, P6984, DOI 10.1128/AEM.01903-13; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Franz O, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.11.e3; GARABEDIAN MJ, 1985, P NATL ACAD SCI USA, V82, P1396, DOI 10.1073/pnas.82.5.1396; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; GOODRICK CL, 1983, EXP AGING RES, V9, P203, DOI 10.1080/03610738308258453; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; Haselton Aaron T, 2011, J Vis Exp, DOI 10.3791/2722; Heck MJ, 2017, J GERONTOL A-BIOL, V72, P616, DOI 10.1093/gerona/glw094; Hildebrandt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023796; Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Jiang JC, 2000, FASEB J, V14, P2135; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Lee C, 2016, F1000RES, V5, pF1000, DOI DOI 10.12688/F1000RESEARCH.7136.1; Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35359; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MCCARTER RJ, 1989, AM J PHYSIOL, V257, pE175, DOI 10.1152/ajpendo.1989.257.2.E175; Mirzaei H, 2016, CURR OPIN CLIN NUTR, V19, P74, DOI 10.1097/MCO.0000000000000239; Mirzaei H, 2014, TRENDS ENDOCRIN MET, V25, P558, DOI 10.1016/j.tem.2014.07.002; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarraf-Zadeh L, 2013, DEV BIOL, V381, P97, DOI 10.1016/j.ydbio.2013.06.008; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700; Whitaker R, 2014, AGING-US, V6, P355, DOI 10.18632/aging.100662; Yatsenko A. S., 2014, JOVE-J VIS EXP, V88; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105	67	9	9	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1993	2003		10.1096/fj.201700934R	http://dx.doi.org/10.1096/fj.201700934R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196499				2022-12-26	WOS:000429051400021
J	Merriman, C; Huang, Q; Gu, W; Yu, LP; Fu, D				Merriman, Chengfeng; Huang, Qiong; Gu, Wei; Yu, Liping; Fu, Dax			A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cells; cell surface antigen; pancreatic islet; therapeutic target; ZnT8	ZINC TRANSPORTER ZNT8; INSULIN-DEPENDENT DIABETICS; BETA-CELLS; B-CELLS; TYPE-1; AUTOANTIBODIES; AUTOANTIGEN; RISK; MICE; IDENTIFICATION	The islet-specific zinc transporter ZnT8 is a major self-antigen found in insulin granules of pancreatic -cells. Frequent insulin secretion exposes ZnT8 to the cell surface, but the humoral antigenicity of the surface-displayed ZnT8 remains unknown. Here we show that a membrane-embedded human ZnT8 antigen triggered a vigorous immune response in ZnT8 knock-out mice. Approximately 50% of serum immunoreactivities toward ZnT8 were mapped to its transmembrane domain that is accessible to extracellular ZnT8 antibody (ZnT8A). ZnT8A binding was detected on live rat insulinoma INS-1E cells, and the binding specificity was validated by a CRISPR/Cas9 mediated ZnT8 knock-out. Applying established ZnT8A assays to purified serum antibodies from patients with type 1 diabetes, we detected human ZnT8A bound to live INS-1E cells, whereas a ZnT8 knock-out specifically reduced the surface binding. Our results demonstrate that ZnT8 is a cell surface self-antigen, raising the possibility of a direct involvement in antibody-mediated -cell dysfunction and cytotoxicity.	[Merriman, Chengfeng; Huang, Qiong; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA; [Gu, Wei] Amgen Inc, Sect Metab Disorders, Thousand Oaks, CA 91320 USA; [Yu, Liping] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	Johns Hopkins University; Johns Hopkins Medicine; Amgen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961	National Institutes of Health [S10OD016374, S10OD016315, S10RR13777001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374, S10OD016315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Hao Zhang from the Flow Cytometry and Immunology Core Facility at Johns Hopkins Bloomberg School of Public Health for assistance in flow cytometry data acquisition and analysis. The Zeiss confocal microscope was supported through National Institutes of Health shared instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was supported through National Institutes of Health Grants S10OD016315 and S10RR13777001.	Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; DOBERSEN MJ, 1982, DIABETES, V31, P459, DOI 10.2337/diabetes.31.5.459; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hinman RM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0543-8; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; LERNMARK A, 1978, NEW ENGL J MED, V299, P375, DOI 10.1056/NEJM197808242990802; Li SF, 2013, VACCINE, V31, P1610, DOI 10.1016/j.vaccine.2012.12.008; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Niegowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22266; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; PETERSON C, 1992, DIABETES RES CLIN PR, V17, P33, DOI 10.1016/0168-8227(92)90041-O; RABIN DU, 1994, J IMMUNOL, V152, P3183; Scotto M, 2012, DIABETOLOGIA, V55, P2026, DOI 10.1007/s00125-012-2543-z; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tooley JE, 2014, CURR OPIN ENDOCRINOL, V21, P287, DOI 10.1097/MED.0000000000000076; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; VANDEWINKEL M, 1982, J CLIN INVEST, V70, P41, DOI 10.1172/JCI110601; VIVES M, 1992, DIABETES, V41, P1624, DOI 10.2337/diabetes.41.12.1624; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wan H, 2017, P NATL ACAD SCI USA, V114, P10196, DOI 10.1073/pnas.1711169114; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wenzlau JM, 2013, CURR DIABETES REP, V13, P608, DOI 10.1007/s11892-013-0405-9; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	39	13	13	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					579	587		10.1074/jbc.RA117.000195	http://dx.doi.org/10.1074/jbc.RA117.000195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184000	hybrid, Green Published			2022-12-26	WOS:000419915400014
J	Miyazawa, M; Noguchi, K; Kujirai, M; Katayama, K; Yamagoe, S; Sugimoto, Y				Miyazawa, Masanori; Noguchi, Kohji; Kujirai, Mana; Katayama, Kazuhiro; Yamagoe, Satoshi; Sugimoto, Yoshikazu			IL-10 promoter transactivation by the viral K-RTA protein involves the host-cell transcription factors, specificity proteins 1 and 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; interleukin; specificity protein 1 (Sp1); transcription; viral transcription; IL-10; SP3; transactivation	SARCOMA-ASSOCIATED HERPESVIRUS; READING FRAME 50; EFFUSION LYMPHOMA-CELLS; KAPOSIS-SARCOMA; GENE-EXPRESSION; LYTIC-CYCLE; CASTLEMAN-DISEASE; BINDING PROTEIN; ORF50 PROTEIN; DNA-BINDING	Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) causes a persistent infection, presenting latent and lytic replication phases during its life cycle. KSHV-related diseases are associated with deregulated expression of inflammatory cytokines, including IL-6 and IL-10, but the mechanisms underlying this dysregulation are unclear. Herein, we report a molecular mechanism for KSHV-induced IL-10 gene expression. KSHV replication and transcription activator (K-RTA) is a molecular switch for the initiation of expression of viral lytic genes, and we describe, for the first time, that K-RTA significantly activates the promoter of the human IL-10 gene. Of note, mutations involving a basic region of K-RTA reduced the association of K-RTA with the IL-10 promoter. Moreover, the host-cell transcription factors, specificity proteins (SP) 1 and 3, play a pivotal cooperative role in K-RTA-mediated transactivation of the IL-10 promoter. K-RTA can interact with SP1 and SP3 directly in vitro, and electrophoresis mobility shift assays (EMSAs) revealed co-operative interaction involving K-RTA, SP1, and SP3 in binding to the IL-10 promoter. As DNase I footprinting assays indicated that K-RTA did not affect SP3 binding to the IL-10 promoter, SP3 can function to recruit K-RTA to the IL-10 promoter. These findings indicate that K-RTA can directly contribute to IL-10 up-regulation via a functional interplay with the cellular transcription factors SP1 and SP3.	[Miyazawa, Masanori; Noguchi, Kohji; Kujirai, Mana; Katayama, Kazuhiro; Sugimoto, Yoshikazu] Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan; [Yamagoe, Satoshi] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan	Keio University; National Institute of Infectious Diseases (NIID)	Noguchi, K (corresponding author), Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	nogu-chi-kj@pha.keio.ac.jp	Katayama, Kazuhiro/AAH-2914-2019	Katayama, Kazuhiro/0000-0003-4232-7661	Japan Society for the Promotion of Science KAKENHI [S1411004, 15K14409, 26460076]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science KAKENHI S1411004, 15K14409, and 26460076. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki Y, 2000, BLOOD, V96, P1599, DOI 10.1182/blood.V96.4.1599.h8001599_1599_1601; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bjerke GA, 2011, MOL CELL BIOL, V31, P3723, DOI 10.1128/MCB.01456-10; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Chang PJ, 2005, J VIROL, V79, P8750, DOI 10.1128/JVI.79.14.8750-8763.2005; Chang PJ, 2004, J VIROL, V78, P10657, DOI 10.1128/JVI.78.19.10657-10673.2004; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen JG, 2000, J VIROL, V74, P8623, DOI 10.1128/JVI.74.18.8623-8634.2000; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Guito Jonathan, 2012, Front Microbiol, V3, P30, DOI 10.3389/fmicb.2012.00030; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jackson B, 2011, J CELL SCI, V124, P1681, DOI 10.1242/jcs.077552; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Jones KD, 1999, BLOOD, V94, P2871; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Murray PJ, 1997, J IMMUNOL, V158, P315; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Noguchi K, 2017, J BIOL CHEM, V292, P1910, DOI 10.1074/jbc.M116.747048; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Palmeri D, 2011, J VIROL, V85, P11901, DOI 10.1128/JVI.05479-11; Persson LM, 2010, J VIROL, V84, P1334, DOI 10.1128/JVI.01301-09; Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Roan F, 2002, VIROLOGY, V301, P293, DOI 10.1006/viro.2002.1582; Santarelli R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04241; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song MJ, 2002, J VIROL, V76, P5000, DOI 10.1128/JVI.76.10.5000-5013.2002; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang L, 1998, DNA CELL BIOL, V17, P735	57	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					662	676		10.1074/jbc.M117.802900	http://dx.doi.org/10.1074/jbc.M117.802900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184003	Green Published, hybrid			2022-12-26	WOS:000419915400021
J	Nagy, N; de la Zerda, A; Kaber, G; Johnson, PY; Hu, KH; Kratochvil, MJ; Yadava, K; Zhao, WT; Cui, Y; Navarro, G; Annes, JP; Wight, TN; Heilshorn, SC; Bollyky, PL; Butte, MJ				Nagy, Nadine; de la Zerda, Adi; Kaber, Gernot; Johnson, Pamela Y.; Hu, Kenneth H.; Kratochvil, Michael J.; Yadava, Koshika; Zhao, Wenting; Cui, Yi; Navarro, Guadalupe; Annes, Justin P.; Wight, Thomas N.; Heilshorn, Sarah C.; Bollyky, Paul L.; Butte, Manish J.			Hyaluronan content governs tissue stiffness in pancreatic islet inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; autoimmune disease; diabetes; atomic force microscopy (AFM); hydrogels; tissue stiffness; extracellular matrix	MOLECULAR-WEIGHT HYALURONAN; EXTRACELLULAR-MATRIX; BINDING PROTEINS; STEM-CELLS; ACID; INHIBITION; INTEGRITY; INSULITIS; AUTOIMMUNITY; CONTRIBUTES	We have identified a novel role for hyaluronan (HA), an extracellular matrix polymer, in governing the mechanical properties of inflamed tissues. We recently reported that insulitis in type 1 diabetes of mice and humans is preceded by intraislet accumulation of HA, a highly hygroscopic polymer. Using the double transgenic DO11.10 x RIPmOVA (DORmO) mouse model of type 1 diabetes, we asked whether autoimmune insulitis was associated with changes in the stiffness of islets. To measure islet stiffness, we used atomic force microscopy (AFM) and developed a novel bed of nails-like approach that uses quartz glass nanopillars to anchor islets, solving a long-standing problem of keeping tissue-scale objects immobilized while performing AFM. We measured stiffness via AFM nanoindentation with a spherical indenter and found that insulitis made islets mechanically soft compared with controls. Conversely, treatment with 4-methylumbelliferone, a small-molecule inhibitor of HA synthesis, reduced HA accumulation, diminished swelling, and restored basal tissue stiffness. These results indicate that HA content governs the mechanical properties of islets. In hydrogels with variable HA content, we confirmed that increased HA leads to mechanically softer hydrogels, consistent with our model. In light of recent reports that the insulin production of islets is mechanosensitive, these findings open up an exciting new avenue of research into the fundamental mechanisms by which inflammation impacts local cellular responses.	[Nagy, Nadine; Kaber, Gernot; Kratochvil, Michael J.; Yadava, Koshika; Bollyky, Paul L.] Stanford Univ, Dept Med, Div Infect Dis, 279 Campus Dr,Beckman Ctr,Rm B237, Stanford, CA 94305 USA; [de la Zerda, Adi; Kratochvil, Michael J.; Zhao, Wenting; Cui, Yi; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Hu, Kenneth H.] Stanford Univ, Stanford Biophys, Stanford, CA 94305 USA; [Navarro, Guadalupe; Annes, Justin P.] Stanford Univ, Dept Med, Div Endocrinol, Stanford, CA 94305 USA; [Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol Allergy & Rheumatol, Stanford, CA 94305 USA; [Johnson, Pamela Y.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA; [Butte, Manish J.] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Benaroya Research Institute; University of California System; University of California Los Angeles	Nagy, N (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, 279 Campus Dr,Beckman Ctr,Rm B237, Stanford, CA 94305 USA.	nnagy@stanford.edu	Butte, Manish/T-8860-2019; Cui, Yi/L-5804-2013; zhao, wenting/AAB-5269-2019; ZHAO, Wenting/M-8613-2016; Butte, Manish/AAM-8604-2020	Butte, Manish/0000-0002-4490-5595; Cui, Yi/0000-0002-6103-6352; zhao, wenting/0000-0002-6143-5185; ZHAO, Wenting/0000-0002-6143-5185; Butte, Manish/0000-0002-4490-5595; Heilshorn, Sarah/0000-0002-9801-6304; Annes, Justin/0000-0001-8431-3589	Deutsche Forschungsgemeinschaft [NA 965/2-1, KA 3441/1-1]; National Institutes of Health [R01 DK096087-01, R01 GM111808, U01 AI101984, R01 DK101530, R01 GM110482, U01 AI101990]; National Science Foundation Graduate Research Fellowship; National Science Foundation [CBET-1264833]; Stanford Diabetes Research Center; Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology; Juvenile Diabetes Research Foundation [1-SRA-2018-518-S-B, nPOD 25-2010-648, 3-PDF-2014-224-A-N]; Harrington Foundation; Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101990, U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101530, P30DK017047, R01DK096087, P30DK116074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111808, R01GM110482] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Stanford Diabetes Research Center; Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Harrington Foundation; Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants NA 965/2-1 (to N. N.) and KA 3441/1-1 (to G. K.); National Institutes of Health Grants R01 DK096087-01, R01 GM111808, and U01 AI101984 (to P. L. B.), R01 DK101530 (to J. P. A.), and R01 GM110482 (to M. J. B.); National Institutes of Health Pilot Project Grant U01 AI101990 (to T. N. W.); a National Science Foundation Graduate Research Fellowship (to A. d. l. Z.); National Science Foundation Grant CBET-1264833 (to M. J. B.); a P&F award from the Stanford Diabetes Research Center (to N. N.); a grant from the Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology (to M. J. K.); Juvenile Diabetes Research Foundation Grants 1-SRA-2018-518-S-B (to P. L. B.), nPOD 25-2010-648 (to T. N. W.), and 3-PDF-2014-224-A-N (to N. N.); a Harrington Foundation grant (to P. L. B.); and a grant from the Stanford Child Health Research Institute (to M. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assavag-Asherie N., 2015, PLOS ONE, V1; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Bollyky PL, 2012, CURR DIABETES REP, V12, P471, DOI 10.1007/s11892-012-0297-0; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Cavallari G, 2012, CELL TRANSPLANT, V21, P2771, DOI 10.3727/096368912X637046; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Chaurasia SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037456; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hanson L, 2015, NAT NANOTECHNOL, V10, P554, DOI [10.1038/nnano.2015.88, 10.1038/NNANO.2015.88]; Harrington S, 2017, TISSUE ENG PT A, V23, P1088, DOI [10.1089/ten.tea.2016.0477, 10.1089/ten.TEA.2016.0477]; Hesterberg, 2015, RESAMPLE RESAMPLING; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Irving-Rodgers HF, 2008, DIABETOLOGIA, V51, P1680, DOI 10.1007/s00125-008-1085-x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; KATO Y, 1995, J RHEUMATOL, V22, P158; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kuipers HF, 2016, P NATL ACAD SCI USA, V113, P1339, DOI 10.1073/pnas.1525086113; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li YP, 2006, BIOMATERIALS, V27, P1437, DOI 10.1016/j.biomaterials.2005.08.020; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Morgan JT, 2014, BIOTECHNIQUES, V56, P40, DOI 10.2144/000114126; Mueller AM, 2014, J BIOL CHEM, V289, P22888, DOI 10.1074/jbc.M114.559583; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagy N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00123; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Nyitray CE, 2014, TISSUE ENG PT A, V20, P1888, DOI [10.1089/ten.TEA.2013.0692, 10.1089/ten.tea.2013.0692]; Rehfeldt F, 2012, INTEGR BIOL-UK, V4, P422, DOI 10.1039/c2ib00150k; Responte DJ, 2012, J R SOC INTERFACE, V9, P3564, DOI 10.1098/rsif.2012.0399; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Screen HRC, 2006, ACTA BIOMATER, V2, P505, DOI 10.1016/j.actbio.2006.05.008; Serban Monica A, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1014s40; Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Velten F, 1999, BIOMATERIALS, V20, P2161, DOI 10.1016/S0142-9612(99)00119-2; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	54	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					567	578		10.1074/jbc.RA117.000148	http://dx.doi.org/10.1074/jbc.RA117.000148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183997	hybrid, Green Published			2022-12-26	WOS:000419915400013
J	Kaireit, TF; Sorrentino, SA; Renne, J; Schoenfeld, C; Voskrebenzev, A; Gutberlet, M; Schulz, A; Jakob, PM; Hansen, G; Wacker, F; Welte, T; Tummler, B; Vogel-Claussen, J				Kaireit, Till F.; Sorrentino, Sajoscha A.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Schulz, Angela; Jakob, Peter M.; Hansen, Gesine; Wacker, Frank; Welte, Tobias; Tuemmler, Burkhard; Vogel-Claussen, Jens			Functional lung MRI for regional monitoring of patients with cystic fibrosis	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; HYPERTONIC SALINE; FOURIER DECOMPOSITION; CLEARANCE INDEX; MUCOCILIARY CLEARANCE; RESPIRATORY PHASE; CONTROLLED-TRIAL; T-1; PERFUSION; PERFORMANCE	Purpose To test quantitative functional lung MRI techniques in young adults with cystic fibrosis (CF) compared to healthy volunteers and to monitor immediate treatment effects of a single inhalation of hypertonic saline in comparison to clinical routine pulmonary function tests. Materials and methods Sixteen clinically stable CF patients and 12 healthy volunteers prospectively underwent two functional lung MRI scans and pulmonary function tests before and 2h after a single treatment of inhaled hypertonic saline or without any treatment. MRI-derived oxygen enhanced T-1 relaxation measurements, fractional ventilation, first-pass perfusion parameters and a morpho-functional CF-MRI score were acquired. Results Compared to healthy controls functional lung MRI detected and quantified significantly increased ventilation heterogeneity in CF patients. Regional functional lung MRI measures of ventilation and perfusion as well as the CF-MRI score and pulmonary function tests could not detect a significant treatment effect two hours after a single treatment with hypertonic saline in young adults with CF (p>0.05). Conclusion This study shows the feasibility of functional lung MRI as a non-invasive, radiation-free tool for monitoring patients with CF.	[Kaireit, Till F.; Sorrentino, Sajoscha A.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Kaireit, Till F.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Hansen, Gesine; Wacker, Frank; Welte, Tobias; Tuemmler, Burkhard; Vogel-Claussen, Jens] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany; [Schulz, Angela; Hansen, Gesine; Tuemmler, Burkhard] Hannover Med Sch, Dept Pediat Pulmonol Allergol & Neonatol, Hannover, Germany; [Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Welte, Tobias] Hannover Med Sch, Dept Resp Med, Hannover, Germany	Hannover Medical School; Hannover Medical School; University of Wurzburg; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019	Vogel-Claussen, Jens/0000-0001-5595-6948	Ernst-August-Schrader; BMBF; German Center for Lung Research, Disease Area CF	Ernst-August-Schrader; BMBF(Federal Ministry of Education & Research (BMBF)); German Center for Lung Research, Disease Area CF	This work was supported by the Ernst-August-Schrader and the BMBF, German Center for Lung Research, Disease Area CF. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2016, RESP MED, V112, P59, DOI 10.1016/j.rmed.2016.01.020; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bauman G, 2017, MAGN RESON MED, V77, P74, DOI 10.1002/mrm.26490; Bauman G, 2013, MAGN RESON MED, V69, P229, DOI 10.1002/mrm.24236; Bauman G, 2011, RADIOLOGY, V260, P551, DOI 10.1148/radiol.11102313; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; Bellin MF, 2008, EUR J RADIOL, V66, P160, DOI 10.1016/j.ejrad.2008.01.023; Deimling M, 2016, ISMRM 16 SCI M EXH; Dietrich O, 2010, INVEST RADIOL, V45, P165, DOI 10.1097/RLI.0b013e3181cd74e2; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Ellemunter H, 2016, J CYST FIBROS, V15, P123, DOI 10.1016/j.jcf.2015.06.009; Fuchs SI, 2016, RESP MED, V116, P93, DOI 10.1016/j.rmed.2016.04.015; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Jakob PM, 2004, MAGN RESON MED, V51, P1009, DOI 10.1002/mrm.20051; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Liou TG, 2010, J CYST FIBROS, V9, P250, DOI 10.1016/j.jcf.2010.04.002; Maffessanti M, 1996, J THORAC IMAG, V11, P27, DOI 10.1097/00005382-199601110-00002; Marshall H, 2017, THORAX, V72, P760, DOI 10.1136/thoraxjnl-2016-208948; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Nichols MB, 2008, J MAGN RESON IMAGING, V27, P224, DOI 10.1002/jmri.21243; O'Sullivan BP, 2009, SEMIN RESP CRIT CARE, V30, P505, DOI 10.1055/s-0029-1238909; Paulin GA, 2015, J MAGN RESON IMAGING, V41, P1701, DOI 10.1002/jmri.24744; Puderbach M, 2007, INVEST RADIOL, V42, P715, DOI 10.1097/RLI.0b013e318074fd81; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Reeves EP, 2012, SCI WORLD J, DOI 10.1100/2012/465230; Renne J, 2015, J MAGN RESON IMAGING, V41, P60, DOI 10.1002/jmri.24535; Robinson M, 1996, AM J RESP CRIT CARE, V153, P1503, DOI 10.1164/ajrccm.153.5.8630593; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schonfeld C, 2015, J MAGN RESON IMAGING, V42, P72, DOI 10.1002/jmri.24764; Smith L, 2017, AM J RESP CRIT CARE; Sourbron S, 2007, PHYS MED BIOL, V52, P429, DOI 10.1088/0031-9155/52/2/009; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stoltz DA, 2015, NEW ENGL J MED, V372, P1574, DOI 10.1056/NEJMc1502191; Triphan SMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172479; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Voskrebenzev A, 2016, MAGN RESON MED; Voskrebenzev A, 2016, MAGN RESON MED, V76, P1542, DOI 10.1002/mrm.26047; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Zapke M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-106; Zhang WJ, 2016, RADIOLOGY, V278, P906, DOI 10.1148/radiol.2015141876	49	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187483	10.1371/journal.pone.0187483	http://dx.doi.org/10.1371/journal.pone.0187483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216201	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800009
J	Russ, GR; Lowe, JR; Rizzari, JR; Bergseth, BJ; Alcala, AC				Russ, Garry R.; Lowe, Jake R.; Rizzari, Justin R.; Bergseth, Brock J.; Alcala, Angel C.			Partitioning no-take marine reserve (NTMR) and benthic habitat effects on density of small and large-bodied tropical wrasses	PLOS ONE			English	Article							CORAL-REEF FISH; GREAT-BARRIER-REEF; LABRID FISHES; EXTINCTION VULNERABILITY; TROPHIC RELATIONSHIPS; PATTERNS; MANAGEMENT; ABUNDANCE; IMPACTS; BIODIVERSITY	No-take marine reserves (NTMRs) are increasingly implemented for fisheries management and biodiversity conservation. Yet, assessing NTMR effectiveness depends on partitioning the effects of NTMR protection and benthic habitat on protected species. Such partitioning is often difficult, since most studies lack well-designed sampling programs (i.e. Before-After-Control-Impact-Pair designs) spanning long-term time scales. Spanning 31 years, this study quantifies the effects of NTMR protection and changes to benthic habitat on the density of tropical wrasses (F. Labridae) at Sumilon and Apo Islands, Philippines. Five species of wrasse were studied: two species of large-bodied (40-50 cm TL) Hemigymnus that were vulnerable to fishing, and three species of small-bodied (10-25 cm TL) Thalassoma and Cirrhilabrus that were not targeted by fishing. NTMR protection had no measurable effect on wrasse density, irrespective of species or body size, over 20 (Sumilon) and 31 (Apo) years of protection. However, the density of wrasses was often affected strongly by benthic cover. Hemigymnus spp. had a positive association with hard coral cover, while Thalassoma spp. and Cirrhilabrus spp. had strong positive associations with cover of rubble and dead substratum. These associations were most apparent after environmental disturbances (typhoons, coral bleaching, crown of thorns starfish (COTS) outbreaks, use of explosives and drive nets) reduced live hard coral cover and increased cover of rubble, dead substratum and sand. Disturbances that reduced hard coral cover often reduced the density of Hemigymnus spp. and increased the density of Thalassoma spp. and Cirrhilabrus spp. rapidly (1- 2 years). As hard coral recovered, density of Hemigymnus spp. often increased while density of Thalassoma spp. and Cirrhilabrus spp. often decreased, often on scales of 5-10 years. This study demonstrates that wrasse population density was influenced more by changes to benthic cover than by protection from fishing.	[Russ, Garry R.; Lowe, Jake R.; Rizzari, Justin R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Russ, Garry R.; Rizzari, Justin R.; Bergseth, Brock J.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Rizzari, Justin R.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia; [Alcala, Angel C.] SUAKCREM, Dumaguete, Negros, Philippines	James Cook University; James Cook University; University of Tasmania	Lowe, JR (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	jake.lowe@my.jcu.edu.au	Lowe, Jake/AAI-4407-2020	Lowe, Jake/0000-0002-2001-646X; Bergseth, Brock/0000-0002-5486-175X	ARC; Pew Fellowship; ARC Centre of Excellence for Coral Reef Studies [CE0561435, CE140100020]; Australian Government Research Training Program (RTP) Scholarship	ARC(Australian Research Council); Pew Fellowship; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was funded by a Pew Fellowship (GRR and ACA), an ARC Discovery grant (GRR and ACA) and the ARC Centre of Excellence for Coral Reef Studies (GRR) (CE0561435, CE140100020). JRL was supported by an Australian Government Research Training Program (RTP) Scholarship.	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Ackerman JL, 2004, THESIS; Alcala AC, 2002, ASIAN FISH SC, V15, P177; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; [Anonymous], 2017, R LANG ENV STAT COMP; Arceo HO, 2001, B MAR SCI, V69, P579; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Bernardi G, 2004, MARINE FRESHWATER B, V144; BRETT JR, 1965, J FISH RES BOARD CAN, V22, P1491, DOI 10.1139/f65-128; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Cowlishaw M, 2014, THESIS; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; ECKERT GJ, 1984, MAR BIOL, V78, P123, DOI 10.1007/BF00394691; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fulton CJ, 2002, MAR ECOL PROG SER, V236, P255, DOI 10.3354/meps236255; Fulton CJ, 2002, MAR ECOL PROG SER, V226, P135, DOI 10.3354/meps226135; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gouezo M, 2015, MAR ECOL PROG SER, V540, P73, DOI 10.3354/meps11518; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grant JWA, 1997, BEHAV ECOLOGY TELEOS, P83; Green AL, 1996, MAR ECOL PROG SER, V133, P1, DOI 10.3354/meps133001; Grutter AS, 1998, J FISH BIOL, V53, P49, DOI 10.1111/j.1095-8649.1998.tb00108.x; Grutter AS, 1995, MAR FRESHWATER RES, V46, P897, DOI 10.1071/MF9950897; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Holbrook SJ, 1996, STRUCTURE DYNAMICS T, P19; Hubble M, 2003, THESIS; Hughes TP, 2015, NAT CLIM CHANGE, V5, P508, DOI 10.1038/nclimate2604; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Kramer MJ, 2014, MAR ECOL PROG SER, V511, P105, DOI 10.3354/meps10953; Kuiter R.H., 2001, ZOONETICS, V2001, P304; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan T, 2002, AMBIO, V31, P543, DOI 10.1639/0044-7447(2002)031[0543:EOTCME]2.0.CO;2; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McLaren BW, 2015, J EXP MAR BIOL ECOL, V471, P153, DOI 10.1016/j.jembe.2015.06.002; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Pasko L, 2010, ZOO BIOL, V29, P767, DOI 10.1002/zoo.20307; Polunin NVC, 1996, REEF FISHERIES; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Randall JE, 1990, FISHES GREAT BARRIER; Randall JE, 1997, FISHES GREAT BARRIER; Russ GR, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3056-y; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Russ GR, 2015, CORAL REEFS, V34, P773, DOI 10.1007/s00338-015-1296-9; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; RUSS GR, 1989, MAR ECOL PROG SER, V56, P13, DOI 10.3354/meps056013; Sadovy Y., 2000, REEF FISHES HONG KON; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; SPRINGER VG, 1974, ISRAEL J ZOOL, V23, P45; THRESHER RE, 1986, B MAR SCI, V38, P253; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Westneat M, 2001, FAO SPECIES IDENTIFI, P3381; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	87	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188515	10.1371/journal.pone.0188515	http://dx.doi.org/10.1371/journal.pone.0188515			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216194	Green Published, gold, Green Accepted			2022-12-26	WOS:000417337800029
J	Wahabzada, M; Besser, M; Khosravani, M; Kuska, MT; Kersting, K; Mahlein, AK; Sturmer, E				Wahabzada, Mirwaes; Besser, Manuela; Khosravani, Milad; Kuska, Matheus Thomas; Kersting, Kristian; Mahlein, Anne-Katrin; Stuermer, Ewa			Monitoring wound healing in a 3D wound model by hyperspectral imaging and efficient clustering	PLOS ONE			English	Article								Wound healing is a complex and dynamic process with different distinct and overlapping phases from homeostasis, inflammation and proliferation to remodelling. Monitoring the healing response of injured tissue is of high importance for basic research and clinical practice. In traditional application, biological markers characterize normal and abnormal wound healing. Understanding functional relationships of these biological processes is essential for developing new treatment strategies. However, most of the present techniques (in vitro or in vivo) include invasive microscopic or analytical tissue sampling. In the present study, a non-invasive alternative for monitoring processes during wound healing is introduced. Within this context, hyperspectral imaging (HSI) is an emerging and innovative non-invasive imaging technique with different opportunities in medical applications. HSI acquires the spectral reflectance of an object, depending on its biochemical and structural characteristics. An in-vitro 3-dimensional (3-D) wound model was established and incubated without and with acute and chronic wound fluid (AWF, CWF), respectively. Hyperspectral images of each individual specimen of this 3-D wound model were assessed at day 0/5/10 in vitro, and reflectance spectra were evaluated. For analysing the complex hyperspectral data, an efficient unsupervised approach for clustering massive hyperspectral data was designed, based on efficient hierarchical decomposition of spectral information according to archetypal data points. It represents, to the best of our knowledge, the first application of an advanced Data Mining approach in context of non-invasive analysis of wounds using hyperspectral imagery. By this, temporal and spatial pattern of hyperspectral clusters were determined within the tissue discs and among the different treatments. Results from non-invasive imaging were compared to the number of cells in the various clusters, assessed by Hematoxylin/Eosin (H/E) staining. It was possible to correlate cell quantity and spectral reflectance during wound closure in a 3-D wound model in vitro.	[Wahabzada, Mirwaes; Kuska, Matheus Thomas; Mahlein, Anne-Katrin] Univ Bonn, INRES Phytomed, Nussalle 9, Bonn, Germany; [Besser, Manuela; Khosravani, Milad; Stuermer, Ewa] Univ Witten Herdecke, Dept Translat Wound Res, Ctr Biomed Educ & Res ZBAF, Witten, Germany; [Kersting, Kristian] Tech Univ Darmstadt, CS Dept, Darmstadt, Germany; [Mahlein, Anne-Katrin] Inst Sugar Beet Res IfZ, Gottingen, Germany	University of Bonn; Witten Herdecke University; Technical University of Darmstadt	Mahlein, AK (corresponding author), Univ Bonn, INRES Phytomed, Nussalle 9, Bonn, Germany.; Mahlein, AK (corresponding author), Inst Sugar Beet Res IfZ, Gottingen, Germany.	mahlein@ifz-goettingen.de		Mahlein, Anne-Katrin/0000-0003-1091-3690				Bauckhage C, 2013, KUNSTL INTELL, V27, P313, DOI 10.1007/s13218-013-0273-0; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Dasgupta S, 2009, IEEE T INFORM THEORY, V55, P3229, DOI 10.1109/TIT.2009.2021326; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Edelman GJ, 2012, FORENSIC SCI INT, V223, P28, DOI 10.1016/j.forsciint.2012.09.012; Faloutsos C., 1995, SIGMOD Record, V24, P163, DOI 10.1145/568271.223812; Farkas DL, 2001, PIGM CELL RES, V14, P2, DOI 10.1034/j.1600-0749.2001.140102.x; Gerstner AOH, 2014, LARYNGO RHINO OTOL, V92; Gillies Robert, 2003, Diabetes Technol Ther, V5, P847, DOI 10.1089/152091503322527058; Greenman RL, 2005, LANCET, V366, P1711, DOI 10.1016/S0140-6736(05)67696-9; Jansson K, 1996, IN VITRO CELL DEV-AN, V32, P534; Kersting K, 2010, JMLR WORKSH CONF PRO, V13, P253; Kester RT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574756; Kiyotoki S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026010; Kuska M, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0073-7; Leucker M, FUNCTIONAL PLANT BIO, V44, P1; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Mahlein AK, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-3; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Meroni M, 2009, REMOTE SENS ENVIRON, V113, P2037, DOI 10.1016/j.rse.2009.05.003; Moore G.K., 1979, HYDROLOGICAL SCI B, V24, P477, DOI [10.1080/02626667909491887, DOI 10.1080/02626667909491887]; Muldoon TJ, 2012, HEAD NECK-J SCI SPEC, V34, P305, DOI 10.1002/hed.21735; Neidrauer M, 2009, STUD MECHANOBIOL TIS, V1, P381; Paul DW, 2015, WOUND REPAIR REGEN, V23, P149, DOI 10.1111/wrr.12262; Payette JR, 2005, PLAST RECONSTR SURG, V115, P539, DOI 10.1097/01.PRS.0000148415.54546.CA; Qin JW, 2009, J FOOD ENG, V93, P183, DOI 10.1016/j.jfoodeng.2009.01.014; Randeberg LL, 2014, HYPERSPECTRAL CHARAC; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmidt WD, 2001, J INVEST DERMATOL, V116, P531, DOI 10.1046/j.1523-1747.2001.01297.x; Sen CK, 2016, PLAST RECONSTR SURG, V138, p119S, DOI 10.1097/PRS.0000000000002654; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sowa MG, 2001, BURNS, V27, P241, DOI 10.1016/S0305-4179(00)00111-X; Thomas S, 2017, FUNCT PLANT BIOL, V44, P23, DOI 10.1071/FP16127; Thurau C, 2012, DATA MIN KNOWL DISC, V24, P325, DOI 10.1007/s10618-011-0216-z; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; Wollina Uwe, 2005, Int J Low Extrem Wounds, V4, P97, DOI 10.1177/1534734605277465; Xu RX, 2012, BIOMED OPT EXPRESS, V3, P1433, DOI 10.1364/BOE.3.001433; Yudovsky D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3535592; Yudovsky Dmitry, 2010, J Diabetes Sci Technol, V4, P1099	41	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186425	10.1371/journal.pone.0186425	http://dx.doi.org/10.1371/journal.pone.0186425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216188	Green Submitted, gold, Green Published			2022-12-26	WOS:000417337800004
J	Kropp, HM; Betz, K; Wirth, J; Diederichs, K; Marx, A				Kropp, Heike M.; Betz, Karin; Wirth, Johannes; Diederichs, Kay; Marx, Andreas			Crystal structures of ternary complexes of archaeal B-family DNA polymerases	PLOS ONE			English	Article							ENZYMATIC INCORPORATION; CATALYZED INCORPORATION; STRUCTURE VALIDATION; URACIL RECOGNITION; NUCLEOTIDE; REPLICATION; MECHANISM; VISUALIZATION; MOLPROBITY; SUBSTRATE	Archaeal B-family polymerases drive biotechnology by accepting a wide substrate range of chemically modified nucleotides. By now no structural data for archaeal B-family DNA polymerases in a closed, ternary complex are available, which would be the basis for developing next generation nucleotides. We present the ternary crystal structures of KOD and 9 degrees N DNA polymerases complexed with DNA and the incoming dATP. The structures reveal a third metal ion in the active site, which was so far only observed for the eukaryotic B-family DNA polymerase delta and no other B-family DNA polymerase. The structures reveal a wide inner channel and numerous interactions with the template strand that provide space for modifications within the enzyme and may account for the high processivity, respectively. The crystal structures provide insights into the superiority over other DNA polymerases concerning the acceptance of modified nucleotides.	[Kropp, Heike M.; Betz, Karin; Wirth, Johannes; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Marx, Andreas] Univ Konstanz, Dept Chem, Constance, Baden Wurttembe, Germany	University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany.; Marx, A (corresponding author), Univ Konstanz, Dept Chem, Constance, Baden Wurttembe, Germany.	andreas.marx@uni-konstanz.de		Wirth, Johannes/0000-0002-2216-3332	European Research Council (ERC) [339834]; Konstanz Research School Chemical Biology	European Research Council (ERC)(European Research Council (ERC)); Konstanz Research School Chemical Biology	This work was supported by the European Research Council (ERC Advanced Grant 339834) and the Konstanz Research School Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Baccaro A, 2012, ANGEW CHEM INT EDIT, V51, P254, DOI 10.1002/anie.201105717; Balintova J, 2015, CHEM SCI, V6, P575, DOI 10.1039/c4sc01906g; Banerjee A, 2015, BIOCONJUGATE CHEM, V26, P1582, DOI 10.1021/acs.bioconjchem.5b00221; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; Bergen K, 2012, J AM CHEM SOC, V134, P11840, DOI 10.1021/ja3017889; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Borsenberger V, 2009, ORG BIOMOL CHEM, V7, P3826, DOI 10.1039/b906956a; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Burak MJ, 2016, EMBO J, V35, P2045, DOI 10.15252/embj.201694332; Busskamp H, 2014, CHEM COMMUN, V50, P10827, DOI 10.1039/c4cc04332d; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Darmostuk M, 2015, BIOTECHNOL ADV; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Forterre P, 2013, J MOL BIOL, V425, P4714, DOI 10.1016/j.jmb.2013.09.032; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Guo J, 2017, ACTA CRYSTALLOGR D, V73; Guo J, 2008, P NATL ACAD SCI USA, V105, P9145, DOI 10.1073/pnas.0804023105; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; Held HA, 2002, NUCLEIC ACIDS RES, V30, P3857, DOI 10.1093/nar/gkf500; Hikida Y, 2017, BIOCHEM BIOPH RES CO, V483, P52, DOI 10.1016/j.bbrc.2017.01.007; Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Hottin A, 2017, CHEM-EUR J, V23, P2109, DOI 10.1002/chem.201604515; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann GF, 2005, ANGEW CHEM INT EDIT, V44, P2144, DOI 10.1002/anie.200461143; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Mackova M, 2015, CHEMBIOCHEM, V16, P2225, DOI 10.1002/cbic.201500315; Masud MM, 2003, CHEMBIOCHEM, V4, P584, DOI 10.1002/cbic.200200539; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Obeid S, 2013, J AM CHEM SOC, V135, P15667, DOI 10.1021/ja405346s; Obeid S, 2012, CHEM COMMUN, V48, P8320, DOI 10.1039/c2cc34181f; Obeid S, 2010, P NATL ACAD SCI USA, V107, P21327, DOI 10.1073/pnas.1013804107; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Ostergaard ME, 2011, CHEM-EUR J, V17, P3157, DOI 10.1002/chem.201002109; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren XM, 2014, BIOORGAN MED CHEM, V22, P4384, DOI 10.1016/j.bmc.2014.05.050; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Sefah K, 2014, P NATL ACAD SCI USA, V111, P1449, DOI 10.1073/pnas.1311778111; Smart OS, 2011, GRADE VERSION 1212; Southworth MW, 1996, P NATL ACAD SCI USA, V93, P5281, DOI 10.1073/pnas.93.11.5281; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Tan LJ, 2016, CHEM COMMUN, V52, P954, DOI 10.1039/c5cc09131d; Tasara T, 2003, NUCLEIC ACIDS RES, V31, P2636, DOI 10.1093/nar/gkg371; Verga D, 2015, CHEM COMMUN, V51, P7379, DOI 10.1039/c5cc01387a; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Vyas R, 2015, J AM CHEM SOC, V137, P5225, DOI 10.1021/jacs.5b02109; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wynne SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070892; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0118-2; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	76	28	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188005	10.1371/journal.pone.0188005	http://dx.doi.org/10.1371/journal.pone.0188005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211756	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200024
J	Schmidt, P; Sanchez, OS; Kind, CJ				Schmidt, Patrick; Sanchez, Oceane Spinelli; Kind, Claus-Joachim			Stone heat treatment in the Early Mesolithic of southwestern Germany: Interpretation and identification	PLOS ONE			English	Article							LENGTH-FAST CHALCEDONY; SOUTH-AFRICA; WATER; FLINT; TRANSFORMATIONS; SILCRETE; CAVE; AGE; BEHAVIOR; QUARTZ	The Early Mesolithic of southwestern Germany, the so-called Beuronian (9600-7100 BC), is a period of important transformations in the way people lived, in their subsistence and in the stone tools they produced. One of the perhaps most spectacular re-inventions of that time is heat treatment of stones prior to their manufacture into tools. Although heat treatment has been understood as one of the defining characteristics of the Beuronian of southwestern Germany, and although its existence has been known for almost 30 years now, relatively few systematic studies on it are available. In this paper, we present such a study, aiming to shed light on two questions: (1) what technique and heating parameters were used in the Beuronian and (2) how reliable are the macroscopic proxies traditionally used to identify heat treatment in this context? We investigate these questions using a non-destructive archaeometric technique for measuring past heating temperatures of heat-treated stones and a quantitative surface roughness analysis aiming to understand the relations between surface aspect and heat treatment. These methods are applied to 46 Jurassic chert artefacts from the site Helga-Abri located in the Swabian Alb region of southwestern Germany. Our results document that an opportunistic low-investment procedure was used to heat stone, probably relying on the use of the above-ground part of regular camp-fires. We also found that the traditionally used macroscopic criteria, such as colour and surface gloss, cannot be unambiguously used to identify heat treatment in assemblages made from Jurassic chert. These findings have important implications for our understanding of the Beuronian lithic chaine operatoire in terms of the investment in time and resources necessary, and for the refinement of archaeological techniques used to identify heat treatment in the Mesolithic of the Swabian Alb.	[Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany; [Sanchez, Oceane Spinelli] Univ Bordeaux Montaigne, IRAMAT, CRP2A, UMR 5060, Maison Archeol, Pessac, France; [Kind, Claus-Joachim] State Off Cultural Heritage Baden Wurttemberg, Esslingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS)	Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.; Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany.	patrick.schmidt@uni-tuebingen.de	Schmidt, Patrick/D-3925-2016	Schmidt, Patrick/0000-0002-8727-6127	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG) [SCHM 3275/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. Financial support for PS was provided by the Deutsche Forschungsgemeinschaft (DFG) (grant number SCHM 3275/2-1).	[Anonymous], 1974, PLAINS ANTHROPOL; [Anonymous], 1964, TEBIWA; Bentsen SE, 2014, J ARCHAEOL RES, V22, P141, DOI 10.1007/s10814-013-9069-x; Blumentritt R, 1978, HOHLEFELS BEI SCHELK, V46; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; BURKERT W., 2001, THESIS; Collins M.B., 1974, PLAINS ANTHROPOL, V19, P134, DOI [10.1080/2052546.1974.11908696, DOI 10.1080/2052546.1974.11908696]; Conard N.J., 2015, EISZEITARCHAOLOGIE S; Conard N. J., 2015, HUMAN ORIGIN SITES W, V41, P6; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Domanski M., 1994, ARCHAEOMETRY, V36, P177, DOI DOI 10.1111/J.1475-4754.1994.TB00963.X; Domanski M, 2009, J ARCHAEOL SCI, V36, P1400, DOI 10.1016/j.jas.2009.02.002; Dutkiewicz E., 2015, WORLD HERITAGE PAPER, V41, P74; Eriksen BV, 2006, COLOURFUL LITHICS CH; Fernandes P., 2012, QUATERNAIRE CONTINEN, P22; Fisher L, 2008, NEOLITHIC CHERT EXPL, P1; FLORKE OW, 1982, CONTRIB MINERAL PETR, V80, P324, DOI 10.1007/BF00378005; Fukuda J, 2009, MINERAL MAG, V73, P825, DOI 10.1180/minmag.2009.073.5.825; GRAETSCH H, 1985, PHYS CHEM MINER, V12, P300, DOI 10.1007/BF00310343; Griffiths DR, 1987, HUMAN USES FLINT CHE, P43; Guilbert R., 2003, BULL SOC PREHIST FR, V100, P463; Guilbert R., 2001, PALEO, V13, P245; Hahn J., 1983, ARCH OLOGISCHES KORR, V13, P19; Hahn J, 1998, AKTUELLE FORSCHUNGEN, V12, P251; Hess T., 2014, MITTEILUNGEN GESELLS, V23, P37; Hess T., 2019, HELGA ABRI ACHTAL DI; Inizan ML, 1976, QUATERNARIA, V19, P1; Jochim M., 1998, HUNTER GATHERER LAND, DOI DOI 10.1007/978-1-4419-8664-1; Jochim MA, 1979, HUNTER GATHERER SUBS; Kind C.-J., 2012, MESOLITHIKUM TALAUE; Kind C.-J., 2009, PREISTORIA ALPINA, V44, P137; Kind C-J, 2003, MESOLITHIKUM TALAUE; Kind Claus-Joachim, 2014, Quartaer, V61, P129; Koltsov L.V., 1999, TANGED POINTS CULTUR, P346; Lea V, 2005, ANTIQUITY, V79, P51, DOI 10.1017/S0003598X00113699; Lea V, 26 C SOC PREH FRANC, P263; Mandeville M.D., 1973, PLAINS ANTHROPOL, V18, P177, DOI [DOI 10.1080/2052546.1973.11908640, https://doi.org/10.1080/2052546.1973.11908640]; Micheelsen H., 1966, MEDD DANSK GEOL FORE, V16, P285; Milot J, 2017, ARCHAEOMETRY, V59, P417, DOI 10.1111/arcm.12256; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; OLAUSSON DS, 1982, J ARCHAEOL SCI, V9, P275, DOI 10.1016/0305-4403(82)90023-1; Pasda C., 1994, FUNDBERICHTE BADEN W, V19, P99; Patterson L.W., 1979, PLAINS ANTHROPOL, V24, P255; Peters E., 1934, GERMANICA, V18, P81; Porraz G, 2016, SOUTH AFR HUMANIT, V29, P203; Price T.D., 1982, P PREHIST SOC, V48, P467, DOI DOI 10.1017/50079497X00008483; Reinerth H, 1930, AUSGRABUNG MESOLITHI, V6, P200; Roque-Rosell J, 2010, INT C NOV 2010 BOST; Schild R, 1997, MAN FLINT, P325; Schmidt P, 2013, ARCHAEOMETRY, V55, P794, DOI 10.1111/j.1475-4754.2012.00712.x; Schmidt P, 2017, ARCHAEOMETRY; Schmidt P, 2017, J ARCHAEOL SCI-REP, V15, P611, DOI 10.1016/j.jasrep.2016.08.014; Schmidt P, 2017, PHYS CHEM MINER, V44, P21, DOI 10.1007/s00269-016-0833-6; Schmidt P, 2016, ARCHAEOL ANTHROP SCI, V8, P839, DOI 10.1007/s12520-015-0259-y; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2014, ARCHAEOL ANTHROP SCI, V6, P107, DOI 10.1007/s12520-013-0162-3; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2013, PHYS CHEM MINER, V40, P331, DOI 10.1007/s00269-013-0574-8; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Schmidt P, 2011, SPECTROCHIM ACTA A, V81, P552, DOI 10.1016/j.saa.2011.06.050; Schmidt RR., 1913, ALTSTEINZEITLICHEN S; Szymczak K., 2002, SWIATOWIT, V5, P229; Taute W, 1973, ARCH OLOGISCHE INFOR, V2, P59; Terradas X., 2001, CYPSELA, V13, P31; Tixier J, 1980, PREHISTOIRE PIERRE T; Wadley L, 2014, J HUM EVOL, V70, P49, DOI 10.1016/j.jhevol.2013.11.003; Was M., 2005, MONOGRAFIE INSTYTUTU, V3, P271; Was M., 2006, STONE TECHNIQUE TECH, P173; Wisniewski A., 2006, STONE TECHNIQUE TECH, P179	70	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188576	10.1371/journal.pone.0188576	http://dx.doi.org/10.1371/journal.pone.0188576			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211749	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200040
J	Yang, H; Chen, QX; Sun, FY; Zhao, NN; Wen, LR; Li, L; Ran, G				Yang, Hui; Chen, Qiuxia; Sun, Fangyun; Zhao, Nana; Wen, Lirong; Li, Lin; Ran, Gai			Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K/PKD1/Akt pathway	PLOS ONE			English	Article							C-MYC; CELLS; ACETYLATION; INHIBITION; STEATOSIS; MECHANISM; FACTOR-5; GLUCOSE; BINDING; ALTERS	Resveratrol (RSV), a natural polyphenol, has been reported to produce effect on genes transcription in lipid metabolism. In this study, we aim to explore the novel mechanisms of RSV on the regulation of caveolin-1 (Cav-1) transcription. Via body weight, blood glucose, serum lipid, and liver pathology detection, we found that RSV decreased body weight, blood glucose and lipid accumulation in rats fed high-fat diet. Based on co-immunoprecipitation (CoIP) and western blotting assay, we found that RSV up-regulated klf5 phosphorylation and decreased the interaction of klf5 with c-Myc, which were accompanied by down-regulation of Cav-1 expression in livers of rats fed with high-fat diet. Moreover, in HEK293 cells, we observed RSV enhanced klf5 phosphorylation and separated the interaction of klf5 with c-Myc through inhibiting the activation of PI3K/PKD1/Akt pathway, which maybe promoted c-Myc binding to the promoter to inhibit Cav-1 expression. The results of the present study demonstrated that RSV activated klf5 phosphorylation by inhibiting PI3K/PKD1/Akt pathway, and then attenuated the interaction of klf5 with c-Myc, subsequently probably promoted the c-Myc binding to the promoter to repress Cav-1 expression.	[Yang, Hui; Chen, Qiuxia] Kecheng Peoples Hosp, Dept Clin Nutr, Quzhou, Zhejiang, Peoples R China; [Sun, Fangyun; Li, Lin; Ran, Gai] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Zhao, Nana] Shandong Med Coll, Sch Basic Med Sci, Linyi, Shandong, Peoples R China; [Wen, Lirong] Huazhong Univ Sci & Technol, Sch Econ, Wuhan, Hubei, Peoples R China	Wenzhou Medical University; Huazhong University of Science & Technology	Ran, G (corresponding author), Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China.	15958706236@163.com						Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Fernandez-Rojo MA, 2016, TRENDS MOL MED, V22, P889, DOI 10.1016/j.molmed.2016.08.007; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; Fernandez-Rojo MA, 2012, HEPATOLOGY, V55, P1574, DOI 10.1002/hep.24810; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Ishikawa K, 2015, SCI REP-UK, V5, DOI 10.1038/srep16386; Kessoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22251; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Leontieva OV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.202; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Oishi Yumiko, 2011, Nihon Rinsho, V69 Suppl 1, P264; Park DS, 2001, BIOCHEMISTRY-US, V40, P3354, DOI 10.1021/bi002787b; Thiel G, 2014, MOL NUTR FOOD RES, V58, P1402, DOI 10.1002/mnfr.201300913; Wang HB, 2015, ONCOTARGET, V6, P15857, DOI 10.18632/oncotarget.4327; Wei GB, 2016, CELL PHYSIOL BIOCHEM, V39, P33, DOI 10.1159/000445603; Wu Y, 2016, STEM CELLS, V34, P83, DOI 10.1002/stem.2209; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zhang Y, 2015, MOL NUTR FOOD RES, V59, P1443, DOI 10.1002/mnfr.201500016; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189156	10.1371/journal.pone.0189156	http://dx.doi.org/10.1371/journal.pone.0189156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211809	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200071
J	Figorilli, F; Putignano, A; Roux, O; Houssel-Debry, P; Francoz, C; Paugam-Burtz, C; Soubrane, O; Agarwal, B; Durand, F; Jalan, R				Figorilli, Francesco; Putignano, Antonella; Roux, Olivier; Houssel-Debry, Pauline; Francoz, Claire; Paugam-Burtz, Catherine; Soubrane, Olivier; Agarwal, Banwari; Durand, Francois; Jalan, Rajiv			Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; INFLAMMATORY RESPONSE SYNDROME; COLLEGE-HOSPITAL CRITERIA; SINGLE-CENTER EXPERIENCE; EARLY INDICATORS; DISEASE MELD; APACHE-II; PROGNOSIS; MODEL; MULTICENTER	Introduction King's College Hospital criteria are currently used to select liver transplant candidates in acetaminophen- related acute liver failure (ALF). Although widely accepted, they show a poor sensitivity in predicting pre-transplant mortality and cannot predict the outcome after surgery. In this study we aimed to develop a new prognostic score that can allow patient selection for liver transplantation more appropriately and identify patients at high risk of futile transplantation. Methods We analysed consecutive patients admitted to the Royal Free and Beaujon Hospitals between 1990 and 2015. Clinical and laboratory data at admission were collected. Predictors of 3-month mortality in the non-transplanted patients admitted to the Royal Free Hospital were used to develop the new score, which was then validated against the Beaujon cohort. The Beaujon-transplanted group was also used to assess the ability of the new score in identifying patients at high risk of transplant futility. Results 152 patients were included of who 44 were transplanted. SOFA, CLIF-C OF and CLIF-ACLF scores were the best predictors of 3-month mortality among non-transplanted patients. CLIF-C OF score and high dosages of norepinephrine requirement were the only significant predictors of 3-month mortality in the non-transplanted patients, and therefore were included in the ALF-OFs score. In non-transplanted patients, ALF-OFs showed good performance in both exploratory (AUC = 0.89; sensitivity = 82.6%; specificity = 89.5%) and the validation cohort (AUC = 0.988; sensitivity = 100%; specificity = 92.3%). ALF-OFs score was also able to identify patients at high risk of transplant futility (AUC = 0.917; sensitivity = 100%; specificity = 79.2%). Conclusion ALF-OFs is a new prognostic score in acetaminophen-related ALF that can predict both the need for liver transplant and high risk of transplant futility, improving candidate selection for liver transplantation.	[Figorilli, Francesco; Putignano, Antonella; Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, Liver Failure Grp, Royal Free Campus, London, England; [Roux, Olivier; Houssel-Debry, Pauline; Francoz, Claire; Durand, Francois] Hosp Beaujon, AP HP, Hepatol & Liver Intens Care Unit, Clichy, France; [Paugam-Burtz, Catherine] Univ Paris Diderot, Hosp Beaujon, AP HP, Anaesthesiol Intens Care Unit, Clichy, France; [Soubrane, Olivier] Hosp Beaujon, AP HP, Hepatobiliary Pancreat Surg, Clichy, France; [Agarwal, Banwari] Royal Free Hosp, Royal Free London NHS Fdn Trust, Intens Care Unit, London, England	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Figorilli, F; Jalan, R (corresponding author), UCL Med Sch, UCL Inst Liver & Digest Hlth, Liver Failure Grp, Royal Free Campus, London, England.	francesco.figorilli@gmail.com; r.jalan@ucl.ac.uk	Soubrane, Olivier/H-7799-2016; Roux, Olivier/AAE-1002-2020; Soubrane, Olivier/ABB-4434-2021	Roux, Olivier/0000-0003-1563-7066; Agarwal, Banwari/0000-0001-5508-2590; Putignano, Antonella/0000-0002-4083-2405				Bailey B, 2003, CRIT CARE MED, V31, P299, DOI 10.1097/00003246-200301000-00048; Barber KM, 2007, HEPATOLOGY, V46, p510A; Barshes NR, 2006, TRANSPLANTATION, V81, P195, DOI 10.1097/01.tp.0000188149.90975.63; Bateman DN, 2014, BRIT J CLIN PHARMACO, V78, P610, DOI 10.1111/bcp.12362; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; Cholongitas EB, 2006, HEPATOLOGY, V43, P881, DOI 10.1002/hep.21121; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Craig DGN, 2010, ALIMENT PHARM THER, V31, P1064, DOI 10.1111/j.1365-2036.2010.04279.x; Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Reuben A, 2016, ANN INTERN MED; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Rutherford A, 2012, GASTROENTEROLOGY, V143, P1237, DOI 10.1053/j.gastro.2012.07.113; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2006, CRIT CARE MED, V34, P337, DOI 10.1097/01.CCM.0000194724.70031.B6; Speiser JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122929; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; William A., 1991, CHEST, V100, P1619	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188151	10.1371/journal.pone.0188151	http://dx.doi.org/10.1371/journal.pone.0188151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206839	gold, Green Submitted, Green Published			2022-12-26	WOS:000417110700008
J	Ahlgren, EC; Fekry, M; Wiemann, M; Soderberg, CA; Bernfur, K; Gakh, O; Rasmussen, M; Hojrup, P; Emanuelsson, C; Isaya, G; Al-Karadaghi, S				Ahlgren, Eva-Christina; Fekry, Mostafa; Wiemann, Mathias; Soederberg, Christopher A.; Bernfur, Katja; Gakh, Olex; Rasmussen, Morten; Hojrup, Peter; Emanuelsson, Cecilia; Isaya, Grazia; Al-Karadaghi, Salam			Iron-induced oligomerization of human FXN81-210 and bacterial CyaY frataxin and the effect of iron chelators	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; YEAST FRATAXIN; FRIEDREICH ATAXIA; BINDING-PROPERTIES; CLUSTER SYNTHESIS; ESCHERICHIA-COLI; N-TERMINUS; PROTEIN; FERROCHELATASE; MATURATION	Patients suffering from the progressive neurodegenerative disease Friedreich's ataxia have reduced expression levels of the protein frataxin. Three major isoforms of human frataxin have been identified, FXN42-210, FXN56-210 and FXN81-210, of which FXN81-210 is considered to be the mature form. Both long forms, FXN42-210 and FXN56-210, have been shown to spontaneously form oligomeric particles stabilized by the extended N-terminal sequence. The short variant FXN81-210, on other hand, has only been observed in the monomeric state. However, a highly homologous E. coli frataxin CyaY, which also lacks an N-terminal extension, has been shown to oligomerize in the presence of iron. To explore the mechanisms of stabilization of short variant frataxin oligomers we compare here the effect of iron on the oligomerization of CyaY and FXN81-210. Using dynamic light scattering, small-angle X-ray scattering, electron microscopy (EM) and cross linking mass spectrometry (MS), we show that at aerobic conditions in the presence of iron both FXN81-210 and CyaY form oligomers. However, while CyaY oligomers are stable over time, FXN81-210 oligomers are unstable and dissociate into monomers after about 24 h. EM and MS studies suggest that within the oligomers FXN81-210 and CyaY monomers are packed in a head-to-tail fashion in ring-shaped structures with potential iron-binding sites located at the interface between monomers. The higher stability of CyaY oligomers can be explained by a higher number of acidic residues at the interface between monomers, which may result in a more stable iron binding. We also show that CyaY oligomers may be dissociated by ferric iron chelators deferiprone and DFO, as well as by the ferrous iron chelator BIPY. Surprisingly, deferiprone and DFO stimulate FXN81-210 oligomerization, while BIPY does not show any effect on oligomerization in this case. The results suggest that FXN81-210 oligomerization is primarily driven by ferric iron, while both ferric and ferrous iron participate in CyaY oligomer stabilization. Analysis of the amino acid sequences of bacterial and eukaryotic frataxins suggests that variations in the position of the acidic residues in helix 1, beta-strand 1 and the loop between them may control the mode of frataxin oligomerization.	[Ahlgren, Eva-Christina; Fekry, Mostafa; Wiemann, Mathias; Soederberg, Christopher A.; Bernfur, Katja; Emanuelsson, Cecilia; Al-Karadaghi, Salam] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Fekry, Mostafa] Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt; [Gakh, Olex] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Gakh, Olex; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Rasmussen, Morten; Hojrup, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Lund University; Egyptian Knowledge Bank (EKB); Cairo University; Mayo Clinic; Mayo Clinic; University of Southern Denmark	Al-Karadaghi, S (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Salam.Al-Karadaghi@biochemistry.lu.se	Højrup, Peter/ABG-8477-2020	Wiemann, Mathias/0000-0003-0803-0370; Fekry, Mostafa/0000-0003-1818-5683; Hojrup, Peter/0000-0002-7838-6180	National Institute of Health (NIH) [AG15709-19]; Swedish Natural Sciences Research Council (Vetenskapsradet); European Union Mobility Program Erasmus; School in Pharmaceutical Sciences at Lund University (FLAEK); Villum Fonden [00007292] Funding Source: researchfish	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Natural Sciences Research Council (Vetenskapsradet); European Union Mobility Program Erasmus; School in Pharmaceutical Sciences at Lund University (FLAEK); Villum Fonden(Villum Fonden)	The funding or sources of support received during this study include National Institute of Health (NIH) Award Number AG15709-19 to Grazia Isaya, Swedish Natural Sciences Research Council (Vetenskapsradet, www.vr.se), European Union Mobility Program Erasmus (https://ec.europa.eu/programmes/erasmus-plus/), The researsh School in Pharmaceutical Sciences at Lund University (FLAEK, http://www.flak.lu.se). There was no additional external funding received for this study.	Abrahao A, 2015, NEUROGENETICS; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Brittenham GM, 2003, ALCOHOL, V30, P151, DOI 10.1016/S0741-8329(03)00101-0; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Faraj SE, 2013, FEBS OPEN BIO, V3, P310, DOI 10.1016/j.fob.2013.07.004; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gentry LE, 2013, BIOCHEMISTRY-US, V52, P6085, DOI 10.1021/bi400443n; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; MODELL B, 1982, BRIT MED J, V284, P1081, DOI 10.1136/bmj.284.6322.1081; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Pandolfo M, 2013, J NEUROCHEM, V126, P142, DOI 10.1111/jnc.12300; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Perez LR, 2010, DALTON T, V39, P2177, DOI 10.1039/b919237a; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Soderberg C.G., 2016, J BIOL CHEM; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	57	13	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188937	10.1371/journal.pone.0188937	http://dx.doi.org/10.1371/journal.pone.0188937			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200434	Green Published, gold			2022-12-26	WOS:000417033200023
J	Raleigh, MD; Peterson, SJ; Laudenbach, M; Baruffaldi, F; Carroll, FI; Comer, SD; Navarro, HA; Langston, TL; Runyon, SP; Winston, S; Pravetoni, M; Pentel, PR				Raleigh, M. D.; Peterson, S. J.; Laudenbach, M.; Baruffaldi, F.; Carroll, F. I.; Comer, S. D.; Navarro, H. A.; Langston, T. L.; Runyon, S. P.; Winston, S.; Pravetoni, M.; Pentel, P. R.			Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse	PLOS ONE			English	Article							CONJUGATE VACCINE; RELEASE NALTREXONE; HEROIN-ADDICTS; DRUG-ABUSE; NICOTINE; COCAINE; DEPENDENCE; ANTIBODY; MORPHINE; BRAIN	Among vaccines aimed at treating substance use disorders, those targeting opioids present several unique medication development challenges. 1) Opioid overdose is a common complication of abuse, so it is desirable for an opioid vaccine to block the toxic as well as the addictive effects of opioids. 2) It is important that an opioid vaccine not interfere with the action of opioid antagonists used to reverse opioid overdose or treat addiction. 3) Some opioids are immunosuppressive and chronic ongoing opioid use could interfere with vaccine immunogenicity. 4) Although antibody-bound oxycodone is unable to enter the brain because of its size, it might still be able to activate peripheral opioid receptors. To assess vaccine impact on opioid toxicity, rats vaccinated with oxycodone conjugated to keyhole limpet hemocyanin subunit dimer (OXY-dKLH) adsorbed to alum or controls vaccinated with dKLH were compared with regard to oxycodone-induced hotplate analgesia and oxycodone-induced respiratory depression and bradycardia. Vaccination shifted the dose-response curves to the right, representing protection, for each of these endpoints. Naloxone was equally effective in both OXY-dKLH and control groups, providing complete and rapid reversal of respiratory depression. The administration of a long-acting naltrexone formulation during vaccination did not impair vaccine immunogenicity in mice. Similarly, serum anti-oxycodone antibody titers were not altered by continuous morphine infusion during vaccination compared to opioid-naive controls. Competitive ELISA assay showed negligible or low affinity of immune antiserum for endogenous opioids or opioid antagonists. In vitro receptor binding assays showed that antibody-bound oxycodone does not activate mu opioid receptors. These data support further study of OXY-dKLH as a potential treatment for oxycodone abuse and suggest that vaccination might also reduce the severity of oxycodone overdose.	[Raleigh, M. D.; Peterson, S. J.; Laudenbach, M.; Baruffaldi, F.; Pravetoni, M.; Pentel, P. R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; [Carroll, F. I.; Navarro, H. A.; Langston, T. L.; Runyon, S. P.] Res Triangle Inst, POB 12194, Res Triangle Pk, NC 27709 USA; [Comer, S. D.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, New York, NY USA; [Comer, S. D.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Winston, S.] Winston Biopharmaceut Consulting, Boulder, CO USA; [Pravetoni, M.; Pentel, P. R.] Univ Minnesota, Med Sch, Dept Med, Minneapolis, MN USA; [Pravetoni, M.] Univ Minnesota, Med Sch, Ctr Immunol, Minneapolis, MN USA	Minneapolis Medical Research Foundation; Research Triangle Institute; Columbia University; New York State Psychiatry Institute; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Raleigh, MD (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA.	rale0011@umn.edu		Pravetoni, Marco/0000-0003-1036-0184	National Institutes of Health, National Institute on Drug Abuse [DA038876]	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by National Institutes of Health, National Institute on Drug Abuse (https://www.drugabuse.gov/) grant DA038876 (MP, PRP). SW was a consultant on this study and owns the company Winston Pharmaceutical Consulting. The specific roles of this author are articulated in the 'author contributions' section.	Akbarzadeh A., 2009, Journal of Pharmacology and Toxicology, V4, P30, DOI 10.3923/jpt.2009.30.35; Akbarzadeh A, 2007, ASAIN J BIOCH, V2, P58; Alexander M, 2005, J SURG RES, V129, P161, DOI 10.1016/j.jss.2005.04.028; Appel PW, 2004, AM J DRUG ALCOHOL AB, V30, P129, DOI 10.1081/ADA-120029870; Borg L, 1999, ADDICTION, V94, P489, DOI 10.1046/j.1360-0443.1999.9444894.x; Bremer PT, 2016, ANGEW CHEM INT EDIT, V55, P3772, DOI 10.1002/anie.201511654; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Comer SD, 2007, EXPERT OPIN INV DRUG, V16, P1285, DOI 10.1517/13543784.16.8.1285; Cooper ZD, 2012, BEHAV PHARMACOL, V23, P271, DOI 10.1097/FBP.0b013e3283536d6f; Fahim REF, 2013, EXPERT REV VACCINES, V12, P333, DOI [10.1586/erv.13.13, 10.1586/ERV.13.13]; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2006, CLIN INFECT DIS, V43, pS173, DOI 10.1086/508180; Gentry WB, 2006, INT IMMUNOPHARMACOL, V6, P968, DOI 10.1016/j.intimp.2006.01.008; Giglio Rebecca E, 2015, Inj Epidemiol, V2, P10; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; He GA, 2001, ACTA PHARMACOL SIN, V22, P530; Jones JD, 2011, AM J ADDICTION, V20, P190, DOI 10.1111/j.1521-0391.2011.00120.x; Kimishima A, 2017, ACS CHEM BIOL, V12, P36, DOI 10.1021/acschembio.6b00977; Kosten T, 2014, BRIT J CLIN PHARMACO, V77, P368, DOI 10.1111/bcp.12115; Kosten TR, 2014, DRUG ALCOHOL DEPEN, V140, P42, DOI 10.1016/j.drugalcdep.2014.04.003; Krupitsky E, 2013, ADDICTION, V108, P1628, DOI 10.1111/add.12208; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lebrec H, 2014, J IMMUNOTOXICOL, V11, P213, DOI 10.3109/1547691X.2013.822948; LEHMAN TM, 1979, LIFE SCI, V25, P1591, DOI 10.1016/0024-3205(79)90442-9; Li Q, 2014, INT J NEUROPSYCHOPHA; Moroz E, 2016, VACCINE, V34, P1363, DOI 10.1016/j.vaccine.2016.01.051; Orson FM, 2014, EXPERT OPIN BIOL TH, V14, P1271, DOI 10.1517/14712598.2014.920319; Pentel P, 2015, BIOL TREAT SUBSTANCE, P37; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Pravetoni M, 2016, HUM VACC IMMUNOTHER, V12, P3005, DOI 10.1080/21645515.2016.1212785; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101807; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096547; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Quaglio G, 2002, ADDICTION, V97, P985, DOI 10.1046/j.1360-0443.2002.00147.x; Rahim RT, 2001, INT IMMUNOPHARMACOL, V1, P2001, DOI 10.1016/S1567-5769(01)00128-X; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Rosenberg H, 2003, PSYCHOL ADDICT BEHAV, V17, P203, DOI 10.1037/0893-164X.17.3.203; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Shen XYY, 2013, DRUG ALCOHOL DEPEN, V129, P41, DOI 10.1016/j.drugalcdep.2012.09.007; Skolnick P, 2015, TRENDS PHARMACOL SCI, V36, P628, DOI 10.1016/j.tips.2015.07.002; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality, NAT SURV DRUG US HLT; Treweek JB, 2012, MOL PHARMACEUT, V9, P969, DOI 10.1021/mp200588v; Tuncok Y, 2001, EXP CLIN PSYCHOPHARM, V9, P228; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631; Wong J, 2012, POISONING DRUG OVERD, P514; Woody GE, 2004, NEW TREATMENTS ADDIC, P125	52	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0184876	10.1371/journal.pone.0184876	http://dx.doi.org/10.1371/journal.pone.0184876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194445	Green Published, gold, Green Submitted			2022-12-26	WOS:000416867800003
J	Bommana, S; Walker, E; Desclozeaux, M; Timms, P; Polkinghorne, A				Bommana, Sankhya; Walker, Evelyn; Desclozeaux, Marion; Timms, Peter; Polkinghorne, Adam			Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep	PLOS ONE			English	Article							KOALAS PHASCOLARCTOS-CINEREUS; LINKED-IMMUNOSORBENT-ASSAY; DIAGNOSIS; TRACHOMATIS; PREVALENCE; EPITOPES; ABORTION; CATTLE; LAMBS	Chlamydia pecorum is a globally recognised livestock pathogen due to the significant clinical and economic impact it poses to livestock producers. Routine serological diagnosis is through a complement fixation test (CFT), which is often criticised for cross-reactivity, poor sensitivity and specificity. Although serology remains the preferred method in veterinary diagnostic laboratories, serological assays based on surface antigens of C. pecorum have not been established until now. In this study, we evaluated the use of two chlamydial recombinant protein antigens (PmpG and MOMP-G) by a direct IgG ELISA method for detection of ovine anti-chlamydial antibodies. Using the Pepscan method we then identified B cell epitopes across PmpG and MOMP-G proteins, in lambs with (a) naturally occurring asymptomatic C. pecorum infections (b) C. pecorum-associated polyarthritis and (c) recombinant PmpG and MOMP-G vaccine. Plasma IgG antibodies to PmpG in natural infection of lambs were detected earlier in infection than CFT and served as an acute phase marker. Antibodies to MOMP-G IgG were significantly heightened in lambs with C. pecorum-associated polyarthritis. PmpG and MOMP-G specific B-cell epitope mapping revealed epitope responses in immunised lambs cluster with some of the epitope responses in naturally infected lambs. B-cell epitope mapping further revealed that lambs with polyarthritis recognised several unique PmpG (50% frequency, peptide 8, 25, 40, 41 and 50) and MOMP (50% frequency, peptide 50) epitopes in comparison to asymptomatic infections. The findings of this study will have implications towards improved serodiagnosis of C. pecorum infections in livestock and inform the downstream development of alternative peptide-based antigens for future C. pecorum vaccine studies.	[Bommana, Sankhya; Walker, Evelyn; Desclozeaux, Marion; Timms, Peter; Polkinghorne, Adam] Univ Sunshine Coast, Ctr Anim Hlth Innovat, Sippy Downs, Qld, Australia; [Walker, Evelyn] Cent West Local Land Serv, Dubbo, Australia	University of the Sunshine Coast	Polkinghorne, A (corresponding author), Univ Sunshine Coast, Ctr Anim Hlth Innovat, Sippy Downs, Qld, Australia.	apolking@usc.edu.au		Polkinghorne, Adam/0000-0002-6567-2962; Timms, Peter/0000-0002-1682-0025	Australian Research Council Linkage Grant [LP140100315]	Australian Research Council Linkage Grant(Australian Research Council)	This work was funded by an Australian Research Council Linkage Grant (LP140100315) awarded to AP, PT, and EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann NL, 2015, J CLIN MICROBIOL, V53, P1573, DOI 10.1128/JCM.03534-14; Casson N, 2007, J CLIN MICROBIOL, V45, P234, DOI 10.1128/JCM.01867-06; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Desclozeaux M, 2017, VACCINE, V35, P3461, DOI 10.1016/j.vaccine.2017.03.091; Forsbach-Birk V, 2010, CLIN MICROBIOL INFEC, V16, P1237, DOI 10.1111/j.1469-0691.2009.03041.x; Forsbach-Birk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080310; Giannitti F, 2016, J VET DIAGN INVEST, V28, P184, DOI 10.1177/1040638715625729; Hagemann JB, 2016, J CLIN MICROBIOL, V54, P1883, DOI 10.1128/JCM.00351-16; Haralambieva I, 2001, DIAGN MICR INFEC DIS, V41, P99, DOI 10.1016/S0732-8893(01)00299-1; Jelocnik M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-121; Jelocnik M, 2013, J CLIN MICROBIOL, V51, P2625, DOI 10.1128/JCM.00992-13; Kaltenboeck B, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0832-4; Kaltenboeck B, 1997, J CLIN MICROBIOL, V35, P2293, DOI 10.1128/JCM.35.9.2293-2298.1997; Kollipara A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074808; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Menon S, 2016, J MED MICROBIOL, V65, P915, DOI 10.1099/jmm.0.000311; Paton MW, 2003, AUST VET J, V81, P694, DOI 10.1111/j.1751-0813.2003.tb12543.x; PEREZMARTINEZ JA, 1986, AM J VET RES, V47, P1501; Polkinghorne A, 2009, VET MICROBIOL, V135, P142, DOI 10.1016/j.vetmic.2008.09.034; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Rahman KS, 2015, CLIN VACCINE IMMUNOL, V22, P539, DOI 10.1128/CVI.00102-15; Rahman KS, 2016, J BIOL CHEM, V291, P14585, DOI 10.1074/jbc.M116.729020; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; Sackett D, 2006, ASSESSING EC COST EN; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Timms P, 2010, CHLAMYDIAL INFECTION; Walker E, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0832-3; Waugh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146934; Wilson DP, 2015, J WILDLIFE DIS, V51, P833, DOI 10.7589/2014-12-278; Yang RC, 2014, VET J, V201, P322, DOI 10.1016/j.tvjl.2014.05.037	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188370	10.1371/journal.pone.0188370	http://dx.doi.org/10.1371/journal.pone.0188370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190736	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900052
J	Choi, JE; Kim, YK; Cho, YS; Lee, K; Park, HW; Yoon, SH; Kim, HJ; Chung, WH				Choi, Ji Eun; Kim, Yi-Kyung; Cho, Young Sang; Lee, Kieun; Park, Hyun Woo; Yoon, Sung Hoon; Kim, Hyung-Jin; Chung, Won-Ho			Morphological correlation between caloric tests and vestibular hydrops in Meniere's disease using intravenous Gd enhanced inner ear MRI	PLOS ONE			English	Article							SINGLE-DOSE GADODIAMIDE; VIDEO-HEAD IMPULSE; ENDOLYMPHATIC HYDROPS; DISSOCIATION; SYSTEM; STIMULATION; DYSFUNCTION; PROGRESSION; AFFERENTS; UTILITY	The purpose of this study was to prove the hypothesis that caloric response in Meniere's disease (MD) is reduced by hydropic expansion of the vestibular labyrinth, not by vestibular hypofunction, by evaluating the correlation morphologically using an intravenous Gadolinium (IV-Gd) inner ear MRI. In study I, the prevalence of abnormal video Head Impulse Test (vHIT) results among the patients with definite unilateral MD (n = 24) and vestibular neuritis (VN) (n = 22) were investigated. All patients showed abnormal canal paresis (CP) (>26%) on caloric tests. The prevalence of abnormal vHIT in patients with abnormal CP was significantly lower in MD patients (12.5%) than that in VN patients (81.8%) (p < 0.001). In study II, morphological correlation between caloric tests and vestibular hydrops level was evaluated in unilateral MD patients (n = 16) who had normal vHIT results. Eleven patients (61%) had abnormal CP. After taking the images of IV-Gd inner ear MRI, the vestibular hydrops ratio (endolymph volume/total lymph volume = %VH) was measured. In addition, the relative vestibular hydrops ratio (%RVH = (%VHaffected ear-% VHunaffected ear) /(% VHaffected ear + %VH and affected ear)) was calculated. Each ratio (%VH and %RVH) was compared with average peak slow phase velocity (PSPV) and CP, respectively. In the MD patients, % VH of the affected ear correlated significantly with mean PSPV on the same side (rs = -0.569, p = 0.024), while % RVH correlated significantly with CP (rs = 0.602, p = 0.014). In most MD patients (87.5%) compared to VN patients, vHIT results were normal even though the caloric function was reduced. In addition, the reduced caloric function with normal vHIT was related to the severity of the vestibular hydrops measured by the IV-Gd inner ear MRI. These findings concluded that the abnormal caloric tests with normal vHIT in MD indicated severe endolymphatic hydrops rather than vestibular hypofunction.	[Choi, Ji Eun] Dankook Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Cheonan, South Korea; [Kim, Yi-Kyung; Kim, Hyung-Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Cho, Young Sang; Lee, Kieun; Chung, Won-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Hyun Woo] Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Jinju, South Korea; [Yoon, Sung Hoon] Samsung Med Ctr, Hearing Res Lab, Seoul, South Korea	Dankook University; Dankook University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Chung, WH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	whchung12@gmail.com	Choi, Ji Eun/I-5707-2015	Choi, Ji Eun/0000-0001-8105-813X	Samsung Medical Center intramural grant, clinical research development program [OTC1700661]	Samsung Medical Center intramural grant, clinical research development program	This study was supported by a Samsung Medical Center intramural grant, clinical research development program (OTC1700661) to Won-Ho Chung.	Alhabib SF, 2016, EUR ARCH OTORHINOLAR; Blodow A, 2014, ACTA OTO-LARYNGOL, V134, P1239, DOI 10.3109/00016489.2014.939300; Cerchiai N, 2016, OTOL NEUROTOL, V37, P380, DOI 10.1097/MAO.0000000000000983; COOPER CW, 1993, BRIT J GEN PRACT, V43, P164; Eatock RA, 2011, ANNU REV NEUROSCI, V34, P501, DOI 10.1146/annurev-neuro-061010-113710; Fiorino F, 2011, OTOL NEUROTOL, V32, P1152, DOI 10.1097/MAO.0b013e31822a1ce2; Fiorino F, 2011, EUR ARCH OTO-RHINO-L, V268, P181, DOI 10.1007/s00405-010-1353-5; FRAYSSE BG, 1980, ANN OTO RHINOL LARYN, V89, P2, DOI 10.1177/00034894800896S201; GENTINE A, 1991, ACTA OTO-LARYNGOL, V111, P463, DOI 10.3109/00016489109138370; GOLDBERG JM, 1977, BRAIN RES, V122, P545, DOI 10.1016/0006-8993(77)90465-6; Gurkov R, 2013, LARYNGOSCOPE, V123, P503, DOI 10.1002/lary.23395; Gurkov R, 2012, OTOL NEUROTOL, V33, P1375, DOI 10.1097/MAO.0b013e318268d087; Gurkov R, 2012, OTOL NEUROTOL, V33, P1040, DOI 10.1097/MAO.0b013e31825d9a95; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Kato M, 2011, OTOL NEUROTOL, V32, P1480, DOI 10.1097/MAO.0b013e318235568d; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; MacDougall HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061488; McCall AA, 2009, BMC EAR NOSE THROAT, V9, DOI 10.1186/1472-6815-9-4; McCaslin DL, 2015, AM J AUDIOL, V24, P1, DOI 10.1044/2014_AJA-14-0040; Mcgarvie LA, 2015, ACTA OTO-LARYNGOL, V135, P859, DOI 10.3109/00016489.2015.1015606; McGarvie LA, 2015, ANN NY ACAD SCI, V1343, P58, DOI 10.1111/nyas.12687; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Naganawa S, 2013, MAGN RESON MED SCI, V12, P261, DOI 10.2463/mrms.2013-0019; Naganawa S, 2013, MAGN RESON MED SCI, V12, P147, DOI 10.2463/mrms.2012-0050; Naganawa S, 2013, MAGN RESON MED SCI, V12, P63, DOI 10.2463/mrms.2012-0027; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213, DOI 10.2463/mrms.11.213; Naganawa S, 2012, MAGN RESON MED SCI, V11, P145, DOI 10.2463/mrms.11.145; Park HJ, 2005, ACTA OTO-LARYNGOL, V125, P852, DOI 10.1080/00016480510033667; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Seth Rosenberg, 1992, SURG TECHNIQUES TEMP; STAHLE J, 1991, ACTA OTO-LARYNGOL, P78; Tsuji K, 2000, ANN OTO RHINOL LARYN, V109, P26, DOI 10.1177/00034894001090S505	32	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188301	10.1371/journal.pone.0188301	http://dx.doi.org/10.1371/journal.pone.0188301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190293	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900045
J	Janghorban, M; Langer, EM; Wang, XY; Zachman, D; Daniel, CJ; Hooper, J; Fleming, WH; Agarwal, A; Sears, RC				Janghorban, Mahnaz; Langer, Ellen M.; Wang, Xiaoyan; Zachman, Derek; Daniel, Colin J.; Hooper, Jody; Fleming, William H.; Agarwal, Anupriya; Sears, Rosalie C.			The tumor suppressor phosphatase PP2A-56a regulates stemness and promotes the initiation of malignancies in a novel murine model	PLOS ONE			English	Article							C-MYC PROTEIN; BETA-CATENIN; 2A; SUBUNIT; PHOSPHORYLATION; EXPRESSION; SKIN; GROWTH; STABILIZATION; CELLS	dProtein phosphatase 2A (PP2A) is a ubiquitously expressed Serine-Threonine phosphatase mediating 30-50% of protein phosphatase activity. PP2A functions as a heterotrimeric complex, with the B subunits directing target specificity to regulate the activity of many key pathways that control cellular phenotypes. PP2A-B56 alpha has been shown to play a tumor suppressor role and to negatively control c-MYC stability and activity. Loss of B56 alpha promotes cellular transformation, likely at least in part through its regulation of c-MYC. Here we report generation of a B56 alpha hypomorph mouse with very low B56 alpha expression that we used to study the physiologic activity of the PP2A-B56 alpha phosphatase. The predominant phenotype we observed in mice with B56 alpha deficiency in the whole body was spontaneous skin lesion formation with hyperproliferation of the epidermis, hair follicles and sebaceous glands. Increased levels of c-MYC phosphorylation on Serine62 and c-MYC activity were observed in the skin lesions of the B56 alpha(hm/hm) mice. B56 alpha deficiency was found to increase the number of skin stem cells, and consistent with this, papilloma initiation was accelerated in a carcinogenesis model. Further analysis of additional tissues revealed increased inflammation in spleen, liver, lung, and intestinal lymph nodes as well as in the skin lesions, resembling elevated extramedullary hematopoiesis phenotypes in the B56 alpha(hm/hm) mice. We also observed an increase in the clonogenicity of bone marrow stem cells in B56 alpha(hm/hm) mice. Overall, this model suggests that B56 alpha is important for stem cells to maintain homeostasis and that B56 alpha loss leading to increased activity of important oncogenes, including c-MYC, can result in aberrant cell growth and increased stem cells that can contribute to the initiation of malignancy.	[Janghorban, Mahnaz; Langer, Ellen M.; Wang, Xiaoyan; Daniel, Colin J.; Sears, Rosalie C.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Zachman, Derek; Fleming, William H.] Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR USA; [Hooper, Jody] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fleming, William H.; Agarwal, Anupriya; Sears, Rosalie C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Sears, Rosalie C.] Oregon Hlth & Sci Univ, Brenden Colson Ctr Pancreat Care, Portland, OR 97201 USA	Oregon Health & Science University; Johns Hopkins University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.; Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Brenden Colson Ctr Pancreat Care, Portland, OR 97201 USA.	searsr@ohsu.edu		Sears, Rosalie/0000-0003-1558-2413; , Jody/0000-0002-8209-3559	National Cancer Institute [R01 CA129040, R01 CA100855, R01 CA100855-05S3]; NATIONAL CANCER INSTITUTE [R01CA186241, R01CA196228] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute R01 CA129040, R01 CA100855, and R01 CA100855-05S3 to RCS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; z	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Baek S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-139; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Breuer R, 2014, J BIOL CHEM, V289, P14996, DOI 10.1074/jbc.M113.533547; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Everett AD, 2002, AM J PHYSIOL-LUNG C, V282, pL1266, DOI 10.1152/ajplung.00262.2001; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Honeycutt KA, 2010, MOL CARCINOGEN, V49, P315, DOI 10.1002/mc.20617; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Little SC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5876; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sohawon D, 2012, J MED IMAG RADIAT ON, V56, P538, DOI 10.1111/j.1754-9485.2012.02397.x; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tyagi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13894; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xu P, 2013, BIOL OPEN, V2, P479, DOI 10.1242/bio.20134051; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Zachman DK, 2013, STEM CELL RES, V11, P1013, DOI 10.1016/j.scr.2013.07.001; Zhang Q, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00094; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	58	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188910	10.1371/journal.pone.0188910	http://dx.doi.org/10.1371/journal.pone.0188910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190822	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900166
J	Marangoni, A; Foschi, C; Micucci, M; Palomino, RAN; Toschi, TG; Vitali, B; Camarda, L; Mandrioli, M; De Giorgio, M; Aldini, R; Corazza, I; Chiarini, A; Cevenini, R; Budriesi, R				Marangoni, Antonella; Foschi, Claudio; Micucci, Matteo; Palomino, Rogers Alberto Nahui; Toschi, Tullia Gallina; Vitali, Beatrice; Camarda, Luca; Mandrioli, Mara; De Giorgio, Marta; Aldini, Rita; Corazza, Ivan; Chiarini, Alberto; Cevenini, Roberto; Budriesi, Roberta			In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases	PLOS ONE			English	Article							BLUE-GREEN-ALGA; C-PHYCOCYANIN; ANTIBACTERIAL ACTIVITY; CALCIUM SPIRULAN; EFFICACY; CAROTENOIDS; MECHANISMS; CULTURE; GROWTH; LIPIDS	The high incidence of vulvo-vaginal candidiasis, combined with the growing problems about azole resistance and toxicity of antifungal drugs, highlights the need for the development of new effective strategies for the treatment of this condition. In this context, natural compounds represent promising alternatives. The cyanobacterium Spirulina platensis, a bluegreen alga, exhibits antimicrobial activities against several microorganisms. Nevertheless, only few data about the antifungal properties of Spirulina platensis are available and its potential toxic effects have not been largely investigated. The aim of this study was to evaluate the in vitro activity of a fully-characterized water extract of Spirulina platensis against 22 strains of Candida spp. Prior to considering its potential topical use, we both investigated whether the extract exerted target activities on guinea pig uterine smooth muscle, and the impact of Spirulina platensis on the dominant microorganisms of the vaginal microbiota (i. e., lactobacilli), in order to exclude possible adverse events. By means of a broth microdilution assay, we found that the microalga extract possesses good antifungal properties (MIC: 0.125-0.5 mg/ml), against all the Candida species with a fungicidal activity. At the concentrations active against candida, Spirulina platensis did not modify the spontaneous basic waves pattern of uterine myometrium as underlined by the absence of aberrant contractions, and did not affect the main health-promoting bacteria of the vaginal ecosystem. Finally, we evaluated the selectivity index of our extract by testing its cytotoxicity on three different cell lines and it showed values ranging between 2 and 16. Further in vivo studies are needed, in particular to evaluate the use of control-release formulations in order to maintain Spirulina platensis concentrations at anti-Candida active doses but below the toxic levels found in the present work.	[Marangoni, Antonella; Foschi, Claudio; Corazza, Ivan; Cevenini, Roberto] Alma Mater Studiorum Univ Bologna, St Orsola Malpighi Univ Hosp, Dept Specialized Expt & Diagnost Med DIMES, Operat Unit Clin Microbiol, Bologna, Italy; [Micucci, Matteo; Palomino, Rogers Alberto Nahui; Vitali, Beatrice; Camarda, Luca; De Giorgio, Marta; Aldini, Rita; Chiarini, Alberto; Budriesi, Roberta] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBit, Bologna, Italy; [Toschi, Tullia Gallina; Mandrioli, Mara] Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci DiSTAL, Cesena, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Bologna	Micucci, M (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBit, Bologna, Italy.	matteo.micucci2@unibo.it	Corazza, Ivan/AAY-8566-2021; Micucci, Matteo/AAM-6126-2020; Foschi, Claudio/A-7299-2016	Corazza, Ivan/0000-0003-2078-1978; Foschi, Claudio/0000-0001-7253-8799; NAHUI PALOMINO, Rogers Alberto/0000-0003-4923-2120; MICUCCI, MATTEO/0000-0003-3525-1531; Marangoni, Antonella/0000-0002-7397-6560; Gallina Toschi, Tullia/0000-0001-7241-2280				Abd El Baky HH, 2015, NUTR HOSP, V32, P231, DOI 10.3305/nh.2015.32.1.8804; Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Ajayan KV, 2011, BIORESOURCE TECHNOL, V102, P7591, DOI 10.1016/j.biortech.2011.05.013; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bautista CT, 2016, AM J PREV MED; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Blinkova L P, 2001, Zh Mikrobiol Epidemiol Immunobiol, P114; Boselli E, 2001, J CHROMATOGR A, V917, P239, DOI 10.1016/S0021-9673(01)00688-4; Canton E, 2003, DIAGN MICR INFEC DIS, V45, P203, DOI 10.1016/S0732-8893(02)00525-4; Carosati E, 2012, CURR MED CHEM, V19, P4306, DOI 10.2174/092986712802884204; Chen F, 1996, BIOTECHNOL LETT, V18, P603, DOI 10.1007/BF00140211; Chen F, 1997, ENZYME MICROB TECH, V20, P221, DOI 10.1016/S0141-0229(96)00116-0; Chen YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24253; CLSI, 2007, M11A7 CLSI; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; El-Sheekh MM, 2010, FOLIA MICROBIOL, V55, P61, DOI 10.1007/s12223-010-0010-0; Ensign LM, 2014, J CONTROL RELEASE, V190, P500, DOI 10.1016/j.jconrel.2014.04.033; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Cuesta Carla, 2014, J Clin Exp Dent, V6, pe576, DOI 10.4317/jced.51798; Gehrke ITS, 2013, J ETHNOPHARMACOL, V148, P486, DOI 10.1016/j.jep.2013.04.043; GEIGER AM, 1995, AM J PUBLIC HEALTH, V85, P1146, DOI 10.2105/AJPH.85.8_Pt_1.1146; Girardin-Andreani C., 2008, J MED FOOD, V11, P313; Hayashi T, 1996, J NAT PROD, V59, P83, DOI 10.1021/np960017o; Henrikson R, 1989, EARTH FOOD SPIRULINA; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kaushik P, 2008, INDIAN J MICROBIOL, V48, P353, DOI 10.1007/s12088-008-0020-7; Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607; KOEHN FE, 1992, J NAT PROD, V55, P613, DOI 10.1021/np50083a009; Lawrenz E, 2011, J APPL PHYCOL, V23, P865, DOI 10.1007/s10811-010-9600-0; Li B, 2006, BIOTECHNOL APPL BIOC, V43, P155, DOI 10.1042/BA20050142; Lin CC, 2013, BIORESOURCE TECHNOL, V135, P640, DOI 10.1016/j.biortech.2012.09.138; Liu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087818; Marangoni A, 2004, FEMS IMMUNOL MED MIC, V40, P187, DOI 10.1016/S0928-8244(03)00345-6; MARQUEZ FJ, 1993, J FERMENT BIOENG, V76, P408, DOI 10.1016/0922-338X(93)90034-6; Mishima T, 1998, CLIN EXP METASTAS, V16, P541, DOI 10.1023/A:1006594318633; Mundt S, 2001, INT J HYG ENVIR HEAL, V203, P327, DOI 10.1078/1438-4639-00045; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; Ozdemir G, 2004, PHYTOTHER RES, V18, P754, DOI 10.1002/ptr.1541; PAOLETTI C, 1976, LIPIDS, V11, P258, DOI 10.1007/BF02544051; Parolin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131220; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Ramage G, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00220; Rathod SD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-43; Riss J, 2007, J AGR FOOD CHEM, V55, P7962, DOI 10.1021/jf070529g; Romay C, 2003, CURR PROTEIN PEPT SC, V4, P207, DOI 10.2174/1389203033487216; Sarada R, 1999, PROCESS BIOCHEM, V34, P795, DOI 10.1016/S0032-9592(98)00153-8; SIEGELMAN H W, 1978, P71; Ferreira GLS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/147804; Siroli L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00166; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Soltani M, 2012, J MYCOL MED, V22, P329, DOI 10.1016/j.mycmed.2012.10.001; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; Tallarida RJ, 1986, MANUAL PHARM CALCULA; Vonshak A, 1997, SPIRULINA PLATENSIS; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Yu QL, 2013, INT J ANTIMICROB AG, V41, P179, DOI 10.1016/j.ijantimicag.2012.10.009	59	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188567	10.1371/journal.pone.0188567	http://dx.doi.org/10.1371/journal.pone.0188567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190763	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900076
J	Compaore, R; Yameogo, MWE; Millogo, T; Tougri, H; Kouanda, S				Compaore, Rachidatou; Yameogo, Maurice Wambi Evariste; Millogo, Tieba; Tougri, Halima; Kouanda, Seni			Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso	PLOS ONE			English	Article							PREVENTION	Background Burkina Faso implemented the seasonal malaria chemoprevention (SMC) in 2014 in seven pilot health districts, following the new recommendation by the WHO in 2012 for the prevention of the disease in children under five years old, for areas of highly seasonal malaria transmission. The objective of this study was to assess the implementation fidelity of the seasonal malaria chemoprevention strategy in one of the districts, Kaya Health District. Methodology We conducted a case study, with a quantitative and qualitative mixed methods. Data were collected after two campaigns of implementation of the intervention, in 2014 and 2015, through a review of specific documents of SMC intervention, and individual interview with key informants (n = 21) involved at various levels in the implementation of the strategy and a household survey with the parents (n = 284) of eligible children for the SMC strategy in 2015 in the Kaya health district. The analysis framework focused on the fidelity of the intervention's content, its coverage, and its schedule, as well as the potential moderating factors, using the model proposed by Hasson, originally from Carroll. Results All components of the intervention were implemented. Villages and sectors were covered at 100%. In terms of intervention doses received, less than one-third of eligible children (32.3%) received the recommended four doses in 2015. Implementation of the strategy faced some difficulties due to insufficient training of community distributors, inadequate supply of inputs and insufficient financial resources for remuneration, advocacy and supervision, but also because of the contextual constraints due to the rainy season. Moreover, an interaction between the different moderating factors, influencing the degree of implementation of the strategy was noted. Conclusion Taking into account the moderating factors of the implementation is necessary for achieving the highest possible degree of implementation fidelity and then, reach the expected beneficial effects.	[Compaore, Rachidatou; Yameogo, Maurice Wambi Evariste; Millogo, Tieba; Tougri, Halima; Kouanda, Seni] IRSS, Ouagadougou, Burkina Faso; [Compaore, Rachidatou; Yameogo, Maurice Wambi Evariste; Millogo, Tieba; Tougri, Halima; Kouanda, Seni] IASP, Ouagadougou, Burkina Faso		Kouanda, S (corresponding author), IRSS, Ouagadougou, Burkina Faso.; Kouanda, S (corresponding author), IASP, Ouagadougou, Burkina Faso.	skouanda@irss.bf	COMPAORE, Rachidatou/AAP-8782-2021; MILLOGO, Tieba/AAJ-6028-2020	COMPAORE, Rachidatou/0000-0002-7456-8593; MILLOGO, Tieba/0000-0003-3548-3789; Kouanda, Seni/0000-0003-2426-7669	WHO/HRP	WHO/HRP	This research was carried out by RC as partial fulfillment of his master program in public health at "Institut Africain de sante publique (IASP)", the African Institute of Public Health. RC received scholarship from WHO/HRP for her master program. Only the authors were responsible for the design, the analysis, the interpretation of data and writing the manuscript.	Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Berman P., 1976, EDUC FORUM, V3, P345, DOI DOI 10.1080/00131727609336469; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Bradley F, 1999, BMJ-BRIT MED J, V318, P711; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Dusenbury L, 2003, HEALTH EDUC RES, V18, P237, DOI 10.1093/her/18.2.237; Elliott DS, 2004, PREV SCI, V5, P47, DOI 10.1023/B:PREV.0000013981.28071.52; Faye SL, 2012, AUTREPART, P129; Fixsen DL, 2005, TAMPA FL U S FLA LOU; Gilson L, 2008, HEALTH POLICY PLANN, V23, P294, DOI 10.1093/heapol/czn019; Hasson H, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-23; Institut National de la Statistique et de la De A mographie (INSD), 2008, REC RAL POP HAB RGPH; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Koscalova A, 2014, CAPITALISATION MISE; Kouanda S, 2013, INT J EPIDEMIOL, V42, P741, DOI 10.1093/ije/dyt076; Meremikwu MM, 2012, COCHRANE LIB; Newman RD, 2012, WORLD MALARIA REPORT; Perez D, 2009, TROP MED INT HEALTH, V14, P167; Pitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032900; Ridde V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069865; Rogers E.M., 1995, DIFFUSION INNOVATION, V12; Sanou A., 2013, VALUATION PROCESSUS; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Webster J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S8; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, WHO POL REC SEAS MAL; World Health Organization (WHO), 2012, OTHERS WHO POLICY RE	33	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187460	10.1371/journal.pone.0187460	http://dx.doi.org/10.1371/journal.pone.0187460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186137	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900005
J	Persichini, T; Funari, A; Colasanti, M; Sacchetti, B				Persichini, Tiziana; Funari, Alessia; Colasanti, Marco; Sacchetti, Benedetto			Clonogenic, myogenic progenitors expressing MCAM/CD146 are incorporated as adventitial reticular cells in the microvascular compartment of human post-natal skeletal muscle	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MOLECULAR REGULATION; ADHESION MOLECULE; IDENTIFICATION; REGENERATION; PERICYTES; SPECIFICATION; HETEROGENEITY; MULTIPOTENT; POPULATION	Recent observation identifies subendothelial (mural) cells expressing MCAM, a specific system of clonogenic, self-renewing, osteoprogenitors (a.k.a, "mesenchymal stem cells") in the microvascular compartment of post-natal human bone marrow (BM). In this study, we used MCAM/CD146, as a marker to localize, isolate and assay subendothelial clonogenic cells from the microvasculature of postnatal human skeletal muscle. We show here that these cells share with their BM counterpart, anatomic position (subendothelial/adventitial) and ex vivo clonogenicity (CFU-Fs). When assayed under the stringent conditions, these cells display a high spontaneous myogenic potential (independent of co-culture with myoblasts or of in vivo fusion with local myoblasts), which is otherwise only attained in cultures of satellite cells. These muscle-derived mural cells activated a myogenic program in culture. Cultured CD146(+) cells expressed the myogenic factors (Pax7, Pax3 and Myf5), NCAM/CD56, des min as well as proteins characteristic of more advanced myogenic differentiation, such as myosin heavy chain. In vivo, these cells spontaneously generate myotubes and myofibrils. These data identify the anatomy and phenotype of a novel class of committed myogenic progenitor in human post-natal skeletal muscle of subendothelial cells associated with the abluminal surface of microvascular compartment distinct from satellite cells.	[Persichini, Tiziana; Colasanti, Marco; Sacchetti, Benedetto] Univ ROMA TRE, Dept Sci, Rome, Italy; [Funari, Alessia] Univ Sapienza, Dept Mol Med, Rome, Italy; [Sacchetti, Benedetto] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy	Italfarmaco; Roma Tre University; Sapienza University Rome; Istituto Superiore di Sanita (ISS)	Persichini, T; Sacchetti, B (corresponding author), Univ ROMA TRE, Dept Sci, Rome, Italy.; Sacchetti, B (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy.	tiziana.persichini@uniroma3.it; benedetto.sacchetti@uniroma1.it		PERSICHINI, TIZIANA/0000-0001-8291-6706				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Boldrin L, 2007, CURR OPIN NEUROL, V20, P577, DOI 10.1097/WCO.0b013e3282ef5919; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen WCW, 2015, STEM CELLS, V33, P557, DOI 10.1002/stem.1868; Chen WCW, 2014, JOVE-J VIS EXP, DOI 10.3791/51195; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Huard J, 2003, FASEB J, V17, pA1374; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Partridge TA, 2003, MUSCLE NERVE, V27, P133, DOI 10.1002/mus.10243; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pujades C, 2002, INT J DEV BIOL, V46, P263; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Tajbakhsh S, 2005, EXP CELL RES, V306, P364, DOI 10.1016/j.yexcr.2005.03.033; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188844	10.1371/journal.pone.0188844	http://dx.doi.org/10.1371/journal.pone.0188844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186180	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900065
J	Toyoda, H; Honda, Y; Tanaka, S; Miyagawa, T; Honda, M; Honda, K; Tokunaga, K; Kodama, T				Toyoda, Hiromi; Honda, Yoshiko; Tanaka, Susumu; Miyagawa, Taku; Honda, Makoto; Honda, Kazuki; Tokunaga, Katsushi; Kodama, Tohru			Narcolepsy susceptibility gene CCR3 modulates sleep-wake patterns in mice	PLOS ONE			English	Article							NON-REM SLEEP; CEREBROSPINAL-FLUID; LIPOPOLYSACCHARIDE; CATAPLEXY; CYTOKINE; NEURONS; DEFICIENCY; FREQUENCY; ABLATION; ALPHA	Narcolepsy is caused by the loss of hypocretin (Hcrt) neurons and is associated with multiple genetic and environmental factors. Although abnormalities in immunity are suggested to be involved in the etiology of narcolepsy, no decisive mechanism has been established. We previously reported chemokine (C-C motif) receptor 3 (CCR3) as a novel susceptibility gene for narcolepsy. To understand the role of CCR3 in the development of narcolepsy, we investigated sleep-wake patterns of Ccr3 knockout (KO) mice. Ccr3 KO mice exhibited fragmented sleep patterns in the light phase, whereas the overall sleep structure in the dark phase did not differ between Ccr3 KO mice and wild-type (WT) littermates. Intraperitoneal injection of lipopolysaccharide (LPS) promoted wakefulness and suppressed both REM and NREM sleep in the light phase in both Ccr3 KO and WT mice. Conversely, LPS suppressed wakefulness and promoted NREM sleep in the dark phase in both genotypes. After LPS administration, the proportion of time spent in wakefulness was higher, and the proportion of time spent in NREM sleep was lower in Ccr3 KO compared to WT mice only in the light phase. LPS-induced changes in sleep patterns were larger in Ccr3 KO compared to WT mice. Furthermore, we quantified the number of Hcrt neurons and found that Ccr3 KO mice had fewer Hcrt neurons in the lateral hypothalamus compared to WT mice. We found abnormalities in sleep patterns in the resting phase and in the number of Hcrt neurons in Ccr3 KO mice. These observations suggest a role for CCR3 in sleep-wake regulation in narcolepsy patients.	[Toyoda, Hiromi; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Toyoda, Hiromi; Honda, Yoshiko; Miyagawa, Taku; Honda, Makoto; Honda, Kazuki; Kodama, Tohru] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo, Japan; [Tanaka, Susumu] Kansai Med Univ, Dept Anat & Cell Sci, Hirakata, Osaka, Japan; [Honda, Makoto] Seiwa Hosp, Inst Neuropsychiat, Tokyo, Japan	University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Kansai Medical University	Toyoda, H (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan.; Toyoda, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo, Japan.	htoyoda@m.u-tokyo.ac.jp	Tanaka, Susumu/AAC-4739-2019	Tanaka, Susumu/0000-0003-4804-7839; KODAMA, TOHRU/0000-0001-6915-4428	JSPS KAKENHI [26870117, 17K17646, 16K08540]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 26870117 (HT), 17K17646 (HT), and 16K08540 (TK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dauvilliers Y, 2014, BRAIN BEHAV IMMUN, V37, P260, DOI 10.1016/j.bbi.2013.12.019; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Gaykema RPA, 2009, BRAIN BEHAV IMMUN, V23, P926, DOI 10.1016/j.bbi.2009.03.005; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Holm A, 2015, EUR J HUM GENET, V23, P1573, DOI 10.1038/ejhg.2015.4; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Karashima A, 2004, NEUROSCI RES, V50, P283, DOI 10.1016/j.neures.2004.07.007; Khatami R, 2004, LANCET, V363, P1199, DOI 10.1016/S0140-6736(04)15951-5; Khatami R, 2007, SLEEP, V30, P980, DOI 10.1093/sleep/30.8.980; Koepsell TD, 2010, J SLEEP RES, V19, P80, DOI 10.1111/j.1365-2869.2009.00756.x; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kornum BR, 2015, BRAIN BEHAV IMMUN, V49, P54, DOI 10.1016/j.bbi.2015.03.004; Kornum BR, 2011, CURR OPIN NEUROBIOL, V21, P897, DOI 10.1016/j.conb.2011.09.003; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; LANCEL M, 1995, AM J PHYSIOL-REG I, V268, pR1310, DOI 10.1152/ajpregu.1995.268.5.R1310; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Opp MR, 1998, LIFE SCI, V62, P923, DOI 10.1016/S0024-3205(98)00010-1; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Szentirmai E, 2014, BRAIN BEHAV IMMUN, V36, P200, DOI 10.1016/j.bbi.2013.11.017; Tabuchi S, 2014, J NEUROSCI, V34, P6495, DOI 10.1523/JNEUROSCI.0073-14.2014; Tanaka S, 2014, HUM IMMUNOL, V75, P940, DOI 10.1016/j.humimm.2014.06.023; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toth LA, 2001, AM J PHYSIOL-REG I, V280, pR1806, DOI 10.1152/ajpregu.2001.280.6.R1806; Toyoda H, 2015, BRAIN BEHAV IMMUN, V49, P148, DOI 10.1016/j.bbi.2015.05.003; Wainwright DA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090017; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Yamasaki M, 2016, J HUM GENET, V61, P873, DOI 10.1038/jhg.2016.65; Zhang J, 2016, ENEURO, V3	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187888	10.1371/journal.pone.0187888	http://dx.doi.org/10.1371/journal.pone.0187888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186205	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900016
J	Doan, TN; Eisen, DP; Rose, MT; Slack, A; Stearnes, G; McBryde, ES				Doan, Tan N.; Eisen, Damon P.; Rose, Morgan T.; Slack, Andrew; Stearnes, Grace; McBryde, Emma S.			Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis	PLOS ONE			English	Article							QUANTIFERON-TB-GOLD; HEALTH-CARE WORKERS; IN-TUBE TEST; SKIN-TEST; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; ACTIVE TUBERCULOSIS; HIGH-RISK; IMMUNOSUPPRESSIVE THERAPY; RHEUMATOID-ARTHRITIS	Background Accurate diagnosis and subsequent treatment of latent tuberculosis infection (LTBI) is essential for TB elimination. However, the absence of a gold standard test for diagnosing LTBI makes assessment of the true prevalence of LTBI and the accuracy of diagnostic tests challenging. Bayesian latent class models can be used to make inferences about disease prevalence and the sensitivity and specificity of diagnostic tests using data on the concordance between tests. We performed the largest meta-analysis to date aiming to evaluate the performance of tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) for LTBI diagnosis in various patient populations using Bayesian latent class modelling. Methods Systematic search of PubMeb, Embase and African Index Medicus was conducted without date and language restrictions on September 11, 2017 to identify studies that compared the performance of TST and IGRAs for LTBI diagnosis. Two IGRA methods were considered: QuantiFERON-TB Gold In Tube (QFT-GIT) and T-SPOT. TB. Studies were included if they reported 2x2 agreement data between TST and QFT-GIT or T-SPOT. TB. A Bayesian latent class model was developed to estimate the sensitivity and specificity of TST and IGRAs in various populations, including immune-competent adults, immune-compromised adults and children. A TST cut-off value of 10 mm was used for immune-competent subjects and 5 mm for immune-compromised individuals. Findings A total of 157 studies were included in the analysis. In immune-competent adults, the sensitivity of TST and QFT-GIT were estimated to be 84% (95% credible interval [CrI] 82-85%) and 52% (50-53%), respectively. The specificity of QFT-GIT was 97% (96-97%) in nonBCG- vaccinated and 93% (92-94%) in BCG-vaccinated immune-competent adults. The estimated figures for TST were 100% (99-100%) and 79% (76-82%), respectively. T-SPOT. TB has comparable specificity (97% for both tests) and better sensitivity (68% versus 52%) than QFT-GIT in immune-competent adults. In immune-compromised adults, both TST and QFT-GIT display low sensitivity but high specificity. QFT-GIT and TST are equally specific (98% for both tests) in non-BCG-vaccinated children; however, QFT-GIT is more specific than TST (98% versus 82%) in BCG-vaccinated group. TST is more sensitive than QFT-GIT (82% versus 73%) in children. Conclusions This study is the first to assess the utility of TST and IGRAs for LTBI diagnosis in different population groups using all available data with Bayesian latent class modelling. Our results challenge the current beliefs about the performance of LTBI screening tests, and have important implications for LTBI screening policy and practice. We estimated that the performance of IGRAs is not as reliable as previously measured in the general population. However, IGRAs are not or minimally affected by BCG and should be the preferred tests in this setting. Adoption of IGRAs in settings where BCG is widely administered will allow for a more accurate identification and treatment of LTBI.	[Doan, Tan N.; McBryde, Emma S.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Doan, Tan N.; McBryde, Emma S.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia; [Doan, Tan N.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Eisen, Damon P.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Eisen, Damon P.; Slack, Andrew; Stearnes, Grace] Townsville Hosp & Hlth Serv, Townsville, Qld, Australia; [Rose, Morgan T.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; James Cook University; Queensland University of Technology (QUT); James Cook University	Doan, TN (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia.; Doan, TN (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia.; Doan, TN (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.	tan.doan@uqconnect.edu.au	eisen, damon/AAC-7433-2019; McBryde, Emma/D-2220-2018	Doan, Tan/0000-0002-5514-8518; Eisen, Damon/0000-0002-8987-4358; McBryde, Emma/0000-0002-9570-9172				Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Adjoh K, 2013, INT J MYCOBACT, V2, P26, DOI 10.1016/j.ijmyco.2012.12.001; Aichelburg MC, 2014, INT J TUBERC LUNG D, V18, P709, DOI 10.5588/ijtld.13.0813; Al Hajoj S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154803; Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111986; American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; Ang M, 2013, BRIT J OPHTHALMOL, V97, P1062, DOI 10.1136/bjophthalmol-2012-302199; Anibarro L, 2011, SCAND J INFECT DIS, V43, P424, DOI 10.3109/00365548.2011.558912; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Bergot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043520; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; Bienek DR, 2009, INT J TUBERC LUNG D, V13, P1416; Biraro IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146098; Borkowska Dagmara, 2011, Pneumonol Alergol Pol, V79, P264; Kussen GMB, 2016, BRAZ J INFECT DIS, V20, P69, DOI 10.1016/j.bjid.2015.10.007; Bourgarit A, 2015, ANN AM THORAC SOC, V12, P1138, DOI 10.1513/AnnalsATS.201412-600OC; Bozkanat E, 2016, J PAK MED ASSOC, V66, P270; Brock I, 2001, INT J TUBERC LUNG D, V5, P462; Caglayan V, 2011, TUBERK TORAK, V59, P43, DOI 10.5578/tt.1129; Casas S, 2011, LIVER TRANSPLANT, V17, P1205, DOI 10.1002/lt.22375; Casas S, 2011, DIAGN MICR INFEC DIS, V71, P57, DOI 10.1016/j.diagmicrobio.2010.12.020; Charisis A, 2014, INT J TUBERC LUNG D, V18, P1040, DOI 10.5588/ijtld.14.0018; Chkhartishvili N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-513; Cho H, 2016, LUPUS, V25, P1341, DOI 10.1177/0961203316639381; Chun JK, 2008, DIAGN MICR INFEC DIS, V62, P389, DOI 10.1016/j.diagmicrobio.2008.08.022; Costa JT, 2009, EUR RESPIR J, V34, P1423, DOI 10.1183/09031936.00053809; Costa JT, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-19; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Costa JT, 2010, REV PORT PNEUMOL, V16, P211, DOI 10.1016/S0873-2159(15)30022-2; Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1; de Leon DP, 2008, J RHEUMATOL, V35, P776; de Souza FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102773; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Di Renzi S, 2012, AM J INFECT CONTROL, V40, P459, DOI 10.1016/j.ajic.2011.07.002; Diel R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-77; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; EI-Sokkary RH, 2015, CENT EUR J PUBL HEAL, V23, P324; Erkens CGM, 2014, INT J TUBERC LUNG D, V18, P413, DOI 10.5588/ijtld.13.0589; Ferguson TW, 2015, TRANSPLANTATION, V99, P1084, DOI 10.1097/TP.0000000000000451; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrarini MAG, 2016, EPIDEMIOL INFECT, V144, P712, DOI 10.1017/S0950268815001727; Ferreira TF, 2015, REV SOC BRAS MED TRO, V48, P724, DOI 10.1590/0037-8682-0258-2015; Fox BD, 2009, LUNG, V187, P413, DOI 10.1007/s00408-009-9182-2; Franken WPJ, 2007, CLIN VACCINE IMMUNOL, V14, P477, DOI 10.1128/CVI.00463-06; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Garazzino S, 2014, PEDIATR INFECT DIS J, V33, pE226, DOI 10.1097/INF.0000000000000353; Girardi E, 2009, EURO SURVEILL, V14; Goebel KM, 2015, COMMUN DIS INTELL, V39, pE191; Gogus F, 2010, CLIN EXP MED, V10, P173, DOI 10.1007/s10238-009-0082-9; Goodwin DJ, 2014, MIL MED, V179, P333, DOI 10.7205/MILMED-D-13-00364; Government of Canada, 2014, CAN TUB STAND 2014 D; Grare M, 2010, ARCH PEDIATRIE, V17, P77, DOI 10.1016/j.arcped.2009.07.021; Grare M, 2010, DIAGN MICR INFEC DIS, V66, P366, DOI 10.1016/j.diagmicrobio.2009.11.002; Garcell HG, 2014, J INFECT PUBLIC HEAL, V7, P356, DOI 10.1016/j.jiph.2014.02.001; Hansted Edita, 2009, BMC Pulm Med, V9, P41, DOI 10.1186/1471-2466-9-41; Hanta I, 2012, RHEUMATOL INT, V32, P3599, DOI 10.1007/s00296-011-2243-x; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124097; Herrmann J-L, 2009, Pathol Biol (Paris), V57, pe49, DOI 10.1016/j.patbio.2008.02.010; Hoffmann M, 2010, SWISS MED WKLY, V140, P286, DOI smw-12960; Howley MM, 2015, PEDIATR INFECT DIS J, V34, P35, DOI 10.1097/INF.0000000000000494; Hsia EC, 2012, ARTHRITIS RHEUM-US, V64, P2068, DOI 10.1002/art.34382; Huang YW, 2010, INT J TUBERC LUNG D, V14, P1430; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; James Pratibha Malini, 2014, J Int Assoc Provid AIDS Care, V13, P47, DOI 10.1177/2325957412469687; Janssens JP, 2008, SWISS MED WKLY, V138, P585, DOI 2008/39/smw-12243; Jeong YJ, 2012, J KOREAN MED SCI, V27, P761, DOI 10.3346/jkms.2012.27.7.761; Jo KW, 2013, TUBERC RESPIR DIS, V75, P18, DOI 10.4046/trd.2013.75.1.18; Jo KW, 2012, RESPIROLOGY, V17, P1125, DOI 10.1111/j.1440-1843.2012.02218.x; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Jones-Lopez EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138358; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Serrano-Escobedo CJ, 2013, ARCH MED RES, V44, P242, DOI 10.1016/j.arcmed.2013.02.004; Jung DH, 2012, TUBERC RESPIR DIS, V73, P219, DOI 10.4046/trd.2012.73.4.219; Karadag O, 2010, RHEUMATOL INT, V30, P1483, DOI 10.1007/s00296-010-1444-z; Kasambira TS, 2011, INT J TUBERC LUNG D, V15, P628, DOI 10.5588/ijtld.10.0555; Katsenos S, 2010, INT J TUBERC LUNG D, V14, P545; Khawcharoenporn T, 2015, RESPIROLOGY, V20, P340, DOI 10.1111/resp.12442; Kik SV, 2009, INT J TUBERC LUNG D, V13, P820; Kim EY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-207; Kim HC, 2014, SCAND J INFECT DIS, V46, P763, DOI 10.3109/00365548.2014.938691; Kim JH, 2013, SEMIN ARTHRITIS RHEU, V42, P424, DOI 10.1016/j.semarthrit.2012.07.001; Kobashi Y, 2012, INTERNAL MED, V51, P1199, DOI 10.2169/internalmedicine.51.5703; Kurti Z, 2015, J GASTROINTEST LIVER, V24, P467, DOI 10.15403/jgld.2014.1121.244.bcg; Kus Jan, 2011, Pneumonol Alergol Pol, V79, P407; Larcher C, 2012, MED LAV, V103, P26; Latorre I, 2014, J INFECTION, V69, P600, DOI 10.1016/j.jinf.2014.07.026; Laurence YV, 2015, PHARMACOECONOMICS, V33, P939, DOI 10.1007/s40273-015-0279-6; Lee KJ, 2010, SCAND J INFECT DIS, V42, P672, DOI 10.3109/00365548.2010.485575; Lee SH, 2010, RESP MED, V104, P448, DOI 10.1016/j.rmed.2009.10.006; Legesse M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-89; Leung CC, 2008, EUR RESPIR J, V31, P266, DOI 10.1183/09031936.00054707; Leung CC, 2015, RESPIROLOGY, V20, P496, DOI 10.1111/resp.12483; Leung CC, 2010, AM J RESP CRIT CARE, V182, P834, DOI 10.1164/rccm.200912-1875OC; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Ling DI, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-67; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Lowenthal P, 2016, PEDIATR INFECT DIS J, V35, P231, DOI 10.1097/INF.0000000000000986; Lucet JC, 2015, INFECT CONT HOSP EP, V36, P569, DOI 10.1017/ice.2015.19; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Manuel O, 2007, AM J TRANSPLANT, V7, P2797, DOI 10.1111/j.1600-6143.2007.02011.x; Marco Mouriño A., 2011, Rev. esp. sanid. penit., V13, P15, DOI 10.4321/s1575-06202011000100003; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Marquez C, 2016, PEDIATR INFECT DIS J, V35, P524, DOI 10.1097/INF.0000000000001062; Mathad JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092308; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Mendez-Echevarria A, 2011, PEDIATR INFECT DIS J, V30, P426, DOI 10.1097/INF.0b013e3182001294; Minguez S, 2012, CLIN RHEUMATOL, V31, P785, DOI 10.1007/s10067-012-1938-z; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moon HW, 2011, J CLIN LAB ANAL, V25, P382, DOI 10.1002/jcla.20479; Moon SM, 2013, TRANSPL INFECT DIS, V15, P104, DOI 10.1111/j.1399-3062.2012.00765.x; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mostafavi E, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016032; Moyo S, 2011, INT J TUBERC LUNG D, V15, P1176, DOI 10.5588/ijtld.10.0770; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Nienhaus A, 2011, Pneumologie, V65, P726, DOI 10.1055/s-0031-1291392; Nkurunungi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047340; Onur H, 2012, INFLAMMATION, V35, P1518, DOI 10.1007/s10753-012-9466-1; Oren E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1959-3; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Palazzo R, 2008, CLIN VACCINE IMMUNOL, V15, P327, DOI 10.1128/CVI.00342-07; Palomar R, 2011, NEFROLOGIA, V31, P169, DOI 10.3265/Nefrologia.pre2011.Jan.10765; Papay P, 2011, INFLAMM BOWEL DIS, V17, P84, DOI 10.1002/ibd.21427; Pattnaik Satyajit, 2012, Indian J Tuberc, V59, P214; Pavic I, 2011, PEDIATR INFECT DIS J, V30, P866, DOI 10.1097/INF.0b013e318220c52a; Pavic I, 2015, LABMEDICINE, V46, P200, DOI 10.1309/LMCQLO8PG0IZ5APX; Petrucci R, 2008, PEDIATR INFECT DIS J, V27, P1073, DOI 10.1097/INF.0b013e31817d05a3; Porsa E, 2006, CLIN VACCINE IMMUNOL, V13, P53, DOI 10.1128/CVI.13.1.53-58.2006; Queensland Health, 2016, MAN LAT TUB AD; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Ramos JM, 2013, CLIN EXP MED, V13, P177, DOI 10.1007/s10238-012-0192-7; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Reechaipichitkul W, 2015, ASIAN PAC J ALLERGY, V33, P236, DOI 10.12932/AP0576.33.3.2015; Ribeiro-Rodrigues R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096564; Ringshausen Felix C, 2009, J Occup Med Toxicol, V4, P11, DOI 10.1186/1745-6673-4-11; Rose W, 2015, J PEDIAT INF DIS SOC, V4, P96, DOI 10.1093/jpids/piu024; Sadatsafavi M, 2010, J CLIN EPIDEMIOL, V63, P257, DOI 10.1016/j.jclinepi.2009.04.008; Salinas C, 2015, MED CLIN-BARCELONA, V145, P7, DOI 10.1016/j.medcli.2013.12.017; Saracino A, 2009, NEW MICROBIOL, V32, P369; Sauzullo I, 2010, INT J TUBERC LUNG D, V14, P834; Sauzullo I, 2014, J IMMUNOL METHODS, V414, P51, DOI 10.1016/j.jim.2014.07.013; Scrivo R, 2012, CLIN RHEUMATOL, V31, P1567, DOI 10.1007/s10067-012-2049-6; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Silverman MS, 2007, CLIN BIOCHEM, V40, P913, DOI 10.1016/j.clinbiochem.2007.04.006; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Song GG, 2013, INT J RHEUM DIS, V16, P279, DOI 10.1111/1756-185X.12098; Song SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100267; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; Spicer KB, 2015, PEDIATR INFECT DIS J, V34, P599, DOI 10.1097/INF.0000000000000680; Subtil A, 2012, STAT PROBABIL LETT, V82, P1407, DOI 10.1016/j.spl.2012.03.030; Takahashi H, 2007, RHEUMATOL INT, V27, P1143, DOI 10.1007/s00296-007-0361-2; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Talebi-Taher M, 2011, INT J OCCUP MED ENV, V24, P359, DOI 10.2478/s13382-011-0046-7; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tripodi Dominique, 2009, J Occup Med Toxicol, V4, P30, DOI 10.1186/1745-6673-4-30; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Tsolia MN, 2010, PEDIATR INFECT DIS J, V29, P1137, DOI 10.1097/INF.0b013e3181ebfe8a; Vassilopoulos D, 2011, CLIN VACCINE IMMUNOL, V18, P2102, DOI 10.1128/CVI.05299-11; Vikram HR, 2009, LIVER TRANSPLANT, V15, P834, DOI 10.1002/lt.21787; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; Whitaker JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058202; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wong SH, 2016, THORAX, V71, P64, DOI 10.1136/thoraxjnl-2015-207811; World Health Organization, 2017, TUB FACT SHEET; Yassin MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023733; Yoo JW, 2016, RESP MED, V111, P77, DOI 10.1016/j.rmed.2015.12.002; Zhao J, 2011, INT J TUBERC LUNG D, V15, P134; Zhao XR, 2009, AM J CLIN PATHOL, V132, P678, DOI 10.1309/AJCPUHC34NBDGKKL; Zwerling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054748; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014	184	47	48	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188631	10.1371/journal.pone.0188631	http://dx.doi.org/10.1371/journal.pone.0188631			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182688	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000416402000046
J	Dutta, R; Tregenza, T; Balakrishnan, R				Dutta, Rochishnu; Tregenza, Tom; Balakrishnan, Rohini			Reproductive isolation in the acoustically divergent groups of tettigoniid, Mecopoda elongata	PLOS ONE			English	Article							BUSH-CRICKET; SELECTIVE PHONOTAXIS; FEMALE PREFERENCE; SONG RECOGNITION; COURTSHIP SONGS; CALLING SONG; ORTHOPTERA; DIVERSITY; SPECIATION; GRYLLIDAE	Sympatric divergent populations of the same species provide an opportunity to study the evolution and maintenance of reproductive isolation. Male mating calls are important in sexual selection in acoustically communicating species, and they also have the potential to maintain isolation among species or incipient species. We studied divergent south Indian populations of the bush cricket Mecopoda elongata which are extremely difficult to distinguish morphologically, but which exhibit striking divergence in male acoustic signals. We performed phonotactic experiments investigating the relative preference of females of the "Chirper" song type for calls of all 5 of the song types found in the region (in varying degrees of sympatry). We found that Chirper females preferred their own song type and were completely unresponsive to three trilling song types. Chirper females were occasionally attracted to the call type "Double Chirper" (the call most similar to their own type), suggesting call preference alone cannot provide a complete isolating mechanism. To investigate the basis of call preference we investigated the response of chirper females to variation in chirp rate. Chirper females responded most frequently to a mean chirp rate characteristic of their own song type rather than a higher chirp rate which would be more characteristic of the Double-Chirper song type. This suggests females drive stabilising selection on male chirp rate, which may contribute to the maintenance of isolation. Finally, a no-choice mating experiment using Chirper females and Chirper and Double Chirper males revealed a significant preference of Chirper females to mate with their own song type, even without a requirement for phonotaxis. Overall, the strong specificity of Chirper females for their 'own' song type provides evidence for behavioural isolation among divergent sympatric Mecopoda song types being maintained by female preference for both male song type and subsequent mating probability driven by other cues.	[Dutta, Rochishnu; Tregenza, Tom] Univ Exeter, Ctr Ecol & Conservat, Dept Biosci, Coll Life & Environm Sci, Penryn Campus, Penryn, England; [Balakrishnan, Rohini] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India; [Dutta, Rochishnu] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India	University of Exeter; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Mohali	Dutta, R (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Dept Biosci, Coll Life & Environm Sci, Penryn Campus, Penryn, England.; Dutta, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India.	rochishnudutta@gmail.com	Dutta, Rochishnu/S-9603-2019; Balakrishnan, Rohini/Z-5881-2019	Dutta, Rochishnu/0000-0003-2216-2505; 	University of Exeter	University of Exeter	The research was funded by University of Exeter, and necessary logistical support was provided by IISc, Bangalore.	Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bush SL, 2009, J EXP BIOL, V212, P648, DOI 10.1242/jeb.024786; Cade W. H., 2000, T AM ENTOMOLOGICAL S; CLARIDGE MF, 1973, J ENTOMOL SER B, V42, P29; Coyne J. A., 2004, SINAUER AS INCORPORA; Deily JA, 2004, J EXP BIOL, V207, P3523, DOI 10.1242/jeb.01179; Ferreira RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015363; Fertschai I, 2007, J EXP BIOL, V210, P465, DOI 10.1242/jeb.02655; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grace JL, 2012, CURR ZOOL, V58, P416, DOI 10.1093/czoolo/58.3.416; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Heller KG, 2006, CONT T ENT, P137; HENRY CS, 1994, TRENDS ECOL EVOL, V9, P388, DOI 10.1016/0169-5347(94)90061-2; Hirtenlehner S, 2014, J COMP PHYSIOL A, V200, P239, DOI 10.1007/s00359-014-0881-7; Honda-Sumi E, 2005, ANIM BEHAV, V69, P881, DOI 10.1016/j.anbehav.2004.05.015; Kolics B, 2008, BIOLOGIA, V63, P254, DOI 10.2478/s11756-008-0028-9; Korsunovskaya O. S., 2009, ENTMOL REV, V88, P1032; Kowalski K, 2011, ZOOLOGY, V114, P29, DOI 10.1016/j.zool.2010.09.002; Lehmann G. U. C., 2017, PHYSIOL ENTOMOL, V99, P3695; Nandi D, 2013, ANIM BEHAV, V86, P1003, DOI 10.1016/j.anbehav.2013.09.003; Nityananda V, 2007, J COMP PHYSIOL A, V193, P983, DOI 10.1007/s00359-007-0251-9; Nityananda V, 2006, BIOACOUSTICS, V15, P223, DOI 10.1080/09524622.2006.9753552; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Orci KM, 2005, ZOOL ANZ, V244, P31, DOI 10.1016/j.jcz.2004.11.002; PERDECK A. C., 1958, BEHAVIOUR, V12, P1, DOI 10.1163/156853957X00074; Popple LW, 2008, EVOL ECOL, V22, P203, DOI 10.1007/s10682-007-9169-5; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Ryan M. J., 1992, AM NATURALIST, V139; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Schul J, 1998, J COMP PHYSIOL A, V182, P687, DOI 10.1007/s003590050213; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; Shaw KL, 2000, ZOOL J LINN SOC-LOND, V129, P73, DOI 10.1111/j.1096-3642.2000.tb00009.x; STOUT JF, 1983, J COMP PHYSIOL, V153, P509, DOI 10.1007/BF00612605; Team R. C, 2014, R LANG ENV STAT COMP; Walker TJ, 2003, ANN ENTOMOL SOC AM, V96, P433, DOI 10.1603/0013-8746(2003)096[0433:TRCOTG]2.0.CO;2; WALKER TJ, 1964, Q REV BIOL, V39, P345, DOI 10.1086/404325; WELLS MM, 1992, EVOLUTION, V46, P31, DOI 10.1111/j.1558-5646.1992.tb01982.x	37	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188843	10.1371/journal.pone.0188843	http://dx.doi.org/10.1371/journal.pone.0188843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182676	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000416402000060
J	Yamaguchi, K; Mezaki, H; Fujiwara, M; Hara, Y; Kawasaki, T				Yamaguchi, Koji; Mezaki, Hirohisa; Fujiwara, Masayuki; Hara, Yuki; Kawasaki, Tsutomu			Arabidopsis ubiquitin ligase PUB12 interacts with and negatively regulates Chitin Elicitor Receptor Kinase 1 (CERK1)	PLOS ONE			English	Article							PLANT INNATE IMMUNITY; DISEASE RESISTANCE; PROTEASOME SYSTEM; CELL-DEATH; PROTEIN; THALIANA; PHOSPHORYLATION; ACTIVATION; PBL27; LYK5	In Arabidopsis, fungal chitin is recognized as a pathogen-associated molecular pattern (PAMP) by the chitin receptor complex containing the lysin-motif (LysM) receptor-like kinases CERK1 and LYK5. Upon the perception of chitin, CERK1 phosphorylates the receptor- like cytoplasmic kinase, PBL27, which activates the intracellular mitogen-activated protein kinase (MAPK) cascade. However, the mechanisms by which the CERK1-PBL27 complex is regulated remain largely unknown. We identified ubiquitin ligase PUB12 as a component of the PBL27 complex using co-immunoprecipitation and mass spectrometry. However, PUB12 did not interact directly with PBL27. Instead, the ARM domains of PUB12 and its paralog PUB13 interacted with the intracellular domain of CERK1 in a manner that was dependent on its autophosphorylation, suggesting that the phosphorylation-based auto-activation of CERK1 may be required for its interaction with PUB12. The co-expression of PUB12 in Nicotiana benthamiana reduced the accumulation of CERK1. The pub12 pub13 mutant exhibited enhanced chitin-induced immune responses such as ROS production, MAPK activation, and callose deposition. These results suggest that PUB12 and PUB13 are involved in the negative regulation of the chitin receptor complex, which may contribute to the transient desensitization of chitin-induced responses.	[Yamaguchi, Koji; Mezaki, Hirohisa; Hara, Yuki; Kawasaki, Tsutomu] Kindai Univ, Grad Sch Agr, Dept Adv Biosci, Nakamachi, Nara, Japan; [Fujiwara, Masayuki] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University	Kawasaki, T (corresponding author), Kindai Univ, Grad Sch Agr, Dept Adv Biosci, Nakamachi, Nara, Japan.	t-kawasaki@nara.kindai.ac.jp			Japan Society for the Promotion of Science (JSPS) [JP15H02489, JP15H01242, JP16H01474, JP15K18649]; Grants-in-Aid for Scientific Research [15H02489] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) [Grants-in-Aid for Scientific Research (A) (JP15H02489) and for Scientific Research on Innovative Areas (JP15H01242 and JP16H01474) to T.K., and a Grant-in-Aid for Scientific Research (JP15K18649) to K.Y]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancot F, 2009, ONCOGENE, V28, P2185, DOI 10.1038/onc.2009.88; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Erwig J, 2017, NEW PHYTOL, V215, P382, DOI 10.1111/nph.14592; Fujiwara M, 2014, PLANT CELL PHYSIOL, V55, P781, DOI 10.1093/pcp/pcu038; Li B, 2014, MOL PLANT PATHOL, V15, P737, DOI 10.1111/mpp.12128; Liao DH, 2017, NEW PHYTOL, V214, P1646, DOI 10.1111/nph.14472; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Petutschnig EK, 2014, NEW PHYTOL, V204, P955, DOI 10.1111/nph.12920; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Pietraszewska-Bogiel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065055; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Segonzac C, 2014, EMBO J, V33, P2069, DOI 10.15252/embj.201488698; Shinya T, 2014, PLANT J, V79, P56, DOI 10.1111/tpj.12535; Suzuki M, 2016, PLANT CELL PHYSIOL, V57, P2312, DOI 10.1093/pcp/pcw150; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yamada K, 2016, EMBO J, V35, P2468, DOI 10.15252/embj.201694248	25	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188886	10.1371/journal.pone.0188886	http://dx.doi.org/10.1371/journal.pone.0188886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182677	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000062
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			PvdO is required for the oxidation of dihydropyoverdine as the last step of fluorophore formation in Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLGLYCINE-GENERATING ENZYME; POLYACRYLAMIDE GELS; ELECTROPHORETIC TRANSFER; PYOVERDINE CHROMOPHORE; SIDEROPHORE; AERUGINOSA; PROTEINS; IDENTIFICATION; NITROCELLULOSE; BIOSYNTHESIS	Pyoverdines are important siderophores that guarantee iron supply to important pathogenic and non-pathogenic pseudomonads in host habitats. A key characteristic of all pyoverdines is the fluorescent dihydroxyquinoline group that contributes two ligands to the iron complexes. Pyoverdines are derived from the non-ribosomally synthesized peptide ferribactin, and their fluorophore is generated by periplasmic oxidation and cyclization reactions of D-tyrosine and L-diaminobutyric acid. The formation of the fluorophore is known to be driven by the periplasmic tyrosinase PvdP. Here we report that the putative periplasmic oxidoreductase PvdO of Pseudomonas fluorescens A506 is required for the final oxidation of dihydropyoverdine to pyoverdine, which completes the fluorophore. The pvdO deletion mutant accumulates dihydropyoverdine, and this phenotype is fully complemented by recombinant PvdO. The autoxidation of dihydropyoverdine at alkaline pH and the presence of high copper concentrations can mask this phenotype. Mutagenesis of conserved residues with potential catalytic function identified Glu-260 as an essential residue whose mutation abolished function without affecting stability or transport. Glu-260 of PvdO is at the exact position of the active-site cysteine in the structurally related formylglycine-generating enzyme. Evolution thus used the same protein fold for two distinct functionalities. As purified PvdO was inactive, additional factors are required for catalysis.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Science Foundation (DFG) [GRK1798, BR 2285/7-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Science Foundation (DFG) Grant GRK1798 "Signaling at the Plant-Soil Interface" and Project BR 2285/7-1. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHTGARY AM, 1994, INORG CHEM, V33, P6391, DOI 10.1021/ic00104a059; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baysse C, 2002, FEBS LETT, V523, P23, DOI 10.1016/S0014-5793(02)02915-0; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bultreys A, 2001, APPL ENVIRON MICROB, V67, P1718, DOI 10.1128/AEM.67.4.1718-1727.2001; Buongiorno D, 2013, COORDIN CHEM REV, V257, P541, DOI 10.1016/j.ccr.2012.04.028; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ellermann M, 2017, FREE RADICAL BIO MED, V105, P68, DOI 10.1016/j.freeradbiomed.2016.10.489; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Holder PG, 2015, J BIOL CHEM, V290, P15730, DOI 10.1074/jbc.M115.652669; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jacques P, 2003, LETT APPL MICROBIOL, V36, P259, DOI 10.1046/j.1472-765X.2003.01304.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Meury M, 2017, ANGEW CHEM INT EDIT, V56, P8115, DOI 10.1002/anie.201702901; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ringel MT, 2017, J BIOL CHEM, V292, P18660, DOI 10.1074/jbc.M117.812545; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6446, DOI 10.1021/bi00525a025; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6457, DOI 10.1021/bi00525a026; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0; Yuan ZL, 2017, BIOCHEM BIOPH RES CO, V484, P195, DOI 10.1016/j.bbrc.2016.12.181	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2330	2341		10.1074/jbc.RA117.000121	http://dx.doi.org/10.1074/jbc.RA117.000121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29208656	Green Published, hybrid			2022-12-26	WOS:000425308300008
J	Gludovacz, E; Maresch, D; de Carvalho, LL; Puxbaum, V; Baier, LJ; Sutzl, L; Guedez, G; Grunwald-Gruber, C; Ulm, B; Pils, S; Ristl, R; Altmann, F; Jilma, B; Salminen, TA; Borth, N; Boehm, T				Gludovacz, Elisabeth; Maresch, Daniel; de Carvalho, Leonor Lopes; Puxbaum, Verena; Baier, Laurenz J.; Suetzl, Leander; Guedez, Gabriela; Gruenwald-Gruber, Clemens; Ulm, Barbara; Pils, Sophie; Ristl, Robin; Altmann, Friedrich; Jilma, Bernd; Salminen, Tiina A.; Borth, Nicole; Boehm, Thomas			Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION PROTEIN-1 VAP-1; N-LINKED GLYCAN; HUMAN-PREGNANCY; PLASMA; GLYCOSYLATION; HISTAMINE; PURIFICATION; ENVIRONMENT; INHIBITION; EXPRESSION	N-Glycosylation plays a fundamental role in many biological processes. Human diamine oxidase (hDAO), required for histamine catabolism, has multiple N-glycosylation sites, but their roles, for example in DAO secretion, are unclear. We recently reported that the N-glycosylation sites Asn-168, Asn-538, and Asn-745 in recombinant hDAO (rhDAO) carry complex-type glycans, whereas Asn-110 carries only mammalian-atypical oligomannosidic glycans. Here, we show that Asn-110 in native hDAO from amniotic fluid and Caco-2 cells, DAO from porcine kidneys, and rhDAO produced in two different HEK293 cell lines is also consistently occupied by oligomannosidic glycans. Glycans at Asn-168 were predominantly sialylated with bi-to tetra-antennary branches, and Asn-538 and Asn-745 had similar complex-type glycans with some tissue-and cell linespecific variations. The related copper-containing amine oxidase human vascular adhesion protein-1 also exclusively displayed high-mannose glycosylation at Asn-137. X-ray structures revealed that the residues adjacent to Asn-110 and Asn-137 form a highly conserved hydrophobic cleft interacting with the core trisaccharide. Asn-110 replacement with Gln completely abrogated rhDAOsecretion and caused retention in the endoplasmic reticulum. Mutations of Asn-168, Asn-538, and Asn-745 reduced rhDAO secretion by 13, 71, and 32%, respectively. Asn-538/ 745 double and Asn-168/538/745 triple substitutions reduced rhDAO secretion by 85 and 94%. Because of their locations in the DAO structure, Asn-538 and Asn-745 glycosylations might be important for efficient DAO dimer formation. These functional results are reflected in the high evolutionary conservation of all four glycosylation sites. Human DAO is abundant only in the gastrointestinal tract, kidney, and placenta, and glycosylation seems essential for reaching high enzyme expression levels in these tissues.	[Gludovacz, Elisabeth; Puxbaum, Verena; Baier, Laurenz J.; Borth, Nicole] Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria; [Maresch, Daniel; Gruenwald-Gruber, Clemens; Altmann, Friedrich; Boehm, Thomas] Univ Nat Resources & Life Sci, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria; [Suetzl, Leander] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria; [Gludovacz, Elisabeth; Jilma, Bernd; Boehm, Thomas] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Clin Pharmacol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Ulm, Barbara; Pils, Sophie] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Obstet & Gynecol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat IMS, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [de Carvalho, Leonor Lopes; Guedez, Gabriela; Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Tykistokatu 6A, FIN-20520 Turku, Finland	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Abo Akademi University	Borth, N (corresponding author), Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.; Boehm, T (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Clin Pharmacol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	nicole.borth@boku.ac.at; thomas.boehm@meduniwien.ac.at	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021; Guédez, Gabriela/O-2180-2019	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Guédez, Gabriela/0000-0002-3711-8470; Jilma, Bernd/0000-0001-5652-7977; Gludovacz, Elisabeth/0000-0002-1837-2422; Sutzl, Leander/0000-0002-8889-2343; Ristl, Robin/0000-0002-4163-9236; Altmann, Friedrich/0000-0002-0112-7877; Grunwald-Gruber, Clemens/0000-0002-6097-8348	Academy of Finland [288534]; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Grant 288534 (to T.A.S.), the National Doctoral Programme in Informational and Structural Biology (to L.L.C.), and The Sigrid Juselius Foundation (to T.A.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bartko J, 2016, ALCOHOL, V54, P51, DOI 10.1016/j.alcohol.2016.06.001; BAYLIN SB, 1975, BIOCHIM BIOPHYS ACTA, V397, P294, DOI 10.1016/0005-2744(75)90119-9; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Bligt-Linden E, 2013, J MED CHEM, V56, P9837, DOI 10.1021/jm401372d; Boehm T, 2017, CLIN BIOCHEM, V50, P444, DOI 10.1016/j.clinbiochem.2016.12.011; Caramelo JJ, 2015, FEBS LETT, V589, P3379, DOI 10.1016/j.febslet.2015.07.021; CRABBE JC, 1976, BIOCHEM J, V155, P679; DAGOSTINO L, 1986, DIGESTION, V34, P243, DOI 10.1159/000199337; DANIELE B, 1990, GASTROENTEROLOGY, V99, P1675, DOI 10.1016/0016-5085(90)90474-F; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dumont J, 2016, CRIT REV BIOTECHNOL, V36, P1110, DOI 10.3109/07388551.2015.1084266; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; GAHL WA, 1982, BRIT J OBSTET GYNAEC, V89, P202, DOI 10.1111/j.1471-0528.1982.tb03614.x; Gludovacz E, 2016, J BIOTECHNOL, V227, P120, DOI 10.1016/j.jbiotec.2016.04.002; Green M.R., 2012, MOL CLONING LAB MANU; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Imamura Y, 1997, GENOMICS, V40, P277, DOI 10.1006/geno.1996.4570; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Klanert G, 2014, BIOTECHNOL J, V9, P538, DOI 10.1002/biot.201300216; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAYMON CARL W., 1939, JOUR INVEST DERMAT, V2, P301; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Maintz L, 2008, HUM REPROD UPDATE, V14, P485, DOI 10.1093/humupd/dmn014; McGrath AP, 2010, BIOCHEMISTRY-US, V49, P8316, DOI 10.1021/bi1010915; McGrath AP, 2010, ACTA CRYSTALLOGR F, V66, P137, DOI 10.1107/S1744309109052130; McGrath AP, 2009, BIOCHEMISTRY-US, V48, P9810, DOI 10.1021/bi9014192; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Miller H, 1940, J AMER MED ASSOC, V114, P1742; Nymalm Y, 2003, ACTA CRYSTALLOGR D, V59, P1288, DOI 10.1107/S090744490300979X; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pichler J, 2009, J BIOTECHNOL, V141, P80, DOI 10.1016/j.jbiotec.2009.03.001; Probst OC, 2006, J CELL SCI, V119, P4935, DOI 10.1242/jcs.03283; Rose DR, 2012, CURR OPIN STRUC BIOL, V22, P558, DOI 10.1016/j.sbi.2012.06.005; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 2007, PROG INFLAM RES, P237, DOI DOI 10.1007/978-3-7643-7975-9_; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; SATTLER J, 1988, AGENTS ACTIONS, V23, P361, DOI 10.1007/BF02142588; Schwelberger HG, 2007, J NEURAL TRANSM, V114, P757, DOI 10.1007/s00702-007-0684-x; Schwelberger HG, 1999, INFLAMM RES, V48, pS83; Schwelberger HG, 2013, J NEURAL TRANSM, V120, P983, DOI 10.1007/s00702-013-0983-3; SJAASTAD OV, 1967, Q J EXP PHYSIOL CMS, V52, P319, DOI 10.1113/expphysiol.1967.sp001918; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; Slominska-Wojewodzka M, 2015, MOLECULES, V20, P9816, DOI 10.3390/molecules20069816; SOUTHREN AL, 1964, AM J OBSTET GYNECOL, V89, P199; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Toyoda T, 2002, J BIOCHEM, V131, P511, DOI 10.1093/oxfordjournals.jbchem.a003128; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2016, SYMBOL NOMENCLATURE; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang H, 2016, J PROTEOME RES, V15, P923, DOI 10.1021/acs.jproteome.5b00921; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	71	8	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1070	1087		10.1074/jbc.M117.814244	http://dx.doi.org/10.1074/jbc.M117.814244			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187599	Green Published, hybrid			2022-12-26	WOS:000422864500026
J	Zang, K; Li, FH; Ma, QJ				Zang, Kun; Li, Fuhua; Ma, Qingjun			The dUTPase of white spot syndrome virus assembles its active sites in a noncanonical manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYURIDINE TRIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PROTEIN STRUCTURES; TRIMERIC DUTPASES; ESCHERICHIA-COLI; PYROPHOSPHATASE; MECHANISM; LIGAND; IDENTIFICATION; REFINEMENT	dUTPases are essential enzymes for maintaining genome integrity and have recently been shown to play moonlighting roles when containing extra sequences. Interestingly, the trimeric dUTPase of white spot syndrome virus (wDUT) harbors a sequence insert at the position preceding the C-terminal catalytic motifV(pre-V insert), rarely seen in other dUTPases. However, whether this extra sequence endowswDUTwith additional properties is unknown. Herein, we present the crystal structures of wDUT in both ligand-free and ligand-bound forms. We observed that the pre-V insert in wDUT forms an unusual beta-hairpin structure in the domain-swapping region and thereby facilitates a unique orientation of the adjacent C-terminal segment, positioning the catalytic motif V onto the active site of its own subunit instead of a third subunit. Consequently, wDUT employs two-subunit active sites, unlike the widely accepted paradigm that the active site of trimeric dUTPase is contributed by all three subunits. According to results from local structural comparisons, the active-site configuration ofwDUTis similar to that of known dUTPases. However, we also found that residues in the second-shell region of the active site are reconfigured in wDUT as an adaption to its unique C-terminal orientation. We also show that deletion of the pre-V insert significantly reduces wDUT's enzymatic activity and thermal stability. We hypothesize that this rare structural arrangement confers additional functionality to wDUT. In conclusion, our study expands the structural diversity in the conserved dUTPase family and illustrates how sequence insertion and amino acid substitution drive protein evolution cooperatively.	[Zang, Kun; Li, Fuhua; Ma, Qingjun] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China; [Zang, Kun; Li, Fuhua; Ma, Qingjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China; [Zang, Kun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, QJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China.; Ma, QJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China.	qma@qdio.ac.cn			National Natural Science Foundation of China [31572660]; 1000 Talents Program of China; 100 Talents Program of the Chinese Academy of Sciences; AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant [2015ASTP]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1000 Talents Program of China; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant	This work was supported by National Natural Science Foundation of China Grant 31572660, the 1000 Talents Program of China, the 100 Talents Program of the Chinese Academy of Sciences, and the AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant 2015ASTP (to Q. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Tormo-Mas MA, 2013, MOL CELL, V49, P947, DOI 10.1016/j.molcel.2012.12.013; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Ariza ME, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00504; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Chu RY, 1996, J BIOL CHEM, V271, P27670, DOI 10.1074/jbc.271.44.27670; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Garcia-Nafria J, 2013, ACTA CRYSTALLOGR D, V69, P1367, DOI 10.1107/S090744491300735X; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; Homma K, 2009, ACTA CRYSTALLOGR F, V65, P1030, DOI 10.1107/S1744309109034459; Hormozdiari F, 2009, J COMPUT BIOL, V16, P159, DOI 10.1089/cmb.2008.03TT; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu XQ, 2005, VIRUS RES, V110, P21, DOI 10.1016/j.virusres.2005.01.003; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Madrid AS, 2012, J VIROL, V86, P8693, DOI 10.1128/JVI.00252-12; Maiques E, 2016, NUCLEIC ACIDS RES, V44, P5457, DOI 10.1093/nar/gkw317; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyahara S, 2012, J MED CHEM, V55, P5483, DOI 10.1021/jm300416h; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy GN, 2016, J AM CHEM SOC, V138, P15035, DOI 10.1021/jacs.6b09012; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nyiri K, 2017, BBA-GEN SUBJECTS, V1861, P3593, DOI 10.1016/j.bbagen.2016.05.024; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Penades JR, 2013, CURR OPIN MICROBIOL, V16, P163, DOI 10.1016/j.mib.2013.02.005; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Tchigvintsev A, 2011, BIOCHEM J, V437, P243, DOI 10.1042/BJ20110304; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Verbruggen B, 2016, VIRUSES, V8, pE23; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Williams D, 2011, BBA-MOL CELL RES, V1813, P315, DOI 10.1016/j.bbamcr.2010.11.021; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zhang R, 2017, J VIROL, V91, DOI [10.1128/JVI.01148-17, 10.1128/jvi.01148-17]	57	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1088	1099		10.1074/jbc.M117.815266	http://dx.doi.org/10.1074/jbc.M117.815266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187596	Green Published, hybrid			2022-12-26	WOS:000422864500027
J	Amoakoh-Coleman, M; Ogum-Alangea, D; Modey-Amoah, E; Ntumy, MY; Adanu, RM; Oppong, SA				Amoakoh-Coleman, Mary; Ogum-Alangea, Deda; Modey-Amoah, Emefa; Ntumy, Michael Yao; Adanu, Richard M.; Oppong, Samuel A.			Blood pressure patterns and body mass index status in pregnancy: An assessment among women reporting for antenatal care at the Korle-Bu Teaching hospital, Ghana	PLOS ONE			English	Article							RISK-FACTORS; WEIGHT-GAIN; OBESITY; PREECLAMPSIA; OVERWEIGHT; OUTCOMES; BOOKING	Background Maternal obesity in pregnancy has been linked with increased risk of pregnancy induced hypertension (PIH). In some tertiary referral hospitals in Ghana, PIH is the leading cause of institutional maternal mortality. Objective To evaluate blood pressure changes during pregnancy amongst different body mass index (BMI) groups and how this relates to the risk of developing PIH. Methods Women who had a dating ultrasound before 20 weeks gestation and registering for antenatal care at the Korle-Bu Teaching Hospital in Accra, between February and December 2013 and met the inclusion criteria were recruited into a cohort study. BMI was assessed at baseline. Blood pressure measurements were taken at (+/- 2) 24, 28 and 36 weeks. Primary outcome measure of interest during follow-up was a diagnosis of PIH at these points. BP changes during follow up at the three points were measured. Descriptive analysis of baseline factors was carried out and compared for the BMI groups. Relative risk (RR) of PIH was estimated at 95% confidence interval. Results Mean (SD) age for the 361 women was 30.9 (4.8) years. Incidence of PIH amongst the cohort was 10.5% (95% CI: 7.45% - 14.45%) and 40.4% and 33.0% of them were overweight and obese respectively at baseline. Pregnant women who were obese at baseline had a three-fold increased risk of PIH compared to those with normal BMI [RR = 3.01 (1.06-8.52), p = 0.04]. Conclusion Obese women have a significantly increased risk of PIH. Women should be screened at booking for obesity status. Antenatal protocols should have interventions for prevention or early detection of obesity and management of obesity to improve outcomes.	[Amoakoh-Coleman, Mary] Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Legon, Ghana; [Amoakoh-Coleman, Mary] Univ Ghana, Dept Epidemiol & Dis Control, Sch Publ Hlth, Legon, Ghana; [Amoakoh-Coleman, Mary] Univ Med Ctr, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Ogum-Alangea, Deda; Modey-Amoah, Emefa; Adanu, Richard M.] Univ Ghana, Dept Populat Family & Reprod Hlth, Sch Publ Hlth, Legon, Ghana; [Ntumy, Michael Yao; Oppong, Samuel A.] Univ Ghana, Dept Obstet & Gynecol, Sch Med & Dent, Accra, Ghana	University of Ghana; University of Ghana; Utrecht University; Utrecht University Medical Center; University of Ghana; University of Ghana	Oppong, SA (corresponding author), Univ Ghana, Dept Obstet & Gynecol, Sch Med & Dent, Accra, Ghana.	wak72@yahoo.com	Alangea, Deda Ogum/AAB-3257-2020	Alangea, Deda Ogum/0000-0001-7496-8514; Modey, Emefa Judith/0000-0002-9116-462X	Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana	Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana	The study was funded by the Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana. The funder have no role in data collection, analysis of results, data interpretation and the final decision to submit this manuscript.	Addo V N, 2010, Ghana Med J, V44, P64; Adu-Bonsaffoh K, MATERNAL DEATHS ATTR; Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; Amoah AGB, 2003, PUBLIC HEALTH NUTR, V6, P751, DOI 10.1079/PHN2003506; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Biritwum Rb, 2005, Ghana Med J, V39, P82; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conklin AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150736; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Der E M, 2013, Ghana Med J, V47, P158; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ehrenthal DB, 2011, J WOMENS HEALTH, V20, P67, DOI 10.1089/jwh.2010.1970; Ghana Statistical Service, 2011, GHAN DEM HLTH SURV 2; Ghana Statistical Service Noguchi Memorial Institute for Medical Research & ORC Macro., 2004, DEM HLTH SURV 2003; Jeremiah Israel NSACAN, 2011, J MED MED SCI, V2, P1152; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Kongubol A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-59; Lee QY, MATERNAL MORTALITY G; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Lord J, 2007, BJOG-INT J OBSTET GY, V114, P236, DOI 10.1111/j.1471-0528.2006.01199.x; Measure DHS, 2008, GHAN DEM HLTH SURV 2; Measure DHS. Ghana Statistical Service-GSS Ghana Health Service-GHS and ICF International, 2015, GHANA DEMOGRAPHIC HL; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Muti M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0110-5; Nohr EA, PREPREGNANCY OBESITY; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Satpathy HK, 1941, MATERNAL OBESITY PRE; Savitri AI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011626; Soni-Trinidad CF, MATERNAL MORBIDITY M; Stringhini S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3589-5; Tsukamoto H, 2007, EUR J OBSTET GYN R B, V133, P53, DOI 10.1016/j.ejogrb.2006.07.031; van Middendorp D, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-59; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188671	10.1371/journal.pone.0188671	http://dx.doi.org/10.1371/journal.pone.0188671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211781	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200042
J	Cattaneo, ER; Prieto, ED; Garcia-Fabiani, MB; Montanaro, MA; Guillou, H; Gonzalez-Baro, MR				Cattaneo, Elizabeth R.; Prieto, Eduardo D.; Garcia-Fabiani, Maria B.; Montanaro, Mauro A.; Guillou, Herve; Gonzalez-Baro, Maria R.			Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study	PLOS ONE			English	Article							ARACHIDONIC-ACID; CANCER CELLS; VISCOELASTICITY; DISCRIMINATION; FIXATION	In mammalian cells, de novo glycerolipid synthesis begins with the acylation of glycerol-3-phosphate, catalyzed by glycerol-3-phosphate acyltransferases (GPAT). GPAT2 is a mitochondrial isoform primarily expressed in testis under physiological conditions, and overexpressed in several types of cancers and cancer-derived human cell lines where its expression contributes to the tumor phenotype. Using gene silencing and atomic force microscopy, we studied the correlation between GPAT2 expression and cell surface topography, roughness and membrane permeability in MDA-MB-231 cells. In addition, we analyzed the glycerolipid composition by gas-liquid chromatography. GPAT2 expression altered the arachidonic acid content in glycerolipids, and the lack of GPAT2 seems to be partially compensated by the overexpression of another arachidonic-acid-metabolizing enzyme, AGPAT11. GPAT2 expressing cells exhibited a rougher topography and less membrane damage than GPAT2 silenced cells. Pore-like structures were present only in GPAT2 subexpressing cells, correlating with higher membrane damage evidenced by lactate dehydrogenase release. These GPAT2-induced changes are consistent with its proposed function as a tumor-promoting gene, and might be used as a phenotypic differentiation marker. AFM provides the basis for the identification and quantification of those changes, and demonstrates the utility of this technique in the study of cancer cell biology.	[Cattaneo, Elizabeth R.; Garcia-Fabiani, Maria B.; Montanaro, Mauro A.; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Fac Ciencias Med, CONICET, Inst Invest Bioquim La Plata Rodolfo R Brenner, La Plata, Buenos Aires, Argentina; [Prieto, Eduardo D.] Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Guillou, Herve] Univ Toulouse, Toxalim, INRA, ENVT,INP Purpan,UPS, Toulouse, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Gonzalez-Baro, MR (corresponding author), Univ Nacl La Plata, Fac Ciencias Med, CONICET, Inst Invest Bioquim La Plata Rodolfo R Brenner, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar	Guillou, Herve/AAG-2826-2020; Guillou, Hervé/AGL-0750-2022	Guillou, Herve/0000-0002-5363-9081; Guillou, Hervé/0000-0002-5363-9081; Gonzalez-Baro, Maria R./0000-0002-6778-284X	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT2014-3214]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP20013-0310]; Universidad Nacional de La Plata [M202]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de La Plata(National University of La Plata)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina-PICT2014-3214 (MRGB), http:/www.agencia.mincyt.gob.ar/frontend/agencia/convocatoria/304; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. PIP20013-0310 (MRGB), http://proyectosinv.concet.gov.ar/; Universidad Nacional de La Plata M202 (MRGB), http://secyt.presi.unlp.edu.ar/Wordpress/?p=5090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MODERN RES ED TOPICS; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Berdyyeva T, 2005, ULTRAMICROSCOPY, V102, P189, DOI 10.1016/j.ultramic.2004.09.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Cho SJ, 2002, CELL BIOL INT, V26, P35, DOI 10.1006/cbir.2001.0849; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Fonteh AN, 2001, J BIOL CHEM, V276, P1439, DOI 10.1074/jbc.M006551200; Francis LW, 2010, BIOL CELL, V102, P133, DOI 10.1042/BC20090127; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Garcia-Fabiani MB, 2015, BIOCHEM J, V471, P211, DOI 10.1042/BJ20150730; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Girasole M, 2003, AIP C P, V696, P467; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6; Kaul-Ghanekar R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-350; Kronlage C, 2015, BIOPHYS J, V109, P687, DOI 10.1016/j.bpj.2015.06.066; Lara-Cruz C, 2016, INT J NANOMED, V11, P5149, DOI 10.2147/IJN.S108768; Lara-Cruz C, 2008, 9 C NAC MICR AS MEX; Layton BE, 2004, BIOTECHNIQUES, V37, P564, DOI 10.2144/04374BI01; Lekka M, 2012, NAT NANOTECHNOL, V7, P691, DOI 10.1038/nnano.2012.196; Li M, 2016, BIONANOSCIENCE, V6, P22, DOI 10.1007/s12668-015-0180-y; Moloney M, 2004, ULTRAMICROSCOPY, V100, P153, DOI 10.1016/j.ultramic.2003.12.010; Pellon-Maison M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100896; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Ricci D., 2004, METH MOL B, V242, P25; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sokolov I, 2007, CANCER NANOTECHNOL, V1, P1; Wang JY, 2009, BIOSENS BIOELECTRON, V25, P721, DOI 10.1016/j.bios.2009.08.011; Wang YH, 2016, SCANNING, V38, P558, DOI 10.1002/sca.21300; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Weyn B, 1998, J MICROSC-OXFORD, V189, P172, DOI 10.1046/j.1365-2818.1998.00299.x; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Wolf Leslie A., 1999, Cell Biochemistry and Biophysics, V30, P353, DOI 10.1007/BF02738119; Yeow N., 2017, ADV COLLOID INTERFAC	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189031	10.1371/journal.pone.0189031	http://dx.doi.org/10.1371/journal.pone.0189031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211789	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200058
J	Daga, FB; Diniz, A; Boer, ER; Gracitelli, CPB; Abe, RY; Medeiros, FA				Daga, Fablo B.; Diniz-Filho, Alberto; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Medeiros, Felipe A.			Fear of falling and postural reactivity in patients with glaucoma	PLOS ONE			English	Article							RISK-FACTORS; OLDER-ADULTS; VISUAL IMPAIRMENT; MOTION PERCEPTION; ELDERLY-PATIENTS; ASSOCIATION; PERFORMANCE; MOBILITY; VISION	Purpose To investigate the relationship between postural metrics obtained by dynamic visual stimulation in a virtual reality environment and the presence of fear of falling in glaucoma patients. Methods This cross-sectional study included 35 glaucoma patients and 26 controls that underwent evaluation of postural balance by a force platform during presentation of static and dynamic visual stimuli with head-mounted goggles (Oculus Rift). In dynamic condition, a peripheral translational stimulus was used to induce vection and assess postural reactivity. Standard deviations of torque moments (SDTM) were calculated as indicative of postural stability. Fear of falling was assessed by a standardized questionnaire. The relationship between a summary score of fear of falling and postural metrics was investigated using linear regression models, adjusting for potentially confounding factors. Results Subjects with glaucoma reported greater fear of falling compared to controls (-0.21 vs. 0.27; P = 0.039). In glaucoma patients, postural metrics during dynamic visual stimulus were more associated with fear of falling (R-2 = 18.8%; P = 0.001) than static (R-2 = 3.0%; P = 0.005) and dark field (R-2 = 5.7%; P = 0.007) conditions. In the univariable model, fear of falling was not significantly associated with binocular standard perimetry mean sensitivity (P = 0.855). In the multivariable model, each 1 Nm larger SDTM in anteroposterior direction during dynamic stimulus was associated with a worsening of 0.42 units in the fear of falling questionnaire score (P = 0.001). Conclusion In glaucoma patients, postural reactivity to a dynamic visual stimulus using a virtual reality environment was more strongly associated with fear of falling than visual field testing and traditional balance assessment.	[Daga, Fablo B.; Medeiros, Felipe A.] Duke Univ, Duke Eye Ctr, Durham, NC 27708 USA; [Daga, Fablo B.; Medeiros, Felipe A.] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA; [Daga, Fablo B.; Gracitelli, Carolina P. B.] Univ Fed Sao Paulo, Dept Ophthalmol & Vis Sci, Sao Paulo, Brazil; [Daga, Fablo B.; Diniz-Filho, Alberto; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Duke University; Duke University; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California San Diego	Medeiros, FA (corresponding author), Duke Univ, Duke Eye Ctr, Durham, NC 27708 USA.; Medeiros, FA (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.; Medeiros, FA (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.	felipe.medeiros@duke.edu	; Diniz-Filho, Alberto/C-8564-2015	Abe, Ricardo/0000-0002-7023-2144; Diniz-Filho, Alberto/0000-0002-0371-2359	National Institutes of Health/National Eye Institute [EY021818]; Brazilian National Council for Scientific and Technological Development (CNPq) [233829/2014-8]; Alcon Laboratories (Fort Worth, TX); Bausch & Lomb (Garden City, NY); Carl Zeiss Meditec (Jena, Germany); Heidelberg Engineering (Heidelberg, Germany); Merck (White House Station, NJ); Allergan (Irvine, CA); Sensimed (Lausanne, Switzerland); Topcon (Livermore, CA); Reichert (Dewey, NY); National Eye Institute (Bethesda, MD); Novartis (Basel, Switzerland); nGoggle (San Diego, CA)	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alcon Laboratories (Fort Worth, TX); Bausch & Lomb (Garden City, NY); Carl Zeiss Meditec (Jena, Germany); Heidelberg Engineering (Heidelberg, Germany); Merck (White House Station, NJ)(Merck & Company); Allergan (Irvine, CA)(AbbVieAllergan); Sensimed (Lausanne, Switzerland); Topcon (Livermore, CA); Reichert (Dewey, NY); National Eye Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Novartis (Basel, Switzerland); nGoggle (San Diego, CA)	National Institutes of Health/National Eye Institute grant EY021818 (F.A.M), fellowship grant from Brazilian National Council for Scientific and Technological Development (CNPq) 233829/2014-8 (A.D.F.). Financial support FAM: Alcon Laboratories (Fort Worth, TX), Bausch & Lomb (Garden City, NY), Carl Zeiss Meditec (Jena, Germany), Heidelberg Engineering (Heidelberg, Germany), Merck (White House Station, NJ), Allergan (Irvine, CA), Sensimed (Lausanne, Switzerland), Topcon (Livermore, CA), Reichert (Dewey, NY), National Eye Institute (Bethesda, MD); Research support Alcon Laboratories (Fort Worth, TX), Allergan (Irvine, CA), Carl Zeiss Meditec (Jena, Germany), Reichert (Dewey, NY); Consultant Allergan (Irvine, CA), Carl-Zeiss Meditec, (Jena, Germany), Novartis (Basel, Switzerland), nGoggle (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; Black AA, 2011, OPTOMETRY VISION SCI, V88, P1275, DOI 10.1097/OPX.0b013e31822f4d6a; Boer ER, 2015, INVESTIGATIVE OPHTHA, V56; Caldwell G., 2004, RES METHODS BIOMECHA, P73; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; Coleman AL, 2004, OPHTHALMOLOGY, V111, P857, DOI 10.1016/j.ophtha.2003.09.033; Diniz A, 2015, OPHTHALMOLOGY, V122, P1131, DOI 10.1016/j.ophtha.2015.02.010; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; GLYNN RJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P205, DOI 10.1001/archopht.1991.01080020051041; Habak C, 2002, VISION RES, V42, P2843, DOI 10.1016/S0042-6989(02)00355-3; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Karwatsky P, 2006, OPTOMETRY VISION SCI, V83, P466, DOI 10.1097/01.opx.0000225107.38719.0d; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Lawson SN, 2013, PHYSIOTHER CAN, V65, P31, DOI 10.3138/ptc.2011-17; MAKI BE, 1991, J GERONTOL, V46, pM123, DOI 10.1093/geronj/46.4.M123; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; NICKENS H, 1985, ARCH INTERN MED, V145, P1089, DOI 10.1001/archinte.145.6.1089; Peterka R J, 1990, J Vestib Res, V1, P73; Peterka R J, 1990, J Vestib Res, V1, P87; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; PREVIC FH, 1993, PERCEPT PSYCHOPHYS, V54, P93, DOI 10.3758/BF03206941; Ramulu PY, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.037; RING C, 1988, ARCH PHYS MED REHAB, V69, P261; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Shabana N, 2003, SURV OPHTHALMOL, V48, P92, DOI 10.1016/S0039-6257(02)00401-0; Suzuki Mizue, 2002, Nurs Health Sci, V4, P155, DOI 10.1046/j.1442-2018.2002.00123.x; Tanabe S, 2012, CLIN OPHTHALMOL, V6, P327, DOI 10.2147/OPTH.S28281; TINETTI ME, 1993, J GERONTOL, V48, P35, DOI 10.1093/geronj/48.Special_Issue.35; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TOBIS JS, 1985, J AM GERIATR SOC, V33, P330, DOI 10.1111/j.1532-5415.1985.tb07132.x; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P2803; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Velozo CA, 2001, AM J PHYS MED REHAB, V80, P662, DOI 10.1097/00002060-200109000-00006; Wang MY, 2012, INVEST OPHTH VIS SCI, V53, P7967, DOI 10.1167/iovs.12-10701; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644; Yuki K, 2013, INVEST OPHTH VIS SCI, V54, P7739, DOI 10.1167/iovs.13-12079	41	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187220	10.1371/journal.pone.0187220	http://dx.doi.org/10.1371/journal.pone.0187220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211742	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200013
J	Saison-Ridinger, M; DelGiorno, KE; Zhang, TJ; Kraus, A; French, R; Jaquish, D; Tsui, C; Erikson, G; Spike, BT; Shokhirev, MN; Liddle, C; Yu, RT; Downes, M; Evans, RM; Saghatelian, A; Lowy, AM; Wahl, GM				Saison-Ridinger, Maya; DelGiorno, Kathleen E.; Zhang, Tejia; Kraus, Annabelle; French, Randall; Jaquish, Dawn; Tsui, Crystal; Erikson, Galina; Spike, Benjamin T.; Shokhirev, Maxim N.; Liddle, Christopher; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Saghatelian, Alan; Lowy, Andrew M.; Wahl, Geoffrey M.			Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy	PLOS ONE			English	Article							GENETIC ALTERATIONS; TUMOR-GROWTH; VITAMIN-D; FIBROBLASTS; STROMA; MICROENVIRONMENT; BREAST; IDENTIFICATION; SUPPRESSION; MUTATIONS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely dense fibrotic stroma, which contributes to tumor growth, metastasis, and drug resistance. During tumorigenesis, quiescent pancreatic stellate cells (PSCs) are activated and become major contributors to fibrosis, by increasing growth factor signaling and extracellular matrix deposition. The p53 tumor suppressor is known to restrict tumor initiation and progression through cell autonomous mechanisms including apoptosis, cell cycle arrest, and senescence. There is growing evidence that stromal p53 also exerts anti-tumor activity by paracrine mechanisms, though a role for stromal p53 in PDAC has not yet been described. Here, we demonstrate that activation of stromal p53 exerts anti-tumor effects in PDAC. We show that primary cancer-associated PSCs (caPSCs) isolated from human PDAC express wild-type p53, which can be activated by the Mdm2 antagonist Nutlin-3a. Our work reveals that p53 acts as a major regulator of PSC activation and as a modulator of PDAC fibrosis. In vitro, p53 activation by Nutlin-3a induces profound transcriptional changes, which reprogram activated PSCs to quiescence. Using immunofluorescence and lipidomics, we have also found that p53 activation induces lipid droplet accumulation in both normal and tumor-associated fibroblasts, revealing a previously undescribed role for p53 in lipid storage. In vivo, treatment of tumor-bearing mice with the clinical form of Nutlin-3a induces stromal p53 activation, reverses caPSCs activation, and decreases fibrosis. All together our work uncovers new functions for stromal p53 in PDAC.	[Saison-Ridinger, Maya; DelGiorno, Kathleen E.; Kraus, Annabelle; Tsui, Crystal; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Zhang, Tejia; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Peptide Biol Lab, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [French, Randall; Jaquish, Dawn; Lowy, Andrew M.] Univ Calif San Diego, Dept Surg, Div Surg Oncol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Erikson, Galina; Shokhirev, Maxim N.] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Spike, Benjamin T.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Sydney Med Sch, Westmead, NSW, Australia	Salk Institute; Salk Institute; University of California System; University of California San Diego; Salk Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu	DelGiorno, Kathy/AAJ-9911-2021; Evans, Ronald/AAF-4001-2019	DelGiorno, Kathy/0000-0002-5749-8394; Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627	San Diego NCI Cancer Centers Council [PTC2014]; NIH [CA155620, CA014195]; Leona M. and Harry B Helmsley Charitable Trust [2012-PG-MED002]; Lustgarten Foundation; Stand Up to Cancer Dream Team Translational Cancer Research grant [SU2C-AACR-DT0509, SU2C-AACR-DT2016]; Freeberg Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Salk Alumni Faculty fellowship; Helmsley Charitable Trust; Salk Women and Science award; NCI Cancer Center Support Grant [CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA155620, T32CA009370] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG008962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, R24DK090962] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021815] Funding Source: NIH RePORTER	San Diego NCI Cancer Centers Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B Helmsley Charitable Trust; Lustgarten Foundation; Stand Up to Cancer Dream Team Translational Cancer Research grant; Freeberg Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals(Ferring Pharmaceuticals); Salk Alumni Faculty fellowship; Helmsley Charitable Trust; Salk Women and Science award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the San Diego NCI Cancer Centers Council (#PTC2014 to G. M.W and A.M.L), NIH grants (CA155620 to A.M.L, CA014195 to R.M.E), the Leona M. and Harry B Helmsley Charitable Trust grant (2012-PG-MED002 to G.M.W and R.M.E), the Lustgarten Foundation (to R.M.E), Stand Up to Cancer Dream Team Translational Cancer Research grant (SU2C-AACR-DT0509 to G.M.W and R.M.E and SU2C-AACR-DT2016 to R.M.E), the Freeberg Foundation (to G.M.W) and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (to A.S.). M.S.R was partly supported by the Salk Alumni Faculty fellowship, the Helmsley Charitable Trust and the Salk Women and Science award. This study was also supported by the following Salk core facilities and their staff: the Advanced Biophotonics, Flow Cytometry, Functional Genomics, Integrative Genomics and Bioinformatics (G.E and M.N.S), Next Generation Sequencing and Mass Spectrometry Cores. Salk cores are supported by the NCI Cancer Center Support Grant P30 (CA014195) and the Helmsley Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Apte MV, 2015, PANCREATOLOGY, V15, pS32, DOI 10.1016/j.pan.2015.02.013; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Bar J, 2010, SEMIN CELL DEV BIOL, V21, P47, DOI 10.1016/j.semcdb.2009.11.006; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Blachnio-Zabielska AU, 2013, J LIPID RES, V54, P1705, DOI 10.1194/jlr.D035006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Campbell I, 2009, CANCER RES, V69, P6769; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chai MG, 2013, JOVE-J VIS EXP, DOI 10.3791/50395; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Davis TA, 2011, CHEM SCI, V2, P1076, DOI 10.1039/c1sc00061f; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gao ZJ, 2010, PANCREATOLOGY, V10, P186, DOI 10.1159/000236012; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00318; He XY, 2015, CELL REP, V13, P888, DOI 10.1016/j.celrep.2015.09.045; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jiang SX, 2015, ANAL METHODS-UK, V7, P8466, DOI 10.1039/c5ay01413a; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kranz D, 2006, CANCER RES, V66, P10274, DOI 10.1158/0008-5472.CAN-06-1527; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu W, 2013, J LIPID RES, V54, P244, DOI 10.1194/jlr.M031732; Lizardo DY, 2017, MOL BIOSYST, V13, P498, DOI 10.1039/c6mb00842a; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Mei L, 2016, J GASTROINTEST ONCOL, V7, P487, DOI 10.21037/jgo.2016.03.03; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Reichrath J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00166; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Thiam AR, 2017, J CELL SCI, V130, P315, DOI 10.1242/jcs.192021; Thompson T, 2010, MOL CANCER THER, V9, P1158, DOI 10.1158/1535-7163.MCT-09-1036; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wernert N, 2001, ANTICANCER RES, V21, P2259; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	71	22	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189051	10.1371/journal.pone.0189051	http://dx.doi.org/10.1371/journal.pone.0189051			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211796	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200060
J	Sanz-Torrent, M; Andreu, L; Ferreiro, JR; Coll-Florit, M; Trueswell, JC				Sanz-Torrent, Monica; Andreu, Llorenc; Rodriguez Ferreiro, Javier; Coll-Florit, Marta; Trueswell, John C.			Auditory word recognition of verbs: Effects of verb argument structure on referent identification	PLOS ONE			English	Article							TIME-COURSE; SENTENCE COMPREHENSION; EYE-MOVEMENTS; LANGUAGE COMPREHENSION; LEXICAL ORGANIZATION; SPOKEN LANGUAGE; COMPLEXITY; APHASIA; NOUNS; RETRIEVAL	Word recognition includes the activation of a range of syntactic and semantic knowledge that is relevant to language interpretation and reference. Here we explored whether or not the number of arguments a verb takes impinges negatively on verb processing time. In this study, three experiments compared the dynamics of spoken word recognition for verbs with different preferred argument structure. Listeners' eye movements were recorded as they searched an array of pictures in response to hearing a verb. Results were similar in all the experiments. The time to identify the referent increased as a function of the number of arguments, above and beyond any effects of label appropriateness (and other controlled variables, such as letter, phoneme and syllable length, phonological neighborhood, oral and written lexical frequencies, imageability and rated age of acquisition). The findings indicate that the number of arguments a verb takes, influences referent identification during spoken word recognition. Representational complexity and amount of information generated by the lexical item that aids target identification are discussed as possible sources of this finding.	[Sanz-Torrent, Monica; Rodriguez Ferreiro, Javier] Univ Barcelona, Grp Recerca Cognit & Llenguatge GRECIL, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain; [Andreu, Llorenc] Univ Oberta Catalunya, Grp Recerca Cognit & Llenguatge GRECIL, Estudis Psicol & Ciencies Educ, Barcelona, Spain; [Trueswell, John C.] Univ Oberta Catalunya, Estudis Arts & Humanitats, Barcelona, Spain; [Trueswell, John C.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Barcelona; UOC Universitat Oberta de Catalunya; UOC Universitat Oberta de Catalunya; University of Pennsylvania	Andreu, L (corresponding author), Univ Oberta Catalunya, Grp Recerca Cognit & Llenguatge GRECIL, Estudis Psicol & Ciencies Educ, Barcelona, Spain.	landreub@uoc.edu	Andreu, Llorenç/P-2099-2019; Rodríguez-Ferreiro, Javier/B-5232-2011; Andreu, Llorenç/K-4286-2015	Andreu, Llorenç/0000-0001-8568-2511; Rodríguez-Ferreiro, Javier/0000-0001-9828-8302; Andreu, Llorenç/0000-0001-8568-2511; Coll-Florit, Marta/0000-0002-8636-458X; Sanz-Torrent, Monica/0000-0002-2012-1956	Ministerio de Economia y Competitividad (Madrid, Spain) [EDU2013-44678-P]	Ministerio de Economia y Competitividad (Madrid, Spain)	This work was supported by the Ministerio de Economia y Competitividad (Madrid, Spain), Grant number: EDU2013-44678-P to PI: LA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Assadollahi R, 2008, BMC NEUROSCI, V21, P1; Atchley RA, 2006, BRAIN LANG, V99, P236, DOI 10.1016/j.bandl.2005.08.005; Baayen RH, 2006, J MEM LANG, V55, P290, DOI 10.1016/j.jml.2006.03.008; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Balconi C, 2005, J PSYCHOLINGUIST RES, V34, P71, DOI 10.1007/s10936-005-3633-6; Bastiaanse R, 1998, APHASIOLOGY, V12, P951, DOI 10.1080/02687039808249463; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008; Berndt RS, 2002, APHASIOLOGY, V16, P83, DOI 10.1080/02687040143000212; Breedin SD, 1996, COGNITIVE NEUROPSYCH, V13, P51, DOI 10.1080/026432996382060; Breedin SD, 1998, BRAIN LANG, V63, P1, DOI 10.1006/brln.1997.1923; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; CARLSON GN, 1988, SYNTAX SEMANTICS, V21, P263; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Cuetos F, 2011, PSICOLOGICA, V32, P133; Dahan D, 2005, PSYCHON B REV, V12, P453, DOI 10.3758/BF03193787; Dahan D, 2001, LANG COGNITIVE PROC, V16, P507, DOI 10.1080/01690960143000074; Dahan D, 2001, COGNITIVE PSYCHOL, V42, P317, DOI 10.1006/cogp.2001.0750; De Bleser R, 2003, J NEUROLINGUIST, V16, P213, DOI 10.1016/S0911-6044(02)00015-5; Dobel C, 2001, EXP BRAIN RES, V140, P77, DOI 10.1007/s002210100794; Duchon A, 2013, BEHAV RES METHODS, V45, P1246, DOI 10.3758/s13428-013-0326-1; Fischer B., 1992, EYE MOVEMENTS VISUAL, P31, DOI [DOI 10.1007/978-1-4612-2852-3_3, 10.1007/978-1-4612-2852-3_3]; Forsythe A, 2008, BEHAV RES METHODS, V40, P116, DOI 10.3758/BRM.40.1.116; Gelman A., 2007, DATA ANAL USING REGR; Gennari S, 2003, COGNITION, V89, pB27, DOI 10.1016/S0010-0277(03)00069-6; Gennari SP, 2009, COGNITION, V111, P1, DOI 10.1016/j.cognition.2008.12.006; Gillette J, 1999, COGNITION, V73, P135, DOI 10.1016/S0010-0277(99)00036-0; *GRUP SINT ESP, 2012, BAS DAT SINT ESP ACT; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; INHOFF AW, 1985, J PSYCHOLINGUIST RES, V14, P45, DOI 10.1007/BF01067473; Jackendoff R. S., 2002, FDN LANGUAGE BRAIN M; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Jonkers R, 1996, BRAIN LANG, V55, P37; JONKERS R, 1998, APHASIOLOGY, V12, P193; Kauschke C, 2008, J PSYCHOLINGUIST RES, V37, P443, DOI 10.1007/s10936-008-9073-3; Kim M, 2000, BRAIN LANG, V74, P1, DOI 10.1006/brln.2000.2315; KOHN SE, 1989, CORTEX, V25, P57, DOI 10.1016/S0010-9452(89)80006-1; MacWhinney B., 2000, CHILDES PROJECT, V2; Magnuson JS, 2003, J EXP PSYCHOL GEN, V132, P202, DOI 10.1037/0096-3445.132.2.202; Marslen-Wilson W., 2007, OXFORD HDB PSYCHOLIN, P175, DOI DOI 10.1093/OXFORDHB/9780198568971.013.0011; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; McElree B, 2001, COGNITION, V78, pB17, DOI 10.1016/S0010-0277(00)00113-X; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Melinger A, 2007, J MEM LANG, V56, P472, DOI 10.1016/j.jml.2006.12.001; Moss H.E., 2007, OXFORD HDB PSYCHOLIN, P217; Novick JM, 2003, J PSYCHOLINGUIST RES, V32, P57, DOI 10.1023/A:1021985032200; Olmos J., 2012, EFFECT VERB ARGUMENT, V47, P637; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Rodriguez-Ferreiro J, 2009, J NEUROLINGUIST, V22, P37, DOI 10.1016/j.jneuroling.2008.05.003; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; SCHMAUDER AR, 1991, J EXP PSYCHOL LEARN, V17, P49, DOI 10.1037/0278-7393.17.1.49; SCHMAUDER AR, 1991, J EXP PSYCHOL LEARN, V17, P1188; Sebastian N., 2000, LEXESP LEXICO INFORM; Seidenberg M. S., 2007, OXFORD HDB PSYCHOLIN, P235, DOI [DOI 10.1093/0XF0RDHB/9780198568971.013.0014, 10.1093/oxfordhb/9780198568971.013.0014]; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Seidenberg MS, 1996, J EXP PSYCHOL LEARN, V22, P48, DOI 10.1037/0278-7393.22.1.48; Shapiro K, 2003, NEUROPSYCHOLOGIA, V41, P1189, DOI 10.1016/S0028-3932(03)00037-X; Shapiro K, 2003, J NEUROLINGUIST, V16, P85, DOI 10.1016/S0911-6044(02)00010-6; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; SHAPIRO LP, 1990, BRAIN LANG, V38, P21, DOI 10.1016/0093-934X(90)90100-U; SHAPIRO LP, 1989, J PSYCHOLINGUIST RES, V18, P223; STEIGER JH, 1985, PSYCHOMETRIKA, V50, P253, DOI 10.1007/BF02294104; Szekely A., 2000, CTR RES LANGUAGE NEW, V12; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Trueswell JC, 1998, J MEM LANG, V39, P102, DOI 10.1006/jmla.1998.2565; Valle-Arroyo F, 1999, NORMAS IMAGINABILIDA; WILLIAMS SE, 1987, BRAIN LANG, V32, P124, DOI 10.1016/0093-934X(87)90120-9	70	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188728	10.1371/journal.pone.0188728	http://dx.doi.org/10.1371/journal.pone.0188728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206841	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700019
J	Kumari, K; Koivisto, H; Viluksela, M; Paldanius, KMA; Marttinen, M; Hiltunen, M; Naarala, J; Tanila, H; Juutilainen, J				Kumari, Kajal; Koivisto, Hennariikka; Viluksela, Matti; Paldanius, Kaisa M. A.; Marttinen, Mikael; Hiltunen, Mikko; Naarala, Jonne; Tanila, Heikki; Juutilainen, Jukka			Behavioral testing of mice exposed to intermediate frequency magnetic fields indicates mild memory impairment	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; SPATIAL MEMORY; NEUROGENESIS; EXPRESSIONS; HIPPOCAMPUS; ACQUISITION; RETENTION; DEFICITS; BRAIN; RATS	Human exposure to intermediate frequency magnetic fields (MF) is increasing due to applications like electronic article surveillance systems and induction heating cooking hobs. However, limited data is available on their possible health effects. The present study assessed behavioral and histopathological consequences of exposing mice to 7.5 kHz MF at 12 or 120 mu T for 5 weeks. No effects were observed on body weight, spontaneous activity, motor coordination, level of anxiety or aggression. In the Morris swim task, mice in the 120 mu T group showed less steep learning curve than the other groups, but did not differ from controls in their search bias in the probe test. The passive avoidance task indicated a clear impairment of memory over 48 h in the 120 mu T group. No effects on astroglial activation or neurogenesis were observed in the hippocampus. The mRNA expression of brain-derived neurotrophic factor did not change but expression of the proinflammatory cytokine tumor necrosis factor alpha mRNA was significantly increased in the 120 mu T group. These findings suggest that 7.5 kHz MF exposure may lead to mild learning and memory impairment, possibly through an inflammatory reaction in the hippocampus.	[Kumari, Kajal; Viluksela, Matti; Naarala, Jonne; Juutilainen, Jukka] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Koivisto, Hennariikka; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Viluksela, Matti] Natl Inst Hlth & Welf, Environm Hlth Unit, Kuopio, Finland; [Paldanius, Kaisa M. A.; Marttinen, Mikael; Hiltunen, Mikko] Univ Eastern Finland, Inst Biomed, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland	Kumari, K (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.	kajal.kumari@uef.fi		Marttinen, Mikael/0000-0001-5861-4601	European Community - GERONIMO [603794]; University of Eastern Finland	European Community - GERONIMO; University of Eastern Finland	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant agreement no: 603794 - the GERONIMO project, 603794.; The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no: 603794 - the GERONIMO project, and from the University of Eastern Finland. We are grateful to Pasi Miettinen who provided his skilful technical assistance.	Ahlbom A, 2008, TOXICOLOGY, V246, P248, DOI 10.1016/j.tox.2008.02.004; Bornhausen M, 2000, BIOELECTROMAGNETICS, V21, P566; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Foroozandeh E, 2013, TOXICOL IND HEALTH, V29, P293, DOI 10.1177/0748233711433931; He LH, 2011, CHINESE MED J-PEKING, V124, P3362, DOI 10.3760/cma.j.issn.0366-6999.2011.20.028; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; JENSEN RA, 1979, PSYCHOPHARMACOLOGY, V64, P125, DOI 10.1007/BF00427358; Kumari K, 2017, ENVIRON RES, V157, P64, DOI 10.1016/j.envres.2017.05.014; Lai H, 1998, BIOELECTROMAGNETICS, V19, P117, DOI 10.1002/(SICI)1521-186X(1998)19:2<117::AID-BEM10>3.0.CO;2-N; Lai H, 1996, BIOELECTROMAGNETICS, V17, P494, DOI 10.1002/(SICI)1521-186X(1996)17:6<494::AID-BEM9>3.0.CO;2-Z; Lai JS, 2016, NEUROTOXICOLOGY, V52, P104, DOI 10.1016/j.neuro.2015.11.010; Li C, 2014, ENVIRON RES, V134, P74, DOI 10.1016/j.envres.2014.06.025; Liu TT, 2008, NEUROREPORT, V19, P549, DOI 10.1097/WNR.0b013e3282f8b1a0; LYSKOV E, 1993, INT J PSYCHOPHYSIOL, V14, P227, DOI 10.1016/0167-8760(93)90036-O; LYSKOV EB, 1993, BIOELECTROMAGNETICS, V14, P87, DOI 10.1002/bem.2250140202; Maei HR, 2009, INTEGR NEUROSCI, V3; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Podda MV, 2014, EUR J NEUROSCI, V39, P893, DOI 10.1111/ejn.12465; Roivainen P, 2014, BIOELECTROMAGNETICS, V35, P245, DOI 10.1002/bem.21850; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P79, DOI 10.1002/(SICI)1521-186X(1998)19:2<79::AID-BEM4>3.0.CO;2-0; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P486, DOI 10.1002/(SICI)1521-186X(1998)19:8<486::AID-BEM6>3.0.CO;2-K; Tanila H, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00011; van Meer P, 2007, BEHAV BRAIN RES, V176, P372, DOI 10.1016/j.bbr.2006.10.024; WILLNER P, 1981, PHARMACOL BIOCHEM BE, V14, P475, DOI 10.1016/0091-3057(81)90305-1; Win-Shwe TT, 2015, INT J ENV RES PUB HE, V12, P4406, DOI 10.3390/ijerph120404406; Win-Shwe TT, 2013, J TOXICOL SCI, V38, P169, DOI 10.2131/jts.38.169; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yavich L, 2005, NEUROBIOL DIS, V20, P303, DOI 10.1016/j.nbd.2005.03.010; Zhang YM, 2015, INT J RADIAT BIOL, V91, P28, DOI 10.3109/09553002.2014.954058; Zhao QR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11768; Ziegelberger G, 2008, HEALTH PHYS, V94, P376, DOI 10.1097/01.HP.0000304155.41715.73	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188880	10.1371/journal.pone.0188880	http://dx.doi.org/10.1371/journal.pone.0188880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206232	Green Submitted, Green Published, gold			2022-12-26	WOS:000417033200019
J	Vissers, C; Ming, GL; Song, HJ				Vissers, Caroline; Ming, Guo-li; Song, Hongjun			Stem cells take the stairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							FATE DECISIONS; NEUROGENESIS	Human embryonic stem cells progress through multiple stages in their path to neural differentiation, but the steps taken along the way are difficult to distinguish, limiting our understanding of this important process. Jing and colleagues (2) now report comprehensive analyses of transcriptome dynamics during this process that reveal five discrete stages, defined in part by highly connected transcription factor networks that link progressive stages. Surprisingly, the third stage, which appears to be critical for neural fate commitment, depends almost entirely on intracellular signaling.	[Vissers, Caroline; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Grad Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.	shongjun@pennmedicine.upenn.edu		Ming, Guo-li/0000-0002-2517-6075	National Institutes of Health [R37NS047344, U19MH106434, P01NS097206, R01AG057497, R01MH105128, R35NS097370, U19AI131130, T32GM007445]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation predoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI131130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128, U19MH106434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097370, P01NS097206, R37NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG057497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (R37NS047344, U19MH106434, P01NS097206, and R01AG057497 to H. S.; R01MH105128, R35NS097370, and U19AI131130 to G.-l. M.; and T32GM007445 to C. V.) and from The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to G-l. M.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a National Science Foundation predoctoral fellowship.	Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Li YY, 2017, J BIOL CHEM, V292, P19590, DOI 10.1074/jbc.M117.796383; Moris N, 2016, NAT REV GENET, V17, P693, DOI 10.1038/nrg.2016.98; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19605	19606		10.1074/jbc.H117.796383	http://dx.doi.org/10.1074/jbc.H117.796383			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29196569	Green Published, hybrid			2022-12-26	WOS:000416911300006
J	Bach, LT; Alvarez-Fernandez, S; Hornick, T; Stuhr, A; Riebesell, U				Bach, Lennart T.; Alvarez-Fernandez, Santiago; Hornick, Thomas; Stuhr, Annegret; Riebesell, Ulf			Simulated ocean acidification reveals winners and losers in coastal phytoplankton	PLOS ONE			English	Article							CHANGING CARBONATE CHEMISTRY; MICROBIAL FOOD-WEB; CO2 CONCENTRATION; ELEVATED CO2; COMMUNITY ECOLOGY; TECHNICAL NOTE; PLANKTON; DYNAMICS; PICOPLANKTON; GROWTH	The oceans absorb similar to 25% of the annual anthropogenic CO2 emissions. This causes a shift in the marine carbonate chemistry termed ocean acidification (OA). OA is expected to influence metabolic processes in phytoplankton species but it is unclear how the combination of individual physiological changes alters the structure of entire phytoplankton communities. To investigate this, we deployed ten pelagic mesocosms (volume similar to 50 m(3)) for 113 days at the west coast of Sweden and simulated OA (pCO(2) = 760 mu atm) in five of them while the other five served as controls (380 mu atm). We found: (1) Bulk chlorophyll a concentration and 10 out of 16 investigated phytoplankton groups were significantly and mostly positively affected by elevated CO2 concentrations. However, CO2 effects on abundance or biomass were generally subtle and present only during certain succession stages. (2) Some of the CO2-affected phytoplankton groups seemed to respond directly to altered carbonate chemistry (e.g. diatoms) while others (e.g. Synechococcus) were more likely to be indirectly affected through CO2 sensitive competitors or grazers. (3) Picoeukaryotic phytoplankton (0.2-2 mu m) showed the clearest and relatively strong positive CO2 responses during several succession stages. We attribute this not only to a CO2 fertilization of their photosynthetic apparatus but also to an increased nutrient competitiveness under acidified (i.e. low pH) conditions. The stimulating influence of high CO2/low pH on picoeukaryote abundance observed in this experiment is strikingly consistent with results from previous studies, suggesting that picoeukaryotes are among the winners in a future ocean.	[Bach, Lennart T.; Stuhr, Annegret; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Alvarez-Fernandez, Santiago] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforsch, Biol Anstalt Helgoland, Helgoland, Germany; [Hornick, Thomas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Expt Limnol, Stechlin, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Bach, LT (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	lbach@geomar.de	Riebesell, Ulf/AAC-9717-2020	Hornick, Thomas/0000-0003-0280-9260; Bach, Lennart/0000-0003-0202-3671	German Federal Ministry of Science and Education (BMBF) [FKZ 03F06550]; German Science Foundation (DFG); association of European marine biological laboratories (ASSEMBLE) [227799]	German Federal Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG)(German Research Foundation (DFG)); association of European marine biological laboratories (ASSEMBLE)	This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). U. Riebesell received additional funding from the Leibniz Award 2012 by the German Science Foundation (DFG). T. Hornick was supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguero-Muniz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175851; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bach LT, 2015, PROG OCEANOGR, V135, P125, DOI 10.1016/j.pocean.2015.04.012; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2849, DOI 10.5194/bg-13-2849-2016; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Calbet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094388; Dutkiewicz S, 2015, NAT CLIM CHANGE, V5, P1002, DOI [10.1038/NCLIMATE2722, 10.1038/nclimate2722]; Endres S, 2013, BIOGEOSCIENCES, V10, P567, DOI 10.5194/bg-10-567-2013; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Engel A, 2008, BIOGEOSCIENCES, V5, P509, DOI 10.5194/bg-5-509-2008; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Gazeau F, 2016, ESTUAR COAST SHELF S, P1; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GOERICKE R, 1992, LIMNOL OCEANOGR, V37, P425; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; Hartmann M, 2013, ENV MICROBIOL REP, V5, P835, DOI 10.1111/1758-2229.12084; Hastie T., 1986, STAT SCI, V1, P297; Hopkins FE, 2010, P NATL ACAD SCI USA, V107, P760, DOI 10.1073/pnas.0907163107; Hoppe CJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079890; Horn HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165800; Hornick T, 2017, BIOGEOSCIENCES, V14, P1, DOI 10.5194/bg-14-1-2017; Hunter-Cevera KR, 2016, MICROB ECOL, V71, P276, DOI 10.1007/s00248-015-0644-1; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kim JH, 2013, BIOGEOSCIENCES, V10, P7525, DOI 10.5194/bg-10-7525-2013; Kottmeier D. M., 2016, LIMNOL OCEANOGR; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; Legrand C, 1998, AQUAT MICROB ECOL, V15, P65, DOI 10.3354/ame015065; Li SN, 2016, MAR FRESHWATER RES, V67, P319, DOI 10.1071/MF14353; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lindh MV, 2013, ENV MICROBIOL REP, V5, P252, DOI 10.1111/1758-2229.12009; Lomas MW, 2012, AQUAT MICROB ECOL, V66, P211, DOI 10.3354/ame01576; Lopez-Urrutia A, 2015, LIMNOL OCEANOGR, V60, P733, DOI 10.1002/lno.10049; Maas EW, 2013, AQUAT MICROB ECOL, V70, P1, DOI 10.3354/ame01633; Maat DS, 2014, APPL ENVIRON MICROB, V80, P3119, DOI 10.1128/AEM.03639-13; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; McKie-Krisberg ZM, 2015, MICROB ECOL, V70, P21, DOI 10.1007/s00248-014-0543-x; McKie-Krisberg ZM, 2014, ISME J, V8, P1953, DOI 10.1038/ismej.2014.16; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; OLSON RJ, 1989, CYTOMETRY, V10, P636, DOI 10.1002/cyto.990100520; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Paul C, 2015, MAR ECOL PROG SER, V528, P39, DOI 10.3354/meps11264; Paulino AI, 2008, BIOGEOSCIENCES, V5, P739, DOI 10.5194/bg-5-739-2008; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2017, NAT GEOSCI, V10, P19, DOI [10.1038/ngeo2854, 10.1038/NGEO2854]; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Sanders RW, 2012, FEMS MICROBIOL ECOL, V82, P242, DOI 10.1111/j.1574-6941.2011.01253.x; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Schulz KG, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00064; Sommer U, 2016, BIOL REV; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Stoecker DK, 2017, ANNU REV MAR SCI, V9, P311, DOI 10.1146/annurev-marine-010816-060617; STRAUSS SY, 1991, TRENDS ECOL EVOL, V6, P206, DOI 10.1016/0169-5347(91)90023-Q; Taucher J, 2015, LIMNOL OCEANOGR, V60, P901, DOI 10.1002/lno.10063; Taucher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169737; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; Thomson PG, 2016, MAR ECOL PROG SER, V554, P51, DOI 10.3354/meps11803; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Wolf-Gladrow D, 1997, MAR CHEM, V59, P17, DOI 10.1016/S0304-4203(97)00069-8; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wu Y, 2014, LIMNOL OCEANOGR, V59, P1027, DOI 10.4319/lo.2014.59.3.1027; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236; Zuur Alain F., 2009, P1	83	37	39	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188198	10.1371/journal.pone.0188198	http://dx.doi.org/10.1371/journal.pone.0188198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190760	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000416841900038
J	Borsci, S; Buckle, P; Huddy, J; Alaestante, Z; Ni, ZF; Hanna, GB				Borsci, Simone; Buckle, Peter; Huddy, Jeremy; Alaestante, Zenia; Ni, Zhifang; Hanna, George B.			Usability study of pH strips for nasogastric tube placement	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; X-RAY; POSITION; DESIGN; CONFIRMATION; DISLODGMENT; TECHNOLOGY; EXPERIENCE; SYSTEM; RISK	Aims (1) To model the process of use and usability of pH strips (2) to identify, through simulation studies, the likelihood of misreading pH strips, and to assess professional's acceptance, trust and perceived usability of pH strips. Methods This study was undertaken in four phases and used a mixed method approach (an audit, a semi-structured interview, a survey and simulation study). The three months audit was of 24 patients, the semi-structured interview was performed with 19 health professionals and informed the process of use of pH strips. A survey of 134 professionals and novices explored the likelihood of misinterpreting pH strips. Standardised questionnaires were used to assess professionals perceived usability, trust and acceptance of pH strip use in a simulated study. Results The audit found that in 45.7% of the cases aspiration could not be achieved, and that 54% of the NG-tube insertions required x-ray confirmation. None of those interviewed had received formal training on pH strips use. In the simulated study, participants made up to 11.15% errors in reading the strips with important implications for decision making regarding NG tube placement. No difference was identified between professionals and novices in their likelihood of misinterpreting the pH value of the strips. Whilst the overall experience of usage is poor (47.3%), health professionals gave a positive level of trust in both the interview (62.6%) and the survey (68.7%) and acceptance (interview group 65.1%, survey group 74.7%). They also reported anxiety in the use of strips (interview group 29.7%, survey group 49.7%). Conclusions Significant errors occur when using pH strips in a simulated study. Manufacturers should consider developing new pH strips, specifically designed for bedside use, that are more usable and less likely to be misread.	[Borsci, Simone; Buckle, Peter; Huddy, Jeremy; Alaestante, Zenia; Ni, Zhifang; Hanna, George B.] Imperial Coll, Natl Inst Hlth Res Diagnost Evidence Cooperat Lon, Fac Med, Dept Surg & Canc, London, England	Imperial College London	Borsci, S (corresponding author), Imperial Coll, Natl Inst Hlth Res Diagnost Evidence Cooperat Lon, Fac Med, Dept Surg & Canc, London, England.	s.borsci@imperial.ac.uk	Borsci, Simone/AAB-2369-2019; Borsci, Simone/GRS-3540-2022	Borsci, Simone/0000-0002-3591-3577; Borsci, Simone/0000-0002-3591-3577; Ni, Melody/0000-0001-7356-848X; Buckle, Peter/0000-0002-3985-2441	Innovate UK/Medical Research Council [102134]; NIHR Diagnostic Evidence Co-operative London; Imperial College London; Imperial College Healthcare NHS Trust	Innovate UK/Medical Research Council(UK Research & Innovation (UKRI)Innovate UK); NIHR Diagnostic Evidence Co-operative London; Imperial College London(General Electric); Imperial College Healthcare NHS Trust	This research was funded by Innovate UK/Medical Research Council (project code: 102134), and supported by the NIHR Diagnostic Evidence Co-operative London, partnership between Imperial College London and Imperial College Healthcare NHS Trust. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson O, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2015-000064; Anderson O, 2012, WORK, V41, P4689, DOI 10.3233/WOR-2012-0111-4689; Bate P, 2006, QUAL SAF HEALTH CARE, V15, P307, DOI 10.1136/qshc.2005.016527; Bear DE, 2016, JPEN-PARENTER ENTER, V40, P581, DOI 10.1177/0148607115575034; Borsci S, 2015, INT J HUM-COMPUT INT, V31, P484, DOI 10.1080/10447318.2015.1064648; Chan EY, 2012, INT J NURS STUD, V49, P310, DOI 10.1016/j.ijnurstu.2011.09.014; Clemente RJ, 2010, P NUTR SOC, V69, pE160, DOI 10.1017/S0029665109993569; Clemente Rowan, 2016, Br J Nurs, V25, P326, DOI 10.12968/bjon.2016.25.6.326; Dubois E, 2011, INT J ARTS TECHNOL, V4, P408, DOI 10.1504/IJART.2011.043441; Federici S, 2016, DISABIL REHABIL-ASSI, V11, P22, DOI 10.3109/17483107.2014.930191; Finstad K, 2010, INTERACT COMPUT, V22, P323, DOI 10.1016/j.intcom.2010.04.004; Gilbertson H, 2015, DIET NUTR CRITICAL C, P1369; Gilbertson HR, 2011, JPEN-PARENTER ENTER, V35, P540, DOI 10.1177/0148607110383285; Hanna G, IMPROVING SAFETY NAS; Lewis J.R., 2013, P SIGCHI C HUM FACT, P2099, DOI DOI 10.1145/2470654.2481287; Mcknight D.H., 2011, ACM TRANS MANAG INF, V2, P1, DOI [10.1145/1985347.1985353, DOI 10.1145/1985347.1985353]; Metheny NA, 2012, AM J CRIT CARE, V21, P352, DOI 10.4037/ajcc2012549; Mordiffi SZ, 2016, INT J NURS STUD, V61, P248, DOI 10.1016/j.ijnurstu.2016.06.011; National Patient Safety Agency, 2005, PAT SAF AL NPSA PSA0; Ni M, 2014, EMJ GASTROENTEROL, V3, P49; Roberts HW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013616; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Seder CW, 2010, CRIT CARE MED, V38, P797, DOI 10.1097/CCM.0b013e3181c311f8; Seder CW, 2008, NUTR CLIN PRACT, V23, P651, DOI 10.1177/0884533608326139; Sheridan TB, 2008, HUM FACTORS, V50, P418, DOI 10.1518/001872008X250773; Stanton, 2000, TASK ANAL; Taylor SJ, 2005, J HUM NUTR DIET, V18, P371, DOI 10.1111/j.1365-277X.2005.00635.x; Taylor Stephen, 2014, Br J Nurs, V23, P354; Taylor Stephen J, 2015, Br J Nurs, V24, P371, DOI 10.12968/bjon.2015.24.7.371; Taylor SJ, 2013, INTENS CRIT CARE NUR, V29, P59, DOI 10.1016/j.iccn.2012.07.002; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540	32	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189013	10.1371/journal.pone.0189013	http://dx.doi.org/10.1371/journal.pone.0189013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190683	Green Published, gold			2022-12-26	WOS:000416841900191
J	Gromova, I; Svensson, S; Gromov, P; Moreira, JMA				Gromova, Irina; Svensson, Sofia; Gromov, Pavel; Moreira, Jose M. A.			Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer	PLOS ONE			English	Article							IN-SITU; PROXIMITY LIGATION; CERVICAL-CANCER; YXXQ MOTIF; PROTEIN; CELLS; ACTIVATION; CARCINOMA; APOPTOSIS; EXPRESSION	Bladder cancer associated protein (Blcap) expression is commonly down-regulated in invasive bladder cancer, and may have prognostic value given that its expression is negatively correlated with patient survival. We have previously investigated the expression patterns and cellular localization of Blcap in bladder cancer, where we found that about 20% of the lesions examined displayed strong nuclear expression of Blcap, and that this phenotype was associated with overall poor disease outcome. Here we report on the analysis of possible functional associations between nuclear expression of Blcap and canonical signaling pathways. We performed serial immunohistochemistry (IHC) analysis of bladder tissue samples, with serial sections stained with phospho-specific antibodies recognizing key signaling intermediates, such as P-Stat3, P-Akt, and P-Erk1/2, among others, in an immunophenotyping approach we have established and reported previously. Using this approach, we found that nuclear localization of Blcap was associated with expression of P-Stat3. A parallel analysis, cytokine profiling of bladder tumor interstitial fluids of samples expressing (or not) Blcap, showed interleukin (IL)-6, IL-8, and monocyte chemotactic protein 1 (MCP-1) to be correlated with nuclear expression of Blcap, independently supporting a role for Stat3 signaling in localization of Blcap. Multiple indirect immunofluorescence analysis of tissue biopsies confirmed that Blcap co-localized with Stat3. Furthermore, we could also demonstrate, using an in situ proximity ligation assay that Blcap and Stat3 are in close physical proximity of each other in bladder tissue, and that Blcap physically interacts with Stat3 as determined by co-immunoprecipitation of these proteins. Our data indicates that Blcap is a novel Stat3 interaction partner and suggests a role for Blcap in the Stat3-mediated progression of precancerous lesions to invasive tumors of the bladder.	[Gromova, Irina; Svensson, Sofia; Gromov, Pavel] Danish Canc Soc, Res Ctr, Genome Instabil Unit, Canc Prote, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Svensson, Sofia] Novo Nordisk AS, Biopharm API, Bagsvaerd, Denmark	Danish Cancer Society; University of Copenhagen; Novo Nordisk	Moreira, JMA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	jomo@sund.ku.dk		Moreira, Jose/0000-0002-9944-1214; Gromova, Irina/0000-0003-4357-5958	Danish Cancer Society through the budget of the Institute of Cancer Biology	Danish Cancer Society through the budget of the Institute of Cancer Biology	This work was funded by the Danish Cancer Society through the budget of the Institute of Cancer Biology.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Babjuk M, 2016, EUR UROL; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Bergkvist A, 1965, Acta Chir Scand, V130, P371; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Chen W, 2017, ONCOTARGET, V8, P39417, DOI 10.18632/oncotarget.17034; Daino K, 2009, INT J CANCER, V125, P612, DOI 10.1002/ijc.24392; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Golabesk T, 2016, UROLOGY; Gromov P, 2008, PROTEOM CLIN APPL, V2, P974, DOI 10.1002/prca.200780163; Gromov P, 2016, METHODS MOL BIOL, V1459, P231, DOI 10.1007/978-1-4939-3804-9_16; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Gromova I, 2015, MOL ONCOL, V9, P1636, DOI 10.1016/j.molonc.2015.05.003; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hu XD, 2015, CANCER LETT, V357, P510, DOI 10.1016/j.canlet.2014.12.006; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Pencik J, 2016, CYTOKINE, V87, P26, DOI 10.1016/j.cyto.2016.06.017; Peng M, 2012, EXP THER MED, V3, P336, DOI 10.3892/etm.2011.408; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sylvester RJ, 2005, UROLOGY, V66, P90, DOI 10.1016/j.urology.2005.06.135; Ulaganathan VK, 2015, NATURE, V528, P570, DOI 10.1038/nature16449; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Zhao M, 2016, ONCOL REP, V35, P3050, DOI 10.3892/or.2016.4686; Zilberman DE, 2011, UROL ONCOL-SEMIN ORI, V29, P21, DOI 10.1016/j.urolonc.2008.11.006; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	37	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188827	10.1371/journal.pone.0188827	http://dx.doi.org/10.1371/journal.pone.0188827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190807	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900134
J	Shen, LH; Sun, Z; Chu, SC; Cai, ZH; Nie, P; Wu, CZ; Yuan, RS; Hu, LH; He, B				Shen, Linghong; Sun, Zhe; Chu, Shichun; Cai, Zhaohua; Nie, Peng; Wu, Caizhe; Yuan, Ruosen; Hu, Liuhua; He, Ben			Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation	PLOS ONE			English	Article							ER STRESS; ACCELERATED ATHEROSCLEROSIS; OXIDATIVE STRESS; APOE-DEFICIENT; PROTEIN; DYSLIPIDEMIA; INTEGRATION; MECHANISMS; CHOLESTIN; PATHWAYS	Xuezhikang (XZK), an extract of red yeast rice, is a traditional Chinese medicine widely used for the treatment of cardiovascular diseases in China and other countries. However, whether XZK treatment can improve atherosclerotic plaque stability is not fully understood. Based on our previously developed mouse model of spontaneous vulnerable plaque formation and rupture in carotid arteries in ApoE(-/-) mice. We showed that low-dose (600 mg/kg/d) XZK improved plaque stability without decreasing plaque area, whereas high-dose (1200 mg/kg/d) XZK dramatically inhibited vulnerable plaque progression accompanied by decreased plaque area. Mechanistically, XZK significantly suppressed lesional endoplasmic reticulum (ER) stress in mouse carotid arteries. In vitro, XZK inhibited 7-KC-induced activation of ER stress in RAW264.7 macrophages, as assessed by the reduced levels of p-PERK, p-IRE1 alpha, p-eIF2 alpha, c-ATF6, s-XBP1, and CHOP. Compared to controls, the XZK-treated group displayed dramatically decreased apoptotic cell numbers (shown by decreased TUNEL-and cleaved caspase3-positive cells), lower necrotic core area and ratio, and reduced expression of NF-kappa B target gene. In RAW264.7 cells, XZK inhibited 7-KC-induced upregulation of apoptosis, protein expression of apoptotic markers (cleaved caspase-3 and cleaved PARP), and NF-kappa B activation (shown by target gene transcription and I kappa Ba reduction). Collectively, our results suggest that XZK effectively suppresses vulnerable plaque progression and rupture by mitigating macrophage ER stress and consequently inhibiting apoptosis and the NF-kappa B pro-inflammatory pathway, thereby providing an alternative therapeutic strategy for stabilizing atherosclerotic plaques.	[Shen, Linghong; He, Ben] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China; [Sun, Zhe; Chu, Shichun; Cai, Zhaohua; Nie, Peng; Wu, Caizhe; Yuan, Ruosen; Hu, Liuhua] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, LH; He, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China.	rjshenlinghong@126.com; rjheben@126.com	Nie, Peng/GQI-1872-2022; Cai, Zhaohua/CAH-8221-2022		National Natural Science Foundation of China [91539106, 81770428, 2017YFC0909301, 81330006, 81370399, 81600337, 81500266]; Shanghai Municipal Natural Science Foundation [15ZR1425800]; Shanghai Municipal Commission of Health and Family Planning [20154Y0036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants numbers 91539106, 81770428, 2017YFC0909301, 81330006, 81370399, 81600337, and 81500266 from the National Natural Science Foundation of China; grants numbers 15ZR1425800 from the Shanghai Municipal Natural Science Foundation; and grant number 20154Y0036 from the Shanghai Municipal Commission of Health and Family Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Bowes AJ, 2009, AM J PATHOL, V174, P330, DOI 10.2353/ajpath.2009.080385; Bromati CR, 2011, AM J PHYSIOL-REG I, V300, pR92, DOI 10.1152/ajpregu.00169.2010; Burleigh ME, 2005, J MOL CELL CARDIOL, V39, P443, DOI 10.1016/j.yjmcc.2005.06.011; Cao RH, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/781780; Childress L, 2013, J CLIN LIPIDOL, V7, P117, DOI 10.1016/j.jacl.2012.09.003; Cominacini L, 2015, CURR MED CHEM, V22, P1565, DOI 10.2174/0929867322666150311150829; Cui ML, 2016, HYPERTENSION, V67, P153, DOI 10.1161/HYPERTENSIONAHA.115.06114; Dandekar A, 2015, METHODS MOL BIOL, V1292, P205, DOI 10.1007/978-1-4939-2522-3_15; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Garbin U, 2014, ANTIOXID REDOX SIGN, V21, P850, DOI 10.1089/ars.2014.5870; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Heber D, 1999, AM J CLIN NUTR, V69, P231; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Jin SX, 2012, ARTERIOSCL THROM VAS, V32, P2372, DOI 10.1161/ATVBAHA.111.236158; Kataoka Y, 2015, CARDIOVASC DIAGN THE, V5, P280, DOI 10.3978/j.issn.2223-3652.2015.05.06; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Linton MF, 2016, CIRC J, V80, P2259, DOI 10.1253/circj.CJ-16-0924; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Moriarty PM, 2014, J CLIN LIPIDOL, V8, P568, DOI 10.1016/j.jacl.2014.09.002; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schoenhagen P, 2002, CIRCULATION, V106, P760, DOI 10.1161/01.CIR.0000025708.36290.05; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/636547; Song YF, 2016, AQUAT TOXICOL, V175, P20, DOI 10.1016/j.aquatox.2016.03.003; SWAIN J, 1995, FEBS LETT, V368, P513, DOI 10.1016/0014-5793(95)00726-P; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Yang CW, 2012, COMPLEMENT THER MED, V20, P466, DOI 10.1016/j.ctim.2012.07.004; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zhao SP, 2004, CIRCULATION, V110, P915, DOI 10.1161/01.CIR.0000139985.81163.CE; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060146, 10.1371/journal.pone.0062731, 10.3389/fnsyn.2013.00008, 10.1371/journal.pone.0070631, 10.1371/journal.pone.0081900, 10.1371/journal.pone.0070686]	49	16	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188841	10.1371/journal.pone.0188841	http://dx.doi.org/10.1371/journal.pone.0188841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190732	Green Submitted, Green Published, gold			2022-12-26	WOS:000416841900140
J	Chambers, C; Sokhey, T; Gaebler-Spira, D; Kording, KP				Chambers, Claire; Sokhey, Taegh; Gaebler-Spira, Deborah; Kording, Konrad P.			The integration of probabilistic information during sensorimotor estimation is unimpaired in children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; PSYCHOMETRIC PROPERTIES; COORDINATION; POPULATION; PLASTICITY; CHILDHOOD; LESIONS; UPDATE; BRAIN	Background It is important to understand the motor deficits of children with Cerebral Palsy (CP). Our understanding of this motor disorder can be enriched by computational models of motor control. One crucial stage in generating movement involves combining uncertain information from different sources, and deficits in this process could contribute to reduced motor function in children with CP. Healthy adults can integrate previously-learned information (prior) with incoming sensory information (likelihood) in a close-to-optimal way when estimating object location, consistent with the use of Bayesian statistics. However, there are few studies investigating how children with CP perform sensorimotor integration. We compare sensorimotor estimation in children with CP and age-matched controls using a model-based analysis to understand the process. Methods and findings We examined Bayesian sensorimotor integration in children with CP, aged between 5 and 12 years old, with Gross Motor Function Classification System (GMFCS) levels 1-3 and compared their estimation behavior with age-matched typically-developing (TD) children. We used a simple sensorimotor estimation task which requires participants to combine probabilistic information from different sources: a likelihood distribution (current sensory information) with a prior distribution (learned target information). In order to examine sensorimotor integration, we quantified how participants weighed statistical information from the two sources (prior and likelihood) and compared this to the statistical optimal weighting. We found that the weighing of statistical information in children with CP was as statistically efficient as that of TD children. Conclusions We conclude that Bayesian sensorimotor integration is not impaired in children with CP and therefore, does not contribute to their motor deficits. Future research has the potential to enrich our understanding of motor disorders by investigating the stages of motor processing set out by computational models. Therapeutic interventions should exploit the ability of children with CP to use statistical information.	[Chambers, Claire; Sokhey, Taegh; Gaebler-Spira, Deborah; Kording, Konrad P.] Shirley Ryan Abilitylab, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Chambers, Claire; Kording, Konrad P.] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Biomed Engn, Chicago, IL 60611 USA; [Chambers, Claire; Gaebler-Spira, Deborah; Kording, Konrad P.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Sokhey, Taegh] Northwestern Univ, Dept Biol Sci, Evanston, IL USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Chambers, C (corresponding author), Shirley Ryan Abilitylab, Sensory Motor Performance Program, Chicago, IL 60611 USA.; Chambers, C (corresponding author), Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Biomed Engn, Chicago, IL 60611 USA.; Chambers, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	claire.chambers@northwestern.edu	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499; Gaebler-Spira, Deborah/0000-0001-6827-4241	NIH [5R01NS063399-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant 5R01NS063399-08 (KPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2015, J VISION, V15, DOI 10.1167/15.3.7; Arneson CL, 2004, DISABIL HLTH J, V2, P45, DOI DOI 10.1016/J.DHJ0.2008.08.001; Ayres A.J., 2005, SENSORY INTEGRATION; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bertucco M, 2015, J HAND THER, V28, P185, DOI 10.1016/j.jht.2014.11.002; Bhasin Tanya Karapurkar, 2006, Morbidity and Mortality Weekly Report, V55, P1; BREAKEY AS, 1974, J NERV MENT DIS, V158, P70, DOI 10.1097/00005053-197401000-00009; Burtner PA, 2014, DEV MED CHILD NEUROL, V56, P259, DOI 10.1111/dmcn.12364; Cataldo M F, 1978, J Behav Med, V1, P311, DOI 10.1007/BF00846682; Chambers C, 2017, BIORXIV; Chu VWT, 2013, J NEUROPHYSIOL, V109, P2169, DOI 10.1152/jn.00908.2012; Clayton Kellie, 2003, Physical & Occupational Therapy in Pediatrics, V23, P43, DOI 10.1300/J006v23n01_04; Dunning A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125461; Englander ZA, 2013, NEUROIMAGE-CLIN, V2, P440, DOI 10.1016/j.nicl.2013.03.006; Haith AM, 2013, THEORETICAL MODELS M, P7; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Krageloh-Mann I, 2002, DEV MED CHILD NEUROL, V44, P477; Krumlinde-Sundholm L, 2002, DEV MED CHILD NEUROL, V44, P604; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Lopez-Ortiz Citlali, 2012, Arts Health, V4, P39; Marblestone AH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00094; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Ostensjo S, 2004, DEV MED CHILD NEUROL, V46, P580; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; OUVRIER RA, 1993, J CHILD NEUROL, V8, P145, DOI 10.1177/088307389300800206; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Papadelis C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00725; Pihko E, 2014, HUM BRAIN MAPP, V35, P4105, DOI 10.1002/hbm.22462; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2, DOI [10.1002/9780470479216.corpsy0114, DOI 10.1002/9780470479216.CORPSY0114]; Riquelme I, 2010, CLIN NEUROPHYSIOL, V121, P1314, DOI 10.1016/j.clinph.2010.03.010; Rosenbaum P, 2006, RAD 2006 IEEE C APR, P8, DOI DOI 10.1109/RADAR.2006.1631770; Sabes PN, 1997, J NEUROSCI, V17, P7119; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sanger TD, 2004, NEURAL COMPUT, V16, P1873, DOI 10.1162/0899766041336431; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; Scott SH, 2003, CURR OPIN NEUROL, V16, P693, DOI 10.1097/00019052-200312000-00008; Shumway-Cook A., 2007, MOTOR CONTROL TRANSL; Sketch SM, 2017, SIMULATING IMPACT SE; Staudt M, 2000, NEUROPEDIATRICS, V31, P257, DOI 10.1055/s-2000-9239; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tinazzi M, 2000, BRAIN, V123, P42, DOI 10.1093/brain/123.1.42; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Toyokawa S, 2017, DEV MED CHILD NEUROL, V59, P317, DOI 10.1111/dmcn.13278; Trivedi R, 2008, PEDIATR NEUROL, V39, P341, DOI 10.1016/j.pediatrneurol.2008.07.012; Vilares I, 2012, CURR BIOL, V22, P1641, DOI 10.1016/j.cub.2012.07.010; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wilson BN, 2009, PHYS OCCUP THER PEDI, V29, P182, DOI 10.1080/01942630902784761; Wingert JR, 2010, HUM BRAIN MAPP, V31, P1772, DOI 10.1002/hbm.20977; Wolpert DM, 2016, CURR OPIN NEUROBIOL, V37, P7, DOI 10.1016/j.conb.2015.12.003; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Young SJ, 2011, J CHILD NEUROL, V26, P37, DOI 10.1177/0883073810371828	58	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188741	10.1371/journal.pone.0188741	http://dx.doi.org/10.1371/journal.pone.0188741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO0ZL	29186196	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900056
J	Jacobs, DS; Catto, S; Mutumi, GL; Finger, N; Webala, PW				Jacobs, David S.; Catto, Sarah; Mutumi, Gregory L.; Finger, Nikita; Webala, Paul W.			Testing the Sensory Drive Hypothesis: Geographic variation in echolocation frequencies of Geoffroy's horseshoe bat (Rhinolophidae: Rhinolophus clivosus)	PLOS ONE			English	Article							CALL FREQUENCIES; SONG STRUCTURE; CHIROPTERA; SEX; AUDITION; BEHAVIOR; HABITAT; CLIMATE; SIGNALS; RANGE	Geographic variation in sensory traits is usually influenced by adaptive processes because these traits are involved in crucial life-history aspects including orientation, communication, lineage recognition and mate choice. Studying this variation can therefore provide insights into lineage diversification. According to the Sensory Drive Hypothesis, lineage diversification may be driven by adaptation of sensory systems to local environments. It predicts that acoustic signals vary in association with local climatic conditions so that atmospheric attenuation is minimized and transmission of the signals maximized. To test this prediction, we investigated the influence of climatic factors (specifically relative humidity and temperature) on geographic variation in the resting frequencies of the echolocation pulses of Geoffroy's horseshoe bat, Rhinolophus clivosus. If the evolution of phenotypic variation in this lineage tracks climate variation, human induced climate change may lead to decreases in detection volumes and a reduction in foraging efficiency. A complex non-linear interaction between relative humidity and temperature affects atmospheric attenuation of sound and principal components composed of these correlated variables were, therefore, used in a linear mixed effects model to assess their contribution to observed variation in resting frequencies. A principal component composed predominantly of mean annual temperature (factor loading of -0.8455) significantly explained a proportion of the variation in resting frequency across sites (P < 0.05). Specifically, at higher relative humidity (around 60%) prevalent across the distribution of R. clivosus, increasing temperature had a strong negative effect on resting frequency. Climatic factors thus strongly influence acoustic signal divergence in this lineage, supporting the prediction of the Sensory Drive Hypothesis. The predicted future increase in temperature due to climate change is likely to decrease the detection volume in echolocating bats and adversely impact their foraging efficiency.	[Jacobs, David S.; Catto, Sarah; Mutumi, Gregory L.; Finger, Nikita] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa; [Webala, Paul W.] Maasai Mara Univ, Dept Forestry & Wildlife Management, Narok, Kenya; [Mutumi, Gregory L.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of Cape Town; University of California System; University of California Merced	Jacobs, DS (corresponding author), Univ Cape Town, Dept Biol Sci, Cape Town, South Africa.	david.jacobs@uct.ac.za	mutumi, gregory/GYD-4103-2022; Mutumi, Gregory/AAH-8447-2021; Jacobs, David Steve/L-9118-2013	mutumi, gregory/0000-0003-1911-2232; Jacobs, David Steve/0000-0002-3243-8571; Finger, Nikita/0000-0002-5161-3646	South African Research Chair Initiative (SARChI) of the Department of Science and Technology [GUN 64798]; British Ecological Society; International Foundation of Science	South African Research Chair Initiative (SARChI) of the Department of Science and Technology; British Ecological Society; International Foundation of Science(International Foundation for Science)	This research was supported by a grant to DSJ from the South African Research Chair Initiative (SARChI) of the Department of Science and Technology (http://www.dst.govza), administered by the National Research Foundation (http://www.nrf.ac.za), grant number GUN 64798. SC received a student assistantship from the National Research Foundation. PWW was supported by an overseas grant of the British Ecological Society (http://www.britishecologicalsociety.org) and the International Foundation of Science (http://www.ifs.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter J, 2005, EXTENT FREQUENCY EUR; Akaike H., 1976, SYSTEM IDENTIFICATIO; [Anonymous], 1999, WALKERS MAMMALS WORL; Anthony E.L.P., 1988, P47; Armstrong KN, 2007, J MAMMAL, V88, P94, DOI 10.1644/06-MAMM-A-115R1.1; Barclay RMR, 1999, CAN J ZOOL, V77, P530, DOI 10.1139/cjz-77-4-530; Bastian A, 2015, ANIM BEHAV, V101, P141, DOI 10.1016/j.anbehav.2014.12.010; Benda Petr, 2012, Vespertilio, V16, P69; Benda Petr, 2008, Acta Societatis Zoologicae Bohemicae, V72, P1; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Chaverri G, 2017, J ACOUST SOC AM, V142, P146, DOI 10.1121/1.4992029; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Coyne J.A., 2004, SPECIATION; Csorba G., 2003, HORSESHOE BATS WORLD; Dechmann DN, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00066; DING T, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0070368; Dool SE, 2016, MOL PHYLOGENET EVOL, V97, P196, DOI 10.1016/j.ympev.2016.01.003; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; Fenton MB, 1999, ACTA CHIROPTEROL, V1, P127; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Finger NM, 2017, ANIM BEHAV, V127, P135, DOI 10.1016/j.anbehav.2017.03.005; Gillam EH, 2007, ANIM BEHAV, V74, P277, DOI 10.1016/j.anbehav.2006.12.006; Gillam EH, 2009, BEHAV ECOL SOCIOBIOL, V64, P69, DOI 10.1007/s00265-009-0819-1; Goiti U, 2003, ACTA CHIROPTEROL, V5, P75, DOI 10.3161/001.005.0106; Griffin D.R., 1958, LISTENING DARK ACOUS; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jiang TL, 2015, INTEGR ZOOL, V10, P241, DOI 10.1111/1749-4877.12129; Jiang TL, 2013, ETHOLOGY, V119, P881, DOI 10.1111/eth.12130; Jiang TL, 2010, J ACOUST SOC AM, V128, P2204, DOI 10.1121/1.3478855; Jones G, 1996, S ZOOLOGICAL SOC LON, DOI [10.1002/ece3.3251, DOI 10.1002/ECE3.3251]; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; Law BS, 2002, ACTA CHIROPTEROL, V4, P201, DOI 10.3161/001.004.0208; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; Luo JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0961; Maluleke T, 2017, ECOL EVOL, V7, P7347, DOI 10.1002/ece3.3251; Mutumi GL, 2017, ECOLOGY EVOLUTION; Mutumi GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148053; NEUWEILER G, 1984, NATURWISSENSCHAFTEN, V71, P446, DOI 10.1007/BF00455897; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Noack T., 1893, Zoologische Garten, Vxxxiv, P289; Odendaal LJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-60; Odendaal LJ, 2011, J COMP PHYSIOL A, V197, P435, DOI 10.1007/s00359-010-0601-x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Racey P.A., 1988, P31; Rughetti M, 2014, ACTA CHIROPTEROL, V16, P149, DOI 10.3161/150811014X683363; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; SCHULLER G, 1976, J COMP PHYSIOL, V105, P9, DOI 10.1007/BF01380049; Shieh BS, 2004, ZOOL STUD, V43, P132; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Snell-Rood EC, 2012, J ACOUST SOC AM, V131, P1650, DOI 10.1121/1.3672695; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Stilz WP, 2012, J ACOUST SOC AM, V132, P1765, DOI 10.1121/1.4733537; Stoffberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031946; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Team RC, 2014, R LANG ENV STAT COMP; THOMAS DW, 1987, J MAMMAL, V68, P842, DOI 10.2307/1381562; Thomas JA, 2004, ECHOLOCATION BATS DO; THORPE RS, 1987, B ZOOL, V54, P3; Tobias JA, 2010, EVOLUTION, V64, P2820, DOI 10.1111/j.1558-5646.2010.01067.x; Warren PS, 2002, AUK, V119, P349, DOI 10.1642/0004-8038(2002)119[0349:GVADIS]2.0.CO;2; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; ZANN R, 1993, AUK, V110, P716; Zuckerwar, 2002, HDB SPEED SOUND REAL, V1	79	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187769	10.1371/journal.pone.0187769	http://dx.doi.org/10.1371/journal.pone.0187769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186147	Green Submitted, Green Published, gold			2022-12-26	WOS:000416484900010
J	Arnold, C; Demirel, E; Feldner, A; Genove, G; Zhang, HJ; Sticht, C; Wieland, T; Hecker, M; Heximer, S; Korff, T				Arnold, Caroline; Demirel, Eda; Feldner, Anja; Genove, Guillem; Zhang, Hangjun; Sticht, Carsten; Wieland, Thomas; Hecker, Markus; Heximer, Scott; Korff, Thomas			Hypertension-evoked RhoA activity in vascular smooth muscle cells requires RGS5	FASEB JOURNAL			English	Article						vascular remodeling; G protein signaling; VSMC phenotype; blood pressure	PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEINS; N-TERMINAL KINASE; BLOOD-PRESSURE; CARDIOVASCULAR-SYSTEM; TENASCIN-C; IN-VIVO; PHOSPHORYLATION; DIFFERENTIATION; PHOSPHATASE	G protein-mediated signaling plays a decisive role in blood pressure regulation and the phenotype of vascular smooth muscle cells (VSMCs); however, the relevance of proteins that restrict G protein activity is not well characterized in this context. Here, we investigated the influence of regulator of G protein signaling 5 (RGS5), an inhibitor of G alpha(q/11) and G alpha(i/o) activity, on blood pressure and the VSMC phenotype during experimental hypertension. In mice, loss of RGS5 did not affect baseline blood pressure, but prevented hypertension-induced structural remodeling. RGS5-deficient arterial VSMCs did not acquire a synthetic phenotype as evidenced by their inability to decrease the abundance of contractile markers-alpha-smooth muscle actin and smooth muscle-myosin heavy chain-or to proliferate under these conditions. Mechanistically, hypertensive pressure levels or biomechanical stretch are sufficient to increase the expression of RGS5. Loss of RGS5 severely impairs the activation of RhoA and stress fiber formation. In stretch-exposed VSMCs, RhoA activity was amplified upon inhibition of PKC, which mimics the downstream effects evoked by RGS5-mediated inhibition of G alpha(q/11) signaling. Collectively, our findings underline that RhoA activation may depend on the restriction of G protein activity and identify RGS5 as a mechanosensitive regulatory protein that is required to promote the synthetic VSMC phenotype as a prerequisite for structural renovation of the arterial wall during hypertension.	[Arnold, Caroline; Demirel, Eda; Feldner, Anja; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Sticht, Carsten] Heidelberg Univ, Ctr Med Res, Heidelberg, Germany; [Wieland, Thomas] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Heidelberg, Germany; [Genove, Guillem] Karolinska Inst, Integrated Cardiometab Ctr, Huddinge, Sweden; [Zhang, Hangjun; Heximer, Scott] Univ Toronto, Dept Physiol, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Karolinska Institutet; University of Toronto	Korff, T (corresponding author), Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de	Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Genove, Guillem/0000-0002-8558-3107	Deutsche Forschungsgemeinschaft [SFB TR23]; operating grants from the Canadian Institutes of Health Research [MOP-106670]; Heart and Stroke Foundation of Canada [T6799]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); operating grants from the Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB TR23, Projects B6, C5, C6), operating grants from the Canadian Institutes of Health Research (MOP-106670; to S.H.), and the Grants-in-Aid Program of the Heart and Stroke Foundation of Canada (T6799; to S.H.). The authors acknowledge the excellent technical assistance of Maria Harlacher, Gudrun Scheib, and Yvonne Feuchter (Institute of Physiology and Pathophysiology). The authors declare no conflicts of interest.	Althoff TF, 2012, J EXP MED, V209, P2277, DOI 10.1084/jem.20120350; Arnold C, 2014, EMBO MOL MED, V6, P1075, DOI 10.15252/emmm.201403864; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; CHEN YF, 1985, AM J PHYSIOL, V249, pH71; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chrissobolis S, 2001, CIRC RES, V88, P774, DOI 10.1161/hh0801.090441; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Grobe JL, 2011, HYPERTENSION, V57, P600, DOI 10.1161/HYPERTENSIONAHA.110.165829; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hilzendeger AM, 2013, HYPERTENSION, V61, P716, DOI 10.1161/HYPERTENSIONAHA.111.00356; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Iyoda T, 2012, J BIOL CHEM, V287, P22635, DOI 10.1074/jbc.M111.335695; Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131; Kubo T, 1996, Hypertens Res, V19, P213, DOI 10.1291/hypres.19.213; Lee DL, 2004, HYPERTENSION, V44, P796, DOI 10.1161/01.HYP.0000148303.98066.ab; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Madamanchi NR, 1998, ONCOGENE, V16, P417, DOI 10.1038/sj.onc.1201551; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; MIRONNEAU J, 1995, CELL SIGNAL, V7, P471, DOI 10.1016/0898-6568(95)00014-G; Mori K, 2009, J BIOL CHEM, V284, P5067, DOI 10.1074/jbc.M806853200; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nalli AD, 2014, CELL BIOCHEM BIOPHYS, V70, P867, DOI 10.1007/s12013-014-9992-6; Numaguchi K, 1999, CIRC RES, V85, P5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Satta J, 2002, J AM COLL CARDIOL, V39, P96, DOI 10.1016/S0735-1097(01)01705-3; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Spyroglou A, 2012, J ENDOCRINOL, V215, P375, DOI 10.1530/JOE-12-0429; Walsh Michael P., 2007, V365, P209; WEN YS, 1992, ENDOCRINOLOGY, V131, P1377, DOI 10.1210/en.131.3.1377; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; Wirth A, 2010, BBA-MOL BASIS DIS, V1802, P1276, DOI 10.1016/j.bbadis.2010.05.002; Yang Z, 2011, J BIOL CHEM, V286, P11444, DOI [10.1074/jbc.M110.212480, 10.1074/jbc.M111.229344]; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454	51	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2021	2035		10.1096/fj.201700384RR	http://dx.doi.org/10.1096/fj.201700384RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208700				2022-12-26	WOS:000429051400024
J	Stifter, SA; Matthews, AY; Mangan, NE; Fung, KY; Drew, A; Tate, MD; da Costa, TPS; Hampsey, D; Mayall, J; Hansbro, PM; Minambres, AG; Eid, SG; Mak, J; Scoble, J; Lovrecz, G; deWeerd, NA; Hertzog, PJ				Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; da Costa, Tatiana P. Soares; Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.; Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson; Scoble, Judy; Lovrecz, George; deWeerd, Nicole A.; Hertzog, Paul J.			Defining the distinct, intrinsic properties of the novel type I interferon, IFN epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BETA; ALPHA; MOUSE; CELLS; PURIFICATION; ACTIVATION; MATURATION; BINDING	The type I interferons (IFNs) are a family of cytokines with diverse biological activities, including antiviral, antiproliferative, and immunoregulatory functions. The discovery of the hormonally regulated, constitutively expressed IFN epsilon has suggested a function for IFNs in reproductive tract homeostasis and protection from infections, but its intrinsic activities are untested. We report here the expression, purification, and functional characterization of murine IFN epsilon (mIFN epsilon). Recombinant mIFN epsilon (rmIFN epsilon) exhibited an alpha-helical fold characteristic of type I IFNs and bound to IFN alpha/beta receptor 1 (IFNAR1) and IFNAR2, but, unusually, it had a preference for IFNAR1. Nevertheless, rmIFN epsilon induced typical type I IFN signaling activity, including STAT1 phosphorylation and activation of canonical type I IFN signaling reporters, demonstrating that it uses the JAK-STAT signaling pathway. We also found that rmIFN epsilon induces the activation of T, B, and NK cells and exhibits antiviral, antiproliferative, and antibacterial activities typical of type I IFNs, albeit with 100-1000-fold reduced potency compared with rmIFN epsilon 1 and rmIFN epsilon. Surprisingly, although the type I IFNs generally do not display cross-species activities, rmIFN epsilon exhibited high antiviral activity on human cells, suppressing HIV replication and inducing the expression of known HIV restriction factors in human lymphocytes. Our findings define the intrinsic properties of murine IFN epsilon, indicating that it distinctly interacts with IFNAR and elicits pathogen-suppressing activity with a potency enabling host defense but with limited toxicity, appropriate for a protein expressed constitutively in a sensitive mucosal site, such as the reproductive tract.	[Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; deWeerd, Nicole A.; Hertzog, Paul J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia; [Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; deWeerd, Nicole A.; Hertzog, Paul J.] Monash Univ, Sch Clin Sci Monash Hlth, Dept Mol & Translat Sci, 27-31 Wright St, Clayton, Vic 3168, Australia; [da Costa, Tatiana P. Soares] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW 2300, Australia; [Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.] Univ Newcastle, Newcastle, NSW 2300, Australia; [Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson] Deakin Univ, Sch Med, Geelong, Vic 3220, Australia; [Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson] CSIRO, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Mak, Johnson] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia; [Scoble, Judy; Lovrecz, George] CSIRO Mfg, Parkville, Vic 3052, Australia; [Stifter, Sebastian A.] Centenary Inst, Mycobacterial Lab, Camperdown, NSW 2050, Australia; [Fung, Ka Yee] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Hudson Institute of Medical Research; Monash University; La Trobe University; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Centenary Institute; Walter & Eliza Hall Institute	Hertzog, PJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	paul.hertzog@hudson.org.au	Hansbro, Phil/G-7486-2013; mak, johnson/H-4605-2014; mak, johnson/S-2457-2019; de Weerd, Nicole/X-5886-2019; Scoble, Judith A/B-4919-2016; Hertzog, Paul/I-7053-2013	Hansbro, Phil/0000-0002-4741-3035; mak, johnson/0000-0002-5229-5707; mak, johnson/0000-0002-5229-5707; de Weerd, Nicole/0000-0002-7985-189X; Scoble, Judith A/0000-0002-6652-0717; Tate, Michelle/0000-0002-0587-5514; Mangan, Niamh/0000-0003-3844-0709; lovrecz, George/0000-0001-9977-5065; Mayall, Jemma/0000-0002-0915-5020; Stifter, Sebastian/0000-0002-7825-222X; Hertzog, Paul/0000-0002-1373-8472; Soares da Costa, Tatiana P./0000-0002-6275-7485	National Health and Medical Research Council (NHMRC) [APP1070732]; NHMRC [APP1126524, APP1117527, 035733, 1123319, APP1003591, APP1059242, APP1091976]; Australian Research Council [DP110103616]; Deakin University; National Collaborative Research Infrastructure Strategy; Australian Centre for HIV and Hepatitis Virology Research Grants [2013-34, 2015-12]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Deakin University; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Centre for HIV and Hepatitis Virology Research Grants; Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council (NHMRC) New Investigator Grant APP1070732 (2014 - 2016) and NHMRC Project Grant APP1126524 (to N. D. W.), NHMRC Senior Principal Research Fellowship APP1117527 and NHMRC Project Grant APP1126524 (to P. J. H.), Australian Research Council Fellowship DP110103616 (to N. E. M.), NHMRC Fellowships 035733 and 1123319 (to M. D. T.), NHMRC Grants APP1003591 and APP1059242 (to J. C. H. and P. M. H.), a Deakin University scholarship (to A. G. M.), funding from the National Collaborative Research Infrastructure Strategy (to G. L.), Australian Centre for HIV and Hepatitis Virology Research Grants 2013-34 and 2015-12 (to P. J. H., N. E. M., and J. M.), and NHMRCFellowship APP1091976 (to T. P. S. d. C.). Research at the Hudson Institute was supported by the Victorian Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Atzeni F, 2002, CELL IMMUNOL, V220, P20, DOI 10.1016/S0008-8749(03)00002-9; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Christensen JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37111; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; da Costa TPS, 2016, STRUCTURE, V24, P1282, DOI 10.1016/j.str.2016.05.019; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Weerd NA, 2017, J BIOL CHEM, V292, P7554, DOI 10.1074/jbc.M116.773788; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Denton PW, 2011, AIDS REV, V13, P135; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Garcia-Minambres A, 2017, IMMUNOL CELL BIOL, V95, P478, DOI 10.1038/icb.2016.123; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HALLORAN PF, 1989, J IMMUNOL, V142, P4241; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; KNIGHT E, 1975, J BIOL CHEM, V250, P4139; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; MERIGAN TC, 1964, SCIENCE, V145, P811, DOI 10.1126/science.145.3634.811-a; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033934; Peng FW, 2007, PROTEIN EXPRES PURIF, V53, P356, DOI 10.1016/j.pep.2006.12.013; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; SAMUEL CE, 1977, VIROLOGY, V77, P556, DOI 10.1016/0042-6822(77)90481-0; SENDA T, 1995, J MOL BIOL, V253, P187, DOI 10.1006/jmbi.1995.0544; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255; Nguyen-Pham TN, 2011, CELL MOL IMMUNOL, V8, P341, DOI 10.1038/cmi.2011.7; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Trajanovska S, 2003, J INTERF CYTOK RES, V23, P351, DOI 10.1089/107999003322226005; Yamamoto K, 2009, J INTERF CYTOK RES, V29, P161, DOI 10.1089/jir.2008.0038; Yang LM, 2013, J INTERF CYTOK RES, V33, P760, DOI 10.1089/jir.2013.0037	42	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3168	3179		10.1074/jbc.M117.800755	http://dx.doi.org/10.1074/jbc.M117.800755			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29187603	Green Published, hybrid			2022-12-26	WOS:000426562800012
J	Canales, A; Rosinger, M; Sastre, J; Felli, IC; Jimenez-Barbero, J; Gimenez-Gallego, G; Fernandez-Tornero, C				Canales, Angeles; Rosinger, Marcel; Sastre, Javier; Felli, Isabella C.; Jimenez-Barbero, Jesus; Gimenez-Gallego, Guillermo; Fernandez-Tornero, Carlos			Hidden alpha-helical propensity segments within disordered regions of the transcriptional activator CHOP	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; ENDOPLASMIC-RETICULUM STRESS; C/EBP HOMOLOGOUS PROTEIN; SEDIMENTATION-VELOCITY; MOLECULAR RECOGNITION; ESCHERICHIA-COLI; BINDING REGIONS; DOMAIN; GENE; GCN4	C/EBP-homologous protein (CHOP) is a key determinant of the apoptotic response to endoplasmic reticulum stress or DNA damage. As a member of the C/EBP family, CHOP contains a low complexity N-terminal region involved in transcriptional activation, followed by a bZIP that binds DNA after dimerization. However, in contrast to other C/EBPs, CHOP directs binding to non-canonical C/EBP sites due to unique substitutions in its DNA-binding domain. Herein, we show that the N-terminal region of CHOP is intrinsically unstructured but contains two segments presenting a-helical propensity. One of these segments is conserved in other C/EBPs and mediates essential roles of CHOP, including regulation through phosphorylation. The second segment is placed within a proteolytic-resistant portion of the protein and exhibits reduced flexibility. Moreover, the DNA-binding region of CHOP also contains a segment with a-helical character towards its most N-terminal part. Our results suggest that structure-prone segments scattered within disordered regions may be critical for macromolecular recognition during CHOP-mediated transcriptional activation.	[Canales, Angeles] Univ Complutense Madrid, Dept Quim Organ 1, Madrid, Spain; [Rosinger, Marcel; Sastre, Javier; Jimenez-Barbero, Jesus; Gimenez-Gallego, Guillermo; Fernandez-Tornero, Carlos] CSIC, Ctr Invest Biol, Madrid, Spain; [Felli, Isabella C.] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Jimenez-Barbero, Jesus] CIC bioGUNE, Bizkaia Sci & Technol Pk, Derio, Spain; [Jimenez-Barbero, Jesus] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Jimenez-Barbero, Jesus] Univ Basque Country, Fac Sci & Technol, Dept Organ Chem 2, Leioa, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Florence; CIC bioGUNE; Basque Foundation for Science; University of Basque Country	Canales, A (corresponding author), Univ Complutense Madrid, Dept Quim Organ 1, Madrid, Spain.; Fernandez-Tornero, C (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	ma.canales@quim.ucm.es; cftornero@cib.csic.es	Fernandez-Tornero, Carlos/AAV-8028-2021; Fernandez-Tornero, Carlos/I-6888-2015; Felli, Isabella C./O-1751-2015; JIMENEZ-BARBERO, JESUS/D-4431-2014; Canales, Angeles/K-7499-2015	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Felli, Isabella C./0000-0002-6018-9090; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Canales, Angeles/0000-0003-0542-3080	Spanish Ministry of Economy and Competitiveness [BFU2013-48374-P, CTQ2016-76263-P]; Ramon Areces Foundation; European Commission [261863]; PharmaMar	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon Areces Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); PharmaMar	This work was supported by the Spanish Ministry of Economy and Competitiveness [BFU2013-48374-P to C.F.-T., CTQ2016-76263-P to A.C.]; the Ramon Areces Foundation [to C.F.-T.]; and the European Commission [BioNMR (Contract No. 261863) to I.C.F.]. PharmaMar supported this project during the initial stages. The funders had no role in study design, data collection and analysis,	Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lobanov MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027142; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; ORTEGA S, 1992, BIO-TECHNOL, V10, P795, DOI 10.1038/nbt0792-795; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ubeda M, 2003, J BIOL CHEM, V278, P40514, DOI 10.1074/jbc.M306404200; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189171	10.1371/journal.pone.0189171	http://dx.doi.org/10.1371/journal.pone.0189171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211802	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200074
J	Elliott, AD; Bedard, N; Ustione, A; Baird, MA; Davidson, MW; Tkaczyk, T; Piston, DW				Elliott, Amicia D.; Bedard, Noah; Ustione, Alessandro; Baird, Michelle A.; Davidson, Michael W.; Tkaczyk, Tomasz; Piston, David W.			Hyperspectral imaging for simultaneous measurements of two FRET biosensors in pancreatic beta-cells	PLOS ONE			English	Article							FLUORESCENT PROTEIN FRET; MAPPING SPECTROMETER; MICROSCOPY; OPTIMIZATION; APOPTOSIS	Fluorescent protein (FP) biosensors based on Forster resonance energy transfer (FRET) are commonly used to study molecular processes in living cells. There are FP-FRET biosensors for many cellular molecules, but it remains difficult to perform simultaneous measurements of multiple biosensors. The overlapping emission spectra of the commonly used FPs, including CFP/YFP and GFP/RFP make dual FRET measurements challenging. In addition, a snapshot imaging modality is required for simultaneous imaging. The Image Mapping Spectrometer (IMS) is a snapshot hyperspectral imaging system that collects high resolution spectral data and can be used to overcome these challenges. We have previously demonstrated the IMS's capabilities for simultaneously imaging GFP and CFP/YFP-based biosensors in pancreatic beta-cells. Here, we demonstrate a further capability of the IMS to image simultaneously two FRET biosensors with a single excitation band, one for cAMP and the other for Caspase-3. We use these measurements to measure simultaneously cAMP signaling and Caspase-3 activation in pancreatic beta-cells during oxidative stress and hyperglycemia, which are essential components in the pathology of diabetes.	[Elliott, Amicia D.] Natl Inst Gen Med Sci, Bethesda, MD USA; [Bedard, Noah; Tkaczyk, Tomasz] Rice Univ, Bioengn, Houston, TX USA; [Ustione, Alessandro; Piston, David W.] Washington Univ, St Louis, MO 63130 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Rice University; Washington University (WUSTL); State University System of Florida; Florida State University	Piston, DW (corresponding author), Washington Univ, St Louis, MO 63130 USA.	piston@wustl.edu		Elliott, Amicia/0000-0002-3089-1786	National Institutes of Health [CA124319, DK085064, DK098659, EB009186, EB016832, GM117582]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants CA124319, DK085064, DK098659, EB009186, EB016832, and GM117582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arai Y, 2013, MICROSCOPY-JPN, V62, P419, DOI 10.1093/jmicro/dft037; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen SY, 2014, BIOMED OPT EXPRESS, V5, P338, DOI 10.1364/BOE.5.000338; Elliott AD, 2012, J CELL SCI, V125, P4833, DOI 10.1242/jcs.108258; Favreau PF, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046010; Gao LA, 2010, OPT EXPRESS, V18, P14330, DOI 10.1364/OE.18.014330; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lavagnino Z, 2016, BIOPHYS J, V111, P409, DOI 10.1016/j.bpj.2016.06.014; Lerner J. M., 2010, CURRENT PROTOCOLS CY; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Mansfield JR, 2010, METHODS, V52, P271, DOI 10.1016/j.ymeth.2010.10.001; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA., 2009, COLD SPRING HARB PRO, V2009, DOI [10.1101/pdb.ip64, DOI 10.1101/PDB.IP64]; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216	23	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188789	10.1371/journal.pone.0188789	http://dx.doi.org/10.1371/journal.pone.0188789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211763	Green Published, Green Submitted, gold			2022-12-26	WOS:000417212200048
J	Li, L; Ma, XW; Zhan, RL; Wu, HX; Yao, QS; Xu, WT; Luo, C; Zhou, YG; Liang, QZ; Wang, SB				Li, Li; Ma, Xiao-Wei; Zhan, Ru-Lin; Wu, Hong-Xia; Yao, Quan-Sheng; Xu, Wen-Tian; Luo, Chun; Zhou, Yi-Gang; Liang, Qing-Zhi; Wang, Song-Biao			Profiling of volatile fragrant components in a mini-core collection of mango germplasms from seven countries	PLOS ONE			English	Article							MANGIFERA-INDICA L.; AROMA COMPONENTS; CULTIVARS; FRUIT; VARIETIES; CONSTITUENTS	Aroma is important in assessing the quality of fresh fruit and their processed products, and could provide good indicators for the development of local cultivars in the mango industry. In this study, the volatile diversity of 25 mango cultivars from China, America, Thailand, India, Cuba, Indonesia, and the Philippines was investigated. The volatile compositions, their relative contents, and the intervarietal differences were detected with headspace solid phase microextraction tandem gas chromatography-mass spectrometer methods. The similarities were also evaluated with a cluster analysis and correlation analysis of the volatiles. The differences in mango volatiles in different districts are also discussed. Our results show significant differences in the volatile compositions and their relative contents among the individual cultivars and regions. In total, 127 volatiles were found in all the cultivars, belonging to various chemical classes. The highest and lowest qualitative abundances of volatiles were detected in 'ihua' and 'allika' cultivars, respectively. Based on the cumulative occurrence of members of the classes of volatiles, the cultivars were grouped into monoterpenes (16 cultivars), proportion and balanced (eight cultivars), and nonterpene groups (one cultivars). Terpene hydrocarbons were the major volatiles in these cultivars, with terpinolene, 3-carene, caryophyllene and a-Pinene the dominant components depending on the cultivars. Monoterpenes, some of the primary volatile components, were the most abundant aroma compounds, whereas aldehydes were the least abundant in the mango pulp. beta-Myrcene, a major terpene, accounted for 58.93% of the total flavor volatile compounds in 'iaofei' (Philippens). gamma-Octanoic lactone was the only ester in the total flavor volatile compounds, with its highest concentration in 'uiya' (China). Hexamethyl cyclotrisiloxane was the most abundant volatile compound in 'agovar' (India), accounting for 46.66% of the total flavor volatiles. A typical aldehydic aroma 2,6-di-tert-butyl-4-sec-butylphenol,was detected in 'leck'. A highly significant positive correlation was detected between Alc and K, Alk and Nt, O and L. Cultivars originating from America, Thailand, Cuba, India, Indonesia and the Philippines were more similar to each other than to those from China. This study provides a high-value dataset for use in development of health care products, diversified mango breeding, and local extension of mango cultivars.	[Li, Li; Ma, Xiao-Wei; Zhan, Ru-Lin; Wu, Hong-Xia; Yao, Quan-Sheng; Xu, Wen-Tian; Luo, Chun; Zhou, Yi-Gang; Liang, Qing-Zhi; Wang, Song-Biao] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, SB (corresponding author), Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China.	wsbcjy@163.com			Special Fund for Agro-scientific Research in the Public Interest [201203092-3]; National Nature Science Foundation of Guangdong Province [2016A030307005]; Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes [1630062015001, 1630062015007, 1630062016007]	Special Fund for Agro-scientific Research in the Public Interest; National Nature Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes	This research was supported by the the Special Fund for Agro-scientific Research in the Public Interest (201203092-3), the National Nature Science Foundation of Guangdong Province (2016A030307005) and Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes (1630062015001, 1630062015007, 1630062016007). All the funders of these fundings belong to Chinese government. These fundings are public welfare research funds and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EHA, 2001, J FOOD COMPOS ANAL, V14, P227, DOI 10.1006/jfca.2000.0968; Araguez I, 2013, BIOTECHNOL J, V8, P1144, DOI 10.1002/biot.201300113; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; El Hadi MAM, 2013, MOLECULES, V18, P8200, DOI 10.3390/molecules18078200; ENGEL KH, 1983, J AGR FOOD CHEM, V31, P796, DOI 10.1021/jf00118a029; Huang GuoDi, 2000, China Fruits, P47; IDSTEIN H, 1985, PHYTOCHEMISTRY, V24, P2313, DOI 10.1016/S0031-9422(00)83033-2; John KS, 1999, PHYTOCHEMISTRY, V52, P891, DOI 10.1016/S0031-9422(99)00296-4; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V29, P205, DOI 10.1016/S0925-5214(02)00250-8; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Ledeker CN, 2014, LWT-FOOD SCI TECHNOL, V56, P138, DOI 10.1016/j.lwt.2013.11.011; Liu FX, 2013, FOOD CHEM, V138, P396, DOI 10.1016/j.foodchem.2012.09.111; MACLEOD AJ, 1985, J AGR FOOD CHEM, V33, P380, DOI 10.1021/jf00063a015; MACLEOD AJ, 1982, PHYTOCHEMISTRY, V21, P2523, DOI 10.1016/0031-9422(82)85249-7; Masibo M, 2009, FOOD REV INT, V25, P346, DOI 10.1080/87559120903153524; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Musharraf SG, 2016, FOOD CHEM, V196, P1355, DOI 10.1016/j.foodchem.2015.10.040; Negri AS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00056; Orchard J, 2012, SCI TECHNOLOGY, P108; Pandit SS, 2007, CURR SCI INDIA, V93, P1135; Pandit SS, 2009, FOOD CHEM, V114, P363, DOI 10.1016/j.foodchem.2008.09.107; Pino JA, 2005, J AGR FOOD CHEM, V53, P2213, DOI 10.1021/jf0402633; Po MS Dar, 2015, VOLATILE DIVERSITY M, p[458, 461]; Quijano CE, 2007, FLAVOUR FRAG J, V22, P401, DOI 10.1002/ffj.1812; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Tang CZ Yufan, 2015, PLOS ONE, V10; Wei CB, 2011, MOLECULES, V16, P5104, DOI 10.3390/molecules16065104; WILSON CW, 1990, J AGR FOOD CHEM, V38, P1556, DOI 10.1021/jf00097a028	28	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187487	10.1371/journal.pone.0187487	http://dx.doi.org/10.1371/journal.pone.0187487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211747	Green Submitted, Green Published, gold			2022-12-26	WOS:000417212200018
J	Younis, S; Rashid, S				Younis, Saima; Rashid, Sajid			Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study	PLOS ONE			English	Article							RECEPTOR 1; CONOPEPTIDE; CELLS; IDENTIFICATION; VISUALIZATION; METASTASIS; SERVER	Lysophosphatidic acid receptor 6 (LPAR6) is a G-protein coupled receptor (GPCR) involved in hair development and cytoskeleton formation in mammals. Its proliferation is implicated in several forms of cancer including liver cancer, squamous cell carcinoma and metastatic prostate cancer. Current study emphasizes the isolation of competitive non-lipid and stable peptide antagonists for Lysophosphatidic acid ligand. A total of 148 conotoxin structures were characterized for their binding abilities against LPAR6. Subsequently, top 10 conotoxins were selected on the basis of binding energy values, residual contributions and conformational cluster saturations. BuIA (a member of Alpha-conotoxins family), contryphan-R and contryphan-Lo (Synthetic class) conotoxins, exhibiting efficient binding parameters were subjected to molecular dynamics simulation assays and topology analysis. We propose that BuIA might be a potent antagonist due to its predominant binding at the extracellular region of LPAR6. Current study provides a backbone for understanding structural and functional insights of LPAR6 and findings of this study may be helpful in designing novel therapeutic targets for the treatment of cancers caused by elevated LPAR6 expression.	[Younis, Saima; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Younis, Saima/GQP-0173-2022; Rashid, Sajid/K-8640-2019	Rashid, Sajid/0000-0003-2122-2799; Younis, Saima/0000-0002-1461-5212				Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Accelrys Software Inc, 2007, DISC STUD MOD ENV RE; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geach TJ, 2014, DEVELOPMENT, V141, P940, DOI 10.1242/dev.104901; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jimenez EC, 2007, BIOCHEMISTRY-US, V46, P8717, DOI 10.1021/bi700582m; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kern SE, 2007, ANESTH ANALG, V104, P1514, DOI 10.1213/01.ane.0000262038.58546.e6; Ketscher A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.34; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lewis R., CONOTOXINS MOL THERA, P45; Liao Y, 2013, DIGEST DIS SCI, V58, P3524, DOI 10.1007/s10620-013-2878-4; Llona-Minguez S, 2015, PROG LIPID RES, V58, P51, DOI 10.1016/j.plipres.2015.01.004; Lou LQ, 2013, J INT MED RES, V41, P55, DOI 10.1177/0300060512474124; Lv GM, 2011, J SURG ONCOL, V104, P685, DOI 10.1002/jso.22016; Maiga A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.36; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Mazzocca A, 2015, CANCER RES, V75, P532, DOI 10.1158/0008-5472.CAN-14-1607; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Morimoto Y, 2014, GENE, V551, P189, DOI 10.1016/j.gene.2014.08.056; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Okusa MD, 2003, AM J PHYSIOL-RENAL, V285, pF565, DOI 10.1152/ajprenal.00023.2003; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Petrel C, 2013, BIOCHEM PHARMACOL, V85, P1663, DOI 10.1016/j.bcp.2013.03.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raza SEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097612; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Schleicher SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022182; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Stoddard NC, 2015, BIOMOL THER, V23, P1, DOI 10.4062/biomolther.2014.109; Su SC, 2013, CLIN CANCER RES, V19, P6461, DOI 10.1158/1078-0432.CCR-13-1284; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusnady GE, 2005, BIOINFORMATICS, V21, P1276, DOI 10.1093/bioinformatics/bti121; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189154	10.1371/journal.pone.0189154	http://dx.doi.org/10.1371/journal.pone.0189154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211777	Green Submitted, gold, Green Published			2022-12-26	WOS:000417212200069
J	Bennani-Baiti, B; Dietzel, M; Baltzer, PA				Bennani-Baiti, Barbara; Dietzel, Matthias; Baltzer, Pascal A.			MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications	PLOS ONE			English	Article							HIGH-SPATIAL-RESOLUTION; CARCINOMA IN-SITU; BREAST MRI; SCREENING MAMMOGRAPHY; LESIONS; CANCER; RISK; METAANALYSIS; ENHANCEMENT; MULTICENTER	Purpose Assess the performance of breast MRI to diagnose breast cancer in BI-RADS 4 microcalcifications detected by mammography. Materials and methods This retrospective, IRB-approved study included 248 consecutive contrast-enhanced breast MRI (1.5T, protocol in accordance with EUSOBI recommendations) performed to further diagnose BI-RADS 4 microcalcifications detected at mammography during a 3-year period. Standard of reference had to be established by histopathology. Routine consensus reading results by two radiologists were dichotomized as positive or negative and compared with the reference standard (benign vs malignant) to calculate diagnostic parameters. Results There were 107 malignant and 141 benign microcalcifications. Malignancy rates were 18.3% (23/126 BI-RADS 4a), 41.7% (25/60 BI-RADS 4b) and 95% (59/62 BI-RADS 4c). There were 103 true-positive, 116 true-negative, 25 false-positive, and 4 false-negative (one invasive cancer, three DCIS; 2 BI-RADS 4c, 1 BI-RADS 4b on mammography) breast MRI findings, effecting a sensitivity, specificity, PPV, and NPV of 96.3% (95%-CI 90.7-99.0%), 82.3% (95%-CI 75.0-88.2%), 80.5% (95%-CI 72.5-87.0%) and 96.7% (95%-CI 91.7-99.1%), respectively. Conclusion MRI is an accurate tool to further diagnose BI-RADS 4a and 4b microcalcifications and may be helpful to avoid unnecessary biopsies in BI-RADS 4a and 4b lesions. BI-RADS 4c microcalcifications should be biopsied irrespective of MRI findings.	[Bennani-Baiti, Barbara] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Bennani-Baiti, Barbara; Baltzer, Pascal A.] Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Dietzel, Matthias] Univ Erlangen Nurnberg, Dept Radiol, Nurnberg, Germany	University of Vienna; Medical University of Vienna; University of Erlangen Nuremberg	Bennani-Baiti, B (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.; Bennani-Baiti, B; Baltzer, PA (corresponding author), Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	barbara.bennani-baiti@univie.ac.at; pascal.baltzer@meduniwien.ac.at		Baltzer, Pascal/0000-0002-3755-5398	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Baltzer PAT, 2015, EUR J RADIOL, V84, P86, DOI 10.1016/j.ejrad.2014.10.023; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Bennani-Baiti B, 2016, RADIOLOGY; Bennani-Baiti B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160346; Bluekens AMJ, 2012, RADIOLOGY, V265, P707, DOI 10.1148/radiol.12111461; Castronovo V, 1998, INT J ONCOL, V12, P305; Clauser P, 2017, EUR J RADIOL, V92, P51, DOI 10.1016/j.ejrad.2017.04.014; D'Orsi CJ., 2013, ACR BIRADS ATLAS BRE; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gutierrez RL, 2009, AM J ROENTGENOL, V193, P994, DOI 10.2214/AJR.08.1983; Herrmann KH, 2011, J MAGN RESON IMAGING, V34, P973, DOI 10.1002/jmri.22689; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Jiang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099669; KAISER WA, 1989, RADIOLOGY, V170, P681, DOI 10.1148/radiology.170.3.2916021; Kettritz U, 2004, CANCER-AM CANCER SOC, V100, P245, DOI 10.1002/cncr.11887; Kuhl CK, 1999, JMRI-J MAGN RESON IM, V9, P187, DOI 10.1002/(SICI)1522-2586(199902)9:2<187::AID-JMRI6>3.0.CO;2-2; Kuhl CK, 2000, EUR RADIOL, V10, P46, DOI 10.1007/s003300050006; Lehman CD, 2014, ACR PRACTICE PARAMET; Li E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111217; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Mann RM, 2014, INVEST RADIOL, V49, P579, DOI 10.1097/RLI.0000000000000057; Obuchowski NA, 2010, EUR RADIOL, V20, P584, DOI 10.1007/s00330-009-1590-4; Pinker K, 2014, CLIN CANCER RES, V20, P3540, DOI 10.1158/1078-0432.CCR-13-2810; Pinker K, 2009, INVEST RADIOL, V44, P553, DOI 10.1097/RLI.0b013e3181b4c127; Rominger M, 2012, ROFO-FORTSCHR RONTG, V184, P1144, DOI 10.1055/s-0032-1313102; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Spick C, 2014, EUR RADIOL, V24, P1204, DOI 10.1007/s00330-014-3153-6; Stehouwer BL, 2014, EUR RADIOL, V24, P603, DOI 10.1007/s00330-013-3029-1; STOMPER PC, 1989, RADIOLOGY, V172, P235, DOI 10.1148/radiology.172.1.2544922; Strobel K, 2015, RADIOLOGY, V274, P343, DOI 10.1148/radiol.14140645; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	34	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188679	10.1371/journal.pone.0188679	http://dx.doi.org/10.1371/journal.pone.0188679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190656	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900099
J	Hornova, J; Ruzicka, P; Hrubina, M; Stastny, E; Koskova, A; Fulin, P; Gallo, J; Daniel, M				Hornova, Jana; Ruzicka, Pavel; Hrubina, Maros; Stastny, Eduard; Koskova, Andrea; Fulin, Petr; Gallo, Jiri; Daniel, Matej			Magnification of digital hip radiographs differs between clinical workplaces	PLOS ONE			English	Article							ARTHROPLASTY; ACCURACY; MARKERS; REPLACEMENT	Preoperative planning for total hip arthroplasty includes templating on anteroposterior radiographs. It is necessary to consider radiographic magnification in order to scale templates accurately. Studies dealing with hip templating report different values of radiographic magnification. It is not clear if the observed difference in magnification between the studies is caused by variability in studied groups, methodology or instrumentation. We hypothesize that there is a difference in magnification between clinical workplaces. Within this study, radiographic magnification was estimated on 337 radiographs of patients after total hip surgery from five orthopaedic departments in the Czech Republic. Magnification was determined for each patient as a ratio between diameter of implanted femoral head measured on radiogram and its true size. One-way ANOVA revealed significant differences in magnification between workplaces (F(4,332) = 132, p <= 0.001). These results suggest that radiographic magnification depends on the workplace where it is taken or more precisely on radiographic device. It indicates potential limits in generalizability of results of studies dealing with preoperative planning accuracy to other institutions.	[Hornova, Jana; Ruzicka, Pavel; Daniel, Matej] Czech Tech Univ, Fac Mech Engn, Lab Biomech, Prague, Czech Republic; [Hrubina, Maros] Hosp Pelhrimov, Dept Orthopaed, Pelhrimov, Czech Republic; [Stastny, Eduard] Charles Univ Prague, Dept Paediat & Adult Orthopaed Surg & Traumatol, Fac Med 2, Prague, Czech Republic; [Stastny, Eduard; Fulin, Petr] Teaching Hosp Motol Prague, Prague, Czech Republic; [Koskova, Andrea] Hosp Jablonec Nad Nisou, Dept Radiol, Jablonec Nad Nisou, Czech Republic; [Fulin, Petr] Charles Univ Prague, Fac Med 1, Dept Orthopaed, Prague, Czech Republic; [Gallo, Jiri] Palacky Univ, Teaching Hosp Olomouc, Fac Med & Dent, Dept Orthopaed, Olomouc, Czech Republic; [Hrubina, Maros] Comenius Univ, Jessenius Fac Med Martin, Orthopaed Clin, Bratislava, Slovakia; [Hrubina, Maros] Univ Hosp Martin, Martin, Slovakia	Czech Technical University Prague; Charles University Prague; Charles University Prague; Palacky University Olomouc; University Hospital Olomouc; Comenius University Bratislava	Daniel, M (corresponding author), Czech Tech Univ, Fac Mech Engn, Lab Biomech, Prague, Czech Republic.	matej.daniel@fs.cvut.cz	Fulín, Petr/K-5738-2017; Hrubina, Maros/X-7318-2018	Fulín, Petr/0000-0002-4604-9921; Hrubina, Maros/0000-0003-0755-5570; Gallo, Jiri/0000-0002-7424-8653; Daniel, Matej/0000-0003-0532-1965	Czech Health Research Council [15-31269A]; student grant project University Palacky [IGA_LF UPOL_2017_021]	Czech Health Research Council; student grant project University Palacky	This work was supported by Czech Health Research Council, Project No. 15-31269A (URL: https://www.rvvi.cz/cep?s=jednoduche-vyhledavani&ss=detail&n=0&h=NV15-31269A) (authors: MD PR JH); and student grant project University Palacky, Project No. IGA_LF UPOL_2017_021 (URL: http://www.psup.cz/iga-grantove-projekty/) (author: JG).	Archibeck MJ, 2016, CLIN ORTHOP RELAT R, V474, P1812, DOI 10.1007/s11999-016-4704-8; Bayne CO, 2009, J ARTHROPLASTY, V24, P407, DOI 10.1016/j.arth.2007.11.020; Boese CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128529; Davies AM, 2006, IMAGING HIP BONY PEL; Descamps S, 2010, SKELETAL RADIOL, V39, P273, DOI 10.1007/s00256-009-0732-8; Franken M, 2010, J BONE JOINT SURG BR, V92B, P136, DOI 10.1302/0301-620X.92B1.22257; Heinert G, 2009, J BONE JOINT SURG BR, V91B, P459, DOI 10.1302/0301-620X.91B4.21730; Jahnke A, 2015, ARCH ORTHOP TRAUM SU, V135, P1609, DOI 10.1007/s00402-015-2302-y; King RJ, 2009, J BONE JOINT SURG BR, V91B, P1217, DOI 10.1302/0301-620X.91B9.22615; Leo LKH, 2015, J ORTHOP TRAUMA REHA, V19, P31, DOI 10.1016/j.jotr.2014.03.002; Petretta R, 2015, CLIN ORTHOP RELAT R, V473, P3752, DOI 10.1007/s11999-015-4321-y; Pourmoghaddam A, 2015, J ARTHROPLASTY, V30, P622, DOI 10.1016/j.arth.2014.11.021; Scheerlinck T, 2010, ACTA ORTHOP BELG, V76, P432; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sershon RA, 2017, J ARTHROPLASTY, V32, P1024, DOI 10.1016/j.arth.2016.09.020; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinclair VF, 2014, J ARTHROPLASTY, V29, P1658, DOI 10.1016/j.arth.2014.03.013; The B, 2005, MED PHYS, V32, P2580, DOI 10.1118/1.1984293	18	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188743	10.1371/journal.pone.0188743	http://dx.doi.org/10.1371/journal.pone.0188743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190787	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900115
J	Saggu, SK; Mishra, PC				Saggu, Sandeep Kaur; Mishra, Prakash Chandra			Characterization of thermostable alkaline proteases from Bacillus infantis SKS1 isolated from garden soil	PLOS ONE			English	Article							FIBRINOLYTIC ENZYME; SP NOV.; PURIFICATION	Proteases are one of the largest groups of hydrolytic enzymes constituting about 60% of total worldwide sales of industrial enzymes due to their wide applications in detergent, leather, textile, food and pharmaceutical industry. Microbial proteases have been preferred over animal and plant proteases because of their fundamental features and ease in production. Bacillus infantis SKS1, an alkaline protease producing bacteria has been isolated from garden soil of north India and identified using morphological, biochemical and molecular methods. 16S rDNA sequence amplified using universal primers has 99% sequence identity with corresponding gene sequence of Bacillus infantis strain FM 34 and Bacillus sp. Beige. The bacterial culture and its 16S rDNA gene sequence have been deposited to Microbial Culture Collection (Pune, India) with accession number MCC 3035 and GenBank with accession number KR092197 respectively. The partially purified extract of Bacillus infantis SKS1 was thermostable and active in presence of Mg2+, acetyl acetone and laundry detergents implicating its application in industry. Production of these enzymes using this strain was maximized by optimization of various parameters including temperature, pH, media components and other growth conditions. Our results show that fructose and dextrose serve as the best carbon sources for production of these enzymes, highlighting the use of this strain for enzyme production utilizing relatively inexpensive substrates like beet molasses and corn steep liquor. Additionally, this strain showed maximum production of enzymes at 40 degrees C similar to bacterial species used for commercial production of alkaline proteases. Characterization of alkaline proteases from this strain of Bacillus infantis and optimization of parameters for its production would help in understanding its industrial application and large-scale production.	[Saggu, Sandeep Kaur; Mishra, Prakash Chandra] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Mishra, PC (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	pm.biotech@gndu.ac.in		Mishra, Prakash Chandra/0000-0002-6059-7174				Akbar SM, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21367; Banerjee UC, 1999, PROCESS BIOCHEM, V35, P213, DOI 10.1016/S0032-9592(99)00053-9; Banik RM, 2004, MICROBIOL RES, V159, P135, DOI 10.1016/j.micres.2004.01.002; Beg QK, 2002, PROCESS BIOCHEM, V37, P1103, DOI 10.1016/S0032-9592(01)00320-X; Bester DJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-64; BHOSALE SH, 1995, ENZYME MICROB TECH, V17, P136, DOI 10.1016/0141-0229(94)00045-S; Boominadhan U., 2009, BOT RES INT, V2, P83; Chatterjee S, 2015, J ADV PHARM TECHNOL, V6, P2, DOI 10.4103/2231-4040.150361; Chellappan S, 2011, J IND MICROBIOL BIOT, V38, P743, DOI 10.1007/s10295-010-0914-3; Chen TL, 2006, EXTREMOPHILES, V10, P35, DOI 10.1007/s00792-005-0469-9; Choudhary V., 2012, J ACAD IND RES, V1, P301; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cui H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123926; Dewan S., 2017, GLOBAL MARKETS ENZYM; El Hidri D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/648141; Ellaiah P, 2002, J SCI IND RES INDIA, V61, P690; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hindhumathi M., 2011, Research in Biotechnology, V2, P13; HINMAN RL, 1994, CHEMTECH, V24, P45; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Johnvesly B, 2001, PROCESS BIOCHEM, V37, P139, DOI 10.1016/S0032-9592(01)00191-1; Kang BS, 1999, J MICROBIOL, V37, P14; Ko KS, 2006, INT J SYST EVOL MICR, V56, P2541, DOI 10.1099/ijs.0.64213-0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kranthi V. S., 2012, CENTRAL EUR J EXP BI, V1, P113; Kumar CG, 2002, LETT APPL MICROBIOL, V34, P13, DOI [10.1046/j.1472-765x.2002.01044.x, 10.1046/j.1472-765X.2002.01044.x]; Kumar D J Mukesh, 2014, Pak J Biol Sci, V17, P529; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Mienda BS., 2014, RES J PHARM BIOL CHE, V5, P388, DOI DOI 10.1007/S00253-002-1142-1; Nallusamy S, 2016, OPEN BIOTECHNOLOGY J, V10, P335, DOI [10.2174/1874070701610010335, DOI 10.2174/1874070701610010335]; Nascimento TP, 2016, J CHROMATOGR B, V1025, P16, DOI 10.1016/j.jchromb.2016.04.046; Nisha S, 2014, AFR J BIOTECHNOL, V13, P1707; Niyonzima FN, 2015, PREP BIOCHEM BIOTECH, V45, P233, DOI 10.1080/10826068.2014.907183; Oda K, 2012, J BIOCHEM, V151, P13, DOI 10.1093/jb/mvr129; Pammi N, 2015, INT J ENV BIOL, V5, P32; Pathak AP, 2012, INDIAN J EXP BIOL, V50, P569; Patil U, 2013, ISRN BIOCH; Paul D, 2007, BANGLADESH J MICROBI, V24, P57, DOI DOI 10.3329/BJM.V24I1.1239; Peng Y, 2003, COMP BIOCHEM PHYS B, V134, P45, DOI 10.1016/S1096-4959(02)00183-5; Rao K, 2007, AFR J BIOTECHNOL, V6, P2493; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sakpal H.C., 2015, J PHARM BIOL SCI, V10, P58; Santos e Silva F. de A., 2016, African Journal of Agricultural Research, V11, P3733; Singh J, 2001, PROCESS BIOCHEM, V36, P781, DOI 10.1016/S0032-9592(00)00275-2; SINISTERRA JV, 1992, ULTRASONICS, V30, P180, DOI 10.1016/0041-624X(92)90070-3; Sivanandhini T, 2015, RES J PHARM BIOL CHE, V6, P1234; Stanbury PF, 1984, PRINCIPLES FERMENTAT; Suganthi C., 2013, J GENET ENG BIOTECHN, V11, P47, DOI [10.1016/j.jgeb.2013.02.002, DOI 10.1016/J.JGEB.2013.02.002]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thangam EB, 2002, BIOTECHNOL APPL BIOC, V35, P149, DOI 10.1042/BA20010013; Wilson P, 2012, AFR J MICROBIOL RES, V6, P5542, DOI 10.5897/AJMR11.158	52	25	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188724	10.1371/journal.pone.0188724	http://dx.doi.org/10.1371/journal.pone.0188724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190780	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900109
J	Shen, DL; Skibbens, RV				Shen, Donglai; Skibbens, Robert V.			Chl1 DNA helicase and Scc2 function in chromosome condensation through cohesin deposition	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; WARSAW BREAKAGE SYNDROME; DE-LANGE-SYNDROME; G-QUADRUPLEX DNA; BUDDING YEAST; NIPPED-B; PERICENTROMERIC COHESION; GENOME INSTABILITY; GENE-EXPRESSION	Chl1 DNA helicase promotes sister chromatid cohesion and associates with both the cohesion establishment acetyltransferase Eco1/Ctf7 and the DNA polymerase processivity factor PCNA that supports Eco1/Ctf7 function. Mutation in CHL1 results in precocious sister chromatid separation and cell aneuploidy, defects that arise through reduced levels of chromatin-bound cohesins which normally tether together sister chromatids (trans tethering). Mutation of Chl1 family members (BACH1/BRIP/FANCJ and DDX11/ChlR1) also exhibit genotoxic sensitivities, consistent with a role for Chl1 in trans tethering which is required for efficient DNA repair. Chl1 promotes the recruitment of Scc2 to DNA which is required for cohesin deposition onto DNA. There is limited evidence, however, that Scc2 also directs the deposition onto DNA of condensins which promote tethering in cis (intramolecular DNA links). Here, we test the ability of Chl1 to promote cis tethering and the role of both Chl1 and Scc2 to promote condensin recruitment to DNA. The results reveal that chl1 mutant cells exhibit significant condensation defects both within the rDNA locus and genome-wide. Importantly, chl1 mutant cell condensation defects do not result from reduced chromatin binding of condensin, but instead through reduced chromatin binding of cohesin. We tested scc2-4 mutant cells and similarly found no evidence of reduced condensin recruitment to chromatin. Consistent with a role for Scc2 specifically in cohesin deposition, scc2-4 mutant cell condensation defects are irreversible. We thus term Chl1 a novel regulator of both chromatin condensation and sister chromatid cohesion through cohesin-based mechanisms. These results reveal an exciting interface between DNA structure and the highly conserved cohesin complex.	[Shen, Donglai; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institute of General Medical Sciences [1R15GM110631-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110631] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, 1R15GM110631-01 to Robert Skibbens, PhD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; Bermudez VP, 2012, P NATL ACAD SCI USA, V109, P9366, DOI 10.1073/pnas.1206840109; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Borges V, 2013, CHROMOSOMA, V122, P121, DOI 10.1007/s00412-013-0396-y; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chmielewski JP, 2012, CHROMOSOMA, V121, P585, DOI 10.1007/s00412-012-0383-8; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Feng XD, 2014, ASIAN PAC J CANCER P, V15, P9459, DOI 10.7314/APJCP.2014.15.21.9459; Fernius J, 2013, CURR BIOL, V23, P599, DOI 10.1016/j.cub.2013.02.022; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalitsis P, 2017, CHROMOSOME RES, V25, P61, DOI 10.1007/s10577-017-9553-0; Kobayashi T, 2011, GENES CELLS, V16, P617, DOI 10.1111/j.1365-2443.2011.01519.x; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kuryavyi V, 2010, STRUCTURE, V18, P73, DOI 10.1016/j.str.2009.10.015; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Mannini L, 2011, MUTAT RES-REV MUTAT, V728, P81, DOI 10.1016/j.mrrev.2011.07.004; Maradeo ME, 2010, CELL CYCLE, V9, P4370, DOI 10.4161/cc.9.21.13634; Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mehta GD, 2013, FEBS LETT, V587, P2299, DOI 10.1016/j.febslet.2013.06.035; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Muto A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004671; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Pek JW, 2011, CURR BIOL, V21, P39, DOI 10.1016/j.cub.2010.11.051; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Petrova B, 2013, MOL CELL BIOL, V33, P984, DOI 10.1128/MCB.01400-12; Piskadlo Ewa, 2016, F1000Res, V5, DOI 10.12688/f1000research.8727.1; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rankin S, 2016, RECENT ADV COHESIN B, V5, P1909; Rollins RA, 1999, GENETICS, V152, P577; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; Shen D, 2017, CELL CYCLE, P1; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Sonneville R, 2015, CELL REP, V12, P405, DOI 10.1016/j.celrep.2015.06.046; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tong K, 2015, P NATL ACAD SCI USA, V112, P7021, DOI 10.1073/pnas.1501369112; Tong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100470; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Tsutsui Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004542; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Woodward J, 2016, GENE DEV, V30, P2173, DOI 10.1101/gad.284562.116; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Yin L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.88; Zakari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005308	91	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188739	10.1371/journal.pone.0188739	http://dx.doi.org/10.1371/journal.pone.0188739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186203	gold, Green Published			2022-12-26	WOS:000416484900055
J	Rajkumar, P; Cha, BY; Yin, JY; Arend, LJ; Paunescu, TG; Hirabayashi, Y; Donowitz, M; Pluznick, JL				Rajkumar, Premraj; Cha, Boyoung; Yin, Jianyi; Arend, Lois J.; Paunescu, Teodor G.; Hirabayashi, Yoshio; Donowitz, Mark; Pluznick, Jennifer L.			Identifying the localization and exploring a functional role for Gprc5c in the kidney	FASEB JOURNAL			English	Article						pH regulation; proximal tubule; NHE3	PROTEIN-COUPLED RECEPTOR; BLOOD-PRESSURE REGULATION; TUMOR-SUPPRESSOR GENE; ACID-BASE-BALANCE; RETINOIC ACID; PROXIMAL TUBULE; MOLECULAR-CLONING; SERUM BICARBONATE; WNT/BETA-CATENIN; COLLECTING DUCT	The investigation of orphan GPCRs (GPRs) has the potential to uncover novel insights into whole animal physiology. In this study, our goal was to determine the renal localization of Gprc5c, a receptor that we previously reported to be highly expressed in murine whole kidney, and to examine physiologic parameters in Gprc5c knockout (KO) mice to gain insight into function. Gprc5c localized to the apical membrane of renal proximal tubules (PTs) in mice, rats, and humans. With the comparison of Gprc5c wild-type (WT) and KO mice, we found that Gprc5c KO mice have altered acid-base homeostasis. Specifically, Gprc5c KO mice have lower blood pH and higher urine pH compared with WT mice, with a reduced level of titratable acids in their urine. In an in vitro GPCR internalization assay, we observed that Gprc5c internalization (an index of activation) was triggered by alkaline extracellular pH. Furthermore, with the use of an in vitro BCECF assay, we observed that Gprc5c increases Na+/H+ exchanger 3 (NHE3) activity at alkaline pH. We also find that the NHE3 activity is reduced in Gprc5c KO mice by 2 photon imaging in seminaphthorhodafluors (SNARF)-4F-loaded kidney sections. NHE3 is a primary contributor to apical transport of H+ in the renal PT. Together, these data imply that Gprc5c modulates the renal contribution to systemic pH homeostasis, at least in part, by taking part in the regulation of NHE3.	[Rajkumar, Premraj; Donowitz, Mark; Pluznick, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St,205A WBSB, Baltimore, MD 21205 USA; [Cha, Boyoung; Yin, Jianyi] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Arend, Lois J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Paunescu, Teodor G.] Harvard Med Sch, Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA; [Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Saitama, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; RIKEN	Pluznick, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St,205A WBSB, Baltimore, MD 21205 USA.	jpluznick@jhmi.edu	Paunescu, Teodor/AAX-7533-2020; Arend, Lois/ABE-2002-2020	Arend, Lois/0000-0001-5434-7630; Hirabayashi, Yoshio/0000-0002-5774-7354; Paunescu, Teodor/0000-0003-0227-9028	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R00-DK081610]; National Kidney Foundation of Maryland Mini-Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK081610, P30DK089502] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Kidney Foundation of Maryland Mini-Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Gregory Blass and Alexander Staruschenko (Medical College of Wisconsin, Milwaukee, WI, USA) and P. Richard Grimm and Paul Welling (University of Maryland, College Park, MD, USA) for sharing their protocols for urine ammonia measurement and blood collection from the abdominal aorta, respectively. The authors are grateful to Peter S. Aronson (Yale University, New Haven, CT, USA) for sharing the Megalin antibody. The authors are also grateful to the members of the J.L.P. and M.D. laboratories for their helpful discussions. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R00-DK081610 (to J.L.P.), and a National Kidney Foundation of Maryland Mini-Grant (to P.R.). The authors declare no conflicts of interest.	Amisten S, 2017, ENDOCR J, V64, P325, DOI 10.1507/endocrj.EJ16-0338; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Brauner-Osborne H, 2001, BBA-GENE STRUCT EXPR, V1518, P237, DOI 10.1016/S0167-4781(01)00197-X; BROWN SES, 1991, AM J PHYSIOL, V261, pC954, DOI 10.1152/ajpcell.1991.261.6.C954; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008; Curthoys NP, 2014, CLIN J AM SOC NEPHRO, V9, P1627, DOI 10.2215/CJN.10391012; Dang YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095548; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Grimm PR, 2015, J CLIN INVEST, V125, P2136, DOI 10.1172/JCI78558; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Imanishi S, 2007, J REPROD DEVELOP, V53, P1131, DOI 10.1262/jrd.18102; Inoue S, 2004, J INVEST DERMATOL, V122, P565, DOI 10.1046/j.0022-202X.2004.12628.x; Iversen NK, 2012, RESP PHYSIOL NEUROBI, V180, P252, DOI 10.1016/j.resp.2011.11.015; Kang N, 2015, BIOCHEM BIOPH RES CO, V460, P616, DOI 10.1016/j.bbrc.2015.03.078; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Kim SH, 2015, BIOCHEM BIOPH RES CO, V460, P404, DOI 10.1016/j.bbrc.2015.03.046; KINSELLA JL, 1980, AM J PHYSIOL, V238, pF461, DOI 10.1152/ajprenal.1980.238.6.F461; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kurabayashi N, 2013, DEVELOPMENT, V140, P4335, DOI 10.1242/dev.099754; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li HC, 2013, J MOL MED, V91, P951, DOI 10.1007/s00109-013-1015-3; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mitch WE, 2006, J NEPHROL, V19, pS70; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Navaneethan SD, 2011, CLIN J AM SOC NEPHRO, V6, P2395, DOI 10.2215/CJN.03730411; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2012, CURR OPIN NEPHROL HY, V21, P404, DOI 10.1097/MNH.0b013e328354a6bd; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Rajkumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111053; Raphael KL, 2016, CLIN J AM SOC NEPHRO, V11, P308, DOI 10.2215/CJN.06200615; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Robbins MJ, 2002, MOL BRAIN RES, V106, P136, DOI 10.1016/S0169-328X(02)00420-5; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Skelton LA, 2010, J NEPHROL, V23, pS4; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Sun XM, 2015, AM J PHYSIOL-RENAL, V309, pF120, DOI 10.1152/ajprenal.00507.2014; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tokonami N, 2013, J CLIN INVEST, V123, P3166, DOI 10.1172/JCI67562; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Weiner ID, 2017, PHYSIOL REV, V97, P465, DOI 10.1152/physrev.00011.2016; Wu C, 2015, INT J BIOCHEM CELL B, V64, P75, DOI 10.1016/j.biocel.2015.03.008; Xu JS, 2005, AM J RESP CELL MOL, V32, P381, DOI 10.1165/rcmb.2004-0343OC	66	10	10	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2046	2059		10.1096/fj.201700610RR	http://dx.doi.org/10.1096/fj.201700610RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196502	Green Published			2022-12-26	WOS:000429051400026
J	Peixoto, AS; Geyer, RR; Iqbal, A; Truzzi, DR; Soares Moretti, AI; Laurindo, FRM; Augusto, O				Peixoto, Albert Souza; Ryan Geyer, R.; Iqbal, Asif; Truzzi, Daniela R.; Soares Moretti, Ana I.; Laurindo, Francisco R. M.; Augusto, Ohara			Peroxynitrite preferentially oxidizes the dithiol redox motifs of protein-disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inactivation; hydrogen peroxide; kinetics; protein aggregation; protein disulfide isomerase; peroxynitrite; protein nitration; thiol oxidation	AMYOTROPHIC-LATERAL-SCLEROSIS; CARBONATE RADICAL-ANION; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; SUPEROXIDE-DISMUTASE; PEROXIDASE-ACTIVITY; TYROSINE NITRATION; HYDROGEN-PEROXIDE; OXIDATION; GLUTATHIONE	Protein-disulfide isomerase (PDI) is a ubiquitous dithiol-disulfide oxidoreductase that performs an array of cellular functions, such as cellular signaling and responses to cell-damaging events. PDI can become dysfunctional by post-translational modifications, including those promoted by biological oxidants, and its dysfunction has been associated with several diseases in which oxidative stress plays a role. Because the kinetics and products of the reaction of these oxidants with PDI remain incompletely characterized, we investigated the reaction of PDI with the biological oxidant peroxynitrite. First, by determining the rate constant of the oxidation of PDI's redox-active Cys residues (Cys(53) and Cys(397)) by hydrogen peroxide (k = 17.3 +/- 1.3 m(-1) s(-1) at pH 7.4 and 25 degrees C), we established that the measured decay of the intrinsic PDI fluorescence is appropriate for kinetic studies. The reaction of these PDI residues with peroxynitrite was considerably faster (k = (6.9 +/- 0.2) x 10(4) m(-1) s(-1)), and both Cys residues were kinetically indistinguishable. Limited proteolysis, kinetic simulations, and MS analyses confirmed that peroxynitrite preferentially oxidizes the redox-active Cys residues of PDI to the corresponding sulfenic acids, which reacted with the resolving thiols at the active sites to produce disulfides (i.e. Cys(53)-Cys(56) and Cys(397)-Cys(400)). A fraction of peroxynitrite, however, decayed to radicals that hydroxylated and nitrated other active-site residues (Trp(52), Trp(396), and Tyr(393)). Excess peroxynitrite promoted further PDI oxidation, nitration, inactivation, and covalent oligomerization. We conclude that these PDI modifications may contribute to the pathogenic mechanism of several diseases associated with dysfunctional PDI.	[Peixoto, Albert Souza; Ryan Geyer, R.; Iqbal, Asif; Truzzi, Daniela R.; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, Ave Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil; [Soares Moretti, Ana I.; Laurindo, Francisco R. M.] Univ Sao Paulo, Heart Inst InCor, Sch Med, Vasc Biol Lab, BR-05403000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Ave Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Augusto, Ohara/D-3839-2012; Peixoto, Álbert Souza/E-4532-2018; moretti, ana IS/J-9064-2012; Truzzi, Daniela R/B-2540-2014	Augusto, Ohara/0000-0002-7220-4286; Peixoto, Álbert Souza/0000-0002-7234-7252; moretti, ana IS/0000-0003-3402-5778; Truzzi, Daniela R/0000-0003-4421-9621	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57721-3, 2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) [573530/2008-4]; Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant [2011.1.9352.1.8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant; Conselho Nacional de Desenvolvimento Cientifico Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2008/57721-3 and 2013/07937-8, Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) Grant 573530/2008-4, and Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant 2011.1.9352.1.8. The authors are members of Nucleo de Apoio a Pesquisa (NAP) Redoxoma (PRPUSP) and the Research, Innovation and Dissemination Center (RIDC) Redoxoma (FAPESP). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of scholarships from Conselho Nacional de Desenvolvimento Cientifico Tecnologico.; Recipients of scholarships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Annibal A, 2016, J CHROMATOGR B, V1019, P147, DOI 10.1016/j.jchromb.2015.12.022; Araujo TLS, 2017, REDOX BIOL, V12, P1004, DOI 10.1016/j.redox.2017.04.034; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Davies MJ, 2016, BIOCHEM J, V473, P805, DOI 10.1042/BJ20151227; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; de Menezes SL, 2001, J BIOL CHEM, V276, P39879, DOI 10.1074/jbc.M104012200; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Dost B, 2012, J COMPUT BIOL, V19, P337, DOI 10.1089/cmb.2009.0267; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Genaro-Mattos TC, 2015, BIOCHEMISTRY-US, V54, P2841, DOI 10.1021/bi501409d; Gonzalez-Perilli L, 2017, BBA-GEN SUBJECTS, V1861, P1131, DOI 10.1016/j.bbagen.2017.02.013; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Iqbal A, 2014, ARCH BIOCHEM BIOPHYS, V557, P72, DOI 10.1016/j.abb.2014.06.013; Kaetzel RS, 2004, ARCH BIOCHEM BIOPHYS, V423, P136, DOI 10.1016/j.abb.2003.10.016; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P1815, DOI 10.1089/ars.2007.1624; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Karimi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38572; Khan MMG, 2011, ONCOL RES, V19, P445, DOI 10.3727/096504011X13123323849717; Kim HT, 2000, ANTIOXID REDOX SIGN, V2, P485, DOI 10.1089/15230860050192260; Kozarova A, 2007, J AM SOC MASS SPECTR, V18, P260, DOI 10.1016/j.jasms.2006.09.023; Lappi AK, 2011, J MOL BIOL, V409, P238, DOI 10.1016/j.jmb.2011.03.024; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Marshall A, 2013, BIOCHEM BIOPH RES CO, V430, P231, DOI 10.1016/j.bbrc.2012.10.142; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parakh S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00030; Pescatore LA, 2012, J BIOL CHEM, V287, P29290, DOI 10.1074/jbc.M112.394551; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Santos CXC, 2000, ARCH BIOCHEM BIOPHYS, V377, P146, DOI 10.1006/abbi.2000.1751; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Tanaka LY, 2017, FREE RADICAL BIO MED, V109, P11, DOI 10.1016/j.freeradbiomed.2017.01.025; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Vattemi G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002964; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	70	13	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1450	1465		10.1074/jbc.M117.807016	http://dx.doi.org/10.1074/jbc.M117.807016			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191937	hybrid, Green Published			2022-12-26	WOS:000423515000029
J	Fuchs, ACD; Maldoner, L; Hipp, K; Hartmann, MD; Martin, J				Fuchs, Adrian C. D.; Maldoner, Lorena; Hipp, Katharina; Hartmann, Marcus D.; Martin, Joerg			Structural characterization of the bacterial proteasome homolog BPH reveals a tetradecameric double-ring complex with unique inner cavity properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; OXIDATIVE STRESS; HEAT-SHOCK; OXIDIZED PROTEINS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DEGRADATION; ACTIVATION; SEQUENCE	Eukaryotic and archaeal proteasomes are paradigms for self-compartmentalizing proteases. To a large extent, their function requires interplay with hexameric ATPases associated with diverse cellular activities(AAA+) that act as substrate unfoldases. Bacteria have various types of self-compartmentalizing proteases; in addition to the proteasome itself, these include the proteasome homolog HslV, which functions together with the AAA+ HslU; the ClpP protease with its partner AAA+ ClpX; and Anbu, a recently characterized ancestral proteasome variant. Previous bioinformatic analysis has revealed a novel bacterial member of the proteasome family Betaproteobacteria proteasome homolog (BPH). Using cluster analysis, we here affirmed that BPH evolutionarily descends from HslV. Crystal structures of the Thiobacillus denitrificans and Cupriavidus metallidurans BPHs disclosed a homo-oligomeric double-ring architecture in which the active sites face the interior of the cylinder. Using small-angle X-ray scattering (SAXS) and electron microscopy averaging, we found that BPH forms tetra-decamers in solution, unlike the dodecamers seen in HslV. Although the highly acidic inner surface of BPH was in striking contrast to the cavity characteristics of the proteasome and HslV, a classical proteasomal reaction mechanism could be inferred from the covalent binding of the proteasome-specific inhibitor epoxomicin to BPH. A ligand-bound structure implied that the elongated BPH inner pore loop may be involved in substrate recognition. The apparent lack of a partner unfoldase and other unique features, such as Ser replacing Thr as the catalytic residue in certain BPH subfamilies, suggest a proteolytic function for BPH distinct from those of known bacterial self-compartmentalizing proteases.	[Fuchs, Adrian C. D.; Maldoner, Lorena; Hartmann, Marcus D.; Martin, Joerg] Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany; [Hipp, Katharina] Max Planck Inst Dev Biol, Electron Microscopy Facil, Spemannstr 35, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Hartmann, MD; Martin, J (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	marcus.hartmann@tuebingen.mpg.de; joerg.martin@tuebingen.mpg.de	Hartmann, Marcus/L-8759-2019	Hartmann, Marcus/0000-0001-6937-5677	European Community's Seventh Framework Programme under BioStruct-X [283570]; Max Planck Society	European Community's Seventh Framework Programme under BioStruct-X; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant Agreement 283570). This work was further supported by institutional funds from the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Campbell MG, 2015, ELIFE, V4, DOI 10.7554/eLife.06380; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; De Mot R, 2007, TRENDS MICROBIOL, V15, P335, DOI 10.1016/j.tim.2007.06.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouzan D, 2012, J BIOL CHEM, V287, P39254, DOI 10.1074/jbc.M112.386458; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fuchs ACD, 2017, STRUCTURE, V25, P834, DOI 10.1016/j.str.2017.04.005; Gersch M, 2016, ACS CHEM BIOL, V11, P389, DOI 10.1021/acschembio.5b00757; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Huber EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10900; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Jastrab JB, 2015, ANNU REV MICROBIOL, V69, P109, DOI 10.1146/annurev-micro-091014-104201; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Knight WE, 2016, P NATL ACAD SCI USA, V113, pE7116, DOI 10.1073/pnas.1607728113; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001; Rho SH, 2008, PROTEINS, V71, P1020, DOI 10.1002/prot.21758; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valas RE, 2008, J MOL EVOL, V66, P494, DOI 10.1007/s00239-008-9075-7; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; YAMADA S, 1995, J BIOCHEM, V117, P1162, DOI 10.1093/oxfordjournals.jbchem.a124839; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9	53	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					920	930		10.1074/jbc.M117.815258	http://dx.doi.org/10.1074/jbc.M117.815258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29183996	hybrid, Green Published			2022-12-26	WOS:000422864500013
J	Gonzalez, E; Johnson, KM; Pallan, PS; Phan, TTN; Zhang, W; Lei, L; Wawrzak, Z; Yoshimoto, FK; Egli, M; Guengerich, FP				Gonzalez, Eric; Johnson, Kevin M.; Pallan, Pradeep S.; Phan, Thanh T. N.; Zhang, Wei; Lei, Li; Wawrzak, Zdzislaw; Yoshimoto, Francis K.; Egli, Martin; Guengerich, F. Peter			Inherent steroid 17,20-lyase activity in defunct cytochrome P450 17A enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomimetic models	C-13 NMR-SPECTRA; ANDROGEN FORMATION; ADRENAL-CORTEX; SIDE-CHAIN; P450C17; BIOSYNTHESIS; PROGESTERONE; CYP17; HYDROXYLATION; B(5)	Cytochrome P450 (P450) 17A1 catalyzes the oxidations of progesterone and pregnenolone and is the major source of androgens. The enzyme catalyzes both 17-hydroxylation and a subsequent 17,20-lyase reaction, and several mechanisms have been proposed for the latter step. Zebrafish P450 17A2 catalyzes only the 17-hydroxylations. We previously reported high similarity of the crystal structures of zebrafish P450 17A1 and 17A2 and human P450 17A1. Five residues near the heme, which differed, were changed. We also crystallized this five-residue zebrafish P450 17A1 mutant, and the active site still resembled the structure in the other proteins, with some important differences. These P450 17A1 and 17A2 mutants had catalytic profiles more similar to each other than did the wildtype proteins. Docking with these structures can explain several minor products, which require multiple enzyme conformations. The 17-hydroperoxy (OOH) derivatives of the steroids were used as oxygen surrogates. Human P450 17A1 and zebrafish P450s 17A1 and P450 17A2 readily converted these to the lyase products in the absence of other proteins or cofactors (with catalytically competent kinetics) plus hydroxylated 17-hydroxysteroids. The 17-OOH results indicate that a Compound I (FeO3+) intermediate is capable of formation and can be used to rationalize the products. We conclude that zebrafish P450 17A2 is capable of lyase activity with the 17-OOH steroids because it can achieve an appropriate conformation for lyase catalysis in this system that is precluded in the conventional reaction.	[Gonzalez, Eric; Johnson, Kevin M.; Pallan, Pradeep S.; Phan, Thanh T. N.; Zhang, Wei; Lei, Li; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Argonne Natl Lab, Adv Photon Source, Life Sci Collaborat Access Team, Sect 21, Argonne, IL 60439 USA; [Yoshimoto, Francis K.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Johnson, Kevin M.] Genentech Inc, Dept Drug Metab & Pharmacokinet, 1 DNA Way, San Francisco, CA 94080 USA; [Zhang, Wei] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, 189 Songling Rd, Qingdao 266000, Shandong, Peoples R China	Vanderbilt University; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas at San Antonio (UTSA); Roche Holding; Genentech; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999; Zhang, Wei/0000-0001-9459-680X	National Institutes of Health [R01 GM118122, R01 GM103937, T32 ES007028]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122, R25GM062459, R01GM103937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.), R01 GM103937 (to M. E. and F. P. G.), and T32 ES007028 (to E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BAILEY EJ, 1962, J CHEM SOC, P1578, DOI 10.1039/jr9620001578; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETANCOR C, 1988, J CHEM SOC CHEM COMM, P947, DOI 10.1039/c39880000947; Bonomo S, 2017, J CHEM INF MODEL, V57, P1123, DOI 10.1021/acs.jcim.6b00759; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FALARDEAU P, 1974, J LABELLED COMPD, V10, P239, DOI 10.1002/jlcr.2590100208; FISCHER RT, 1991, J BIOL CHEM, V266, P6124; GARDNER JN, 1968, J ORG CHEM, V33, P3294, DOI 10.1021/jo01272a055; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; KADLUBAR FF, 1973, BIOCHEM BIOPH RES CO, V54, P1255, DOI 10.1016/0006-291X(73)91122-4; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; KOBAYASHI Y, 1993, BIOL PHARM BULL, V16, P1175; KOPECKY KR, 1969, CAN J CHEMISTRY, V47, P709, DOI 10.1139/v69-114; Korde SS, 1999, MAGN RESON CHEM, V37, P594, DOI 10.1002/(SICI)1097-458X(199908)37:8<594::AID-MRC484>3.0.CO;2-J; Lei L., 2016, CURR PROTOC PROTEIN, V84, DOI [10.1002/0471140864.ps2916s84, DOI 10.1002/0471140864.PS2916S8427038268]; MAK AY, 1992, J AM CHEM SOC, V114, P8309, DOI 10.1021/ja00047a063; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; MANSUY D, 1982, TETRAHEDRON LETT, V23, P2781, DOI 10.1016/S0040-4039(00)87457-2; Mapes S, 1999, J CLIN ENDOCR METAB, V84, P3382, DOI 10.1210/jc.84.9.3382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER SL, 1991, J CHEM SOC CHEM COMM, P157, DOI 10.1039/c39910000157; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Njar VCO, 1999, CURR PHARM DESIGN, V5, P163; Njar VCO, 2015, J MED CHEM, V58, P2077, DOI 10.1021/jm501239f; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; RICHARDS.WH, 1974, J AM CHEM SOC, V96, P6652, DOI 10.1021/ja00828a018; Suzuki T, 2000, CLIN ENDOCRINOL, V53, P739, DOI 10.1046/j.1365-2265.2000.01144.x; SWERN D, 1969, ANAL CHEM, V41, P412, DOI 10.1021/ac60272a038; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; SZENDI Z, 1995, STEROIDS, V60, P442, DOI 10.1016/0039-128X(94)00047-G; TAN L, 1975, HORM RES, V6, P213, DOI 10.1159/000178695; TAN L, 1975, BIOCHEM BIOPH RES CO, V65, P1320, DOI 10.1016/S0006-291X(75)80374-3; TAN L, 1972, BIOCHIM BIOPHYS ACTA, V260, P731, DOI 10.1016/0005-2760(72)90022-7; Turcu AF, 2015, J CLIN ENDOCR METAB, V100, P2283, DOI 10.1210/jc.2015-1023; Van Den Akker ELT, 2002, J CLIN ENDOCR METAB, V87, P5714, DOI 10.1210/jc.2001-011880; Wang CX, 2017, J BIOL CHEM, V292, P10767, DOI 10.1074/jbc.M117.792465; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	70	20	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					541	556		10.1074/jbc.RA117.000504	http://dx.doi.org/10.1074/jbc.RA117.000504			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29212707	Green Published, hybrid			2022-12-26	WOS:000419915400011
J	Ottoy, J; Verhaeghe, J; Niemantsverdriet, E; Engelborghs, S; Stroobants, S; Staelens, S				Ottoy, Julie; Verhaeghe, Jeroen; Niemantsverdriet, Ellis; Engelborghs, Sebastiaan; Stroobants, Sigrid; Staelens, Steven			A simulation study on the impact of the blood flow-dependent component in [F-18]AV45 SUVR in Alzheimer's disease	PLOS ONE			English	Article							WHITE-MATTER REFERENCE; AMYLOID PET; REFERENCE REGION; BETA; QUANTIFICATION; RADIOTRACERS; ASSOCIATION; METABOLISM; PERFUSION; DEMENTIA	Background Increased brain uptake on [F-18]AV45 PET is a biomarker for Alzheimer's disease (AD). The standardised uptake value ratio (SUVR) is widely used for quantification but is subject to variability. Here we evaluate how SUVR of a cortical target region is affected by blood flow changes in the target and two frequently used reference regions. Methods Regional baseline time-activity curves (TACs) were simulated based on metabolite-corrected plasma input functions and pharmacokinetic parameters obtained from our previously acquired data in healthy control (HC; n = 10), amnestic mild cognitive impairment (aMCI; n = 15) and AD cohorts (n = 9). Blood flow changes were simulated by altering the regional tracer delivery rate K1 (and clearance rate k2) between -40% and +40% from its regional baseline value in the target region and/or cerebellar grey (CB) or subcortical white matter (WM) reference regions. The corresponding change in SUVR was calculated at 50-60 min post-injection. Results A -40% blood flow reduction in the target resulted in an increased SUVRtarget (e.g. SUVRprecuneus: +10.0 +/- 5% in HC, +2.5 +/- 2% in AD), irrespective of the used reference region. A -40% blood flow reduction in the WM reference region increased SUVRWM (+11.5 +/- 4% in HC, +13.5 +/- 3% in AD) while a blood flow reduction in CB decreased SUVRCB (-9.5 +/- 6% in HC, -5.5 +/- 2% in AD), irrespective of the used target region. A -40% flow reduction in both the precuneus and reference WM (i.e., global flow change) induced an increased SUVR (+22.5 +/- 8% in HC, +16.0 +/- 4% in AD). When considering reference CB instead, SUVR was decreased by less than -5% (both in HC and AD). Conclusion Blood flow changes introduce alterations in [F-18]AV45 PET SUVR. Flow reductions in the CB and WM reference regions resulted in a decreased and increased SUVR of the target, respectively. SUVR was more affected by global blood flow changes when considering WM instead of CB normalization.	[Ottoy, Julie; Verhaeghe, Jeroen; Staelens, Steven] Univ Antwerp, Mol Imaging Ctr Antwerp, Antwerp, Belgium; [Niemantsverdriet, Ellis; Engelborghs, Sebastiaan] Univ Antwerp, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Hoge Beuken & Middelheim, Dept Neurol, Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Hoge Beuken & Middelheim, Memory Clin, Antwerp, Belgium; [Stroobants, Sigrid] Antwerp Univ Hosp, Dept Nucl Med, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Staelens, S (corresponding author), Univ Antwerp, Mol Imaging Ctr Antwerp, Antwerp, Belgium.	steven.staelens@uantwerpen.be	Verhaeghe, Jeroen/I-1539-2016; Staelens, Steven/D-8385-2017	Verhaeghe, Jeroen/0000-0002-4493-1902; Staelens, Steven/0000-0003-3376-0519; Niemantsverdriet, Ellis/0000-0002-5781-3817; Stroobants, Sigrid/0000-0002-6450-9944; Ottoy, Julie/0000-0002-9879-7497	IWT TGO BIOADAPTAD; University of Antwerp; University Hospital [120835 A14/0161]; University Hospital Antwerp; Institute Born-Bunge (IBB); Flanders Impulse Program on Networks for Dementia Research (VIND)	IWT TGO BIOADAPTAD; University of Antwerp; University Hospital; University Hospital Antwerp; Institute Born-Bunge (IBB); Flanders Impulse Program on Networks for Dementia Research (VIND)	This study was in part funded by IWT TGO BIOADAPTAD and by the University of Antwerp and its University Hospital, under grant agreement no 120835 A14/0161; University Hospital Antwerp; the University of Antwerp Research Fund; the Institute Born-Bunge (IBB, www.bornbunge.be); and the Flanders Impulse Program on Networks for Dementia Research (VIND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegret M, 2012, J ALZHEIMERS DIS, V30, P109, DOI 10.3233/JAD-2012-111850; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Barker R, 2014, BRAIN, V137, P1524, DOI 10.1093/brain/awu040; Becker GA, 2013, J NUCL MED, V54, P723, DOI 10.2967/jnumed.112.107185; Blautzik J, 2017, EUR J NUCL MED MOL I, V44, P1364, DOI 10.1007/s00259-017-3666-8; BRAAK H, 1989, J NEUROL SCI, V93, P277, DOI 10.1016/0022-510X(89)90197-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Brendel M, 2015, NEUROIMAGE, V108, P450, DOI 10.1016/j.neuroimage.2014.11.055; CARSON R E, 1986, P347; Catafau AM, 2015, CLIN TRANSL IMAGING, V3, P39, DOI 10.1007/s40336-014-0098-3; Chen KW, 2015, J NUCL MED, V56, P560, DOI 10.2967/jnumed.114.149732; Chen YJ, 2015, J NUCL MED, V56, P1199, DOI 10.2967/jnumed.114.152405; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Cselenyi Z, 2015, J CEREBR BLOOD F MET, V35, P1485, DOI 10.1038/jcbfm.2015.66; Fleisher AS, 2017, ALZHEIMERS DEMENT, V13, P1117, DOI 10.1016/j.jalz.2017.02.009; Hauser T, 2013, ACAD RADIOL, V20, P705, DOI 10.1016/j.acra.2013.01.020; Ishii K, 1997, J NUCL MED, V38, P925; Lacalle-Aurioles M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081548; Landau SM, 2014, EUR J NUCL MED MOL I, V41, P1398, DOI 10.1007/s00259-014-2753-3; Landau SM, 2015, J NUCL MED, V56, P567, DOI 10.2967/jnumed.114.148981; Lehtovirta M, 1998, J NEUROL NEUROSUR PS, V64, P742, DOI 10.1136/jnnp.64.6.742; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Ossenkoppele R, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/1758-9193-5-36, 10.1186/alzrt195]; Ottoy J, 2017, J NUCL MED, V58, P1483, DOI 10.2967/jnumed.116.184481; Schwarz CG, 2017, NEUROIMAGE, V144, P113, DOI 10.1016/j.neuroimage.2016.08.056; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shokouhi S, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0172-3; Slifstein M, 2001, NUCL MED BIOL, V28, P595, DOI 10.1016/S0969-8051(01)00214-1; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; van Berckel BNM, 2013, J NUCL MED, V54, P1570, DOI 10.2967/jnumed.112.113654; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Yamaji S, 1997, J NUCL MED, V38, P1471; Yang L., 2012, NEW ENGL J MED, V363, P1	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189155	10.1371/journal.pone.0189155	http://dx.doi.org/10.1371/journal.pone.0189155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211812	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200070
J	Gastelum, G; Poteshkina, A; Veena, M; Artiga, E; Weckstein, G; Frost, P				Gastelum, Gilberto; Poteshkina, Aleksandra; Veena, Mysore; Artiga, Edgar; Weckstein, Geraldine; Frost, Patrick			Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2 alpha expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis	PLOS ONE			English	Article							MULTIPLE-MYELOMA; IN-VIVO; MAMMALIAN TARGET; VEGF EXPRESSION; INHIBITORS; ANGIOGENESIS; RAPAMYCIN; GROWTH; PHD3; HIF-1-ALPHA	Multiple myeloma (MM) is an incurable disease of malignant plasma B-cells that infiltrate the bone marrow (BM), resulting in bone destruction, anemia, renal impairment and infections. Physiologically, the BM microenvironment is hypoxic and this promotes MM progression and contributes to resistance to chemotherapy. Since aberrant hypoxic responses may result in the selection of more aggressive tumor phenotypes, we hypothesized that targeting the hypoxia-inducible factor (HIF) pathways will be an effective anti-MM therapeutic strategy. We demonstrated that MM cells are resistant to hypoxia-mediated apoptosis in vivo and in vitro, and that constitutive expression of HIF2 alpha contributed to this resistance. Since epigenetic silencing of the prolyl-hydroxylase-domain-3 (PHD3) enzyme responsible for the O-2-dependent regulation of HIF2 alpha is frequently observed in MM tumors, we asked if PHD3 plays a role in regulating sensitivity to hypoxia. We found that restoring PHD3 expression using a lentivirus vector or overcoming PHD3 epigenetic silencing using a demethyltransferase inhibitor, 5-Aza-2'-deoxycytidine (5-Aza-dC), rescued O-2-dependent regulation of HIF2a and restored sensitivity of MM cells to hypoxia-mediated apoptosis. This provides a rationale for targeting the PHD3-mediated regulation of the adaptive cellular hypoxic response in MM and suggests that targeting the O-2-sensing pathway, alone or in combination with other anti-myeloma chemotherapeutics, may have clinical efficacy.	[Gastelum, Gilberto; Poteshkina, Aleksandra; Veena, Mysore; Artiga, Edgar; Weckstein, Geraldine; Frost, Patrick] Greater Los Angeles Vet Adm Healthcare Syst, Dept Hematol Oncol, Los Angeles, CA 90073 USA; [Veena, Mysore; Frost, Patrick] Univ Calif Los Angeles, Dept Hematol Oncol, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Frost, P (corresponding author), Greater Los Angeles Vet Adm Healthcare Syst, Dept Hematol Oncol, Los Angeles, CA 90073 USA.; Frost, P (corresponding author), Univ Calif Los Angeles, Dept Hematol Oncol, Los Angeles, CA 90095 USA.	Patrick.Frost@va.gov		Frost, Patrick/0000-0003-3348-5983	MERIT grant from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [1I01BX001532]	MERIT grant from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service	This work was supported by a MERIT grant 1I01BX001532 to PF, from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service.	Asosingh K, 2005, HAEMATOLOGICA, V90, P810; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Erez N, 2003, CANCER RES, V63, P8777; Frost P, 2007, ONCOGENE, V26, P2255, DOI 10.1038/sj.onc.1210019; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Frost P, 2013, J ONCOL, V2013, DOI 10.1155/2013/897025; Frost P, 2009, MOL CANCER THER, V8, P83, DOI 10.1158/1535-7163.MCT-08-0254; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hu JS, 2013, MOL CANCER THER, V12, P1763, DOI 10.1158/1535-7163.MCT-13-0123; Hu YZ, 2009, MOL CANCER THER, V8, P2329, DOI 10.1158/1535-7163.MCT-09-0150; Iriondo O, 2015, ONCOTARGET, V6, P31721, DOI 10.18632/oncotarget.5564; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Khong T, 2008, HAEMATOLOGICA, V93, P860, DOI 10.3324/haematol.12261; Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Maiso P, 2015, CANCER RES, V75, P2071, DOI 10.1158/0008-5472.CAN-14-3400; Mysore VS, 2016, MOL CANCER RES, V14, P253, DOI 10.1158/1541-7786.MCR-15-0361; Nakazawa MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10539; Place TL, 2013, HYPOXIA, V1, P13, DOI 10.2147/HP.S50091; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Radhakrishnan P, 2016, CANCER RES, V76, P2219, DOI 10.1158/0008-5472.CAN-15-1474; Rajkumar SV, 2000, CLIN CANCER RES, V6, P3111; Sciorra VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040053; Shah R, 2007, BLOOD, V110, p635A, DOI 10.1182/blood.V110.11.2132.2132; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Szablowski JO, 2015, MOL CANC THER; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zhong H, 1999, CANCER RES, V59, P5830	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188438	10.1371/journal.pone.0188438	http://dx.doi.org/10.1371/journal.pone.0188438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206844	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700011
J	Shang, LN; Chen, TT; Deng, YF; Huang, YY; Huang, YH; Xian, J; Lu, WS; Yang, LH; Huang, Q				Shang, Lina; Chen, Tingting; Deng, Yufeng; Huang, Yiyuan; Huang, Yuanheng; Xian, Jing; Lu, Wensheng; Yang, Lihui; Huang, Qin			Caveolin-3 promotes glycometabolism, growth and proliferation in muscle cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; GLUCOSE; MICE; HYPERTROPHY; METABOLISM; DISEASE; RATS	Objective Caveolin-3 (CAV3) protein is known to be expressed specifically in various myocytes, but its physiological function remains unclear. CAV3, located at the cell membrane, may promote the sensitivity of the Akt signaling pathway, which is closely related to glucose metabolism and to cell growth and proliferation. Methods The CAV3 gene was stably transfected into C2C12 muscle cells, and the effects were evaluated by biochemical assays, WB and confocal microscopy for the observation of cellular glucose metabolism, growth and proliferation, and the effect of CAV3 on the Akt signaling pathway with no insulin stimulation. Results After C2C12 cells were transfected with the mouse CAV3 gene, which increased CAV3 expression, the abundance of the CAV3 and GLUT4 proteins on the cell membrane increased, but the total GLUT4 protein content of the cell was unchanged. Glucose uptake was increased, and this did not affect the glycogen synthesis, but the cell surface area and cell proliferation increased. While there were significant increases in p-Akt and p-p70s6K, which is a downstream component of Akt signaling, the level of GSK3 beta protein, another component of Akt signaling did not change. Conclusions The muscle, CAV3 protein can activate Akt signaling, increase GLUT4 protein localization in the cell membrane, increase glucose uptake, and promote myocyte growth and proliferation. CAV3 protein has a physiological role in glycometabolism, growth and proliferation, independent of insulin stimulation.	[Shang, Lina; Chen, Tingting; Deng, Yufeng; Huang, Yiyuan; Huang, Yuanheng; Yang, Lihui; Huang, Qin] Guangxi Med Univ, Sch Basic Med Sci, Dept Physiol, Nanning, Guangxi, Peoples R China; [Xian, Jing] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Guangxi, Peoples R China; [Lu, Wensheng] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Huang, Q (corresponding author), Guangxi Med Univ, Sch Basic Med Sci, Dept Physiol, Nanning, Guangxi, Peoples R China.	hqgxmu@163.com	Lu, Wen-sheng/AAW-7161-2021	lu, wensheng/0000-0003-4179-1171	National Natural Science Foundation of China [8166090188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No.8166090188).	BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Deng YF, 2017, BIOCHEM BIOPH RES CO, V486, P218, DOI 10.1016/j.bbrc.2017.02.072; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Feng WW, 2015, J DIABETES INVEST, V6, P396, DOI 10.1111/jdi.12350; Gazzerro E, 2011, Handb Clin Neurol, V101, P135, DOI 10.1016/B978-0-08-045031-5.00010-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Ishikawa Y, 2005, CELL SIGNAL, V17, P1175, DOI 10.1016/j.cellsig.2005.03.025; Kim HS, 2009, EUR J APPL PHYSIOL, V106, P173, DOI 10.1007/s00421-009-1001-1; Li Z, 2017, AM J PHYSL ENDOCRINO; Luo J, 2017, BRIT J PHARM; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Park CH, 2016, MOL CELL BIOCHEM, V422, P151, DOI 10.1007/s11010-016-2814-y; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Sashidhara KV, 2014, EUR J MED CHEM, V86, P570, DOI 10.1016/j.ejmech.2014.09.015; Sassi AH, 2012, J PHYSIOL BIOCHEM, V68, P683, DOI 10.1007/s13105-012-0192-9; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Scherer PE, 1997, J BIOL CHEM, V272, P20698, DOI 10.1074/jbc.272.33.20698; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sotgia F, 2003, AM J PATHOL, V163, P2619, DOI 10.1016/S0002-9440(10)63616-4; Stoppani E, 2011, BBA-MOL BASIS DIS, V1812, P468, DOI 10.1016/j.bbadis.2010.12.005; Tan Z, 2012, J NUTR BIOCHEM, V23, P1716, DOI 10.1016/j.jnutbio.2011.12.003; Visvanathan R, 2016, FOOD CHEM, V211, P853, DOI 10.1016/j.foodchem.2016.05.090; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189004	10.1371/journal.pone.0189004	http://dx.doi.org/10.1371/journal.pone.0189004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206848	Green Published, gold, Green Submitted			2022-12-26	WOS:000417110700039
J	Sundstrom, L; Myhre, S; Sundqvist, M; Ahnmark, A; McCoull, W; Raubo, P; Groombridge, SD; Polla, M; Nystrom, AC; Kristensson, L; Nagard, M; Winzell, MS				Sundstrom, Linda; Myhre, Susanna; Sundqvist, Monika; Ahnmark, Andrea; McCoull, William; Raubo, Piotr; Groombridge, Sam D.; Polla, Magnus; Nystrom, Ann-Christin; Kristensson, Lisbeth; Nagard, Mats; Winzell, Maria Sorhede			The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1	PLOS ONE			English	Article							COUPLED RECEPTOR 120; CHAIN FATTY-ACIDS; SECRETION; AGONISTS; OBESITY; POTENT; CELLS; IDENTIFICATION; PHARMACOLOGY; HOMEOSTASIS	The mechanism behind the glucose lowering effect occurring after specific activation of GPR120 is not completely understood. In this study, a potent and selective GPR120 agonist was developed and its pharmacological properties were compared with the previously described GPR120 agonist Metabolex-36. Effects of both compounds on signaling pathways and GLP-1 secretion were investigated in vitro. The acute glucose lowering effect was studied in lean wild-type and GPR120 null mice following oral or intravenous glucose tolerance tests. In vitro, in GPR120 overexpressing cells, both agonists signaled through G alpha(q), G alpha(s) and the beta-arrestin pathway. However, in mouse islets the signaling pathway was different since the agonists reduced cAMP production. The GPR120 agonists stimulated GLP-1 secretion both in vitro in STC-1 cells and in vivo following oral administration. In vivo GPR120 activation induced significant glucose lowering and increased insulin secretion after intravenous glucose administration in lean mice, while the agonists had no effect in GPR120 null mice. Exendin 9-39, a GLP-1 receptor antagonist, abolished the GPR120 induced effects on glucose and insulin following an intravenous glucose challenge. In conclusion, GLP-1 secretion is an important mechanism behind the acute glucose lowering effect following specific GPR120 activation.	[Sundstrom, Linda; Kristensson, Lisbeth] AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden; [Myhre, Susanna; Sundqvist, Monika; Ahnmark, Andrea; Polla, Magnus; Nystrom, Ann-Christin; Nagard, Mats; Winzell, Maria Sorhede] AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden; [McCoull, William; Raubo, Piotr; Groombridge, Sam D.] AstraZeneca, IMED Biotech Unit, Med Chem, Alderley Pk, Macclesfield, Cheshire, England	AstraZeneca; AstraZeneca; AstraZeneca	Winzell, MS (corresponding author), AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden.	Maria.Sorhede-Winzell@astrazeneca.com		Sundstrom, Linda/0000-0002-3620-1467	AstraZeneca	AstraZeneca(AstraZeneca)	The present study was funded by AstraZeneca. The funder provided support in the form of salaries for all authors [LS, SM, MS, AA, WM, PR, SDG, MP, CAN, LK, MN, MSW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams GL, 2017, ACS MED CHEM LETT, V8, P96, DOI 10.1021/acsmedchemlett.6b00394; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anbazhagan AN, 2016, AM J PHYSIOL-CELL PH, V310, pC612, DOI 10.1152/ajpcell.00123.2015; [Anonymous], International patent, Patent No. [WO 2020/048207, 2020048207]; Azevedo CMG, 2016, J MED CHEM, V59, P8868, DOI 10.1021/acs.jmedchem.6b00685; Bjursell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114942; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Chambers AP, 2017, CELL METAB, V25, P927, DOI 10.1016/j.cmet.2017.02.008; Cox JM, 2017, ACS MED CHEM LETT, V8, P49, DOI 10.1021/acsmedchemlett.6b00360; Dusaulcy R, 2016, ENDOCRINOLOGY, V157, P536, DOI 10.1210/en.2015-1725; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Gabrielsson J, 2015, EUR J PHARM SCI, V67, P144, DOI 10.1016/j.ejps.2014.11.006; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday ND, 2012, FRONT ENDOCRINOL, V2, P112, DOI DOI 10.3389/FEND0.2011.00112; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hudson BD, 2013, MOL ENDOCRINOL, V27, P1177, DOI 10.1210/me.2013-1085; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li A, 2015, FUTURE MED CHEM, V7, P2429, DOI 10.4155/fmc.15.160; Liu HD, 2015, EUR J PHARMACOL, V763, P160, DOI 10.1016/j.ejphar.2015.06.028; Ma J, [No title captured], Patent No. [WO 2010/048207, 2010048207]; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; Mo XL, 2013, PROG MOL BIOL TRANSL, V114, P251, DOI 10.1016/B978-0-12-386933-3.00007-8; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Nauck MA, 2003, DRUG NEWS PERSPECT, V16, P413, DOI 10.1358/dnp.2003.16.7.829353; Nauck MA, 2016, DIABETES, V65, P2440, DOI 10.2337/db16-0107; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paulsen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088227; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sparks SM, 2017, BIOORG MED CHEM LETT, V27, P1278, DOI 10.1016/j.bmcl.2017.01.034; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Suckow AT, 2014, J BIOL CHEM, V289, P15751, DOI 10.1074/jbc.M114.568683; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Tanagho PA, 2016, ENDOCR METAB IMMUNE, V16, P8, DOI 10.2174/1871530316666151123115611; Tsukahara T, 2015, AM J PATHOL, V185, P185, DOI 10.1016/j.ajpath.2014.09.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009	52	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189060	10.1371/journal.pone.0189060	http://dx.doi.org/10.1371/journal.pone.0189060			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206860	Green Published, Green Submitted, gold			2022-12-26	WOS:000417110700042
J	Abe, S; Abe, K; Zhang, JD; Harada, T; Mizumoto, G; Oshikawa, H; Akiyama, H; Shimamura, K				Abe, Shin-ichi; Abe, Kazuko; Zhang, Jidong; Harada, Tomoaki; Mizumoto, Go; Oshikawa, Hiroki; Akiyama, Haruhiko; Shimamura, Kenji			Roles of CD34(+) cells and ALK5 signaling in the reconstruction of seminiferous tubule-like structures in 3-D re-aggregate culture of dissociated cells from neonatal mouse testes	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; TESTICULAR PERITUBULAR CELLS; FACTOR-BETA TGF-BETA-1; SERTOLI-CELLS; CORD FORMATION; FETAL MOUSE; RAT TESTIS; IN-VITRO; IMMUNOHISTOCHEMICAL LOCALIZATION; GONADAL DEVELOPMENT	Tissue reconstruction in vitro can provide, if successful, a refined and simple system to analyze the underlying mechanisms that drive the morphogenesis and maintain the ordered structure. We have recently succeeded in reconstruction of seminiferous cord-like and tubule-like structures using 3-D re-aggregate culture of dissociated testicular cells. In testis formation, endothelial cells that migrated from mesonephroi to embryonic gonads have been shown to be critical for development of testis cords, but how endothelial cells contribute to testis cord formation remains unknown. To decipher the roles of endothelial and peritubular cells in the reconstruction of cord-like and tubule-like structures, we investigated the behavior of CD34(+) endothelial and p75(+) cells, and peritubular myoid cells (PTMCs) in 3-D re-aggregate cultures of testicular cells. The results showed that these 3 types of cells had the capacity of re-aggregation on their own and with each other, and of segregation into 3 layers in a re-aggregate, which were very similar to interstitial and peritubular tissues in vivo. Observation of behaviors of fluorescent Sertoli cells and other non-fluorescent types of cells using testes from Sox9-EGFP transgenic mice showed dynamic cell movement and segregation in re-aggregate cultures. Cultures of testicular cells deprived of interstitial and peritubular cells resulted in dysmorphic structures, but re-addition of them restored tubule-like structures. Purified CD34(+) cells in culture differentiated into p75(+) cells and PTMCs. These results indicate that CD34(+) cells differentiate into p75(+) cells, which then differentiate into PTMCs. TGF beta signaling inhibitors, SB431542 and ALK5i, disturbed the reconstruction of cord-like and tubule-like structures, and the latter compromised re-construction of interstitial-like and peritubular-like structures, as well as the proliferation of CD34(+), p75(+), PTMCs, and Sertoli cells, and their movement and differentiation. These results indicate that CD34(+) cells and signaling through ALK5 play pivotal roles in the morphogenesis of interstitial-like, peritubular-like and cord-like structures.	[Abe, Shin-ichi; Abe, Kazuko; Mizumoto, Go] Kumamoto Hlth Sci Univ, Ctr Gen Educ, Kumamoto, Japan; [Zhang, Jidong] ZunYi Med Univ, Sch Basic Med Sci, Zunyi, Guizhou, Peoples R China; [Harada, Tomoaki; Oshikawa, Hiroki] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto, Japan; [Akiyama, Haruhiko] Gifu Univ, Grad Sch Med, Dept Orthopaed, Gifu, Japan; [Shimamura, Kenji] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan	Kumamoto Health Science University; Zunyi Medical University; Kumamoto University; Gifu University; Kumamoto University	Abe, S (corresponding author), Kumamoto Hlth Sci Univ, Ctr Gen Educ, Kumamoto, Japan.	abe@kumamoto-hsu.ac.jp		Zhang, jidong/0000-0002-7934-7079; Abe, Shin-ichi/0000-0002-7886-9545	Japan Society for The Promotion of Science KAKENHI [15K07129]; Kumamoto Health Science University special fellowship [2015-C-12, 2017-C-07]; National Natural Science Foundation of China [31660338]; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research [15K07129] Funding Source: KAKEN	Japan Society for The Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kumamoto Health Science University special fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for The Promotion of Science KAKENHI Grant Number 15K07129, Kumamoto Health Science University special fellowship grant number 2015-C-12 and 2017-C-07 to SA; the National Natural Science Foundation of China grant No. 31660338 to JZ; and the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University, to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Lopes JP, 2017, BIOMATERIALS, V130, P76, DOI 10.1016/j.biomaterials.2017.03.025; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; BUEHR M, 1993, DEVELOPMENT, V117, P273; Campagnolo L, 2001, BIOL REPROD, V64, P464, DOI 10.1095/biolreprod64.2.464; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cool J, 2008, SEX DEV, V2, P128, DOI 10.1159/000143430; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; Cupp AS, 1999, BIOL REPROD, V60, P1304, DOI 10.1095/biolreprod60.6.1304; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Gassei K, 2007, ANN NY ACAD SCI, V1120, P152, DOI 10.1196/annals.1411.015; GAUTIER C, 1994, MOL CELL ENDOCRINOL, V99, P55, DOI 10.1016/0303-7207(94)90146-5; HADLEY MA, 1990, DEV BIOL, V140, P318, DOI 10.1016/0012-1606(90)90082-T; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hess RA, 2012, SERTOLI CELL BIOL, P19; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Itman C, 2013, IUBMB LIFE, V65, P85, DOI 10.1002/iub.1115; Itman C, 2011, ENDOCRINOLOGY, V152, P2076, DOI 10.1210/en.2010-1453; Jeanes A, 2005, REPRODUCTION, V130, P509, DOI 10.1530/rep.1.00718; Kita K, 2007, BIOL REPROD, V76, P211, DOI 10.1095/biolreprod.106.056895; Kuroda N, 2004, HISTOL HISTOPATHOL, V19, P743, DOI 10.14670/HH-19.743; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; MERCHANTLARIOS H, 1993, INT J DEV BIOL, V37, P407; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Nel-Themaat L, 2010, J ANDROL, V31, P5, DOI 10.2164/jandrol.109.008235; Nel-Themaat L, 2009, DEV DYNAM, V238, P1100, DOI 10.1002/dvdy.21954; Nishino K, 2001, EXP CELL RES, V267, P225, DOI 10.1006/excr.2001.5238; Olaso R, 1997, MOL CELL ENDOCRINOL, V126, P165, DOI 10.1016/S0303-7207(96)03984-6; Pendergraft SS, 2017, BIOL REPROD, V96, P720, DOI 10.1095/biolreprod.116.143446; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Russo MA, 1999, BIOL REPROD, V61, P1123, DOI 10.1095/biolreprod61.4.1123; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; TUNG PS, 1980, BIOL REPROD, V23, P207, DOI 10.1093/biolreprod/23.1.207; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612; Zhang JD, 2014, GEN COMP ENDOCR, V205, P121, DOI 10.1016/j.ygcen.2014.03.030	46	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188705	10.1371/journal.pone.0188705	http://dx.doi.org/10.1371/journal.pone.0188705			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190781	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900104
J	Delfini, J; Moda-Cirino, V; Ruas, CD; Neto, JD; Ruas, PM; Buratto, JS; Ruas, EA; Goncalves, LSA				Delfini, Jessica; Moda-Cirino, Vania; Ruas, Claudete de Fatima; Neto, Jose Dos Santos; Ruas, Paulo Mauricio; Buratto, Juliana Sawada; Ruas, Eduardo Augusto; Azeredo Goncalves, Leandro Simoes			Distinctness of Brazilian common bean cultivars with carioca and black grain by means of morphoagronomic and molecular descriptors	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; GENETIC DIVERSITY; MICROSATELLITE MARKERS; ACCESSIONS; INFERENCE; SOFTWARE; BIOFORTIFICATION; POPULATIONS; SEQUENCE; TRAITS	Common bean (Phaseolus vulgaris L.) is one of the most important legumes for human consumption and is a staple food in the diet of the population of some countries of Latin America, Africa and Asia. The distinction between cultivars is based predominantly on morphological descriptors, which proved inefficient for the differentiation of some cultivars. This study had the objective of describing, distinguishing and evaluating the agronomic potential of 39 common bean cultivars of the carioca and black grain groups registered for cultivation in Brazil, based on 49 morphoagronomic descriptors and microsatellite (simple sequence repeat - SSR) markers. The morphoagronomic traits of each commercial group were characterized in four environments. Thirty-seven SSR markers were used for the molecular description. The morphological data, analyzed by the Shanonon-Weaver index, detected low variability among cultivars for qualitative data. On the other hand, the estimates of variance analysis, relative importance of the traits and hierarchical grouping analysis applied to the quantitative variables showed that the descriptors related to plant morphology were the most important for the carioca group, and those related to seed morphology were determining for the black group. The genetic parameters estimated for SSR markers by hierarchical and Bayesian cluster analysis identified 116 alleles, with 33 and 30 polymorphic loci and 24 and 22 private alleles for the carioca and black groups, respectively. The combined use of morphoagronomic and molecular descriptors improves the distinguishability of cultivars, contributing in a more efficient way to breeding and to the protection of cultivars.	[Delfini, Jessica; Neto, Jose Dos Santos; Azeredo Goncalves, Leandro Simoes] Univ Estadual Londrina, Agron Dept, Rodovia Celso Garcia Cid, Londrina, Brazil; [Delfini, Jessica; Moda-Cirino, Vania; Neto, Jose Dos Santos; Buratto, Juliana Sawada] Inst Agron Parana IAPAR, Rodovia Celso Garcia Cid, Londrina, Brazil; [Ruas, Claudete de Fatima; Ruas, Paulo Mauricio; Ruas, Eduardo Augusto] Univ Estadual Londrina, Biol Dept, Rodovia Celso Garcia Cid, Londrina, Brazil	Universidade Estadual de Londrina; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Londrina	Goncalves, LSA (corresponding author), Univ Estadual Londrina, Agron Dept, Rodovia Celso Garcia Cid, Londrina, Brazil.; Moda-Cirino, V (corresponding author), Inst Agron Parana IAPAR, Rodovia Celso Garcia Cid, Londrina, Brazil.	vamoci@iapar.br; leandrosag@uel.br	Goncalves, Leandro/J-5505-2017	Goncalves, Leandro/0000-0001-9700-9375; Delfini, Jessica/0000-0002-7616-7734	Instituto Agronomico do Parana -IAPAR; CAPES	Instituto Agronomico do Parana -IAPAR; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Parana State's resource through the Instituto Agronomico do Parana -IAPAR, and CAPES.	Arunga E. E., 2015, Journal of Plant Breeding and Crop Science, V7, P240; Baba VY, 2016, GENET RESOUR CROP EV, V63, P1371, DOI 10.1007/s10722-015-0325-4; Blair MW, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00275; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Buso GSC, 2006, MOL ECOL NOTES, V6, P252, DOI 10.1111/j.1471-8286.2006.01210.x; Cabral PDS, 2011, GENET MOL RES, V10, P140, DOI 10.4238/vol10-1gmr993; Cardoso PCB, 2014, GENET MOL RES, V13, P1964, DOI 10.4238/2014.March.24.1; Cargnelutti A, 2008, CIENC RURAL, V38, P2138, DOI 10.1590/S0103-84782008000800008; Chediak GL de C, 2007, ANALISE PUREZA GENET; Cockram J, 2012, THEOR APPL GENET, V125, P1735, DOI 10.1007/s00122-012-1950-3; COMPANHIA NACIONAL DE ABASTEMENTO (CONAB), 2009, AC SAFR BRAS SAFR 20; Cruz CD, 2001, MODELOS BIOMETRICOS; Cruz CD, 2016, ACTA SCI-AGRON, V38, P547, DOI [10.4025/actasciagron.v38i4.32629, 10.4025/actasciagron.v38i3.32629]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FAO, 2013, FAOSTAT FAO STAT DAT; Ferreira ME, 1998, INTRO USO MARCADORES; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Ghalmi N, 2010, GENET RESOUR CROP EV, V57, P371, DOI 10.1007/s10722-009-9476-5; Ribeiro CAG, 2013, PESQUI AGROPECU BRAS, V48, P270, DOI 10.1590/S0100-204X2013000300005; Grisi MCM, 2007, GENET MOL RES, V6, P691; Hegay S, 2014, GENET RESOUR CROP EV, V61, P555, DOI 10.1007/s10722-013-0056-3; Kadirvel P, 2016, PLANT GENET RESOUR, P1; Perseguini JMKC, 2011, GENET MOL BIOL, V34, P88, DOI 10.1590/S1415-47572011000100017; Lewis PO, 2001, GENETIC DATA ANAL GD; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; MAPA, 2017, REG NAC CULT RNC MAP; Marinho CD, 2011, GENET MOL RES, V10, P792, DOI 10.4238/vol10-2gmr1271; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Coelho Cileide Maria Medeiros, 2007, Cienc. Rural, V37, P1241, DOI 10.1590/S0103-84782007000500004; Moda-Cirino V, 2016, ANN REPORT BEAN IMPR; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Roldan-Ruiz I, 2001, THEOR APPL GENET, V103, P1138, DOI 10.1007/s001220100571; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Cabral PDS, 2011, REV CIENC AGRON, V42, P898, DOI 10.1590/S1806-66902011000400011; SINGH D, 1981, Indian Journal of Genetics and Plant Breeding, V41, P237; Wilson GA, 2003, GENETICS, V163, P1177; Yeh FC, 1997, POPGENE VERSION 1 32; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	45	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188798	10.1371/journal.pone.0188798	http://dx.doi.org/10.1371/journal.pone.0188798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190665	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900127
J	Scott, CH; Cha, KM; Ngai, J; Jiang, CT; Cheng, K; Stokes, RA; Ho, KWK; George, J; Gonzalez, FJ; Gunton, JE				Scott, Christopher H.; Cha, Kuan-Minn; Ngai, Jason; Jiang, Changtao; Cheng, Kim; Stokes, Rebecca A.; Ho, Kenneth W. K.; George, Jacob; Gonzalez, Frank J.; Gunton, Jenny E.			Hepatic Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) regulates metabolism in mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; CRYPTOGENIC CIRRHOSIS; LIPID-ACCUMULATION; GENE-EXPRESSION; HIF-1-ALPHA; STEATOHEPATITIS; STEATOSIS; DISEASE; ACTIVATION; PROTEIN	Background & aims Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) and its partners hypoxia-inducible factors (HIF)-1 alpha and HIF-2 alpha are candidate factors for the well-known link between the liver, metabolic dysfunction and elevation in circulating lipids and glucose. Methods: Hepatocyte-specific ARNT-null (LARNT), HIF-1 alpha-null (LHIF1 alpha) and HIF-2 alpha-null (LHIF2 alpha) mice were created. Results LARNT mice had increased fasting glucose, impaired glucose tolerance, increased glucose production, raised post-prandial serum triglycerides (TG) and markedly lower hepatic ATP versus littermate controls. There was increased expression of G6Pase, Chrebp, Fas and Scd-1 mRNAs in LARNT animals. Surprisingly, LHIF1 alpha and LHIF2 alpha mice exhibited no alterations in any metabolic parameter assessed. Conclusions These results provide convincing evidence that reduced hepatic ARNT can contribute to inappropriate hepatic glucose production and post-prandial dyslipidaemia. Hepatic ARNT may be a novel therapeutic target for improving post-prandial hypertriglyceridemia and glucose homeostasis.	[Scott, Christopher H.; Cha, Kuan-Minn; Cheng, Kim; Stokes, Rebecca A.; George, Jacob; Gunton, Jenny E.] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Scott, Christopher H.; Cha, Kuan-Minn; Ngai, Jason; Cheng, Kim; Stokes, Rebecca A.; Ho, Kenneth W. K.; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Jiang, Changtao; Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [George, Jacob] Univ Sydney, Westmead Inst Med Res, Storr Liver Unit, Sydney, NSW, Australia; [Gunton, Jenny E.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Diabet & Endocrinol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; Garvan Institute of Medical Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; University of Sydney	Gunton, JE (corresponding author), Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Westmead Hosp, Dept Diabet & Endocrinol, Sydney, NSW, Australia.	Jenny.gunton@sydney.edu.au	Gunton, Jenny E/AAH-7719-2021	Jiang, Changtao/0000-0002-5206-2372	NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Athyros VG, 2006, CURR MED RES OPIN, V22, P873, DOI 10.1185/030079906X104696; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; BURCHELL A, 1985, DIABETOLOGIA, V28, P852, DOI 10.1007/BF00291077; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Garinis GA, 2010, INT J OBESITY, V34, P1255, DOI 10.1038/ijo.2010.40; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kawano Y, 2010, ARCH BIOCHEM BIOPHYS, V504, P221, DOI 10.1016/j.abb.2010.09.001; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Kucejova B, 2011, ONCOGENE, V30, P2147, DOI 10.1038/onc.2010.587; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Lavoie JM, 2006, CELL MOL LIFE SCI, V63, P1393, DOI 10.1007/s00018-006-6600-y; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; McCullough AJ, 1998, AM J GASTROENTEROL, V93, P2022; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Nath B, 2012, HEPATOLOGY; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Visinoni S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1132, DOI 10.1152/ajpendo.90552.2008; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zollner G, 2010, PHARMACOL THERAPEUT, V126, P228, DOI 10.1016/j.pharmthera.2010.03.005	50	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0186543	10.1371/journal.pone.0186543	http://dx.doi.org/10.1371/journal.pone.0186543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190746	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900008
J	Son, HJ; Sung, H; Park, SY; Kim, T; Lee, HJ; Kim, SM; Chong, YP; Lee, SO; Choi, SH; Kim, YS; Woo, JH; Kim, SH				Son, Hyo-Ju; Sung, Heungsup; Park, Se Yoon; Kim, Taeeun; Lee, Hyun Jeong; Kim, Sun-Mi; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han			Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers	PLOS ONE			English	Article							BETA-D-GLUCAN; INVASIVE FUNGAL-INFECTIONS; SERUM 1,3-BETA-D-GLUCAN; PNEUMONIA; METAANALYSIS; ACCURACY; COLONIZATION	Background Diagnosis of pneumocystis pneumonia (PCP) relies on microscopic visualization of P. jirovecii, or detection of Pneumocystis DNA in respiratory specimens, which involves invasive procedures such as bronchoalveolar lavage. The (1-3)-beta-D-glucan (BG) assay has been proposed as a less invasive and less expensive diagnostic test to rule out PCP. We therefore compared blood levels of BG in patients with PCP with those of patients with candidemia, chronic disseminated candidiasis (CDC), invasive aspergillosis, mucormycosis, and tuberculosis and those of healthy volunteers. Methods Adult patients who were diagnosed with PCP, candidemia, CDC, invasive aspergillosis, mucormycosis, and tuberculosis whose blood samples were available, and healthy volunteers were enrolled in a tertiary hospital in Seoul, South Korea, during a 21-month period. The blood samples were assayed with the Goldstream Fungus (1-3)-beta-D-glucan test (Gold Mountain River Tech Development, Beijing, China). Results A total of 136 individuals including 50 patients P. jirovecii, 15 candidemia, 6 CDC, 15 invasive aspergillosis, 10 mucormycosis, and 40 controls (20 TB and 20 healthy volunteers) were included. The mean +/- SD of the concentration of 1-3-beta-D-glucan in the patients with PCP (290.08 pg/mL +/- 199.98) were similar to those of patients with candidemia (314.14 pg/mL +/- 205.60, p = 0.90 at an alpha = 0.005) and CDC (129.74 pg/mL +/- 182.79, p = 0.03 at an alpha = 0.005),	[Son, Hyo-Ju; Park, Se Yoon; Kim, Taeeun; Lee, Hyun Jeong; Kim, Sun-Mi; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Sung, Heungsup] Univ Ulsan, Coll Med, Asan Med Ctr, Lab Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	kimsunghanmd@hotmail.com	Lee, Sang-Oh/AGV-5413-2022; Chong, Yong Pil/AAB-2623-2021	Lee, Sang-Oh/0000-0003-1381-8787; Kim, Sung-Han/0000-0002-6596-8253	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI16C0272]; Asan Institute for Life Sciences [2015-0193]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences	This study was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI16C0272), and the Asan Institute for Life Sciences (2015-0193) to Sung-Han Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angebault C, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw128; de Boer MGJ, 2011, J INFECTION, V62, P93, DOI 10.1016/j.jinf.2010.10.007; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Esteves F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.11.025; Harris JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023158; Held J, 2011, CLIN MICROBIOL INFEC, V17, P595, DOI 10.1111/j.1469-0691.2010.03318.x; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Jang Y-R, 2017, MED MYCOLOG IN PRESS; Jung J, 2015, CLIN INFECT DIS, V61, P1664, DOI 10.1093/cid/civ660; Karageorgopoulos DE, 2013, CLIN MICROBIOL INFEC, V19, P39, DOI 10.1111/j.1469-0691.2011.03760.x; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; Masood A, 2005, LEUKEMIA RES, V29, P493, DOI 10.1016/j.leukres.2004.10.003; Nakamura H, 2009, INTERNAL MED, V48, P195, DOI 10.2169/internalmedicine.48.1680; Obayashi T, 2008, CLIN INFECT DIS, V46, P1864, DOI 10.1086/588295; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; Ostrosky-Zeichner L, 2005, CLIN INFECT DIS, V41, P654, DOI 10.1086/432470; Pini P, 2016, INFECTION, V44, P223, DOI 10.1007/s15010-015-0849-8; Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868; Prattes J, 2014, MYCOSES, V57, P679, DOI 10.1111/myc.12221; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Tasaka S, 2014, J INFECT CHEMOTHER, V20, P678, DOI 10.1016/j.jiac.2014.07.001; Theel ES, 2013, J CLIN MICROBIOL, V51, P3478, DOI 10.1128/JCM.01737-13; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588	26	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188860	10.1371/journal.pone.0188860	http://dx.doi.org/10.1371/journal.pone.0188860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190812	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900146
J	Tang, J; Huang, ZF; Chiba, H; Han, YK; Wang, M; Fan, XL				Tang, Jing; Huang, Zhenfu; Chiba, Hideyuki; Han, Yuke; Wang, Min; Fan, Xiaoling			Systematics of the genus Zinaida Evans, 1937 (Hesperiidae: Hesperiinae: Baorini)	PLOS ONE			English	Article							IQ-TREE; LEPIDOPTERA; CHINA	Traditionally, species of the genus Zinaida were assigned to the genus Polytremis, until molecular evidence revealed that the former is a distinct genus. Nine species in Polytremis sensu Evans have since been removed and assigned to Zinaida; however, there is still uncertainty as to the taxonomic status of an additional seven Polytremis species. Moreover, the interspecific relationships within Zinaida have remained unresolved. To further investigate the taxonomic statuses and interspecific relationships within Zinaida, a molecular phylogeny of most species of Zinaida and its allies was inferred based on regions of the mitochondrial COI-COII and 16S and nuclear EF-1 alpha genes (3006 bp). The results revealed that Zinaida is monophyletic and consists of four intra-generic clades that correspond to morphological characteristics. Clade A (Z. suprema group) consists of P. kiraizana, Z. suprema, and P. gigantea, with the latter two as sister species. Clade B (Z. nascens group) consists of seven species, and is the sister group of Clade C (Z. pellucida group), which comprises sister species Z. pellucida and Z. zina. In Clade B, Z. caerulescens and Z. gotama, and Z. theca and Z. fukia are sister species, respectively. On the basis of our molecular evidence and morphological features, we have moved P. gigantea, P. kiraizana, P. jigongi, and P. micropunctata to the genus Zinaida as new combinations. We review morphological characteristics and discuss the distribution of each of these groups in the light of our phylogenetic hypothesis, and provide a comprehensive taxonomic checklist.	[Tang, Jing; Huang, Zhenfu; Han, Yuke; Wang, Min; Fan, Xiaoling] South China Agr Univ, Dept Entomol, Coll Agr, Guangzhou, Guangdong, Peoples R China; [Chiba, Hideyuki] Bernice P Bishop Museum, Honolulu, HI 96817 USA	South China Agricultural University	Fan, XL (corresponding author), South China Agr Univ, Dept Entomol, Coll Agr, Guangzhou, Guangdong, Peoples R China.; Chiba, H (corresponding author), Bernice P Bishop Museum, Honolulu, HI 96817 USA.	skipper@bekkoame.ne.jp; fanxiaol66@scau.edu.cn		Han, Yuke/0000-0001-6171-9631	Natural Science Foundation of China [31172136, 31471984]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant numbers:31172136 and 31471984), XLF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bridges C.A., 1994, CATALOGUE FAMILY GRO; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chiba H, 2009, ZOOTAXA, P48, DOI 10.11646/zootaxa.2202.1.2; Chou I, 1994, MONOGRAPHIA RHOPALOC; Evans W.H., 1949, ENTOMOLOGY; Evans WH, 1937, CATALOGUE ASIAN HESP; Evans WH., 1932, IDENTIFICATION INDIA; Fan XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156861; Fan Xiaoling, 2010, Zootaxa, V2490, P1; Heppner JB, 1992, LEPIDOPTERA TAIWAN 2, V1; Hsu Y.-F., 1989, Chinese Journal of Entomology, V9, P77; Huang BK, 2001, FAUNA INSECTS FUJIAN, V4; Huang HA, 2003, NEUE ENTOMOLOGISCHE, V55, P1; Huang Hao, 2002, Atalanta (Marktleuthen), V33, P109; Huang Hao, 2004, Neue Entomologische Nachrichten, V57, P171; Huang Qitong, 2017, Journal of South China Agricultural University, V38, P69; Huang ZF, 2016, ZOOKEYS, P33, DOI 10.3897/zookeys.638.10026; Jiang WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20820; Jiang WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084098; Kotaro S, 2016, BUTTERFLIES, V71, P36; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee SM., 1982, BUTTERFLIES OF KOREA; Leech JH, 1893, BUTTERFLIES CHINA JA, P606; Mabille P., 1876, B SOC ENTOMOL FR, V5; Miller M.A., 2010, P GAT COMP ENV WORKS; Moore P., 1877, ANN MAG NAT HIST, V20, P43; Murayama S.-i., 1981, New Entomologist, V30, P64; Murray RP., 1874, ENTOMOL MON MAG, V11, P166; Mutke J., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P521; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Rambaut A., 2014, TRACER V1 6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shirozu T., 1952, SIEBOLDIA, V1, P11; Sonan J., 1938, Zephyrus Fukuoka, V7, P250; Sugiyama Hitoshi, 1999, Pallarge, V7, P1; Tong XS, 1993, BUTTERFLIES FAUNA ZH; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Wang ZC, 1999, MONOGRAPHIA ORIGINAL; Wang ZG, 1998, INSECT FAUNA HENAN L; Wu OS, 2017, BUTTERFLIES OF CHINA; Yamanaka M., 1980, TYO TO GA S1, V30, P126; Yuan F, 2015, INSECTA, V55; Zhu JQ, 2016, ZOOKEYS, P37, DOI 10.3897/zookeys.555.6144; Zhu JQ, 2012, ZOOTAXA, P63, DOI 10.11646/zootaxa.3274.1.7	47	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188883	10.1371/journal.pone.0188883	http://dx.doi.org/10.1371/journal.pone.0188883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190765	gold, Green Published, Green Submitted			2022-12-26	WOS:000416841900157
J	Ooi, CC; Mantalas, GL; Koh, W; Neff, NF; Fuchigami, T; Wong, DJ; Wilson, RJ; Park, SM; Gambhir, SS; Quake, SR; Wang, SX				Ooi, Chin Chun; Mantalas, Gary L.; Koh, Winston; Neff, Norma F.; Fuchigami, Teruaki; Wong, Dawson J.; Wilson, Robert J.; Park, Seung-min; Gambhir, Sanjiv S.; Quake, Stephen R.; Wang, Shan X.			High-throughput full-length single-cell mRNA-seq of rare cells	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; CANCER-PATIENTS; BREAST-CANCER; LUNG-CANCER; STEM-CELLS; SEPARATION; TRANSCRIPTOMICS; IDENTIFICATION; HETEROGENEITY; RESISTANCE	Single-cell characterization techniques, such as mRNA-seq, have been applied to a diverse range of applications in cancer biology, yielding great insight into mechanisms leading to therapy resistance and tumor clonality. While single-cell techniques can yield a wealth of information, a common bottleneck is the lack of throughput, with many current processing methods being limited to the analysis of small volumes of single cell suspensions with cell densities on the order of 107 per mL. In this work, we present a high-throughput full-length mRNA-seq protocol incorporating a magnetic sifter and magnetic nanoparticle-antibody conjugates for rare cell enrichment, and Smart-seq2 chemistry for sequencing. We evaluate the efficiency and quality of this protocol with a simulated circulating tumor cell system, whereby non-small-cell lung cancer cell lines (NCI-H1650 and NCI-H1975) are spiked into whole blood, before being enriched for single-cell mRNA-seq by EpCAM-functionalized magnetic nanoparticles and the magnetic sifter. We obtain high efficiency (> 90%) capture and release of these simulated rare cells via the magnetic sifter, with reproducible transcriptome data. In addition, while mRNA-seq data is typically only used for gene expression analysis of transcriptomic data, we demonstrate the use of full-length mRNA-seq chemistries like Smart-seq2 to facilitate variant analysis of expressed genes. This enables the use of mRNA-seq data for differentiating cells in a heterogeneous population by both their phenotypic and variant profile. In a simulated heterogeneous mixture of circulating tumor cells in whole blood, we utilize this high-throughput protocol to differentiate these heterogeneous cells by both their phenotype (lung cancer versus white blood cells), and mutational profile (H1650 versus H1975 cells), in a single sequencing run. This high -throughput method can help facilitate single-cell analysis of rare cell populations, such as circulating tumor or endothelial cells, with demonstrably high-quality transcriptomic data.	[Ooi, Chin Chun] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Mantalas, Gary L.; Koh, Winston; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Fuchigami, Teruaki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi, Japan; [Wong, Dawson J.; Wang, Shan X.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wilson, Robert J.; Wang, Shan X.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Park, Seung-min; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; [Park, Seung-min; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Stanford, CA USA; [Gambhir, Sanjiv S.; Wang, Shan X.] Stanford Univ, Sch Med, Canary Ctr Stanford Canc Early Detect, Palo Alto, CA USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA USA	Stanford University; Stanford University; Nagoya Institute of Technology; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ooi, CC (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	ooichinchun@ihpc.a-star.edu.sg	Park, Seung-min/AAK-2650-2021; Fuchigami, Teruaki/ABC-8886-2022; Koh, Lian Chye Winston/GYD-5873-2022	Park, Seung-min/0000-0002-2123-6245; Koh, Lian Chye Winston/0000-0003-4611-6490; Ooi, Chin Chun/0000-0003-4813-4529	Center for Cancer Nanotechnology Excellence [U54CA151459]; Innovative Molecular Analysis Technologies [R33CA138330]; NATIONAL CANCER INSTITUTE [U54CA199075] Funding Source: NIH RePORTER	Center for Cancer Nanotechnology Excellence; Innovative Molecular Analysis Technologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Cancer Nanotechnology Excellence (U54CA151459) and the Innovative Molecular Analysis Technologies (R33CA138330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BLOBEL GA, 1984, VIRCHOWS ARCH B, V45, P407, DOI 10.1007/BF02889883; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Chalmers JJ, 1998, BIOTECHNOL PROGR, V14, P141, DOI 10.1021/bp970140l; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Earhart CM, 2014, LAB CHIP, V14, P78, DOI 10.1039/c3lc50580d; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Ibrahim SF, 2003, CURR OPIN BIOTECH, V14, P5, DOI 10.1016/S0958-1669(02)00009-5; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; KESSINGER A, 1988, BLOOD, V71, P723; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pantel K, 2007, NAT CLIN PRACT ONCOL, V4, P62, DOI 10.1038/ncponc0737; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tibbe AGJ, 1999, NAT BIOTECHNOL, V17, P1210, DOI 10.1038/70761; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023	61	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0188510	10.1371/Journal.pone.0188510	http://dx.doi.org/10.1371/Journal.pone.0188510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186152	Green Published, Green Submitted, gold			2022-12-26	WOS:000416484900040
J	Chen, MM; Ju, Y; Chen, M; Xie, ZG; Zhou, KJ; Tan, Y; Mo, JJ				Chen, Minmei; Ju, Yu; Chen, Min; Xie, Zhenguo; Zhou, Kaijiao; Tan, Yi; Mo, Jianjun			Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015	PLOS ONE			English	Article							ENTEROVIRUS; VACCINE; TOOL	Hand, foot, and mouth disease (HFMD) is a significant public health challenge in China. Human enterovirus 71 (EV71) is regarded as the predominant causative pathogen of HFMD. Since 2015, two inactivated EV71 vaccines have been approved in mainland China, and because their use could change the HFMD pathogen spectrum, this should now be monitored. However, the epidemiological and genetic trends of EV71 with respect to HFMD in Guangxi, southern China, are still not clear. In this study, we describe the epidemiological and genetic characterization of this virus in clinically-diagnosed HFMD reported from 2010 to 2015 in Guangxi. Data showed that a two-year epidemic cycle, with a predominance of EV71 infections, contributed to HFMD outbreaks in Guangxi. Furthermore, this virus is a major causative agent of severe and fatal HFMD. Interestingly, in Guangxi, EV71-positive rates tended to decrease over time. In particular, EV71-positive rates were found in Fang-chenggang city, which reported very few severe and fatal cases over the six-year period. Phylogenetic analysis of the VP1 gene revealed that the major circulating strains belonged exclusively to genotype C, subtype 4a (C4a), and most clustered with strains circulating in southern China. The most interesting finding was that a strain isolated in 2012 clustered with Vietnamese strains isolated from 2011-2012. The data highlight the importance of pathogen surveillance for HFMD in China, especially Guangxi, which is located on the border of China and the Association of Southeast Asian Nations.	[Chen, Minmei; Ju, Yu; Chen, Min; Xie, Zhenguo; Zhou, Kaijiao; Tan, Yi; Mo, Jianjun] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Inst Acute Infect Dis Control & Prevent, Nanning, Guangxi, Peoples R China		Chen, MM (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Inst Acute Infect Dis Control & Prevent, Nanning, Guangxi, Peoples R China.	13707719199@163.com			Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center [2012051]; Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision	Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center; Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision	Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center (2012051). The Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision http://www.gxhfpc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donato C, 2016, VIROLOGY, V495, P1, DOI 10.1016/j.virol.2016.04.026; Geoghegan JL, 2015, J VIROL, V89, P8871, DOI 10.1128/JVI.00706-15; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Luo KW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167269; Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862; Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tian HF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176604; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100545; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163789	23	22	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188640	10.1371/journal.pone.0188640	http://dx.doi.org/10.1371/journal.pone.0188640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216216	gold, Green Submitted, Green Published			2022-12-26	WOS:000417337800034
J	Hang, J; Zavaljevski, N; Yang, Y; Desai, V; Ruck, RC; Macareo, LR; Jarman, RG; Reifman, J; Kuschner, RA; Keiser, PB				Hang, Jun; Zavaljevski, Nela; Yang, Yu; Desai, Valmik; Ruck, Richard C.; Macareo, Louis R.; Jarman, Richard G.; Reifman, Jaques; Kuschner, Robert A.; Keiser, Paul B.			Composition and variation of respiratory microbiota in healthy military personnel	PLOS ONE			English	Article							COMMUNITY; INFECTIONS; PROFILES; CHILDREN; DISEASE; TRACT	Certain occupational and geographical exposures have been associated with an increased risk of lung disease. As a baseline for future studies, we sought to characterize the upper respiratory microbiomes of healthy military personnel in a garrison environment. Nasal, oropharyngeal, and nasopharyngeal swabs were collected from 50 healthy active duty volunteers eight times over the course of one year (1107 swabs, completion rate = 92.25%) and subjected to pyrosequencing of the V1-V3 region of 16S rDNA. Respiratory bacterial taxa were characterized at the genus level, using QIIME 1.8 and the Ribosomal Database Project classifier. High levels of Staphylococcus, Corynebacterium, and Propionibacterium were observed among both nasal and nasopharyngeal microbiota, comprising more than 75% of all operational taxonomical units (OTUs). In contrast, Streptococcus was the sole dominant bacterial genus (approximately 50% of all OTUs) in the oropharynx. The average bacterial diversity was greater in the oropharynx than in the nasal or nasopharyngeal region at all time points. Diversity analysis indicated a significant overlap between nasal and nasopharyngeal samples, whereas oropharyngeal samples formed a cluster distinct from these two regions. The study produced a large set of pyrosequencing data on the V1-V3 region of bacterial 16S rDNA for the respiratory microbiomes of healthy active duty Service Members. Pre-processing of sequencing reads showed good data quality. The derived microbiome profiles were consistent both internally and with previous reports, suggesting their utility for further analyses and association studies based on sequence and demographic data.	[Hang, Jun; Yang, Yu; Ruck, Richard C.; Macareo, Louis R.; Jarman, Richard G.; Kuschner, Robert A.; Keiser, Paul B.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; [Zavaljevski, Nela; Desai, Valmik; Reifman, Jaques] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Dept Def Biotechnol High Performance Comp Softwar, Ft Detrick, MD USA; [Ruck, Richard C.] MCHK HC, Schofield Barracks, HI USA; [Macareo, Louis R.] US Armed Forces Res Inst Med Sci, Bangkok, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Hang, J (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.	jun.hang.civ@mail.mil		Keiser, Paul/0000-0002-6271-4426; Hang, Jun/0000-0002-6597-7045	Immunizations Healthcare Branch; Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD); Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center	Immunizations Healthcare Branch; Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD); Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center	This work was supported by the Immunizations Healthcare Branch, the Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD) and the Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; [Anonymous], 2012, PLOS ONE, V7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dube FS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1934-z; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Hang J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-31; Huang YJ, 2017, TRANSL RES, V179, P71, DOI 10.1016/j.trsl.2016.06.007; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Sanchez JL, 2015, CLIN MICROBIOL REV, V28, P743, DOI 10.1128/CMR.00039-14; Santee CA, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0179-9; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Stearns JC, 2015, ISME J, V9, P1246, DOI 10.1038/ismej.2014.250; Tarabichi Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0133-2; Taylor SL, 2016, CELL MICROBIOL, V18, P652, DOI 10.1111/cmi.12589; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zhou YJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r1	29	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188461	10.1371/journal.pone.0188461	http://dx.doi.org/10.1371/journal.pone.0188461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216202	Green Submitted, Green Published, gold			2022-12-26	WOS:000417337800024
J	McKeithen, DN; Omosun, YO; Ryans, K; Mu, J; Xie, ZL; Simoneaux, T; Blas-Machado, U; Eko, FO; Black, CM; Igietseme, JU; He, Q				McKeithen, Danielle N.; Omosun, Yusuf O.; Ryans, Khamia; Mu, Jing; Xie, Zhonglin; Simoneaux, Tankya; Blas-Machado, Uriel; Eko, Francis O.; Black, Carolyn M.; Igietseme, Joseph U.; He, Qing			The emerging role of ASC in dendritic cell metabolism during Chlamydia infection	PLOS ONE			English	Article							INFLAMMASOME-INDEPENDENT ROLE; SPECK-LIKE PROTEIN; NLRP3 INFLAMMASOME; PYRUVATE-DEHYDROGENASE; NONCANONICAL INFLAMMASOMES; ACTIN POLYMERIZATION; IL-1-BETA SECRETION; AIM2 INFLAMMASOME; INDUCED ARTHRITIS; BACK AGAIN	Chlamydia trachomatis is a bacterial agent that causes sexually transmitted infections worldwide. The regulatory functions of dendritic cells (DCs) play a major role in protective immunity against Chlamydia infections. Here, we investigated the role of ASC in DCs metabolism and the regulation of DCs activation and function during Chlamydia infection. Following Chlamydia stimulation, maturation and antigen presenting functions were impaired in ASC(-/-) DCs compared to wild type (WT) DCs, in addition, ASC deficiency induced a tolerant phenotype in Chlamydia stimulated DCs. Using real-time extracellular flux analysis, we showed that activation in Chlamydia stimulated WT DCs is associated with a metabolic change in which mitochondrial oxidative phosphorylation (OXPHOS) is inhibited and the cells become committed to utilizing glucose through aerobic glycolysis for differentiation and antigen presenting functions. However, in ASC(-/-) DCs Chlamydia-induced metabolic change was prevented and there was a significant effect on mitochondrial morphology. The mitochondria of Chlamydia stimulated ASC(-/-) DCs had disrupted cristae compared to the normal narrow pleomorphic cristae found in stimulated WT DCs. In conclusion, our results suggest that Chlamydia-mediated activation of DCs is associated with a metabolic transition in which OXPHOS is inhibited, thereby dedicating the DCs to aerobic glycolysis, while ASC deficiency disrupts DCs function by inhibiting the reprogramming of DCs metabolism within the mitochondria, from glycolysis to electron transport chain.	[McKeithen, Danielle N.; Omosun, Yusuf O.; Ryans, Khamia; Simoneaux, Tankya; Eko, Francis O.; Igietseme, Joseph U.; He, Qing] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [McKeithen, Danielle N.; Ryans, Khamia] Clark Atlanta Univ, Dept Biol, Atlanta, GA 30314 USA; [Mu, Jing; Xie, Zhonglin] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA; [Blas-Machado, Uriel] Univ Georgia, Coll Vet Med, Atlanta, GA USA; [Black, Carolyn M.; Igietseme, Joseph U.] Ctr Dis Control & Prevent CDC, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA USA	Morehouse School of Medicine; Clark Atlanta University; University System of Georgia; Georgia State University; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	He, Q (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	qhe@msm.edu	Omosun, Yusuf/P-9944-2019	Omosun, Yusuf/0000-0003-4759-6254	NIH from National Institute on Minority Health and Health Disparities (NIM HD) [8G12MD007602]; Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) [1SC2HD086066-01A1]; National Institute of General Medical Sciences (NIGMS) [1SC1A1103041-01A1]	NIH from National Institute on Minority Health and Health Disparities (NIM HD); Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIH grant 8G12MD007602 from the National Institute on Minority Health and Health Disparities (NIM HD), 1SC2HD086066-01A1 from Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) to Y.O. and 1SC1A1103041-01A1 from National Institute of General Medical Sciences (NIGMS) to Q.H.	Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; [Anonymous], 2016, CURR TOP MICROBIOL I; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bround MJ, 2016, J BIOL CHEM, V291, P23490, DOI 10.1074/jbc.M116.756973; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Caution K, 2015, SCI REP-UK, V5, DOI 10.1038/srep18479; Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Finethy R, 2015, INFECT IMMUN, V83, P4740, DOI 10.1128/IAI.00856-15; Goguet-Rubio P, 2016, P NATL ACAD SCI USA, V113, P11004, DOI 10.1073/pnas.1602751113; Hafner LM, 2015, CONTRACEPTION, V92, P108, DOI 10.1016/j.contraception.2015.01.004; He Q, 2005, J IMMUNOL, V174, P4860, DOI 10.4049/jimmunol.174.8.4860; He Q, 2007, IMMUNOLOGY, V122, P28, DOI 10.1111/j.1365-2567.2007.02608.x; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liu GT, 2004, J IMMUNOTHER, V27, P220, DOI 10.1097/00002371-200405000-00006; Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Matsuo J, 2015, INFECT IMMUN, V83, P2917, DOI 10.1128/IAI.02968-14; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; O'Neill LAJ, 2014, NAT IMMUNOL, V15, P314, DOI 10.1038/ni.2852; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Omosun Y, 2015, INFECT IMMUN, V83, P4662, DOI 10.1128/IAI.00993-15; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pender MP, 1999, IMMUNOL CELL BIOL, V77, P216, DOI 10.1046/j.1440-1711.1999.00818.x; Pettengill MA, 2016, BIOMED J, V39, P306, DOI 10.1016/j.bj.2016.07.001; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rodriguez-Garcia M, 2016, MUCOSAL IMMUNOLOGY; Russell AN, 2016, J INFECT DIS, V214, P1884, DOI 10.1093/infdis/jiw485; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shao RJ, 2012, FERTIL STERIL, V98, P1175, DOI 10.1016/j.fertnstert.2012.07.1113; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Sorrentino R, 2015, AM J PATHOL, V185, P3115, DOI 10.1016/j.ajpath.2015.07.009; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Torrone E, 2007, PREVALENCE CHLAMYDIA, V63, P834; Boari JT, 2016, IMMUNOL CELL BIOL, V94, P903, DOI 10.1038/icb.2016.87; Vigano E, 2013, EUR J IMMUNOL, V43, P2240, DOI 10.1002/eji.201343800; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003; Zhu Y, 2015, VACCINE, V33, P298, DOI 10.1016/j.vaccine.2014.11.028	58	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188643	10.1371/journal.pone.0188643	http://dx.doi.org/10.1371/journal.pone.0188643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216217	gold, Green Published, Green Submitted			2022-12-26	WOS:000417337800035
J	Belanger-Champagne, C; Vainionpaa, H; Peura, P; Toivonen, H; Eerola, P; Dendooven, P				Belanger-Champagne, Camille; Vainionpaa, Hannes; Peura, Pauli; Toivonen, Harri; Eerola, Paula; Dendooven, Peter			Design of a novel instrument for active neutron interrogation of artillery shells	PLOS ONE			English	Article							RAY ACTIVATION-ANALYSIS; EXPLOSIVES	The most common explosives can be uniquely identified by measuring the elemental H/N ratio with a precision better than 10%. Monte Carlo simulations were used to design two variants of a new prompt gamma neutron activation instrument that can achieve this precision. The instrument features an intense pulsed neutron generator with precise timing. Measuring the hydrogen peak from the target explosive is especially challenging because the instrument itself contains hydrogen, which is needed for neutron moderation and shielding. By iterative design optimization, the fraction of the hydrogen peak counts coming from the explosive under interrogation increased from 53(-7)(-7)% to 74(-10)(+8)% (statistical only) for the benchmark design. In the optimized design variants, the hydrogen signal from a high-explosive shell can be measured to a statistics-only precision better than 1% in less than 30 minutes for an average neutron production yield of 10(9) n/s.	[Belanger-Champagne, Camille; Peura, Pauli; Eerola, Paula; Dendooven, Peter] Helsinki Inst Phys, Helsinki, Finland; [Vainionpaa, Hannes] JHV Phys, Riihimaki, Finland; [Toivonen, Harri] HT Nucl, Hyvinkaa, Finland	Helsinki Institute of Physics	Belanger-Champagne, C (corresponding author), Helsinki Inst Phys, Helsinki, Finland.	camille.belanger-champagne@helsinki.fi		Belanger-Champagne, Camille/0000-0003-2368-2617; Dendooven, Peter/0000-0003-1859-1315; Peura, Pauli/0000-0002-8541-0169	Finnish Scientific Advisory Board for Defence; Tekes-The Finnish Funding agency for Innovation; Tekes [1845/31/2014]; Finnish Scientific Advisory Board for Defence [2500-0050]	Finnish Scientific Advisory Board for Defence; Tekes-The Finnish Funding agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Scientific Advisory Board for Defence	This work is supported by the Finnish Scientific Advisory Board for Defence and Tekes-The Finnish Funding agency for Innovation. Tekes (grant 1845/31/2014, recipient Paula Eerola, see www.tekes.fi) provided support in the form of salaries for authors C. B.-C., P.P. and P.D., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Finnish Scientific Advisory Board for Defence (grant 2500-0050, recipient Hannes Vainionpaa, see www.defmin.fi/en/tasks and activities/defence_policy/scientific advisory board for defence) provided support in the form of part of the salary of H.V., consumable materials and consultation fees paid by the grantee to HT Nuclear Ltd, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. H. V. is a founder and majority owner of JHV Physics Oy. H.T. is the owner and only employee of HT Nuclear Ltd.; This work is supported by the Finnish Scientific Advisory Board for Defence and Tekes-The Finnish Funding agency for Innovation.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Alfassi Z. B., 1995, PROMPT GAMMA NEUTRON; Alfassi ZB., 1994, CHEM ANAL NUCL METHO; Blachot J, 2012, NUCL DATA SHEETS, V113, P2391, DOI 10.1016/j.nds.2012.10.002; BROWN DR, 1994, NUCL INSTRUM METH A, V353, P684, DOI 10.1016/0168-9002(94)91751-5; Buffler A, 2004, RADIAT PHYS CHEM, V71, P853, DOI 10.1016/j.radphyschem.2004.04.110; CAFFREY AJ, 1992, IEEE T NUCL SCI, V39, P1422, DOI 10.1109/23.173218; Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; Cherubini N, 2016, CHALLENGES, V7; LEE WC, 1995, NUCL INSTRUM METH B, V99, P739, DOI 10.1016/0168-583X(95)00221-9; Litz M, 2012, ARLTR5871; Naqvi AA, 2013, APPL RADIAT ISOTOPES, V78, P145, DOI 10.1016/j.apradiso.2013.04.006; Naqvi AA, 2003, NUCL INSTRUM METH A, V511, P400, DOI 10.1016/S0168-9002(03)01949-1; ORTEC, PINS3 CF CHEM EXPL I; ORTEC, PINS3 CW PORT IS NEU; Paul RL, 2000, J RADIOANAL NUCL CH, V243, P181, DOI 10.1023/A:1006796003933; PAUL RL, 1995, J RADIOAN NUCL CH AR, V191, P245, DOI 10.1007/BF02038220; Poole CM, 2012, AUSTRALAS PHYS ENG S, V35, P329, DOI 10.1007/s13246-012-0159-8; Seabury EH, 2009, AIP CONF PROC, V1099, P928, DOI 10.1063/1.3120193; SODERN, NEUTR IND PROMPT PHO; St-Gobain Crystals, BRILLANCE SCIENT PER; THOMPSON LC, 1954, PHYS REV, V94, P941, DOI 10.1103/PhysRev.94.941; Twomey TR, 2007, INLCON0712304; Vainionpaa JH, 2015, NUCL INSTRUM METH B, V350, P88, DOI 10.1016/j.nimb.2014.12.077; Vourvopoulos G, 2001, TALANTA, V54, P459, DOI 10.1016/S0039-9140(00)00544-0; Yinon J., 1999, FORENSIC ENV DETECTI	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188959	10.1371/journal.pone.0188959	http://dx.doi.org/10.1371/journal.pone.0188959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211773	Green Published, gold, Green Submitted			2022-12-26	WOS:000417212200052
J	Ghazi, Z; Jahanshahi, S; Li, YF				Ghazi, Zohaib; Jahanshahi, Shahrzad; Li, Yingfu			RiboFACSeq: A new method for investigating metabolic and transport pathways in bacterial cells by combining a riboswitch-based sensor, fluorescence-activated cell sorting and next-generation sequencing	PLOS ONE			English	Article							COENZYME B-12 SYNTHESIS; SALMONELLA-TYPHIMURIUM LT2; ESCHERICHIA-COLI; NUCLEOTIDE LOOP; VITAMIN-B12 TRANSPORT; OUTER-MEMBRANE; SUBSTRATE-SPECIFICITY; BINDING-PROTEIN; BTUB AFFECT; LAST STEP	The elucidation of the cellular processes involved in vitamin and cofactor biosynthesis is a challenging task. The conventional approaches to these investigations rely on the discovery and purification of the products (i.e proteins and metabolites) of a particular transport or bio-synthetic pathway, prior to their subsequent analysis. However, the purification of low-abundance proteins or metabolites is a formidable undertaking that presents considerable technical challenges. As a solution, we present an alternative approach to such studies that circumvents the purification step. The proposed approach takes advantage of: (1) the molecular detection capabilities of a riboswitch-based sensor to detect the cellular levels of its cognate molecule, as a means to probe the integrity of the transport and biosynthetic pathways of the target molecule in cells, (2) the high-throughput screening ability of fluorescence-activated cell sorters to isolate cells in which only these specific pathways are disrupted, and (3) the ability of next-generation sequencing to quickly identify the genes of the FACS-sorted populations. This approach was named "RiboFACSeq". Following their identification by RiboFACSeq, the role of these genes in the presumed pathway needs to be verified through appropriate functional assays. To demonstrate the utility of our approach, an adenosylcobalamin (AdoCbl)-responsive riboswitch-based sensor was used in this study to demonstrate that RiboFACSeq can be used to track and sort cells carrying genetic mutations in known AdoCbl transport and biosynthesis genes with desirable sensitivity and specificity. This method could potentially be used to elucidate any pathway of interest, as long as a suitable riboswitch-based sensor can be created. We believe that RiboFACSeq would be especially useful for the elucidation of biological pathways in which the proteins and/or their metabolites are present at very low physiological concentrations in cells, as is the case with vitamin and cofactor biosynthesis.	[Ghazi, Zohaib; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Jahanshahi, Shahrzad; Li, Yingfu] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada	McMaster University; McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Li, YF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.	liying@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-05806]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) via a Discovery Grant to YL (RGPIN-2015-05806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMER BMM, 1995, J BACTERIOL, V177, P4742, DOI 10.1128/jb.177.16.4742-4747.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSFORD PJ, 1977, J BACTERIOL, V132, P796, DOI 10.1128/JB.132.3.796-805.1977; Bohmer RM, 2011, CYTOM PART A, V79A, P646, DOI 10.1002/cyto.a.21096; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; BRAUN V, 1989, J BACTERIOL, V171, P6387, DOI 10.1128/jb.171.11.6387-6390.1989; BRAUN V, 1993, MOL MICROBIOL, V8, P261, DOI 10.1111/j.1365-2958.1993.tb01570.x; Bushnell B., 2014, BBMAP FAST ACCURATE; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Chakravorty D, 2013, ADV ENZYME BIOTECHNO, P89; Claas KR, 2010, J BACTERIOL, V192, P145, DOI 10.1128/JB.01159-09; Crofts TS, 2013, CHEM BIOL, V20, P1265, DOI 10.1016/j.chembiol.2013.08.006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; DIGIROLA.PM, 1971, J BACTERIOL, V106, P751, DOI 10.1128/JB.106.3.751-757.1971; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; FISCHER E, 1989, J BACTERIOL, V171, P5127, DOI 10.1128/jb.171.9.5127-5134.1989; Fowler CC, 2010, CHEM BIOL, V17, P756, DOI 10.1016/j.chembiol.2010.05.025; Gallo S, 2008, CHEMBIOCHEM, V9, P1408, DOI 10.1002/cbic.200800099; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANTKE K, 1981, FEMS MICROBIOL LETT, V12, P31; Hazra AB, 2013, CHEM BIOL, V20, P1275, DOI 10.1016/j.chembiol.2013.08.007; KADNER RJ, 1973, J BACTERIOL, V115, P514, DOI 10.1128/JB.115.2.514-521.1973; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; Maggio-Hall LA, 1999, P NATL ACAD SCI USA, V96, P11798, DOI 10.1073/pnas.96.21.11798; Maggio-Hall LA, 2004, MICROBIOL-SGM, V150, P1385, DOI 10.1099/mic.0.26952-0; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41575; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; OTOOLE GA, 1994, J BIOL CHEM, V269, P26503; OTOOLE GA, 1993, J BACTERIOL, V175, P6328, DOI 10.1128/JB.175.19.6328-6336.1993; OTOOLE GA, 1993, J BACTERIOL, V175, P3317, DOI 10.1128/jb.175.11.3317-3326.1993; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rebeille F, 2007, NAT PROD REP, V24, P949, DOI 10.1039/b703104c; RIOUX CR, 1989, MOL GEN GENET, V217, P301, DOI 10.1007/BF02464897; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; RUBINO SD, 1987, J BIOL CHEM, V262, P4382; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCOTT AI, 1993, ANGEW CHEM INT EDIT, V32, P1223, DOI 10.1002/anie.199312233; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; Thomas MG, 2000, J BIOL CHEM, V275, P27576; Trzebiatowski JR, 1997, J BIOL CHEM, V272, P17662, DOI 10.1074/jbc.272.28.17662; TRZEBIATOWSKI JR, 1994, J BACTERIOL, V176, P3568, DOI 10.1128/JB.176.12.3568-3575.1994; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06	57	3	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188399	10.1371/journal.pone.0188399	http://dx.doi.org/10.1371/journal.pone.0188399			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211762	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200029
J	Moron-Rios, A; Gomez-Cornelio, S; Ortega-Morales, BO; De la Rosa-Garcia, S; Partida-Martinez, LP; Quintana, P; Alayon-Gamboa, JA; Cappello-Garcia, S; Gonzalez-Gomez, S				Moron-Rios, Alejandro; Gomez-Cornelio, Sergio; Otto Ortega-Morales, Benjamin; De la Rosa-Garcia, Susana; Pamela Partida-Martinez, Laila; Quintana, Patricia; Armando Alayon-Gamboa, Jose; Cappello-Garcia, Silvia; Gonzalez-Gomez, Santiago			Interactions between abundant fungal species influence the fungal community assemblage on limestone	PLOS ONE			English	Article							LABORATORY CONDITIONS; FRESH-WATER; WOOD; COLONIZATION; COMPETITION; SANDSTONE; STONE; ROCKS; BIODETERIORATION; COEXISTENCE	The assembly of fungal communities on stone materials is mainly influenced by the differential bioreceptivity of such materials and environmental conditions. However, little is known about the role of fungal interactions in the colonization and establishment of fungal species. We analyzed the effects of intra-and interspecific interactions between 11 species of fungi in oligotrophic and copiotrophic media and on limestone coupons. In a previous study, these species were the most frequently isolated in the epilithic biofilms of limestone walls exposed to a subtropical climate. In the culture media, we found a greater frequency of intra-and interspecific inhibitory effects in the oligotrophic medium than in the copiotrophic medium. On the limestone coupons, all fungi were able to establish; however, the colonization success rate varied significantly. Cladosporium cladosporioides had a less extensive colonization in isolation (control) than in dual interactions (coexistence) with other species. Phoma eupyrena exhibited the highest colonization success rate and competitive dominance among all tested species. X-ray diffraction (XRD) and scanning electron microscope (SEM) analyses revealed that Pestalotiopsis maculans and Paraconiothyrium sp. produced calcium oxalate crystals during their growth on coupon surfaces, both in isolation and in dual interactions. Our results demonstrate that interactions between abundant fungal species influence the fungal colonization on substrates, the biomineralization and the fungal community assemblage growing in limestone biofilms.	[Moron-Rios, Alejandro; Gomez-Cornelio, Sergio; Armando Alayon-Gamboa, Jose] Colegio Frontera Sur, Ciudad Ind Lerma, Campeche, Mexico; [Gomez-Cornelio, Sergio] Univ Politecn Ctr, Dept Ingn Biotecnol, Carretera Fed Villahermosa Teapa, Tumbulushal, Tabasco, Mexico; [Otto Ortega-Morales, Benjamin] Univ Autonoma Campeche, Dept Microbiol Ambiental & Biotecnol, Campeche, Mexico; [De la Rosa-Garcia, Susana; Cappello-Garcia, Silvia] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Carr Villahermosa Cardenas, Villahermosa, Mexico; [Pamela Partida-Martinez, Laila] Ctr Invest Estudios Avanzados, Unidad Irapuato, Dept Ingn Genet, Irapuato, Mexico; [Quintana, Patricia; Gonzalez-Gomez, Santiago] IPN, CINVESTAV, Dept Fis Aplicada, Cordemex, Merida, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Juarez Autonoma de Tabasco; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Gomez-Cornelio, S (corresponding author), Colegio Frontera Sur, Ciudad Ind Lerma, Campeche, Mexico.; Gomez-Cornelio, S (corresponding author), Univ Politecn Ctr, Dept Ingn Biotecnol, Carretera Fed Villahermosa Teapa, Tumbulushal, Tabasco, Mexico.	sagomezcornelio@gmail.com	Partida, Laila Pamela/A-5935-2009; Ortega Morales, Benjamín Otto/K-3747-2018; Moron-Rios, Alejandro/E-6395-2013; Gómez-Cornelio, Sergio/HHM-9206-2022	Partida, Laila Pamela/0000-0001-8037-2856; Ortega Morales, Benjamín Otto/0000-0003-2458-244X; Moron-Rios, Alejandro/0000-0001-8790-0383; Gómez-Cornelio, Sergio/0000-0001-5102-9012; Gonzalez Gomez, William Santiago/0000-0002-6923-4425; De la Rosa-Garcia, Susana/0000-0002-6654-4532	El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia [138, 239290]	El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia 138); Consejo Nacional de Ciencia y Tecnologia for the doctoral scholarship granted to SGC (239290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyawansa HA, 2014, FUNGAL DIVERS, V68, P69, DOI 10.1007/s13225-014-0305-6; ASTHANA A, 1990, MYCOLOGIA, V82, P554, DOI 10.2307/3760044; BARLOCHER F, 1991, MYCOLOGIA, V83, P82, DOI 10.2307/3759834; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Burford EP, 2003, MINERAL MAG, V67, P1127, DOI 10.1180/0026461036760154; Carlsson F, 2014, FUNGAL ECOL, V11, P100, DOI 10.1016/j.funeco.2014.05.003; Chagnon PL, 2016, OECOLOGIA, V180, P181, DOI 10.1007/s00442-015-3457-5; DELATORRE MA, 1991, SCI TOTAL ENVIRON, V107, P159, DOI 10.1016/0048-9697(91)90257-F; Duarte S, 2013, FUNGAL ECOL, V6, P187, DOI 10.1016/j.funeco.2013.02.001; Ferreira V, 2010, MYCOLOGIA, V102, P1004, DOI 10.3852/09-248; Fomina M, 2010, GEOMICROBIOL J, V27, P624, DOI 10.1080/01490451003702974; Fryar SC, 2005, FUNGAL DIVERS, V18, P59; Fryar SC, 2001, MICROBIAL ECOL, V41, P245, DOI 10.1007/s002480000075; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gaylarde C, 2015, INT BIODETER BIODEGR, V104, P411, DOI 10.1016/j.ibiod.2015.07.010; Giannantonio DJ, 2009, INT BIODETER BIODEGR, V63, P252, DOI 10.1016/j.ibiod.2008.10.002; Gleeson DB, 2010, GEOMICROBIOL J, V27, P559, DOI 10.1080/01490451003702982; Gomez-Cornelio S, 2016, ACTA BOT MEX, V117, P59, DOI 10.21829/abm117.2016.1168; Gomez-Cornelio S, 2012, FUNGAL BIOL-UK, V116, P1064, DOI 10.1016/j.funbio.2012.07.010; Gonzalez-Gomez WS, 2015, INT J ROCK MECH MIN, V75, P182, DOI 10.1016/j.ijrmms.2014.12.010; Gorbushina A.A., 2000, JOURNEY DIVERSE MICR, P317; Gorbushina AA, 2005, MYCOL RES, V109, P1288, DOI 10.1017/S0953756205003631; Gorbushina AA, 2002, MICROBIOLOGY+, V71, P350, DOI 10.1023/A:1015823232025; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; GUILLITTE O, 1995, SCI TOTAL ENVIRON, V167, P215, DOI 10.1016/0048-9697(95)04582-L; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hiscox J, 2015, FUNGAL ECOL, V14, P24, DOI 10.1016/j.funeco.2014.11.001; Holmer L, 1997, OIKOS, V79, P77, DOI 10.2307/3546092; Jain A, 2009, BUILD ENVIRON, V44, P1276, DOI 10.1016/j.buildenv.2008.09.019; Jones EBG, 2002, FUNGAL DIVERS, V10, P241; Koide RT, 2005, NEW PHYTOL, V165, P305, DOI 10.1111/j.1469-8137.2004.01216.x; Li W, 2009, MYCOPATHOLOGIA, V167, P37, DOI 10.1007/s11046-008-9143-y; Lopez-Gonzalez RC, 2017, FUNGAL ECOL, V26, P1, DOI 10.1016/j.funeco.2016.11.004; Michael G, 2014, FUNGAL BIOL REV, V28, P36, DOI 10.1016/j.fbr.2014.05.001; Miller AZ, 2008, SCI TOTAL ENVIRON, V405, P278, DOI 10.1016/j.scitotenv.2008.06.066; Ortega-Morales BO, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00201; Ruibal C, 2008, PERSOONIA, V21, P93, DOI 10.3767/003158508X371379; Schoneberg A, 2015, J APPL MICROBIOL, V118, P1165, DOI 10.1111/jam.12775; Sierra-Fernandez A, 2017, ACS APPL MATER INTER, V9, P24873, DOI 10.1021/acsami.7b06130; STAHL PD, 1992, SOIL BIOL BIOCHEM, V24, P309, DOI 10.1016/0038-0717(92)90190-9; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Stohr SN, 2004, MICROB ECOL, V48, P431, DOI 10.1007/s00248-003-1064-1; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Treton C, 2004, MICROB ECOL, V48, P439, DOI 10.1007/s00248-003-0195-8; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; Yuen TK, 1999, MICROB ECOL, V37, P257, DOI 10.1007/s002489900151	47	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188443	10.1371/journal.pone.0188443	http://dx.doi.org/10.1371/journal.pone.0188443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211748	gold, Green Published, Green Submitted			2022-12-26	WOS:000417212200032
J	Dani, P; Ujaoney, AK; Apte, SK; Basu, B				Dani, Pratiksha; Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti			Regulation of potassium dependent ATPase (kdp) operon of Deinococcus radiodurans	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; EXPRESSION; SYSTEM; ACCUMULATION; DESICCATION; RESISTANCE; SEQUENCE; PROTEIN; STRESS	The genome of D. radiodurans harbors genes for structural and regulatory proteins of Kdp ATPase, in an operon pattern, on Mega plasmid 1. Organization of its two-component regulatory genes is unique. Here we demonstrate that both, the structural as well as regulatory components of the kdp operon of D. radiodurans are expressed quickly as the cells experience potassium limitation but are not expressed upon increase in osmolarity. The cognate DNA binding response regulator (RR) effects the expression of kdp operon during potassium deficiency through specific interaction with the kdp promoter. Deletion of the gene encoding RR protein renders the mutant D. radiodurans (Delta RR) unable to express kdp operon under potassium limitation. The Delta RR D. radiodurans displays no growth defect when grown on rich media or when exposed to oxidative or heat stress but shows reduced growth following gamma irradiation. The study elucidates the functional and regulatory aspects of the novel kdp operon of this extremophile, for the first time.	[Dani, Pratiksha; Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti] Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India; [Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti] Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Basu, B (corresponding author), Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India.; Basu, B (corresponding author), Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India.	bbasu@barc.gov.in		Basu, Bhakti/0000-0002-7381-6671	Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	The work was funded by Department of Atomic Energy, India.	Alahari A, 2001, J BACTERIOL, V183, P5778, DOI 10.1128/JB.183.19.5778-5781.2001; Ali MK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00570; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anaganti N, 2016, J BIOSCIENCES, V41, P193, DOI 10.1007/s12038-016-9608-y; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; Ballal A, 2005, APPL ENVIRON MICROB, V71, P5297, DOI 10.1128/AEM.71.9.5297-5303.2005; Ballal A, 2008, ARCH BIOCHEM BIOPHYS, V474, P65, DOI 10.1016/j.abb.2008.02.017; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Basu B, 2008, BBA-PROTEINS PROTEOM, V1784, P1256, DOI 10.1016/j.bbapap.2008.05.009; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BURRELL AD, 1971, BIOCHIM BIOPHYS ACTA, V247, P38, DOI 10.1016/0005-2787(71)90805-7; Checchetto V, 2016, PLANT CELL PHYSIOL, V57, P862, DOI 10.1093/pcp/pcw032; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Durand A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006114; Eltsov M, 2005, J BACTERIOL, V187, P8047, DOI 10.1128/JB.187.23.8047-8054.2005; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Epstein W, 2016, J BACTERIOL, V198, P212, DOI 10.1128/JB.00602-15; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Frymier JS, 1997, J BACTERIOL, V179, P3061, DOI 10.1128/jb.179.9.3061-3063.1997; Gries CM, 2013, MOL MICROBIOL, V89, P760, DOI 10.1111/mmi.12312; Grundling A, 2013, MBIO, V4, DOI 10.1128/mBio.00784-13; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Heermann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089671; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Holland AD, 2006, APPL MICROBIOL BIOT, V72, P1074, DOI 10.1007/s00253-006-0399-1; Hughes FM, 1999, ADV ENZYME REGUL, V39, P157, DOI 10.1016/S0065-2571(98)00010-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Ochrombel I, 2011, BBA-BIOENERGETICS, V1807, P444, DOI 10.1016/j.bbabio.2011.01.008; POLAREK JW, 1992, J BACTERIOL, V174, P2145, DOI 10.1128/JB.174.7.2145-2151.1992; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Schramke H, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.438; Solovjev V, 2011, METAGENOMICITAPP, P61; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SUGIURA A, 1993, BIOSCI BIOTECH BIOCH, V57, P356, DOI 10.1271/bbb.57.356; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; Supply, 2012, OSMOTIC STRESS KDPD, P181; TreunerLange A, 1997, J BACTERIOL, V179, P4501, DOI 10.1128/jb.179.14.4501-4512.1997; Tsai CH, 2015, APPL ENVIRON MICROB, V81, P1745, DOI 10.1128/AEM.03709-14; Ujaoney AK, 2017, BBA-PROTEINS PROTEOM, V1865, P1215, DOI 10.1016/j.bbapap.2017.06.014; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188998	10.1371/journal.pone.0188998	http://dx.doi.org/10.1371/journal.pone.0188998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206865	Green Submitted, Green Published, gold			2022-12-26	WOS:000417110700038
J	Orengo, DJ; Aguade, M; Juan, E				Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira			Characterization of dFOXO binding sites upstream of the Insulin Receptor P2 promoter across the Drosophila phylogeny	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AFX; GENOME SEQUENCE; LIFE-SPAN; EVOLUTION; DNA; IDENTIFICATION; GENE; EXPRESSION; FEEDBACK; MELANOGASTER	The insulin/TOR signal transduction pathway plays a critical role in determining such important traits as body and organ size, metabolic homeostasis and life span. Although this pathway is highly conserved across the animal kingdom, the affected traits can exhibit important differences even between closely related species. Evolutionary studies of regulatory regions require the reliable identification of transcription factor binding sites. Here we have focused on the Insulin Receptor (InR) expression from its P2 promoter in the Drosophila genus, which in D. melanogaster is up-regulated by hypophosphorylated Drosophila FOXO (dFOXO). We have finely characterized this transcription factor binding sites in vitro along the 1.3 kb region upstream of the InR P2 promoter in five Drosophila species. Moreover, we have tested the effect of mutations in the characterized dFOXO sites of D. melanogaster in transgenic flies. The number of experimentally established binding sites varies across the 1.3 kb region of any particular species, and their distribution also differs among species. In D. melanogaster, InR expression from P2 is differentially affected by dFOXO binding sites at the proximal and distal halves of the species 1.3 kb fragment. The observed uneven distribution of binding sites across this fragment might underlie their differential contribution to regulate InR transcription.	[Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain; [Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Juan, E (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain.; Juan, E (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.	ejuan@ub.edu	Orengo, Dorcas/AAG-6201-2021	Orengo, Dorcas/0000-0001-7911-3224; Aguade, Montserrat/0000-0002-3884-7800	 [BFU2012-35168];  [BFU2015-63732];  [2014SGR-1055]	; ; 	This study was supported by BFU2012-35168 and BFU2015-63732 (http://www.mineco.gob.es/portal/site/mineco/) and 2014SGR-1055 (http://sac.gencat.cat/sacgencat/AppJava/organisme_fitxa.jsp?codi=17422) to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Burland T G, 2000, Methods Mol Biol, V132, P71; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casas-Tinto S, 2007, BBA-GENE STRUCT EXPR, V1769, P236, DOI 10.1016/j.bbaexp.2007.03.003; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Galas DJ, 1978, NUCLEIC ACIDS RES, V5, P1345; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Hafen E, 2003, PLOS BIOL, V1, P319, DOI 10.1371/journal.pbio.0000086; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lang M, 2010, NUCLEIC ACIDS RES, V38, P6404, DOI 10.1093/nar/gkq504; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lynch M, 2015, P NATL ACAD SCI USA, V112, pE30, DOI 10.1073/pnas.1421641112; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; Obsil T, 2011, BBA-MOL CELL RES, V1813, P1946, DOI 10.1016/j.bbamcr.2010.11.025; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wei YL, 2016, DEVELOPMENT, V143, P3591, DOI 10.1242/dev.138073; Weigelt J, 2001, BIOCHEMISTRY-US, V40, P5861, DOI 10.1021/bi001663w; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wit J, 2015, J EVOLUTION BIOL, V28, P1892, DOI 10.1111/jeb.12706; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yindeeyoungyeon W, 2000, BIOTECHNIQUES, V29, P1034, DOI 10.2144/00295st05	48	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188357	10.1371/journal.pone.0188357	http://dx.doi.org/10.1371/journal.pone.0188357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200426	Green Published, Green Submitted, gold			2022-12-26	WOS:000417033200005
J	Graf, JF; Zavodszky, MI				Graf, John F.; Zavodszky, Maria I.			Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures	PLOS ONE			English	Article							SINGLE-CELL ANALYSIS; COLORECTAL-CANCER; EXPRESSION; SIGNATURES; DIVERSITY	Background Tumor heterogeneity can manifest itself by sub-populations of cells having distinct phenotypic profiles expressed as diverse molecular, morphological and spatial distributions. This inherent heterogeneity poses challenges in terms of diagnosis, prognosis and efficient treatment. Consequently, tools and techniques are being developed to properly characterize and quantify tumor heterogeneity. Multiplexed immunofluorescence (MxIF) is one such technology that offers molecular insight into both inter-individual and intratumor heterogeneity. It enables the quantification of both the concentration and spatial distribution of 60+ proteins across a tissue section. Upon bioimage processing, protein expression data can be generated for each cell from a tissue field of view. Results The Multi-Omics Heterogeneity Analysis (MOHA) tool was developed to compute tissue heterogeneity metrics from MxIF spatially resolved tissue imaging data. This technique computes the molecular state of each cell in a sample based on a pathway or gene set. Spatial states are then computed based on the spatial arrangements of the cells as distinguished by their respective molecular states. MOHA computes tissue heterogeneity metrics from the distributions of these molecular and spatially defined states. A colorectal cancer cohort of approximately 700 subjects with MxIF data is presented to demonstrate the MOHA methodology. Within this dataset, statistically significant correlations were found between the intratumor AKT pathway state diversity and cancer stage and histological tumor grade. Furthermore, intratumor spatial diversity metrics were found to correlate with cancer recurrence. Conclusions MOHA provides a simple and robust approach to characterize molecular and spatial heterogeneity of tissues. Research projects that generate spatially resolved tissue imaging data can take full advantage of this useful technique. The MOHA algorithm is implemented as a freely available R script (see supplementary information).	[Graf, John F.; Zavodszky, Maria I.] GE Global Res, Niskayuna, NY 12309 USA	General Electric	Graf, JF; Zavodszky, MI (corresponding author), GE Global Res, Niskayuna, NY 12309 USA.	graf@ge.com; zavodszm@ge.com		Graf, John/0000-0002-0396-9867	GE Global Research, the research and development division of General Electric company	GE Global Research, the research and development division of General Electric company	GE Global Research, the research and development division of General Electric company, funded the development of this work and approved of the decision to publish. The funder provided support in the form of salaries for authors JFG and MIZ. The study design, data collection and analysis, and preparation of the manuscript was that of the authors. The specific roles of these authors are articulated in the 'author contributions' section.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Hajirasouliha I, 2014, BIOINFORMATICS, V30, P78, DOI 10.1093/bioinformatics/btu284; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harizanova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160591; Heindl A, 2015, LAB INVEST, V95, P377, DOI 10.1038/labinvest.2014.155; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Janiszewska M, 2015, NAT GENET, V47, P1212, DOI 10.1038/ng.3391; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Knijnenburg TA, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0050-6; Kolling J, 2012, BIOINFORMATICS, V28, P1143, DOI 10.1093/bioinformatics/bts104; Kovacheva VN, 2014, BIOINFORMATICS, V30, P420, DOI 10.1093/bioinformatics/btt676; Kruger JM, 2013, J PATHOL, V229, P569, DOI 10.1002/path.4150; Laurinavicius A, 2016, VIRCHOWS ARCH, V468, P493, DOI 10.1007/s00428-016-1907-z; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McKinley ET, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93487; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Naik RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25261; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Nawaz S, 2015, MODERN PATHOL, V28, P766, DOI 10.1038/modpathol.2015.37; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Perakis SO, 2016, ADV EXP MED BIOL, V937, P183, DOI 10.1007/978-3-319-42059-2_10; Plancoulaine B, 2015, VIRCHOWS ARCH; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Saus E, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00054; Schubert W, 2014, J MOL RECOGNIT, V27, P3, DOI 10.1002/jmr.2326; Schwarz RF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003535; Setiadi AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012420; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sood A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87030; Twu P, 2014, MEASURE HETEROGENEIT; Yang YC, 2015, J GASTROINTEST SURG, V19, P1113, DOI 10.1007/s11605-015-2761-z; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhong Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24146	41	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188878	10.1371/journal.pone.0188878	http://dx.doi.org/10.1371/journal.pone.0188878			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190747	Green Submitted, gold, Green Published			2022-12-26	WOS:000416841900156
J	Liu, J; Li, G; Chen, C; Chen, DC; Zhou, QS				Liu, Jiao; Li, Guang; Chen, Chuang; Chen, Dechang; Zhou, Qingshan			MiR-6835 promoted LPS-induced inflammation of HUVECs associated with the interaction between TLR-4 and AdipoR1 in lipid rafts	PLOS ONE			English	Article							STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; SEPSIS; LIPOPOLYSACCHARIDE; TRANSLOCATION; PROTEINS; CHOLESTEROL; RECEPTOR; ENDOTHELIUM; RECOGNITION	Background High mortality rate of critically-ill patients could be induced by sepsis and septic shock, which is the extremely life threatening. The purpose of this work is to identify and evaluate the potential regulatory mechanism of LPS-induced inflammation associated with miR-6835 and lipid rafts in HUVECs. Methods The 3' UTR luciferase activity of AdipoR1 was detected, which was predicted the potential target gene of miR-6835. Moreover, the treated HUVECs with or without inhibitors or mimics of miR-6835 were used. Furthermore, the bio-functions of HUVECs were explored. The protein expression levels of SIRT-1, AMPK, and AdipoR1 were assessed, which were involved in the AdipoR1 signaling pathway. Then, the interaction between TLR-4 and AdipoR1 in lipid rafts and its mediation role on LPS-induced inflammation was investigated in HUVECs. Results MiR-6835 targeted directly on AdipoR1, and suppressed its expression in mRNA (mimics of miR-6835: 0.731 +/- 0.016 vs control: 1.527 +/- 0.015, P<0.001) and proteins levels, then regulated protein expression of SIRT-1 and AMPK, which were the downstream target genes of AdipoR1 signaling pathway. MiR-6835 enhanced LPS-induced inflammation process in HUVECs (TNF-alpha: LPS+mimics of miR-6835: 1638.51 +/- 78.43 vs LPS: 918.73 +/- 39.73, P<0.001; IL-6: LPS+mimics of miR-6835: 1249.35 +/- 69.51 vs LPS: 687.52 +/- 43.64, P<0.001), which was associated with the interaction between TLR-4 and AdipoR1 in lipid rafts. Conclusions MiR-6835 is the key regulator of LPS-induced inflammation process in HUVECs. The interaction between TLR-4 and AdipoR1 mediated by lipid rafts at membrane of HUVECs with inflammation process induced by miR-6835. Our results demonstrated a hopeful strategy for treatment on sepsis by aiming at lipid rafts and miR-6835.	[Liu, Jiao; Li, Guang; Zhou, Qingshan] Wuhan Univ, Renmin Hosp, Dept Crit Care Med, Wuhan, Hubei, Peoples R China; [Chen, Chuang] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China; [Chen, Dechang] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China	Wuhan University; Wuhan University; Naval Medical University	Zhou, QS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Crit Care Med, Wuhan, Hubei, Peoples R China.	zhouqingshan688@163.com			National Natural Science Foundation of China [30600524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30600524). The study sponsors had no involvement in the study.; This work was supported by grants from the National Natural Science Foundation of China (No.30600524).	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Aird WC, 2007, CURR DRUG TARGETS, V8, P501, DOI 10.2174/138945007780362782; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Badshah H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beutler B, 2001, J ENDOTOXIN RES, V7, P277, DOI 10.1177/09680519010070040901; Bockmeyer CL, 2007, HAEMATOLOGICA, V93, P137, DOI 10.3324/haematol.11677; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boothe T, 2016, MOL METAB, V5, P366, DOI 10.1016/j.molmet.2016.01.009; Chaari A, 2016, WORLD J GASTRO ONCOL, V8, P526, DOI 10.4251/wjgo.v8.i7.526; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fu YH, 2015, FREE RADICAL BIO MED, V89, P777, DOI 10.1016/j.freeradbiomed.2015.10.407; Henneke P, 2002, CRIT CARE MED, V30, pS207, DOI 10.1097/00003246-200205001-00006; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Kang QX, 2016, J SURG RES, V202, P87, DOI 10.1016/j.jss.2015.12.034; Kinasewitz GT, 2005, CRIT CARE MED, V33, P2214, DOI 10.1097/01.CCM.0000181296.53204.DE; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lecompte S, 2017, CELL MOL LIFE SCI, V74, P2487, DOI 10.1007/s00018-017-2465-5; Lee EJ, 2014, BBA-MOL CELL BIOL L, V1841, P190, DOI 10.1016/j.bbalip.2013.10.006; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Opal SM, 2014, CRIT CARE MED, V42, P1714, DOI 10.1097/CCM.0000000000000325; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Sun XL, 2016, P NATL ACAD SCI USA, V113, P769, DOI 10.1073/pnas.1524523113; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160431; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhu Y, 2000, ARTERIOSCL THROM VAS, V20, P2465, DOI 10.1161/01.ATV.20.11.2465	43	6	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188604	10.1371/journal.pone.0188604	http://dx.doi.org/10.1371/journal.pone.0188604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190778	Green Published, gold, Green Submitted			2022-12-26	WOS:000416841900082
J	Wang, YR; Wei, SS; Chen, LT; Pei, JL; Wu, H; Pei, YC; Chen, YB; Wang, DY				Wang, Yuerong; Wei, Shuangshuang; Chen, Lintao; Pei, Jinli; Wu, Hao; Pei, Yechun; Chen, Yibo; Wang, Dayong			Transcriptomic analysis of gene expression in mice treated with troxerutin	PLOS ONE			English	Article							SIGNAL-RECOGNITION PARTICLE; NEUROPEPTIDE Y1 RECEPTOR; RIBOSOMAL-PROTEIN L3; MHC CLASS-I; TENASCIN-R; OXIDATIVE STRESS; PEPTIDE-YY; HIGH-FAT; PANCREATIC-POLYPEPTIDE; COGNITIVE DEFICITS	Troxerutin, a semi-synthetic derivative of the natural bioflavanoid rutin, has been reported to possess many beneficial effects in human bodies, such as vasoprotection, immune support, anti-inflammation and anti-aging. However, the effects of troxerutin on genome-wide transcription in blood cells are still unknown. In order to find out effects of troxerutin on gene transcription, a high-throughput RNA sequencing was employed to analysis differential gene expression in blood cells consisting of leucocytes, erythrocytes and platelets isolated from the mice received subcutaneous injection of troxerutin. Transcriptome analysis demonstrated that the expression of only fifteen genes was significantly changed by the treatment with troxerutin, among which 5 genes were up-regulated and 10 genes were down-regulated. Bioinformatic analysis of the fifteen differentially expressed genes was made by utilizing the Gene Ontology (GO), and the differential expression induced by troxerutin was further evaluated by real-time quantitative PCR (Q-PCR).	[Wang, Yuerong; Wei, Shuangshuang; Chen, Lintao; Pei, Jinli; Wu, Hao; Wang, Dayong] Hainan Univ, Hainan Key Labs Sustainable Utilizat Trop Bioreso, Haikou, Hainan, Peoples R China; [Wang, Yuerong; Wei, Shuangshuang; Chen, Lintao; Pei, Jinli; Wu, Hao; Pei, Yechun; Chen, Yibo; Wang, Dayong] Hainan Univ, Inst Trop Agr & Forestry, Lab Biotechnol & Mol Pharmacol, Haikou, Hainan, Peoples R China; [Pei, Yechun] Hainan Univ, Dept Anim Sci, Haikou, Hainan, Peoples R China	Hainan University; Hainan University; Hainan University	Wang, DY (corresponding author), Hainan Univ, Hainan Key Labs Sustainable Utilizat Trop Bioreso, Haikou, Hainan, Peoples R China.; Wang, DY (corresponding author), Hainan Univ, Inst Trop Agr & Forestry, Lab Biotechnol & Mol Pharmacol, Haikou, Hainan, Peoples R China.	wangdy@hainu.edu.cn		Wang, Dayong/0000-0002-2086-1663	National Natural Science Foundation of China [31460226]; Natural Science Foundation of Hainan Province [317039, 314058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province	This work was supported by a research fund from the National Natural Science Foundation of China (31460226, D.W.), and two research funds from the Natural Science Foundation of Hainan Province (317039, S.W. and 314058, D.W.).	Adam BS, 2005, PHYTOMEDICINE, V12, P52, DOI 10.1016/j.phymed.2004.01.007; Anlar B, 2012, INT J BIOCHEM CELL B, V44, P1385, DOI 10.1016/j.biocel.2012.05.009; ArchimowiczCyrylowska B, 1996, PHYTOTHER RES, V10, P659, DOI 10.1002/(SICI)1099-1573(199612)10:8&lt;659::AID-PTR930&gt;3.0.CO;2-U; Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; BLASIG IE, 1987, BIOMED BIOCHIM ACTA, V46, pS539; BOISSEAU MR, 1995, J CARDIOVASC SURG, V36, P369; Chang JL, 2015, J HEPATOL, V63, P1413, DOI 10.1016/j.jhep.2015.07.033; Chung HK, 2005, ARZNEIMITTELFORSCH, V55, P573; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Dufresne D, 2012, J MED GENET, V49, P451, DOI 10.1136/jmedgenet-2012-100831; El Ayachi I, 2011, J COMP NEUROL, V519, P2379, DOI 10.1002/cne.22632; Endo Y, 2005, IMMUNOGENETICS, V57, P837, DOI 10.1007/s00251-005-0058-1; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008; Farzi A, 2015, ACTA PHYSIOL, V213, P603, DOI 10.1111/apha.12445; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Freitag S, 2003, BEHAV BRAIN RES, V145, P189, DOI 10.1016/S0166-4328(03)00109-8; Gamalinda M, 2013, NUCLEIC ACIDS RES, V41, P1965, DOI 10.1093/nar/gks1272; Gamalinday M, 2015, TRANSLATION, V3, DOI 10.4161/21690731.2014.975018; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Geetha R, 2015, MOL CELL BIOCHEM, V407, P263, DOI 10.1007/s11010-015-2474-3; Geetha R, 2014, MOL CELL BIOCHEM, V387, P123, DOI 10.1007/s11010-013-1877-2; Gohel MS, 2009, CURR VASC PHARMACOL, V7, P303, DOI 10.2174/157016109788340758; Gurevicius K, 2004, MOL CELL NEUROSCI, V25, P515, DOI 10.1016/j.mcn.2003.12.001; Holt CB, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/653260; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Jakovcevski I, 2013, AMINO ACIDS, V44, P1115, DOI 10.1007/s00726-012-1446-0; Kessler M, 2002, J DERMATOL TREAT, V13, P133, DOI 10.1080/09546630260199505; Kobayashi Y, 2010, J TOXICOL SCI, V35, P827, DOI 10.2131/jts.35.827; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KS, 2014, INT J MOL MED, V33, P934, DOI 10.3892/ijmm.2014.1641; Li JJ, 2015, MATER EXPRESS, V5, P83, DOI 10.1166/mex.2015.1222; Liao H, 2005, J BIOL CHEM, V280, P8316, DOI 10.1074/jbc.M412730200; Liu WJ, 2013, J SOLUTION CHEM, V42, P1169, DOI 10.1007/s10953-013-0033-7; Lu J, 2013, J IMMUNOL, V190, P3466, DOI 10.4049/jimmunol.1202862; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006; Lu YX, 2016, NEUROPEPTIDES, V59, P117, DOI 10.1016/j.npep.2016.07.003; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Macia L, 2012, DIABETES, V61, P3228, DOI 10.2337/db12-0156; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Marhic C, 1991, Rev Fr Gynecol Obstet, V86, P209; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Maurya D, 2004, RADIOPROTECTION NORM, P221; Maurya DK, 2005, MOL CELL BIOCHEM, V280, P57, DOI 10.1007/s11010-005-8052-3; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; Michel MC, 1998, PHARMACOL REV, V50, P143; Montag-Sallaz M, 2003, GENES BRAIN BEHAV, V2, P20, DOI 10.1034/j.1601-183X.2003.00003.x; Munshi A, 2005, METH MOLEC MED, V110, P21; Ohkia A, 2004, CLIN CANCER RES, V10, P2452, DOI 10.1158/1078-0432.CCR-03-0170; Panat NA, 2016, FOOD CHEM, V194, P32, DOI 10.1016/j.foodchem.2015.07.078; Pang XH, 2010, INT J COLORECTAL DIS, V25, P1047, DOI 10.1007/s00384-010-0964-z; Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106; Pyrzanowska J, 2012, PHARMACOL REP, V64, P808, DOI 10.1016/S1734-1140(12)70876-9; Rajagopalan G, 2017, CLIN EXP PHARMACOL P, V44, P103, DOI 10.1111/1440-1681.12671; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Rock KL, 2016, TRENDS IMMUNOL, V37, P724, DOI 10.1016/j.it.2016.08.010; Russo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38369; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sampath S, 2014, MOL CELL BIOCHEM, V395, P11, DOI 10.1007/s11010-014-2107-2; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; Smit EF, 2016, NAT REV CLIN ONCOL, V13, P75, DOI 10.1038/nrclinonc.2015.223; Smolock EM, 2012, CIRCULATION, V126, P2418, DOI 10.1161/CIRCULATIONAHA.112.125971; Subastri A, 2017, BIOMED PHARMACOTHER, V88, P325, DOI 10.1016/j.biopha.2017.01.042; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vinothkumar R, 2014, EXP MOL PATHOL, V96, P15, DOI 10.1016/j.yexmp.2013.10.009; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang W, 2015, MED RES REV, V35, P225, DOI 10.1002/med.21327; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; WIJAYANEGARA H, 1992, J INT MED RES, V20, P54, DOI 10.1177/030006059202000107; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yu YZ, 2017, MOL MED REP, V15, P3473, DOI 10.3892/mmr.2017.6456; Zhang SY, 2017, BRAIN RES, V1657, P355, DOI 10.1016/j.brainres.2016.12.009; Zhang TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep35008; Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	81	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188261	10.1371/journal.pone.0188261	http://dx.doi.org/10.1371/journal.pone.0188261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190643	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900042
J	Hrabakova, L; Grum-Grzhimaylo, AA; Koloniuk, I; Debets, AJM; Sarkisova, T; Petrzik, K				Hrabakova, Lenka; Grum-Grzhimaylo, Alexey A.; Koloniuk, Igor; Debets, Alfons J. M.; Sarkisova, Tatiana; Petrzik, Karel			The alkalophilic fungus Sodiomyces alkalinus hosts beta- and gammapartitiviruses together with a new fusarivirus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; CONFERS HYPOVIRULENCE; GENOME ORGANIZATION; DSRNA MYCOVIRUS; VIRUS-INFECTION; DNA MYCOVIRUS; PLANT; TRANSMISSION; PARTITIVIRUS	Mixed infection by three dsRNA viruses, a novel betapartitivirus, a gammapartitivirus, and a novel fusarivirus, has been identified in four isolates of the obligate alkalophilic fungus Sodiomyces alkalinus. The first, Sodiomyces alkalinus partitivirus 1 (SaPV1), is placed within the genus Betapartitivirus and is related to Ustilaginoidea virens partitivirus 2. The taxonomic position of the second virus is less clear as it shares high (85%) amino acid sequence identity but significantly low (77%) nucleotide sequence identity of the capsid protein with Colletotrichum truncatum partitivirus 1. The third, the novel Sodiomyces alkalinus fusarivirus 1 (SaFV1), is related to Fusarium poae fusarivirus 1. All the viruses show efficient vertical transmission through asexual and sexual spores. These novel coexisting viruses do not evoke apparent phenotypic alteration to their fungal host. This is the first description of a viral infection in an alkalophilic fungus.	[Hrabakova, Lenka; Koloniuk, Igor; Sarkisova, Tatiana; Petrzik, Karel] Czech Acad Sci, Biol Ctr, Inst Plant Mol Biol, Dept Plant Virol, Ceske Budejovice, Czech Republic; [Hrabakova, Lenka] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Grum-Grzhimaylo, Alexey A.; Debets, Alfons J. M.] Wageningen Univ, Lab Genet, Wageningen, Netherlands	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Wageningen University & Research	Petrzik, K (corresponding author), Czech Acad Sci, Biol Ctr, Inst Plant Mol Biol, Dept Plant Virol, Ceske Budejovice, Czech Republic.	petrzik@umbr.cas.cz	Koloniuk, Igor/G-9526-2014; Sarkisova, Tatiana/G-9551-2014; Petrzik, Karel/B-6957-2008; Koloniuk, Igor/X-5540-2019	Koloniuk, Igor/0000-0002-5893-6683; Petrzik, Karel/0000-0001-9668-1223; Koloniuk, Igor/0000-0002-5893-6683; Grum-Grzhimaylo, Alexey/0000-0001-5512-6223	Biology Centre of the Czech Academy of Sciences [RV060077344]	Biology Centre of the Czech Academy of Sciences(Czech Academy of Sciences)	Funded by RV060077344 for Biology Centre of the Czech Academy of Sciences.	Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011; Bouneb M, 2016, FUNGAL BIOL-UK, V120, P351, DOI 10.1016/j.funbio.2015.11.004; BUCK KW, 1970, NATURE, V225, P945, DOI 10.1038/225945a0; BUCK KW, 1978, BIOCHEM BIOPH RES CO, V84, P639, DOI 10.1016/0006-291X(78)90753-2; Chen L, 2006, ARCH VIROL, V151, P849, DOI 10.1007/s00705-005-0685-8; Chiba S, 2016, VIRUS RES, V219, P62, DOI 10.1016/j.virusres.2015.10.017; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446; Gene, 2004, NAT CTR BIOT INF 200; Ghabrial SA, 1998, VIRUS GENES, V16, P119, DOI 10.1023/A:1007966229595; Grum-Grzhimaylo AA, 2013, PERSOONIA, V31, P147, DOI 10.3767/003158513X673080; Grum-Grzhimaylo AA, 2016, FUNGAL DIVERS, V76, P27, DOI 10.1007/s13225-015-0320-2; Guo MP, 2017, PLANT DIS, V101, P726, DOI [10.1094/PDIS-07-16-0951-RE, 10.1094/pdis-07-16-0951-re]; Herrero N, 2009, ARCH VIROL, V154, P327, DOI 10.1007/s00705-008-0293-5; Ihrmark K, 2002, FUNGAL GENET BIOL, V36, P147, DOI 10.1016/S1087-1845(02)00011-7; Jurvansuu J, 2014, VIROLOGY, V462, P25, DOI 10.1016/j.virol.2014.05.021; Kim JW, 2005, VIRUS GENES, V31, P175, DOI 10.1007/s11262-005-1793-y; Kim JW, 2003, VIRUS GENES, V27, P249, DOI 10.1023/A:1026343831909; Kondo H, 2013, VIROLOGY, V435, P201, DOI 10.1016/j.virol.2012.10.002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwon SJ, 2007, MOL CELLS, V23, P304, DOI 10.1007/s10059-009-0112-1; Li PF, 2015, VIROLOGY, V481, P151, DOI 10.1016/j.virol.2015.02.047; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042147; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Liu R, 2015, VIRUSES-BASEL, V7, P2470, DOI 10.3390/v7052470; Liu S, 2016, P NATL ACAD SCI USA, V113, P12803, DOI 10.1073/pnas.1608013113; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Nibert ML, 2014, VIRUS RES, V188, P128, DOI 10.1016/j.virusres.2014.04.007; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Nuss DL, 2011, ADV VIRUS RES, V80, P25, DOI 10.1016/B978-0-12-385987-7.00002-6; Ong JWL, 2017, VIROLOGY, V510, P297, DOI 10.1016/j.virol.2017.07.031; Osaki H, 2004, MYCOL RES, V108, P635, DOI 10.1017/S095375620400005X; Osaki H, 2016, VIRUS GENES, V52, P835, DOI 10.1007/s11262-016-1379-x; Park YJ, 2005, VIRUS RES, V109, P71, DOI 10.1016/j.virusres.2004.10.011; Perera OP, 2012, J INVERTEBR PATHOL, V109, P11, DOI 10.1016/j.jip.2011.08.004; Petrzik K, 2016, VIROLOGY, V489, P12, DOI 10.1016/j.virol.2015.11.009; Preisig O, 1998, VIROLOGY, V252, P399, DOI 10.1006/viro.1998.9480; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sasaki A, 2016, VIRUS RES, V219, P73, DOI 10.1016/j.virusres.2015.12.009; Schmitt MJ, 2002, FEMS MICROBIOL REV, V26, P257, DOI 10.1016/S0168-6445(02)00099-2; Syller J, 2016, MOL PLANT PATHOL, V17, P769, DOI 10.1111/mpp.12322; Taylor DJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-88; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tuomivirta TT, 2005, VIRUS RES, V110, P31, DOI 10.1016/j.virusres.2004.12.005; Vainio EJ, 2015, ISME J, V9, P497, DOI 10.1038/ismej.2014.145; Wang LP, 2014, J VIROL, V88, P7517, DOI 10.1128/JVI.00538-14; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Xiao XQ, 2014, J VIROL, V88, P10120, DOI 10.1128/JVI.01036-14; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Zhang R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00360; Zheng L, 2014, VIROLOGY, V456, P220, DOI 10.1016/j.virol.2014.03.029; Zhong J., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1016/J.VIRUSRES.2015.11.012	57	9	9	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2017	12	11							e0187799	10.1371/journal.pone.0187799	http://dx.doi.org/10.1371/journal.pone.0187799			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO0ZL	29186149	gold, Green Published, Green Submitted			2022-12-26	WOS:000416484900013
J	Ahn, S; Choe, K; Lee, S; Kim, K; Song, E; Seo, H; Kim, I; Kim, P				Ahn, Soyeon; Choe, Kibaek; Lee, Seunghun; Kim, Kangsan; Song, Eunjoo; Seo, Howon; Kim, Injune; Kim, Pilhan			Intravital longitudinal wide-area imaging of dynamic bone marrow engraftment and multilineage differentiation through nuclear-cytoplasmic labeling	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; CONFOCAL MICROSCOPY; SELF-RENEWAL; MULTIPHOTON MICROSCOPY; FLUORESCENT PROTEINS; NICHE; TRANSPLANTATION; MOUSE; TRACKING	Bone marrow is a vital tissue that produces the majority of erythrocytes, thrombocytes, and immune cells. Bone marrow transplantation (BMT) has been widely performed in patients with blood disorders and cancers. However, the cellular-level behaviors of the transplanted bone marrow cells over wide-areas of the host bone marrow after the BMT are not fully understood yet. In this work, we performed a longitudinal wide-area cellular-level observation of the calvarial bone marrow after the BMT in vivo. Using a H2B-GFP/beta-actin-DsRed double-transgenic mouse model as a donor, a subcellular-level nuclear-cytoplasmic visualization of the transplanted bone marrow cells was achieved, which enabled a direct in vivo dynamic monitoring of the distribution and proliferation of the transplanted bone marrow cells. The same spots in the wide-area of the calvarial bone marrow were repeatedly identified using fluorescently labeled vasculature as a distinct landmark. It revealed various dynamic cellular-level behaviors of the transplanted BM cells in early stage such as cluster formation, migration, and active proliferation in vivo.	[Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea; [Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea; [Lee, Seunghun; Kim, Kangsan; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, P (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea.; Kim, P (corresponding author), Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea.	pilhan.kim@kaist.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2013M3A6A4044716]; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2017M3A9E4047243]; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea [HI13C2181, HI15C0399]	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea	This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project (HI13C2181, HI15C0399) funded by Ministry of Health and Welfare, Republic of Korea.; Authors thank Yoonha Hwang, Jinhyo Ahn and Inwon Park at KAIST for their help on this project. This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project funded by Ministry of Health and Welfare, Republic of Korea (HI13C2181, HI15C0399).	Ahn YC, 2014, BIOMED OPT EXPRESS, V5, P312, DOI 10.1364/BOE.5.000312; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; Askenasy N, 2003, BRIT J HAEMATOL, V120, P505, DOI 10.1046/j.1365-2141.2003.04114.x; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Carlson AL, 2013, PLOS ONE, V8; Choe K, 2015, J CLIN INVEST, V125, P4042, DOI 10.1172/JCI76509; Choe K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036005; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Hoffman RM, 2008, SENSORS-BASEL, V8, P1157, DOI 10.3390/s8021157; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horan JT, 2008, J CLIN ONCOL, V26, P5797, DOI 10.1200/JCO.2007.13.5244; Hwang Y, 2014, OPT EXPRESS, V22, P11465, DOI 10.1364/OE.22.011465; Khurana M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2965545; KING MA, 1979, J NUCL MED, V20, P1142; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Malide D, 2014, JOVE-J VIS EXP, DOI 10.3791/51669; Malide D, 2012, BLOOD, V120, pE105, DOI 10.1182/blood-2012-06-440636; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Rieger MA, 2008, CELLS TISSUES ORGANS, V188, P139, DOI 10.1159/000114540; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Runnels JM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3520571; Scott MK, 2014, JOVE-J VIS EXP, DOI 10.3791/51683; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Seo H, 2015, BIOMED OPT EXPRESS, V6, P2158, DOI 10.1364/BOE.6.002158; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song E, 2015, BIOMED OPT EXPRESS, V6, P4154, DOI 10.1364/BOE.6.004154; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suarez-Alvarez B, 2012, ADV EXP MED BIOL, V741, P152, DOI 10.1007/978-1-4614-2098-9_11; Sugiyama N, 2012, BIOMED OPT EXPRESS, V3, P2175, DOI 10.1364/BOE.3.002175; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Turcotte R, 2014, BIOMED OPT EXPRESS, V5, P3578, DOI 10.1364/BOE.5.003578; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhao YB, 2013, METHODS MOL BIOL, V1052, P57, DOI 10.1007/7651_2013_28	49	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187660	10.1371/journal.pone.0187660	http://dx.doi.org/10.1371/journal.pone.0187660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29190775	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900036
J	Ahn, SH; Chun, SM; Park, C; Lee, JH; Lee, SW; Lee, TH				Ahn, Sun-Hee; Chun, Sung-Min; Park, Chungoo; Lee, Jong-Hee; Lee, Seok-Woo; Lee, Tae-Hoon			Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; PATHWAYS; SEQUENCE; DISEASES; GROWTH	Periodontal disease is caused by dental plaque biofilms. Fusobacterium nucleatum is an important periodontal pathogen involved in the development of bacterial complexity in dental plaque biofilms. Human gingival fibroblasts (GFs) act as the first line of defense against oral microorganisms and locally orchestrate immune responses by triggering the production of reactive oxygen species and pro-inflammatory cytokines (IL-6 and IL-8). The frequency and severity of periodontal diseases is known to increase in elderly subjects. However, despite several studies exploring the effects of aging in periodontal disease, the underlying mechanisms through which aging affects the interaction between F. nucleatum and human GFs remain unclear. To identify genes affected by infection, aging, or both, we performed an RNA-Seq analysis using GFs isolated from a single healthy donor that were passaged for a short period of time (P4) 'young GFs' or for longer period of time (P22) 'old GFs', and infected or not with F. nucleatum. Comparing F. nucleatum-infected and uninfected GF (P4) cells the differentially expressed genes (DEGs) were involved in host defense mechanisms (i.e., immune responses and defense responses), whereas comparing F. nucleatum-infected and uninfected GF(P22) cells the DEGs were involved in cell maintenance (i.e., TGF-beta signaling, skeletal development). Most DEGs in F. nucleatum-infected GF(P22) cells were downregulated (85%) and were significantly associated with host defense responses such as inflammatory responses, when compared to the DEGs in F. nucleatum-infected GF (P4) cells. Five genes (GADD45b, KLF10, CSRNP1, ID1, and TM4SF1) were upregulated in response to F. nucleatum infection; however, this effect was only seen in GF(P22) cells. The genes identified here appear to interact with each other in a network associated with free radical scavenging, cell cycle, and cancer; therefore, they could be potential candidates involved in the aged GF's response to F. nucleatum infection. Further studies are needed to confirm these observations.	[Ahn, Sun-Hee; Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea; [Chun, Sung-Min; Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea; [Lee, Jong-Hee] World Inst Kimchi, Gwangju, South Korea; [Lee, Seok-Woo] Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Dent Educ & Periodontol, Gwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, TH (corresponding author), Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea.; Lee, TH (corresponding author), Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea.	thlee83@jnu.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2016M3A9B6903087, 2017R1A2B2005938]; NRF - Ministry of Education [2016R1A6A3A11932468]; World Institute of Kimchi [KE1701-2]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; NRF - Ministry of Education; World Institute of Kimchi	This work was supported by the Bio & Medical Technology Development Program (2016M3A9B6903087) and the Basic Science Research Program (2017R1A2B2005938) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning. Sun Hee Ahn was supported by the Basic Science Research Program (2016R1A6A3A11932468) through the NRF funded by the Ministry of Education and The grant from the World Institute of Kimchi (KE1701-2) to Dr. Jong-Hee Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2016, MOL ORAL MICROBIOL; Ahn SH, 2016, ARCH MICROBIOL, V198, P573, DOI 10.1007/s00203-016-1223-7; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.300; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Domon H, 2014, J PERIODONTAL RES, V49, P536, DOI 10.1111/jre.12134; Eftang LL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-9; Gavazzi G, 2004, CLIN INFECT DIS, V39, P83, DOI 10.1086/421559; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Gonzalez OA, 2014, J CLIN PERIODONTOL, V41, P327, DOI 10.1111/jcpe.12212; Guo W, 2013, INT J CANCER, V133, P2043, DOI 10.1002/ijc.28223; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hajishengallis G, 2010, MOL ORAL MICROBIOL, V25, P25, DOI 10.1111/j.2041-1014.2009.00562.x; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Harrison DE, 2014, IMMUN AGEING, V11, DOI 10.1186/s12979-014-0024-6; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Kang CI, 2011, INT J INFECT DIS, V15, pE58, DOI 10.1016/j.ijid.2010.09.012; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Liu B, 2009, NEUROBIOL DIS, V33, P104, DOI 10.1016/j.nbd.2008.09.020; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Meyer Keith C, 2005, Proc Am Thorac Soc, V2, P433, DOI 10.1513/pats.200508-081JS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naito Y, 2005, DIGESTION, V72, P164, DOI 10.1159/000088396; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pechenino AS, 2006, PROSTATE, V66, P522, DOI 10.1002/pros.20364; Rajendran Maheaswari, 2013, J Indian Soc Periodontol, V17, P169, DOI 10.4103/0972-124X.113064; Shaik-Dasthagirisaheb Yazdani B, 2010, Immun Ageing, V7, P15, DOI 10.1186/1742-4933-7-15; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Sharma-Kuinkel BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060463; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tal S, 2005, J INFECTION, V50, P296, DOI 10.1016/j.jinf.2004.04.004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792; YOSHIKAWA TT, 1984, GERONTOLOGY, V30, P275, DOI 10.1159/000212646; Zhan YB, 2014, J PERIODONTOL, V85, P1059, DOI 10.1902/jop.2014.130523; Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036	59	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188755	10.1371/journal.pone.0188755	http://dx.doi.org/10.1371/journal.pone.0188755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190775	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900118
